data_2kte_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kte _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 120.894 0.378 . . . . 71.430000000000007 111.377 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 4.2 mm? 67.95 90.24 0.09 OUTLIER Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 114.911 -1.04 . . . . 74.209999999999994 112.454 -172.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -88.32 -159.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 122.309 2.006 . . . . 64.439999999999998 109.702 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 7.8 p-10 -65.86 116.16 6.73 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.945 0.879 . . . . 73.040000000000006 111.151 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 50.0 mm -120.6 124.46 72.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 106.578 -1.638 . . . . 74.25 106.578 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.9 m -111.38 136.76 50.06 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.834 -0.802 . . . . 71.430000000000007 108.834 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.07 142.96 32.88 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.058 -1.089 . . . . 73.530000000000001 108.058 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.0 p -137.31 134.15 35.76 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 118.332 0.514 . . . . 38.060000000000002 109.785 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.92 131.84 13.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.236 -0.653 . . . . 74.450000000000003 109.236 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.491 ' CG2' ' HG3' ' A' ' 95' ' ' LYS . 2.7 m -94.52 120.97 35.57 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-O 121.798 0.809 . . . . 74.510000000000005 110.674 -175.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.2 mt -95.64 140.35 30.58 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.053 -0.976 . . . . 61.100000000000001 110.018 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.99 25.09 0.38 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.169 0.588 . . . . 75.549999999999997 112.21 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.84 160.47 44.56 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 122.655 0.382 . . . . 55.32 110.074 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 38.7 Cg_endo -67.4 157.41 61.9 Favored 'Trans proline' 0 C--O 1.256 1.402 0 C-N-CA 123.194 2.596 . . . . 62.149999999999999 111.55 175.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.9 tt -62.64 -27.16 42.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.785 -0.643 . . . . 75.319999999999993 112.119 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.41 -31.9 65.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.903 0.382 . . . . 75.420000000000002 111.481 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.446 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 5.0 tmtt? -79.1 -37.71 38.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 108.849 -0.797 . . . . 74.209999999999994 108.849 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.428 HG13 HG22 ' A' ' 96' ' ' THR . 4.3 p -66.28 -39.84 85.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 120.074 -0.65 . . . . 71.299999999999997 110.243 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.495 ' NE1' ' HD3' ' A' ' 71' ' ' PRO . 50.2 t90 -58.11 -48.24 80.81 Favored 'General case' 0 C--O 1.213 -0.867 0 O-C-N 123.704 0.628 . . . . 64.510000000000005 111.153 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.49 -29.99 69.57 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 120.125 -0.63 . . . . 72.310000000000002 110.586 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 94.6 m -67.01 -26.27 66.7 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.993 0.425 . . . . 64.510000000000005 111.522 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.633 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.7 m -115.33 19.84 7.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 121.374 -0.829 . . . . 74.120000000000005 112.112 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.8 m -142.24 4.78 1.63 Allowed 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.842 0.682 . . . . 70.140000000000001 112.842 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.8 p -110.51 162.21 14.92 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.749 -0.834 . . . . 72.409999999999997 108.749 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -56.47 -44.78 80.89 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 123.474 0.709 . . . . 62.210000000000001 111.089 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.11 -46.61 64.46 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.402 -0.817 . . . . 70.340000000000003 111.005 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.06 -40.68 88.37 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 115.615 -0.721 . . . . 44.25 112.814 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.4 mt -68.92 -39.89 80.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 120.804 0.335 . . . . 71.349999999999994 110.842 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.387 0 CA-C-N 116.04 -0.527 . . . . 62.310000000000002 110.671 174.368 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 . . . . . 0 CA--C 1.501 -0.923 0 N-CA-C 108.261 -1.014 . . . . 74.430000000000007 108.261 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -99.1 61.54 1.24 Allowed 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.328 -0.949 . . . . 65.099999999999994 109.295 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.422 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 20.0 t80 -65.58 132.51 49.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.108 -1.405 . . . . 73.430000000000007 110.201 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -109.93 133.41 53.21 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.752 -0.462 . . . . 72.230000000000004 109.752 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.7 tp -78.02 106.15 9.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.43 -1.322 . . . . 72.549999999999997 107.43 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -130.16 145.0 51.68 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.529 -1.286 . . . . 74.239999999999995 107.529 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -84.21 59.3 5.26 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.984 0.897 . . . . 71.010000000000005 109.277 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.27 77.53 0.58 Allowed Glycine 0 N--CA 1.414 -2.824 0 N-CA-C 109.38 -1.488 . . . . 64.209999999999994 109.38 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 C--N 1.314 -0.952 0 CA-C-O 121.94 0.876 . . . . 61.149999999999999 108.717 -176.615 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.408 -2.56 0 N-CA-C 107.983 -1.118 . . . . 61.039999999999999 107.983 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -133.97 140.83 47.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.756 -1.201 . . . . 75.030000000000001 107.756 -172.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.422 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 3.0 t -90.16 136.77 23.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 107.927 -1.138 . . . . 55.509999999999998 107.927 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.6 tp -83.52 -58.07 2.97 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.82 -1.178 . . . . 74.340000000000003 107.82 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.47 138.98 14.93 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.772 -1.104 . . . . 62.149999999999999 109.183 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.444 HG22 HD21 ' A' ' 74' ' ' LEU . 11.2 p -119.37 124.26 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 N-CA-C 108.978 -0.749 . . . . 74.120000000000005 108.978 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 28.2 mm-40 -105.12 140.84 37.69 Favored 'General case' 0 CA--C 1.48 -1.741 0 CA-C-N 115.663 -0.699 . . . . 72.439999999999998 109.602 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.32 126.48 92.61 Favored Pre-proline 0 C--N 1.279 -2.48 0 CA-C-N 113.604 -1.635 . . . . 73.439999999999998 109.047 -166.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HD3' ' NE1' ' A' ' 26' ' ' TRP . 36.9 Cg_exo 5.89 42.99 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 1 C-N-CA 128.131 5.887 . . . . 38.060000000000002 118.428 -160.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 p -132.76 -39.13 0.99 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.312 -0.404 . . . . 73.239999999999995 111.867 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 40.5 tt0 -150.43 145.11 25.85 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 119.325 -0.95 . . . . 73.030000000000001 110.988 -172.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.582 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -139.25 135.11 33.54 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.676 -0.861 . . . . 73.409999999999997 108.676 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.495 ' HG ' HG21 ' A' ' 86' ' ' THR . 13.8 m -140.54 126.04 18.96 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.689 0.28 . . . . 72.230000000000004 110.945 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -146.01 157.23 43.87 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 120.613 0.244 . . . . 72.030000000000001 111.02 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -120.95 123.86 43.5 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.978 -1.119 . . . . 74.299999999999997 107.978 -174.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -108.26 111.28 23.16 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 106.187 -1.783 . . . . 70.239999999999995 106.187 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.29 1.2 m-20 -79.1 10.16 3.78 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 116.808 2.151 . . . . 62.119999999999997 116.808 -170.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -75.85 94.95 3.41 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 104.529 -2.397 . . . . 75.319999999999993 104.529 167.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 83.68 -37.82 0.07 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.885 2.074 . . . . 75.219999999999999 109.718 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.94 47.45 0.56 Allowed Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 111.07 -0.812 . . . . 38.060000000000002 111.07 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -85.25 112.37 20.7 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.608 0.718 . . . . 73.540000000000006 110.402 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.1 t -101.77 117.27 46.83 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 N-CA-C 106.705 -1.591 . . . . 73.109999999999999 106.705 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.32 147.12 20.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-O 121.555 0.693 . . . . 73.450000000000003 110.518 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.495 HG21 ' HG ' ' A' ' 75' ' ' SER . 46.7 m -128.88 132.73 47.75 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 115.019 -0.991 . . . . 72.409999999999997 108.711 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.633 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 14.4 m-85 -112.7 145.56 40.28 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.978 -1.119 . . . . 74.25 107.978 177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.468 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 69.4 mt-30 -130.84 144.17 51.26 Favored 'General case' 0 C--N 1.277 -2.573 0 O-C-N 123.591 0.557 . . . . 74.340000000000003 110.932 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.0 mt -114.9 120.9 41.53 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 123.707 0.63 . . . . 65.319999999999993 110.25 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -103.48 122.74 45.54 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.454 -0.943 . . . . 74.120000000000005 108.454 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -77.66 112.7 14.74 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.101 -0.5 . . . . 74.120000000000005 111.479 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.0 mt -125.58 160.2 30.18 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.365 -0.834 . . . . 72.329999999999998 108.963 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.76 123.94 6.89 Favored Glycine 0 N--CA 1.424 -2.152 0 N-CA-C 109.114 -1.594 . . . . 75.430000000000007 109.114 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 84.58 -10.03 0.87 Allowed 'General case' 0 CA--C 1.485 -1.522 0 C-N-CA 125.709 1.604 . . . . 64.209999999999994 111.812 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.491 ' HG3' ' CG2' ' A' ' 17' ' ' THR . 2.1 ptpt -154.99 174.87 14.56 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 108.519 -0.919 . . . . 72.049999999999997 108.519 -176.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.428 HG22 HG13 ' A' ' 25' ' ' VAL . 63.8 m -135.41 132.49 37.57 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 110.039 -0.356 . . . . 64.519999999999996 110.039 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.73 117.27 4.82 Favored Glycine 0 N--CA 1.423 -2.224 0 N-CA-C 109.831 -1.308 . . . . 73.200000000000003 109.831 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -99.77 129.98 45.94 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 108.81 -0.811 . . . . 71.439999999999998 108.81 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.468 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 37.7 m -117.38 121.41 41.01 Favored 'General case' 0 N--CA 1.408 -2.529 0 C-N-CA 119.196 -1.002 . . . . 75.530000000000001 108.778 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.54 140.01 35.41 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-O 122.265 1.031 . . . . 74.409999999999997 109.017 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 100' ' ' LEU . 18.5 mt -136.19 124.95 37.54 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.117 0 CA-C-N 113.054 -1.885 . . . . 75.299999999999997 107.027 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . 10.3 t60 -120.25 131.87 55.11 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.919 -1.141 . . . . 74.109999999999999 107.919 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.6 m -142.88 132.48 23.77 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.696 -1.224 . . . . 72.349999999999994 107.696 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.87 127.09 9.11 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 120.497 -0.859 . . . . 64.439999999999998 111.201 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 . . . . . 0 N--CA 1.432 -1.361 0 CA-C-O 122.557 1.17 . . . . 73.25 111.432 -179.601 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 106.904 -1.517 . . . . 75.319999999999993 106.904 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.47 HD11 ' HB3' ' A' ' 115' ' ' ALA . 9.6 pt -62.15 -43.96 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.914 0.779 . . . . 74.340000000000003 110.166 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.62 -80.05 0.37 Allowed Glycine 0 N--CA 1.422 -2.283 0 C-N-CA 119.862 -1.161 . . . . 65.010000000000005 114.451 173.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.1 mptp? -104.2 -34.12 8.48 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.694 0.628 . . . . 61.140000000000001 112.694 -168.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 112' ' ' ILE . . . -65.03 -34.17 77.8 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 120.664 0.268 . . . . 63.140000000000001 111.68 -176.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.55 122.59 1.03 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.498 -1.297 . . . . 70.219999999999999 107.498 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -86.3 89.14 7.77 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.101 0.477 . . . . 72.209999999999994 111.584 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.4 tptt 179.64 152.84 0.44 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.045 -1.835 . . . . 74.319999999999993 106.045 171.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.2 p -111.76 -50.7 2.9 Favored 'General case' 0 C--N 1.286 -2.18 0 C-N-CA 120.028 -0.669 . . . . 75.5 111.37 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.2 p -63.22 -46.32 87.52 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.657 0.783 . . . . 74.450000000000003 111.187 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.91 -47.03 83.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.209 -0.905 . . . . 74.450000000000003 110.72 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.6 t -59.28 -35.03 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 116.357 -0.383 . . . . 71.409999999999997 111.237 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -66.56 -50.63 62.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.469 -0.937 . . . . 64.219999999999999 108.469 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.87 -40.53 98.42 Favored Glycine 0 C--O 1.241 0.547 0 CA-C-N 116.061 -0.518 . . . . 73.209999999999994 112.564 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -64.45 -38.77 92.2 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 122.877 0.471 . . . . 72.340000000000003 111.184 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.0 mmt -69.87 -36.83 75.82 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 121.361 -0.136 . . . . 73.150000000000006 111.353 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.49 -56.22 24.71 Favored 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 123.201 0.313 . . . . 73.400000000000006 110.737 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.83 -37.68 88.62 Favored Glycine 0 C--O 1.245 0.828 0 C-N-CA 120.672 -0.775 . . . . 62.229999999999997 111.745 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.8 -63.13 5.36 Favored Glycine 0 N--CA 1.438 -1.175 0 CA-C-N 115.309 -0.445 . . . . 62.420000000000002 112.408 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.633 ' O ' HG21 ' A' ' 134' ' ' VAL . 90.9 m95 -56.07 -45.25 79.38 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 113.342 0.867 . . . . 73.420000000000002 113.342 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.4 m -54.66 -51.44 65.48 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.708 0.63 . . . . 64.129999999999995 110.743 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.96 -43.61 64.8 Favored Glycine 0 C--O 1.25 1.125 0 C-N-CA 120.525 -0.845 . . . . 63.439999999999998 112.425 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.57 -57.6 11.35 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.848 0 CA-C-O 119.161 -0.447 . . . . 73.409999999999997 111.705 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.633 HG21 ' O ' ' A' ' 130' ' ' TRP . 27.4 m -64.19 -35.58 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 C-N-CA 118.906 -1.118 . . . . 75.549999999999997 112.841 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 42.3 t30 -57.81 -70.4 0.14 Allowed 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.558 0.536 . . . . 74.049999999999997 112.0 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.23 -28.13 27.49 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 118.93 -1.108 . . . . 74.230000000000004 112.062 -172.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -73.61 -38.08 65.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 118.722 -1.191 . . . . 70.140000000000001 110.804 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.5 mm? -70.78 -42.95 69.7 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 118.345 -1.342 . . . . 63.149999999999999 109.338 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 135' ' ' ASN . 2.3 tmm_? -57.73 -40.98 80.9 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 115.788 -0.642 . . . . 72.439999999999998 110.552 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -73.14 -36.67 66.7 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 113.422 0.897 . . . . 75.349999999999994 113.422 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.79 58.48 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.093 0.473 . . . . 74.409999999999997 110.968 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 32.1 m -85.36 -30.24 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 119.9 -0.72 . . . . 72.510000000000005 111.571 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -92.69 -26.19 17.9 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.102 0.779 . . . . 72.239999999999995 113.102 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 C--N 1.297 -1.708 0 N-CA-C 105.461 -2.051 . . . . 72.439999999999998 105.461 -177.443 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.519 0 N-CA-C 108.578 -0.897 . . . . 64.310000000000002 108.578 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 tp -67.33 116.54 37.73 Favored Pre-proline 0 C--N 1.313 -0.981 0 O-C-N 123.767 0.667 . . . . 72.400000000000006 110.686 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -99.78 -157.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.251 0 C-N-CA 123.01 2.473 . . . . 64.120000000000005 108.959 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 5.1 p-10 -70.37 131.77 44.61 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.006 -0.678 . . . . 72.329999999999998 110.166 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.3 tt -132.41 138.95 51.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.933 -0.765 . . . . 72.5 108.933 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 m -111.77 134.83 53.08 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.797 -0.445 . . . . 75.430000000000007 109.797 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -136.9 124.1 21.77 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.082 -1.451 . . . . 64.299999999999997 107.082 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 m -117.84 134.02 55.35 Favored 'General case' 0 C--N 1.261 -3.266 0 N-CA-C 109.244 -0.651 . . . . 61.109999999999999 109.244 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.34 133.09 28.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 109.263 -0.643 . . . . 75.329999999999998 109.263 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -97.14 125.39 41.61 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 116.198 -0.455 . . . . 72.019999999999996 111.016 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.8 mp -101.06 139.58 36.55 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.096 -0.502 . . . . 74.230000000000004 110.077 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -80.06 29.94 0.27 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.987 0.915 . . . . 72.540000000000006 111.343 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.97 157.8 74.65 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.735 -0.839 . . . . 73.510000000000005 108.735 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.93 159.8 44.39 Favored 'Trans proline' 0 C--O 1.26 1.582 0 C-N-CA 123.087 2.525 . . . . 62.310000000000002 111.756 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -66.66 -24.9 33.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.85 -0.614 . . . . 62.219999999999999 111.535 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.531 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.0 pt20 -66.11 -40.81 91.02 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.313 -0.403 . . . . 75.219999999999999 111.392 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -74.66 -39.91 61.75 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.017 0.437 . . . . 64.040000000000006 111.011 -175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.437 HG13 HG22 ' A' ' 96' ' ' THR . 7.1 p -65.03 -38.37 82.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.319 -0.4 . . . . 75.209999999999994 110.079 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -58.68 -46.92 86.16 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.81 -0.632 . . . . 74.230000000000004 109.968 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 35.6 mt-10 -61.45 -38.29 86.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.923 0.392 . . . . 61.439999999999998 110.114 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.4 m -66.65 -11.72 55.1 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-N 115.987 -0.551 . . . . 75.230000000000004 111.757 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.613 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.8 m -128.82 9.21 2.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 121.178 -0.951 . . . . 71.099999999999994 112.529 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.3 t -124.96 -9.17 7.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.584 0.23 . . . . 43.32 111.529 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.9 p -94.46 154.21 17.55 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.851 -1.537 . . . . 55.420000000000002 106.851 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.0 m -57.2 -39.46 75.46 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 118.504 0.593 . . . . 75.140000000000001 111.645 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.86 -43.67 87.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.99 -1.005 . . . . 72.310000000000002 109.783 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.58 -40.64 53.37 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 115.055 -0.975 . . . . 36.950000000000003 112.886 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.35 -48.42 88.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 122.748 0.419 . . . . 45.25 110.015 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 112.62 0.6 . . . . 51.229999999999997 112.62 177.202 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 . . . . . 0 CA--C 1.505 -0.766 0 N-CA-C 112.525 0.565 . . . . 65.219999999999999 112.525 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -85.46 -2.11 57.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.243 -0.89 . . . . 72.239999999999995 111.087 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -76.87 118.83 19.85 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.829 -0.804 . . . . 70.439999999999998 108.829 -175.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.23 151.93 30.41 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.815 -0.629 . . . . 74.409999999999997 109.837 -173.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.449 HD12 HG13 ' A' ' 68' ' ' VAL . 3.0 tm? -81.65 104.88 12.37 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.961 -1.866 . . . . 65.299999999999997 105.961 175.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -134.83 137.69 43.53 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 106.168 -1.79 . . . . 62.219999999999999 106.168 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 6.5 pt-20 -91.75 70.25 5.68 Favored 'General case' 0 C--N 1.26 -3.312 0 CA-C-N 119.826 1.194 . . . . 74.239999999999995 109.821 174.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 131.19 96.42 0.71 Allowed Glycine 0 N--CA 1.401 -3.678 0 CA-C-N 113.784 -1.553 . . . . 36.950000000000003 110.91 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.295 -1.798 0 N-CA-C 106.91 -1.515 . . . . 72.409999999999997 106.91 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 26.6 p . . . . . 0 N--CA 1.425 -1.681 0 CA-C-O 120.759 0.314 . . . . 72.030000000000001 110.492 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -123.48 118.83 28.3 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 108.519 -0.919 . . . . 64.299999999999997 108.519 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.5 t -85.51 127.05 40.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 106.472 -1.677 . . . . 72.049999999999997 106.472 174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.7 tp -72.76 -53.39 11.74 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 124.209 0.943 . . . . 73.099999999999994 108.641 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.05 150.62 6.62 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.205 -0.907 . . . . 61.310000000000002 110.255 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 48' ' ' GLU . 59.7 t -121.14 118.88 57.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 107.459 -1.311 . . . . 62.32 107.459 173.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 41.9 mt-30 -111.67 141.76 44.86 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 123.958 0.903 . . . . 75.239999999999995 110.149 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.18 134.25 94.76 Favored Pre-proline 0 C--N 1.287 -2.129 0 CA-C-N 114.128 -1.396 . . . . 55.25 110.184 -162.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo 0.53 48.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.175 1 C-N-CA 128.434 6.089 . . . . 73.140000000000001 117.557 -163.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 m -146.58 -45.24 0.19 Allowed 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.876 -0.602 . . . . 72.239999999999995 111.265 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 29.0 tt0 -141.38 128.55 20.92 Favored 'General case' 0 C--O 1.21 -0.978 0 C-N-CA 117.243 -1.783 . . . . 63.450000000000003 111.905 -169.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.637 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.9 tm? -133.52 132.26 40.75 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 109.318 -0.623 . . . . 73.540000000000006 109.318 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.3 m -138.12 126.21 22.83 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.728 -0.389 . . . . 60.329999999999998 110.724 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -146.67 154.84 41.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.399 0.142 . . . . 72.239999999999995 110.782 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -123.55 123.66 41.1 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.031 -1.1 . . . . 63.32 108.031 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -101.4 140.34 35.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.339 0.59 . . . . 62.229999999999997 112.282 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -93.2 -172.46 2.96 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 103.625 -2.731 . . . . 72.329999999999998 103.625 167.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.1 m 66.76 30.4 8.06 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 122.841 1.305 . . . . 65.109999999999999 107.497 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.479 ' OE1' ' HG3' ' A' ' 114' ' ' LYS . 7.8 mm-40 56.88 53.9 7.67 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.329 1.852 . . . . 72.340000000000003 114.266 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.44 -37.22 2.68 Favored Glycine 0 C--N 1.312 -0.785 0 N-CA-C 109.821 -1.312 . . . . 73.530000000000001 109.821 174.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.448 ' CZ2' ' HB3' ' A' ' 81' ' ' GLU . 2.8 m0 70.65 -164.85 0.15 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.706 1.603 . . . . 74.549999999999997 111.973 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -91.38 118.86 37.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.653 -0.499 . . . . 73.510000000000005 109.653 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.7 144.63 33.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.399 -0.593 . . . . 74.109999999999999 109.399 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.439 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 38.9 m -130.68 139.42 50.32 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 115.909 -0.587 . . . . 75.109999999999999 109.925 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.637 ' CD2' HD13 ' A' ' 74' ' ' LEU . 10.0 m-85 -117.73 140.17 50.04 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.915 -1.143 . . . . 73.329999999999998 107.915 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.503 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 82.8 mt-30 -130.07 140.21 50.86 Favored 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 115.689 -0.687 . . . . 71.340000000000003 110.083 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.8 mt -118.71 124.42 47.29 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.049 0.452 . . . . 75.420000000000002 110.038 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -109.55 116.55 31.99 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.784 -0.821 . . . . 72.530000000000001 108.784 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.61 111.21 15.66 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.722 -0.672 . . . . 74.129999999999995 110.738 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 81.1 mt -109.84 153.8 23.91 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.912 -1.144 . . . . 74.340000000000003 107.912 176.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.48 39.63 3.01 Favored Glycine 0 C--N 1.29 -2.002 0 C-N-CA 121.145 -0.55 . . . . 36.950000000000003 111.917 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -156.74 -42.82 0.07 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 124.405 1.082 . . . . 75.120000000000005 109.305 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.0 ptpt -155.92 177.06 11.84 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.852 -1.166 . . . . 73.209999999999994 107.852 -168.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.437 HG22 HG13 ' A' ' 25' ' ' VAL . 38.9 m -113.32 125.72 54.59 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.854 -0.795 . . . . 72.510000000000005 108.854 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.06 109.69 3.67 Favored Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 110.526 -1.03 . . . . 53.509999999999998 110.526 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -98.05 132.43 43.61 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.409 -0.96 . . . . 73.150000000000006 108.409 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 28.0 m -122.23 122.94 40.31 Favored 'General case' 0 N--CA 1.406 -2.652 0 C-N-CA 119.496 -0.882 . . . . 73.519999999999996 109.038 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -103.13 140.19 37.66 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-O 122.023 0.916 . . . . 61.32 108.678 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.8 mp -135.64 124.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.453 0 N-CA-C 105.981 -1.859 . . . . 73.540000000000006 105.981 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 24.1 t60 -114.59 131.84 56.55 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.326 -1.361 . . . . 73.319999999999993 107.326 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.7 t -137.74 150.17 47.05 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.861 -1.163 . . . . 73.409999999999997 107.861 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -104.17 158.13 16.86 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 110.525 -1.03 . . . . 70.319999999999993 110.525 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 . . . . . 0 C--N 1.318 -0.791 0 CA-C-N 117.612 0.706 . . . . 72.340000000000003 112.214 -178.376 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.423 -1.804 0 N-CA-C 104.674 -2.343 . . . . 73.140000000000001 104.674 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.8 pt -57.53 -39.82 71.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 118.504 0.593 . . . . 70.239999999999995 111.896 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.99 -64.83 3.03 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.751 -0.261 . . . . 63.310000000000002 112.952 175.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.479 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 0.5 OUTLIER -50.82 -48.05 59.91 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 125.243 1.417 . . . . 74.219999999999999 111.884 -177.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.68 61.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 114.604 1.335 . . . . 72.010000000000005 114.604 -173.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 60.98 33.36 19.79 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.012 0.91 . . . . 63.520000000000003 109.208 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.414 ' HB3' ' H ' ' A' ' 118' ' ' LYS . 5.7 mm-40 -109.29 -164.47 0.94 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.096 -0.956 . . . . 75.409999999999997 112.182 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.414 ' H ' ' HB3' ' A' ' 117' ' ' GLU . 26.7 mmtp -76.45 -170.15 1.42 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.255 -0.884 . . . . 74.049999999999997 108.881 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.2 p -126.72 -68.22 0.82 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.251 -0.98 . . . . 72.540000000000006 112.754 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.5 t -62.34 -44.5 96.34 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 123.158 0.286 . . . . 63.130000000000003 110.561 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p -70.61 -34.07 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 119.36 -0.936 . . . . 71.430000000000007 110.313 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.5 t -68.14 -42.81 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.648 -0.251 . . . . 72.329999999999998 110.987 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.8 ttp85 -59.24 -50.76 72.78 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.896 -0.779 . . . . 63.219999999999999 108.896 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.53 -41.76 99.63 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-N 115.736 -0.665 . . . . 43.009999999999998 113.061 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.401 ' O ' ' HA3' ' A' ' 129' ' ' GLY . 2.3 tmmm? -68.79 -32.15 71.68 Favored 'General case' 0 C--O 1.198 -1.61 0 N-CA-C 112.196 0.443 . . . . 74.140000000000001 112.196 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.451 ' HA ' ' HE3' ' A' ' 126' ' ' MET . 2.6 mmt -78.31 -42.37 30.93 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.234 -0.586 . . . . 73.349999999999994 110.604 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -56.93 -63.55 1.17 Allowed 'General case' 0 C--O 1.251 1.149 0 C-N-CA 124.232 1.013 . . . . 73.5 109.348 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.31 -34.24 64.15 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.262 -0.881 . . . . 45.240000000000002 111.722 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -61.4 -59.37 10.01 Favored Glycine 0 C--O 1.209 -1.419 0 CA-C-O 119.256 -0.746 . . . . 62.240000000000002 112.333 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -59.49 -38.66 81.45 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 117.931 0.866 . . . . 74.439999999999998 112.646 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.2 m -60.5 -52.91 63.17 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 120.504 -0.479 . . . . 73.409999999999997 110.796 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.49 -49.56 18.95 Favored Glycine 0 C--O 1.242 0.595 0 C-N-CA 121.162 -0.542 . . . . 74.129999999999995 113.562 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 77.3 mt -61.1 -49.64 83.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 C-N-CA 122.699 0.399 . . . . 74.25 111.154 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.471 ' HA ' HD23 ' A' ' 138' ' ' LEU . 97.3 t -63.48 -49.78 81.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.223 -0.991 . . . . 70.329999999999998 111.441 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -55.28 -63.89 1.02 Allowed 'General case' 0 C--O 1.246 0.905 0 O-C-N 123.785 0.678 . . . . 54.210000000000001 111.864 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 7.0 tp10 -81.98 -40.83 21.62 Favored 'General case' 0 C--O 1.174 -2.896 0 C-N-CA 118.424 -1.31 . . . . 62.299999999999997 113.211 -173.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.427 ' O ' ' HD3' ' A' ' 137' ' ' ARG . 2.1 tmt_? -64.19 -37.04 86.04 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.976 1.262 . . . . 71.329999999999998 110.028 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.3 mm? -69.93 -50.16 44.82 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 119.125 -1.03 . . . . 63.509999999999998 110.206 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 139' ' ' ARG . 1.9 tmm_? -61.62 -36.52 80.98 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 121.359 0.6 . . . . 73.129999999999995 111.246 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -70.86 -47.76 57.58 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 123.746 0.818 . . . . 74.439999999999998 108.891 -177.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.01 75.01 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 111.608 0.225 . . . . 61.240000000000002 111.608 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.56 -32.17 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 119.718 -0.793 . . . . 73.299999999999997 110.923 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.49 -48.41 22.73 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 120.173 -0.611 . . . . 64.109999999999999 111.519 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.437 ' O ' ' HE2' ' A' ' 140' ' ' LYS . 8.0 pt-20 . . . . . 0 C--N 1.312 -1.026 0 C-N-CA 123.769 0.828 . . . . 75.299999999999997 110.611 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.423 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . . . . . . 0 N--CA 1.442 -0.871 0 N-CA-C 106.638 -1.616 . . . . 74.25 106.638 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.8 tp -108.45 99.7 34.18 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 120.116 -0.634 . . . . 65.109999999999999 110.438 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 43.1 Cg_endo -95.97 -159.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.136 2.557 . . . . 74.329999999999998 110.047 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 1.6 m-20 -76.4 109.57 10.22 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.65 -0.5 . . . . 70.409999999999997 109.65 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.492 HG23 ' HB3' ' A' ' 102' ' ' HIS . 10.9 tp -102.31 128.37 55.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.268 -1.382 . . . . 74.120000000000005 107.268 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.1 m -111.04 129.11 56.01 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 109.083 -0.71 . . . . 72.230000000000004 109.083 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -131.31 132.1 44.28 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.716 -0.674 . . . . 73.040000000000006 110.646 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 m -118.43 132.81 56.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.887 -1.153 . . . . 73.219999999999999 107.887 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.66 140.7 20.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.922 -0.77 . . . . 73.409999999999997 108.922 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 p -103.02 132.45 49.27 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.612 0.72 . . . . 75.409999999999997 112.905 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 139' ' ' ARG . 2.2 mm? -108.79 140.48 42.16 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.302 -0.863 . . . . 64.430000000000007 110.897 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -80.57 25.46 0.42 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.603 1.161 . . . . 71.019999999999996 111.314 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -131.76 165.34 36.42 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 108.678 -0.86 . . . . 74.409999999999997 108.678 -174.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.441 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 46.2 Cg_endo -72.09 161.3 45.1 Favored 'Trans proline' 0 C--O 1.257 1.456 0 C-N-CA 121.907 1.738 . . . . 75.099999999999994 111.06 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.0 tt -58.21 -31.11 41.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 115.906 -0.588 . . . . 73.340000000000003 110.795 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -56.4 -50.59 71.17 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.937 0.895 . . . . 74.310000000000002 111.729 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -73.64 -36.55 65.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.116 -0.493 . . . . 74.129999999999995 110.618 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.407 HG22 ' HB ' ' A' ' 96' ' ' THR . 46.1 t -67.69 -41.13 85.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.761 -0.459 . . . . 73.329999999999998 109.761 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 46.3 t90 -61.29 -46.98 88.09 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.962 -1.017 . . . . 74.310000000000002 110.226 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -23.63 63.73 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.312 -0.555 . . . . 72.109999999999999 111.68 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.8 m -67.49 -18.1 64.93 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 121.431 0.634 . . . . 73.340000000000003 111.337 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.571 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 9.9 m -123.05 17.5 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 O-C-N 121.463 -0.773 . . . . 65.010000000000005 110.837 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.5 m -142.12 9.08 1.88 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.15 0.796 . . . . 70.450000000000003 113.15 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.4 p -114.07 168.56 9.71 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 121.635 -0.666 . . . . 71.319999999999993 109.771 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.651 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 15.9 m -58.38 -40.55 82.61 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 123.85 0.719 . . . . 74.519999999999996 109.507 175.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -68.85 -46.88 67.36 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.692 -1.14 . . . . 75.540000000000006 110.955 -177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.5 -47.99 25.56 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.84 -0.695 . . . . 73.310000000000002 113.62 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.04 -34.29 62.55 Favored 'Isoleucine or valine' 0 C--O 1.256 1.401 0 CA-C-O 121.182 0.515 . . . . 71.129999999999995 110.722 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.737 0 CA-C-N 115.702 -0.681 . . . . 74.430000000000007 112.062 174.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.651 ' O ' ' HB3' ' A' ' 32' ' ' SER . 43.1 t-20 . . . . . 0 CA--C 1.495 -1.166 0 N-CA-C 105.935 -1.876 . . . . 63.219999999999999 105.935 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -90.81 69.61 6.51 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 113.288 0.848 . . . . 71.019999999999996 113.288 -170.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 94.0 m-85 -77.39 130.36 36.98 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.584 -1.265 . . . . 75.430000000000007 107.584 171.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -109.44 145.04 36.83 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.448 -0.945 . . . . 74.109999999999999 108.448 -174.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.0 tp -89.2 103.32 15.95 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 106.301 -1.74 . . . . 74.510000000000005 106.301 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 82.3 tttt -133.43 132.24 40.89 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.812 -1.551 . . . . 74.400000000000006 106.812 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.11 76.36 6.13 Favored 'General case' 0 C--N 1.258 -3.376 0 CA-C-O 122.922 1.344 . . . . 72.510000000000005 108.842 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.33 57.48 0.11 Allowed Glycine 0 N--CA 1.405 -3.415 0 CA-C-N 112.47 -2.15 . . . . 70.209999999999994 110.244 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 14.8 tt0 . . . . . 0 CA--C 1.504 -0.824 0 N-CA-C 109.403 -0.591 . . . . 73.129999999999995 109.403 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.428 -1.564 0 CA-C-O 121.183 0.516 . . . . 64.209999999999994 111.526 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 28.9 ttpp -121.52 118.01 28.22 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 105.359 -2.089 . . . . 53.509999999999998 105.359 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.7 t -85.67 135.22 25.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 120.155 -0.618 . . . . 73.420000000000002 109.529 -174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.3 tp -83.17 -56.14 3.95 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.043 -0.725 . . . . 72.109999999999999 109.043 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.5 149.32 16.89 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.228 -0.896 . . . . 52.130000000000003 109.997 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.54 119.31 53.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.524 -1.287 . . . . 74.010000000000005 107.524 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 13.1 mm-40 -103.63 141.79 35.43 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 121.24 0.543 . . . . 72.140000000000001 110.442 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.17 130.65 93.65 Favored Pre-proline 0 C--N 1.271 -2.824 0 CA-C-N 114.031 -1.44 . . . . 73.200000000000003 109.062 -167.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo 2.6 48.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.371 1 C-N-CA 128.189 5.926 . . . . 71.329999999999998 117.66 -162.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 6.9 m -142.72 -36.87 0.38 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.941 -0.572 . . . . 74.530000000000001 110.564 175.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.5 tt0 -147.77 144.61 28.36 Favored 'General case' 0 C--O 1.201 -1.451 0 C-N-CA 118.035 -1.466 . . . . 72.230000000000004 111.847 -174.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.484 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -139.0 134.46 33.09 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.015 -1.106 . . . . 65.319999999999993 108.015 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 p -141.69 126.53 18.15 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.656 -0.418 . . . . 54.329999999999998 112.115 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -145.23 155.77 43.44 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 110.234 -0.284 . . . . 75.109999999999999 110.234 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -122.19 134.01 54.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.722 -1.214 . . . . 72.129999999999995 107.722 -173.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -113.78 125.05 53.67 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.971 -1.122 . . . . 74.409999999999997 107.971 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.26 -28.81 69.97 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.125 1.157 . . . . 63.340000000000003 114.125 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.7 m -66.67 94.81 0.31 Allowed 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.955 0.883 . . . . 71.150000000000006 109.722 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.265 63.2 mm-40 77.56 4.71 3.05 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 127.865 2.466 . . . . 75.409999999999997 114.16 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.32 58.78 6.27 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.599 -0.728 . . . . 61.229999999999997 112.778 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -98.32 133.07 43.23 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.702 -0.399 . . . . 75.200000000000003 109.965 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.46 120.41 63.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.063 -1.088 . . . . 73.5 108.063 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.63 150.55 18.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.322 0.582 . . . . 71.439999999999998 110.918 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 88.3 m -137.87 137.68 38.34 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.577 -0.898 . . . . 74.099999999999994 108.577 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 26.3 m-85 -122.27 147.05 46.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.007 -1.109 . . . . 75.040000000000006 108.007 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 72' ' ' THR . 24.3 mt-30 -131.49 141.3 49.73 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 123.482 0.489 . . . . 61.420000000000002 111.127 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -112.93 124.1 51.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.1 0.476 . . . . 72.5 111.226 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.71 123.99 51.09 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 125.143 1.377 . . . . 73.010000000000005 109.475 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -84.8 123.14 30.1 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.132 -0.486 . . . . 72.129999999999995 110.832 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.7 mt -124.9 157.84 34.98 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.053 -1.091 . . . . 72.109999999999999 108.053 174.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 94' ' ' GLU . . . -82.31 50.22 4.28 Favored Glycine 0 C--N 1.3 -1.423 0 N-CA-C 115.269 0.868 . . . . 72.319999999999993 115.269 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 93' ' ' GLY . 6.1 tp10 167.65 -39.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.256 1.022 . . . . 54.520000000000003 108.983 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -126.16 175.69 7.59 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.039 -1.097 . . . . 62.5 108.039 -173.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.407 ' HB ' HG22 ' A' ' 25' ' ' VAL . 60.9 m -122.2 134.71 54.71 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.616 -0.513 . . . . 70.219999999999999 109.616 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -93.84 114.56 4.77 Favored Glycine 0 N--CA 1.416 -2.654 0 N-CA-C 109.106 -1.598 . . . . 73.430000000000007 109.106 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -101.96 134.65 44.83 Favored 'General case' 0 C--N 1.268 -2.977 0 N-CA-C 108.948 -0.76 . . . . 72.209999999999994 108.948 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.8 m -120.2 126.82 51.6 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 108.28 -1.007 . . . . 62.43 108.28 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.444 ' C ' HD12 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -104.4 137.21 42.61 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 106.885 -1.524 . . . . 71.109999999999999 106.885 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 101' ' ' ILE . 2.4 mp -135.23 123.67 39.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.747 0 N-CA-C 106.134 -1.802 . . . . 71.409999999999997 106.134 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.492 ' HB3' HG23 ' A' ' 12' ' ' ILE . 3.4 t-160 -121.27 132.33 54.74 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.533 -1.284 . . . . 65.219999999999999 107.533 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.2 t -136.19 154.57 50.91 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.461 -0.94 . . . . 65.109999999999999 108.461 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.81 170.58 53.24 Favored Glycine 0 C--O 1.262 1.867 0 N-CA-C 109.253 -1.539 . . . . 37.600000000000001 109.253 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 34.8 t-105 . . . . . 0 C--O 1.223 -0.321 0 C-N-CA 123.07 0.548 . . . . 73.439999999999998 110.202 179.481 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 119' ' ' SER . 22.1 t . . . . . 0 C--O 1.216 -0.703 0 N-CA-C 107.547 -1.279 . . . . 75.420000000000002 107.547 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -32.98 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 120.892 0.377 . . . . 74.319999999999993 111.164 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.51 -89.47 0.93 Allowed Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.905 -0.589 . . . . 61.130000000000003 114.259 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -57.53 -23.88 52.85 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 125.122 1.369 . . . . 65.129999999999995 114.68 -172.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.14 -13.98 62.73 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.906 0.384 . . . . 71.030000000000001 111.797 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.7 m120 76.06 -19.83 0.39 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.099 1.36 . . . . 70.439999999999998 114.201 175.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.47 154.94 36.71 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.865 -0.42 . . . . 52.340000000000003 109.865 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -67.99 149.06 50.19 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.145 0.498 . . . . 63.229999999999997 111.2 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.424 ' HB3' HG11 ' A' ' 111' ' ' VAL . 3.0 p -58.29 -44.55 88.55 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 124.293 1.037 . . . . 74.349999999999994 111.814 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.4 p -65.2 -45.99 82.54 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.343 -0.844 . . . . 71.530000000000001 111.497 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.84 -37.72 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 120.132 -0.627 . . . . 74.319999999999993 109.616 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.589 ' O ' ' HG3' ' A' ' 126' ' ' MET . 54.3 t -61.53 -45.88 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 120.818 -0.353 . . . . 71.239999999999995 111.134 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -55.44 -49.54 72.16 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.471 0.482 . . . . 72.019999999999996 111.138 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.22 -42.42 90.97 Favored Glycine 0 CA--C 1.5 -0.858 0 CA-C-N 115.891 -0.595 . . . . 62.439999999999998 112.781 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 126' ' ' MET . 2.4 tmmm? -68.63 -44.1 74.91 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 113.095 0.776 . . . . 72.349999999999994 113.095 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.589 ' HG3' ' O ' ' A' ' 122' ' ' VAL 0.382 0.0 OUTLIER -77.1 -29.28 54.8 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 118.196 -1.402 . . . . 74.0 113.778 -177.774 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -71.66 -55.81 7.01 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.867 -0.733 . . . . 75.519999999999996 109.119 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.37 -38.01 95.73 Favored Glycine 0 CA--C 1.5 -0.869 0 CA-C-N 115.526 -0.761 . . . . 73.310000000000002 112.254 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.82 -58.14 11.99 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 111.713 -0.555 . . . . 37.600000000000001 111.713 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.548 ' O ' ' HB ' ' A' ' 134' ' ' VAL . 94.3 m95 -64.42 -36.78 85.26 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.073 1.138 . . . . 74.219999999999999 114.073 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.0 p -67.64 -53.87 24.36 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.148 -0.621 . . . . 74.5 110.976 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.1 -48.58 38.74 Favored Glycine 0 C--O 1.246 0.9 0 C-N-CA 121.492 -0.385 . . . . 74.129999999999995 113.428 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.01 -54.0 36.94 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.281 0 CA-C-O 119.185 -0.436 . . . . 73.120000000000005 110.666 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' A' ' 130' ' ' TRP . 6.2 t -58.83 -40.71 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 113.608 0.966 . . . . 75.310000000000002 113.608 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -53.76 -59.54 4.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.244 0.545 . . . . 74.140000000000001 111.043 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.24 -42.14 26.61 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 113.258 0.836 . . . . 73.140000000000001 113.258 -174.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -65.24 -41.48 94.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.225 0.466 . . . . 74.230000000000004 109.767 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.2 mm? -66.65 -51.45 56.05 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.646 -0.422 . . . . 74.140000000000001 109.922 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.429 ' HA ' HD13 ' A' ' 18' ' ' LEU . 4.6 tmm_? -64.28 -31.78 73.11 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.951 0.405 . . . . 75.239999999999995 110.99 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -79.08 -44.72 21.53 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 113.489 0.922 . . . . 75.310000000000002 113.489 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.62 -23.89 67.41 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.624 -0.431 . . . . 61.439999999999998 111.096 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 24.0 m -85.35 -33.9 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 120.512 -0.475 . . . . 74.230000000000004 111.336 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -85.73 -70.47 0.59 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.937 0.717 . . . . 55.119999999999997 112.937 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.709 0 CA-C-O 121.389 0.614 . . . . 73.109999999999999 111.801 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.026 0 N-CA-C 108.879 -0.786 . . . . 62.310000000000002 108.879 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.4 mt 54.16 78.38 0.39 Allowed Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 113.815 -1.539 . . . . 53.43 113.37 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.85 -159.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 122.635 2.223 . . . . 64.319999999999993 108.865 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.53 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 44.3 m-20 -64.49 104.33 0.78 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.242 0.46 . . . . 73.030000000000001 112.242 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 77.3 mt -93.38 126.5 45.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.46 -1.681 . . . . 75.540000000000006 106.46 174.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.2 m -111.45 127.94 55.84 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.045 -0.662 . . . . 75.230000000000004 109.713 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -131.89 126.12 33.39 Favored 'General case' 0 C--O 1.197 -1.658 0 N-CA-C 108.955 -0.757 . . . . 64.349999999999994 108.955 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.3 m -118.1 142.66 47.18 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 119.624 -0.83 . . . . 70.120000000000005 109.825 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.86 141.73 16.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.42 -0.956 . . . . 65.340000000000003 108.42 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.61 127.08 53.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.324 -0.621 . . . . 72.120000000000005 109.324 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 4.7 mp -106.39 140.08 39.87 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 122.998 0.519 . . . . 72.420000000000002 109.717 -175.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -75.05 -2.02 25.48 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 124.091 0.956 . . . . 74.510000000000005 112.074 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.07 159.78 29.33 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 116.328 -0.396 . . . . 72.340000000000003 111.825 -172.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.49 153.61 73.73 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.305 2.67 . . . . 62.109999999999999 111.778 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.7 tt -48.86 -40.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.103 0.961 . . . . 62.219999999999999 112.628 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -70.98 -29.65 65.69 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.231 -0.588 . . . . 71.430000000000007 111.954 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -73.88 -36.82 64.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.629 0.728 . . . . 73.030000000000001 109.109 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.43 ' O ' HG21 ' A' ' 29' ' ' VAL . 58.3 t -69.72 -41.24 79.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.534 -0.913 . . . . 72.439999999999998 108.534 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -58.77 -47.95 82.93 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.293 -0.867 . . . . 75.319999999999993 111.61 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -64.65 -35.24 80.4 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.302 -0.959 . . . . 72.510000000000005 110.776 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.2 m -63.75 -23.91 67.56 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 112.177 0.436 . . . . 62.509999999999998 112.177 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.583 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 16.0 m -121.72 15.2 5.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 112.789 0.662 . . . . 73.510000000000005 112.789 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.5 t -142.76 9.72 1.77 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 119.481 -0.888 . . . . 61.130000000000003 112.66 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.7 p -122.22 171.78 8.77 Favored 'General case' 0 C--O 1.247 0.972 0 O-C-N 121.455 -0.778 . . . . 74.409999999999997 110.557 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 m -63.72 -48.86 75.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.548 -0.538 . . . . 74.209999999999994 109.548 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.29 -41.86 96.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.846 -0.615 . . . . 73.510000000000005 111.691 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.32 -49.45 20.34 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 120.078 -1.058 . . . . 40.030000000000001 114.073 -176.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.9 mt -72.14 -50.68 35.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 118.344 1.072 . . . . 64.319999999999993 112.499 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.405 0 CA-C-O 121.205 0.526 . . . . 72.510000000000005 111.301 -178.047 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 . . . . . 0 CA--C 1.488 -1.423 0 N-CA-C 107.156 -1.424 . . . . 72.450000000000003 107.156 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -105.83 79.3 1.41 Allowed 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.941 0.877 . . . . 75.450000000000003 110.525 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -90.53 119.81 31.1 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.556 -1.202 . . . . 75.5 110.546 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -119.56 153.36 35.53 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.304 -1.739 . . . . 72.239999999999995 106.304 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -74.78 104.31 5.37 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.594 -1.262 . . . . 75.329999999999998 107.594 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.523 ' HD3' ' HA ' ' A' ' 50' ' ' GLN . 47.4 tttp -132.97 144.54 50.18 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.711 -1.588 . . . . 64.230000000000004 106.711 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -91.76 69.79 5.63 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-O 122.097 0.951 . . . . 72.049999999999997 108.449 174.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.95 61.1 0.19 Allowed Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 110.119 -1.193 . . . . 71.019999999999996 110.119 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.523 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.473 -2.016 0 N-CA-C 106.489 -1.671 . . . . 64.239999999999995 106.489 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 48.4 m . . . . . 0 C--O 1.246 0.889 0 CA-C-O 120.775 0.321 . . . . 73.150000000000006 111.635 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 90.8 mttt -142.02 133.68 26.92 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 116.28 -0.418 . . . . 62.240000000000002 110.65 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 36.2 t -90.58 136.71 23.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 106.271 -1.751 . . . . 73.140000000000001 106.271 175.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.8 tp -78.98 -61.42 2.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.109 -1.071 . . . . 64.25 108.109 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -162.37 153.99 18.34 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.905 -1.043 . . . . 64.540000000000006 108.877 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.8 p -131.19 131.82 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.34 0 CA-C-O 121.625 0.726 . . . . 63.140000000000001 110.458 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.567 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 85.7 mm-40 -110.29 141.75 42.85 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 114.363 -1.29 . . . . 71.129999999999995 108.077 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.52 136.07 96.01 Favored Pre-proline 0 C--N 1.288 -2.085 0 CA-C-N 115.024 -0.989 . . . . 72.310000000000002 109.635 -164.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo 0.59 50.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.366 1.491 1 C-N-CA 128.301 6.001 . . . . 74.030000000000001 117.484 -162.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 4.7 m -145.19 -46.83 0.23 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 112.001 0.371 . . . . 61.420000000000002 112.001 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 11.0 tp10 -132.71 126.76 33.26 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.48 -0.933 . . . . 74.420000000000002 108.48 -171.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -135.7 132.72 37.26 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.517 -0.549 . . . . 75.239999999999995 109.517 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.5 m -135.05 126.72 29.0 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 123.221 0.326 . . . . 73.310000000000002 111.432 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -146.23 155.64 42.83 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.003 -0.436 . . . . 71.140000000000001 111.654 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -123.05 125.8 45.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.795 -1.187 . . . . 74.329999999999998 107.795 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -139.86 160.99 38.64 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.791 -0.363 . . . . 74.200000000000003 111.492 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.423 ' HB3' ' CD1' ' A' ' 83' ' ' TRP . 48.6 t0 74.31 163.69 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.042 1.337 . . . . 70.230000000000004 111.546 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.9 m -59.11 -39.37 82.08 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.389 1.075 . . . . 74.040000000000006 112.009 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.89 -5.12 54.95 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.007 0.743 . . . . 52.299999999999997 113.007 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.43 73.62 0.68 Allowed Glycine 0 N--CA 1.442 -0.946 0 O-C-N 123.594 0.559 . . . . 54.030000000000001 113.004 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 79' ' ' ASP . 50.6 m95 -85.98 112.97 21.7 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.696 -1.224 . . . . 72.010000000000005 107.696 177.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.32 101.98 13.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 106.967 -1.494 . . . . 74.230000000000004 106.967 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.5 m -108.85 144.78 16.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 120.973 0.416 . . . . 73.310000000000002 110.309 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.467 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 7.4 m -131.3 143.02 50.22 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.689 -0.856 . . . . 72.109999999999999 108.689 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.584 ' CD2' HD13 ' A' ' 74' ' ' LEU . 11.0 m-85 -120.8 147.53 45.22 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.829 -0.804 . . . . 71.230000000000004 108.829 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.476 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 72.9 mt-30 -133.2 144.5 49.86 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 112.795 0.665 . . . . 73.319999999999993 112.795 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.517 ' HB3' ' HA ' ' A' ' 72' ' ' THR . 1.9 tm? -98.03 134.16 41.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.203 -0.908 . . . . 62.25 111.361 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -123.73 116.04 22.38 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.769 -2.308 . . . . 63.039999999999999 104.769 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -93.08 115.16 27.84 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.475 -0.89 . . . . 64.439999999999998 111.321 -175.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.8 mt -103.88 153.38 20.84 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.986 -1.116 . . . . 71.0 107.986 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.33 54.64 4.91 Favored Glycine 0 C--N 1.282 -2.431 0 C-N-CA 121.087 -0.577 . . . . 38.329999999999998 112.856 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 174.59 -33.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.323 0.649 . . . . 72.340000000000003 109.908 -177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 7.2 ptpt -150.33 175.27 11.98 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.772 -0.825 . . . . 65.219999999999999 108.772 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.0 m -111.47 123.15 49.62 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 121.176 0.512 . . . . 75.0 111.101 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.99 131.09 10.36 Favored Glycine 0 N--CA 1.406 -3.343 0 N-CA-C 108.484 -1.847 . . . . 38.329999999999998 108.484 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -120.12 134.5 55.24 Favored 'General case' 0 C--N 1.261 -3.277 0 C-N-CA 122.866 0.467 . . . . 73.209999999999994 109.804 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 90.8 m -117.77 127.17 53.64 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.917 -0.772 . . . . 74.439999999999998 108.917 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -103.62 140.56 37.39 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 108.59 -0.893 . . . . 75.5 108.59 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.9 mp -136.22 124.66 36.59 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.943 0 CA-C-N 113.662 -1.608 . . . . 61.539999999999999 106.973 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 18.2 t-160 -114.47 112.77 23.52 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.584 -1.265 . . . . 72.200000000000003 107.584 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.2 m -107.31 132.36 53.21 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.302 -1.74 . . . . 52.229999999999997 106.302 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.55 154.81 20.1 Favored Glycine 0 N--CA 1.426 -2.009 0 C-N-CA 120.838 -0.696 . . . . 38.329999999999998 112.894 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 115.157 -0.522 . . . . 75.530000000000001 109.979 178.525 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.218 -0.571 0 N-CA-C 103.622 -2.732 . . . . 73.129999999999995 103.622 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -62.39 -37.84 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.247 1.385 . . . . 73.129999999999995 113.767 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 131.22 -75.76 0.42 Allowed Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.471 -0.871 . . . . 54.329999999999998 113.847 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -117.03 5.48 12.83 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 113.735 1.013 . . . . 63.530000000000001 113.735 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.36 65.1 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.589 -0.845 . . . . 71.109999999999999 111.354 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 174.91 137.44 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.174 -1.788 . . . . 44.409999999999997 106.174 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.25 -18.67 61.2 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.773 0.657 . . . . 73.329999999999998 112.773 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.451 ' HB3' HG23 ' A' ' 121' ' ' VAL . 43.0 tptt -91.37 97.77 11.3 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.413 -0.915 . . . . 75.420000000000002 110.577 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.3 t -58.48 -37.97 76.64 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.356 -1.293 . . . . 65.010000000000005 111.621 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.403 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 29.5 t -66.13 -45.07 82.33 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.964 -0.294 . . . . 50.130000000000003 111.51 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 118' ' ' LYS . 12.6 m -69.91 -34.48 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 119.453 -0.899 . . . . 75.140000000000001 109.64 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 63.0 t -66.29 -44.68 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 120.468 -0.493 . . . . 73.299999999999997 111.509 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.435 ' HD3' ' N ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -68.01 -37.15 81.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.996 -0.682 . . . . 74.129999999999995 111.276 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.435 ' N ' ' HD3' ' A' ' 123' ' ' ARG . . . -63.51 -45.59 94.41 Favored Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 111.012 -0.835 . . . . 74.319999999999993 111.012 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.28 -40.1 95.28 Favored 'General case' 0 C--O 1.193 -1.869 0 CA-C-N 115.011 -0.595 . . . . 74.200000000000003 111.95 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 24.2 mmt -69.32 -40.91 77.34 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.354 -0.538 . . . . 72.019999999999996 111.073 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.61 -57.66 11.17 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.419 0.628 . . . . 64.510000000000005 109.695 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.09 -38.63 59.41 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.47 -0.787 . . . . 63.32 112.389 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.79 -54.11 36.04 Favored Glycine 0 CA--C 1.491 -1.417 0 CA-C-O 119.72 -0.489 . . . . 54.140000000000001 112.036 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -61.91 -35.16 77.54 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 117.424 0.612 . . . . 72.299999999999997 112.456 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.2 m -62.37 -48.37 80.07 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 120.439 -0.504 . . . . 72.109999999999999 110.906 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.7 -46.44 24.32 Favored Glycine 0 C--O 1.247 0.907 0 C-N-CA 120.688 -0.768 . . . . 74.420000000000002 113.661 -177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.51 -52.32 59.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 122.347 0.259 . . . . 74.329999999999998 110.871 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.648 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 96.4 t -65.24 -48.48 83.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 119.81 -0.756 . . . . 61.0 112.318 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -59.39 -60.45 3.84 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 112.738 0.644 . . . . 74.530000000000001 112.738 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 32.4 tt0 -74.46 -48.98 24.15 Favored 'General case' 0 C--O 1.208 -1.091 0 C-N-CA 120.047 -0.661 . . . . 74.439999999999998 112.726 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.542 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 1.2 tmm_? -67.85 -32.27 72.67 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.032 -0.667 . . . . 71.239999999999995 111.41 -170.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.648 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 3.4 mm? -70.25 -51.86 27.41 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.769 -0.772 . . . . 73.319999999999993 110.023 174.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -34.26 76.26 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.894 -0.594 . . . . 73.230000000000004 111.584 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -71.27 -51.47 24.3 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.979 -0.748 . . . . 70.420000000000002 108.979 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.14 -26.85 68.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 74.040000000000006 111.87 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 30.1 m -83.8 -30.66 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.137 -0.625 . . . . 63.399999999999999 111.979 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -79.57 -12.86 59.84 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.156 0.979 . . . . 74.430000000000007 109.745 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 N--CA 1.419 -2.001 0 N-CA-C 107.419 -1.326 . . . . 75.109999999999999 107.419 172.913 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 112.762 0.652 . . . . 61.299999999999997 112.762 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 61.75 83.97 0.2 Allowed Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 124.122 0.969 . . . . 74.030000000000001 111.855 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -89.18 -168.22 0.32 Allowed 'Trans proline' 0 N--CA 1.429 -2.32 0 C-N-CA 122.448 2.098 . . . . 65.120000000000005 112.178 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.642 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 6.3 p-10 -61.29 131.14 49.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.995 -1.002 . . . . 72.340000000000003 113.065 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.2 tp -135.99 138.74 47.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.966 -1.124 . . . . 51.43 107.966 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.7 m -117.75 133.64 55.73 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 120.85 0.357 . . . . 71.299999999999997 110.083 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -133.73 153.64 51.55 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.794 -1.928 . . . . 75.010000000000005 105.794 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.5 m -138.0 149.88 46.49 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.154 -0.966 . . . . 75.540000000000006 110.629 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.24 144.86 16.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.008 -0.738 . . . . 61.530000000000001 109.008 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.3 122.74 46.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.944 0.878 . . . . 75.219999999999999 112.156 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.8 mp -100.94 140.43 35.24 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 115.54 -0.755 . . . . 73.530000000000001 110.695 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -92.11 46.39 1.26 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.359 -1.291 . . . . 65.540000000000006 109.184 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -143.68 161.65 45.47 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.426 -0.953 . . . . 74.409999999999997 108.426 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.15 150.22 89.23 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 122.467 2.111 . . . . 62.310000000000002 111.135 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.1 tt -56.29 -33.34 37.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.594 0.559 . . . . 71.230000000000004 112.127 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -60.9 -42.23 97.64 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 112.194 0.442 . . . . 64.310000000000002 112.194 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -74.44 -37.79 63.18 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.259 0.552 . . . . 71.120000000000005 109.605 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.85 -41.1 91.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.463 -0.789 . . . . 73.099999999999994 109.206 177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.562 ' CE2' ' HD3' ' A' ' 71' ' ' PRO . 74.9 t90 -64.7 -46.09 83.82 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.141 -1.39 . . . . 74.310000000000002 109.777 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.59 -38.9 78.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.596 0.758 . . . . 72.200000000000003 110.185 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.417 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 62.8 m -57.73 -29.98 65.18 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 112.191 0.441 . . . . 72.209999999999994 112.191 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.4 m -110.3 18.64 6.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 O-C-N 121.852 -0.53 . . . . 71.349999999999994 112.037 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.5 p -135.7 -12.02 2.04 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.154 0.502 . . . . 74.230000000000004 112.05 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.7 p -94.75 148.86 21.85 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.09 -0.707 . . . . 73.140000000000001 109.09 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 m -53.52 -45.83 69.89 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.794 0.838 . . . . 65.230000000000004 112.709 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -69.23 -32.45 71.7 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.848 0.356 . . . . 75.329999999999998 111.458 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 28' ' ' THR . . . -72.31 -48.36 25.08 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.391 -0.909 . . . . 73.319999999999993 111.52 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.15 -32.17 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.139 0.976 . . . . 64.400000000000006 111.738 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 124.171 0.989 . . . . 65.239999999999995 112.914 -178.483 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 . . . . . 0 CA--C 1.501 -0.938 0 N-CA-C 109.779 -0.452 . . . . 63.329999999999998 109.779 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.43 73.33 10.52 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.988 0.899 . . . . 62.509999999999998 110.042 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -83.69 121.77 27.72 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.993 -2.225 . . . . 74.239999999999995 104.993 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -109.76 145.88 35.91 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 112.292 0.479 . . . . 64.329999999999998 112.292 -167.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -75.43 105.55 6.51 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.71 -1.589 . . . . 74.140000000000001 106.71 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -131.05 145.25 51.96 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.655 -1.979 . . . . 54.439999999999998 105.655 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -87.36 34.04 0.69 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 118.963 0.801 . . . . 71.209999999999994 110.673 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 148.8 76.25 0.02 OUTLIER Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 108.501 -1.839 . . . . 64.549999999999997 108.501 -175.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 C--N 1.303 -1.437 0 N-CA-C 106.894 -1.521 . . . . 74.230000000000004 106.894 -178.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.416 -2.14 0 CA-C-O 120.823 0.345 . . . . 72.430000000000007 110.108 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -155.24 143.45 20.2 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.518 -0.919 . . . . 65.299999999999997 108.518 -176.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.412 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 27.1 t -88.91 127.44 41.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 105.71 -1.959 . . . . 73.219999999999999 105.71 173.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -70.74 -53.03 17.08 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.437 -1.32 . . . . 74.140000000000001 107.437 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.65 145.36 5.41 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.202 -0.908 . . . . 65.409999999999997 109.258 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.457 HG23 HD23 ' A' ' 74' ' ' LEU . 10.4 p -121.44 119.23 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 121.781 0.8 . . . . 65.349999999999994 109.115 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 84.2 mm-40 -113.87 141.53 47.23 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.011 -0.995 . . . . 74.400000000000006 112.509 -176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.39 133.24 94.4 Favored Pre-proline 0 C--N 1.296 -1.754 0 CA-C-N 113.498 -1.683 . . . . 63.25 108.073 -167.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.562 ' HD3' ' CE2' ' A' ' 26' ' ' TRP . 9.5 Cg_exo -11.83 62.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.99 1 C-N-CA 126.587 4.858 . . . . 74.5 118.333 -156.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.2 p -142.24 -44.67 0.33 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.179 -1.373 . . . . 62.219999999999999 109.549 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 69' ' ' GLN . 37.1 mt-10 -143.33 141.01 30.82 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 113.262 0.838 . . . . 72.040000000000006 113.262 -171.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.554 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.1 tm? -136.49 130.86 33.17 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 107.278 -1.378 . . . . 71.329999999999998 107.278 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -140.86 126.37 18.87 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 120.384 -0.527 . . . . 72.25 110.717 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -146.01 155.4 42.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.64 0.257 . . . . 74.340000000000003 111.315 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 29.0 mt-10 -121.64 136.03 54.96 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 105.552 -2.018 . . . . 72.530000000000001 105.552 -175.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -155.51 162.79 40.63 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.188 -1.005 . . . . 75.400000000000006 113.571 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.7 t70 75.65 163.47 0.26 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 112.809 -1.996 . . . . 74.239999999999995 112.63 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -60.59 -33.38 72.65 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.642 1.177 . . . . 72.430000000000007 111.89 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.04 -33.63 70.48 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 120.722 0.296 . . . . 75.329999999999998 111.716 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.1 65.15 1.08 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.63 -0.795 . . . . 62.539999999999999 112.232 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.408 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 35.1 m95 -92.95 141.28 28.59 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.201 -1.407 . . . . 75.409999999999997 107.201 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.07 101.84 8.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 122.353 1.073 . . . . 53.210000000000001 109.121 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 m -97.54 142.69 13.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 115.435 -0.802 . . . . 71.409999999999997 110.603 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.3 m -132.31 122.0 24.43 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.334 -1.358 . . . . 74.140000000000001 107.334 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.554 ' CD2' HD13 ' A' ' 74' ' ' LEU . 11.9 m-85 -112.65 138.64 49.15 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.341 -0.985 . . . . 74.519999999999996 108.341 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.476 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 35.0 mt-30 -113.81 128.38 56.39 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 115.281 -0.872 . . . . 54.25 110.932 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.29 119.45 38.42 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.881 -1.155 . . . . 75.349999999999994 107.881 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -104.19 117.1 33.42 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.906 -1.146 . . . . 74.510000000000005 107.906 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -77.94 112.22 14.62 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.718 -0.674 . . . . 65.400000000000006 109.855 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 98.8 mt -115.21 140.91 48.68 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.14 -1.43 . . . . 73.439999999999998 107.14 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.38 58.9 4.96 Favored Glycine 0 C--N 1.276 -2.788 0 CA-C-N 115.654 -0.703 . . . . 72.010000000000005 111.907 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 179.51 -47.05 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.592 0.757 . . . . 73.219999999999999 109.307 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 9.8 ptpt -142.52 175.39 9.83 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.254 -1.388 . . . . 72.430000000000007 107.254 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.8 m -111.15 124.86 53.05 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 119.794 -0.763 . . . . 74.439999999999998 110.307 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.48 108.27 3.62 Favored Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 110.085 -1.206 . . . . 74.209999999999994 110.085 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -98.29 129.39 44.99 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.795 -0.817 . . . . 75.200000000000003 108.795 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 8.0 m -116.31 123.15 46.93 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 107.958 -1.127 . . . . 73.109999999999999 107.958 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.467 HD12 ' CE1' ' A' ' 87' ' ' PHE . 2.9 tp -100.18 119.34 38.21 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.724 -0.843 . . . . 64.129999999999995 108.724 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 101' ' ' ILE . 2.9 mp -117.01 123.17 71.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 105.928 -1.879 . . . . 64.340000000000003 105.928 175.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.642 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 22.9 t-160 -108.59 113.52 26.59 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.665 -1.606 . . . . 62.539999999999999 106.665 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -125.93 155.55 41.13 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 105.762 -1.94 . . . . 72.129999999999995 105.762 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.28 153.8 17.54 Favored Glycine 0 C--N 1.26 -3.684 0 N-CA-C 108.833 -1.707 . . . . 71.209999999999994 108.833 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 43.6 t90 . . . . . 0 C--N 1.29 -1.985 0 N-CA-C 108.806 -0.812 . . . . 73.299999999999997 108.806 179.624 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.434 -1.257 0 N-CA-C 109.934 -0.395 . . . . 65.239999999999995 109.934 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.429 HD12 ' HB3' ' A' ' 115' ' ' ALA . 5.9 pt -62.21 -44.17 98.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.913 -0.585 . . . . 72.209999999999994 110.407 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.84 -52.7 3.62 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 114.413 0.525 . . . . 72.140000000000001 114.413 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.29 -42.1 16.17 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 112.861 0.689 . . . . 73.319999999999993 112.861 -172.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.429 ' HB3' HD12 ' A' ' 112' ' ' ILE . . . -67.06 -30.5 70.58 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.552 -0.459 . . . . 61.329999999999998 110.485 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.413 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 22.1 t-20 -175.51 145.17 0.71 Allowed 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.317 -1.364 . . . . 71.439999999999998 107.317 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -90.23 -17.87 26.72 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 113.172 0.804 . . . . 75.109999999999999 113.172 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 9.5 mmpt? -99.56 109.66 22.17 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.403 0.62 . . . . 70.129999999999995 110.798 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -67.48 -33.34 74.91 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.547 -0.751 . . . . 70.310000000000002 111.23 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 p -65.94 -46.67 77.33 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 111.756 0.28 . . . . 73.030000000000001 111.756 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 118' ' ' LYS . 30.2 m -70.27 -34.51 58.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 119.77 -0.772 . . . . 71.549999999999997 110.917 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.413 ' CG2' ' HB3' ' A' ' 116' ' ' ASN . 99.4 t -65.86 -45.56 91.04 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 C-N-CA 120.394 -0.522 . . . . 64.239999999999995 110.594 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -61.8 -43.64 98.45 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 111.865 0.32 . . . . 74.430000000000007 111.865 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -62.51 -47.38 89.78 Favored Glycine 0 CA--C 1.497 -1.079 0 CA-C-N 115.837 -0.62 . . . . 73.409999999999997 111.925 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -72.22 -29.58 64.09 Favored 'General case' 0 C--O 1.193 -1.899 0 N-CA-C 112.796 0.665 . . . . 73.140000000000001 112.796 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.4 mmt -67.5 -48.93 65.66 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.012 -0.675 . . . . 73.450000000000003 111.66 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.33 -50.16 55.29 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.249 -0.98 . . . . 71.099999999999994 110.961 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.93 -40.2 97.04 Favored Glycine 0 C--O 1.239 0.418 0 N-CA-C 111.445 -0.662 . . . . 72.019999999999996 111.445 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.516 ' O ' HG21 ' A' ' 133' ' ' ILE . . . -64.44 -58.07 11.36 Favored Glycine 0 CA--C 1.482 -1.99 0 CA-C-O 119.007 -0.885 . . . . 74.140000000000001 111.928 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -57.67 -36.11 71.48 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.86 0.83 . . . . 75.540000000000006 112.44 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.3 m -61.1 -51.84 67.42 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 120.736 -0.385 . . . . 73.439999999999998 110.259 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.4 -50.49 15.86 Favored Glycine 0 C--O 1.25 1.113 0 C-N-CA 121.194 -0.526 . . . . 54.140000000000001 113.858 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.516 HG21 ' O ' ' A' ' 129' ' ' GLY . 10.5 tp -63.79 -49.27 82.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-O 119.554 -0.26 . . . . 74.420000000000002 110.879 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.696 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 71.8 t -62.84 -47.35 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 120.046 -0.662 . . . . 64.25 112.148 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.406 ' HA ' HG13 ' A' ' 16' ' ' ILE . 26.6 t-20 -55.38 -62.03 1.95 Allowed 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 111.98 0.363 . . . . 71.420000000000002 111.98 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 35.9 tt0 -80.4 -41.05 25.31 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 119.538 -0.865 . . . . 72.200000000000003 113.327 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -35.69 78.23 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.116 -1.034 . . . . 75.299999999999997 110.144 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.696 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 3.1 mm? -68.82 -51.82 36.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.129 0.49 . . . . 74.109999999999999 110.13 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.616 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 1.6 tmm_? -63.65 -36.34 83.5 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 115.691 -0.686 . . . . 71.140000000000001 110.416 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -74.7 -34.77 62.69 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 122.836 0.454 . . . . 74.340000000000003 109.789 -179.07 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.5 -26.98 63.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.469 0.652 . . . . 74.430000000000007 110.765 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.408 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 25.6 m -85.66 -25.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 C-N-CA 119.701 -0.799 . . . . 62.130000000000003 111.466 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 51.7 mt-10 -76.42 -41.89 46.11 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.628 -0.879 . . . . 74.120000000000005 108.628 174.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 . . . . . 0 CA--C 1.509 -0.626 0 C-N-CA 126.465 1.906 . . . . 62.020000000000003 110.499 -174.852 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -1.854 0 N-CA-C 106.274 -1.75 . . . . 71.299999999999997 106.274 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.414 ' H ' HD23 ' A' ' 9' ' ' LEU . 2.4 pt? -74.23 119.47 76.54 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 120.079 -0.648 . . . . 64.019999999999996 110.211 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.83 -162.14 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.162 1.908 . . . . 74.540000000000006 107.73 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -72.51 105.11 4.05 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 118.535 -1.266 . . . . 70.299999999999997 108.51 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 72.7 mt -91.25 123.67 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 106.912 -1.514 . . . . 75.409999999999997 106.912 -177.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.4 m -119.51 129.2 54.58 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 108.149 -1.056 . . . . 73.519999999999996 108.149 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -139.49 132.55 29.56 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.244 -1.391 . . . . 72.430000000000007 107.244 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 p -117.98 140.72 49.33 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 109.391 -0.596 . . . . 54.5 109.391 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.32 140.49 19.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.876 -0.787 . . . . 74.310000000000002 108.876 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' THR . 12.7 p -99.24 118.96 37.09 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.746 0.784 . . . . 72.109999999999999 112.389 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.4 140.07 30.12 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.723 -1.126 . . . . 72.430000000000007 109.633 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.4 30.67 0.69 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.441 0.639 . . . . 75.230000000000004 110.663 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.403 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -127.83 163.92 40.15 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.256 -1.016 . . . . 75.150000000000006 108.256 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 36.0 Cg_endo -66.13 152.72 80.51 Favored 'Trans proline' 0 C--O 1.255 1.362 0 C-N-CA 122.433 2.088 . . . . 64.349999999999994 110.724 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 tt -61.26 -31.38 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.009 -0.541 . . . . 71.219999999999999 112.021 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.589 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.2 pt20 -60.29 -45.14 94.39 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.619 0.247 . . . . 61.130000000000003 110.891 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -68.06 -39.5 82.99 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.374 -0.375 . . . . 72.040000000000006 111.91 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.6 -41.1 87.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.504 -0.554 . . . . 61.520000000000003 109.504 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.534 ' CZ2' ' HD3' ' A' ' 71' ' ' PRO . 60.3 t90 -63.9 -46.61 84.07 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.153 -0.93 . . . . 72.239999999999995 110.063 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 41.2 mt-10 -63.61 -37.99 89.42 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 120.991 -0.284 . . . . 53.399999999999999 110.544 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.0 m -56.84 -36.07 69.56 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.935 0.398 . . . . 64.019999999999996 111.384 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.662 HG11 ' CE1' ' A' ' 98' ' ' PHE . 30.9 m -103.76 16.04 5.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 112.018 0.377 . . . . 73.019999999999996 112.018 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.6 t -145.88 6.63 1.05 Allowed 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.012 -0.675 . . . . 44.520000000000003 112.146 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.9 p -108.32 170.3 8.1 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 121.775 -0.578 . . . . 72.319999999999993 110.555 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 t -59.91 -62.17 2.07 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 124.143 0.902 . . . . 72.219999999999999 111.103 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -78.05 -27.92 48.81 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 119.57 -0.852 . . . . 73.409999999999997 111.883 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.93 -48.68 84.48 Favored Glycine 0 C--O 1.216 -1.018 0 N-CA-C 110.888 -0.885 . . . . 54.310000000000002 110.888 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.18 -43.76 78.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 122.026 0.917 . . . . 74.120000000000005 110.359 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.84 0 N-CA-C 113.884 1.068 . . . . 54.210000000000001 113.884 -175.456 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 CA--C 1.503 -0.852 0 N-CA-C 109.923 -0.399 . . . . 73.420000000000002 109.923 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.93 53.37 2.8 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.73 0.776 . . . . 73.120000000000005 110.765 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -72.31 152.28 42.21 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.138 -0.937 . . . . 74.340000000000003 108.573 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -137.55 151.53 48.48 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.888 -0.782 . . . . 72.140000000000001 108.888 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -75.41 104.45 5.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.539 -1.652 . . . . 72.430000000000007 106.539 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' O ' HG13 ' A' ' 65' ' ' VAL . 12.9 tptp -134.82 132.14 38.31 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 107.186 -1.412 . . . . 71.430000000000007 107.186 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -95.55 86.96 4.59 Favored 'General case' 0 C--N 1.26 -3.321 0 CA-C-O 122.674 1.225 . . . . 73.510000000000005 108.571 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.09 105.14 2.26 Favored Glycine 1 N--CA 1.395 -4.084 0 CA-C-N 113.256 -1.793 . . . . 71.329999999999998 109.564 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.781 0 N-CA-C 106.931 -1.507 . . . . 75.519999999999996 106.931 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.417 -2.075 0 CA-C-O 121.47 0.652 . . . . 72.519999999999996 111.726 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -137.24 138.41 40.09 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 107.009 -1.478 . . . . 74.219999999999999 107.009 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 47' ' ' LYS . 23.5 t -88.71 135.09 26.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 C-N-CA 119.516 -0.874 . . . . 72.409999999999997 109.249 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -76.53 -60.43 2.35 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.248 -1.76 . . . . 74.349999999999994 106.248 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.95 152.93 6.72 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.19 -0.914 . . . . 60.229999999999997 108.912 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.41 118.58 57.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 105.957 -1.868 . . . . 73.230000000000004 105.957 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 14.9 mm-40 -98.42 140.18 33.06 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.871 -0.788 . . . . 63.030000000000001 108.871 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.69 126.8 93.07 Favored Pre-proline 0 C--N 1.265 -3.094 0 CA-C-N 113.739 -1.573 . . . . 64.329999999999998 107.966 -168.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.534 ' HD3' ' CZ2' ' A' ' 26' ' ' TRP . 92.0 Cg_exo 2.03 51.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.117 1 C-N-CA 127.601 5.534 . . . . 71.349999999999994 117.351 -159.228 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.2 p -138.78 -39.14 0.5 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.005 -0.998 . . . . 73.430000000000007 111.557 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 36.9 tt0 -151.2 149.0 28.92 Favored 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 119.046 -1.062 . . . . 62.520000000000003 111.347 -174.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.534 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -137.0 134.06 36.21 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.613 -1.255 . . . . 75.420000000000002 107.613 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.471 ' OG ' HG21 ' A' ' 86' ' ' THR . 22.4 m -141.62 126.53 18.21 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.819 -0.352 . . . . 60.219999999999999 111.266 177.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -143.91 154.0 42.89 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.819 -0.438 . . . . 73.120000000000005 109.819 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -122.86 124.71 43.87 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 123.066 0.546 . . . . 73.140000000000001 109.585 -171.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 6.4 t-105 -117.38 115.63 25.61 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.971 -1.492 . . . . 75.510000000000005 106.971 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -82.6 152.57 25.87 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.584 -0.846 . . . . 73.310000000000002 109.16 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.6 m 74.88 84.84 0.1 Allowed 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 123.858 0.863 . . . . 74.200000000000003 110.235 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 57.87 0.41 0.11 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 127.263 2.225 . . . . 73.099999999999994 115.62 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.45 -35.41 20.18 Favored Glycine 0 C--N 1.312 -0.796 0 N-CA-C 110.645 -0.982 . . . . 75.0 110.645 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 52.3 m95 66.63 -161.82 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.272 1.429 . . . . 75.519999999999996 109.766 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 p -116.67 126.68 74.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.99 -0.744 . . . . 71.510000000000005 108.99 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.4 m -116.31 136.61 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 CA-C-N 115.299 -0.864 . . . . 73.120000000000005 110.301 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.471 HG21 ' OG ' ' A' ' 75' ' ' SER . 34.9 m -124.54 127.03 46.79 Favored 'General case' 0 C--N 1.279 -2.498 0 N-CA-C 107.535 -1.283 . . . . 74.430000000000007 107.535 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD2' HD13 ' A' ' 74' ' ' LEU . 13.4 m-85 -112.38 130.11 56.08 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.465 -0.939 . . . . 72.109999999999999 108.465 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -109.33 137.5 47.11 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.439 -0.8 . . . . 73.219999999999999 110.257 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.39 120.34 40.01 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.281 -0.872 . . . . 75.439999999999998 110.026 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -111.54 116.83 31.51 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.207 -1.034 . . . . 71.040000000000006 108.207 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.86 123.39 27.18 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.267 0.556 . . . . 74.420000000000002 109.528 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.6 mt -126.35 159.54 32.91 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.33 -0.85 . . . . 63.119999999999997 109.204 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.67 128.16 8.52 Favored Glycine 0 N--CA 1.409 -3.132 0 N-CA-C 108.693 -1.763 . . . . 63.009999999999998 108.693 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 83.89 -3.81 1.11 Allowed 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 125.011 1.324 . . . . 74.010000000000005 111.977 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -164.46 173.41 12.15 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.002 -0.74 . . . . 71.25 109.002 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' THR . 85.3 m -124.79 132.64 53.33 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.368 -0.604 . . . . 61.32 109.368 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.56 105.03 3.25 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 110.059 -1.216 . . . . 51.140000000000001 110.059 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.662 ' CE1' HG11 ' A' ' 29' ' ' VAL . 67.9 t80 -98.33 134.28 41.56 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.998 -0.741 . . . . 74.140000000000001 108.998 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 m -125.14 125.79 44.25 Favored 'General case' 0 N--CA 1.405 -2.678 0 C-N-CA 119.619 -0.832 . . . . 51.009999999999998 109.23 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.488 HD21 ' CE3' ' A' ' 130' ' ' TRP . 1.8 tp -100.26 124.04 45.22 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.074 -1.084 . . . . 72.310000000000002 108.074 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 3.5 mp -121.26 124.59 72.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 106.923 -1.51 . . . . 72.329999999999998 106.923 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -120.69 122.1 39.71 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.15 -1.056 . . . . 74.310000000000002 108.15 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -142.87 163.93 31.46 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.814 -1.551 . . . . 54.340000000000003 106.814 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -179.1 132.37 1.87 Allowed Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 108.502 -1.839 . . . . 62.439999999999998 108.502 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 31.5 t90 . . . . . 0 C--N 1.296 -1.746 0 C-N-CA 119.228 -0.989 . . . . 74.120000000000005 110.291 -178.151 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.22 -0.482 0 N-CA-C 104.82 -2.289 . . . . 64.310000000000002 104.82 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.9 pt -58.72 -32.63 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 118.418 0.554 . . . . 60.420000000000002 112.038 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.3 -113.12 3.91 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.61 -0.805 . . . . 71.420000000000002 113.702 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.84 -9.35 58.19 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.22 0.822 . . . . 65.010000000000005 113.22 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.72 -22.4 61.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.073 -0.343 . . . . 62.420000000000002 110.073 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 53.1 t30 43.01 89.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.655 1.582 . . . . 71.450000000000003 114.806 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.18 154.18 38.76 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 100.297 -3.964 . . . . 75.540000000000006 100.297 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.435 ' HB2' HG22 ' A' ' 121' ' ' VAL . 9.9 mmpt? -72.38 122.19 20.78 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 119.629 1.104 . . . . 72.409999999999997 111.776 -168.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 11.0 p -44.44 -50.47 9.33 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 125.119 1.368 . . . . 74.400000000000006 114.276 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.6 p -65.35 -45.86 82.52 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 116.337 -0.392 . . . . 65.329999999999998 112.026 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 118' ' ' LYS . 11.0 m -70.62 -33.55 53.56 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 C-N-CA 119.909 -0.716 . . . . 74.120000000000005 110.346 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 118' ' ' LYS . 69.5 t -60.22 -46.92 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 O-C-N 123.087 0.242 . . . . 54.229999999999997 110.368 176.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -57.47 -46.43 83.67 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.53 -0.759 . . . . 72.230000000000004 110.361 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.64 -47.25 50.37 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.598 -0.728 . . . . 63.0 113.0 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.466 ' O ' ' HA3' ' A' ' 129' ' ' GLY . 0.9 OUTLIER -62.79 -31.92 72.99 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 123.789 0.836 . . . . 64.450000000000003 112.425 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 25.8 mmt -72.71 -48.94 34.65 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.863 -0.735 . . . . 73.420000000000002 110.956 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.86 -65.74 0.63 Allowed 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.507 0.67 . . . . 72.0 110.548 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.04 -31.54 66.64 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.437 -0.801 . . . . 73.129999999999995 112.813 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -67.07 -59.3 7.06 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-O 119.408 -0.662 . . . . 74.409999999999997 112.013 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.488 ' CE3' HD21 ' A' ' 100' ' ' LEU . 97.7 m95 -61.88 -35.95 79.84 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 117.833 0.817 . . . . 72.329999999999998 112.833 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.8 m -62.28 -50.19 72.66 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 120.786 -0.366 . . . . 75.219999999999999 110.586 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.33 -48.21 19.77 Favored Glycine 0 C--O 1.247 0.939 0 C-N-CA 121.102 -0.57 . . . . 42.130000000000003 113.511 -177.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.57 -60.71 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 123.218 0.607 . . . . 64.140000000000001 110.347 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.408 ' HA ' HD23 ' A' ' 138' ' ' LEU . 98.0 t -57.64 -44.4 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 113.049 0.759 . . . . 74.319999999999993 113.049 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -56.4 -63.95 1.02 Allowed 'General case' 0 C--O 1.246 0.912 0 N-CA-C 112.143 0.423 . . . . 74.319999999999993 112.143 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -79.43 -34.84 41.31 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.184 0.809 . . . . 73.549999999999997 113.184 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -70.32 -39.43 74.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.534 -0.867 . . . . 75.519999999999996 111.265 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.5 mm? -70.47 -43.21 70.27 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 119.468 -0.893 . . . . 62.140000000000001 110.594 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -58.25 -37.2 74.44 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.045 -0.525 . . . . 72.239999999999995 110.094 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -74.37 -37.1 63.55 Favored 'General case' 0 C--O 1.199 -1.558 0 N-CA-C 113.782 1.031 . . . . 64.109999999999999 113.782 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.72 -23.94 65.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.832 0.349 . . . . 41.32 111.377 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.1 m -90.81 -23.32 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 120.739 -0.384 . . . . 75.540000000000006 110.715 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -82.39 -54.56 5.12 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.122 0.416 . . . . 62.539999999999999 112.122 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 C--N 1.312 -1.052 0 N-CA-C 109.746 -0.464 . . . . 71.109999999999999 109.746 -177.686 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.683 ' O ' HG22 ' A' ' 112' ' ' ILE . . . . . . . . 0 CA--C 1.497 -1.071 0 CA-C-O 119.339 -0.363 . . . . 73.230000000000004 111.857 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.51 HD22 ' HE ' ' A' ' 123' ' ' ARG 0.38 4.5 mm? 97.08 85.6 0.02 OUTLIER Pre-proline 0 CA--C 1.51 -0.59 0 C-N-CA 127.27 2.228 . . . . 74.439999999999998 116.737 -176.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -91.93 -153.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.684 0 C-N-CA 123.623 2.882 . . . . 43.520000000000003 109.023 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 5.6 p-10 -58.5 146.82 34.02 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.672 0.789 . . . . 64.329999999999998 113.068 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.7 tp -152.42 139.38 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.226 -0.657 . . . . 70.109999999999999 109.226 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.1 m -113.42 140.1 48.35 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.406 -0.59 . . . . 74.349999999999994 109.406 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.474 ' HD3' ' N ' ' A' ' 15' ' ' SER . 5.7 tmtt? -141.56 137.73 32.18 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.489 -1.671 . . . . 72.540000000000006 106.489 175.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.474 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 24.5 p -118.23 150.19 39.85 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.392 0.542 . . . . 71.109999999999999 111.096 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -158.65 134.7 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.582 -0.525 . . . . 74.219999999999999 109.582 177.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.34 130.95 44.45 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.404 0.621 . . . . 71.230000000000004 111.706 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 2.5 mm? -99.74 139.28 35.62 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 123.411 0.685 . . . . 73.439999999999998 109.784 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' HG3' ' NH2' ' A' ' 139' ' ' ARG . 20.8 mm-40 -92.67 27.49 2.31 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.574 0.702 . . . . 64.319999999999993 109.131 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -122.6 161.98 40.84 Favored Pre-proline 0 C--O 1.246 0.912 0 C-N-CA 123.826 0.851 . . . . 75.329999999999998 109.255 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 20' ' ' ALA . 35.7 Cg_endo -64.9 149.49 89.44 Favored 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 122.713 2.275 . . . . 74.329999999999998 110.921 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.1 tt -56.81 -34.02 42.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.611 -0.722 . . . . 72.519999999999996 112.399 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 29.9 pt20 -64.88 -36.5 84.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.919 0.39 . . . . 55.409999999999997 111.069 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -79.67 -28.74 40.74 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 112.037 0.384 . . . . 74.439999999999998 112.037 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.2 -42.14 75.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.157 -1.053 . . . . 65.209999999999994 108.157 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 54.4 t90 -59.72 -47.79 84.26 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.617 -1.174 . . . . 74.310000000000002 111.303 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.568 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 9.3 pt-20 -70.05 -27.87 65.0 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 119.925 -0.71 . . . . 72.200000000000003 112.289 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 m -59.46 -35.63 74.44 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.2 0.524 . . . . 72.0 110.401 174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.584 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 26.4 m -106.9 25.1 2.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 112.186 0.439 . . . . 64.439999999999998 112.186 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.568 ' OG ' ' HA ' ' A' ' 27' ' ' GLU . 60.2 p -141.37 -11.33 0.94 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.733 0.642 . . . . 75.430000000000007 112.733 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -94.25 161.63 14.18 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 120.306 -0.558 . . . . 72.129999999999995 111.434 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -50.12 -56.53 10.53 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 125.772 1.629 . . . . 65.209999999999994 111.553 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.14 -33.3 56.73 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.947 0.721 . . . . 72.5 112.947 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.99 -48.2 67.7 Favored Glycine 0 CA--C 1.505 -0.592 0 C-N-CA 120.905 -0.664 . . . . 75.319999999999993 111.691 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.3 mt -70.42 -45.42 75.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.204 0.526 . . . . 73.209999999999994 111.383 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 112.859 0.688 . . . . 55.149999999999999 112.859 -176.212 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.3 t30 . . . . . 0 CA--C 1.484 -1.566 0 N-CA-C 104.278 -2.49 . . . . 73.049999999999997 104.278 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -93.44 79.25 4.38 Favored 'General case' 0 C--N 1.281 -2.379 0 C-N-CA 118.741 -1.184 . . . . 75.019999999999996 113.082 -171.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -75.16 119.04 18.76 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.43 -1.692 . . . . 73.450000000000003 106.43 168.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -125.09 153.4 42.99 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.893 -1.521 . . . . 71.549999999999997 106.893 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.495 HD12 HG21 ' A' ' 68' ' ' VAL . 3.5 mm? -74.09 102.9 4.36 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 116.689 -2.004 . . . . 61.119999999999997 107.996 175.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 39.5 tptt -132.73 132.79 42.7 Favored 'General case' 0 N--CA 1.391 -3.418 0 N-CA-C 105.694 -1.965 . . . . 63.140000000000001 105.694 171.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -86.4 66.63 9.61 Favored 'General case' 0 C--N 1.259 -3.36 0 CA-C-O 122.27 1.033 . . . . 61.5 109.23 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 123.43 51.9 0.21 Allowed Glycine 0 N--CA 1.397 -3.921 0 CA-C-N 114.579 -1.191 . . . . 64.420000000000002 110.142 -176.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.512 ' H ' ' HB ' ' A' ' 65' ' ' VAL . 12.2 tt0 . . . . . 0 CA--C 1.498 -1.054 0 N-CA-C 106.534 -1.654 . . . . 65.420000000000002 106.534 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.425 -1.716 0 N-CA-C 108.176 -1.046 . . . . 60.229999999999997 108.176 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -143.07 147.11 34.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.394 -1.706 . . . . 74.030000000000001 106.394 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.512 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 42.9 t -90.32 137.45 21.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.636 -1.246 . . . . 64.239999999999995 107.636 177.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.74 -61.56 1.95 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.084 -1.45 . . . . 74.430000000000007 107.084 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.56 156.76 10.02 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.119 -1.067 . . . . 64.099999999999994 108.119 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 46' ' ' LEU . 13.5 p -125.04 135.17 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-O 121.177 0.513 . . . . 61.539999999999999 110.396 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 71.9 mm-40 -102.81 141.16 36.09 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.314 -0.995 . . . . 75.409999999999997 108.314 173.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.88 127.04 93.33 Favored Pre-proline 0 C--N 1.266 -3.031 0 N-CA-C 107.401 -1.333 . . . . 74.099999999999994 107.401 -168.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo 4.12 48.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.077 1 C-N-CA 127.628 5.552 . . . . 72.200000000000003 117.895 -161.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -137.65 -35.24 0.66 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.264 -0.425 . . . . 74.219999999999999 109.983 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 38.8 tt0 -149.55 148.28 29.18 Favored 'General case' 0 C--O 1.205 -1.237 0 C-N-CA 118.574 -1.25 . . . . 74.329999999999998 110.363 -175.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.582 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -143.04 130.91 21.55 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 107.705 -1.22 . . . . 64.340000000000003 107.705 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -132.66 127.1 34.13 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 110.224 -0.287 . . . . 74.099999999999994 110.224 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.254 35.8 p90 -145.81 157.84 43.9 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.208 -0.308 . . . . 74.109999999999999 111.768 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.262 36.1 mt-10 -120.07 144.67 47.46 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 123.624 0.77 . . . . 74.329999999999998 109.97 -169.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -114.67 120.47 40.23 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.0 -2.222 . . . . 72.230000000000004 105.0 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -83.11 10.61 7.79 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.619 0.723 . . . . 74.540000000000006 112.866 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.4 p -90.76 92.64 8.89 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 107.857 -1.164 . . . . 74.349999999999994 107.857 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 78.08 6.93 2.6 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.91 1.284 . . . . 64.439999999999998 112.403 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.87 62.73 3.07 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 114.805 -1.089 . . . . 61.32 113.777 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -100.28 150.64 22.36 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.825 -0.75 . . . . 74.040000000000006 109.742 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.13 109.93 2.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 108.216 -1.031 . . . . 75.140000000000001 108.216 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.11 154.67 5.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 115.86 -0.609 . . . . 63.399999999999999 109.817 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 15.3 m -139.89 140.3 36.43 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.179 -0.674 . . . . 70.450000000000003 109.179 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.584 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 15.0 m-85 -113.66 139.59 48.92 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.578 -1.267 . . . . 74.549999999999997 107.578 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.22 133.74 55.41 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.094 -1.076 . . . . 73.219999999999999 108.094 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.03 128.02 56.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.453 0.644 . . . . 74.150000000000006 109.948 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -115.96 130.84 57.0 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.692 -1.225 . . . . 74.420000000000002 107.692 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -94.29 121.17 35.53 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.417 0.627 . . . . 72.140000000000001 109.798 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 81.1 mt -114.2 156.0 25.06 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.245 -1.02 . . . . 60.229999999999997 108.245 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.95 49.57 4.25 Favored Glycine 0 C--N 1.289 -2.072 0 CA-C-N 116.255 -0.43 . . . . 51.310000000000002 112.137 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -177.17 -40.56 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.808 0.813 . . . . 60.439999999999998 109.118 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 9.2 ptpt -149.42 175.97 11.0 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 115.461 -0.79 . . . . 74.530000000000001 108.961 -171.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 64.8 m -108.22 130.4 55.15 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 109.03 -0.73 . . . . 65.140000000000001 109.03 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.53 124.4 7.59 Favored Glycine 0 N--CA 1.416 -2.675 0 N-CA-C 110.072 -1.211 . . . . 74.329999999999998 110.072 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.545 ' CE1' HG13 ' A' ' 29' ' ' VAL . 93.1 t80 -112.06 134.33 53.68 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-O 121.195 0.522 . . . . 71.420000000000002 110.077 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 m -124.01 126.3 46.04 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.976 -1.12 . . . . 70.239999999999995 107.976 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -103.03 138.7 39.55 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.84 0.829 . . . . 73.329999999999998 108.788 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.53 124.86 41.14 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.033 0 CA-C-N 113.457 -1.701 . . . . 64.140000000000001 107.673 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 4.3 t60 -112.77 127.38 56.13 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 104.807 -2.294 . . . . 71.129999999999995 104.807 173.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -142.24 164.86 29.02 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.66 -1.978 . . . . 74.209999999999994 105.66 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.11 178.71 39.37 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 119.698 -1.239 . . . . 44.039999999999999 111.848 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 105.192 -2.151 . . . . 71.129999999999995 105.192 178.0 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 105.73 -1.952 . . . . 74.409999999999997 105.73 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.683 HG22 ' O ' ' A' ' 8' ' ' ALA . 6.9 pt -62.07 -32.85 55.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 118.428 0.558 . . . . 55.140000000000001 111.959 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.77 -127.28 6.48 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.563 -0.827 . . . . 64.409999999999997 112.467 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -69.75 -9.32 54.08 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.713 1.205 . . . . 55.109999999999999 114.023 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.44 84.24 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.035 0.754 . . . . 75.150000000000006 113.035 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -148.46 165.31 31.54 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 122.432 -0.167 . . . . 71.239999999999995 110.793 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.04 -68.24 0.33 Allowed 'General case' 0 C--N 1.316 -0.871 0 O-C-N 124.615 1.197 . . . . 65.299999999999997 111.243 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' HG22 ' A' ' 122' ' ' VAL . 34.1 mtmm -106.34 151.35 24.98 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 113.245 0.831 . . . . 71.049999999999997 113.245 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.0 t -77.15 -30.19 54.93 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.349 -0.982 . . . . 71.439999999999998 108.349 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.3 t -64.48 -41.68 96.33 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.09 -0.504 . . . . 74.230000000000004 110.574 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.69 -33.5 53.12 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.763 0 C-N-CA 119.698 -0.801 . . . . 65.450000000000003 110.33 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 118' ' ' LYS . 76.4 t -65.2 -41.67 92.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.254 -0.43 . . . . 72.299999999999997 110.067 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.51 ' HE ' HD22 ' A' ' 9' ' ' LEU . 2.9 tpm_? -54.44 -52.81 60.62 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.518 -0.765 . . . . 73.530000000000001 109.474 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -62.51 -54.31 35.08 Favored Glycine 0 CA--C 1.505 -0.576 0 O-C-N 123.623 0.577 . . . . 54.420000000000002 113.232 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -60.35 -41.01 92.77 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.483 0.92 . . . . 63.350000000000001 113.483 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.94 -39.59 42.28 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.226 -0.99 . . . . 72.030000000000001 110.98 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -67.39 -61.51 1.87 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.73 -0.47 . . . . 53.420000000000002 109.73 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -69.91 -32.34 69.95 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.262 -0.881 . . . . 71.310000000000002 111.895 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.76 -58.73 7.92 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-O 119.776 -0.458 . . . . 61.229999999999997 112.507 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -63.58 -36.69 84.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 113.281 0.845 . . . . 75.340000000000003 113.281 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.9 p -65.58 -51.31 60.74 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.767 -0.773 . . . . 70.540000000000006 111.412 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.54 -47.92 32.13 Favored Glycine 0 C--O 1.245 0.801 0 C-N-CA 121.01 -0.614 . . . . 60.520000000000003 113.329 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.62 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 45.9 mm -65.25 -51.26 67.2 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 N-CA-C 111.475 0.176 . . . . 73.219999999999999 111.475 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 97.5 t -62.14 -48.92 86.2 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.575 0 C-N-CA 119.269 -0.972 . . . . 74.25 110.68 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.424 ' HA ' HG13 ' A' ' 16' ' ' ILE . 9.7 t30 -60.76 -63.68 1.21 Allowed 'General case' 0 C--O 1.252 1.235 0 C-N-CA 119.654 -0.818 . . . . 74.310000000000002 112.741 -175.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.69 -41.11 18.09 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 118.773 -1.171 . . . . 71.510000000000005 112.737 -174.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.62 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 14.4 tpp180 -70.55 -37.55 74.05 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.023 -0.671 . . . . 74.299999999999997 111.851 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 0.1 OUTLIER -68.22 -44.31 76.04 Favored 'General case' 0 C--O 1.251 1.139 0 N-CA-C 107.314 -1.365 . . . . 75.299999999999997 107.314 177.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.624 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -60.5 -36.95 79.58 Favored 'General case' 0 C--O 1.203 -1.378 0 CA-C-N 116.046 -0.525 . . . . 70.030000000000001 110.495 177.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 10.9 mmmm -73.33 -35.6 66.06 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 114.616 1.339 . . . . 74.219999999999999 114.616 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.97 -33.94 76.46 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.488 -0.485 . . . . 74.430000000000007 109.707 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.0 m -85.04 -21.56 7.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-N 116.015 -0.539 . . . . 63.210000000000001 111.927 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 78.8 mm-40 -77.68 -33.05 53.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.331 -0.548 . . . . 63.350000000000001 109.914 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 . . . . . 0 CA--C 1.548 0.869 0 CA-C-N 115.905 -0.589 . . . . 63.530000000000001 110.332 178.727 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 106.668 -1.605 . . . . 73.209999999999994 106.668 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.7 tp -111.25 96.37 30.45 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.628 -0.879 . . . . 75.349999999999994 108.628 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 2.7 Cg_exo -75.92 -179.43 5.18 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.126 2.551 . . . . 62.009999999999998 112.829 -177.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 8.4 m-20 -65.09 124.27 21.68 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.344 -0.844 . . . . 74.439999999999998 111.033 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.4 mt -110.3 130.71 63.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.407 -1.331 . . . . 74.319999999999993 107.407 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 m -126.25 129.17 48.39 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.746 -0.835 . . . . 73.209999999999994 108.746 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -141.41 133.9 28.32 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.285 -1.376 . . . . 72.120000000000005 107.285 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 m -116.69 139.57 50.4 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 107.278 -1.379 . . . . 74.349999999999994 107.278 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.439 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -148.59 133.83 10.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.512 -0.921 . . . . 74.400000000000006 108.512 -178.393 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.448 ' CG2' ' HG3' ' A' ' 95' ' ' LYS . 3.4 m -104.37 125.59 50.73 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.775 -0.824 . . . . 70.109999999999999 108.775 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 138' ' ' LEU . 4.7 mp -102.44 140.5 36.64 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.065 -0.516 . . . . 75.519999999999996 110.415 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -82.86 51.31 1.88 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.908 -0.775 . . . . 72.519999999999996 108.908 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.34 159.55 51.62 Favored Pre-proline 0 N--CA 1.433 -1.285 0 CA-C-N 115.787 -0.642 . . . . 72.099999999999994 109.838 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.25 156.47 55.47 Favored 'Trans proline' 0 C--O 1.262 1.713 0 C-N-CA 122.944 2.429 . . . . 71.109999999999999 111.199 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.8 tt -64.72 -29.83 48.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.64 -0.709 . . . . 74.319999999999993 112.014 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -72.07 -28.78 63.55 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.695 -0.802 . . . . 75.510000000000005 111.796 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -77.37 -41.73 39.12 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.712 -0.395 . . . . 75.420000000000002 109.975 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG11 HG22 ' A' ' 96' ' ' THR . 7.1 p -65.47 -39.1 84.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.48 -0.563 . . . . 75.540000000000006 109.48 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.468 ' NE1' ' HD3' ' A' ' 71' ' ' PRO . 66.9 t90 -58.89 -47.19 85.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.192 -0.913 . . . . 74.319999999999993 111.376 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.03 -33.25 75.13 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 119.398 -0.921 . . . . 62.509999999999998 110.19 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 94.9 m -62.02 -15.41 44.04 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 121.583 0.706 . . . . 54.310000000000002 112.129 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.439 HG13 ' CE1' ' A' ' 98' ' ' PHE . 20.3 m -121.83 7.53 5.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.082 -1.011 . . . . 61.539999999999999 112.009 176.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.7 m -127.71 -11.62 5.5 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.753 0.649 . . . . 64.109999999999999 112.753 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.5 p -91.61 163.23 14.19 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.106 -0.701 . . . . 74.439999999999998 109.106 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.55 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 9.3 m -53.36 -47.09 69.72 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.153 0.581 . . . . 72.310000000000002 111.615 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.402 ' OE1' ' HB2' ' A' ' 32' ' ' SER . 1.4 mp0 -64.92 -48.77 72.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.721 -0.672 . . . . 73.310000000000002 110.729 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.26 -43.66 94.92 Favored Glycine 0 C--O 1.247 0.962 0 CA-C-N 115.427 -0.806 . . . . 36.920000000000002 113.233 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.85 -43.72 97.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 109.907 -0.405 . . . . 74.519999999999996 109.907 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 112.199 0.444 . . . . 36.920000000000002 112.199 176.167 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.55 ' O ' ' HB3' ' A' ' 32' ' ' SER . 12.7 m120 . . . . . 0 CA--C 1.489 -1.387 0 N-CA-C 106.066 -1.827 . . . . 73.400000000000006 106.066 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -92.72 70.66 4.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 112.554 0.576 . . . . 71.439999999999998 112.554 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -78.51 119.95 22.53 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 106.206 -1.775 . . . . 74.140000000000001 106.206 172.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -124.5 149.58 46.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 112.688 0.625 . . . . 64.430000000000007 112.688 -171.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.1 tp -82.76 106.13 14.35 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.211 -0.904 . . . . 62.43 108.793 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -133.67 141.54 47.63 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.223 -2.139 . . . . 73.349999999999994 105.223 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.517 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 7.8 pt-20 -93.96 75.94 4.15 Favored 'General case' 0 C--N 1.27 -2.852 0 CA-C-N 120.185 1.357 . . . . 54.109999999999999 110.745 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.55 72.43 0.19 Allowed Glycine 1 N--CA 1.391 -4.348 0 CA-C-N 113.332 -1.758 . . . . 63.119999999999997 109.959 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.291 -1.95 0 N-CA-C 105.287 -2.116 . . . . 72.209999999999994 105.287 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.438 -1.05 0 CA-C-O 120.963 0.411 . . . . 72.109999999999999 111.452 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -134.56 129.33 34.86 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.779 -1.563 . . . . 75.099999999999994 106.779 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.2 t -91.2 136.7 23.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 C-N-CA 118.132 -1.427 . . . . 70.219999999999999 108.816 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.45 -60.24 2.03 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.984 -1.117 . . . . 72.109999999999999 107.984 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.88 136.47 14.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.299 -0.409 . . . . 75.129999999999995 110.739 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 48' ' ' GLU . 47.3 t -118.11 119.27 60.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.595 -0.891 . . . . 72.349999999999994 108.595 176.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 42.7 mt-30 -116.14 140.88 48.84 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.705 -0.68 . . . . 63.229999999999997 110.491 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.39 131.51 93.23 Favored Pre-proline 0 C--N 1.281 -2.389 0 CA-C-N 113.9 -1.5 . . . . 74.239999999999995 110.314 -162.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.468 ' HD3' ' NE1' ' A' ' 26' ' ' TRP . 55.3 Cg_exo 2.26 49.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.261 1 C-N-CA 128.144 5.896 . . . . 73.219999999999999 117.319 -162.293 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 p -140.71 -48.25 0.42 Allowed 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.538 -0.755 . . . . 75.010000000000005 111.138 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 32.1 tt0 -140.15 128.43 22.53 Favored 'General case' 0 C--O 1.21 -0.976 0 C-N-CA 118.802 -1.159 . . . . 70.439999999999998 110.852 -172.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.485 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -133.19 132.21 41.29 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 109.504 -0.554 . . . . 61.039999999999999 109.504 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.7 t -140.37 126.99 20.29 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.778 -0.453 . . . . 70.340000000000003 109.778 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -146.17 159.45 43.29 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 122.884 0.473 . . . . 74.400000000000006 111.098 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -117.74 122.69 44.14 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 104.679 -2.341 . . . . 71.109999999999999 104.679 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -110.63 147.79 33.54 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.124 -0.944 . . . . 73.519999999999996 111.188 -173.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 t70 71.83 -174.93 0.17 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.753 1.621 . . . . 53.43 109.902 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.5 t -85.11 -5.4 59.34 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.598 -0.688 . . . . 73.420000000000002 110.35 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -85.3 -37.48 19.93 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.789 -0.641 . . . . 73.200000000000003 110.307 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.95 60.85 1.06 Allowed Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.254 -1.138 . . . . 73.430000000000007 110.254 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -81.39 106.22 13.19 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 107.851 -1.166 . . . . 75.319999999999993 107.851 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.4 t -84.92 106.05 14.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.123 -1.066 . . . . 73.120000000000005 108.123 -177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.21 134.86 49.91 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 108.74 -0.837 . . . . 73.310000000000002 108.74 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.7 m -125.56 130.44 51.7 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.568 -0.901 . . . . 75.25 108.568 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CD2' HD13 ' A' ' 74' ' ' LEU . 11.1 m-85 -116.41 133.58 55.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.432 -0.951 . . . . 72.310000000000002 108.432 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -111.43 130.61 55.65 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 115.389 -0.823 . . . . 74.310000000000002 109.634 177.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.38 122.17 45.73 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.559 -0.746 . . . . 74.510000000000005 109.521 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -112.91 120.28 40.86 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.152 -1.055 . . . . 74.430000000000007 108.152 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -80.6 117.61 21.45 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.367 0.604 . . . . 72.409999999999997 109.772 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 7.0 mp -109.92 158.67 17.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.501 -1.666 . . . . 70.200000000000003 106.501 172.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -62.07 -37.27 94.18 Favored Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.964 -0.636 . . . . 74.140000000000001 114.371 -173.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -120.18 -3.2 10.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 117.393 0.597 . . . . 73.329999999999998 111.731 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.0 ptpt -153.17 175.78 12.66 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.61 -0.885 . . . . 44.140000000000001 108.61 -173.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.406 HG22 HG11 ' A' ' 25' ' ' VAL . 51.8 m -129.29 124.25 33.92 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.869 -0.732 . . . . 73.209999999999994 111.231 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.414 ' N ' HD13 ' A' ' 92' ' ' LEU . . . -84.18 113.44 3.74 Favored Glycine 0 N--CA 1.423 -2.207 0 N-CA-C 110.202 -1.159 . . . . 36.920000000000002 110.202 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.439 ' CE1' HG13 ' A' ' 29' ' ' VAL . 79.5 t80 -104.14 132.65 50.17 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 108.576 -0.898 . . . . 74.140000000000001 108.576 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 12.4 m -121.17 122.07 39.18 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.308 -0.997 . . . . 74.120000000000005 108.308 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.433 HD21 ' CE3' ' A' ' 130' ' ' TRP . 4.2 tp -100.78 124.47 46.47 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.821 -0.807 . . . . 72.439999999999998 108.821 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.54 124.29 66.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 106.87 -1.53 . . . . 64.129999999999995 106.87 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.529 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 8.0 t60 -112.02 113.65 26.06 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.948 -1.131 . . . . 73.319999999999993 107.948 177.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.2 m -118.28 132.87 56.27 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.137 -1.06 . . . . 73.439999999999998 108.137 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.28 132.51 11.27 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.117 -0.793 . . . . 65.310000000000002 111.117 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.0 t90 . . . . . 0 C--N 1.31 -1.146 0 CA-C-O 121.414 0.626 . . . . 72.120000000000005 109.756 179.332 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 108.14 -1.059 . . . . 75.120000000000005 108.14 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 pt -58.26 -33.16 46.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 124.347 1.059 . . . . 74.519999999999996 113.15 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.93 -137.23 8.98 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 108.807 -1.717 . . . . 71.019999999999996 108.807 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -104.28 18.76 21.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.759 0.79 . . . . 72.319999999999993 109.325 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.12 -39.5 86.48 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.838 0.828 . . . . 74.209999999999994 109.716 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -139.72 143.52 37.07 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.258 -1.756 . . . . 54.140000000000001 106.258 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -70.32 -23.84 62.9 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 113.659 0.985 . . . . 73.140000000000001 113.659 -172.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.488 ' HB2' HG22 ' A' ' 122' ' ' VAL . 75.6 mmtt -111.44 -176.51 2.96 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 122.002 -0.436 . . . . 52.399999999999999 109.876 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.1 p -130.81 -73.47 0.54 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 111.659 0.244 . . . . 64.239999999999995 111.659 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -62.06 -36.06 80.52 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 123.443 0.697 . . . . 72.120000000000005 109.295 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.66 -45.51 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.366 -0.834 . . . . 70.129999999999995 110.011 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 118' ' ' LYS . 72.9 t -61.37 -38.96 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 116.336 -0.393 . . . . 74.030000000000001 111.023 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.448 ' NH1' ' HB2' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -62.9 -45.34 92.98 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.833 -0.803 . . . . 74.420000000000002 108.833 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.42 -49.72 59.35 Favored Glycine 0 C--O 1.245 0.812 0 CA-C-N 115.738 -0.664 . . . . 63.340000000000003 111.987 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -60.5 -39.38 87.53 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.408 0.683 . . . . 72.420000000000002 112.259 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.9 mmt -68.55 -38.49 80.82 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.55 -0.46 . . . . 64.25 111.313 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.448 ' HB2' ' NH1' ' A' ' 123' ' ' ARG . 12.6 t70 -61.47 -53.11 60.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.194 -0.669 . . . . 61.530000000000001 109.194 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.37 -45.28 91.28 Favored Glycine 0 C--O 1.249 1.07 0 CA-C-N 115.108 -0.951 . . . . 73.200000000000003 111.89 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.33 -54.22 39.72 Favored Glycine 0 C--O 1.217 -0.952 0 O-C-N 123.999 0.47 . . . . 72.439999999999998 112.826 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.433 ' CE3' HD21 ' A' ' 100' ' ' LEU . 85.6 m95 -60.63 -34.95 75.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.7 0.63 . . . . 74.040000000000006 112.7 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.7 m -64.41 -55.16 22.85 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.163 0.289 . . . . 72.310000000000002 110.628 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.71 -48.21 51.07 Favored Glycine 0 C--O 1.248 0.972 0 C-N-CA 121.327 -0.463 . . . . 75.420000000000002 112.859 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.5 -57.44 12.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 CA-C-O 118.945 -0.55 . . . . 61.450000000000003 111.897 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.458 ' HA ' HD12 ' A' ' 138' ' ' LEU . 93.9 t -57.93 -42.2 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 119.079 -1.048 . . . . 62.149999999999999 112.804 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.439 ' HA ' HG13 ' A' ' 16' ' ' ILE . 36.9 t30 -54.73 -67.84 0.23 Allowed 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.473 0.483 . . . . 71.340000000000003 111.947 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -76.09 -40.33 53.29 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 120.355 -0.538 . . . . 62.149999999999999 111.982 -173.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -66.37 -44.07 84.21 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 119.444 -0.903 . . . . 73.540000000000006 111.723 -172.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 134' ' ' VAL . 10.8 mp -70.83 -43.83 67.74 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.789 -0.765 . . . . 62.119999999999997 111.419 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -60.56 -36.28 78.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.941 0.4 . . . . 60.240000000000002 110.381 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.436 ' HZ1' ' HG2' ' A' ' 144' ' ' GLU . 22.2 mmmt -75.63 -37.5 59.66 Favored 'General case' 0 C--O 1.185 -2.296 0 C-N-CA 119.807 -0.757 . . . . 71.519999999999996 112.25 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.04 -33.96 76.93 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.032 0.444 . . . . 45.420000000000002 110.756 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 28.1 m -78.96 -28.33 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 120.482 -0.487 . . . . 74.129999999999995 110.901 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -82.37 -73.67 0.38 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.416 0.627 . . . . 73.219999999999999 110.694 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.436 ' HG2' ' HZ1' ' A' ' 140' ' ' LYS . 42.5 mm-40 . . . . . 0 N--CA 1.431 -1.391 0 CA-C-N 115.019 -0.991 . . . . 72.209999999999994 109.19 -174.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.63 ' O ' HG23 ' A' ' 112' ' ' ILE . . . . . . . . 0 CA--C 1.504 -0.811 0 N-CA-C 107.592 -1.262 . . . . 51.420000000000002 107.592 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 tm? 86.89 81.15 0.05 OUTLIER Pre-proline 0 N--CA 1.411 -2.386 0 C-N-CA 129.351 3.06 . . . . 63.149999999999999 107.977 -163.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -102.27 -153.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 123.727 2.952 . . . . 70.430000000000007 110.698 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 1.1 m-20 -55.95 103.4 0.1 Allowed 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 123.893 0.746 . . . . 73.230000000000004 111.431 175.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.446 HG21 ' HB3' ' A' ' 102' ' ' HIS . 9.6 tp -102.65 131.63 50.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.952 -1.87 . . . . 74.099999999999994 105.952 170.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.9 m -117.66 129.49 55.77 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.002 0.429 . . . . 64.239999999999995 109.89 -176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -131.57 126.35 34.61 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.556 -1.276 . . . . 64.230000000000004 107.556 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.1 m -116.95 133.65 55.74 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.932 -0.396 . . . . 72.420000000000002 109.932 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.88 139.54 21.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.874 -0.787 . . . . 74.120000000000005 108.874 -175.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 p -97.67 125.11 42.25 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.208 0.527 . . . . 61.310000000000002 111.656 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.07 139.57 30.81 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.763 -0.653 . . . . 74.340000000000003 109.667 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -82.07 30.62 0.39 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.935 0.772 . . . . 73.319999999999993 111.105 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.449 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -129.23 159.57 68.39 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 116.071 -0.513 . . . . 75.209999999999994 110.732 -173.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.74 156.44 42.98 Favored 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 123.505 2.803 . . . . 74.209999999999994 112.042 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.419 HG12 HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -52.07 -41.72 33.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.167 -0.924 . . . . 62.210000000000001 111.107 -177.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 12.4 pt20 -68.35 -34.85 76.82 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 119.98 -0.688 . . . . 74.019999999999996 111.033 -176.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -71.51 -38.47 71.12 Favored 'General case' 0 N--CA 1.441 -0.901 0 O-C-N 123.297 0.373 . . . . 75.409999999999997 110.38 -174.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.455 HG23 ' HB ' ' A' ' 96' ' ' THR . 47.8 t -71.11 -41.18 75.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.097 -0.705 . . . . 70.140000000000001 109.097 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 45.8 t90 -59.83 -47.69 84.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.474 -0.785 . . . . 73.439999999999998 111.444 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 23' ' ' GLN . 11.5 pt-20 -66.29 -32.1 73.31 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.695 0.283 . . . . 42.109999999999999 110.64 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.3 m -65.66 -15.33 62.67 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 121.655 0.741 . . . . 74.530000000000001 111.683 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.588 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 13.6 m -125.3 18.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 O-C-N 121.138 -0.976 . . . . 72.299999999999997 112.276 177.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 p -134.33 -12.55 2.42 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.499 0.555 . . . . 75.519999999999996 112.499 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.9 p -94.53 163.35 13.43 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.135 -0.691 . . . . 72.120000000000005 109.135 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.53 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 17.9 t -56.64 -53.17 60.73 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 123.612 0.57 . . . . 74.040000000000006 111.094 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -57.21 -40.34 77.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.45 -0.796 . . . . 45.340000000000003 111.369 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.7 -48.01 24.17 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 120.824 -0.703 . . . . 75.120000000000005 113.372 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.3 mt -67.05 -33.29 62.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 122.699 0.4 . . . . 72.150000000000006 111.766 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 115.449 1.648 . . . . 71.219999999999999 115.449 -174.812 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 . . . . . 0 CA--C 1.496 -1.131 0 N-CA-C 110.03 -0.359 . . . . 65.019999999999996 110.03 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -137.39 69.58 1.4 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.503 0.668 . . . . 72.140000000000001 109.936 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.53 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 86.0 m-85 -91.61 136.37 33.18 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.812 -0.631 . . . . 74.340000000000003 110.015 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -137.52 143.5 41.67 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.67 -0.863 . . . . 62.329999999999998 108.67 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 46' ' ' LEU . 2.3 pt? -75.62 106.42 7.17 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.062 0.934 . . . . 73.120000000000005 110.017 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 15.8 tppt? -131.26 145.13 51.77 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.984 -1.858 . . . . 71.049999999999997 105.984 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.18 77.77 6.68 Favored 'General case' 0 C--N 1.278 -2.52 0 C-N-CA 118.773 -1.171 . . . . 73.409999999999997 109.223 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.87 67.53 0.31 Allowed Glycine 0 N--CA 1.413 -2.864 0 CA-C-N 114.695 -1.139 . . . . 71.340000000000003 112.973 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.271 0 N-CA-C 106.873 -1.528 . . . . 70.530000000000001 106.873 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.43 -1.44 0 CA-C-O 121.24 0.543 . . . . 52.109999999999999 111.883 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -154.33 127.25 8.24 Favored 'General case' 0 C--O 1.193 -1.886 0 C-N-CA 125.478 1.511 . . . . 74.140000000000001 107.23 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -89.99 123.91 42.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 106.9 -1.519 . . . . 74.040000000000006 106.9 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 tt -72.92 -60.27 2.31 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.567 -1.271 . . . . 74.340000000000003 107.567 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.33 150.01 8.89 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.522 -0.763 . . . . 62.0 109.638 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.6 p -121.89 131.85 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 121.208 0.527 . . . . 75.519999999999996 109.757 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 75.3 mm-40 -104.08 141.41 36.27 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.201 -0.909 . . . . 74.340000000000003 109.193 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.11 126.98 93.35 Favored Pre-proline 0 C--N 1.276 -2.594 0 CA-C-N 114.268 -1.333 . . . . 75.329999999999998 108.623 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo 6.75 44.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.357 1 C-N-CA 128.096 5.864 . . . . 74.129999999999995 117.715 -162.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 p -137.14 -38.5 0.62 Allowed 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.707 -0.679 . . . . 65.319999999999993 112.139 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 30.2 tt0 -150.77 147.81 27.75 Favored 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 118.316 -1.354 . . . . 63.409999999999997 111.252 -173.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.588 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.6 tm? -142.02 136.1 29.92 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.068 -0.716 . . . . 64.530000000000001 109.068 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 p -140.64 127.64 20.72 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.241 0.46 . . . . 73.430000000000007 112.241 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -141.37 156.05 45.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.413 -0.358 . . . . 72.150000000000006 110.638 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -121.25 148.87 43.7 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.242 -1.392 . . . . 71.430000000000007 107.242 -171.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.402 ' HD1' ' OG1' ' A' ' 80' ' ' THR . 9.3 t-105 -119.36 126.52 51.61 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.79 -1.559 . . . . 71.439999999999998 106.79 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -70.06 -17.1 63.23 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.606 0.965 . . . . 70.0 113.606 -170.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.402 ' OG1' ' HD1' ' A' ' 78' ' ' TRP . 67.8 p -79.49 95.41 5.8 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 120.369 -0.533 . . . . 64.230000000000004 109.911 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 82.7 -15.79 0.64 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.289 1.436 . . . . 73.25 113.461 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.85 54.61 0.81 Allowed Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.049 -1.072 . . . . 51.439999999999998 114.231 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -92.81 149.44 21.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.835 -1.172 . . . . 74.030000000000001 107.835 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.7 p -142.84 124.82 12.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.156 -0.683 . . . . 73.019999999999996 109.156 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.2 149.96 21.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 121.418 0.627 . . . . 63.329999999999998 110.446 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.1 m -135.67 137.76 42.13 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.721 -0.672 . . . . 63.310000000000002 109.761 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.588 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 12.5 m-85 -113.74 129.09 56.63 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 107.396 -1.335 . . . . 73.340000000000003 107.396 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.457 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -112.13 134.16 53.85 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 105.91 -1.885 . . . . 70.129999999999995 105.91 177.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.426 ' C ' HD21 ' A' ' 89' ' ' LEU . 6.9 tt -115.3 126.41 54.44 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.228 -0.656 . . . . 50.240000000000002 109.228 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -111.09 116.71 31.6 Favored 'General case' 0 N--CA 1.415 -2.175 0 N-CA-C 107.922 -1.14 . . . . 72.409999999999997 107.922 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -80.03 116.91 20.42 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.854 0.835 . . . . 73.140000000000001 110.364 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -120.96 159.86 24.72 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.662 -1.236 . . . . 50.350000000000001 107.662 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.57 140.82 19.21 Favored Glycine 0 C--N 1.268 -3.2 0 N-CA-C 107.599 -2.201 . . . . 51.32 107.599 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 84.63 -24.88 0.14 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.147 1.379 . . . . 74.150000000000006 111.339 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.5 175.36 14.13 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.82 -0.807 . . . . 72.310000000000002 108.82 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.455 ' HB ' HG23 ' A' ' 25' ' ' VAL . 84.8 m -126.59 129.98 49.63 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.273 -0.64 . . . . 71.049999999999997 109.273 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.61 109.89 3.6 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 110.972 -0.851 . . . . 75.25 110.972 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.406 ' CE1' HG13 ' A' ' 29' ' ' VAL . 88.4 t80 -98.5 134.14 41.88 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 109.094 -0.706 . . . . 74.219999999999999 109.094 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 88' ' ' GLN . 23.7 m -123.11 118.93 28.82 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.331 -0.989 . . . . 72.430000000000007 108.331 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.468 HD11 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.56 140.8 34.31 Favored 'General case' 0 N--CA 1.41 -2.432 0 N-CA-C 108.876 -0.787 . . . . 61.399999999999999 108.876 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.468 ' N ' HD11 ' A' ' 100' ' ' LEU . 18.5 mt -136.07 124.75 37.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.856 0 CA-C-N 113.56 -1.655 . . . . 74.540000000000006 107.821 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.446 ' HB3' HG21 ' A' ' 12' ' ' ILE . 6.1 t60 -118.92 125.19 48.88 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.048 -1.834 . . . . 73.099999999999994 106.048 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.6 t -142.29 165.54 27.14 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 106.871 -1.529 . . . . 63.109999999999999 106.871 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -135.51 156.55 22.77 Favored Glycine 0 C--N 1.289 -2.074 0 N-CA-C 109.197 -1.561 . . . . 72.019999999999996 109.197 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 . . . . . 0 C--N 1.304 -1.411 0 CA-C-N 117.527 0.663 . . . . 73.530000000000001 112.289 -178.699 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.419 -1.993 0 N-CA-C 106.77 -1.567 . . . . 71.450000000000003 106.77 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -57.0 -32.38 39.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 123.313 0.645 . . . . 51.310000000000002 112.1 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.59 46.7 0.18 Allowed Glycine 0 CA--C 1.484 -1.874 0 C-N-CA 119.793 -1.194 . . . . 35.979999999999997 111.324 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 54.79 32.81 18.32 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.76 0.824 . . . . 74.219999999999999 111.669 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.28 -15.38 62.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.977 0.894 . . . . 63.140000000000001 109.435 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -152.01 174.47 13.62 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 104.383 -2.451 . . . . 70.200000000000003 104.383 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -48.61 -86.61 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 116.289 1.959 . . . . 72.340000000000003 116.289 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -119.02 149.73 41.15 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.957 -1.127 . . . . 72.430000000000007 107.957 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.9 p -65.0 -41.0 95.76 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.602 0.593 . . . . 75.430000000000007 112.602 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.7 t -68.23 -38.85 82.28 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.458 -0.497 . . . . 55.509999999999998 111.112 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.1 m -69.04 -34.13 62.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 C-N-CA 119.976 -0.689 . . . . 75.109999999999999 109.822 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.428 ' O ' ' HG2' ' A' ' 126' ' ' MET . 56.3 t -66.94 -46.66 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 116.35 -0.387 . . . . 71.120000000000005 110.733 177.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.08 -41.15 99.37 Favored 'General case' 0 C--O 1.209 -1.077 0 N-CA-C 109.425 -0.583 . . . . 65.340000000000003 109.425 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.56 -49.24 70.93 Favored Glycine 0 CA--C 1.502 -0.75 0 CA-C-N 116.223 -0.444 . . . . 51.340000000000003 112.159 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.407 ' HE2' ' HA ' ' A' ' 122' ' ' VAL . 2.1 tmmm? -62.19 -32.64 73.31 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 123.413 0.685 . . . . 75.430000000000007 111.571 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 25.2 mmt -76.59 -44.94 32.39 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 120.338 -0.545 . . . . 64.319999999999993 110.191 176.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -58.9 -62.82 1.59 Allowed 'General case' 0 C--O 1.25 1.12 0 C-N-CA 123.912 0.885 . . . . 75.219999999999999 110.687 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.0 -42.07 60.03 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.696 -0.684 . . . . 70.319999999999993 111.866 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.565 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -58.9 -62.11 6.61 Favored Glycine 0 N--CA 1.437 -1.28 0 O-C-N 124.057 0.504 . . . . 74.109999999999999 112.043 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -60.82 -30.19 69.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.64 0.978 . . . . 75.439999999999998 113.64 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 73.1 m -63.4 -50.83 68.31 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 119.958 -0.697 . . . . 72.230000000000004 110.614 174.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.78 -46.15 54.77 Favored Glycine 0 C--O 1.251 1.218 0 C-N-CA 120.663 -0.779 . . . . 44.100000000000001 112.615 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 129' ' ' GLY . 52.1 mm -58.87 -57.86 9.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 123.023 0.529 . . . . 72.219999999999999 110.292 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.42 ' HA ' HD23 ' A' ' 138' ' ' LEU . 93.1 t -62.97 -45.99 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 112.438 0.533 . . . . 65.409999999999997 112.438 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -57.03 -61.56 2.37 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 123.22 0.325 . . . . 74.340000000000003 111.746 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -84.65 -34.21 23.1 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 119.004 -1.078 . . . . 63.25 113.723 -172.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -70.32 -39.05 75.01 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.285 -0.966 . . . . 61.399999999999999 109.711 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.6 mm? -67.69 -48.95 65.13 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.874 -0.73 . . . . 62.020000000000003 109.778 174.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -58.25 -33.26 69.18 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.361 -0.381 . . . . 75.420000000000002 111.094 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -72.89 -48.31 38.39 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 112.188 0.44 . . . . 63.420000000000002 112.188 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.01 70.5 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.946 -0.302 . . . . 72.540000000000006 111.585 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.449 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 25.6 m -79.92 -33.08 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 120.594 -0.443 . . . . 74.129999999999995 111.556 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.48 -69.0 0.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.074 -0.65 . . . . 72.109999999999999 109.334 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 . . . . . 0 CA--C 1.505 -0.776 0 C-N-CA 123.558 0.743 . . . . 64.140000000000001 111.424 174.756 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -1.931 0 N-CA-C 106.894 -1.521 . . . . 62.049999999999997 106.894 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.32 125.9 92.3 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 108.9 -0.778 . . . . 72.120000000000005 108.9 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -83.66 -158.43 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.051 2.5 . . . . 53.020000000000003 113.755 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.39 149.14 50.68 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.006 -0.997 . . . . 71.140000000000001 110.594 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 66.7 mt -123.97 139.48 50.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.82 -0.807 . . . . 73.239999999999995 108.82 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.5 m -139.58 131.38 27.52 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.904 -0.776 . . . . 62.149999999999999 108.904 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -145.88 151.43 37.86 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.376 -0.602 . . . . 63.32 109.376 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 p -117.39 151.81 36.27 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.126 -0.694 . . . . 64.340000000000003 109.126 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.433 HG23 HG11 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -158.44 143.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 107.586 -1.264 . . . . 60.299999999999997 107.586 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 p -111.08 129.62 55.86 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.272 0.558 . . . . 64.349999999999994 112.438 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -101.88 139.66 37.22 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.074 -1.084 . . . . 74.230000000000004 108.074 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.443 ' CD ' ' HE ' ' A' ' 139' ' ' ARG 0.25 0.0 OUTLIER -93.29 53.36 1.91 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.826 1.298 . . . . 61.439999999999998 112.065 -177.873 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.5 160.16 52.15 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 113.332 -1.758 . . . . 71.219999999999999 108.41 -177.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.55 155.52 57.85 Favored 'Trans proline' 0 C--O 1.257 1.459 0 C-N-CA 122.803 2.335 . . . . 75.450000000000003 111.628 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 tt -56.57 -32.67 37.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.405 -0.816 . . . . 73.150000000000006 111.794 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -62.65 -40.23 96.39 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 123.12 0.262 . . . . 52.420000000000002 110.755 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -69.41 -42.49 75.0 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 116.298 -0.41 . . . . 75.209999999999994 110.869 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG22 ' HB ' ' A' ' 96' ' ' THR . 46.0 t -66.52 -42.49 90.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.55 -0.537 . . . . 74.030000000000001 109.55 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -61.89 -47.49 84.73 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.561 -0.745 . . . . 74.530000000000001 111.208 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.455 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 13.3 pt-20 -68.47 -29.51 68.16 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.78 -0.368 . . . . 74.409999999999997 111.319 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.6 m -60.75 -29.26 69.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.368 0.604 . . . . 72.150000000000006 111.27 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.583 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 15.2 m -113.1 19.62 7.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.25 -0.432 . . . . 74.439999999999998 112.147 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.455 ' OG ' ' HA ' ' A' ' 27' ' ' GLU . 37.8 p -136.68 -20.7 1.32 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.077 0.769 . . . . 74.25 113.077 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.8 p -96.34 161.81 13.77 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 120.584 -0.446 . . . . 72.319999999999993 110.94 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 m -58.76 -55.52 34.07 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 123.588 0.555 . . . . 44.200000000000003 110.776 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.28 -44.77 84.28 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 123.653 0.781 . . . . 72.400000000000006 110.581 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -48.87 65.34 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.4 -0.818 . . . . 53.399999999999999 113.238 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.2 mt -69.45 -43.1 81.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.411 . . . . 73.120000000000005 110.777 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.897 0 N-CA-C 112.859 0.689 . . . . 74.299999999999997 112.859 177.782 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.404 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . 44.4 t-20 . . . . . 0 N--CA 1.434 -1.27 0 N-CA-C 107.629 -1.249 . . . . 73.140000000000001 107.629 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -88.93 75.12 8.09 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-O 122.076 0.941 . . . . 71.150000000000006 109.873 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 84.0 m-85 -78.79 119.81 22.53 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.622 -1.251 . . . . 73.319999999999993 107.622 172.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -117.55 146.87 43.29 Favored 'General case' 0 CA--C 1.484 -1.585 0 O-C-N 123.374 0.422 . . . . 73.209999999999994 110.23 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.1 tp -78.85 104.57 9.58 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 106.838 -1.542 . . . . 72.0 106.838 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 50' ' ' GLN . 58.2 tttm -133.33 133.67 42.82 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.148 -1.427 . . . . 74.219999999999999 107.148 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -88.14 73.07 9.04 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-O 123.033 1.396 . . . . 61.310000000000002 109.102 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.0 57.03 0.19 Allowed Glycine 1 N--CA 1.392 -4.262 0 CA-C-N 112.825 -1.989 . . . . 61.130000000000003 109.992 -177.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.311 -1.105 0 N-CA-C 105.965 -1.865 . . . . 62.310000000000002 105.965 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.423 -1.82 0 N-CA-C 108.488 -0.93 . . . . 74.129999999999995 108.488 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 53.4 mtmt -148.97 123.52 9.75 Favored 'General case' 0 C--O 1.198 -1.639 0 N-CA-C 108.435 -0.95 . . . . 63.299999999999997 108.435 177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.19 135.89 24.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.014 -1.106 . . . . 72.120000000000005 108.014 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.3 tp -80.36 -62.59 1.63 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.054 -0.721 . . . . 72.329999999999998 109.054 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.78 149.87 28.79 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.21 -0.905 . . . . 75.129999999999995 109.835 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 66.7 t -125.89 123.17 63.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.803 -0.814 . . . . 71.510000000000005 108.803 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 81.5 mm-40 -107.81 140.78 40.39 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.344 0.592 . . . . 74.340000000000003 110.291 174.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.77 123.94 88.19 Favored Pre-proline 0 C--N 1.277 -2.545 0 CA-C-N 113.873 -1.512 . . . . 72.010000000000005 109.213 -165.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo 6.86 49.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.639 1 C-N-CA 127.75 5.633 . . . . 71.329999999999998 116.603 -161.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 p -138.9 -41.5 0.48 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.105 -0.952 . . . . 74.219999999999999 112.077 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 39.3 tt0 -148.15 145.09 28.2 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 119.973 -0.691 . . . . 70.430000000000007 110.197 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.62 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.9 tm? -142.12 135.91 29.54 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.343 -0.984 . . . . 73.349999999999994 108.343 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.2 m -139.45 126.25 20.79 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 121.029 -0.268 . . . . 65.120000000000005 110.651 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 36.1 p90 -145.76 156.97 43.95 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 122.2 0.2 . . . . 75.010000000000005 111.242 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 24.0 mt-10 -120.39 124.6 45.91 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.085 -1.82 . . . . 74.209999999999994 106.085 -174.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -130.07 157.51 42.19 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 116.222 -0.445 . . . . 72.299999999999997 110.592 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 78.85 -176.33 0.09 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.267 1.827 . . . . 75.209999999999994 109.789 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.3 p -73.11 -18.47 61.29 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 114.433 1.272 . . . . 60.399999999999999 114.433 -173.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -92.83 -18.77 22.44 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.092 -0.643 . . . . 74.439999999999998 110.989 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.89 60.63 2.88 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 120.002 -1.094 . . . . 43.439999999999998 110.54 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.496 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 95.9 m95 -78.33 121.21 24.16 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.551 -0.907 . . . . 73.540000000000006 108.551 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 76' ' ' PHE . 8.7 p -99.19 107.74 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 CA-C-O 122.516 1.151 . . . . 72.209999999999994 111.592 -173.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -99.84 146.48 8.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.41 -1.268 . . . . 63.509999999999998 108.369 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.465 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 42.4 m -130.5 135.82 48.35 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 109.139 -0.689 . . . . 71.329999999999998 109.139 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.62 ' CD2' HD13 ' A' ' 74' ' ' LEU . 13.4 m-85 -112.59 135.55 53.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.2 -1.037 . . . . 72.310000000000002 108.2 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.15 137.91 52.65 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.392 -0.966 . . . . 75.230000000000004 108.392 176.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -113.1 131.52 55.79 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.77 0.319 . . . . 74.120000000000005 111.296 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -120.7 139.06 53.6 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.231 1.013 . . . . 72.439999999999998 108.678 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -96.73 128.71 43.94 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.087 0.47 . . . . 65.310000000000002 109.996 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.56 153.54 45.08 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.981 -1.118 . . . . 74.5 107.981 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.98 57.54 5.07 Favored Glycine 0 C--N 1.289 -2.053 0 C-N-CA 121.488 -0.387 . . . . 71.239999999999995 113.667 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 171.65 -44.54 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 124.434 1.093 . . . . 75.230000000000004 108.323 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -130.78 172.59 11.83 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.167 -1.379 . . . . 73.129999999999995 109.115 -170.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.433 ' HB ' HG22 ' A' ' 25' ' ' VAL . 74.0 m -116.52 130.91 57.02 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 109.22 -0.659 . . . . 70.129999999999995 109.22 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.08 119.8 5.66 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.059 -1.216 . . . . 53.130000000000003 110.059 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -108.0 133.23 52.61 Favored 'General case' 0 C--N 1.269 -2.895 0 N-CA-C 108.082 -1.081 . . . . 74.049999999999997 108.082 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.7 m -122.77 122.51 38.87 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.761 -0.829 . . . . 71.099999999999994 108.761 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.481 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.19 139.05 36.42 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 121.854 0.835 . . . . 73.099999999999994 109.404 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.481 ' N ' HD13 ' A' ' 100' ' ' LEU . 14.0 mt -136.49 128.88 45.03 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 113.334 -1.757 . . . . 73.299999999999997 108.047 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . 8.7 t-80 -120.38 125.82 48.95 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.698 -0.853 . . . . 73.530000000000001 108.698 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.7 t -142.83 159.87 41.41 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 104.777 -2.305 . . . . 75.439999999999998 104.777 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.55 -169.04 36.12 Favored Glycine 0 C--N 1.292 -1.89 0 C-N-CA 119.967 -1.111 . . . . 51.140000000000001 112.325 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 97.9 m95 . . . . . 0 C--N 1.31 -1.14 0 CA-C-O 121.502 0.668 . . . . 74.310000000000002 112.421 -179.426 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.434 -1.23 0 N-CA-C 107.552 -1.277 . . . . 64.109999999999999 107.552 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.9 pt -55.65 -31.8 29.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 123.955 0.784 . . . . 65.209999999999994 113.062 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.29 -135.08 7.4 Favored Glycine 0 CA--C 1.486 -1.747 0 C-N-CA 119.893 -1.146 . . . . 37.380000000000003 111.801 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -80.07 11.2 3.56 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.904 0.705 . . . . 70.0 112.904 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.43 -15.52 63.58 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.991 -0.744 . . . . 65.040000000000006 108.991 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . 0.3 0.0 OUTLIER 59.32 10.0 1.62 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 128.515 2.726 . . . . 72.340000000000003 116.642 172.267 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.81 161.39 18.38 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.916 -0.713 . . . . 65.219999999999999 110.059 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -82.61 145.2 29.81 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.742 -0.836 . . . . 74.340000000000003 108.742 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 p -57.19 -40.4 77.31 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.919 0.711 . . . . 54.509999999999998 112.919 -176.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.1 p -67.8 -46.12 72.84 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.567 -0.288 . . . . 52.509999999999998 111.626 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.64 -33.87 62.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 C-N-CA 120.295 -0.562 . . . . 64.140000000000001 109.641 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.07 -46.14 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.275 -0.421 . . . . 72.409999999999997 110.887 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -66.22 -45.61 80.11 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 121.007 -0.277 . . . . 75.230000000000004 110.902 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.47 -43.21 99.03 Favored Glycine 0 N--CA 1.446 -0.657 0 O-C-N 123.608 0.568 . . . . 55.340000000000003 112.053 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -38.47 73.88 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.686 0.625 . . . . 62.43 112.686 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.82 -45.73 49.54 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.981 -0.688 . . . . 72.540000000000006 110.854 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.06 -59.2 3.67 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.441 -0.345 . . . . 62.240000000000002 111.618 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.74 -40.99 93.97 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.541 -0.624 . . . . 52.539999999999999 111.541 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.49 -60.15 8.69 Favored Glycine 0 N--CA 1.436 -1.315 0 O-C-N 124.054 0.503 . . . . 52.329999999999998 112.3 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -63.37 -35.68 81.21 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.592 0.96 . . . . 74.329999999999998 113.592 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.2 m -68.29 -54.54 16.85 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.166 -0.614 . . . . 72.450000000000003 110.94 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.19 -47.04 39.11 Favored Glycine 0 C--O 1.244 0.735 0 C-N-CA 120.829 -0.7 . . . . 73.200000000000003 112.95 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.711 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 46.2 mm -67.3 -49.8 68.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.955 0 CA-C-O 119.577 -0.249 . . . . 65.049999999999997 111.228 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 78.6 t -61.84 -49.6 83.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 118.793 -1.163 . . . . 50.25 112.218 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -61.6 -64.83 0.81 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.702 0.63 . . . . 61.32 112.702 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.05 -39.23 50.77 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.863 -0.735 . . . . 65.310000000000002 112.723 -172.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.711 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -69.61 -40.93 76.33 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.006 -0.677 . . . . 72.239999999999995 111.886 -176.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.2 mm? -62.63 -48.88 77.42 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 119.063 -1.055 . . . . 73.129999999999995 109.271 175.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.443 ' HE ' ' CD ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -61.0 -38.79 87.29 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.735 -0.666 . . . . 74.430000000000007 110.452 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -76.89 -36.76 56.47 Favored 'General case' 0 CA--C 1.471 -2.093 0 N-CA-C 113.721 1.008 . . . . 73.439999999999998 113.721 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 -27.42 64.02 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.131 -0.627 . . . . 44.539999999999999 110.611 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 23.8 m -80.2 -26.71 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 116.201 -0.454 . . . . 75.239999999999995 110.76 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -84.31 -60.36 2.11 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 119.98 -0.688 . . . . 74.439999999999998 111.512 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 113.985 1.106 . . . . 71.540000000000006 113.985 -170.298 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 121.042 0.448 . . . . 64.140000000000001 110.461 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 tt 177.99 100.99 0.13 Allowed Pre-proline 0 N--CA 1.434 -1.266 0 N-CA-C 105.775 -1.935 . . . . 64.340000000000003 105.775 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -92.96 -179.42 0.95 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.413 2.075 . . . . 72.420000000000002 110.118 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 3.2 p-10 -68.24 112.28 5.06 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.836 -0.802 . . . . 71.230000000000004 108.836 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.442 HG21 ' HB3' ' A' ' 102' ' ' HIS . 9.1 tp -97.33 125.44 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 C-N-CA 118.456 -1.298 . . . . 75.510000000000005 108.283 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 60.7 m -107.18 128.98 54.89 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 107.425 -1.324 . . . . 73.030000000000001 107.425 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -131.09 136.52 48.47 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.68 -1.23 . . . . 74.430000000000007 107.68 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -118.3 134.95 54.6 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 120.754 0.312 . . . . 61.299999999999997 111.211 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.459 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.78 139.98 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.033 0.444 . . . . 53.399999999999999 109.917 -179.091 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 p -101.09 126.74 47.81 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.137 0.494 . . . . 74.549999999999997 110.969 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.19 138.17 31.8 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.617 -0.72 . . . . 64.310000000000002 110.603 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -86.83 30.12 0.76 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 113.997 -1.456 . . . . 74.140000000000001 109.613 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.15 158.41 73.74 Favored Pre-proline 0 C--O 1.251 1.142 0 CA-C-N 115.564 -0.743 . . . . 62.229999999999997 109.37 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.97 150.76 87.61 Favored 'Trans proline' 0 C--O 1.25 1.091 0 C-N-CA 123.286 2.657 . . . . 75.129999999999995 112.109 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -40.24 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.091 -0.958 . . . . 70.519999999999996 111.68 -176.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -67.83 -35.77 79.19 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.997 -0.681 . . . . 74.430000000000007 111.179 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -72.66 -37.48 67.93 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.627 -0.509 . . . . 62.509999999999998 109.627 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.03 -41.15 89.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.908 -0.587 . . . . 61.210000000000001 109.618 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -60.02 -47.03 87.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.593 -0.73 . . . . 74.140000000000001 110.086 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -60.79 -39.79 90.17 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.362 0.665 . . . . 73.439999999999998 110.475 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.7 m -60.97 -23.29 65.23 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.536 0.734 . . . . 72.129999999999995 112.055 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.585 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 10.7 m -119.25 19.87 6.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 112.508 0.558 . . . . 73.310000000000002 112.508 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 61.0 p -137.46 -22.09 1.14 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.933 0.716 . . . . 63.520000000000003 112.933 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -91.63 154.61 18.91 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.456 -0.572 . . . . 63.420000000000002 109.456 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 27.7 t -63.01 -40.78 98.78 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.605 -0.887 . . . . 75.019999999999996 108.605 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -62.3 -48.97 77.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.678 -1.147 . . . . 71.420000000000002 109.638 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.78 -47.59 60.26 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.151 -0.931 . . . . 71.209999999999994 113.402 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.2 mt -69.47 -48.46 66.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 117.601 0.7 . . . . 73.219999999999999 111.895 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.087 0 N-CA-C 112.461 0.541 . . . . 70.5 112.461 179.579 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 CA--C 1.488 -1.424 0 N-CA-C 107.082 -1.451 . . . . 64.120000000000005 107.082 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.79 78.86 3.28 Favored 'General case' 0 CA--C 1.469 -2.139 0 CA-C-O 121.177 0.513 . . . . 74.409999999999997 110.911 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.415 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 83.1 m-85 -68.28 126.55 29.94 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.594 -1.185 . . . . 72.319999999999993 109.009 175.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -127.45 138.75 53.04 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.987 -0.745 . . . . 71.129999999999995 108.987 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.5 tt -75.56 103.72 5.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 106.641 -1.615 . . . . 65.519999999999996 106.641 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 1.2 tpmt? -133.91 145.13 49.32 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.53 -1.656 . . . . 73.299999999999997 106.53 172.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -87.68 48.12 1.6 Allowed 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 119.298 0.954 . . . . 73.519999999999996 110.185 174.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.68 49.96 0.03 OUTLIER Glycine 0 N--CA 1.42 -2.409 0 CA-C-N 115.32 -0.855 . . . . 62.140000000000001 111.0 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.5 OUTLIER . . . . . 0 CA--C 1.487 -1.463 0 N-CA-C 106.082 -1.822 . . . . 74.0 106.082 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 20.4 p . . . . . 0 N--CA 1.429 -1.503 0 N-CA-C 108.553 -0.906 . . . . 72.150000000000006 108.553 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 9.6 mtmp? -145.38 135.5 23.84 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.35 -0.982 . . . . 74.340000000000003 108.35 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.2 t -90.28 130.61 39.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.602 -1.258 . . . . 62.119999999999997 107.602 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.2 tp -76.03 -59.91 2.55 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.055 -1.091 . . . . 75.030000000000001 108.055 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -162.16 141.08 9.33 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.352 -0.84 . . . . 61.119999999999997 109.776 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 p -116.99 120.46 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.982 0 CA-C-O 121.583 0.706 . . . . 65.0 110.036 175.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 2.2 mp0 -94.15 141.04 29.0 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.617 -1.174 . . . . 73.200000000000003 108.85 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 122.69 83.57 Favored Pre-proline 0 C--N 1.276 -2.613 0 CA-C-N 114.379 -1.282 . . . . 51.439999999999998 108.969 -164.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo 0.12 62.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.014 1 C-N-CA 126.771 4.981 . . . . 62.520000000000003 115.488 -159.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -143.47 -42.24 0.29 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 113.67 -1.605 . . . . 73.209999999999994 110.983 175.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.4 tt0 -150.84 145.46 25.7 Favored 'General case' 0 C--O 1.204 -1.318 0 C-N-CA 119.834 -0.746 . . . . 74.439999999999998 110.491 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.61 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.0 tm? -137.05 137.63 39.56 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.063 -1.088 . . . . 73.010000000000005 108.063 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.7 p -140.76 126.88 19.58 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.803 -0.359 . . . . 65.340000000000003 110.992 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -144.23 156.91 44.49 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 120.794 0.33 . . . . 74.019999999999996 111.07 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 20.6 mt-10 -121.07 136.78 54.91 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 105.963 -1.866 . . . . 75.530000000000001 105.963 -173.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -147.94 158.71 44.19 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 120.188 -0.605 . . . . 74.420000000000002 112.409 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 73.84 171.34 0.3 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.05 -1.432 . . . . 73.5 113.195 172.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.6 p -66.47 -34.46 77.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.934 0.894 . . . . 70.340000000000003 111.862 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.46 -15.11 60.9 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 112.438 0.533 . . . . 74.310000000000002 112.438 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.29 67.64 1.79 Allowed Glycine 0 C--O 1.247 0.91 0 C-N-CA 121.058 -0.591 . . . . 54.329999999999998 112.411 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.444 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 33.2 m95 -93.95 130.21 40.13 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.33 -0.618 . . . . 75.349999999999994 109.33 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.1 t -110.8 111.43 36.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.854 -1.165 . . . . 73.230000000000004 107.854 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.3 m -109.23 140.59 27.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 115.946 -0.57 . . . . 73.129999999999995 109.67 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.42 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 58.3 m -126.09 135.14 51.37 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.9 -0.778 . . . . 74.349999999999994 108.9 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.61 ' CD2' HD13 ' A' ' 74' ' ' LEU . 11.7 m-85 -111.25 132.59 54.23 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.793 -1.188 . . . . 73.519999999999996 107.793 177.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.469 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 27.3 mt-30 -114.35 141.45 47.61 Favored 'General case' 0 C--N 1.276 -2.614 0 O-C-N 123.643 0.589 . . . . 75.239999999999995 110.568 177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.6 tp -104.18 141.18 36.71 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.705 -0.68 . . . . 64.120000000000005 110.918 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -124.92 116.68 22.59 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 106.164 -1.791 . . . . 74.349999999999994 106.164 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -86.22 119.15 26.2 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.999 -0.546 . . . . 65.109999999999999 111.796 -173.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 74.6 mt -125.18 149.52 47.85 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.046 -1.464 . . . . 71.140000000000001 107.046 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.84 58.84 1.79 Allowed Glycine 0 C--N 1.28 -2.536 0 C-N-CA 120.44 -0.886 . . . . 63.200000000000003 112.476 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -177.15 -52.84 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.119 -1.808 . . . . 62.210000000000001 106.119 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.67 175.8 7.7 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.006 -1.479 . . . . 74.349999999999994 107.006 -175.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.1 m -120.87 130.39 53.9 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 120.341 -0.543 . . . . 71.129999999999995 109.697 -178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.52 124.79 7.86 Favored Glycine 0 N--CA 1.408 -3.216 0 N-CA-C 109.099 -1.6 . . . . 72.340000000000003 109.099 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -117.27 134.18 55.11 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 108.812 -0.81 . . . . 74.129999999999995 108.812 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 23.5 m -125.95 129.24 48.88 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.517 -0.92 . . . . 65.549999999999997 108.517 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -104.79 142.26 35.03 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.005 -0.739 . . . . 74.230000000000004 109.005 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 100' ' ' LEU . 3.6 mp -136.13 125.25 38.61 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 106.829 -1.545 . . . . 72.409999999999997 106.829 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 23.2 t-160 -119.3 124.33 46.4 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.09 -0.707 . . . . 61.130000000000003 109.09 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.0 t -139.44 164.09 30.79 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 106.49 -1.67 . . . . 71.030000000000001 106.49 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -110.42 160.54 13.28 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.752 -0.737 . . . . 54.520000000000003 112.099 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 . . . . . 0 CA--C 1.559 1.32 0 CA-C-O 122.623 1.201 . . . . 72.540000000000006 110.205 179.656 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.485 -1.542 0 CA-C-O 120.902 0.382 . . . . 72.439999999999998 110.355 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.47 -38.46 70.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.56 -1.2 . . . . 71.040000000000006 112.245 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.17 70.3 0.24 Allowed Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.168 -1.491 . . . . 74.420000000000002 113.016 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt 61.93 31.66 18.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.729 1.011 . . . . 75.140000000000001 113.729 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.35 -13.3 61.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.654 0.264 . . . . 73.420000000000002 110.696 174.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 m120 93.65 139.25 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.377 1.871 . . . . 72.120000000000005 112.891 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 86.27 158.68 0.08 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.391 1.876 . . . . 55.039999999999999 111.353 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -59.28 149.43 28.76 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.187 0.595 . . . . 74.230000000000004 112.168 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.58 -52.81 64.07 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.221 1.008 . . . . 75.200000000000003 110.592 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.8 t -60.82 -36.74 79.85 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.611 -0.722 . . . . 74.409999999999997 110.2 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.25 -47.45 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.653 -0.703 . . . . 72.239999999999995 109.898 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.16 -41.18 80.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 110.701 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -63.22 -48.81 76.72 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.486 -0.779 . . . . 73.450000000000003 109.424 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.76 96.97 Favored Glycine 0 CA--C 1.495 -1.213 0 CA-C-N 115.231 -0.895 . . . . 60.420000000000002 112.03 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -66.55 -35.21 79.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 122.78 0.432 . . . . 71.010000000000005 111.521 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 24.1 mmt -70.92 -45.09 64.85 Favored 'General case' 0 C--O 1.211 -0.939 0 C-N-CA 120.315 -0.554 . . . . 72.519999999999996 111.003 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -67.26 -53.84 26.27 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.406 -0.918 . . . . 72.239999999999995 111.104 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.97 -45.64 95.21 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.917 -0.473 . . . . 63.539999999999999 111.917 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.65 -52.65 49.47 Favored Glycine 0 CA--C 1.487 -1.701 0 N-CA-C 111.494 -0.642 . . . . 64.519999999999996 111.494 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -65.15 -26.3 68.11 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 113.372 0.878 . . . . 73.230000000000004 113.372 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.1 m -67.81 -54.68 17.17 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.55 -0.537 . . . . 74.5 109.55 174.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.87 -42.4 86.19 Favored Glycine 0 C--O 1.245 0.826 0 CA-C-N 115.992 -0.549 . . . . 54.210000000000001 113.053 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.679 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 39.5 mm -65.37 -57.58 10.39 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 CA-C-O 119.599 -0.239 . . . . 72.209999999999994 110.937 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 69.6 t -57.99 -48.02 85.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 112.486 0.55 . . . . 72.120000000000005 112.486 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.459 ' HA ' HG13 ' A' ' 16' ' ' ILE . 43.4 t30 -59.69 -63.31 1.35 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.041 0.448 . . . . 75.129999999999995 111.995 -177.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -74.85 -48.27 25.92 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 112.447 0.536 . . . . 72.109999999999999 112.447 -173.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.679 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -63.56 -38.64 91.91 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 112.107 0.41 . . . . 74.239999999999995 112.107 -175.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.3 mm? -68.1 -48.38 65.63 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 119.298 -0.961 . . . . 64.340000000000003 110.594 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -58.42 -36.04 72.99 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.53 0.681 . . . . 74.140000000000001 109.698 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -75.97 -38.85 57.04 Favored 'General case' 0 C--O 1.185 -2.329 0 N-CA-C 112.339 0.496 . . . . 75.420000000000002 112.339 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.17 68.58 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.152 -0.619 . . . . 73.540000000000006 111.446 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.6 m -78.56 -36.09 19.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.067 -0.653 . . . . 73.219999999999999 110.213 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -87.8 -58.95 2.38 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.39 1.256 . . . . 72.120000000000005 114.39 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--N 1.308 -1.224 0 CA-C-O 121.74 0.781 . . . . 74.019999999999996 111.442 -172.722 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.323 0 N-CA-C 106.945 -1.502 . . . . 72.409999999999997 106.945 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.53 129.72 2.58 Favored Pre-proline 0 N--CA 1.418 -2.028 0 N-CA-C 105.898 -1.889 . . . . 73.519999999999996 105.898 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -85.44 -167.94 0.45 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 121.78 1.653 . . . . 75.430000000000007 110.121 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 14.1 t70 -100.35 113.07 25.52 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 105.675 -1.972 . . . . 61.310000000000002 105.675 171.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 14.5 tt -106.86 130.79 58.23 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.982 0 C-N-CA 119.81 -0.756 . . . . 75.400000000000006 109.478 -177.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.2 m -114.37 128.92 56.59 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 106.984 -1.488 . . . . 63.43 106.984 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 20.0 tptt -134.67 152.69 51.95 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.392 -1.336 . . . . 61.200000000000003 107.392 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.2 p -128.75 133.91 48.25 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 120.812 -0.355 . . . . 71.209999999999994 110.342 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.28 135.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.333 -1.358 . . . . 75.319999999999993 107.333 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.8 p -102.8 131.49 49.62 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.47 0.544 . . . . 72.420000000000002 112.47 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.36 140.94 40.92 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 122.005 0.907 . . . . 75.299999999999997 113.094 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -70.36 13.42 0.17 Allowed 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 128.583 2.753 . . . . 62.549999999999997 112.779 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.449 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -130.86 164.03 44.76 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-O 118.969 -0.539 . . . . 75.109999999999999 110.107 -172.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.449 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 37.5 Cg_endo -64.8 154.95 70.14 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.85 2.367 . . . . 62.340000000000003 111.904 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.0 tt -57.69 -33.35 44.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.688 -1.142 . . . . 74.239999999999995 112.666 -175.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 3.9 pt20 -65.05 -41.31 95.3 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.364 -0.38 . . . . 72.120000000000005 111.756 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -72.64 -38.9 67.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.321 -0.4 . . . . 61.509999999999998 110.988 -173.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.414 HG13 HG23 ' A' ' 96' ' ' THR . 8.6 p -68.28 -41.0 83.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 120.385 -0.526 . . . . 74.420000000000002 109.918 178.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -62.28 -47.25 85.15 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.636 -0.711 . . . . 73.099999999999994 111.451 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 23' ' ' GLN . 11.6 pt-20 -69.0 -27.9 66.11 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 120.35 -0.54 . . . . 65.310000000000002 111.523 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.0 m -57.13 -36.38 70.63 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 121.411 0.624 . . . . 72.049999999999997 110.026 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.422 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 4.0 m -107.74 23.14 3.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.125 -0.489 . . . . 75.209999999999994 111.795 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.9 t -145.06 11.29 1.35 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.945 0.402 . . . . 65.129999999999995 110.743 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.0 p -117.31 162.14 18.39 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.871 -0.518 . . . . 72.310000000000002 110.335 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -51.93 -62.23 1.76 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.325 1.05 . . . . 64.120000000000005 111.467 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.58 -35.52 75.43 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.837 0.68 . . . . 63.439999999999998 112.837 -175.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.85 -48.39 72.37 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.928 -0.653 . . . . 50.299999999999997 111.743 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.478 HD12 ' CD1' ' A' ' 44' ' ' PHE . 64.1 mt -70.46 -39.37 76.24 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 CA-C-O 120.594 0.235 . . . . 73.340000000000003 111.385 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.261 0 CA-C-N 116.015 -0.539 . . . . 73.099999999999994 110.434 176.183 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 . . . . . 0 CA--C 1.475 -1.909 0 N-CA-C 108.274 -1.01 . . . . 70.5 108.274 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -110.08 74.08 0.87 Allowed 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 119.704 -0.798 . . . . 63.219999999999999 109.787 -172.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.478 ' CD1' HD12 ' A' ' 35' ' ' ILE . 18.6 t80 -106.9 129.26 54.75 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.08 -0.964 . . . . 72.510000000000005 110.722 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -136.0 150.53 49.26 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.522 -1.659 . . . . 73.329999999999998 106.522 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -80.43 109.33 14.84 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 118.813 -1.155 . . . . 72.120000000000005 111.601 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 22.3 tptm -128.52 143.4 50.96 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 104.522 -2.399 . . . . 72.319999999999993 104.522 173.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -87.83 78.17 8.41 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.407 1.098 . . . . 62.240000000000002 109.239 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.36 99.2 2.22 Favored Glycine 1 N--CA 1.395 -4.084 0 N-CA-C 108.122 -1.991 . . . . 44.140000000000001 108.122 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 7.3 tt0 . . . . . 0 C--N 1.29 -1.998 0 N-CA-C 107.268 -1.382 . . . . 71.530000000000001 107.268 -174.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.424 -1.733 0 N-CA-C 112.945 0.72 . . . . 74.129999999999995 112.945 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 89.4 mttt -138.09 143.94 40.66 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.807 -1.923 . . . . 75.409999999999997 105.807 175.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.2 t -91.2 136.77 23.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 107.526 -1.287 . . . . 64.519999999999996 107.526 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.1 tt -87.09 -58.19 2.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.863 -1.162 . . . . 71.430000000000007 107.863 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.34 145.88 10.07 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.219 -1.03 . . . . 74.109999999999999 108.219 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.81 119.8 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-O 122.207 1.003 . . . . 74.519999999999996 111.378 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 15.4 mm100 -104.92 142.51 34.64 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 113.941 -1.481 . . . . 74.340000000000003 109.064 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.81 129.19 94.26 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 114.354 -1.294 . . . . 63.130000000000003 108.262 -167.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -1.99 52.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.558 1 C-N-CA 128.105 5.87 . . . . 62.43 117.919 -160.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.0 p -137.23 -42.64 0.56 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.667 -1.151 . . . . 64.310000000000002 109.922 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 41.2 tt0 -144.35 127.28 16.39 Favored 'General case' 0 C--O 1.19 -2.042 0 C-N-CA 119.629 -0.828 . . . . 63.030000000000001 109.453 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 tp -133.95 127.72 32.98 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 108.589 -0.893 . . . . 74.239999999999995 108.589 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.444 ' HG ' HG21 ' A' ' 86' ' ' THR . 6.0 m -135.2 127.13 29.51 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.468 -0.493 . . . . 73.230000000000004 111.269 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -142.09 156.55 45.4 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.008 0.373 . . . . 71.239999999999995 112.008 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -120.71 129.28 53.58 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.915 -1.143 . . . . 74.439999999999998 107.915 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -113.99 118.94 35.53 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.142 -1.059 . . . . 75.219999999999999 108.142 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' A' ' 80' ' ' THR . 34.5 t70 -82.39 -178.85 7.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.2 -1.037 . . . . 72.450000000000003 108.2 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.428 ' H ' ' CG ' ' A' ' 79' ' ' ASP . 20.6 m 69.16 25.32 5.78 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-O 123.77 1.748 . . . . 73.430000000000007 106.515 -171.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.482 ' CB ' ' HB2' ' A' ' 115' ' ' ALA . 23.9 mm-40 59.93 45.61 12.11 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 112.231 -2.259 . . . . 71.430000000000007 113.643 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.37 -21.6 56.25 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 108.159 -1.977 . . . . 51.219999999999999 108.159 170.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 74.44 -175.53 0.14 Allowed 'General case' 0 C--O 1.245 0.845 0 C-N-CA 126.95 2.1 . . . . 74.400000000000006 112.908 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.7 p -96.85 115.04 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-O 122.19 0.995 . . . . 65.409999999999997 109.888 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.56 146.41 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 CA-C-N 114.549 -1.205 . . . . 72.409999999999997 109.046 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.492 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 92.9 m -136.79 133.46 35.98 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 108.569 -0.9 . . . . 71.439999999999998 108.569 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.422 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 15.5 m-85 -119.03 135.85 54.42 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.825 -1.176 . . . . 74.129999999999995 107.825 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.519 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 42.7 mt-30 -118.83 146.44 44.85 Favored 'General case' 0 C--N 1.263 -3.194 0 CA-C-N 115.57 -0.741 . . . . 71.519999999999996 110.393 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.32 126.55 55.5 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.243 -0.889 . . . . 75.239999999999995 109.351 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -114.88 116.67 28.93 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 107.629 -1.249 . . . . 41.5 107.629 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -83.18 121.16 26.71 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.764 -0.653 . . . . 75.239999999999995 110.762 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.542 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 73.8 mt -123.85 156.56 35.97 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.036 -1.098 . . . . 71.439999999999998 108.036 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.13 59.69 1.39 Allowed Glycine 0 C--N 1.282 -2.429 0 C-N-CA 120.517 -0.849 . . . . 74.310000000000002 113.121 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 175.43 -39.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.595 1.158 . . . . 72.439999999999998 108.672 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 3.8 ptpt -144.85 175.81 9.93 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.457 -1.682 . . . . 65.150000000000006 106.457 -174.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.414 HG23 HG13 ' A' ' 25' ' ' VAL . 62.6 m -116.47 131.62 56.9 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.099 -0.704 . . . . 75.549999999999997 109.099 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.4 119.0 5.35 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 108.66 -1.776 . . . . 64.409999999999997 108.66 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -103.86 130.38 51.44 Favored 'General case' 0 C--N 1.257 -3.448 0 N-CA-C 107.171 -1.418 . . . . 73.219999999999999 107.171 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 14.7 m -114.86 123.72 49.89 Favored 'General case' 0 N--CA 1.397 -3.095 0 N-CA-C 107.607 -1.257 . . . . 73.120000000000005 107.607 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.447 HD11 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.56 140.65 34.53 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 108.486 -0.931 . . . . 74.349999999999994 108.486 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 4.6 mp -135.92 123.54 35.35 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.16 0 CA-C-N 113.758 -1.565 . . . . 74.239999999999995 107.137 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 17.5 t60 -122.48 126.2 47.36 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.475 -0.935 . . . . 74.430000000000007 108.475 175.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -142.93 164.27 30.54 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 106.428 -1.693 . . . . 75.329999999999998 106.428 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.4 143.23 9.8 Favored Glycine 0 CA--C 1.48 -2.104 0 N-CA-C 109.95 -1.26 . . . . 60.119999999999997 109.95 176.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 8.0 m95 . . . . . 0 C--N 1.303 -1.437 0 N-CA-C 109.311 -0.625 . . . . 74.25 109.311 -176.959 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 112' ' ' ILE . 5.2 p . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 104.859 -2.274 . . . . 74.209999999999994 104.859 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.4 ' H ' HG22 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -58.09 -39.51 73.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 119.98 1.264 . . . . 71.230000000000004 112.024 -176.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 55.18 47.41 74.33 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 111.994 -0.443 . . . . 40.210000000000001 111.994 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -166.07 -70.12 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.818 0.342 . . . . 74.120000000000005 110.93 -171.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.482 ' HB2' ' CB ' ' A' ' 81' ' ' GLU . . . -72.82 -40.79 65.52 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 116.514 2.042 . . . . 75.230000000000004 116.514 -171.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.16 100.88 0.97 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.876 -1.898 . . . . 74.019999999999996 105.876 -168.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . 0.271 36.7 mm-40 -94.93 89.01 5.47 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 114.866 1.432 . . . . 75.010000000000005 114.866 -172.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.462 ' HB3' HG11 ' A' ' 121' ' ' VAL . 52.5 tttp -179.43 91.25 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.453 -1.703 . . . . 71.329999999999998 106.926 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 m -48.44 -40.68 27.02 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 125.483 1.513 . . . . 72.450000000000003 112.912 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 25.8 t -65.14 -46.58 80.36 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 120.964 -0.294 . . . . 73.219999999999999 111.119 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 118' ' ' LYS . 9.6 p -71.13 -34.4 54.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 C-N-CA 119.73 -0.788 . . . . 61.119999999999997 110.047 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.8 -47.09 94.5 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 N-CA-C 110.443 -0.206 . . . . 63.030000000000001 110.443 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -57.64 -52.98 63.19 Favored 'General case' 0 C--O 1.257 1.467 0 O-C-N 123.852 0.72 . . . . 72.129999999999995 110.869 177.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.76 -40.64 99.07 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 114.979 -1.009 . . . . 61.439999999999998 112.811 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.39 -32.53 70.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.041 0.756 . . . . 70.019999999999996 113.041 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 72.9 mtm -62.06 -54.82 36.09 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.638 -0.825 . . . . 75.540000000000006 110.244 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.98 -62.95 1.24 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.848 -0.741 . . . . 72.349999999999994 112.325 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.04 -34.95 82.91 Favored Glycine 0 CA--C 1.497 -1.043 0 CA-C-N 116.101 -0.499 . . . . 54.43 112.303 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.79 -54.34 15.34 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 111.62 -0.592 . . . . 63.329999999999998 111.62 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.462 ' O ' HG12 ' A' ' 134' ' ' VAL . 72.5 m95 -59.99 -44.56 94.43 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 112.927 0.714 . . . . 75.409999999999997 112.927 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.402 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 25.0 m -58.62 -49.5 77.25 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.469 0.48 . . . . 64.530000000000001 110.507 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.94 -46.19 60.57 Favored Glycine 0 C--O 1.25 1.14 0 C-N-CA 120.983 -0.627 . . . . 65.340000000000003 112.85 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mm -66.54 -52.54 45.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 CA-C-O 119.334 -0.365 . . . . 73.340000000000003 111.411 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 130' ' ' TRP . 4.2 p -62.93 -36.16 74.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 117.955 0.343 . . . . 53.240000000000002 111.206 -175.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.57 -64.97 0.77 Allowed 'General case' 0 C--N 1.351 0.644 0 O-C-N 123.394 0.434 . . . . 74.010000000000005 110.359 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.95 -40.45 71.99 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 112.602 0.593 . . . . 72.430000000000007 112.602 -173.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -62.53 -51.68 66.45 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 120.566 -0.454 . . . . 64.230000000000004 110.829 -177.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 49.9 mt -70.63 -41.08 72.67 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.328 -0.949 . . . . 75.439999999999998 111.679 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.628 ' NE ' ' HG3' ' A' ' 143' ' ' GLU . 1.1 tmt_? -60.63 -34.83 74.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.359 -0.608 . . . . 73.439999999999998 109.359 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -71.13 -42.56 69.04 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 119.995 -0.682 . . . . 73.340000000000003 111.434 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.26 -28.88 69.06 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 111.961 0.356 . . . . 70.129999999999995 111.961 -176.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.431 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 21.4 m -88.74 -26.36 5.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 112.485 0.55 . . . . 75.040000000000006 112.485 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.628 ' HG3' ' NE ' ' A' ' 139' ' ' ARG . 5.7 mm-40 -97.37 -34.8 10.91 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.136 0.791 . . . . 72.030000000000001 113.136 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 C--N 1.307 -1.265 0 CA-C-O 121.436 0.636 . . . . 63.299999999999997 110.523 -175.721 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 121.201 0.524 . . . . 51.130000000000003 110.798 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp 78.57 86.09 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 125.512 1.525 . . . . 75.299999999999997 114.531 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.67 148.22 46.7 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 122.668 2.245 . . . . 71.340000000000003 109.919 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.59 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 6.3 p-10 -58.4 142.02 49.66 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 113.994 1.109 . . . . 71.230000000000004 113.994 -172.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.7 tp -121.66 137.43 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 106.493 -1.669 . . . . 54.520000000000003 106.493 171.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.8 m -118.74 128.82 54.85 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.406 -0.961 . . . . 72.209999999999994 108.406 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -133.5 132.67 41.28 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 107.662 -1.236 . . . . 72.25 107.662 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 p -118.45 139.49 51.33 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-O 120.645 0.26 . . . . 53.140000000000001 110.836 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.43 134.88 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.767 -0.827 . . . . 75.400000000000006 108.767 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.03 121.8 42.87 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 120.967 0.413 . . . . 72.530000000000001 110.923 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.406 HD22 ' HB3' ' A' ' 138' ' ' LEU . 4.8 mp -101.76 137.66 39.76 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.638 -0.505 . . . . 42.020000000000003 109.638 -175.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -86.43 59.12 5.45 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.268 1.032 . . . . 75.340000000000003 110.959 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.21 161.14 46.34 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.984 -1.117 . . . . 61.210000000000001 107.984 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.94 152.16 82.16 Favored 'Trans proline' 0 C--O 1.26 1.609 0 C-N-CA 122.524 2.15 . . . . 73.420000000000002 110.442 176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -32.36 48.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.892 -0.594 . . . . 73.430000000000007 111.679 -176.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -65.15 -29.01 69.82 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.177 0.436 . . . . 75.409999999999997 112.177 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -78.92 -40.11 33.0 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.633 0.73 . . . . 72.340000000000003 110.37 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG11 HG22 ' A' ' 96' ' ' THR . 7.3 p -69.43 -39.55 78.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 116.072 -0.513 . . . . 73.329999999999998 109.749 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 43.1 t90 -58.12 -47.63 82.69 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.369 0.668 . . . . 75.450000000000003 111.928 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.77 -39.37 94.09 Favored 'General case' 0 C--O 1.214 -0.816 0 C-N-CA 119.576 -0.85 . . . . 72.239999999999995 109.749 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.9 m -59.23 -31.98 69.55 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-O 121.087 0.47 . . . . 72.329999999999998 111.629 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.685 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 25.2 m -107.19 17.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 112.946 0.721 . . . . 64.299999999999997 112.946 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.5 m -139.65 -3.35 1.49 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 112.301 0.482 . . . . 71.340000000000003 112.301 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.0 p -97.22 145.99 25.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.37 -0.974 . . . . 71.219999999999999 108.37 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 p -52.03 -54.06 34.55 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.86 0.689 . . . . 72.140000000000001 112.86 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.75 -38.78 87.3 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.444 -0.798 . . . . 73.040000000000006 110.533 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -41.61 95.99 Favored Glycine 0 C--O 1.247 0.939 0 N-CA-C 112.045 -0.422 . . . . 62.420000000000002 112.045 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.6 mt -69.83 -48.32 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 O-C-N 122.545 -0.385 . . . . 72.340000000000003 110.602 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.706 0.632 . . . . 74.519999999999996 112.706 -177.837 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.542 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . 19.8 m120 . . . . . 0 CA--C 1.493 -1.244 0 N-CA-C 107.196 -1.409 . . . . 72.329999999999998 107.196 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -96.63 76.76 2.86 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.011 0.91 . . . . 65.310000000000002 110.449 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 42' ' ' ASN . 94.5 m-85 -74.88 119.3 18.88 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.832 -1.531 . . . . 71.230000000000004 109.775 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -109.41 151.31 26.84 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.126 -1.064 . . . . 72.25 108.126 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -77.2 103.18 6.99 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.493 -1.299 . . . . 72.099999999999994 107.493 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -134.03 146.12 50.07 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.305 -0.998 . . . . 75.140000000000001 108.305 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -92.81 79.55 4.71 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.076 0.941 . . . . 64.430000000000007 108.778 173.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.64 47.37 0.53 Allowed Glycine 0 N--CA 1.416 -2.653 0 C-N-CA 119.361 -1.399 . . . . 52.32 112.863 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.011 0 N-CA-C 107.471 -1.307 . . . . 74.439999999999998 107.471 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.439 -1.012 0 CA-C-O 120.838 0.351 . . . . 38.090000000000003 110.792 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -143.61 135.46 26.48 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.969 0.908 . . . . 65.530000000000001 108.685 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.1 t -90.59 136.88 22.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.617 -1.253 . . . . 73.239999999999995 107.617 175.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 tt -79.73 -61.11 2.1 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.981 -1.488 . . . . 65.150000000000006 106.981 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.0 150.02 9.38 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-N 115.15 -0.932 . . . . 75.530000000000001 109.018 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.98 119.03 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.484 0 CA-C-O 122.118 0.961 . . . . 73.239999999999995 109.565 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 11.4 mm100 -94.54 141.24 28.82 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 114.961 -1.018 . . . . 74.030000000000001 109.316 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 123.01 84.84 Favored Pre-proline 0 C--N 1.272 -2.78 0 CA-C-N 114.312 -1.313 . . . . 74.430000000000007 108.968 -166.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo 7.3 50.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.346 1 C-N-CA 127.638 5.559 . . . . 60.399999999999999 116.339 -160.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 p -139.81 -37.53 0.48 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.177 -0.919 . . . . 73.340000000000003 112.077 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 35.3 tt0 -150.29 148.05 28.39 Favored 'General case' 0 C--O 1.2 -1.532 0 C-N-CA 119.066 -1.053 . . . . 64.239999999999995 110.339 -176.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.573 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -141.37 132.99 27.07 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.831 -1.174 . . . . 38.090000000000003 107.831 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 p -141.03 129.13 22.06 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 120.695 -0.402 . . . . 70.200000000000003 112.019 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -142.8 153.55 43.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.811 0.338 . . . . 72.310000000000002 111.672 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -124.48 124.95 43.4 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 125.012 1.325 . . . . 73.519999999999996 107.783 -173.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 18.6 p-90 -143.58 155.78 44.39 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.152 -1.019 . . . . 74.209999999999994 113.232 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 76.18 160.4 0.22 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.852 1.661 . . . . 75.530000000000001 112.582 173.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 m -68.3 -30.93 70.04 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.207 1.003 . . . . 63.409999999999997 110.646 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -71.27 -21.49 62.08 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.033 -0.728 . . . . 73.25 109.033 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.66 80.36 0.68 Allowed Glycine 0 N--CA 1.426 -1.987 0 CA-C-N 114.882 -1.054 . . . . 70.519999999999996 114.641 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -104.92 128.59 53.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.365 -0.606 . . . . 74.129999999999995 109.365 173.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.24 111.78 29.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.625 -1.25 . . . . 72.430000000000007 107.625 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.26 149.12 19.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 120.477 -0.489 . . . . 75.319999999999993 110.377 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.42 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 39.2 m -129.47 140.77 51.18 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.491 -0.929 . . . . 72.430000000000007 108.491 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.685 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 16.0 m-85 -118.35 142.59 47.37 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.844 -1.539 . . . . 74.319999999999993 106.844 174.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.425 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 69.3 mt-30 -125.1 137.57 54.18 Favored 'General case' 0 C--N 1.268 -2.958 0 O-C-N 123.472 0.482 . . . . 73.310000000000002 110.532 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -117.36 120.06 37.01 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.457 -0.792 . . . . 75.430000000000007 109.179 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -114.06 116.71 29.58 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.586 -0.894 . . . . 71.049999999999997 108.586 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.01 118.98 23.88 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.876 0.846 . . . . 70.239999999999995 110.919 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 96.4 mt -123.15 153.11 40.46 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.449 -0.945 . . . . 71.129999999999995 108.449 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.97 50.38 4.15 Favored Glycine 0 C--N 1.287 -2.17 0 C-N-CA 120.892 -0.67 . . . . 72.549999999999997 112.411 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -179.41 -32.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.343 0.592 . . . . 72.230000000000004 109.446 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 9.6 ptpt -156.27 175.05 14.5 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.202 -1.407 . . . . 71.329999999999998 107.202 -175.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.433 HG22 HG11 ' A' ' 25' ' ' VAL . 87.8 m -119.79 128.19 53.49 Favored 'General case' 0 C--N 1.272 -2.771 0 N-CA-C 108.616 -0.883 . . . . 70.209999999999994 108.616 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.6 107.32 3.01 Favored Glycine 0 N--CA 1.412 -2.962 0 N-CA-C 109.868 -1.293 . . . . 38.090000000000003 109.868 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.478 ' CE1' HG12 ' A' ' 29' ' ' VAL . 92.8 t80 -100.54 133.35 45.11 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.939 -0.763 . . . . 74.430000000000007 108.939 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 70.4 m -126.31 125.37 42.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 119.049 -1.061 . . . . 72.430000000000007 109.161 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -104.02 141.87 35.45 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.443 -0.799 . . . . 65.540000000000006 108.851 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 100' ' ' LEU . 3.5 mp -135.65 123.93 37.98 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 N-CA-C 106.024 -1.843 . . . . 70.010000000000005 106.024 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.59 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 9.7 t60 -120.55 113.73 20.7 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.486 -1.302 . . . . 55.219999999999999 107.486 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.8 t -132.57 153.84 50.6 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.543 -1.28 . . . . 74.310000000000002 107.543 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.15 167.96 20.81 Favored Glycine 0 N--CA 1.415 -2.74 0 N-CA-C 109.939 -1.265 . . . . 62.43 109.939 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 67.2 t90 . . . . . 0 C--N 1.311 -1.084 0 N-CA-C 106.998 -1.482 . . . . 71.109999999999999 106.998 175.734 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.471 HG23 ' H ' ' A' ' 113' ' ' GLY . 12.3 p . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 120.528 0.204 . . . . 75.340000000000003 111.503 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.498 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -61.85 -36.81 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.57 0.7 . . . . 74.010000000000005 110.619 174.044 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.471 ' H ' HG23 ' A' ' 111' ' ' VAL . . . 149.3 -108.35 0.4 Allowed Glycine 0 N--CA 1.409 -3.105 0 N-CA-C 108.758 -1.737 . . . . 72.349999999999994 108.758 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -134.85 32.35 3.25 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.856 0.36 . . . . 74.030000000000001 111.318 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.78 -22.88 59.2 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 112.825 0.676 . . . . 71.409999999999997 112.825 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -153.92 -73.24 0.13 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.61 -0.268 . . . . 53.32 110.48 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -156.73 -90.03 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 111.765 0.283 . . . . 72.209999999999994 111.765 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -121.03 136.37 55.0 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.051 -1.463 . . . . 74.030000000000001 107.051 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.25 -37.55 75.14 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 115.114 1.524 . . . . 62.219999999999999 115.114 -174.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.89 -46.17 79.35 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.401 0.519 . . . . 72.299999999999997 112.401 177.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.2 m -69.97 -33.84 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.191 -0.604 . . . . 73.219999999999999 109.776 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 126' ' ' MET . 53.6 t -64.64 -43.11 96.67 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 CA-C-N 115.732 -0.667 . . . . 74.129999999999995 111.113 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -39.82 93.32 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.214 -1.032 . . . . 72.209999999999994 108.214 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -59.6 -47.71 89.59 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-N 115.571 -0.74 . . . . 41.210000000000001 112.021 177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -66.43 -34.41 77.9 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.274 -0.463 . . . . 71.019999999999996 111.857 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 23.5 mmt -62.06 -52.5 63.69 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 110.265 -0.272 . . . . 45.43 110.265 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.45 -52.78 64.19 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.837 0.31 . . . . 74.109999999999999 111.837 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.51 -45.99 87.27 Favored Glycine 0 C--O 1.26 1.744 0 C-N-CA 120.834 -0.698 . . . . 64.439999999999998 112.6 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.47 62.56 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 111.938 -0.465 . . . . 72.200000000000003 111.938 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -65.45 -22.94 66.81 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.555 0.576 . . . . 75.329999999999998 112.555 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.8 m -64.91 -55.69 17.78 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.761 -0.829 . . . . 54.520000000000003 108.761 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.45 -44.47 73.1 Favored Glycine 0 C--O 1.252 1.241 0 C-N-CA 120.648 -0.787 . . . . 65.25 113.591 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.19 -51.91 62.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 122.231 0.212 . . . . 73.030000000000001 111.464 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.457 ' HA ' HD21 ' A' ' 138' ' ' LEU . 78.9 t -63.66 -44.62 98.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.806 -0.358 . . . . 72.340000000000003 111.595 -177.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -55.56 -64.83 0.72 Allowed 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.794 0.684 . . . . 71.319999999999993 111.803 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -82.73 -31.83 28.23 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 119.41 -0.916 . . . . 73.319999999999993 113.202 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.422 HH11 ' HB1' ' A' ' 141' ' ' ALA . 0.2 OUTLIER -74.01 -40.2 63.07 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 118.024 -1.47 . . . . 72.510000000000005 110.179 -176.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.457 HD21 ' HA ' ' A' ' 134' ' ' VAL . 4.2 mm? -69.41 -46.59 66.46 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 119.552 -0.859 . . . . 75.450000000000003 110.045 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 0.9 OUTLIER -63.76 -36.16 82.97 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 115.759 -0.655 . . . . 74.400000000000006 110.658 -178.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -70.76 -37.47 73.4 Favored 'General case' 0 C--O 1.198 -1.654 0 O-C-N 121.703 -0.623 . . . . 71.340000000000003 112.27 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.422 ' HB1' HH11 ' A' ' 137' ' ' ARG . . . -64.61 -27.98 69.31 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.254 0.549 . . . . 62.219999999999999 110.838 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 16.6 m -91.81 -22.58 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.895 -0.593 . . . . 55.32 111.953 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 61.2 mt-10 -91.85 -32.37 15.35 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.429 -0.508 . . . . 62.539999999999999 111.934 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 N--CA 1.44 -0.946 0 CA-C-O 122.932 1.349 . . . . 72.219999999999999 110.83 -174.565 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 112.944 0.72 . . . . 65.099999999999994 112.944 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.0 tp 68.47 90.93 0.08 OUTLIER Pre-proline 0 C--O 1.243 0.744 0 C-N-CA 124.765 1.226 . . . . 74.510000000000005 111.644 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.59 -164.97 0.21 Allowed 'Trans proline' 0 N--CA 1.436 -1.861 0 C-N-CA 122.38 2.054 . . . . 72.450000000000003 110.356 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -64.97 103.93 0.79 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.129 0.966 . . . . 75.140000000000001 111.837 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 50.0 mm -98.06 123.16 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 106.023 -1.843 . . . . 74.219999999999999 106.023 174.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 12.7 t -117.39 140.96 48.9 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 109.162 -0.681 . . . . 63.420000000000002 109.162 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -146.71 132.33 18.82 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.787 -1.19 . . . . 72.430000000000007 107.787 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.7 p -117.87 141.33 48.54 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 109.48 -0.563 . . . . 71.099999999999994 109.48 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.71 142.77 8.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.075 -1.084 . . . . 65.129999999999995 108.075 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 p -106.23 128.72 54.16 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.298 0.571 . . . . 71.5 111.509 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 138' ' ' LEU . 5.7 mp -103.57 140.11 37.97 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.857 -0.611 . . . . 75.420000000000002 111.079 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -81.73 46.22 0.96 Allowed 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 124.277 1.031 . . . . 74.129999999999995 110.686 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.26 158.89 57.2 Favored Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 109.202 -0.666 . . . . 73.329999999999998 109.202 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.37 153.32 71.4 Favored 'Trans proline' 0 C--O 1.259 1.544 0 C-N-CA 122.77 2.313 . . . . 74.200000000000003 110.7 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -60.15 -32.58 50.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.798 -0.637 . . . . 65.400000000000006 111.482 -174.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.75 -39.29 93.91 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 120.698 -0.401 . . . . 74.340000000000003 111.656 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -70.9 -39.18 72.9 Favored 'General case' 0 C--O 1.212 -0.916 0 C-N-CA 120.996 -0.282 . . . . 74.040000000000006 111.133 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.415 HG23 ' HB ' ' A' ' 96' ' ' THR . 47.2 t -68.02 -41.17 84.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.412 0.625 . . . . 74.120000000000005 109.842 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.576 ' CZ2' ' HD3' ' A' ' 71' ' ' PRO . 29.4 t90 -63.66 -46.72 84.32 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.492 -1.231 . . . . 70.430000000000007 110.177 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -70.23 -29.41 66.22 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 121.036 -0.266 . . . . 74.530000000000001 111.491 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.526 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 39.7 m -56.14 -33.26 65.01 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-O 121.129 0.49 . . . . 73.140000000000001 111.735 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -108.18 16.6 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 O-C-N 121.406 -0.809 . . . . 74.519999999999996 112.044 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.43 ' HA ' HD13 ' A' ' 35' ' ' ILE . 42.5 p -137.61 0.32 2.24 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.788 0.662 . . . . 73.140000000000001 112.788 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.7 p -107.89 169.39 8.64 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 121.698 -0.627 . . . . 73.200000000000003 111.595 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.2 t -63.01 -44.71 95.25 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.914 -0.585 . . . . 74.129999999999995 109.744 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.09 -45.17 78.07 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.686 0.616 . . . . 75.329999999999998 111.165 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 28' ' ' THR . . . -72.38 -48.03 26.16 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.909 -0.663 . . . . 64.019999999999996 114.051 -175.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 30' ' ' SER . 80.3 mt -69.04 -34.12 62.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 116.932 0.366 . . . . 52.25 111.114 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.791 0 CA-C-N 115.953 -0.567 . . . . 44.119999999999997 111.463 176.656 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 106.757 -1.571 . . . . 74.120000000000005 106.757 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.12 65.27 8.67 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.76 0.79 . . . . 74.230000000000004 112.165 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -108.62 132.78 53.55 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.4 -0.818 . . . . 74.319999999999993 109.865 171.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -139.03 150.14 45.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.19 -1.041 . . . . 73.439999999999998 108.19 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.423 HD12 ' CZ2' ' A' ' 26' ' ' TRP . 6.0 tt -75.74 104.2 6.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.766 -0.827 . . . . 73.340000000000003 108.766 -178.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 14.0 tppt? -133.97 146.07 50.12 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.882 -1.525 . . . . 72.450000000000003 106.882 172.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.4 ' CA ' HG11 ' A' ' 68' ' ' VAL . 8.1 pt-20 -79.57 54.79 1.84 Allowed 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 122.024 0.916 . . . . 72.099999999999994 109.478 170.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 130.01 64.52 0.1 Allowed Glycine 0 N--CA 1.406 -3.312 0 N-CA-C 109.977 -1.249 . . . . 74.230000000000004 109.977 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.47 -2.104 0 N-CA-C 106.355 -1.72 . . . . 62.130000000000003 106.355 178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 C--O 1.251 1.15 0 N-CA-C 107.45 -1.315 . . . . 71.209999999999994 107.45 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 34.4 mtmt -143.64 139.91 29.84 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 109.427 -0.583 . . . . 74.140000000000001 109.427 -172.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.447 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 41.8 t -90.65 129.44 41.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 N-CA-C 104.942 -2.244 . . . . 63.43 104.942 167.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.6 tp -75.06 -59.2 2.84 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.912 -0.773 . . . . 75.450000000000003 108.912 -176.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.53 140.67 14.0 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.955 -1.02 . . . . 64.209999999999994 109.274 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.4 HG11 ' CA ' ' A' ' 48' ' ' GLU . 9.5 p -119.28 121.0 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 N-CA-C 107.604 -1.258 . . . . 71.510000000000005 107.604 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 14.7 mm100 -96.55 142.81 28.17 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 114.56 -1.2 . . . . 74.219999999999999 109.603 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.71 120.99 73.16 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 107.508 -1.293 . . . . 75.450000000000003 107.508 -164.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HD3' ' CZ2' ' A' ' 26' ' ' TRP . 16.6 Cg_exo -7.54 64.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.294 1 C-N-CA 126.527 4.818 . . . . 75.099999999999994 116.844 -154.548 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 p -140.26 -40.47 0.43 Allowed 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 113.237 -1.801 . . . . 61.049999999999997 109.767 175.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 36.9 tt0 -150.54 149.22 29.65 Favored 'General case' 0 C--O 1.195 -1.81 0 C-N-CA 119.405 -0.918 . . . . 74.400000000000006 110.259 -175.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 tp -145.91 128.18 15.8 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.907 -0.775 . . . . 74.400000000000006 108.907 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.413 ' OG ' HG21 ' A' ' 86' ' ' THR . 13.6 m -134.23 127.23 31.48 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.774 -0.37 . . . . 74.310000000000002 111.022 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.521 ' CE2' ' HE2' ' A' ' 87' ' ' PHE . 54.8 p90 -138.93 155.66 47.87 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 112.113 0.412 . . . . 71.299999999999997 112.113 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -122.76 125.88 46.38 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.003 -1.48 . . . . 71.400000000000006 107.003 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.417 ' CE3' ' HB2' ' A' ' 79' ' ' ASP . 15.7 p-90 -139.83 162.07 36.05 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.367 -0.933 . . . . 73.030000000000001 112.751 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.417 ' HB2' ' CE3' ' A' ' 78' ' ' TRP . 19.0 t70 72.89 161.84 0.25 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.612 1.565 . . . . 62.520000000000003 112.338 173.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.4 t -73.11 -23.18 60.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.392 0.277 . . . . 73.040000000000006 111.274 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -34.25 76.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 110.154 -0.313 . . . . 71.450000000000003 110.154 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.72 75.64 1.29 Allowed Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.82 -0.627 . . . . 61.200000000000003 111.855 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -102.02 128.46 48.45 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.408 -0.96 . . . . 75.540000000000006 108.408 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.4 t -111.43 107.72 23.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 108.347 -0.983 . . . . 70.420000000000002 108.347 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.54 144.98 17.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.312 0.577 . . . . 74.219999999999999 110.363 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.43 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 39.9 m -136.42 134.23 37.52 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.801 -0.636 . . . . 73.120000000000005 109.407 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.521 ' HE2' ' CE2' ' A' ' 76' ' ' PHE . 39.8 m-85 -120.93 143.5 48.94 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.251 -1.018 . . . . 71.25 108.251 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 93.0 mt-30 -124.67 139.99 53.35 Favored 'General case' 0 C--N 1.278 -2.52 0 O-C-N 123.516 0.51 . . . . 72.0 110.676 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -122.6 120.22 33.13 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.722 -0.672 . . . . 71.329999999999998 110.458 -174.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -113.31 127.5 56.17 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 123.308 0.643 . . . . 74.200000000000003 109.81 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.72 120.68 26.68 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.731 -0.668 . . . . 75.400000000000006 111.366 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.6 mt -125.47 153.33 43.7 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.238 -0.892 . . . . 75.150000000000006 108.632 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.99 61.43 4.33 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 121.755 -0.26 . . . . 55.130000000000003 113.35 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 168.65 -54.49 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 125.21 1.404 . . . . 51.539999999999999 107.854 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -126.43 174.07 8.9 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 114.111 -1.404 . . . . 62.109999999999999 109.108 -167.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.415 ' HB ' HG23 ' A' ' 25' ' ' VAL . 87.7 m -119.89 130.84 55.03 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.889 -0.782 . . . . 74.530000000000001 108.889 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.58 111.26 3.61 Favored Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 110.258 -1.137 . . . . 74.420000000000002 110.258 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -103.45 131.43 50.55 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 109.412 -0.588 . . . . 71.409999999999997 109.412 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 84.8 m -124.29 128.02 48.51 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.982 -1.118 . . . . 74.340000000000003 107.982 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.493 HD21 ' CE1' ' A' ' 87' ' ' PHE . 2.9 tm? -102.25 139.29 38.05 Favored 'General case' 0 N--CA 1.397 -3.079 0 N-CA-C 108.532 -0.914 . . . . 75.140000000000001 108.532 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 3.8 mp -135.68 124.43 39.1 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.268 0 N-CA-C 106.258 -1.756 . . . . 71.340000000000003 106.258 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -121.04 131.92 54.57 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.362 -0.977 . . . . 61.329999999999998 108.362 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.3 m -142.69 138.94 30.94 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.673 -1.232 . . . . 72.120000000000005 107.673 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.11 -167.01 22.2 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.227 -0.987 . . . . 65.230000000000004 110.731 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 . . . . . 0 N--CA 1.426 -1.667 0 N-CA-C 108.861 -0.792 . . . . 74.450000000000003 108.861 175.921 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 108.516 -0.92 . . . . 64.450000000000003 108.516 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.0 pt -58.76 -32.59 47.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 112.853 0.686 . . . . 61.100000000000001 112.853 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.84 -122.41 6.94 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.022 -1.085 . . . . 75.420000000000002 111.978 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -100.4 10.27 41.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.13 0.491 . . . . 74.040000000000006 109.878 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.63 -34.91 79.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.987 -1.116 . . . . 53.350000000000001 107.987 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -166.38 122.84 1.28 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.886 -1.894 . . . . 60.130000000000003 105.886 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.1 166.68 16.44 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.586 0.958 . . . . 74.140000000000001 113.586 -174.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm 71.24 87.22 0.12 Allowed 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.705 -1.134 . . . . 63.240000000000002 112.902 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.2 p -56.43 -39.81 73.72 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.469 1.108 . . . . 62.109999999999999 112.78 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 123' ' ' ARG . 3.2 p -68.18 -39.25 82.57 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.597 0.713 . . . . 75.510000000000005 110.646 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.07 -45.49 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 115.707 -0.679 . . . . 73.200000000000003 109.42 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.401 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 75.9 t -55.78 -37.56 47.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 O-C-N 123.642 0.589 . . . . 65.409999999999997 110.204 175.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 120' ' ' SER . 18.5 tpp180 -57.37 -58.65 7.33 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.184 0.594 . . . . 70.299999999999997 110.378 177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.68 -43.8 93.64 Favored Glycine 0 CA--C 1.494 -1.244 0 CA-C-N 115.678 -0.692 . . . . 75.329999999999998 112.817 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.439 ' O ' ' HA3' ' A' ' 129' ' ' GLY . 2.7 tmmm? -65.52 -38.56 90.02 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 112.66 0.615 . . . . 75.209999999999994 112.66 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 25.7 mmt -72.84 -45.9 55.88 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.231 -0.988 . . . . 60.520000000000003 110.269 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -67.91 -63.78 0.99 Allowed 'General case' 0 C--O 1.257 1.455 0 CA-C-O 121.343 0.592 . . . . 71.200000000000003 111.849 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -75.75 -33.41 51.53 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 115.779 -0.646 . . . . 63.520000000000003 112.219 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -66.77 -50.09 50.42 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 111.67 -0.572 . . . . 60.399999999999999 111.67 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -64.39 -31.17 72.27 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 120.054 -0.658 . . . . 73.420000000000002 111.616 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.1 m -58.47 -57.35 13.35 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 120.71 -0.396 . . . . 71.109999999999999 110.896 173.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.62 -46.7 37.9 Favored Glycine 0 C--O 1.242 0.597 0 CA-C-N 116.07 -0.514 . . . . 37.590000000000003 113.742 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.0 mt -62.57 -51.24 74.58 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 119.693 -0.194 . . . . 71.019999999999996 110.976 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.651 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 68.6 t -59.37 -43.97 91.45 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 120.786 -0.366 . . . . 74.319999999999993 111.483 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -56.1 -60.13 3.93 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 111.777 0.288 . . . . 71.450000000000003 111.777 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -77.26 -46.45 23.09 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.244 0.831 . . . . 75.349999999999994 113.244 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -64.51 -39.16 93.26 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.425 0.557 . . . . 75.239999999999995 111.725 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 3.9 mm? -67.25 -49.73 63.29 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.454 -0.498 . . . . 62.43 110.536 176.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -62.43 -32.54 73.41 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.952 -0.567 . . . . 74.209999999999994 109.827 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -76.51 -39.66 52.36 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 113.201 0.815 . . . . 65.430000000000007 113.201 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.32 -23.71 67.08 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.217 0.532 . . . . 71.239999999999995 111.177 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.3 m -90.24 -34.11 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 120.209 -0.596 . . . . 73.209999999999994 111.91 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.48 -31.44 26.51 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.169 0.803 . . . . 74.129999999999995 113.169 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 121.092 0.472 . . . . 71.120000000000005 109.896 -177.819 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.518 0 N-CA-C 103.945 -2.613 . . . . 71.409999999999997 103.945 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.503 HD22 ' CZ3' ' A' ' 83' ' ' TRP . 4.4 pp -100.38 130.2 26.33 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 118.982 -1.087 . . . . 73.0 113.109 -175.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 49.3 Cg_endo -97.62 -160.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.651 2.901 . . . . 62.119999999999997 110.317 173.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 12.0 p-10 -81.6 97.46 7.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.607 1.194 . . . . 72.420000000000002 108.813 173.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 61.6 mt -91.68 128.25 43.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 114.69 -1.141 . . . . 54.450000000000003 109.019 -173.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.573 ' O ' ' HD2' ' A' ' 14' ' ' LYS . 13.6 t -120.08 140.79 50.5 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 119.648 -0.821 . . . . 75.230000000000004 110.556 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.573 ' HD2' ' O ' ' A' ' 13' ' ' THR . 5.9 mptp? -137.72 145.38 42.45 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.349 -1.352 . . . . 70.129999999999995 107.349 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -129.81 136.63 49.81 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 118.522 0.601 . . . . 43.350000000000001 110.514 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.11 141.38 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 110.06 -0.348 . . . . 74.109999999999999 110.06 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 p -101.04 135.4 42.56 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.073 0.463 . . . . 65.310000000000002 112.09 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 139' ' ' ARG . 3.0 mm? -104.15 140.07 38.32 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.35 0.66 . . . . 72.400000000000006 110.219 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -86.11 34.22 0.62 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.136 0.494 . . . . 70.109999999999999 110.261 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -133.88 164.73 41.92 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.38 -0.6 . . . . 75.519999999999996 109.38 -174.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.487 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -66.6 153.03 79.46 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.286 1.99 . . . . 72.239999999999995 111.025 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.11 -33.26 42.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.341 -0.845 . . . . 72.219999999999999 112.452 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.19 -27.68 62.72 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.451 -0.5 . . . . 75.099999999999994 111.223 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.0 tmtm? -79.83 -31.99 40.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.958 -1.127 . . . . 71.319999999999993 107.958 -177.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.4 t -71.17 -41.35 75.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.053 -1.092 . . . . 64.209999999999994 108.053 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.651 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 77.5 t90 -60.69 -47.17 87.47 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.639 -1.164 . . . . 74.450000000000003 111.269 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 10.5 pt-20 -59.97 -36.61 77.49 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 109.003 -0.74 . . . . 63.140000000000001 109.003 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 28' ' ' THR . 61.9 m -65.91 -7.54 17.15 Favored 'General case' 0 CA--C 1.573 1.836 0 CA-C-O 121.417 0.627 . . . . 74.239999999999995 112.646 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.569 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 11.9 m -131.48 17.19 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 O-C-N 121.306 -0.871 . . . . 54.020000000000003 111.63 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.3 m -145.32 10.03 1.26 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 116.29 -0.414 . . . . 62.310000000000002 111.833 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.3 p -110.75 -178.32 3.45 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.225 -0.657 . . . . 72.329999999999998 109.225 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.6 p -56.64 -62.46 1.71 Allowed 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 123.711 0.632 . . . . 73.030000000000001 111.999 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.43 -31.24 71.87 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.27 -0.877 . . . . 74.099999999999994 110.844 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.89 -48.66 20.24 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.04 -1.076 . . . . 64.439999999999998 112.861 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.416 HG21 ' CE2' ' A' ' 76' ' ' PHE . 51.6 mt -68.95 -34.5 64.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 123.13 0.572 . . . . 73.400000000000006 110.895 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-N 115.526 -0.761 . . . . 73.140000000000001 112.043 173.801 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 107.048 -1.464 . . . . 62.020000000000003 107.048 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -90.56 70.98 6.87 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.766 0.793 . . . . 75.219999999999999 109.46 -175.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -58.9 137.19 57.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.093 -1.412 . . . . 75.510000000000005 110.711 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.86 121.88 15.67 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.928 -1.508 . . . . 72.329999999999998 106.928 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.8 tp -94.42 101.78 13.72 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.362 -1.718 . . . . 65.219999999999999 106.362 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 tpmt? -134.94 145.58 48.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.263 -1.384 . . . . 63.399999999999999 107.263 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.02 61.71 7.0 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 122.69 1.234 . . . . 74.409999999999997 109.248 171.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.87 87.84 0.8 Allowed Glycine 0 N--CA 1.414 -2.783 0 CA-C-N 114.404 -1.271 . . . . 63.350000000000001 110.48 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.429 0 N-CA-C 106.282 -1.748 . . . . 71.420000000000002 106.282 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 86.0 m . . . . . 0 N--CA 1.428 -1.536 0 CA-C-O 121.377 0.608 . . . . 72.409999999999997 109.597 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -137.12 132.13 33.62 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.824 -1.546 . . . . 71.200000000000003 106.824 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 t -90.56 133.99 30.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 N-CA-C 107.2 -1.407 . . . . 61.009999999999998 107.2 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.83 -50.76 16.0 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.345 -1.354 . . . . 64.140000000000001 107.345 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.51 143.61 5.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.237 -1.347 . . . . 73.150000000000006 108.464 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG23 HD21 ' A' ' 74' ' ' LEU . 12.1 p -121.57 123.04 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 CA-C-O 121.332 0.587 . . . . 61.350000000000001 109.793 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 84.0 mm-40 -104.78 141.92 35.64 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.322 -0.854 . . . . 73.420000000000002 111.714 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.83 124.59 87.96 Favored Pre-proline 0 C--N 1.294 -1.81 0 CA-C-N 113.764 -1.562 . . . . 74.209999999999994 109.441 -164.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.651 ' HA ' ' CD1' ' A' ' 26' ' ' TRP . 81.4 Cg_exo -1.29 56.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.305 1 C-N-CA 127.491 5.46 . . . . 75.129999999999995 117.489 -159.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -146.59 -34.44 0.28 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.115 -0.948 . . . . 51.530000000000001 112.309 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.9 tt0 -146.37 139.76 25.87 Favored 'General case' 0 C--O 1.214 -0.774 0 C-N-CA 118.904 -1.118 . . . . 75.400000000000006 110.878 -174.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -139.78 136.7 34.36 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.259 -0.645 . . . . 70.439999999999998 109.259 -177.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.409 ' OG ' HG21 ' A' ' 86' ' ' THR . 18.3 m -140.9 125.95 18.34 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 110.017 -0.364 . . . . 75.109999999999999 110.017 175.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 35' ' ' ILE 0.273 12.8 p90 -146.8 158.17 43.85 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.02 0.748 . . . . 73.519999999999996 113.02 -178.429 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.27 21.7 mt-10 -119.19 131.58 55.85 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.643 -2.725 . . . . 75.299999999999997 103.643 -173.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.422 ' HE1' HG12 ' A' ' 85' ' ' VAL . 12.6 p-90 -153.11 163.52 39.72 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 114.733 1.383 . . . . 73.549999999999997 114.733 -168.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 t70 72.94 -167.83 0.12 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 112.009 -2.359 . . . . 72.209999999999994 112.237 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.442 ' HB ' ' OE2' ' A' ' 81' ' ' GLU . 1.3 m -78.53 -53.59 7.05 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.465 1.106 . . . . 74.129999999999995 112.129 -170.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.442 ' OE2' ' HB ' ' A' ' 80' ' ' THR . 2.4 mp0 -68.77 -19.62 64.32 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.375 0.509 . . . . 52.32 112.375 -176.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.33 76.33 1.3 Allowed Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.127 -1.035 . . . . 54.229999999999997 111.274 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.503 ' CZ3' HD22 ' A' ' 9' ' ' LEU . 48.7 m95 -109.4 154.42 22.61 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.188 -1.412 . . . . 74.329999999999998 107.188 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.63 123.98 27.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 121.461 0.648 . . . . 65.5 109.735 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.422 HG12 ' HE1' ' A' ' 78' ' ' TRP . 19.1 m -120.25 155.43 23.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 121.484 0.659 . . . . 73.200000000000003 111.259 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.418 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 41.9 m -131.09 137.33 49.06 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.065 -0.97 . . . . 74.230000000000004 108.573 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.63 ' CD2' HD13 ' A' ' 74' ' ' LEU . 13.9 m-85 -120.0 133.11 55.64 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.76 -1.2 . . . . 75.230000000000004 107.76 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.56 132.76 55.81 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 109.52 -0.548 . . . . 73.510000000000005 109.52 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mp -114.6 119.99 38.66 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.52 0.676 . . . . 73.349999999999994 110.724 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -103.21 123.73 47.29 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.533 -1.284 . . . . 74.010000000000005 107.533 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -82.67 128.61 34.51 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.914 -0.714 . . . . 72.129999999999995 109.71 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 74.2 mt -121.07 158.35 28.05 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.36 -1.348 . . . . 72.349999999999994 107.36 174.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.55 48.22 3.62 Favored Glycine 0 C--N 1.3 -1.444 0 O-C-N 123.305 0.378 . . . . 62.100000000000001 114.008 -174.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 172.96 -41.61 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.385 1.074 . . . . 74.310000000000002 109.237 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.5 ptpt -134.15 175.07 9.82 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.03 -0.729 . . . . 62.43 109.03 -173.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 88.9 m -117.72 128.16 54.62 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.817 -0.809 . . . . 63.229999999999997 108.817 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.37 107.7 3.47 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.203 -1.159 . . . . 55.340000000000003 110.203 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -97.32 133.95 41.25 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 109.257 -0.645 . . . . 73.120000000000005 109.257 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.4 m -120.41 121.81 39.35 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 108.187 -1.042 . . . . 75.439999999999998 108.187 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.461 HD11 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.59 139.71 35.89 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-O 121.854 0.835 . . . . 64.409999999999997 109.59 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.461 ' N ' HD11 ' A' ' 100' ' ' LEU . 16.1 mt -137.09 124.85 32.14 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 113.239 -1.801 . . . . 63.219999999999999 107.746 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 23.7 t-160 -117.42 129.06 55.6 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.309 -0.997 . . . . 70.230000000000004 108.309 177.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -141.08 164.41 30.34 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.151 -1.426 . . . . 62.229999999999997 107.151 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.1 167.76 38.25 Favored Glycine 0 C--N 1.291 -1.932 0 C-N-CA 120.17 -1.014 . . . . 61.32 110.864 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 . . . . . 0 C--N 1.307 -1.24 0 CA-C-O 121.952 0.882 . . . . 75.430000000000007 112.535 -177.519 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.412 -2.362 0 N-CA-C 107.649 -1.241 . . . . 74.409999999999997 107.649 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 35.0 pt -58.03 -31.0 40.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 113.049 0.759 . . . . 74.340000000000003 113.049 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.13 40.72 5.1 Favored Glycine 0 CA--C 1.494 -1.265 0 N-CA-C 109.76 -1.336 . . . . 73.120000000000005 109.76 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.42 ' HZ1' ' HB3' ' A' ' 114' ' ' LYS . 5.5 ttpm? 46.04 52.05 10.4 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.909 1.684 . . . . 71.450000000000003 111.849 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.02 -19.77 61.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 122.439 1.114 . . . . 65.209999999999994 108.481 173.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -132.52 -72.27 0.52 Allowed 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 113.701 -1.59 . . . . 74.519999999999996 108.713 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -149.2 -170.81 3.73 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 108.77 -0.826 . . . . 73.25 108.77 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.84 157.02 25.69 Favored 'General case' 0 C--O 1.218 -0.553 0 O-C-N 124.051 0.845 . . . . 54.299999999999997 110.784 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.1 p -56.65 -48.38 77.68 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.218 1.007 . . . . 65.310000000000002 112.72 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 p -63.07 -45.36 92.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.437 0.637 . . . . 74.140000000000001 110.704 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.06 -47.5 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.919 -1.037 . . . . 72.0 110.016 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 126' ' ' MET . 50.8 t -57.48 -41.06 78.0 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.233 0 CA-C-N 116.115 -0.493 . . . . 71.310000000000002 110.697 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -63.24 -51.69 65.17 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.24 -0.437 . . . . 74.310000000000002 111.045 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.64 -42.99 97.05 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-N 115.739 -0.664 . . . . 61.140000000000001 112.234 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -68.93 -32.53 72.2 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 115.085 -0.558 . . . . 65.109999999999999 112.363 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 23.4 mmt -67.03 -46.51 74.23 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.851 -0.74 . . . . 74.209999999999994 111.145 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.89 -58.42 3.47 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.658 -0.817 . . . . 65.099999999999994 111.783 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.33 -44.88 83.84 Favored Glycine 0 C--O 1.246 0.859 0 C-N-CA 121.058 -0.592 . . . . 63.310000000000002 112.075 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.53 -55.46 28.78 Favored Glycine 0 N--CA 1.437 -1.291 0 CA-C-O 119.316 -0.713 . . . . 62.539999999999999 112.22 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.436 ' O ' HG12 ' A' ' 134' ' ' VAL . 62.3 m95 -58.8 -43.51 90.53 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 117.837 0.818 . . . . 72.120000000000005 113.128 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 31.7 m -59.9 -47.06 87.32 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.367 0.417 . . . . 70.420000000000002 110.479 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.45 -47.24 36.23 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.557 -0.83 . . . . 74.219999999999999 112.828 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.8 mt -65.35 -46.14 91.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 122.587 0.355 . . . . 75.409999999999997 111.822 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 5.1 p -66.29 -40.45 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 119.608 -0.837 . . . . 70.329999999999998 109.717 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.576 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 34.3 t30 -58.89 -63.93 1.12 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.015 -0.539 . . . . 64.349999999999994 110.624 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -71.01 -48.8 51.05 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 113.423 0.897 . . . . 71.519999999999996 113.423 -173.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.523 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -69.83 -33.81 72.81 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.702 -0.799 . . . . 71.219999999999999 110.813 -171.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.4 mm? -70.78 -48.91 51.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.991 -1.084 . . . . 64.5 110.264 173.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 135' ' ' ASN . 1.0 OUTLIER -59.3 -40.32 85.78 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.83 -0.623 . . . . 73.420000000000002 110.959 -177.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.438 ' HE3' ' O ' ' A' ' 144' ' ' GLU . 25.7 mmmt -75.85 -36.02 59.75 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 112.887 0.699 . . . . 75.010000000000005 112.887 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.16 -28.2 64.09 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.617 -0.833 . . . . 71.519999999999996 110.629 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.449 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 25.8 m -79.77 -24.63 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 119.584 -0.846 . . . . 43.299999999999997 110.647 176.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.35 -87.16 0.14 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.917 0.865 . . . . 71.25 110.669 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.438 ' O ' ' HE3' ' A' ' 140' ' ' LYS . 39.1 mt-10 . . . . . 0 N--CA 1.432 -1.326 0 C-N-CA 125.09 1.356 . . . . 65.25 107.494 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.656 0 N-CA-C 111.429 0.159 . . . . 73.519999999999996 111.429 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.4 tp 48.66 86.78 0.14 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.315 1.446 . . . . 64.420000000000002 114.286 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.05 138.32 43.51 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.071 1.18 . . . . 41.039999999999999 109.717 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 8.2 p-10 -71.72 110.95 6.61 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.634 0.73 . . . . 72.310000000000002 109.839 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.6 tp -111.17 138.67 38.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.622 -0.717 . . . . 74.129999999999995 110.814 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.3 m -111.67 133.02 54.2 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 108.023 -1.103 . . . . 73.430000000000007 108.023 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -128.14 143.07 51.03 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.892 -1.522 . . . . 73.200000000000003 106.892 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.9 m -122.75 133.48 54.47 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.977 -0.379 . . . . 60.399999999999999 109.977 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.476 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -145.84 131.79 13.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.601 -0.888 . . . . 75.120000000000005 108.601 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.75 122.62 43.0 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-O 121.458 0.647 . . . . 72.109999999999999 112.179 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 138' ' ' LEU . 6.2 mp -95.67 135.85 36.83 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 107.755 -1.202 . . . . 70.030000000000001 107.755 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -87.78 39.78 0.9 Allowed 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.169 -0.469 . . . . 72.0 109.937 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.443 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -135.92 163.86 47.37 Favored Pre-proline 0 C--O 1.245 0.823 0 C-N-CA 124.169 0.987 . . . . 71.340000000000003 109.085 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.443 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 36.4 Cg_endo -63.7 157.71 50.28 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 123.013 2.476 . . . . 74.409999999999997 112.377 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.6 tt -64.87 -27.72 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.738 -0.664 . . . . 74.030000000000001 111.859 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -71.75 -28.24 63.53 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.971 0.415 . . . . 71.200000000000003 111.717 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.589 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 4.4 tmtt? -81.18 -46.11 15.36 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.46 -0.57 . . . . 73.209999999999994 109.46 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 96' ' ' THR . 5.4 p -59.49 -39.18 78.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.237 0.541 . . . . 73.219999999999999 109.846 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.43 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 70.0 t90 -63.35 -44.59 94.4 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.201 -0.909 . . . . 74.519999999999996 111.032 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -65.25 -33.68 76.55 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.442 -0.503 . . . . 72.439999999999998 110.465 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.7 m -59.25 -32.02 69.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.249 0.547 . . . . 71.319999999999993 111.163 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.555 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.5 m -109.46 21.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 112.298 0.481 . . . . 55.130000000000003 112.298 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.423 ' OG ' ' HA ' ' A' ' 27' ' ' GLU . 61.6 p -137.64 -12.24 1.55 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.406 -0.517 . . . . 74.209999999999994 112.216 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.0 p -94.55 158.81 15.37 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.632 -0.507 . . . . 74.150000000000006 109.632 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.9 m -59.9 -48.23 82.55 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 123.036 0.534 . . . . 53.100000000000001 111.195 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.83 -27.31 57.81 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.304 -0.862 . . . . 61.210000000000001 111.089 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.6 -48.81 21.31 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 119.927 -1.13 . . . . 71.430000000000007 111.58 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.1 mt -65.59 -33.42 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.729 0.775 . . . . 72.540000000000006 110.321 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 C-N-CA 124.578 1.151 . . . . 74.549999999999997 112.59 177.941 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 C--O 1.243 0.749 0 N-CA-C 108.725 -0.843 . . . . 62.43 108.725 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -89.14 73.61 8.13 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.888 0.851 . . . . 71.109999999999999 110.081 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.401 ' HE1' ' SG ' ' A' ' 63' ' ' CYS . 93.4 m-85 -70.83 119.99 15.78 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.963 -1.017 . . . . 71.510000000000005 109.947 176.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -113.38 148.32 36.02 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 110.0 -0.37 . . . . 75.5 110.0 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.5 tp -87.27 105.53 17.3 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.824 -1.176 . . . . 52.210000000000001 107.824 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -133.19 137.51 46.21 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 106.488 -1.671 . . . . 61.409999999999997 106.488 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -92.07 75.27 5.49 Favored 'General case' 0 C--N 1.257 -3.421 0 CA-C-O 122.845 1.307 . . . . 51.420000000000002 109.561 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 113.97 87.88 1.59 Allowed Glycine 1 N--CA 1.396 -4.001 0 CA-C-N 113.61 -1.632 . . . . 63.140000000000001 111.027 -179.212 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--N 1.303 -1.415 0 N-CA-C 107.911 -1.144 . . . . 75.109999999999999 107.911 -178.306 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.401 ' SG ' ' HE1' ' A' ' 44' ' ' PHE . 30.5 m . . . . . 0 N--CA 1.425 -1.714 0 N-CA-C 107.612 -1.255 . . . . 50.299999999999997 107.612 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HZ1' ' CD ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -122.5 118.46 28.35 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-O 121.901 0.858 . . . . 64.109999999999999 110.455 -177.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 6.7 t -79.26 137.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 114.872 -1.058 . . . . 65.310000000000002 109.339 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 tt -81.47 -57.63 3.39 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.387 -1.338 . . . . 72.519999999999996 107.387 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.04 153.6 22.47 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.542 -0.753 . . . . 64.430000000000007 109.801 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.54 119.13 52.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.712 -1.218 . . . . 37.920000000000002 107.712 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 22.5 mp0 -106.27 141.19 38.02 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.348 0.659 . . . . 75.519999999999996 110.334 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.67 129.32 94.1 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 114.226 -1.352 . . . . 72.420000000000002 108.446 -167.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HA ' ' CD1' ' A' ' 26' ' ' TRP . 10.8 Cg_exo 2.52 44.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.283 1 C-N-CA 128.434 6.089 . . . . 74.319999999999993 118.602 -162.201 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -139.83 -35.47 0.53 Allowed 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 122.248 -0.283 . . . . 74.239999999999995 110.702 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 40.7 tt0 -145.94 145.21 30.59 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 118.508 -1.277 . . . . 74.030000000000001 109.98 -174.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.595 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -147.5 134.96 20.8 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.529 -1.285 . . . . 55.340000000000003 107.529 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.431 ' HG ' HG21 ' A' ' 86' ' ' THR . 11.1 m -140.51 125.44 18.32 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.269 -0.572 . . . . 63.299999999999997 110.286 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.417 ' HB3' HG11 ' A' ' 65' ' ' VAL . 49.8 p90 -138.2 152.92 49.09 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 109.725 -0.472 . . . . 63.240000000000002 109.725 176.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.476 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 37.8 mt-10 -124.73 126.08 45.1 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-N 115.475 -0.784 . . . . 62.409999999999997 110.818 -171.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.464 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 2.1 t90 -95.54 107.94 20.15 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 104.359 -2.46 . . . . 75.140000000000001 104.359 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.51 140.49 55.67 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.889 -0.596 . . . . 74.340000000000003 111.119 -171.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.1 m 70.18 82.82 0.15 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.598 1.159 . . . . 65.129999999999995 112.279 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 55.63 23.22 5.93 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.954 1.702 . . . . 73.310000000000002 113.833 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' A' ' 78' ' ' TRP . . . -93.98 -24.43 19.97 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 107.865 -2.094 . . . . 60.530000000000001 107.865 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 75.29 -177.16 0.15 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 126.128 1.771 . . . . 75.109999999999999 113.03 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.402 ' HB ' ' HG2' ' A' ' 77' ' ' GLU . 4.4 p -114.81 117.26 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.838 0.828 . . . . 74.319999999999993 109.918 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.51 144.01 16.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 CA-C-N 114.989 -1.005 . . . . 73.239999999999995 108.717 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.463 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 46.9 m -131.56 134.38 46.02 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 108.988 -0.745 . . . . 75.099999999999994 108.988 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.595 ' CD2' HD13 ' A' ' 74' ' ' LEU . 10.9 m-85 -109.99 137.41 47.8 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.452 -1.314 . . . . 75.530000000000001 107.452 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.493 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 7.0 tt0 -125.04 136.98 54.21 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.089 -1.448 . . . . 74.230000000000004 107.089 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -110.91 124.38 51.98 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.202 -0.599 . . . . 70.400000000000006 111.901 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -109.93 137.11 48.18 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 124.717 1.207 . . . . 73.329999999999998 108.383 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -97.93 117.76 32.98 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 120.608 0.242 . . . . 71.400000000000006 111.158 -176.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.2 mt -113.63 159.98 19.06 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.84 -0.8 . . . . 37.920000000000002 108.84 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.52 -26.61 71.95 Favored Glycine 0 C--N 1.293 -1.806 0 N-CA-C 114.908 0.723 . . . . 71.310000000000002 114.908 -174.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 28.0 tt0 -128.08 -0.9 5.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.88 0.84 . . . . 73.230000000000004 110.853 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.527 ' HB3' ' HZ2' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -161.65 176.2 11.22 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.455 -0.778 . . . . 75.010000000000005 108.993 -173.13 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.437 HG22 HG12 ' A' ' 25' ' ' VAL . 31.2 m -116.58 128.14 55.14 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 109.556 -0.535 . . . . 74.140000000000001 109.556 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.15 112.71 3.93 Favored Glycine 0 N--CA 1.419 -2.446 0 N-CA-C 109.486 -1.445 . . . . 43.240000000000002 109.486 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -97.9 133.97 41.67 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 108.038 -1.097 . . . . 74.140000000000001 108.038 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 88' ' ' GLN . 14.0 m -117.81 121.91 42.01 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 107.991 -1.114 . . . . 74.400000000000006 107.991 -178.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.506 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.85 141.25 34.0 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 107.79 -1.189 . . . . 65.109999999999999 107.79 177.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.506 ' N ' HD13 ' A' ' 100' ' ' LEU . 19.6 mt -135.2 124.77 42.81 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.404 0 N-CA-C 106.699 -1.593 . . . . 74.319999999999993 106.699 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 21.8 t-160 -117.83 120.9 39.3 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.151 -1.055 . . . . 73.530000000000001 108.151 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.9 t -141.82 164.6 29.75 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 107.161 -1.422 . . . . 64.239999999999995 107.161 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -176.73 -131.86 1.55 Allowed Glycine 0 C--N 1.285 -2.29 0 N-CA-C 109.413 -1.475 . . . . 72.329999999999998 109.413 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 . . . . . 0 C--N 1.301 -1.506 0 N-CA-C 108.373 -0.973 . . . . 73.5 108.373 175.863 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.66 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 1.8 t . . . . . 0 N--CA 1.439 -0.985 0 N-CA-C 106.646 -1.613 . . . . 62.310000000000002 106.646 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.463 HD12 HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -58.15 -31.72 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.792 0.806 . . . . 74.049999999999997 111.155 177.062 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 148.12 -86.89 0.16 Allowed Glycine 0 N--CA 1.41 -3.093 0 N-CA-C 109.18 -1.568 . . . . 54.240000000000002 109.18 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 61.8 tttp -155.13 22.36 0.43 Allowed 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.45 0.643 . . . . 73.319999999999993 110.266 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.15 84.61 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.155 -0.966 . . . . 64.109999999999999 111.282 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -150.85 25.03 0.75 Allowed 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.362 0.413 . . . . 64.519999999999996 110.967 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 66.85 -41.47 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.382 1.623 . . . . 63.509999999999998 115.382 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -118.06 141.74 48.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.268 0.485 . . . . 62.5 112.159 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.66 ' OG ' ' HA ' ' A' ' 111' ' ' VAL . 70.8 m -75.07 -27.79 60.1 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.987 -0.551 . . . . 71.230000000000004 109.696 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 p -66.04 -47.17 75.28 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.633 -0.712 . . . . 73.340000000000003 111.509 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.0 m -69.92 -33.7 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 120.425 -0.51 . . . . 73.200000000000003 109.897 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.41 -46.32 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 120.155 -0.618 . . . . 70.239999999999995 110.556 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -55.31 -55.95 25.57 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.656 0.782 . . . . 65.430000000000007 111.785 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.0 -47.24 92.25 Favored Glycine 0 C--O 1.249 1.069 0 O-C-N 123.635 0.584 . . . . 62.229999999999997 112.652 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -68.44 -36.95 79.78 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 113.292 0.849 . . . . 75.530000000000001 113.292 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -34.47 71.99 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 119.469 -0.892 . . . . 72.340000000000003 110.859 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.19 -49.64 54.78 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.863 0.363 . . . . 74.400000000000006 110.875 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.45 -41.02 91.23 Favored Glycine 0 C--O 1.251 1.211 0 C-N-CA 120.624 -0.798 . . . . 55.229999999999997 111.238 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.87 -54.03 38.48 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.824 -0.688 . . . . 51.43 112.301 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.514 ' O ' HG12 ' A' ' 134' ' ' VAL . 57.5 m95 -56.99 -37.65 71.95 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 113.097 0.777 . . . . 74.340000000000003 113.097 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.5 m -57.37 -48.08 79.97 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 123.186 0.304 . . . . 73.129999999999995 110.436 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.89 -48.76 31.93 Favored Glycine 0 C--O 1.246 0.897 0 C-N-CA 120.584 -0.817 . . . . 72.549999999999997 112.332 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.24 -52.41 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.044 0.537 . . . . 75.430000000000007 111.653 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.661 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 4.2 p -71.63 -41.03 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 119.874 -0.73 . . . . 72.340000000000003 111.847 -173.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.476 ' HA ' HG13 ' A' ' 16' ' ' ILE . 26.7 t-20 -63.69 -52.18 61.77 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.988 -0.685 . . . . 54.140000000000001 111.234 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 33.5 tt0 -78.99 -44.75 21.69 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 113.183 0.808 . . . . 74.140000000000001 113.183 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.5 ' NH1' ' HB1' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -64.85 -45.3 86.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 119.147 -1.021 . . . . 72.25 109.837 -176.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.661 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.1 mm? -65.47 -52.21 54.53 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.218 0.324 . . . . 71.0 111.557 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -63.73 -35.65 81.27 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.908 0.385 . . . . 74.219999999999999 109.995 -177.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.474 ' NZ ' ' HB3' ' A' ' 144' ' ' GLU . 12.5 mmmt -68.65 -46.16 69.9 Favored 'General case' 0 C--O 1.173 -2.957 0 CA-C-O 119.157 -0.449 . . . . 74.519999999999996 111.088 177.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.5 ' HB1' ' NH1' ' A' ' 137' ' ' ARG . . . -59.48 -29.85 68.13 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.219 0.452 . . . . 73.219999999999999 112.219 -176.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.1 m -86.28 -24.69 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 120.19 -0.604 . . . . 74.430000000000007 112.205 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 78.6 mm-40 -86.08 -57.86 2.86 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.711 0.767 . . . . 73.209999999999994 109.958 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.474 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 2.3 tm-20 . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 107.267 -1.382 . . . . 72.010000000000005 107.267 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.769 0 CA-C-O 121.643 0.735 . . . . 75.150000000000006 111.864 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tt -166.53 109.5 0.68 Allowed Pre-proline 0 N--CA 1.419 -1.979 0 N-CA-C 107.161 -1.422 . . . . 72.340000000000003 107.161 -172.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -82.5 168.74 14.35 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 122.918 2.412 . . . . 71.310000000000002 109.522 171.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 6.2 p-10 -64.53 107.47 1.4 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.638 -1.245 . . . . 72.109999999999999 107.638 170.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 43.2 mm -91.03 124.1 43.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.522 -0.918 . . . . 43.130000000000003 108.522 -174.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.0 m -120.37 128.39 53.19 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.433 -1.321 . . . . 64.150000000000006 107.433 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.555 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 22.4 tptt -140.2 144.56 36.65 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.701 -1.222 . . . . 72.319999999999993 107.701 -176.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.4 m -123.07 134.51 54.25 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.695 -0.402 . . . . 61.200000000000003 110.418 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.415 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -141.7 131.79 25.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.919 -0.771 . . . . 72.200000000000003 108.919 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.87 117.87 32.05 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 121.809 0.814 . . . . 63.229999999999997 111.984 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 138' ' ' LEU . 5.6 mp -92.7 140.07 29.91 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.796 -1.557 . . . . 64.329999999999998 106.796 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.85 15.27 3.4 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.175 0.512 . . . . 64.329999999999998 111.581 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -105.5 159.54 29.16 Favored Pre-proline 0 C--N 1.306 -1.31 0 CA-C-N 115.864 -0.607 . . . . 63.549999999999997 109.719 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.59 154.38 69.27 Favored 'Trans proline' 0 C--O 1.253 1.237 0 C-N-CA 123.028 2.485 . . . . 62.130000000000003 110.91 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.0 tt -60.63 -29.13 44.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.936 -0.575 . . . . 73.319999999999993 112.011 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.451 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.6 pt20 -62.85 -40.58 97.9 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.928 0.394 . . . . 71.409999999999997 111.198 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -68.12 -39.74 82.69 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.283 0.564 . . . . 74.310000000000002 110.909 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' HG21 ' A' ' 29' ' ' VAL . 36.0 t -69.09 -40.75 81.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.328 -0.851 . . . . 73.200000000000003 109.821 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 28.7 t90 -59.06 -47.63 84.53 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 124.021 0.825 . . . . 74.319999999999993 110.397 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 34.2 mt-10 -64.4 -36.45 84.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.07 0.462 . . . . 71.319999999999993 110.731 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.4 m -67.16 -12.36 59.81 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-O 121.422 0.629 . . . . 60.210000000000001 111.976 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.665 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 16.7 m -131.06 13.62 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 120.756 -1.215 . . . . 74.430000000000007 112.906 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.6 t -139.12 4.05 2.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 120.247 -0.581 . . . . 73.099999999999994 112.259 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.4 p -111.57 168.57 9.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.198 -0.667 . . . . 64.230000000000004 109.198 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 16.4 m -60.08 -46.1 90.7 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.926 0.491 . . . . 64.430000000000007 111.447 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -71.12 -41.74 70.14 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.802 -0.635 . . . . 73.239999999999995 110.18 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.21 -48.01 67.78 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 115.158 -0.928 . . . . 74.340000000000003 113.078 -177.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.07 -41.46 89.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 117.289 0.544 . . . . 73.140000000000001 111.205 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 112.535 0.568 . . . . 44.340000000000003 112.535 -179.418 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 32' ' ' SER . 19.7 t-20 . . . . . 0 CA--C 1.494 -1.185 0 N-CA-C 105.611 -1.996 . . . . 73.439999999999998 105.611 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.21 70.77 8.13 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.553 0.692 . . . . 74.140000000000001 111.431 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -107.67 119.87 40.64 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.564 -1.198 . . . . 73.340000000000003 108.404 172.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -121.57 150.37 41.77 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.6 -1.259 . . . . 64.200000000000003 107.6 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -78.44 106.08 10.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 117.316 -1.754 . . . . 71.150000000000006 108.974 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 49' ' ' GLY . 23.7 tptp -130.41 144.7 51.56 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 104.875 -2.269 . . . . 73.540000000000006 104.875 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.99 36.75 0.57 Allowed 'General case' 0 C--N 1.283 -2.312 0 CA-C-O 122.218 1.008 . . . . 62.420000000000002 109.76 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 151.8 66.52 0.01 OUTLIER Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.35 -1.5 . . . . 72.230000000000004 109.35 -175.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 19.4 tt0 . . . . . 0 C--N 1.314 -0.947 0 N-CA-C 107.326 -1.361 . . . . 52.020000000000003 107.326 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.419 -1.992 0 N-CA-C 105.646 -1.983 . . . . 74.230000000000004 105.646 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 42.9 mtpt -133.52 134.29 43.24 Favored 'General case' 0 CA--C 1.468 -2.21 0 C-N-CA 120.139 -0.625 . . . . 64.209999999999994 111.143 -169.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.416 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 22.2 t -90.66 133.82 31.31 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 N-CA-C 105.307 -2.108 . . . . 74.530000000000001 105.307 168.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -78.75 -56.64 4.26 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.038 -1.097 . . . . 73.340000000000003 108.038 -175.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.19 153.27 28.95 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.274 -0.875 . . . . 73.519999999999996 108.88 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.421 HG23 HD22 ' A' ' 74' ' ' LEU . 12.5 p -132.67 119.8 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 CA-C-O 121.885 0.85 . . . . 70.219999999999999 111.621 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 45.9 mt-30 -101.34 141.0 34.86 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.322 -0.854 . . . . 73.209999999999994 110.955 176.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.32 126.2 92.19 Favored Pre-proline 0 C--N 1.279 -2.468 0 CA-C-N 113.875 -1.511 . . . . 70.230000000000004 109.439 -164.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo 7.27 46.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 1 C-N-CA 127.869 5.712 . . . . 54.439999999999998 116.843 -162.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 p -138.7 -38.59 0.52 Allowed 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.773 -0.649 . . . . 73.299999999999997 112.182 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 31.1 tt0 -150.5 142.71 24.16 Favored 'General case' 0 C--O 1.208 -1.127 0 C-N-CA 118.913 -1.115 . . . . 74.420000000000002 110.221 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.581 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -138.52 137.18 36.85 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 108.746 -0.835 . . . . 63.420000000000002 108.746 -177.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.479 ' HG ' HG21 ' A' ' 86' ' ' THR . 13.5 m -139.38 127.37 22.29 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 122.451 -0.156 . . . . 71.310000000000002 110.755 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 43.6 p90 -143.98 157.04 44.59 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.02 -0.425 . . . . 73.239999999999995 112.058 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 36.3 mt-10 -121.04 125.71 48.01 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 107.107 -1.442 . . . . 73.25 107.107 -176.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 51.3 t90 -135.33 148.49 49.48 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 111.925 0.343 . . . . 75.400000000000006 111.925 -176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.48 ' OD1' HG22 ' A' ' 80' ' ' THR . 2.5 t70 77.82 -177.79 0.11 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.073 1.749 . . . . 73.510000000000005 111.909 171.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.48 HG22 ' OD1' ' A' ' 79' ' ' ASP . 1.8 t -58.34 -41.42 84.59 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 113.062 0.764 . . . . 62.409999999999997 113.062 -175.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.23 12.49 11.64 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.211 0.819 . . . . 74.420000000000002 113.211 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.96 57.45 6.9 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 123.42 0.45 . . . . 60.539999999999999 112.757 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.469 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 88.1 m95 -67.38 117.14 8.96 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 109.0 -0.741 . . . . 75.400000000000006 109.0 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 76' ' ' PHE . 7.2 p -101.84 101.16 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 CA-C-O 122.599 1.19 . . . . 74.310000000000002 109.418 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.2 m -100.26 146.85 8.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 CA-C-N 114.096 -1.411 . . . . 63.539999999999999 108.167 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.479 HG21 ' HG ' ' A' ' 75' ' ' SER . 32.7 m -131.56 133.81 45.41 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 109.693 -176.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.665 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 13.2 m-85 -109.32 131.43 55.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.617 -1.253 . . . . 73.329999999999998 107.617 176.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.425 HE21 HD13 ' A' ' 101' ' ' ILE . 5.3 mt-30 -116.66 136.21 53.16 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 109.277 -0.638 . . . . 75.530000000000001 109.277 175.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mp -116.72 128.23 55.14 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.369 0.604 . . . . 71.5 110.552 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -102.85 119.6 39.14 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.104 -1.813 . . . . 71.239999999999995 106.104 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -81.13 111.79 17.9 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.11 0.481 . . . . 73.430000000000007 110.804 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.6 mt -120.95 148.66 43.78 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.669 -1.234 . . . . 74.140000000000001 107.669 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.06 54.24 2.53 Favored Glycine 0 C--N 1.284 -2.313 0 C-N-CA 121.027 -0.606 . . . . 62.020000000000003 112.208 -176.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -175.2 -54.51 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.652 -1.61 . . . . 72.109999999999999 106.652 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.38 175.41 8.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.027 -1.472 . . . . 74.099999999999994 107.027 -176.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.401 ' HB ' HG23 ' A' ' 25' ' ' VAL . 83.1 m -122.31 127.68 50.14 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 109.302 -0.629 . . . . 63.109999999999999 109.302 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.8 106.28 3.26 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.597 -1.401 . . . . 75.109999999999999 109.597 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -98.52 133.88 42.26 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 117.345 0.573 . . . . 72.230000000000004 109.646 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 28.9 m -123.17 120.38 33.03 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.612 -0.884 . . . . 75.239999999999995 108.612 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.63 141.62 33.23 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.961 -0.755 . . . . 72.239999999999995 108.961 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 18.2 mt -136.2 125.45 38.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.007 -1.451 . . . . 75.439999999999998 108.188 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 3.5 t-160 -120.31 117.36 27.59 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.042 -1.096 . . . . 75.150000000000006 108.042 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.2 t -142.15 164.13 31.0 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 103.727 -2.694 . . . . 72.120000000000005 103.727 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -166.65 163.3 36.89 Favored Glycine 0 CA--C 1.49 -1.514 0 C-N-CA 118.282 -1.913 . . . . 53.219999999999999 113.811 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 29.6 t90 . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 122.994 1.378 . . . . 73.239999999999995 109.429 179.222 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 113' ' ' GLY . 14.9 p . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 108.703 -0.851 . . . . 65.109999999999999 108.703 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.524 ' H ' HD12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -59.63 -35.94 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.624 0.25 . . . . 74.299999999999997 111.374 176.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.419 ' H ' HG22 ' A' ' 111' ' ' VAL . . . 126.36 -140.28 11.95 Favored Glycine 0 N--CA 1.422 -2.284 0 N-CA-C 110.242 -1.143 . . . . 75.519999999999996 110.242 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -80.65 -2.5 46.84 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 123.533 0.733 . . . . 73.340000000000003 110.204 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.87 71.28 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.071 0.462 . . . . 54.200000000000003 109.93 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -173.72 114.34 0.22 Allowed 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.209 -1.404 . . . . 74.099999999999994 107.209 174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -78.74 49.47 0.9 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 114.36 1.244 . . . . 73.5 114.36 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -152.61 92.82 1.71 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.235 1.014 . . . . 73.0 108.824 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -57.01 13.57 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 123.516 0.726 . . . . 63.420000000000002 111.474 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.4 m -61.82 -33.3 73.9 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.166 -0.47 . . . . 63.450000000000003 111.375 -176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.85 -47.15 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 109.587 -0.523 . . . . 71.209999999999994 109.587 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.495 ' O ' ' HG2' ' A' ' 126' ' ' MET . 48.6 t -58.23 -43.55 86.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 O-C-N 123.822 0.701 . . . . 75.25 111.124 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -61.67 -48.95 78.49 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.159 -0.473 . . . . 73.230000000000004 110.833 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.42 -43.93 97.53 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 115.634 -0.712 . . . . 53.25 111.799 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -67.45 -34.21 76.72 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.829 -0.686 . . . . 74.340000000000003 112.193 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 25.7 mmt -66.7 -43.07 85.32 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.225 -0.59 . . . . 73.519999999999996 111.479 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.82 -61.51 1.78 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.259 -0.976 . . . . 65.310000000000002 111.772 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.37 -39.0 95.58 Favored Glycine 0 C--O 1.24 0.485 0 C-N-CA 120.928 -0.653 . . . . 61.149999999999999 112.574 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.26 -53.96 29.79 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 119.659 -0.523 . . . . 73.310000000000002 112.3 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -63.28 -29.53 70.84 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 117.51 0.655 . . . . 72.140000000000001 112.48 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.555 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 73.2 m -60.98 -57.4 12.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.427 -0.583 . . . . 65.450000000000003 109.427 174.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.5 -46.83 60.7 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.167 -0.539 . . . . 73.140000000000001 113.646 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.621 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 44.8 mm -59.13 -57.54 10.94 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 C-N-CA 122.728 0.411 . . . . 53.140000000000001 111.205 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 79.0 t -60.49 -44.1 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 O-C-N 123.096 0.248 . . . . 72.450000000000003 111.491 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 131' ' ' THR . 38.7 t-20 -54.24 -61.7 2.14 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 123.953 0.783 . . . . 74.209999999999994 111.148 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -80.89 -38.92 27.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 119.834 -0.747 . . . . 73.030000000000001 112.187 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 3.7 mmt180 -62.11 -46.64 88.17 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.372 0.533 . . . . 72.519999999999996 111.667 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.484 ' HB3' HD22 ' A' ' 18' ' ' LEU . 4.6 mm? -67.98 -48.57 65.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 120.236 -0.585 . . . . 74.450000000000003 110.467 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.576 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -61.81 -33.68 74.57 Favored 'General case' 0 C--O 1.198 -1.646 0 CA-C-N 115.734 -0.666 . . . . 74.430000000000007 109.611 -178.606 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -73.15 -35.68 66.51 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 112.879 0.696 . . . . 74.129999999999995 112.879 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.6 -32.92 71.94 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.032 0.444 . . . . 75.140000000000001 110.701 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.16 -27.0 7.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.744 -0.662 . . . . 63.549999999999997 111.602 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 64.3 mm-40 -87.33 -45.4 10.61 Favored 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 120.136 -0.626 . . . . 71.109999999999999 111.447 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.421 13.2 pt-20 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 126.869 2.068 . . . . 63.210000000000001 115.489 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.362 0 CA-C-O 120.879 0.371 . . . . 72.209999999999994 111.597 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 tp 58.8 88.49 0.12 Allowed Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 124.72 1.208 . . . . 65.420000000000002 113.865 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -68.45 139.05 44.04 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 N-CA-C 108.475 -1.394 . . . . 63.219999999999999 108.475 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.69 153.79 42.47 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.48 0.919 . . . . 73.420000000000002 113.48 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.6 mm -121.78 138.74 51.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.067 -0.969 . . . . 73.510000000000005 110.075 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.1 m -126.01 130.82 51.93 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.827 -1.546 . . . . 70.239999999999995 106.827 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.498 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 41.0 tptt -139.75 145.37 38.2 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.849 -0.797 . . . . 55.450000000000003 108.849 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -118.56 140.63 49.59 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 117.682 0.219 . . . . 73.430000000000007 110.825 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.92 142.58 16.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.052 -0.722 . . . . 74.329999999999998 109.052 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 p -105.3 130.01 53.52 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 112.572 0.582 . . . . 73.299999999999997 112.572 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.53 141.53 33.27 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.826 -0.624 . . . . 63.43 111.038 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -78.9 9.42 4.27 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.033 0.833 . . . . 74.230000000000004 111.441 -176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . . . -120.95 160.56 44.41 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 109.586 -0.524 . . . . 73.319999999999993 109.586 -172.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 20' ' ' ALA . 32.5 Cg_endo -62.89 152.69 77.64 Favored 'Trans proline' 0 C--O 1.256 1.384 0 C-N-CA 123.205 2.603 . . . . 63.350000000000001 111.749 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.9 tt -56.63 -31.67 35.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.301 -0.863 . . . . 74.329999999999998 112.097 -175.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.58 -33.75 76.36 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.111 0.411 . . . . 74.549999999999997 112.111 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.5 -36.11 45.48 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.165 -0.68 . . . . 71.409999999999997 109.165 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.403 ' O ' HG21 ' A' ' 29' ' ' VAL . 46.3 t -66.07 -41.28 89.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.885 -0.783 . . . . 73.219999999999999 108.885 177.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 51.9 t90 -59.06 -47.85 83.72 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.997 -1.001 . . . . 72.239999999999995 111.718 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.42 -30.41 70.14 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.457 -0.897 . . . . 74.129999999999995 110.694 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.9 m -63.79 -22.84 67.11 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-O 121.274 0.559 . . . . 72.129999999999995 111.744 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.599 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 17.0 m -122.81 16.7 5.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 121.741 -0.6 . . . . 62.109999999999999 112.41 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.9 m -144.19 8.49 1.41 Allowed 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.163 0.801 . . . . 61.140000000000001 113.163 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.5 p -116.9 168.93 9.79 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 121.516 -0.74 . . . . 74.150000000000006 109.409 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -60.82 -54.7 41.94 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.268 -0.642 . . . . 74.319999999999993 109.268 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.97 -38.94 87.7 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.133 -0.94 . . . . 62.039999999999999 111.191 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.47 -48.74 28.44 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.687 -0.768 . . . . 40.420000000000002 113.379 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.31 -41.53 78.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 117.636 0.718 . . . . 53.140000000000001 112.785 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 113.558 0.947 . . . . 71.409999999999997 113.558 -176.32 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 109.157 -0.683 . . . . 52.030000000000001 109.157 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.22 72.94 3.34 Favored 'General case' 0 CA--C 1.486 -1.511 0 CA-C-O 121.339 0.59 . . . . 53.420000000000002 111.294 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -84.85 131.14 34.56 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.923 -1.51 . . . . 75.430000000000007 106.923 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.45 ' HB3' HE22 ' A' ' 50' ' ' GLN . 53.7 tt0 -120.01 149.68 41.76 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.145 -0.687 . . . . 72.310000000000002 109.145 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.38 104.27 15.04 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 109.267 -0.642 . . . . 75.109999999999999 109.267 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 12.1 tppt? -132.94 146.01 51.41 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.586 -1.264 . . . . 73.409999999999997 107.586 168.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -87.02 77.45 9.17 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.596 1.189 . . . . 71.340000000000003 108.002 172.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.43 83.44 0.96 Allowed Glycine 0 N--CA 1.406 -3.342 0 CA-C-N 114.327 -1.306 . . . . 45.420000000000002 109.959 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 48.7 tt0 . . . . . 0 CA--C 1.487 -1.479 0 N-CA-C 108.215 -1.031 . . . . 60.229999999999997 108.215 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.427 -1.595 0 N-CA-C 109.389 -0.597 . . . . 55.219999999999999 109.389 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HZ3' ' CG ' ' A' ' 79' ' ' ASP . 22.9 pttm -158.31 145.26 17.71 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.233 -0.655 . . . . 64.329999999999998 109.233 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.6 t -89.26 126.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 107.271 -1.381 . . . . 71.400000000000006 107.271 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 tt -74.79 -53.41 9.22 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.009 -1.478 . . . . 65.530000000000001 107.009 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.9 141.93 5.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.016 -0.993 . . . . 63.119999999999997 109.108 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.407 HG23 HD23 ' A' ' 74' ' ' LEU . 14.3 p -122.3 120.04 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-O 121.981 0.896 . . . . 70.430000000000007 108.953 173.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 84.4 mm-40 -105.17 142.14 35.48 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 114.013 -1.449 . . . . 74.040000000000006 109.778 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 135.94 95.65 Favored Pre-proline 0 C--N 1.283 -2.316 0 CA-C-N 114.569 -1.196 . . . . 62.299999999999997 109.103 -165.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -3.07 54.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.614 1 C-N-CA 128.323 6.015 . . . . 53.119999999999997 117.977 -162.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -152.23 -37.63 0.11 Allowed 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.617 -0.72 . . . . 55.420000000000002 110.809 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 35.1 tt0 -139.72 129.14 24.16 Favored 'General case' 0 C--O 1.198 -1.621 0 C-N-CA 117.351 -1.74 . . . . 64.010000000000005 112.142 -174.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.569 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -131.15 134.39 46.49 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.717 -0.845 . . . . 74.349999999999994 108.717 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.4 m -140.26 126.7 20.11 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.639 -0.255 . . . . 61.350000000000001 110.497 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -142.45 154.7 44.79 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.813 0.34 . . . . 74.340000000000003 110.271 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -122.63 132.25 54.19 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.688 -0.856 . . . . 62.43 108.688 -172.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.464 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 15.6 t-105 -112.98 106.14 14.34 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.124 -1.806 . . . . 75.540000000000006 106.124 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.411 ' CG ' ' HZ3' ' A' ' 64' ' ' LYS . 10.0 m-20 -72.49 172.26 10.83 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.238 -0.437 . . . . 74.319999999999993 110.69 -175.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.1 m 65.3 43.89 3.39 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 122.196 0.998 . . . . 72.530000000000001 109.448 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 64.51 32.37 11.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.352 -1.295 . . . . 71.010000000000005 113.508 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.464 ' HA3' ' CD1' ' A' ' 78' ' ' TRP . . . -86.81 -17.86 59.11 Favored Glycine 0 C--O 1.238 0.373 0 N-CA-C 109.308 -1.517 . . . . 42.310000000000002 109.308 171.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 28.6 m95 81.22 -174.17 0.04 OUTLIER 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.634 1.974 . . . . 74.510000000000005 112.217 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.32 122.96 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 121.758 0.79 . . . . 70.409999999999997 110.196 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m -116.8 152.36 18.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-O 121.317 0.58 . . . . 73.230000000000004 110.198 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.1 m -139.49 142.22 37.33 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 109.083 -0.71 . . . . 74.319999999999993 109.083 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.599 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 15.0 m-85 -121.23 140.35 52.16 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.89 -1.152 . . . . 75.239999999999995 107.89 176.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.88 132.79 53.26 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.357 -1.349 . . . . 63.039999999999999 107.357 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.84 122.18 44.61 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.738 0.78 . . . . 73.120000000000005 111.988 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -102.76 125.46 49.51 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.589 -1.187 . . . . 73.349999999999994 108.92 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -84.4 125.83 32.68 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.522 -0.763 . . . . 73.239999999999995 110.603 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.6 mt -125.43 153.04 44.06 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.856 -1.535 . . . . 64.409999999999997 106.856 171.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.18 38.22 2.73 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 114.613 0.605 . . . . 36.719999999999999 114.613 -172.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -176.02 -38.66 0.01 OUTLIER 'General case' 0 C--O 1.24 0.588 0 N-CA-C 109.372 -0.603 . . . . 73.340000000000003 109.372 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -127.12 175.81 7.85 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.115 -1.068 . . . . 74.349999999999994 108.115 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.4 m -121.54 129.07 52.66 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 120.709 -0.396 . . . . 73.040000000000006 110.281 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.42 106.16 3.32 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 109.489 -1.444 . . . . 62.530000000000001 109.489 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -98.58 134.47 41.47 Favored 'General case' 0 C--N 1.27 -2.864 0 O-C-N 121.801 -0.823 . . . . 65.420000000000002 109.652 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.6 m -118.84 121.7 40.63 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.387 -0.968 . . . . 74.219999999999999 108.387 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -101.83 142.34 33.29 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.694 0.759 . . . . 72.329999999999998 109.131 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 100' ' ' LEU . 17.7 mt -136.15 124.44 36.43 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.911 0 CA-C-N 113.92 -1.491 . . . . 72.430000000000007 107.653 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -120.22 118.24 29.95 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.294 -1.743 . . . . 72.040000000000006 106.294 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -138.79 164.19 30.25 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.811 -1.181 . . . . 74.049999999999997 107.811 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.21 170.1 34.37 Favored Glycine 0 N--CA 1.413 -2.889 0 N-CA-C 109.777 -1.329 . . . . 51.439999999999998 109.777 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 . . . . . 0 C--N 1.292 -1.917 0 N-CA-C 109.003 -0.74 . . . . 74.299999999999997 109.003 -176.708 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.432 -1.343 0 N-CA-C 107.218 -1.401 . . . . 73.409999999999997 107.218 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.476 HD12 ' H ' ' A' ' 112' ' ' ILE . 0.2 OUTLIER -62.42 -39.42 84.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 112.344 0.498 . . . . 64.239999999999995 112.344 179.359 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.92 -128.61 8.83 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.663 -0.78 . . . . 54.420000000000002 112.741 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -75.42 -7.39 53.93 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.69 0.796 . . . . 71.019999999999996 111.765 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.13 -34.02 71.56 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 123.137 0.273 . . . . 63.119999999999997 110.544 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -163.06 -81.7 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 119.676 -0.809 . . . . 71.200000000000003 112.887 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -151.28 -162.1 1.47 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.698 1.199 . . . . 55.119999999999997 109.231 -173.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.428 ' HB2' HG22 ' A' ' 121' ' ' VAL . 3.7 mppt? -75.43 154.38 37.13 Favored 'General case' 0 C--O 1.212 -0.895 0 C-N-CA 122.994 0.517 . . . . 65.310000000000002 110.289 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.0 m -60.21 -41.6 93.38 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.922 1.082 . . . . 65.409999999999997 113.922 -175.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.2 t -69.7 -45.87 67.27 Favored 'General case' 0 C--O 1.256 1.438 0 C-N-CA 120.116 -0.634 . . . . 74.310000000000002 111.138 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 118' ' ' LYS . 27.6 m -69.94 -36.74 70.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 119.16 -1.016 . . . . 73.310000000000002 110.928 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 126' ' ' MET . 21.4 t -61.27 -45.68 98.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.253 0 O-C-N 123.167 0.292 . . . . 75.239999999999995 111.407 175.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -64.44 -40.45 95.76 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.882 -0.327 . . . . 71.409999999999997 111.237 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.03 -45.0 95.04 Favored Glycine 0 CA--C 1.492 -1.356 0 N-CA-C 111.225 -0.75 . . . . 61.310000000000002 111.225 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -68.22 -32.33 72.46 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.697 -0.752 . . . . 65.420000000000002 111.195 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 21.3 mmt -64.06 -49.37 72.59 Favored 'General case' 0 C--O 1.206 -1.21 0 C-N-CA 121.068 -0.253 . . . . 63.520000000000003 111.252 176.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.92 -51.38 62.19 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 119.839 -0.744 . . . . 63.020000000000003 110.973 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.76 -44.97 95.49 Favored Glycine 0 C--O 1.241 0.545 0 C-N-CA 121.232 -0.508 . . . . 73.230000000000004 111.981 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.556 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -62.46 -50.89 60.44 Favored Glycine 0 CA--C 1.487 -1.679 0 N-CA-C 111.352 -0.699 . . . . 44.130000000000003 111.352 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.512 ' O ' HG11 ' A' ' 134' ' ' VAL . 77.4 m95 -59.51 -37.24 77.78 Favored 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 118.83 -0.605 . . . . 75.340000000000003 112.496 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.498 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 90.1 m -54.32 -54.4 40.84 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 109.859 -0.422 . . . . 74.030000000000001 109.859 176.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.62 -45.33 67.16 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.804 -0.634 . . . . 45.530000000000001 113.538 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 129' ' ' GLY . 36.2 pt -74.68 -36.67 41.19 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.416 0 N-CA-C 113.213 0.819 . . . . 74.140000000000001 113.213 -176.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 130' ' ' TRP . 4.2 p -74.92 -38.82 44.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 118.671 -1.212 . . . . 60.340000000000003 110.494 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.3 -60.25 3.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.742 -0.383 . . . . 74.209999999999994 110.896 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.2 -43.95 66.39 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.248 0.462 . . . . 53.020000000000003 112.248 -173.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.51 ' O ' ' HD2' ' A' ' 137' ' ' ARG . 2.0 tmm_? -70.27 -41.56 73.28 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.228 -0.589 . . . . 73.519999999999996 110.454 -173.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.0 mm? -63.96 -45.46 89.02 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 119.839 -0.744 . . . . 63.520000000000003 109.198 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.4 ' HD2' ' C ' ' A' ' 139' ' ' ARG . 3.9 tmm_? -59.03 -42.28 89.81 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.815 -0.629 . . . . 71.519999999999996 110.187 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -65.27 -51.66 59.34 Favored 'General case' 0 C--O 1.166 -3.311 0 CA-C-O 119.502 -0.285 . . . . 73.420000000000002 111.382 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.2 73.48 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 123.359 0.412 . . . . 72.530000000000001 112.106 -175.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 31.2 m -74.34 -26.45 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 119.665 -0.814 . . . . 73.230000000000004 110.736 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.95 -53.28 4.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 118.815 -1.154 . . . . 52.350000000000001 112.63 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--N 1.304 -1.371 0 C-N-CA 124.229 1.012 . . . . 73.450000000000003 110.776 -175.87 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.254 0.074 . . . . 75.409999999999997 110.824 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.52 -29.16 62.29 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.693 0.282 . . . . 63.020000000000003 111.401 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.23 -28.09 64.98 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.204 0.526 . . . . 73.310000000000002 111.351 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -84.76 96.03 9.13 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 113.535 0.939 . . . . 71.209999999999994 113.535 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -160.26 127.64 4.48 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 106.192 -1.781 . . . . 71.430000000000007 106.192 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.408 ' HG2' ' HG2' ' A' ' 110' ' ' GLU . 40.4 mt-10 63.95 78.95 0.27 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 122.577 1.18 . . . . 72.420000000000002 109.938 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -114.82 -75.49 0.59 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.216 -1.356 . . . . 70.319999999999993 110.279 -172.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 50.75 26.18 2.44 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.191 0.996 . . . . 71.430000000000007 111.377 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 4.2 mm? 67.95 90.24 0.09 OUTLIER Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 114.911 -1.04 . . . . 74.209999999999994 112.454 -172.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -88.32 -159.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 122.309 2.006 . . . . 64.439999999999998 109.702 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 7.8 p-10 -65.86 116.16 6.73 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.945 0.879 . . . . 73.040000000000006 111.151 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 50.0 mm -120.6 124.46 72.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 106.578 -1.638 . . . . 74.25 106.578 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.9 m -111.38 136.76 50.06 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.834 -0.802 . . . . 71.430000000000007 108.834 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.07 142.96 32.88 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.058 -1.089 . . . . 73.530000000000001 108.058 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.0 p -137.31 134.15 35.76 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 118.332 0.514 . . . . 38.060000000000002 109.785 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.92 131.84 13.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.236 -0.653 . . . . 74.450000000000003 109.236 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.491 ' CG2' ' HG3' ' A' ' 95' ' ' LYS . 2.7 m -94.52 120.97 35.57 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-O 121.798 0.809 . . . . 74.510000000000005 110.674 -175.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.2 mt -95.64 140.35 30.58 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.053 -0.976 . . . . 61.100000000000001 110.018 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.99 25.09 0.38 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.169 0.588 . . . . 75.549999999999997 112.21 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.84 160.47 44.56 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 122.655 0.382 . . . . 55.32 110.074 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 38.7 Cg_endo -67.4 157.41 61.9 Favored 'Trans proline' 0 C--O 1.256 1.402 0 C-N-CA 123.194 2.596 . . . . 62.149999999999999 111.55 175.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.9 tt -62.64 -27.16 42.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.785 -0.643 . . . . 75.319999999999993 112.119 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.41 -31.9 65.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.903 0.382 . . . . 75.420000000000002 111.481 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.446 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 5.0 tmtt? -79.1 -37.71 38.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 108.849 -0.797 . . . . 74.209999999999994 108.849 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.428 HG13 HG22 ' A' ' 96' ' ' THR . 4.3 p -66.28 -39.84 85.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 120.074 -0.65 . . . . 71.299999999999997 110.243 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.495 ' NE1' ' HD3' ' A' ' 71' ' ' PRO . 50.2 t90 -58.11 -48.24 80.81 Favored 'General case' 0 C--O 1.213 -0.867 0 O-C-N 123.704 0.628 . . . . 64.510000000000005 111.153 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.49 -29.99 69.57 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 120.125 -0.63 . . . . 72.310000000000002 110.586 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 94.6 m -67.01 -26.27 66.7 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.993 0.425 . . . . 64.510000000000005 111.522 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.633 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.7 m -115.33 19.84 7.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 121.374 -0.829 . . . . 74.120000000000005 112.112 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.8 m -142.24 4.78 1.63 Allowed 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.842 0.682 . . . . 70.140000000000001 112.842 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.8 p -110.51 162.21 14.92 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.749 -0.834 . . . . 72.409999999999997 108.749 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -56.47 -44.78 80.89 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 123.474 0.709 . . . . 62.210000000000001 111.089 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.11 -46.61 64.46 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.402 -0.817 . . . . 70.340000000000003 111.005 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.06 -40.68 88.37 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 115.615 -0.721 . . . . 44.25 112.814 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.4 mt -68.92 -39.89 80.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 120.804 0.335 . . . . 71.349999999999994 110.842 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.09 -30.5 71.64 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.04 -0.527 . . . . 62.310000000000002 110.671 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.8 mttp 70.28 20.22 6.27 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.126 1.371 . . . . 63.340000000000003 109.347 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 98.0 m95 64.23 12.46 7.14 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.637 1.175 . . . . 75.120000000000005 111.827 -175.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -104.7 84.97 2.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.185 -1.783 . . . . 75.109999999999999 106.185 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.9 mpt? 69.09 86.23 0.12 Allowed Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 114.687 -1.142 . . . . 73.340000000000003 109.304 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.01 114.1 3.06 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.752 2.301 . . . . 70.450000000000003 112.507 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -100.52 164.56 11.84 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.261 -1.014 . . . . 74.430000000000007 108.261 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -99.1 61.54 1.24 Allowed 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.328 -0.949 . . . . 65.099999999999994 109.295 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.422 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 20.0 t80 -65.58 132.51 49.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.108 -1.405 . . . . 73.430000000000007 110.201 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -109.93 133.41 53.21 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.752 -0.462 . . . . 72.230000000000004 109.752 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.7 tp -78.02 106.15 9.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.43 -1.322 . . . . 72.549999999999997 107.43 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -130.16 145.0 51.68 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.529 -1.286 . . . . 74.239999999999995 107.529 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -84.21 59.3 5.26 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.984 0.897 . . . . 71.010000000000005 109.277 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.27 77.53 0.58 Allowed Glycine 0 N--CA 1.414 -2.824 0 N-CA-C 109.38 -1.488 . . . . 64.209999999999994 109.38 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -75.43 -44.48 44.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.94 0.876 . . . . 61.149999999999999 108.717 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -143.93 156.97 44.62 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.299 -2.112 . . . . 53.119999999999997 105.299 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -109.79 147.73 32.73 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.989 -0.745 . . . . 72.340000000000003 108.989 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.442 ' CE1' ' HZ3' ' A' ' 106' ' ' LYS . 16.3 t-160 -109.38 137.76 46.76 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.63 -1.248 . . . . 75.120000000000005 107.63 -171.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.5 mp -146.31 -50.22 0.22 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.643 -0.873 . . . . 75.219999999999999 108.643 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -111.31 163.28 14.13 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.037 -0.983 . . . . 75.349999999999994 108.595 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -80.68 116.6 63.21 Favored Pre-proline 0 N--CA 1.425 -1.679 0 N-CA-C 108.626 -0.879 . . . . 74.040000000000006 108.626 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.413 ' HB3' ' OG ' ' A' ' 61' ' ' SER . 73.6 Cg_exo -55.47 106.3 0.18 Allowed 'Trans proline' 0 C--O 1.248 1.024 0 C-N-CA 123.012 2.475 . . . . 73.409999999999997 113.401 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -86.98 -34.41 19.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.082 -1.451 . . . . 74.439999999999998 107.082 174.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.73 147.62 20.6 Favored Glycine 0 N--CA 1.417 -2.602 0 N-CA-C 108.899 -1.68 . . . . 38.060000000000002 108.899 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -48.53 114.45 1.2 Allowed 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 123.697 2.932 . . . . 75.099999999999994 113.133 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' A' ' 57' ' ' PRO . 34.2 m -130.2 139.72 36.48 Favored Pre-proline 0 N--CA 1.424 -1.742 0 N-CA-C 108.476 -0.935 . . . . 72.329999999999998 108.476 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.0 -160.52 0.1 Allowed 'Trans proline' 0 C--O 1.262 1.694 0 C-N-CA 122.249 1.966 . . . . 71.340000000000003 112.242 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.9 p -87.03 142.81 27.66 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 107.983 -1.118 . . . . 61.039999999999999 107.983 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -133.97 140.83 47.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.756 -1.201 . . . . 75.030000000000001 107.756 -172.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.422 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 3.0 t -90.16 136.77 23.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 107.927 -1.138 . . . . 55.509999999999998 107.927 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.6 tp -83.52 -58.07 2.97 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.82 -1.178 . . . . 74.340000000000003 107.82 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.47 138.98 14.93 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.772 -1.104 . . . . 62.149999999999999 109.183 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.444 HG22 HD21 ' A' ' 74' ' ' LEU . 11.2 p -119.37 124.26 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 N-CA-C 108.978 -0.749 . . . . 74.120000000000005 108.978 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 28.2 mm-40 -105.12 140.84 37.69 Favored 'General case' 0 CA--C 1.48 -1.741 0 CA-C-N 115.663 -0.699 . . . . 72.439999999999998 109.602 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.32 126.48 92.61 Favored Pre-proline 0 C--N 1.279 -2.48 0 CA-C-N 113.604 -1.635 . . . . 73.439999999999998 109.047 -166.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HD3' ' NE1' ' A' ' 26' ' ' TRP . 36.9 Cg_exo 5.89 42.99 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 1 C-N-CA 128.131 5.887 . . . . 38.060000000000002 118.428 -160.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 p -132.76 -39.13 0.99 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.312 -0.404 . . . . 73.239999999999995 111.867 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 40.5 tt0 -150.43 145.11 25.85 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 119.325 -0.95 . . . . 73.030000000000001 110.988 -172.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.582 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -139.25 135.11 33.54 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.676 -0.861 . . . . 73.409999999999997 108.676 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.495 ' HG ' HG21 ' A' ' 86' ' ' THR . 13.8 m -140.54 126.04 18.96 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.689 0.28 . . . . 72.230000000000004 110.945 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -146.01 157.23 43.87 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 120.613 0.244 . . . . 72.030000000000001 111.02 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -120.95 123.86 43.5 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.978 -1.119 . . . . 74.299999999999997 107.978 -174.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -108.26 111.28 23.16 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 106.187 -1.783 . . . . 70.239999999999995 106.187 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.29 1.2 m-20 -79.1 10.16 3.78 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 116.808 2.151 . . . . 62.119999999999997 116.808 -170.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -75.85 94.95 3.41 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 104.529 -2.397 . . . . 75.319999999999993 104.529 167.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 83.68 -37.82 0.07 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.885 2.074 . . . . 75.219999999999999 109.718 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.94 47.45 0.56 Allowed Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 111.07 -0.812 . . . . 38.060000000000002 111.07 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -85.25 112.37 20.7 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.608 0.718 . . . . 73.540000000000006 110.402 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.1 t -101.77 117.27 46.83 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 N-CA-C 106.705 -1.591 . . . . 73.109999999999999 106.705 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.32 147.12 20.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-O 121.555 0.693 . . . . 73.450000000000003 110.518 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.495 HG21 ' HG ' ' A' ' 75' ' ' SER . 46.7 m -128.88 132.73 47.75 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 115.019 -0.991 . . . . 72.409999999999997 108.711 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.633 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 14.4 m-85 -112.7 145.56 40.28 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.978 -1.119 . . . . 74.25 107.978 177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.468 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 69.4 mt-30 -130.84 144.17 51.26 Favored 'General case' 0 C--N 1.277 -2.573 0 O-C-N 123.591 0.557 . . . . 74.340000000000003 110.932 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.0 mt -114.9 120.9 41.53 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 123.707 0.63 . . . . 65.319999999999993 110.25 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -103.48 122.74 45.54 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.454 -0.943 . . . . 74.120000000000005 108.454 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -77.66 112.7 14.74 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.101 -0.5 . . . . 74.120000000000005 111.479 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.0 mt -125.58 160.2 30.18 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.365 -0.834 . . . . 72.329999999999998 108.963 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.76 123.94 6.89 Favored Glycine 0 N--CA 1.424 -2.152 0 N-CA-C 109.114 -1.594 . . . . 75.430000000000007 109.114 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 84.58 -10.03 0.87 Allowed 'General case' 0 CA--C 1.485 -1.522 0 C-N-CA 125.709 1.604 . . . . 64.209999999999994 111.812 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.491 ' HG3' ' CG2' ' A' ' 17' ' ' THR . 2.1 ptpt -154.99 174.87 14.56 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 108.519 -0.919 . . . . 72.049999999999997 108.519 -176.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.428 HG22 HG13 ' A' ' 25' ' ' VAL . 63.8 m -135.41 132.49 37.57 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 110.039 -0.356 . . . . 64.519999999999996 110.039 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.73 117.27 4.82 Favored Glycine 0 N--CA 1.423 -2.224 0 N-CA-C 109.831 -1.308 . . . . 73.200000000000003 109.831 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -99.77 129.98 45.94 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 108.81 -0.811 . . . . 71.439999999999998 108.81 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.468 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 37.7 m -117.38 121.41 41.01 Favored 'General case' 0 N--CA 1.408 -2.529 0 C-N-CA 119.196 -1.002 . . . . 75.530000000000001 108.778 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.54 140.01 35.41 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-O 122.265 1.031 . . . . 74.409999999999997 109.017 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 100' ' ' LEU . 18.5 mt -136.19 124.95 37.54 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.117 0 CA-C-N 113.054 -1.885 . . . . 75.299999999999997 107.027 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . 10.3 t60 -120.25 131.87 55.11 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.919 -1.141 . . . . 74.109999999999999 107.919 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.6 m -142.88 132.48 23.77 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.696 -1.224 . . . . 72.349999999999994 107.696 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.87 127.09 9.11 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 120.497 -0.859 . . . . 64.439999999999998 111.201 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -128.25 124.59 37.03 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 122.557 1.17 . . . . 73.25 111.432 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.445 ' HG3' ' H ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -177.18 -156.55 0.04 OUTLIER 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 100.611 -3.848 . . . . 74.420000000000002 100.611 -176.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 106' ' ' LYS . 1.5 mp0 -70.08 129.32 90.86 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 106.959 -1.497 . . . . 74.299999999999997 106.959 168.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.7 92.46 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.106 1.871 . . . . 75.349999999999994 110.853 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -95.84 175.65 6.42 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.12 -1.437 . . . . 73.010000000000005 107.12 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 60.7 mt-10 -86.19 -26.49 25.08 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 121.541 0.686 . . . . 74.409999999999997 109.437 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.3 t -119.95 162.24 18.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 106.904 -1.517 . . . . 75.319999999999993 106.904 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.47 HD11 ' HB3' ' A' ' 115' ' ' ALA . 9.6 pt -62.15 -43.96 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.914 0.779 . . . . 74.340000000000003 110.166 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.62 -80.05 0.37 Allowed Glycine 0 N--CA 1.422 -2.283 0 C-N-CA 119.862 -1.161 . . . . 65.010000000000005 114.451 173.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.1 mptp? -104.2 -34.12 8.48 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.694 0.628 . . . . 61.140000000000001 112.694 -168.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 112' ' ' ILE . . . -65.03 -34.17 77.8 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 120.664 0.268 . . . . 63.140000000000001 111.68 -176.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.55 122.59 1.03 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.498 -1.297 . . . . 70.219999999999999 107.498 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -86.3 89.14 7.77 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.101 0.477 . . . . 72.209999999999994 111.584 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.4 tptt 179.64 152.84 0.44 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.045 -1.835 . . . . 74.319999999999993 106.045 171.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.2 p -111.76 -50.7 2.9 Favored 'General case' 0 C--N 1.286 -2.18 0 C-N-CA 120.028 -0.669 . . . . 75.5 111.37 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.2 p -63.22 -46.32 87.52 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.657 0.783 . . . . 74.450000000000003 111.187 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.91 -47.03 83.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.209 -0.905 . . . . 74.450000000000003 110.72 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.6 t -59.28 -35.03 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 116.357 -0.383 . . . . 71.409999999999997 111.237 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -66.56 -50.63 62.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.469 -0.937 . . . . 64.219999999999999 108.469 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.87 -40.53 98.42 Favored Glycine 0 C--O 1.241 0.547 0 CA-C-N 116.061 -0.518 . . . . 73.209999999999994 112.564 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -64.45 -38.77 92.2 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 122.877 0.471 . . . . 72.340000000000003 111.184 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.0 mmt -69.87 -36.83 75.82 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 121.361 -0.136 . . . . 73.150000000000006 111.353 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.49 -56.22 24.71 Favored 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 123.201 0.313 . . . . 73.400000000000006 110.737 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.83 -37.68 88.62 Favored Glycine 0 C--O 1.245 0.828 0 C-N-CA 120.672 -0.775 . . . . 62.229999999999997 111.745 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.8 -63.13 5.36 Favored Glycine 0 N--CA 1.438 -1.175 0 CA-C-N 115.309 -0.445 . . . . 62.420000000000002 112.408 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.633 ' O ' HG21 ' A' ' 134' ' ' VAL . 90.9 m95 -56.07 -45.25 79.38 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 113.342 0.867 . . . . 73.420000000000002 113.342 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.4 m -54.66 -51.44 65.48 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.708 0.63 . . . . 64.129999999999995 110.743 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.96 -43.61 64.8 Favored Glycine 0 C--O 1.25 1.125 0 C-N-CA 120.525 -0.845 . . . . 63.439999999999998 112.425 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.57 -57.6 11.35 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.848 0 CA-C-O 119.161 -0.447 . . . . 73.409999999999997 111.705 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.633 HG21 ' O ' ' A' ' 130' ' ' TRP . 27.4 m -64.19 -35.58 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 C-N-CA 118.906 -1.118 . . . . 75.549999999999997 112.841 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 42.3 t30 -57.81 -70.4 0.14 Allowed 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.558 0.536 . . . . 74.049999999999997 112.0 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.23 -28.13 27.49 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 118.93 -1.108 . . . . 74.230000000000004 112.062 -172.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -73.61 -38.08 65.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 118.722 -1.191 . . . . 70.140000000000001 110.804 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.5 mm? -70.78 -42.95 69.7 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 118.345 -1.342 . . . . 63.149999999999999 109.338 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 135' ' ' ASN . 2.3 tmm_? -57.73 -40.98 80.9 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 115.788 -0.642 . . . . 72.439999999999998 110.552 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -73.14 -36.67 66.7 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 113.422 0.897 . . . . 75.349999999999994 113.422 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.79 58.48 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.093 0.473 . . . . 74.409999999999997 110.968 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 32.1 m -85.36 -30.24 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 119.9 -0.72 . . . . 72.510000000000005 111.571 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -92.69 -26.19 17.9 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.102 0.779 . . . . 72.239999999999995 113.102 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' A' ' 145' ' ' LEU . 28.2 tt0 -150.76 -137.63 0.08 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 105.461 -2.051 . . . . 72.439999999999998 105.461 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.487 ' H ' ' HG2' ' A' ' 144' ' ' GLU . 1.9 pt? -142.33 -66.21 0.4 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.736 -0.468 . . . . 71.409999999999997 109.736 173.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -170.34 154.57 4.85 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 123.406 0.683 . . . . 65.519999999999996 109.599 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -159.27 -81.41 0.05 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.945 -1.131 . . . . 73.010000000000005 107.945 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -148.46 100.59 3.15 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.901 -0.777 . . . . 74.349999999999994 108.901 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -148.9 126.19 11.5 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 123.981 0.912 . . . . 74.530000000000001 108.66 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -84.69 125.72 32.76 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.767 -0.457 . . . . 75.310000000000002 109.767 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -119.55 154.62 33.59 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.242 -1.021 . . . . 74.409999999999997 108.242 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 . . . . . 0 C--N 1.3 -1.55 0 N-CA-C 109.086 -0.709 . . . . 75.120000000000005 109.086 179.664 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 CA--C 1.504 -0.818 0 N-CA-C 109.75 -0.463 . . . . 63.109999999999999 109.75 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.57 129.91 55.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.591 -0.277 . . . . 72.209999999999994 111.1 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.57 -28.29 22.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.478 -0.564 . . . . 60.240000000000002 109.478 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -89.55 -170.0 2.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.871 -1.159 . . . . 63.450000000000003 107.871 171.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -133.3 18.01 4.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 118.975 0.807 . . . . 74.140000000000001 111.999 -172.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -147.11 139.61 24.79 Favored 'General case' 0 N--CA 1.402 -2.847 0 CA-C-O 121.686 0.755 . . . . 75.510000000000005 110.651 -174.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -64.54 -44.82 89.6 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 113.919 -1.491 . . . . 75.129999999999995 109.716 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.16 118.62 23.71 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.142 -0.935 . . . . 64.310000000000002 108.578 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 tp -67.33 116.54 37.73 Favored Pre-proline 0 C--N 1.313 -0.981 0 O-C-N 123.767 0.667 . . . . 72.400000000000006 110.686 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -99.78 -157.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.251 0 C-N-CA 123.01 2.473 . . . . 64.120000000000005 108.959 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 5.1 p-10 -70.37 131.77 44.61 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.006 -0.678 . . . . 72.329999999999998 110.166 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.3 tt -132.41 138.95 51.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.933 -0.765 . . . . 72.5 108.933 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 m -111.77 134.83 53.08 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.797 -0.445 . . . . 75.430000000000007 109.797 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -136.9 124.1 21.77 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.082 -1.451 . . . . 64.299999999999997 107.082 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 m -117.84 134.02 55.35 Favored 'General case' 0 C--N 1.261 -3.266 0 N-CA-C 109.244 -0.651 . . . . 61.109999999999999 109.244 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.34 133.09 28.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 109.263 -0.643 . . . . 75.329999999999998 109.263 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -97.14 125.39 41.61 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 116.198 -0.455 . . . . 72.019999999999996 111.016 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.8 mp -101.06 139.58 36.55 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.096 -0.502 . . . . 74.230000000000004 110.077 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -80.06 29.94 0.27 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.987 0.915 . . . . 72.540000000000006 111.343 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.97 157.8 74.65 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.735 -0.839 . . . . 73.510000000000005 108.735 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.93 159.8 44.39 Favored 'Trans proline' 0 C--O 1.26 1.582 0 C-N-CA 123.087 2.525 . . . . 62.310000000000002 111.756 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -66.66 -24.9 33.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.85 -0.614 . . . . 62.219999999999999 111.535 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.531 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.0 pt20 -66.11 -40.81 91.02 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.313 -0.403 . . . . 75.219999999999999 111.392 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -74.66 -39.91 61.75 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.017 0.437 . . . . 64.040000000000006 111.011 -175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG13 HG22 ' A' ' 96' ' ' THR . 7.1 p -65.03 -38.37 82.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.319 -0.4 . . . . 75.209999999999994 110.079 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -58.68 -46.92 86.16 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.81 -0.632 . . . . 74.230000000000004 109.968 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 35.6 mt-10 -61.45 -38.29 86.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.923 0.392 . . . . 61.439999999999998 110.114 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.4 m -66.65 -11.72 55.1 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-N 115.987 -0.551 . . . . 75.230000000000004 111.757 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.613 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.8 m -128.82 9.21 2.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 121.178 -0.951 . . . . 71.099999999999994 112.529 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.3 t -124.96 -9.17 7.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.584 0.23 . . . . 43.32 111.529 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.9 p -94.46 154.21 17.55 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.851 -1.537 . . . . 55.420000000000002 106.851 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.0 m -57.2 -39.46 75.46 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 118.504 0.593 . . . . 75.140000000000001 111.645 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.86 -43.67 87.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.99 -1.005 . . . . 72.310000000000002 109.783 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.624 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . -72.58 -40.64 53.37 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 115.055 -0.975 . . . . 36.950000000000003 112.886 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.35 -48.42 88.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 122.748 0.419 . . . . 45.25 110.015 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.64 -52.98 54.57 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.62 0.6 . . . . 51.229999999999997 112.62 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.624 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 28.3 mtmm 69.36 -47.74 0.59 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 123.904 0.882 . . . . 64.150000000000006 113.206 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -56.43 -49.83 73.41 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.325 2.25 . . . . 74.310000000000002 109.902 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.501 ' CE2' ' HD2' ' A' ' 41' ' ' PRO . 32.9 t80 -135.64 167.95 20.17 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 106.182 -1.784 . . . . 72.510000000000005 106.182 -177.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.494 ' HB3' ' HD3' ' A' ' 41' ' ' PRO 0.271 49.5 ttm -87.4 -72.34 0.07 OUTLIER Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 113.958 1.095 . . . . 74.109999999999999 113.958 -179.084 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.501 ' HD2' ' CE2' ' A' ' 39' ' ' PHE . 7.1 Cg_exo -73.44 114.74 4.12 Favored 'Trans proline' 0 C--N 1.378 2.126 0 CA-C-N 121.726 1.652 . . . . 53.439999999999998 111.629 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.406 HD22 ' HB3' ' A' ' 39' ' ' PHE . 35.2 m-80 -140.14 162.67 34.68 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 112.525 0.565 . . . . 65.219999999999999 112.525 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -85.46 -2.11 57.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.243 -0.89 . . . . 72.239999999999995 111.087 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -76.87 118.83 19.85 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.829 -0.804 . . . . 70.439999999999998 108.829 -175.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.23 151.93 30.41 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.815 -0.629 . . . . 74.409999999999997 109.837 -173.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.449 HD12 HG13 ' A' ' 68' ' ' VAL . 3.0 tm? -81.65 104.88 12.37 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.961 -1.866 . . . . 65.299999999999997 105.961 175.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -134.83 137.69 43.53 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 106.168 -1.79 . . . . 62.219999999999999 106.168 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 6.5 pt-20 -91.75 70.25 5.68 Favored 'General case' 0 C--N 1.26 -3.312 0 CA-C-N 119.826 1.194 . . . . 74.239999999999995 109.821 174.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 131.19 96.42 0.71 Allowed Glycine 0 N--CA 1.401 -3.678 0 CA-C-N 113.784 -1.553 . . . . 36.950000000000003 110.91 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.44 150.83 50.62 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.91 -1.515 . . . . 72.409999999999997 106.91 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -131.73 150.19 52.23 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.686 0.616 . . . . 73.430000000000007 110.2 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -95.6 146.69 24.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.288 -1.375 . . . . 75.140000000000001 107.288 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.404 ' C ' ' H ' ' A' ' 55' ' ' GLN . 97.8 m-70 -121.82 143.29 49.49 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.207 -1.035 . . . . 75.310000000000002 108.207 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.5 tp -78.46 42.15 0.42 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 122.239 1.019 . . . . 74.519999999999996 110.935 -174.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' H ' ' C ' ' A' ' 53' ' ' HIS . 87.4 mt-30 -85.37 -29.06 24.76 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 107.971 -1.122 . . . . 75.120000000000005 107.971 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.5 m 55.92 77.9 0.41 Allowed Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 114.399 -1.273 . . . . 70.230000000000004 112.213 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -74.92 167.91 26.01 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.049 2.5 . . . . 53.450000000000003 110.958 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -81.93 131.94 35.26 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 110.0 -0.371 . . . . 74.129999999999995 110.0 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.12 -125.49 7.2 Favored Glycine 0 N--CA 1.418 -2.509 0 N-CA-C 110.334 -1.106 . . . . 53.299999999999997 110.334 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -83.43 149.65 13.13 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 C-N-CA 121.975 1.783 . . . . 72.129999999999995 111.672 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.4 m -78.71 135.53 59.86 Favored Pre-proline 0 N--CA 1.422 -1.849 0 N-CA-C 108.01 -1.108 . . . . 73.310000000000002 108.01 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.42 149.11 48.61 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 123.212 2.608 . . . . 36.950000000000003 113.593 -174.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 26.6 p -110.27 167.23 10.35 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 115.46 -0.791 . . . . 72.030000000000001 110.492 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -123.48 118.83 28.3 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 108.519 -0.919 . . . . 64.299999999999997 108.519 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.5 t -85.51 127.05 40.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 106.472 -1.677 . . . . 72.049999999999997 106.472 174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.7 tp -72.76 -53.39 11.74 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 124.209 0.943 . . . . 73.099999999999994 108.641 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.05 150.62 6.62 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.205 -0.907 . . . . 61.310000000000002 110.255 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 48' ' ' GLU . 59.7 t -121.14 118.88 57.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 107.459 -1.311 . . . . 62.32 107.459 173.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 41.9 mt-30 -111.67 141.76 44.86 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 123.958 0.903 . . . . 75.239999999999995 110.149 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.18 134.25 94.76 Favored Pre-proline 0 C--N 1.287 -2.129 0 CA-C-N 114.128 -1.396 . . . . 55.25 110.184 -162.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo 0.53 48.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.175 1 C-N-CA 128.434 6.089 . . . . 73.140000000000001 117.557 -163.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 m -146.58 -45.24 0.19 Allowed 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.876 -0.602 . . . . 72.239999999999995 111.265 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 29.0 tt0 -141.38 128.55 20.92 Favored 'General case' 0 C--O 1.21 -0.978 0 C-N-CA 117.243 -1.783 . . . . 63.450000000000003 111.905 -169.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.637 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.9 tm? -133.52 132.26 40.75 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 109.318 -0.623 . . . . 73.540000000000006 109.318 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.3 m -138.12 126.21 22.83 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.728 -0.389 . . . . 60.329999999999998 110.724 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -146.67 154.84 41.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.399 0.142 . . . . 72.239999999999995 110.782 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -123.55 123.66 41.1 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.031 -1.1 . . . . 63.32 108.031 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -101.4 140.34 35.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.339 0.59 . . . . 62.229999999999997 112.282 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -93.2 -172.46 2.96 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 103.625 -2.731 . . . . 72.329999999999998 103.625 167.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.1 m 66.76 30.4 8.06 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 122.841 1.305 . . . . 65.109999999999999 107.497 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.479 ' OE1' ' HG3' ' A' ' 114' ' ' LYS . 7.8 mm-40 56.88 53.9 7.67 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.329 1.852 . . . . 72.340000000000003 114.266 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.44 -37.22 2.68 Favored Glycine 0 C--N 1.312 -0.785 0 N-CA-C 109.821 -1.312 . . . . 73.530000000000001 109.821 174.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.448 ' CZ2' ' HB3' ' A' ' 81' ' ' GLU . 2.8 m0 70.65 -164.85 0.15 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.706 1.603 . . . . 74.549999999999997 111.973 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -91.38 118.86 37.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.653 -0.499 . . . . 73.510000000000005 109.653 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.7 144.63 33.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.399 -0.593 . . . . 74.109999999999999 109.399 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.439 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 38.9 m -130.68 139.42 50.32 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 115.909 -0.587 . . . . 75.109999999999999 109.925 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.637 ' CD2' HD13 ' A' ' 74' ' ' LEU . 10.0 m-85 -117.73 140.17 50.04 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.915 -1.143 . . . . 73.329999999999998 107.915 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.503 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 82.8 mt-30 -130.07 140.21 50.86 Favored 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 115.689 -0.687 . . . . 71.340000000000003 110.083 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.8 mt -118.71 124.42 47.29 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.049 0.452 . . . . 75.420000000000002 110.038 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -109.55 116.55 31.99 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.784 -0.821 . . . . 72.530000000000001 108.784 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.61 111.21 15.66 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.722 -0.672 . . . . 74.129999999999995 110.738 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 81.1 mt -109.84 153.8 23.91 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.912 -1.144 . . . . 74.340000000000003 107.912 176.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.48 39.63 3.01 Favored Glycine 0 C--N 1.29 -2.002 0 C-N-CA 121.145 -0.55 . . . . 36.950000000000003 111.917 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -156.74 -42.82 0.07 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 124.405 1.082 . . . . 75.120000000000005 109.305 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.0 ptpt -155.92 177.06 11.84 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.852 -1.166 . . . . 73.209999999999994 107.852 -168.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.437 HG22 HG13 ' A' ' 25' ' ' VAL . 38.9 m -113.32 125.72 54.59 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.854 -0.795 . . . . 72.510000000000005 108.854 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.06 109.69 3.67 Favored Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 110.526 -1.03 . . . . 53.509999999999998 110.526 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -98.05 132.43 43.61 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.409 -0.96 . . . . 73.150000000000006 108.409 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 28.0 m -122.23 122.94 40.31 Favored 'General case' 0 N--CA 1.406 -2.652 0 C-N-CA 119.496 -0.882 . . . . 73.519999999999996 109.038 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -103.13 140.19 37.66 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-O 122.023 0.916 . . . . 61.32 108.678 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.8 mp -135.64 124.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.453 0 N-CA-C 105.981 -1.859 . . . . 73.540000000000006 105.981 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 24.1 t60 -114.59 131.84 56.55 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.326 -1.361 . . . . 73.319999999999993 107.326 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.7 t -137.74 150.17 47.05 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.861 -1.163 . . . . 73.409999999999997 107.861 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -104.17 158.13 16.86 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 110.525 -1.03 . . . . 70.319999999999993 110.525 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -129.53 92.86 3.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 117.612 0.706 . . . . 72.340000000000003 112.214 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -179.27 -75.33 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.194 -1.409 . . . . 74.430000000000007 107.194 171.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.471 ' HG3' ' ND2' ' A' ' 109' ' ' ASN . 11.3 pt-20 176.03 141.88 0.22 Allowed Pre-proline 0 C--O 1.242 0.667 0 C-N-CA 125.165 1.386 . . . . 64.439999999999998 107.92 177.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -73.79 120.18 6.27 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.46 1.44 . . . . 54.210000000000001 109.841 174.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.471 ' ND2' ' HG3' ' A' ' 107' ' ' GLU . 0.7 OUTLIER -99.81 -160.55 0.81 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.685 -1.598 . . . . 71.239999999999995 106.685 178.573 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.98 -10.42 59.35 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 122.396 1.093 . . . . 72.120000000000005 109.115 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 109' ' ' ASN . 14.8 p -142.5 176.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 N-CA-C 104.674 -2.343 . . . . 73.140000000000001 104.674 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.8 pt -57.53 -39.82 71.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 118.504 0.593 . . . . 70.239999999999995 111.896 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.99 -64.83 3.03 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.751 -0.261 . . . . 63.310000000000002 112.952 175.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.479 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 0.5 OUTLIER -50.82 -48.05 59.91 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 125.243 1.417 . . . . 74.219999999999999 111.884 -177.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.68 61.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 114.604 1.335 . . . . 72.010000000000005 114.604 -173.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 60.98 33.36 19.79 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.012 0.91 . . . . 63.520000000000003 109.208 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.414 ' HB3' ' H ' ' A' ' 118' ' ' LYS . 5.7 mm-40 -109.29 -164.47 0.94 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.096 -0.956 . . . . 75.409999999999997 112.182 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.414 ' H ' ' HB3' ' A' ' 117' ' ' GLU . 26.7 mmtp -76.45 -170.15 1.42 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.255 -0.884 . . . . 74.049999999999997 108.881 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.2 p -126.72 -68.22 0.82 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.251 -0.98 . . . . 72.540000000000006 112.754 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.5 t -62.34 -44.5 96.34 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 123.158 0.286 . . . . 63.130000000000003 110.561 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p -70.61 -34.07 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 119.36 -0.936 . . . . 71.430000000000007 110.313 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.5 t -68.14 -42.81 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.648 -0.251 . . . . 72.329999999999998 110.987 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.8 ttp85 -59.24 -50.76 72.78 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.896 -0.779 . . . . 63.219999999999999 108.896 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.53 -41.76 99.63 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-N 115.736 -0.665 . . . . 43.009999999999998 113.061 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.401 ' O ' ' HA3' ' A' ' 129' ' ' GLY . 2.3 tmmm? -68.79 -32.15 71.68 Favored 'General case' 0 C--O 1.198 -1.61 0 N-CA-C 112.196 0.443 . . . . 74.140000000000001 112.196 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.451 ' HA ' ' HE3' ' A' ' 126' ' ' MET . 2.6 mmt -78.31 -42.37 30.93 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.234 -0.586 . . . . 73.349999999999994 110.604 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -56.93 -63.55 1.17 Allowed 'General case' 0 C--O 1.251 1.149 0 C-N-CA 124.232 1.013 . . . . 73.5 109.348 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.31 -34.24 64.15 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.262 -0.881 . . . . 45.240000000000002 111.722 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -61.4 -59.37 10.01 Favored Glycine 0 C--O 1.209 -1.419 0 CA-C-O 119.256 -0.746 . . . . 62.240000000000002 112.333 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -59.49 -38.66 81.45 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 117.931 0.866 . . . . 74.439999999999998 112.646 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.2 m -60.5 -52.91 63.17 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 120.504 -0.479 . . . . 73.409999999999997 110.796 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.49 -49.56 18.95 Favored Glycine 0 C--O 1.242 0.595 0 C-N-CA 121.162 -0.542 . . . . 74.129999999999995 113.562 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 77.3 mt -61.1 -49.64 83.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 C-N-CA 122.699 0.399 . . . . 74.25 111.154 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.471 ' HA ' HD23 ' A' ' 138' ' ' LEU . 97.3 t -63.48 -49.78 81.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.223 -0.991 . . . . 70.329999999999998 111.441 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -55.28 -63.89 1.02 Allowed 'General case' 0 C--O 1.246 0.905 0 O-C-N 123.785 0.678 . . . . 54.210000000000001 111.864 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 7.0 tp10 -81.98 -40.83 21.62 Favored 'General case' 0 C--O 1.174 -2.896 0 C-N-CA 118.424 -1.31 . . . . 62.299999999999997 113.211 -173.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.521 ' NH2' ' HA ' ' A' ' 37' ' ' LYS . 2.1 tmt_? -64.19 -37.04 86.04 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.976 1.262 . . . . 71.329999999999998 110.028 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.3 mm? -69.93 -50.16 44.82 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 119.125 -1.03 . . . . 63.509999999999998 110.206 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 139' ' ' ARG . 1.9 tmm_? -61.62 -36.52 80.98 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 121.359 0.6 . . . . 73.129999999999995 111.246 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -70.86 -47.76 57.58 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 123.746 0.818 . . . . 74.439999999999998 108.891 -177.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.01 75.01 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 111.608 0.225 . . . . 61.240000000000002 111.608 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.56 -32.17 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 119.718 -0.793 . . . . 73.299999999999997 110.923 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.49 -48.41 22.73 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 120.173 -0.611 . . . . 64.109999999999999 111.519 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.437 ' O ' ' HE2' ' A' ' 140' ' ' LYS . 8.0 pt-20 -171.71 105.38 0.2 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.769 0.828 . . . . 75.299999999999997 110.611 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 57.7 tp -70.36 97.01 1.2 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.561 0.696 . . . . 64.230000000000004 110.463 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -97.06 -44.49 6.96 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.428 -0.806 . . . . 74.540000000000006 111.969 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -144.82 173.99 11.38 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.671 0.272 . . . . 73.310000000000002 110.441 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.94 174.34 7.21 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.788 -0.819 . . . . 73.340000000000003 108.788 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -156.11 132.01 9.81 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.207 -0.597 . . . . 72.129999999999995 110.294 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -145.33 164.32 31.82 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.988 -1.116 . . . . 72.510000000000005 107.988 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -125.43 141.63 51.95 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.162 -0.681 . . . . 73.0 109.162 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 60.4 m80 . . . . . 0 C--N 1.303 -1.442 0 N-CA-C 109.428 -0.582 . . . . 72.150000000000006 109.428 -177.353 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.51 -0.594 0 N-CA-C 108.613 -0.884 . . . . 64.140000000000001 108.613 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 68.52 -39.18 0.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.993 1.849 . . . . 51.130000000000003 115.993 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -61.42 -31.08 71.0 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 123.262 0.625 . . . . 74.409999999999997 112.274 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.61 ' ND2' ' HB2' ' A' ' 127' ' ' ASP . 28.6 p-10 -86.46 35.9 0.68 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.704 0.764 . . . . 72.019999999999996 110.451 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -75.4 1.45 13.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.083 0.953 . . . . 71.349999999999994 112.922 -175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.24 -1.52 30.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.755 0.65 . . . . 72.150000000000006 112.755 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.5 t30 76.7 -27.64 0.18 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.138 1.375 . . . . 65.439999999999998 113.224 170.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.423 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -97.88 -163.26 1.03 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.638 -1.616 . . . . 74.25 106.638 172.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.8 tp -108.45 99.7 34.18 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 120.116 -0.634 . . . . 65.109999999999999 110.438 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 43.1 Cg_endo -95.97 -159.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.136 2.557 . . . . 74.329999999999998 110.047 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 1.6 m-20 -76.4 109.57 10.22 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.65 -0.5 . . . . 70.409999999999997 109.65 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.492 HG23 ' HB3' ' A' ' 102' ' ' HIS . 10.9 tp -102.31 128.37 55.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.268 -1.382 . . . . 74.120000000000005 107.268 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.1 m -111.04 129.11 56.01 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 109.083 -0.71 . . . . 72.230000000000004 109.083 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -131.31 132.1 44.28 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.716 -0.674 . . . . 73.040000000000006 110.646 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 m -118.43 132.81 56.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.887 -1.153 . . . . 73.219999999999999 107.887 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.66 140.7 20.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.922 -0.77 . . . . 73.409999999999997 108.922 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 p -103.02 132.45 49.27 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.612 0.72 . . . . 75.409999999999997 112.905 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 139' ' ' ARG . 2.2 mm? -108.79 140.48 42.16 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.302 -0.863 . . . . 64.430000000000007 110.897 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -80.57 25.46 0.42 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.603 1.161 . . . . 71.019999999999996 111.314 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -131.76 165.34 36.42 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 108.678 -0.86 . . . . 74.409999999999997 108.678 -174.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.441 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 46.2 Cg_endo -72.09 161.3 45.1 Favored 'Trans proline' 0 C--O 1.257 1.456 0 C-N-CA 121.907 1.738 . . . . 75.099999999999994 111.06 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.0 tt -58.21 -31.11 41.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 115.906 -0.588 . . . . 73.340000000000003 110.795 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -56.4 -50.59 71.17 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.937 0.895 . . . . 74.310000000000002 111.729 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -73.64 -36.55 65.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.116 -0.493 . . . . 74.129999999999995 110.618 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.407 HG22 ' HB ' ' A' ' 96' ' ' THR . 46.1 t -67.69 -41.13 85.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.761 -0.459 . . . . 73.329999999999998 109.761 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 46.3 t90 -61.29 -46.98 88.09 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.962 -1.017 . . . . 74.310000000000002 110.226 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -23.63 63.73 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.312 -0.555 . . . . 72.109999999999999 111.68 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.8 m -67.49 -18.1 64.93 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 121.431 0.634 . . . . 73.340000000000003 111.337 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.571 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 9.9 m -123.05 17.5 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 O-C-N 121.463 -0.773 . . . . 65.010000000000005 110.837 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.5 m -142.12 9.08 1.88 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.15 0.796 . . . . 70.450000000000003 113.15 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.4 p -114.07 168.56 9.71 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 121.635 -0.666 . . . . 71.319999999999993 109.771 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.651 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 15.9 m -58.38 -40.55 82.61 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 123.85 0.719 . . . . 74.519999999999996 109.507 175.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -68.85 -46.88 67.36 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.692 -1.14 . . . . 75.540000000000006 110.955 -177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.5 -47.99 25.56 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.84 -0.695 . . . . 73.310000000000002 113.62 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.04 -34.29 62.55 Favored 'Isoleucine or valine' 0 C--O 1.256 1.401 0 CA-C-O 121.182 0.515 . . . . 71.129999999999995 110.722 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.61 -30.56 43.26 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.702 -0.681 . . . . 74.430000000000007 112.062 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm 74.7 -57.74 0.6 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.912 1.285 . . . . 73.209999999999994 111.499 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -92.55 155.02 18.07 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 104.875 -2.269 . . . . 74.540000000000006 104.875 171.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -75.2 87.22 2.45 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.842 0.83 . . . . 74.319999999999993 110.042 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 59.4 mtm -131.3 118.18 17.08 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.594 -1.262 . . . . 72.209999999999994 107.594 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.71 96.71 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.43 2.087 . . . . 75.010000000000005 112.145 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.651 ' O ' ' HB3' ' A' ' 32' ' ' SER . 43.1 t-20 -134.34 143.2 47.54 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.935 -1.876 . . . . 63.219999999999999 105.935 176.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -90.81 69.61 6.51 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 113.288 0.848 . . . . 71.019999999999996 113.288 -170.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 94.0 m-85 -77.39 130.36 36.98 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.584 -1.265 . . . . 75.430000000000007 107.584 171.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -109.44 145.04 36.83 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.448 -0.945 . . . . 74.109999999999999 108.448 -174.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.0 tp -89.2 103.32 15.95 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 106.301 -1.74 . . . . 74.510000000000005 106.301 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 82.3 tttt -133.43 132.24 40.89 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.812 -1.551 . . . . 74.400000000000006 106.812 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.11 76.36 6.13 Favored 'General case' 0 C--N 1.258 -3.376 0 CA-C-O 122.922 1.344 . . . . 72.510000000000005 108.842 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.33 57.48 0.11 Allowed Glycine 0 N--CA 1.405 -3.415 0 CA-C-N 112.47 -2.15 . . . . 70.209999999999994 110.244 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 14.8 tt0 -91.43 142.64 27.45 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 109.403 -0.591 . . . . 73.129999999999995 109.403 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.75 147.88 43.4 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.466 -0.939 . . . . 74.349999999999994 108.466 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -129.82 147.04 51.55 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.145 -0.622 . . . . 71.540000000000006 109.943 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -133.51 140.0 46.97 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.628 -1.619 . . . . 63.520000000000003 106.628 175.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.44 75.64 10.23 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.513 -1.292 . . . . 74.420000000000002 107.513 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -89.94 -46.65 8.39 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.675 -1.148 . . . . 75.200000000000003 109.999 -174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.2 t -114.94 -62.53 0.03 OUTLIER Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-O 119.1 -0.476 . . . . 72.519999999999996 109.866 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.43 123.75 9.79 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 121.263 1.309 . . . . 71.299999999999997 110.374 173.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -104.68 -25.1 12.84 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.601 0.715 . . . . 73.25 109.232 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.52 -68.24 1.43 Allowed Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.241 -0.89 . . . . 74.25 112.538 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.81 104.62 0.48 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.562 2.175 . . . . 61.329999999999998 111.416 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.5 p -85.64 113.72 52.66 Favored Pre-proline 0 N--CA 1.425 -1.678 0 CA-C-N 115.493 -0.776 . . . . 65.049999999999997 110.862 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.77 -179.97 4.7 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.343 2.029 . . . . 74.319999999999993 111.115 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 12.1 p -110.53 169.9 8.44 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.183 0.516 . . . . 64.209999999999994 111.526 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 28.9 ttpp -121.52 118.01 28.22 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 105.359 -2.089 . . . . 53.509999999999998 105.359 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.7 t -85.67 135.22 25.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 120.155 -0.618 . . . . 73.420000000000002 109.529 -174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.3 tp -83.17 -56.14 3.95 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.043 -0.725 . . . . 72.109999999999999 109.043 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.5 149.32 16.89 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.228 -0.896 . . . . 52.130000000000003 109.997 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.54 119.31 53.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.524 -1.287 . . . . 74.010000000000005 107.524 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 13.1 mm-40 -103.63 141.79 35.43 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 121.24 0.543 . . . . 72.140000000000001 110.442 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.17 130.65 93.65 Favored Pre-proline 0 C--N 1.271 -2.824 0 CA-C-N 114.031 -1.44 . . . . 73.200000000000003 109.062 -167.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo 2.6 48.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.371 1 C-N-CA 128.189 5.926 . . . . 71.329999999999998 117.66 -162.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 6.9 m -142.72 -36.87 0.38 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.941 -0.572 . . . . 74.530000000000001 110.564 175.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.5 tt0 -147.77 144.61 28.36 Favored 'General case' 0 C--O 1.201 -1.451 0 C-N-CA 118.035 -1.466 . . . . 72.230000000000004 111.847 -174.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.484 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -139.0 134.46 33.09 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.015 -1.106 . . . . 65.319999999999993 108.015 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 p -141.69 126.53 18.15 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.656 -0.418 . . . . 54.329999999999998 112.115 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -145.23 155.77 43.44 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 110.234 -0.284 . . . . 75.109999999999999 110.234 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -122.19 134.01 54.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.722 -1.214 . . . . 72.129999999999995 107.722 -173.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -113.78 125.05 53.67 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.971 -1.122 . . . . 74.409999999999997 107.971 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.26 -28.81 69.97 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.125 1.157 . . . . 63.340000000000003 114.125 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.7 m -66.67 94.81 0.31 Allowed 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.955 0.883 . . . . 71.150000000000006 109.722 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.265 63.2 mm-40 77.56 4.71 3.05 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 127.865 2.466 . . . . 75.409999999999997 114.16 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.32 58.78 6.27 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.599 -0.728 . . . . 61.229999999999997 112.778 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -98.32 133.07 43.23 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.702 -0.399 . . . . 75.200000000000003 109.965 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.46 120.41 63.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.063 -1.088 . . . . 73.5 108.063 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.63 150.55 18.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.322 0.582 . . . . 71.439999999999998 110.918 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 88.3 m -137.87 137.68 38.34 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.577 -0.898 . . . . 74.099999999999994 108.577 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 26.3 m-85 -122.27 147.05 46.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.007 -1.109 . . . . 75.040000000000006 108.007 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 72' ' ' THR . 24.3 mt-30 -131.49 141.3 49.73 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 123.482 0.489 . . . . 61.420000000000002 111.127 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -112.93 124.1 51.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.1 0.476 . . . . 72.5 111.226 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.71 123.99 51.09 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 125.143 1.377 . . . . 73.010000000000005 109.475 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -84.8 123.14 30.1 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.132 -0.486 . . . . 72.129999999999995 110.832 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.7 mt -124.9 157.84 34.98 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.053 -1.091 . . . . 72.109999999999999 108.053 174.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 94' ' ' GLU . . . -82.31 50.22 4.28 Favored Glycine 0 C--N 1.3 -1.423 0 N-CA-C 115.269 0.868 . . . . 72.319999999999993 115.269 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 93' ' ' GLY . 6.1 tp10 167.65 -39.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.256 1.022 . . . . 54.520000000000003 108.983 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -126.16 175.69 7.59 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.039 -1.097 . . . . 62.5 108.039 -173.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.407 ' HB ' HG22 ' A' ' 25' ' ' VAL . 60.9 m -122.2 134.71 54.71 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.616 -0.513 . . . . 70.219999999999999 109.616 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -93.84 114.56 4.77 Favored Glycine 0 N--CA 1.416 -2.654 0 N-CA-C 109.106 -1.598 . . . . 73.430000000000007 109.106 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -101.96 134.65 44.83 Favored 'General case' 0 C--N 1.268 -2.977 0 N-CA-C 108.948 -0.76 . . . . 72.209999999999994 108.948 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.8 m -120.2 126.82 51.6 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 108.28 -1.007 . . . . 62.43 108.28 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.444 ' C ' HD12 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -104.4 137.21 42.61 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 106.885 -1.524 . . . . 71.109999999999999 106.885 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 101' ' ' ILE . 2.4 mp -135.23 123.67 39.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.747 0 N-CA-C 106.134 -1.802 . . . . 71.409999999999997 106.134 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.492 ' HB3' HG23 ' A' ' 12' ' ' ILE . 3.4 t-160 -121.27 132.33 54.74 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.533 -1.284 . . . . 65.219999999999999 107.533 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.2 t -136.19 154.57 50.91 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.461 -0.94 . . . . 65.109999999999999 108.461 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.81 170.58 53.24 Favored Glycine 0 C--O 1.262 1.867 0 N-CA-C 109.253 -1.539 . . . . 37.600000000000001 109.253 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 34.8 t-105 -52.75 -60.23 3.52 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 123.07 0.548 . . . . 73.439999999999998 110.202 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp 170.14 110.86 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 123.977 0.911 . . . . 65.319999999999993 109.295 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 176.03 124.1 0.15 Allowed Pre-proline 0 C--N 1.329 -0.321 0 O-C-N 124.527 1.142 . . . . 75.409999999999997 108.823 171.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -92.78 41.06 0.26 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.022 2.481 . . . . 53.420000000000002 111.303 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -86.66 -172.15 3.88 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.292 -0.413 . . . . 64.140000000000001 111.364 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -91.69 -38.82 12.19 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.134 1.161 . . . . 63.039999999999999 114.134 -172.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 119' ' ' SER . 22.1 t -129.68 155.6 41.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.547 -1.279 . . . . 75.420000000000002 107.547 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -32.98 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 120.892 0.377 . . . . 74.319999999999993 111.164 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.51 -89.47 0.93 Allowed Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.905 -0.589 . . . . 61.130000000000003 114.259 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -57.53 -23.88 52.85 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 125.122 1.369 . . . . 65.129999999999995 114.68 -172.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.14 -13.98 62.73 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.906 0.384 . . . . 71.030000000000001 111.797 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.7 m120 76.06 -19.83 0.39 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.099 1.36 . . . . 70.439999999999998 114.201 175.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.47 154.94 36.71 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.865 -0.42 . . . . 52.340000000000003 109.865 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -67.99 149.06 50.19 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.145 0.498 . . . . 63.229999999999997 111.2 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.424 ' HB3' HG11 ' A' ' 111' ' ' VAL . 3.0 p -58.29 -44.55 88.55 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 124.293 1.037 . . . . 74.349999999999994 111.814 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.4 p -65.2 -45.99 82.54 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.343 -0.844 . . . . 71.530000000000001 111.497 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.84 -37.72 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 120.132 -0.627 . . . . 74.319999999999993 109.616 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.589 ' O ' ' HG3' ' A' ' 126' ' ' MET . 54.3 t -61.53 -45.88 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 120.818 -0.353 . . . . 71.239999999999995 111.134 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -55.44 -49.54 72.16 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.471 0.482 . . . . 72.019999999999996 111.138 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.22 -42.42 90.97 Favored Glycine 0 CA--C 1.5 -0.858 0 CA-C-N 115.891 -0.595 . . . . 62.439999999999998 112.781 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 126' ' ' MET . 2.4 tmmm? -68.63 -44.1 74.91 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 113.095 0.776 . . . . 72.349999999999994 113.095 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.589 ' HG3' ' O ' ' A' ' 122' ' ' VAL 0.382 0.0 OUTLIER -77.1 -29.28 54.8 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 118.196 -1.402 . . . . 74.0 113.778 -177.774 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.61 ' HB2' ' ND2' ' A' ' 4' ' ' ASN . 27.0 t70 -71.66 -55.81 7.01 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.867 -0.733 . . . . 75.519999999999996 109.119 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.37 -38.01 95.73 Favored Glycine 0 CA--C 1.5 -0.869 0 CA-C-N 115.526 -0.761 . . . . 73.310000000000002 112.254 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.82 -58.14 11.99 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 111.713 -0.555 . . . . 37.600000000000001 111.713 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.548 ' O ' ' HB ' ' A' ' 134' ' ' VAL . 94.3 m95 -64.42 -36.78 85.26 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.073 1.138 . . . . 74.219999999999999 114.073 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.0 p -67.64 -53.87 24.36 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.148 -0.621 . . . . 74.5 110.976 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.1 -48.58 38.74 Favored Glycine 0 C--O 1.246 0.9 0 C-N-CA 121.492 -0.385 . . . . 74.129999999999995 113.428 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.4 HG12 ' NE2' ' A' ' 149' ' ' HIS . 77.0 mt -64.01 -54.0 36.94 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.281 0 CA-C-O 119.185 -0.436 . . . . 73.120000000000005 110.666 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' A' ' 130' ' ' TRP . 6.2 t -58.83 -40.71 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 113.608 0.966 . . . . 75.310000000000002 113.608 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -53.76 -59.54 4.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.244 0.545 . . . . 74.140000000000001 111.043 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.24 -42.14 26.61 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 113.258 0.836 . . . . 73.140000000000001 113.258 -174.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 148' ' ' HIS . 1.9 tmt_? -65.24 -41.48 94.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.225 0.466 . . . . 74.230000000000004 109.767 -174.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.2 mm? -66.65 -51.45 56.05 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.646 -0.422 . . . . 74.140000000000001 109.922 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.429 ' HA ' HD13 ' A' ' 18' ' ' LEU . 4.6 tmm_? -64.28 -31.78 73.11 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.951 0.405 . . . . 75.239999999999995 110.99 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -79.08 -44.72 21.53 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 113.489 0.922 . . . . 75.310000000000002 113.489 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.62 -23.89 67.41 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.624 -0.431 . . . . 61.439999999999998 111.096 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 24.0 m -85.35 -33.9 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 120.512 -0.475 . . . . 74.230000000000004 111.336 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -85.73 -70.47 0.59 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.937 0.717 . . . . 55.119999999999997 112.937 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.92 141.73 40.6 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.389 0.614 . . . . 73.109999999999999 111.801 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.532 HD11 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -93.13 17.07 11.53 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.392 1.256 . . . . 74.439999999999998 114.392 -171.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -77.61 -56.52 4.45 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.467 -0.938 . . . . 62.420000000000002 108.467 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -128.04 108.37 10.6 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.154 -0.618 . . . . 72.030000000000001 109.749 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.471 ' O ' ' HA ' ' A' ' 137' ' ' ARG . 55.3 p-80 -82.32 -10.22 59.17 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.894 -0.594 . . . . 72.209999999999994 110.907 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.549 ' CE1' ' HB3' ' A' ' 151' ' ' HIS . 13.7 t-80 -157.21 126.59 6.02 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.2 -1.778 . . . . 72.439999999999998 106.2 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -83.0 -25.03 32.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.061 0.458 . . . . 65.150000000000006 110.523 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.549 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 54.6 t-80 -77.82 111.88 14.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.654 -0.703 . . . . 64.310000000000002 109.572 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.3 p80 . . . . . 0 C--N 1.283 -2.304 0 CA-C-N 114.385 -1.279 . . . . 72.299999999999997 110.161 177.866 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 CA--C 1.51 -0.592 0 N-CA-C 110.033 -0.358 . . . . 71.200000000000003 110.033 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.66 122.39 9.26 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.786 -0.45 . . . . 74.129999999999995 109.786 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -75.35 -40.04 58.66 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.747 -1.575 . . . . 71.319999999999993 106.747 173.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -137.61 133.09 33.98 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 106.333 -1.729 . . . . 74.219999999999999 106.333 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -91.93 60.49 3.87 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.501 -0.926 . . . . 70.430000000000007 108.501 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.327 0.6 OUTLIER 36.27 60.32 0.88 Allowed 'General case' 0 C--N 1.345 0.398 0 C-N-CA 125.987 1.715 . . . . 74.019999999999996 115.548 178.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -80.63 -43.74 19.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.154 -0.475 . . . . 74.340000000000003 111.209 -177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 106' ' ' LYS . . . -117.09 19.98 13.98 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.879 -0.786 . . . . 62.310000000000002 108.879 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.4 mt 54.16 78.38 0.39 Allowed Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 113.815 -1.539 . . . . 53.43 113.37 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.85 -159.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 122.635 2.223 . . . . 64.319999999999993 108.865 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.53 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 44.3 m-20 -64.49 104.33 0.78 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.242 0.46 . . . . 73.030000000000001 112.242 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 77.3 mt -93.38 126.5 45.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.46 -1.681 . . . . 75.540000000000006 106.46 174.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.2 m -111.45 127.94 55.84 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.045 -0.662 . . . . 75.230000000000004 109.713 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -131.89 126.12 33.39 Favored 'General case' 0 C--O 1.197 -1.658 0 N-CA-C 108.955 -0.757 . . . . 64.349999999999994 108.955 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.3 m -118.1 142.66 47.18 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 119.624 -0.83 . . . . 70.120000000000005 109.825 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.86 141.73 16.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.42 -0.956 . . . . 65.340000000000003 108.42 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.61 127.08 53.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.324 -0.621 . . . . 72.120000000000005 109.324 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 4.7 mp -106.39 140.08 39.87 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 122.998 0.519 . . . . 72.420000000000002 109.717 -175.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -75.05 -2.02 25.48 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 124.091 0.956 . . . . 74.510000000000005 112.074 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.07 159.78 29.33 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 116.328 -0.396 . . . . 72.340000000000003 111.825 -172.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.49 153.61 73.73 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.305 2.67 . . . . 62.109999999999999 111.778 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.7 tt -48.86 -40.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.103 0.961 . . . . 62.219999999999999 112.628 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -70.98 -29.65 65.69 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.231 -0.588 . . . . 71.430000000000007 111.954 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -73.88 -36.82 64.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.629 0.728 . . . . 73.030000000000001 109.109 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.43 ' O ' HG21 ' A' ' 29' ' ' VAL . 58.3 t -69.72 -41.24 79.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.534 -0.913 . . . . 72.439999999999998 108.534 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -58.77 -47.95 82.93 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.293 -0.867 . . . . 75.319999999999993 111.61 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -64.65 -35.24 80.4 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.302 -0.959 . . . . 72.510000000000005 110.776 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.2 m -63.75 -23.91 67.56 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 112.177 0.436 . . . . 62.509999999999998 112.177 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.583 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 16.0 m -121.72 15.2 5.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 112.789 0.662 . . . . 73.510000000000005 112.789 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.5 t -142.76 9.72 1.77 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 119.481 -0.888 . . . . 61.130000000000003 112.66 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.7 p -122.22 171.78 8.77 Favored 'General case' 0 C--O 1.247 0.972 0 O-C-N 121.455 -0.778 . . . . 74.409999999999997 110.557 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 m -63.72 -48.86 75.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.548 -0.538 . . . . 74.209999999999994 109.548 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.29 -41.86 96.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.846 -0.615 . . . . 73.510000000000005 111.691 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.32 -49.45 20.34 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 120.078 -1.058 . . . . 40.030000000000001 114.073 -176.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.9 mt -72.14 -50.68 35.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 118.344 1.072 . . . . 64.319999999999993 112.499 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.8 -48.32 69.33 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.205 0.526 . . . . 72.510000000000005 111.301 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.498 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 0.5 OUTLIER 62.71 7.04 2.31 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.931 1.292 . . . . 61.219999999999999 112.262 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.5 m95 73.53 23.73 2.39 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.649 1.18 . . . . 75.239999999999995 113.22 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -68.13 -52.13 38.29 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 104.614 -2.365 . . . . 75.030000000000001 104.614 168.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.4 mmt -132.85 131.08 21.82 Favored Pre-proline 0 N--CA 1.426 -1.641 0 N-CA-C 105.422 -2.066 . . . . 75.150000000000006 105.422 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.79 105.47 1.32 Allowed 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 121.395 1.397 . . . . 72.340000000000003 109.877 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -121.22 149.61 42.59 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.156 -1.424 . . . . 72.450000000000003 107.156 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -105.83 79.3 1.41 Allowed 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.941 0.877 . . . . 75.450000000000003 110.525 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -90.53 119.81 31.1 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.556 -1.202 . . . . 75.5 110.546 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -119.56 153.36 35.53 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.304 -1.739 . . . . 72.239999999999995 106.304 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -74.78 104.31 5.37 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.594 -1.262 . . . . 75.329999999999998 107.594 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.523 ' HD3' ' HA ' ' A' ' 50' ' ' GLN . 47.4 tttp -132.97 144.54 50.18 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.711 -1.588 . . . . 64.230000000000004 106.711 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -91.76 69.79 5.63 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-O 122.097 0.951 . . . . 72.049999999999997 108.449 174.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.95 61.1 0.19 Allowed Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 110.119 -1.193 . . . . 71.019999999999996 110.119 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.523 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -95.55 112.72 24.39 Favored 'General case' 0 CA--C 1.473 -2.016 0 N-CA-C 106.489 -1.671 . . . . 64.239999999999995 106.489 -179.187 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.56 134.46 55.03 Favored 'General case' 0 C--N 1.276 -2.621 0 C-N-CA 119.283 -0.967 . . . . 64.430000000000007 109.425 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -110.57 117.87 34.68 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 103.411 -2.811 . . . . 62.329999999999998 103.411 173.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -109.47 162.61 14.21 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.891 0.377 . . . . 74.239999999999995 111.239 -169.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.63 148.76 44.47 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.106 -0.952 . . . . 74.25 109.438 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -85.99 147.51 26.18 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.126 -1.064 . . . . 71.140000000000001 108.126 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.1 m 71.27 103.03 0.03 OUTLIER Pre-proline 0 C--O 1.214 -0.771 0 O-C-N 124.72 1.262 . . . . 74.030000000000001 109.193 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.92 98.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 123.294 2.663 . . . . 74.239999999999995 114.953 -172.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -102.2 176.32 5.23 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.075 -1.083 . . . . 73.310000000000002 108.075 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.94 147.18 49.2 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.591 -1.404 . . . . 60.340000000000003 109.591 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.49 89.84 0.12 Allowed 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.542 2.161 . . . . 70.519999999999996 113.794 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -86.93 -47.34 0.51 Allowed Pre-proline 0 C--N 1.299 -1.618 0 CA-C-N 115.585 -0.734 . . . . 74.409999999999997 110.321 173.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -75.78 145.55 28.98 Favored 'Trans proline' 0 C--N 1.386 2.525 0 C-N-CA 121.423 1.416 . . . . 74.319999999999993 109.202 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 48.4 m -89.23 168.8 11.99 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.775 0.321 . . . . 73.150000000000006 111.635 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 90.8 mttt -142.02 133.68 26.92 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 116.28 -0.418 . . . . 62.240000000000002 110.65 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 36.2 t -90.58 136.71 23.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 106.271 -1.751 . . . . 73.140000000000001 106.271 175.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.8 tp -78.98 -61.42 2.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.109 -1.071 . . . . 64.25 108.109 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -162.37 153.99 18.34 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.905 -1.043 . . . . 64.540000000000006 108.877 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.8 p -131.19 131.82 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.34 0 CA-C-O 121.625 0.726 . . . . 63.140000000000001 110.458 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.567 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 85.7 mm-40 -110.29 141.75 42.85 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 114.363 -1.29 . . . . 71.129999999999995 108.077 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.52 136.07 96.01 Favored Pre-proline 0 C--N 1.288 -2.085 0 CA-C-N 115.024 -0.989 . . . . 72.310000000000002 109.635 -164.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo 0.59 50.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.366 1.491 1 C-N-CA 128.301 6.001 . . . . 74.030000000000001 117.484 -162.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 4.7 m -145.19 -46.83 0.23 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 112.001 0.371 . . . . 61.420000000000002 112.001 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 11.0 tp10 -132.71 126.76 33.26 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.48 -0.933 . . . . 74.420000000000002 108.48 -171.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -135.7 132.72 37.26 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.517 -0.549 . . . . 75.239999999999995 109.517 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.5 m -135.05 126.72 29.0 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 123.221 0.326 . . . . 73.310000000000002 111.432 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -146.23 155.64 42.83 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.003 -0.436 . . . . 71.140000000000001 111.654 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -123.05 125.8 45.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.795 -1.187 . . . . 74.329999999999998 107.795 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -139.86 160.99 38.64 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.791 -0.363 . . . . 74.200000000000003 111.492 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.423 ' HB3' ' CD1' ' A' ' 83' ' ' TRP . 48.6 t0 74.31 163.69 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.042 1.337 . . . . 70.230000000000004 111.546 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.9 m -59.11 -39.37 82.08 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.389 1.075 . . . . 74.040000000000006 112.009 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.89 -5.12 54.95 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.007 0.743 . . . . 52.299999999999997 113.007 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.43 73.62 0.68 Allowed Glycine 0 N--CA 1.442 -0.946 0 O-C-N 123.594 0.559 . . . . 54.030000000000001 113.004 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 79' ' ' ASP . 50.6 m95 -85.98 112.97 21.7 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.696 -1.224 . . . . 72.010000000000005 107.696 177.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.32 101.98 13.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 106.967 -1.494 . . . . 74.230000000000004 106.967 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.5 m -108.85 144.78 16.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 120.973 0.416 . . . . 73.310000000000002 110.309 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.467 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 7.4 m -131.3 143.02 50.22 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.689 -0.856 . . . . 72.109999999999999 108.689 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.584 ' CD2' HD13 ' A' ' 74' ' ' LEU . 11.0 m-85 -120.8 147.53 45.22 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.829 -0.804 . . . . 71.230000000000004 108.829 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.476 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 72.9 mt-30 -133.2 144.5 49.86 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 112.795 0.665 . . . . 73.319999999999993 112.795 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.517 ' HB3' ' HA ' ' A' ' 72' ' ' THR . 1.9 tm? -98.03 134.16 41.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.203 -0.908 . . . . 62.25 111.361 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -123.73 116.04 22.38 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.769 -2.308 . . . . 63.039999999999999 104.769 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -93.08 115.16 27.84 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.475 -0.89 . . . . 64.439999999999998 111.321 -175.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.8 mt -103.88 153.38 20.84 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.986 -1.116 . . . . 71.0 107.986 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.33 54.64 4.91 Favored Glycine 0 C--N 1.282 -2.431 0 C-N-CA 121.087 -0.577 . . . . 38.329999999999998 112.856 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 174.59 -33.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.323 0.649 . . . . 72.340000000000003 109.908 -177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 7.2 ptpt -150.33 175.27 11.98 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.772 -0.825 . . . . 65.219999999999999 108.772 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.0 m -111.47 123.15 49.62 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 121.176 0.512 . . . . 75.0 111.101 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.99 131.09 10.36 Favored Glycine 0 N--CA 1.406 -3.343 0 N-CA-C 108.484 -1.847 . . . . 38.329999999999998 108.484 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -120.12 134.5 55.24 Favored 'General case' 0 C--N 1.261 -3.277 0 C-N-CA 122.866 0.467 . . . . 73.209999999999994 109.804 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 90.8 m -117.77 127.17 53.64 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.917 -0.772 . . . . 74.439999999999998 108.917 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -103.62 140.56 37.39 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 108.59 -0.893 . . . . 75.5 108.59 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.9 mp -136.22 124.66 36.59 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.943 0 CA-C-N 113.662 -1.608 . . . . 61.539999999999999 106.973 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 18.2 t-160 -114.47 112.77 23.52 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.584 -1.265 . . . . 72.200000000000003 107.584 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.2 m -107.31 132.36 53.21 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.302 -1.74 . . . . 52.229999999999997 106.302 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.55 154.81 20.1 Favored Glycine 0 N--CA 1.426 -2.009 0 C-N-CA 120.838 -0.696 . . . . 38.329999999999998 112.894 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -68.98 -43.34 75.11 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.157 -0.522 . . . . 75.530000000000001 109.979 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 20.4 ptmt 38.16 91.0 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.306 1.595 . . . . 74.120000000000005 115.306 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.493 ' HB2' ' HD3' ' A' ' 108' ' ' PRO . 47.1 mt-10 -62.14 -52.66 65.56 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 120.341 -0.544 . . . . 72.150000000000006 110.29 176.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 107' ' ' GLU . 77.8 Cg_endo -102.0 -170.82 0.08 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.717 0 C-N-CA 121.831 1.688 . . . . 52.32 110.478 171.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -113.36 21.96 14.69 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.793 0.806 . . . . 71.310000000000002 109.06 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.71 -64.04 1.11 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.643 -1.162 . . . . 72.409999999999997 109.378 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.66 172.76 12.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 103.622 -2.732 . . . . 73.129999999999995 103.622 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -62.39 -37.84 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.247 1.385 . . . . 73.129999999999995 113.767 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 131.22 -75.76 0.42 Allowed Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.471 -0.871 . . . . 54.329999999999998 113.847 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -117.03 5.48 12.83 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 113.735 1.013 . . . . 63.530000000000001 113.735 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.36 65.1 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.589 -0.845 . . . . 71.109999999999999 111.354 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 174.91 137.44 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.174 -1.788 . . . . 44.409999999999997 106.174 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.25 -18.67 61.2 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.773 0.657 . . . . 73.329999999999998 112.773 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.451 ' HB3' HG23 ' A' ' 121' ' ' VAL . 43.0 tptt -91.37 97.77 11.3 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.413 -0.915 . . . . 75.420000000000002 110.577 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.3 t -58.48 -37.97 76.64 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.356 -1.293 . . . . 65.010000000000005 111.621 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.403 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 29.5 t -66.13 -45.07 82.33 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.964 -0.294 . . . . 50.130000000000003 111.51 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 118' ' ' LYS . 12.6 m -69.91 -34.48 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 119.453 -0.899 . . . . 75.140000000000001 109.64 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 63.0 t -66.29 -44.68 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 120.468 -0.493 . . . . 73.299999999999997 111.509 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.435 ' HD3' ' N ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -68.01 -37.15 81.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.996 -0.682 . . . . 74.129999999999995 111.276 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.435 ' N ' ' HD3' ' A' ' 123' ' ' ARG . . . -63.51 -45.59 94.41 Favored Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 111.012 -0.835 . . . . 74.319999999999993 111.012 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.28 -40.1 95.28 Favored 'General case' 0 C--O 1.193 -1.869 0 CA-C-N 115.011 -0.595 . . . . 74.200000000000003 111.95 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 24.2 mmt -69.32 -40.91 77.34 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.354 -0.538 . . . . 72.019999999999996 111.073 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.61 -57.66 11.17 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.419 0.628 . . . . 64.510000000000005 109.695 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.09 -38.63 59.41 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.47 -0.787 . . . . 63.32 112.389 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.79 -54.11 36.04 Favored Glycine 0 CA--C 1.491 -1.417 0 CA-C-O 119.72 -0.489 . . . . 54.140000000000001 112.036 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -61.91 -35.16 77.54 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 117.424 0.612 . . . . 72.299999999999997 112.456 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.2 m -62.37 -48.37 80.07 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 120.439 -0.504 . . . . 72.109999999999999 110.906 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.7 -46.44 24.32 Favored Glycine 0 C--O 1.247 0.907 0 C-N-CA 120.688 -0.768 . . . . 74.420000000000002 113.661 -177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.51 -52.32 59.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 122.347 0.259 . . . . 74.329999999999998 110.871 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.648 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 96.4 t -65.24 -48.48 83.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 119.81 -0.756 . . . . 61.0 112.318 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -59.39 -60.45 3.84 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 112.738 0.644 . . . . 74.530000000000001 112.738 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 32.4 tt0 -74.46 -48.98 24.15 Favored 'General case' 0 C--O 1.208 -1.091 0 C-N-CA 120.047 -0.661 . . . . 74.439999999999998 112.726 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.542 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 1.2 tmm_? -67.85 -32.27 72.67 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.032 -0.667 . . . . 71.239999999999995 111.41 -170.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.648 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 3.4 mm? -70.25 -51.86 27.41 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.769 -0.772 . . . . 73.319999999999993 110.023 174.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -34.26 76.26 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.894 -0.594 . . . . 73.230000000000004 111.584 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -71.27 -51.47 24.3 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.979 -0.748 . . . . 70.420000000000002 108.979 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.14 -26.85 68.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 74.040000000000006 111.87 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 30.1 m -83.8 -30.66 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.137 -0.625 . . . . 63.399999999999999 111.979 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -79.57 -12.86 59.84 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.156 0.979 . . . . 74.430000000000007 109.745 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -85.38 71.31 10.83 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 107.419 -1.326 . . . . 75.109999999999999 107.419 172.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -113.52 138.28 50.36 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.15 -0.477 . . . . 75.549999999999997 110.978 -177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -81.12 109.45 15.69 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.3 -0.864 . . . . 72.239999999999995 110.556 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -88.38 -30.69 19.33 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.481 -1.303 . . . . 74.200000000000003 107.481 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -88.2 73.74 8.88 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 107.047 -1.464 . . . . 75.230000000000004 107.047 172.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -119.38 -8.01 10.12 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.936 -1.029 . . . . 75.310000000000002 108.487 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -163.07 144.72 9.9 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 103.893 -2.632 . . . . 74.540000000000006 103.893 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -84.84 123.89 30.97 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.319 -0.952 . . . . 72.340000000000003 110.061 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 76.1 m80 . . . . . 0 C--N 1.293 -1.891 0 N-CA-C 108.743 -0.836 . . . . 75.150000000000006 108.743 178.453 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.507 -0.696 0 N-CA-C 108.472 -0.936 . . . . 74.340000000000003 108.472 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.46 119.39 30.82 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.364 -0.606 . . . . 51.310000000000002 109.364 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -81.34 -28.45 34.49 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.515 -0.766 . . . . 63.329999999999998 110.116 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -56.27 107.77 0.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.623 -0.717 . . . . 63.340000000000003 112.225 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -138.94 27.0 2.43 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.672 1.225 . . . . 62.450000000000003 107.818 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -99.93 24.42 8.52 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 113.811 -1.541 . . . . 73.109999999999999 110.502 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -123.4 71.67 1.09 Allowed 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 122.576 1.179 . . . . 74.120000000000005 111.554 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 66.74 30.01 8.3 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 112.013 -2.358 . . . . 61.299999999999997 112.762 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 61.75 83.97 0.2 Allowed Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 124.122 0.969 . . . . 74.030000000000001 111.855 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -89.18 -168.22 0.32 Allowed 'Trans proline' 0 N--CA 1.429 -2.32 0 C-N-CA 122.448 2.098 . . . . 65.120000000000005 112.178 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.642 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 6.3 p-10 -61.29 131.14 49.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.995 -1.002 . . . . 72.340000000000003 113.065 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.2 tp -135.99 138.74 47.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.966 -1.124 . . . . 51.43 107.966 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.7 m -117.75 133.64 55.73 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 120.85 0.357 . . . . 71.299999999999997 110.083 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -133.73 153.64 51.55 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.794 -1.928 . . . . 75.010000000000005 105.794 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.5 m -138.0 149.88 46.49 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.154 -0.966 . . . . 75.540000000000006 110.629 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.24 144.86 16.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.008 -0.738 . . . . 61.530000000000001 109.008 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.3 122.74 46.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.944 0.878 . . . . 75.219999999999999 112.156 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.8 mp -100.94 140.43 35.24 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 115.54 -0.755 . . . . 73.530000000000001 110.695 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -92.11 46.39 1.26 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.359 -1.291 . . . . 65.540000000000006 109.184 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -143.68 161.65 45.47 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.426 -0.953 . . . . 74.409999999999997 108.426 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.15 150.22 89.23 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 122.467 2.111 . . . . 62.310000000000002 111.135 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.1 tt -56.29 -33.34 37.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.594 0.559 . . . . 71.230000000000004 112.127 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -60.9 -42.23 97.64 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 112.194 0.442 . . . . 64.310000000000002 112.194 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -74.44 -37.79 63.18 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.259 0.552 . . . . 71.120000000000005 109.605 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.85 -41.1 91.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.463 -0.789 . . . . 73.099999999999994 109.206 177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.562 ' CE2' ' HD3' ' A' ' 71' ' ' PRO . 74.9 t90 -64.7 -46.09 83.82 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.141 -1.39 . . . . 74.310000000000002 109.777 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.59 -38.9 78.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.596 0.758 . . . . 72.200000000000003 110.185 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.417 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 62.8 m -57.73 -29.98 65.18 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 112.191 0.441 . . . . 72.209999999999994 112.191 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.4 m -110.3 18.64 6.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 O-C-N 121.852 -0.53 . . . . 71.349999999999994 112.037 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.5 p -135.7 -12.02 2.04 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.154 0.502 . . . . 74.230000000000004 112.05 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.7 p -94.75 148.86 21.85 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.09 -0.707 . . . . 73.140000000000001 109.09 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 m -53.52 -45.83 69.89 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.794 0.838 . . . . 65.230000000000004 112.709 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -69.23 -32.45 71.7 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.848 0.356 . . . . 75.329999999999998 111.458 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 28' ' ' THR . . . -72.31 -48.36 25.08 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.391 -0.909 . . . . 73.319999999999993 111.52 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.15 -32.17 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.139 0.976 . . . . 64.400000000000006 111.738 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.85 -29.18 11.13 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.171 0.989 . . . . 65.239999999999995 112.914 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 71.5 1.97 4.08 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.871 0.693 . . . . 53.109999999999999 112.871 170.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 57.5 t90 63.36 62.75 0.94 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.7 1.238 . . . . 73.420000000000002 108.154 -174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -143.77 -58.11 0.39 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.803 -1.544 . . . . 73.329999999999998 107.856 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 55.5 ttm -147.27 111.22 4.01 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 108.393 -0.966 . . . . 72.340000000000003 108.393 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.14 103.33 0.62 Allowed 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.312 2.008 . . . . 71.349999999999994 111.463 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -126.85 155.5 42.83 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.976 -0.557 . . . . 63.329999999999998 109.779 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.43 73.33 10.52 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.988 0.899 . . . . 62.509999999999998 110.042 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -83.69 121.77 27.72 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.993 -2.225 . . . . 74.239999999999995 104.993 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -109.76 145.88 35.91 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 112.292 0.479 . . . . 64.329999999999998 112.292 -167.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -75.43 105.55 6.51 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.71 -1.589 . . . . 74.140000000000001 106.71 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -131.05 145.25 51.96 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.655 -1.979 . . . . 54.439999999999998 105.655 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -87.36 34.04 0.69 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 118.963 0.801 . . . . 71.209999999999994 110.673 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 148.8 76.25 0.02 OUTLIER Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 108.501 -1.839 . . . . 64.549999999999997 108.501 -175.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -87.21 162.11 17.65 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.894 -1.521 . . . . 74.230000000000004 106.894 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -118.76 159.51 23.57 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.013 -1.106 . . . . 62.32 108.013 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -96.13 139.98 31.51 Favored 'General case' 0 N--CA 1.422 -1.848 0 C-N-CA 119.865 -0.734 . . . . 75.200000000000003 109.631 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -138.23 154.76 49.08 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.836 -1.542 . . . . 72.450000000000003 106.836 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.6 mt -74.89 81.32 2.15 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.833 0.825 . . . . 65.230000000000004 108.906 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -137.35 15.53 2.98 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.244 -1.344 . . . . 75.140000000000001 110.428 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.8 p -101.82 107.58 52.58 Favored Pre-proline 0 N--CA 1.428 -1.564 0 N-CA-C 108.243 -1.021 . . . . 74.120000000000005 108.243 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -53.19 124.16 14.97 Favored 'Trans proline' 0 C--O 1.247 0.961 0 C-N-CA 123.589 2.86 . . . . 75.530000000000001 113.542 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.0 t80 70.22 -64.05 0.37 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.631 1.572 . . . . 74.120000000000005 113.271 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.82 109.48 3.85 Favored Glycine 0 C--N 1.309 -0.92 0 CA-C-O 119.384 -0.676 . . . . 74.430000000000007 111.982 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.84 110.39 0.97 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.726 2.284 . . . . 63.229999999999997 110.41 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.0 m -116.51 99.27 52.67 Favored Pre-proline 0 N--CA 1.419 -1.987 0 CA-C-N 115.868 -0.605 . . . . 73.239999999999995 110.152 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 80' ' ' THR . 30.0 Cg_endo -71.28 101.39 1.11 Allowed 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 122.212 1.942 . . . . 74.049999999999997 110.485 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.1 p -122.35 141.77 51.21 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 115.346 -0.843 . . . . 72.430000000000007 110.108 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -155.24 143.45 20.2 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.518 -0.919 . . . . 65.299999999999997 108.518 -176.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.412 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 27.1 t -88.91 127.44 41.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 105.71 -1.959 . . . . 73.219999999999999 105.71 173.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -70.74 -53.03 17.08 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.437 -1.32 . . . . 74.140000000000001 107.437 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.65 145.36 5.41 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.202 -0.908 . . . . 65.409999999999997 109.258 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.457 HG23 HD23 ' A' ' 74' ' ' LEU . 10.4 p -121.44 119.23 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 121.781 0.8 . . . . 65.349999999999994 109.115 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 84.2 mm-40 -113.87 141.53 47.23 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.011 -0.995 . . . . 74.400000000000006 112.509 -176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.39 133.24 94.4 Favored Pre-proline 0 C--N 1.296 -1.754 0 CA-C-N 113.498 -1.683 . . . . 63.25 108.073 -167.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.562 ' HD3' ' CE2' ' A' ' 26' ' ' TRP . 9.5 Cg_exo -11.83 62.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.99 1 C-N-CA 126.587 4.858 . . . . 74.5 118.333 -156.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.2 p -142.24 -44.67 0.33 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.179 -1.373 . . . . 62.219999999999999 109.549 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 69' ' ' GLN . 37.1 mt-10 -143.33 141.01 30.82 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 113.262 0.838 . . . . 72.040000000000006 113.262 -171.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.554 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.1 tm? -136.49 130.86 33.17 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 107.278 -1.378 . . . . 71.329999999999998 107.278 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -140.86 126.37 18.87 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 120.384 -0.527 . . . . 72.25 110.717 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -146.01 155.4 42.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.64 0.257 . . . . 74.340000000000003 111.315 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 29.0 mt-10 -121.64 136.03 54.96 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 105.552 -2.018 . . . . 72.530000000000001 105.552 -175.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -155.51 162.79 40.63 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.188 -1.005 . . . . 75.400000000000006 113.571 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.7 t70 75.65 163.47 0.26 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 112.809 -1.996 . . . . 74.239999999999995 112.63 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.444 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 8.3 m -60.59 -33.38 72.65 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.642 1.177 . . . . 72.430000000000007 111.89 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.04 -33.63 70.48 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 120.722 0.296 . . . . 75.329999999999998 111.716 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.1 65.15 1.08 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.63 -0.795 . . . . 62.539999999999999 112.232 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.408 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 35.1 m95 -92.95 141.28 28.59 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.201 -1.407 . . . . 75.409999999999997 107.201 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.07 101.84 8.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 122.353 1.073 . . . . 53.210000000000001 109.121 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 m -97.54 142.69 13.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 115.435 -0.802 . . . . 71.409999999999997 110.603 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.3 m -132.31 122.0 24.43 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.334 -1.358 . . . . 74.140000000000001 107.334 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.554 ' CD2' HD13 ' A' ' 74' ' ' LEU . 11.9 m-85 -112.65 138.64 49.15 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.341 -0.985 . . . . 74.519999999999996 108.341 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.476 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 35.0 mt-30 -113.81 128.38 56.39 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 115.281 -0.872 . . . . 54.25 110.932 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.29 119.45 38.42 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.881 -1.155 . . . . 75.349999999999994 107.881 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -104.19 117.1 33.42 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.906 -1.146 . . . . 74.510000000000005 107.906 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -77.94 112.22 14.62 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.718 -0.674 . . . . 65.400000000000006 109.855 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 98.8 mt -115.21 140.91 48.68 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.14 -1.43 . . . . 73.439999999999998 107.14 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.38 58.9 4.96 Favored Glycine 0 C--N 1.276 -2.788 0 CA-C-N 115.654 -0.703 . . . . 72.010000000000005 111.907 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 179.51 -47.05 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.592 0.757 . . . . 73.219999999999999 109.307 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 9.8 ptpt -142.52 175.39 9.83 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.254 -1.388 . . . . 72.430000000000007 107.254 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.8 m -111.15 124.86 53.05 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 119.794 -0.763 . . . . 74.439999999999998 110.307 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.48 108.27 3.62 Favored Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 110.085 -1.206 . . . . 74.209999999999994 110.085 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -98.29 129.39 44.99 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.795 -0.817 . . . . 75.200000000000003 108.795 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 8.0 m -116.31 123.15 46.93 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 107.958 -1.127 . . . . 73.109999999999999 107.958 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.467 HD12 ' CE1' ' A' ' 87' ' ' PHE . 2.9 tp -100.18 119.34 38.21 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.724 -0.843 . . . . 64.129999999999995 108.724 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 101' ' ' ILE . 2.9 mp -117.01 123.17 71.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 105.928 -1.879 . . . . 64.340000000000003 105.928 175.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.642 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 22.9 t-160 -108.59 113.52 26.59 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.665 -1.606 . . . . 62.539999999999999 106.665 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -125.93 155.55 41.13 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 105.762 -1.94 . . . . 72.129999999999995 105.762 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.28 153.8 17.54 Favored Glycine 0 C--N 1.26 -3.684 0 N-CA-C 108.833 -1.707 . . . . 71.209999999999994 108.833 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 43.6 t90 -148.29 95.0 2.39 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.806 -0.812 . . . . 73.299999999999997 108.806 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -83.08 -56.18 3.94 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.78 -1.193 . . . . 71.400000000000006 107.78 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -175.46 154.98 1.65 Allowed Pre-proline 0 N--CA 1.441 -0.896 0 N-CA-C 106.954 -1.499 . . . . 54.210000000000001 106.954 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -69.82 110.14 2.49 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 121.701 1.6 . . . . 74.219999999999999 109.287 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -158.88 -177.62 6.65 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 105.629 -1.989 . . . . 54.340000000000003 105.629 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -88.07 -31.32 19.31 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 118.866 0.757 . . . . 60.299999999999997 109.572 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.05 152.6 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 116.161 -0.472 . . . . 65.239999999999995 109.934 -175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.429 HD12 ' HB3' ' A' ' 115' ' ' ALA . 5.9 pt -62.21 -44.17 98.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.913 -0.585 . . . . 72.209999999999994 110.407 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.84 -52.7 3.62 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 114.413 0.525 . . . . 72.140000000000001 114.413 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.29 -42.1 16.17 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 112.861 0.689 . . . . 73.319999999999993 112.861 -172.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.429 ' HB3' HD12 ' A' ' 112' ' ' ILE . . . -67.06 -30.5 70.58 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.552 -0.459 . . . . 61.329999999999998 110.485 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.413 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 22.1 t-20 -175.51 145.17 0.71 Allowed 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.317 -1.364 . . . . 71.439999999999998 107.317 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -90.23 -17.87 26.72 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 113.172 0.804 . . . . 75.109999999999999 113.172 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 9.5 mmpt? -99.56 109.66 22.17 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.403 0.62 . . . . 70.129999999999995 110.798 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -67.48 -33.34 74.91 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.547 -0.751 . . . . 70.310000000000002 111.23 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 p -65.94 -46.67 77.33 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 111.756 0.28 . . . . 73.030000000000001 111.756 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 118' ' ' LYS . 30.2 m -70.27 -34.51 58.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 119.77 -0.772 . . . . 71.549999999999997 110.917 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.413 ' CG2' ' HB3' ' A' ' 116' ' ' ASN . 99.4 t -65.86 -45.56 91.04 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 C-N-CA 120.394 -0.522 . . . . 64.239999999999995 110.594 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -61.8 -43.64 98.45 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 111.865 0.32 . . . . 74.430000000000007 111.865 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -62.51 -47.38 89.78 Favored Glycine 0 CA--C 1.497 -1.079 0 CA-C-N 115.837 -0.62 . . . . 73.409999999999997 111.925 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -72.22 -29.58 64.09 Favored 'General case' 0 C--O 1.193 -1.899 0 N-CA-C 112.796 0.665 . . . . 73.140000000000001 112.796 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.4 mmt -67.5 -48.93 65.66 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.012 -0.675 . . . . 73.450000000000003 111.66 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.33 -50.16 55.29 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.249 -0.98 . . . . 71.099999999999994 110.961 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.93 -40.2 97.04 Favored Glycine 0 C--O 1.239 0.418 0 N-CA-C 111.445 -0.662 . . . . 72.019999999999996 111.445 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.516 ' O ' HG21 ' A' ' 133' ' ' ILE . . . -64.44 -58.07 11.36 Favored Glycine 0 CA--C 1.482 -1.99 0 CA-C-O 119.007 -0.885 . . . . 74.140000000000001 111.928 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -57.67 -36.11 71.48 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.86 0.83 . . . . 75.540000000000006 112.44 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.3 m -61.1 -51.84 67.42 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 120.736 -0.385 . . . . 73.439999999999998 110.259 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.4 -50.49 15.86 Favored Glycine 0 C--O 1.25 1.113 0 C-N-CA 121.194 -0.526 . . . . 54.140000000000001 113.858 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.516 HG21 ' O ' ' A' ' 129' ' ' GLY . 10.5 tp -63.79 -49.27 82.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-O 119.554 -0.26 . . . . 74.420000000000002 110.879 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.696 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 71.8 t -62.84 -47.35 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 120.046 -0.662 . . . . 64.25 112.148 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.406 ' HA ' HG13 ' A' ' 16' ' ' ILE . 26.6 t-20 -55.38 -62.03 1.95 Allowed 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 111.98 0.363 . . . . 71.420000000000002 111.98 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 35.9 tt0 -80.4 -41.05 25.31 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 119.538 -0.865 . . . . 72.200000000000003 113.327 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -35.69 78.23 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.116 -1.034 . . . . 75.299999999999997 110.144 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.696 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 3.1 mm? -68.82 -51.82 36.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.129 0.49 . . . . 74.109999999999999 110.13 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.616 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 1.6 tmm_? -63.65 -36.34 83.5 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 115.691 -0.686 . . . . 71.140000000000001 110.416 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -74.7 -34.77 62.69 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 122.836 0.454 . . . . 74.340000000000003 109.789 -179.07 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.5 -26.98 63.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.469 0.652 . . . . 74.430000000000007 110.765 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.408 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 25.6 m -85.66 -25.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 C-N-CA 119.701 -0.799 . . . . 62.130000000000003 111.466 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 51.7 mt-10 -76.42 -41.89 46.11 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.628 -0.879 . . . . 74.120000000000005 108.628 174.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 72.61 173.75 0.3 Allowed 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 126.465 1.906 . . . . 62.020000000000003 110.499 -174.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.43 HD22 ' H ' ' A' ' 145' ' ' LEU . 2.4 pt? -118.01 151.57 37.21 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 121.175 0.512 . . . . 74.109999999999999 109.687 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -101.46 161.61 13.51 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 106.514 -1.661 . . . . 73.040000000000006 106.514 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -56.01 125.77 22.97 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.664 -0.495 . . . . 72.400000000000006 109.664 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 27.8 p80 54.95 15.69 1.24 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 126.413 1.885 . . . . 72.140000000000001 113.422 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -103.65 74.46 1.25 Allowed 'General case' 0 C--O 1.247 0.96 0 CA-C-O 121.868 0.842 . . . . 74.409999999999997 109.07 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -99.75 161.28 13.71 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.868 -1.06 . . . . 75.209999999999994 109.153 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -122.24 143.99 49.25 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.18 -0.674 . . . . 75.129999999999995 109.18 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 . . . . . 0 C--N 1.309 -1.161 0 N-CA-C 109.133 -0.691 . . . . 73.5 109.133 179.316 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 C--O 1.235 0.307 0 N-CA-C 109.415 -0.587 . . . . 65.430000000000007 109.415 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.51 166.39 10.95 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.749 -0.834 . . . . 70.150000000000006 108.749 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -85.06 -28.33 25.73 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.055 0.455 . . . . 73.319999999999993 110.316 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -56.39 133.56 53.08 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 114.87 -1.059 . . . . 53.130000000000003 112.644 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -110.76 13.87 22.3 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.281 -1.378 . . . . 74.310000000000002 107.281 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -138.46 122.66 18.09 Favored 'General case' 0 N--CA 1.39 -3.442 0 N-CA-C 106.403 -1.703 . . . . 75.200000000000003 106.403 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -93.18 3.0 56.42 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 114.697 -1.138 . . . . 75.230000000000004 109.993 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.15 141.3 28.71 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 106.274 -1.75 . . . . 71.299999999999997 106.274 173.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.4 pt? -74.23 119.47 76.54 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 120.079 -0.648 . . . . 64.019999999999996 110.211 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.83 -162.14 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.162 1.908 . . . . 74.540000000000006 107.73 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -72.51 105.11 4.05 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 118.535 -1.266 . . . . 70.299999999999997 108.51 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 72.7 mt -91.25 123.67 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 106.912 -1.514 . . . . 75.409999999999997 106.912 -177.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.4 m -119.51 129.2 54.58 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 108.149 -1.056 . . . . 73.519999999999996 108.149 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -139.49 132.55 29.56 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.244 -1.391 . . . . 72.430000000000007 107.244 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 p -117.98 140.72 49.33 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 109.391 -0.596 . . . . 54.5 109.391 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.32 140.49 19.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.876 -0.787 . . . . 74.310000000000002 108.876 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' THR . 12.7 p -99.24 118.96 37.09 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.746 0.784 . . . . 72.109999999999999 112.389 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.4 140.07 30.12 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.723 -1.126 . . . . 72.430000000000007 109.633 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.4 30.67 0.69 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.441 0.639 . . . . 75.230000000000004 110.663 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -127.83 163.92 40.15 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.256 -1.016 . . . . 75.150000000000006 108.256 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 36.0 Cg_endo -66.13 152.72 80.51 Favored 'Trans proline' 0 C--O 1.255 1.362 0 C-N-CA 122.433 2.088 . . . . 64.349999999999994 110.724 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 tt -61.26 -31.38 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.009 -0.541 . . . . 71.219999999999999 112.021 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.589 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.2 pt20 -60.29 -45.14 94.39 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.619 0.247 . . . . 61.130000000000003 110.891 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -68.06 -39.5 82.99 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.374 -0.375 . . . . 72.040000000000006 111.91 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.6 -41.1 87.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.504 -0.554 . . . . 61.520000000000003 109.504 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.534 ' CZ2' ' HD3' ' A' ' 71' ' ' PRO . 60.3 t90 -63.9 -46.61 84.07 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.153 -0.93 . . . . 72.239999999999995 110.063 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 41.2 mt-10 -63.61 -37.99 89.42 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 120.991 -0.284 . . . . 53.399999999999999 110.544 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.0 m -56.84 -36.07 69.56 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.935 0.398 . . . . 64.019999999999996 111.384 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.662 HG11 ' CE1' ' A' ' 98' ' ' PHE . 30.9 m -103.76 16.04 5.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 112.018 0.377 . . . . 73.019999999999996 112.018 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.6 t -145.88 6.63 1.05 Allowed 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.012 -0.675 . . . . 44.520000000000003 112.146 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.9 p -108.32 170.3 8.1 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 121.775 -0.578 . . . . 72.319999999999993 110.555 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 t -59.91 -62.17 2.07 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 124.143 0.902 . . . . 72.219999999999999 111.103 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -78.05 -27.92 48.81 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 119.57 -0.852 . . . . 73.409999999999997 111.883 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.93 -48.68 84.48 Favored Glycine 0 C--O 1.216 -1.018 0 N-CA-C 110.888 -0.885 . . . . 54.310000000000002 110.888 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.18 -43.76 78.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 122.026 0.917 . . . . 74.120000000000005 110.359 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.79 -36.12 83.3 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 113.884 1.068 . . . . 54.210000000000001 113.884 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.78 1.88 11.45 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 112.254 0.465 . . . . 73.140000000000001 112.254 -174.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -89.3 -39.02 13.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 121.036 -0.266 . . . . 75.409999999999997 110.361 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -133.93 -56.01 0.87 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.962 1.468 . . . . 72.439999999999998 114.962 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 84.6 mtp -147.89 139.82 14.12 Favored Pre-proline 0 CA--C 1.513 -0.454 0 N-CA-C 109.651 -0.499 . . . . 73.349999999999994 109.651 -174.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -68.06 108.83 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.42 2.08 . . . . 65.310000000000002 111.894 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -132.9 144.16 49.98 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.698 -0.683 . . . . 73.420000000000002 109.923 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.93 53.37 2.8 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.73 0.776 . . . . 73.120000000000005 110.765 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -72.31 152.28 42.21 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.138 -0.937 . . . . 74.340000000000003 108.573 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -137.55 151.53 48.48 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.888 -0.782 . . . . 72.140000000000001 108.888 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -75.41 104.45 5.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.539 -1.652 . . . . 72.430000000000007 106.539 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' O ' HG13 ' A' ' 65' ' ' VAL . 12.9 tptp -134.82 132.14 38.31 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 107.186 -1.412 . . . . 71.430000000000007 107.186 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -95.55 86.96 4.59 Favored 'General case' 0 C--N 1.26 -3.321 0 CA-C-O 122.674 1.225 . . . . 73.510000000000005 108.571 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.09 105.14 2.26 Favored Glycine 1 N--CA 1.395 -4.084 0 CA-C-N 113.256 -1.793 . . . . 71.329999999999998 109.564 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.55 149.49 29.99 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.931 -1.507 . . . . 75.519999999999996 106.931 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.08 154.2 45.83 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.563 -0.903 . . . . 74.010000000000005 108.563 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -128.75 147.67 50.79 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.097 0.475 . . . . 75.120000000000005 111.286 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -115.81 153.12 32.03 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.304 -0.998 . . . . 74.530000000000001 108.304 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.2 mt 73.54 65.62 0.1 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.479 1.112 . . . . 74.510000000000005 110.064 -176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.04 109.61 1.87 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.367 -1.288 . . . . 72.319999999999993 110.466 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.9 p -153.72 148.48 19.65 Favored Pre-proline 0 N--CA 1.417 -2.12 0 N-CA-C 107.277 -1.379 . . . . 75.409999999999997 107.277 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.61 -40.35 85.84 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.893 2.396 . . . . 64.129999999999995 112.414 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -131.65 143.22 50.15 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.828 -0.804 . . . . 75.540000000000006 108.828 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.27 -101.02 0.25 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.213 -0.755 . . . . 41.399999999999999 111.213 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.55 2.63 7.97 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 122.753 2.302 . . . . 71.120000000000005 111.805 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.1 t 71.63 112.94 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.211 1.405 . . . . 74.430000000000007 110.14 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -80.12 44.25 1.69 Allowed 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 123.686 2.924 . . . . 74.340000000000003 113.09 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 18.5 p -116.52 142.7 46.53 Favored 'General case' 0 N--CA 1.417 -2.075 0 CA-C-O 121.47 0.652 . . . . 72.519999999999996 111.726 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -137.24 138.41 40.09 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 107.009 -1.478 . . . . 74.219999999999999 107.009 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 47' ' ' LYS . 23.5 t -88.71 135.09 26.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 C-N-CA 119.516 -0.874 . . . . 72.409999999999997 109.249 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -76.53 -60.43 2.35 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.248 -1.76 . . . . 74.349999999999994 106.248 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.95 152.93 6.72 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.19 -0.914 . . . . 60.229999999999997 108.912 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.41 118.58 57.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 105.957 -1.868 . . . . 73.230000000000004 105.957 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 14.9 mm-40 -98.42 140.18 33.06 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.871 -0.788 . . . . 63.030000000000001 108.871 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.69 126.8 93.07 Favored Pre-proline 0 C--N 1.265 -3.094 0 CA-C-N 113.739 -1.573 . . . . 64.329999999999998 107.966 -168.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.534 ' HD3' ' CZ2' ' A' ' 26' ' ' TRP . 92.0 Cg_exo 2.03 51.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.117 1 C-N-CA 127.601 5.534 . . . . 71.349999999999994 117.351 -159.228 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.2 p -138.78 -39.14 0.5 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.005 -0.998 . . . . 73.430000000000007 111.557 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 36.9 tt0 -151.2 149.0 28.92 Favored 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 119.046 -1.062 . . . . 62.520000000000003 111.347 -174.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.534 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -137.0 134.06 36.21 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.613 -1.255 . . . . 75.420000000000002 107.613 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.471 ' OG ' HG21 ' A' ' 86' ' ' THR . 22.4 m -141.62 126.53 18.21 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.819 -0.352 . . . . 60.219999999999999 111.266 177.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -143.91 154.0 42.89 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.819 -0.438 . . . . 73.120000000000005 109.819 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -122.86 124.71 43.87 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 123.066 0.546 . . . . 73.140000000000001 109.585 -171.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 6.4 t-105 -117.38 115.63 25.61 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.971 -1.492 . . . . 75.510000000000005 106.971 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -82.6 152.57 25.87 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.584 -0.846 . . . . 73.310000000000002 109.16 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.6 m 74.88 84.84 0.1 Allowed 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 123.858 0.863 . . . . 74.200000000000003 110.235 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 57.87 0.41 0.11 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 127.263 2.225 . . . . 73.099999999999994 115.62 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.45 -35.41 20.18 Favored Glycine 0 C--N 1.312 -0.796 0 N-CA-C 110.645 -0.982 . . . . 75.0 110.645 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 52.3 m95 66.63 -161.82 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.272 1.429 . . . . 75.519999999999996 109.766 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 p -116.67 126.68 74.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.99 -0.744 . . . . 71.510000000000005 108.99 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.4 m -116.31 136.61 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 CA-C-N 115.299 -0.864 . . . . 73.120000000000005 110.301 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.471 HG21 ' OG ' ' A' ' 75' ' ' SER . 34.9 m -124.54 127.03 46.79 Favored 'General case' 0 C--N 1.279 -2.498 0 N-CA-C 107.535 -1.283 . . . . 74.430000000000007 107.535 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD2' HD13 ' A' ' 74' ' ' LEU . 13.4 m-85 -112.38 130.11 56.08 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.465 -0.939 . . . . 72.109999999999999 108.465 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -109.33 137.5 47.11 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.439 -0.8 . . . . 73.219999999999999 110.257 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.39 120.34 40.01 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.281 -0.872 . . . . 75.439999999999998 110.026 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -111.54 116.83 31.51 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.207 -1.034 . . . . 71.040000000000006 108.207 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.86 123.39 27.18 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.267 0.556 . . . . 74.420000000000002 109.528 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.6 mt -126.35 159.54 32.91 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.33 -0.85 . . . . 63.119999999999997 109.204 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.67 128.16 8.52 Favored Glycine 0 N--CA 1.409 -3.132 0 N-CA-C 108.693 -1.763 . . . . 63.009999999999998 108.693 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 83.89 -3.81 1.11 Allowed 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 125.011 1.324 . . . . 74.010000000000005 111.977 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -164.46 173.41 12.15 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.002 -0.74 . . . . 71.25 109.002 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' THR . 85.3 m -124.79 132.64 53.33 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.368 -0.604 . . . . 61.32 109.368 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.56 105.03 3.25 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 110.059 -1.216 . . . . 51.140000000000001 110.059 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.662 ' CE1' HG11 ' A' ' 29' ' ' VAL . 67.9 t80 -98.33 134.28 41.56 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.998 -0.741 . . . . 74.140000000000001 108.998 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 m -125.14 125.79 44.25 Favored 'General case' 0 N--CA 1.405 -2.678 0 C-N-CA 119.619 -0.832 . . . . 51.009999999999998 109.23 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.488 HD21 ' CE3' ' A' ' 130' ' ' TRP . 1.8 tp -100.26 124.04 45.22 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.074 -1.084 . . . . 72.310000000000002 108.074 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 3.5 mp -121.26 124.59 72.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 106.923 -1.51 . . . . 72.329999999999998 106.923 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -120.69 122.1 39.71 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.15 -1.056 . . . . 74.310000000000002 108.15 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -142.87 163.93 31.46 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.814 -1.551 . . . . 54.340000000000003 106.814 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -179.1 132.37 1.87 Allowed Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 108.502 -1.839 . . . . 62.439999999999998 108.502 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -92.15 144.66 25.2 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.228 -0.989 . . . . 74.120000000000005 110.291 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -127.7 -73.05 0.61 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 106.293 -1.743 . . . . 73.340000000000003 106.293 -177.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.435 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 32.9 tt0 167.27 -57.63 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 127.772 2.429 . . . . 74.340000000000003 108.443 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 107' ' ' GLU . 72.1 Cg_endo -82.34 146.78 14.06 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 121.12 1.213 . . . . 70.319999999999993 112.764 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -100.97 -20.64 15.33 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.783 -1.098 . . . . 74.109999999999999 108.815 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -63.5 -48.03 79.29 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.718 -0.674 . . . . 75.230000000000004 111.897 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.73 166.58 13.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 N-CA-C 104.82 -2.289 . . . . 64.310000000000002 104.82 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.9 pt -58.72 -32.63 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 118.418 0.554 . . . . 60.420000000000002 112.038 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.3 -113.12 3.91 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.61 -0.805 . . . . 71.420000000000002 113.702 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.84 -9.35 58.19 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.22 0.822 . . . . 65.010000000000005 113.22 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.72 -22.4 61.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.073 -0.343 . . . . 62.420000000000002 110.073 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 53.1 t30 43.01 89.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.655 1.582 . . . . 71.450000000000003 114.806 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.18 154.18 38.76 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 100.297 -3.964 . . . . 75.540000000000006 100.297 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.435 ' HB2' HG22 ' A' ' 121' ' ' VAL . 9.9 mmpt? -72.38 122.19 20.78 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 119.629 1.104 . . . . 72.409999999999997 111.776 -168.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 11.0 p -44.44 -50.47 9.33 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 125.119 1.368 . . . . 74.400000000000006 114.276 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.6 p -65.35 -45.86 82.52 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 116.337 -0.392 . . . . 65.329999999999998 112.026 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 118' ' ' LYS . 11.0 m -70.62 -33.55 53.56 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 C-N-CA 119.909 -0.716 . . . . 74.120000000000005 110.346 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 118' ' ' LYS . 69.5 t -60.22 -46.92 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 O-C-N 123.087 0.242 . . . . 54.229999999999997 110.368 176.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -57.47 -46.43 83.67 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.53 -0.759 . . . . 72.230000000000004 110.361 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.64 -47.25 50.37 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.598 -0.728 . . . . 63.0 113.0 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.466 ' O ' ' HA3' ' A' ' 129' ' ' GLY . 0.9 OUTLIER -62.79 -31.92 72.99 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 123.789 0.836 . . . . 64.450000000000003 112.425 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 25.8 mmt -72.71 -48.94 34.65 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.863 -0.735 . . . . 73.420000000000002 110.956 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.86 -65.74 0.63 Allowed 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.507 0.67 . . . . 72.0 110.548 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.04 -31.54 66.64 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.437 -0.801 . . . . 73.129999999999995 112.813 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -67.07 -59.3 7.06 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-O 119.408 -0.662 . . . . 74.409999999999997 112.013 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.488 ' CE3' HD21 ' A' ' 100' ' ' LEU . 97.7 m95 -61.88 -35.95 79.84 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 117.833 0.817 . . . . 72.329999999999998 112.833 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.8 m -62.28 -50.19 72.66 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 120.786 -0.366 . . . . 75.219999999999999 110.586 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.33 -48.21 19.77 Favored Glycine 0 C--O 1.247 0.939 0 C-N-CA 121.102 -0.57 . . . . 42.130000000000003 113.511 -177.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.57 -60.71 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 123.218 0.607 . . . . 64.140000000000001 110.347 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.408 ' HA ' HD23 ' A' ' 138' ' ' LEU . 98.0 t -57.64 -44.4 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 113.049 0.759 . . . . 74.319999999999993 113.049 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -56.4 -63.95 1.02 Allowed 'General case' 0 C--O 1.246 0.912 0 N-CA-C 112.143 0.423 . . . . 74.319999999999993 112.143 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -79.43 -34.84 41.31 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.184 0.809 . . . . 73.549999999999997 113.184 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -70.32 -39.43 74.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.534 -0.867 . . . . 75.519999999999996 111.265 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.5 mm? -70.47 -43.21 70.27 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 119.468 -0.893 . . . . 62.140000000000001 110.594 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -58.25 -37.2 74.44 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.045 -0.525 . . . . 72.239999999999995 110.094 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -74.37 -37.1 63.55 Favored 'General case' 0 C--O 1.199 -1.558 0 N-CA-C 113.782 1.031 . . . . 64.109999999999999 113.782 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.72 -23.94 65.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.832 0.349 . . . . 41.32 111.377 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.1 m -90.81 -23.32 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 120.739 -0.384 . . . . 75.540000000000006 110.715 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -82.39 -54.56 5.12 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.122 0.416 . . . . 62.539999999999999 112.122 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -129.64 -172.3 2.72 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.746 -0.464 . . . . 71.109999999999999 109.746 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.3 mt -132.42 89.5 2.66 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.272 -0.64 . . . . 65.319999999999993 109.272 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -65.46 139.65 58.53 Favored 'General case' 0 C--O 1.256 1.408 0 N-CA-C 114.169 1.174 . . . . 74.340000000000003 114.169 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -70.02 143.0 52.67 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.507 -2.405 . . . . 64.049999999999997 104.507 168.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -58.35 115.72 3.16 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 118.719 0.69 . . . . 75.049999999999997 111.76 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -67.26 116.48 8.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.024 -0.989 . . . . 72.120000000000005 109.654 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -70.97 127.28 32.05 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.206 -0.664 . . . . 72.120000000000005 109.206 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -61.34 138.55 58.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.809 0.814 . . . . 72.200000000000003 112.896 -172.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--N 1.281 -2.41 0 N-CA-C 105.515 -2.031 . . . . 74.430000000000007 105.515 177.174 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 108.298 -1.001 . . . . 75.140000000000001 108.298 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.65 23.33 5.45 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.026 0.441 . . . . 72.030000000000001 111.367 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -99.45 -48.8 4.65 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.073 0.768 . . . . 71.129999999999995 113.073 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 5' ' ' ASN . 47.8 t30 -104.72 80.81 1.69 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 119.553 -0.859 . . . . 64.219999999999999 113.096 -176.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 4' ' ' ASN . 6.6 p30 165.66 160.26 0.03 OUTLIER 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 126.633 1.973 . . . . 73.25 107.177 169.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 7' ' ' ASN . 0.7 OUTLIER -96.77 -69.11 0.77 Allowed 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 113.402 0.889 . . . . 73.409999999999997 113.402 -177.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.48 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 21.7 t-20 74.05 -24.47 0.21 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.19 1.396 . . . . 74.409999999999997 113.254 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.683 ' O ' HG22 ' A' ' 112' ' ' ILE . . . 79.55 -46.65 0.35 Allowed 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 126.734 2.014 . . . . 73.230000000000004 111.857 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.51 HD22 ' HE ' ' A' ' 123' ' ' ARG 0.38 4.5 mm? 97.08 85.6 0.02 OUTLIER Pre-proline 0 CA--C 1.51 -0.59 0 C-N-CA 127.27 2.228 . . . . 74.439999999999998 116.737 -176.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -91.93 -153.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.684 0 C-N-CA 123.623 2.882 . . . . 43.520000000000003 109.023 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 5.6 p-10 -58.5 146.82 34.02 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.672 0.789 . . . . 64.329999999999998 113.068 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.7 tp -152.42 139.38 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.226 -0.657 . . . . 70.109999999999999 109.226 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.1 m -113.42 140.1 48.35 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.406 -0.59 . . . . 74.349999999999994 109.406 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.474 ' HD3' ' N ' ' A' ' 15' ' ' SER . 5.7 tmtt? -141.56 137.73 32.18 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.489 -1.671 . . . . 72.540000000000006 106.489 175.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.474 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 24.5 p -118.23 150.19 39.85 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.392 0.542 . . . . 71.109999999999999 111.096 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -158.65 134.7 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.582 -0.525 . . . . 74.219999999999999 109.582 177.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.34 130.95 44.45 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.404 0.621 . . . . 71.230000000000004 111.706 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 2.5 mm? -99.74 139.28 35.62 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 123.411 0.685 . . . . 73.439999999999998 109.784 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' HG3' ' NH2' ' A' ' 139' ' ' ARG . 20.8 mm-40 -92.67 27.49 2.31 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.574 0.702 . . . . 64.319999999999993 109.131 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -122.6 161.98 40.84 Favored Pre-proline 0 C--O 1.246 0.912 0 C-N-CA 123.826 0.851 . . . . 75.329999999999998 109.255 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 20' ' ' ALA . 35.7 Cg_endo -64.9 149.49 89.44 Favored 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 122.713 2.275 . . . . 74.329999999999998 110.921 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.1 tt -56.81 -34.02 42.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.611 -0.722 . . . . 72.519999999999996 112.399 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 29.9 pt20 -64.88 -36.5 84.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.919 0.39 . . . . 55.409999999999997 111.069 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -79.67 -28.74 40.74 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 112.037 0.384 . . . . 74.439999999999998 112.037 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.2 -42.14 75.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.157 -1.053 . . . . 65.209999999999994 108.157 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 54.4 t90 -59.72 -47.79 84.26 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.617 -1.174 . . . . 74.310000000000002 111.303 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.568 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 9.3 pt-20 -70.05 -27.87 65.0 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 119.925 -0.71 . . . . 72.200000000000003 112.289 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 m -59.46 -35.63 74.44 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.2 0.524 . . . . 72.0 110.401 174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.584 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 26.4 m -106.9 25.1 2.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 112.186 0.439 . . . . 64.439999999999998 112.186 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.568 ' OG ' ' HA ' ' A' ' 27' ' ' GLU . 60.2 p -141.37 -11.33 0.94 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.733 0.642 . . . . 75.430000000000007 112.733 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -94.25 161.63 14.18 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 120.306 -0.558 . . . . 72.129999999999995 111.434 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -50.12 -56.53 10.53 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 125.772 1.629 . . . . 65.209999999999994 111.553 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.14 -33.3 56.73 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.947 0.721 . . . . 72.5 112.947 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.99 -48.2 67.7 Favored Glycine 0 CA--C 1.505 -0.592 0 C-N-CA 120.905 -0.664 . . . . 75.319999999999993 111.691 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.3 mt -70.42 -45.42 75.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.204 0.526 . . . . 73.209999999999994 111.383 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.04 -50.28 66.84 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 112.859 0.688 . . . . 55.149999999999999 112.859 -176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 12.2 tmtt? 65.14 7.83 4.38 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 123.213 1.482 . . . . 63.240000000000002 109.698 -175.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -95.41 158.69 15.35 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 113.583 -1.644 . . . . 64.219999999999999 107.019 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -86.89 -18.92 29.72 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.944 0.878 . . . . 73.329999999999998 109.204 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.8 ttt -93.4 116.28 66.26 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 106.983 -1.488 . . . . 65.530000000000001 106.983 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.32 121.09 5.9 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.764 1.643 . . . . 65.540000000000006 113.538 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -100.17 144.12 29.57 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 104.278 -2.49 . . . . 73.049999999999997 104.278 170.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -93.44 79.25 4.38 Favored 'General case' 0 C--N 1.281 -2.379 0 C-N-CA 118.741 -1.184 . . . . 75.019999999999996 113.082 -171.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -75.16 119.04 18.76 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.43 -1.692 . . . . 73.450000000000003 106.43 168.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -125.09 153.4 42.99 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.893 -1.521 . . . . 71.549999999999997 106.893 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.495 HD12 HG21 ' A' ' 68' ' ' VAL . 3.5 mm? -74.09 102.9 4.36 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 116.689 -2.004 . . . . 61.119999999999997 107.996 175.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 39.5 tptt -132.73 132.79 42.7 Favored 'General case' 0 N--CA 1.391 -3.418 0 N-CA-C 105.694 -1.965 . . . . 63.140000000000001 105.694 171.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -86.4 66.63 9.61 Favored 'General case' 0 C--N 1.259 -3.36 0 CA-C-O 122.27 1.033 . . . . 61.5 109.23 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 123.43 51.9 0.21 Allowed Glycine 0 N--CA 1.397 -3.921 0 CA-C-N 114.579 -1.191 . . . . 64.420000000000002 110.142 -176.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.512 ' H ' ' HB ' ' A' ' 65' ' ' VAL . 12.2 tt0 -73.82 96.97 2.66 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 106.534 -1.654 . . . . 65.420000000000002 106.534 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.14 141.31 48.94 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-O 122.017 0.913 . . . . 60.32 113.16 -177.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -129.7 144.52 51.33 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 104.65 -2.352 . . . . 72.319999999999993 104.65 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -110.23 139.49 45.34 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.705 -0.85 . . . . 73.129999999999995 108.705 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.475 ' H ' HD21 ' A' ' 54' ' ' LEU . 2.3 pt? -97.08 176.91 5.77 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.291 0.567 . . . . 75.120000000000005 111.707 -173.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -124.2 -161.64 1.01 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.427 -1.694 . . . . 73.319999999999993 106.427 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.429 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 26.5 m -56.59 -50.07 89.96 Favored Pre-proline 0 CA--C 1.566 1.596 0 CA-C-N 118.29 0.496 . . . . 72.5 111.223 174.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' A' ' 56' ' ' SER . 11.4 Cg_exo -75.57 146.36 30.6 Favored 'Trans proline' 0 C--N 1.373 1.828 0 N-CA-C 108.614 -1.341 . . . . 73.329999999999998 108.614 168.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -55.5 -42.08 73.95 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.285 0.365 . . . . 73.219999999999999 111.932 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.85 -113.13 4.22 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 111.463 -0.655 . . . . 72.340000000000003 111.463 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.1 -161.5 0.15 Allowed 'Trans proline' 0 C--O 1.244 0.808 0 C-N-CA 123.149 2.566 . . . . 64.310000000000002 110.535 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.8 m -81.83 116.64 64.47 Favored Pre-proline 0 N--CA 1.427 -1.604 0 N-CA-C 107.84 -1.17 . . . . 73.439999999999998 107.84 174.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.46 81.02 0.13 Allowed 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 123.245 2.63 . . . . 64.400000000000006 114.273 -176.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 9.5 p -143.8 144.41 31.78 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.176 -1.046 . . . . 60.229999999999997 108.176 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -143.07 147.11 34.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.394 -1.706 . . . . 74.030000000000001 106.394 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.512 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 42.9 t -90.32 137.45 21.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.636 -1.246 . . . . 64.239999999999995 107.636 177.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.74 -61.56 1.95 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.084 -1.45 . . . . 74.430000000000007 107.084 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.56 156.76 10.02 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.119 -1.067 . . . . 64.099999999999994 108.119 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 46' ' ' LEU . 13.5 p -125.04 135.17 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-O 121.177 0.513 . . . . 61.539999999999999 110.396 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 71.9 mm-40 -102.81 141.16 36.09 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.314 -0.995 . . . . 75.409999999999997 108.314 173.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.88 127.04 93.33 Favored Pre-proline 0 C--N 1.266 -3.031 0 N-CA-C 107.401 -1.333 . . . . 74.099999999999994 107.401 -168.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo 4.12 48.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.077 1 C-N-CA 127.628 5.552 . . . . 72.200000000000003 117.895 -161.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -137.65 -35.24 0.66 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.264 -0.425 . . . . 74.219999999999999 109.983 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 38.8 tt0 -149.55 148.28 29.18 Favored 'General case' 0 C--O 1.205 -1.237 0 C-N-CA 118.574 -1.25 . . . . 74.329999999999998 110.363 -175.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.582 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -143.04 130.91 21.55 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 107.705 -1.22 . . . . 64.340000000000003 107.705 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -132.66 127.1 34.13 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 110.224 -0.287 . . . . 74.099999999999994 110.224 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.254 35.8 p90 -145.81 157.84 43.9 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.208 -0.308 . . . . 74.109999999999999 111.768 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.262 36.1 mt-10 -120.07 144.67 47.46 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 123.624 0.77 . . . . 74.329999999999998 109.97 -169.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -114.67 120.47 40.23 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.0 -2.222 . . . . 72.230000000000004 105.0 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -83.11 10.61 7.79 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.619 0.723 . . . . 74.540000000000006 112.866 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.4 p -90.76 92.64 8.89 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 107.857 -1.164 . . . . 74.349999999999994 107.857 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 78.08 6.93 2.6 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.91 1.284 . . . . 64.439999999999998 112.403 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.87 62.73 3.07 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 114.805 -1.089 . . . . 61.32 113.777 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -100.28 150.64 22.36 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.825 -0.75 . . . . 74.040000000000006 109.742 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.13 109.93 2.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 108.216 -1.031 . . . . 75.140000000000001 108.216 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.11 154.67 5.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 115.86 -0.609 . . . . 63.399999999999999 109.817 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 15.3 m -139.89 140.3 36.43 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.179 -0.674 . . . . 70.450000000000003 109.179 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.584 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 15.0 m-85 -113.66 139.59 48.92 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.578 -1.267 . . . . 74.549999999999997 107.578 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.22 133.74 55.41 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.094 -1.076 . . . . 73.219999999999999 108.094 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.03 128.02 56.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.453 0.644 . . . . 74.150000000000006 109.948 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -115.96 130.84 57.0 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.692 -1.225 . . . . 74.420000000000002 107.692 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -94.29 121.17 35.53 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.417 0.627 . . . . 72.140000000000001 109.798 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 81.1 mt -114.2 156.0 25.06 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.245 -1.02 . . . . 60.229999999999997 108.245 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.95 49.57 4.25 Favored Glycine 0 C--N 1.289 -2.072 0 CA-C-N 116.255 -0.43 . . . . 51.310000000000002 112.137 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -177.17 -40.56 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.808 0.813 . . . . 60.439999999999998 109.118 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 9.2 ptpt -149.42 175.97 11.0 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 115.461 -0.79 . . . . 74.530000000000001 108.961 -171.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 64.8 m -108.22 130.4 55.15 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 109.03 -0.73 . . . . 65.140000000000001 109.03 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.53 124.4 7.59 Favored Glycine 0 N--CA 1.416 -2.675 0 N-CA-C 110.072 -1.211 . . . . 74.329999999999998 110.072 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.545 ' CE1' HG13 ' A' ' 29' ' ' VAL . 93.1 t80 -112.06 134.33 53.68 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-O 121.195 0.522 . . . . 71.420000000000002 110.077 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 m -124.01 126.3 46.04 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.976 -1.12 . . . . 70.239999999999995 107.976 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -103.03 138.7 39.55 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.84 0.829 . . . . 73.329999999999998 108.788 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.53 124.86 41.14 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.033 0 CA-C-N 113.457 -1.701 . . . . 64.140000000000001 107.673 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 4.3 t60 -112.77 127.38 56.13 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 104.807 -2.294 . . . . 71.129999999999995 104.807 173.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -142.24 164.86 29.02 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.66 -1.978 . . . . 74.209999999999994 105.66 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.11 178.71 39.37 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 119.698 -1.239 . . . . 44.039999999999999 111.848 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -74.42 114.64 13.04 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.192 -2.151 . . . . 71.129999999999995 105.192 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -78.87 77.03 5.35 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 115.003 1.482 . . . . 73.049999999999997 115.003 -169.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -102.28 -44.83 0.19 Allowed Pre-proline 0 C--N 1.289 -2.039 0 CA-C-N 113.639 -1.619 . . . . 72.120000000000005 109.915 170.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -39.52 106.8 0.06 OUTLIER 'Trans proline' 1 C--N 1.422 4.43 0 C-N-CA 123.562 2.841 . . . . 44.329999999999998 113.788 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -101.43 -64.52 1.05 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.545 -0.752 . . . . 72.549999999999997 109.055 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -101.66 -42.76 6.08 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.654 -0.869 . . . . 72.420000000000002 108.654 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.5 t -133.58 155.33 40.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 105.73 -1.952 . . . . 74.409999999999997 105.73 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.683 HG22 ' O ' ' A' ' 8' ' ' ALA . 6.9 pt -62.07 -32.85 55.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 118.428 0.558 . . . . 55.140000000000001 111.959 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.77 -127.28 6.48 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.563 -0.827 . . . . 64.409999999999997 112.467 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -69.75 -9.32 54.08 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.713 1.205 . . . . 55.109999999999999 114.023 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.44 84.24 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.035 0.754 . . . . 75.150000000000006 113.035 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -148.46 165.31 31.54 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 122.432 -0.167 . . . . 71.239999999999995 110.793 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.04 -68.24 0.33 Allowed 'General case' 0 C--N 1.316 -0.871 0 O-C-N 124.615 1.197 . . . . 65.299999999999997 111.243 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' HG22 ' A' ' 122' ' ' VAL . 34.1 mtmm -106.34 151.35 24.98 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 113.245 0.831 . . . . 71.049999999999997 113.245 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.0 t -77.15 -30.19 54.93 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.349 -0.982 . . . . 71.439999999999998 108.349 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.3 t -64.48 -41.68 96.33 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.09 -0.504 . . . . 74.230000000000004 110.574 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.69 -33.5 53.12 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.763 0 C-N-CA 119.698 -0.801 . . . . 65.450000000000003 110.33 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 118' ' ' LYS . 76.4 t -65.2 -41.67 92.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.254 -0.43 . . . . 72.299999999999997 110.067 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.51 ' HE ' HD22 ' A' ' 9' ' ' LEU . 2.9 tpm_? -54.44 -52.81 60.62 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.518 -0.765 . . . . 73.530000000000001 109.474 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -62.51 -54.31 35.08 Favored Glycine 0 CA--C 1.505 -0.576 0 O-C-N 123.623 0.577 . . . . 54.420000000000002 113.232 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -60.35 -41.01 92.77 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.483 0.92 . . . . 63.350000000000001 113.483 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.94 -39.59 42.28 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.226 -0.99 . . . . 72.030000000000001 110.98 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -67.39 -61.51 1.87 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.73 -0.47 . . . . 53.420000000000002 109.73 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -69.91 -32.34 69.95 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.262 -0.881 . . . . 71.310000000000002 111.895 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.76 -58.73 7.92 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-O 119.776 -0.458 . . . . 61.229999999999997 112.507 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -63.58 -36.69 84.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 113.281 0.845 . . . . 75.340000000000003 113.281 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.9 p -65.58 -51.31 60.74 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.767 -0.773 . . . . 70.540000000000006 111.412 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.54 -47.92 32.13 Favored Glycine 0 C--O 1.245 0.801 0 C-N-CA 121.01 -0.614 . . . . 60.520000000000003 113.329 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.62 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 45.9 mm -65.25 -51.26 67.2 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 N-CA-C 111.475 0.176 . . . . 73.219999999999999 111.475 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 97.5 t -62.14 -48.92 86.2 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.575 0 C-N-CA 119.269 -0.972 . . . . 74.25 110.68 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.424 ' HA ' HG13 ' A' ' 16' ' ' ILE . 9.7 t30 -60.76 -63.68 1.21 Allowed 'General case' 0 C--O 1.252 1.235 0 C-N-CA 119.654 -0.818 . . . . 74.310000000000002 112.741 -175.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.69 -41.11 18.09 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 118.773 -1.171 . . . . 71.510000000000005 112.737 -174.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.62 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 14.4 tpp180 -70.55 -37.55 74.05 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.023 -0.671 . . . . 74.299999999999997 111.851 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 0.1 OUTLIER -68.22 -44.31 76.04 Favored 'General case' 0 C--O 1.251 1.139 0 N-CA-C 107.314 -1.365 . . . . 75.299999999999997 107.314 177.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.624 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -60.5 -36.95 79.58 Favored 'General case' 0 C--O 1.203 -1.378 0 CA-C-N 116.046 -0.525 . . . . 70.030000000000001 110.495 177.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.502 ' HE3' ' NE2' ' A' ' 150' ' ' HIS . 10.9 mmmm -73.33 -35.6 66.06 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 114.616 1.339 . . . . 74.219999999999999 114.616 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.97 -33.94 76.46 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.488 -0.485 . . . . 74.430000000000007 109.707 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.0 m -85.04 -21.56 7.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-N 116.015 -0.539 . . . . 63.210000000000001 111.927 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 78.8 mm-40 -77.68 -33.05 53.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.331 -0.548 . . . . 63.350000000000001 109.914 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -87.73 20.39 3.02 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.905 -0.589 . . . . 63.530000000000001 110.332 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -61.44 -28.96 69.65 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.758 1.223 . . . . 73.400000000000006 114.29 -173.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.515 ' HG2' ' H ' ' A' ' 147' ' ' HIS . 36.1 tt0 -152.67 -168.02 2.92 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 105.584 -2.006 . . . . 71.140000000000001 105.584 -170.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.515 ' H ' ' HG2' ' A' ' 146' ' ' GLU . 33.7 m80 -74.84 78.74 2.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.928 0.871 . . . . 75.420000000000002 109.201 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -130.41 101.39 5.72 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.135 -1.432 . . . . 72.430000000000007 107.135 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -98.79 132.46 44.13 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.966 -0.561 . . . . 71.349999999999994 109.734 -176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.502 ' NE2' ' HE3' ' A' ' 140' ' ' LYS . 43.8 p-80 -155.96 -174.65 5.05 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.312 -0.996 . . . . 74.430000000000007 108.312 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -65.48 140.0 58.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 74.150000000000006 111.555 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 N--CA 1.431 -1.383 0 N-CA-C 107.455 -1.313 . . . . 70.209999999999994 107.455 178.404 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 110.084 -0.339 . . . . 51.329999999999998 110.084 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.85 96.5 4.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.097 -0.705 . . . . 71.109999999999999 109.097 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -99.33 -29.34 12.84 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.43 -0.805 . . . . 64.209999999999994 110.356 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -99.49 135.84 40.3 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.79 -0.641 . . . . 54.450000000000003 111.65 -175.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.36 130.2 42.23 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 105.387 -2.079 . . . . 55.310000000000002 105.387 169.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.01 112.38 6.43 Favored 'General case' 0 C--N 1.269 -2.895 0 CA-C-O 121.722 0.772 . . . . 72.329999999999998 111.471 -172.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 119' ' ' SER . 29.6 t-20 -163.48 -43.32 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 105.807 -1.923 . . . . 62.439999999999998 105.807 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -104.24 -165.25 1.13 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.668 -1.605 . . . . 73.209999999999994 106.668 171.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.7 tp -111.25 96.37 30.45 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.628 -0.879 . . . . 75.349999999999994 108.628 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 2.7 Cg_exo -75.92 -179.43 5.18 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.126 2.551 . . . . 62.009999999999998 112.829 -177.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 8.4 m-20 -65.09 124.27 21.68 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.344 -0.844 . . . . 74.439999999999998 111.033 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.4 mt -110.3 130.71 63.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.407 -1.331 . . . . 74.319999999999993 107.407 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 m -126.25 129.17 48.39 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.746 -0.835 . . . . 73.209999999999994 108.746 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -141.41 133.9 28.32 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.285 -1.376 . . . . 72.120000000000005 107.285 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 m -116.69 139.57 50.4 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 107.278 -1.379 . . . . 74.349999999999994 107.278 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.439 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -148.59 133.83 10.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.512 -0.921 . . . . 74.400000000000006 108.512 -178.393 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.448 ' CG2' ' HG3' ' A' ' 95' ' ' LYS . 3.4 m -104.37 125.59 50.73 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.775 -0.824 . . . . 70.109999999999999 108.775 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 138' ' ' LEU . 4.7 mp -102.44 140.5 36.64 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.065 -0.516 . . . . 75.519999999999996 110.415 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -82.86 51.31 1.88 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.908 -0.775 . . . . 72.519999999999996 108.908 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.34 159.55 51.62 Favored Pre-proline 0 N--CA 1.433 -1.285 0 CA-C-N 115.787 -0.642 . . . . 72.099999999999994 109.838 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.25 156.47 55.47 Favored 'Trans proline' 0 C--O 1.262 1.713 0 C-N-CA 122.944 2.429 . . . . 71.109999999999999 111.199 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.8 tt -64.72 -29.83 48.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.64 -0.709 . . . . 74.319999999999993 112.014 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -72.07 -28.78 63.55 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.695 -0.802 . . . . 75.510000000000005 111.796 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -77.37 -41.73 39.12 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.712 -0.395 . . . . 75.420000000000002 109.975 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG11 HG22 ' A' ' 96' ' ' THR . 7.1 p -65.47 -39.1 84.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.48 -0.563 . . . . 75.540000000000006 109.48 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.468 ' NE1' ' HD3' ' A' ' 71' ' ' PRO . 66.9 t90 -58.89 -47.19 85.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.192 -0.913 . . . . 74.319999999999993 111.376 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.03 -33.25 75.13 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 119.398 -0.921 . . . . 62.509999999999998 110.19 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 94.9 m -62.02 -15.41 44.04 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 121.583 0.706 . . . . 54.310000000000002 112.129 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.439 HG13 ' CE1' ' A' ' 98' ' ' PHE . 20.3 m -121.83 7.53 5.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.082 -1.011 . . . . 61.539999999999999 112.009 176.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.7 m -127.71 -11.62 5.5 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.753 0.649 . . . . 64.109999999999999 112.753 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.5 p -91.61 163.23 14.19 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.106 -0.701 . . . . 74.439999999999998 109.106 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.55 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 9.3 m -53.36 -47.09 69.72 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.153 0.581 . . . . 72.310000000000002 111.615 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.402 ' OE1' ' HB2' ' A' ' 32' ' ' SER . 1.4 mp0 -64.92 -48.77 72.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.721 -0.672 . . . . 73.310000000000002 110.729 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . -65.26 -43.66 94.92 Favored Glycine 0 C--O 1.247 0.962 0 CA-C-N 115.427 -0.806 . . . . 36.920000000000002 113.233 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.85 -43.72 97.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 109.907 -0.405 . . . . 74.519999999999996 109.907 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.7 -50.97 67.09 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.199 0.444 . . . . 36.920000000000002 112.199 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 22.9 mtmm 67.41 21.89 9.57 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.309 1.052 . . . . 75.420000000000002 110.536 -175.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -144.65 148.21 33.99 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 104.109 -2.552 . . . . 73.519999999999996 104.109 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -81.83 71.43 8.86 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.796 0.808 . . . . 70.219999999999999 110.211 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 57.4 tpp -124.11 122.03 26.19 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 107.958 -1.127 . . . . 74.230000000000004 107.958 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -75.56 84.88 1.67 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.96 1.773 . . . . 71.439999999999998 112.621 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.55 ' O ' ' HB3' ' A' ' 32' ' ' SER . 12.7 m120 -128.03 143.87 51.09 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.066 -1.827 . . . . 73.400000000000006 106.066 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -92.72 70.66 4.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 112.554 0.576 . . . . 71.439999999999998 112.554 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -78.51 119.95 22.53 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 106.206 -1.775 . . . . 74.140000000000001 106.206 172.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -124.5 149.58 46.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 112.688 0.625 . . . . 64.430000000000007 112.688 -171.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.1 tp -82.76 106.13 14.35 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.211 -0.904 . . . . 62.43 108.793 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -133.67 141.54 47.63 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.223 -2.139 . . . . 73.349999999999994 105.223 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.517 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 7.8 pt-20 -93.96 75.94 4.15 Favored 'General case' 0 C--N 1.27 -2.852 0 CA-C-N 120.185 1.357 . . . . 54.109999999999999 110.745 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.55 72.43 0.19 Allowed Glycine 1 N--CA 1.391 -4.348 0 CA-C-N 113.332 -1.758 . . . . 63.119999999999997 109.959 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.6 120.17 40.01 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 105.287 -2.116 . . . . 72.209999999999994 105.287 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -119.14 163.48 16.97 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.694 -0.484 . . . . 74.129999999999995 109.694 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -93.29 128.14 39.17 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.05 0.929 . . . . 73.530000000000001 111.674 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -122.72 140.45 52.86 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.208 -1.775 . . . . 73.010000000000005 106.208 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.66 82.65 3.3 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 122.093 0.949 . . . . 72.219999999999999 111.414 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -107.97 -168.36 1.36 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.577 -1.638 . . . . 74.040000000000006 106.577 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m -67.07 137.08 94.32 Favored Pre-proline 0 N--CA 1.432 -1.352 0 N-CA-C 107.246 -1.39 . . . . 72.219999999999999 107.246 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -30.93 97.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.781 1 C-N-CA 125.46 4.107 . . . . 74.5 115.68 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -104.05 86.13 2.52 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.058 -1.09 . . . . 75.129999999999995 108.058 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.41 112.67 1.0 Allowed Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.223 -0.898 . . . . 74.099999999999994 111.012 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -58.19 -32.72 96.4 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.634 2.223 . . . . 70.430000000000007 111.334 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.2 m -94.45 105.38 17.76 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 107.68 -1.23 . . . . 73.239999999999995 107.68 172.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.79 131.92 42.45 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.605 2.204 . . . . 74.019999999999996 111.057 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 65.1 m -129.75 146.12 51.52 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.411 -0.516 . . . . 72.109999999999999 111.452 -177.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -134.56 129.33 34.86 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.779 -1.563 . . . . 75.099999999999994 106.779 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.2 t -91.2 136.7 23.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 C-N-CA 118.132 -1.427 . . . . 70.219999999999999 108.816 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.45 -60.24 2.03 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.984 -1.117 . . . . 72.109999999999999 107.984 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.88 136.47 14.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.299 -0.409 . . . . 75.129999999999995 110.739 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 48' ' ' GLU . 47.3 t -118.11 119.27 60.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.595 -0.891 . . . . 72.349999999999994 108.595 176.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 42.7 mt-30 -116.14 140.88 48.84 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.705 -0.68 . . . . 63.229999999999997 110.491 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.39 131.51 93.23 Favored Pre-proline 0 C--N 1.281 -2.389 0 CA-C-N 113.9 -1.5 . . . . 74.239999999999995 110.314 -162.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.468 ' HD3' ' NE1' ' A' ' 26' ' ' TRP . 55.3 Cg_exo 2.26 49.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.261 1 C-N-CA 128.144 5.896 . . . . 73.219999999999999 117.319 -162.293 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 p -140.71 -48.25 0.42 Allowed 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.538 -0.755 . . . . 75.010000000000005 111.138 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 32.1 tt0 -140.15 128.43 22.53 Favored 'General case' 0 C--O 1.21 -0.976 0 C-N-CA 118.802 -1.159 . . . . 70.439999999999998 110.852 -172.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.485 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -133.19 132.21 41.29 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 109.504 -0.554 . . . . 61.039999999999999 109.504 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.7 t -140.37 126.99 20.29 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.778 -0.453 . . . . 70.340000000000003 109.778 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -146.17 159.45 43.29 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 122.884 0.473 . . . . 74.400000000000006 111.098 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -117.74 122.69 44.14 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 104.679 -2.341 . . . . 71.109999999999999 104.679 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -110.63 147.79 33.54 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.124 -0.944 . . . . 73.519999999999996 111.188 -173.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 t70 71.83 -174.93 0.17 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.753 1.621 . . . . 53.43 109.902 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.5 t -85.11 -5.4 59.34 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.598 -0.688 . . . . 73.420000000000002 110.35 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -85.3 -37.48 19.93 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.789 -0.641 . . . . 73.200000000000003 110.307 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.95 60.85 1.06 Allowed Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.254 -1.138 . . . . 73.430000000000007 110.254 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -81.39 106.22 13.19 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 107.851 -1.166 . . . . 75.319999999999993 107.851 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.4 t -84.92 106.05 14.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.123 -1.066 . . . . 73.120000000000005 108.123 -177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.21 134.86 49.91 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 108.74 -0.837 . . . . 73.310000000000002 108.74 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.7 m -125.56 130.44 51.7 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.568 -0.901 . . . . 75.25 108.568 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CD2' HD13 ' A' ' 74' ' ' LEU . 11.1 m-85 -116.41 133.58 55.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.432 -0.951 . . . . 72.310000000000002 108.432 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -111.43 130.61 55.65 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 115.389 -0.823 . . . . 74.310000000000002 109.634 177.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.38 122.17 45.73 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.559 -0.746 . . . . 74.510000000000005 109.521 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -112.91 120.28 40.86 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.152 -1.055 . . . . 74.430000000000007 108.152 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -80.6 117.61 21.45 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.367 0.604 . . . . 72.409999999999997 109.772 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 7.0 mp -109.92 158.67 17.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.501 -1.666 . . . . 70.200000000000003 106.501 172.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -62.07 -37.27 94.18 Favored Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.964 -0.636 . . . . 74.140000000000001 114.371 -173.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -120.18 -3.2 10.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 117.393 0.597 . . . . 73.329999999999998 111.731 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.0 ptpt -153.17 175.78 12.66 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.61 -0.885 . . . . 44.140000000000001 108.61 -173.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.406 HG22 HG11 ' A' ' 25' ' ' VAL . 51.8 m -129.29 124.25 33.92 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.869 -0.732 . . . . 73.209999999999994 111.231 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.414 ' N ' HD13 ' A' ' 92' ' ' LEU . . . -84.18 113.44 3.74 Favored Glycine 0 N--CA 1.423 -2.207 0 N-CA-C 110.202 -1.159 . . . . 36.920000000000002 110.202 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.439 ' CE1' HG13 ' A' ' 29' ' ' VAL . 79.5 t80 -104.14 132.65 50.17 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 108.576 -0.898 . . . . 74.140000000000001 108.576 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 12.4 m -121.17 122.07 39.18 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.308 -0.997 . . . . 74.120000000000005 108.308 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.433 HD21 ' CE3' ' A' ' 130' ' ' TRP . 4.2 tp -100.78 124.47 46.47 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.821 -0.807 . . . . 72.439999999999998 108.821 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.54 124.29 66.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 106.87 -1.53 . . . . 64.129999999999995 106.87 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.529 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 8.0 t60 -112.02 113.65 26.06 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.948 -1.131 . . . . 73.319999999999993 107.948 177.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.2 m -118.28 132.87 56.27 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.137 -1.06 . . . . 73.439999999999998 108.137 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.28 132.51 11.27 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.117 -0.793 . . . . 65.310000000000002 111.117 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -95.16 -22.77 17.63 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.414 0.626 . . . . 72.120000000000005 109.756 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -114.73 97.75 6.45 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.539 0.685 . . . . 74.340000000000003 111.93 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -136.04 70.14 63.4 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 107.578 -1.267 . . . . 73.299999999999997 107.578 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.48 -39.08 0.44 Allowed 'Trans proline' 0 C--O 1.246 0.912 0 C-N-CA 122.464 2.11 . . . . 65.530000000000001 112.954 -174.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -102.6 -164.75 1.11 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.073 -1.454 . . . . 75.049999999999997 107.073 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -67.04 -29.77 69.65 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.229 -1.026 . . . . 73.530000000000001 108.229 171.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.0 p -111.87 162.23 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-N 114.639 -1.164 . . . . 75.120000000000005 108.14 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 pt -58.26 -33.16 46.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 124.347 1.059 . . . . 74.519999999999996 113.15 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.93 -137.23 8.98 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 108.807 -1.717 . . . . 71.019999999999996 108.807 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -104.28 18.76 21.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.759 0.79 . . . . 72.319999999999993 109.325 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.12 -39.5 86.48 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.838 0.828 . . . . 74.209999999999994 109.716 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -139.72 143.52 37.07 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.258 -1.756 . . . . 54.140000000000001 106.258 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -70.32 -23.84 62.9 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 113.659 0.985 . . . . 73.140000000000001 113.659 -172.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.488 ' HB2' HG22 ' A' ' 122' ' ' VAL . 75.6 mmtt -111.44 -176.51 2.96 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 122.002 -0.436 . . . . 52.399999999999999 109.876 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 7' ' ' ASN . 17.1 p -130.81 -73.47 0.54 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 111.659 0.244 . . . . 64.239999999999995 111.659 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -62.06 -36.06 80.52 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 123.443 0.697 . . . . 72.120000000000005 109.295 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.66 -45.51 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.366 -0.834 . . . . 70.129999999999995 110.011 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 118' ' ' LYS . 72.9 t -61.37 -38.96 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 116.336 -0.393 . . . . 74.030000000000001 111.023 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.448 ' NH1' ' HB2' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -62.9 -45.34 92.98 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.833 -0.803 . . . . 74.420000000000002 108.833 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.42 -49.72 59.35 Favored Glycine 0 C--O 1.245 0.812 0 CA-C-N 115.738 -0.664 . . . . 63.340000000000003 111.987 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -60.5 -39.38 87.53 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.408 0.683 . . . . 72.420000000000002 112.259 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.9 mmt -68.55 -38.49 80.82 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.55 -0.46 . . . . 64.25 111.313 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.448 ' HB2' ' NH1' ' A' ' 123' ' ' ARG . 12.6 t70 -61.47 -53.11 60.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.194 -0.669 . . . . 61.530000000000001 109.194 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.37 -45.28 91.28 Favored Glycine 0 C--O 1.249 1.07 0 CA-C-N 115.108 -0.951 . . . . 73.200000000000003 111.89 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.33 -54.22 39.72 Favored Glycine 0 C--O 1.217 -0.952 0 O-C-N 123.999 0.47 . . . . 72.439999999999998 112.826 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.433 ' CE3' HD21 ' A' ' 100' ' ' LEU . 85.6 m95 -60.63 -34.95 75.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.7 0.63 . . . . 74.040000000000006 112.7 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.7 m -64.41 -55.16 22.85 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.163 0.289 . . . . 72.310000000000002 110.628 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.71 -48.21 51.07 Favored Glycine 0 C--O 1.248 0.972 0 C-N-CA 121.327 -0.463 . . . . 75.420000000000002 112.859 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.5 -57.44 12.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 CA-C-O 118.945 -0.55 . . . . 61.450000000000003 111.897 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.458 ' HA ' HD12 ' A' ' 138' ' ' LEU . 93.9 t -57.93 -42.2 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 119.079 -1.048 . . . . 62.149999999999999 112.804 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.439 ' HA ' HG13 ' A' ' 16' ' ' ILE . 36.9 t30 -54.73 -67.84 0.23 Allowed 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.473 0.483 . . . . 71.340000000000003 111.947 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -76.09 -40.33 53.29 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 120.355 -0.538 . . . . 62.149999999999999 111.982 -173.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -66.37 -44.07 84.21 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 119.444 -0.903 . . . . 73.540000000000006 111.723 -172.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 134' ' ' VAL . 10.8 mp -70.83 -43.83 67.74 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.789 -0.765 . . . . 62.119999999999997 111.419 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -60.56 -36.28 78.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.941 0.4 . . . . 60.240000000000002 110.381 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.436 ' HZ1' ' HG2' ' A' ' 144' ' ' GLU . 22.2 mmmt -75.63 -37.5 59.66 Favored 'General case' 0 C--O 1.185 -2.296 0 C-N-CA 119.807 -0.757 . . . . 71.519999999999996 112.25 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.04 -33.96 76.93 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.032 0.444 . . . . 45.420000000000002 110.756 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 28.1 m -78.96 -28.33 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 120.482 -0.487 . . . . 74.129999999999995 110.901 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -82.37 -73.67 0.38 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.416 0.627 . . . . 73.219999999999999 110.694 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.436 ' HG2' ' HZ1' ' A' ' 140' ' ' LYS . 42.5 mm-40 -120.43 100.32 7.08 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.019 -0.991 . . . . 72.209999999999994 109.19 -174.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.477 HD22 ' H ' ' A' ' 145' ' ' LEU . 2.5 pt? -88.69 0.09 56.78 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.434 0.635 . . . . 74.230000000000004 111.08 -176.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -81.94 -171.78 3.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.087 -0.961 . . . . 75.230000000000004 108.958 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . 4.5 p80 -66.58 98.09 0.48 Allowed 'General case' 0 CA--C 1.55 0.947 0 CA-C-O 122.064 0.935 . . . . 72.540000000000006 111.162 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . 0.258 6.0 p-80 -89.65 80.17 6.67 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 122.368 1.08 . . . . 74.209999999999994 113.03 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 147' ' ' HIS . 6.5 p-80 -159.78 115.99 2.49 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.444 -1.707 . . . . 70.430000000000007 107.363 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -177.17 -175.03 0.54 Allowed 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.129 -0.693 . . . . 75.219999999999999 109.129 -173.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -64.03 103.15 0.56 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.637 -0.875 . . . . 75.120000000000005 108.637 172.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 . . . . . 0 C--N 1.285 -2.225 0 N-CA-C 108.151 -1.055 . . . . 54.32 108.151 -176.787 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 110.155 -0.313 . . . . 71.120000000000005 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.86 87.99 0.11 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.358 1.063 . . . . 71.200000000000003 113.265 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -76.02 -29.22 58.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.526 0.679 . . . . 72.420000000000002 109.594 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -129.32 157.74 41.06 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.256 -1.016 . . . . 70.120000000000005 108.256 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -100.57 -166.48 1.32 Allowed 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 106.313 -1.736 . . . . 75.310000000000002 106.313 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' A' ' 8' ' ' ALA . 1.7 mp0 -63.91 -40.06 95.62 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.585 0.707 . . . . 73.239999999999995 110.923 -175.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 3.3 t-20 72.73 -35.89 0.34 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 126.705 2.002 . . . . 61.219999999999999 112.1 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.63 ' O ' HG23 ' A' ' 112' ' ' ILE . . . 159.26 -31.12 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 127.285 2.234 . . . . 51.420000000000002 107.592 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 tm? 86.89 81.15 0.05 OUTLIER Pre-proline 0 N--CA 1.411 -2.386 0 C-N-CA 129.351 3.06 . . . . 63.149999999999999 107.977 -163.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HG3' ' OD1' ' A' ' 7' ' ' ASN . 14.7 Cg_endo -102.27 -153.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 123.727 2.952 . . . . 70.430000000000007 110.698 -177.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 1.1 m-20 -55.95 103.4 0.1 Allowed 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 123.893 0.746 . . . . 73.230000000000004 111.431 175.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.446 HG21 ' HB3' ' A' ' 102' ' ' HIS . 9.6 tp -102.65 131.63 50.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.952 -1.87 . . . . 74.099999999999994 105.952 170.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.9 m -117.66 129.49 55.77 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.002 0.429 . . . . 64.239999999999995 109.89 -176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -131.57 126.35 34.61 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.556 -1.276 . . . . 64.230000000000004 107.556 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.1 m -116.95 133.65 55.74 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.932 -0.396 . . . . 72.420000000000002 109.932 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.88 139.54 21.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.874 -0.787 . . . . 74.120000000000005 108.874 -175.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 p -97.67 125.11 42.25 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.208 0.527 . . . . 61.310000000000002 111.656 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.07 139.57 30.81 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.763 -0.653 . . . . 74.340000000000003 109.667 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -82.07 30.62 0.39 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.935 0.772 . . . . 73.319999999999993 111.105 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.449 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -129.23 159.57 68.39 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 116.071 -0.513 . . . . 75.209999999999994 110.732 -173.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.74 156.44 42.98 Favored 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 123.505 2.803 . . . . 74.209999999999994 112.042 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.419 HG12 HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -52.07 -41.72 33.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.167 -0.924 . . . . 62.210000000000001 111.107 -177.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 12.4 pt20 -68.35 -34.85 76.82 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 119.98 -0.688 . . . . 74.019999999999996 111.033 -176.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -71.51 -38.47 71.12 Favored 'General case' 0 N--CA 1.441 -0.901 0 O-C-N 123.297 0.373 . . . . 75.409999999999997 110.38 -174.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.455 HG23 ' HB ' ' A' ' 96' ' ' THR . 47.8 t -71.11 -41.18 75.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.097 -0.705 . . . . 70.140000000000001 109.097 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 45.8 t90 -59.83 -47.69 84.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.474 -0.785 . . . . 73.439999999999998 111.444 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 23' ' ' GLN . 11.5 pt-20 -66.29 -32.1 73.31 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.695 0.283 . . . . 42.109999999999999 110.64 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.3 m -65.66 -15.33 62.67 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 121.655 0.741 . . . . 74.530000000000001 111.683 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.588 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 13.6 m -125.3 18.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 O-C-N 121.138 -0.976 . . . . 72.299999999999997 112.276 177.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 p -134.33 -12.55 2.42 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.499 0.555 . . . . 75.519999999999996 112.499 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.9 p -94.53 163.35 13.43 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.135 -0.691 . . . . 72.120000000000005 109.135 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.53 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 17.9 t -56.64 -53.17 60.73 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 123.612 0.57 . . . . 74.040000000000006 111.094 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -57.21 -40.34 77.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.45 -0.796 . . . . 45.340000000000003 111.369 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.7 -48.01 24.17 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 120.824 -0.703 . . . . 75.120000000000005 113.372 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.3 mt -67.05 -33.29 62.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 122.699 0.4 . . . . 72.150000000000006 111.766 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.3 -30.56 28.8 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.449 1.648 . . . . 71.219999999999999 115.449 -174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.527 ' HE2' ' NE2' ' A' ' 151' ' ' HIS . 83.4 tttt 74.14 -48.76 0.66 Allowed 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 124.085 0.954 . . . . 71.120000000000005 110.404 -178.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.484 ' HA ' ' CE1' ' A' ' 149' ' ' HIS . 65.1 m95 -94.87 -159.98 0.75 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.683 -1.599 . . . . 75.019999999999996 106.683 175.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -105.83 -91.04 0.4 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.302 -1.74 . . . . 75.129999999999995 106.302 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 65.7 mtt 53.24 175.71 0.03 OUTLIER Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 124.5 1.12 . . . . 73.040000000000006 113.818 173.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.17 109.72 2.39 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.561 1.507 . . . . 72.010000000000005 109.971 170.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -139.67 152.81 47.02 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 110.03 -0.359 . . . . 65.019999999999996 110.03 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -137.39 69.58 1.4 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.503 0.668 . . . . 72.140000000000001 109.936 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.53 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 86.0 m-85 -91.61 136.37 33.18 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.812 -0.631 . . . . 74.340000000000003 110.015 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -137.52 143.5 41.67 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.67 -0.863 . . . . 62.329999999999998 108.67 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 46' ' ' LEU . 2.3 pt? -75.62 106.42 7.17 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.062 0.934 . . . . 73.120000000000005 110.017 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 15.8 tppt? -131.26 145.13 51.77 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.984 -1.858 . . . . 71.049999999999997 105.984 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.18 77.77 6.68 Favored 'General case' 0 C--N 1.278 -2.52 0 C-N-CA 118.773 -1.171 . . . . 73.409999999999997 109.223 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.87 67.53 0.31 Allowed Glycine 0 N--CA 1.413 -2.864 0 CA-C-N 114.695 -1.139 . . . . 71.340000000000003 112.973 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -138.0 127.16 24.37 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.873 -1.528 . . . . 70.530000000000001 106.873 -178.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.71 145.3 47.63 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 113.364 0.875 . . . . 75.239999999999995 113.364 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -95.46 115.23 27.14 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.681 -1.229 . . . . 63.009999999999998 107.681 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -145.19 139.23 27.08 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.527 -0.761 . . . . 72.439999999999998 109.564 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.53 154.54 18.64 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.653 -1.98 . . . . 73.109999999999999 105.653 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -121.01 86.93 2.66 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.455 0.645 . . . . 75.329999999999998 110.749 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.4 m -160.0 143.27 10.27 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 106.828 -1.545 . . . . 74.430000000000007 106.828 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.6 85.13 0.38 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.321 2.014 . . . . 74.209999999999994 113.753 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -137.3 -70.45 0.45 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.623 -0.717 . . . . 74.329999999999998 110.189 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.89 68.75 1.52 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.327 -1.109 . . . . 63.310000000000002 110.327 -173.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.87 -80.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.658 2.238 . . . . 53.530000000000001 111.808 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.1 m -137.39 81.28 31.23 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 109.045 -0.724 . . . . 62.450000000000003 109.045 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -68.4 100.93 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.207 2.604 . . . . 75.519999999999996 110.937 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.2 p -134.08 169.53 17.01 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.935 -0.575 . . . . 52.109999999999999 111.883 -173.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -154.33 127.25 8.24 Favored 'General case' 0 C--O 1.193 -1.886 0 C-N-CA 125.478 1.511 . . . . 74.140000000000001 107.23 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -89.99 123.91 42.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 106.9 -1.519 . . . . 74.040000000000006 106.9 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 tt -72.92 -60.27 2.31 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.567 -1.271 . . . . 74.340000000000003 107.567 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.33 150.01 8.89 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.522 -0.763 . . . . 62.0 109.638 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.6 p -121.89 131.85 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 121.208 0.527 . . . . 75.519999999999996 109.757 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 75.3 mm-40 -104.08 141.41 36.27 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.201 -0.909 . . . . 74.340000000000003 109.193 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.11 126.98 93.35 Favored Pre-proline 0 C--N 1.276 -2.594 0 CA-C-N 114.268 -1.333 . . . . 75.329999999999998 108.623 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo 6.75 44.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.357 1 C-N-CA 128.096 5.864 . . . . 74.129999999999995 117.715 -162.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 p -137.14 -38.5 0.62 Allowed 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.707 -0.679 . . . . 65.319999999999993 112.139 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 30.2 tt0 -150.77 147.81 27.75 Favored 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 118.316 -1.354 . . . . 63.409999999999997 111.252 -173.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.588 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.6 tm? -142.02 136.1 29.92 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.068 -0.716 . . . . 64.530000000000001 109.068 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 p -140.64 127.64 20.72 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.241 0.46 . . . . 73.430000000000007 112.241 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -141.37 156.05 45.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.413 -0.358 . . . . 72.150000000000006 110.638 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -121.25 148.87 43.7 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.242 -1.392 . . . . 71.430000000000007 107.242 -171.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.402 ' HD1' ' OG1' ' A' ' 80' ' ' THR . 9.3 t-105 -119.36 126.52 51.61 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.79 -1.559 . . . . 71.439999999999998 106.79 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -70.06 -17.1 63.23 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.606 0.965 . . . . 70.0 113.606 -170.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.402 ' OG1' ' HD1' ' A' ' 78' ' ' TRP . 67.8 p -79.49 95.41 5.8 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 120.369 -0.533 . . . . 64.230000000000004 109.911 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 82.7 -15.79 0.64 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.289 1.436 . . . . 73.25 113.461 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.85 54.61 0.81 Allowed Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.049 -1.072 . . . . 51.439999999999998 114.231 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -92.81 149.44 21.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.835 -1.172 . . . . 74.030000000000001 107.835 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.7 p -142.84 124.82 12.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.156 -0.683 . . . . 73.019999999999996 109.156 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.2 149.96 21.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 121.418 0.627 . . . . 63.329999999999998 110.446 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.1 m -135.67 137.76 42.13 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.721 -0.672 . . . . 63.310000000000002 109.761 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.588 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 12.5 m-85 -113.74 129.09 56.63 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 107.396 -1.335 . . . . 73.340000000000003 107.396 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.457 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -112.13 134.16 53.85 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 105.91 -1.885 . . . . 70.129999999999995 105.91 177.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.426 ' C ' HD21 ' A' ' 89' ' ' LEU . 6.9 tt -115.3 126.41 54.44 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.228 -0.656 . . . . 50.240000000000002 109.228 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -111.09 116.71 31.6 Favored 'General case' 0 N--CA 1.415 -2.175 0 N-CA-C 107.922 -1.14 . . . . 72.409999999999997 107.922 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -80.03 116.91 20.42 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.854 0.835 . . . . 73.140000000000001 110.364 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -120.96 159.86 24.72 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.662 -1.236 . . . . 50.350000000000001 107.662 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.57 140.82 19.21 Favored Glycine 0 C--N 1.268 -3.2 0 N-CA-C 107.599 -2.201 . . . . 51.32 107.599 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 84.63 -24.88 0.14 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.147 1.379 . . . . 74.150000000000006 111.339 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.5 175.36 14.13 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.82 -0.807 . . . . 72.310000000000002 108.82 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.455 ' HB ' HG23 ' A' ' 25' ' ' VAL . 84.8 m -126.59 129.98 49.63 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.273 -0.64 . . . . 71.049999999999997 109.273 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.61 109.89 3.6 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 110.972 -0.851 . . . . 75.25 110.972 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.406 ' CE1' HG13 ' A' ' 29' ' ' VAL . 88.4 t80 -98.5 134.14 41.88 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 109.094 -0.706 . . . . 74.219999999999999 109.094 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 88' ' ' GLN . 23.7 m -123.11 118.93 28.82 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.331 -0.989 . . . . 72.430000000000007 108.331 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.468 HD11 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.56 140.8 34.31 Favored 'General case' 0 N--CA 1.41 -2.432 0 N-CA-C 108.876 -0.787 . . . . 61.399999999999999 108.876 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.468 ' N ' HD11 ' A' ' 100' ' ' LEU . 18.5 mt -136.07 124.75 37.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.856 0 CA-C-N 113.56 -1.655 . . . . 74.540000000000006 107.821 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.446 ' HB3' HG21 ' A' ' 12' ' ' ILE . 6.1 t60 -118.92 125.19 48.88 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.048 -1.834 . . . . 73.099999999999994 106.048 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.6 t -142.29 165.54 27.14 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 106.871 -1.529 . . . . 63.109999999999999 106.871 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -135.51 156.55 22.77 Favored Glycine 0 C--N 1.289 -2.074 0 N-CA-C 109.197 -1.561 . . . . 72.019999999999996 109.197 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -104.3 16.3 26.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 117.527 0.663 . . . . 73.530000000000001 112.289 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -135.4 92.2 2.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.672 -1.233 . . . . 73.239999999999995 107.672 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.81 82.32 2.63 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 115.292 -0.867 . . . . 70.140000000000001 113.31 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -100.87 2.47 0.66 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.626 2.217 . . . . 71.019999999999996 114.328 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -132.54 -163.04 1.29 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.818 -0.808 . . . . 75.140000000000001 108.818 -174.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 7' ' ' ASN . 9.1 pt-20 -82.16 5.68 18.94 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.676 1.227 . . . . 71.409999999999997 110.112 171.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.25 149.54 21.76 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-N 113.219 -1.809 . . . . 71.450000000000003 106.77 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -57.0 -32.38 39.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 123.313 0.645 . . . . 51.310000000000002 112.1 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.59 46.7 0.18 Allowed Glycine 0 CA--C 1.484 -1.874 0 C-N-CA 119.793 -1.194 . . . . 35.979999999999997 111.324 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 54.79 32.81 18.32 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.76 0.824 . . . . 74.219999999999999 111.669 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.28 -15.38 62.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.977 0.894 . . . . 63.140000000000001 109.435 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -152.01 174.47 13.62 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 104.383 -2.451 . . . . 70.200000000000003 104.383 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -48.61 -86.61 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 116.289 1.959 . . . . 72.340000000000003 116.289 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -119.02 149.73 41.15 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.957 -1.127 . . . . 72.430000000000007 107.957 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.41 ' C ' ' HG2' ' A' ' 6' ' ' GLU . 6.9 p -65.0 -41.0 95.76 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.602 0.593 . . . . 75.430000000000007 112.602 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.403 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 10.7 t -68.23 -38.85 82.28 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.458 -0.497 . . . . 55.509999999999998 111.112 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.1 m -69.04 -34.13 62.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 C-N-CA 119.976 -0.689 . . . . 75.109999999999999 109.822 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.428 ' O ' ' HG2' ' A' ' 126' ' ' MET . 56.3 t -66.94 -46.66 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 116.35 -0.387 . . . . 71.120000000000005 110.733 177.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.08 -41.15 99.37 Favored 'General case' 0 C--O 1.209 -1.077 0 N-CA-C 109.425 -0.583 . . . . 65.340000000000003 109.425 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.56 -49.24 70.93 Favored Glycine 0 CA--C 1.502 -0.75 0 CA-C-N 116.223 -0.444 . . . . 51.340000000000003 112.159 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.407 ' HE2' ' HA ' ' A' ' 122' ' ' VAL . 2.1 tmmm? -62.19 -32.64 73.31 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 123.413 0.685 . . . . 75.430000000000007 111.571 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 25.2 mmt -76.59 -44.94 32.39 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 120.338 -0.545 . . . . 64.319999999999993 110.191 176.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -58.9 -62.82 1.59 Allowed 'General case' 0 C--O 1.25 1.12 0 C-N-CA 123.912 0.885 . . . . 75.219999999999999 110.687 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.0 -42.07 60.03 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.696 -0.684 . . . . 70.319999999999993 111.866 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.565 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -58.9 -62.11 6.61 Favored Glycine 0 N--CA 1.437 -1.28 0 O-C-N 124.057 0.504 . . . . 74.109999999999999 112.043 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -60.82 -30.19 69.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.64 0.978 . . . . 75.439999999999998 113.64 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 73.1 m -63.4 -50.83 68.31 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 119.958 -0.697 . . . . 72.230000000000004 110.614 174.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.78 -46.15 54.77 Favored Glycine 0 C--O 1.251 1.218 0 C-N-CA 120.663 -0.779 . . . . 44.100000000000001 112.615 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 129' ' ' GLY . 52.1 mm -58.87 -57.86 9.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 123.023 0.529 . . . . 72.219999999999999 110.292 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.42 ' HA ' HD23 ' A' ' 138' ' ' LEU . 93.1 t -62.97 -45.99 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 112.438 0.533 . . . . 65.409999999999997 112.438 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -57.03 -61.56 2.37 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 123.22 0.325 . . . . 74.340000000000003 111.746 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -84.65 -34.21 23.1 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 119.004 -1.078 . . . . 63.25 113.723 -172.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -70.32 -39.05 75.01 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.285 -0.966 . . . . 61.399999999999999 109.711 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.6 mm? -67.69 -48.95 65.13 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.874 -0.73 . . . . 62.020000000000003 109.778 174.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -58.25 -33.26 69.18 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.361 -0.381 . . . . 75.420000000000002 111.094 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -72.89 -48.31 38.39 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 112.188 0.44 . . . . 63.420000000000002 112.188 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.01 70.5 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.946 -0.302 . . . . 72.540000000000006 111.585 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.449 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 25.6 m -79.92 -33.08 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 120.594 -0.443 . . . . 74.129999999999995 111.556 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.48 -69.0 0.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.074 -0.65 . . . . 72.109999999999999 109.334 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -172.88 111.31 0.22 Allowed 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 123.558 0.743 . . . . 64.140000000000001 111.424 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.9 tp -74.53 106.23 6.02 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.75 -1.574 . . . . 75.140000000000001 106.75 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -106.95 5.18 27.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 114.222 1.194 . . . . 75.129999999999995 114.222 -170.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.429 ' CG ' ' H ' ' A' ' 148' ' ' HIS 0.256 7.3 p80 -152.42 -85.49 0.07 Allowed 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.571 -0.452 . . . . 53.240000000000002 111.9 173.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.429 ' H ' ' CG ' ' A' ' 147' ' ' HIS . 44.1 m80 -136.24 -74.01 0.44 Allowed 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 118.192 0.451 . . . . 71.519999999999996 111.645 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.484 ' CE1' ' HA ' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -179.73 172.95 1.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.447 0.467 . . . . 54.450000000000003 111.086 -178.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -101.99 118.43 36.9 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 105.364 -2.087 . . . . 73.530000000000001 105.364 172.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.53 ' HA ' ' CD1' ' A' ' 133' ' ' ILE . 49.9 t-80 -153.19 133.36 13.42 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.387 -0.525 . . . . 62.140000000000001 109.943 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 C--N 1.303 -1.436 0 N-CA-C 108.928 -0.767 . . . . 73.450000000000003 108.928 176.447 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 109.278 -0.638 . . . . 63.329999999999998 109.278 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.65 85.82 0.14 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.987 0.915 . . . . 64.409999999999997 111.29 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -77.09 -29.37 54.9 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.82 -1.082 . . . . 62.549999999999997 111.523 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -71.54 135.88 47.25 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.203 0.525 . . . . 63.520000000000003 110.861 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -152.71 -177.27 6.14 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.939 -1.504 . . . . 71.400000000000006 106.939 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -91.65 178.17 6.0 Favored 'General case' 0 N--CA 1.392 -3.37 0 CA-C-O 122.086 0.946 . . . . 71.519999999999996 112.459 -173.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.655 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 20.3 p30 -51.24 -49.91 60.19 Favored 'General case' 0 C--N 1.267 -3.003 0 CA-C-N 112.143 -2.299 . . . . 73.510000000000005 113.342 -174.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.62 103.66 15.6 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.894 -1.521 . . . . 62.049999999999997 106.894 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.32 125.9 92.3 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 108.9 -0.778 . . . . 72.120000000000005 108.9 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -83.66 -158.43 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.051 2.5 . . . . 53.020000000000003 113.755 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.39 149.14 50.68 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.006 -0.997 . . . . 71.140000000000001 110.594 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 66.7 mt -123.97 139.48 50.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.82 -0.807 . . . . 73.239999999999995 108.82 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.5 m -139.58 131.38 27.52 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.904 -0.776 . . . . 62.149999999999999 108.904 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -145.88 151.43 37.86 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.376 -0.602 . . . . 63.32 109.376 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 p -117.39 151.81 36.27 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.126 -0.694 . . . . 64.340000000000003 109.126 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.433 HG23 HG11 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -158.44 143.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 107.586 -1.264 . . . . 60.299999999999997 107.586 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 p -111.08 129.62 55.86 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.272 0.558 . . . . 64.349999999999994 112.438 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -101.88 139.66 37.22 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.074 -1.084 . . . . 74.230000000000004 108.074 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.443 ' CD ' ' HE ' ' A' ' 139' ' ' ARG 0.25 0.0 OUTLIER -93.29 53.36 1.91 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.826 1.298 . . . . 61.439999999999998 112.065 -177.873 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.5 160.16 52.15 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 113.332 -1.758 . . . . 71.219999999999999 108.41 -177.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.55 155.52 57.85 Favored 'Trans proline' 0 C--O 1.257 1.459 0 C-N-CA 122.803 2.335 . . . . 75.450000000000003 111.628 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 tt -56.57 -32.67 37.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.405 -0.816 . . . . 73.150000000000006 111.794 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -62.65 -40.23 96.39 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 123.12 0.262 . . . . 52.420000000000002 110.755 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -69.41 -42.49 75.0 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 116.298 -0.41 . . . . 75.209999999999994 110.869 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG22 ' HB ' ' A' ' 96' ' ' THR . 46.0 t -66.52 -42.49 90.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.55 -0.537 . . . . 74.030000000000001 109.55 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -61.89 -47.49 84.73 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.561 -0.745 . . . . 74.530000000000001 111.208 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.455 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 13.3 pt-20 -68.47 -29.51 68.16 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.78 -0.368 . . . . 74.409999999999997 111.319 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.6 m -60.75 -29.26 69.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.368 0.604 . . . . 72.150000000000006 111.27 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.583 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 15.2 m -113.1 19.62 7.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.25 -0.432 . . . . 74.439999999999998 112.147 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.455 ' OG ' ' HA ' ' A' ' 27' ' ' GLU . 37.8 p -136.68 -20.7 1.32 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.077 0.769 . . . . 74.25 113.077 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.8 p -96.34 161.81 13.77 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 120.584 -0.446 . . . . 72.319999999999993 110.94 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 m -58.76 -55.52 34.07 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 123.588 0.555 . . . . 44.200000000000003 110.776 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.28 -44.77 84.28 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 123.653 0.781 . . . . 72.400000000000006 110.581 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -48.87 65.34 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.4 -0.818 . . . . 53.399999999999999 113.238 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.2 mt -69.45 -43.1 81.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.411 . . . . 73.120000000000005 110.777 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.35 -31.9 72.96 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.859 0.689 . . . . 74.299999999999997 112.859 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.7 tptp 64.45 24.95 13.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 122.913 1.339 . . . . 62.310000000000002 108.557 -173.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 66.99 9.83 7.2 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 113.662 -1.608 . . . . 74.450000000000003 112.375 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.479 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 40.0 m-85 -76.46 -71.78 0.37 Allowed 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 120.807 0.337 . . . . 73.400000000000006 110.646 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.403 ' SD ' ' HB3' ' A' ' 39' ' ' PHE . 1.8 mpt? -99.12 105.64 33.47 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 110.003 -0.369 . . . . 73.340000000000003 110.003 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 39' ' ' PHE . 35.9 Cg_exo -63.69 96.17 0.2 Allowed 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 122.837 2.358 . . . . 74.209999999999994 110.858 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.404 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . 44.4 t-20 -138.95 149.87 45.25 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.629 -1.249 . . . . 73.140000000000001 107.629 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -88.93 75.12 8.09 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-O 122.076 0.941 . . . . 71.150000000000006 109.873 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 84.0 m-85 -78.79 119.81 22.53 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.622 -1.251 . . . . 73.319999999999993 107.622 172.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -117.55 146.87 43.29 Favored 'General case' 0 CA--C 1.484 -1.585 0 O-C-N 123.374 0.422 . . . . 73.209999999999994 110.23 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.1 tp -78.85 104.57 9.58 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 106.838 -1.542 . . . . 72.0 106.838 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 50' ' ' GLN . 58.2 tttm -133.33 133.67 42.82 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.148 -1.427 . . . . 74.219999999999999 107.148 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -88.14 73.07 9.04 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-O 123.033 1.396 . . . . 61.310000000000002 109.102 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.0 57.03 0.19 Allowed Glycine 1 N--CA 1.392 -4.262 0 CA-C-N 112.825 -1.989 . . . . 61.130000000000003 109.992 -177.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -82.21 124.65 30.1 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 105.965 -1.865 . . . . 62.310000000000002 105.965 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.35 135.27 54.42 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-O 121.286 0.565 . . . . 63.350000000000001 110.766 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -128.71 146.74 50.8 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.463 -1.68 . . . . 72.209999999999994 106.463 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -110.15 140.37 44.32 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.317 0.579 . . . . 71.310000000000002 110.355 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -130.93 150.91 51.87 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 107.123 -1.436 . . . . 72.019999999999996 107.123 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -72.73 155.24 40.17 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.422 -1.325 . . . . 63.340000000000003 107.422 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.403 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 20.8 m -46.34 -43.76 36.46 Favored Pre-proline 0 CA--C 1.573 1.851 0 N-CA-C 116.445 2.017 . . . . 52.130000000000003 116.445 -174.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 56' ' ' SER . 8.4 Cg_endo -52.21 -67.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 122.179 1.919 . . . . 75.109999999999999 113.049 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -176.94 -179.52 0.94 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.664 0.785 . . . . 75.439999999999998 108.9 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.78 168.35 24.78 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 109.748 -1.341 . . . . 75.439999999999998 109.748 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.01 -67.5 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.8 2.333 . . . . 73.420000000000002 112.321 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.1 m -148.23 85.34 6.39 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 108.833 -0.803 . . . . 54.310000000000002 108.833 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -72.41 140.76 33.95 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.288 1.992 . . . . 74.420000000000002 111.295 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 21.5 p -129.08 141.26 51.27 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 108.488 -0.93 . . . . 74.129999999999995 108.488 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 53.4 mtmt -148.97 123.52 9.75 Favored 'General case' 0 C--O 1.198 -1.639 0 N-CA-C 108.435 -0.95 . . . . 63.299999999999997 108.435 177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.19 135.89 24.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.014 -1.106 . . . . 72.120000000000005 108.014 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.3 tp -80.36 -62.59 1.63 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.054 -0.721 . . . . 72.329999999999998 109.054 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.78 149.87 28.79 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.21 -0.905 . . . . 75.129999999999995 109.835 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 66.7 t -125.89 123.17 63.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.803 -0.814 . . . . 71.510000000000005 108.803 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 81.5 mm-40 -107.81 140.78 40.39 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.344 0.592 . . . . 74.340000000000003 110.291 174.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.77 123.94 88.19 Favored Pre-proline 0 C--N 1.277 -2.545 0 CA-C-N 113.873 -1.512 . . . . 72.010000000000005 109.213 -165.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo 6.86 49.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.639 1 C-N-CA 127.75 5.633 . . . . 71.329999999999998 116.603 -161.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 p -138.9 -41.5 0.48 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.105 -0.952 . . . . 74.219999999999999 112.077 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 39.3 tt0 -148.15 145.09 28.2 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 119.973 -0.691 . . . . 70.430000000000007 110.197 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.62 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.9 tm? -142.12 135.91 29.54 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.343 -0.984 . . . . 73.349999999999994 108.343 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.2 m -139.45 126.25 20.79 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 121.029 -0.268 . . . . 65.120000000000005 110.651 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 36.1 p90 -145.76 156.97 43.95 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 122.2 0.2 . . . . 75.010000000000005 111.242 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 24.0 mt-10 -120.39 124.6 45.91 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.085 -1.82 . . . . 74.209999999999994 106.085 -174.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -130.07 157.51 42.19 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 116.222 -0.445 . . . . 72.299999999999997 110.592 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 78.85 -176.33 0.09 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.267 1.827 . . . . 75.209999999999994 109.789 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.3 p -73.11 -18.47 61.29 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 114.433 1.272 . . . . 60.399999999999999 114.433 -173.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -92.83 -18.77 22.44 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.092 -0.643 . . . . 74.439999999999998 110.989 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.89 60.63 2.88 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 120.002 -1.094 . . . . 43.439999999999998 110.54 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.496 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 95.9 m95 -78.33 121.21 24.16 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.551 -0.907 . . . . 73.540000000000006 108.551 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 76' ' ' PHE . 8.7 p -99.19 107.74 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 CA-C-O 122.516 1.151 . . . . 72.209999999999994 111.592 -173.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -99.84 146.48 8.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.41 -1.268 . . . . 63.509999999999998 108.369 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.465 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 42.4 m -130.5 135.82 48.35 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 109.139 -0.689 . . . . 71.329999999999998 109.139 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.62 ' CD2' HD13 ' A' ' 74' ' ' LEU . 13.4 m-85 -112.59 135.55 53.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.2 -1.037 . . . . 72.310000000000002 108.2 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.15 137.91 52.65 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.392 -0.966 . . . . 75.230000000000004 108.392 176.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -113.1 131.52 55.79 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.77 0.319 . . . . 74.120000000000005 111.296 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -120.7 139.06 53.6 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.231 1.013 . . . . 72.439999999999998 108.678 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -96.73 128.71 43.94 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.087 0.47 . . . . 65.310000000000002 109.996 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.56 153.54 45.08 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.981 -1.118 . . . . 74.5 107.981 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.98 57.54 5.07 Favored Glycine 0 C--N 1.289 -2.053 0 C-N-CA 121.488 -0.387 . . . . 71.239999999999995 113.667 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 171.65 -44.54 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 124.434 1.093 . . . . 75.230000000000004 108.323 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -130.78 172.59 11.83 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.167 -1.379 . . . . 73.129999999999995 109.115 -170.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.433 ' HB ' HG22 ' A' ' 25' ' ' VAL . 74.0 m -116.52 130.91 57.02 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 109.22 -0.659 . . . . 70.129999999999995 109.22 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.08 119.8 5.66 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.059 -1.216 . . . . 53.130000000000003 110.059 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -108.0 133.23 52.61 Favored 'General case' 0 C--N 1.269 -2.895 0 N-CA-C 108.082 -1.081 . . . . 74.049999999999997 108.082 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.7 m -122.77 122.51 38.87 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.761 -0.829 . . . . 71.099999999999994 108.761 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.481 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.19 139.05 36.42 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 121.854 0.835 . . . . 73.099999999999994 109.404 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.481 ' N ' HD13 ' A' ' 100' ' ' LEU . 14.0 mt -136.49 128.88 45.03 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 113.334 -1.757 . . . . 73.299999999999997 108.047 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . 8.7 t-80 -120.38 125.82 48.95 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.698 -0.853 . . . . 73.530000000000001 108.698 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.7 t -142.83 159.87 41.41 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 104.777 -2.305 . . . . 75.439999999999998 104.777 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.55 -169.04 36.12 Favored Glycine 0 C--N 1.292 -1.89 0 C-N-CA 119.967 -1.111 . . . . 51.140000000000001 112.325 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -85.71 98.61 10.8 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.502 0.668 . . . . 74.310000000000002 112.421 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -98.55 136.98 37.88 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.942 -1.026 . . . . 44.32 109.155 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -115.7 145.06 33.76 Favored Pre-proline 0 C--N 1.284 -2.239 0 N-CA-C 107.558 -1.275 . . . . 60.329999999999998 107.558 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.444 ' C ' HD21 ' A' ' 109' ' ' ASN . 14.2 Cg_exo -70.53 89.76 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.874 1.716 . . . . 73.150000000000006 111.154 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.444 HD21 ' C ' ' A' ' 108' ' ' PRO . 0.9 OUTLIER -135.13 -176.32 4.21 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.35 -1.352 . . . . 74.319999999999993 107.35 178.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.655 ' O ' ' HB2' ' A' ' 7' ' ' ASN . 11.6 tm-20 -81.61 1.18 35.03 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 123.148 1.451 . . . . 52.210000000000001 108.803 174.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 109' ' ' ASN . 1.7 m -143.24 179.87 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 126.693 1.997 . . . . 64.109999999999999 107.552 175.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.9 pt -55.65 -31.8 29.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 123.955 0.784 . . . . 65.209999999999994 113.062 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.29 -135.08 7.4 Favored Glycine 0 CA--C 1.486 -1.747 0 C-N-CA 119.893 -1.146 . . . . 37.380000000000003 111.801 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -80.07 11.2 3.56 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.904 0.705 . . . . 70.0 112.904 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.43 -15.52 63.58 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.991 -0.744 . . . . 65.040000000000006 108.991 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . 0.3 0.0 OUTLIER 59.32 10.0 1.62 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 128.515 2.726 . . . . 72.340000000000003 116.642 172.267 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.81 161.39 18.38 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.916 -0.713 . . . . 65.219999999999999 110.059 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -82.61 145.2 29.81 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.742 -0.836 . . . . 74.340000000000003 108.742 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 p -57.19 -40.4 77.31 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.919 0.711 . . . . 54.509999999999998 112.919 -176.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.1 p -67.8 -46.12 72.84 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.567 -0.288 . . . . 52.509999999999998 111.626 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.64 -33.87 62.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 C-N-CA 120.295 -0.562 . . . . 64.140000000000001 109.641 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.07 -46.14 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.275 -0.421 . . . . 72.409999999999997 110.887 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -66.22 -45.61 80.11 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 121.007 -0.277 . . . . 75.230000000000004 110.902 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.47 -43.21 99.03 Favored Glycine 0 N--CA 1.446 -0.657 0 O-C-N 123.608 0.568 . . . . 55.340000000000003 112.053 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -38.47 73.88 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.686 0.625 . . . . 62.43 112.686 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.82 -45.73 49.54 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.981 -0.688 . . . . 72.540000000000006 110.854 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.06 -59.2 3.67 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.441 -0.345 . . . . 62.240000000000002 111.618 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.74 -40.99 93.97 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.541 -0.624 . . . . 52.539999999999999 111.541 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.49 -60.15 8.69 Favored Glycine 0 N--CA 1.436 -1.315 0 O-C-N 124.054 0.503 . . . . 52.329999999999998 112.3 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -63.37 -35.68 81.21 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.592 0.96 . . . . 74.329999999999998 113.592 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.2 m -68.29 -54.54 16.85 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.166 -0.614 . . . . 72.450000000000003 110.94 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.19 -47.04 39.11 Favored Glycine 0 C--O 1.244 0.735 0 C-N-CA 120.829 -0.7 . . . . 73.200000000000003 112.95 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.711 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 46.2 mm -67.3 -49.8 68.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.955 0 CA-C-O 119.577 -0.249 . . . . 65.049999999999997 111.228 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 78.6 t -61.84 -49.6 83.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 118.793 -1.163 . . . . 50.25 112.218 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -61.6 -64.83 0.81 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.702 0.63 . . . . 61.32 112.702 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.05 -39.23 50.77 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.863 -0.735 . . . . 65.310000000000002 112.723 -172.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.711 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -69.61 -40.93 76.33 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.006 -0.677 . . . . 72.239999999999995 111.886 -176.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.2 mm? -62.63 -48.88 77.42 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 119.063 -1.055 . . . . 73.129999999999995 109.271 175.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.443 ' HE ' ' CD ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -61.0 -38.79 87.29 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.735 -0.666 . . . . 74.430000000000007 110.452 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -76.89 -36.76 56.47 Favored 'General case' 0 CA--C 1.471 -2.093 0 N-CA-C 113.721 1.008 . . . . 73.439999999999998 113.721 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 -27.42 64.02 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.131 -0.627 . . . . 44.539999999999999 110.611 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 23.8 m -80.2 -26.71 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 116.201 -0.454 . . . . 75.239999999999995 110.76 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -84.31 -60.36 2.11 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 119.98 -0.688 . . . . 74.439999999999998 111.512 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.25 154.96 40.88 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.985 1.106 . . . . 71.540000000000006 113.985 -170.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 145' ' ' LEU . 2.2 pt? -87.48 79.34 8.41 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 122.572 1.177 . . . . 72.450000000000003 108.354 173.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -82.48 83.22 7.61 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.713 -1.13 . . . . 52.140000000000001 109.5 -175.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -101.12 147.54 26.11 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.08 -0.964 . . . . 71.519999999999996 108.973 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -152.01 179.9 8.07 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.245 -0.65 . . . . 73.230000000000004 109.245 -171.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -68.13 138.13 55.46 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 107.99 -1.115 . . . . 75.420000000000002 107.99 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 44.7 p-80 -113.53 127.95 56.27 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 121.066 0.46 . . . . 74.439999999999998 110.484 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -70.86 -15.45 62.63 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 115.223 1.564 . . . . 74.150000000000006 115.223 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 . . . . . 0 C--N 1.299 -1.591 0 N-CA-C 108.324 -0.991 . . . . 74.510000000000005 108.324 177.352 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 107.763 -1.199 . . . . 72.140000000000001 107.763 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.13 100.78 0.63 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.435 -0.579 . . . . 73.209999999999994 109.435 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -62.28 -28.89 70.04 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.71 0.804 . . . . 71.340000000000003 109.969 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.71 132.89 55.64 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.324 -0.991 . . . . 71.340000000000003 108.324 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -114.91 3.5 14.58 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.364 0.602 . . . . 54.409999999999997 110.698 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -81.38 104.89 12.14 Favored 'General case' 0 N--CA 1.409 -2.479 0 CA-C-O 122.461 1.124 . . . . 63.219999999999999 109.34 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 123' ' ' ARG . 60.9 t30 -68.32 -11.92 60.26 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 112.622 -2.081 . . . . 73.200000000000003 113.12 -175.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.61 -72.38 0.27 Allowed 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.042 0.448 . . . . 64.140000000000001 110.461 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 tt 177.99 100.99 0.13 Allowed Pre-proline 0 N--CA 1.434 -1.266 0 N-CA-C 105.775 -1.935 . . . . 64.340000000000003 105.775 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -92.96 -179.42 0.95 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.413 2.075 . . . . 72.420000000000002 110.118 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 3.2 p-10 -68.24 112.28 5.06 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.836 -0.802 . . . . 71.230000000000004 108.836 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.442 HG21 ' HB3' ' A' ' 102' ' ' HIS . 9.1 tp -97.33 125.44 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 C-N-CA 118.456 -1.298 . . . . 75.510000000000005 108.283 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 60.7 m -107.18 128.98 54.89 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 107.425 -1.324 . . . . 73.030000000000001 107.425 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -131.09 136.52 48.47 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.68 -1.23 . . . . 74.430000000000007 107.68 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -118.3 134.95 54.6 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 120.754 0.312 . . . . 61.299999999999997 111.211 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.459 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.78 139.98 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.033 0.444 . . . . 53.399999999999999 109.917 -179.091 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 p -101.09 126.74 47.81 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.137 0.494 . . . . 74.549999999999997 110.969 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.19 138.17 31.8 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.617 -0.72 . . . . 64.310000000000002 110.603 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -86.83 30.12 0.76 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 113.997 -1.456 . . . . 74.140000000000001 109.613 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.15 158.41 73.74 Favored Pre-proline 0 C--O 1.251 1.142 0 CA-C-N 115.564 -0.743 . . . . 62.229999999999997 109.37 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.97 150.76 87.61 Favored 'Trans proline' 0 C--O 1.25 1.091 0 C-N-CA 123.286 2.657 . . . . 75.129999999999995 112.109 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -40.24 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.091 -0.958 . . . . 70.519999999999996 111.68 -176.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -67.83 -35.77 79.19 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.997 -0.681 . . . . 74.430000000000007 111.179 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -72.66 -37.48 67.93 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.627 -0.509 . . . . 62.509999999999998 109.627 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.03 -41.15 89.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.908 -0.587 . . . . 61.210000000000001 109.618 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -60.02 -47.03 87.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.593 -0.73 . . . . 74.140000000000001 110.086 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -60.79 -39.79 90.17 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.362 0.665 . . . . 73.439999999999998 110.475 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.7 m -60.97 -23.29 65.23 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.536 0.734 . . . . 72.129999999999995 112.055 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.585 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 10.7 m -119.25 19.87 6.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 112.508 0.558 . . . . 73.310000000000002 112.508 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 61.0 p -137.46 -22.09 1.14 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.933 0.716 . . . . 63.520000000000003 112.933 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -91.63 154.61 18.91 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.456 -0.572 . . . . 63.420000000000002 109.456 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 27.7 t -63.01 -40.78 98.78 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.605 -0.887 . . . . 75.019999999999996 108.605 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -62.3 -48.97 77.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.678 -1.147 . . . . 71.420000000000002 109.638 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.78 -47.59 60.26 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.151 -0.931 . . . . 71.209999999999994 113.402 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.2 mt -69.47 -48.46 66.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 117.601 0.7 . . . . 73.219999999999999 111.895 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.71 -45.55 78.39 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.461 0.541 . . . . 70.5 112.461 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 tttp 57.48 23.83 9.56 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 123.145 1.45 . . . . 75.129999999999995 108.63 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 65.3 13.29 8.69 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.843 2.057 . . . . 70.230000000000004 114.504 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -72.4 -44.47 62.45 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.835 0.826 . . . . 72.230000000000004 109.322 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.6 ptm -128.68 125.31 23.02 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 114.655 -1.157 . . . . 65.209999999999994 109.433 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.05 94.24 1.08 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.168 1.912 . . . . 64.510000000000005 113.385 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -140.22 143.92 36.27 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.082 -1.451 . . . . 64.120000000000005 107.082 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.79 78.86 3.28 Favored 'General case' 0 CA--C 1.469 -2.139 0 CA-C-O 121.177 0.513 . . . . 74.409999999999997 110.911 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.415 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 83.1 m-85 -68.28 126.55 29.94 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.594 -1.185 . . . . 72.319999999999993 109.009 175.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -127.45 138.75 53.04 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.987 -0.745 . . . . 71.129999999999995 108.987 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.5 tt -75.56 103.72 5.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 106.641 -1.615 . . . . 65.519999999999996 106.641 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 1.2 tpmt? -133.91 145.13 49.32 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.53 -1.656 . . . . 73.299999999999997 106.53 172.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -87.68 48.12 1.6 Allowed 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 119.298 0.954 . . . . 73.519999999999996 110.185 174.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.68 49.96 0.03 OUTLIER Glycine 0 N--CA 1.42 -2.409 0 CA-C-N 115.32 -0.855 . . . . 62.140000000000001 111.0 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -79.24 104.77 10.1 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 106.082 -1.822 . . . . 74.0 106.082 176.633 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -151.44 148.93 28.68 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 108.859 -0.793 . . . . 71.420000000000002 108.859 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -124.07 146.99 48.22 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 105.351 -2.092 . . . . 75.120000000000005 105.351 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -109.81 142.66 40.77 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.244 -0.651 . . . . 64.439999999999998 109.244 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -127.29 137.5 52.85 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.962 -0.755 . . . . 63.229999999999997 108.962 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.406 ' C ' ' HG ' ' A' ' 56' ' ' SER . 1.5 mp0 -82.5 91.39 6.88 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.151 -1.425 . . . . 72.409999999999997 107.151 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.406 ' HG ' ' C ' ' A' ' 55' ' ' GLN . 41.7 m -156.9 120.28 2.24 Favored Pre-proline 0 C--N 1.297 -1.692 0 N-CA-C 108.93 -0.767 . . . . 74.219999999999999 108.93 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.95 115.33 3.21 Favored 'Trans proline' 0 C--O 1.244 0.824 0 C-N-CA 121.74 1.627 . . . . 70.25 108.174 173.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.1 t80 71.1 94.22 0.08 Allowed 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.658 -1.238 . . . . 70.540000000000006 107.658 -170.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.41 152.85 40.2 Favored Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 115.37 -0.832 . . . . 74.140000000000001 112.904 -175.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.461 ' O ' HG22 ' A' ' 80' ' ' THR . 17.6 Cg_endo -60.08 -33.76 95.04 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.041 2.494 . . . . 75.329999999999998 112.492 177.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.2 t 70.39 92.42 0.06 OUTLIER Pre-proline 0 C--O 1.249 1.07 0 C-N-CA 123.964 0.906 . . . . 71.319999999999993 111.593 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.37 -158.62 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.97 2.446 . . . . 72.340000000000003 109.632 175.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 20.4 p -88.37 141.5 28.49 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 119.306 -0.958 . . . . 72.150000000000006 108.553 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 9.6 mtmp? -145.38 135.5 23.84 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.35 -0.982 . . . . 74.340000000000003 108.35 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.2 t -90.28 130.61 39.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.602 -1.258 . . . . 62.119999999999997 107.602 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.2 tp -76.03 -59.91 2.55 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.055 -1.091 . . . . 75.030000000000001 108.055 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -162.16 141.08 9.33 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.352 -0.84 . . . . 61.119999999999997 109.776 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 p -116.99 120.46 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.982 0 CA-C-O 121.583 0.706 . . . . 65.0 110.036 175.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 2.2 mp0 -94.15 141.04 29.0 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.617 -1.174 . . . . 73.200000000000003 108.85 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 122.69 83.57 Favored Pre-proline 0 C--N 1.276 -2.613 0 CA-C-N 114.379 -1.282 . . . . 51.439999999999998 108.969 -164.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo 0.12 62.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.014 1 C-N-CA 126.771 4.981 . . . . 62.520000000000003 115.488 -159.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -143.47 -42.24 0.29 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 113.67 -1.605 . . . . 73.209999999999994 110.983 175.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.4 tt0 -150.84 145.46 25.7 Favored 'General case' 0 C--O 1.204 -1.318 0 C-N-CA 119.834 -0.746 . . . . 74.439999999999998 110.491 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.61 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.0 tm? -137.05 137.63 39.56 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.063 -1.088 . . . . 73.010000000000005 108.063 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.7 p -140.76 126.88 19.58 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.803 -0.359 . . . . 65.340000000000003 110.992 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -144.23 156.91 44.49 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 120.794 0.33 . . . . 74.019999999999996 111.07 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 20.6 mt-10 -121.07 136.78 54.91 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 105.963 -1.866 . . . . 75.530000000000001 105.963 -173.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -147.94 158.71 44.19 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 120.188 -0.605 . . . . 74.420000000000002 112.409 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 73.84 171.34 0.3 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.05 -1.432 . . . . 73.5 113.195 172.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 60' ' ' PRO . 11.6 p -66.47 -34.46 77.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.934 0.894 . . . . 70.340000000000003 111.862 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.401 ' O ' ' HE3' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -74.46 -15.11 60.9 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 112.438 0.533 . . . . 74.310000000000002 112.438 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.29 67.64 1.79 Allowed Glycine 0 C--O 1.247 0.91 0 C-N-CA 121.058 -0.591 . . . . 54.329999999999998 112.411 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.444 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 33.2 m95 -93.95 130.21 40.13 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.33 -0.618 . . . . 75.349999999999994 109.33 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.1 t -110.8 111.43 36.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.854 -1.165 . . . . 73.230000000000004 107.854 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.3 m -109.23 140.59 27.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 115.946 -0.57 . . . . 73.129999999999995 109.67 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.42 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 58.3 m -126.09 135.14 51.37 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.9 -0.778 . . . . 74.349999999999994 108.9 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.61 ' CD2' HD13 ' A' ' 74' ' ' LEU . 11.7 m-85 -111.25 132.59 54.23 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.793 -1.188 . . . . 73.519999999999996 107.793 177.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.469 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 27.3 mt-30 -114.35 141.45 47.61 Favored 'General case' 0 C--N 1.276 -2.614 0 O-C-N 123.643 0.589 . . . . 75.239999999999995 110.568 177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.6 tp -104.18 141.18 36.71 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.705 -0.68 . . . . 64.120000000000005 110.918 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -124.92 116.68 22.59 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 106.164 -1.791 . . . . 74.349999999999994 106.164 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -86.22 119.15 26.2 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.999 -0.546 . . . . 65.109999999999999 111.796 -173.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 74.6 mt -125.18 149.52 47.85 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.046 -1.464 . . . . 71.140000000000001 107.046 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.84 58.84 1.79 Allowed Glycine 0 C--N 1.28 -2.536 0 C-N-CA 120.44 -0.886 . . . . 63.200000000000003 112.476 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -177.15 -52.84 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.119 -1.808 . . . . 62.210000000000001 106.119 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.67 175.8 7.7 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.006 -1.479 . . . . 74.349999999999994 107.006 -175.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.1 m -120.87 130.39 53.9 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 120.341 -0.543 . . . . 71.129999999999995 109.697 -178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.52 124.79 7.86 Favored Glycine 0 N--CA 1.408 -3.216 0 N-CA-C 109.099 -1.6 . . . . 72.340000000000003 109.099 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -117.27 134.18 55.11 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 108.812 -0.81 . . . . 74.129999999999995 108.812 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 23.5 m -125.95 129.24 48.88 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.517 -0.92 . . . . 65.549999999999997 108.517 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -104.79 142.26 35.03 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.005 -0.739 . . . . 74.230000000000004 109.005 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 100' ' ' LEU . 3.6 mp -136.13 125.25 38.61 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 106.829 -1.545 . . . . 72.409999999999997 106.829 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 23.2 t-160 -119.3 124.33 46.4 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.09 -0.707 . . . . 61.130000000000003 109.09 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.0 t -139.44 164.09 30.79 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 106.49 -1.67 . . . . 71.030000000000001 106.49 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -110.42 160.54 13.28 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.752 -0.737 . . . . 54.520000000000003 112.099 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -84.8 22.39 1.37 Allowed 'General case' 0 CA--C 1.559 1.32 0 CA-C-O 122.623 1.201 . . . . 72.540000000000006 110.205 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HE3' ' O ' ' A' ' 81' ' ' GLU . 16.0 ptpt -142.96 156.65 44.91 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.453 -0.779 . . . . 64.450000000000003 110.481 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -63.87 122.05 74.72 Favored Pre-proline 0 C--N 1.313 -0.98 0 C-N-CA 124.254 1.021 . . . . 75.109999999999999 110.773 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.71 107.08 2.32 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 122.212 1.941 . . . . 73.129999999999995 111.108 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -110.01 -156.95 0.6 Allowed 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.443 -1.317 . . . . 61.009999999999998 107.443 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -58.98 -33.3 70.51 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.232 0.924 . . . . 75.109999999999999 111.465 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.1 155.52 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 CA-C-N 116.272 -0.422 . . . . 72.439999999999998 110.355 169.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.47 -38.46 70.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.56 -1.2 . . . . 71.040000000000006 112.245 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.17 70.3 0.24 Allowed Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.168 -1.491 . . . . 74.420000000000002 113.016 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt 61.93 31.66 18.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.729 1.011 . . . . 75.140000000000001 113.729 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.35 -13.3 61.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.654 0.264 . . . . 73.420000000000002 110.696 174.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 m120 93.65 139.25 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.377 1.871 . . . . 72.120000000000005 112.891 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 86.27 158.68 0.08 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.391 1.876 . . . . 55.039999999999999 111.353 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -59.28 149.43 28.76 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.187 0.595 . . . . 74.230000000000004 112.168 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.58 -52.81 64.07 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.221 1.008 . . . . 75.200000000000003 110.592 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.8 t -60.82 -36.74 79.85 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.611 -0.722 . . . . 74.409999999999997 110.2 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.25 -47.45 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.653 -0.703 . . . . 72.239999999999995 109.898 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.16 -41.18 80.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 110.701 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.453 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 74.4 ttt180 -63.22 -48.81 76.72 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.486 -0.779 . . . . 73.450000000000003 109.424 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.76 96.97 Favored Glycine 0 CA--C 1.495 -1.213 0 CA-C-N 115.231 -0.895 . . . . 60.420000000000002 112.03 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -66.55 -35.21 79.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 122.78 0.432 . . . . 71.010000000000005 111.521 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 24.1 mmt -70.92 -45.09 64.85 Favored 'General case' 0 C--O 1.211 -0.939 0 C-N-CA 120.315 -0.554 . . . . 72.519999999999996 111.003 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -67.26 -53.84 26.27 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.406 -0.918 . . . . 72.239999999999995 111.104 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.97 -45.64 95.21 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.917 -0.473 . . . . 63.539999999999999 111.917 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.65 -52.65 49.47 Favored Glycine 0 CA--C 1.487 -1.701 0 N-CA-C 111.494 -0.642 . . . . 64.519999999999996 111.494 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -65.15 -26.3 68.11 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 113.372 0.878 . . . . 73.230000000000004 113.372 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.1 m -67.81 -54.68 17.17 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.55 -0.537 . . . . 74.5 109.55 174.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.87 -42.4 86.19 Favored Glycine 0 C--O 1.245 0.826 0 CA-C-N 115.992 -0.549 . . . . 54.210000000000001 113.053 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.679 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 39.5 mm -65.37 -57.58 10.39 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 CA-C-O 119.599 -0.239 . . . . 72.209999999999994 110.937 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 69.6 t -57.99 -48.02 85.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 112.486 0.55 . . . . 72.120000000000005 112.486 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.459 ' HA ' HG13 ' A' ' 16' ' ' ILE . 43.4 t30 -59.69 -63.31 1.35 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.041 0.448 . . . . 75.129999999999995 111.995 -177.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -74.85 -48.27 25.92 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 112.447 0.536 . . . . 72.109999999999999 112.447 -173.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.679 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -63.56 -38.64 91.91 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 112.107 0.41 . . . . 74.239999999999995 112.107 -175.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.3 mm? -68.1 -48.38 65.63 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 119.298 -0.961 . . . . 64.340000000000003 110.594 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -58.42 -36.04 72.99 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.53 0.681 . . . . 74.140000000000001 109.698 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -75.97 -38.85 57.04 Favored 'General case' 0 C--O 1.185 -2.329 0 N-CA-C 112.339 0.496 . . . . 75.420000000000002 112.339 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.17 68.58 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.152 -0.619 . . . . 73.540000000000006 111.446 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.6 m -78.56 -36.09 19.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.067 -0.653 . . . . 73.219999999999999 110.213 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -87.8 -58.95 2.38 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.39 1.256 . . . . 72.120000000000005 114.39 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -130.74 115.73 17.04 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.74 0.781 . . . . 74.019999999999996 111.442 -172.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.43 25.35 0.63 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 113.593 0.961 . . . . 73.310000000000002 113.593 -174.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.79 145.85 48.42 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.873 -0.788 . . . . 62.109999999999999 108.873 173.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -111.94 156.6 21.84 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.598 -0.441 . . . . 75.540000000000006 110.595 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -123.86 153.17 41.47 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.308 -1.738 . . . . 75.209999999999994 106.308 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -114.61 116.44 28.76 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 118.764 -1.174 . . . . 72.200000000000003 110.63 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -72.49 145.71 47.34 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.402 -0.962 . . . . 74.049999999999997 108.402 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -57.93 -54.11 50.69 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 123.728 0.642 . . . . 72.239999999999995 110.028 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.2 t60 . . . . . 0 C--O 1.25 1.081 0 N-CA-C 108.2 -1.037 . . . . 63.340000000000003 108.2 178.169 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.306 0.098 . . . . 73.129999999999995 111.216 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.28 127.81 32.8 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.744 0.306 . . . . 52.32 110.574 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -100.99 -48.72 4.34 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.049 -0.523 . . . . 71.329999999999998 111.884 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -140.95 -164.33 1.72 Allowed 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 109.502 -0.555 . . . . 74.319999999999993 109.502 -172.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -78.8 96.09 5.53 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.075 -1.454 . . . . 72.120000000000005 107.075 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -114.49 80.21 1.37 Allowed 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 107.513 -1.292 . . . . 63.039999999999999 107.513 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -66.32 -36.77 83.77 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 120.623 -0.431 . . . . 72.239999999999995 109.912 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 110' ' ' GLU . . . -135.2 -66.17 0.59 Allowed 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 106.945 -1.502 . . . . 72.409999999999997 106.945 177.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.53 129.72 2.58 Favored Pre-proline 0 N--CA 1.418 -2.028 0 N-CA-C 105.898 -1.889 . . . . 73.519999999999996 105.898 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -85.44 -167.94 0.45 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 121.78 1.653 . . . . 75.430000000000007 110.121 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 14.1 t70 -100.35 113.07 25.52 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 105.675 -1.972 . . . . 61.310000000000002 105.675 171.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 14.5 tt -106.86 130.79 58.23 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.982 0 C-N-CA 119.81 -0.756 . . . . 75.400000000000006 109.478 -177.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.2 m -114.37 128.92 56.59 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 106.984 -1.488 . . . . 63.43 106.984 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 20.0 tptt -134.67 152.69 51.95 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.392 -1.336 . . . . 61.200000000000003 107.392 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.2 p -128.75 133.91 48.25 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 120.812 -0.355 . . . . 71.209999999999994 110.342 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.28 135.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.333 -1.358 . . . . 75.319999999999993 107.333 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.8 p -102.8 131.49 49.62 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.47 0.544 . . . . 72.420000000000002 112.47 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.36 140.94 40.92 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 122.005 0.907 . . . . 75.299999999999997 113.094 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -70.36 13.42 0.17 Allowed 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 128.583 2.753 . . . . 62.549999999999997 112.779 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.449 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -130.86 164.03 44.76 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-O 118.969 -0.539 . . . . 75.109999999999999 110.107 -172.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.449 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 37.5 Cg_endo -64.8 154.95 70.14 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.85 2.367 . . . . 62.340000000000003 111.904 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.0 tt -57.69 -33.35 44.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.688 -1.142 . . . . 74.239999999999995 112.666 -175.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 3.9 pt20 -65.05 -41.31 95.3 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.364 -0.38 . . . . 72.120000000000005 111.756 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -72.64 -38.9 67.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.321 -0.4 . . . . 61.509999999999998 110.988 -173.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.414 HG13 HG23 ' A' ' 96' ' ' THR . 8.6 p -68.28 -41.0 83.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 120.385 -0.526 . . . . 74.420000000000002 109.918 178.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -62.28 -47.25 85.15 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.636 -0.711 . . . . 73.099999999999994 111.451 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 23' ' ' GLN . 11.6 pt-20 -69.0 -27.9 66.11 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 120.35 -0.54 . . . . 65.310000000000002 111.523 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.0 m -57.13 -36.38 70.63 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 121.411 0.624 . . . . 72.049999999999997 110.026 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.422 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 4.0 m -107.74 23.14 3.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.125 -0.489 . . . . 75.209999999999994 111.795 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.9 t -145.06 11.29 1.35 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.945 0.402 . . . . 65.129999999999995 110.743 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.0 p -117.31 162.14 18.39 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.871 -0.518 . . . . 72.310000000000002 110.335 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -51.93 -62.23 1.76 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.325 1.05 . . . . 64.120000000000005 111.467 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.58 -35.52 75.43 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.837 0.68 . . . . 63.439999999999998 112.837 -175.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.85 -48.39 72.37 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.928 -0.653 . . . . 50.299999999999997 111.743 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.478 HD12 ' CD1' ' A' ' 44' ' ' PHE . 64.1 mt -70.46 -39.37 76.24 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 CA-C-O 120.594 0.235 . . . . 73.340000000000003 111.385 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.04 -51.32 64.42 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.015 -0.539 . . . . 73.099999999999994 110.434 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.533 ' HB2' ' NH1' ' A' ' 137' ' ' ARG 0.257 0.4 OUTLIER 45.39 29.02 0.53 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.541 1.537 . . . . 72.120000000000005 114.335 177.647 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -158.32 159.35 35.81 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 102.514 -3.143 . . . . 72.549999999999997 102.514 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -86.75 52.34 2.48 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 119.979 1.263 . . . . 74.109999999999999 109.873 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 92.2 mtp -122.37 109.96 32.71 Favored Pre-proline 0 C--N 1.312 -1.057 0 N-CA-C 105.525 -2.028 . . . . 73.239999999999995 105.525 176.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.12 110.2 0.65 Allowed 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 122.617 2.212 . . . . 62.140000000000001 113.136 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -113.69 142.81 45.56 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 108.274 -1.01 . . . . 70.5 108.274 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -110.08 74.08 0.87 Allowed 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 119.704 -0.798 . . . . 63.219999999999999 109.787 -172.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.478 ' CD1' HD12 ' A' ' 35' ' ' ILE . 18.6 t80 -106.9 129.26 54.75 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.08 -0.964 . . . . 72.510000000000005 110.722 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -136.0 150.53 49.26 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.522 -1.659 . . . . 73.329999999999998 106.522 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -80.43 109.33 14.84 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 118.813 -1.155 . . . . 72.120000000000005 111.601 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 22.3 tptm -128.52 143.4 50.96 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 104.522 -2.399 . . . . 72.319999999999993 104.522 173.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -87.83 78.17 8.41 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.407 1.098 . . . . 62.240000000000002 109.239 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.36 99.2 2.22 Favored Glycine 1 N--CA 1.395 -4.084 0 N-CA-C 108.122 -1.991 . . . . 44.140000000000001 108.122 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 7.3 tt0 -153.99 117.7 4.68 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.268 -1.382 . . . . 71.530000000000001 107.268 -174.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -148.31 162.03 40.35 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-O 121.086 0.47 . . . . 71.540000000000006 110.914 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 96.6 m-85 -98.28 122.16 41.09 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 108.014 -1.106 . . . . 71.450000000000003 108.014 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.442 ' C ' ' H ' ' A' ' 55' ' ' GLN . 1.7 p-80 -145.56 154.34 42.07 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.753 -0.658 . . . . 74.349999999999994 109.545 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.0 mp 73.44 -16.48 0.48 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.31 1.044 . . . . 74.030000000000001 112.266 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.442 ' H ' ' C ' ' A' ' 53' ' ' HIS . 48.8 tt0 -128.1 23.65 6.05 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.125 -1.435 . . . . 74.140000000000001 107.125 -178.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m 75.03 143.82 0.1 Allowed Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.336 1.454 . . . . 64.030000000000001 111.157 -174.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 52' ' ' PHE . 17.2 Cg_exo -69.49 -16.44 38.67 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.452 2.101 . . . . 74.400000000000006 111.52 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -95.82 106.36 18.48 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.7 -1.222 . . . . 73.219999999999999 107.7 177.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.87 -139.51 6.72 Favored Glycine 0 C--N 1.294 -1.799 0 N-CA-C 109.099 -1.601 . . . . 71.519999999999996 109.099 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -65.39 -22.86 59.21 Favored 'Trans proline' 0 N--CA 1.473 0.293 0 C-N-CA 122.175 1.916 . . . . 73.099999999999994 109.404 174.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.9 m -134.88 134.26 21.74 Favored Pre-proline 0 N--CA 1.411 -2.376 0 N-CA-C 106.954 -1.498 . . . . 72.109999999999999 106.954 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -92.94 32.92 0.24 Allowed 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 122.747 2.298 . . . . 72.140000000000001 112.239 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.5 p -111.69 165.25 12.2 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 112.945 0.72 . . . . 74.129999999999995 112.945 -174.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 89.4 mttt -138.09 143.94 40.66 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.807 -1.923 . . . . 75.409999999999997 105.807 175.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.2 t -91.2 136.77 23.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 107.526 -1.287 . . . . 64.519999999999996 107.526 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.1 tt -87.09 -58.19 2.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.863 -1.162 . . . . 71.430000000000007 107.863 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.34 145.88 10.07 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.219 -1.03 . . . . 74.109999999999999 108.219 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.81 119.8 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-O 122.207 1.003 . . . . 74.519999999999996 111.378 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 15.4 mm100 -104.92 142.51 34.64 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 113.941 -1.481 . . . . 74.340000000000003 109.064 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.81 129.19 94.26 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 114.354 -1.294 . . . . 63.130000000000003 108.262 -167.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -1.99 52.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.558 1 C-N-CA 128.105 5.87 . . . . 62.43 117.919 -160.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.0 p -137.23 -42.64 0.56 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.667 -1.151 . . . . 64.310000000000002 109.922 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 41.2 tt0 -144.35 127.28 16.39 Favored 'General case' 0 C--O 1.19 -2.042 0 C-N-CA 119.629 -0.828 . . . . 63.030000000000001 109.453 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 tp -133.95 127.72 32.98 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 108.589 -0.893 . . . . 74.239999999999995 108.589 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.444 ' HG ' HG21 ' A' ' 86' ' ' THR . 6.0 m -135.2 127.13 29.51 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.468 -0.493 . . . . 73.230000000000004 111.269 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -142.09 156.55 45.4 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.008 0.373 . . . . 71.239999999999995 112.008 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -120.71 129.28 53.58 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.915 -1.143 . . . . 74.439999999999998 107.915 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -113.99 118.94 35.53 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.142 -1.059 . . . . 75.219999999999999 108.142 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' A' ' 80' ' ' THR . 34.5 t70 -82.39 -178.85 7.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.2 -1.037 . . . . 72.450000000000003 108.2 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.428 ' H ' ' CG ' ' A' ' 79' ' ' ASP . 20.6 m 69.16 25.32 5.78 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-O 123.77 1.748 . . . . 73.430000000000007 106.515 -171.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.482 ' CB ' ' HB2' ' A' ' 115' ' ' ALA . 23.9 mm-40 59.93 45.61 12.11 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 112.231 -2.259 . . . . 71.430000000000007 113.643 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.37 -21.6 56.25 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 108.159 -1.977 . . . . 51.219999999999999 108.159 170.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 74.44 -175.53 0.14 Allowed 'General case' 0 C--O 1.245 0.845 0 C-N-CA 126.95 2.1 . . . . 74.400000000000006 112.908 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.7 p -96.85 115.04 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-O 122.19 0.995 . . . . 65.409999999999997 109.888 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.56 146.41 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 CA-C-N 114.549 -1.205 . . . . 72.409999999999997 109.046 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.492 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 92.9 m -136.79 133.46 35.98 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 108.569 -0.9 . . . . 71.439999999999998 108.569 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.422 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 15.5 m-85 -119.03 135.85 54.42 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.825 -1.176 . . . . 74.129999999999995 107.825 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.519 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 42.7 mt-30 -118.83 146.44 44.85 Favored 'General case' 0 C--N 1.263 -3.194 0 CA-C-N 115.57 -0.741 . . . . 71.519999999999996 110.393 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.32 126.55 55.5 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.243 -0.889 . . . . 75.239999999999995 109.351 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -114.88 116.67 28.93 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 107.629 -1.249 . . . . 41.5 107.629 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -83.18 121.16 26.71 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.764 -0.653 . . . . 75.239999999999995 110.762 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.542 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 73.8 mt -123.85 156.56 35.97 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.036 -1.098 . . . . 71.439999999999998 108.036 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.13 59.69 1.39 Allowed Glycine 0 C--N 1.282 -2.429 0 C-N-CA 120.517 -0.849 . . . . 74.310000000000002 113.121 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 175.43 -39.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.595 1.158 . . . . 72.439999999999998 108.672 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 3.8 ptpt -144.85 175.81 9.93 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.457 -1.682 . . . . 65.150000000000006 106.457 -174.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.414 HG23 HG13 ' A' ' 25' ' ' VAL . 62.6 m -116.47 131.62 56.9 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.099 -0.704 . . . . 75.549999999999997 109.099 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.4 119.0 5.35 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 108.66 -1.776 . . . . 64.409999999999997 108.66 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -103.86 130.38 51.44 Favored 'General case' 0 C--N 1.257 -3.448 0 N-CA-C 107.171 -1.418 . . . . 73.219999999999999 107.171 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 14.7 m -114.86 123.72 49.89 Favored 'General case' 0 N--CA 1.397 -3.095 0 N-CA-C 107.607 -1.257 . . . . 73.120000000000005 107.607 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.447 HD11 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.56 140.65 34.53 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 108.486 -0.931 . . . . 74.349999999999994 108.486 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 4.6 mp -135.92 123.54 35.35 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.16 0 CA-C-N 113.758 -1.565 . . . . 74.239999999999995 107.137 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 17.5 t60 -122.48 126.2 47.36 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.475 -0.935 . . . . 74.430000000000007 108.475 175.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -142.93 164.27 30.54 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 106.428 -1.693 . . . . 75.329999999999998 106.428 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.4 143.23 9.8 Favored Glycine 0 CA--C 1.48 -2.104 0 N-CA-C 109.95 -1.26 . . . . 60.119999999999997 109.95 176.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -71.58 140.03 49.65 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.311 -0.625 . . . . 74.25 109.311 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -86.5 83.46 7.64 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.069 -1.085 . . . . 70.129999999999995 108.069 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.428 ' HB2' ' HD3' ' A' ' 108' ' ' PRO . 13.6 mm-40 -87.58 -59.31 0.27 Allowed Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 114.935 -1.029 . . . . 74.209999999999994 112.858 -176.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.483 ' HG2' ' O ' ' A' ' 112' ' ' ILE . 1.3 Cg_endo -88.02 -78.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 121.982 1.788 . . . . 74.109999999999999 115.986 -171.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.35 -169.84 1.57 Allowed 'General case' 0 C--N 1.318 -0.794 0 O-C-N 122.294 -0.254 . . . . 71.209999999999994 111.374 -172.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 8' ' ' ALA . 35.8 tt0 -63.83 -47.71 79.73 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.007 0.817 . . . . 74.540000000000006 108.82 174.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 112' ' ' ILE . 5.2 p -94.55 176.66 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 104.859 -2.274 . . . . 74.209999999999994 104.859 171.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.483 ' O ' ' HG2' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -58.09 -39.51 73.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 119.98 1.264 . . . . 71.230000000000004 112.024 -176.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 55.18 47.41 74.33 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 111.994 -0.443 . . . . 40.210000000000001 111.994 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -166.07 -70.12 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.818 0.342 . . . . 74.120000000000005 110.93 -171.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.482 ' HB2' ' CB ' ' A' ' 81' ' ' GLU . . . -72.82 -40.79 65.52 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 116.514 2.042 . . . . 75.230000000000004 116.514 -171.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.16 100.88 0.97 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.876 -1.898 . . . . 74.019999999999996 105.876 -168.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . 0.271 36.7 mm-40 -94.93 89.01 5.47 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 114.866 1.432 . . . . 75.010000000000005 114.866 -172.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.462 ' HB3' HG11 ' A' ' 121' ' ' VAL . 52.5 tttp -179.43 91.25 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.453 -1.703 . . . . 71.329999999999998 106.926 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 m -48.44 -40.68 27.02 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 125.483 1.513 . . . . 72.450000000000003 112.912 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 25.8 t -65.14 -46.58 80.36 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 120.964 -0.294 . . . . 73.219999999999999 111.119 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 118' ' ' LYS . 9.6 p -71.13 -34.4 54.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 C-N-CA 119.73 -0.788 . . . . 61.119999999999997 110.047 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.8 -47.09 94.5 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 N-CA-C 110.443 -0.206 . . . . 63.030000000000001 110.443 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -57.64 -52.98 63.19 Favored 'General case' 0 C--O 1.257 1.467 0 O-C-N 123.852 0.72 . . . . 72.129999999999995 110.869 177.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.76 -40.64 99.07 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 114.979 -1.009 . . . . 61.439999999999998 112.811 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.39 -32.53 70.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.041 0.756 . . . . 70.019999999999996 113.041 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 72.9 mtm -62.06 -54.82 36.09 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.638 -0.825 . . . . 75.540000000000006 110.244 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.98 -62.95 1.24 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.848 -0.741 . . . . 72.349999999999994 112.325 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.04 -34.95 82.91 Favored Glycine 0 CA--C 1.497 -1.043 0 CA-C-N 116.101 -0.499 . . . . 54.43 112.303 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.79 -54.34 15.34 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 111.62 -0.592 . . . . 63.329999999999998 111.62 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.462 ' O ' HG12 ' A' ' 134' ' ' VAL . 72.5 m95 -59.99 -44.56 94.43 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 112.927 0.714 . . . . 75.409999999999997 112.927 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.402 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 25.0 m -58.62 -49.5 77.25 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.469 0.48 . . . . 64.530000000000001 110.507 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.94 -46.19 60.57 Favored Glycine 0 C--O 1.25 1.14 0 C-N-CA 120.983 -0.627 . . . . 65.340000000000003 112.85 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mm -66.54 -52.54 45.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 CA-C-O 119.334 -0.365 . . . . 73.340000000000003 111.411 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 130' ' ' TRP . 4.2 p -62.93 -36.16 74.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 117.955 0.343 . . . . 53.240000000000002 111.206 -175.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.57 -64.97 0.77 Allowed 'General case' 0 C--N 1.351 0.644 0 O-C-N 123.394 0.434 . . . . 74.010000000000005 110.359 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.95 -40.45 71.99 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 112.602 0.593 . . . . 72.430000000000007 112.602 -173.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.533 ' NH1' ' HB2' ' A' ' 37' ' ' LYS . 9.2 tpp85 -62.53 -51.68 66.45 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 120.566 -0.454 . . . . 64.230000000000004 110.829 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 49.9 mt -70.63 -41.08 72.67 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.328 -0.949 . . . . 75.439999999999998 111.679 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.628 ' NE ' ' HG3' ' A' ' 143' ' ' GLU . 1.1 tmt_? -60.63 -34.83 74.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.359 -0.608 . . . . 73.439999999999998 109.359 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -71.13 -42.56 69.04 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 119.995 -0.682 . . . . 73.340000000000003 111.434 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -66.26 -28.88 69.06 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 111.961 0.356 . . . . 70.129999999999995 111.961 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.431 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 21.4 m -88.74 -26.36 5.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 112.485 0.55 . . . . 75.040000000000006 112.485 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.628 ' HG3' ' NE ' ' A' ' 139' ' ' ARG . 5.7 mm-40 -97.37 -34.8 10.91 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.136 0.791 . . . . 72.030000000000001 113.136 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -131.38 -78.01 0.52 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.436 0.636 . . . . 63.299999999999997 110.523 -175.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 59.4 tp -178.27 157.06 1.03 Allowed 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 104.438 -2.43 . . . . 64.310000000000002 104.438 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.456 ' HB3' ' HB1' ' A' ' 141' ' ' ALA . 1.9 pp20? -82.58 162.85 21.81 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.749 -0.834 . . . . 65.450000000000003 108.749 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -157.58 150.63 23.34 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.064 -1.087 . . . . 64.439999999999998 108.064 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -78.22 83.24 4.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.164 -0.68 . . . . 73.400000000000006 109.164 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.35 -61.78 2.37 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.811 -1.086 . . . . 74.010000000000005 111.258 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -167.42 178.14 5.64 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.218 -1.401 . . . . 75.150000000000006 107.218 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -116.71 127.43 54.4 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.205 -1.405 . . . . 75.099999999999994 107.205 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 5.0 t60 . . . . . 0 C--N 1.296 -1.742 0 N-CA-C 107.14 -1.43 . . . . 71.129999999999995 107.14 179.504 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.505 -0.761 0 N-CA-C 109.395 -0.595 . . . . 71.349999999999994 109.395 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.38 107.06 9.53 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.745 -1.205 . . . . 70.329999999999998 107.745 175.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -85.07 -37.7 20.0 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.206 -0.906 . . . . 71.140000000000001 111.428 -172.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -86.53 92.02 8.74 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 113.725 1.009 . . . . 53.25 113.725 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -144.53 129.56 18.52 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 106.552 -1.647 . . . . 74.530000000000001 106.552 169.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -136.5 103.5 5.27 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-O 121.925 0.869 . . . . 75.25 112.368 -170.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.526 ' OD1' ' HA ' ' A' ' 108' ' ' PRO . 32.5 t-20 -131.1 55.92 1.82 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.444 -2.058 . . . . 63.32 105.444 175.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 66.19 39.31 4.28 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 112.148 -2.296 . . . . 51.130000000000003 110.798 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp 78.57 86.09 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 125.512 1.525 . . . . 75.299999999999997 114.531 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.67 148.22 46.7 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 122.668 2.245 . . . . 71.340000000000003 109.919 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.59 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 6.3 p-10 -58.4 142.02 49.66 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 113.994 1.109 . . . . 71.230000000000004 113.994 -172.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.7 tp -121.66 137.43 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 106.493 -1.669 . . . . 54.520000000000003 106.493 171.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.8 m -118.74 128.82 54.85 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.406 -0.961 . . . . 72.209999999999994 108.406 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -133.5 132.67 41.28 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 107.662 -1.236 . . . . 72.25 107.662 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 p -118.45 139.49 51.33 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-O 120.645 0.26 . . . . 53.140000000000001 110.836 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.43 134.88 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.767 -0.827 . . . . 75.400000000000006 108.767 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.03 121.8 42.87 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 120.967 0.413 . . . . 72.530000000000001 110.923 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.406 HD22 ' HB3' ' A' ' 138' ' ' LEU . 4.8 mp -101.76 137.66 39.76 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.638 -0.505 . . . . 42.020000000000003 109.638 -175.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -86.43 59.12 5.45 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.268 1.032 . . . . 75.340000000000003 110.959 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.21 161.14 46.34 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.984 -1.117 . . . . 61.210000000000001 107.984 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.94 152.16 82.16 Favored 'Trans proline' 0 C--O 1.26 1.609 0 C-N-CA 122.524 2.15 . . . . 73.420000000000002 110.442 176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -32.36 48.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.892 -0.594 . . . . 73.430000000000007 111.679 -176.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -65.15 -29.01 69.82 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.177 0.436 . . . . 75.409999999999997 112.177 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -78.92 -40.11 33.0 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.633 0.73 . . . . 72.340000000000003 110.37 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG11 HG22 ' A' ' 96' ' ' THR . 7.3 p -69.43 -39.55 78.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 116.072 -0.513 . . . . 73.329999999999998 109.749 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 43.1 t90 -58.12 -47.63 82.69 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.369 0.668 . . . . 75.450000000000003 111.928 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.77 -39.37 94.09 Favored 'General case' 0 C--O 1.214 -0.816 0 C-N-CA 119.576 -0.85 . . . . 72.239999999999995 109.749 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.9 m -59.23 -31.98 69.55 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-O 121.087 0.47 . . . . 72.329999999999998 111.629 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.685 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 25.2 m -107.19 17.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 112.946 0.721 . . . . 64.299999999999997 112.946 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.5 m -139.65 -3.35 1.49 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 112.301 0.482 . . . . 71.340000000000003 112.301 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.0 p -97.22 145.99 25.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.37 -0.974 . . . . 71.219999999999999 108.37 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 p -52.03 -54.06 34.55 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.86 0.689 . . . . 72.140000000000001 112.86 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.75 -38.78 87.3 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.444 -0.798 . . . . 73.040000000000006 110.533 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -41.61 95.99 Favored Glycine 0 C--O 1.247 0.939 0 N-CA-C 112.045 -0.422 . . . . 62.420000000000002 112.045 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.6 mt -69.83 -48.32 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 O-C-N 122.545 -0.385 . . . . 72.340000000000003 110.602 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.03 -52.8 62.49 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.706 0.632 . . . . 74.519999999999996 112.706 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.1 pttm 30.49 65.35 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.741 1.756 . . . . 75.0 115.741 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 65.69 -15.15 0.12 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.216 1.932 . . . . 74.299999999999997 116.216 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -65.91 -56.52 11.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.305 -0.628 . . . . 71.420000000000002 109.305 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 15.7 tpt -159.09 116.66 1.64 Allowed Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.257 -1.386 . . . . 61.020000000000003 107.257 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -72.04 89.28 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.09 1.86 . . . . 72.430000000000007 113.223 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.542 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . 19.8 m120 -114.48 144.47 43.28 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.196 -1.409 . . . . 72.329999999999998 107.196 173.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -96.63 76.76 2.86 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.011 0.91 . . . . 65.310000000000002 110.449 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 42' ' ' ASN . 94.5 m-85 -74.88 119.3 18.88 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.832 -1.531 . . . . 71.230000000000004 109.775 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -109.41 151.31 26.84 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.126 -1.064 . . . . 72.25 108.126 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -77.2 103.18 6.99 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.493 -1.299 . . . . 72.099999999999994 107.493 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -134.03 146.12 50.07 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.305 -0.998 . . . . 75.140000000000001 108.305 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -92.81 79.55 4.71 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.076 0.941 . . . . 64.430000000000007 108.778 173.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.64 47.37 0.53 Allowed Glycine 0 N--CA 1.416 -2.653 0 C-N-CA 119.361 -1.399 . . . . 52.32 112.863 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.16 129.88 34.72 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.471 -1.307 . . . . 74.439999999999998 107.471 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.05 153.5 35.22 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.497 -1.668 . . . . 70.099999999999994 106.497 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.408 ' HE2' ' SG ' ' A' ' 63' ' ' CYS . 98.3 m-85 -111.34 114.46 27.64 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.017 -0.734 . . . . 75.409999999999997 109.017 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -114.88 148.79 38.13 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.968 -0.753 . . . . 74.120000000000005 108.968 -175.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 79.74 1.65 2.16 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.755 1.622 . . . . 73.129999999999995 112.036 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -96.01 -46.42 6.52 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.311 0.577 . . . . 74.540000000000006 110.677 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.2 p -100.17 115.9 65.04 Favored Pre-proline 0 N--CA 1.421 -1.885 0 CA-C-N 115.504 -0.771 . . . . 74.230000000000004 110.177 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.63 -56.44 1.49 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.2 1.934 . . . . 64.319999999999993 109.878 176.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.6 t80 179.82 131.47 0.09 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.97 -1.122 . . . . 73.510000000000005 107.97 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.42 -96.65 0.53 Allowed Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 111.343 -0.703 . . . . 74.310000000000002 111.343 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.62 106.5 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.122 2.548 . . . . 61.409999999999997 111.56 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.5 m -99.72 136.44 20.27 Favored Pre-proline 0 C--N 1.298 -1.64 0 CA-C-N 115.719 -0.673 . . . . 74.319999999999993 111.474 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -86.6 -148.14 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.6 2.867 . . . . 72.420000000000002 111.085 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.408 ' SG ' ' HE2' ' A' ' 52' ' ' PHE . 8.4 p -102.47 147.41 26.77 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 120.838 0.351 . . . . 38.090000000000003 110.792 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -143.61 135.46 26.48 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.969 0.908 . . . . 65.530000000000001 108.685 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.1 t -90.59 136.88 22.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.617 -1.253 . . . . 73.239999999999995 107.617 175.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 tt -79.73 -61.11 2.1 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.981 -1.488 . . . . 65.150000000000006 106.981 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.0 150.02 9.38 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-N 115.15 -0.932 . . . . 75.530000000000001 109.018 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.98 119.03 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.484 0 CA-C-O 122.118 0.961 . . . . 73.239999999999995 109.565 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 11.4 mm100 -94.54 141.24 28.82 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 114.961 -1.018 . . . . 74.030000000000001 109.316 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 123.01 84.84 Favored Pre-proline 0 C--N 1.272 -2.78 0 CA-C-N 114.312 -1.313 . . . . 74.430000000000007 108.968 -166.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo 7.3 50.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.346 1 C-N-CA 127.638 5.559 . . . . 60.399999999999999 116.339 -160.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 p -139.81 -37.53 0.48 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.177 -0.919 . . . . 73.340000000000003 112.077 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 35.3 tt0 -150.29 148.05 28.39 Favored 'General case' 0 C--O 1.2 -1.532 0 C-N-CA 119.066 -1.053 . . . . 64.239999999999995 110.339 -176.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.573 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -141.37 132.99 27.07 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.831 -1.174 . . . . 38.090000000000003 107.831 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 p -141.03 129.13 22.06 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 120.695 -0.402 . . . . 70.200000000000003 112.019 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -142.8 153.55 43.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.811 0.338 . . . . 72.310000000000002 111.672 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -124.48 124.95 43.4 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 125.012 1.325 . . . . 73.519999999999996 107.783 -173.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 18.6 p-90 -143.58 155.78 44.39 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.152 -1.019 . . . . 74.209999999999994 113.232 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 76.18 160.4 0.22 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.852 1.661 . . . . 75.530000000000001 112.582 173.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 m -68.3 -30.93 70.04 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.207 1.003 . . . . 63.409999999999997 110.646 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -71.27 -21.49 62.08 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.033 -0.728 . . . . 73.25 109.033 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.66 80.36 0.68 Allowed Glycine 0 N--CA 1.426 -1.987 0 CA-C-N 114.882 -1.054 . . . . 70.519999999999996 114.641 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -104.92 128.59 53.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.365 -0.606 . . . . 74.129999999999995 109.365 173.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.24 111.78 29.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.625 -1.25 . . . . 72.430000000000007 107.625 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.26 149.12 19.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 120.477 -0.489 . . . . 75.319999999999993 110.377 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.42 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 39.2 m -129.47 140.77 51.18 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.491 -0.929 . . . . 72.430000000000007 108.491 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.685 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 16.0 m-85 -118.35 142.59 47.37 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.844 -1.539 . . . . 74.319999999999993 106.844 174.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.425 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 69.3 mt-30 -125.1 137.57 54.18 Favored 'General case' 0 C--N 1.268 -2.958 0 O-C-N 123.472 0.482 . . . . 73.310000000000002 110.532 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -117.36 120.06 37.01 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.457 -0.792 . . . . 75.430000000000007 109.179 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -114.06 116.71 29.58 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.586 -0.894 . . . . 71.049999999999997 108.586 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.01 118.98 23.88 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.876 0.846 . . . . 70.239999999999995 110.919 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 96.4 mt -123.15 153.11 40.46 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.449 -0.945 . . . . 71.129999999999995 108.449 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.97 50.38 4.15 Favored Glycine 0 C--N 1.287 -2.17 0 C-N-CA 120.892 -0.67 . . . . 72.549999999999997 112.411 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -179.41 -32.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.343 0.592 . . . . 72.230000000000004 109.446 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 9.6 ptpt -156.27 175.05 14.5 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.202 -1.407 . . . . 71.329999999999998 107.202 -175.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.433 HG22 HG11 ' A' ' 25' ' ' VAL . 87.8 m -119.79 128.19 53.49 Favored 'General case' 0 C--N 1.272 -2.771 0 N-CA-C 108.616 -0.883 . . . . 70.209999999999994 108.616 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.6 107.32 3.01 Favored Glycine 0 N--CA 1.412 -2.962 0 N-CA-C 109.868 -1.293 . . . . 38.090000000000003 109.868 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.478 ' CE1' HG12 ' A' ' 29' ' ' VAL . 92.8 t80 -100.54 133.35 45.11 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.939 -0.763 . . . . 74.430000000000007 108.939 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 70.4 m -126.31 125.37 42.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 119.049 -1.061 . . . . 72.430000000000007 109.161 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -104.02 141.87 35.45 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.443 -0.799 . . . . 65.540000000000006 108.851 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 100' ' ' LEU . 3.5 mp -135.65 123.93 37.98 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 N-CA-C 106.024 -1.843 . . . . 70.010000000000005 106.024 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.59 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 9.7 t60 -120.55 113.73 20.7 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.486 -1.302 . . . . 55.219999999999999 107.486 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.8 t -132.57 153.84 50.6 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.543 -1.28 . . . . 74.310000000000002 107.543 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.15 167.96 20.81 Favored Glycine 0 N--CA 1.415 -2.74 0 N-CA-C 109.939 -1.265 . . . . 62.43 109.939 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 67.2 t90 -66.06 -39.32 90.0 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 106.998 -1.482 . . . . 71.109999999999999 106.998 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt 64.33 95.85 0.05 OUTLIER 'General case' 0 C--O 1.246 0.874 0 N-CA-C 115.912 1.819 . . . . 73.200000000000003 115.912 171.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -84.45 120.35 74.17 Favored Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 105.745 -1.946 . . . . 73.040000000000006 105.745 165.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.526 ' HA ' ' OD1' ' A' ' 7' ' ' ASN . 51.8 Cg_endo -65.58 78.75 0.26 Allowed 'Trans proline' 0 C--O 1.241 0.628 0 C-N-CA 123.103 2.535 . . . . 63.299999999999997 115.855 -170.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -143.92 -93.54 0.11 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.47 -0.787 . . . . 71.439999999999998 110.19 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -139.32 -64.73 0.49 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.04 0.448 . . . . 71.219999999999999 111.994 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.471 HG23 ' H ' ' A' ' 113' ' ' GLY . 12.3 p -118.21 155.33 20.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 116.128 -0.487 . . . . 75.340000000000003 111.503 -170.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.498 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -61.85 -36.81 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.57 0.7 . . . . 74.010000000000005 110.619 174.044 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.471 ' H ' HG23 ' A' ' 111' ' ' VAL . . . 149.3 -108.35 0.4 Allowed Glycine 0 N--CA 1.409 -3.105 0 N-CA-C 108.758 -1.737 . . . . 72.349999999999994 108.758 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -134.85 32.35 3.25 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.856 0.36 . . . . 74.030000000000001 111.318 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.78 -22.88 59.2 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 112.825 0.676 . . . . 71.409999999999997 112.825 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -153.92 -73.24 0.13 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.61 -0.268 . . . . 53.32 110.48 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -156.73 -90.03 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 111.765 0.283 . . . . 72.209999999999994 111.765 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -121.03 136.37 55.0 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.051 -1.463 . . . . 74.030000000000001 107.051 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.25 -37.55 75.14 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 115.114 1.524 . . . . 62.219999999999999 115.114 -174.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.89 -46.17 79.35 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.401 0.519 . . . . 72.299999999999997 112.401 177.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.2 m -69.97 -33.84 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.191 -0.604 . . . . 73.219999999999999 109.776 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 126' ' ' MET . 53.6 t -64.64 -43.11 96.67 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 CA-C-N 115.732 -0.667 . . . . 74.129999999999995 111.113 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -39.82 93.32 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.214 -1.032 . . . . 72.209999999999994 108.214 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -59.6 -47.71 89.59 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-N 115.571 -0.74 . . . . 41.210000000000001 112.021 177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -66.43 -34.41 77.9 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.274 -0.463 . . . . 71.019999999999996 111.857 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 23.5 mmt -62.06 -52.5 63.69 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 110.265 -0.272 . . . . 45.43 110.265 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.45 -52.78 64.19 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.837 0.31 . . . . 74.109999999999999 111.837 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.51 -45.99 87.27 Favored Glycine 0 C--O 1.26 1.744 0 C-N-CA 120.834 -0.698 . . . . 64.439999999999998 112.6 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.47 62.56 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 111.938 -0.465 . . . . 72.200000000000003 111.938 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -65.45 -22.94 66.81 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.555 0.576 . . . . 75.329999999999998 112.555 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.8 m -64.91 -55.69 17.78 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.761 -0.829 . . . . 54.520000000000003 108.761 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.45 -44.47 73.1 Favored Glycine 0 C--O 1.252 1.241 0 C-N-CA 120.648 -0.787 . . . . 65.25 113.591 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.19 -51.91 62.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 122.231 0.212 . . . . 73.030000000000001 111.464 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.457 ' HA ' HD21 ' A' ' 138' ' ' LEU . 78.9 t -63.66 -44.62 98.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.806 -0.358 . . . . 72.340000000000003 111.595 -177.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -55.56 -64.83 0.72 Allowed 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.794 0.684 . . . . 71.319999999999993 111.803 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -82.73 -31.83 28.23 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 119.41 -0.916 . . . . 73.319999999999993 113.202 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.422 HH11 ' HB1' ' A' ' 141' ' ' ALA . 0.2 OUTLIER -74.01 -40.2 63.07 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 118.024 -1.47 . . . . 72.510000000000005 110.179 -176.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.457 HD21 ' HA ' ' A' ' 134' ' ' VAL . 4.2 mm? -69.41 -46.59 66.46 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 119.552 -0.859 . . . . 75.450000000000003 110.045 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 0.9 OUTLIER -63.76 -36.16 82.97 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 115.759 -0.655 . . . . 74.400000000000006 110.658 -178.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -70.76 -37.47 73.4 Favored 'General case' 0 C--O 1.198 -1.654 0 O-C-N 121.703 -0.623 . . . . 71.340000000000003 112.27 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.422 ' HB1' HH11 ' A' ' 137' ' ' ARG . . . -64.61 -27.98 69.31 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.254 0.549 . . . . 62.219999999999999 110.838 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 16.6 m -91.81 -22.58 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.895 -0.593 . . . . 55.32 111.953 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 61.2 mt-10 -91.85 -32.37 15.35 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.429 -0.508 . . . . 62.539999999999999 111.934 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -77.76 90.13 4.03 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.932 1.349 . . . . 72.219999999999999 110.83 -174.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.13 -149.88 0.27 Allowed 'General case' 0 C--N 1.277 -2.561 1 N-CA-C 99.102 -4.407 . . . . 72.349999999999994 99.102 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -85.4 80.1 9.23 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 120.077 1.308 . . . . 71.219999999999999 110.527 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -148.23 143.59 27.1 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.047 -1.094 . . . . 71.219999999999999 108.047 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -122.41 105.92 10.6 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.693 -0.855 . . . . 75.329999999999998 108.693 172.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -114.06 121.91 45.28 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 116.111 -0.495 . . . . 74.450000000000003 109.98 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -102.43 137.02 41.23 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.36 -0.978 . . . . 74.239999999999995 108.36 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -93.11 -60.34 1.82 Allowed 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.985 -0.746 . . . . 72.010000000000005 108.985 -173.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 . . . . . 0 N--CA 1.418 -2.03 0 N-CA-C 105.92 -1.881 . . . . 72.439999999999998 105.92 177.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 mmt . . . . . 0 CA--C 1.498 -1.057 0 N-CA-C 109.58 -0.526 . . . . 74.5 109.58 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.36 143.44 23.57 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 123.972 0.795 . . . . 71.129999999999995 111.861 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -80.41 -29.14 37.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.341 0.591 . . . . 74.319999999999993 109.526 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.6 -169.19 2.38 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.229 -1.026 . . . . 72.299999999999997 108.229 175.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.06 168.55 10.01 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.352 0.596 . . . . 54.420000000000002 110.453 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -109.3 96.41 6.28 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 114.785 -1.098 . . . . 71.099999999999994 110.782 -173.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 t30 60.03 35.41 21.43 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 124.076 0.95 . . . . 70.439999999999998 111.051 171.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 56.97 67.4 0.99 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.9 -1.5 . . . . 65.099999999999994 112.944 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.0 tp 68.47 90.93 0.08 OUTLIER Pre-proline 0 C--O 1.243 0.744 0 C-N-CA 124.765 1.226 . . . . 74.510000000000005 111.644 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.59 -164.97 0.21 Allowed 'Trans proline' 0 N--CA 1.436 -1.861 0 C-N-CA 122.38 2.054 . . . . 72.450000000000003 110.356 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -64.97 103.93 0.79 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.129 0.966 . . . . 75.140000000000001 111.837 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 50.0 mm -98.06 123.16 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 106.023 -1.843 . . . . 74.219999999999999 106.023 174.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 12.7 t -117.39 140.96 48.9 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 109.162 -0.681 . . . . 63.420000000000002 109.162 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -146.71 132.33 18.82 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.787 -1.19 . . . . 72.430000000000007 107.787 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.7 p -117.87 141.33 48.54 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 109.48 -0.563 . . . . 71.099999999999994 109.48 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.71 142.77 8.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.075 -1.084 . . . . 65.129999999999995 108.075 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 p -106.23 128.72 54.16 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.298 0.571 . . . . 71.5 111.509 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 138' ' ' LEU . 5.7 mp -103.57 140.11 37.97 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.857 -0.611 . . . . 75.420000000000002 111.079 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -81.73 46.22 0.96 Allowed 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 124.277 1.031 . . . . 74.129999999999995 110.686 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.26 158.89 57.2 Favored Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 109.202 -0.666 . . . . 73.329999999999998 109.202 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.37 153.32 71.4 Favored 'Trans proline' 0 C--O 1.259 1.544 0 C-N-CA 122.77 2.313 . . . . 74.200000000000003 110.7 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -60.15 -32.58 50.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.798 -0.637 . . . . 65.400000000000006 111.482 -174.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.75 -39.29 93.91 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 120.698 -0.401 . . . . 74.340000000000003 111.656 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -70.9 -39.18 72.9 Favored 'General case' 0 C--O 1.212 -0.916 0 C-N-CA 120.996 -0.282 . . . . 74.040000000000006 111.133 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.415 HG23 ' HB ' ' A' ' 96' ' ' THR . 47.2 t -68.02 -41.17 84.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.412 0.625 . . . . 74.120000000000005 109.842 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.576 ' CZ2' ' HD3' ' A' ' 71' ' ' PRO . 29.4 t90 -63.66 -46.72 84.32 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.492 -1.231 . . . . 70.430000000000007 110.177 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -70.23 -29.41 66.22 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 121.036 -0.266 . . . . 74.530000000000001 111.491 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.526 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 39.7 m -56.14 -33.26 65.01 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-O 121.129 0.49 . . . . 73.140000000000001 111.735 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -108.18 16.6 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 O-C-N 121.406 -0.809 . . . . 74.519999999999996 112.044 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.43 ' HA ' HD13 ' A' ' 35' ' ' ILE . 42.5 p -137.61 0.32 2.24 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.788 0.662 . . . . 73.140000000000001 112.788 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.7 p -107.89 169.39 8.64 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 121.698 -0.627 . . . . 73.200000000000003 111.595 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.2 t -63.01 -44.71 95.25 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.914 -0.585 . . . . 74.129999999999995 109.744 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.09 -45.17 78.07 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.686 0.616 . . . . 75.329999999999998 111.165 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 28' ' ' THR . . . -72.38 -48.03 26.16 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.909 -0.663 . . . . 64.019999999999996 114.051 -175.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 30' ' ' SER . 80.3 mt -69.04 -34.12 62.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 116.932 0.366 . . . . 52.25 111.114 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 40' ' ' MET . . . -52.89 -39.18 62.49 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.953 -0.567 . . . . 44.119999999999997 111.463 176.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt 70.88 -60.29 0.51 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.029 0.932 . . . . 74.519999999999996 113.285 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -103.74 -172.21 2.07 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.807 -0.812 . . . . 73.549999999999997 108.807 -174.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.435 ' HB3' ' CE1' ' A' ' 152' ' ' HIS . 58.8 t80 -81.29 79.36 7.94 Favored 'General case' 0 C--O 1.248 1.0 0 N-CA-C 114.925 1.454 . . . . 74.519999999999996 114.925 -171.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.437 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 16.8 ptp 171.02 117.12 0.05 OUTLIER Pre-proline 0 C--N 1.312 -1.044 0 C-N-CA 126.993 2.117 . . . . 73.530000000000001 107.975 169.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.09 149.66 52.76 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.982 1.788 . . . . 65.299999999999997 111.16 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -123.94 164.34 19.5 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.757 -1.571 . . . . 74.120000000000005 106.757 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.12 65.27 8.67 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.76 0.79 . . . . 74.230000000000004 112.165 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -108.62 132.78 53.55 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.4 -0.818 . . . . 74.319999999999993 109.865 171.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -139.03 150.14 45.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.19 -1.041 . . . . 73.439999999999998 108.19 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.423 HD12 ' CZ2' ' A' ' 26' ' ' TRP . 6.0 tt -75.74 104.2 6.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.766 -0.827 . . . . 73.340000000000003 108.766 -178.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 14.0 tppt? -133.97 146.07 50.12 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.882 -1.525 . . . . 72.450000000000003 106.882 172.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.4 ' CA ' HG11 ' A' ' 68' ' ' VAL . 8.1 pt-20 -79.57 54.79 1.84 Allowed 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 122.024 0.916 . . . . 72.099999999999994 109.478 170.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 130.01 64.52 0.1 Allowed Glycine 0 N--CA 1.406 -3.312 0 N-CA-C 109.977 -1.249 . . . . 74.230000000000004 109.977 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -100.0 106.35 18.12 Favored 'General case' 0 CA--C 1.47 -2.104 0 N-CA-C 106.355 -1.72 . . . . 62.130000000000003 106.355 178.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.45 135.44 47.14 Favored 'General case' 0 C--N 1.272 -2.796 0 C-N-CA 119.417 -0.913 . . . . 72.329999999999998 110.676 175.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -122.29 125.32 45.73 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 104.167 -2.531 . . . . 74.319999999999993 104.167 174.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -109.56 140.14 43.72 Favored 'General case' 0 C--N 1.283 -2.295 0 C-N-CA 119.435 -0.906 . . . . 75.230000000000004 111.006 -171.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.9 tp -138.8 112.95 8.65 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 103.695 -2.705 . . . . 73.349999999999994 103.695 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -70.05 138.33 52.0 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 123.395 0.434 . . . . 74.0 110.236 -173.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 m 72.42 89.92 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.746 1.218 . . . . 73.219999999999999 111.693 -176.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.45 123.41 11.1 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 122.148 1.899 . . . . 74.329999999999998 111.573 178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -128.29 -70.93 0.67 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.442 -1.318 . . . . 75.310000000000002 107.442 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.64 -84.75 1.77 Allowed Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 107.633 -2.187 . . . . 51.219999999999999 107.633 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -65.73 122.4 10.0 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 121.635 1.557 . . . . 63.509999999999998 109.067 172.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.546 ' OG ' ' HB ' ' A' ' 80' ' ' THR . 20.1 m -114.12 155.46 45.46 Favored Pre-proline 0 C--N 1.286 -2.192 0 N-CA-C 108.667 -0.864 . . . . 44.130000000000003 108.667 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.21 100.34 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.034 1.822 . . . . 62.32 112.347 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 24.7 p -88.82 143.57 26.81 Favored 'General case' 0 C--O 1.251 1.15 0 N-CA-C 107.45 -1.315 . . . . 71.209999999999994 107.45 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 34.4 mtmt -143.64 139.91 29.84 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 109.427 -0.583 . . . . 74.140000000000001 109.427 -172.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.447 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 41.8 t -90.65 129.44 41.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 N-CA-C 104.942 -2.244 . . . . 63.43 104.942 167.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.6 tp -75.06 -59.2 2.84 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.912 -0.773 . . . . 75.450000000000003 108.912 -176.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.53 140.67 14.0 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.955 -1.02 . . . . 64.209999999999994 109.274 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.4 HG11 ' CA ' ' A' ' 48' ' ' GLU . 9.5 p -119.28 121.0 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 N-CA-C 107.604 -1.258 . . . . 71.510000000000005 107.604 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 14.7 mm100 -96.55 142.81 28.17 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 114.56 -1.2 . . . . 74.219999999999999 109.603 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.71 120.99 73.16 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 107.508 -1.293 . . . . 75.450000000000003 107.508 -164.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HD3' ' CZ2' ' A' ' 26' ' ' TRP . 16.6 Cg_exo -7.54 64.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.294 1 C-N-CA 126.527 4.818 . . . . 75.099999999999994 116.844 -154.548 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 p -140.26 -40.47 0.43 Allowed 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 113.237 -1.801 . . . . 61.049999999999997 109.767 175.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 36.9 tt0 -150.54 149.22 29.65 Favored 'General case' 0 C--O 1.195 -1.81 0 C-N-CA 119.405 -0.918 . . . . 74.400000000000006 110.259 -175.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 tp -145.91 128.18 15.8 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.907 -0.775 . . . . 74.400000000000006 108.907 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.413 ' OG ' HG21 ' A' ' 86' ' ' THR . 13.6 m -134.23 127.23 31.48 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.774 -0.37 . . . . 74.310000000000002 111.022 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.521 ' CE2' ' HE2' ' A' ' 87' ' ' PHE . 54.8 p90 -138.93 155.66 47.87 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 112.113 0.412 . . . . 71.299999999999997 112.113 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -122.76 125.88 46.38 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.003 -1.48 . . . . 71.400000000000006 107.003 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.417 ' CE3' ' HB2' ' A' ' 79' ' ' ASP . 15.7 p-90 -139.83 162.07 36.05 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.367 -0.933 . . . . 73.030000000000001 112.751 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.417 ' HB2' ' CE3' ' A' ' 78' ' ' TRP . 19.0 t70 72.89 161.84 0.25 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.612 1.565 . . . . 62.520000000000003 112.338 173.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.546 ' HB ' ' OG ' ' A' ' 61' ' ' SER . 7.4 t -73.11 -23.18 60.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.392 0.277 . . . . 73.040000000000006 111.274 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -34.25 76.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 110.154 -0.313 . . . . 71.450000000000003 110.154 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.72 75.64 1.29 Allowed Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.82 -0.627 . . . . 61.200000000000003 111.855 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -102.02 128.46 48.45 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.408 -0.96 . . . . 75.540000000000006 108.408 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.4 t -111.43 107.72 23.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 108.347 -0.983 . . . . 70.420000000000002 108.347 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.54 144.98 17.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.312 0.577 . . . . 74.219999999999999 110.363 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.43 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 39.9 m -136.42 134.23 37.52 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.801 -0.636 . . . . 73.120000000000005 109.407 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.521 ' HE2' ' CE2' ' A' ' 76' ' ' PHE . 39.8 m-85 -120.93 143.5 48.94 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.251 -1.018 . . . . 71.25 108.251 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 93.0 mt-30 -124.67 139.99 53.35 Favored 'General case' 0 C--N 1.278 -2.52 0 O-C-N 123.516 0.51 . . . . 72.0 110.676 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -122.6 120.22 33.13 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.722 -0.672 . . . . 71.329999999999998 110.458 -174.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -113.31 127.5 56.17 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 123.308 0.643 . . . . 74.200000000000003 109.81 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.72 120.68 26.68 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.731 -0.668 . . . . 75.400000000000006 111.366 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.6 mt -125.47 153.33 43.7 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.238 -0.892 . . . . 75.150000000000006 108.632 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.99 61.43 4.33 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 121.755 -0.26 . . . . 55.130000000000003 113.35 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 168.65 -54.49 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 125.21 1.404 . . . . 51.539999999999999 107.854 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -126.43 174.07 8.9 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 114.111 -1.404 . . . . 62.109999999999999 109.108 -167.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.415 ' HB ' HG23 ' A' ' 25' ' ' VAL . 87.7 m -119.89 130.84 55.03 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.889 -0.782 . . . . 74.530000000000001 108.889 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.58 111.26 3.61 Favored Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 110.258 -1.137 . . . . 74.420000000000002 110.258 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -103.45 131.43 50.55 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 109.412 -0.588 . . . . 71.409999999999997 109.412 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 84.8 m -124.29 128.02 48.51 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.982 -1.118 . . . . 74.340000000000003 107.982 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.493 HD21 ' CE1' ' A' ' 87' ' ' PHE . 2.9 tm? -102.25 139.29 38.05 Favored 'General case' 0 N--CA 1.397 -3.079 0 N-CA-C 108.532 -0.914 . . . . 75.140000000000001 108.532 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 3.8 mp -135.68 124.43 39.1 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.268 0 N-CA-C 106.258 -1.756 . . . . 71.340000000000003 106.258 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -121.04 131.92 54.57 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.362 -0.977 . . . . 61.329999999999998 108.362 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.3 m -142.69 138.94 30.94 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.673 -1.232 . . . . 72.120000000000005 107.673 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.11 -167.01 22.2 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.227 -0.987 . . . . 65.230000000000004 110.731 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -79.78 102.49 9.09 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.861 -0.792 . . . . 74.450000000000003 108.861 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -48.04 -41.26 25.26 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 116.692 2.108 . . . . 65.340000000000003 116.692 -173.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 59.73 -177.77 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.532 0 CA-C-N 118.449 0.568 . . . . 75.409999999999997 110.687 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -100.88 33.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.274 1.983 . . . . 63.549999999999997 109.068 167.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -125.4 172.36 9.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.183 -0.462 . . . . 70.120000000000005 110.288 -172.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -92.93 -40.62 10.49 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 117.915 0.325 . . . . 71.150000000000006 111.262 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.25 150.89 11.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 108.516 -0.92 . . . . 64.450000000000003 108.516 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.0 pt -58.76 -32.59 47.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 112.853 0.686 . . . . 61.100000000000001 112.853 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.84 -122.41 6.94 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.022 -1.085 . . . . 75.420000000000002 111.978 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -100.4 10.27 41.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.13 0.491 . . . . 74.040000000000006 109.878 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.63 -34.91 79.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.987 -1.116 . . . . 53.350000000000001 107.987 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -166.38 122.84 1.28 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.886 -1.894 . . . . 60.130000000000003 105.886 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.1 166.68 16.44 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.586 0.958 . . . . 74.140000000000001 113.586 -174.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm 71.24 87.22 0.12 Allowed 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.705 -1.134 . . . . 63.240000000000002 112.902 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.2 p -56.43 -39.81 73.72 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.469 1.108 . . . . 62.109999999999999 112.78 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 123' ' ' ARG . 3.2 p -68.18 -39.25 82.57 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.597 0.713 . . . . 75.510000000000005 110.646 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.07 -45.49 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 115.707 -0.679 . . . . 73.200000000000003 109.42 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.401 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 75.9 t -55.78 -37.56 47.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 O-C-N 123.642 0.589 . . . . 65.409999999999997 110.204 175.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 120' ' ' SER . 18.5 tpp180 -57.37 -58.65 7.33 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.184 0.594 . . . . 70.299999999999997 110.378 177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.68 -43.8 93.64 Favored Glycine 0 CA--C 1.494 -1.244 0 CA-C-N 115.678 -0.692 . . . . 75.329999999999998 112.817 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.439 ' O ' ' HA3' ' A' ' 129' ' ' GLY . 2.7 tmmm? -65.52 -38.56 90.02 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 112.66 0.615 . . . . 75.209999999999994 112.66 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 25.7 mmt -72.84 -45.9 55.88 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.231 -0.988 . . . . 60.520000000000003 110.269 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -67.91 -63.78 0.99 Allowed 'General case' 0 C--O 1.257 1.455 0 CA-C-O 121.343 0.592 . . . . 71.200000000000003 111.849 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -75.75 -33.41 51.53 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 115.779 -0.646 . . . . 63.520000000000003 112.219 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -66.77 -50.09 50.42 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 111.67 -0.572 . . . . 60.399999999999999 111.67 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -64.39 -31.17 72.27 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 120.054 -0.658 . . . . 73.420000000000002 111.616 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.1 m -58.47 -57.35 13.35 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 120.71 -0.396 . . . . 71.109999999999999 110.896 173.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.62 -46.7 37.9 Favored Glycine 0 C--O 1.242 0.597 0 CA-C-N 116.07 -0.514 . . . . 37.590000000000003 113.742 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.0 mt -62.57 -51.24 74.58 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 119.693 -0.194 . . . . 71.019999999999996 110.976 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.651 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 68.6 t -59.37 -43.97 91.45 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 120.786 -0.366 . . . . 74.319999999999993 111.483 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -56.1 -60.13 3.93 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 111.777 0.288 . . . . 71.450000000000003 111.777 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -77.26 -46.45 23.09 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.244 0.831 . . . . 75.349999999999994 113.244 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -64.51 -39.16 93.26 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.425 0.557 . . . . 75.239999999999995 111.725 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 3.9 mm? -67.25 -49.73 63.29 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.454 -0.498 . . . . 62.43 110.536 176.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -62.43 -32.54 73.41 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.952 -0.567 . . . . 74.209999999999994 109.827 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -76.51 -39.66 52.36 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 113.201 0.815 . . . . 65.430000000000007 113.201 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.32 -23.71 67.08 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.217 0.532 . . . . 71.239999999999995 111.177 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.3 m -90.24 -34.11 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 120.209 -0.596 . . . . 73.209999999999994 111.91 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.48 -31.44 26.51 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.169 0.803 . . . . 74.129999999999995 113.169 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -139.2 107.38 5.75 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.092 0.472 . . . . 71.120000000000005 109.896 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.05 159.45 16.83 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.286 -1.005 . . . . 71.230000000000004 108.286 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.85 115.15 16.37 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.266 0.555 . . . . 74.230000000000004 110.111 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -69.41 -33.81 73.55 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.171 -0.922 . . . . 72.329999999999998 111.142 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -153.66 174.55 14.35 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.365 -1.346 . . . . 72.549999999999997 107.365 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -68.82 91.81 0.47 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 122.106 0.955 . . . . 74.340000000000003 109.631 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -90.7 117.61 29.49 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.3 -0.864 . . . . 74.420000000000002 109.216 -174.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -81.18 143.75 32.13 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.254 -0.579 . . . . 73.430000000000007 109.445 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.435 ' CE1' ' HB3' ' A' ' 39' ' ' PHE . 1.3 p-80 . . . . . 0 C--N 1.304 -1.4 0 CA-C-N 115.646 -0.707 . . . . 73.120000000000005 111.357 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 112.954 0.724 . . . . 74.430000000000007 112.954 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.05 85.02 2.25 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.318 0.58 . . . . 62.329999999999998 111.784 -177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -99.21 -28.02 13.53 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.652 -0.704 . . . . 61.200000000000003 109.629 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -67.91 121.43 16.02 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.351 -0.84 . . . . 73.010000000000005 109.775 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -120.26 115.38 23.48 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 105.747 -1.945 . . . . 71.230000000000004 105.747 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 21.0 mt-10 -132.12 -171.31 2.6 Favored 'General case' 0 N--CA 1.388 -3.558 0 N-CA-C 108.4 -0.963 . . . . 75.239999999999995 108.4 -169.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -175.84 -35.19 0.01 OUTLIER 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 104.33 -2.47 . . . . 71.109999999999999 104.33 -175.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 6' ' ' GLU . . . -127.2 179.07 5.63 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 103.945 -2.613 . . . . 71.409999999999997 103.945 168.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.503 HD22 ' CZ3' ' A' ' 83' ' ' TRP . 4.4 pp -100.38 130.2 26.33 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 118.982 -1.087 . . . . 73.0 113.109 -175.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 49.3 Cg_endo -97.62 -160.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.651 2.901 . . . . 62.119999999999997 110.317 173.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 12.0 p-10 -81.6 97.46 7.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.607 1.194 . . . . 72.420000000000002 108.813 173.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 61.6 mt -91.68 128.25 43.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 114.69 -1.141 . . . . 54.450000000000003 109.019 -173.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.573 ' O ' ' HD2' ' A' ' 14' ' ' LYS . 13.6 t -120.08 140.79 50.5 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 119.648 -0.821 . . . . 75.230000000000004 110.556 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.573 ' HD2' ' O ' ' A' ' 13' ' ' THR . 5.9 mptp? -137.72 145.38 42.45 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.349 -1.352 . . . . 70.129999999999995 107.349 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -129.81 136.63 49.81 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 118.522 0.601 . . . . 43.350000000000001 110.514 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.11 141.38 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 110.06 -0.348 . . . . 74.109999999999999 110.06 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 p -101.04 135.4 42.56 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.073 0.463 . . . . 65.310000000000002 112.09 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 139' ' ' ARG . 3.0 mm? -104.15 140.07 38.32 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.35 0.66 . . . . 72.400000000000006 110.219 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -86.11 34.22 0.62 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.136 0.494 . . . . 70.109999999999999 110.261 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -133.88 164.73 41.92 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.38 -0.6 . . . . 75.519999999999996 109.38 -174.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.487 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -66.6 153.03 79.46 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.286 1.99 . . . . 72.239999999999995 111.025 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.11 -33.26 42.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.341 -0.845 . . . . 72.219999999999999 112.452 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.19 -27.68 62.72 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.451 -0.5 . . . . 75.099999999999994 111.223 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.0 tmtm? -79.83 -31.99 40.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.958 -1.127 . . . . 71.319999999999993 107.958 -177.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.4 t -71.17 -41.35 75.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.053 -1.092 . . . . 64.209999999999994 108.053 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.651 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 77.5 t90 -60.69 -47.17 87.47 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.639 -1.164 . . . . 74.450000000000003 111.269 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 10.5 pt-20 -59.97 -36.61 77.49 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 109.003 -0.74 . . . . 63.140000000000001 109.003 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 28' ' ' THR . 61.9 m -65.91 -7.54 17.15 Favored 'General case' 0 CA--C 1.573 1.836 0 CA-C-O 121.417 0.627 . . . . 74.239999999999995 112.646 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.569 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 11.9 m -131.48 17.19 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 O-C-N 121.306 -0.871 . . . . 54.020000000000003 111.63 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.3 m -145.32 10.03 1.26 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 116.29 -0.414 . . . . 62.310000000000002 111.833 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.3 p -110.75 -178.32 3.45 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.225 -0.657 . . . . 72.329999999999998 109.225 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.6 p -56.64 -62.46 1.71 Allowed 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 123.711 0.632 . . . . 73.030000000000001 111.999 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.43 -31.24 71.87 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.27 -0.877 . . . . 74.099999999999994 110.844 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.89 -48.66 20.24 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.04 -1.076 . . . . 64.439999999999998 112.861 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.416 HG21 ' CE2' ' A' ' 76' ' ' PHE . 51.6 mt -68.95 -34.5 64.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 123.13 0.572 . . . . 73.400000000000006 110.895 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.41 -29.81 26.13 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-N 115.526 -0.761 . . . . 73.140000000000001 112.043 173.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt 78.8 -57.42 0.44 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.156 1.382 . . . . 74.5 110.589 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -122.74 167.12 13.87 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 105.982 -1.859 . . . . 75.450000000000003 105.982 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -71.33 92.61 1.06 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.261 0.467 . . . . 73.109999999999999 112.261 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 80.7 mmm -157.22 138.55 9.7 Favored Pre-proline 0 C--N 1.312 -1.032 0 C-N-CA 125.816 1.647 . . . . 70.239999999999995 107.446 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.96 98.99 0.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.819 1.68 . . . . 70.129999999999995 110.825 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -101.43 151.2 22.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.048 -1.464 . . . . 62.020000000000003 107.048 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -90.56 70.98 6.87 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.766 0.793 . . . . 75.219999999999999 109.46 -175.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -58.9 137.19 57.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.093 -1.412 . . . . 75.510000000000005 110.711 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.86 121.88 15.67 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.928 -1.508 . . . . 72.329999999999998 106.928 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.8 tp -94.42 101.78 13.72 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.362 -1.718 . . . . 65.219999999999999 106.362 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 tpmt? -134.94 145.58 48.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.263 -1.384 . . . . 63.399999999999999 107.263 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.02 61.71 7.0 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 122.69 1.234 . . . . 74.409999999999997 109.248 171.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.87 87.84 0.8 Allowed Glycine 0 N--CA 1.414 -2.783 0 CA-C-N 114.404 -1.271 . . . . 63.350000000000001 110.48 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.2 122.68 45.86 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.282 -1.748 . . . . 71.420000000000002 106.282 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.66 152.98 49.44 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 109.513 -0.551 . . . . 74.099999999999994 109.513 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -95.74 124.66 39.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.822 0.82 . . . . 73.230000000000004 110.961 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -142.65 155.87 44.99 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.206 -1.776 . . . . 70.319999999999993 106.206 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.296 6.8 mp -83.02 72.03 10.1 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 122.239 1.019 . . . . 64.319999999999993 113.705 -175.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -140.65 8.97 2.19 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 112.82 -1.991 . . . . 72.019999999999996 106.742 170.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.7 m -144.45 151.3 50.49 Favored Pre-proline 0 N--CA 1.426 -1.639 0 N-CA-C 105.229 -2.137 . . . . 64.310000000000002 105.229 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.85 -72.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.517 1.478 . . . . 71.140000000000001 110.247 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.9 p90 179.75 179.34 0.51 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 107.511 -1.292 . . . . 72.200000000000003 107.511 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.98 122.98 7.31 Favored Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 108.663 -1.775 . . . . 42.210000000000001 108.663 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -46.63 -36.31 18.6 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 123.793 2.995 . . . . 43.530000000000001 111.758 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 m -122.66 112.6 30.78 Favored Pre-proline 0 N--CA 1.412 -2.372 0 N-CA-C 105.543 -2.021 . . . . 70.019999999999996 105.543 172.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.34 103.24 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.901 2.401 . . . . 52.310000000000002 113.313 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 86.0 m -136.27 142.94 44.0 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 121.377 0.608 . . . . 72.409999999999997 109.597 176.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -137.12 132.13 33.62 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.824 -1.546 . . . . 71.200000000000003 106.824 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 t -90.56 133.99 30.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 N-CA-C 107.2 -1.407 . . . . 61.009999999999998 107.2 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.83 -50.76 16.0 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.345 -1.354 . . . . 64.140000000000001 107.345 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.51 143.61 5.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.237 -1.347 . . . . 73.150000000000006 108.464 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG23 HD21 ' A' ' 74' ' ' LEU . 12.1 p -121.57 123.04 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 CA-C-O 121.332 0.587 . . . . 61.350000000000001 109.793 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 84.0 mm-40 -104.78 141.92 35.64 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.322 -0.854 . . . . 73.420000000000002 111.714 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.83 124.59 87.96 Favored Pre-proline 0 C--N 1.294 -1.81 0 CA-C-N 113.764 -1.562 . . . . 74.209999999999994 109.441 -164.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.651 ' HA ' ' CD1' ' A' ' 26' ' ' TRP . 81.4 Cg_exo -1.29 56.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.305 1 C-N-CA 127.491 5.46 . . . . 75.129999999999995 117.489 -159.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -146.59 -34.44 0.28 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.115 -0.948 . . . . 51.530000000000001 112.309 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.9 tt0 -146.37 139.76 25.87 Favored 'General case' 0 C--O 1.214 -0.774 0 C-N-CA 118.904 -1.118 . . . . 75.400000000000006 110.878 -174.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -139.78 136.7 34.36 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.259 -0.645 . . . . 70.439999999999998 109.259 -177.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.409 ' OG ' HG21 ' A' ' 86' ' ' THR . 18.3 m -140.9 125.95 18.34 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 110.017 -0.364 . . . . 75.109999999999999 110.017 175.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 35' ' ' ILE 0.273 12.8 p90 -146.8 158.17 43.85 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.02 0.748 . . . . 73.519999999999996 113.02 -178.429 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.27 21.7 mt-10 -119.19 131.58 55.85 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.643 -2.725 . . . . 75.299999999999997 103.643 -173.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.422 ' HE1' HG12 ' A' ' 85' ' ' VAL . 12.6 p-90 -153.11 163.52 39.72 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 114.733 1.383 . . . . 73.549999999999997 114.733 -168.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 t70 72.94 -167.83 0.12 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 112.009 -2.359 . . . . 72.209999999999994 112.237 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.442 ' HB ' ' OE2' ' A' ' 81' ' ' GLU . 1.3 m -78.53 -53.59 7.05 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.465 1.106 . . . . 74.129999999999995 112.129 -170.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.442 ' OE2' ' HB ' ' A' ' 80' ' ' THR . 2.4 mp0 -68.77 -19.62 64.32 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.375 0.509 . . . . 52.32 112.375 -176.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.33 76.33 1.3 Allowed Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.127 -1.035 . . . . 54.229999999999997 111.274 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.503 ' CZ3' HD22 ' A' ' 9' ' ' LEU . 48.7 m95 -109.4 154.42 22.61 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.188 -1.412 . . . . 74.329999999999998 107.188 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.63 123.98 27.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 121.461 0.648 . . . . 65.5 109.735 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.422 HG12 ' HE1' ' A' ' 78' ' ' TRP . 19.1 m -120.25 155.43 23.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 121.484 0.659 . . . . 73.200000000000003 111.259 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.418 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 41.9 m -131.09 137.33 49.06 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.065 -0.97 . . . . 74.230000000000004 108.573 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.63 ' CD2' HD13 ' A' ' 74' ' ' LEU . 13.9 m-85 -120.0 133.11 55.64 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.76 -1.2 . . . . 75.230000000000004 107.76 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.56 132.76 55.81 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 109.52 -0.548 . . . . 73.510000000000005 109.52 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mp -114.6 119.99 38.66 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.52 0.676 . . . . 73.349999999999994 110.724 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -103.21 123.73 47.29 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.533 -1.284 . . . . 74.010000000000005 107.533 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -82.67 128.61 34.51 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.914 -0.714 . . . . 72.129999999999995 109.71 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 74.2 mt -121.07 158.35 28.05 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.36 -1.348 . . . . 72.349999999999994 107.36 174.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.55 48.22 3.62 Favored Glycine 0 C--N 1.3 -1.444 0 O-C-N 123.305 0.378 . . . . 62.100000000000001 114.008 -174.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 172.96 -41.61 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.385 1.074 . . . . 74.310000000000002 109.237 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.5 ptpt -134.15 175.07 9.82 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.03 -0.729 . . . . 62.43 109.03 -173.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 88.9 m -117.72 128.16 54.62 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.817 -0.809 . . . . 63.229999999999997 108.817 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.37 107.7 3.47 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.203 -1.159 . . . . 55.340000000000003 110.203 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -97.32 133.95 41.25 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 109.257 -0.645 . . . . 73.120000000000005 109.257 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.4 m -120.41 121.81 39.35 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 108.187 -1.042 . . . . 75.439999999999998 108.187 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.461 HD11 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.59 139.71 35.89 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-O 121.854 0.835 . . . . 64.409999999999997 109.59 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.461 ' N ' HD11 ' A' ' 100' ' ' LEU . 16.1 mt -137.09 124.85 32.14 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 113.239 -1.801 . . . . 63.219999999999999 107.746 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 23.7 t-160 -117.42 129.06 55.6 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.309 -0.997 . . . . 70.230000000000004 108.309 177.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -141.08 164.41 30.34 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.151 -1.426 . . . . 62.229999999999997 107.151 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.1 167.76 38.25 Favored Glycine 0 C--N 1.291 -1.932 0 C-N-CA 120.17 -1.014 . . . . 61.32 110.864 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 -88.56 59.9 5.36 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.952 0.882 . . . . 75.430000000000007 112.535 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -143.43 147.77 35.1 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 104.123 -2.547 . . . . 72.340000000000003 104.123 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -79.88 155.02 75.6 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 118.411 0.55 . . . . 73.530000000000001 110.259 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -69.08 -30.18 25.88 Favored 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 122.486 2.124 . . . . 74.299999999999997 110.367 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.428 HD21 ' HG3' ' A' ' 110' ' ' GLU . 4.7 p-10 -83.82 158.64 21.61 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-N 114.524 -1.217 . . . . 73.340000000000003 108.029 177.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.428 ' HG3' HD21 ' A' ' 109' ' ' ASN . 85.7 mt-10 71.59 -160.24 0.12 Allowed 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.399 -1.334 . . . . 73.140000000000001 107.399 -175.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.25 154.99 41.02 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 N-CA-C 107.649 -1.241 . . . . 74.409999999999997 107.649 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 35.0 pt -58.03 -31.0 40.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 113.049 0.759 . . . . 74.340000000000003 113.049 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.13 40.72 5.1 Favored Glycine 0 CA--C 1.494 -1.265 0 N-CA-C 109.76 -1.336 . . . . 73.120000000000005 109.76 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.42 ' HZ1' ' HB3' ' A' ' 114' ' ' LYS . 5.5 ttpm? 46.04 52.05 10.4 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.909 1.684 . . . . 71.450000000000003 111.849 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.02 -19.77 61.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 122.439 1.114 . . . . 65.209999999999994 108.481 173.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -132.52 -72.27 0.52 Allowed 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 113.701 -1.59 . . . . 74.519999999999996 108.713 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -149.2 -170.81 3.73 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 108.77 -0.826 . . . . 73.25 108.77 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.84 157.02 25.69 Favored 'General case' 0 C--O 1.218 -0.553 0 O-C-N 124.051 0.845 . . . . 54.299999999999997 110.784 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.1 p -56.65 -48.38 77.68 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.218 1.007 . . . . 65.310000000000002 112.72 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 p -63.07 -45.36 92.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.437 0.637 . . . . 74.140000000000001 110.704 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.06 -47.5 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.919 -1.037 . . . . 72.0 110.016 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 126' ' ' MET . 50.8 t -57.48 -41.06 78.0 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.233 0 CA-C-N 116.115 -0.493 . . . . 71.310000000000002 110.697 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -63.24 -51.69 65.17 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.24 -0.437 . . . . 74.310000000000002 111.045 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.64 -42.99 97.05 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-N 115.739 -0.664 . . . . 61.140000000000001 112.234 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -68.93 -32.53 72.2 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 115.085 -0.558 . . . . 65.109999999999999 112.363 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 23.4 mmt -67.03 -46.51 74.23 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.851 -0.74 . . . . 74.209999999999994 111.145 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.89 -58.42 3.47 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.658 -0.817 . . . . 65.099999999999994 111.783 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.33 -44.88 83.84 Favored Glycine 0 C--O 1.246 0.859 0 C-N-CA 121.058 -0.592 . . . . 63.310000000000002 112.075 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.53 -55.46 28.78 Favored Glycine 0 N--CA 1.437 -1.291 0 CA-C-O 119.316 -0.713 . . . . 62.539999999999999 112.22 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.436 ' O ' HG12 ' A' ' 134' ' ' VAL . 62.3 m95 -58.8 -43.51 90.53 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 117.837 0.818 . . . . 72.120000000000005 113.128 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 31.7 m -59.9 -47.06 87.32 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.367 0.417 . . . . 70.420000000000002 110.479 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.45 -47.24 36.23 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.557 -0.83 . . . . 74.219999999999999 112.828 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.8 mt -65.35 -46.14 91.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 122.587 0.355 . . . . 75.409999999999997 111.822 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 5.1 p -66.29 -40.45 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 119.608 -0.837 . . . . 70.329999999999998 109.717 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.576 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 34.3 t30 -58.89 -63.93 1.12 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.015 -0.539 . . . . 64.349999999999994 110.624 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -71.01 -48.8 51.05 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 113.423 0.897 . . . . 71.519999999999996 113.423 -173.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.523 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -69.83 -33.81 72.81 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.702 -0.799 . . . . 71.219999999999999 110.813 -171.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.4 mm? -70.78 -48.91 51.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.991 -1.084 . . . . 64.5 110.264 173.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 135' ' ' ASN . 1.0 OUTLIER -59.3 -40.32 85.78 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.83 -0.623 . . . . 73.420000000000002 110.959 -177.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.438 ' HE3' ' O ' ' A' ' 144' ' ' GLU . 25.7 mmmt -75.85 -36.02 59.75 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 112.887 0.699 . . . . 75.010000000000005 112.887 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.16 -28.2 64.09 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.617 -0.833 . . . . 71.519999999999996 110.629 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.449 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 25.8 m -79.77 -24.63 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 119.584 -0.846 . . . . 43.299999999999997 110.647 176.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.35 -87.16 0.14 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.917 0.865 . . . . 71.25 110.669 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.438 ' O ' ' HE3' ' A' ' 140' ' ' LYS . 39.1 mt-10 -143.47 107.2 4.64 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 125.09 1.356 . . . . 65.25 107.494 -172.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 37.9 tp -68.84 106.05 2.56 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.19 0.519 . . . . 74.120000000000005 110.423 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -158.47 172.18 18.78 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.432 -1.692 . . . . 65.200000000000003 106.432 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -89.55 102.43 15.11 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.835 -1.543 . . . . 62.450000000000003 106.835 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -121.44 26.81 8.63 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.72 -1.215 . . . . 74.349999999999994 107.72 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -75.52 103.31 5.59 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.063 -0.971 . . . . 73.319999999999993 111.001 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -112.51 102.2 10.31 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.882 -0.784 . . . . 64.299999999999997 108.882 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -102.08 -65.57 0.98 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.475 -0.49 . . . . 73.400000000000006 110.976 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 . . . . . 0 C--N 1.315 -0.934 0 N-CA-C 108.192 -1.04 . . . . 75.299999999999997 108.192 -177.894 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 CA--C 1.508 -0.643 0 CA-C-O 120.511 0.196 . . . . 62.229999999999997 111.172 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.63 104.53 6.22 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.42 0.629 . . . . 72.140000000000001 109.547 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -73.12 -28.71 62.42 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.848 -1.069 . . . . 74.439999999999998 109.959 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -158.33 170.88 21.23 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.598 -1.63 . . . . 75.319999999999993 106.598 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 68.19 42.18 1.79 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.814 0.816 . . . . 72.510000000000005 111.895 176.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -93.75 34.21 1.23 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.645 -1.243 . . . . 72.140000000000001 107.645 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -110.11 80.73 1.34 Allowed 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 105.022 -2.214 . . . . 73.150000000000006 105.022 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 106' ' ' LYS . . . -32.9 100.73 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 110.399 -3.091 . . . . 73.519999999999996 111.429 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.4 tp 48.66 86.78 0.14 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.315 1.446 . . . . 64.420000000000002 114.286 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.05 138.32 43.51 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.071 1.18 . . . . 41.039999999999999 109.717 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 8.2 p-10 -71.72 110.95 6.61 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.634 0.73 . . . . 72.310000000000002 109.839 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.6 tp -111.17 138.67 38.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.622 -0.717 . . . . 74.129999999999995 110.814 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.3 m -111.67 133.02 54.2 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 108.023 -1.103 . . . . 73.430000000000007 108.023 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -128.14 143.07 51.03 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.892 -1.522 . . . . 73.200000000000003 106.892 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.9 m -122.75 133.48 54.47 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.977 -0.379 . . . . 60.399999999999999 109.977 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.476 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -145.84 131.79 13.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.601 -0.888 . . . . 75.120000000000005 108.601 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.75 122.62 43.0 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-O 121.458 0.647 . . . . 72.109999999999999 112.179 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 138' ' ' LEU . 6.2 mp -95.67 135.85 36.83 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 107.755 -1.202 . . . . 70.030000000000001 107.755 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -87.78 39.78 0.9 Allowed 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.169 -0.469 . . . . 72.0 109.937 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.443 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -135.92 163.86 47.37 Favored Pre-proline 0 C--O 1.245 0.823 0 C-N-CA 124.169 0.987 . . . . 71.340000000000003 109.085 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.443 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 36.4 Cg_endo -63.7 157.71 50.28 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 123.013 2.476 . . . . 74.409999999999997 112.377 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.6 tt -64.87 -27.72 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.738 -0.664 . . . . 74.030000000000001 111.859 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -71.75 -28.24 63.53 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.971 0.415 . . . . 71.200000000000003 111.717 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.589 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 4.4 tmtt? -81.18 -46.11 15.36 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.46 -0.57 . . . . 73.209999999999994 109.46 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 96' ' ' THR . 5.4 p -59.49 -39.18 78.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.237 0.541 . . . . 73.219999999999999 109.846 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.43 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 70.0 t90 -63.35 -44.59 94.4 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.201 -0.909 . . . . 74.519999999999996 111.032 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -65.25 -33.68 76.55 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.442 -0.503 . . . . 72.439999999999998 110.465 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.7 m -59.25 -32.02 69.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.249 0.547 . . . . 71.319999999999993 111.163 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.555 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.5 m -109.46 21.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 112.298 0.481 . . . . 55.130000000000003 112.298 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.423 ' OG ' ' HA ' ' A' ' 27' ' ' GLU . 61.6 p -137.64 -12.24 1.55 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.406 -0.517 . . . . 74.209999999999994 112.216 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.0 p -94.55 158.81 15.37 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.632 -0.507 . . . . 74.150000000000006 109.632 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.9 m -59.9 -48.23 82.55 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 123.036 0.534 . . . . 53.100000000000001 111.195 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.83 -27.31 57.81 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.304 -0.862 . . . . 61.210000000000001 111.089 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.6 -48.81 21.31 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 119.927 -1.13 . . . . 71.430000000000007 111.58 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.479 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 68.1 mt -65.59 -33.42 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.729 0.775 . . . . 72.540000000000006 110.321 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.87 -30.04 63.48 Favored 'General case' 0 C--O 1.249 1.064 0 C-N-CA 124.578 1.151 . . . . 74.549999999999997 112.59 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 35' ' ' ILE . 3.9 mppt? 73.93 -71.89 0.12 Allowed 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 125.276 1.43 . . . . 74.239999999999995 108.557 -171.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 79.5 t90 171.33 -42.93 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.904 -1.517 . . . . 75.200000000000003 106.904 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -79.88 21.93 0.52 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.894 -1.048 . . . . 65.340000000000003 113.046 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 15.5 tpt -166.02 79.48 1.13 Allowed Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 108.277 -1.008 . . . . 73.219999999999999 108.277 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -82.74 98.62 0.89 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.07 1.846 . . . . 63.439999999999998 112.765 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -137.24 165.81 25.26 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.725 -0.843 . . . . 62.43 108.725 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -89.14 73.61 8.13 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.888 0.851 . . . . 71.109999999999999 110.081 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.401 ' HE1' ' SG ' ' A' ' 63' ' ' CYS . 93.4 m-85 -70.83 119.99 15.78 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.963 -1.017 . . . . 71.510000000000005 109.947 176.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -113.38 148.32 36.02 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 110.0 -0.37 . . . . 75.5 110.0 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.5 tp -87.27 105.53 17.3 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.824 -1.176 . . . . 52.210000000000001 107.824 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -133.19 137.51 46.21 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 106.488 -1.671 . . . . 61.409999999999997 106.488 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -92.07 75.27 5.49 Favored 'General case' 0 C--N 1.257 -3.421 0 CA-C-O 122.845 1.307 . . . . 51.420000000000002 109.561 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 113.97 87.88 1.59 Allowed Glycine 1 N--CA 1.396 -4.001 0 CA-C-N 113.61 -1.632 . . . . 63.140000000000001 111.027 -179.212 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -87.65 -75.16 0.42 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.911 -1.144 . . . . 75.109999999999999 107.911 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.98 161.74 24.85 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.143 -1.429 . . . . 62.140000000000001 107.143 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.05 148.04 46.03 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.855 1.057 . . . . 75.430000000000007 113.855 -171.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 64' ' ' LYS . 11.1 t60 -110.06 162.84 14.16 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 104.424 -2.436 . . . . 63.450000000000003 104.424 176.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.2 mt 72.62 16.23 4.8 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 106.492 -1.67 . . . . 65.530000000000001 106.492 -168.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 -158.37 -169.05 2.63 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 100.622 -3.844 . . . . 63.520000000000003 100.622 -176.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.2 m -108.46 115.55 57.73 Favored Pre-proline 0 C--N 1.289 -2.027 0 CA-C-N 120.356 1.434 . . . . 71.299999999999997 111.814 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.16 133.95 22.2 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 N-CA-C 107.041 -1.946 . . . . 64.540000000000006 107.041 170.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -90.81 -44.38 9.46 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.284 -0.566 . . . . 74.430000000000007 110.551 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.1 101.59 0.72 Allowed Glycine 0 C--O 1.214 -1.145 0 C-N-CA 120.198 -1.001 . . . . 60.100000000000001 112.593 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -79.64 34.85 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.362 2.708 . . . . 70.25 112.508 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.419 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 32.4 t -90.07 -56.02 0.28 Allowed Pre-proline 0 N--CA 1.434 -1.272 0 CA-C-N 116.277 -0.42 . . . . 73.25 110.556 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' A' ' 61' ' ' SER . 53.5 Cg_endo -89.14 -176.01 1.26 Allowed 'Trans proline' 0 C--N 1.369 1.622 0 CA-C-N 120.313 1.148 . . . . 72.120000000000005 110.343 175.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.401 ' SG ' ' HE1' ' A' ' 44' ' ' PHE . 30.5 m -90.68 158.81 16.71 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.612 -1.255 . . . . 50.299999999999997 107.612 176.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HZ1' ' CD ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -122.5 118.46 28.35 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-O 121.901 0.858 . . . . 64.109999999999999 110.455 -177.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 6.7 t -79.26 137.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 114.872 -1.058 . . . . 65.310000000000002 109.339 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 tt -81.47 -57.63 3.39 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.387 -1.338 . . . . 72.519999999999996 107.387 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.04 153.6 22.47 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.542 -0.753 . . . . 64.430000000000007 109.801 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.54 119.13 52.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.712 -1.218 . . . . 37.920000000000002 107.712 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 22.5 mp0 -106.27 141.19 38.02 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.348 0.659 . . . . 75.519999999999996 110.334 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.67 129.32 94.1 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 114.226 -1.352 . . . . 72.420000000000002 108.446 -167.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HA ' ' CD1' ' A' ' 26' ' ' TRP . 10.8 Cg_exo 2.52 44.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.283 1 C-N-CA 128.434 6.089 . . . . 74.319999999999993 118.602 -162.201 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -139.83 -35.47 0.53 Allowed 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 122.248 -0.283 . . . . 74.239999999999995 110.702 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 40.7 tt0 -145.94 145.21 30.59 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 118.508 -1.277 . . . . 74.030000000000001 109.98 -174.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.595 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -147.5 134.96 20.8 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.529 -1.285 . . . . 55.340000000000003 107.529 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.431 ' HG ' HG21 ' A' ' 86' ' ' THR . 11.1 m -140.51 125.44 18.32 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.269 -0.572 . . . . 63.299999999999997 110.286 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.417 ' HB3' HG11 ' A' ' 65' ' ' VAL . 49.8 p90 -138.2 152.92 49.09 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 109.725 -0.472 . . . . 63.240000000000002 109.725 176.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.476 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 37.8 mt-10 -124.73 126.08 45.1 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-N 115.475 -0.784 . . . . 62.409999999999997 110.818 -171.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.464 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 2.1 t90 -95.54 107.94 20.15 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 104.359 -2.46 . . . . 75.140000000000001 104.359 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.51 140.49 55.67 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.889 -0.596 . . . . 74.340000000000003 111.119 -171.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.1 m 70.18 82.82 0.15 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.598 1.159 . . . . 65.129999999999995 112.279 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 55.63 23.22 5.93 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.954 1.702 . . . . 73.310000000000002 113.833 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' A' ' 78' ' ' TRP . . . -93.98 -24.43 19.97 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 107.865 -2.094 . . . . 60.530000000000001 107.865 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 75.29 -177.16 0.15 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 126.128 1.771 . . . . 75.109999999999999 113.03 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.402 ' HB ' ' HG2' ' A' ' 77' ' ' GLU . 4.4 p -114.81 117.26 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.838 0.828 . . . . 74.319999999999993 109.918 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.51 144.01 16.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 CA-C-N 114.989 -1.005 . . . . 73.239999999999995 108.717 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.463 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 46.9 m -131.56 134.38 46.02 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 108.988 -0.745 . . . . 75.099999999999994 108.988 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.595 ' CD2' HD13 ' A' ' 74' ' ' LEU . 10.9 m-85 -109.99 137.41 47.8 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.452 -1.314 . . . . 75.530000000000001 107.452 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.493 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 7.0 tt0 -125.04 136.98 54.21 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.089 -1.448 . . . . 74.230000000000004 107.089 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -110.91 124.38 51.98 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.202 -0.599 . . . . 70.400000000000006 111.901 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -109.93 137.11 48.18 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 124.717 1.207 . . . . 73.329999999999998 108.383 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -97.93 117.76 32.98 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 120.608 0.242 . . . . 71.400000000000006 111.158 -176.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.2 mt -113.63 159.98 19.06 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.84 -0.8 . . . . 37.920000000000002 108.84 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.52 -26.61 71.95 Favored Glycine 0 C--N 1.293 -1.806 0 N-CA-C 114.908 0.723 . . . . 71.310000000000002 114.908 -174.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 28.0 tt0 -128.08 -0.9 5.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.88 0.84 . . . . 73.230000000000004 110.853 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.527 ' HB3' ' HZ2' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -161.65 176.2 11.22 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.455 -0.778 . . . . 75.010000000000005 108.993 -173.13 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.437 HG22 HG12 ' A' ' 25' ' ' VAL . 31.2 m -116.58 128.14 55.14 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 109.556 -0.535 . . . . 74.140000000000001 109.556 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.15 112.71 3.93 Favored Glycine 0 N--CA 1.419 -2.446 0 N-CA-C 109.486 -1.445 . . . . 43.240000000000002 109.486 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -97.9 133.97 41.67 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 108.038 -1.097 . . . . 74.140000000000001 108.038 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 88' ' ' GLN . 14.0 m -117.81 121.91 42.01 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 107.991 -1.114 . . . . 74.400000000000006 107.991 -178.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.506 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.85 141.25 34.0 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 107.79 -1.189 . . . . 65.109999999999999 107.79 177.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.506 ' N ' HD13 ' A' ' 100' ' ' LEU . 19.6 mt -135.2 124.77 42.81 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.404 0 N-CA-C 106.699 -1.593 . . . . 74.319999999999993 106.699 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 21.8 t-160 -117.83 120.9 39.3 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.151 -1.055 . . . . 73.530000000000001 108.151 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.9 t -141.82 164.6 29.75 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 107.161 -1.422 . . . . 64.239999999999995 107.161 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -176.73 -131.86 1.55 Allowed Glycine 0 C--N 1.285 -2.29 0 N-CA-C 109.413 -1.475 . . . . 72.329999999999998 109.413 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -84.72 78.82 9.79 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.373 -0.973 . . . . 73.5 108.373 175.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -82.84 84.9 7.22 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 114.39 -1.277 . . . . 72.129999999999995 111.277 -177.426 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -107.18 117.27 56.68 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 115.05 -0.977 . . . . 74.450000000000003 109.979 -174.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -50.78 -35.01 46.8 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 124.053 3.169 . . . . 73.219999999999999 114.921 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -142.66 85.76 1.91 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.182 0.515 . . . . 71.530000000000001 110.719 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -179.12 172.19 1.27 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 105.76 -1.941 . . . . 64.510000000000005 105.76 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.66 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 1.8 t -105.12 168.64 2.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 106.646 -1.613 . . . . 62.310000000000002 106.646 176.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.463 HD12 HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -58.15 -31.72 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.792 0.806 . . . . 74.049999999999997 111.155 177.062 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 148.12 -86.89 0.16 Allowed Glycine 0 N--CA 1.41 -3.093 0 N-CA-C 109.18 -1.568 . . . . 54.240000000000002 109.18 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 61.8 tttp -155.13 22.36 0.43 Allowed 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.45 0.643 . . . . 73.319999999999993 110.266 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.15 84.61 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.155 -0.966 . . . . 64.109999999999999 111.282 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -150.85 25.03 0.75 Allowed 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.362 0.413 . . . . 64.519999999999996 110.967 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 66.85 -41.47 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.382 1.623 . . . . 63.509999999999998 115.382 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -118.06 141.74 48.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.268 0.485 . . . . 62.5 112.159 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.66 ' OG ' ' HA ' ' A' ' 111' ' ' VAL . 70.8 m -75.07 -27.79 60.1 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.987 -0.551 . . . . 71.230000000000004 109.696 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 p -66.04 -47.17 75.28 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.633 -0.712 . . . . 73.340000000000003 111.509 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.0 m -69.92 -33.7 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 120.425 -0.51 . . . . 73.200000000000003 109.897 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.41 -46.32 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 120.155 -0.618 . . . . 70.239999999999995 110.556 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -55.31 -55.95 25.57 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.656 0.782 . . . . 65.430000000000007 111.785 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.0 -47.24 92.25 Favored Glycine 0 C--O 1.249 1.069 0 O-C-N 123.635 0.584 . . . . 62.229999999999997 112.652 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -68.44 -36.95 79.78 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 113.292 0.849 . . . . 75.530000000000001 113.292 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -34.47 71.99 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 119.469 -0.892 . . . . 72.340000000000003 110.859 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.19 -49.64 54.78 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.863 0.363 . . . . 74.400000000000006 110.875 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.45 -41.02 91.23 Favored Glycine 0 C--O 1.251 1.211 0 C-N-CA 120.624 -0.798 . . . . 55.229999999999997 111.238 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.412 ' HA2' ' CB ' ' A' ' 152' ' ' HIS . . . -61.87 -54.03 38.48 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.824 -0.688 . . . . 51.43 112.301 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.514 ' O ' HG12 ' A' ' 134' ' ' VAL . 57.5 m95 -56.99 -37.65 71.95 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 113.097 0.777 . . . . 74.340000000000003 113.097 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.5 m -57.37 -48.08 79.97 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 123.186 0.304 . . . . 73.129999999999995 110.436 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.89 -48.76 31.93 Favored Glycine 0 C--O 1.246 0.897 0 C-N-CA 120.584 -0.817 . . . . 72.549999999999997 112.332 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.24 -52.41 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.044 0.537 . . . . 75.430000000000007 111.653 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.661 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 4.2 p -71.63 -41.03 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 119.874 -0.73 . . . . 72.340000000000003 111.847 -173.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.476 ' HA ' HG13 ' A' ' 16' ' ' ILE . 26.7 t-20 -63.69 -52.18 61.77 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.988 -0.685 . . . . 54.140000000000001 111.234 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 33.5 tt0 -78.99 -44.75 21.69 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 113.183 0.808 . . . . 74.140000000000001 113.183 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.5 ' NH1' ' HB1' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -64.85 -45.3 86.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 119.147 -1.021 . . . . 72.25 109.837 -176.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.661 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.1 mm? -65.47 -52.21 54.53 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.218 0.324 . . . . 71.0 111.557 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -63.73 -35.65 81.27 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.908 0.385 . . . . 74.219999999999999 109.995 -177.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.474 ' NZ ' ' HB3' ' A' ' 144' ' ' GLU . 12.5 mmmt -68.65 -46.16 69.9 Favored 'General case' 0 C--O 1.173 -2.957 0 CA-C-O 119.157 -0.449 . . . . 74.519999999999996 111.088 177.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.5 ' HB1' ' NH1' ' A' ' 137' ' ' ARG . . . -59.48 -29.85 68.13 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.219 0.452 . . . . 73.219999999999999 112.219 -176.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.1 m -86.28 -24.69 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 120.19 -0.604 . . . . 74.430000000000007 112.205 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 78.6 mm-40 -86.08 -57.86 2.86 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.711 0.767 . . . . 73.209999999999994 109.958 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.474 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 2.3 tm-20 -139.7 100.26 3.91 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.267 -1.382 . . . . 72.010000000000005 107.267 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -24.79 -59.96 0.06 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 118.797 2.888 . . . . 74.439999999999998 118.797 -170.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -129.53 97.63 4.6 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.498 -1.281 . . . . 74.230000000000004 114.112 -168.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 70.6 t60 177.44 131.44 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.194 0.998 . . . . 73.439999999999998 109.047 173.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -167.99 152.76 6.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.817 -1.179 . . . . 75.030000000000001 107.817 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -174.79 106.97 0.1 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.022 -1.473 . . . . 75.430000000000007 107.022 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -121.52 -70.02 0.8 Allowed 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 112.891 0.7 . . . . 60.210000000000001 112.891 -173.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 171.43 -44.5 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 103.075 -2.935 . . . . 73.430000000000007 103.075 -172.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.412 ' CB ' ' HA2' ' A' ' 129' ' ' GLY . 96.0 m-70 . . . . . 0 N--CA 1.412 -2.35 0 N-CA-C 103.126 -2.916 . . . . 74.219999999999999 103.126 170.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.5 mtp . . . . . 0 CA--C 1.513 -0.471 0 CA-C-O 120.88 0.372 . . . . 52.5 110.12 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.29 65.37 1.25 Allowed 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.705 -0.68 . . . . 54.219999999999999 109.621 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -84.68 -27.46 27.05 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.861 -1.063 . . . . 65.530000000000001 111.323 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.56 ' ND2' ' H ' ' A' ' 5' ' ' ASN . 6.8 t30 -70.88 -169.96 0.4 Allowed 'General case' 0 CA--C 1.571 1.785 0 CA-C-N 115.576 -0.738 . . . . 74.450000000000003 111.563 -174.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.56 ' H ' ' ND2' ' A' ' 4' ' ' ASN . 8.0 t30 -52.26 -31.29 31.8 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 125.583 1.553 . . . . 72.349999999999994 113.591 -173.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.4 ' HG3' ' HB3' ' A' ' 10' ' ' PRO . 1.5 pm0 -75.1 74.51 2.27 Favored 'General case' 0 C--N 1.263 -3.169 0 CA-C-N 114.593 -1.185 . . . . 72.420000000000002 113.344 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -84.57 -10.99 56.88 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.901 -1.518 . . . . 71.400000000000006 106.901 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 110' ' ' GLU . . . -78.68 -72.43 0.38 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.393 1.477 . . . . 75.150000000000006 111.864 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tt -166.53 109.5 0.68 Allowed Pre-proline 0 N--CA 1.419 -1.979 0 N-CA-C 107.161 -1.422 . . . . 72.340000000000003 107.161 -172.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 2.7 Cg_exo -82.5 168.74 14.35 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 122.918 2.412 . . . . 71.310000000000002 109.522 171.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 6.2 p-10 -64.53 107.47 1.4 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.638 -1.245 . . . . 72.109999999999999 107.638 170.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 43.2 mm -91.03 124.1 43.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.522 -0.918 . . . . 43.130000000000003 108.522 -174.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.0 m -120.37 128.39 53.19 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.433 -1.321 . . . . 64.150000000000006 107.433 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.555 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 22.4 tptt -140.2 144.56 36.65 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.701 -1.222 . . . . 72.319999999999993 107.701 -176.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.4 m -123.07 134.51 54.25 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.695 -0.402 . . . . 61.200000000000003 110.418 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.415 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -141.7 131.79 25.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.919 -0.771 . . . . 72.200000000000003 108.919 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.87 117.87 32.05 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 121.809 0.814 . . . . 63.229999999999997 111.984 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 138' ' ' LEU . 5.6 mp -92.7 140.07 29.91 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.796 -1.557 . . . . 64.329999999999998 106.796 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.85 15.27 3.4 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.175 0.512 . . . . 64.329999999999998 111.581 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -105.5 159.54 29.16 Favored Pre-proline 0 C--N 1.306 -1.31 0 CA-C-N 115.864 -0.607 . . . . 63.549999999999997 109.719 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.59 154.38 69.27 Favored 'Trans proline' 0 C--O 1.253 1.237 0 C-N-CA 123.028 2.485 . . . . 62.130000000000003 110.91 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.0 tt -60.63 -29.13 44.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.936 -0.575 . . . . 73.319999999999993 112.011 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.451 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.6 pt20 -62.85 -40.58 97.9 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.928 0.394 . . . . 71.409999999999997 111.198 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -68.12 -39.74 82.69 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.283 0.564 . . . . 74.310000000000002 110.909 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' HG21 ' A' ' 29' ' ' VAL . 36.0 t -69.09 -40.75 81.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.328 -0.851 . . . . 73.200000000000003 109.821 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 28.7 t90 -59.06 -47.63 84.53 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 124.021 0.825 . . . . 74.319999999999993 110.397 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 34.2 mt-10 -64.4 -36.45 84.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.07 0.462 . . . . 71.319999999999993 110.731 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.4 m -67.16 -12.36 59.81 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-O 121.422 0.629 . . . . 60.210000000000001 111.976 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.665 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 16.7 m -131.06 13.62 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 120.756 -1.215 . . . . 74.430000000000007 112.906 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.6 t -139.12 4.05 2.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 120.247 -0.581 . . . . 73.099999999999994 112.259 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.4 p -111.57 168.57 9.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.198 -0.667 . . . . 64.230000000000004 109.198 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 16.4 m -60.08 -46.1 90.7 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.926 0.491 . . . . 64.430000000000007 111.447 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -71.12 -41.74 70.14 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.802 -0.635 . . . . 73.239999999999995 110.18 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . -66.21 -48.01 67.78 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 115.158 -0.928 . . . . 74.340000000000003 113.078 -177.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.07 -41.46 89.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 117.289 0.544 . . . . 73.140000000000001 111.205 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.99 -51.78 62.67 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.535 0.568 . . . . 44.340000000000003 112.535 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 62.3 mttp 56.36 27.31 11.78 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.271 0.629 . . . . 73.200000000000003 111.567 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -88.25 -70.54 0.63 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.059 -1.089 . . . . 63.109999999999999 108.059 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 t80 157.96 -41.75 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 103.868 -2.641 . . . . 73.299999999999997 103.868 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 25.9 ttt -93.65 124.86 55.73 Favored Pre-proline 0 N--CA 1.424 -1.751 0 CA-C-N 112.662 -2.063 . . . . 73.019999999999996 106.178 175.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.65 141.61 67.16 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.733 1.622 . . . . 71.319999999999993 111.398 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 32' ' ' SER . 19.7 t-20 -111.95 158.71 19.17 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 105.611 -1.996 . . . . 73.439999999999998 105.611 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.21 70.77 8.13 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.553 0.692 . . . . 74.140000000000001 111.431 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -107.67 119.87 40.64 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.564 -1.198 . . . . 73.340000000000003 108.404 172.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -121.57 150.37 41.77 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.6 -1.259 . . . . 64.200000000000003 107.6 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -78.44 106.08 10.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 117.316 -1.754 . . . . 71.150000000000006 108.974 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 49' ' ' GLY . 23.7 tptp -130.41 144.7 51.56 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 104.875 -2.269 . . . . 73.540000000000006 104.875 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.99 36.75 0.57 Allowed 'General case' 0 C--N 1.283 -2.312 0 CA-C-O 122.218 1.008 . . . . 62.420000000000002 109.76 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 151.8 66.52 0.01 OUTLIER Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.35 -1.5 . . . . 72.230000000000004 109.35 -175.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 19.4 tt0 -74.16 124.17 25.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.326 -1.361 . . . . 52.020000000000003 107.326 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -132.62 150.18 52.2 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.12 0.486 . . . . 61.229999999999997 111.38 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -128.83 147.29 50.79 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.389 -1.708 . . . . 75.5 106.389 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -110.17 140.32 44.4 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.589 0.709 . . . . 73.239999999999995 112.609 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.6 mt -126.97 -175.05 3.31 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.147 -1.388 . . . . 75.109999999999999 107.714 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -77.73 -9.38 58.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.205 0.526 . . . . 73.0 110.305 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.8 p -140.16 163.74 42.0 Favored Pre-proline 0 N--CA 1.434 -1.227 0 C-N-CA 124.957 1.303 . . . . 72.420000000000002 107.948 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -87.69 1.58 6.87 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.212 1.941 . . . . 64.400000000000006 114.042 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -131.81 147.06 52.46 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.938 -0.393 . . . . 74.420000000000002 109.938 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.27 147.96 4.72 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 111.282 -0.727 . . . . 62.149999999999999 111.282 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -80.33 85.62 1.79 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.205 1.937 . . . . 64.310000000000002 111.57 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.4 m -158.07 -56.73 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.222 0 C-N-CA 123.819 0.848 . . . . 74.340000000000003 110.865 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.52 114.38 2.87 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 121.448 1.432 . . . . 71.010000000000005 112.574 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 14.0 p -88.26 142.41 27.77 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 105.646 -1.983 . . . . 74.230000000000004 105.646 173.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 42.9 mtpt -133.52 134.29 43.24 Favored 'General case' 0 CA--C 1.468 -2.21 0 C-N-CA 120.139 -0.625 . . . . 64.209999999999994 111.143 -169.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.416 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 22.2 t -90.66 133.82 31.31 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 N-CA-C 105.307 -2.108 . . . . 74.530000000000001 105.307 168.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -78.75 -56.64 4.26 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.038 -1.097 . . . . 73.340000000000003 108.038 -175.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.19 153.27 28.95 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.274 -0.875 . . . . 73.519999999999996 108.88 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.421 HG23 HD22 ' A' ' 74' ' ' LEU . 12.5 p -132.67 119.8 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 CA-C-O 121.885 0.85 . . . . 70.219999999999999 111.621 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 45.9 mt-30 -101.34 141.0 34.86 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.322 -0.854 . . . . 73.209999999999994 110.955 176.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.32 126.2 92.19 Favored Pre-proline 0 C--N 1.279 -2.468 0 CA-C-N 113.875 -1.511 . . . . 70.230000000000004 109.439 -164.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo 7.27 46.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 1 C-N-CA 127.869 5.712 . . . . 54.439999999999998 116.843 -162.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 p -138.7 -38.59 0.52 Allowed 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.773 -0.649 . . . . 73.299999999999997 112.182 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 31.1 tt0 -150.5 142.71 24.16 Favored 'General case' 0 C--O 1.208 -1.127 0 C-N-CA 118.913 -1.115 . . . . 74.420000000000002 110.221 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.581 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -138.52 137.18 36.85 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 108.746 -0.835 . . . . 63.420000000000002 108.746 -177.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.479 ' HG ' HG21 ' A' ' 86' ' ' THR . 13.5 m -139.38 127.37 22.29 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 122.451 -0.156 . . . . 71.310000000000002 110.755 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 43.6 p90 -143.98 157.04 44.59 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.02 -0.425 . . . . 73.239999999999995 112.058 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 36.3 mt-10 -121.04 125.71 48.01 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 107.107 -1.442 . . . . 73.25 107.107 -176.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 51.3 t90 -135.33 148.49 49.48 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 111.925 0.343 . . . . 75.400000000000006 111.925 -176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.48 ' OD1' HG22 ' A' ' 80' ' ' THR . 2.5 t70 77.82 -177.79 0.11 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.073 1.749 . . . . 73.510000000000005 111.909 171.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.48 HG22 ' OD1' ' A' ' 79' ' ' ASP . 1.8 t -58.34 -41.42 84.59 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 113.062 0.764 . . . . 62.409999999999997 113.062 -175.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.23 12.49 11.64 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.211 0.819 . . . . 74.420000000000002 113.211 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.96 57.45 6.9 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 123.42 0.45 . . . . 60.539999999999999 112.757 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.469 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 88.1 m95 -67.38 117.14 8.96 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 109.0 -0.741 . . . . 75.400000000000006 109.0 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 76' ' ' PHE . 7.2 p -101.84 101.16 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 CA-C-O 122.599 1.19 . . . . 74.310000000000002 109.418 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.2 m -100.26 146.85 8.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 CA-C-N 114.096 -1.411 . . . . 63.539999999999999 108.167 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.479 HG21 ' HG ' ' A' ' 75' ' ' SER . 32.7 m -131.56 133.81 45.41 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 109.693 -176.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.665 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 13.2 m-85 -109.32 131.43 55.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.617 -1.253 . . . . 73.329999999999998 107.617 176.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.425 HE21 HD13 ' A' ' 101' ' ' ILE . 5.3 mt-30 -116.66 136.21 53.16 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 109.277 -0.638 . . . . 75.530000000000001 109.277 175.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mp -116.72 128.23 55.14 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.369 0.604 . . . . 71.5 110.552 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -102.85 119.6 39.14 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.104 -1.813 . . . . 71.239999999999995 106.104 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -81.13 111.79 17.9 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.11 0.481 . . . . 73.430000000000007 110.804 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.6 mt -120.95 148.66 43.78 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.669 -1.234 . . . . 74.140000000000001 107.669 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.06 54.24 2.53 Favored Glycine 0 C--N 1.284 -2.313 0 C-N-CA 121.027 -0.606 . . . . 62.020000000000003 112.208 -176.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -175.2 -54.51 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.652 -1.61 . . . . 72.109999999999999 106.652 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.38 175.41 8.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.027 -1.472 . . . . 74.099999999999994 107.027 -176.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.401 ' HB ' HG23 ' A' ' 25' ' ' VAL . 83.1 m -122.31 127.68 50.14 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 109.302 -0.629 . . . . 63.109999999999999 109.302 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.8 106.28 3.26 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.597 -1.401 . . . . 75.109999999999999 109.597 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -98.52 133.88 42.26 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 117.345 0.573 . . . . 72.230000000000004 109.646 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 28.9 m -123.17 120.38 33.03 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.612 -0.884 . . . . 75.239999999999995 108.612 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.63 141.62 33.23 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.961 -0.755 . . . . 72.239999999999995 108.961 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 18.2 mt -136.2 125.45 38.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.007 -1.451 . . . . 75.439999999999998 108.188 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 3.5 t-160 -120.31 117.36 27.59 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.042 -1.096 . . . . 75.150000000000006 108.042 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.2 t -142.15 164.13 31.0 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 103.727 -2.694 . . . . 72.120000000000005 103.727 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -166.65 163.3 36.89 Favored Glycine 0 CA--C 1.49 -1.514 0 C-N-CA 118.282 -1.913 . . . . 53.219999999999999 113.811 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -85.55 66.27 9.58 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 122.994 1.378 . . . . 73.239999999999995 109.429 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -87.07 173.31 9.36 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.038 -1.437 . . . . 72.219999999999999 110.562 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.15 138.76 96.04 Favored Pre-proline 0 C--O 1.253 1.249 0 CA-C-N 115.352 -0.84 . . . . 72.109999999999999 110.031 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.47 87.76 1.06 Allowed 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 107.841 -1.638 . . . . 73.299999999999997 107.841 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.445 ' ND2' HG13 ' A' ' 111' ' ' VAL . 54.0 t30 -174.31 167.47 4.03 Favored 'General case' 0 C--O 1.249 1.071 0 N-CA-C 107.621 -1.252 . . . . 74.140000000000001 107.621 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 8' ' ' ALA . 20.7 pt-20 -70.26 -14.83 62.78 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.639 0.776 . . . . 74.150000000000006 112.84 -177.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.445 HG13 ' ND2' ' A' ' 109' ' ' ASN . 14.9 p -111.91 152.38 13.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.703 -0.851 . . . . 65.109999999999999 108.703 175.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.524 ' H ' HD12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -59.63 -35.94 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.624 0.25 . . . . 74.299999999999997 111.374 176.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.419 ' H ' HG22 ' A' ' 111' ' ' VAL . . . 126.36 -140.28 11.95 Favored Glycine 0 N--CA 1.422 -2.284 0 N-CA-C 110.242 -1.143 . . . . 75.519999999999996 110.242 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -80.65 -2.5 46.84 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 123.533 0.733 . . . . 73.340000000000003 110.204 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.87 71.28 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.071 0.462 . . . . 54.200000000000003 109.93 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -173.72 114.34 0.22 Allowed 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.209 -1.404 . . . . 74.099999999999994 107.209 174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -78.74 49.47 0.9 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 114.36 1.244 . . . . 73.5 114.36 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -152.61 92.82 1.71 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.235 1.014 . . . . 73.0 108.824 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -57.01 13.57 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 123.516 0.726 . . . . 63.420000000000002 111.474 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.4 m -61.82 -33.3 73.9 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.166 -0.47 . . . . 63.450000000000003 111.375 -176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.85 -47.15 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 109.587 -0.523 . . . . 71.209999999999994 109.587 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.495 ' O ' ' HG2' ' A' ' 126' ' ' MET . 48.6 t -58.23 -43.55 86.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 O-C-N 123.822 0.701 . . . . 75.25 111.124 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -61.67 -48.95 78.49 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.159 -0.473 . . . . 73.230000000000004 110.833 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.42 -43.93 97.53 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 115.634 -0.712 . . . . 53.25 111.799 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -67.45 -34.21 76.72 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.829 -0.686 . . . . 74.340000000000003 112.193 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 25.7 mmt -66.7 -43.07 85.32 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.225 -0.59 . . . . 73.519999999999996 111.479 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.82 -61.51 1.78 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.259 -0.976 . . . . 65.310000000000002 111.772 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.37 -39.0 95.58 Favored Glycine 0 C--O 1.24 0.485 0 C-N-CA 120.928 -0.653 . . . . 61.149999999999999 112.574 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.26 -53.96 29.79 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 119.659 -0.523 . . . . 73.310000000000002 112.3 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -63.28 -29.53 70.84 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 117.51 0.655 . . . . 72.140000000000001 112.48 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.555 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 73.2 m -60.98 -57.4 12.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.427 -0.583 . . . . 65.450000000000003 109.427 174.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.5 -46.83 60.7 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.167 -0.539 . . . . 73.140000000000001 113.646 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.621 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 44.8 mm -59.13 -57.54 10.94 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 C-N-CA 122.728 0.411 . . . . 53.140000000000001 111.205 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 79.0 t -60.49 -44.1 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 O-C-N 123.096 0.248 . . . . 72.450000000000003 111.491 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 131' ' ' THR . 38.7 t-20 -54.24 -61.7 2.14 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 123.953 0.783 . . . . 74.209999999999994 111.148 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -80.89 -38.92 27.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 119.834 -0.747 . . . . 73.030000000000001 112.187 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 3.7 mmt180 -62.11 -46.64 88.17 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.372 0.533 . . . . 72.519999999999996 111.667 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.484 ' HB3' HD22 ' A' ' 18' ' ' LEU . 4.6 mm? -67.98 -48.57 65.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 120.236 -0.585 . . . . 74.450000000000003 110.467 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.576 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -61.81 -33.68 74.57 Favored 'General case' 0 C--O 1.198 -1.646 0 CA-C-N 115.734 -0.666 . . . . 74.430000000000007 109.611 -178.606 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -73.15 -35.68 66.51 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 112.879 0.696 . . . . 74.129999999999995 112.879 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.6 -32.92 71.94 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.032 0.444 . . . . 75.140000000000001 110.701 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.16 -27.0 7.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.744 -0.662 . . . . 63.549999999999997 111.602 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 64.3 mm-40 -87.33 -45.4 10.61 Favored 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 120.136 -0.626 . . . . 71.109999999999999 111.447 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.421 13.2 pt-20 59.71 -22.07 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.869 2.068 . . . . 63.210000000000001 115.489 -172.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' A' ' 143' ' ' GLU . 8.4 mp -73.47 168.82 18.47 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 107.804 -1.184 . . . . 73.420000000000002 107.804 168.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -77.84 75.98 4.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.417 0.627 . . . . 74.0 111.958 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -105.54 152.49 23.0 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.559 -0.904 . . . . 64.450000000000003 108.559 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -94.8 -167.92 1.73 Allowed 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.187 -0.672 . . . . 70.239999999999995 109.187 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -73.89 159.92 32.14 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.735 -1.209 . . . . 74.549999999999997 107.735 172.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -65.63 -53.73 37.51 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.322 0.582 . . . . 75.430000000000007 109.483 -175.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -177.03 -177.62 0.76 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 126.357 1.863 . . . . 72.230000000000004 106.313 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 38.7 m80 . . . . . 0 C--O 1.262 1.732 0 O-C-N 124.04 0.837 . . . . 74.109999999999999 110.244 -175.996 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 CA--C 1.495 -1.159 0 N-CA-C 108.58 -0.896 . . . . 73.019999999999996 108.58 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.29 91.58 6.24 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.572 0.701 . . . . 65.099999999999994 109.827 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -96.2 -48.38 5.66 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.407 -0.815 . . . . 70.439999999999998 109.455 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . 0.25 4.6 p-10 -92.69 71.09 4.91 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.296 1.046 . . . . 73.439999999999998 112.677 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -87.32 104.24 16.22 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 107.222 -1.399 . . . . 71.349999999999994 107.222 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -111.45 80.15 1.28 Allowed 'General case' 0 C--N 1.259 -3.328 0 CA-C-N 113.912 -1.495 . . . . 61.310000000000002 110.246 -172.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -126.41 19.76 7.42 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.861 -1.063 . . . . 73.25 110.236 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 67.47 77.39 0.26 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.616 1.166 . . . . 72.209999999999994 111.597 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 tp 58.8 88.49 0.12 Allowed Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 124.72 1.208 . . . . 65.420000000000002 113.865 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -68.45 139.05 44.04 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 N-CA-C 108.475 -1.394 . . . . 63.219999999999999 108.475 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.69 153.79 42.47 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.48 0.919 . . . . 73.420000000000002 113.48 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.6 mm -121.78 138.74 51.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.067 -0.969 . . . . 73.510000000000005 110.075 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.1 m -126.01 130.82 51.93 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.827 -1.546 . . . . 70.239999999999995 106.827 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.498 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 41.0 tptt -139.75 145.37 38.2 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.849 -0.797 . . . . 55.450000000000003 108.849 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -118.56 140.63 49.59 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 117.682 0.219 . . . . 73.430000000000007 110.825 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.92 142.58 16.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.052 -0.722 . . . . 74.329999999999998 109.052 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 p -105.3 130.01 53.52 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 112.572 0.582 . . . . 73.299999999999997 112.572 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.53 141.53 33.27 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.826 -0.624 . . . . 63.43 111.038 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -78.9 9.42 4.27 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.033 0.833 . . . . 74.230000000000004 111.441 -176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . . . -120.95 160.56 44.41 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 109.586 -0.524 . . . . 73.319999999999993 109.586 -172.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 20' ' ' ALA . 32.5 Cg_endo -62.89 152.69 77.64 Favored 'Trans proline' 0 C--O 1.256 1.384 0 C-N-CA 123.205 2.603 . . . . 63.350000000000001 111.749 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.9 tt -56.63 -31.67 35.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.301 -0.863 . . . . 74.329999999999998 112.097 -175.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.58 -33.75 76.36 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.111 0.411 . . . . 74.549999999999997 112.111 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.5 -36.11 45.48 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.165 -0.68 . . . . 71.409999999999997 109.165 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.403 ' O ' HG21 ' A' ' 29' ' ' VAL . 46.3 t -66.07 -41.28 89.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.885 -0.783 . . . . 73.219999999999999 108.885 177.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 51.9 t90 -59.06 -47.85 83.72 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.997 -1.001 . . . . 72.239999999999995 111.718 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.42 -30.41 70.14 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.457 -0.897 . . . . 74.129999999999995 110.694 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.9 m -63.79 -22.84 67.11 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-O 121.274 0.559 . . . . 72.129999999999995 111.744 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.599 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 17.0 m -122.81 16.7 5.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 121.741 -0.6 . . . . 62.109999999999999 112.41 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.9 m -144.19 8.49 1.41 Allowed 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.163 0.801 . . . . 61.140000000000001 113.163 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.5 p -116.9 168.93 9.79 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 121.516 -0.74 . . . . 74.150000000000006 109.409 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -60.82 -54.7 41.94 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.268 -0.642 . . . . 74.319999999999993 109.268 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.97 -38.94 87.7 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.133 -0.94 . . . . 62.039999999999999 111.191 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.47 -48.74 28.44 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.687 -0.768 . . . . 40.420000000000002 113.379 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.31 -41.53 78.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 117.636 0.718 . . . . 53.140000000000001 112.785 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' A' ' 40' ' ' MET . . . -59.11 -31.17 68.68 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.558 0.947 . . . . 71.409999999999997 113.558 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 85.7 tttt 60.64 54.5 3.66 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.523 0.729 . . . . 72.230000000000004 111.324 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . 0.325 7.6 p90 52.39 -45.36 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 119.679 3.214 . . . . 74.510000000000005 119.679 171.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -78.96 -16.25 57.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 119.06 0.845 . . . . 75.439999999999998 112.933 -174.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.595 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -127.31 93.11 41.91 Favored Pre-proline 0 C--N 1.298 -1.636 0 N-CA-C 108.584 -0.895 . . . . 73.5 108.584 179.522 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.6 100.05 0.56 Allowed 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 122.467 2.111 . . . . 73.439999999999998 112.017 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.61 142.68 51.19 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.157 -0.683 . . . . 52.030000000000001 109.157 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.22 72.94 3.34 Favored 'General case' 0 CA--C 1.486 -1.511 0 CA-C-O 121.339 0.59 . . . . 53.420000000000002 111.294 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -84.85 131.14 34.56 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.923 -1.51 . . . . 75.430000000000007 106.923 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.45 ' HB3' HE22 ' A' ' 50' ' ' GLN . 53.7 tt0 -120.01 149.68 41.76 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.145 -0.687 . . . . 72.310000000000002 109.145 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.38 104.27 15.04 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 109.267 -0.642 . . . . 75.109999999999999 109.267 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 12.1 tppt? -132.94 146.01 51.41 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.586 -1.264 . . . . 73.409999999999997 107.586 168.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -87.02 77.45 9.17 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.596 1.189 . . . . 71.340000000000003 108.002 172.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.43 83.44 0.96 Allowed Glycine 0 N--CA 1.406 -3.342 0 CA-C-N 114.327 -1.306 . . . . 45.420000000000002 109.959 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 48.7 tt0 -149.42 132.85 16.61 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 108.215 -1.031 . . . . 60.229999999999997 108.215 -177.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.25 141.22 51.09 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 120.258 -0.577 . . . . 73.409999999999997 110.584 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -95.89 114.76 26.52 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.191 -1.781 . . . . 73.549999999999997 106.191 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -114.64 140.14 49.06 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 119.71 -0.796 . . . . 72.0 110.641 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.2 tp -166.87 148.01 5.95 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 103.824 -2.658 . . . . 71.310000000000002 103.824 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.1 tm0? -85.56 -56.3 3.57 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.564 -0.854 . . . . 72.140000000000001 108.995 -175.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.5 m -109.51 100.8 43.49 Favored Pre-proline 0 N--CA 1.434 -1.227 0 N-CA-C 108.113 -1.069 . . . . 72.129999999999995 108.113 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.79 134.9 8.68 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.145 2.563 . . . . 64.420000000000002 113.789 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -123.85 101.61 7.36 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.125 -1.065 . . . . 71.120000000000005 108.125 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.09 -86.74 0.43 Allowed Glycine 0 C--N 1.305 -1.179 0 N-CA-C 110.648 -0.981 . . . . 53.409999999999997 110.648 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -93.03 136.42 1.32 Allowed 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.375 2.05 . . . . 63.340000000000003 111.827 176.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.491 ' HB2' ' NE1' ' A' ' 78' ' ' TRP . 16.1 m -78.67 163.85 58.84 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.481 -0.933 . . . . 73.25 108.481 175.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.27 110.51 0.8 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.294 1.996 . . . . 60.240000000000002 111.285 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.9 p -111.82 167.02 10.69 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 109.389 -0.597 . . . . 55.219999999999999 109.389 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HZ3' ' CG ' ' A' ' 79' ' ' ASP . 22.9 pttm -158.31 145.26 17.71 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.233 -0.655 . . . . 64.329999999999998 109.233 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.6 t -89.26 126.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 107.271 -1.381 . . . . 71.400000000000006 107.271 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 tt -74.79 -53.41 9.22 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.009 -1.478 . . . . 65.530000000000001 107.009 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.9 141.93 5.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.016 -0.993 . . . . 63.119999999999997 109.108 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.407 HG23 HD23 ' A' ' 74' ' ' LEU . 14.3 p -122.3 120.04 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-O 121.981 0.896 . . . . 70.430000000000007 108.953 173.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 84.4 mm-40 -105.17 142.14 35.48 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 114.013 -1.449 . . . . 74.040000000000006 109.778 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 135.94 95.65 Favored Pre-proline 0 C--N 1.283 -2.316 0 CA-C-N 114.569 -1.196 . . . . 62.299999999999997 109.103 -165.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -3.07 54.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.614 1 C-N-CA 128.323 6.015 . . . . 53.119999999999997 117.977 -162.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -152.23 -37.63 0.11 Allowed 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.617 -0.72 . . . . 55.420000000000002 110.809 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 35.1 tt0 -139.72 129.14 24.16 Favored 'General case' 0 C--O 1.198 -1.621 0 C-N-CA 117.351 -1.74 . . . . 64.010000000000005 112.142 -174.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.569 HD13 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -131.15 134.39 46.49 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.717 -0.845 . . . . 74.349999999999994 108.717 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.4 m -140.26 126.7 20.11 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.639 -0.255 . . . . 61.350000000000001 110.497 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -142.45 154.7 44.79 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.813 0.34 . . . . 74.340000000000003 110.271 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -122.63 132.25 54.19 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.688 -0.856 . . . . 62.43 108.688 -172.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.491 ' NE1' ' HB2' ' A' ' 61' ' ' SER . 15.6 t-105 -112.98 106.14 14.34 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.124 -1.806 . . . . 75.540000000000006 106.124 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.411 ' CG ' ' HZ3' ' A' ' 64' ' ' LYS . 10.0 m-20 -72.49 172.26 10.83 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.238 -0.437 . . . . 74.319999999999993 110.69 -175.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.1 m 65.3 43.89 3.39 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 122.196 0.998 . . . . 72.530000000000001 109.448 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 64.51 32.37 11.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.352 -1.295 . . . . 71.010000000000005 113.508 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.464 ' HA3' ' CD1' ' A' ' 78' ' ' TRP . . . -86.81 -17.86 59.11 Favored Glycine 0 C--O 1.238 0.373 0 N-CA-C 109.308 -1.517 . . . . 42.310000000000002 109.308 171.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 28.6 m95 81.22 -174.17 0.04 OUTLIER 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.634 1.974 . . . . 74.510000000000005 112.217 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.32 122.96 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 121.758 0.79 . . . . 70.409999999999997 110.196 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m -116.8 152.36 18.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-O 121.317 0.58 . . . . 73.230000000000004 110.198 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.1 m -139.49 142.22 37.33 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 109.083 -0.71 . . . . 74.319999999999993 109.083 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.599 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 15.0 m-85 -121.23 140.35 52.16 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.89 -1.152 . . . . 75.239999999999995 107.89 176.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.88 132.79 53.26 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.357 -1.349 . . . . 63.039999999999999 107.357 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.84 122.18 44.61 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.738 0.78 . . . . 73.120000000000005 111.988 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -102.76 125.46 49.51 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.589 -1.187 . . . . 73.349999999999994 108.92 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -84.4 125.83 32.68 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.522 -0.763 . . . . 73.239999999999995 110.603 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.6 mt -125.43 153.04 44.06 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.856 -1.535 . . . . 64.409999999999997 106.856 171.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.18 38.22 2.73 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 114.613 0.605 . . . . 36.719999999999999 114.613 -172.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -176.02 -38.66 0.01 OUTLIER 'General case' 0 C--O 1.24 0.588 0 N-CA-C 109.372 -0.603 . . . . 73.340000000000003 109.372 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -127.12 175.81 7.85 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.115 -1.068 . . . . 74.349999999999994 108.115 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.4 m -121.54 129.07 52.66 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 120.709 -0.396 . . . . 73.040000000000006 110.281 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.42 106.16 3.32 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 109.489 -1.444 . . . . 62.530000000000001 109.489 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -98.58 134.47 41.47 Favored 'General case' 0 C--N 1.27 -2.864 0 O-C-N 121.801 -0.823 . . . . 65.420000000000002 109.652 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.6 m -118.84 121.7 40.63 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.387 -0.968 . . . . 74.219999999999999 108.387 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -101.83 142.34 33.29 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.694 0.759 . . . . 72.329999999999998 109.131 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 100' ' ' LEU . 17.7 mt -136.15 124.44 36.43 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.911 0 CA-C-N 113.92 -1.491 . . . . 72.430000000000007 107.653 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -120.22 118.24 29.95 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.294 -1.743 . . . . 72.040000000000006 106.294 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -138.79 164.19 30.25 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.811 -1.181 . . . . 74.049999999999997 107.811 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.21 170.1 34.37 Favored Glycine 0 N--CA 1.413 -2.889 0 N-CA-C 109.777 -1.329 . . . . 51.439999999999998 109.777 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -83.86 100.62 11.09 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.003 -0.74 . . . . 74.299999999999997 109.003 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.443 ' H ' ' HD2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -79.18 79.86 5.57 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.236 1.017 . . . . 63.43 110.764 -179.246 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -85.92 -60.14 0.28 Allowed Pre-proline 0 C--N 1.304 -1.408 0 CA-C-N 115.037 -0.983 . . . . 64.239999999999995 112.226 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.8 -23.45 76.63 Favored 'Trans proline' 0 C--N 1.383 2.395 0 C-N-CA 121.701 1.601 . . . . 64.209999999999994 113.332 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 66.8 t30 61.44 19.93 10.71 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.491 1.116 . . . . 71.409999999999997 111.964 175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -130.23 -73.25 0.56 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.871 -0.788 . . . . 75.340000000000003 108.871 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 p -141.24 146.7 23.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.218 -1.401 . . . . 73.409999999999997 107.218 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.476 ' H ' HD12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -62.42 -39.42 84.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 112.344 0.498 . . . . 64.239999999999995 112.344 179.359 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.92 -128.61 8.83 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.663 -0.78 . . . . 54.420000000000002 112.741 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -75.42 -7.39 53.93 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.69 0.796 . . . . 71.019999999999996 111.765 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.13 -34.02 71.56 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 123.137 0.273 . . . . 63.119999999999997 110.544 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -163.06 -81.7 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 119.676 -0.809 . . . . 71.200000000000003 112.887 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -151.28 -162.1 1.47 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.698 1.199 . . . . 55.119999999999997 109.231 -173.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.428 ' HB2' HG22 ' A' ' 121' ' ' VAL . 3.7 mppt? -75.43 154.38 37.13 Favored 'General case' 0 C--O 1.212 -0.895 0 C-N-CA 122.994 0.517 . . . . 65.310000000000002 110.289 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.0 m -60.21 -41.6 93.38 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.922 1.082 . . . . 65.409999999999997 113.922 -175.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.2 t -69.7 -45.87 67.27 Favored 'General case' 0 C--O 1.256 1.438 0 C-N-CA 120.116 -0.634 . . . . 74.310000000000002 111.138 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 118' ' ' LYS . 27.6 m -69.94 -36.74 70.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 119.16 -1.016 . . . . 73.310000000000002 110.928 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 126' ' ' MET . 21.4 t -61.27 -45.68 98.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.253 0 O-C-N 123.167 0.292 . . . . 75.239999999999995 111.407 175.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -64.44 -40.45 95.76 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.882 -0.327 . . . . 71.409999999999997 111.237 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.03 -45.0 95.04 Favored Glycine 0 CA--C 1.492 -1.356 0 N-CA-C 111.225 -0.75 . . . . 61.310000000000002 111.225 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -68.22 -32.33 72.46 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.697 -0.752 . . . . 65.420000000000002 111.195 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 21.3 mmt -64.06 -49.37 72.59 Favored 'General case' 0 C--O 1.206 -1.21 0 C-N-CA 121.068 -0.253 . . . . 63.520000000000003 111.252 176.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.92 -51.38 62.19 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 119.839 -0.744 . . . . 63.020000000000003 110.973 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.76 -44.97 95.49 Favored Glycine 0 C--O 1.241 0.545 0 C-N-CA 121.232 -0.508 . . . . 73.230000000000004 111.981 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.556 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -62.46 -50.89 60.44 Favored Glycine 0 CA--C 1.487 -1.679 0 N-CA-C 111.352 -0.699 . . . . 44.130000000000003 111.352 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.512 ' O ' HG11 ' A' ' 134' ' ' VAL . 77.4 m95 -59.51 -37.24 77.78 Favored 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 118.83 -0.605 . . . . 75.340000000000003 112.496 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.498 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 90.1 m -54.32 -54.4 40.84 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 109.859 -0.422 . . . . 74.030000000000001 109.859 176.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.62 -45.33 67.16 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.804 -0.634 . . . . 45.530000000000001 113.538 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 129' ' ' GLY . 36.2 pt -74.68 -36.67 41.19 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.416 0 N-CA-C 113.213 0.819 . . . . 74.140000000000001 113.213 -176.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 130' ' ' TRP . 4.2 p -74.92 -38.82 44.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 118.671 -1.212 . . . . 60.340000000000003 110.494 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.3 -60.25 3.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.742 -0.383 . . . . 74.209999999999994 110.896 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.2 -43.95 66.39 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.248 0.462 . . . . 53.020000000000003 112.248 -173.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.51 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 2.0 tmm_? -70.27 -41.56 73.28 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.228 -0.589 . . . . 73.519999999999996 110.454 -173.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.0 mm? -63.96 -45.46 89.02 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 119.839 -0.744 . . . . 63.520000000000003 109.198 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.4 ' HD2' ' C ' ' A' ' 139' ' ' ARG . 3.9 tmm_? -59.03 -42.28 89.81 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.815 -0.629 . . . . 71.519999999999996 110.187 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -65.27 -51.66 59.34 Favored 'General case' 0 C--O 1.166 -3.311 0 CA-C-O 119.502 -0.285 . . . . 73.420000000000002 111.382 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.2 73.48 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 123.359 0.412 . . . . 72.530000000000001 112.106 -175.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 31.2 m -74.34 -26.45 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 119.665 -0.814 . . . . 73.230000000000004 110.736 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.95 -53.28 4.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 118.815 -1.154 . . . . 52.350000000000001 112.63 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -143.63 107.15 4.59 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 124.229 1.012 . . . . 73.450000000000003 110.776 -175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 83.0 mt -68.27 -23.11 64.73 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.069 0.548 . . . . 73.230000000000004 111.759 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -73.21 104.44 4.26 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.875 0.845 . . . . 54.020000000000003 110.421 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -148.33 144.04 27.29 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 104.957 -2.238 . . . . 74.200000000000003 104.957 171.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -120.89 133.95 55.29 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.773 -0.771 . . . . 72.200000000000003 109.766 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -158.04 148.11 20.21 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 103.504 -2.776 . . . . 74.019999999999996 103.504 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -101.26 161.99 13.22 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.933 -1.136 . . . . 74.5 107.933 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -72.37 111.29 7.44 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.395 -1.335 . . . . 64.120000000000005 107.395 170.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 . . . . . 0 C--O 1.241 0.649 0 C-N-CA 125.592 1.557 . . . . 70.409999999999997 109.54 -170.95 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 120.894 0.378 . . . . 71.430000000000007 111.377 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 4.2 mm? 67.95 90.24 0.09 OUTLIER Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 114.911 -1.04 . . . . 74.209999999999994 112.454 -172.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -88.32 -159.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 122.309 2.006 . . . . 64.439999999999998 109.702 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 7.8 p-10 -65.86 116.16 6.73 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.945 0.879 . . . . 73.040000000000006 111.151 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 50.0 mm -120.6 124.46 72.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 106.578 -1.638 . . . . 43.130000000000003 106.578 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.9 m -111.38 136.76 50.06 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.834 -0.802 . . . . 71.430000000000007 108.834 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -142.07 142.96 32.88 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.058 -1.089 . . . . 72.299999999999997 108.058 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.0 p -137.31 134.15 35.76 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 118.332 0.514 . . . . 34.200000000000003 109.785 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.92 131.84 13.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.236 -0.653 . . . . 74.450000000000003 109.236 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.477 ' CG2' ' HG3' ' A' ' 95' ' ' LYS . 2.7 m -94.52 120.97 35.57 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-O 121.798 0.809 . . . . 74.510000000000005 110.674 -175.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.2 mt -95.64 140.35 30.58 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.053 -0.976 . . . . 61.100000000000001 110.018 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.99 25.09 0.38 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.169 0.588 . . . . 75.549999999999997 112.21 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.84 160.47 44.56 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 122.655 0.382 . . . . 55.32 110.074 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 38.7 Cg_endo -67.4 157.41 61.9 Favored 'Trans proline' 0 C--O 1.256 1.402 0 C-N-CA 123.194 2.596 . . . . 62.149999999999999 111.55 175.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.9 tt -62.64 -27.16 42.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.785 -0.643 . . . . 75.319999999999993 112.119 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.41 -31.9 65.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.903 0.382 . . . . 75.420000000000002 111.481 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 5.0 tmtt? -79.1 -37.71 38.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 108.849 -0.797 . . . . 74.209999999999994 108.849 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 96' ' ' THR . 4.3 p -66.28 -39.84 85.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 120.074 -0.65 . . . . 71.299999999999997 110.243 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.483 ' NE1' ' HD3' ' A' ' 71' ' ' PRO . 50.2 t90 -58.11 -48.24 80.81 Favored 'General case' 0 C--O 1.213 -0.867 0 O-C-N 123.704 0.628 . . . . 64.510000000000005 111.153 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.49 -29.99 69.57 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 120.125 -0.63 . . . . 72.310000000000002 110.586 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 94.6 m -67.01 -26.27 66.7 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.993 0.425 . . . . 64.510000000000005 111.522 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.641 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.7 m -115.33 19.84 7.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 121.374 -0.829 . . . . 74.120000000000005 112.112 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.8 m -142.24 4.78 1.63 Allowed 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.842 0.682 . . . . 70.140000000000001 112.842 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.8 p -110.51 162.21 14.92 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.749 -0.834 . . . . 72.409999999999997 108.749 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -56.47 -44.78 80.89 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 123.474 0.709 . . . . 62.210000000000001 111.089 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.11 -46.61 64.46 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.402 -0.817 . . . . 70.340000000000003 111.005 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.06 -40.68 88.37 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 115.615 -0.721 . . . . 44.25 112.814 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.4 mt -68.92 -39.89 80.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 120.804 0.335 . . . . 71.349999999999994 110.842 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.387 0 CA-C-N 116.04 -0.527 . . . . 62.310000000000002 110.671 174.368 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 . . . . . 0 CA--C 1.501 -0.923 0 N-CA-C 108.261 -1.014 . . . . 74.430000000000007 108.261 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -99.1 61.54 1.24 Allowed 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.328 -0.949 . . . . 65.099999999999994 109.295 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.507 ' HD2' ' HG ' ' A' ' 63' ' ' CYS . 20.0 t80 -65.58 132.51 49.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.108 -1.405 . . . . 73.430000000000007 110.201 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -109.93 133.41 53.21 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.752 -0.462 . . . . 72.230000000000004 109.752 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 68' ' ' VAL . 15.7 tp -78.02 106.15 9.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.43 -1.322 . . . . 72.549999999999997 107.43 177.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -130.16 145.0 51.68 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.529 -1.286 . . . . 74.239999999999995 107.529 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -84.21 59.3 5.26 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.984 0.897 . . . . 71.010000000000005 109.277 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.27 77.53 0.58 Allowed Glycine 0 N--CA 1.414 -2.824 0 N-CA-C 109.38 -1.488 . . . . 64.209999999999994 109.38 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 C--N 1.314 -0.952 0 CA-C-O 121.94 0.876 . . . . 61.149999999999999 108.717 -176.615 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.507 ' HG ' ' HD2' ' A' ' 44' ' ' PHE . 3.9 p . . . . . 0 N--CA 1.408 -2.56 0 N-CA-C 107.983 -1.118 . . . . 61.039999999999999 107.983 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -133.97 140.83 47.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.756 -1.201 . . . . 75.030000000000001 107.756 -172.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.444 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 3.0 t -90.16 136.77 23.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 107.927 -1.138 . . . . 55.509999999999998 107.927 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.6 tp -83.52 -58.07 2.97 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.82 -1.178 . . . . 74.340000000000003 107.82 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.47 138.98 14.93 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.772 -1.104 . . . . 53.520000000000003 109.183 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.616 HG23 HD23 ' A' ' 74' ' ' LEU . 11.2 p -119.37 124.26 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 N-CA-C 108.978 -0.749 . . . . 74.120000000000005 108.978 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 28.2 mm-40 -105.12 140.84 37.69 Favored 'General case' 0 CA--C 1.48 -1.741 0 CA-C-N 115.663 -0.699 . . . . 72.439999999999998 109.602 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.32 126.48 92.61 Favored Pre-proline 0 C--N 1.279 -2.48 0 CA-C-N 113.604 -1.635 . . . . 72.530000000000001 109.047 -166.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.483 ' HD3' ' NE1' ' A' ' 26' ' ' TRP . 36.9 Cg_exo 5.89 42.99 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 1 C-N-CA 128.131 5.887 . . . . 32.229999999999997 118.428 -160.696 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 p -132.76 -39.13 0.99 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.312 -0.404 . . . . 73.239999999999995 111.867 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 40.5 tt0 -150.43 145.11 25.85 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 119.325 -0.95 . . . . 73.030000000000001 110.988 -172.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.682 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -139.25 135.11 33.54 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.676 -0.861 . . . . 73.409999999999997 108.676 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.8 m -140.54 126.04 18.96 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.689 0.28 . . . . 72.230000000000004 110.945 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.468 ' HD2' HD11 ' A' ' 74' ' ' LEU . 34.8 p90 -146.01 157.23 43.87 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 120.613 0.244 . . . . 72.030000000000001 111.02 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -120.95 123.86 43.5 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.978 -1.119 . . . . 74.299999999999997 107.978 -174.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -108.26 111.28 23.16 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 106.187 -1.783 . . . . 64.430000000000007 106.187 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.29 1.2 m-20 -79.1 10.16 3.78 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 116.808 2.151 . . . . 62.119999999999997 116.808 -170.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -75.85 94.95 3.41 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 104.529 -2.397 . . . . 75.319999999999993 104.529 167.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 83.68 -37.82 0.07 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.885 2.074 . . . . 75.219999999999999 109.718 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.94 47.45 0.56 Allowed Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 111.07 -0.812 . . . . 34.229999999999997 111.07 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -85.25 112.37 20.7 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.608 0.718 . . . . 73.540000000000006 110.402 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.1 t -101.77 117.27 46.83 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 N-CA-C 106.705 -1.591 . . . . 73.109999999999999 106.705 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.32 147.12 20.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-O 121.555 0.693 . . . . 73.450000000000003 110.518 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.526 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 46.7 m -128.88 132.73 47.75 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 115.019 -0.991 . . . . 72.409999999999997 108.711 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.682 ' CD2' HD12 ' A' ' 74' ' ' LEU . 14.4 m-85 -112.7 145.56 40.28 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.978 -1.119 . . . . 74.25 107.978 177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 69.4 mt-30 -130.84 144.17 51.26 Favored 'General case' 0 C--N 1.277 -2.573 0 O-C-N 123.591 0.557 . . . . 74.340000000000003 110.932 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.0 mt -114.9 120.9 41.53 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 123.707 0.63 . . . . 65.319999999999993 110.25 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -103.48 122.74 45.54 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.454 -0.943 . . . . 74.120000000000005 108.454 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -77.66 112.7 14.74 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.101 -0.5 . . . . 74.120000000000005 111.479 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.0 mt -125.58 160.2 30.18 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.365 -0.834 . . . . 72.329999999999998 108.963 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.76 123.94 6.89 Favored Glycine 0 N--CA 1.424 -2.152 0 N-CA-C 109.114 -1.594 . . . . 75.430000000000007 109.114 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 84.58 -10.03 0.87 Allowed 'General case' 0 CA--C 1.485 -1.522 0 C-N-CA 125.709 1.604 . . . . 64.209999999999994 111.812 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.477 ' HG3' ' CG2' ' A' ' 17' ' ' THR . 2.1 ptpt -154.99 174.87 14.56 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 108.519 -0.919 . . . . 72.049999999999997 108.519 -176.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.617 HG21 HG11 ' A' ' 25' ' ' VAL . 63.8 m -135.41 132.49 37.57 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 110.039 -0.356 . . . . 64.519999999999996 110.039 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.73 117.27 4.82 Favored Glycine 0 N--CA 1.423 -2.224 0 N-CA-C 109.831 -1.308 . . . . 73.200000000000003 109.831 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -99.77 129.98 45.94 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 108.81 -0.811 . . . . 71.439999999999998 108.81 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 37.7 m -117.38 121.41 41.01 Favored 'General case' 0 N--CA 1.408 -2.529 0 C-N-CA 119.196 -1.002 . . . . 72.420000000000002 108.778 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.54 140.01 35.41 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-O 122.265 1.031 . . . . 74.409999999999997 109.017 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 18.5 mt -136.19 124.95 37.54 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.117 0 CA-C-N 113.054 -1.885 . . . . 75.299999999999997 107.027 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.496 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . 10.3 t60 -120.25 131.87 55.11 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.919 -1.141 . . . . 74.109999999999999 107.919 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.6 m -142.88 132.48 23.77 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.696 -1.224 . . . . 23.109999999999999 107.696 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.87 127.09 9.11 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 120.497 -0.859 . . . . 64.439999999999998 111.201 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 . . . . . 0 N--CA 1.432 -1.361 0 CA-C-O 122.557 1.17 . . . . 73.25 111.432 -179.601 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 106.904 -1.517 . . . . 75.319999999999993 106.904 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 115' ' ' ALA . 9.6 pt -62.15 -43.96 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.914 0.779 . . . . 74.340000000000003 110.166 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.62 -80.05 0.37 Allowed Glycine 0 N--CA 1.422 -2.283 0 C-N-CA 119.862 -1.161 . . . . 65.010000000000005 114.451 173.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.1 mptp? -104.2 -34.12 8.48 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.694 0.628 . . . . 61.140000000000001 112.694 -168.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.604 ' HB3' HD12 ' A' ' 112' ' ' ILE . . . -65.03 -34.17 77.8 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 120.664 0.268 . . . . 63.140000000000001 111.68 -176.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -167.55 122.59 1.03 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.498 -1.297 . . . . 70.219999999999999 107.498 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -86.3 89.14 7.77 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.101 0.477 . . . . 50.210000000000001 111.584 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 31.4 tptt 179.64 152.84 0.44 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.045 -1.835 . . . . 74.319999999999993 106.045 171.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.2 p -111.76 -50.7 2.9 Favored 'General case' 0 C--N 1.286 -2.18 0 C-N-CA 120.028 -0.669 . . . . 75.5 111.37 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.2 p -63.22 -46.32 87.52 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.657 0.783 . . . . 74.450000000000003 111.187 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.91 -47.03 83.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.209 -0.905 . . . . 74.450000000000003 110.72 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.6 t -59.28 -35.03 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 116.357 -0.383 . . . . 71.409999999999997 111.237 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -66.56 -50.63 62.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.469 -0.937 . . . . 64.219999999999999 108.469 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.87 -40.53 98.42 Favored Glycine 0 C--O 1.241 0.547 0 CA-C-N 116.061 -0.518 . . . . 73.209999999999994 112.564 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -64.45 -38.77 92.2 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 122.877 0.471 . . . . 72.340000000000003 111.184 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.0 mmt -69.87 -36.83 75.82 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 121.361 -0.136 . . . . 73.150000000000006 111.353 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.49 -56.22 24.71 Favored 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 123.201 0.313 . . . . 61.240000000000002 110.737 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.83 -37.68 88.62 Favored Glycine 0 C--O 1.245 0.828 0 C-N-CA 120.672 -0.775 . . . . 62.229999999999997 111.745 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.8 -63.13 5.36 Favored Glycine 0 N--CA 1.438 -1.175 0 CA-C-N 115.309 -0.445 . . . . 62.420000000000002 112.408 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.642 ' O ' HG22 ' A' ' 134' ' ' VAL . 90.9 m95 -56.07 -45.25 79.38 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 113.342 0.867 . . . . 73.420000000000002 113.342 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.4 m -54.66 -51.44 65.48 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.708 0.63 . . . . 64.129999999999995 110.743 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.96 -43.61 64.8 Favored Glycine 0 C--O 1.25 1.125 0 C-N-CA 120.525 -0.845 . . . . 63.439999999999998 112.425 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.57 -57.6 11.35 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.848 0 CA-C-O 119.161 -0.447 . . . . 73.409999999999997 111.705 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 130' ' ' TRP . 27.4 m -64.19 -35.58 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 C-N-CA 118.906 -1.118 . . . . 75.549999999999997 112.841 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 42.3 t30 -57.81 -70.4 0.14 Allowed 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.558 0.536 . . . . 74.049999999999997 112.0 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.23 -28.13 27.49 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 118.93 -1.108 . . . . 74.230000000000004 112.062 -172.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -73.61 -38.08 65.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 118.722 -1.191 . . . . 70.140000000000001 110.804 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.5 mm? -70.78 -42.95 69.7 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 118.345 -1.342 . . . . 63.149999999999999 109.338 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 135' ' ' ASN . 2.3 tmm_? -57.73 -40.98 80.9 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 115.788 -0.642 . . . . 72.439999999999998 110.552 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -73.14 -36.67 66.7 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 113.422 0.897 . . . . 75.349999999999994 113.422 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.79 58.48 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.093 0.473 . . . . 62.149999999999999 110.968 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.471 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 32.1 m -85.36 -30.24 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 119.9 -0.72 . . . . 72.510000000000005 111.571 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -92.69 -26.19 17.9 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.102 0.779 . . . . 63.32 113.102 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 C--N 1.297 -1.708 0 N-CA-C 105.461 -2.051 . . . . 72.439999999999998 105.461 -177.443 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.519 0 N-CA-C 108.578 -0.897 . . . . 64.310000000000002 108.578 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 tp -67.33 116.54 37.73 Favored Pre-proline 0 C--N 1.313 -0.981 0 O-C-N 123.767 0.667 . . . . 72.400000000000006 110.686 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -99.78 -157.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.251 0 C-N-CA 123.01 2.473 . . . . 64.120000000000005 108.959 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.623 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 5.1 p-10 -70.37 131.77 44.61 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.006 -0.678 . . . . 72.329999999999998 110.166 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.3 tt -132.41 138.95 51.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.933 -0.765 . . . . 72.5 108.933 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 m -111.77 134.83 53.08 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.797 -0.445 . . . . 75.430000000000007 109.797 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.505 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -136.9 124.1 21.77 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.082 -1.451 . . . . 64.299999999999997 107.082 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 m -117.84 134.02 55.35 Favored 'General case' 0 C--N 1.261 -3.266 0 N-CA-C 109.244 -0.651 . . . . 61.109999999999999 109.244 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.34 133.09 28.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 109.263 -0.643 . . . . 72.409999999999997 109.263 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -97.14 125.39 41.61 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 116.198 -0.455 . . . . 72.019999999999996 111.016 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.47 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.8 mp -101.06 139.58 36.55 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.096 -0.502 . . . . 74.230000000000004 110.077 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -80.06 29.94 0.27 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.987 0.915 . . . . 72.540000000000006 111.343 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.97 157.8 74.65 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.735 -0.839 . . . . 73.510000000000005 108.735 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.93 159.8 44.39 Favored 'Trans proline' 0 C--O 1.26 1.582 0 C-N-CA 123.087 2.525 . . . . 62.310000000000002 111.756 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -66.66 -24.9 33.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.85 -0.614 . . . . 62.219999999999999 111.535 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.532 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.0 pt20 -66.11 -40.81 91.02 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.313 -0.403 . . . . 75.219999999999999 111.392 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -74.66 -39.91 61.75 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.017 0.437 . . . . 64.040000000000006 111.011 -175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.641 HG11 HG21 ' A' ' 96' ' ' THR . 7.1 p -65.03 -38.37 82.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.319 -0.4 . . . . 75.209999999999994 110.079 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -58.68 -46.92 86.16 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.81 -0.632 . . . . 74.230000000000004 109.968 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 35.6 mt-10 -61.45 -38.29 86.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.923 0.392 . . . . 61.439999999999998 110.114 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.4 m -66.65 -11.72 55.1 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-N 115.987 -0.551 . . . . 74.340000000000003 111.757 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.62 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.8 m -128.82 9.21 2.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 121.178 -0.951 . . . . 54.109999999999999 112.529 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.3 t -124.96 -9.17 7.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.584 0.23 . . . . 43.039999999999999 111.529 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.9 p -94.46 154.21 17.55 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.851 -1.537 . . . . 55.420000000000002 106.851 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.0 m -57.2 -39.46 75.46 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 118.504 0.593 . . . . 75.140000000000001 111.645 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 2.2 mp0 -65.86 -43.67 87.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.99 -1.005 . . . . 72.310000000000002 109.783 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.58 -40.64 53.37 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 115.055 -0.975 . . . . 34.130000000000003 112.886 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.35 -48.42 88.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 122.748 0.419 . . . . 45.25 110.015 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 112.62 0.6 . . . . 51.229999999999997 112.62 177.202 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 . . . . . 0 CA--C 1.505 -0.766 0 N-CA-C 112.525 0.565 . . . . 65.219999999999999 112.525 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -85.46 -2.11 57.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.243 -0.89 . . . . 72.239999999999995 111.087 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -76.87 118.83 19.85 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.829 -0.804 . . . . 70.439999999999998 108.829 -175.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.23 151.93 30.41 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.815 -0.629 . . . . 74.409999999999997 109.837 -173.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.762 HD11 HG11 ' A' ' 68' ' ' VAL . 3.0 tm? -81.65 104.88 12.37 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.961 -1.866 . . . . 65.299999999999997 105.961 175.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -134.83 137.69 43.53 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 106.168 -1.79 . . . . 62.219999999999999 106.168 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 6.5 pt-20 -91.75 70.25 5.68 Favored 'General case' 0 C--N 1.26 -3.312 0 CA-C-N 119.826 1.194 . . . . 74.209999999999994 109.821 174.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 131.19 96.42 0.71 Allowed Glycine 0 N--CA 1.401 -3.678 0 CA-C-N 113.784 -1.553 . . . . 32.350000000000001 110.91 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.295 -1.798 0 N-CA-C 106.91 -1.515 . . . . 72.409999999999997 106.91 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 26.6 p . . . . . 0 N--CA 1.425 -1.681 0 CA-C-O 120.759 0.314 . . . . 45.310000000000002 110.492 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -123.48 118.83 28.3 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 108.519 -0.919 . . . . 64.299999999999997 108.519 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 76' ' ' PHE . 28.5 t -85.51 127.05 40.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 106.472 -1.677 . . . . 72.049999999999997 106.472 174.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.7 tp -72.76 -53.39 11.74 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 124.209 0.943 . . . . 62.420000000000002 108.641 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.05 150.62 6.62 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.205 -0.907 . . . . 61.310000000000002 110.255 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.762 HG11 HD11 ' A' ' 46' ' ' LEU . 59.7 t -121.14 118.88 57.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 107.459 -1.311 . . . . 60.420000000000002 107.459 173.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 41.9 mt-30 -111.67 141.76 44.86 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 123.958 0.903 . . . . 75.239999999999995 110.149 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.18 134.25 94.76 Favored Pre-proline 0 C--N 1.287 -2.129 0 CA-C-N 114.128 -1.396 . . . . 51.140000000000001 110.184 -162.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo 0.53 48.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.175 1 C-N-CA 128.434 6.089 . . . . 73.140000000000001 117.557 -163.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 7.5 m -146.58 -45.24 0.19 Allowed 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.876 -0.602 . . . . 72.239999999999995 111.265 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 29.0 tt0 -141.38 128.55 20.92 Favored 'General case' 0 C--O 1.21 -0.978 0 C-N-CA 117.243 -1.783 . . . . 63.450000000000003 111.905 -169.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.709 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.9 tm? -133.52 132.26 40.75 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 109.318 -0.623 . . . . 73.540000000000006 109.318 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.3 m -138.12 126.21 22.83 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.728 -0.389 . . . . 60.329999999999998 110.724 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.482 ' HD2' HD11 ' A' ' 74' ' ' LEU . 39.5 p90 -146.67 154.84 41.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.399 0.142 . . . . 72.239999999999995 110.782 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -123.55 123.66 41.1 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.031 -1.1 . . . . 63.32 108.031 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -101.4 140.34 35.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.339 0.59 . . . . 55.409999999999997 112.282 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -93.2 -172.46 2.96 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 103.625 -2.731 . . . . 72.329999999999998 103.625 167.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.1 m 66.76 30.4 8.06 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 122.841 1.305 . . . . 54.229999999999997 107.497 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.49 ' OE1' ' HG3' ' A' ' 114' ' ' LYS . 7.8 mm-40 56.88 53.9 7.67 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.329 1.852 . . . . 72.340000000000003 114.266 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.44 -37.22 2.68 Favored Glycine 0 C--N 1.312 -0.785 0 N-CA-C 109.821 -1.312 . . . . 73.530000000000001 109.821 174.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.742 ' HZ2' ' HB2' ' A' ' 115' ' ' ALA . 2.8 m0 70.65 -164.85 0.15 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.706 1.603 . . . . 74.549999999999997 111.973 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -91.38 118.86 37.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.653 -0.499 . . . . 73.510000000000005 109.653 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.7 144.63 33.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.399 -0.593 . . . . 52.149999999999999 109.399 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.457 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 38.9 m -130.68 139.42 50.32 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 115.909 -0.587 . . . . 75.109999999999999 109.925 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.709 ' CD2' HD12 ' A' ' 74' ' ' LEU . 10.0 m-85 -117.73 140.17 50.04 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.915 -1.143 . . . . 70.219999999999999 107.915 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.62 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 82.8 mt-30 -130.07 140.21 50.86 Favored 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 115.689 -0.687 . . . . 71.340000000000003 110.083 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 72' ' ' THR . 75.8 mt -118.71 124.42 47.29 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.049 0.452 . . . . 75.420000000000002 110.038 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -109.55 116.55 31.99 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.784 -0.821 . . . . 72.150000000000006 108.784 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.61 111.21 15.66 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.722 -0.672 . . . . 74.129999999999995 110.738 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 81.1 mt -109.84 153.8 23.91 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.912 -1.144 . . . . 74.340000000000003 107.912 176.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.48 39.63 3.01 Favored Glycine 0 C--N 1.29 -2.002 0 C-N-CA 121.145 -0.55 . . . . 33.520000000000003 111.917 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -156.74 -42.82 0.07 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 124.405 1.082 . . . . 54.409999999999997 109.305 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.0 ptpt -155.92 177.06 11.84 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.852 -1.166 . . . . 73.209999999999994 107.852 -168.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.641 HG21 HG11 ' A' ' 25' ' ' VAL . 38.9 m -113.32 125.72 54.59 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.854 -0.795 . . . . 72.510000000000005 108.854 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.06 109.69 3.67 Favored Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 110.526 -1.03 . . . . 53.509999999999998 110.526 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -98.05 132.43 43.61 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.409 -0.96 . . . . 73.150000000000006 108.409 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 28.0 m -122.23 122.94 40.31 Favored 'General case' 0 N--CA 1.406 -2.652 0 C-N-CA 119.496 -0.882 . . . . 72.430000000000007 109.038 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.468 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -103.13 140.19 37.66 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-O 122.023 0.916 . . . . 61.32 108.678 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.8 mp -135.64 124.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.453 0 N-CA-C 105.981 -1.859 . . . . 73.540000000000006 105.981 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 24.1 t60 -114.59 131.84 56.55 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.326 -1.361 . . . . 73.120000000000005 107.326 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.7 t -137.74 150.17 47.05 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.861 -1.163 . . . . 73.409999999999997 107.861 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -104.17 158.13 16.86 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 110.525 -1.03 . . . . 70.319999999999993 110.525 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 . . . . . 0 C--N 1.318 -0.791 0 CA-C-N 117.612 0.706 . . . . 72.340000000000003 112.214 -178.376 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.477 HG22 ' H ' ' A' ' 112' ' ' ILE . 14.8 p . . . . . 0 N--CA 1.423 -1.804 0 N-CA-C 104.674 -2.343 . . . . 44.5 104.674 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.561 HD12 ' HB3' ' A' ' 115' ' ' ALA . 8.8 pt -57.53 -39.82 71.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 118.504 0.593 . . . . 70.239999999999995 111.896 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.99 -64.83 3.03 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.751 -0.261 . . . . 63.310000000000002 112.952 175.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.49 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 0.5 OUTLIER -50.82 -48.05 59.91 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 125.243 1.417 . . . . 74.219999999999999 111.884 -177.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.742 ' HB2' ' HZ2' ' A' ' 83' ' ' TRP . . . -71.57 -23.68 61.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 114.604 1.335 . . . . 72.010000000000005 114.604 -173.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 60.98 33.36 19.79 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.012 0.91 . . . . 63.520000000000003 109.208 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -109.29 -164.47 0.94 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.096 -0.956 . . . . 74.129999999999995 112.182 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.402 ' HB2' HG23 ' A' ' 122' ' ' VAL . 26.7 mmtp -76.45 -170.15 1.42 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.255 -0.884 . . . . 74.049999999999997 108.881 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.461 ' HB3' HG23 ' A' ' 111' ' ' VAL . 14.2 p -126.72 -68.22 0.82 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.251 -0.98 . . . . 72.540000000000006 112.754 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.5 t -62.34 -44.5 96.34 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 123.158 0.286 . . . . 63.130000000000003 110.561 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p -70.61 -34.07 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 119.36 -0.936 . . . . 71.430000000000007 110.313 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 112' ' ' ILE . 73.5 t -68.14 -42.81 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.648 -0.251 . . . . 72.329999999999998 110.987 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.8 ttp85 -59.24 -50.76 72.78 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.896 -0.779 . . . . 63.219999999999999 108.896 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.53 -41.76 99.63 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-N 115.736 -0.665 . . . . 43.009999999999998 113.061 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.401 ' O ' ' HA3' ' A' ' 129' ' ' GLY . 2.3 tmmm? -68.79 -32.15 71.68 Favored 'General case' 0 C--O 1.198 -1.61 0 N-CA-C 112.196 0.443 . . . . 74.140000000000001 112.196 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.462 ' HA ' ' CE ' ' A' ' 126' ' ' MET . 2.6 mmt -78.31 -42.37 30.93 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.234 -0.586 . . . . 73.349999999999994 110.604 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -56.93 -63.55 1.17 Allowed 'General case' 0 C--O 1.251 1.149 0 C-N-CA 124.232 1.013 . . . . 73.299999999999997 109.348 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.31 -34.24 64.15 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.262 -0.881 . . . . 45.240000000000002 111.722 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -61.4 -59.37 10.01 Favored Glycine 0 C--O 1.209 -1.419 0 CA-C-O 119.256 -0.746 . . . . 62.240000000000002 112.333 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.417 ' HE3' HG23 ' A' ' 134' ' ' VAL . 61.1 m95 -59.49 -38.66 81.45 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 117.931 0.866 . . . . 74.439999999999998 112.646 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.2 m -60.5 -52.91 63.17 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 120.504 -0.479 . . . . 71.209999999999994 110.796 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.49 -49.56 18.95 Favored Glycine 0 C--O 1.242 0.595 0 C-N-CA 121.162 -0.542 . . . . 74.129999999999995 113.562 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 77.3 mt -61.1 -49.64 83.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 C-N-CA 122.699 0.399 . . . . 74.25 111.154 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.523 ' HA ' HD23 ' A' ' 138' ' ' LEU . 97.3 t -63.48 -49.78 81.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.223 -0.991 . . . . 62.420000000000002 111.441 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -55.28 -63.89 1.02 Allowed 'General case' 0 C--O 1.246 0.905 0 O-C-N 123.785 0.678 . . . . 54.210000000000001 111.864 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 7.0 tp10 -81.98 -40.83 21.62 Favored 'General case' 0 C--O 1.174 -2.896 0 C-N-CA 118.424 -1.31 . . . . 61.219999999999999 113.211 -173.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.44 ' O ' ' HD3' ' A' ' 137' ' ' ARG . 2.1 tmt_? -64.19 -37.04 86.04 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.976 1.262 . . . . 71.329999999999998 110.028 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.3 mm? -69.93 -50.16 44.82 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 119.125 -1.03 . . . . 60.310000000000002 110.206 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 139' ' ' ARG . 1.9 tmm_? -61.62 -36.52 80.98 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 121.359 0.6 . . . . 73.129999999999995 111.246 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -70.86 -47.76 57.58 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 123.746 0.818 . . . . 74.439999999999998 108.891 -177.664 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.01 75.01 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 111.608 0.225 . . . . 61.240000000000002 111.608 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.56 -32.17 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 119.718 -0.793 . . . . 55.240000000000002 110.923 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.49 -48.41 22.73 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 120.173 -0.611 . . . . 64.109999999999999 111.519 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.464 ' HG3' ' HE2' ' A' ' 140' ' ' LYS . 8.0 pt-20 . . . . . 0 C--N 1.312 -1.026 0 C-N-CA 123.769 0.828 . . . . 75.299999999999997 110.611 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . . . . . . 0 N--CA 1.442 -0.871 0 N-CA-C 106.638 -1.616 . . . . 62.109999999999999 106.638 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.8 tp -108.45 99.7 34.18 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 120.116 -0.634 . . . . 43.149999999999999 110.438 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 43.1 Cg_endo -95.97 -159.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.136 2.557 . . . . 74.329999999999998 110.047 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 1.6 m-20 -76.4 109.57 10.22 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.65 -0.5 . . . . 70.409999999999997 109.65 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.6 HG22 ' HB3' ' A' ' 102' ' ' HIS . 10.9 tp -102.31 128.37 55.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.268 -1.382 . . . . 74.120000000000005 107.268 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.1 m -111.04 129.11 56.01 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 109.083 -0.71 . . . . 72.230000000000004 109.083 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 25.2 mmmt -131.31 132.1 44.28 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.716 -0.674 . . . . 73.040000000000006 110.646 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 m -118.43 132.81 56.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.887 -1.153 . . . . 73.219999999999999 107.887 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.66 140.7 20.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.922 -0.77 . . . . 54.329999999999998 108.922 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 p -103.02 132.45 49.27 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.612 0.72 . . . . 75.409999999999997 112.905 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 139' ' ' ARG . 2.2 mm? -108.79 140.48 42.16 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.302 -0.863 . . . . 64.430000000000007 110.897 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -80.57 25.46 0.42 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.603 1.161 . . . . 71.019999999999996 111.314 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -131.76 165.34 36.42 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 108.678 -0.86 . . . . 73.239999999999995 108.678 -174.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 46.2 Cg_endo -72.09 161.3 45.1 Favored 'Trans proline' 0 C--O 1.257 1.456 0 C-N-CA 121.907 1.738 . . . . 75.099999999999994 111.06 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.0 tt -58.21 -31.11 41.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 115.906 -0.588 . . . . 73.340000000000003 110.795 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -56.4 -50.59 71.17 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.937 0.895 . . . . 74.310000000000002 111.729 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -73.64 -36.55 65.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.116 -0.493 . . . . 74.129999999999995 110.618 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.44 HG21 ' HB ' ' A' ' 96' ' ' THR . 46.1 t -67.69 -41.13 85.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.761 -0.459 . . . . 73.329999999999998 109.761 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 46.3 t90 -61.29 -46.98 88.09 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.962 -1.017 . . . . 74.310000000000002 110.226 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -23.63 63.73 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.312 -0.555 . . . . 72.109999999999999 111.68 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.8 m -67.49 -18.1 64.93 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 121.431 0.634 . . . . 73.340000000000003 111.337 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.576 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 9.9 m -123.05 17.5 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 O-C-N 121.463 -0.773 . . . . 65.010000000000005 110.837 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.5 m -142.12 9.08 1.88 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.15 0.796 . . . . 70.450000000000003 113.15 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.4 p -114.07 168.56 9.71 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 121.635 -0.666 . . . . 61.409999999999997 109.771 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.655 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 15.9 m -58.38 -40.55 82.61 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 123.85 0.719 . . . . 74.519999999999996 109.507 175.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -68.85 -46.88 67.36 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.692 -1.14 . . . . 75.540000000000006 110.955 -177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.5 -47.99 25.56 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.84 -0.695 . . . . 73.310000000000002 113.62 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.04 -34.29 62.55 Favored 'Isoleucine or valine' 0 C--O 1.256 1.401 0 CA-C-O 121.182 0.515 . . . . 71.129999999999995 110.722 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.737 0 CA-C-N 115.702 -0.681 . . . . 74.430000000000007 112.062 174.981 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.655 ' O ' ' HB3' ' A' ' 32' ' ' SER . 43.1 t-20 . . . . . 0 CA--C 1.495 -1.166 0 N-CA-C 105.935 -1.876 . . . . 63.219999999999999 105.935 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -90.81 69.61 6.51 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 113.288 0.848 . . . . 71.019999999999996 113.288 -170.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.484 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 94.0 m-85 -77.39 130.36 36.98 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.584 -1.265 . . . . 74.430000000000007 107.584 171.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -109.44 145.04 36.83 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.448 -0.945 . . . . 74.109999999999999 108.448 -174.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.0 tp -89.2 103.32 15.95 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 106.301 -1.74 . . . . 74.510000000000005 106.301 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 82.3 tttt -133.43 132.24 40.89 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.812 -1.551 . . . . 74.400000000000006 106.812 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.442 ' HA ' HG23 ' A' ' 68' ' ' VAL . 10.4 pt-20 -91.11 76.36 6.13 Favored 'General case' 0 C--N 1.258 -3.376 0 CA-C-O 122.922 1.344 . . . . 72.510000000000005 108.842 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.33 57.48 0.11 Allowed Glycine 0 N--CA 1.405 -3.415 0 CA-C-N 112.47 -2.15 . . . . 70.209999999999994 110.244 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 14.8 tt0 . . . . . 0 CA--C 1.504 -0.824 0 N-CA-C 109.403 -0.591 . . . . 73.129999999999995 109.403 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.428 -1.564 0 CA-C-O 121.183 0.516 . . . . 64.209999999999994 111.526 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 28.9 ttpp -121.52 118.01 28.22 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 105.359 -2.089 . . . . 53.509999999999998 105.359 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 50' ' ' GLN . 21.7 t -85.67 135.22 25.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 120.155 -0.618 . . . . 73.420000000000002 109.529 -174.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.3 tp -83.17 -56.14 3.95 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.043 -0.725 . . . . 72.109999999999999 109.043 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.5 149.32 16.89 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.228 -0.896 . . . . 52.130000000000003 109.997 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' ' 48' ' ' GLU . 21.9 t -126.54 119.31 53.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.524 -1.287 . . . . 74.010000000000005 107.524 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 13.1 mm-40 -103.63 141.79 35.43 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 121.24 0.543 . . . . 72.140000000000001 110.442 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.17 130.65 93.65 Favored Pre-proline 0 C--N 1.271 -2.824 0 CA-C-N 114.031 -1.44 . . . . 73.040000000000006 109.062 -167.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo 2.6 48.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.371 1 C-N-CA 128.189 5.926 . . . . 71.329999999999998 117.66 -162.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 6.9 m -142.72 -36.87 0.38 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.941 -0.572 . . . . 74.530000000000001 110.564 175.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.5 tt0 -147.77 144.61 28.36 Favored 'General case' 0 C--O 1.201 -1.451 0 C-N-CA 118.035 -1.466 . . . . 72.230000000000004 111.847 -174.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.659 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -139.0 134.46 33.09 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.015 -1.106 . . . . 65.319999999999993 108.015 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 p -141.69 126.53 18.15 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.656 -0.418 . . . . 45.219999999999999 112.115 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.55 ' HD2' HD11 ' A' ' 74' ' ' LEU . 31.1 p90 -145.23 155.77 43.44 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 110.234 -0.284 . . . . 75.109999999999999 110.234 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -122.19 134.01 54.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.722 -1.214 . . . . 72.129999999999995 107.722 -173.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -113.78 125.05 53.67 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.971 -1.122 . . . . 74.409999999999997 107.971 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.26 -28.81 69.97 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.125 1.157 . . . . 63.340000000000003 114.125 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.7 m -66.67 94.81 0.31 Allowed 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.955 0.883 . . . . 71.150000000000006 109.722 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.265 63.2 mm-40 77.56 4.71 3.05 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 127.865 2.466 . . . . 75.409999999999997 114.16 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.32 58.78 6.27 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.599 -0.728 . . . . 61.229999999999997 112.778 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -98.32 133.07 43.23 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.702 -0.399 . . . . 74.230000000000004 109.965 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.46 120.41 63.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.063 -1.088 . . . . 72.329999999999998 108.063 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.63 150.55 18.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.322 0.582 . . . . 62.109999999999999 110.918 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.521 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 88.3 m -137.87 137.68 38.34 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.577 -0.898 . . . . 74.099999999999994 108.577 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.659 ' CD2' HD12 ' A' ' 74' ' ' LEU . 26.3 m-85 -122.27 147.05 46.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.007 -1.109 . . . . 75.0 108.007 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 72' ' ' THR . 24.3 mt-30 -131.49 141.3 49.73 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 123.482 0.489 . . . . 61.420000000000002 111.127 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -112.93 124.1 51.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.1 0.476 . . . . 72.5 111.226 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.71 123.99 51.09 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 125.143 1.377 . . . . 65.150000000000006 109.475 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -84.8 123.14 30.1 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.132 -0.486 . . . . 72.129999999999995 110.832 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.7 mt -124.9 157.84 34.98 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.053 -1.091 . . . . 55.43 108.053 174.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 94' ' ' GLU . . . -82.31 50.22 4.28 Favored Glycine 0 C--N 1.3 -1.423 0 N-CA-C 115.269 0.868 . . . . 72.319999999999993 115.269 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 93' ' ' GLY . 6.1 tp10 167.65 -39.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.256 1.022 . . . . 54.520000000000003 108.983 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -126.16 175.69 7.59 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.039 -1.097 . . . . 62.5 108.039 -173.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.44 ' HB ' HG21 ' A' ' 25' ' ' VAL . 60.9 m -122.2 134.71 54.71 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.616 -0.513 . . . . 70.219999999999999 109.616 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -93.84 114.56 4.77 Favored Glycine 0 N--CA 1.416 -2.654 0 N-CA-C 109.106 -1.598 . . . . 73.430000000000007 109.106 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -101.96 134.65 44.83 Favored 'General case' 0 C--N 1.268 -2.977 0 N-CA-C 108.948 -0.76 . . . . 63.439999999999998 108.948 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 35.8 m -120.2 126.82 51.6 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 108.28 -1.007 . . . . 62.43 108.28 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -104.4 137.21 42.61 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 106.885 -1.524 . . . . 71.109999999999999 106.885 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.521 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.4 mp -135.23 123.67 39.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.747 0 N-CA-C 106.134 -1.802 . . . . 71.409999999999997 106.134 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.6 ' HB3' HG22 ' A' ' 12' ' ' ILE . 3.4 t-160 -121.27 132.33 54.74 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.533 -1.284 . . . . 65.219999999999999 107.533 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.2 t -136.19 154.57 50.91 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.461 -0.94 . . . . 65.109999999999999 108.461 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.81 170.58 53.24 Favored Glycine 0 C--O 1.262 1.867 0 N-CA-C 109.253 -1.539 . . . . 32.130000000000003 109.253 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 34.8 t-105 . . . . . 0 C--O 1.223 -0.321 0 C-N-CA 123.07 0.548 . . . . 73.439999999999998 110.202 179.481 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 119' ' ' SER . 22.1 t . . . . . 0 C--O 1.216 -0.703 0 N-CA-C 107.547 -1.279 . . . . 75.420000000000002 107.547 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.549 HD13 HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -59.85 -32.98 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 120.892 0.377 . . . . 74.319999999999993 111.164 178.148 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.51 -89.47 0.93 Allowed Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.905 -0.589 . . . . 61.130000000000003 114.259 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -57.53 -23.88 52.85 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 125.122 1.369 . . . . 65.129999999999995 114.68 -172.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.14 -13.98 62.73 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.906 0.384 . . . . 71.030000000000001 111.797 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.7 m120 76.06 -19.83 0.39 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.099 1.36 . . . . 70.439999999999998 114.201 175.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.47 154.94 36.71 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.865 -0.42 . . . . 52.340000000000003 109.865 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HB2' HG12 ' A' ' 121' ' ' VAL . 99.3 mttt -67.99 149.06 50.19 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.145 0.498 . . . . 63.229999999999997 111.2 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.639 ' HB3' HG13 ' A' ' 111' ' ' VAL . 3.0 p -58.29 -44.55 88.55 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 124.293 1.037 . . . . 74.349999999999994 111.814 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.4 p -65.2 -45.99 82.54 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.343 -0.844 . . . . 71.530000000000001 111.497 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 118' ' ' LYS . 7.2 p -69.84 -37.72 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 120.132 -0.627 . . . . 74.319999999999993 109.616 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.593 ' O ' ' HG3' ' A' ' 126' ' ' MET . 54.3 t -61.53 -45.88 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 120.818 -0.353 . . . . 71.239999999999995 111.134 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -55.44 -49.54 72.16 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.471 0.482 . . . . 72.019999999999996 111.138 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.22 -42.42 90.97 Favored Glycine 0 CA--C 1.5 -0.858 0 CA-C-N 115.891 -0.595 . . . . 62.439999999999998 112.781 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -68.63 -44.1 74.91 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 113.095 0.776 . . . . 72.349999999999994 113.095 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.593 ' HG3' ' O ' ' A' ' 122' ' ' VAL 0.382 0.0 OUTLIER -77.1 -29.28 54.8 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 118.196 -1.402 . . . . 74.0 113.778 -177.774 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -71.66 -55.81 7.01 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.867 -0.733 . . . . 75.519999999999996 109.119 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.37 -38.01 95.73 Favored Glycine 0 CA--C 1.5 -0.869 0 CA-C-N 115.526 -0.761 . . . . 73.310000000000002 112.254 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.82 -58.14 11.99 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 111.713 -0.555 . . . . 34.32 111.713 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.529 ' O ' ' HB ' ' A' ' 134' ' ' VAL . 94.3 m95 -64.42 -36.78 85.26 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.073 1.138 . . . . 74.219999999999999 114.073 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.0 p -67.64 -53.87 24.36 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.148 -0.621 . . . . 60.340000000000003 110.976 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.1 -48.58 38.74 Favored Glycine 0 C--O 1.246 0.9 0 C-N-CA 121.492 -0.385 . . . . 74.129999999999995 113.428 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.01 -54.0 36.94 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.281 0 CA-C-O 119.185 -0.436 . . . . 73.120000000000005 110.666 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 130' ' ' TRP . 6.2 t -58.83 -40.71 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 113.608 0.966 . . . . 75.310000000000002 113.608 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -53.76 -59.54 4.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.244 0.545 . . . . 74.140000000000001 111.043 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.24 -42.14 26.61 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 113.258 0.836 . . . . 64.299999999999997 113.258 -174.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -65.24 -41.48 94.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.225 0.466 . . . . 74.230000000000004 109.767 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.2 mm? -66.65 -51.45 56.05 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.646 -0.422 . . . . 74.140000000000001 109.922 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.432 ' HA ' HD12 ' A' ' 18' ' ' LEU . 4.6 tmm_? -64.28 -31.78 73.11 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.951 0.405 . . . . 75.239999999999995 110.99 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.41 ' HE3' ' HG3' ' A' ' 144' ' ' GLU . 11.4 mmmm -79.08 -44.72 21.53 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 113.489 0.922 . . . . 75.310000000000002 113.489 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.62 -23.89 67.41 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.624 -0.431 . . . . 61.439999999999998 111.096 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.444 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 24.0 m -85.35 -33.9 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 120.512 -0.475 . . . . 44.450000000000003 111.336 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -85.73 -70.47 0.59 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.937 0.717 . . . . 55.119999999999997 112.937 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.41 ' HG3' ' HE3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.709 0 CA-C-O 121.389 0.614 . . . . 73.109999999999999 111.801 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.026 0 N-CA-C 108.879 -0.786 . . . . 62.310000000000002 108.879 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.4 mt 54.16 78.38 0.39 Allowed Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 113.815 -1.539 . . . . 53.43 113.37 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.85 -159.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 122.635 2.223 . . . . 64.319999999999993 108.865 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 44.3 m-20 -64.49 104.33 0.78 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.242 0.46 . . . . 73.030000000000001 112.242 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 77.3 mt -93.38 126.5 45.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.46 -1.681 . . . . 71.140000000000001 106.46 174.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.2 m -111.45 127.94 55.84 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.045 -0.662 . . . . 55.439999999999998 109.713 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 29.7 mmmt -131.89 126.12 33.39 Favored 'General case' 0 C--O 1.197 -1.658 0 N-CA-C 108.955 -0.757 . . . . 64.349999999999994 108.955 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.3 m -118.1 142.66 47.18 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 119.624 -0.83 . . . . 65.209999999999994 109.825 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -150.86 141.73 16.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.42 -0.956 . . . . 65.340000000000003 108.42 -178.698 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.47 HG22 ' HG3' ' A' ' 95' ' ' LYS . 0.8 OUTLIER -106.61 127.08 53.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.324 -0.621 . . . . 72.120000000000005 109.324 -178.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.7 mp -106.39 140.08 39.87 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 122.998 0.519 . . . . 72.420000000000002 109.717 -175.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -75.05 -2.02 25.48 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 124.091 0.956 . . . . 74.510000000000005 112.074 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.412 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -99.07 159.78 29.33 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 116.328 -0.396 . . . . 72.340000000000003 111.825 -172.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.49 153.61 73.73 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.305 2.67 . . . . 62.109999999999999 111.778 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.7 tt -48.86 -40.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.103 0.961 . . . . 62.219999999999999 112.628 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -70.98 -29.65 65.69 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.231 -0.588 . . . . 71.430000000000007 111.954 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -73.88 -36.82 64.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.629 0.728 . . . . 73.030000000000001 109.109 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' HG22 ' A' ' 29' ' ' VAL . 58.3 t -69.72 -41.24 79.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.534 -0.913 . . . . 64.25 108.534 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -58.77 -47.95 82.93 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.293 -0.867 . . . . 75.319999999999993 111.61 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -64.65 -35.24 80.4 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.302 -0.959 . . . . 72.510000000000005 110.776 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.2 m -63.75 -23.91 67.56 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 112.177 0.436 . . . . 62.32 112.177 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 16.0 m -121.72 15.2 5.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 112.789 0.662 . . . . 61.32 112.789 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.5 t -142.76 9.72 1.77 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 119.481 -0.888 . . . . 61.130000000000003 112.66 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.7 p -122.22 171.78 8.77 Favored 'General case' 0 C--O 1.247 0.972 0 O-C-N 121.455 -0.778 . . . . 74.409999999999997 110.557 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 m -63.72 -48.86 75.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.548 -0.538 . . . . 74.209999999999994 109.548 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.29 -41.86 96.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.846 -0.615 . . . . 73.510000000000005 111.691 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.32 -49.45 20.34 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 120.078 -1.058 . . . . 40.030000000000001 114.073 -176.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.9 mt -72.14 -50.68 35.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 118.344 1.072 . . . . 64.319999999999993 112.499 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.405 0 CA-C-O 121.205 0.526 . . . . 72.510000000000005 111.301 -178.047 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 . . . . . 0 CA--C 1.488 -1.423 0 N-CA-C 107.156 -1.424 . . . . 70.310000000000002 107.156 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -105.83 79.3 1.41 Allowed 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.941 0.877 . . . . 75.450000000000003 110.525 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -90.53 119.81 31.1 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.556 -1.202 . . . . 75.5 110.546 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -119.56 153.36 35.53 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.304 -1.739 . . . . 72.239999999999995 106.304 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -74.78 104.31 5.37 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.594 -1.262 . . . . 75.329999999999998 107.594 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 50' ' ' GLN . 47.4 tttp -132.97 144.54 50.18 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.711 -1.588 . . . . 64.230000000000004 106.711 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -91.76 69.79 5.63 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-O 122.097 0.951 . . . . 72.049999999999997 108.449 174.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.95 61.1 0.19 Allowed Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 110.119 -1.193 . . . . 71.019999999999996 110.119 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.651 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.473 -2.016 0 N-CA-C 106.489 -1.671 . . . . 64.239999999999995 106.489 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 48.4 m . . . . . 0 C--O 1.246 0.889 0 CA-C-O 120.775 0.321 . . . . 73.150000000000006 111.635 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 90.8 mttt -142.02 133.68 26.92 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 116.28 -0.418 . . . . 62.240000000000002 110.65 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.501 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 36.2 t -90.58 136.71 23.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 106.271 -1.751 . . . . 73.140000000000001 106.271 175.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.8 tp -78.98 -61.42 2.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.109 -1.071 . . . . 64.25 108.109 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -162.37 153.99 18.34 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.905 -1.043 . . . . 43.140000000000001 108.877 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.573 HG23 HD23 ' A' ' 74' ' ' LEU . 12.8 p -131.19 131.82 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.34 0 CA-C-O 121.625 0.726 . . . . 63.140000000000001 110.458 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.7 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 85.7 mm-40 -110.29 141.75 42.85 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 114.363 -1.29 . . . . 71.129999999999995 108.077 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.52 136.07 96.01 Favored Pre-proline 0 C--N 1.288 -2.085 0 CA-C-N 115.024 -0.989 . . . . 72.310000000000002 109.635 -164.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo 0.59 50.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.366 1.491 1 C-N-CA 128.301 6.001 . . . . 74.030000000000001 117.484 -162.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.59 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 4.7 m -145.19 -46.83 0.23 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 112.001 0.371 . . . . 61.420000000000002 112.001 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.7 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 11.0 tp10 -132.71 126.76 33.26 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.48 -0.933 . . . . 74.420000000000002 108.48 -171.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.66 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -135.7 132.72 37.26 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.517 -0.549 . . . . 75.239999999999995 109.517 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.5 m -135.05 126.72 29.0 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 123.221 0.326 . . . . 73.310000000000002 111.432 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.43 ' HD1' HD11 ' A' ' 74' ' ' LEU . 31.9 p90 -146.23 155.64 42.83 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.003 -0.436 . . . . 71.140000000000001 111.654 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -123.05 125.8 45.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.795 -1.187 . . . . 74.329999999999998 107.795 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -139.86 160.99 38.64 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.791 -0.363 . . . . 74.200000000000003 111.492 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 83' ' ' TRP . 48.6 t0 74.31 163.69 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.042 1.337 . . . . 61.329999999999998 111.546 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.9 m -59.11 -39.37 82.08 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.389 1.075 . . . . 74.040000000000006 112.009 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -79.89 -5.12 54.95 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.007 0.743 . . . . 52.299999999999997 113.007 -178.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 105' ' ' TRP . . . 68.43 73.62 0.68 Allowed Glycine 0 N--CA 1.442 -0.946 0 O-C-N 123.594 0.559 . . . . 54.030000000000001 113.004 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.442 ' CD1' ' HB3' ' A' ' 79' ' ' ASP . 50.6 m95 -85.98 112.97 21.7 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.696 -1.224 . . . . 64.0 107.696 177.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.32 101.98 13.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 106.967 -1.494 . . . . 74.230000000000004 106.967 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.5 m -108.85 144.78 16.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 120.973 0.416 . . . . 72.209999999999994 110.309 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 7.4 m -131.3 143.02 50.22 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.689 -0.856 . . . . 72.109999999999999 108.689 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.66 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.0 m-85 -120.8 147.53 45.22 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.829 -0.804 . . . . 71.230000000000004 108.829 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.584 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 72.9 mt-30 -133.2 144.5 49.86 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 112.795 0.665 . . . . 73.319999999999993 112.795 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 72' ' ' THR . 1.9 tm? -98.03 134.16 41.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.203 -0.908 . . . . 62.25 111.361 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -123.73 116.04 22.38 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.769 -2.308 . . . . 63.039999999999999 104.769 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -93.08 115.16 27.84 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.475 -0.89 . . . . 64.439999999999998 111.321 -175.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.8 mt -103.88 153.38 20.84 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.986 -1.116 . . . . 71.0 107.986 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.33 54.64 4.91 Favored Glycine 0 C--N 1.282 -2.431 0 C-N-CA 121.087 -0.577 . . . . 33.43 112.856 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 174.59 -33.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.323 0.649 . . . . 72.340000000000003 109.908 -177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 7.2 ptpt -150.33 175.27 11.98 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.772 -0.825 . . . . 65.219999999999999 108.772 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.0 m -111.47 123.15 49.62 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 121.176 0.512 . . . . 71.310000000000002 111.101 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.99 131.09 10.36 Favored Glycine 0 N--CA 1.406 -3.343 0 N-CA-C 108.484 -1.847 . . . . 34.119999999999997 108.484 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -120.12 134.5 55.24 Favored 'General case' 0 C--N 1.261 -3.277 0 C-N-CA 122.866 0.467 . . . . 73.209999999999994 109.804 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 90.8 m -117.77 127.17 53.64 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.917 -0.772 . . . . 74.439999999999998 108.917 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.567 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -103.62 140.56 37.39 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 108.59 -0.893 . . . . 75.5 108.59 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.501 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.9 mp -136.22 124.66 36.59 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.943 0 CA-C-N 113.662 -1.608 . . . . 61.539999999999999 106.973 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 18.2 t-160 -114.47 112.77 23.52 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.584 -1.265 . . . . 72.200000000000003 107.584 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.2 m -107.31 132.36 53.21 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.302 -1.74 . . . . 52.229999999999997 106.302 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.55 154.81 20.1 Favored Glycine 0 N--CA 1.426 -2.009 0 C-N-CA 120.838 -0.696 . . . . 24.440000000000001 112.894 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.405 ' HB2' ' O ' ' A' ' 82' ' ' GLY . 73.6 t-105 . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 115.157 -0.522 . . . . 75.530000000000001 109.979 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.448 HG12 HD13 ' A' ' 112' ' ' ILE . 10.5 t . . . . . 0 C--O 1.218 -0.571 0 N-CA-C 103.622 -2.732 . . . . 73.129999999999995 103.622 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -62.39 -37.84 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.247 1.385 . . . . 73.129999999999995 113.767 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 131.22 -75.76 0.42 Allowed Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.471 -0.871 . . . . 54.329999999999998 113.847 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -117.03 5.48 12.83 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 113.735 1.013 . . . . 63.530000000000001 113.735 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.45 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -73.08 -40.36 65.1 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.589 -0.845 . . . . 71.109999999999999 111.354 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 174.91 137.44 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.174 -1.788 . . . . 44.409999999999997 106.174 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.25 -18.67 61.2 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.773 0.657 . . . . 73.329999999999998 112.773 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.591 ' HB3' HG22 ' A' ' 121' ' ' VAL . 43.0 tptt -91.37 97.77 11.3 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.413 -0.915 . . . . 75.420000000000002 110.577 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.3 t -58.48 -37.97 76.64 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.356 -1.293 . . . . 65.010000000000005 111.621 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.44 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 29.5 t -66.13 -45.07 82.33 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.964 -0.294 . . . . 50.130000000000003 111.51 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 118' ' ' LYS . 12.6 m -69.91 -34.48 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 119.453 -0.899 . . . . 75.140000000000001 109.64 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 63.0 t -66.29 -44.68 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 120.468 -0.493 . . . . 73.299999999999997 111.509 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.44 ' HG3' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -68.01 -37.15 81.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.996 -0.682 . . . . 74.129999999999995 111.276 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.428 ' N ' ' HD3' ' A' ' 123' ' ' ARG . . . -63.51 -45.59 94.41 Favored Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 111.012 -0.835 . . . . 74.319999999999993 111.012 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.28 -40.1 95.28 Favored 'General case' 0 C--O 1.193 -1.869 0 CA-C-N 115.011 -0.595 . . . . 74.200000000000003 111.95 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 24.2 mmt -69.32 -40.91 77.34 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.354 -0.538 . . . . 72.019999999999996 111.073 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.61 -57.66 11.17 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.419 0.628 . . . . 64.510000000000005 109.695 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.09 -38.63 59.41 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.47 -0.787 . . . . 63.32 112.389 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.79 -54.11 36.04 Favored Glycine 0 CA--C 1.491 -1.417 0 CA-C-O 119.72 -0.489 . . . . 54.140000000000001 112.036 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -61.91 -35.16 77.54 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 117.424 0.612 . . . . 72.299999999999997 112.456 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.2 m -62.37 -48.37 80.07 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 120.439 -0.504 . . . . 72.109999999999999 110.906 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.7 -46.44 24.32 Favored Glycine 0 C--O 1.247 0.907 0 C-N-CA 120.688 -0.768 . . . . 74.420000000000002 113.661 -177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.51 -52.32 59.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 122.347 0.259 . . . . 74.329999999999998 110.871 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.648 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 96.4 t -65.24 -48.48 83.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 119.81 -0.756 . . . . 41.350000000000001 112.318 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.403 ' HA ' HG13 ' A' ' 16' ' ' ILE . 9.1 t30 -59.39 -60.45 3.84 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 112.738 0.644 . . . . 74.530000000000001 112.738 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 32.4 tt0 -74.46 -48.98 24.15 Favored 'General case' 0 C--O 1.208 -1.091 0 C-N-CA 120.047 -0.661 . . . . 74.439999999999998 112.726 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.542 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 1.2 tmm_? -67.85 -32.27 72.67 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.032 -0.667 . . . . 71.239999999999995 111.41 -170.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.648 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 3.4 mm? -70.25 -51.86 27.41 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.769 -0.772 . . . . 73.319999999999993 110.023 174.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -34.26 76.26 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.894 -0.594 . . . . 73.230000000000004 111.584 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -71.27 -51.47 24.3 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.979 -0.748 . . . . 70.420000000000002 108.979 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.14 -26.85 68.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 74.040000000000006 111.87 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.412 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 30.1 m -83.8 -30.66 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.137 -0.625 . . . . 63.399999999999999 111.979 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -79.57 -12.86 59.84 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.156 0.979 . . . . 74.430000000000007 109.745 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 N--CA 1.419 -2.001 0 N-CA-C 107.419 -1.326 . . . . 75.109999999999999 107.419 172.913 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 112.762 0.652 . . . . 61.299999999999997 112.762 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 61.75 83.97 0.2 Allowed Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 124.122 0.969 . . . . 74.030000000000001 111.855 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -89.18 -168.22 0.32 Allowed 'Trans proline' 0 N--CA 1.429 -2.32 0 C-N-CA 122.448 2.098 . . . . 65.120000000000005 112.178 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.65 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 6.3 p-10 -61.29 131.14 49.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.995 -1.002 . . . . 72.340000000000003 113.065 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.2 tp -135.99 138.74 47.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.966 -1.124 . . . . 51.43 107.966 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.7 m -117.75 133.64 55.73 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 120.85 0.357 . . . . 71.299999999999997 110.083 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -133.73 153.64 51.55 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.794 -1.928 . . . . 75.010000000000005 105.794 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.5 m -138.0 149.88 46.49 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.154 -0.966 . . . . 75.540000000000006 110.629 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.435 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.24 144.86 16.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.008 -0.738 . . . . 60.030000000000001 109.008 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.3 122.74 46.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.944 0.878 . . . . 75.219999999999999 112.156 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.618 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.8 mp -100.94 140.43 35.24 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 115.54 -0.755 . . . . 73.530000000000001 110.695 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -92.11 46.39 1.26 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.359 -1.291 . . . . 63.399999999999999 109.184 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.434 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -143.68 161.65 45.47 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.426 -0.953 . . . . 63.340000000000003 108.426 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 33.6 Cg_endo -63.15 150.22 89.23 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 122.467 2.111 . . . . 62.009999999999998 111.135 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.1 tt -56.29 -33.34 37.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.594 0.559 . . . . 71.230000000000004 112.127 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -60.9 -42.23 97.64 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 112.194 0.442 . . . . 64.310000000000002 112.194 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -74.44 -37.79 63.18 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.259 0.552 . . . . 71.120000000000005 109.605 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.516 HG13 HD22 ' A' ' 18' ' ' LEU . 76.8 t -62.85 -41.1 91.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.463 -0.789 . . . . 73.099999999999994 109.206 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.565 ' CE2' ' HD3' ' A' ' 71' ' ' PRO . 74.9 t90 -64.7 -46.09 83.82 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.141 -1.39 . . . . 72.129999999999995 109.777 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.59 -38.9 78.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.596 0.758 . . . . 72.200000000000003 110.185 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.426 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 62.8 m -57.73 -29.98 65.18 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 112.191 0.441 . . . . 72.209999999999994 112.191 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG13 HD11 ' A' ' 138' ' ' LEU . 17.4 m -110.3 18.64 6.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 O-C-N 121.852 -0.53 . . . . 63.350000000000001 112.037 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.5 p -135.7 -12.02 2.04 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.154 0.502 . . . . 63.340000000000003 112.05 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.7 p -94.75 148.86 21.85 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.09 -0.707 . . . . 73.140000000000001 109.09 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 m -53.52 -45.83 69.89 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.794 0.838 . . . . 65.230000000000004 112.709 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -69.23 -32.45 71.7 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.848 0.356 . . . . 75.329999999999998 111.458 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 28' ' ' THR . . . -72.31 -48.36 25.08 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.391 -0.909 . . . . 73.319999999999993 111.52 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.15 -32.17 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.139 0.976 . . . . 64.400000000000006 111.738 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 124.171 0.989 . . . . 65.239999999999995 112.914 -178.483 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 . . . . . 0 CA--C 1.501 -0.938 0 N-CA-C 109.779 -0.452 . . . . 63.329999999999998 109.779 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.43 73.33 10.52 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.988 0.899 . . . . 51.539999999999999 110.042 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -83.69 121.77 27.72 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.993 -2.225 . . . . 74.239999999999995 104.993 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -109.76 145.88 35.91 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 112.292 0.479 . . . . 64.329999999999998 112.292 -167.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -75.43 105.55 6.51 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.71 -1.589 . . . . 74.140000000000001 106.71 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -131.05 145.25 51.96 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.655 -1.979 . . . . 54.439999999999998 105.655 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HA ' HG12 ' A' ' 68' ' ' VAL . 5.1 pt-20 -87.36 34.04 0.69 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 118.963 0.801 . . . . 71.209999999999994 110.673 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.8 76.25 0.02 OUTLIER Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 108.501 -1.839 . . . . 64.549999999999997 108.501 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.436 ' HB3' ' H ' ' A' ' 65' ' ' VAL . 32.8 tt0 . . . . . 0 C--N 1.303 -1.437 0 N-CA-C 106.894 -1.521 . . . . 74.230000000000004 106.894 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.416 -2.14 0 CA-C-O 120.823 0.345 . . . . 72.430000000000007 110.108 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -155.24 143.45 20.2 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.518 -0.919 . . . . 65.299999999999997 108.518 -176.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.436 ' H ' ' HB3' ' A' ' 50' ' ' GLN . 27.1 t -88.91 127.44 41.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 105.71 -1.959 . . . . 73.219999999999999 105.71 173.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.403 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 2.1 tm? -70.74 -53.03 17.08 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.437 -1.32 . . . . 74.140000000000001 107.437 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.65 145.36 5.41 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.202 -0.908 . . . . 65.409999999999997 109.258 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.629 HG23 HD23 ' A' ' 74' ' ' LEU . 10.4 p -121.44 119.23 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 121.781 0.8 . . . . 65.349999999999994 109.115 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 84.2 mm-40 -113.87 141.53 47.23 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.011 -0.995 . . . . 74.400000000000006 112.509 -176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.39 133.24 94.4 Favored Pre-proline 0 C--N 1.296 -1.754 0 CA-C-N 113.498 -1.683 . . . . 63.25 108.073 -167.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.565 ' HD3' ' CE2' ' A' ' 26' ' ' TRP . 9.5 Cg_exo -11.83 62.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.99 1 C-N-CA 126.587 4.858 . . . . 74.5 118.333 -156.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.2 p -142.24 -44.67 0.33 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.179 -1.373 . . . . 62.219999999999999 109.549 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 69' ' ' GLN . 37.1 mt-10 -143.33 141.01 30.82 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 113.262 0.838 . . . . 72.040000000000006 113.262 -171.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.629 HD23 HG23 ' A' ' 68' ' ' VAL . 2.1 tm? -136.49 130.86 33.17 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 107.278 -1.378 . . . . 71.329999999999998 107.278 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -140.86 126.37 18.87 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 120.384 -0.527 . . . . 72.25 110.717 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.474 ' HD1' HD11 ' A' ' 74' ' ' LEU . 33.5 p90 -146.01 155.4 42.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.64 0.257 . . . . 74.340000000000003 111.315 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 29.0 mt-10 -121.64 136.03 54.96 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 105.552 -2.018 . . . . 54.329999999999998 105.552 -175.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -155.51 162.79 40.63 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.188 -1.005 . . . . 75.400000000000006 113.571 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.428 ' HB3' ' CD1' ' A' ' 83' ' ' TRP . 24.7 t70 75.65 163.47 0.26 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 112.809 -1.996 . . . . 74.239999999999995 112.63 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -60.59 -33.38 72.65 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.642 1.177 . . . . 72.430000000000007 111.89 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 115' ' ' ALA . 5.4 mm-40 -71.04 -33.63 70.48 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 120.722 0.296 . . . . 75.329999999999998 111.716 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.1 65.15 1.08 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.63 -0.795 . . . . 62.539999999999999 112.232 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.428 ' CD1' ' HB3' ' A' ' 79' ' ' ASP . 35.1 m95 -92.95 141.28 28.59 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.201 -1.407 . . . . 71.109999999999999 107.201 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.07 101.84 8.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 122.353 1.073 . . . . 32.310000000000002 109.121 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 m -97.54 142.69 13.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 115.435 -0.802 . . . . 71.409999999999997 110.603 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.3 m -132.31 122.0 24.43 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.334 -1.358 . . . . 74.140000000000001 107.334 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.628 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.9 m-85 -112.65 138.64 49.15 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.341 -0.985 . . . . 64.230000000000004 108.341 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.548 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 35.0 mt-30 -113.81 128.38 56.39 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 115.281 -0.872 . . . . 51.420000000000002 110.932 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.29 119.45 38.42 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.881 -1.155 . . . . 75.349999999999994 107.881 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -104.19 117.1 33.42 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.906 -1.146 . . . . 64.310000000000002 107.906 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -77.94 112.22 14.62 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.718 -0.674 . . . . 65.400000000000006 109.855 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 98.8 mt -115.21 140.91 48.68 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.14 -1.43 . . . . 73.439999999999998 107.14 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.38 58.9 4.96 Favored Glycine 0 C--N 1.276 -2.788 0 CA-C-N 115.654 -0.703 . . . . 72.010000000000005 111.907 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 179.51 -47.05 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.592 0.757 . . . . 71.349999999999994 109.307 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 9.8 ptpt -142.52 175.39 9.83 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.254 -1.388 . . . . 72.430000000000007 107.254 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.8 m -111.15 124.86 53.05 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 119.794 -0.763 . . . . 74.329999999999998 110.307 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.48 108.27 3.62 Favored Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 110.085 -1.206 . . . . 74.209999999999994 110.085 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -98.29 129.39 44.99 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.795 -0.817 . . . . 75.200000000000003 108.795 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 8.0 m -116.31 123.15 46.93 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 107.958 -1.127 . . . . 52.009999999999998 107.958 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.404 HD12 ' CE1' ' A' ' 87' ' ' PHE . 2.9 tp -100.18 119.34 38.21 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.724 -0.843 . . . . 64.129999999999995 108.724 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.01 123.17 71.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 105.928 -1.879 . . . . 64.340000000000003 105.928 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.65 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 22.9 t-160 -108.59 113.52 26.59 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.665 -1.606 . . . . 53.130000000000003 106.665 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -125.93 155.55 41.13 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 105.762 -1.94 . . . . 45.229999999999997 105.762 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.28 153.8 17.54 Favored Glycine 0 C--N 1.26 -3.684 0 N-CA-C 108.833 -1.707 . . . . 71.209999999999994 108.833 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 43.6 t90 . . . . . 0 C--N 1.29 -1.985 0 N-CA-C 108.806 -0.812 . . . . 73.299999999999997 108.806 179.624 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.434 -1.257 0 N-CA-C 109.934 -0.395 . . . . 65.239999999999995 109.934 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 115' ' ' ALA . 5.9 pt -62.21 -44.17 98.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.913 -0.585 . . . . 72.209999999999994 110.407 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.84 -52.7 3.62 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 114.413 0.525 . . . . 72.140000000000001 114.413 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.29 -42.1 16.17 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 112.861 0.689 . . . . 73.319999999999993 112.861 -172.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.64 ' HB3' HD12 ' A' ' 112' ' ' ILE . . . -67.06 -30.5 70.58 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.552 -0.459 . . . . 61.329999999999998 110.485 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.421 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 22.1 t-20 -175.51 145.17 0.71 Allowed 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.317 -1.364 . . . . 63.340000000000003 107.317 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -90.23 -17.87 26.72 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 113.172 0.804 . . . . 75.109999999999999 113.172 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 9.5 mmpt? -99.56 109.66 22.17 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.403 0.62 . . . . 70.129999999999995 110.798 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -67.48 -33.34 74.91 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.547 -0.751 . . . . 70.310000000000002 111.23 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 p -65.94 -46.67 77.33 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 111.756 0.28 . . . . 73.030000000000001 111.756 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 118' ' ' LYS . 30.2 m -70.27 -34.51 58.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 119.77 -0.772 . . . . 71.549999999999997 110.917 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 116' ' ' ASN . 99.4 t -65.86 -45.56 91.04 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 C-N-CA 120.394 -0.522 . . . . 64.239999999999995 110.594 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -61.8 -43.64 98.45 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 111.865 0.32 . . . . 74.430000000000007 111.865 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -62.51 -47.38 89.78 Favored Glycine 0 CA--C 1.497 -1.079 0 CA-C-N 115.837 -0.62 . . . . 73.409999999999997 111.925 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -72.22 -29.58 64.09 Favored 'General case' 0 C--O 1.193 -1.899 0 N-CA-C 112.796 0.665 . . . . 73.140000000000001 112.796 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.4 mmt -67.5 -48.93 65.66 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.012 -0.675 . . . . 73.450000000000003 111.66 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.33 -50.16 55.29 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.249 -0.98 . . . . 71.099999999999994 110.961 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.93 -40.2 97.04 Favored Glycine 0 C--O 1.239 0.418 0 N-CA-C 111.445 -0.662 . . . . 72.019999999999996 111.445 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.52 ' O ' HG22 ' A' ' 133' ' ' ILE . . . -64.44 -58.07 11.36 Favored Glycine 0 CA--C 1.482 -1.99 0 CA-C-O 119.007 -0.885 . . . . 74.140000000000001 111.928 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -57.67 -36.11 71.48 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.86 0.83 . . . . 75.540000000000006 112.44 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.3 m -61.1 -51.84 67.42 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 120.736 -0.385 . . . . 72.450000000000003 110.259 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.4 -50.49 15.86 Favored Glycine 0 C--O 1.25 1.113 0 C-N-CA 121.194 -0.526 . . . . 54.140000000000001 113.858 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 129' ' ' GLY . 10.5 tp -63.79 -49.27 82.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-O 119.554 -0.26 . . . . 74.420000000000002 110.879 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 71.8 t -62.84 -47.35 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 120.046 -0.662 . . . . 64.25 112.148 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.435 ' HA ' HG13 ' A' ' 16' ' ' ILE . 26.6 t-20 -55.38 -62.03 1.95 Allowed 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 111.98 0.363 . . . . 71.25 111.98 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.558 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 35.9 tt0 -80.4 -41.05 25.31 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 119.538 -0.865 . . . . 72.200000000000003 113.327 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -35.69 78.23 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.116 -1.034 . . . . 75.299999999999997 110.144 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 3.1 mm? -68.82 -51.82 36.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.129 0.49 . . . . 74.109999999999999 110.13 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.62 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 1.6 tmm_? -63.65 -36.34 83.5 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 115.691 -0.686 . . . . 71.140000000000001 110.416 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -74.7 -34.77 62.69 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 122.836 0.454 . . . . 74.340000000000003 109.789 -179.07 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.5 -26.98 63.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.469 0.652 . . . . 74.430000000000007 110.765 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.434 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 25.6 m -85.66 -25.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 C-N-CA 119.701 -0.799 . . . . 53.219999999999999 111.466 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.62 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 51.7 mt-10 -76.42 -41.89 46.11 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.628 -0.879 . . . . 74.120000000000005 108.628 174.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 . . . . . 0 CA--C 1.509 -0.626 0 C-N-CA 126.465 1.906 . . . . 62.020000000000003 110.499 -174.852 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -1.854 0 N-CA-C 106.274 -1.75 . . . . 71.299999999999997 106.274 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.569 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.4 pt? -74.23 119.47 76.54 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 120.079 -0.648 . . . . 64.019999999999996 110.211 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.83 -162.14 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.162 1.908 . . . . 74.540000000000006 107.73 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -72.51 105.11 4.05 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 118.535 -1.266 . . . . 70.299999999999997 108.51 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 72.7 mt -91.25 123.67 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 106.912 -1.514 . . . . 75.409999999999997 106.912 -177.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.4 m -119.51 129.2 54.58 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 108.149 -1.056 . . . . 73.519999999999996 108.149 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -139.49 132.55 29.56 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.244 -1.391 . . . . 72.430000000000007 107.244 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 p -117.98 140.72 49.33 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 109.391 -0.596 . . . . 54.5 109.391 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.32 140.49 19.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.876 -0.787 . . . . 74.310000000000002 108.876 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' THR . 12.7 p -99.24 118.96 37.09 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.746 0.784 . . . . 72.109999999999999 112.389 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 139' ' ' ARG . 3.4 mm? -91.4 140.07 30.12 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.723 -1.126 . . . . 72.430000000000007 109.633 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.4 30.67 0.69 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.441 0.639 . . . . 75.230000000000004 110.663 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.423 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -127.83 163.92 40.15 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.256 -1.016 . . . . 75.150000000000006 108.256 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 36.0 Cg_endo -66.13 152.72 80.51 Favored 'Trans proline' 0 C--O 1.255 1.362 0 C-N-CA 122.433 2.088 . . . . 64.349999999999994 110.724 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 tt -61.26 -31.38 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.009 -0.541 . . . . 71.030000000000001 112.021 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.2 pt20 -60.29 -45.14 94.39 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.619 0.247 . . . . 61.130000000000003 110.891 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -68.06 -39.5 82.99 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.374 -0.375 . . . . 72.040000000000006 111.91 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.6 -41.1 87.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.504 -0.554 . . . . 53.329999999999998 109.504 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.545 ' CZ2' ' HD3' ' A' ' 71' ' ' PRO . 60.3 t90 -63.9 -46.61 84.07 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.153 -0.93 . . . . 65.140000000000001 110.063 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 41.2 mt-10 -63.61 -37.99 89.42 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 120.991 -0.284 . . . . 44.439999999999998 110.544 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.0 m -56.84 -36.07 69.56 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.935 0.398 . . . . 51.25 111.384 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.664 HG11 ' CE1' ' A' ' 98' ' ' PHE . 30.9 m -103.76 16.04 5.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 112.018 0.377 . . . . 73.019999999999996 112.018 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.6 t -145.88 6.63 1.05 Allowed 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.012 -0.675 . . . . 44.520000000000003 112.146 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.9 p -108.32 170.3 8.1 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 121.775 -0.578 . . . . 72.319999999999993 110.555 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 t -59.91 -62.17 2.07 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 124.143 0.902 . . . . 33.32 111.103 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -78.05 -27.92 48.81 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 119.57 -0.852 . . . . 73.409999999999997 111.883 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.93 -48.68 84.48 Favored Glycine 0 C--O 1.216 -1.018 0 N-CA-C 110.888 -0.885 . . . . 54.310000000000002 110.888 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.18 -43.76 78.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 122.026 0.917 . . . . 74.120000000000005 110.359 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.84 0 N-CA-C 113.884 1.068 . . . . 54.210000000000001 113.884 -175.456 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 CA--C 1.503 -0.852 0 N-CA-C 109.923 -0.399 . . . . 72.319999999999993 109.923 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.93 53.37 2.8 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.73 0.776 . . . . 73.120000000000005 110.765 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -72.31 152.28 42.21 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.138 -0.937 . . . . 74.340000000000003 108.573 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -137.55 151.53 48.48 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.888 -0.782 . . . . 72.140000000000001 108.888 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -75.41 104.45 5.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.539 -1.652 . . . . 72.430000000000007 106.539 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.406 ' O ' HG11 ' A' ' 65' ' ' VAL . 12.9 tptp -134.82 132.14 38.31 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 107.186 -1.412 . . . . 71.430000000000007 107.186 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -95.55 86.96 4.59 Favored 'General case' 0 C--N 1.26 -3.321 0 CA-C-O 122.674 1.225 . . . . 73.510000000000005 108.571 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.09 105.14 2.26 Favored Glycine 1 N--CA 1.395 -4.084 0 CA-C-N 113.256 -1.793 . . . . 71.329999999999998 109.564 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.781 0 N-CA-C 106.931 -1.507 . . . . 75.519999999999996 106.931 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 18.5 p . . . . . 0 N--CA 1.417 -2.075 0 CA-C-O 121.47 0.652 . . . . 41.030000000000001 111.726 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 50' ' ' GLN . 20.4 pttp -137.24 138.41 40.09 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 107.009 -1.478 . . . . 74.219999999999999 107.009 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 47' ' ' LYS . 23.5 t -88.71 135.09 26.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 C-N-CA 119.516 -0.874 . . . . 72.409999999999997 109.249 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -76.53 -60.43 2.35 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.248 -1.76 . . . . 72.530000000000001 106.248 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.95 152.93 6.72 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.19 -0.914 . . . . 54.409999999999997 108.912 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.41 118.58 57.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 105.957 -1.868 . . . . 73.230000000000004 105.957 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 14.9 mm-40 -98.42 140.18 33.06 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.871 -0.788 . . . . 63.030000000000001 108.871 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.69 126.8 93.07 Favored Pre-proline 0 C--N 1.265 -3.094 0 CA-C-N 113.739 -1.573 . . . . 64.329999999999998 107.966 -168.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.545 ' HD3' ' CZ2' ' A' ' 26' ' ' TRP . 92.0 Cg_exo 2.03 51.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.117 1 C-N-CA 127.601 5.534 . . . . 71.349999999999994 117.351 -159.228 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.2 p -138.78 -39.14 0.5 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.005 -0.998 . . . . 73.430000000000007 111.557 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 36.9 tt0 -151.2 149.0 28.92 Favored 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 119.046 -1.062 . . . . 62.520000000000003 111.347 -174.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.638 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -137.0 134.06 36.21 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.613 -1.255 . . . . 75.420000000000002 107.613 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.467 ' OG ' HG23 ' A' ' 86' ' ' THR . 22.4 m -141.62 126.53 18.21 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.819 -0.352 . . . . 24.23 111.266 177.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.477 ' HD1' HD11 ' A' ' 74' ' ' LEU . 36.6 p90 -143.91 154.0 42.89 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.819 -0.438 . . . . 73.120000000000005 109.819 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 63' ' ' CYS . 41.0 mt-10 -122.86 124.71 43.87 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 123.066 0.546 . . . . 73.140000000000001 109.585 -171.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 6.4 t-105 -117.38 115.63 25.61 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.971 -1.492 . . . . 74.140000000000001 106.971 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -82.6 152.57 25.87 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.584 -0.846 . . . . 73.310000000000002 109.16 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.6 m 74.88 84.84 0.1 Allowed 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 123.858 0.863 . . . . 74.200000000000003 110.235 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 57.87 0.41 0.11 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 127.263 2.225 . . . . 73.099999999999994 115.62 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.45 -35.41 20.18 Favored Glycine 0 C--N 1.312 -0.796 0 N-CA-C 110.645 -0.982 . . . . 75.0 110.645 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 52.3 m95 66.63 -161.82 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.272 1.429 . . . . 75.519999999999996 109.766 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 p -116.67 126.68 74.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.99 -0.744 . . . . 71.510000000000005 108.99 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.4 m -116.31 136.61 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 CA-C-N 115.299 -0.864 . . . . 41.119999999999997 110.301 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.467 HG23 ' OG ' ' A' ' 75' ' ' SER . 34.9 m -124.54 127.03 46.79 Favored 'General case' 0 C--N 1.279 -2.498 0 N-CA-C 107.535 -1.283 . . . . 74.430000000000007 107.535 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.638 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.4 m-85 -112.38 130.11 56.08 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.465 -0.939 . . . . 64.129999999999995 108.465 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.405 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 5.2 mm-40 -109.33 137.5 47.11 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.439 -0.8 . . . . 73.219999999999999 110.257 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.39 120.34 40.01 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.281 -0.872 . . . . 75.439999999999998 110.026 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -111.54 116.83 31.51 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.207 -1.034 . . . . 71.040000000000006 108.207 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.86 123.39 27.18 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.267 0.556 . . . . 71.120000000000005 109.528 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.6 mt -126.35 159.54 32.91 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.33 -0.85 . . . . 62.149999999999999 109.204 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.67 128.16 8.52 Favored Glycine 0 N--CA 1.409 -3.132 0 N-CA-C 108.693 -1.763 . . . . 63.009999999999998 108.693 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 83.89 -3.81 1.11 Allowed 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 125.011 1.324 . . . . 71.329999999999998 111.977 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -164.46 173.41 12.15 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.002 -0.74 . . . . 71.25 109.002 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 17' ' ' THR . 85.3 m -124.79 132.64 53.33 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.368 -0.604 . . . . 55.039999999999999 109.368 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.56 105.03 3.25 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 110.059 -1.216 . . . . 51.140000000000001 110.059 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.664 ' CE1' HG11 ' A' ' 29' ' ' VAL . 67.9 t80 -98.33 134.28 41.56 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.998 -0.741 . . . . 74.140000000000001 108.998 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 9.8 m -125.14 125.79 44.25 Favored 'General case' 0 N--CA 1.405 -2.678 0 C-N-CA 119.619 -0.832 . . . . 51.009999999999998 109.23 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.479 HD22 HG21 ' A' ' 134' ' ' VAL . 1.8 tp -100.26 124.04 45.22 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.074 -1.084 . . . . 72.310000000000002 108.074 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 3.5 mp -121.26 124.59 72.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 106.923 -1.51 . . . . 72.329999999999998 106.923 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -120.69 122.1 39.71 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.15 -1.056 . . . . 74.310000000000002 108.15 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -142.87 163.93 31.46 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.814 -1.551 . . . . 54.340000000000003 106.814 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -179.1 132.37 1.87 Allowed Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 108.502 -1.839 . . . . 62.439999999999998 108.502 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 31.5 t90 . . . . . 0 C--N 1.296 -1.746 0 C-N-CA 119.228 -0.989 . . . . 74.120000000000005 110.291 -178.151 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.22 -0.482 0 N-CA-C 104.82 -2.289 . . . . 64.310000000000002 104.82 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.9 pt -58.72 -32.63 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 118.418 0.554 . . . . 60.420000000000002 112.038 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.3 -113.12 3.91 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.61 -0.805 . . . . 71.420000000000002 113.702 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.84 -9.35 58.19 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.22 0.822 . . . . 65.010000000000005 113.22 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.72 -22.4 61.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.073 -0.343 . . . . 62.420000000000002 110.073 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 53.1 t30 43.01 89.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.655 1.582 . . . . 71.450000000000003 114.806 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.18 154.18 38.76 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 100.297 -3.964 . . . . 71.439999999999998 100.297 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.599 ' HB2' HG22 ' A' ' 121' ' ' VAL . 9.9 mmpt? -72.38 122.19 20.78 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 119.629 1.104 . . . . 72.409999999999997 111.776 -168.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 11.0 p -44.44 -50.47 9.33 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 125.119 1.368 . . . . 74.400000000000006 114.276 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.6 p -65.35 -45.86 82.52 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 116.337 -0.392 . . . . 64.040000000000006 112.026 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.599 HG22 ' HB2' ' A' ' 118' ' ' LYS . 11.0 m -70.62 -33.55 53.56 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 C-N-CA 119.909 -0.716 . . . . 74.120000000000005 110.346 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.54 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 69.5 t -60.22 -46.92 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 O-C-N 123.087 0.242 . . . . 54.229999999999997 110.368 176.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -57.47 -46.43 83.67 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.53 -0.759 . . . . 72.230000000000004 110.361 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.64 -47.25 50.37 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.598 -0.728 . . . . 63.0 113.0 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -62.79 -31.92 72.99 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 123.789 0.836 . . . . 64.450000000000003 112.425 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 25.8 mmt -72.71 -48.94 34.65 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.863 -0.735 . . . . 73.420000000000002 110.956 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.86 -65.74 0.63 Allowed 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.507 0.67 . . . . 72.0 110.548 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.04 -31.54 66.64 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.437 -0.801 . . . . 73.129999999999995 112.813 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -67.07 -59.3 7.06 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-O 119.408 -0.662 . . . . 74.409999999999997 112.013 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.416 ' CE3' HD21 ' A' ' 100' ' ' LEU . 97.7 m95 -61.88 -35.95 79.84 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 117.833 0.817 . . . . 72.329999999999998 112.833 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.8 m -62.28 -50.19 72.66 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 120.786 -0.366 . . . . 74.349999999999994 110.586 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.33 -48.21 19.77 Favored Glycine 0 C--O 1.247 0.939 0 C-N-CA 121.102 -0.57 . . . . 42.130000000000003 113.511 -177.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.57 -60.71 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 123.218 0.607 . . . . 64.140000000000001 110.347 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.479 HG21 HD22 ' A' ' 100' ' ' LEU . 98.0 t -57.64 -44.4 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 113.049 0.759 . . . . 74.319999999999993 113.049 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -56.4 -63.95 1.02 Allowed 'General case' 0 C--O 1.246 0.912 0 N-CA-C 112.143 0.423 . . . . 74.319999999999993 112.143 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -79.43 -34.84 41.31 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.184 0.809 . . . . 73.549999999999997 113.184 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -70.32 -39.43 74.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.534 -0.867 . . . . 75.519999999999996 111.265 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.5 mm? -70.47 -43.21 70.27 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 119.468 -0.893 . . . . 62.140000000000001 110.594 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.407 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.9 tmm_? -58.25 -37.2 74.44 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.045 -0.525 . . . . 72.239999999999995 110.094 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 8.5 mmmm -74.37 -37.1 63.55 Favored 'General case' 0 C--O 1.199 -1.558 0 N-CA-C 113.782 1.031 . . . . 64.109999999999999 113.782 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.72 -23.94 65.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.832 0.349 . . . . 41.130000000000003 111.377 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.1 m -90.81 -23.32 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 120.739 -0.384 . . . . 60.32 110.715 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -82.39 -54.56 5.12 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.122 0.416 . . . . 62.539999999999999 112.122 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 C--N 1.312 -1.052 0 N-CA-C 109.746 -0.464 . . . . 63.100000000000001 109.746 -177.686 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 112' ' ' ILE . . . . . . . . 0 CA--C 1.497 -1.071 0 CA-C-O 119.339 -0.363 . . . . 73.230000000000004 111.857 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.604 HD21 ' HE ' ' A' ' 123' ' ' ARG 0.38 4.5 mm? 97.08 85.6 0.02 OUTLIER Pre-proline 0 CA--C 1.51 -0.59 0 C-N-CA 127.27 2.228 . . . . 74.439999999999998 116.737 -176.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -91.93 -153.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.684 0 C-N-CA 123.623 2.882 . . . . 43.520000000000003 109.023 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 5.6 p-10 -58.5 146.82 34.02 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.672 0.789 . . . . 64.329999999999998 113.068 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.483 HG22 ' HB3' ' A' ' 102' ' ' HIS . 10.7 tp -152.42 139.38 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.226 -0.657 . . . . 70.109999999999999 109.226 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.1 m -113.42 140.1 48.35 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.406 -0.59 . . . . 74.349999999999994 109.406 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HD3' ' N ' ' A' ' 15' ' ' SER . 5.7 tmtt? -141.56 137.73 32.18 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.489 -1.671 . . . . 72.540000000000006 106.489 175.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.488 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 24.5 p -118.23 150.19 39.85 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.392 0.542 . . . . 71.109999999999999 111.096 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.489 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -158.65 134.7 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.582 -0.525 . . . . 74.219999999999999 109.582 177.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.34 130.95 44.45 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.404 0.621 . . . . 71.230000000000004 111.706 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 2.5 mm? -99.74 139.28 35.62 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 123.411 0.685 . . . . 73.439999999999998 109.784 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.431 ' HG3' ' NH2' ' A' ' 139' ' ' ARG . 20.8 mm-40 -92.67 27.49 2.31 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.574 0.702 . . . . 64.319999999999993 109.131 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -122.6 161.98 40.84 Favored Pre-proline 0 C--O 1.246 0.912 0 C-N-CA 123.826 0.851 . . . . 75.329999999999998 109.255 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 35.7 Cg_endo -64.9 149.49 89.44 Favored 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 122.713 2.275 . . . . 74.329999999999998 110.921 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.1 tt -56.81 -34.02 42.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.611 -0.722 . . . . 42.340000000000003 112.399 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 29.9 pt20 -64.88 -36.5 84.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.919 0.39 . . . . 55.409999999999997 111.069 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HA ' ' HG2' ' A' ' 27' ' ' GLU . 11.6 mptt -79.67 -28.74 40.74 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 112.037 0.384 . . . . 74.439999999999998 112.037 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.2 -42.14 75.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.157 -1.053 . . . . 62.200000000000003 108.157 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 54.4 t90 -59.72 -47.79 84.26 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.617 -1.174 . . . . 73.140000000000001 111.303 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.557 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 9.3 pt-20 -70.05 -27.87 65.0 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 119.925 -0.71 . . . . 72.200000000000003 112.289 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 m -59.46 -35.63 74.44 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.2 0.524 . . . . 72.0 110.401 174.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.601 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 26.4 m -106.9 25.1 2.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 112.186 0.439 . . . . 64.439999999999998 112.186 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.557 ' OG ' ' HA ' ' A' ' 27' ' ' GLU . 60.2 p -141.37 -11.33 0.94 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.733 0.642 . . . . 75.430000000000007 112.733 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -94.25 161.63 14.18 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 120.306 -0.558 . . . . 72.129999999999995 111.434 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -50.12 -56.53 10.53 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 125.772 1.629 . . . . 65.209999999999994 111.553 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.14 -33.3 56.73 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.947 0.721 . . . . 72.5 112.947 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.99 -48.2 67.7 Favored Glycine 0 CA--C 1.505 -0.592 0 C-N-CA 120.905 -0.664 . . . . 75.319999999999993 111.691 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 30' ' ' SER . 63.3 mt -70.42 -45.42 75.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.204 0.526 . . . . 60.119999999999997 111.383 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 112.859 0.688 . . . . 55.149999999999999 112.859 -176.212 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.3 t30 . . . . . 0 CA--C 1.484 -1.566 0 N-CA-C 104.278 -2.49 . . . . 73.049999999999997 104.278 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -93.44 79.25 4.38 Favored 'General case' 0 C--N 1.281 -2.379 0 C-N-CA 118.741 -1.184 . . . . 75.019999999999996 113.082 -171.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.438 ' HB3' HD12 ' A' ' 35' ' ' ILE . 99.6 m-85 -75.16 119.04 18.76 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.43 -1.692 . . . . 73.450000000000003 106.43 168.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -125.09 153.4 42.99 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.893 -1.521 . . . . 71.549999999999997 106.893 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.652 HD12 HG21 ' A' ' 68' ' ' VAL . 3.5 mm? -74.09 102.9 4.36 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 116.689 -2.004 . . . . 44.039999999999999 107.996 175.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 39.5 tptt -132.73 132.79 42.7 Favored 'General case' 0 N--CA 1.391 -3.418 0 N-CA-C 105.694 -1.965 . . . . 61.299999999999997 105.694 171.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -86.4 66.63 9.61 Favored 'General case' 0 C--N 1.259 -3.36 0 CA-C-O 122.27 1.033 . . . . 61.5 109.23 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 123.43 51.9 0.21 Allowed Glycine 0 N--CA 1.397 -3.921 0 CA-C-N 114.579 -1.191 . . . . 64.420000000000002 110.142 -176.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.573 ' H ' ' HB ' ' A' ' 65' ' ' VAL . 12.2 tt0 . . . . . 0 CA--C 1.498 -1.054 0 N-CA-C 106.534 -1.654 . . . . 65.420000000000002 106.534 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.425 -1.716 0 N-CA-C 108.176 -1.046 . . . . 60.229999999999997 108.176 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -143.07 147.11 34.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.394 -1.706 . . . . 74.030000000000001 106.394 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.573 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 42.9 t -90.32 137.45 21.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.636 -1.246 . . . . 64.239999999999995 107.636 177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 2.3 tm? -77.74 -61.56 1.95 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.084 -1.45 . . . . 74.430000000000007 107.084 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.56 156.76 10.02 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.119 -1.067 . . . . 64.099999999999994 108.119 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.652 HG21 HD12 ' A' ' 46' ' ' LEU . 13.5 p -125.04 135.17 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-O 121.177 0.513 . . . . 61.539999999999999 110.396 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 71.9 mm-40 -102.81 141.16 36.09 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.314 -0.995 . . . . 75.409999999999997 108.314 173.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.88 127.04 93.33 Favored Pre-proline 0 C--N 1.266 -3.031 0 N-CA-C 107.401 -1.333 . . . . 74.099999999999994 107.401 -168.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo 4.12 48.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.077 1 C-N-CA 127.628 5.552 . . . . 72.200000000000003 117.895 -161.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -137.65 -35.24 0.66 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.264 -0.425 . . . . 74.219999999999999 109.983 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 38.8 tt0 -149.55 148.28 29.18 Favored 'General case' 0 C--O 1.205 -1.237 0 C-N-CA 118.574 -1.25 . . . . 74.329999999999998 110.363 -175.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.639 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -143.04 130.91 21.55 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 107.705 -1.22 . . . . 55.539999999999999 107.705 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -132.66 127.1 34.13 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 110.224 -0.287 . . . . 62.450000000000003 110.224 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.421 ' HA ' ' H ' ' A' ' 66' ' ' LEU 0.254 35.8 p90 -145.81 157.84 43.9 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.208 -0.308 . . . . 73.400000000000006 111.768 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.262 36.1 mt-10 -120.07 144.67 47.46 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 123.624 0.77 . . . . 74.329999999999998 109.97 -169.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -114.67 120.47 40.23 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.0 -2.222 . . . . 72.230000000000004 105.0 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -83.11 10.61 7.79 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.619 0.723 . . . . 74.540000000000006 112.866 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.4 p -90.76 92.64 8.89 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 107.857 -1.164 . . . . 74.349999999999994 107.857 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 78.08 6.93 2.6 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.91 1.284 . . . . 64.439999999999998 112.403 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.87 62.73 3.07 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 114.805 -1.089 . . . . 61.32 113.777 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -100.28 150.64 22.36 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.825 -0.75 . . . . 74.040000000000006 109.742 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.13 109.93 2.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 108.216 -1.031 . . . . 75.140000000000001 108.216 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.11 154.67 5.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 115.86 -0.609 . . . . 42.509999999999998 109.817 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 15.3 m -139.89 140.3 36.43 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.179 -0.674 . . . . 70.450000000000003 109.179 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.639 ' CD2' HD12 ' A' ' 74' ' ' LEU . 15.0 m-85 -113.66 139.59 48.92 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.578 -1.267 . . . . 74.549999999999997 107.578 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.22 133.74 55.41 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.094 -1.076 . . . . 73.219999999999999 108.094 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.03 128.02 56.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.453 0.644 . . . . 74.150000000000006 109.948 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -115.96 130.84 57.0 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.692 -1.225 . . . . 74.420000000000002 107.692 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -94.29 121.17 35.53 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.417 0.627 . . . . 72.140000000000001 109.798 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 81.1 mt -114.2 156.0 25.06 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.245 -1.02 . . . . 60.229999999999997 108.245 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.95 49.57 4.25 Favored Glycine 0 C--N 1.289 -2.072 0 CA-C-N 116.255 -0.43 . . . . 51.310000000000002 112.137 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -177.17 -40.56 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.808 0.813 . . . . 60.439999999999998 109.118 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 9.2 ptpt -149.42 175.97 11.0 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 115.461 -0.79 . . . . 74.530000000000001 108.961 -171.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 64.8 m -108.22 130.4 55.15 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 109.03 -0.73 . . . . 54.340000000000003 109.03 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.53 124.4 7.59 Favored Glycine 0 N--CA 1.416 -2.675 0 N-CA-C 110.072 -1.211 . . . . 74.329999999999998 110.072 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CE1' HG11 ' A' ' 29' ' ' VAL . 93.1 t80 -112.06 134.33 53.68 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-O 121.195 0.522 . . . . 71.310000000000002 110.077 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 m -124.01 126.3 46.04 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.976 -1.12 . . . . 70.239999999999995 107.976 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.521 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -103.03 138.7 39.55 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.84 0.829 . . . . 73.329999999999998 108.788 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 100' ' ' LEU . 4.0 mp -135.53 124.86 41.14 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.033 0 CA-C-N 113.457 -1.701 . . . . 64.140000000000001 107.673 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 4.3 t60 -112.77 127.38 56.13 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 104.807 -2.294 . . . . 71.129999999999995 104.807 173.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -142.24 164.86 29.02 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.66 -1.978 . . . . 74.209999999999994 105.66 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.11 178.71 39.37 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 119.698 -1.239 . . . . 44.039999999999999 111.848 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 105.192 -2.151 . . . . 71.129999999999995 105.192 178.0 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 119' ' ' SER . 14.5 t . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 105.73 -1.952 . . . . 74.409999999999997 105.73 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 8' ' ' ALA . 6.9 pt -62.07 -32.85 55.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 118.428 0.558 . . . . 52.240000000000002 111.959 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.77 -127.28 6.48 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.563 -0.827 . . . . 64.409999999999997 112.467 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -69.75 -9.32 54.08 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.713 1.205 . . . . 55.109999999999999 114.023 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.44 84.24 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.035 0.754 . . . . 75.150000000000006 113.035 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -148.46 165.31 31.54 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 122.432 -0.167 . . . . 71.239999999999995 110.793 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.04 -68.24 0.33 Allowed 'General case' 0 C--N 1.316 -0.871 0 O-C-N 124.615 1.197 . . . . 65.299999999999997 111.243 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.455 ' HE2' HG13 ' A' ' 121' ' ' VAL . 34.1 mtmm -106.34 151.35 24.98 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 113.245 0.831 . . . . 71.049999999999997 113.245 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.443 ' HB2' HG22 ' A' ' 111' ' ' VAL . 9.0 t -77.15 -30.19 54.93 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.349 -0.982 . . . . 71.439999999999998 108.349 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.3 t -64.48 -41.68 96.33 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.09 -0.504 . . . . 71.109999999999999 110.574 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.455 HG13 ' HE2' ' A' ' 118' ' ' LYS . 33.0 m -70.69 -33.5 53.12 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.763 0 C-N-CA 119.698 -0.801 . . . . 65.450000000000003 110.33 177.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 118' ' ' LYS . 76.4 t -65.2 -41.67 92.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.254 -0.43 . . . . 53.509999999999998 110.067 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.604 ' HE ' HD21 ' A' ' 9' ' ' LEU . 2.9 tpm_? -54.44 -52.81 60.62 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.518 -0.765 . . . . 73.530000000000001 109.474 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -62.51 -54.31 35.08 Favored Glycine 0 CA--C 1.505 -0.576 0 O-C-N 123.623 0.577 . . . . 54.420000000000002 113.232 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -60.35 -41.01 92.77 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.483 0.92 . . . . 63.350000000000001 113.483 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.94 -39.59 42.28 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.226 -0.99 . . . . 72.030000000000001 110.98 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -67.39 -61.51 1.87 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.73 -0.47 . . . . 53.420000000000002 109.73 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -69.91 -32.34 69.95 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.262 -0.881 . . . . 71.310000000000002 111.895 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.76 -58.73 7.92 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-O 119.776 -0.458 . . . . 61.229999999999997 112.507 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -63.58 -36.69 84.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 113.281 0.845 . . . . 75.340000000000003 113.281 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.9 p -65.58 -51.31 60.74 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.767 -0.773 . . . . 70.540000000000006 111.412 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.54 -47.92 32.13 Favored Glycine 0 C--O 1.245 0.801 0 C-N-CA 121.01 -0.614 . . . . 60.520000000000003 113.329 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.619 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 45.9 mm -65.25 -51.26 67.2 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 N-CA-C 111.475 0.176 . . . . 71.510000000000005 111.475 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.521 HG21 ' HG ' ' A' ' 100' ' ' LEU . 97.5 t -62.14 -48.92 86.2 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.575 0 C-N-CA 119.269 -0.972 . . . . 71.209999999999994 110.68 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.489 ' HA ' HG13 ' A' ' 16' ' ' ILE . 9.7 t30 -60.76 -63.68 1.21 Allowed 'General case' 0 C--O 1.252 1.235 0 C-N-CA 119.654 -0.818 . . . . 74.310000000000002 112.741 -175.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.69 -41.11 18.09 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 118.773 -1.171 . . . . 71.510000000000005 112.737 -174.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.619 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 14.4 tpp180 -70.55 -37.55 74.05 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.023 -0.671 . . . . 74.299999999999997 111.851 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 0.1 OUTLIER -68.22 -44.31 76.04 Favored 'General case' 0 C--O 1.251 1.139 0 N-CA-C 107.314 -1.365 . . . . 75.299999999999997 107.314 177.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.636 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -60.5 -36.95 79.58 Favored 'General case' 0 C--O 1.203 -1.378 0 CA-C-N 116.046 -0.525 . . . . 70.030000000000001 110.495 177.646 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.49 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 10.9 mmmm -73.33 -35.6 66.06 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 114.616 1.339 . . . . 74.219999999999999 114.616 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.97 -33.94 76.46 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.488 -0.485 . . . . 74.430000000000007 109.707 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.436 HG21 ' HB3' ' A' ' 18' ' ' LEU . 11.0 m -85.04 -21.56 7.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-N 116.015 -0.539 . . . . 63.210000000000001 111.927 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 78.8 mm-40 -77.68 -33.05 53.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.331 -0.548 . . . . 63.350000000000001 109.914 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 . . . . . 0 CA--C 1.548 0.869 0 CA-C-N 115.905 -0.589 . . . . 63.530000000000001 110.332 178.727 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.423 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 106.668 -1.605 . . . . 73.209999999999994 106.668 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.7 tp -111.25 96.37 30.45 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.628 -0.879 . . . . 75.349999999999994 108.628 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 2.7 Cg_exo -75.92 -179.43 5.18 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.126 2.551 . . . . 62.009999999999998 112.829 -177.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 8.4 m-20 -65.09 124.27 21.68 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.344 -0.844 . . . . 74.439999999999998 111.033 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 49.4 mt -110.3 130.71 63.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.407 -1.331 . . . . 74.319999999999993 107.407 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 m -126.25 129.17 48.39 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.746 -0.835 . . . . 72.329999999999998 108.746 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.433 ' HE3' ' HB ' ' A' ' 16' ' ' ILE . 9.5 tmtm? -141.41 133.9 28.32 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.285 -1.376 . . . . 72.120000000000005 107.285 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 m -116.69 139.57 50.4 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 107.278 -1.379 . . . . 74.349999999999994 107.278 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.457 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -148.59 133.83 10.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.512 -0.921 . . . . 74.400000000000006 108.512 -178.393 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.425 ' CG2' ' HG3' ' A' ' 95' ' ' LYS . 3.4 m -104.37 125.59 50.73 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.775 -0.824 . . . . 70.109999999999999 108.775 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.7 mp -102.44 140.5 36.64 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.065 -0.516 . . . . 75.519999999999996 110.415 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -82.86 51.31 1.88 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.908 -0.775 . . . . 72.519999999999996 108.908 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.34 159.55 51.62 Favored Pre-proline 0 N--CA 1.433 -1.285 0 CA-C-N 115.787 -0.642 . . . . 72.099999999999994 109.838 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.25 156.47 55.47 Favored 'Trans proline' 0 C--O 1.262 1.713 0 C-N-CA 122.944 2.429 . . . . 71.109999999999999 111.199 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.8 tt -64.72 -29.83 48.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.64 -0.709 . . . . 74.319999999999993 112.014 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -72.07 -28.78 63.55 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.695 -0.802 . . . . 70.299999999999997 111.796 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -77.37 -41.73 39.12 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.712 -0.395 . . . . 75.420000000000002 109.975 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.533 HG11 HG21 ' A' ' 96' ' ' THR . 7.1 p -65.47 -39.1 84.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.48 -0.563 . . . . 75.540000000000006 109.48 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.463 ' NE1' ' HD3' ' A' ' 71' ' ' PRO . 66.9 t90 -58.89 -47.19 85.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.192 -0.913 . . . . 74.319999999999993 111.376 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.03 -33.25 75.13 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 119.398 -0.921 . . . . 62.509999999999998 110.19 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 94.9 m -62.02 -15.41 44.04 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 121.583 0.706 . . . . 42.210000000000001 112.129 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.451 HG11 ' CE1' ' A' ' 98' ' ' PHE . 20.3 m -121.83 7.53 5.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.082 -1.011 . . . . 61.539999999999999 112.009 176.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.416 ' HB3' HD22 ' A' ' 46' ' ' LEU . 18.7 m -127.71 -11.62 5.5 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.753 0.649 . . . . 54.119999999999997 112.753 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.5 p -91.61 163.23 14.19 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.106 -0.701 . . . . 74.439999999999998 109.106 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.564 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 9.3 m -53.36 -47.09 69.72 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.153 0.581 . . . . 72.310000000000002 111.615 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 32' ' ' SER . 1.4 mp0 -64.92 -48.77 72.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.721 -0.672 . . . . 73.040000000000006 110.729 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.26 -43.66 94.92 Favored Glycine 0 C--O 1.247 0.962 0 CA-C-N 115.427 -0.806 . . . . 33.229999999999997 113.233 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.85 -43.72 97.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 109.907 -0.405 . . . . 74.519999999999996 109.907 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 112.199 0.444 . . . . 25.449999999999999 112.199 176.167 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.564 ' O ' ' HB3' ' A' ' 32' ' ' SER . 12.7 m120 . . . . . 0 CA--C 1.489 -1.387 0 N-CA-C 106.066 -1.827 . . . . 73.120000000000005 106.066 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -92.72 70.66 4.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 112.554 0.576 . . . . 71.439999999999998 112.554 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -78.51 119.95 22.53 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 106.206 -1.775 . . . . 65.319999999999993 106.206 172.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -124.5 149.58 46.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 112.688 0.625 . . . . 64.430000000000007 112.688 -171.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 30' ' ' SER . 23.1 tp -82.76 106.13 14.35 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.211 -0.904 . . . . 62.43 108.793 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -133.67 141.54 47.63 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.223 -2.139 . . . . 73.349999999999994 105.223 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.581 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 7.8 pt-20 -93.96 75.94 4.15 Favored 'General case' 0 C--N 1.27 -2.852 0 CA-C-N 120.185 1.357 . . . . 54.109999999999999 110.745 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.55 72.43 0.19 Allowed Glycine 1 N--CA 1.391 -4.348 0 CA-C-N 113.332 -1.758 . . . . 63.119999999999997 109.959 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.291 -1.95 0 N-CA-C 105.287 -2.116 . . . . 70.150000000000006 105.287 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.438 -1.05 0 CA-C-O 120.963 0.411 . . . . 65.299999999999997 111.452 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -134.56 129.33 34.86 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.779 -1.563 . . . . 75.099999999999994 106.779 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.2 t -91.2 136.7 23.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 C-N-CA 118.132 -1.427 . . . . 70.219999999999999 108.816 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.448 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 1.9 tm? -87.45 -60.24 2.03 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.984 -1.117 . . . . 71.200000000000003 107.984 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.88 136.47 14.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.299 -0.409 . . . . 75.129999999999995 110.739 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 48' ' ' GLU . 47.3 t -118.11 119.27 60.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.595 -0.891 . . . . 72.349999999999994 108.595 176.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 42.7 mt-30 -116.14 140.88 48.84 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.705 -0.68 . . . . 63.229999999999997 110.491 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.39 131.51 93.23 Favored Pre-proline 0 C--N 1.281 -2.389 0 CA-C-N 113.9 -1.5 . . . . 72.319999999999993 110.314 -162.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HD3' ' NE1' ' A' ' 26' ' ' TRP . 55.3 Cg_exo 2.26 49.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.261 1 C-N-CA 128.144 5.896 . . . . 73.219999999999999 117.319 -162.293 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 p -140.71 -48.25 0.42 Allowed 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.538 -0.755 . . . . 74.310000000000002 111.138 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 32.1 tt0 -140.15 128.43 22.53 Favored 'General case' 0 C--O 1.21 -0.976 0 C-N-CA 118.802 -1.159 . . . . 70.439999999999998 110.852 -172.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.551 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -133.19 132.21 41.29 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 109.504 -0.554 . . . . 61.039999999999999 109.504 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.7 t -140.37 126.99 20.29 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.778 -0.453 . . . . 70.340000000000003 109.778 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.451 ' HD1' HD11 ' A' ' 74' ' ' LEU . 32.2 p90 -146.17 159.45 43.29 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 122.884 0.473 . . . . 71.019999999999996 111.098 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HG2' HG22 ' A' ' 84' ' ' VAL . 24.9 mt-10 -117.74 122.69 44.14 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 104.679 -2.341 . . . . 71.109999999999999 104.679 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -110.63 147.79 33.54 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.124 -0.944 . . . . 73.519999999999996 111.188 -173.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 t70 71.83 -174.93 0.17 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.753 1.621 . . . . 53.43 109.902 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.5 t -85.11 -5.4 59.34 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.598 -0.688 . . . . 73.420000000000002 110.35 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.405 ' OE1' ' HB2' ' A' ' 115' ' ' ALA . 14.3 mm-40 -85.3 -37.48 19.93 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.789 -0.641 . . . . 73.200000000000003 110.307 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.95 60.85 1.06 Allowed Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.254 -1.138 . . . . 73.430000000000007 110.254 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -81.39 106.22 13.19 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 107.851 -1.166 . . . . 75.319999999999993 107.851 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.444 HG23 ' HB2' ' A' ' 105' ' ' TRP . 84.4 t -84.92 106.05 14.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.123 -1.066 . . . . 70.430000000000007 108.123 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.21 134.86 49.91 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 108.74 -0.837 . . . . 73.310000000000002 108.74 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.7 m -125.56 130.44 51.7 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.568 -0.901 . . . . 60.299999999999997 108.568 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.551 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.1 m-85 -116.41 133.58 55.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.432 -0.951 . . . . 71.239999999999995 108.432 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.522 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 1.9 mm-40 -111.43 130.61 55.65 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 115.389 -0.823 . . . . 74.310000000000002 109.634 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.38 122.17 45.73 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.559 -0.746 . . . . 74.510000000000005 109.521 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -112.91 120.28 40.86 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.152 -1.055 . . . . 74.430000000000007 108.152 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -80.6 117.61 21.45 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.367 0.604 . . . . 72.409999999999997 109.772 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 7.0 mp -109.92 158.67 17.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.501 -1.666 . . . . 70.200000000000003 106.501 172.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -62.07 -37.27 94.18 Favored Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.964 -0.636 . . . . 74.140000000000001 114.371 -173.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -120.18 -3.2 10.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 117.393 0.597 . . . . 73.329999999999998 111.731 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.0 ptpt -153.17 175.78 12.66 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.61 -0.885 . . . . 24.0 108.61 -173.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.533 HG21 HG11 ' A' ' 25' ' ' VAL . 51.8 m -129.29 124.25 33.92 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.869 -0.732 . . . . 73.209999999999994 111.231 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.422 ' N ' HD13 ' A' ' 92' ' ' LEU . . . -84.18 113.44 3.74 Favored Glycine 0 N--CA 1.423 -2.207 0 N-CA-C 110.202 -1.159 . . . . 33.530000000000001 110.202 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.451 ' CE1' HG11 ' A' ' 29' ' ' VAL . 79.5 t80 -104.14 132.65 50.17 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 108.576 -0.898 . . . . 64.230000000000004 108.576 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 12.4 m -121.17 122.07 39.18 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.308 -0.997 . . . . 72.140000000000001 108.308 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.514 HD13 HG21 ' A' ' 134' ' ' VAL . 4.2 tp -100.78 124.47 46.47 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.821 -0.807 . . . . 72.439999999999998 108.821 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.54 124.29 66.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 106.87 -1.53 . . . . 64.129999999999995 106.87 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 8.0 t60 -112.02 113.65 26.06 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.948 -1.131 . . . . 73.319999999999993 107.948 177.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.2 m -118.28 132.87 56.27 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.137 -1.06 . . . . 73.439999999999998 108.137 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.28 132.51 11.27 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.117 -0.793 . . . . 65.310000000000002 111.117 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.444 ' HB2' HG23 ' A' ' 84' ' ' VAL . 83.0 t90 . . . . . 0 C--N 1.31 -1.146 0 CA-C-O 121.414 0.626 . . . . 71.040000000000006 109.756 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 108.14 -1.059 . . . . 73.409999999999997 108.14 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 pt -58.26 -33.16 46.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 124.347 1.059 . . . . 61.210000000000001 113.15 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.93 -137.23 8.98 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 108.807 -1.717 . . . . 71.019999999999996 108.807 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -104.28 18.76 21.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.759 0.79 . . . . 72.319999999999993 109.325 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.405 ' HB2' ' OE1' ' A' ' 81' ' ' GLU . . . -60.12 -39.5 86.48 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.838 0.828 . . . . 74.209999999999994 109.716 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -139.72 143.52 37.07 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.258 -1.756 . . . . 54.140000000000001 106.258 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -70.32 -23.84 62.9 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 113.659 0.985 . . . . 73.140000000000001 113.659 -172.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.543 ' HB2' HG23 ' A' ' 122' ' ' VAL . 75.6 mmtt -111.44 -176.51 2.96 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 122.002 -0.436 . . . . 52.399999999999999 109.876 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.1 p -130.81 -73.47 0.54 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 111.659 0.244 . . . . 64.239999999999995 111.659 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -62.06 -36.06 80.52 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 123.443 0.697 . . . . 72.120000000000005 109.295 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.66 -45.51 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.366 -0.834 . . . . 70.129999999999995 110.011 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.543 HG23 ' HB2' ' A' ' 118' ' ' LYS . 72.9 t -61.37 -38.96 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 116.336 -0.393 . . . . 74.030000000000001 111.023 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.45 ' NH1' ' HB2' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -62.9 -45.34 92.98 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.833 -0.803 . . . . 74.420000000000002 108.833 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.42 -49.72 59.35 Favored Glycine 0 C--O 1.245 0.812 0 CA-C-N 115.738 -0.664 . . . . 63.340000000000003 111.987 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -60.5 -39.38 87.53 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.408 0.683 . . . . 72.420000000000002 112.259 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.9 mmt -68.55 -38.49 80.82 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.55 -0.46 . . . . 62.420000000000002 111.313 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.45 ' HB2' ' NH1' ' A' ' 123' ' ' ARG . 12.6 t70 -61.47 -53.11 60.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.194 -0.669 . . . . 61.530000000000001 109.194 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.37 -45.28 91.28 Favored Glycine 0 C--O 1.249 1.07 0 CA-C-N 115.108 -0.951 . . . . 73.200000000000003 111.89 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.33 -54.22 39.72 Favored Glycine 0 C--O 1.217 -0.952 0 O-C-N 123.999 0.47 . . . . 72.439999999999998 112.826 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.408 ' CE3' HD21 ' A' ' 100' ' ' LEU . 85.6 m95 -60.63 -34.95 75.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.7 0.63 . . . . 74.040000000000006 112.7 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.407 ' HA ' ' HG3' ' A' ' 14' ' ' LYS . 63.7 m -64.41 -55.16 22.85 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.163 0.289 . . . . 72.310000000000002 110.628 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.71 -48.21 51.07 Favored Glycine 0 C--O 1.248 0.972 0 C-N-CA 121.327 -0.463 . . . . 75.420000000000002 112.859 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.5 -57.44 12.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 CA-C-O 118.945 -0.55 . . . . 61.450000000000003 111.897 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.514 HG21 HD13 ' A' ' 100' ' ' LEU . 93.9 t -57.93 -42.2 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 119.079 -1.048 . . . . 62.149999999999999 112.804 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.457 ' HA ' HG13 ' A' ' 16' ' ' ILE . 36.9 t30 -54.73 -67.84 0.23 Allowed 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.473 0.483 . . . . 71.340000000000003 111.947 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -76.09 -40.33 53.29 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 120.355 -0.538 . . . . 62.149999999999999 111.982 -173.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 137' ' ' ARG . 4.3 tpp180 -66.37 -44.07 84.21 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 119.444 -0.903 . . . . 73.540000000000006 111.723 -172.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.532 ' HB3' HD21 ' A' ' 18' ' ' LEU . 10.8 mp -70.83 -43.83 67.74 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.789 -0.765 . . . . 62.119999999999997 111.419 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -60.56 -36.28 78.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.941 0.4 . . . . 60.240000000000002 110.381 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -75.63 -37.5 59.66 Favored 'General case' 0 C--O 1.185 -2.296 0 C-N-CA 119.807 -0.757 . . . . 71.519999999999996 112.25 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.04 -33.96 76.93 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.032 0.444 . . . . 45.420000000000002 110.756 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 28.1 m -78.96 -28.33 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 120.482 -0.487 . . . . 70.150000000000006 110.901 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -82.37 -73.67 0.38 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.416 0.627 . . . . 73.219999999999999 110.694 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 . . . . . 0 N--CA 1.431 -1.391 0 CA-C-N 115.019 -0.991 . . . . 72.209999999999994 109.19 -174.339 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 112' ' ' ILE . . . . . . . . 0 CA--C 1.504 -0.811 0 N-CA-C 107.592 -1.262 . . . . 45.219999999999999 107.592 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 9' ' ' LEU . 2.2 tm? 86.89 81.15 0.05 OUTLIER Pre-proline 0 N--CA 1.411 -2.386 0 C-N-CA 129.351 3.06 . . . . 63.149999999999999 107.977 -163.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -102.27 -153.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 123.727 2.952 . . . . 70.430000000000007 110.698 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 1.1 m-20 -55.95 103.4 0.1 Allowed 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 123.893 0.746 . . . . 73.230000000000004 111.431 175.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.516 HG22 ' HB3' ' A' ' 102' ' ' HIS . 9.6 tp -102.65 131.63 50.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.952 -1.87 . . . . 74.099999999999994 105.952 170.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.9 m -117.66 129.49 55.77 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.002 0.429 . . . . 64.239999999999995 109.89 -176.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -131.57 126.35 34.61 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.556 -1.276 . . . . 64.230000000000004 107.556 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.1 m -116.95 133.65 55.74 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.932 -0.396 . . . . 71.420000000000002 109.932 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.422 HG21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -145.88 139.54 21.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.874 -0.787 . . . . 73.150000000000006 108.874 -175.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 p -97.67 125.11 42.25 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.208 0.527 . . . . 55.329999999999998 111.656 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.07 139.57 30.81 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.763 -0.653 . . . . 74.340000000000003 109.667 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -82.07 30.62 0.39 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.935 0.772 . . . . 73.319999999999993 111.105 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.468 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -129.23 159.57 68.39 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 116.071 -0.513 . . . . 75.209999999999994 110.732 -173.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.74 156.44 42.98 Favored 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 123.505 2.803 . . . . 74.209999999999994 112.042 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.593 HG12 HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -52.07 -41.72 33.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.167 -0.924 . . . . 62.210000000000001 111.107 -177.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -68.35 -34.85 76.82 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 119.98 -0.688 . . . . 74.019999999999996 111.033 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HA ' ' HG2' ' A' ' 27' ' ' GLU . 22.7 tptm -71.51 -38.47 71.12 Favored 'General case' 0 N--CA 1.441 -0.901 0 O-C-N 123.297 0.373 . . . . 75.409999999999997 110.38 -174.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.572 HG21 ' HB ' ' A' ' 96' ' ' THR . 47.8 t -71.11 -41.18 75.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.097 -0.705 . . . . 70.140000000000001 109.097 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 45.8 t90 -59.83 -47.69 84.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.474 -0.785 . . . . 73.439999999999998 111.444 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 11.5 pt-20 -66.29 -32.1 73.31 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.695 0.283 . . . . 42.109999999999999 110.64 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.3 m -65.66 -15.33 62.67 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 121.655 0.741 . . . . 74.530000000000001 111.683 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 13.6 m -125.3 18.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 O-C-N 121.138 -0.976 . . . . 72.239999999999995 112.276 177.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 p -134.33 -12.55 2.42 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.499 0.555 . . . . 75.519999999999996 112.499 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.9 p -94.53 163.35 13.43 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.135 -0.691 . . . . 61.009999999999998 109.135 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.59 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 17.9 t -56.64 -53.17 60.73 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 123.612 0.57 . . . . 74.040000000000006 111.094 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -57.21 -40.34 77.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.45 -0.796 . . . . 45.340000000000003 111.369 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.7 -48.01 24.17 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 120.824 -0.703 . . . . 75.120000000000005 113.372 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.3 mt -67.05 -33.29 62.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 122.699 0.4 . . . . 72.150000000000006 111.766 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 115.449 1.648 . . . . 71.219999999999999 115.449 -174.812 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 . . . . . 0 CA--C 1.496 -1.131 0 N-CA-C 110.03 -0.359 . . . . 65.019999999999996 110.03 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -137.39 69.58 1.4 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.503 0.668 . . . . 72.140000000000001 109.936 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.59 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 86.0 m-85 -91.61 136.37 33.18 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.812 -0.631 . . . . 74.340000000000003 110.015 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -137.52 143.5 41.67 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.67 -0.863 . . . . 62.140000000000001 108.67 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 46' ' ' LEU . 2.3 pt? -75.62 106.42 7.17 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.062 0.934 . . . . 73.120000000000005 110.017 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 15.8 tppt? -131.26 145.13 51.77 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.984 -1.858 . . . . 71.049999999999997 105.984 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.18 77.77 6.68 Favored 'General case' 0 C--N 1.278 -2.52 0 C-N-CA 118.773 -1.171 . . . . 73.409999999999997 109.223 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.87 67.53 0.31 Allowed Glycine 0 N--CA 1.413 -2.864 0 CA-C-N 114.695 -1.139 . . . . 71.340000000000003 112.973 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.585 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.271 0 N-CA-C 106.873 -1.528 . . . . 70.530000000000001 106.873 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.413 ' HG ' ' HE1' ' A' ' 44' ' ' PHE . 8.2 p . . . . . 0 N--CA 1.43 -1.44 0 CA-C-O 121.24 0.543 . . . . 52.100000000000001 111.883 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -154.33 127.25 8.24 Favored 'General case' 0 C--O 1.193 -1.886 0 C-N-CA 125.478 1.511 . . . . 72.010000000000005 107.23 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -89.99 123.91 42.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 106.9 -1.519 . . . . 74.040000000000006 106.9 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 tt -72.92 -60.27 2.31 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.567 -1.271 . . . . 74.299999999999997 107.567 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.33 150.01 8.89 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.522 -0.763 . . . . 54.210000000000001 109.638 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.533 HG23 HD23 ' A' ' 74' ' ' LEU . 9.6 p -121.89 131.85 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 121.208 0.527 . . . . 75.519999999999996 109.757 176.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 75.3 mm-40 -104.08 141.41 36.27 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.201 -0.909 . . . . 74.340000000000003 109.193 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.11 126.98 93.35 Favored Pre-proline 0 C--N 1.276 -2.594 0 CA-C-N 114.268 -1.333 . . . . 75.329999999999998 108.623 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo 6.75 44.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.357 1 C-N-CA 128.096 5.864 . . . . 74.129999999999995 117.715 -162.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 p -137.14 -38.5 0.62 Allowed 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.707 -0.679 . . . . 65.209999999999994 112.139 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 30.2 tt0 -150.77 147.81 27.75 Favored 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 118.316 -1.354 . . . . 63.409999999999997 111.252 -173.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.691 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.6 tm? -142.02 136.1 29.92 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.068 -0.716 . . . . 53.43 109.068 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 p -140.64 127.64 20.72 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.241 0.46 . . . . 73.030000000000001 112.241 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.455 ' HD1' HD11 ' A' ' 74' ' ' LEU . 43.3 p90 -141.37 156.05 45.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.413 -0.358 . . . . 71.439999999999998 110.638 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -121.25 148.87 43.7 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.242 -1.392 . . . . 71.329999999999998 107.242 -171.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.408 ' HD1' ' OG1' ' A' ' 80' ' ' THR . 9.3 t-105 -119.36 126.52 51.61 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.79 -1.559 . . . . 65.010000000000005 106.79 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -70.06 -17.1 63.23 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.606 0.965 . . . . 70.0 113.606 -170.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.408 ' OG1' ' HD1' ' A' ' 78' ' ' TRP . 67.8 p -79.49 95.41 5.8 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 120.369 -0.533 . . . . 64.230000000000004 109.911 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 82.7 -15.79 0.64 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.289 1.436 . . . . 73.25 113.461 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.85 54.61 0.81 Allowed Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.049 -1.072 . . . . 51.439999999999998 114.231 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -92.81 149.44 21.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.835 -1.172 . . . . 74.030000000000001 107.835 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.7 p -142.84 124.82 12.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.156 -0.683 . . . . 73.019999999999996 109.156 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.2 149.96 21.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 121.418 0.627 . . . . 63.329999999999998 110.446 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.1 m -135.67 137.76 42.13 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.721 -0.672 . . . . 63.310000000000002 109.761 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.691 ' CD2' HD12 ' A' ' 74' ' ' LEU . 12.5 m-85 -113.74 129.09 56.63 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 107.396 -1.335 . . . . 73.340000000000003 107.396 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.553 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -112.13 134.16 53.85 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 105.91 -1.885 . . . . 70.129999999999995 105.91 177.075 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.593 HD21 HG12 ' A' ' 22' ' ' ILE . 6.9 tt -115.3 126.41 54.44 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.228 -0.656 . . . . 50.240000000000002 109.228 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -111.09 116.71 31.6 Favored 'General case' 0 N--CA 1.415 -2.175 0 N-CA-C 107.922 -1.14 . . . . 72.409999999999997 107.922 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -80.03 116.91 20.42 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.854 0.835 . . . . 73.140000000000001 110.364 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -120.96 159.86 24.72 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.662 -1.236 . . . . 50.350000000000001 107.662 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.57 140.82 19.21 Favored Glycine 0 C--N 1.268 -3.2 0 N-CA-C 107.599 -2.201 . . . . 51.32 107.599 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 84.63 -24.88 0.14 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.147 1.379 . . . . 74.150000000000006 111.339 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.5 175.36 14.13 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.82 -0.807 . . . . 72.310000000000002 108.82 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.572 ' HB ' HG21 ' A' ' 25' ' ' VAL . 84.8 m -126.59 129.98 49.63 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.273 -0.64 . . . . 71.049999999999997 109.273 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.61 109.89 3.6 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 110.972 -0.851 . . . . 75.25 110.972 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.422 ' CE1' HG11 ' A' ' 29' ' ' VAL . 88.4 t80 -98.5 134.14 41.88 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 109.094 -0.706 . . . . 70.209999999999994 109.094 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' A' ' 88' ' ' GLN . 23.7 m -123.11 118.93 28.82 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.331 -0.989 . . . . 44.43 108.331 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.56 140.8 34.31 Favored 'General case' 0 N--CA 1.41 -2.432 0 N-CA-C 108.876 -0.787 . . . . 61.399999999999999 108.876 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 100' ' ' LEU . 18.5 mt -136.07 124.75 37.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.856 0 CA-C-N 113.56 -1.655 . . . . 63.340000000000003 107.821 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.516 ' HB3' HG22 ' A' ' 12' ' ' ILE . 6.1 t60 -118.92 125.19 48.88 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.048 -1.834 . . . . 73.099999999999994 106.048 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.6 t -142.29 165.54 27.14 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 106.871 -1.529 . . . . 63.109999999999999 106.871 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -135.51 156.55 22.77 Favored Glycine 0 C--N 1.289 -2.074 0 N-CA-C 109.197 -1.561 . . . . 72.019999999999996 109.197 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 . . . . . 0 C--N 1.304 -1.411 0 CA-C-N 117.527 0.663 . . . . 72.439999999999998 112.289 -178.699 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.428 HG23 ' HB3' ' A' ' 119' ' ' SER . 8.0 p . . . . . 0 N--CA 1.419 -1.993 0 N-CA-C 106.77 -1.567 . . . . 63.219999999999999 106.77 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.663 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -57.0 -32.38 39.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 123.313 0.645 . . . . 51.310000000000002 112.1 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.59 46.7 0.18 Allowed Glycine 0 CA--C 1.484 -1.874 0 C-N-CA 119.793 -1.194 . . . . 31.43 111.324 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 54.79 32.81 18.32 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.76 0.824 . . . . 74.219999999999999 111.669 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.402 ' HB3' HG13 ' A' ' 112' ' ' ILE . . . -71.28 -15.38 62.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.977 0.894 . . . . 63.140000000000001 109.435 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -152.01 174.47 13.62 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 104.383 -2.451 . . . . 70.200000000000003 104.383 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -48.61 -86.61 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 116.289 1.959 . . . . 64.439999999999998 116.289 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -119.02 149.73 41.15 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.957 -1.127 . . . . 72.430000000000007 107.957 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.428 ' HB3' HG23 ' A' ' 111' ' ' VAL . 6.9 p -65.0 -41.0 95.76 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.602 0.593 . . . . 75.430000000000007 112.602 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.7 t -68.23 -38.85 82.28 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.458 -0.497 . . . . 55.509999999999998 111.112 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.1 m -69.04 -34.13 62.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 C-N-CA 119.976 -0.689 . . . . 75.109999999999999 109.822 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.5 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 56.3 t -66.94 -46.66 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 116.35 -0.387 . . . . 71.120000000000005 110.733 177.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.08 -41.15 99.37 Favored 'General case' 0 C--O 1.209 -1.077 0 N-CA-C 109.425 -0.583 . . . . 63.509999999999998 109.425 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.56 -49.24 70.93 Favored Glycine 0 CA--C 1.502 -0.75 0 CA-C-N 116.223 -0.444 . . . . 51.340000000000003 112.159 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 122' ' ' VAL . 2.1 tmmm? -62.19 -32.64 73.31 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 123.413 0.685 . . . . 75.430000000000007 111.571 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 25.2 mmt -76.59 -44.94 32.39 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 120.338 -0.545 . . . . 64.319999999999993 110.191 176.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -58.9 -62.82 1.59 Allowed 'General case' 0 C--O 1.25 1.12 0 C-N-CA 123.912 0.885 . . . . 75.219999999999999 110.687 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.0 -42.07 60.03 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.696 -0.684 . . . . 70.319999999999993 111.866 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.583 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -58.9 -62.11 6.61 Favored Glycine 0 N--CA 1.437 -1.28 0 O-C-N 124.057 0.504 . . . . 74.109999999999999 112.043 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.464 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.5 m95 -60.82 -30.19 69.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.64 0.978 . . . . 73.540000000000006 113.64 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 73.1 m -63.4 -50.83 68.31 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 119.958 -0.697 . . . . 72.230000000000004 110.614 174.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.78 -46.15 54.77 Favored Glycine 0 C--O 1.251 1.218 0 C-N-CA 120.663 -0.779 . . . . 44.100000000000001 112.615 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 129' ' ' GLY . 52.1 mm -58.87 -57.86 9.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 123.023 0.529 . . . . 72.219999999999999 110.292 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HD23 ' A' ' 138' ' ' LEU . 93.1 t -62.97 -45.99 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 112.438 0.533 . . . . 65.409999999999997 112.438 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -57.03 -61.56 2.37 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 123.22 0.325 . . . . 74.340000000000003 111.746 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -84.65 -34.21 23.1 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 119.004 -1.078 . . . . 63.25 113.723 -172.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -70.32 -39.05 75.01 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.285 -0.966 . . . . 61.399999999999999 109.711 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.6 mm? -67.69 -48.95 65.13 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.874 -0.73 . . . . 62.020000000000003 109.778 174.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -58.25 -33.26 69.18 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.361 -0.381 . . . . 75.420000000000002 111.094 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -72.89 -48.31 38.39 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 112.188 0.44 . . . . 63.420000000000002 112.188 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.01 70.5 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.946 -0.302 . . . . 72.540000000000006 111.585 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.468 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 25.6 m -79.92 -33.08 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 120.594 -0.443 . . . . 74.129999999999995 111.556 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.48 -69.0 0.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.074 -0.65 . . . . 72.109999999999999 109.334 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 . . . . . 0 CA--C 1.505 -0.776 0 C-N-CA 123.558 0.743 . . . . 64.140000000000001 111.424 174.756 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -1.931 0 N-CA-C 106.894 -1.521 . . . . 62.049999999999997 106.894 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.402 ' CD1' ' HA ' ' A' ' 123' ' ' ARG . 6.2 tt -69.32 125.9 92.3 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 108.9 -0.778 . . . . 62.539999999999999 108.9 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -83.66 -158.43 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.051 2.5 . . . . 53.020000000000003 113.755 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.39 149.14 50.68 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.006 -0.997 . . . . 71.140000000000001 110.594 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 66.7 mt -123.97 139.48 50.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.82 -0.807 . . . . 73.239999999999995 108.82 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.5 m -139.58 131.38 27.52 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.904 -0.776 . . . . 42.420000000000002 108.904 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -145.88 151.43 37.86 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.376 -0.602 . . . . 63.32 109.376 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 p -117.39 151.81 36.27 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.126 -0.694 . . . . 64.340000000000003 109.126 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.533 HG21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -158.44 143.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 107.586 -1.264 . . . . 52.539999999999999 107.586 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 p -111.08 129.62 55.86 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.272 0.558 . . . . 64.349999999999994 112.438 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -101.88 139.66 37.22 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.074 -1.084 . . . . 74.230000000000004 108.074 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.527 ' CD ' ' HE ' ' A' ' 139' ' ' ARG 0.25 0.0 OUTLIER -93.29 53.36 1.91 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.826 1.298 . . . . 55.119999999999997 112.065 -177.873 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.5 160.16 52.15 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 113.332 -1.758 . . . . 71.219999999999999 108.41 -177.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HG2' ' HG2' ' A' ' 24' ' ' LYS . 28.9 Cg_endo -62.55 155.52 57.85 Favored 'Trans proline' 0 C--O 1.257 1.459 0 C-N-CA 122.803 2.335 . . . . 75.450000000000003 111.628 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 tt -56.57 -32.67 37.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.405 -0.816 . . . . 73.150000000000006 111.794 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -62.65 -40.23 96.39 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 123.12 0.262 . . . . 51.140000000000001 110.755 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 21' ' ' PRO . 14.2 mmmm -69.41 -42.49 75.0 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 116.298 -0.41 . . . . 75.209999999999994 110.869 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.477 HG21 ' HB ' ' A' ' 96' ' ' THR . 46.0 t -66.52 -42.49 90.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.55 -0.537 . . . . 74.030000000000001 109.55 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -61.89 -47.49 84.73 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.561 -0.745 . . . . 74.140000000000001 111.208 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.436 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 13.3 pt-20 -68.47 -29.51 68.16 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.78 -0.368 . . . . 74.409999999999997 111.319 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.6 m -60.75 -29.26 69.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.368 0.604 . . . . 72.150000000000006 111.27 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.581 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 15.2 m -113.1 19.62 7.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.25 -0.432 . . . . 74.439999999999998 112.147 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 27' ' ' GLU . 37.8 p -136.68 -20.7 1.32 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.077 0.769 . . . . 74.25 113.077 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.8 p -96.34 161.81 13.77 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 120.584 -0.446 . . . . 64.230000000000004 110.94 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 m -58.76 -55.52 34.07 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 123.588 0.555 . . . . 44.200000000000003 110.776 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 1.5 mp0 -57.28 -44.77 84.28 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 123.653 0.781 . . . . 72.400000000000006 110.581 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -48.87 65.34 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.4 -0.818 . . . . 53.399999999999999 113.238 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.2 mt -69.45 -43.1 81.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.411 . . . . 73.120000000000005 110.777 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.897 0 N-CA-C 112.859 0.689 . . . . 74.299999999999997 112.859 177.782 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.422 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . 44.4 t-20 . . . . . 0 N--CA 1.434 -1.27 0 N-CA-C 107.629 -1.249 . . . . 73.140000000000001 107.629 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -88.93 75.12 8.09 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-O 122.076 0.941 . . . . 71.150000000000006 109.873 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 84.0 m-85 -78.79 119.81 22.53 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.622 -1.251 . . . . 73.319999999999993 107.622 172.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -117.55 146.87 43.29 Favored 'General case' 0 CA--C 1.484 -1.585 0 O-C-N 123.374 0.422 . . . . 73.209999999999994 110.23 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.421 HD13 ' CB ' ' A' ' 30' ' ' SER . 30.1 tp -78.85 104.57 9.58 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 106.838 -1.542 . . . . 72.0 106.838 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 58.2 tttm -133.33 133.67 42.82 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.148 -1.427 . . . . 74.219999999999999 107.148 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HA ' HG23 ' A' ' 68' ' ' VAL . 4.7 pt-20 -88.14 73.07 9.04 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-O 123.033 1.396 . . . . 61.310000000000002 109.102 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.0 57.03 0.19 Allowed Glycine 1 N--CA 1.392 -4.262 0 CA-C-N 112.825 -1.989 . . . . 61.130000000000003 109.992 -177.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.311 -1.105 0 N-CA-C 105.965 -1.865 . . . . 62.310000000000002 105.965 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.423 -1.82 0 N-CA-C 108.488 -0.93 . . . . 74.129999999999995 108.488 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 53.4 mtmt -148.97 123.52 9.75 Favored 'General case' 0 C--O 1.198 -1.639 0 N-CA-C 108.435 -0.95 . . . . 63.299999999999997 108.435 177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 46.1 t -89.19 135.89 24.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.014 -1.106 . . . . 72.120000000000005 108.014 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.3 tp -80.36 -62.59 1.63 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.054 -0.721 . . . . 72.329999999999998 109.054 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.78 149.87 28.79 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.21 -0.905 . . . . 75.129999999999995 109.835 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG23 ' HA ' ' A' ' 48' ' ' GLU . 66.7 t -125.89 123.17 63.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.803 -0.814 . . . . 71.510000000000005 108.803 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.534 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 81.5 mm-40 -107.81 140.78 40.39 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.344 0.592 . . . . 74.340000000000003 110.291 174.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.77 123.94 88.19 Favored Pre-proline 0 C--N 1.277 -2.545 0 CA-C-N 113.873 -1.512 . . . . 72.010000000000005 109.213 -165.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo 6.86 49.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.639 1 C-N-CA 127.75 5.633 . . . . 71.329999999999998 116.603 -161.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 p -138.9 -41.5 0.48 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.105 -0.952 . . . . 74.219999999999999 112.077 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 39.3 tt0 -148.15 145.09 28.2 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 119.973 -0.691 . . . . 70.430000000000007 110.197 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.7 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.9 tm? -142.12 135.91 29.54 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.343 -0.984 . . . . 73.349999999999994 108.343 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.2 m -139.45 126.25 20.79 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 121.029 -0.268 . . . . 65.120000000000005 110.651 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 36.1 p90 -145.76 156.97 43.95 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 122.2 0.2 . . . . 74.420000000000002 111.242 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 24.0 mt-10 -120.39 124.6 45.91 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.085 -1.82 . . . . 74.209999999999994 106.085 -174.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -130.07 157.51 42.19 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 116.222 -0.445 . . . . 72.299999999999997 110.592 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 78.85 -176.33 0.09 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.267 1.827 . . . . 75.209999999999994 109.789 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.3 p -73.11 -18.47 61.29 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 114.433 1.272 . . . . 60.399999999999999 114.433 -173.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.401 ' HB2' ' NE1' ' A' ' 83' ' ' TRP . 3.7 mp0 -92.83 -18.77 22.44 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.092 -0.643 . . . . 70.319999999999993 110.989 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.89 60.63 2.88 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 120.002 -1.094 . . . . 43.439999999999998 110.54 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 95.9 m95 -78.33 121.21 24.16 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.551 -0.907 . . . . 72.129999999999995 108.551 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 76' ' ' PHE . 8.7 p -99.19 107.74 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 CA-C-O 122.516 1.151 . . . . 63.240000000000002 111.592 -173.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -99.84 146.48 8.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.41 -1.268 . . . . 63.509999999999998 108.369 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 42.4 m -130.5 135.82 48.35 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 109.139 -0.689 . . . . 53.439999999999998 109.139 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.7 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.4 m-85 -112.59 135.55 53.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.2 -1.037 . . . . 72.310000000000002 108.2 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.15 137.91 52.65 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.392 -0.966 . . . . 75.230000000000004 108.392 176.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -113.1 131.52 55.79 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.77 0.319 . . . . 73.450000000000003 111.296 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -120.7 139.06 53.6 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.231 1.013 . . . . 72.439999999999998 108.678 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -96.73 128.71 43.94 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.087 0.47 . . . . 65.310000000000002 109.996 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.56 153.54 45.08 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.981 -1.118 . . . . 73.420000000000002 107.981 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.98 57.54 5.07 Favored Glycine 0 C--N 1.289 -2.053 0 C-N-CA 121.488 -0.387 . . . . 71.239999999999995 113.667 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 171.65 -44.54 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 124.434 1.093 . . . . 75.230000000000004 108.323 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -130.78 172.59 11.83 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.167 -1.379 . . . . 73.129999999999995 109.115 -170.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.477 ' HB ' HG21 ' A' ' 25' ' ' VAL . 74.0 m -116.52 130.91 57.02 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 109.22 -0.659 . . . . 65.549999999999997 109.22 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.08 119.8 5.66 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.059 -1.216 . . . . 53.130000000000003 110.059 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -108.0 133.23 52.61 Favored 'General case' 0 C--N 1.269 -2.895 0 N-CA-C 108.082 -1.081 . . . . 74.049999999999997 108.082 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.7 m -122.77 122.51 38.87 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.761 -0.829 . . . . 44.409999999999997 108.761 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.483 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.19 139.05 36.42 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 121.854 0.835 . . . . 73.099999999999994 109.404 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.534 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 14.0 mt -136.49 128.88 45.03 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 113.334 -1.757 . . . . 73.299999999999997 108.047 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.523 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . 8.7 t-80 -120.38 125.82 48.95 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.698 -0.853 . . . . 60.420000000000002 108.698 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.7 t -142.83 159.87 41.41 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 104.777 -2.305 . . . . 75.439999999999998 104.777 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.55 -169.04 36.12 Favored Glycine 0 C--N 1.292 -1.89 0 C-N-CA 119.967 -1.111 . . . . 51.140000000000001 112.325 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 97.9 m95 . . . . . 0 C--N 1.31 -1.14 0 CA-C-O 121.502 0.668 . . . . 73.319999999999993 112.421 -179.426 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.434 -1.23 0 N-CA-C 107.552 -1.277 . . . . 64.109999999999999 107.552 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 112' ' ' ILE . 2.9 pt -55.65 -31.8 29.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 123.955 0.784 . . . . 65.209999999999994 113.062 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.29 -135.08 7.4 Favored Glycine 0 CA--C 1.486 -1.747 0 C-N-CA 119.893 -1.146 . . . . 34.130000000000003 111.801 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -80.07 11.2 3.56 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.904 0.705 . . . . 70.0 112.904 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.43 -15.52 63.58 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.991 -0.744 . . . . 62.420000000000002 108.991 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . 0.3 0.0 OUTLIER 59.32 10.0 1.62 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 128.515 2.726 . . . . 72.340000000000003 116.642 172.267 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.81 161.39 18.38 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.916 -0.713 . . . . 65.219999999999999 110.059 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -82.61 145.2 29.81 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.742 -0.836 . . . . 74.340000000000003 108.742 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 p -57.19 -40.4 77.31 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.919 0.711 . . . . 43.450000000000003 112.919 -176.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.1 p -67.8 -46.12 72.84 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.567 -0.288 . . . . 52.509999999999998 111.626 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.64 -33.87 62.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 C-N-CA 120.295 -0.562 . . . . 64.140000000000001 109.641 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.07 -46.14 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.275 -0.421 . . . . 72.409999999999997 110.887 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.402 ' HA ' ' CD1' ' A' ' 9' ' ' LEU . 44.4 ttm180 -66.22 -45.61 80.11 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 121.007 -0.277 . . . . 73.420000000000002 110.902 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.47 -43.21 99.03 Favored Glycine 0 N--CA 1.446 -0.657 0 O-C-N 123.608 0.568 . . . . 55.340000000000003 112.053 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -38.47 73.88 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.686 0.625 . . . . 62.43 112.686 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.82 -45.73 49.54 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.981 -0.688 . . . . 72.540000000000006 110.854 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.06 -59.2 3.67 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.441 -0.345 . . . . 62.240000000000002 111.618 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.74 -40.99 93.97 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.541 -0.624 . . . . 52.539999999999999 111.541 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.49 -60.15 8.69 Favored Glycine 0 N--CA 1.436 -1.315 0 O-C-N 124.054 0.503 . . . . 52.329999999999998 112.3 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.419 ' HE3' HG23 ' A' ' 134' ' ' VAL . 67.8 m95 -63.37 -35.68 81.21 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.592 0.96 . . . . 70.329999999999998 113.592 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.2 m -68.29 -54.54 16.85 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.166 -0.614 . . . . 65.140000000000001 110.94 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.19 -47.04 39.11 Favored Glycine 0 C--O 1.244 0.735 0 C-N-CA 120.829 -0.7 . . . . 73.200000000000003 112.95 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.711 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 46.2 mm -67.3 -49.8 68.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.955 0 CA-C-O 119.577 -0.249 . . . . 65.049999999999997 111.228 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.533 HG12 HG21 ' A' ' 16' ' ' ILE . 78.6 t -61.84 -49.6 83.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 118.793 -1.163 . . . . 50.25 112.218 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -61.6 -64.83 0.81 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.702 0.63 . . . . 61.32 112.702 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.05 -39.23 50.77 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.863 -0.735 . . . . 65.310000000000002 112.723 -172.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.711 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -69.61 -40.93 76.33 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.006 -0.677 . . . . 70.409999999999997 111.886 -176.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.2 mm? -62.63 -48.88 77.42 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 119.063 -1.055 . . . . 73.129999999999995 109.271 175.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.527 ' HE ' ' CD ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -61.0 -38.79 87.29 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.735 -0.666 . . . . 72.519999999999996 110.452 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -76.89 -36.76 56.47 Favored 'General case' 0 CA--C 1.471 -2.093 0 N-CA-C 113.721 1.008 . . . . 73.439999999999998 113.721 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 -27.42 64.02 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.131 -0.627 . . . . 43.020000000000003 110.611 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.434 HG11 HG22 ' A' ' 25' ' ' VAL . 23.8 m -80.2 -26.71 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 116.201 -0.454 . . . . 72.299999999999997 110.76 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -84.31 -60.36 2.11 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 119.98 -0.688 . . . . 74.439999999999998 111.512 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 113.985 1.106 . . . . 71.540000000000006 113.985 -170.298 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 121.042 0.448 . . . . 64.140000000000001 110.461 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 tt 177.99 100.99 0.13 Allowed Pre-proline 0 N--CA 1.434 -1.266 0 N-CA-C 105.775 -1.935 . . . . 64.340000000000003 105.775 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -92.96 -179.42 0.95 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.413 2.075 . . . . 40.43 110.118 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.589 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 3.2 p-10 -68.24 112.28 5.06 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.836 -0.802 . . . . 62.140000000000001 108.836 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.531 HG22 ' HB3' ' A' ' 102' ' ' HIS . 9.1 tp -97.33 125.44 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 C-N-CA 118.456 -1.298 . . . . 70.409999999999997 108.283 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 60.7 m -107.18 128.98 54.89 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 107.425 -1.324 . . . . 73.030000000000001 107.425 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -131.09 136.52 48.47 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.68 -1.23 . . . . 74.430000000000007 107.68 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -118.3 134.95 54.6 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 120.754 0.312 . . . . 61.299999999999997 111.211 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.509 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.78 139.98 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.033 0.444 . . . . 53.399999999999999 109.917 -179.091 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 p -101.09 126.74 47.81 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.137 0.494 . . . . 74.549999999999997 110.969 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.408 HD11 ' HB3' ' A' ' 138' ' ' LEU . 4.0 mm? -91.19 138.17 31.8 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.617 -0.72 . . . . 64.310000000000002 110.603 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -86.83 30.12 0.76 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 113.997 -1.456 . . . . 74.140000000000001 109.613 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.15 158.41 73.74 Favored Pre-proline 0 C--O 1.251 1.142 0 CA-C-N 115.564 -0.743 . . . . 62.229999999999997 109.37 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.97 150.76 87.61 Favored 'Trans proline' 0 C--O 1.25 1.091 0 C-N-CA 123.286 2.657 . . . . 75.129999999999995 112.109 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -40.24 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.091 -0.958 . . . . 70.519999999999996 111.68 -176.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -67.83 -35.77 79.19 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.997 -0.681 . . . . 74.430000000000007 111.179 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -72.66 -37.48 67.93 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.627 -0.509 . . . . 62.509999999999998 109.627 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.03 -41.15 89.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.908 -0.587 . . . . 61.210000000000001 109.618 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -60.02 -47.03 87.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.593 -0.73 . . . . 74.140000000000001 110.086 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -60.79 -39.79 90.17 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.362 0.665 . . . . 73.439999999999998 110.475 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.7 m -60.97 -23.29 65.23 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.536 0.734 . . . . 72.129999999999995 112.055 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.589 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 10.7 m -119.25 19.87 6.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 112.508 0.558 . . . . 73.310000000000002 112.508 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.427 ' HB2' HD12 ' A' ' 46' ' ' LEU . 61.0 p -137.46 -22.09 1.14 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.933 0.716 . . . . 63.030000000000001 112.933 176.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -91.63 154.61 18.91 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.456 -0.572 . . . . 63.420000000000002 109.456 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 27.7 t -63.01 -40.78 98.78 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.605 -0.887 . . . . 63.420000000000002 108.605 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -62.3 -48.97 77.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.678 -1.147 . . . . 71.420000000000002 109.638 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.78 -47.59 60.26 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.151 -0.931 . . . . 71.209999999999994 113.402 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HA ' HH22 ' A' ' 137' ' ' ARG . 70.2 mt -69.47 -48.46 66.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 117.601 0.7 . . . . 73.219999999999999 111.895 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.087 0 N-CA-C 112.461 0.541 . . . . 70.5 112.461 179.579 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 CA--C 1.488 -1.424 0 N-CA-C 107.082 -1.451 . . . . 64.120000000000005 107.082 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.79 78.86 3.28 Favored 'General case' 0 CA--C 1.469 -2.139 0 CA-C-O 121.177 0.513 . . . . 74.409999999999997 110.911 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 83.1 m-85 -68.28 126.55 29.94 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.594 -1.185 . . . . 63.43 109.009 175.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -127.45 138.75 53.04 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.987 -0.745 . . . . 65.400000000000006 108.987 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 30' ' ' SER . 5.5 tt -75.56 103.72 5.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 106.641 -1.615 . . . . 65.519999999999996 106.641 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 1.2 tpmt? -133.91 145.13 49.32 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.53 -1.656 . . . . 73.299999999999997 106.53 172.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -87.68 48.12 1.6 Allowed 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 119.298 0.954 . . . . 73.519999999999996 110.185 174.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.68 49.96 0.03 OUTLIER Glycine 0 N--CA 1.42 -2.409 0 CA-C-N 115.32 -0.855 . . . . 62.140000000000001 111.0 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.5 OUTLIER . . . . . 0 CA--C 1.487 -1.463 0 N-CA-C 106.082 -1.822 . . . . 74.0 106.082 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 20.4 p . . . . . 0 N--CA 1.429 -1.503 0 N-CA-C 108.553 -0.906 . . . . 72.150000000000006 108.553 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 9.6 mtmp? -145.38 135.5 23.84 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.35 -0.982 . . . . 74.340000000000003 108.35 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 50' ' ' GLN . 30.2 t -90.28 130.61 39.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.602 -1.258 . . . . 62.119999999999997 107.602 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.2 tp -76.03 -59.91 2.55 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.055 -1.091 . . . . 75.030000000000001 108.055 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -162.16 141.08 9.33 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.352 -0.84 . . . . 61.119999999999997 109.776 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.505 HG23 HD23 ' A' ' 74' ' ' LEU . 9.4 p -116.99 120.46 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.982 0 CA-C-O 121.583 0.706 . . . . 65.0 110.036 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 2.2 mp0 -94.15 141.04 29.0 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.617 -1.174 . . . . 73.200000000000003 108.85 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 122.69 83.57 Favored Pre-proline 0 C--N 1.276 -2.613 0 CA-C-N 114.379 -1.282 . . . . 51.439999999999998 108.969 -164.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo 0.12 62.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.014 1 C-N-CA 126.771 4.981 . . . . 62.520000000000003 115.488 -159.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -143.47 -42.24 0.29 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 113.67 -1.605 . . . . 73.209999999999994 110.983 175.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.4 tt0 -150.84 145.46 25.7 Favored 'General case' 0 C--O 1.204 -1.318 0 C-N-CA 119.834 -0.746 . . . . 74.439999999999998 110.491 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.694 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.0 tm? -137.05 137.63 39.56 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.063 -1.088 . . . . 73.010000000000005 108.063 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.7 p -140.76 126.88 19.58 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.803 -0.359 . . . . 65.340000000000003 110.992 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.46 ' HD1' HD11 ' A' ' 74' ' ' LEU . 31.2 p90 -144.23 156.91 44.49 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 120.794 0.33 . . . . 72.519999999999996 111.07 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 20.6 mt-10 -121.07 136.78 54.91 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 105.963 -1.866 . . . . 75.530000000000001 105.963 -173.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -147.94 158.71 44.19 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 120.188 -0.605 . . . . 74.420000000000002 112.409 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 73.84 171.34 0.3 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.05 -1.432 . . . . 73.5 113.195 172.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.6 p -66.47 -34.46 77.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.934 0.894 . . . . 70.340000000000003 111.862 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.46 -15.11 60.9 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 112.438 0.533 . . . . 74.310000000000002 112.438 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.29 67.64 1.79 Allowed Glycine 0 C--O 1.247 0.91 0 C-N-CA 121.058 -0.591 . . . . 54.329999999999998 112.411 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.456 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 33.2 m95 -93.95 130.21 40.13 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.33 -0.618 . . . . 63.340000000000003 109.33 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.432 HG22 ' HG2' ' A' ' 77' ' ' GLU . 42.1 t -110.8 111.43 36.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.854 -1.165 . . . . 73.230000000000004 107.854 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.3 m -109.23 140.59 27.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 115.946 -0.57 . . . . 73.129999999999995 109.67 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 58.3 m -126.09 135.14 51.37 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.9 -0.778 . . . . 74.349999999999994 108.9 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.694 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.7 m-85 -111.25 132.59 54.23 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.793 -1.188 . . . . 73.430000000000007 107.793 177.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.57 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 27.3 mt-30 -114.35 141.45 47.61 Favored 'General case' 0 C--N 1.276 -2.614 0 O-C-N 123.643 0.589 . . . . 75.239999999999995 110.568 177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.6 tp -104.18 141.18 36.71 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.705 -0.68 . . . . 64.120000000000005 110.918 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -124.92 116.68 22.59 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 106.164 -1.791 . . . . 74.349999999999994 106.164 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -86.22 119.15 26.2 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.999 -0.546 . . . . 65.109999999999999 111.796 -173.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 74.6 mt -125.18 149.52 47.85 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.046 -1.464 . . . . 71.010000000000005 107.046 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.84 58.84 1.79 Allowed Glycine 0 C--N 1.28 -2.536 0 C-N-CA 120.44 -0.886 . . . . 63.200000000000003 112.476 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -177.15 -52.84 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.119 -1.808 . . . . 62.210000000000001 106.119 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.67 175.8 7.7 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.006 -1.479 . . . . 74.340000000000003 107.006 -175.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.1 m -120.87 130.39 53.9 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 120.341 -0.543 . . . . 62.039999999999999 109.697 -178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.52 124.79 7.86 Favored Glycine 0 N--CA 1.408 -3.216 0 N-CA-C 109.099 -1.6 . . . . 72.340000000000003 109.099 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -117.27 134.18 55.11 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 108.812 -0.81 . . . . 74.129999999999995 108.812 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 23.5 m -125.95 129.24 48.88 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.517 -0.92 . . . . 65.549999999999997 108.517 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.505 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -104.79 142.26 35.03 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.005 -0.739 . . . . 74.230000000000004 109.005 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.494 ' N ' HD13 ' A' ' 100' ' ' LEU . 3.6 mp -136.13 125.25 38.61 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 106.829 -1.545 . . . . 72.409999999999997 106.829 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.589 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 23.2 t-160 -119.3 124.33 46.4 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.09 -0.707 . . . . 53.25 109.09 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.0 t -139.44 164.09 30.79 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 106.49 -1.67 . . . . 71.030000000000001 106.49 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -110.42 160.54 13.28 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.752 -0.737 . . . . 54.520000000000003 112.099 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 . . . . . 0 CA--C 1.559 1.32 0 CA-C-O 122.623 1.201 . . . . 72.540000000000006 110.205 179.656 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.485 -1.542 0 CA-C-O 120.902 0.382 . . . . 70.319999999999993 110.355 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.423 ' H ' HG12 ' A' ' 112' ' ' ILE . 1.1 pt -58.47 -38.46 70.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.56 -1.2 . . . . 71.040000000000006 112.245 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.17 70.3 0.24 Allowed Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.168 -1.491 . . . . 74.420000000000002 113.016 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt 61.93 31.66 18.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.729 1.011 . . . . 75.140000000000001 113.729 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.35 -13.3 61.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.654 0.264 . . . . 73.420000000000002 110.696 174.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 m120 93.65 139.25 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.377 1.871 . . . . 72.120000000000005 112.891 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 86.27 158.68 0.08 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.391 1.876 . . . . 55.039999999999999 111.353 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HB2' HG23 ' A' ' 121' ' ' VAL . 30.9 mmmt -59.28 149.43 28.76 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.187 0.595 . . . . 74.230000000000004 112.168 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.58 -52.81 64.07 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.221 1.008 . . . . 75.200000000000003 110.592 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.8 t -60.82 -36.74 79.85 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.611 -0.722 . . . . 74.409999999999997 110.2 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 118' ' ' LYS . 71.6 t -70.25 -47.45 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.653 -0.703 . . . . 72.239999999999995 109.898 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.16 -41.18 80.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 110.701 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -63.22 -48.81 76.72 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.486 -0.779 . . . . 73.450000000000003 109.424 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.76 96.97 Favored Glycine 0 CA--C 1.495 -1.213 0 CA-C-N 115.231 -0.895 . . . . 60.420000000000002 112.03 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -66.55 -35.21 79.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 122.78 0.432 . . . . 71.010000000000005 111.521 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 24.1 mmt -70.92 -45.09 64.85 Favored 'General case' 0 C--O 1.211 -0.939 0 C-N-CA 120.315 -0.554 . . . . 64.510000000000005 111.003 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -67.26 -53.84 26.27 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.406 -0.918 . . . . 72.239999999999995 111.104 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.97 -45.64 95.21 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.917 -0.473 . . . . 63.539999999999999 111.917 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.65 -52.65 49.47 Favored Glycine 0 CA--C 1.487 -1.701 0 N-CA-C 111.494 -0.642 . . . . 64.519999999999996 111.494 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.402 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.7 m95 -65.15 -26.3 68.11 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 113.372 0.878 . . . . 73.030000000000001 113.372 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.1 m -67.81 -54.68 17.17 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.55 -0.537 . . . . 74.5 109.55 174.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.87 -42.4 86.19 Favored Glycine 0 C--O 1.245 0.826 0 CA-C-N 115.992 -0.549 . . . . 54.210000000000001 113.053 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.681 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 39.5 mm -65.37 -57.58 10.39 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 CA-C-O 119.599 -0.239 . . . . 72.209999999999994 110.937 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 69.6 t -57.99 -48.02 85.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 112.486 0.55 . . . . 72.120000000000005 112.486 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.509 ' HA ' HG13 ' A' ' 16' ' ' ILE . 43.4 t30 -59.69 -63.31 1.35 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.041 0.448 . . . . 75.129999999999995 111.995 -177.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -74.85 -48.27 25.92 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 112.447 0.536 . . . . 72.109999999999999 112.447 -173.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.681 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -63.56 -38.64 91.91 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 112.107 0.41 . . . . 74.239999999999995 112.107 -175.474 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.3 mm? -68.1 -48.38 65.63 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 119.298 -0.961 . . . . 64.340000000000003 110.594 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -58.42 -36.04 72.99 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.53 0.681 . . . . 74.140000000000001 109.698 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -75.97 -38.85 57.04 Favored 'General case' 0 C--O 1.185 -2.329 0 N-CA-C 112.339 0.496 . . . . 75.420000000000002 112.339 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.17 68.58 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.152 -0.619 . . . . 73.540000000000006 111.446 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.6 m -78.56 -36.09 19.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.067 -0.653 . . . . 73.219999999999999 110.213 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -87.8 -58.95 2.38 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.39 1.256 . . . . 72.120000000000005 114.39 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--N 1.308 -1.224 0 CA-C-O 121.74 0.781 . . . . 71.230000000000004 111.442 -172.722 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . . . . . . 0 CA--C 1.491 -1.323 0 N-CA-C 106.945 -1.502 . . . . 64.329999999999998 106.945 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.456 HD11 ' HA3' ' A' ' 104' ' ' GLY . 2.4 pt? -162.53 129.72 2.58 Favored Pre-proline 0 N--CA 1.418 -2.028 0 N-CA-C 105.898 -1.889 . . . . 60.43 105.898 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -85.44 -167.94 0.45 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 121.78 1.653 . . . . 75.430000000000007 110.121 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 14.1 t70 -100.35 113.07 25.52 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 105.675 -1.972 . . . . 61.310000000000002 105.675 171.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' A' ' 102' ' ' HIS . 14.5 tt -106.86 130.79 58.23 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.982 0 C-N-CA 119.81 -0.756 . . . . 75.400000000000006 109.478 -177.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 36.2 m -114.37 128.92 56.59 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 106.984 -1.488 . . . . 63.43 106.984 178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.408 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 20.0 tptt -134.67 152.69 51.95 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.392 -1.336 . . . . 61.200000000000003 107.392 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.2 p -128.75 133.91 48.25 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 120.812 -0.355 . . . . 71.209999999999994 110.342 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.28 135.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.333 -1.358 . . . . 75.319999999999993 107.333 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.8 p -102.8 131.49 49.62 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.47 0.544 . . . . 72.420000000000002 112.47 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.9 mp -108.36 140.94 40.92 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 122.005 0.907 . . . . 75.299999999999997 113.094 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -70.36 13.42 0.17 Allowed 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 128.583 2.753 . . . . 62.549999999999997 112.779 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.483 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -130.86 164.03 44.76 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-O 118.969 -0.539 . . . . 75.109999999999999 110.107 -172.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 37.5 Cg_endo -64.8 154.95 70.14 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.85 2.367 . . . . 62.340000000000003 111.904 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.401 ' HA ' HG21 ' A' ' 96' ' ' THR . 14.0 tt -57.69 -33.35 44.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.688 -1.142 . . . . 74.239999999999995 112.666 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 10.1 pt20 -65.05 -41.31 95.3 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.364 -0.38 . . . . 72.120000000000005 111.756 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -72.64 -38.9 67.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.321 -0.4 . . . . 61.509999999999998 110.988 -173.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.468 HG11 HG21 ' A' ' 96' ' ' THR . 8.6 p -68.28 -41.0 83.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 120.385 -0.526 . . . . 74.420000000000002 109.918 178.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -62.28 -47.25 85.15 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.636 -0.711 . . . . 73.099999999999994 111.451 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 23' ' ' GLN . 11.6 pt-20 -69.0 -27.9 66.11 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 120.35 -0.54 . . . . 65.310000000000002 111.523 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.0 m -57.13 -36.38 70.63 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 121.411 0.624 . . . . 72.049999999999997 110.026 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.498 HG21 ' HE2' ' A' ' 98' ' ' PHE . 4.0 m -107.74 23.14 3.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.125 -0.489 . . . . 75.209999999999994 111.795 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.9 t -145.06 11.29 1.35 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.945 0.402 . . . . 60.109999999999999 110.743 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.0 p -117.31 162.14 18.39 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.871 -0.518 . . . . 53.240000000000002 110.335 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -51.93 -62.23 1.76 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.325 1.05 . . . . 64.120000000000005 111.467 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.58 -35.52 75.43 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.837 0.68 . . . . 63.439999999999998 112.837 -175.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.85 -48.39 72.37 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.928 -0.653 . . . . 50.299999999999997 111.743 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.496 HD12 ' CD1' ' A' ' 44' ' ' PHE . 64.1 mt -70.46 -39.37 76.24 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 CA-C-O 120.594 0.235 . . . . 54.119999999999997 111.385 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.261 0 CA-C-N 116.015 -0.539 . . . . 73.099999999999994 110.434 176.183 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 . . . . . 0 CA--C 1.475 -1.909 0 N-CA-C 108.274 -1.01 . . . . 54.420000000000002 108.274 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -110.08 74.08 0.87 Allowed 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 119.704 -0.798 . . . . 63.219999999999999 109.787 -172.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.496 ' CD1' HD12 ' A' ' 35' ' ' ILE . 18.6 t80 -106.9 129.26 54.75 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.08 -0.964 . . . . 72.510000000000005 110.722 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -136.0 150.53 49.26 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.522 -1.659 . . . . 73.329999999999998 106.522 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -80.43 109.33 14.84 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 118.813 -1.155 . . . . 72.120000000000005 111.601 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 22.3 tptm -128.52 143.4 50.96 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 104.522 -2.399 . . . . 55.149999999999999 104.522 173.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -87.83 78.17 8.41 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.407 1.098 . . . . 62.240000000000002 109.239 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.36 99.2 2.22 Favored Glycine 1 N--CA 1.395 -4.084 0 N-CA-C 108.122 -1.991 . . . . 44.140000000000001 108.122 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 7.3 tt0 . . . . . 0 C--N 1.29 -1.998 0 N-CA-C 107.268 -1.382 . . . . 71.530000000000001 107.268 -174.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.424 -1.733 0 N-CA-C 112.945 0.72 . . . . 62.140000000000001 112.945 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 89.4 mttt -138.09 143.94 40.66 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.807 -1.923 . . . . 75.409999999999997 105.807 175.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 50' ' ' GLN . 18.2 t -91.2 136.77 23.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 107.526 -1.287 . . . . 54.140000000000001 107.526 173.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.1 tt -87.09 -58.19 2.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.863 -1.162 . . . . 63.229999999999997 107.863 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.34 145.88 10.07 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.219 -1.03 . . . . 74.109999999999999 108.219 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.81 119.8 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-O 122.207 1.003 . . . . 74.519999999999996 111.378 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 15.4 mm100 -104.92 142.51 34.64 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 113.941 -1.481 . . . . 74.340000000000003 109.064 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.81 129.19 94.26 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 114.354 -1.294 . . . . 51.32 108.262 -167.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -1.99 52.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.558 1 C-N-CA 128.105 5.87 . . . . 62.43 117.919 -160.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.0 p -137.23 -42.64 0.56 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.667 -1.151 . . . . 64.310000000000002 109.922 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 41.2 tt0 -144.35 127.28 16.39 Favored 'General case' 0 C--O 1.19 -2.042 0 C-N-CA 119.629 -0.828 . . . . 63.030000000000001 109.453 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.442 HD23 ' HD2' ' A' ' 87' ' ' PHE . 7.0 tp -133.95 127.72 32.98 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 108.589 -0.893 . . . . 74.010000000000005 108.589 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 m -135.2 127.13 29.51 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.468 -0.493 . . . . 73.230000000000004 111.269 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -142.09 156.55 45.4 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.008 0.373 . . . . 71.239999999999995 112.008 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -120.71 129.28 53.58 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.915 -1.143 . . . . 74.439999999999998 107.915 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -113.99 118.94 35.53 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.142 -1.059 . . . . 75.219999999999999 108.142 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 80' ' ' THR . 34.5 t70 -82.39 -178.85 7.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.2 -1.037 . . . . 72.450000000000003 108.2 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.403 ' H ' ' CG ' ' A' ' 79' ' ' ASP . 20.6 m 69.16 25.32 5.78 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-O 123.77 1.748 . . . . 73.430000000000007 106.515 -171.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.569 ' CB ' ' HB2' ' A' ' 115' ' ' ALA . 23.9 mm-40 59.93 45.61 12.11 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 112.231 -2.259 . . . . 71.430000000000007 113.643 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.37 -21.6 56.25 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 108.159 -1.977 . . . . 51.219999999999999 108.159 170.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 74.44 -175.53 0.14 Allowed 'General case' 0 C--O 1.245 0.845 0 C-N-CA 126.95 2.1 . . . . 74.400000000000006 112.908 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.7 p -96.85 115.04 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-O 122.19 0.995 . . . . 65.409999999999997 109.888 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.56 146.41 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 CA-C-N 114.549 -1.205 . . . . 72.409999999999997 109.046 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 92.9 m -136.79 133.46 35.98 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 108.569 -0.9 . . . . 71.439999999999998 108.569 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.442 ' HD2' HD23 ' A' ' 74' ' ' LEU . 15.5 m-85 -119.03 135.85 54.42 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.825 -1.176 . . . . 74.129999999999995 107.825 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.65 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 42.7 mt-30 -118.83 146.44 44.85 Favored 'General case' 0 C--N 1.263 -3.194 0 CA-C-N 115.57 -0.741 . . . . 71.519999999999996 110.393 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.32 126.55 55.5 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.243 -0.889 . . . . 75.239999999999995 109.351 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -114.88 116.67 28.93 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 107.629 -1.249 . . . . 41.5 107.629 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -83.18 121.16 26.71 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.764 -0.653 . . . . 75.239999999999995 110.762 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 73.8 mt -123.85 156.56 35.97 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.036 -1.098 . . . . 71.040000000000006 108.036 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.13 59.69 1.39 Allowed Glycine 0 C--N 1.282 -2.429 0 C-N-CA 120.517 -0.849 . . . . 74.310000000000002 113.121 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 175.43 -39.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.595 1.158 . . . . 72.439999999999998 108.672 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 3.8 ptpt -144.85 175.81 9.93 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.457 -1.682 . . . . 65.150000000000006 106.457 -174.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.468 HG21 HG11 ' A' ' 25' ' ' VAL . 62.6 m -116.47 131.62 56.9 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.099 -0.704 . . . . 75.549999999999997 109.099 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.4 119.0 5.35 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 108.66 -1.776 . . . . 64.409999999999997 108.66 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.498 ' HE2' HG21 ' A' ' 29' ' ' VAL . 45.3 t80 -103.86 130.38 51.44 Favored 'General case' 0 C--N 1.257 -3.448 0 N-CA-C 107.171 -1.418 . . . . 73.219999999999999 107.171 178.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 14.7 m -114.86 123.72 49.89 Favored 'General case' 0 N--CA 1.397 -3.095 0 N-CA-C 107.607 -1.257 . . . . 73.120000000000005 107.607 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.56 140.65 34.53 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 108.486 -0.931 . . . . 74.349999999999994 108.486 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 4.6 mp -135.92 123.54 35.35 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.16 0 CA-C-N 113.758 -1.565 . . . . 74.239999999999995 107.137 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.478 ' HB3' HG22 ' A' ' 12' ' ' ILE . 17.5 t60 -122.48 126.2 47.36 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.475 -0.935 . . . . 74.430000000000007 108.475 175.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -142.93 164.27 30.54 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 106.428 -1.693 . . . . 75.329999999999998 106.428 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.456 ' HA3' HD11 ' A' ' 9' ' ' LEU . . . -154.4 143.23 9.8 Favored Glycine 0 CA--C 1.48 -2.104 0 N-CA-C 109.95 -1.26 . . . . 60.119999999999997 109.95 176.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 8.0 m95 . . . . . 0 C--N 1.303 -1.437 0 N-CA-C 109.311 -0.625 . . . . 74.25 109.311 -176.959 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 5.2 p . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 104.859 -2.274 . . . . 62.439999999999998 104.859 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.09 -39.51 73.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 119.98 1.264 . . . . 71.230000000000004 112.024 -176.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 55.18 47.41 74.33 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 111.994 -0.443 . . . . 40.210000000000001 111.994 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -166.07 -70.12 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.818 0.342 . . . . 74.120000000000005 110.93 -171.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.569 ' HB2' ' CB ' ' A' ' 81' ' ' GLU . . . -72.82 -40.79 65.52 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 116.514 2.042 . . . . 75.230000000000004 116.514 -171.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.16 100.88 0.97 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.876 -1.898 . . . . 74.019999999999996 105.876 -168.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . 0.271 36.7 mm-40 -94.93 89.01 5.47 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 114.866 1.432 . . . . 75.010000000000005 114.866 -172.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.613 ' HB3' HG12 ' A' ' 121' ' ' VAL . 52.5 tttp -179.43 91.25 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.453 -1.703 . . . . 53.420000000000002 106.926 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 m -48.44 -40.68 27.02 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 125.483 1.513 . . . . 72.450000000000003 112.912 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 25.8 t -65.14 -46.58 80.36 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 120.964 -0.294 . . . . 71.140000000000001 111.119 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 118' ' ' LYS . 9.6 p -71.13 -34.4 54.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 C-N-CA 119.73 -0.788 . . . . 55.439999999999998 110.047 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.8 -47.09 94.5 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 N-CA-C 110.443 -0.206 . . . . 63.030000000000001 110.443 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.401 ' HA ' ' HE2' ' A' ' 126' ' ' MET . 50.7 mtt180 -57.64 -52.98 63.19 Favored 'General case' 0 C--O 1.257 1.467 0 O-C-N 123.852 0.72 . . . . 72.129999999999995 110.869 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.76 -40.64 99.07 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 114.979 -1.009 . . . . 61.439999999999998 112.811 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.39 -32.53 70.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.041 0.756 . . . . 70.019999999999996 113.041 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.401 ' HE2' ' HA ' ' A' ' 123' ' ' ARG . 72.9 mtm -62.06 -54.82 36.09 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.638 -0.825 . . . . 75.540000000000006 110.244 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.98 -62.95 1.24 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.848 -0.741 . . . . 72.349999999999994 112.325 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.04 -34.95 82.91 Favored Glycine 0 CA--C 1.497 -1.043 0 CA-C-N 116.101 -0.499 . . . . 54.43 112.303 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.79 -54.34 15.34 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 111.62 -0.592 . . . . 63.329999999999998 111.62 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.45 ' O ' HG12 ' A' ' 134' ' ' VAL . 72.5 m95 -59.99 -44.56 94.43 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 112.927 0.714 . . . . 75.409999999999997 112.927 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.408 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 25.0 m -58.62 -49.5 77.25 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.469 0.48 . . . . 64.530000000000001 110.507 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.94 -46.19 60.57 Favored Glycine 0 C--O 1.25 1.14 0 C-N-CA 120.983 -0.627 . . . . 65.340000000000003 112.85 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mm -66.54 -52.54 45.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 CA-C-O 119.334 -0.365 . . . . 73.340000000000003 111.411 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 130' ' ' TRP . 4.2 p -62.93 -36.16 74.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 117.955 0.343 . . . . 53.240000000000002 111.206 -175.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.57 -64.97 0.77 Allowed 'General case' 0 C--N 1.351 0.644 0 O-C-N 123.394 0.434 . . . . 74.010000000000005 110.359 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.95 -40.45 71.99 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 112.602 0.593 . . . . 72.430000000000007 112.602 -173.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -62.53 -51.68 66.45 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 120.566 -0.454 . . . . 64.230000000000004 110.829 -177.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 18' ' ' LEU . 49.9 mt -70.63 -41.08 72.67 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.328 -0.949 . . . . 75.439999999999998 111.679 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.642 ' NE ' ' HG3' ' A' ' 143' ' ' GLU . 1.1 tmt_? -60.63 -34.83 74.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.359 -0.608 . . . . 73.439999999999998 109.359 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 144' ' ' GLU . 23.3 mmmt -71.13 -42.56 69.04 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 119.995 -0.682 . . . . 73.340000000000003 111.434 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.26 -28.88 69.06 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 111.961 0.356 . . . . 44.32 111.961 -176.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 21.4 m -88.74 -26.36 5.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 112.485 0.55 . . . . 75.040000000000006 112.485 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.642 ' HG3' ' NE ' ' A' ' 139' ' ' ARG . 5.7 mm-40 -97.37 -34.8 10.91 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.136 0.791 . . . . 72.030000000000001 113.136 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.425 ' HB3' ' HE3' ' A' ' 140' ' ' LYS . 35.9 tt0 . . . . . 0 C--N 1.307 -1.265 0 CA-C-O 121.436 0.636 . . . . 63.299999999999997 110.523 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 121.201 0.524 . . . . 51.130000000000003 110.798 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp 78.57 86.09 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 125.512 1.525 . . . . 75.299999999999997 114.531 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.67 148.22 46.7 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 122.668 2.245 . . . . 71.340000000000003 109.919 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.574 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 6.3 p-10 -58.4 142.02 49.66 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 113.994 1.109 . . . . 71.230000000000004 113.994 -172.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.7 tp -121.66 137.43 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 106.493 -1.669 . . . . 53.140000000000001 106.493 171.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.8 m -118.74 128.82 54.85 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.406 -0.961 . . . . 72.209999999999994 108.406 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -133.5 132.67 41.28 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 107.662 -1.236 . . . . 72.25 107.662 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 p -118.45 139.49 51.33 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-O 120.645 0.26 . . . . 53.140000000000001 110.836 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -146.43 134.88 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.767 -0.827 . . . . 75.400000000000006 108.767 -178.329 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.03 121.8 42.87 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 120.967 0.413 . . . . 72.530000000000001 110.923 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.8 mp -101.76 137.66 39.76 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.638 -0.505 . . . . 42.020000000000003 109.638 -175.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -86.43 59.12 5.45 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.268 1.032 . . . . 75.340000000000003 110.959 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.21 161.14 46.34 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.984 -1.117 . . . . 61.210000000000001 107.984 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.94 152.16 82.16 Favored 'Trans proline' 0 C--O 1.26 1.609 0 C-N-CA 122.524 2.15 . . . . 73.420000000000002 110.442 176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -32.36 48.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.892 -0.594 . . . . 73.430000000000007 111.679 -176.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -65.15 -29.01 69.82 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.177 0.436 . . . . 75.409999999999997 112.177 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -78.92 -40.11 33.0 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.633 0.73 . . . . 72.340000000000003 110.37 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 96' ' ' THR . 7.3 p -69.43 -39.55 78.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 116.072 -0.513 . . . . 73.329999999999998 109.749 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 43.1 t90 -58.12 -47.63 82.69 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.369 0.668 . . . . 73.150000000000006 111.928 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.77 -39.37 94.09 Favored 'General case' 0 C--O 1.214 -0.816 0 C-N-CA 119.576 -0.85 . . . . 72.239999999999995 109.749 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.9 m -59.23 -31.98 69.55 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-O 121.087 0.47 . . . . 71.239999999999995 111.629 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.694 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 25.2 m -107.19 17.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 112.946 0.721 . . . . 64.299999999999997 112.946 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.5 m -139.65 -3.35 1.49 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 112.301 0.482 . . . . 71.340000000000003 112.301 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.0 p -97.22 145.99 25.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.37 -0.974 . . . . 71.219999999999999 108.37 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 p -52.03 -54.06 34.55 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.86 0.689 . . . . 72.140000000000001 112.86 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.75 -38.78 87.3 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.444 -0.798 . . . . 73.040000000000006 110.533 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -41.61 95.99 Favored Glycine 0 C--O 1.247 0.939 0 N-CA-C 112.045 -0.422 . . . . 62.420000000000002 112.045 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.6 mt -69.83 -48.32 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 O-C-N 122.545 -0.385 . . . . 72.340000000000003 110.602 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.706 0.632 . . . . 71.5 112.706 -177.837 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.563 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . 19.8 m120 . . . . . 0 CA--C 1.493 -1.244 0 N-CA-C 107.196 -1.409 . . . . 72.329999999999998 107.196 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -96.63 76.76 2.86 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.011 0.91 . . . . 65.310000000000002 110.449 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 42' ' ' ASN . 94.5 m-85 -74.88 119.3 18.88 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.832 -1.531 . . . . 71.230000000000004 109.775 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -109.41 151.31 26.84 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.126 -1.064 . . . . 70.319999999999993 108.126 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -77.2 103.18 6.99 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.493 -1.299 . . . . 72.099999999999994 107.493 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 20.4 tptm -134.03 146.12 50.07 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.305 -0.998 . . . . 75.140000000000001 108.305 174.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HB3' HG12 ' A' ' 68' ' ' VAL . 8.6 pt-20 -92.81 79.55 4.71 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.076 0.941 . . . . 64.430000000000007 108.778 173.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.64 47.37 0.53 Allowed Glycine 0 N--CA 1.416 -2.653 0 C-N-CA 119.361 -1.399 . . . . 52.32 112.863 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.011 0 N-CA-C 107.471 -1.307 . . . . 74.439999999999998 107.471 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.439 -1.012 0 CA-C-O 120.838 0.351 . . . . 33.399999999999999 110.792 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -143.61 135.46 26.48 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.969 0.908 . . . . 65.530000000000001 108.685 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.1 t -90.59 136.88 22.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.617 -1.253 . . . . 73.239999999999995 107.617 175.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 tt -79.73 -61.11 2.1 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.981 -1.488 . . . . 65.150000000000006 106.981 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.0 150.02 9.38 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-N 115.15 -0.932 . . . . 75.530000000000001 109.018 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.515 HG23 HD23 ' A' ' 74' ' ' LEU . 8.5 p -123.98 119.03 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.484 0 CA-C-O 122.118 0.961 . . . . 73.239999999999995 109.565 175.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 11.4 mm100 -94.54 141.24 28.82 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 114.961 -1.018 . . . . 74.030000000000001 109.316 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 123.01 84.84 Favored Pre-proline 0 C--N 1.272 -2.78 0 CA-C-N 114.312 -1.313 . . . . 71.5 108.968 -166.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo 7.3 50.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.346 1 C-N-CA 127.638 5.559 . . . . 54.530000000000001 116.339 -160.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 p -139.81 -37.53 0.48 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.177 -0.919 . . . . 73.340000000000003 112.077 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 35.3 tt0 -150.29 148.05 28.39 Favored 'General case' 0 C--O 1.2 -1.532 0 C-N-CA 119.066 -1.053 . . . . 64.239999999999995 110.339 -176.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.687 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -141.37 132.99 27.07 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.831 -1.174 . . . . 34.310000000000002 107.831 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 p -141.03 129.13 22.06 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 120.695 -0.402 . . . . 52.310000000000002 112.019 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.459 ' HD2' HD11 ' A' ' 74' ' ' LEU . 44.7 p90 -142.8 153.55 43.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.811 0.338 . . . . 63.420000000000002 111.672 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -124.48 124.95 43.4 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 125.012 1.325 . . . . 73.519999999999996 107.783 -173.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 18.6 p-90 -143.58 155.78 44.39 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.152 -1.019 . . . . 74.209999999999994 113.232 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 76.18 160.4 0.22 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.852 1.661 . . . . 75.530000000000001 112.582 173.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 m -68.3 -30.93 70.04 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.207 1.003 . . . . 63.409999999999997 110.646 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.572 ' HG3' ' HB2' ' A' ' 115' ' ' ALA . 9.4 mm-40 -71.27 -21.49 62.08 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.033 -0.728 . . . . 73.25 109.033 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.66 80.36 0.68 Allowed Glycine 0 N--CA 1.426 -1.987 0 CA-C-N 114.882 -1.054 . . . . 70.519999999999996 114.641 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -104.92 128.59 53.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.365 -0.606 . . . . 74.129999999999995 109.365 173.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.24 111.78 29.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.625 -1.25 . . . . 65.329999999999998 107.625 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.26 149.12 19.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 120.477 -0.489 . . . . 75.319999999999993 110.377 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.451 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 39.2 m -129.47 140.77 51.18 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.491 -0.929 . . . . 71.200000000000003 108.491 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.694 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 16.0 m-85 -118.35 142.59 47.37 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.844 -1.539 . . . . 74.319999999999993 106.844 174.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.518 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 69.3 mt-30 -125.1 137.57 54.18 Favored 'General case' 0 C--N 1.268 -2.958 0 O-C-N 123.472 0.482 . . . . 73.310000000000002 110.532 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -117.36 120.06 37.01 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.457 -0.792 . . . . 75.430000000000007 109.179 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -114.06 116.71 29.58 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.586 -0.894 . . . . 71.049999999999997 108.586 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.01 118.98 23.88 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.876 0.846 . . . . 70.239999999999995 110.919 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 96.4 mt -123.15 153.11 40.46 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.449 -0.945 . . . . 71.129999999999995 108.449 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.97 50.38 4.15 Favored Glycine 0 C--N 1.287 -2.17 0 C-N-CA 120.892 -0.67 . . . . 72.549999999999997 112.411 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -179.41 -32.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.343 0.592 . . . . 72.230000000000004 109.446 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 9.6 ptpt -156.27 175.05 14.5 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.202 -1.407 . . . . 71.329999999999998 107.202 -175.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.616 HG21 HG11 ' A' ' 25' ' ' VAL . 87.8 m -119.79 128.19 53.49 Favored 'General case' 0 C--N 1.272 -2.771 0 N-CA-C 108.616 -0.883 . . . . 70.209999999999994 108.616 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.6 107.32 3.01 Favored Glycine 0 N--CA 1.412 -2.962 0 N-CA-C 109.868 -1.293 . . . . 35.450000000000003 109.868 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.509 ' CE1' HG11 ' A' ' 29' ' ' VAL . 92.8 t80 -100.54 133.35 45.11 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.939 -0.763 . . . . 74.430000000000007 108.939 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 70.4 m -126.31 125.37 42.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 119.049 -1.061 . . . . 45.299999999999997 109.161 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -104.02 141.87 35.45 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.443 -0.799 . . . . 65.540000000000006 108.851 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.5 mp -135.65 123.93 37.98 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 N-CA-C 106.024 -1.843 . . . . 70.010000000000005 106.024 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 9.7 t60 -120.55 113.73 20.7 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.486 -1.302 . . . . 45.149999999999999 107.486 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.8 t -132.57 153.84 50.6 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.543 -1.28 . . . . 74.310000000000002 107.543 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.15 167.96 20.81 Favored Glycine 0 N--CA 1.415 -2.74 0 N-CA-C 109.939 -1.265 . . . . 62.43 109.939 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 67.2 t90 . . . . . 0 C--N 1.311 -1.084 0 N-CA-C 106.998 -1.482 . . . . 71.109999999999999 106.998 175.734 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 113' ' ' GLY . 12.3 p . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 120.528 0.204 . . . . 74.310000000000002 111.503 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.625 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -61.85 -36.81 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.57 0.7 . . . . 74.010000000000005 110.619 174.044 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.526 ' H ' HG22 ' A' ' 111' ' ' VAL . . . 149.3 -108.35 0.4 Allowed Glycine 0 N--CA 1.409 -3.105 0 N-CA-C 108.758 -1.737 . . . . 72.349999999999994 108.758 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -134.85 32.35 3.25 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.856 0.36 . . . . 74.030000000000001 111.318 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.572 ' HB2' ' HG3' ' A' ' 81' ' ' GLU . . . -58.78 -22.88 59.2 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 112.825 0.676 . . . . 71.409999999999997 112.825 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -153.92 -73.24 0.13 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.61 -0.268 . . . . 53.32 110.48 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -156.73 -90.03 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 111.765 0.283 . . . . 72.209999999999994 111.765 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.462 ' HB3' HG22 ' A' ' 121' ' ' VAL . 24.0 ttmm -121.03 136.37 55.0 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.051 -1.463 . . . . 74.030000000000001 107.051 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.25 -37.55 75.14 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 115.114 1.524 . . . . 62.219999999999999 115.114 -174.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.89 -46.17 79.35 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.401 0.519 . . . . 72.299999999999997 112.401 177.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 118' ' ' LYS . 14.2 m -69.97 -33.84 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.191 -0.604 . . . . 62.009999999999998 109.776 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' A' ' 126' ' ' MET . 53.6 t -64.64 -43.11 96.67 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 CA-C-N 115.732 -0.667 . . . . 74.129999999999995 111.113 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -39.82 93.32 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.214 -1.032 . . . . 72.019999999999996 108.214 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -59.6 -47.71 89.59 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-N 115.571 -0.74 . . . . 41.210000000000001 112.021 177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -66.43 -34.41 77.9 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.274 -0.463 . . . . 71.019999999999996 111.857 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 23.5 mmt -62.06 -52.5 63.69 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 110.265 -0.272 . . . . 45.43 110.265 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.45 -52.78 64.19 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.837 0.31 . . . . 63.399999999999999 111.837 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.51 -45.99 87.27 Favored Glycine 0 C--O 1.26 1.744 0 C-N-CA 120.834 -0.698 . . . . 64.439999999999998 112.6 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.47 62.56 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 111.938 -0.465 . . . . 72.200000000000003 111.938 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.492 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.9 m95 -65.45 -22.94 66.81 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.555 0.576 . . . . 72.230000000000004 112.555 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.8 m -64.91 -55.69 17.78 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.761 -0.829 . . . . 54.520000000000003 108.761 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.45 -44.47 73.1 Favored Glycine 0 C--O 1.252 1.241 0 C-N-CA 120.648 -0.787 . . . . 65.25 113.591 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.19 -51.91 62.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 122.231 0.212 . . . . 63.350000000000001 111.464 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.558 ' HA ' HD23 ' A' ' 138' ' ' LEU . 78.9 t -63.66 -44.62 98.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.806 -0.358 . . . . 72.340000000000003 111.595 -177.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.406 ' HA ' HG13 ' A' ' 16' ' ' ILE . 32.1 t30 -55.56 -64.83 0.72 Allowed 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.794 0.684 . . . . 71.319999999999993 111.803 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -82.73 -31.83 28.23 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 119.41 -0.916 . . . . 73.319999999999993 113.202 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.429 HH11 ' HB2' ' A' ' 141' ' ' ALA . 0.2 OUTLIER -74.01 -40.2 63.07 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 118.024 -1.47 . . . . 65.420000000000002 110.179 -176.595 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.2 mm? -69.41 -46.59 66.46 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 119.552 -0.859 . . . . 75.450000000000003 110.045 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 0.9 OUTLIER -63.76 -36.16 82.97 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 115.759 -0.655 . . . . 74.400000000000006 110.658 -178.616 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.409 ' HE2' ' HB2' ' A' ' 144' ' ' GLU . 8.8 mmmm -70.76 -37.47 73.4 Favored 'General case' 0 C--O 1.198 -1.654 0 O-C-N 121.703 -0.623 . . . . 71.340000000000003 112.27 174.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.429 ' HB2' HH11 ' A' ' 137' ' ' ARG . . . -64.61 -27.98 69.31 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.254 0.549 . . . . 62.219999999999999 110.838 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 16.6 m -91.81 -22.58 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.895 -0.593 . . . . 55.32 111.953 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 61.2 mt-10 -91.85 -32.37 15.35 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.429 -0.508 . . . . 62.539999999999999 111.934 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 140' ' ' LYS . 28.7 tt0 . . . . . 0 N--CA 1.44 -0.946 0 CA-C-O 122.932 1.349 . . . . 72.219999999999999 110.83 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 112.944 0.72 . . . . 65.099999999999994 112.944 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.0 tp 68.47 90.93 0.08 OUTLIER Pre-proline 0 C--O 1.243 0.744 0 C-N-CA 124.765 1.226 . . . . 74.510000000000005 111.644 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.59 -164.97 0.21 Allowed 'Trans proline' 0 N--CA 1.436 -1.861 0 C-N-CA 122.38 2.054 . . . . 72.450000000000003 110.356 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -64.97 103.93 0.79 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.129 0.966 . . . . 75.140000000000001 111.837 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 50.0 mm -98.06 123.16 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 106.023 -1.843 . . . . 63.140000000000001 106.023 174.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 12.7 t -117.39 140.96 48.9 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 109.162 -0.681 . . . . 61.399999999999999 109.162 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -146.71 132.33 18.82 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.787 -1.19 . . . . 72.430000000000007 107.787 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.7 p -117.87 141.33 48.54 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 109.48 -0.563 . . . . 71.099999999999994 109.48 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.71 142.77 8.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.075 -1.084 . . . . 65.129999999999995 108.075 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.429 HG22 ' HA2' ' A' ' 97' ' ' GLY . 3.6 p -106.23 128.72 54.16 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.298 0.571 . . . . 71.5 111.509 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.7 mp -103.57 140.11 37.97 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.857 -0.611 . . . . 75.420000000000002 111.079 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -81.73 46.22 0.96 Allowed 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 124.277 1.031 . . . . 74.129999999999995 110.686 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.26 158.89 57.2 Favored Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 109.202 -0.666 . . . . 73.329999999999998 109.202 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.37 153.32 71.4 Favored 'Trans proline' 0 C--O 1.259 1.544 0 C-N-CA 122.77 2.313 . . . . 74.200000000000003 110.7 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -60.15 -32.58 50.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.798 -0.637 . . . . 63.229999999999997 111.482 -174.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -63.75 -39.29 93.91 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 120.698 -0.401 . . . . 74.340000000000003 111.656 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -70.9 -39.18 72.9 Favored 'General case' 0 C--O 1.212 -0.916 0 C-N-CA 120.996 -0.282 . . . . 74.040000000000006 111.133 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.513 HG21 ' HB ' ' A' ' 96' ' ' THR . 47.2 t -68.02 -41.17 84.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.412 0.625 . . . . 74.120000000000005 109.842 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.592 ' CZ2' ' HD3' ' A' ' 71' ' ' PRO . 29.4 t90 -63.66 -46.72 84.32 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.492 -1.231 . . . . 64.299999999999997 110.177 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -70.23 -29.41 66.22 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 121.036 -0.266 . . . . 74.530000000000001 111.491 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.536 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 39.7 m -56.14 -33.26 65.01 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-O 121.129 0.49 . . . . 73.140000000000001 111.735 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -108.18 16.6 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 O-C-N 121.406 -0.809 . . . . 74.519999999999996 112.044 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.605 ' HA ' HD11 ' A' ' 35' ' ' ILE . 42.5 p -137.61 0.32 2.24 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.788 0.662 . . . . 73.140000000000001 112.788 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.7 p -107.89 169.39 8.64 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 121.698 -0.627 . . . . 62.140000000000001 111.595 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.2 t -63.01 -44.71 95.25 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.914 -0.585 . . . . 74.129999999999995 109.744 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.09 -45.17 78.07 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.686 0.616 . . . . 75.329999999999998 111.165 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 28' ' ' THR . . . -72.38 -48.03 26.16 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.909 -0.663 . . . . 64.019999999999996 114.051 -175.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.605 HD11 ' HA ' ' A' ' 30' ' ' SER . 80.3 mt -69.04 -34.12 62.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 116.932 0.366 . . . . 52.25 111.114 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.791 0 CA-C-N 115.953 -0.567 . . . . 44.119999999999997 111.463 176.656 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 106.757 -1.571 . . . . 74.120000000000005 106.757 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.12 65.27 8.67 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.76 0.79 . . . . 74.230000000000004 112.165 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.557 ' HB3' HD12 ' A' ' 35' ' ' ILE . 95.7 m-85 -108.62 132.78 53.55 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.4 -0.818 . . . . 73.5 109.865 171.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -139.03 150.14 45.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.19 -1.041 . . . . 73.439999999999998 108.19 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.432 HD11 ' CZ2' ' A' ' 26' ' ' TRP . 6.0 tt -75.74 104.2 6.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.766 -0.827 . . . . 73.340000000000003 108.766 -178.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.734 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 14.0 tppt? -133.97 146.07 50.12 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.882 -1.525 . . . . 72.450000000000003 106.882 172.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.41 ' CA ' HG12 ' A' ' 68' ' ' VAL . 8.1 pt-20 -79.57 54.79 1.84 Allowed 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 122.024 0.916 . . . . 54.520000000000003 109.478 170.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 130.01 64.52 0.1 Allowed Glycine 0 N--CA 1.406 -3.312 0 N-CA-C 109.977 -1.249 . . . . 74.230000000000004 109.977 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.734 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.47 -2.104 0 N-CA-C 106.355 -1.72 . . . . 62.130000000000003 106.355 178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 C--O 1.251 1.15 0 N-CA-C 107.45 -1.315 . . . . 71.209999999999994 107.45 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 34.4 mtmt -143.64 139.91 29.84 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 109.427 -0.583 . . . . 74.140000000000001 109.427 -172.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.513 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 41.8 t -90.65 129.44 41.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 N-CA-C 104.942 -2.244 . . . . 63.43 104.942 167.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.6 tp -75.06 -59.2 2.84 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.912 -0.773 . . . . 75.450000000000003 108.912 -176.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.53 140.67 14.0 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.955 -1.02 . . . . 64.209999999999994 109.274 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.498 HG23 HD13 ' A' ' 74' ' ' LEU . 9.5 p -119.28 121.0 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 N-CA-C 107.604 -1.258 . . . . 71.510000000000005 107.604 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 80.3 mm-40 -96.55 142.81 28.17 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 114.56 -1.2 . . . . 74.219999999999999 109.603 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.71 120.99 73.16 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 107.508 -1.293 . . . . 50.149999999999999 107.508 -164.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.592 ' HD3' ' CZ2' ' A' ' 26' ' ' TRP . 16.6 Cg_exo -7.54 64.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.294 1 C-N-CA 126.527 4.818 . . . . 75.099999999999994 116.844 -154.548 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 p -140.26 -40.47 0.43 Allowed 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 113.237 -1.801 . . . . 42.200000000000003 109.767 175.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 36.9 tt0 -150.54 149.22 29.65 Favored 'General case' 0 C--O 1.195 -1.81 0 C-N-CA 119.405 -0.918 . . . . 74.400000000000006 110.259 -175.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.498 HD13 HG23 ' A' ' 68' ' ' VAL . 9.8 tp -145.91 128.18 15.8 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.907 -0.775 . . . . 74.400000000000006 108.907 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.6 m -134.23 127.23 31.48 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.774 -0.37 . . . . 74.310000000000002 111.022 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.529 ' CE2' ' HE2' ' A' ' 87' ' ' PHE . 54.8 p90 -138.93 155.66 47.87 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 112.113 0.412 . . . . 61.140000000000001 112.113 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -122.76 125.88 46.38 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.003 -1.48 . . . . 71.400000000000006 107.003 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.432 ' CE3' ' HB2' ' A' ' 79' ' ' ASP . 15.7 p-90 -139.83 162.07 36.05 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.367 -0.933 . . . . 73.030000000000001 112.751 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.432 ' HB2' ' CE3' ' A' ' 78' ' ' TRP . 19.0 t70 72.89 161.84 0.25 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.612 1.565 . . . . 62.520000000000003 112.338 173.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.4 t -73.11 -23.18 60.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.392 0.277 . . . . 73.040000000000006 111.274 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -34.25 76.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 110.154 -0.313 . . . . 71.450000000000003 110.154 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.72 75.64 1.29 Allowed Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.82 -0.627 . . . . 61.200000000000003 111.855 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -102.02 128.46 48.45 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.408 -0.96 . . . . 75.540000000000006 108.408 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.4 t -111.43 107.72 23.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 108.347 -0.983 . . . . 70.420000000000002 108.347 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.54 144.98 17.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.312 0.577 . . . . 74.219999999999999 110.363 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.458 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 39.9 m -136.42 134.23 37.52 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.801 -0.636 . . . . 73.120000000000005 109.407 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.61 ' CE1' HD23 ' A' ' 100' ' ' LEU . 39.8 m-85 -120.93 143.5 48.94 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.251 -1.018 . . . . 52.140000000000001 108.251 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.543 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 93.0 mt-30 -124.67 139.99 53.35 Favored 'General case' 0 C--N 1.278 -2.52 0 O-C-N 123.516 0.51 . . . . 72.0 110.676 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -122.6 120.22 33.13 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.722 -0.672 . . . . 71.329999999999998 110.458 -174.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -113.31 127.5 56.17 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 123.308 0.643 . . . . 74.200000000000003 109.81 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.72 120.68 26.68 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.731 -0.668 . . . . 75.400000000000006 111.366 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.6 mt -125.47 153.33 43.7 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.238 -0.892 . . . . 75.150000000000006 108.632 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.99 61.43 4.33 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 121.755 -0.26 . . . . 55.130000000000003 113.35 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 168.65 -54.49 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 125.21 1.404 . . . . 51.539999999999999 107.854 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -126.43 174.07 8.9 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 114.111 -1.404 . . . . 62.109999999999999 109.108 -167.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.513 ' HB ' HG21 ' A' ' 25' ' ' VAL . 87.7 m -119.89 130.84 55.03 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.889 -0.782 . . . . 74.530000000000001 108.889 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' A' ' 17' ' ' THR . . . -86.58 111.26 3.61 Favored Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 110.258 -1.137 . . . . 74.420000000000002 110.258 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -103.45 131.43 50.55 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 109.412 -0.588 . . . . 71.409999999999997 109.412 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.543 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 84.8 m -124.29 128.02 48.51 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.982 -1.118 . . . . 74.340000000000003 107.982 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.61 HD23 ' CE1' ' A' ' 87' ' ' PHE . 2.9 tm? -102.25 139.29 38.05 Favored 'General case' 0 N--CA 1.397 -3.079 0 N-CA-C 108.532 -0.914 . . . . 75.140000000000001 108.532 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 3.8 mp -135.68 124.43 39.1 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.268 0 N-CA-C 106.258 -1.756 . . . . 71.340000000000003 106.258 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -121.04 131.92 54.57 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.362 -0.977 . . . . 61.329999999999998 108.362 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.3 m -142.69 138.94 30.94 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.673 -1.232 . . . . 72.120000000000005 107.673 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.11 -167.01 22.2 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.227 -0.987 . . . . 65.230000000000004 110.731 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 . . . . . 0 N--CA 1.426 -1.667 0 N-CA-C 108.861 -0.792 . . . . 74.450000000000003 108.861 175.921 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 108.516 -0.92 . . . . 64.450000000000003 108.516 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.0 pt -58.76 -32.59 47.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 112.853 0.686 . . . . 61.100000000000001 112.853 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.84 -122.41 6.94 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.022 -1.085 . . . . 75.420000000000002 111.978 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -100.4 10.27 41.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.13 0.491 . . . . 72.5 109.878 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.63 -34.91 79.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.987 -1.116 . . . . 53.350000000000001 107.987 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -166.38 122.84 1.28 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.886 -1.894 . . . . 45.25 105.886 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.1 166.68 16.44 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.586 0.958 . . . . 74.140000000000001 113.586 -174.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm 71.24 87.22 0.12 Allowed 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.705 -1.134 . . . . 63.240000000000002 112.902 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.2 p -56.43 -39.81 73.72 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.469 1.108 . . . . 40.539999999999999 112.78 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 123' ' ' ARG . 3.2 p -68.18 -39.25 82.57 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.597 0.713 . . . . 75.510000000000005 110.646 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.07 -45.49 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 115.707 -0.679 . . . . 73.200000000000003 109.42 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.495 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 75.9 t -55.78 -37.56 47.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 O-C-N 123.642 0.589 . . . . 65.409999999999997 110.204 175.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 120' ' ' SER . 18.5 tpp180 -57.37 -58.65 7.33 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.184 0.594 . . . . 70.299999999999997 110.378 177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.68 -43.8 93.64 Favored Glycine 0 CA--C 1.494 -1.244 0 CA-C-N 115.678 -0.692 . . . . 75.329999999999998 112.817 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 122' ' ' VAL . 2.7 tmmm? -65.52 -38.56 90.02 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 112.66 0.615 . . . . 75.209999999999994 112.66 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 25.7 mmt -72.84 -45.9 55.88 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.231 -0.988 . . . . 60.520000000000003 110.269 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -67.91 -63.78 0.99 Allowed 'General case' 0 C--O 1.257 1.455 0 CA-C-O 121.343 0.592 . . . . 71.200000000000003 111.849 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -75.75 -33.41 51.53 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 115.779 -0.646 . . . . 63.520000000000003 112.219 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -66.77 -50.09 50.42 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 111.67 -0.572 . . . . 60.399999999999999 111.67 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.464 ' HE3' HG23 ' A' ' 134' ' ' VAL . 95.5 m95 -64.39 -31.17 72.27 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 120.054 -0.658 . . . . 64.120000000000005 111.616 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.1 m -58.47 -57.35 13.35 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 120.71 -0.396 . . . . 71.109999999999999 110.896 173.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.62 -46.7 37.9 Favored Glycine 0 C--O 1.242 0.597 0 CA-C-N 116.07 -0.514 . . . . 33.420000000000002 113.742 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.0 mt -62.57 -51.24 74.58 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 119.693 -0.194 . . . . 71.019999999999996 110.976 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.638 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 68.6 t -59.37 -43.97 91.45 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 120.786 -0.366 . . . . 62.420000000000002 111.483 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -56.1 -60.13 3.93 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 111.777 0.288 . . . . 71.450000000000003 111.777 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -77.26 -46.45 23.09 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.244 0.831 . . . . 75.349999999999994 113.244 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -64.51 -39.16 93.26 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.425 0.557 . . . . 73.409999999999997 111.725 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.692 ' HB3' HD21 ' A' ' 18' ' ' LEU . 3.9 mm? -67.25 -49.73 63.29 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.454 -0.498 . . . . 62.43 110.536 176.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -62.43 -32.54 73.41 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.952 -0.567 . . . . 74.209999999999994 109.827 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -76.51 -39.66 52.36 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 113.201 0.815 . . . . 65.430000000000007 113.201 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.32 -23.71 67.08 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.217 0.532 . . . . 71.239999999999995 111.177 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.3 m -90.24 -34.11 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 120.209 -0.596 . . . . 73.209999999999994 111.91 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.48 -31.44 26.51 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.169 0.803 . . . . 74.129999999999995 113.169 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 121.092 0.472 . . . . 53.530000000000001 109.896 -177.819 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.518 0 N-CA-C 103.945 -2.613 . . . . 71.329999999999998 103.945 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.51 HD21 ' CZ3' ' A' ' 83' ' ' TRP . 4.4 pp -100.38 130.2 26.33 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 118.982 -1.087 . . . . 72.25 113.109 -175.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -97.62 -160.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.651 2.901 . . . . 62.119999999999997 110.317 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 12.0 p-10 -81.6 97.46 7.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.607 1.194 . . . . 72.420000000000002 108.813 173.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 61.6 mt -91.68 128.25 43.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 114.69 -1.141 . . . . 54.450000000000003 109.019 -173.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.582 ' O ' ' HD2' ' A' ' 14' ' ' LYS . 13.6 t -120.08 140.79 50.5 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 119.648 -0.821 . . . . 72.430000000000007 110.556 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.582 ' HD2' ' O ' ' A' ' 13' ' ' THR . 5.9 mptp? -137.72 145.38 42.45 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.349 -1.352 . . . . 70.120000000000005 107.349 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -129.81 136.63 49.81 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 118.522 0.601 . . . . 43.350000000000001 110.514 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.11 141.38 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 110.06 -0.348 . . . . 74.109999999999999 110.06 -177.058 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 p -101.04 135.4 42.56 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.073 0.463 . . . . 65.310000000000002 112.09 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 139' ' ' ARG . 3.0 mm? -104.15 140.07 38.32 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.35 0.66 . . . . 72.400000000000006 110.219 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -86.11 34.22 0.62 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.136 0.494 . . . . 70.109999999999999 110.261 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -133.88 164.73 41.92 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.38 -0.6 . . . . 75.519999999999996 109.38 -174.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -66.6 153.03 79.46 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.286 1.99 . . . . 72.239999999999995 111.025 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.11 -33.26 42.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.341 -0.845 . . . . 72.219999999999999 112.452 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.19 -27.68 62.72 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.451 -0.5 . . . . 75.099999999999994 111.223 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.0 tmtm? -79.83 -31.99 40.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.958 -1.127 . . . . 71.319999999999993 107.958 -177.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG21 ' HB ' ' A' ' 96' ' ' THR . 45.4 t -71.17 -41.35 75.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.053 -1.092 . . . . 63.119999999999997 108.053 175.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.624 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 77.5 t90 -60.69 -47.17 87.47 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.639 -1.164 . . . . 74.450000000000003 111.269 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 10.5 pt-20 -59.97 -36.61 77.49 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 109.003 -0.74 . . . . 63.140000000000001 109.003 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.9 m -65.91 -7.54 17.15 Favored 'General case' 0 CA--C 1.573 1.836 0 CA-C-O 121.417 0.627 . . . . 74.239999999999995 112.646 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.562 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 11.9 m -131.48 17.19 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 O-C-N 121.306 -0.871 . . . . 54.020000000000003 111.63 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.424 ' HB3' HD13 ' A' ' 46' ' ' LEU . 51.3 m -145.32 10.03 1.26 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 116.29 -0.414 . . . . 62.310000000000002 111.833 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.3 p -110.75 -178.32 3.45 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.225 -0.657 . . . . 72.329999999999998 109.225 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 44' ' ' PHE . 19.6 p -56.64 -62.46 1.71 Allowed 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 123.711 0.632 . . . . 73.030000000000001 111.999 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.43 -31.24 71.87 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.27 -0.877 . . . . 74.099999999999994 110.844 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.89 -48.66 20.24 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.04 -1.076 . . . . 64.439999999999998 112.861 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.432 HG23 ' CE2' ' A' ' 76' ' ' PHE . 51.6 mt -68.95 -34.5 64.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 123.13 0.572 . . . . 73.400000000000006 110.895 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-N 115.526 -0.761 . . . . 73.140000000000001 112.043 173.801 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 107.048 -1.464 . . . . 62.020000000000003 107.048 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -90.56 70.98 6.87 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.766 0.793 . . . . 75.219999999999999 109.46 -175.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.411 ' CE1' ' HB3' ' A' ' 32' ' ' SER . 6.9 p90 -58.9 137.19 57.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.093 -1.412 . . . . 62.219999999999999 110.711 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.86 121.88 15.67 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.928 -1.508 . . . . 72.329999999999998 106.928 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 68' ' ' VAL . 33.8 tp -94.42 101.78 13.72 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.362 -1.718 . . . . 65.219999999999999 106.362 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 1.3 tpmt? -134.94 145.58 48.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.263 -1.384 . . . . 63.009999999999998 107.263 175.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.02 61.71 7.0 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 122.69 1.234 . . . . 74.409999999999997 109.248 171.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.87 87.84 0.8 Allowed Glycine 0 N--CA 1.414 -2.783 0 CA-C-N 114.404 -1.271 . . . . 63.350000000000001 110.48 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.46 ' HB3' ' H ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.429 0 N-CA-C 106.282 -1.748 . . . . 71.420000000000002 106.282 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 86.0 m . . . . . 0 N--CA 1.428 -1.536 0 CA-C-O 121.377 0.608 . . . . 72.409999999999997 109.597 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 77' ' ' GLU . 92.7 mttt -137.12 132.13 33.62 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.824 -1.546 . . . . 71.200000000000003 106.824 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.46 ' H ' ' HB3' ' A' ' 50' ' ' GLN . 10.7 t -90.56 133.99 30.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 N-CA-C 107.2 -1.407 . . . . 61.009999999999998 107.2 174.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.83 -50.76 16.0 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.345 -1.354 . . . . 64.140000000000001 107.345 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.51 143.61 5.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.237 -1.347 . . . . 73.150000000000006 108.464 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.666 HG23 HD23 ' A' ' 74' ' ' LEU . 12.1 p -121.57 123.04 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 CA-C-O 121.332 0.587 . . . . 61.350000000000001 109.793 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.565 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 84.0 mm-40 -104.78 141.92 35.64 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.322 -0.854 . . . . 73.420000000000002 111.714 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.83 124.59 87.96 Favored Pre-proline 0 C--N 1.294 -1.81 0 CA-C-N 113.764 -1.562 . . . . 74.209999999999994 109.441 -164.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.624 ' HA ' ' CD1' ' A' ' 26' ' ' TRP . 81.4 Cg_exo -1.29 56.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.305 1 C-N-CA 127.491 5.46 . . . . 75.129999999999995 117.489 -159.626 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -146.59 -34.44 0.28 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.115 -0.948 . . . . 51.530000000000001 112.309 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.9 tt0 -146.37 139.76 25.87 Favored 'General case' 0 C--O 1.214 -0.774 0 C-N-CA 118.904 -1.118 . . . . 75.400000000000006 110.878 -174.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.706 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -139.78 136.7 34.36 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.259 -0.645 . . . . 70.439999999999998 109.259 -177.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.3 m -140.9 125.95 18.34 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 110.017 -0.364 . . . . 75.109999999999999 110.017 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.46 ' CD1' HD11 ' A' ' 74' ' ' LEU 0.273 12.8 p90 -146.8 158.17 43.85 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.02 0.748 . . . . 73.519999999999996 113.02 -178.429 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 64' ' ' LYS 0.27 21.7 mt-10 -119.19 131.58 55.85 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.643 -2.725 . . . . 75.299999999999997 103.643 -173.492 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.543 ' HE1' HG13 ' A' ' 85' ' ' VAL . 12.6 p-90 -153.11 163.52 39.72 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 114.733 1.383 . . . . 73.549999999999997 114.733 -168.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.412 ' HB2' ' CE3' ' A' ' 78' ' ' TRP . 3.8 t70 72.94 -167.83 0.12 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 112.009 -2.359 . . . . 72.209999999999994 112.237 170.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.444 ' HB ' ' OE2' ' A' ' 81' ' ' GLU . 1.3 m -78.53 -53.59 7.05 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.465 1.106 . . . . 74.129999999999995 112.129 -170.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.444 ' OE2' ' HB ' ' A' ' 80' ' ' THR . 2.4 mp0 -68.77 -19.62 64.32 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.375 0.509 . . . . 52.32 112.375 -176.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.33 76.33 1.3 Allowed Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.127 -1.035 . . . . 54.229999999999997 111.274 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.51 ' CZ3' HD21 ' A' ' 9' ' ' LEU . 48.7 m95 -109.4 154.42 22.61 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.188 -1.412 . . . . 74.329999999999998 107.188 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.63 123.98 27.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 121.461 0.648 . . . . 61.439999999999998 109.735 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.543 HG13 ' HE1' ' A' ' 78' ' ' TRP . 19.1 m -120.25 155.43 23.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 121.484 0.659 . . . . 73.200000000000003 111.259 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.464 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 41.9 m -131.09 137.33 49.06 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.065 -0.97 . . . . 74.230000000000004 108.573 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.9 m-85 -120.0 133.11 55.64 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.76 -1.2 . . . . 75.230000000000004 107.76 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.56 132.76 55.81 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 109.52 -0.548 . . . . 73.510000000000005 109.52 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mp -114.6 119.99 38.66 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.52 0.676 . . . . 73.349999999999994 110.724 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -103.21 123.73 47.29 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.533 -1.284 . . . . 62.399999999999999 107.533 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -82.67 128.61 34.51 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.914 -0.714 . . . . 72.129999999999995 109.71 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 74.2 mt -121.07 158.35 28.05 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.36 -1.348 . . . . 72.349999999999994 107.36 174.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.55 48.22 3.62 Favored Glycine 0 C--N 1.3 -1.444 0 O-C-N 123.305 0.378 . . . . 62.100000000000001 114.008 -174.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 172.96 -41.61 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.385 1.074 . . . . 74.310000000000002 109.237 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.5 ptpt -134.15 175.07 9.82 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.03 -0.729 . . . . 60.109999999999999 109.03 -173.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.433 ' HB ' HG21 ' A' ' 25' ' ' VAL . 88.9 m -117.72 128.16 54.62 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.817 -0.809 . . . . 63.229999999999997 108.817 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.37 107.7 3.47 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.203 -1.159 . . . . 55.340000000000003 110.203 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -97.32 133.95 41.25 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 109.257 -0.645 . . . . 70.340000000000003 109.257 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.4 m -120.41 121.81 39.35 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 108.187 -1.042 . . . . 64.010000000000005 108.187 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.59 139.71 35.89 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-O 121.854 0.835 . . . . 60.420000000000002 109.59 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.464 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 16.1 mt -137.09 124.85 32.14 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 113.239 -1.801 . . . . 63.219999999999999 107.746 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.536 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 23.7 t-160 -117.42 129.06 55.6 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.309 -0.997 . . . . 60.140000000000001 108.309 177.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -141.08 164.41 30.34 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.151 -1.426 . . . . 62.229999999999997 107.151 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.1 167.76 38.25 Favored Glycine 0 C--N 1.291 -1.932 0 C-N-CA 120.17 -1.014 . . . . 61.32 110.864 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 . . . . . 0 C--N 1.307 -1.24 0 CA-C-O 121.952 0.882 . . . . 63.310000000000002 112.535 -177.519 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.412 -2.362 0 N-CA-C 107.649 -1.241 . . . . 73.030000000000001 107.649 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 35.0 pt -58.03 -31.0 40.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 113.049 0.759 . . . . 74.340000000000003 113.049 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.13 40.72 5.1 Favored Glycine 0 CA--C 1.494 -1.265 0 N-CA-C 109.76 -1.336 . . . . 73.120000000000005 109.76 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 46.04 52.05 10.4 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.909 1.684 . . . . 71.450000000000003 111.849 -175.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.02 -19.77 61.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 122.439 1.114 . . . . 50.450000000000003 108.481 173.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -132.52 -72.27 0.52 Allowed 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 113.701 -1.59 . . . . 74.519999999999996 108.713 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -149.2 -170.81 3.73 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 108.77 -0.826 . . . . 73.25 108.77 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.84 157.02 25.69 Favored 'General case' 0 C--O 1.218 -0.553 0 O-C-N 124.051 0.845 . . . . 54.299999999999997 110.784 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.1 p -56.65 -48.38 77.68 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.218 1.007 . . . . 65.310000000000002 112.72 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 p -63.07 -45.36 92.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.437 0.637 . . . . 74.140000000000001 110.704 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.06 -47.5 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.919 -1.037 . . . . 72.0 110.016 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 126' ' ' MET . 50.8 t -57.48 -41.06 78.0 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.233 0 CA-C-N 116.115 -0.493 . . . . 71.310000000000002 110.697 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -63.24 -51.69 65.17 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.24 -0.437 . . . . 74.310000000000002 111.045 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.64 -42.99 97.05 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-N 115.739 -0.664 . . . . 61.140000000000001 112.234 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -68.93 -32.53 72.2 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 115.085 -0.558 . . . . 65.109999999999999 112.363 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.427 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 23.4 mmt -67.03 -46.51 74.23 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.851 -0.74 . . . . 74.209999999999994 111.145 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.89 -58.42 3.47 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.658 -0.817 . . . . 65.099999999999994 111.783 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.33 -44.88 83.84 Favored Glycine 0 C--O 1.246 0.859 0 C-N-CA 121.058 -0.592 . . . . 63.310000000000002 112.075 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.53 -55.46 28.78 Favored Glycine 0 N--CA 1.437 -1.291 0 CA-C-O 119.316 -0.713 . . . . 62.539999999999999 112.22 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.433 ' O ' HG12 ' A' ' 134' ' ' VAL . 62.3 m95 -58.8 -43.51 90.53 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 117.837 0.818 . . . . 72.120000000000005 113.128 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 31.7 m -59.9 -47.06 87.32 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.367 0.417 . . . . 61.310000000000002 110.479 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.45 -47.24 36.23 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.557 -0.83 . . . . 74.219999999999999 112.828 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.8 mt -65.35 -46.14 91.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 122.587 0.355 . . . . 75.409999999999997 111.822 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 5.1 p -66.29 -40.45 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 119.608 -0.837 . . . . 63.109999999999999 109.717 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.593 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 34.3 t30 -58.89 -63.93 1.12 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.015 -0.539 . . . . 64.349999999999994 110.624 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -71.01 -48.8 51.05 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 113.423 0.897 . . . . 71.519999999999996 113.423 -173.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.518 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -69.83 -33.81 72.81 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.702 -0.799 . . . . 71.219999999999999 110.813 -171.559 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.4 mm? -70.78 -48.91 51.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.991 -1.084 . . . . 64.5 110.264 173.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 135' ' ' ASN . 1.0 OUTLIER -59.3 -40.32 85.78 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.83 -0.623 . . . . 73.420000000000002 110.959 -177.297 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 144' ' ' GLU . 25.7 mmmt -75.85 -36.02 59.75 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 112.887 0.699 . . . . 75.010000000000005 112.887 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.16 -28.2 64.09 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.617 -0.833 . . . . 71.519999999999996 110.629 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.513 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 25.8 m -79.77 -24.63 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 119.584 -0.846 . . . . 31.539999999999999 110.647 176.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.35 -87.16 0.14 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.917 0.865 . . . . 71.25 110.669 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.422 ' O ' ' HE3' ' A' ' 140' ' ' LYS . 39.1 mt-10 . . . . . 0 N--CA 1.432 -1.326 0 C-N-CA 125.09 1.356 . . . . 65.25 107.494 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.656 0 N-CA-C 111.429 0.159 . . . . 73.519999999999996 111.429 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.4 tp 48.66 86.78 0.14 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.315 1.446 . . . . 64.420000000000002 114.286 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.05 138.32 43.51 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.071 1.18 . . . . 41.039999999999999 109.717 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 8.2 p-10 -71.72 110.95 6.61 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.634 0.73 . . . . 72.310000000000002 109.839 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.405 HG22 ' HB3' ' A' ' 102' ' ' HIS . 10.6 tp -111.17 138.67 38.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.622 -0.717 . . . . 74.129999999999995 110.814 -173.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.3 m -111.67 133.02 54.2 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 108.023 -1.103 . . . . 73.430000000000007 108.023 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -128.14 143.07 51.03 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.892 -1.522 . . . . 73.200000000000003 106.892 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.9 m -122.75 133.48 54.47 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.977 -0.379 . . . . 60.399999999999999 109.977 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.527 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -145.84 131.79 13.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.601 -0.888 . . . . 75.120000000000005 108.601 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.75 122.62 43.0 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-O 121.458 0.647 . . . . 72.109999999999999 112.179 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 138' ' ' LEU . 6.2 mp -95.67 135.85 36.83 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 107.755 -1.202 . . . . 63.350000000000001 107.755 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -87.78 39.78 0.9 Allowed 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.169 -0.469 . . . . 72.0 109.937 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.483 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -135.92 163.86 47.37 Favored Pre-proline 0 C--O 1.245 0.823 0 C-N-CA 124.169 0.987 . . . . 71.340000000000003 109.085 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 36.4 Cg_endo -63.7 157.71 50.28 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 123.013 2.476 . . . . 63.130000000000003 112.377 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.6 tt -64.87 -27.72 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.738 -0.664 . . . . 74.030000000000001 111.859 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -71.75 -28.24 63.53 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.971 0.415 . . . . 71.200000000000003 111.717 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.59 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 4.4 tmtt? -81.18 -46.11 15.36 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.46 -0.57 . . . . 73.209999999999994 109.46 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.691 HG11 HG21 ' A' ' 96' ' ' THR . 5.4 p -59.49 -39.18 78.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.237 0.541 . . . . 73.219999999999999 109.846 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -63.35 -44.59 94.4 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.201 -0.909 . . . . 74.519999999999996 111.032 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -65.25 -33.68 76.55 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.442 -0.503 . . . . 72.439999999999998 110.465 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.7 m -59.25 -32.02 69.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.249 0.547 . . . . 71.319999999999993 111.163 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.561 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.5 m -109.46 21.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 112.298 0.481 . . . . 53.200000000000003 112.298 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.431 ' HB2' HD22 ' A' ' 46' ' ' LEU . 61.6 p -137.64 -12.24 1.55 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.406 -0.517 . . . . 74.209999999999994 112.216 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.0 p -94.55 158.81 15.37 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.632 -0.507 . . . . 74.150000000000006 109.632 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.9 m -59.9 -48.23 82.55 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 123.036 0.534 . . . . 53.100000000000001 111.195 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.83 -27.31 57.81 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.304 -0.862 . . . . 61.210000000000001 111.089 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.6 -48.81 21.31 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 119.927 -1.13 . . . . 71.430000000000007 111.58 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.1 mt -65.59 -33.42 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.729 0.775 . . . . 72.540000000000006 110.321 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 C-N-CA 124.578 1.151 . . . . 74.549999999999997 112.59 177.941 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 C--O 1.243 0.749 0 N-CA-C 108.725 -0.843 . . . . 51.43 108.725 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -89.14 73.61 8.13 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.888 0.851 . . . . 71.109999999999999 110.081 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.4 ' HE1' ' SG ' ' A' ' 63' ' ' CYS . 93.4 m-85 -70.83 119.99 15.78 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.963 -1.017 . . . . 63.409999999999997 109.947 176.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -113.38 148.32 36.02 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 110.0 -0.37 . . . . 75.5 110.0 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.431 HD22 ' HB2' ' A' ' 30' ' ' SER . 21.5 tp -87.27 105.53 17.3 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.824 -1.176 . . . . 52.210000000000001 107.824 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -133.19 137.51 46.21 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 106.488 -1.671 . . . . 61.409999999999997 106.488 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -92.07 75.27 5.49 Favored 'General case' 0 C--N 1.257 -3.421 0 CA-C-O 122.845 1.307 . . . . 51.420000000000002 109.561 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.97 87.88 1.59 Allowed Glycine 1 N--CA 1.396 -4.001 0 CA-C-N 113.61 -1.632 . . . . 63.140000000000001 111.027 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--N 1.303 -1.415 0 N-CA-C 107.911 -1.144 . . . . 75.109999999999999 107.911 -178.306 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.4 ' SG ' ' HE1' ' A' ' 44' ' ' PHE . 30.5 m . . . . . 0 N--CA 1.425 -1.714 0 N-CA-C 107.612 -1.255 . . . . 50.299999999999997 107.612 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.5 118.46 28.35 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-O 121.901 0.858 . . . . 64.109999999999999 110.455 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 76' ' ' PHE . 6.7 t -79.26 137.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 114.872 -1.058 . . . . 65.310000000000002 109.339 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 tt -81.47 -57.63 3.39 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.387 -1.338 . . . . 71.400000000000006 107.387 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.04 153.6 22.47 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.542 -0.753 . . . . 64.430000000000007 109.801 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.54 119.13 52.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.712 -1.218 . . . . 23.420000000000002 107.712 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 22.5 mp0 -106.27 141.19 38.02 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.348 0.659 . . . . 75.519999999999996 110.334 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.67 129.32 94.1 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 114.226 -1.352 . . . . 63.229999999999997 108.446 -167.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo 2.52 44.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.283 1 C-N-CA 128.434 6.089 . . . . 74.319999999999993 118.602 -162.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -139.83 -35.47 0.53 Allowed 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 122.248 -0.283 . . . . 61.240000000000002 110.702 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 40.7 tt0 -145.94 145.21 30.59 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 118.508 -1.277 . . . . 74.030000000000001 109.98 -174.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.699 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -147.5 134.96 20.8 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.529 -1.285 . . . . 55.340000000000003 107.529 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.1 m -140.51 125.44 18.32 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.269 -0.572 . . . . 63.299999999999997 110.286 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.464 ' HD1' HD11 ' A' ' 74' ' ' LEU . 49.8 p90 -138.2 152.92 49.09 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 109.725 -0.472 . . . . 53.520000000000003 109.725 176.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.409 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 37.8 mt-10 -124.73 126.08 45.1 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-N 115.475 -0.784 . . . . 62.229999999999997 110.818 -171.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.523 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 2.1 t90 -95.54 107.94 20.15 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 104.359 -2.46 . . . . 75.140000000000001 104.359 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.51 140.49 55.67 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.889 -0.596 . . . . 74.340000000000003 111.119 -171.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.1 m 70.18 82.82 0.15 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.598 1.159 . . . . 65.129999999999995 112.279 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 55.63 23.22 5.93 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.954 1.702 . . . . 73.310000000000002 113.833 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.523 ' HA3' ' HB3' ' A' ' 78' ' ' TRP . . . -93.98 -24.43 19.97 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 107.865 -2.094 . . . . 60.530000000000001 107.865 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 75.29 -177.16 0.15 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 126.128 1.771 . . . . 75.109999999999999 113.03 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.409 ' HB ' ' HG2' ' A' ' 77' ' ' GLU . 4.4 p -114.81 117.26 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.838 0.828 . . . . 74.319999999999993 109.918 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.51 144.01 16.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 CA-C-N 114.989 -1.005 . . . . 73.239999999999995 108.717 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 46.9 m -131.56 134.38 46.02 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 108.988 -0.745 . . . . 52.130000000000003 108.988 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.699 ' CD2' HD12 ' A' ' 74' ' ' LEU . 10.9 m-85 -109.99 137.41 47.8 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.452 -1.314 . . . . 63.0 107.452 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.607 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 7.0 tt0 -125.04 136.98 54.21 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.089 -1.448 . . . . 70.219999999999999 107.089 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -110.91 124.38 51.98 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.202 -0.599 . . . . 70.400000000000006 111.901 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -109.93 137.11 48.18 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 124.717 1.207 . . . . 73.329999999999998 108.383 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -97.93 117.76 32.98 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 120.608 0.242 . . . . 64.25 111.158 -176.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.2 mt -113.63 159.98 19.06 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.84 -0.8 . . . . 33.149999999999999 108.84 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.52 -26.61 71.95 Favored Glycine 0 C--N 1.293 -1.806 0 N-CA-C 114.908 0.723 . . . . 71.310000000000002 114.908 -174.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 28.0 tt0 -128.08 -0.9 5.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.88 0.84 . . . . 73.230000000000004 110.853 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -161.65 176.2 11.22 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.455 -0.778 . . . . 75.010000000000005 108.993 -173.13 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.691 HG21 HG11 ' A' ' 25' ' ' VAL . 31.2 m -116.58 128.14 55.14 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 109.556 -0.535 . . . . 74.140000000000001 109.556 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.15 112.71 3.93 Favored Glycine 0 N--CA 1.419 -2.446 0 N-CA-C 109.486 -1.445 . . . . 43.240000000000002 109.486 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -97.9 133.97 41.67 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 108.038 -1.097 . . . . 74.140000000000001 108.038 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 88' ' ' GLN . 14.0 m -117.81 121.91 42.01 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 107.991 -1.114 . . . . 42.210000000000001 107.991 -178.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.85 141.25 34.0 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 107.79 -1.189 . . . . 65.109999999999999 107.79 177.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 19.6 mt -135.2 124.77 42.81 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.404 0 N-CA-C 106.699 -1.593 . . . . 72.319999999999993 106.699 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 21.8 t-160 -117.83 120.9 39.3 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.151 -1.055 . . . . 64.099999999999994 108.151 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.9 t -141.82 164.6 29.75 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 107.161 -1.422 . . . . 64.239999999999995 107.161 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -176.73 -131.86 1.55 Allowed Glycine 0 C--N 1.285 -2.29 0 N-CA-C 109.413 -1.475 . . . . 72.329999999999998 109.413 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 . . . . . 0 C--N 1.301 -1.506 0 N-CA-C 108.373 -0.973 . . . . 73.5 108.373 175.863 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.759 HG12 HD13 ' A' ' 112' ' ' ILE . 1.8 t . . . . . 0 N--CA 1.439 -0.985 0 N-CA-C 106.646 -1.613 . . . . 62.310000000000002 106.646 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.759 HD13 HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -58.15 -31.72 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.792 0.806 . . . . 30.52 111.155 177.062 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 148.12 -86.89 0.16 Allowed Glycine 0 N--CA 1.41 -3.093 0 N-CA-C 109.18 -1.568 . . . . 54.240000000000002 109.18 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 61.8 tttp -155.13 22.36 0.43 Allowed 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.45 0.643 . . . . 73.319999999999993 110.266 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.418 ' HB3' HG13 ' A' ' 112' ' ' ILE . . . -59.95 -39.15 84.61 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.155 -0.966 . . . . 64.109999999999999 111.282 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -150.85 25.03 0.75 Allowed 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.362 0.413 . . . . 64.519999999999996 110.967 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.411 ' O ' HG11 ' A' ' 111' ' ' VAL . 3.5 mp0 66.85 -41.47 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.382 1.623 . . . . 63.509999999999998 115.382 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -118.06 141.74 48.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.268 0.485 . . . . 62.5 112.159 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.672 ' OG ' ' HA ' ' A' ' 111' ' ' VAL . 70.8 m -75.07 -27.79 60.1 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.987 -0.551 . . . . 71.230000000000004 109.696 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 p -66.04 -47.17 75.28 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.633 -0.712 . . . . 73.340000000000003 111.509 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.0 m -69.92 -33.7 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 120.425 -0.51 . . . . 72.439999999999998 109.897 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.41 -46.32 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 120.155 -0.618 . . . . 70.239999999999995 110.556 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -55.31 -55.95 25.57 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.656 0.782 . . . . 63.229999999999997 111.785 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.0 -47.24 92.25 Favored Glycine 0 C--O 1.249 1.069 0 O-C-N 123.635 0.584 . . . . 62.229999999999997 112.652 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -68.44 -36.95 79.78 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 113.292 0.849 . . . . 75.530000000000001 113.292 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -34.47 71.99 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 119.469 -0.892 . . . . 72.340000000000003 110.859 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.19 -49.64 54.78 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.863 0.363 . . . . 74.400000000000006 110.875 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.45 -41.02 91.23 Favored Glycine 0 C--O 1.251 1.211 0 C-N-CA 120.624 -0.798 . . . . 55.229999999999997 111.238 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.87 -54.03 38.48 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.824 -0.688 . . . . 51.43 112.301 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.508 ' O ' HG12 ' A' ' 134' ' ' VAL . 57.5 m95 -56.99 -37.65 71.95 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 113.097 0.777 . . . . 74.340000000000003 113.097 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.5 m -57.37 -48.08 79.97 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 123.186 0.304 . . . . 73.129999999999995 110.436 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.89 -48.76 31.93 Favored Glycine 0 C--O 1.246 0.897 0 C-N-CA 120.584 -0.817 . . . . 72.549999999999997 112.332 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.24 -52.41 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.044 0.537 . . . . 75.430000000000007 111.653 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 4.2 p -71.63 -41.03 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 119.874 -0.73 . . . . 72.340000000000003 111.847 -173.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.527 ' HA ' HG13 ' A' ' 16' ' ' ILE . 26.7 t-20 -63.69 -52.18 61.77 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.988 -0.685 . . . . 54.140000000000001 111.234 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 33.5 tt0 -78.99 -44.75 21.69 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 113.183 0.808 . . . . 74.140000000000001 113.183 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.55 ' NH1' ' HB2' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -64.85 -45.3 86.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 119.147 -1.021 . . . . 64.230000000000004 109.837 -176.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.1 mm? -65.47 -52.21 54.53 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.218 0.324 . . . . 71.0 111.557 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -63.73 -35.65 81.27 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.908 0.385 . . . . 74.219999999999999 109.995 -177.456 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.488 ' NZ ' ' HB3' ' A' ' 144' ' ' GLU . 12.5 mmmt -68.65 -46.16 69.9 Favored 'General case' 0 C--O 1.173 -2.957 0 CA-C-O 119.157 -0.449 . . . . 74.519999999999996 111.088 177.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB2' ' NH1' ' A' ' 137' ' ' ARG . . . -59.48 -29.85 68.13 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.219 0.452 . . . . 73.219999999999999 112.219 -176.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 21.1 m -86.28 -24.69 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 120.19 -0.604 . . . . 74.430000000000007 112.205 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 78.6 mm-40 -86.08 -57.86 2.86 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.711 0.767 . . . . 73.209999999999994 109.958 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.488 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 2.3 tm-20 . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 107.267 -1.382 . . . . 72.010000000000005 107.267 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.475 ' HB1' HG23 ' A' ' 112' ' ' ILE . . . . . . . . 0 N--CA 1.444 -0.769 0 CA-C-O 121.643 0.735 . . . . 75.150000000000006 111.864 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tt -166.53 109.5 0.68 Allowed Pre-proline 0 N--CA 1.419 -1.979 0 N-CA-C 107.161 -1.422 . . . . 72.340000000000003 107.161 -172.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -82.5 168.74 14.35 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 122.918 2.412 . . . . 70.310000000000002 109.522 171.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.53 107.47 1.4 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.638 -1.245 . . . . 72.109999999999999 107.638 170.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 43.2 mm -91.03 124.1 43.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.522 -0.918 . . . . 43.130000000000003 108.522 -174.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.0 m -120.37 128.39 53.19 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.433 -1.321 . . . . 64.150000000000006 107.433 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.562 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 22.4 tptt -140.2 144.56 36.65 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.701 -1.222 . . . . 72.319999999999993 107.701 -176.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.4 m -123.07 134.51 54.25 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.695 -0.402 . . . . 61.200000000000003 110.418 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.439 HG21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -141.7 131.79 25.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.919 -0.771 . . . . 72.200000000000003 108.919 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.87 117.87 32.05 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 121.809 0.814 . . . . 63.229999999999997 111.984 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.658 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.6 mp -92.7 140.07 29.91 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.796 -1.557 . . . . 64.329999999999998 106.796 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.85 15.27 3.4 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.175 0.512 . . . . 64.329999999999998 111.581 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -105.5 159.54 29.16 Favored Pre-proline 0 C--N 1.306 -1.31 0 CA-C-N 115.864 -0.607 . . . . 63.549999999999997 109.719 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.59 154.38 69.27 Favored 'Trans proline' 0 C--O 1.253 1.237 0 C-N-CA 123.028 2.485 . . . . 62.130000000000003 110.91 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.0 tt -60.63 -29.13 44.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.936 -0.575 . . . . 73.319999999999993 112.011 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.6 pt20 -62.85 -40.58 97.9 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.928 0.394 . . . . 71.409999999999997 111.198 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -68.12 -39.74 82.69 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.283 0.564 . . . . 72.400000000000006 110.909 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.467 HG21 ' HB ' ' A' ' 96' ' ' THR . 36.0 t -69.09 -40.75 81.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.328 -0.851 . . . . 61.229999999999997 109.821 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 28.7 t90 -59.06 -47.63 84.53 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 124.021 0.825 . . . . 74.319999999999993 110.397 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 34.2 mt-10 -64.4 -36.45 84.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.07 0.462 . . . . 71.319999999999993 110.731 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.4 m -67.16 -12.36 59.81 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-O 121.422 0.629 . . . . 60.210000000000001 111.976 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.669 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 16.7 m -131.06 13.62 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 120.756 -1.215 . . . . 23.329999999999998 112.906 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.6 t -139.12 4.05 2.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 120.247 -0.581 . . . . 73.099999999999994 112.259 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.4 p -111.57 168.57 9.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.198 -0.667 . . . . 62.130000000000003 109.198 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 16.4 m -60.08 -46.1 90.7 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.926 0.491 . . . . 64.430000000000007 111.447 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -71.12 -41.74 70.14 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.802 -0.635 . . . . 73.239999999999995 110.18 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.21 -48.01 67.78 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 115.158 -0.928 . . . . 74.340000000000003 113.078 -177.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.07 -41.46 89.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 117.289 0.544 . . . . 73.140000000000001 111.205 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 112.535 0.568 . . . . 42.509999999999998 112.535 -179.418 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 32' ' ' SER . 19.7 t-20 . . . . . 0 CA--C 1.494 -1.185 0 N-CA-C 105.611 -1.996 . . . . 73.439999999999998 105.611 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.21 70.77 8.13 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.553 0.692 . . . . 74.140000000000001 111.431 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -107.67 119.87 40.64 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.564 -1.198 . . . . 65.049999999999997 108.404 172.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -121.57 150.37 41.77 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.6 -1.259 . . . . 64.200000000000003 107.6 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 46' ' ' LEU . 2.5 pt? -78.44 106.08 10.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 117.316 -1.754 . . . . 71.150000000000006 108.974 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -130.41 144.7 51.56 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 104.875 -2.269 . . . . 73.540000000000006 104.875 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 11.3 pt-20 -83.99 36.75 0.57 Allowed 'General case' 0 C--N 1.283 -2.312 0 CA-C-O 122.218 1.008 . . . . 53.409999999999997 109.76 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.8 66.52 0.01 OUTLIER Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.35 -1.5 . . . . 72.230000000000004 109.35 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 19.4 tt0 . . . . . 0 C--N 1.314 -0.947 0 N-CA-C 107.326 -1.361 . . . . 51.229999999999997 107.326 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.419 -1.992 0 N-CA-C 105.646 -1.983 . . . . 51.020000000000003 105.646 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 42.9 mtpt -133.52 134.29 43.24 Favored 'General case' 0 CA--C 1.468 -2.21 0 C-N-CA 120.139 -0.625 . . . . 61.149999999999999 111.143 -169.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.2 t -90.66 133.82 31.31 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 N-CA-C 105.307 -2.108 . . . . 74.530000000000001 105.307 168.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.426 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 2.3 tm? -78.75 -56.64 4.26 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.038 -1.097 . . . . 73.340000000000003 108.038 -175.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.19 153.27 28.95 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.274 -0.875 . . . . 73.519999999999996 108.88 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.555 HG23 HD23 ' A' ' 74' ' ' LEU . 12.5 p -132.67 119.8 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 CA-C-O 121.885 0.85 . . . . 70.219999999999999 111.621 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 45.9 mt-30 -101.34 141.0 34.86 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.322 -0.854 . . . . 73.209999999999994 110.955 176.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.32 126.2 92.19 Favored Pre-proline 0 C--N 1.279 -2.468 0 CA-C-N 113.875 -1.511 . . . . 70.230000000000004 109.439 -164.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo 7.27 46.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 1 C-N-CA 127.869 5.712 . . . . 54.439999999999998 116.843 -162.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 p -138.7 -38.59 0.52 Allowed 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.773 -0.649 . . . . 73.299999999999997 112.182 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 31.1 tt0 -150.5 142.71 24.16 Favored 'General case' 0 C--O 1.208 -1.127 0 C-N-CA 118.913 -1.115 . . . . 74.420000000000002 110.221 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.685 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -138.52 137.18 36.85 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 108.746 -0.835 . . . . 63.420000000000002 108.746 -177.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.5 m -139.38 127.37 22.29 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 122.451 -0.156 . . . . 44.439999999999998 110.755 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 43.6 p90 -143.98 157.04 44.59 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.02 -0.425 . . . . 70.530000000000001 112.058 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 36.3 mt-10 -121.04 125.71 48.01 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 107.107 -1.442 . . . . 51.450000000000003 107.107 -176.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 51.3 t90 -135.33 148.49 49.48 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 111.925 0.343 . . . . 75.400000000000006 111.925 -176.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD1' HG22 ' A' ' 80' ' ' THR . 2.5 t70 77.82 -177.79 0.11 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.073 1.749 . . . . 73.510000000000005 111.909 171.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.482 HG22 ' OD1' ' A' ' 79' ' ' ASP . 1.8 t -58.34 -41.42 84.59 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 113.062 0.764 . . . . 62.409999999999997 113.062 -175.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.23 12.49 11.64 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.211 0.819 . . . . 74.420000000000002 113.211 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.96 57.45 6.9 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 123.42 0.45 . . . . 60.539999999999999 112.757 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 88.1 m95 -67.38 117.14 8.96 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 109.0 -0.741 . . . . 75.400000000000006 109.0 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 76' ' ' PHE . 7.2 p -101.84 101.16 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 CA-C-O 122.599 1.19 . . . . 74.310000000000002 109.418 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.2 m -100.26 146.85 8.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 CA-C-N 114.096 -1.411 . . . . 63.539999999999999 108.167 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.508 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 32.7 m -131.56 133.81 45.41 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 109.693 -176.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.685 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.2 m-85 -109.32 131.43 55.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.617 -1.253 . . . . 73.329999999999998 107.617 176.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.5 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 6.9 mt-30 -116.66 136.21 53.16 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 109.277 -0.638 . . . . 75.530000000000001 109.277 175.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mp -116.72 128.23 55.14 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.369 0.604 . . . . 71.5 110.552 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -102.85 119.6 39.14 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.104 -1.813 . . . . 71.239999999999995 106.104 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -81.13 111.79 17.9 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.11 0.481 . . . . 73.430000000000007 110.804 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.6 mt -120.95 148.66 43.78 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.669 -1.234 . . . . 74.140000000000001 107.669 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.06 54.24 2.53 Favored Glycine 0 C--N 1.284 -2.313 0 C-N-CA 121.027 -0.606 . . . . 62.020000000000003 112.208 -176.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -175.2 -54.51 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.652 -1.61 . . . . 72.109999999999999 106.652 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.38 175.41 8.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.027 -1.472 . . . . 74.099999999999994 107.027 -176.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.467 ' HB ' HG21 ' A' ' 25' ' ' VAL . 83.1 m -122.31 127.68 50.14 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 109.302 -0.629 . . . . 61.539999999999999 109.302 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.8 106.28 3.26 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.597 -1.401 . . . . 75.109999999999999 109.597 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -98.52 133.88 42.26 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 117.345 0.573 . . . . 72.230000000000004 109.646 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 28.9 m -123.17 120.38 33.03 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.612 -0.884 . . . . 74.310000000000002 108.612 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.63 141.62 33.23 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.961 -0.755 . . . . 72.239999999999995 108.961 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 18.2 mt -136.2 125.45 38.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.007 -1.451 . . . . 62.310000000000002 108.188 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -120.31 117.36 27.59 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.042 -1.096 . . . . 75.150000000000006 108.042 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.2 t -142.15 164.13 31.0 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 103.727 -2.694 . . . . 72.120000000000005 103.727 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.432 ' HA2' ' H ' ' A' ' 84' ' ' VAL . . . -166.65 163.3 36.89 Favored Glycine 0 CA--C 1.49 -1.514 0 C-N-CA 118.282 -1.913 . . . . 53.219999999999999 113.811 -178.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 29.6 t90 . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 122.994 1.378 . . . . 63.219999999999999 109.429 179.222 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 113' ' ' GLY . 14.9 p . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 108.703 -0.851 . . . . 65.109999999999999 108.703 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.691 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -59.63 -35.94 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.624 0.25 . . . . 74.299999999999997 111.374 176.168 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.457 ' H ' HG22 ' A' ' 111' ' ' VAL . . . 126.36 -140.28 11.95 Favored Glycine 0 N--CA 1.422 -2.284 0 N-CA-C 110.242 -1.143 . . . . 75.519999999999996 110.242 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -80.65 -2.5 46.84 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 123.533 0.733 . . . . 73.340000000000003 110.204 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.87 71.28 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.071 0.462 . . . . 42.229999999999997 109.93 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.448 ' O ' HD11 ' A' ' 112' ' ' ILE . 5.2 t30 -173.72 114.34 0.22 Allowed 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.209 -1.404 . . . . 74.099999999999994 107.209 174.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -78.74 49.47 0.9 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 114.36 1.244 . . . . 73.5 114.36 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -152.61 92.82 1.71 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.235 1.014 . . . . 73.0 108.824 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -57.01 13.57 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 123.516 0.726 . . . . 53.130000000000003 111.474 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.4 m -61.82 -33.3 73.9 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.166 -0.47 . . . . 63.450000000000003 111.375 -176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.85 -47.15 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 109.587 -0.523 . . . . 71.209999999999994 109.587 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.503 ' O ' ' HG2' ' A' ' 126' ' ' MET . 48.6 t -58.23 -43.55 86.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 O-C-N 123.822 0.701 . . . . 75.25 111.124 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -61.67 -48.95 78.49 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.159 -0.473 . . . . 65.109999999999999 110.833 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.42 -43.93 97.53 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 115.634 -0.712 . . . . 53.25 111.799 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -67.45 -34.21 76.72 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.829 -0.686 . . . . 74.340000000000003 112.193 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 25.7 mmt -66.7 -43.07 85.32 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.225 -0.59 . . . . 72.340000000000003 111.479 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.82 -61.51 1.78 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.259 -0.976 . . . . 65.310000000000002 111.772 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.37 -39.0 95.58 Favored Glycine 0 C--O 1.24 0.485 0 C-N-CA 120.928 -0.653 . . . . 61.149999999999999 112.574 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.26 -53.96 29.79 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 119.659 -0.523 . . . . 73.310000000000002 112.3 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.44 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.4 m95 -63.28 -29.53 70.84 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 117.51 0.655 . . . . 72.140000000000001 112.48 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.562 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 73.2 m -60.98 -57.4 12.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.427 -0.583 . . . . 65.450000000000003 109.427 174.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.5 -46.83 60.7 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.167 -0.539 . . . . 73.140000000000001 113.646 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.626 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 44.8 mm -59.13 -57.54 10.94 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 C-N-CA 122.728 0.411 . . . . 53.140000000000001 111.205 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.44 HG23 ' HE3' ' A' ' 130' ' ' TRP . 79.0 t -60.49 -44.1 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 O-C-N 123.096 0.248 . . . . 72.450000000000003 111.491 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 131' ' ' THR . 38.7 t-20 -54.24 -61.7 2.14 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 123.953 0.783 . . . . 74.209999999999994 111.148 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -80.89 -38.92 27.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 119.834 -0.747 . . . . 73.030000000000001 112.187 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.626 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 3.7 mmt180 -62.11 -46.64 88.17 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.372 0.533 . . . . 72.519999999999996 111.667 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.658 ' HB3' HD21 ' A' ' 18' ' ' LEU . 4.6 mm? -67.98 -48.57 65.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 120.236 -0.585 . . . . 74.450000000000003 110.467 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.592 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -61.81 -33.68 74.57 Favored 'General case' 0 C--O 1.198 -1.646 0 CA-C-N 115.734 -0.666 . . . . 73.129999999999995 109.611 -178.606 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -73.15 -35.68 66.51 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 112.879 0.696 . . . . 74.129999999999995 112.879 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.6 -32.92 71.94 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.032 0.444 . . . . 75.140000000000001 110.701 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.16 -27.0 7.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.744 -0.662 . . . . 63.549999999999997 111.602 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 64.3 mm-40 -87.33 -45.4 10.61 Favored 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 120.136 -0.626 . . . . 71.109999999999999 111.447 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.421 13.2 pt-20 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 126.869 2.068 . . . . 63.210000000000001 115.489 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.362 0 CA-C-O 120.879 0.371 . . . . 72.209999999999994 111.597 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 tp 58.8 88.49 0.12 Allowed Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 124.72 1.208 . . . . 61.329999999999998 113.865 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -68.45 139.05 44.04 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 N-CA-C 108.475 -1.394 . . . . 63.219999999999999 108.475 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.69 153.79 42.47 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.48 0.919 . . . . 73.420000000000002 113.48 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.6 mm -121.78 138.74 51.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.067 -0.969 . . . . 73.510000000000005 110.075 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.1 m -126.01 130.82 51.93 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.827 -1.546 . . . . 70.239999999999995 106.827 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 41.0 tptt -139.75 145.37 38.2 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.849 -0.797 . . . . 55.450000000000003 108.849 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -118.56 140.63 49.59 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 117.682 0.219 . . . . 73.430000000000007 110.825 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.92 142.58 16.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.052 -0.722 . . . . 74.329999999999998 109.052 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 p -105.3 130.01 53.52 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 112.572 0.582 . . . . 73.299999999999997 112.572 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.53 141.53 33.27 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.826 -0.624 . . . . 63.43 111.038 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -78.9 9.42 4.27 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.033 0.833 . . . . 74.230000000000004 111.441 -176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -120.95 160.56 44.41 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 109.586 -0.524 . . . . 73.319999999999993 109.586 -172.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 32.5 Cg_endo -62.89 152.69 77.64 Favored 'Trans proline' 0 C--O 1.256 1.384 0 C-N-CA 123.205 2.603 . . . . 63.350000000000001 111.749 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.9 tt -56.63 -31.67 35.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.301 -0.863 . . . . 72.310000000000002 112.097 -175.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -66.58 -33.75 76.36 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.111 0.411 . . . . 74.549999999999997 112.111 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.5 -36.11 45.48 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.165 -0.68 . . . . 71.409999999999997 109.165 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 29' ' ' VAL . 46.3 t -66.07 -41.28 89.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.885 -0.783 . . . . 73.219999999999999 108.885 177.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 51.9 t90 -59.06 -47.85 83.72 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.997 -1.001 . . . . 71.299999999999997 111.718 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.42 -30.41 70.14 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.457 -0.897 . . . . 74.129999999999995 110.694 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.9 m -63.79 -22.84 67.11 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-O 121.274 0.559 . . . . 72.129999999999995 111.744 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.605 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 17.0 m -122.81 16.7 5.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 121.741 -0.6 . . . . 62.109999999999999 112.41 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.534 ' HB3' HD12 ' A' ' 46' ' ' LEU . 53.9 m -144.19 8.49 1.41 Allowed 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.163 0.801 . . . . 61.140000000000001 113.163 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.5 p -116.9 168.93 9.79 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 121.516 -0.74 . . . . 74.150000000000006 109.409 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -60.82 -54.7 41.94 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.268 -0.642 . . . . 43.43 109.268 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.97 -38.94 87.7 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.133 -0.94 . . . . 62.039999999999999 111.191 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.47 -48.74 28.44 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.687 -0.768 . . . . 40.420000000000002 113.379 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.31 -41.53 78.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 117.636 0.718 . . . . 53.140000000000001 112.785 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 113.558 0.947 . . . . 71.409999999999997 113.558 -176.32 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 109.157 -0.683 . . . . 52.030000000000001 109.157 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.22 72.94 3.34 Favored 'General case' 0 CA--C 1.486 -1.511 0 CA-C-O 121.339 0.59 . . . . 52.009999999999998 111.294 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -84.85 131.14 34.56 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.923 -1.51 . . . . 75.430000000000007 106.923 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.473 ' HB3' HE22 ' A' ' 50' ' ' GLN . 53.7 tt0 -120.01 149.68 41.76 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.145 -0.687 . . . . 63.409999999999997 109.145 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' A' ' 30' ' ' SER . 6.0 tt -85.38 104.27 15.04 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 109.267 -0.642 . . . . 75.109999999999999 109.267 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.761 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 12.1 tppt? -132.94 146.01 51.41 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.586 -1.264 . . . . 73.409999999999997 107.586 168.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.486 ' HB3' HG12 ' A' ' 68' ' ' VAL . 11.4 pt-20 -87.02 77.45 9.17 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.596 1.189 . . . . 71.340000000000003 108.002 172.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.43 83.44 0.96 Allowed Glycine 0 N--CA 1.406 -3.342 0 CA-C-N 114.327 -1.306 . . . . 45.420000000000002 109.959 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.761 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 48.7 tt0 . . . . . 0 CA--C 1.487 -1.479 0 N-CA-C 108.215 -1.031 . . . . 60.229999999999997 108.215 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.427 -1.595 0 N-CA-C 109.389 -0.597 . . . . 55.219999999999999 109.389 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 22.9 pttm -158.31 145.26 17.71 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.233 -0.655 . . . . 63.020000000000003 109.233 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.6 t -89.26 126.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 107.271 -1.381 . . . . 71.400000000000006 107.271 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 tt -74.79 -53.41 9.22 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.009 -1.478 . . . . 65.530000000000001 107.009 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.9 141.93 5.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.016 -0.993 . . . . 63.119999999999997 109.108 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.606 HG23 HD23 ' A' ' 74' ' ' LEU . 14.3 p -122.3 120.04 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-O 121.981 0.896 . . . . 70.430000000000007 108.953 173.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 84.4 mm-40 -105.17 142.14 35.48 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 114.013 -1.449 . . . . 74.040000000000006 109.778 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 135.94 95.65 Favored Pre-proline 0 C--N 1.283 -2.316 0 CA-C-N 114.569 -1.196 . . . . 61.520000000000003 109.103 -165.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -3.07 54.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.614 1 C-N-CA 128.323 6.015 . . . . 53.119999999999997 117.977 -162.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -152.23 -37.63 0.11 Allowed 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.617 -0.72 . . . . 55.420000000000002 110.809 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 35.1 tt0 -139.72 129.14 24.16 Favored 'General case' 0 C--O 1.198 -1.621 0 C-N-CA 117.351 -1.74 . . . . 64.010000000000005 112.142 -174.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.68 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -131.15 134.39 46.49 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.717 -0.845 . . . . 53.149999999999999 108.717 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.4 m -140.26 126.7 20.11 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.639 -0.255 . . . . 61.350000000000001 110.497 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HD1' HD11 ' A' ' 74' ' ' LEU . 39.9 p90 -142.45 154.7 44.79 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.813 0.34 . . . . 74.340000000000003 110.271 177.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -122.63 132.25 54.19 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.688 -0.856 . . . . 62.43 108.688 -172.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.486 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 15.6 t-105 -112.98 106.14 14.34 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.124 -1.806 . . . . 64.150000000000006 106.124 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -72.49 172.26 10.83 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.238 -0.437 . . . . 74.319999999999993 110.69 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.1 m 65.3 43.89 3.39 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 122.196 0.998 . . . . 72.530000000000001 109.448 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 64.51 32.37 11.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.352 -1.295 . . . . 71.010000000000005 113.508 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 78' ' ' TRP . . . -86.81 -17.86 59.11 Favored Glycine 0 C--O 1.238 0.373 0 N-CA-C 109.308 -1.517 . . . . 42.310000000000002 109.308 171.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 28.6 m95 81.22 -174.17 0.04 OUTLIER 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.634 1.974 . . . . 74.319999999999993 112.217 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.32 122.96 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 121.758 0.79 . . . . 70.409999999999997 110.196 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m -116.8 152.36 18.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-O 121.317 0.58 . . . . 73.230000000000004 110.198 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 34.1 m -139.49 142.22 37.33 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 109.083 -0.71 . . . . 74.319999999999993 109.083 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.68 ' CD2' HD12 ' A' ' 74' ' ' LEU . 15.0 m-85 -121.23 140.35 52.16 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.89 -1.152 . . . . 75.239999999999995 107.89 176.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.88 132.79 53.26 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.357 -1.349 . . . . 63.039999999999999 107.357 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.84 122.18 44.61 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.738 0.78 . . . . 73.120000000000005 111.988 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -102.76 125.46 49.51 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.589 -1.187 . . . . 73.349999999999994 108.92 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -84.4 125.83 32.68 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.522 -0.763 . . . . 73.239999999999995 110.603 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.6 mt -125.43 153.04 44.06 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.856 -1.535 . . . . 64.409999999999997 106.856 171.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.18 38.22 2.73 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 114.613 0.605 . . . . 31.510000000000002 114.613 -172.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -176.02 -38.66 0.01 OUTLIER 'General case' 0 C--O 1.24 0.588 0 N-CA-C 109.372 -0.603 . . . . 73.340000000000003 109.372 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -127.12 175.81 7.85 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.115 -1.068 . . . . 60.140000000000001 108.115 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.4 m -121.54 129.07 52.66 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 120.709 -0.396 . . . . 71.420000000000002 110.281 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.42 106.16 3.32 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 109.489 -1.444 . . . . 62.530000000000001 109.489 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -98.58 134.47 41.47 Favored 'General case' 0 C--N 1.27 -2.864 0 O-C-N 121.801 -0.823 . . . . 62.030000000000001 109.652 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.6 m -118.84 121.7 40.63 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.387 -0.968 . . . . 74.219999999999999 108.387 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -101.83 142.34 33.29 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.694 0.759 . . . . 71.519999999999996 109.131 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.487 ' N ' HD13 ' A' ' 100' ' ' LEU . 17.7 mt -136.15 124.44 36.43 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.911 0 CA-C-N 113.92 -1.491 . . . . 72.430000000000007 107.653 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -120.22 118.24 29.95 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.294 -1.743 . . . . 72.040000000000006 106.294 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -138.79 164.19 30.25 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.811 -1.181 . . . . 74.049999999999997 107.811 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.21 170.1 34.37 Favored Glycine 0 N--CA 1.413 -2.889 0 N-CA-C 109.777 -1.329 . . . . 51.439999999999998 109.777 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 . . . . . 0 C--N 1.292 -1.917 0 N-CA-C 109.003 -0.74 . . . . 74.299999999999997 109.003 -176.708 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.422 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 11.7 p . . . . . 0 N--CA 1.432 -1.343 0 N-CA-C 107.218 -1.401 . . . . 73.409999999999997 107.218 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.626 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -62.42 -39.42 84.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 112.344 0.498 . . . . 64.239999999999995 112.344 179.359 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.92 -128.61 8.83 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.663 -0.78 . . . . 54.420000000000002 112.741 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -75.42 -7.39 53.93 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.69 0.796 . . . . 71.019999999999996 111.765 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.13 -34.02 71.56 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 123.137 0.273 . . . . 63.119999999999997 110.544 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -163.06 -81.7 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 119.676 -0.809 . . . . 61.450000000000003 112.887 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -151.28 -162.1 1.47 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.698 1.199 . . . . 55.119999999999997 109.231 -173.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.506 ' HB2' HG22 ' A' ' 121' ' ' VAL . 3.7 mppt? -75.43 154.38 37.13 Favored 'General case' 0 C--O 1.212 -0.895 0 C-N-CA 122.994 0.517 . . . . 65.310000000000002 110.289 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 111' ' ' VAL . 50.0 m -60.21 -41.6 93.38 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.922 1.082 . . . . 65.409999999999997 113.922 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.2 t -69.7 -45.87 67.27 Favored 'General case' 0 C--O 1.256 1.438 0 C-N-CA 120.116 -0.634 . . . . 74.310000000000002 111.138 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.506 HG22 ' HB2' ' A' ' 118' ' ' LYS . 27.6 m -69.94 -36.74 70.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 119.16 -1.016 . . . . 73.310000000000002 110.928 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 126' ' ' MET . 21.4 t -61.27 -45.68 98.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.253 0 O-C-N 123.167 0.292 . . . . 75.239999999999995 111.407 175.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -64.44 -40.45 95.76 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.882 -0.327 . . . . 71.409999999999997 111.237 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.03 -45.0 95.04 Favored Glycine 0 CA--C 1.492 -1.356 0 N-CA-C 111.225 -0.75 . . . . 61.310000000000002 111.225 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -68.22 -32.33 72.46 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.697 -0.752 . . . . 65.420000000000002 111.195 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 21.3 mmt -64.06 -49.37 72.59 Favored 'General case' 0 C--O 1.206 -1.21 0 C-N-CA 121.068 -0.253 . . . . 63.520000000000003 111.252 176.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.92 -51.38 62.19 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 119.839 -0.744 . . . . 63.020000000000003 110.973 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.76 -44.97 95.49 Favored Glycine 0 C--O 1.241 0.545 0 C-N-CA 121.232 -0.508 . . . . 73.230000000000004 111.981 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.55 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -62.46 -50.89 60.44 Favored Glycine 0 CA--C 1.487 -1.679 0 N-CA-C 111.352 -0.699 . . . . 44.130000000000003 111.352 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.511 ' O ' HG12 ' A' ' 134' ' ' VAL . 77.4 m95 -59.51 -37.24 77.78 Favored 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 118.83 -0.605 . . . . 70.329999999999998 112.496 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.504 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 90.1 m -54.32 -54.4 40.84 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 109.859 -0.422 . . . . 74.030000000000001 109.859 176.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.62 -45.33 67.16 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.804 -0.634 . . . . 45.530000000000001 113.538 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 129' ' ' GLY . 36.2 pt -74.68 -36.67 41.19 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.416 0 N-CA-C 113.213 0.819 . . . . 74.140000000000001 113.213 -176.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 130' ' ' TRP . 4.2 p -74.92 -38.82 44.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 118.671 -1.212 . . . . 60.340000000000003 110.494 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.3 -60.25 3.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.742 -0.383 . . . . 74.209999999999994 110.896 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.2 -43.95 66.39 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.248 0.462 . . . . 53.020000000000003 112.248 -173.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 2.0 tmm_? -70.27 -41.56 73.28 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.228 -0.589 . . . . 73.519999999999996 110.454 -173.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.0 mm? -63.96 -45.46 89.02 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 119.839 -0.744 . . . . 61.219999999999999 109.198 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -59.03 -42.28 89.81 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.815 -0.629 . . . . 71.519999999999996 110.187 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -65.27 -51.66 59.34 Favored 'General case' 0 C--O 1.166 -3.311 0 CA-C-O 119.502 -0.285 . . . . 73.420000000000002 111.382 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.2 73.48 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 123.359 0.412 . . . . 72.530000000000001 112.106 -175.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 31.2 m -74.34 -26.45 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 119.665 -0.814 . . . . 63.049999999999997 110.736 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.95 -53.28 4.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 118.815 -1.154 . . . . 52.350000000000001 112.63 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--N 1.304 -1.371 0 C-N-CA 124.229 1.012 . . . . 73.450000000000003 110.776 -175.87 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.254 0.074 . . . . 75.409999999999997 110.824 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.52 -29.16 62.29 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.693 0.282 . . . . 63.020000000000003 111.401 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.23 -28.09 64.98 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.204 0.526 . . . . 73.310000000000002 111.351 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -84.76 96.03 9.13 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 113.535 0.939 . . . . 71.209999999999994 113.535 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.26 127.64 4.48 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 106.192 -1.781 . . . . 71.430000000000007 106.192 174.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HG2' ' HG2' ' A' ' 110' ' ' GLU . 40.4 mt-10 63.95 78.95 0.27 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 122.577 1.18 . . . . 72.420000000000002 109.938 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -114.82 -75.49 0.59 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.216 -1.356 . . . . 70.319999999999993 110.279 -172.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 50.75 26.18 2.44 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.191 0.996 . . . . 71.430000000000007 111.377 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 4.2 mm? 67.95 90.24 0.09 OUTLIER Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 114.911 -1.04 . . . . 74.209999999999994 112.454 -172.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -88.32 -159.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 122.309 2.006 . . . . 64.439999999999998 109.702 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 7.8 p-10 -65.86 116.16 6.73 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.945 0.879 . . . . 73.040000000000006 111.151 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 50.0 mm -120.6 124.46 72.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 106.578 -1.638 . . . . 43.130000000000003 106.578 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.9 m -111.38 136.76 50.06 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.834 -0.802 . . . . 71.430000000000007 108.834 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -142.07 142.96 32.88 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.058 -1.089 . . . . 72.299999999999997 108.058 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.0 p -137.31 134.15 35.76 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 118.332 0.514 . . . . 34.200000000000003 109.785 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.92 131.84 13.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.236 -0.653 . . . . 74.450000000000003 109.236 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.477 ' CG2' ' HG3' ' A' ' 95' ' ' LYS . 2.7 m -94.52 120.97 35.57 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-O 121.798 0.809 . . . . 74.510000000000005 110.674 -175.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.2 mt -95.64 140.35 30.58 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.053 -0.976 . . . . 61.100000000000001 110.018 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.99 25.09 0.38 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.169 0.588 . . . . 75.549999999999997 112.21 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.84 160.47 44.56 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 122.655 0.382 . . . . 55.32 110.074 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 38.7 Cg_endo -67.4 157.41 61.9 Favored 'Trans proline' 0 C--O 1.256 1.402 0 C-N-CA 123.194 2.596 . . . . 62.149999999999999 111.55 175.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.9 tt -62.64 -27.16 42.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.785 -0.643 . . . . 75.319999999999993 112.119 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.41 -31.9 65.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.903 0.382 . . . . 75.420000000000002 111.481 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 5.0 tmtt? -79.1 -37.71 38.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 108.849 -0.797 . . . . 74.209999999999994 108.849 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 96' ' ' THR . 4.3 p -66.28 -39.84 85.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 120.074 -0.65 . . . . 71.299999999999997 110.243 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.483 ' NE1' ' HD3' ' A' ' 71' ' ' PRO . 50.2 t90 -58.11 -48.24 80.81 Favored 'General case' 0 C--O 1.213 -0.867 0 O-C-N 123.704 0.628 . . . . 64.510000000000005 111.153 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.49 -29.99 69.57 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 120.125 -0.63 . . . . 72.310000000000002 110.586 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 94.6 m -67.01 -26.27 66.7 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.993 0.425 . . . . 64.510000000000005 111.522 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.641 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.7 m -115.33 19.84 7.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 121.374 -0.829 . . . . 74.120000000000005 112.112 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.8 m -142.24 4.78 1.63 Allowed 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.842 0.682 . . . . 70.140000000000001 112.842 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.8 p -110.51 162.21 14.92 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.749 -0.834 . . . . 72.409999999999997 108.749 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -56.47 -44.78 80.89 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 123.474 0.709 . . . . 62.210000000000001 111.089 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.11 -46.61 64.46 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.402 -0.817 . . . . 70.340000000000003 111.005 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.06 -40.68 88.37 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 115.615 -0.721 . . . . 44.25 112.814 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.4 mt -68.92 -39.89 80.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 120.804 0.335 . . . . 71.349999999999994 110.842 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -63.09 -30.5 71.64 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.04 -0.527 . . . . 62.310000000000002 110.671 174.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.8 mttp 70.28 20.22 6.27 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.126 1.371 . . . . 63.340000000000003 109.347 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 98.0 m95 64.23 12.46 7.14 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.637 1.175 . . . . 64.140000000000001 111.827 -175.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -104.7 84.97 2.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.185 -1.783 . . . . 75.109999999999999 106.185 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.9 mpt? 69.09 86.23 0.12 Allowed Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 114.687 -1.142 . . . . 73.340000000000003 109.304 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.428 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 17.2 Cg_exo -67.01 114.1 3.06 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.752 2.301 . . . . 70.450000000000003 112.507 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -100.52 164.56 11.84 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.261 -1.014 . . . . 74.430000000000007 108.261 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -99.1 61.54 1.24 Allowed 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.328 -0.949 . . . . 65.099999999999994 109.295 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.507 ' HD2' ' HG ' ' A' ' 63' ' ' CYS . 20.0 t80 -65.58 132.51 49.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.108 -1.405 . . . . 73.430000000000007 110.201 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -109.93 133.41 53.21 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.752 -0.462 . . . . 72.230000000000004 109.752 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 68' ' ' VAL . 15.7 tp -78.02 106.15 9.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.43 -1.322 . . . . 72.549999999999997 107.43 177.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -130.16 145.0 51.68 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.529 -1.286 . . . . 74.239999999999995 107.529 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -84.21 59.3 5.26 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.984 0.897 . . . . 71.010000000000005 109.277 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.27 77.53 0.58 Allowed Glycine 0 N--CA 1.414 -2.824 0 N-CA-C 109.38 -1.488 . . . . 64.209999999999994 109.38 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -75.43 -44.48 44.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.94 0.876 . . . . 61.149999999999999 108.717 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -143.93 156.97 44.62 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.299 -2.112 . . . . 45.420000000000002 105.299 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -109.79 147.73 32.73 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.989 -0.745 . . . . 72.340000000000003 108.989 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.46 ' CE1' ' HZ1' ' A' ' 106' ' ' LYS . 16.3 t-160 -109.38 137.76 46.76 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.63 -1.248 . . . . 75.120000000000005 107.63 -171.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.5 mp -146.31 -50.22 0.22 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.643 -0.873 . . . . 75.219999999999999 108.643 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -111.31 163.28 14.13 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.037 -0.983 . . . . 73.329999999999998 108.595 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -80.68 116.6 63.21 Favored Pre-proline 0 N--CA 1.425 -1.679 0 N-CA-C 108.626 -0.879 . . . . 74.040000000000006 108.626 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.431 ' HB3' ' OG ' ' A' ' 61' ' ' SER . 73.6 Cg_exo -55.47 106.3 0.18 Allowed 'Trans proline' 0 C--O 1.248 1.024 0 C-N-CA 123.012 2.475 . . . . 73.409999999999997 113.401 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -86.98 -34.41 19.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.082 -1.451 . . . . 74.439999999999998 107.082 174.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.73 147.62 20.6 Favored Glycine 0 N--CA 1.417 -2.602 0 N-CA-C 108.899 -1.68 . . . . 34.520000000000003 108.899 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -48.53 114.45 1.2 Allowed 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 123.697 2.932 . . . . 75.099999999999994 113.133 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' A' ' 57' ' ' PRO . 34.2 m -130.2 139.72 36.48 Favored Pre-proline 0 N--CA 1.424 -1.742 0 N-CA-C 108.476 -0.935 . . . . 72.329999999999998 108.476 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.0 -160.52 0.1 Allowed 'Trans proline' 0 C--O 1.262 1.694 0 C-N-CA 122.249 1.966 . . . . 71.340000000000003 112.242 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.507 ' HG ' ' HD2' ' A' ' 44' ' ' PHE . 3.9 p -87.03 142.81 27.66 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 107.983 -1.118 . . . . 61.039999999999999 107.983 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -133.97 140.83 47.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.756 -1.201 . . . . 75.030000000000001 107.756 -172.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.444 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 3.0 t -90.16 136.77 23.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 107.927 -1.138 . . . . 55.509999999999998 107.927 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.6 tp -83.52 -58.07 2.97 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.82 -1.178 . . . . 74.340000000000003 107.82 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.47 138.98 14.93 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.772 -1.104 . . . . 53.520000000000003 109.183 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.616 HG23 HD23 ' A' ' 74' ' ' LEU . 11.2 p -119.37 124.26 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 N-CA-C 108.978 -0.749 . . . . 74.120000000000005 108.978 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 28.2 mm-40 -105.12 140.84 37.69 Favored 'General case' 0 CA--C 1.48 -1.741 0 CA-C-N 115.663 -0.699 . . . . 72.439999999999998 109.602 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.32 126.48 92.61 Favored Pre-proline 0 C--N 1.279 -2.48 0 CA-C-N 113.604 -1.635 . . . . 72.530000000000001 109.047 -166.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.483 ' HD3' ' NE1' ' A' ' 26' ' ' TRP . 36.9 Cg_exo 5.89 42.99 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 1 C-N-CA 128.131 5.887 . . . . 32.229999999999997 118.428 -160.696 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 p -132.76 -39.13 0.99 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.312 -0.404 . . . . 73.239999999999995 111.867 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 40.5 tt0 -150.43 145.11 25.85 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 119.325 -0.95 . . . . 73.030000000000001 110.988 -172.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.682 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -139.25 135.11 33.54 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.676 -0.861 . . . . 73.409999999999997 108.676 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.8 m -140.54 126.04 18.96 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.689 0.28 . . . . 72.230000000000004 110.945 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.468 ' HD2' HD11 ' A' ' 74' ' ' LEU . 34.8 p90 -146.01 157.23 43.87 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 120.613 0.244 . . . . 72.030000000000001 111.02 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -120.95 123.86 43.5 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.978 -1.119 . . . . 74.299999999999997 107.978 -174.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -108.26 111.28 23.16 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 106.187 -1.783 . . . . 64.430000000000007 106.187 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.29 1.2 m-20 -79.1 10.16 3.78 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 116.808 2.151 . . . . 62.119999999999997 116.808 -170.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -75.85 94.95 3.41 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 104.529 -2.397 . . . . 75.319999999999993 104.529 167.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 83.68 -37.82 0.07 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.885 2.074 . . . . 75.219999999999999 109.718 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.94 47.45 0.56 Allowed Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 111.07 -0.812 . . . . 34.229999999999997 111.07 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -85.25 112.37 20.7 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.608 0.718 . . . . 73.540000000000006 110.402 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.1 t -101.77 117.27 46.83 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 N-CA-C 106.705 -1.591 . . . . 73.109999999999999 106.705 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.32 147.12 20.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-O 121.555 0.693 . . . . 73.450000000000003 110.518 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.526 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 46.7 m -128.88 132.73 47.75 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 115.019 -0.991 . . . . 72.409999999999997 108.711 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.682 ' CD2' HD12 ' A' ' 74' ' ' LEU . 14.4 m-85 -112.7 145.56 40.28 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.978 -1.119 . . . . 74.25 107.978 177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 69.4 mt-30 -130.84 144.17 51.26 Favored 'General case' 0 C--N 1.277 -2.573 0 O-C-N 123.591 0.557 . . . . 74.340000000000003 110.932 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.0 mt -114.9 120.9 41.53 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 123.707 0.63 . . . . 65.319999999999993 110.25 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -103.48 122.74 45.54 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.454 -0.943 . . . . 74.120000000000005 108.454 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -77.66 112.7 14.74 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.101 -0.5 . . . . 74.120000000000005 111.479 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.0 mt -125.58 160.2 30.18 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.365 -0.834 . . . . 72.329999999999998 108.963 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.76 123.94 6.89 Favored Glycine 0 N--CA 1.424 -2.152 0 N-CA-C 109.114 -1.594 . . . . 75.430000000000007 109.114 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 84.58 -10.03 0.87 Allowed 'General case' 0 CA--C 1.485 -1.522 0 C-N-CA 125.709 1.604 . . . . 64.209999999999994 111.812 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.477 ' HG3' ' CG2' ' A' ' 17' ' ' THR . 2.1 ptpt -154.99 174.87 14.56 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 108.519 -0.919 . . . . 72.049999999999997 108.519 -176.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.617 HG21 HG11 ' A' ' 25' ' ' VAL . 63.8 m -135.41 132.49 37.57 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 110.039 -0.356 . . . . 64.519999999999996 110.039 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.73 117.27 4.82 Favored Glycine 0 N--CA 1.423 -2.224 0 N-CA-C 109.831 -1.308 . . . . 73.200000000000003 109.831 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -99.77 129.98 45.94 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 108.81 -0.811 . . . . 71.439999999999998 108.81 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 37.7 m -117.38 121.41 41.01 Favored 'General case' 0 N--CA 1.408 -2.529 0 C-N-CA 119.196 -1.002 . . . . 72.420000000000002 108.778 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.54 140.01 35.41 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-O 122.265 1.031 . . . . 74.409999999999997 109.017 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 18.5 mt -136.19 124.95 37.54 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.117 0 CA-C-N 113.054 -1.885 . . . . 75.299999999999997 107.027 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.496 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . 10.3 t60 -120.25 131.87 55.11 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.919 -1.141 . . . . 74.109999999999999 107.919 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.6 m -142.88 132.48 23.77 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.696 -1.224 . . . . 23.109999999999999 107.696 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.87 127.09 9.11 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 120.497 -0.859 . . . . 64.439999999999998 111.201 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -128.25 124.59 37.03 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 122.557 1.17 . . . . 73.25 111.432 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.46 ' HZ1' ' CE1' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -177.18 -156.55 0.04 OUTLIER 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 100.611 -3.848 . . . . 74.420000000000002 100.611 -176.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 106' ' ' LYS . 1.5 mp0 -70.08 129.32 90.86 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 106.959 -1.497 . . . . 74.299999999999997 106.959 168.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.7 92.46 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.106 1.871 . . . . 75.349999999999994 110.853 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -95.84 175.65 6.42 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.12 -1.437 . . . . 73.010000000000005 107.12 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.44 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 60.7 mt-10 -86.19 -26.49 25.08 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 121.541 0.686 . . . . 74.409999999999997 109.437 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.3 t -119.95 162.24 18.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 106.904 -1.517 . . . . 75.319999999999993 106.904 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 115' ' ' ALA . 9.6 pt -62.15 -43.96 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.914 0.779 . . . . 74.340000000000003 110.166 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.62 -80.05 0.37 Allowed Glycine 0 N--CA 1.422 -2.283 0 C-N-CA 119.862 -1.161 . . . . 65.010000000000005 114.451 173.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.1 mptp? -104.2 -34.12 8.48 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.694 0.628 . . . . 61.140000000000001 112.694 -168.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.604 ' HB3' HD12 ' A' ' 112' ' ' ILE . . . -65.03 -34.17 77.8 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 120.664 0.268 . . . . 63.140000000000001 111.68 -176.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -167.55 122.59 1.03 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.498 -1.297 . . . . 70.219999999999999 107.498 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -86.3 89.14 7.77 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.101 0.477 . . . . 50.210000000000001 111.584 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 31.4 tptt 179.64 152.84 0.44 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.045 -1.835 . . . . 74.319999999999993 106.045 171.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.2 p -111.76 -50.7 2.9 Favored 'General case' 0 C--N 1.286 -2.18 0 C-N-CA 120.028 -0.669 . . . . 75.5 111.37 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.2 p -63.22 -46.32 87.52 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.657 0.783 . . . . 74.450000000000003 111.187 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.91 -47.03 83.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.209 -0.905 . . . . 74.450000000000003 110.72 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.6 t -59.28 -35.03 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 116.357 -0.383 . . . . 71.409999999999997 111.237 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -66.56 -50.63 62.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.469 -0.937 . . . . 64.219999999999999 108.469 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.87 -40.53 98.42 Favored Glycine 0 C--O 1.241 0.547 0 CA-C-N 116.061 -0.518 . . . . 73.209999999999994 112.564 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -64.45 -38.77 92.2 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 122.877 0.471 . . . . 72.340000000000003 111.184 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.0 mmt -69.87 -36.83 75.82 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 121.361 -0.136 . . . . 73.150000000000006 111.353 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.49 -56.22 24.71 Favored 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 123.201 0.313 . . . . 61.240000000000002 110.737 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.83 -37.68 88.62 Favored Glycine 0 C--O 1.245 0.828 0 C-N-CA 120.672 -0.775 . . . . 62.229999999999997 111.745 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.8 -63.13 5.36 Favored Glycine 0 N--CA 1.438 -1.175 0 CA-C-N 115.309 -0.445 . . . . 62.420000000000002 112.408 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.642 ' O ' HG22 ' A' ' 134' ' ' VAL . 90.9 m95 -56.07 -45.25 79.38 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 113.342 0.867 . . . . 73.420000000000002 113.342 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.4 m -54.66 -51.44 65.48 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.708 0.63 . . . . 64.129999999999995 110.743 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.96 -43.61 64.8 Favored Glycine 0 C--O 1.25 1.125 0 C-N-CA 120.525 -0.845 . . . . 63.439999999999998 112.425 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.57 -57.6 11.35 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.848 0 CA-C-O 119.161 -0.447 . . . . 73.409999999999997 111.705 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 130' ' ' TRP . 27.4 m -64.19 -35.58 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 C-N-CA 118.906 -1.118 . . . . 75.549999999999997 112.841 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 42.3 t30 -57.81 -70.4 0.14 Allowed 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.558 0.536 . . . . 74.049999999999997 112.0 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.23 -28.13 27.49 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 118.93 -1.108 . . . . 74.230000000000004 112.062 -172.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -73.61 -38.08 65.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 118.722 -1.191 . . . . 70.140000000000001 110.804 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.5 mm? -70.78 -42.95 69.7 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 118.345 -1.342 . . . . 63.149999999999999 109.338 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 135' ' ' ASN . 2.3 tmm_? -57.73 -40.98 80.9 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 115.788 -0.642 . . . . 72.439999999999998 110.552 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -73.14 -36.67 66.7 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 113.422 0.897 . . . . 75.349999999999994 113.422 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.79 58.48 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.093 0.473 . . . . 62.149999999999999 110.968 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.471 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 32.1 m -85.36 -30.24 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 119.9 -0.72 . . . . 72.510000000000005 111.571 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -92.69 -26.19 17.9 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.102 0.779 . . . . 63.32 113.102 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.5 ' HG2' ' H ' ' A' ' 145' ' ' LEU . 28.2 tt0 -150.76 -137.63 0.08 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 105.461 -2.051 . . . . 72.439999999999998 105.461 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.5 ' H ' ' HG2' ' A' ' 144' ' ' GLU . 1.9 pt? -142.33 -66.21 0.4 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.736 -0.468 . . . . 70.530000000000001 109.736 173.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -170.34 154.57 4.85 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 123.406 0.683 . . . . 65.519999999999996 109.599 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -159.27 -81.41 0.05 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.945 -1.131 . . . . 73.010000000000005 107.945 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -148.46 100.59 3.15 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.901 -0.777 . . . . 74.349999999999994 108.901 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -148.9 126.19 11.5 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 123.981 0.912 . . . . 74.530000000000001 108.66 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -84.69 125.72 32.76 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.767 -0.457 . . . . 75.310000000000002 109.767 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -119.55 154.62 33.59 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.242 -1.021 . . . . 74.409999999999997 108.242 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 . . . . . 0 C--N 1.3 -1.55 0 N-CA-C 109.086 -0.709 . . . . 75.120000000000005 109.086 179.664 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 CA--C 1.504 -0.818 0 N-CA-C 109.75 -0.463 . . . . 63.109999999999999 109.75 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.57 129.91 55.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.591 -0.277 . . . . 72.209999999999994 111.1 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.57 -28.29 22.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.478 -0.564 . . . . 60.240000000000002 109.478 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -89.55 -170.0 2.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.871 -1.159 . . . . 63.450000000000003 107.871 171.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -133.3 18.01 4.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 118.975 0.807 . . . . 74.140000000000001 111.999 -172.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -147.11 139.61 24.79 Favored 'General case' 0 N--CA 1.402 -2.847 0 CA-C-O 121.686 0.755 . . . . 75.510000000000005 110.651 -174.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -64.54 -44.82 89.6 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 113.919 -1.491 . . . . 75.129999999999995 109.716 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.16 118.62 23.71 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.142 -0.935 . . . . 64.310000000000002 108.578 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 tp -67.33 116.54 37.73 Favored Pre-proline 0 C--N 1.313 -0.981 0 O-C-N 123.767 0.667 . . . . 72.400000000000006 110.686 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -99.78 -157.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.251 0 C-N-CA 123.01 2.473 . . . . 64.120000000000005 108.959 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.623 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 5.1 p-10 -70.37 131.77 44.61 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.006 -0.678 . . . . 72.329999999999998 110.166 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.3 tt -132.41 138.95 51.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.933 -0.765 . . . . 72.5 108.933 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 m -111.77 134.83 53.08 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.797 -0.445 . . . . 75.430000000000007 109.797 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.505 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -136.9 124.1 21.77 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.082 -1.451 . . . . 64.299999999999997 107.082 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 m -117.84 134.02 55.35 Favored 'General case' 0 C--N 1.261 -3.266 0 N-CA-C 109.244 -0.651 . . . . 61.109999999999999 109.244 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.34 133.09 28.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 109.263 -0.643 . . . . 72.409999999999997 109.263 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -97.14 125.39 41.61 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 116.198 -0.455 . . . . 72.019999999999996 111.016 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.47 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.8 mp -101.06 139.58 36.55 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.096 -0.502 . . . . 74.230000000000004 110.077 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -80.06 29.94 0.27 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.987 0.915 . . . . 72.540000000000006 111.343 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.97 157.8 74.65 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.735 -0.839 . . . . 73.510000000000005 108.735 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.93 159.8 44.39 Favored 'Trans proline' 0 C--O 1.26 1.582 0 C-N-CA 123.087 2.525 . . . . 62.310000000000002 111.756 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -66.66 -24.9 33.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.85 -0.614 . . . . 62.219999999999999 111.535 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.532 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.0 pt20 -66.11 -40.81 91.02 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.313 -0.403 . . . . 75.219999999999999 111.392 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -74.66 -39.91 61.75 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.017 0.437 . . . . 64.040000000000006 111.011 -175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.641 HG11 HG21 ' A' ' 96' ' ' THR . 7.1 p -65.03 -38.37 82.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.319 -0.4 . . . . 75.209999999999994 110.079 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -58.68 -46.92 86.16 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.81 -0.632 . . . . 74.230000000000004 109.968 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 35.6 mt-10 -61.45 -38.29 86.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.923 0.392 . . . . 61.439999999999998 110.114 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.4 m -66.65 -11.72 55.1 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-N 115.987 -0.551 . . . . 74.340000000000003 111.757 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.62 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.8 m -128.82 9.21 2.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 121.178 -0.951 . . . . 54.109999999999999 112.529 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.3 t -124.96 -9.17 7.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.584 0.23 . . . . 43.039999999999999 111.529 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.9 p -94.46 154.21 17.55 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.851 -1.537 . . . . 55.420000000000002 106.851 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.0 m -57.2 -39.46 75.46 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 118.504 0.593 . . . . 75.140000000000001 111.645 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 2.2 mp0 -65.86 -43.67 87.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.99 -1.005 . . . . 72.310000000000002 109.783 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.641 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . -72.58 -40.64 53.37 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 115.055 -0.975 . . . . 34.130000000000003 112.886 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.35 -48.42 88.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 122.748 0.419 . . . . 45.25 110.015 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.64 -52.98 54.57 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.62 0.6 . . . . 51.229999999999997 112.62 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.641 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 28.3 mtmm 69.36 -47.74 0.59 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 123.904 0.882 . . . . 64.150000000000006 113.206 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -56.43 -49.83 73.41 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.325 2.25 . . . . 74.310000000000002 109.902 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.51 ' CE2' ' HD2' ' A' ' 41' ' ' PRO . 32.9 t80 -135.64 167.95 20.17 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 106.182 -1.784 . . . . 72.510000000000005 106.182 -177.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.576 ' HB3' ' HD3' ' A' ' 41' ' ' PRO 0.271 49.5 ttm -87.4 -72.34 0.07 OUTLIER Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 113.958 1.095 . . . . 74.109999999999999 113.958 -179.084 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 40' ' ' MET . 7.1 Cg_exo -73.44 114.74 4.12 Favored 'Trans proline' 0 C--N 1.378 2.126 0 CA-C-N 121.726 1.652 . . . . 53.439999999999998 111.629 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -140.14 162.67 34.68 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 112.525 0.565 . . . . 65.219999999999999 112.525 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -85.46 -2.11 57.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.243 -0.89 . . . . 72.239999999999995 111.087 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -76.87 118.83 19.85 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.829 -0.804 . . . . 70.439999999999998 108.829 -175.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.23 151.93 30.41 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.815 -0.629 . . . . 74.409999999999997 109.837 -173.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.762 HD11 HG11 ' A' ' 68' ' ' VAL . 3.0 tm? -81.65 104.88 12.37 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.961 -1.866 . . . . 65.299999999999997 105.961 175.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -134.83 137.69 43.53 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 106.168 -1.79 . . . . 62.219999999999999 106.168 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 6.5 pt-20 -91.75 70.25 5.68 Favored 'General case' 0 C--N 1.26 -3.312 0 CA-C-N 119.826 1.194 . . . . 74.209999999999994 109.821 174.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 131.19 96.42 0.71 Allowed Glycine 0 N--CA 1.401 -3.678 0 CA-C-N 113.784 -1.553 . . . . 32.350000000000001 110.91 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.44 150.83 50.62 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.91 -1.515 . . . . 72.409999999999997 106.91 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -131.73 150.19 52.23 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.686 0.616 . . . . 73.430000000000007 110.2 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -95.6 146.69 24.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.288 -1.375 . . . . 62.340000000000003 107.288 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -121.82 143.29 49.49 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.207 -1.035 . . . . 75.310000000000002 108.207 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.5 tp -78.46 42.15 0.42 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 122.239 1.019 . . . . 74.519999999999996 110.935 -174.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -85.37 -29.06 24.76 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 107.971 -1.122 . . . . 75.120000000000005 107.971 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.5 m 55.92 77.9 0.41 Allowed Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 114.399 -1.273 . . . . 70.230000000000004 112.213 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -74.92 167.91 26.01 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.049 2.5 . . . . 53.450000000000003 110.958 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -81.93 131.94 35.26 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 110.0 -0.371 . . . . 74.129999999999995 110.0 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.12 -125.49 7.2 Favored Glycine 0 N--CA 1.418 -2.509 0 N-CA-C 110.334 -1.106 . . . . 53.299999999999997 110.334 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -83.43 149.65 13.13 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 C-N-CA 121.975 1.783 . . . . 72.129999999999995 111.672 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 50.4 m -78.71 135.53 59.86 Favored Pre-proline 0 N--CA 1.422 -1.849 0 N-CA-C 108.01 -1.108 . . . . 73.310000000000002 108.01 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 32.3 Cg_exo -55.42 149.11 48.61 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 123.212 2.608 . . . . 35.130000000000003 113.593 -174.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 26.6 p -110.27 167.23 10.35 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 115.46 -0.791 . . . . 45.310000000000002 110.492 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -123.48 118.83 28.3 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 108.519 -0.919 . . . . 64.299999999999997 108.519 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 76' ' ' PHE . 28.5 t -85.51 127.05 40.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 106.472 -1.677 . . . . 72.049999999999997 106.472 174.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.7 tp -72.76 -53.39 11.74 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 124.209 0.943 . . . . 62.420000000000002 108.641 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.05 150.62 6.62 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.205 -0.907 . . . . 61.310000000000002 110.255 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.762 HG11 HD11 ' A' ' 46' ' ' LEU . 59.7 t -121.14 118.88 57.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 107.459 -1.311 . . . . 60.420000000000002 107.459 173.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 41.9 mt-30 -111.67 141.76 44.86 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 123.958 0.903 . . . . 75.239999999999995 110.149 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.18 134.25 94.76 Favored Pre-proline 0 C--N 1.287 -2.129 0 CA-C-N 114.128 -1.396 . . . . 51.140000000000001 110.184 -162.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo 0.53 48.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.175 1 C-N-CA 128.434 6.089 . . . . 73.140000000000001 117.557 -163.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 7.5 m -146.58 -45.24 0.19 Allowed 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.876 -0.602 . . . . 72.239999999999995 111.265 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 29.0 tt0 -141.38 128.55 20.92 Favored 'General case' 0 C--O 1.21 -0.978 0 C-N-CA 117.243 -1.783 . . . . 63.450000000000003 111.905 -169.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.709 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.9 tm? -133.52 132.26 40.75 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 109.318 -0.623 . . . . 73.540000000000006 109.318 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.3 m -138.12 126.21 22.83 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.728 -0.389 . . . . 60.329999999999998 110.724 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.482 ' HD2' HD11 ' A' ' 74' ' ' LEU . 39.5 p90 -146.67 154.84 41.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.399 0.142 . . . . 72.239999999999995 110.782 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -123.55 123.66 41.1 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.031 -1.1 . . . . 63.32 108.031 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -101.4 140.34 35.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.339 0.59 . . . . 55.409999999999997 112.282 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -93.2 -172.46 2.96 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 103.625 -2.731 . . . . 72.329999999999998 103.625 167.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.1 m 66.76 30.4 8.06 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 122.841 1.305 . . . . 54.229999999999997 107.497 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.49 ' OE1' ' HG3' ' A' ' 114' ' ' LYS . 7.8 mm-40 56.88 53.9 7.67 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.329 1.852 . . . . 72.340000000000003 114.266 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.44 -37.22 2.68 Favored Glycine 0 C--N 1.312 -0.785 0 N-CA-C 109.821 -1.312 . . . . 73.530000000000001 109.821 174.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.742 ' HZ2' ' HB2' ' A' ' 115' ' ' ALA . 2.8 m0 70.65 -164.85 0.15 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.706 1.603 . . . . 74.549999999999997 111.973 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -91.38 118.86 37.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.653 -0.499 . . . . 73.510000000000005 109.653 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.7 144.63 33.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.399 -0.593 . . . . 52.149999999999999 109.399 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.457 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 38.9 m -130.68 139.42 50.32 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 115.909 -0.587 . . . . 75.109999999999999 109.925 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.709 ' CD2' HD12 ' A' ' 74' ' ' LEU . 10.0 m-85 -117.73 140.17 50.04 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.915 -1.143 . . . . 70.219999999999999 107.915 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.62 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 82.8 mt-30 -130.07 140.21 50.86 Favored 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 115.689 -0.687 . . . . 71.340000000000003 110.083 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 72' ' ' THR . 75.8 mt -118.71 124.42 47.29 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.049 0.452 . . . . 75.420000000000002 110.038 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -109.55 116.55 31.99 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.784 -0.821 . . . . 72.150000000000006 108.784 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.61 111.21 15.66 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.722 -0.672 . . . . 74.129999999999995 110.738 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 81.1 mt -109.84 153.8 23.91 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.912 -1.144 . . . . 74.340000000000003 107.912 176.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.48 39.63 3.01 Favored Glycine 0 C--N 1.29 -2.002 0 C-N-CA 121.145 -0.55 . . . . 33.520000000000003 111.917 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -156.74 -42.82 0.07 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 124.405 1.082 . . . . 54.409999999999997 109.305 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.0 ptpt -155.92 177.06 11.84 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.852 -1.166 . . . . 73.209999999999994 107.852 -168.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.641 HG21 HG11 ' A' ' 25' ' ' VAL . 38.9 m -113.32 125.72 54.59 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.854 -0.795 . . . . 72.510000000000005 108.854 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.06 109.69 3.67 Favored Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 110.526 -1.03 . . . . 53.509999999999998 110.526 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -98.05 132.43 43.61 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.409 -0.96 . . . . 73.150000000000006 108.409 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 28.0 m -122.23 122.94 40.31 Favored 'General case' 0 N--CA 1.406 -2.652 0 C-N-CA 119.496 -0.882 . . . . 72.430000000000007 109.038 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.468 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -103.13 140.19 37.66 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-O 122.023 0.916 . . . . 61.32 108.678 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.8 mp -135.64 124.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.453 0 N-CA-C 105.981 -1.859 . . . . 73.540000000000006 105.981 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 24.1 t60 -114.59 131.84 56.55 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.326 -1.361 . . . . 73.120000000000005 107.326 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.7 t -137.74 150.17 47.05 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.861 -1.163 . . . . 73.409999999999997 107.861 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -104.17 158.13 16.86 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 110.525 -1.03 . . . . 70.319999999999993 110.525 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -129.53 92.86 3.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 117.612 0.706 . . . . 72.340000000000003 112.214 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -179.27 -75.33 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.194 -1.409 . . . . 64.239999999999995 107.194 171.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 176.03 141.88 0.22 Allowed Pre-proline 0 C--O 1.242 0.667 0 C-N-CA 125.165 1.386 . . . . 64.439999999999998 107.92 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -73.79 120.18 6.27 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.46 1.44 . . . . 54.210000000000001 109.841 174.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 111' ' ' VAL . 2.3 m-20 -99.81 -160.55 0.81 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.685 -1.598 . . . . 71.239999999999995 106.685 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.98 -10.42 59.35 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 122.396 1.093 . . . . 72.120000000000005 109.115 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 109' ' ' ASN . 14.8 p -142.5 176.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 N-CA-C 104.674 -2.343 . . . . 44.5 104.674 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.561 HD12 ' HB3' ' A' ' 115' ' ' ALA . 8.8 pt -57.53 -39.82 71.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 118.504 0.593 . . . . 70.239999999999995 111.896 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.99 -64.83 3.03 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.751 -0.261 . . . . 63.310000000000002 112.952 175.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.49 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 0.5 OUTLIER -50.82 -48.05 59.91 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 125.243 1.417 . . . . 74.219999999999999 111.884 -177.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.742 ' HB2' ' HZ2' ' A' ' 83' ' ' TRP . . . -71.57 -23.68 61.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 114.604 1.335 . . . . 72.010000000000005 114.604 -173.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 60.98 33.36 19.79 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.012 0.91 . . . . 63.520000000000003 109.208 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -109.29 -164.47 0.94 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.096 -0.956 . . . . 74.129999999999995 112.182 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.402 ' HB2' HG23 ' A' ' 122' ' ' VAL . 26.7 mmtp -76.45 -170.15 1.42 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.255 -0.884 . . . . 74.049999999999997 108.881 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.461 ' HB3' HG23 ' A' ' 111' ' ' VAL . 14.2 p -126.72 -68.22 0.82 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.251 -0.98 . . . . 72.540000000000006 112.754 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.5 t -62.34 -44.5 96.34 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 123.158 0.286 . . . . 63.130000000000003 110.561 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p -70.61 -34.07 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 119.36 -0.936 . . . . 71.430000000000007 110.313 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 112' ' ' ILE . 73.5 t -68.14 -42.81 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.648 -0.251 . . . . 72.329999999999998 110.987 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.8 ttp85 -59.24 -50.76 72.78 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.896 -0.779 . . . . 63.219999999999999 108.896 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.53 -41.76 99.63 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-N 115.736 -0.665 . . . . 43.009999999999998 113.061 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.401 ' O ' ' HA3' ' A' ' 129' ' ' GLY . 2.3 tmmm? -68.79 -32.15 71.68 Favored 'General case' 0 C--O 1.198 -1.61 0 N-CA-C 112.196 0.443 . . . . 74.140000000000001 112.196 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.462 ' HA ' ' CE ' ' A' ' 126' ' ' MET . 2.6 mmt -78.31 -42.37 30.93 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.234 -0.586 . . . . 73.349999999999994 110.604 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -56.93 -63.55 1.17 Allowed 'General case' 0 C--O 1.251 1.149 0 C-N-CA 124.232 1.013 . . . . 73.299999999999997 109.348 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.31 -34.24 64.15 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.262 -0.881 . . . . 45.240000000000002 111.722 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -61.4 -59.37 10.01 Favored Glycine 0 C--O 1.209 -1.419 0 CA-C-O 119.256 -0.746 . . . . 62.240000000000002 112.333 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.417 ' HE3' HG23 ' A' ' 134' ' ' VAL . 61.1 m95 -59.49 -38.66 81.45 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 117.931 0.866 . . . . 74.439999999999998 112.646 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.2 m -60.5 -52.91 63.17 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 120.504 -0.479 . . . . 71.209999999999994 110.796 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.49 -49.56 18.95 Favored Glycine 0 C--O 1.242 0.595 0 C-N-CA 121.162 -0.542 . . . . 74.129999999999995 113.562 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 77.3 mt -61.1 -49.64 83.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 C-N-CA 122.699 0.399 . . . . 74.25 111.154 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.523 ' HA ' HD23 ' A' ' 138' ' ' LEU . 97.3 t -63.48 -49.78 81.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.223 -0.991 . . . . 62.420000000000002 111.441 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -55.28 -63.89 1.02 Allowed 'General case' 0 C--O 1.246 0.905 0 O-C-N 123.785 0.678 . . . . 54.210000000000001 111.864 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 7.0 tp10 -81.98 -40.83 21.62 Favored 'General case' 0 C--O 1.174 -2.896 0 C-N-CA 118.424 -1.31 . . . . 61.219999999999999 113.211 -173.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.523 ' NH2' ' HA ' ' A' ' 37' ' ' LYS . 2.1 tmt_? -64.19 -37.04 86.04 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.976 1.262 . . . . 71.329999999999998 110.028 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.3 mm? -69.93 -50.16 44.82 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 119.125 -1.03 . . . . 60.310000000000002 110.206 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 139' ' ' ARG . 1.9 tmm_? -61.62 -36.52 80.98 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 121.359 0.6 . . . . 73.129999999999995 111.246 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -70.86 -47.76 57.58 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 123.746 0.818 . . . . 74.439999999999998 108.891 -177.664 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.01 75.01 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 111.608 0.225 . . . . 61.240000000000002 111.608 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.56 -32.17 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 119.718 -0.793 . . . . 55.240000000000002 110.923 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.49 -48.41 22.73 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 120.173 -0.611 . . . . 64.109999999999999 111.519 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.464 ' HG3' ' HE2' ' A' ' 140' ' ' LYS . 8.0 pt-20 -171.71 105.38 0.2 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.769 0.828 . . . . 75.299999999999997 110.611 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 57.7 tp -70.36 97.01 1.2 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.561 0.696 . . . . 64.230000000000004 110.463 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -97.06 -44.49 6.96 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.428 -0.806 . . . . 74.540000000000006 111.969 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -144.82 173.99 11.38 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.671 0.272 . . . . 73.310000000000002 110.441 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.94 174.34 7.21 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.788 -0.819 . . . . 73.340000000000003 108.788 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -156.11 132.01 9.81 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.207 -0.597 . . . . 72.129999999999995 110.294 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -145.33 164.32 31.82 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.988 -1.116 . . . . 72.239999999999995 107.988 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -125.43 141.63 51.95 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.162 -0.681 . . . . 73.0 109.162 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 60.4 m80 . . . . . 0 C--N 1.303 -1.442 0 N-CA-C 109.428 -0.582 . . . . 72.150000000000006 109.428 -177.353 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.51 -0.594 0 N-CA-C 108.613 -0.884 . . . . 64.140000000000001 108.613 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 68.52 -39.18 0.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.993 1.849 . . . . 51.130000000000003 115.993 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -61.42 -31.08 71.0 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 123.262 0.625 . . . . 74.409999999999997 112.274 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.628 ' ND2' ' HB2' ' A' ' 127' ' ' ASP . 28.6 p-10 -86.46 35.9 0.68 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.704 0.764 . . . . 72.019999999999996 110.451 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -75.4 1.45 13.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.083 0.953 . . . . 64.239999999999995 112.922 -175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.24 -1.52 30.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.755 0.65 . . . . 72.150000000000006 112.755 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.411 HD21 HG22 ' A' ' 111' ' ' VAL . 10.5 t30 76.7 -27.64 0.18 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.138 1.375 . . . . 65.439999999999998 113.224 170.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -97.88 -163.26 1.03 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.638 -1.616 . . . . 62.109999999999999 106.638 172.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.8 tp -108.45 99.7 34.18 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 120.116 -0.634 . . . . 43.149999999999999 110.438 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 43.1 Cg_endo -95.97 -159.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.136 2.557 . . . . 74.329999999999998 110.047 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 1.6 m-20 -76.4 109.57 10.22 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.65 -0.5 . . . . 70.409999999999997 109.65 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.6 HG22 ' HB3' ' A' ' 102' ' ' HIS . 10.9 tp -102.31 128.37 55.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.268 -1.382 . . . . 74.120000000000005 107.268 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.1 m -111.04 129.11 56.01 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 109.083 -0.71 . . . . 72.230000000000004 109.083 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 25.2 mmmt -131.31 132.1 44.28 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.716 -0.674 . . . . 73.040000000000006 110.646 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 m -118.43 132.81 56.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.887 -1.153 . . . . 73.219999999999999 107.887 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.66 140.7 20.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.922 -0.77 . . . . 54.329999999999998 108.922 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 p -103.02 132.45 49.27 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.612 0.72 . . . . 75.409999999999997 112.905 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 139' ' ' ARG . 2.2 mm? -108.79 140.48 42.16 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.302 -0.863 . . . . 64.430000000000007 110.897 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -80.57 25.46 0.42 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.603 1.161 . . . . 71.019999999999996 111.314 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -131.76 165.34 36.42 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 108.678 -0.86 . . . . 73.239999999999995 108.678 -174.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 46.2 Cg_endo -72.09 161.3 45.1 Favored 'Trans proline' 0 C--O 1.257 1.456 0 C-N-CA 121.907 1.738 . . . . 75.099999999999994 111.06 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.0 tt -58.21 -31.11 41.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 115.906 -0.588 . . . . 73.340000000000003 110.795 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -56.4 -50.59 71.17 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.937 0.895 . . . . 74.310000000000002 111.729 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -73.64 -36.55 65.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.116 -0.493 . . . . 74.129999999999995 110.618 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.44 HG21 ' HB ' ' A' ' 96' ' ' THR . 46.1 t -67.69 -41.13 85.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.761 -0.459 . . . . 73.329999999999998 109.761 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 46.3 t90 -61.29 -46.98 88.09 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.962 -1.017 . . . . 74.310000000000002 110.226 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -23.63 63.73 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.312 -0.555 . . . . 72.109999999999999 111.68 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.8 m -67.49 -18.1 64.93 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 121.431 0.634 . . . . 73.340000000000003 111.337 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.576 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 9.9 m -123.05 17.5 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 O-C-N 121.463 -0.773 . . . . 65.010000000000005 110.837 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.5 m -142.12 9.08 1.88 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.15 0.796 . . . . 70.450000000000003 113.15 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.4 p -114.07 168.56 9.71 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 121.635 -0.666 . . . . 61.409999999999997 109.771 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.655 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 15.9 m -58.38 -40.55 82.61 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 123.85 0.719 . . . . 74.519999999999996 109.507 175.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -68.85 -46.88 67.36 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.692 -1.14 . . . . 75.540000000000006 110.955 -177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.5 -47.99 25.56 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.84 -0.695 . . . . 73.310000000000002 113.62 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.04 -34.29 62.55 Favored 'Isoleucine or valine' 0 C--O 1.256 1.401 0 CA-C-O 121.182 0.515 . . . . 71.129999999999995 110.722 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.61 -30.56 43.26 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.702 -0.681 . . . . 74.430000000000007 112.062 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm 74.7 -57.74 0.6 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.912 1.285 . . . . 73.209999999999994 111.499 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -92.55 155.02 18.07 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 104.875 -2.269 . . . . 74.540000000000006 104.875 171.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -75.2 87.22 2.45 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.842 0.83 . . . . 71.430000000000007 110.042 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 59.4 mtm -131.3 118.18 17.08 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.594 -1.262 . . . . 72.209999999999994 107.594 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.71 96.71 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.43 2.087 . . . . 75.010000000000005 112.145 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.655 ' O ' ' HB3' ' A' ' 32' ' ' SER . 43.1 t-20 -134.34 143.2 47.54 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.935 -1.876 . . . . 63.219999999999999 105.935 176.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -90.81 69.61 6.51 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 113.288 0.848 . . . . 71.019999999999996 113.288 -170.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.484 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 94.0 m-85 -77.39 130.36 36.98 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.584 -1.265 . . . . 74.430000000000007 107.584 171.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -109.44 145.04 36.83 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.448 -0.945 . . . . 74.109999999999999 108.448 -174.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.0 tp -89.2 103.32 15.95 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 106.301 -1.74 . . . . 74.510000000000005 106.301 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 82.3 tttt -133.43 132.24 40.89 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.812 -1.551 . . . . 74.400000000000006 106.812 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.442 ' HA ' HG23 ' A' ' 68' ' ' VAL . 10.4 pt-20 -91.11 76.36 6.13 Favored 'General case' 0 C--N 1.258 -3.376 0 CA-C-O 122.922 1.344 . . . . 72.510000000000005 108.842 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.33 57.48 0.11 Allowed Glycine 0 N--CA 1.405 -3.415 0 CA-C-N 112.47 -2.15 . . . . 70.209999999999994 110.244 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 14.8 tt0 -91.43 142.64 27.45 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 109.403 -0.591 . . . . 73.129999999999995 109.403 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.75 147.88 43.4 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.466 -0.939 . . . . 74.349999999999994 108.466 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -129.82 147.04 51.55 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.145 -0.622 . . . . 71.540000000000006 109.943 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -133.51 140.0 46.97 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.628 -1.619 . . . . 63.520000000000003 106.628 175.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.44 75.64 10.23 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.513 -1.292 . . . . 74.420000000000002 107.513 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -89.94 -46.65 8.39 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.675 -1.148 . . . . 75.200000000000003 109.999 -174.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.2 t -114.94 -62.53 0.03 OUTLIER Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-O 119.1 -0.476 . . . . 72.519999999999996 109.866 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.43 123.75 9.79 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 121.263 1.309 . . . . 71.299999999999997 110.374 173.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -104.68 -25.1 12.84 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.601 0.715 . . . . 73.25 109.232 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.52 -68.24 1.43 Allowed Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.241 -0.89 . . . . 74.25 112.538 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.81 104.62 0.48 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.562 2.175 . . . . 61.329999999999998 111.416 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.5 p -85.64 113.72 52.66 Favored Pre-proline 0 N--CA 1.425 -1.678 0 CA-C-N 115.493 -0.776 . . . . 65.049999999999997 110.862 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.77 -179.97 4.7 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.343 2.029 . . . . 74.319999999999993 111.115 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 12.1 p -110.53 169.9 8.44 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.183 0.516 . . . . 64.209999999999994 111.526 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 28.9 ttpp -121.52 118.01 28.22 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 105.359 -2.089 . . . . 53.509999999999998 105.359 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 50' ' ' GLN . 21.7 t -85.67 135.22 25.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 120.155 -0.618 . . . . 73.420000000000002 109.529 -174.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.3 tp -83.17 -56.14 3.95 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.043 -0.725 . . . . 72.109999999999999 109.043 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.5 149.32 16.89 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.228 -0.896 . . . . 52.130000000000003 109.997 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' ' 48' ' ' GLU . 21.9 t -126.54 119.31 53.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.524 -1.287 . . . . 74.010000000000005 107.524 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 13.1 mm-40 -103.63 141.79 35.43 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 121.24 0.543 . . . . 72.140000000000001 110.442 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.17 130.65 93.65 Favored Pre-proline 0 C--N 1.271 -2.824 0 CA-C-N 114.031 -1.44 . . . . 73.040000000000006 109.062 -167.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo 2.6 48.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.371 1 C-N-CA 128.189 5.926 . . . . 71.329999999999998 117.66 -162.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 6.9 m -142.72 -36.87 0.38 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.941 -0.572 . . . . 74.530000000000001 110.564 175.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.5 tt0 -147.77 144.61 28.36 Favored 'General case' 0 C--O 1.201 -1.451 0 C-N-CA 118.035 -1.466 . . . . 72.230000000000004 111.847 -174.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.659 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -139.0 134.46 33.09 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.015 -1.106 . . . . 65.319999999999993 108.015 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 p -141.69 126.53 18.15 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.656 -0.418 . . . . 45.219999999999999 112.115 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.55 ' HD2' HD11 ' A' ' 74' ' ' LEU . 31.1 p90 -145.23 155.77 43.44 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 110.234 -0.284 . . . . 75.109999999999999 110.234 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -122.19 134.01 54.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.722 -1.214 . . . . 72.129999999999995 107.722 -173.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -113.78 125.05 53.67 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.971 -1.122 . . . . 74.409999999999997 107.971 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.26 -28.81 69.97 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.125 1.157 . . . . 63.340000000000003 114.125 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.7 m -66.67 94.81 0.31 Allowed 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.955 0.883 . . . . 71.150000000000006 109.722 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.265 63.2 mm-40 77.56 4.71 3.05 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 127.865 2.466 . . . . 75.409999999999997 114.16 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.32 58.78 6.27 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.599 -0.728 . . . . 61.229999999999997 112.778 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -98.32 133.07 43.23 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.702 -0.399 . . . . 74.230000000000004 109.965 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.46 120.41 63.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.063 -1.088 . . . . 72.329999999999998 108.063 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.63 150.55 18.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.322 0.582 . . . . 62.109999999999999 110.918 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.521 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 88.3 m -137.87 137.68 38.34 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.577 -0.898 . . . . 74.099999999999994 108.577 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.659 ' CD2' HD12 ' A' ' 74' ' ' LEU . 26.3 m-85 -122.27 147.05 46.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.007 -1.109 . . . . 75.0 108.007 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 72' ' ' THR . 24.3 mt-30 -131.49 141.3 49.73 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 123.482 0.489 . . . . 61.420000000000002 111.127 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -112.93 124.1 51.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.1 0.476 . . . . 72.5 111.226 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.71 123.99 51.09 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 125.143 1.377 . . . . 65.150000000000006 109.475 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -84.8 123.14 30.1 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.132 -0.486 . . . . 72.129999999999995 110.832 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.7 mt -124.9 157.84 34.98 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.053 -1.091 . . . . 55.43 108.053 174.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 94' ' ' GLU . . . -82.31 50.22 4.28 Favored Glycine 0 C--N 1.3 -1.423 0 N-CA-C 115.269 0.868 . . . . 72.319999999999993 115.269 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 93' ' ' GLY . 6.1 tp10 167.65 -39.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.256 1.022 . . . . 54.520000000000003 108.983 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -126.16 175.69 7.59 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.039 -1.097 . . . . 62.5 108.039 -173.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.44 ' HB ' HG21 ' A' ' 25' ' ' VAL . 60.9 m -122.2 134.71 54.71 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.616 -0.513 . . . . 70.219999999999999 109.616 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -93.84 114.56 4.77 Favored Glycine 0 N--CA 1.416 -2.654 0 N-CA-C 109.106 -1.598 . . . . 73.430000000000007 109.106 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -101.96 134.65 44.83 Favored 'General case' 0 C--N 1.268 -2.977 0 N-CA-C 108.948 -0.76 . . . . 63.439999999999998 108.948 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 35.8 m -120.2 126.82 51.6 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 108.28 -1.007 . . . . 62.43 108.28 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -104.4 137.21 42.61 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 106.885 -1.524 . . . . 71.109999999999999 106.885 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.521 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.4 mp -135.23 123.67 39.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.747 0 N-CA-C 106.134 -1.802 . . . . 71.409999999999997 106.134 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.6 ' HB3' HG22 ' A' ' 12' ' ' ILE . 3.4 t-160 -121.27 132.33 54.74 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.533 -1.284 . . . . 65.219999999999999 107.533 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.2 t -136.19 154.57 50.91 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.461 -0.94 . . . . 65.109999999999999 108.461 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.81 170.58 53.24 Favored Glycine 0 C--O 1.262 1.867 0 N-CA-C 109.253 -1.539 . . . . 32.130000000000003 109.253 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 34.8 t-105 -52.75 -60.23 3.52 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 123.07 0.548 . . . . 73.439999999999998 110.202 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp 170.14 110.86 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 123.977 0.911 . . . . 65.319999999999993 109.295 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 176.03 124.1 0.15 Allowed Pre-proline 0 C--N 1.329 -0.321 0 O-C-N 124.527 1.142 . . . . 75.409999999999997 108.823 171.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -92.78 41.06 0.26 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.022 2.481 . . . . 53.420000000000002 111.303 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -86.66 -172.15 3.88 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.292 -0.413 . . . . 64.140000000000001 111.364 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -91.69 -38.82 12.19 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.134 1.161 . . . . 63.039999999999999 114.134 -172.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 119' ' ' SER . 22.1 t -129.68 155.6 41.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.547 -1.279 . . . . 75.420000000000002 107.547 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.549 HD13 HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -59.85 -32.98 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 120.892 0.377 . . . . 74.319999999999993 111.164 178.148 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.51 -89.47 0.93 Allowed Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.905 -0.589 . . . . 61.130000000000003 114.259 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -57.53 -23.88 52.85 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 125.122 1.369 . . . . 65.129999999999995 114.68 -172.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.14 -13.98 62.73 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.906 0.384 . . . . 71.030000000000001 111.797 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.7 m120 76.06 -19.83 0.39 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.099 1.36 . . . . 70.439999999999998 114.201 175.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.47 154.94 36.71 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.865 -0.42 . . . . 52.340000000000003 109.865 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HB2' HG12 ' A' ' 121' ' ' VAL . 99.3 mttt -67.99 149.06 50.19 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.145 0.498 . . . . 63.229999999999997 111.2 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.639 ' HB3' HG13 ' A' ' 111' ' ' VAL . 3.0 p -58.29 -44.55 88.55 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 124.293 1.037 . . . . 74.349999999999994 111.814 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.4 p -65.2 -45.99 82.54 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.343 -0.844 . . . . 71.530000000000001 111.497 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 118' ' ' LYS . 7.2 p -69.84 -37.72 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 120.132 -0.627 . . . . 74.319999999999993 109.616 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.593 ' O ' ' HG3' ' A' ' 126' ' ' MET . 54.3 t -61.53 -45.88 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 120.818 -0.353 . . . . 71.239999999999995 111.134 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -55.44 -49.54 72.16 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.471 0.482 . . . . 72.019999999999996 111.138 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.22 -42.42 90.97 Favored Glycine 0 CA--C 1.5 -0.858 0 CA-C-N 115.891 -0.595 . . . . 62.439999999999998 112.781 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -68.63 -44.1 74.91 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 113.095 0.776 . . . . 72.349999999999994 113.095 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.593 ' HG3' ' O ' ' A' ' 122' ' ' VAL 0.382 0.0 OUTLIER -77.1 -29.28 54.8 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 118.196 -1.402 . . . . 74.0 113.778 -177.774 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.628 ' HB2' ' ND2' ' A' ' 4' ' ' ASN . 27.0 t70 -71.66 -55.81 7.01 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.867 -0.733 . . . . 75.519999999999996 109.119 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.37 -38.01 95.73 Favored Glycine 0 CA--C 1.5 -0.869 0 CA-C-N 115.526 -0.761 . . . . 73.310000000000002 112.254 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.82 -58.14 11.99 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 111.713 -0.555 . . . . 34.32 111.713 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.529 ' O ' ' HB ' ' A' ' 134' ' ' VAL . 94.3 m95 -64.42 -36.78 85.26 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.073 1.138 . . . . 74.219999999999999 114.073 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.0 p -67.64 -53.87 24.36 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.148 -0.621 . . . . 60.340000000000003 110.976 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.1 -48.58 38.74 Favored Glycine 0 C--O 1.246 0.9 0 C-N-CA 121.492 -0.385 . . . . 74.129999999999995 113.428 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.414 HG12 ' NE2' ' A' ' 149' ' ' HIS . 77.0 mt -64.01 -54.0 36.94 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.281 0 CA-C-O 119.185 -0.436 . . . . 73.120000000000005 110.666 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 130' ' ' TRP . 6.2 t -58.83 -40.71 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 113.608 0.966 . . . . 75.310000000000002 113.608 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -53.76 -59.54 4.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.244 0.545 . . . . 74.140000000000001 111.043 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.24 -42.14 26.61 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 113.258 0.836 . . . . 64.299999999999997 113.258 -174.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 148' ' ' HIS . 1.9 tmt_? -65.24 -41.48 94.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.225 0.466 . . . . 74.230000000000004 109.767 -174.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.2 mm? -66.65 -51.45 56.05 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.646 -0.422 . . . . 74.140000000000001 109.922 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.432 ' HA ' HD12 ' A' ' 18' ' ' LEU . 4.6 tmm_? -64.28 -31.78 73.11 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.951 0.405 . . . . 75.239999999999995 110.99 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.41 ' HE3' ' HG3' ' A' ' 144' ' ' GLU . 11.4 mmmm -79.08 -44.72 21.53 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 113.489 0.922 . . . . 75.310000000000002 113.489 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.62 -23.89 67.41 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.624 -0.431 . . . . 61.439999999999998 111.096 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.444 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 24.0 m -85.35 -33.9 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 120.512 -0.475 . . . . 44.450000000000003 111.336 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -85.73 -70.47 0.59 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.937 0.717 . . . . 55.119999999999997 112.937 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.41 ' HG3' ' HE3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -137.92 141.73 40.6 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.389 0.614 . . . . 73.109999999999999 111.801 -178.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.668 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -93.13 17.07 11.53 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.392 1.256 . . . . 74.439999999999998 114.392 -171.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -77.61 -56.52 4.45 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.467 -0.938 . . . . 62.420000000000002 108.467 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -128.04 108.37 10.6 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.154 -0.618 . . . . 72.030000000000001 109.749 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 137' ' ' ARG . 55.3 p-80 -82.32 -10.22 59.17 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.894 -0.594 . . . . 72.209999999999994 110.907 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 151' ' ' HIS . 13.7 t-80 -157.21 126.59 6.02 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.2 -1.778 . . . . 71.329999999999998 106.2 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -83.0 -25.03 32.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.061 0.458 . . . . 65.150000000000006 110.523 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.558 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 54.6 t-80 -77.82 111.88 14.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.654 -0.703 . . . . 64.310000000000002 109.572 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.3 p80 . . . . . 0 C--N 1.283 -2.304 0 CA-C-N 114.385 -1.279 . . . . 72.299999999999997 110.161 177.866 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 CA--C 1.51 -0.592 0 N-CA-C 110.033 -0.358 . . . . 71.200000000000003 110.033 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.66 122.39 9.26 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.786 -0.45 . . . . 74.129999999999995 109.786 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -75.35 -40.04 58.66 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.747 -1.575 . . . . 71.319999999999993 106.747 173.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -137.61 133.09 33.98 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 106.333 -1.729 . . . . 74.219999999999999 106.333 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -91.93 60.49 3.87 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.501 -0.926 . . . . 70.430000000000007 108.501 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' HB2' HD23 ' A' ' 9' ' ' LEU 0.327 0.6 OUTLIER 36.27 60.32 0.88 Allowed 'General case' 0 C--N 1.345 0.398 0 C-N-CA 125.987 1.715 . . . . 74.019999999999996 115.548 178.854 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -80.63 -43.74 19.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.154 -0.475 . . . . 74.340000000000003 111.209 -177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 106' ' ' LYS . . . -117.09 19.98 13.98 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.879 -0.786 . . . . 62.310000000000002 108.879 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 6' ' ' GLU . 75.4 mt 54.16 78.38 0.39 Allowed Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 113.815 -1.539 . . . . 53.43 113.37 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.85 -159.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 122.635 2.223 . . . . 64.319999999999993 108.865 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 44.3 m-20 -64.49 104.33 0.78 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.242 0.46 . . . . 73.030000000000001 112.242 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 77.3 mt -93.38 126.5 45.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.46 -1.681 . . . . 71.140000000000001 106.46 174.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.2 m -111.45 127.94 55.84 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.045 -0.662 . . . . 55.439999999999998 109.713 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 29.7 mmmt -131.89 126.12 33.39 Favored 'General case' 0 C--O 1.197 -1.658 0 N-CA-C 108.955 -0.757 . . . . 64.349999999999994 108.955 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.3 m -118.1 142.66 47.18 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 119.624 -0.83 . . . . 65.209999999999994 109.825 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -150.86 141.73 16.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.42 -0.956 . . . . 65.340000000000003 108.42 -178.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.47 HG22 ' HG3' ' A' ' 95' ' ' LYS . 0.8 OUTLIER -106.61 127.08 53.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.324 -0.621 . . . . 72.120000000000005 109.324 -178.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.7 mp -106.39 140.08 39.87 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 122.998 0.519 . . . . 72.420000000000002 109.717 -175.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -75.05 -2.02 25.48 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 124.091 0.956 . . . . 74.510000000000005 112.074 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.412 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -99.07 159.78 29.33 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 116.328 -0.396 . . . . 72.340000000000003 111.825 -172.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.49 153.61 73.73 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.305 2.67 . . . . 62.109999999999999 111.778 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.7 tt -48.86 -40.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.103 0.961 . . . . 62.219999999999999 112.628 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -70.98 -29.65 65.69 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.231 -0.588 . . . . 71.430000000000007 111.954 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -73.88 -36.82 64.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.629 0.728 . . . . 73.030000000000001 109.109 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' HG22 ' A' ' 29' ' ' VAL . 58.3 t -69.72 -41.24 79.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.534 -0.913 . . . . 64.25 108.534 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -58.77 -47.95 82.93 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.293 -0.867 . . . . 75.319999999999993 111.61 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -64.65 -35.24 80.4 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.302 -0.959 . . . . 72.510000000000005 110.776 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.2 m -63.75 -23.91 67.56 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 112.177 0.436 . . . . 62.32 112.177 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 16.0 m -121.72 15.2 5.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 112.789 0.662 . . . . 61.32 112.789 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.5 t -142.76 9.72 1.77 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 119.481 -0.888 . . . . 61.130000000000003 112.66 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.7 p -122.22 171.78 8.77 Favored 'General case' 0 C--O 1.247 0.972 0 O-C-N 121.455 -0.778 . . . . 74.409999999999997 110.557 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 m -63.72 -48.86 75.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.548 -0.538 . . . . 74.209999999999994 109.548 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.29 -41.86 96.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.846 -0.615 . . . . 73.510000000000005 111.691 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.32 -49.45 20.34 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 120.078 -1.058 . . . . 40.030000000000001 114.073 -176.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.9 mt -72.14 -50.68 35.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 118.344 1.072 . . . . 64.319999999999993 112.499 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.8 -48.32 69.33 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.205 0.526 . . . . 72.510000000000005 111.301 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.601 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 0.5 OUTLIER 62.71 7.04 2.31 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.931 1.292 . . . . 61.219999999999999 112.262 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.5 m95 73.53 23.73 2.39 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.649 1.18 . . . . 75.239999999999995 113.22 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -68.13 -52.13 38.29 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 104.614 -2.365 . . . . 75.030000000000001 104.614 168.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.4 mmt -132.85 131.08 21.82 Favored Pre-proline 0 N--CA 1.426 -1.641 0 N-CA-C 105.422 -2.066 . . . . 75.150000000000006 105.422 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.79 105.47 1.32 Allowed 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 121.395 1.397 . . . . 72.340000000000003 109.877 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -121.22 149.61 42.59 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.156 -1.424 . . . . 70.310000000000002 107.156 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -105.83 79.3 1.41 Allowed 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.941 0.877 . . . . 75.450000000000003 110.525 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -90.53 119.81 31.1 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.556 -1.202 . . . . 75.5 110.546 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -119.56 153.36 35.53 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.304 -1.739 . . . . 72.239999999999995 106.304 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -74.78 104.31 5.37 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.594 -1.262 . . . . 75.329999999999998 107.594 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 50' ' ' GLN . 47.4 tttp -132.97 144.54 50.18 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.711 -1.588 . . . . 64.230000000000004 106.711 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -91.76 69.79 5.63 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-O 122.097 0.951 . . . . 72.049999999999997 108.449 174.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.95 61.1 0.19 Allowed Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 110.119 -1.193 . . . . 71.019999999999996 110.119 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.651 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -95.55 112.72 24.39 Favored 'General case' 0 CA--C 1.473 -2.016 0 N-CA-C 106.489 -1.671 . . . . 64.239999999999995 106.489 -179.187 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.56 134.46 55.03 Favored 'General case' 0 C--N 1.276 -2.621 0 C-N-CA 119.283 -0.967 . . . . 64.430000000000007 109.425 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -110.57 117.87 34.68 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 103.411 -2.811 . . . . 62.329999999999998 103.411 173.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -109.47 162.61 14.21 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.891 0.377 . . . . 74.239999999999995 111.239 -169.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.63 148.76 44.47 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.106 -0.952 . . . . 74.25 109.438 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -85.99 147.51 26.18 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.126 -1.064 . . . . 71.140000000000001 108.126 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.1 m 71.27 103.03 0.03 OUTLIER Pre-proline 0 C--O 1.214 -0.771 0 O-C-N 124.72 1.262 . . . . 74.030000000000001 109.193 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.92 98.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 123.294 2.663 . . . . 74.239999999999995 114.953 -172.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -102.2 176.32 5.23 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.075 -1.083 . . . . 73.310000000000002 108.075 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.94 147.18 49.2 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.591 -1.404 . . . . 60.340000000000003 109.591 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.49 89.84 0.12 Allowed 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.542 2.161 . . . . 70.519999999999996 113.794 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.403 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 16.5 m -86.93 -47.34 0.51 Allowed Pre-proline 0 C--N 1.299 -1.618 0 CA-C-N 115.585 -0.734 . . . . 74.409999999999997 110.321 173.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 61' ' ' SER . 10.9 Cg_exo -75.78 145.55 28.98 Favored 'Trans proline' 0 C--N 1.386 2.525 0 C-N-CA 121.423 1.416 . . . . 74.319999999999993 109.202 172.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 48.4 m -89.23 168.8 11.99 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.775 0.321 . . . . 73.150000000000006 111.635 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 90.8 mttt -142.02 133.68 26.92 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 116.28 -0.418 . . . . 62.240000000000002 110.65 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.501 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 36.2 t -90.58 136.71 23.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 106.271 -1.751 . . . . 73.140000000000001 106.271 175.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.8 tp -78.98 -61.42 2.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.109 -1.071 . . . . 64.25 108.109 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -162.37 153.99 18.34 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.905 -1.043 . . . . 43.140000000000001 108.877 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.573 HG23 HD23 ' A' ' 74' ' ' LEU . 12.8 p -131.19 131.82 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.34 0 CA-C-O 121.625 0.726 . . . . 63.140000000000001 110.458 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.7 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 85.7 mm-40 -110.29 141.75 42.85 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 114.363 -1.29 . . . . 71.129999999999995 108.077 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.52 136.07 96.01 Favored Pre-proline 0 C--N 1.288 -2.085 0 CA-C-N 115.024 -0.989 . . . . 72.310000000000002 109.635 -164.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo 0.59 50.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.366 1.491 1 C-N-CA 128.301 6.001 . . . . 74.030000000000001 117.484 -162.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.59 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 4.7 m -145.19 -46.83 0.23 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 112.001 0.371 . . . . 61.420000000000002 112.001 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.7 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 11.0 tp10 -132.71 126.76 33.26 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.48 -0.933 . . . . 74.420000000000002 108.48 -171.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.66 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -135.7 132.72 37.26 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.517 -0.549 . . . . 75.239999999999995 109.517 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.5 m -135.05 126.72 29.0 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 123.221 0.326 . . . . 73.310000000000002 111.432 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.43 ' HD1' HD11 ' A' ' 74' ' ' LEU . 31.9 p90 -146.23 155.64 42.83 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.003 -0.436 . . . . 71.140000000000001 111.654 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -123.05 125.8 45.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.795 -1.187 . . . . 74.329999999999998 107.795 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -139.86 160.99 38.64 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.791 -0.363 . . . . 74.200000000000003 111.492 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 83' ' ' TRP . 48.6 t0 74.31 163.69 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.042 1.337 . . . . 61.329999999999998 111.546 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.9 m -59.11 -39.37 82.08 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.389 1.075 . . . . 74.040000000000006 112.009 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -79.89 -5.12 54.95 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.007 0.743 . . . . 52.299999999999997 113.007 -178.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 105' ' ' TRP . . . 68.43 73.62 0.68 Allowed Glycine 0 N--CA 1.442 -0.946 0 O-C-N 123.594 0.559 . . . . 54.030000000000001 113.004 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.442 ' CD1' ' HB3' ' A' ' 79' ' ' ASP . 50.6 m95 -85.98 112.97 21.7 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.696 -1.224 . . . . 64.0 107.696 177.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.32 101.98 13.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 106.967 -1.494 . . . . 74.230000000000004 106.967 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.5 m -108.85 144.78 16.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 120.973 0.416 . . . . 72.209999999999994 110.309 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 7.4 m -131.3 143.02 50.22 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.689 -0.856 . . . . 72.109999999999999 108.689 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.66 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.0 m-85 -120.8 147.53 45.22 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.829 -0.804 . . . . 71.230000000000004 108.829 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.584 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 72.9 mt-30 -133.2 144.5 49.86 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 112.795 0.665 . . . . 73.319999999999993 112.795 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 72' ' ' THR . 1.9 tm? -98.03 134.16 41.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.203 -0.908 . . . . 62.25 111.361 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -123.73 116.04 22.38 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.769 -2.308 . . . . 63.039999999999999 104.769 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -93.08 115.16 27.84 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.475 -0.89 . . . . 64.439999999999998 111.321 -175.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.8 mt -103.88 153.38 20.84 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.986 -1.116 . . . . 71.0 107.986 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.33 54.64 4.91 Favored Glycine 0 C--N 1.282 -2.431 0 C-N-CA 121.087 -0.577 . . . . 33.43 112.856 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 174.59 -33.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.323 0.649 . . . . 72.340000000000003 109.908 -177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 7.2 ptpt -150.33 175.27 11.98 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.772 -0.825 . . . . 65.219999999999999 108.772 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.0 m -111.47 123.15 49.62 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 121.176 0.512 . . . . 71.310000000000002 111.101 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.99 131.09 10.36 Favored Glycine 0 N--CA 1.406 -3.343 0 N-CA-C 108.484 -1.847 . . . . 34.119999999999997 108.484 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -120.12 134.5 55.24 Favored 'General case' 0 C--N 1.261 -3.277 0 C-N-CA 122.866 0.467 . . . . 73.209999999999994 109.804 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 90.8 m -117.77 127.17 53.64 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.917 -0.772 . . . . 74.439999999999998 108.917 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.567 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -103.62 140.56 37.39 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 108.59 -0.893 . . . . 75.5 108.59 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.501 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.9 mp -136.22 124.66 36.59 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.943 0 CA-C-N 113.662 -1.608 . . . . 61.539999999999999 106.973 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 18.2 t-160 -114.47 112.77 23.52 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.584 -1.265 . . . . 72.200000000000003 107.584 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.2 m -107.31 132.36 53.21 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.302 -1.74 . . . . 52.229999999999997 106.302 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.55 154.81 20.1 Favored Glycine 0 N--CA 1.426 -2.009 0 C-N-CA 120.838 -0.696 . . . . 24.440000000000001 112.894 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.405 ' HB2' ' O ' ' A' ' 82' ' ' GLY . 73.6 t-105 -68.98 -43.34 75.11 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.157 -0.522 . . . . 75.530000000000001 109.979 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 20.4 ptmt 38.16 91.0 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.306 1.595 . . . . 74.120000000000005 115.306 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.557 ' HB2' ' HD3' ' A' ' 108' ' ' PRO . 47.1 mt-10 -62.14 -52.66 65.56 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 120.341 -0.544 . . . . 72.150000000000006 110.29 176.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 107' ' ' GLU . 77.8 Cg_endo -102.0 -170.82 0.08 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.717 0 C-N-CA 121.831 1.688 . . . . 52.32 110.478 171.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -113.36 21.96 14.69 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.793 0.806 . . . . 71.310000000000002 109.06 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.71 -64.04 1.11 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.643 -1.162 . . . . 72.409999999999997 109.378 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.448 HG12 HD13 ' A' ' 112' ' ' ILE . 10.5 t -139.66 172.76 12.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 103.622 -2.732 . . . . 73.129999999999995 103.622 177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -62.39 -37.84 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.247 1.385 . . . . 73.129999999999995 113.767 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 131.22 -75.76 0.42 Allowed Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.471 -0.871 . . . . 54.329999999999998 113.847 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -117.03 5.48 12.83 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 113.735 1.013 . . . . 63.530000000000001 113.735 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.45 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -73.08 -40.36 65.1 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.589 -0.845 . . . . 71.109999999999999 111.354 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 174.91 137.44 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.174 -1.788 . . . . 44.409999999999997 106.174 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.25 -18.67 61.2 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.773 0.657 . . . . 73.329999999999998 112.773 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.591 ' HB3' HG22 ' A' ' 121' ' ' VAL . 43.0 tptt -91.37 97.77 11.3 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.413 -0.915 . . . . 75.420000000000002 110.577 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.3 t -58.48 -37.97 76.64 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.356 -1.293 . . . . 65.010000000000005 111.621 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.44 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 29.5 t -66.13 -45.07 82.33 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.964 -0.294 . . . . 50.130000000000003 111.51 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 118' ' ' LYS . 12.6 m -69.91 -34.48 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 119.453 -0.899 . . . . 75.140000000000001 109.64 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 63.0 t -66.29 -44.68 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 120.468 -0.493 . . . . 73.299999999999997 111.509 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.44 ' HG3' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -68.01 -37.15 81.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.996 -0.682 . . . . 74.129999999999995 111.276 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.428 ' N ' ' HD3' ' A' ' 123' ' ' ARG . . . -63.51 -45.59 94.41 Favored Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 111.012 -0.835 . . . . 74.319999999999993 111.012 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.28 -40.1 95.28 Favored 'General case' 0 C--O 1.193 -1.869 0 CA-C-N 115.011 -0.595 . . . . 74.200000000000003 111.95 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 24.2 mmt -69.32 -40.91 77.34 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.354 -0.538 . . . . 72.019999999999996 111.073 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.61 -57.66 11.17 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.419 0.628 . . . . 64.510000000000005 109.695 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.09 -38.63 59.41 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.47 -0.787 . . . . 63.32 112.389 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.79 -54.11 36.04 Favored Glycine 0 CA--C 1.491 -1.417 0 CA-C-O 119.72 -0.489 . . . . 54.140000000000001 112.036 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -61.91 -35.16 77.54 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 117.424 0.612 . . . . 72.299999999999997 112.456 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.2 m -62.37 -48.37 80.07 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 120.439 -0.504 . . . . 72.109999999999999 110.906 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.7 -46.44 24.32 Favored Glycine 0 C--O 1.247 0.907 0 C-N-CA 120.688 -0.768 . . . . 74.420000000000002 113.661 -177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.51 -52.32 59.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 122.347 0.259 . . . . 74.329999999999998 110.871 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.648 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 96.4 t -65.24 -48.48 83.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 119.81 -0.756 . . . . 41.350000000000001 112.318 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.403 ' HA ' HG13 ' A' ' 16' ' ' ILE . 9.1 t30 -59.39 -60.45 3.84 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 112.738 0.644 . . . . 74.530000000000001 112.738 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 32.4 tt0 -74.46 -48.98 24.15 Favored 'General case' 0 C--O 1.208 -1.091 0 C-N-CA 120.047 -0.661 . . . . 74.439999999999998 112.726 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.542 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 1.2 tmm_? -67.85 -32.27 72.67 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.032 -0.667 . . . . 71.239999999999995 111.41 -170.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.648 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 3.4 mm? -70.25 -51.86 27.41 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.769 -0.772 . . . . 73.319999999999993 110.023 174.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -34.26 76.26 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.894 -0.594 . . . . 73.230000000000004 111.584 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -71.27 -51.47 24.3 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.979 -0.748 . . . . 70.420000000000002 108.979 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.14 -26.85 68.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 74.040000000000006 111.87 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.412 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 30.1 m -83.8 -30.66 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.137 -0.625 . . . . 63.399999999999999 111.979 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -79.57 -12.86 59.84 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.156 0.979 . . . . 74.430000000000007 109.745 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -85.38 71.31 10.83 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 107.419 -1.326 . . . . 75.109999999999999 107.419 172.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.473 ' H ' HD23 ' A' ' 145' ' ' LEU . 2.3 pt? -113.52 138.28 50.36 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.15 -0.477 . . . . 74.040000000000006 110.978 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -81.12 109.45 15.69 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.3 -0.864 . . . . 72.239999999999995 110.556 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -88.38 -30.69 19.33 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.481 -1.303 . . . . 74.200000000000003 107.481 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -88.2 73.74 8.88 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 107.047 -1.464 . . . . 75.230000000000004 107.047 172.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -119.38 -8.01 10.12 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.936 -1.029 . . . . 71.219999999999999 108.487 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -163.07 144.72 9.9 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 103.893 -2.632 . . . . 74.540000000000006 103.893 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -84.84 123.89 30.97 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.319 -0.952 . . . . 64.310000000000002 110.061 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 76.1 m80 . . . . . 0 C--N 1.293 -1.891 0 N-CA-C 108.743 -0.836 . . . . 75.150000000000006 108.743 178.453 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.507 -0.696 0 N-CA-C 108.472 -0.936 . . . . 74.340000000000003 108.472 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.46 119.39 30.82 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.364 -0.606 . . . . 51.310000000000002 109.364 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -81.34 -28.45 34.49 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.515 -0.766 . . . . 63.329999999999998 110.116 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -56.27 107.77 0.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.623 -0.717 . . . . 63.340000000000003 112.225 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -138.94 27.0 2.43 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.672 1.225 . . . . 62.450000000000003 107.818 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -99.93 24.42 8.52 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 113.811 -1.541 . . . . 73.109999999999999 110.502 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -123.4 71.67 1.09 Allowed 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 122.576 1.179 . . . . 74.120000000000005 111.554 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 66.74 30.01 8.3 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 112.013 -2.358 . . . . 61.299999999999997 112.762 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 61.75 83.97 0.2 Allowed Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 124.122 0.969 . . . . 74.030000000000001 111.855 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -89.18 -168.22 0.32 Allowed 'Trans proline' 0 N--CA 1.429 -2.32 0 C-N-CA 122.448 2.098 . . . . 65.120000000000005 112.178 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.65 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 6.3 p-10 -61.29 131.14 49.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.995 -1.002 . . . . 72.340000000000003 113.065 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.2 tp -135.99 138.74 47.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.966 -1.124 . . . . 51.43 107.966 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.7 m -117.75 133.64 55.73 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 120.85 0.357 . . . . 71.299999999999997 110.083 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -133.73 153.64 51.55 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.794 -1.928 . . . . 75.010000000000005 105.794 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.5 m -138.0 149.88 46.49 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.154 -0.966 . . . . 75.540000000000006 110.629 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.435 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.24 144.86 16.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.008 -0.738 . . . . 60.030000000000001 109.008 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.3 122.74 46.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.944 0.878 . . . . 75.219999999999999 112.156 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.618 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.8 mp -100.94 140.43 35.24 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 115.54 -0.755 . . . . 73.530000000000001 110.695 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -92.11 46.39 1.26 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.359 -1.291 . . . . 63.399999999999999 109.184 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.434 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -143.68 161.65 45.47 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.426 -0.953 . . . . 63.340000000000003 108.426 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 33.6 Cg_endo -63.15 150.22 89.23 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 122.467 2.111 . . . . 62.009999999999998 111.135 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.1 tt -56.29 -33.34 37.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.594 0.559 . . . . 71.230000000000004 112.127 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -60.9 -42.23 97.64 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 112.194 0.442 . . . . 64.310000000000002 112.194 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -74.44 -37.79 63.18 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.259 0.552 . . . . 71.120000000000005 109.605 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.516 HG13 HD22 ' A' ' 18' ' ' LEU . 76.8 t -62.85 -41.1 91.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.463 -0.789 . . . . 73.099999999999994 109.206 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.565 ' CE2' ' HD3' ' A' ' 71' ' ' PRO . 74.9 t90 -64.7 -46.09 83.82 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.141 -1.39 . . . . 72.129999999999995 109.777 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.59 -38.9 78.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.596 0.758 . . . . 72.200000000000003 110.185 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.426 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 62.8 m -57.73 -29.98 65.18 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 112.191 0.441 . . . . 72.209999999999994 112.191 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG13 HD11 ' A' ' 138' ' ' LEU . 17.4 m -110.3 18.64 6.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 O-C-N 121.852 -0.53 . . . . 63.350000000000001 112.037 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.5 p -135.7 -12.02 2.04 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.154 0.502 . . . . 63.340000000000003 112.05 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.7 p -94.75 148.86 21.85 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.09 -0.707 . . . . 73.140000000000001 109.09 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 m -53.52 -45.83 69.89 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.794 0.838 . . . . 65.230000000000004 112.709 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -69.23 -32.45 71.7 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.848 0.356 . . . . 75.329999999999998 111.458 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 28' ' ' THR . . . -72.31 -48.36 25.08 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.391 -0.909 . . . . 73.319999999999993 111.52 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.15 -32.17 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.139 0.976 . . . . 64.400000000000006 111.738 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.85 -29.18 11.13 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.171 0.989 . . . . 65.239999999999995 112.914 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 71.5 1.97 4.08 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.871 0.693 . . . . 53.109999999999999 112.871 170.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 57.5 t90 63.36 62.75 0.94 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.7 1.238 . . . . 73.420000000000002 108.154 -174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -143.77 -58.11 0.39 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.803 -1.544 . . . . 63.039999999999999 107.856 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 55.5 ttm -147.27 111.22 4.01 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 108.393 -0.966 . . . . 72.340000000000003 108.393 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.14 103.33 0.62 Allowed 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.312 2.008 . . . . 71.349999999999994 111.463 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -126.85 155.5 42.83 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.976 -0.557 . . . . 63.329999999999998 109.779 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.43 73.33 10.52 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.988 0.899 . . . . 51.539999999999999 110.042 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -83.69 121.77 27.72 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.993 -2.225 . . . . 74.239999999999995 104.993 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -109.76 145.88 35.91 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 112.292 0.479 . . . . 64.329999999999998 112.292 -167.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -75.43 105.55 6.51 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.71 -1.589 . . . . 74.140000000000001 106.71 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -131.05 145.25 51.96 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.655 -1.979 . . . . 54.439999999999998 105.655 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HA ' HG12 ' A' ' 68' ' ' VAL . 5.1 pt-20 -87.36 34.04 0.69 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 118.963 0.801 . . . . 71.209999999999994 110.673 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.8 76.25 0.02 OUTLIER Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 108.501 -1.839 . . . . 64.549999999999997 108.501 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.436 ' HB3' ' H ' ' A' ' 65' ' ' VAL . 32.8 tt0 -87.21 162.11 17.65 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.894 -1.521 . . . . 74.230000000000004 106.894 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -118.76 159.51 23.57 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.013 -1.106 . . . . 62.32 108.013 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -96.13 139.98 31.51 Favored 'General case' 0 N--CA 1.422 -1.848 0 C-N-CA 119.865 -0.734 . . . . 73.25 109.631 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -138.23 154.76 49.08 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.836 -1.542 . . . . 55.229999999999997 106.836 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.6 mt -74.89 81.32 2.15 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.833 0.825 . . . . 65.230000000000004 108.906 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -137.35 15.53 2.98 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.244 -1.344 . . . . 75.140000000000001 110.428 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.8 p -101.82 107.58 52.58 Favored Pre-proline 0 N--CA 1.428 -1.564 0 N-CA-C 108.243 -1.021 . . . . 62.329999999999998 108.243 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -53.19 124.16 14.97 Favored 'Trans proline' 0 C--O 1.247 0.961 0 C-N-CA 123.589 2.86 . . . . 75.530000000000001 113.542 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.0 t80 70.22 -64.05 0.37 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.631 1.572 . . . . 74.120000000000005 113.271 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.82 109.48 3.85 Favored Glycine 0 C--N 1.309 -0.92 0 CA-C-O 119.384 -0.676 . . . . 74.430000000000007 111.982 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.84 110.39 0.97 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.726 2.284 . . . . 63.229999999999997 110.41 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.0 m -116.51 99.27 52.67 Favored Pre-proline 0 N--CA 1.419 -1.987 0 CA-C-N 115.868 -0.605 . . . . 73.209999999999994 110.152 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.517 ' HD2' ' HA ' ' A' ' 80' ' ' THR . 30.0 Cg_endo -71.28 101.39 1.11 Allowed 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 122.212 1.942 . . . . 74.049999999999997 110.485 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.1 p -122.35 141.77 51.21 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 115.346 -0.843 . . . . 72.430000000000007 110.108 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -155.24 143.45 20.2 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.518 -0.919 . . . . 65.299999999999997 108.518 -176.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.436 ' H ' ' HB3' ' A' ' 50' ' ' GLN . 27.1 t -88.91 127.44 41.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 105.71 -1.959 . . . . 73.219999999999999 105.71 173.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.403 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 2.1 tm? -70.74 -53.03 17.08 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.437 -1.32 . . . . 74.140000000000001 107.437 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.65 145.36 5.41 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.202 -0.908 . . . . 65.409999999999997 109.258 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.629 HG23 HD23 ' A' ' 74' ' ' LEU . 10.4 p -121.44 119.23 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 121.781 0.8 . . . . 65.349999999999994 109.115 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 84.2 mm-40 -113.87 141.53 47.23 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.011 -0.995 . . . . 74.400000000000006 112.509 -176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.39 133.24 94.4 Favored Pre-proline 0 C--N 1.296 -1.754 0 CA-C-N 113.498 -1.683 . . . . 63.25 108.073 -167.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.565 ' HD3' ' CE2' ' A' ' 26' ' ' TRP . 9.5 Cg_exo -11.83 62.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.99 1 C-N-CA 126.587 4.858 . . . . 74.5 118.333 -156.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.2 p -142.24 -44.67 0.33 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.179 -1.373 . . . . 62.219999999999999 109.549 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 69' ' ' GLN . 37.1 mt-10 -143.33 141.01 30.82 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 113.262 0.838 . . . . 72.040000000000006 113.262 -171.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.629 HD23 HG23 ' A' ' 68' ' ' VAL . 2.1 tm? -136.49 130.86 33.17 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 107.278 -1.378 . . . . 71.329999999999998 107.278 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -140.86 126.37 18.87 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 120.384 -0.527 . . . . 72.25 110.717 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.474 ' HD1' HD11 ' A' ' 74' ' ' LEU . 33.5 p90 -146.01 155.4 42.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.64 0.257 . . . . 74.340000000000003 111.315 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 29.0 mt-10 -121.64 136.03 54.96 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 105.552 -2.018 . . . . 54.329999999999998 105.552 -175.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -155.51 162.79 40.63 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.188 -1.005 . . . . 75.400000000000006 113.571 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.428 ' HB3' ' CD1' ' A' ' 83' ' ' TRP . 24.7 t70 75.65 163.47 0.26 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 112.809 -1.996 . . . . 74.239999999999995 112.63 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.517 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 8.3 m -60.59 -33.38 72.65 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.642 1.177 . . . . 72.430000000000007 111.89 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 115' ' ' ALA . 5.4 mm-40 -71.04 -33.63 70.48 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 120.722 0.296 . . . . 75.329999999999998 111.716 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.1 65.15 1.08 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.63 -0.795 . . . . 62.539999999999999 112.232 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.428 ' CD1' ' HB3' ' A' ' 79' ' ' ASP . 35.1 m95 -92.95 141.28 28.59 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.201 -1.407 . . . . 71.109999999999999 107.201 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.07 101.84 8.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 122.353 1.073 . . . . 32.310000000000002 109.121 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 m -97.54 142.69 13.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 115.435 -0.802 . . . . 71.409999999999997 110.603 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.3 m -132.31 122.0 24.43 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.334 -1.358 . . . . 74.140000000000001 107.334 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.628 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.9 m-85 -112.65 138.64 49.15 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.341 -0.985 . . . . 64.230000000000004 108.341 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.548 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 35.0 mt-30 -113.81 128.38 56.39 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 115.281 -0.872 . . . . 51.420000000000002 110.932 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.29 119.45 38.42 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.881 -1.155 . . . . 75.349999999999994 107.881 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -104.19 117.1 33.42 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.906 -1.146 . . . . 64.310000000000002 107.906 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -77.94 112.22 14.62 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.718 -0.674 . . . . 65.400000000000006 109.855 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 98.8 mt -115.21 140.91 48.68 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.14 -1.43 . . . . 73.439999999999998 107.14 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.38 58.9 4.96 Favored Glycine 0 C--N 1.276 -2.788 0 CA-C-N 115.654 -0.703 . . . . 72.010000000000005 111.907 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 179.51 -47.05 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.592 0.757 . . . . 71.349999999999994 109.307 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 9.8 ptpt -142.52 175.39 9.83 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.254 -1.388 . . . . 72.430000000000007 107.254 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.8 m -111.15 124.86 53.05 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 119.794 -0.763 . . . . 74.329999999999998 110.307 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.48 108.27 3.62 Favored Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 110.085 -1.206 . . . . 74.209999999999994 110.085 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -98.29 129.39 44.99 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.795 -0.817 . . . . 75.200000000000003 108.795 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 8.0 m -116.31 123.15 46.93 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 107.958 -1.127 . . . . 52.009999999999998 107.958 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.404 HD12 ' CE1' ' A' ' 87' ' ' PHE . 2.9 tp -100.18 119.34 38.21 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.724 -0.843 . . . . 64.129999999999995 108.724 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.01 123.17 71.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 105.928 -1.879 . . . . 64.340000000000003 105.928 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.65 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 22.9 t-160 -108.59 113.52 26.59 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.665 -1.606 . . . . 53.130000000000003 106.665 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -125.93 155.55 41.13 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 105.762 -1.94 . . . . 45.229999999999997 105.762 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.28 153.8 17.54 Favored Glycine 0 C--N 1.26 -3.684 0 N-CA-C 108.833 -1.707 . . . . 71.209999999999994 108.833 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 43.6 t90 -148.29 95.0 2.39 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.806 -0.812 . . . . 73.299999999999997 108.806 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -83.08 -56.18 3.94 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.78 -1.193 . . . . 71.400000000000006 107.78 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -175.46 154.98 1.65 Allowed Pre-proline 0 N--CA 1.441 -0.896 0 N-CA-C 106.954 -1.499 . . . . 54.210000000000001 106.954 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -69.82 110.14 2.49 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 121.701 1.6 . . . . 74.219999999999999 109.287 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -158.88 -177.62 6.65 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 105.629 -1.989 . . . . 54.340000000000003 105.629 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -88.07 -31.32 19.31 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 118.866 0.757 . . . . 60.299999999999997 109.572 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.05 152.6 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 116.161 -0.472 . . . . 65.239999999999995 109.934 -175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 115' ' ' ALA . 5.9 pt -62.21 -44.17 98.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.913 -0.585 . . . . 72.209999999999994 110.407 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.84 -52.7 3.62 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 114.413 0.525 . . . . 72.140000000000001 114.413 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.29 -42.1 16.17 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 112.861 0.689 . . . . 73.319999999999993 112.861 -172.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.64 ' HB3' HD12 ' A' ' 112' ' ' ILE . . . -67.06 -30.5 70.58 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.552 -0.459 . . . . 61.329999999999998 110.485 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.421 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 22.1 t-20 -175.51 145.17 0.71 Allowed 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.317 -1.364 . . . . 63.340000000000003 107.317 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -90.23 -17.87 26.72 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 113.172 0.804 . . . . 75.109999999999999 113.172 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 9.5 mmpt? -99.56 109.66 22.17 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.403 0.62 . . . . 70.129999999999995 110.798 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -67.48 -33.34 74.91 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.547 -0.751 . . . . 70.310000000000002 111.23 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 p -65.94 -46.67 77.33 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 111.756 0.28 . . . . 73.030000000000001 111.756 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 118' ' ' LYS . 30.2 m -70.27 -34.51 58.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 119.77 -0.772 . . . . 71.549999999999997 110.917 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 116' ' ' ASN . 99.4 t -65.86 -45.56 91.04 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 C-N-CA 120.394 -0.522 . . . . 64.239999999999995 110.594 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -61.8 -43.64 98.45 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 111.865 0.32 . . . . 74.430000000000007 111.865 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -62.51 -47.38 89.78 Favored Glycine 0 CA--C 1.497 -1.079 0 CA-C-N 115.837 -0.62 . . . . 73.409999999999997 111.925 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -72.22 -29.58 64.09 Favored 'General case' 0 C--O 1.193 -1.899 0 N-CA-C 112.796 0.665 . . . . 73.140000000000001 112.796 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.4 mmt -67.5 -48.93 65.66 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.012 -0.675 . . . . 73.450000000000003 111.66 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.33 -50.16 55.29 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.249 -0.98 . . . . 71.099999999999994 110.961 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.93 -40.2 97.04 Favored Glycine 0 C--O 1.239 0.418 0 N-CA-C 111.445 -0.662 . . . . 72.019999999999996 111.445 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.52 ' O ' HG22 ' A' ' 133' ' ' ILE . . . -64.44 -58.07 11.36 Favored Glycine 0 CA--C 1.482 -1.99 0 CA-C-O 119.007 -0.885 . . . . 74.140000000000001 111.928 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -57.67 -36.11 71.48 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.86 0.83 . . . . 75.540000000000006 112.44 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.3 m -61.1 -51.84 67.42 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 120.736 -0.385 . . . . 72.450000000000003 110.259 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.4 -50.49 15.86 Favored Glycine 0 C--O 1.25 1.113 0 C-N-CA 121.194 -0.526 . . . . 54.140000000000001 113.858 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 129' ' ' GLY . 10.5 tp -63.79 -49.27 82.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-O 119.554 -0.26 . . . . 74.420000000000002 110.879 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 71.8 t -62.84 -47.35 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 120.046 -0.662 . . . . 64.25 112.148 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.435 ' HA ' HG13 ' A' ' 16' ' ' ILE . 26.6 t-20 -55.38 -62.03 1.95 Allowed 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 111.98 0.363 . . . . 71.25 111.98 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.558 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 35.9 tt0 -80.4 -41.05 25.31 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 119.538 -0.865 . . . . 72.200000000000003 113.327 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -35.69 78.23 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.116 -1.034 . . . . 75.299999999999997 110.144 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 3.1 mm? -68.82 -51.82 36.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.129 0.49 . . . . 74.109999999999999 110.13 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.62 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 1.6 tmm_? -63.65 -36.34 83.5 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 115.691 -0.686 . . . . 71.140000000000001 110.416 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -74.7 -34.77 62.69 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 122.836 0.454 . . . . 74.340000000000003 109.789 -179.07 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.5 -26.98 63.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.469 0.652 . . . . 74.430000000000007 110.765 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.434 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 25.6 m -85.66 -25.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 C-N-CA 119.701 -0.799 . . . . 53.219999999999999 111.466 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.62 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 51.7 mt-10 -76.42 -41.89 46.11 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.628 -0.879 . . . . 74.120000000000005 108.628 174.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 72.61 173.75 0.3 Allowed 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 126.465 1.906 . . . . 62.020000000000003 110.499 -174.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.546 ' H ' HD23 ' A' ' 145' ' ' LEU . 2.4 pt? -118.01 151.57 37.21 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 121.175 0.512 . . . . 74.109999999999999 109.687 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 149' ' ' HIS . 11.1 tp10 -101.46 161.61 13.51 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 106.514 -1.661 . . . . 73.040000000000006 106.514 176.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -56.01 125.77 22.97 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.664 -0.495 . . . . 71.209999999999994 109.664 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 27.8 p80 54.95 15.69 1.24 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 126.413 1.885 . . . . 70.140000000000001 113.422 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 146' ' ' GLU . 20.6 t60 -103.65 74.46 1.25 Allowed 'General case' 0 C--O 1.247 0.96 0 CA-C-O 121.868 0.842 . . . . 74.409999999999997 109.07 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -99.75 161.28 13.71 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.868 -1.06 . . . . 75.209999999999994 109.153 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -122.24 143.99 49.25 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.18 -0.674 . . . . 75.129999999999995 109.18 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 . . . . . 0 C--N 1.309 -1.161 0 N-CA-C 109.133 -0.691 . . . . 73.5 109.133 179.316 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 C--O 1.235 0.307 0 N-CA-C 109.415 -0.587 . . . . 65.430000000000007 109.415 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.51 166.39 10.95 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.749 -0.834 . . . . 70.150000000000006 108.749 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -85.06 -28.33 25.73 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.055 0.455 . . . . 52.109999999999999 110.316 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -56.39 133.56 53.08 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 114.87 -1.059 . . . . 53.130000000000003 112.644 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -110.76 13.87 22.3 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.281 -1.378 . . . . 74.310000000000002 107.281 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -138.46 122.66 18.09 Favored 'General case' 0 N--CA 1.39 -3.442 0 N-CA-C 106.403 -1.703 . . . . 75.200000000000003 106.403 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -93.18 3.0 56.42 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 114.697 -1.138 . . . . 75.230000000000004 109.993 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.15 141.3 28.71 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 106.274 -1.75 . . . . 71.299999999999997 106.274 173.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.569 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.4 pt? -74.23 119.47 76.54 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 120.079 -0.648 . . . . 64.019999999999996 110.211 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.83 -162.14 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.162 1.908 . . . . 74.540000000000006 107.73 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -72.51 105.11 4.05 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 118.535 -1.266 . . . . 70.299999999999997 108.51 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 72.7 mt -91.25 123.67 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 106.912 -1.514 . . . . 75.409999999999997 106.912 -177.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.4 m -119.51 129.2 54.58 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 108.149 -1.056 . . . . 73.519999999999996 108.149 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -139.49 132.55 29.56 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.244 -1.391 . . . . 72.430000000000007 107.244 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 p -117.98 140.72 49.33 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 109.391 -0.596 . . . . 54.5 109.391 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.32 140.49 19.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.876 -0.787 . . . . 74.310000000000002 108.876 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' THR . 12.7 p -99.24 118.96 37.09 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.746 0.784 . . . . 72.109999999999999 112.389 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 139' ' ' ARG . 3.4 mm? -91.4 140.07 30.12 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.723 -1.126 . . . . 72.430000000000007 109.633 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.4 30.67 0.69 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.441 0.639 . . . . 75.230000000000004 110.663 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.423 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -127.83 163.92 40.15 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.256 -1.016 . . . . 75.150000000000006 108.256 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 36.0 Cg_endo -66.13 152.72 80.51 Favored 'Trans proline' 0 C--O 1.255 1.362 0 C-N-CA 122.433 2.088 . . . . 64.349999999999994 110.724 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 tt -61.26 -31.38 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.009 -0.541 . . . . 71.030000000000001 112.021 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.2 pt20 -60.29 -45.14 94.39 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.619 0.247 . . . . 61.130000000000003 110.891 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -68.06 -39.5 82.99 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.374 -0.375 . . . . 72.040000000000006 111.91 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.6 -41.1 87.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.504 -0.554 . . . . 53.329999999999998 109.504 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.545 ' CZ2' ' HD3' ' A' ' 71' ' ' PRO . 60.3 t90 -63.9 -46.61 84.07 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.153 -0.93 . . . . 65.140000000000001 110.063 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 41.2 mt-10 -63.61 -37.99 89.42 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 120.991 -0.284 . . . . 44.439999999999998 110.544 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.0 m -56.84 -36.07 69.56 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.935 0.398 . . . . 51.25 111.384 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.664 HG11 ' CE1' ' A' ' 98' ' ' PHE . 30.9 m -103.76 16.04 5.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 112.018 0.377 . . . . 73.019999999999996 112.018 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.6 t -145.88 6.63 1.05 Allowed 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.012 -0.675 . . . . 44.520000000000003 112.146 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.9 p -108.32 170.3 8.1 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 121.775 -0.578 . . . . 72.319999999999993 110.555 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 t -59.91 -62.17 2.07 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 124.143 0.902 . . . . 33.32 111.103 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -78.05 -27.92 48.81 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 119.57 -0.852 . . . . 73.409999999999997 111.883 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.93 -48.68 84.48 Favored Glycine 0 C--O 1.216 -1.018 0 N-CA-C 110.888 -0.885 . . . . 54.310000000000002 110.888 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.18 -43.76 78.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 122.026 0.917 . . . . 74.120000000000005 110.359 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 41' ' ' PRO . . . -64.79 -36.12 83.3 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 113.884 1.068 . . . . 54.210000000000001 113.884 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.78 1.88 11.45 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 112.254 0.465 . . . . 73.140000000000001 112.254 -174.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.452 ' CZ2' HG12 ' A' ' 29' ' ' VAL . 19.2 m0 -89.3 -39.02 13.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 121.036 -0.266 . . . . 75.409999999999997 110.361 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -133.93 -56.01 0.87 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.962 1.468 . . . . 72.439999999999998 114.962 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 84.6 mtp -147.89 139.82 14.12 Favored Pre-proline 0 CA--C 1.513 -0.454 0 N-CA-C 109.651 -0.499 . . . . 73.349999999999994 109.651 -174.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 33.3 Cg_endo -68.06 108.83 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.42 2.08 . . . . 65.310000000000002 111.894 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -132.9 144.16 49.98 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.698 -0.683 . . . . 72.319999999999993 109.923 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.93 53.37 2.8 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.73 0.776 . . . . 73.120000000000005 110.765 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -72.31 152.28 42.21 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.138 -0.937 . . . . 74.340000000000003 108.573 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -137.55 151.53 48.48 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.888 -0.782 . . . . 72.140000000000001 108.888 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -75.41 104.45 5.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.539 -1.652 . . . . 72.430000000000007 106.539 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.406 ' O ' HG11 ' A' ' 65' ' ' VAL . 12.9 tptp -134.82 132.14 38.31 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 107.186 -1.412 . . . . 71.430000000000007 107.186 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -95.55 86.96 4.59 Favored 'General case' 0 C--N 1.26 -3.321 0 CA-C-O 122.674 1.225 . . . . 73.510000000000005 108.571 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.09 105.14 2.26 Favored Glycine 1 N--CA 1.395 -4.084 0 CA-C-N 113.256 -1.793 . . . . 71.329999999999998 109.564 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -150.55 149.49 29.99 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.931 -1.507 . . . . 75.519999999999996 106.931 -178.308 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.08 154.2 45.83 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.563 -0.903 . . . . 74.010000000000005 108.563 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -128.75 147.67 50.79 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.097 0.475 . . . . 73.140000000000001 111.286 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -115.81 153.12 32.03 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.304 -0.998 . . . . 74.530000000000001 108.304 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.2 mt 73.54 65.62 0.1 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.479 1.112 . . . . 74.510000000000005 110.064 -176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.04 109.61 1.87 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.367 -1.288 . . . . 72.319999999999993 110.466 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.9 p -153.72 148.48 19.65 Favored Pre-proline 0 N--CA 1.417 -2.12 0 N-CA-C 107.277 -1.379 . . . . 72.209999999999994 107.277 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.61 -40.35 85.84 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.893 2.396 . . . . 64.129999999999995 112.414 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -131.65 143.22 50.15 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.828 -0.804 . . . . 75.540000000000006 108.828 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.27 -101.02 0.25 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.213 -0.755 . . . . 41.399999999999999 111.213 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.55 2.63 7.97 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 122.753 2.302 . . . . 61.439999999999998 111.805 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.1 t 71.63 112.94 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.211 1.405 . . . . 74.430000000000007 110.14 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -80.12 44.25 1.69 Allowed 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 123.686 2.924 . . . . 74.340000000000003 113.09 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 18.5 p -116.52 142.7 46.53 Favored 'General case' 0 N--CA 1.417 -2.075 0 CA-C-O 121.47 0.652 . . . . 41.030000000000001 111.726 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 50' ' ' GLN . 20.4 pttp -137.24 138.41 40.09 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 107.009 -1.478 . . . . 74.219999999999999 107.009 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 47' ' ' LYS . 23.5 t -88.71 135.09 26.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 C-N-CA 119.516 -0.874 . . . . 72.409999999999997 109.249 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -76.53 -60.43 2.35 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.248 -1.76 . . . . 72.530000000000001 106.248 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.95 152.93 6.72 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.19 -0.914 . . . . 54.409999999999997 108.912 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.41 118.58 57.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 105.957 -1.868 . . . . 73.230000000000004 105.957 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 14.9 mm-40 -98.42 140.18 33.06 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.871 -0.788 . . . . 63.030000000000001 108.871 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.69 126.8 93.07 Favored Pre-proline 0 C--N 1.265 -3.094 0 CA-C-N 113.739 -1.573 . . . . 64.329999999999998 107.966 -168.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.545 ' HD3' ' CZ2' ' A' ' 26' ' ' TRP . 92.0 Cg_exo 2.03 51.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.117 1 C-N-CA 127.601 5.534 . . . . 71.349999999999994 117.351 -159.228 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.2 p -138.78 -39.14 0.5 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.005 -0.998 . . . . 73.430000000000007 111.557 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 36.9 tt0 -151.2 149.0 28.92 Favored 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 119.046 -1.062 . . . . 62.520000000000003 111.347 -174.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.638 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -137.0 134.06 36.21 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.613 -1.255 . . . . 75.420000000000002 107.613 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.467 ' OG ' HG23 ' A' ' 86' ' ' THR . 22.4 m -141.62 126.53 18.21 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.819 -0.352 . . . . 24.23 111.266 177.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.477 ' HD1' HD11 ' A' ' 74' ' ' LEU . 36.6 p90 -143.91 154.0 42.89 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.819 -0.438 . . . . 73.120000000000005 109.819 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 63' ' ' CYS . 41.0 mt-10 -122.86 124.71 43.87 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 123.066 0.546 . . . . 73.140000000000001 109.585 -171.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 6.4 t-105 -117.38 115.63 25.61 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.971 -1.492 . . . . 74.140000000000001 106.971 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -82.6 152.57 25.87 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.584 -0.846 . . . . 73.310000000000002 109.16 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.6 m 74.88 84.84 0.1 Allowed 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 123.858 0.863 . . . . 74.200000000000003 110.235 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 57.87 0.41 0.11 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 127.263 2.225 . . . . 73.099999999999994 115.62 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.45 -35.41 20.18 Favored Glycine 0 C--N 1.312 -0.796 0 N-CA-C 110.645 -0.982 . . . . 75.0 110.645 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 52.3 m95 66.63 -161.82 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.272 1.429 . . . . 75.519999999999996 109.766 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 p -116.67 126.68 74.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.99 -0.744 . . . . 71.510000000000005 108.99 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.4 m -116.31 136.61 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 CA-C-N 115.299 -0.864 . . . . 41.119999999999997 110.301 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.467 HG23 ' OG ' ' A' ' 75' ' ' SER . 34.9 m -124.54 127.03 46.79 Favored 'General case' 0 C--N 1.279 -2.498 0 N-CA-C 107.535 -1.283 . . . . 74.430000000000007 107.535 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.638 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.4 m-85 -112.38 130.11 56.08 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.465 -0.939 . . . . 64.129999999999995 108.465 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.405 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 5.2 mm-40 -109.33 137.5 47.11 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.439 -0.8 . . . . 73.219999999999999 110.257 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.39 120.34 40.01 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.281 -0.872 . . . . 75.439999999999998 110.026 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -111.54 116.83 31.51 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.207 -1.034 . . . . 71.040000000000006 108.207 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.86 123.39 27.18 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.267 0.556 . . . . 71.120000000000005 109.528 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.6 mt -126.35 159.54 32.91 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.33 -0.85 . . . . 62.149999999999999 109.204 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.67 128.16 8.52 Favored Glycine 0 N--CA 1.409 -3.132 0 N-CA-C 108.693 -1.763 . . . . 63.009999999999998 108.693 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 83.89 -3.81 1.11 Allowed 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 125.011 1.324 . . . . 71.329999999999998 111.977 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -164.46 173.41 12.15 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.002 -0.74 . . . . 71.25 109.002 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 17' ' ' THR . 85.3 m -124.79 132.64 53.33 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.368 -0.604 . . . . 55.039999999999999 109.368 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.56 105.03 3.25 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 110.059 -1.216 . . . . 51.140000000000001 110.059 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.664 ' CE1' HG11 ' A' ' 29' ' ' VAL . 67.9 t80 -98.33 134.28 41.56 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.998 -0.741 . . . . 74.140000000000001 108.998 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 9.8 m -125.14 125.79 44.25 Favored 'General case' 0 N--CA 1.405 -2.678 0 C-N-CA 119.619 -0.832 . . . . 51.009999999999998 109.23 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.479 HD22 HG21 ' A' ' 134' ' ' VAL . 1.8 tp -100.26 124.04 45.22 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.074 -1.084 . . . . 72.310000000000002 108.074 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 3.5 mp -121.26 124.59 72.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 106.923 -1.51 . . . . 72.329999999999998 106.923 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -120.69 122.1 39.71 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.15 -1.056 . . . . 74.310000000000002 108.15 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -142.87 163.93 31.46 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.814 -1.551 . . . . 54.340000000000003 106.814 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -179.1 132.37 1.87 Allowed Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 108.502 -1.839 . . . . 62.439999999999998 108.502 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -92.15 144.66 25.2 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.228 -0.989 . . . . 74.120000000000005 110.291 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -127.7 -73.05 0.61 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 106.293 -1.743 . . . . 73.340000000000003 106.293 -177.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.517 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 32.9 tt0 167.27 -57.63 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 127.772 2.429 . . . . 74.340000000000003 108.443 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 107' ' ' GLU . 72.1 Cg_endo -82.34 146.78 14.06 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 121.12 1.213 . . . . 70.319999999999993 112.764 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -100.97 -20.64 15.33 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.783 -1.098 . . . . 64.129999999999995 108.815 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -63.5 -48.03 79.29 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.718 -0.674 . . . . 74.109999999999999 111.897 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.73 166.58 13.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 N-CA-C 104.82 -2.289 . . . . 64.310000000000002 104.82 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.9 pt -58.72 -32.63 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 118.418 0.554 . . . . 60.420000000000002 112.038 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.3 -113.12 3.91 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.61 -0.805 . . . . 71.420000000000002 113.702 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.84 -9.35 58.19 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.22 0.822 . . . . 65.010000000000005 113.22 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.72 -22.4 61.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.073 -0.343 . . . . 62.420000000000002 110.073 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 53.1 t30 43.01 89.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.655 1.582 . . . . 71.450000000000003 114.806 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.18 154.18 38.76 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 100.297 -3.964 . . . . 71.439999999999998 100.297 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.599 ' HB2' HG22 ' A' ' 121' ' ' VAL . 9.9 mmpt? -72.38 122.19 20.78 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 119.629 1.104 . . . . 72.409999999999997 111.776 -168.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 11.0 p -44.44 -50.47 9.33 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 125.119 1.368 . . . . 74.400000000000006 114.276 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.6 p -65.35 -45.86 82.52 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 116.337 -0.392 . . . . 64.040000000000006 112.026 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.599 HG22 ' HB2' ' A' ' 118' ' ' LYS . 11.0 m -70.62 -33.55 53.56 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 C-N-CA 119.909 -0.716 . . . . 74.120000000000005 110.346 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.54 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 69.5 t -60.22 -46.92 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 O-C-N 123.087 0.242 . . . . 54.229999999999997 110.368 176.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -57.47 -46.43 83.67 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.53 -0.759 . . . . 72.230000000000004 110.361 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.64 -47.25 50.37 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.598 -0.728 . . . . 63.0 113.0 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -62.79 -31.92 72.99 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 123.789 0.836 . . . . 64.450000000000003 112.425 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 25.8 mmt -72.71 -48.94 34.65 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.863 -0.735 . . . . 73.420000000000002 110.956 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.86 -65.74 0.63 Allowed 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.507 0.67 . . . . 72.0 110.548 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.04 -31.54 66.64 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.437 -0.801 . . . . 73.129999999999995 112.813 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -67.07 -59.3 7.06 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-O 119.408 -0.662 . . . . 74.409999999999997 112.013 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.416 ' CE3' HD21 ' A' ' 100' ' ' LEU . 97.7 m95 -61.88 -35.95 79.84 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 117.833 0.817 . . . . 72.329999999999998 112.833 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.8 m -62.28 -50.19 72.66 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 120.786 -0.366 . . . . 74.349999999999994 110.586 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.33 -48.21 19.77 Favored Glycine 0 C--O 1.247 0.939 0 C-N-CA 121.102 -0.57 . . . . 42.130000000000003 113.511 -177.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.57 -60.71 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 123.218 0.607 . . . . 64.140000000000001 110.347 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.479 HG21 HD22 ' A' ' 100' ' ' LEU . 98.0 t -57.64 -44.4 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 113.049 0.759 . . . . 74.319999999999993 113.049 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -56.4 -63.95 1.02 Allowed 'General case' 0 C--O 1.246 0.912 0 N-CA-C 112.143 0.423 . . . . 74.319999999999993 112.143 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -79.43 -34.84 41.31 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.184 0.809 . . . . 73.549999999999997 113.184 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -70.32 -39.43 74.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.534 -0.867 . . . . 75.519999999999996 111.265 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.5 mm? -70.47 -43.21 70.27 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 119.468 -0.893 . . . . 62.140000000000001 110.594 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.407 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.9 tmm_? -58.25 -37.2 74.44 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.045 -0.525 . . . . 72.239999999999995 110.094 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 8.5 mmmm -74.37 -37.1 63.55 Favored 'General case' 0 C--O 1.199 -1.558 0 N-CA-C 113.782 1.031 . . . . 64.109999999999999 113.782 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.72 -23.94 65.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.832 0.349 . . . . 41.130000000000003 111.377 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.1 m -90.81 -23.32 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 120.739 -0.384 . . . . 60.32 110.715 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -82.39 -54.56 5.12 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.122 0.416 . . . . 62.539999999999999 112.122 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -129.64 -172.3 2.72 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.746 -0.464 . . . . 63.100000000000001 109.746 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.3 mt -132.42 89.5 2.66 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.272 -0.64 . . . . 65.319999999999993 109.272 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -65.46 139.65 58.53 Favored 'General case' 0 C--O 1.256 1.408 0 N-CA-C 114.169 1.174 . . . . 74.340000000000003 114.169 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -70.02 143.0 52.67 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.507 -2.405 . . . . 62.509999999999998 104.507 168.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -58.35 115.72 3.16 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 118.719 0.69 . . . . 65.340000000000003 111.76 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -67.26 116.48 8.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.024 -0.989 . . . . 64.519999999999996 109.654 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -70.97 127.28 32.05 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.206 -0.664 . . . . 64.25 109.206 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -61.34 138.55 58.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.809 0.814 . . . . 72.200000000000003 112.896 -172.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--N 1.281 -2.41 0 N-CA-C 105.515 -2.031 . . . . 74.129999999999995 105.515 177.174 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 108.298 -1.001 . . . . 75.140000000000001 108.298 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.65 23.33 5.45 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.026 0.441 . . . . 72.030000000000001 111.367 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -99.45 -48.8 4.65 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.073 0.768 . . . . 71.129999999999995 113.073 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 5' ' ' ASN . 47.8 t30 -104.72 80.81 1.69 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 119.553 -0.859 . . . . 64.219999999999999 113.096 -176.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 4' ' ' ASN . 6.6 p30 165.66 160.26 0.03 OUTLIER 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 126.633 1.973 . . . . 73.25 107.177 169.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 7' ' ' ASN . 0.7 OUTLIER -96.77 -69.11 0.77 Allowed 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 113.402 0.889 . . . . 73.409999999999997 113.402 -177.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.449 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 21.7 t-20 74.05 -24.47 0.21 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.19 1.396 . . . . 74.409999999999997 113.254 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 112' ' ' ILE . . . 79.55 -46.65 0.35 Allowed 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 126.734 2.014 . . . . 73.230000000000004 111.857 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.604 HD21 ' HE ' ' A' ' 123' ' ' ARG 0.38 4.5 mm? 97.08 85.6 0.02 OUTLIER Pre-proline 0 CA--C 1.51 -0.59 0 C-N-CA 127.27 2.228 . . . . 74.439999999999998 116.737 -176.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -91.93 -153.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.684 0 C-N-CA 123.623 2.882 . . . . 43.520000000000003 109.023 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 5.6 p-10 -58.5 146.82 34.02 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.672 0.789 . . . . 64.329999999999998 113.068 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.483 HG22 ' HB3' ' A' ' 102' ' ' HIS . 10.7 tp -152.42 139.38 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.226 -0.657 . . . . 70.109999999999999 109.226 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.1 m -113.42 140.1 48.35 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.406 -0.59 . . . . 74.349999999999994 109.406 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HD3' ' N ' ' A' ' 15' ' ' SER . 5.7 tmtt? -141.56 137.73 32.18 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.489 -1.671 . . . . 72.540000000000006 106.489 175.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.488 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 24.5 p -118.23 150.19 39.85 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.392 0.542 . . . . 71.109999999999999 111.096 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.489 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -158.65 134.7 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.582 -0.525 . . . . 74.219999999999999 109.582 177.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.34 130.95 44.45 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.404 0.621 . . . . 71.230000000000004 111.706 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 2.5 mm? -99.74 139.28 35.62 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 123.411 0.685 . . . . 73.439999999999998 109.784 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.431 ' HG3' ' NH2' ' A' ' 139' ' ' ARG . 20.8 mm-40 -92.67 27.49 2.31 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.574 0.702 . . . . 64.319999999999993 109.131 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -122.6 161.98 40.84 Favored Pre-proline 0 C--O 1.246 0.912 0 C-N-CA 123.826 0.851 . . . . 75.329999999999998 109.255 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 35.7 Cg_endo -64.9 149.49 89.44 Favored 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 122.713 2.275 . . . . 74.329999999999998 110.921 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.1 tt -56.81 -34.02 42.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.611 -0.722 . . . . 42.340000000000003 112.399 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 29.9 pt20 -64.88 -36.5 84.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.919 0.39 . . . . 55.409999999999997 111.069 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HG2' HD12 ' A' ' 145' ' ' LEU . 11.6 mptt -79.67 -28.74 40.74 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 112.037 0.384 . . . . 74.439999999999998 112.037 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.2 -42.14 75.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.157 -1.053 . . . . 62.200000000000003 108.157 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 54.4 t90 -59.72 -47.79 84.26 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.617 -1.174 . . . . 73.140000000000001 111.303 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.557 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 9.3 pt-20 -70.05 -27.87 65.0 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 119.925 -0.71 . . . . 72.200000000000003 112.289 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 m -59.46 -35.63 74.44 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.2 0.524 . . . . 72.0 110.401 174.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.601 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 26.4 m -106.9 25.1 2.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 112.186 0.439 . . . . 64.439999999999998 112.186 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.557 ' OG ' ' HA ' ' A' ' 27' ' ' GLU . 60.2 p -141.37 -11.33 0.94 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.733 0.642 . . . . 75.430000000000007 112.733 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -94.25 161.63 14.18 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 120.306 -0.558 . . . . 72.129999999999995 111.434 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -50.12 -56.53 10.53 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 125.772 1.629 . . . . 65.209999999999994 111.553 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.14 -33.3 56.73 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.947 0.721 . . . . 72.5 112.947 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.99 -48.2 67.7 Favored Glycine 0 CA--C 1.505 -0.592 0 C-N-CA 120.905 -0.664 . . . . 75.319999999999993 111.691 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 30' ' ' SER . 63.3 mt -70.42 -45.42 75.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.204 0.526 . . . . 60.119999999999997 111.383 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.04 -50.28 66.84 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 112.859 0.688 . . . . 55.149999999999999 112.859 -176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? 65.14 7.83 4.38 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 123.213 1.482 . . . . 63.240000000000002 109.698 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -95.41 158.69 15.35 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 113.583 -1.644 . . . . 61.439999999999998 107.019 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -86.89 -18.92 29.72 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.944 0.878 . . . . 54.229999999999997 109.204 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 26.8 ttt -93.4 116.28 66.26 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 106.983 -1.488 . . . . 65.530000000000001 106.983 172.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 40' ' ' MET . 6.1 Cg_exo -76.32 121.09 5.9 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.764 1.643 . . . . 65.540000000000006 113.538 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -100.17 144.12 29.57 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 104.278 -2.49 . . . . 73.049999999999997 104.278 170.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -93.44 79.25 4.38 Favored 'General case' 0 C--N 1.281 -2.379 0 C-N-CA 118.741 -1.184 . . . . 75.019999999999996 113.082 -171.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.438 ' HB3' HD12 ' A' ' 35' ' ' ILE . 99.6 m-85 -75.16 119.04 18.76 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.43 -1.692 . . . . 73.450000000000003 106.43 168.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -125.09 153.4 42.99 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.893 -1.521 . . . . 71.549999999999997 106.893 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.652 HD12 HG21 ' A' ' 68' ' ' VAL . 3.5 mm? -74.09 102.9 4.36 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 116.689 -2.004 . . . . 44.039999999999999 107.996 175.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 39.5 tptt -132.73 132.79 42.7 Favored 'General case' 0 N--CA 1.391 -3.418 0 N-CA-C 105.694 -1.965 . . . . 61.299999999999997 105.694 171.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -86.4 66.63 9.61 Favored 'General case' 0 C--N 1.259 -3.36 0 CA-C-O 122.27 1.033 . . . . 61.5 109.23 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 123.43 51.9 0.21 Allowed Glycine 0 N--CA 1.397 -3.921 0 CA-C-N 114.579 -1.191 . . . . 64.420000000000002 110.142 -176.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.573 ' H ' ' HB ' ' A' ' 65' ' ' VAL . 12.2 tt0 -73.82 96.97 2.66 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 106.534 -1.654 . . . . 65.420000000000002 106.534 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.14 141.31 48.94 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-O 122.017 0.913 . . . . 60.32 113.16 -177.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -129.7 144.52 51.33 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 104.65 -2.352 . . . . 72.319999999999993 104.65 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -110.23 139.49 45.34 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.705 -0.85 . . . . 73.129999999999995 108.705 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 54' ' ' LEU . 2.3 pt? -97.08 176.91 5.77 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.291 0.567 . . . . 75.120000000000005 111.707 -173.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -124.2 -161.64 1.01 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.427 -1.694 . . . . 73.319999999999993 106.427 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.466 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 26.5 m -56.59 -50.07 89.96 Favored Pre-proline 0 CA--C 1.566 1.596 0 CA-C-N 118.29 0.496 . . . . 72.5 111.223 174.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 56' ' ' SER . 11.4 Cg_exo -75.57 146.36 30.6 Favored 'Trans proline' 0 C--N 1.373 1.828 0 N-CA-C 108.614 -1.341 . . . . 73.329999999999998 108.614 168.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -55.5 -42.08 73.95 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.285 0.365 . . . . 63.109999999999999 111.932 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.85 -113.13 4.22 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 111.463 -0.655 . . . . 72.340000000000003 111.463 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.1 -161.5 0.15 Allowed 'Trans proline' 0 C--O 1.244 0.808 0 C-N-CA 123.149 2.566 . . . . 64.310000000000002 110.535 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.8 m -81.83 116.64 64.47 Favored Pre-proline 0 N--CA 1.427 -1.604 0 N-CA-C 107.84 -1.17 . . . . 73.439999999999998 107.84 174.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.46 81.02 0.13 Allowed 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 123.245 2.63 . . . . 64.400000000000006 114.273 -176.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 9.5 p -143.8 144.41 31.78 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.176 -1.046 . . . . 60.229999999999997 108.176 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -143.07 147.11 34.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.394 -1.706 . . . . 74.030000000000001 106.394 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.573 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 42.9 t -90.32 137.45 21.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.636 -1.246 . . . . 64.239999999999995 107.636 177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 2.3 tm? -77.74 -61.56 1.95 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.084 -1.45 . . . . 74.430000000000007 107.084 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.56 156.76 10.02 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.119 -1.067 . . . . 64.099999999999994 108.119 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.652 HG21 HD12 ' A' ' 46' ' ' LEU . 13.5 p -125.04 135.17 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-O 121.177 0.513 . . . . 61.539999999999999 110.396 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 71.9 mm-40 -102.81 141.16 36.09 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.314 -0.995 . . . . 75.409999999999997 108.314 173.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.88 127.04 93.33 Favored Pre-proline 0 C--N 1.266 -3.031 0 N-CA-C 107.401 -1.333 . . . . 74.099999999999994 107.401 -168.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo 4.12 48.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.077 1 C-N-CA 127.628 5.552 . . . . 72.200000000000003 117.895 -161.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -137.65 -35.24 0.66 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.264 -0.425 . . . . 74.219999999999999 109.983 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 38.8 tt0 -149.55 148.28 29.18 Favored 'General case' 0 C--O 1.205 -1.237 0 C-N-CA 118.574 -1.25 . . . . 74.329999999999998 110.363 -175.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.639 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -143.04 130.91 21.55 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 107.705 -1.22 . . . . 55.539999999999999 107.705 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -132.66 127.1 34.13 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 110.224 -0.287 . . . . 62.450000000000003 110.224 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.421 ' HA ' ' H ' ' A' ' 66' ' ' LEU 0.254 35.8 p90 -145.81 157.84 43.9 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.208 -0.308 . . . . 73.400000000000006 111.768 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.262 36.1 mt-10 -120.07 144.67 47.46 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 123.624 0.77 . . . . 74.329999999999998 109.97 -169.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -114.67 120.47 40.23 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.0 -2.222 . . . . 72.230000000000004 105.0 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -83.11 10.61 7.79 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.619 0.723 . . . . 74.540000000000006 112.866 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.4 p -90.76 92.64 8.89 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 107.857 -1.164 . . . . 74.349999999999994 107.857 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 78.08 6.93 2.6 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.91 1.284 . . . . 64.439999999999998 112.403 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.87 62.73 3.07 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 114.805 -1.089 . . . . 61.32 113.777 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -100.28 150.64 22.36 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.825 -0.75 . . . . 74.040000000000006 109.742 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.13 109.93 2.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 108.216 -1.031 . . . . 75.140000000000001 108.216 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.11 154.67 5.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 115.86 -0.609 . . . . 42.509999999999998 109.817 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 15.3 m -139.89 140.3 36.43 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.179 -0.674 . . . . 70.450000000000003 109.179 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.639 ' CD2' HD12 ' A' ' 74' ' ' LEU . 15.0 m-85 -113.66 139.59 48.92 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.578 -1.267 . . . . 74.549999999999997 107.578 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.22 133.74 55.41 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.094 -1.076 . . . . 73.219999999999999 108.094 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.03 128.02 56.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.453 0.644 . . . . 74.150000000000006 109.948 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -115.96 130.84 57.0 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.692 -1.225 . . . . 74.420000000000002 107.692 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -94.29 121.17 35.53 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.417 0.627 . . . . 72.140000000000001 109.798 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 81.1 mt -114.2 156.0 25.06 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.245 -1.02 . . . . 60.229999999999997 108.245 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.95 49.57 4.25 Favored Glycine 0 C--N 1.289 -2.072 0 CA-C-N 116.255 -0.43 . . . . 51.310000000000002 112.137 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -177.17 -40.56 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.808 0.813 . . . . 60.439999999999998 109.118 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 9.2 ptpt -149.42 175.97 11.0 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 115.461 -0.79 . . . . 74.530000000000001 108.961 -171.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 64.8 m -108.22 130.4 55.15 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 109.03 -0.73 . . . . 54.340000000000003 109.03 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.53 124.4 7.59 Favored Glycine 0 N--CA 1.416 -2.675 0 N-CA-C 110.072 -1.211 . . . . 74.329999999999998 110.072 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CE1' HG11 ' A' ' 29' ' ' VAL . 93.1 t80 -112.06 134.33 53.68 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-O 121.195 0.522 . . . . 71.310000000000002 110.077 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 m -124.01 126.3 46.04 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.976 -1.12 . . . . 70.239999999999995 107.976 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.521 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -103.03 138.7 39.55 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.84 0.829 . . . . 73.329999999999998 108.788 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 100' ' ' LEU . 4.0 mp -135.53 124.86 41.14 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.033 0 CA-C-N 113.457 -1.701 . . . . 64.140000000000001 107.673 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 4.3 t60 -112.77 127.38 56.13 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 104.807 -2.294 . . . . 71.129999999999995 104.807 173.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -142.24 164.86 29.02 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.66 -1.978 . . . . 74.209999999999994 105.66 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.11 178.71 39.37 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 119.698 -1.239 . . . . 44.039999999999999 111.848 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -74.42 114.64 13.04 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.192 -2.151 . . . . 71.129999999999995 105.192 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -78.87 77.03 5.35 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 115.003 1.482 . . . . 73.049999999999997 115.003 -169.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.489 ' H ' ' HD2' ' A' ' 108' ' ' PRO . 38.5 mt-10 -102.28 -44.83 0.19 Allowed Pre-proline 0 C--N 1.289 -2.039 0 CA-C-N 113.639 -1.619 . . . . 72.120000000000005 109.915 170.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.489 ' HD2' ' H ' ' A' ' 107' ' ' GLU . 26.2 Cg_exo -39.52 106.8 0.06 OUTLIER 'Trans proline' 1 C--N 1.422 4.43 0 C-N-CA 123.562 2.841 . . . . 44.329999999999998 113.788 178.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -101.43 -64.52 1.05 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.545 -0.752 . . . . 72.549999999999997 109.055 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -101.66 -42.76 6.08 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.654 -0.869 . . . . 72.420000000000002 108.654 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 119' ' ' SER . 14.5 t -133.58 155.33 40.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 105.73 -1.952 . . . . 74.409999999999997 105.73 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 8' ' ' ALA . 6.9 pt -62.07 -32.85 55.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 118.428 0.558 . . . . 52.240000000000002 111.959 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.77 -127.28 6.48 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.563 -0.827 . . . . 64.409999999999997 112.467 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -69.75 -9.32 54.08 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.713 1.205 . . . . 55.109999999999999 114.023 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.44 84.24 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.035 0.754 . . . . 75.150000000000006 113.035 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -148.46 165.31 31.54 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 122.432 -0.167 . . . . 71.239999999999995 110.793 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.04 -68.24 0.33 Allowed 'General case' 0 C--N 1.316 -0.871 0 O-C-N 124.615 1.197 . . . . 65.299999999999997 111.243 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.455 ' HE2' HG13 ' A' ' 121' ' ' VAL . 34.1 mtmm -106.34 151.35 24.98 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 113.245 0.831 . . . . 71.049999999999997 113.245 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.443 ' HB2' HG22 ' A' ' 111' ' ' VAL . 9.0 t -77.15 -30.19 54.93 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.349 -0.982 . . . . 71.439999999999998 108.349 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.3 t -64.48 -41.68 96.33 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.09 -0.504 . . . . 71.109999999999999 110.574 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.455 HG13 ' HE2' ' A' ' 118' ' ' LYS . 33.0 m -70.69 -33.5 53.12 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.763 0 C-N-CA 119.698 -0.801 . . . . 65.450000000000003 110.33 177.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 118' ' ' LYS . 76.4 t -65.2 -41.67 92.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.254 -0.43 . . . . 53.509999999999998 110.067 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.604 ' HE ' HD21 ' A' ' 9' ' ' LEU . 2.9 tpm_? -54.44 -52.81 60.62 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.518 -0.765 . . . . 73.530000000000001 109.474 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -62.51 -54.31 35.08 Favored Glycine 0 CA--C 1.505 -0.576 0 O-C-N 123.623 0.577 . . . . 54.420000000000002 113.232 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -60.35 -41.01 92.77 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.483 0.92 . . . . 63.350000000000001 113.483 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.94 -39.59 42.28 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.226 -0.99 . . . . 72.030000000000001 110.98 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -67.39 -61.51 1.87 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.73 -0.47 . . . . 53.420000000000002 109.73 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -69.91 -32.34 69.95 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.262 -0.881 . . . . 71.310000000000002 111.895 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.76 -58.73 7.92 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-O 119.776 -0.458 . . . . 61.229999999999997 112.507 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -63.58 -36.69 84.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 113.281 0.845 . . . . 75.340000000000003 113.281 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.9 p -65.58 -51.31 60.74 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.767 -0.773 . . . . 70.540000000000006 111.412 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.54 -47.92 32.13 Favored Glycine 0 C--O 1.245 0.801 0 C-N-CA 121.01 -0.614 . . . . 60.520000000000003 113.329 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.619 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 45.9 mm -65.25 -51.26 67.2 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 N-CA-C 111.475 0.176 . . . . 71.510000000000005 111.475 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.521 HG21 ' HG ' ' A' ' 100' ' ' LEU . 97.5 t -62.14 -48.92 86.2 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.575 0 C-N-CA 119.269 -0.972 . . . . 71.209999999999994 110.68 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.489 ' HA ' HG13 ' A' ' 16' ' ' ILE . 9.7 t30 -60.76 -63.68 1.21 Allowed 'General case' 0 C--O 1.252 1.235 0 C-N-CA 119.654 -0.818 . . . . 74.310000000000002 112.741 -175.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.69 -41.11 18.09 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 118.773 -1.171 . . . . 71.510000000000005 112.737 -174.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.619 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 14.4 tpp180 -70.55 -37.55 74.05 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.023 -0.671 . . . . 74.299999999999997 111.851 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 0.1 OUTLIER -68.22 -44.31 76.04 Favored 'General case' 0 C--O 1.251 1.139 0 N-CA-C 107.314 -1.365 . . . . 75.299999999999997 107.314 177.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.636 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -60.5 -36.95 79.58 Favored 'General case' 0 C--O 1.203 -1.378 0 CA-C-N 116.046 -0.525 . . . . 70.030000000000001 110.495 177.646 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.511 ' HE3' ' NE2' ' A' ' 150' ' ' HIS . 10.9 mmmm -73.33 -35.6 66.06 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 114.616 1.339 . . . . 74.219999999999999 114.616 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.97 -33.94 76.46 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.488 -0.485 . . . . 74.430000000000007 109.707 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.436 HG21 ' HB3' ' A' ' 18' ' ' LEU . 11.0 m -85.04 -21.56 7.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-N 116.015 -0.539 . . . . 63.210000000000001 111.927 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 78.8 mm-40 -77.68 -33.05 53.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.331 -0.548 . . . . 63.350000000000001 109.914 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -87.73 20.39 3.02 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.905 -0.589 . . . . 63.530000000000001 110.332 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.432 HD12 ' HG2' ' A' ' 24' ' ' LYS . 1.6 pt? -61.44 -28.96 69.65 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.758 1.223 . . . . 73.400000000000006 114.29 -173.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.533 ' HG2' ' H ' ' A' ' 147' ' ' HIS . 36.1 tt0 -152.67 -168.02 2.92 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 105.584 -2.006 . . . . 71.140000000000001 105.584 -170.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.533 ' H ' ' HG2' ' A' ' 146' ' ' GLU . 33.7 m80 -74.84 78.74 2.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.928 0.871 . . . . 72.219999999999999 109.201 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -130.41 101.39 5.72 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.135 -1.432 . . . . 72.430000000000007 107.135 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -98.79 132.46 44.13 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.966 -0.561 . . . . 71.349999999999994 109.734 -176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.511 ' NE2' ' HE3' ' A' ' 140' ' ' LYS . 43.8 p-80 -155.96 -174.65 5.05 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.312 -0.996 . . . . 74.430000000000007 108.312 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -65.48 140.0 58.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 74.150000000000006 111.555 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 N--CA 1.431 -1.383 0 N-CA-C 107.455 -1.313 . . . . 53.219999999999999 107.455 178.404 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 110.084 -0.339 . . . . 51.329999999999998 110.084 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.85 96.5 4.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.097 -0.705 . . . . 71.109999999999999 109.097 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -99.33 -29.34 12.84 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.43 -0.805 . . . . 64.209999999999994 110.356 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -99.49 135.84 40.3 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.79 -0.641 . . . . 54.450000000000003 111.65 -175.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -95.36 130.2 42.23 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 105.387 -2.079 . . . . 55.310000000000002 105.387 169.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.01 112.38 6.43 Favored 'General case' 0 C--N 1.269 -2.895 0 CA-C-O 121.722 0.772 . . . . 72.329999999999998 111.471 -172.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 119' ' ' SER . 29.6 t-20 -163.48 -43.32 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 105.807 -1.923 . . . . 62.439999999999998 105.807 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.423 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -104.24 -165.25 1.13 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.668 -1.605 . . . . 73.209999999999994 106.668 171.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.7 tp -111.25 96.37 30.45 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.628 -0.879 . . . . 75.349999999999994 108.628 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 2.7 Cg_exo -75.92 -179.43 5.18 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.126 2.551 . . . . 62.009999999999998 112.829 -177.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 8.4 m-20 -65.09 124.27 21.68 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.344 -0.844 . . . . 74.439999999999998 111.033 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 49.4 mt -110.3 130.71 63.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.407 -1.331 . . . . 74.319999999999993 107.407 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 m -126.25 129.17 48.39 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.746 -0.835 . . . . 72.329999999999998 108.746 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.433 ' HE3' ' HB ' ' A' ' 16' ' ' ILE . 9.5 tmtm? -141.41 133.9 28.32 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.285 -1.376 . . . . 72.120000000000005 107.285 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 m -116.69 139.57 50.4 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 107.278 -1.379 . . . . 74.349999999999994 107.278 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.457 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -148.59 133.83 10.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.512 -0.921 . . . . 74.400000000000006 108.512 -178.393 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.425 ' CG2' ' HG3' ' A' ' 95' ' ' LYS . 3.4 m -104.37 125.59 50.73 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.775 -0.824 . . . . 70.109999999999999 108.775 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.7 mp -102.44 140.5 36.64 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.065 -0.516 . . . . 75.519999999999996 110.415 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -82.86 51.31 1.88 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.908 -0.775 . . . . 72.519999999999996 108.908 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.34 159.55 51.62 Favored Pre-proline 0 N--CA 1.433 -1.285 0 CA-C-N 115.787 -0.642 . . . . 72.099999999999994 109.838 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.25 156.47 55.47 Favored 'Trans proline' 0 C--O 1.262 1.713 0 C-N-CA 122.944 2.429 . . . . 71.109999999999999 111.199 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.8 tt -64.72 -29.83 48.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.64 -0.709 . . . . 74.319999999999993 112.014 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -72.07 -28.78 63.55 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.695 -0.802 . . . . 70.299999999999997 111.796 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -77.37 -41.73 39.12 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.712 -0.395 . . . . 75.420000000000002 109.975 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.533 HG11 HG21 ' A' ' 96' ' ' THR . 7.1 p -65.47 -39.1 84.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.48 -0.563 . . . . 75.540000000000006 109.48 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.463 ' NE1' ' HD3' ' A' ' 71' ' ' PRO . 66.9 t90 -58.89 -47.19 85.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.192 -0.913 . . . . 74.319999999999993 111.376 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.03 -33.25 75.13 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 119.398 -0.921 . . . . 62.509999999999998 110.19 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 94.9 m -62.02 -15.41 44.04 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 121.583 0.706 . . . . 42.210000000000001 112.129 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.451 HG11 ' CE1' ' A' ' 98' ' ' PHE . 20.3 m -121.83 7.53 5.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.082 -1.011 . . . . 61.539999999999999 112.009 176.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.416 ' HB3' HD22 ' A' ' 46' ' ' LEU . 18.7 m -127.71 -11.62 5.5 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.753 0.649 . . . . 54.119999999999997 112.753 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.5 p -91.61 163.23 14.19 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.106 -0.701 . . . . 74.439999999999998 109.106 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.564 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 9.3 m -53.36 -47.09 69.72 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.153 0.581 . . . . 72.310000000000002 111.615 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 32' ' ' SER . 1.4 mp0 -64.92 -48.77 72.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.721 -0.672 . . . . 73.040000000000006 110.729 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . -65.26 -43.66 94.92 Favored Glycine 0 C--O 1.247 0.962 0 CA-C-N 115.427 -0.806 . . . . 33.229999999999997 113.233 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.85 -43.72 97.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 109.907 -0.405 . . . . 74.519999999999996 109.907 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.7 -50.97 67.09 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.199 0.444 . . . . 25.449999999999999 112.199 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 22.9 mtmm 67.41 21.89 9.57 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.309 1.052 . . . . 75.420000000000002 110.536 -175.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -144.65 148.21 33.99 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 104.109 -2.552 . . . . 71.319999999999993 104.109 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -81.83 71.43 8.86 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.796 0.808 . . . . 70.219999999999999 110.211 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 57.4 tpp -124.11 122.03 26.19 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 107.958 -1.127 . . . . 74.230000000000004 107.958 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -75.56 84.88 1.67 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.96 1.773 . . . . 70.129999999999995 112.621 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.564 ' O ' ' HB3' ' A' ' 32' ' ' SER . 12.7 m120 -128.03 143.87 51.09 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.066 -1.827 . . . . 73.120000000000005 106.066 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -92.72 70.66 4.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 112.554 0.576 . . . . 71.439999999999998 112.554 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -78.51 119.95 22.53 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 106.206 -1.775 . . . . 65.319999999999993 106.206 172.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -124.5 149.58 46.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 112.688 0.625 . . . . 64.430000000000007 112.688 -171.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 30' ' ' SER . 23.1 tp -82.76 106.13 14.35 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.211 -0.904 . . . . 62.43 108.793 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -133.67 141.54 47.63 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.223 -2.139 . . . . 73.349999999999994 105.223 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.581 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 7.8 pt-20 -93.96 75.94 4.15 Favored 'General case' 0 C--N 1.27 -2.852 0 CA-C-N 120.185 1.357 . . . . 54.109999999999999 110.745 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.55 72.43 0.19 Allowed Glycine 1 N--CA 1.391 -4.348 0 CA-C-N 113.332 -1.758 . . . . 63.119999999999997 109.959 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.6 120.17 40.01 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 105.287 -2.116 . . . . 70.150000000000006 105.287 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -119.14 163.48 16.97 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.694 -0.484 . . . . 74.129999999999995 109.694 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -93.29 128.14 39.17 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.05 0.929 . . . . 73.530000000000001 111.674 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -122.72 140.45 52.86 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.208 -1.775 . . . . 73.010000000000005 106.208 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.66 82.65 3.3 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 122.093 0.949 . . . . 72.219999999999999 111.414 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -107.97 -168.36 1.36 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.577 -1.638 . . . . 61.539999999999999 106.577 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m -67.07 137.08 94.32 Favored Pre-proline 0 N--CA 1.432 -1.352 0 N-CA-C 107.246 -1.39 . . . . 51.009999999999998 107.246 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -30.93 97.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.781 1 C-N-CA 125.46 4.107 . . . . 74.5 115.68 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -104.05 86.13 2.52 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.058 -1.09 . . . . 54.140000000000001 108.058 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.41 112.67 1.0 Allowed Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.223 -0.898 . . . . 74.099999999999994 111.012 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -58.19 -32.72 96.4 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.634 2.223 . . . . 70.430000000000007 111.334 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.2 m -94.45 105.38 17.76 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 107.68 -1.23 . . . . 70.340000000000003 107.68 172.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.79 131.92 42.45 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.605 2.204 . . . . 74.019999999999996 111.057 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 65.1 m -129.75 146.12 51.52 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.411 -0.516 . . . . 65.299999999999997 111.452 -177.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -134.56 129.33 34.86 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.779 -1.563 . . . . 75.099999999999994 106.779 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.2 t -91.2 136.7 23.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 C-N-CA 118.132 -1.427 . . . . 70.219999999999999 108.816 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.448 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 1.9 tm? -87.45 -60.24 2.03 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.984 -1.117 . . . . 71.200000000000003 107.984 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.88 136.47 14.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.299 -0.409 . . . . 75.129999999999995 110.739 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 48' ' ' GLU . 47.3 t -118.11 119.27 60.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.595 -0.891 . . . . 72.349999999999994 108.595 176.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 42.7 mt-30 -116.14 140.88 48.84 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.705 -0.68 . . . . 63.229999999999997 110.491 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.39 131.51 93.23 Favored Pre-proline 0 C--N 1.281 -2.389 0 CA-C-N 113.9 -1.5 . . . . 72.319999999999993 110.314 -162.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HD3' ' NE1' ' A' ' 26' ' ' TRP . 55.3 Cg_exo 2.26 49.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.261 1 C-N-CA 128.144 5.896 . . . . 73.219999999999999 117.319 -162.293 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 p -140.71 -48.25 0.42 Allowed 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.538 -0.755 . . . . 74.310000000000002 111.138 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 32.1 tt0 -140.15 128.43 22.53 Favored 'General case' 0 C--O 1.21 -0.976 0 C-N-CA 118.802 -1.159 . . . . 70.439999999999998 110.852 -172.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.551 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -133.19 132.21 41.29 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 109.504 -0.554 . . . . 61.039999999999999 109.504 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.7 t -140.37 126.99 20.29 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.778 -0.453 . . . . 70.340000000000003 109.778 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.451 ' HD1' HD11 ' A' ' 74' ' ' LEU . 32.2 p90 -146.17 159.45 43.29 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 122.884 0.473 . . . . 71.019999999999996 111.098 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HG2' HG22 ' A' ' 84' ' ' VAL . 24.9 mt-10 -117.74 122.69 44.14 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 104.679 -2.341 . . . . 71.109999999999999 104.679 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -110.63 147.79 33.54 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.124 -0.944 . . . . 73.519999999999996 111.188 -173.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 t70 71.83 -174.93 0.17 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.753 1.621 . . . . 53.43 109.902 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.5 t -85.11 -5.4 59.34 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.598 -0.688 . . . . 73.420000000000002 110.35 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.405 ' OE1' ' HB2' ' A' ' 115' ' ' ALA . 14.3 mm-40 -85.3 -37.48 19.93 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.789 -0.641 . . . . 73.200000000000003 110.307 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.95 60.85 1.06 Allowed Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.254 -1.138 . . . . 73.430000000000007 110.254 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -81.39 106.22 13.19 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 107.851 -1.166 . . . . 75.319999999999993 107.851 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.444 HG23 ' HB2' ' A' ' 105' ' ' TRP . 84.4 t -84.92 106.05 14.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.123 -1.066 . . . . 70.430000000000007 108.123 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.21 134.86 49.91 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 108.74 -0.837 . . . . 73.310000000000002 108.74 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.7 m -125.56 130.44 51.7 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.568 -0.901 . . . . 60.299999999999997 108.568 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.551 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.1 m-85 -116.41 133.58 55.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.432 -0.951 . . . . 71.239999999999995 108.432 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.522 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 1.9 mm-40 -111.43 130.61 55.65 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 115.389 -0.823 . . . . 74.310000000000002 109.634 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.38 122.17 45.73 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.559 -0.746 . . . . 74.510000000000005 109.521 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -112.91 120.28 40.86 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.152 -1.055 . . . . 74.430000000000007 108.152 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -80.6 117.61 21.45 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.367 0.604 . . . . 72.409999999999997 109.772 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 7.0 mp -109.92 158.67 17.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.501 -1.666 . . . . 70.200000000000003 106.501 172.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -62.07 -37.27 94.18 Favored Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.964 -0.636 . . . . 74.140000000000001 114.371 -173.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -120.18 -3.2 10.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 117.393 0.597 . . . . 73.329999999999998 111.731 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.0 ptpt -153.17 175.78 12.66 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.61 -0.885 . . . . 24.0 108.61 -173.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.533 HG21 HG11 ' A' ' 25' ' ' VAL . 51.8 m -129.29 124.25 33.92 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.869 -0.732 . . . . 73.209999999999994 111.231 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.422 ' N ' HD13 ' A' ' 92' ' ' LEU . . . -84.18 113.44 3.74 Favored Glycine 0 N--CA 1.423 -2.207 0 N-CA-C 110.202 -1.159 . . . . 33.530000000000001 110.202 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.451 ' CE1' HG11 ' A' ' 29' ' ' VAL . 79.5 t80 -104.14 132.65 50.17 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 108.576 -0.898 . . . . 64.230000000000004 108.576 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 12.4 m -121.17 122.07 39.18 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.308 -0.997 . . . . 72.140000000000001 108.308 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.514 HD13 HG21 ' A' ' 134' ' ' VAL . 4.2 tp -100.78 124.47 46.47 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.821 -0.807 . . . . 72.439999999999998 108.821 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.54 124.29 66.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 106.87 -1.53 . . . . 64.129999999999995 106.87 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 8.0 t60 -112.02 113.65 26.06 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.948 -1.131 . . . . 73.319999999999993 107.948 177.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.2 m -118.28 132.87 56.27 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.137 -1.06 . . . . 73.439999999999998 108.137 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.28 132.51 11.27 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.117 -0.793 . . . . 65.310000000000002 111.117 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.444 ' HB2' HG23 ' A' ' 84' ' ' VAL . 83.0 t90 -95.16 -22.77 17.63 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.414 0.626 . . . . 71.040000000000006 109.756 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -114.73 97.75 6.45 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.539 0.685 . . . . 74.340000000000003 111.93 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -136.04 70.14 63.4 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 107.578 -1.267 . . . . 73.299999999999997 107.578 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.48 -39.08 0.44 Allowed 'Trans proline' 0 C--O 1.246 0.912 0 C-N-CA 122.464 2.11 . . . . 65.530000000000001 112.954 -174.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -102.6 -164.75 1.11 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.073 -1.454 . . . . 75.049999999999997 107.073 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -67.04 -29.77 69.65 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.229 -1.026 . . . . 73.530000000000001 108.229 171.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.0 p -111.87 162.23 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-N 114.639 -1.164 . . . . 73.409999999999997 108.14 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 pt -58.26 -33.16 46.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 124.347 1.059 . . . . 61.210000000000001 113.15 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.93 -137.23 8.98 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 108.807 -1.717 . . . . 71.019999999999996 108.807 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -104.28 18.76 21.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.759 0.79 . . . . 72.319999999999993 109.325 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.405 ' HB2' ' OE1' ' A' ' 81' ' ' GLU . . . -60.12 -39.5 86.48 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.838 0.828 . . . . 74.209999999999994 109.716 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -139.72 143.52 37.07 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.258 -1.756 . . . . 54.140000000000001 106.258 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -70.32 -23.84 62.9 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 113.659 0.985 . . . . 73.140000000000001 113.659 -172.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.543 ' HB2' HG23 ' A' ' 122' ' ' VAL . 75.6 mmtt -111.44 -176.51 2.96 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 122.002 -0.436 . . . . 52.399999999999999 109.876 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 7' ' ' ASN . 17.1 p -130.81 -73.47 0.54 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 111.659 0.244 . . . . 64.239999999999995 111.659 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -62.06 -36.06 80.52 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 123.443 0.697 . . . . 72.120000000000005 109.295 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.66 -45.51 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.366 -0.834 . . . . 70.129999999999995 110.011 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.543 HG23 ' HB2' ' A' ' 118' ' ' LYS . 72.9 t -61.37 -38.96 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 116.336 -0.393 . . . . 74.030000000000001 111.023 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.45 ' NH1' ' HB2' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -62.9 -45.34 92.98 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.833 -0.803 . . . . 74.420000000000002 108.833 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.42 -49.72 59.35 Favored Glycine 0 C--O 1.245 0.812 0 CA-C-N 115.738 -0.664 . . . . 63.340000000000003 111.987 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -60.5 -39.38 87.53 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.408 0.683 . . . . 72.420000000000002 112.259 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.9 mmt -68.55 -38.49 80.82 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.55 -0.46 . . . . 62.420000000000002 111.313 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.45 ' HB2' ' NH1' ' A' ' 123' ' ' ARG . 12.6 t70 -61.47 -53.11 60.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.194 -0.669 . . . . 61.530000000000001 109.194 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.37 -45.28 91.28 Favored Glycine 0 C--O 1.249 1.07 0 CA-C-N 115.108 -0.951 . . . . 73.200000000000003 111.89 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.33 -54.22 39.72 Favored Glycine 0 C--O 1.217 -0.952 0 O-C-N 123.999 0.47 . . . . 72.439999999999998 112.826 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.408 ' CE3' HD21 ' A' ' 100' ' ' LEU . 85.6 m95 -60.63 -34.95 75.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.7 0.63 . . . . 74.040000000000006 112.7 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.407 ' HA ' ' HG3' ' A' ' 14' ' ' LYS . 63.7 m -64.41 -55.16 22.85 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.163 0.289 . . . . 72.310000000000002 110.628 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.71 -48.21 51.07 Favored Glycine 0 C--O 1.248 0.972 0 C-N-CA 121.327 -0.463 . . . . 75.420000000000002 112.859 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.5 -57.44 12.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 CA-C-O 118.945 -0.55 . . . . 61.450000000000003 111.897 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.514 HG21 HD13 ' A' ' 100' ' ' LEU . 93.9 t -57.93 -42.2 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 119.079 -1.048 . . . . 62.149999999999999 112.804 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.457 ' HA ' HG13 ' A' ' 16' ' ' ILE . 36.9 t30 -54.73 -67.84 0.23 Allowed 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.473 0.483 . . . . 71.340000000000003 111.947 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -76.09 -40.33 53.29 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 120.355 -0.538 . . . . 62.149999999999999 111.982 -173.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 137' ' ' ARG . 4.3 tpp180 -66.37 -44.07 84.21 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 119.444 -0.903 . . . . 73.540000000000006 111.723 -172.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.532 ' HB3' HD21 ' A' ' 18' ' ' LEU . 10.8 mp -70.83 -43.83 67.74 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.789 -0.765 . . . . 62.119999999999997 111.419 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -60.56 -36.28 78.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.941 0.4 . . . . 60.240000000000002 110.381 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -75.63 -37.5 59.66 Favored 'General case' 0 C--O 1.185 -2.296 0 C-N-CA 119.807 -0.757 . . . . 71.519999999999996 112.25 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.04 -33.96 76.93 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.032 0.444 . . . . 45.420000000000002 110.756 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 28.1 m -78.96 -28.33 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 120.482 -0.487 . . . . 70.150000000000006 110.901 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -82.37 -73.67 0.38 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.416 0.627 . . . . 73.219999999999999 110.694 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -120.43 100.32 7.08 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.019 -0.991 . . . . 72.209999999999994 109.19 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.624 ' H ' HD23 ' A' ' 145' ' ' LEU . 2.5 pt? -88.69 0.09 56.78 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.434 0.635 . . . . 74.230000000000004 111.08 -176.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -81.94 -171.78 3.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.087 -0.961 . . . . 75.230000000000004 108.958 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -66.58 98.09 0.48 Allowed 'General case' 0 CA--C 1.55 0.947 0 CA-C-O 122.064 0.935 . . . . 71.109999999999999 111.162 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . 0.258 6.0 p-80 -89.65 80.17 6.67 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 122.368 1.08 . . . . 74.209999999999994 113.03 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -159.78 115.99 2.49 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.444 -1.707 . . . . 62.229999999999997 107.363 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -177.17 -175.03 0.54 Allowed 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.129 -0.693 . . . . 75.219999999999999 109.129 -173.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -64.03 103.15 0.56 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.637 -0.875 . . . . 75.120000000000005 108.637 172.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 . . . . . 0 C--N 1.285 -2.225 0 N-CA-C 108.151 -1.055 . . . . 54.109999999999999 108.151 -176.787 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 110.155 -0.313 . . . . 71.120000000000005 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.86 87.99 0.11 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.358 1.063 . . . . 71.200000000000003 113.265 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -76.02 -29.22 58.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.526 0.679 . . . . 72.420000000000002 109.594 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -129.32 157.74 41.06 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.256 -1.016 . . . . 70.120000000000005 108.256 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.402 ' ND2' ' H ' ' A' ' 7' ' ' ASN . 2.9 p-10 -100.57 -166.48 1.32 Allowed 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 106.313 -1.736 . . . . 75.310000000000002 106.313 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 8' ' ' ALA . 1.7 mp0 -63.91 -40.06 95.62 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.585 0.707 . . . . 73.239999999999995 110.923 -175.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 3.3 t-20 72.73 -35.89 0.34 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 126.705 2.002 . . . . 61.219999999999999 112.1 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 112' ' ' ILE . . . 159.26 -31.12 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 127.285 2.234 . . . . 45.219999999999999 107.592 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 9' ' ' LEU . 2.2 tm? 86.89 81.15 0.05 OUTLIER Pre-proline 0 N--CA 1.411 -2.386 0 C-N-CA 129.351 3.06 . . . . 63.149999999999999 107.977 -163.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HG3' ' OD1' ' A' ' 7' ' ' ASN . 14.7 Cg_endo -102.27 -153.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 123.727 2.952 . . . . 70.430000000000007 110.698 -177.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 1.1 m-20 -55.95 103.4 0.1 Allowed 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 123.893 0.746 . . . . 73.230000000000004 111.431 175.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.516 HG22 ' HB3' ' A' ' 102' ' ' HIS . 9.6 tp -102.65 131.63 50.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.952 -1.87 . . . . 74.099999999999994 105.952 170.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.9 m -117.66 129.49 55.77 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.002 0.429 . . . . 64.239999999999995 109.89 -176.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -131.57 126.35 34.61 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.556 -1.276 . . . . 64.230000000000004 107.556 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.1 m -116.95 133.65 55.74 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.932 -0.396 . . . . 71.420000000000002 109.932 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.422 HG21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -145.88 139.54 21.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.874 -0.787 . . . . 73.150000000000006 108.874 -175.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 p -97.67 125.11 42.25 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.208 0.527 . . . . 55.329999999999998 111.656 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.07 139.57 30.81 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.763 -0.653 . . . . 74.340000000000003 109.667 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -82.07 30.62 0.39 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.935 0.772 . . . . 73.319999999999993 111.105 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -129.23 159.57 68.39 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 116.071 -0.513 . . . . 75.209999999999994 110.732 -173.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.74 156.44 42.98 Favored 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 123.505 2.803 . . . . 74.209999999999994 112.042 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.593 HG12 HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -52.07 -41.72 33.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.167 -0.924 . . . . 62.210000000000001 111.107 -177.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -68.35 -34.85 76.82 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 119.98 -0.688 . . . . 74.019999999999996 111.033 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HA ' ' HG2' ' A' ' 27' ' ' GLU . 22.7 tptm -71.51 -38.47 71.12 Favored 'General case' 0 N--CA 1.441 -0.901 0 O-C-N 123.297 0.373 . . . . 75.409999999999997 110.38 -174.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.572 HG21 ' HB ' ' A' ' 96' ' ' THR . 47.8 t -71.11 -41.18 75.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.097 -0.705 . . . . 70.140000000000001 109.097 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 45.8 t90 -59.83 -47.69 84.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.474 -0.785 . . . . 73.439999999999998 111.444 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 11.5 pt-20 -66.29 -32.1 73.31 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.695 0.283 . . . . 42.109999999999999 110.64 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.3 m -65.66 -15.33 62.67 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 121.655 0.741 . . . . 74.530000000000001 111.683 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 13.6 m -125.3 18.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 O-C-N 121.138 -0.976 . . . . 72.239999999999995 112.276 177.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 p -134.33 -12.55 2.42 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.499 0.555 . . . . 75.519999999999996 112.499 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.9 p -94.53 163.35 13.43 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.135 -0.691 . . . . 61.009999999999998 109.135 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.59 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 17.9 t -56.64 -53.17 60.73 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 123.612 0.57 . . . . 74.040000000000006 111.094 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -57.21 -40.34 77.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.45 -0.796 . . . . 45.340000000000003 111.369 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.7 -48.01 24.17 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 120.824 -0.703 . . . . 75.120000000000005 113.372 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.3 mt -67.05 -33.29 62.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 122.699 0.4 . . . . 72.150000000000006 111.766 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.3 -30.56 28.8 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.449 1.648 . . . . 71.219999999999999 115.449 -174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.536 ' HE2' ' NE2' ' A' ' 151' ' ' HIS . 83.4 tttt 74.14 -48.76 0.66 Allowed 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 124.085 0.954 . . . . 71.120000000000005 110.404 -178.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.496 ' HA ' ' CE1' ' A' ' 149' ' ' HIS . 65.1 m95 -94.87 -159.98 0.75 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.683 -1.599 . . . . 75.019999999999996 106.683 175.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -105.83 -91.04 0.4 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.302 -1.74 . . . . 75.129999999999995 106.302 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 65.7 mtt 53.24 175.71 0.03 OUTLIER Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 124.5 1.12 . . . . 73.040000000000006 113.818 173.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.17 109.72 2.39 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.561 1.507 . . . . 72.010000000000005 109.971 170.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -139.67 152.81 47.02 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 110.03 -0.359 . . . . 65.019999999999996 110.03 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -137.39 69.58 1.4 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.503 0.668 . . . . 72.140000000000001 109.936 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.59 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 86.0 m-85 -91.61 136.37 33.18 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.812 -0.631 . . . . 74.340000000000003 110.015 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -137.52 143.5 41.67 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.67 -0.863 . . . . 62.140000000000001 108.67 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 46' ' ' LEU . 2.3 pt? -75.62 106.42 7.17 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.062 0.934 . . . . 73.120000000000005 110.017 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 15.8 tppt? -131.26 145.13 51.77 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.984 -1.858 . . . . 71.049999999999997 105.984 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.18 77.77 6.68 Favored 'General case' 0 C--N 1.278 -2.52 0 C-N-CA 118.773 -1.171 . . . . 73.409999999999997 109.223 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.87 67.53 0.31 Allowed Glycine 0 N--CA 1.413 -2.864 0 CA-C-N 114.695 -1.139 . . . . 71.340000000000003 112.973 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.585 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -138.0 127.16 24.37 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.873 -1.528 . . . . 70.530000000000001 106.873 -178.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -120.71 145.3 47.63 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 113.364 0.875 . . . . 75.239999999999995 113.364 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.411 ' HB3' ' H ' ' A' ' 63' ' ' CYS . 55.3 t80 -95.46 115.23 27.14 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.681 -1.229 . . . . 63.009999999999998 107.681 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -145.19 139.23 27.08 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.527 -0.761 . . . . 72.109999999999999 109.564 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.53 154.54 18.64 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.653 -1.98 . . . . 73.109999999999999 105.653 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -121.01 86.93 2.66 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.455 0.645 . . . . 75.329999999999998 110.749 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.4 m -160.0 143.27 10.27 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 106.828 -1.545 . . . . 54.340000000000003 106.828 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.6 85.13 0.38 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.321 2.014 . . . . 74.209999999999994 113.753 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -137.3 -70.45 0.45 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.623 -0.717 . . . . 74.329999999999998 110.189 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.89 68.75 1.52 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.327 -1.109 . . . . 63.310000000000002 110.327 -173.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.87 -80.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.658 2.238 . . . . 52.43 111.808 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.1 m -137.39 81.28 31.23 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 109.045 -0.724 . . . . 62.450000000000003 109.045 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -68.4 100.93 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.207 2.604 . . . . 75.519999999999996 110.937 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.413 ' HG ' ' HE1' ' A' ' 44' ' ' PHE . 8.2 p -134.08 169.53 17.01 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.935 -0.575 . . . . 52.100000000000001 111.883 -173.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 15.0 tptm -154.33 127.25 8.24 Favored 'General case' 0 C--O 1.193 -1.886 0 C-N-CA 125.478 1.511 . . . . 72.010000000000005 107.23 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -89.99 123.91 42.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 106.9 -1.519 . . . . 74.040000000000006 106.9 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 tt -72.92 -60.27 2.31 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.567 -1.271 . . . . 74.299999999999997 107.567 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.33 150.01 8.89 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.522 -0.763 . . . . 54.210000000000001 109.638 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.533 HG23 HD23 ' A' ' 74' ' ' LEU . 9.6 p -121.89 131.85 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 121.208 0.527 . . . . 75.519999999999996 109.757 176.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 75.3 mm-40 -104.08 141.41 36.27 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.201 -0.909 . . . . 74.340000000000003 109.193 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.11 126.98 93.35 Favored Pre-proline 0 C--N 1.276 -2.594 0 CA-C-N 114.268 -1.333 . . . . 75.329999999999998 108.623 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo 6.75 44.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.357 1 C-N-CA 128.096 5.864 . . . . 74.129999999999995 117.715 -162.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 p -137.14 -38.5 0.62 Allowed 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.707 -0.679 . . . . 65.209999999999994 112.139 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 30.2 tt0 -150.77 147.81 27.75 Favored 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 118.316 -1.354 . . . . 63.409999999999997 111.252 -173.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.691 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.6 tm? -142.02 136.1 29.92 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.068 -0.716 . . . . 53.43 109.068 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 p -140.64 127.64 20.72 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.241 0.46 . . . . 73.030000000000001 112.241 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.455 ' HD1' HD11 ' A' ' 74' ' ' LEU . 43.3 p90 -141.37 156.05 45.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.413 -0.358 . . . . 71.439999999999998 110.638 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -121.25 148.87 43.7 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.242 -1.392 . . . . 71.329999999999998 107.242 -171.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.408 ' HD1' ' OG1' ' A' ' 80' ' ' THR . 9.3 t-105 -119.36 126.52 51.61 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.79 -1.559 . . . . 65.010000000000005 106.79 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -70.06 -17.1 63.23 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.606 0.965 . . . . 70.0 113.606 -170.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.408 ' OG1' ' HD1' ' A' ' 78' ' ' TRP . 67.8 p -79.49 95.41 5.8 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 120.369 -0.533 . . . . 64.230000000000004 109.911 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 82.7 -15.79 0.64 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.289 1.436 . . . . 73.25 113.461 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.85 54.61 0.81 Allowed Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.049 -1.072 . . . . 51.439999999999998 114.231 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -92.81 149.44 21.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.835 -1.172 . . . . 74.030000000000001 107.835 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.7 p -142.84 124.82 12.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.156 -0.683 . . . . 73.019999999999996 109.156 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.2 149.96 21.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 121.418 0.627 . . . . 63.329999999999998 110.446 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.1 m -135.67 137.76 42.13 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.721 -0.672 . . . . 63.310000000000002 109.761 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.691 ' CD2' HD12 ' A' ' 74' ' ' LEU . 12.5 m-85 -113.74 129.09 56.63 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 107.396 -1.335 . . . . 73.340000000000003 107.396 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.553 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -112.13 134.16 53.85 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 105.91 -1.885 . . . . 70.129999999999995 105.91 177.075 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.593 HD21 HG12 ' A' ' 22' ' ' ILE . 6.9 tt -115.3 126.41 54.44 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.228 -0.656 . . . . 50.240000000000002 109.228 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -111.09 116.71 31.6 Favored 'General case' 0 N--CA 1.415 -2.175 0 N-CA-C 107.922 -1.14 . . . . 72.409999999999997 107.922 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -80.03 116.91 20.42 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.854 0.835 . . . . 73.140000000000001 110.364 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -120.96 159.86 24.72 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.662 -1.236 . . . . 50.350000000000001 107.662 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.57 140.82 19.21 Favored Glycine 0 C--N 1.268 -3.2 0 N-CA-C 107.599 -2.201 . . . . 51.32 107.599 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 84.63 -24.88 0.14 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.147 1.379 . . . . 74.150000000000006 111.339 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.5 175.36 14.13 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.82 -0.807 . . . . 72.310000000000002 108.82 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.572 ' HB ' HG21 ' A' ' 25' ' ' VAL . 84.8 m -126.59 129.98 49.63 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.273 -0.64 . . . . 71.049999999999997 109.273 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.61 109.89 3.6 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 110.972 -0.851 . . . . 75.25 110.972 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.422 ' CE1' HG11 ' A' ' 29' ' ' VAL . 88.4 t80 -98.5 134.14 41.88 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 109.094 -0.706 . . . . 70.209999999999994 109.094 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' A' ' 88' ' ' GLN . 23.7 m -123.11 118.93 28.82 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.331 -0.989 . . . . 44.43 108.331 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.56 140.8 34.31 Favored 'General case' 0 N--CA 1.41 -2.432 0 N-CA-C 108.876 -0.787 . . . . 61.399999999999999 108.876 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 100' ' ' LEU . 18.5 mt -136.07 124.75 37.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.856 0 CA-C-N 113.56 -1.655 . . . . 63.340000000000003 107.821 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.516 ' HB3' HG22 ' A' ' 12' ' ' ILE . 6.1 t60 -118.92 125.19 48.88 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.048 -1.834 . . . . 73.099999999999994 106.048 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.6 t -142.29 165.54 27.14 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 106.871 -1.529 . . . . 63.109999999999999 106.871 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -135.51 156.55 22.77 Favored Glycine 0 C--N 1.289 -2.074 0 N-CA-C 109.197 -1.561 . . . . 72.019999999999996 109.197 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -104.3 16.3 26.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 117.527 0.663 . . . . 72.439999999999998 112.289 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -135.4 92.2 2.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.672 -1.233 . . . . 73.239999999999995 107.672 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.431 ' HB3' HG22 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -158.81 82.32 2.63 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 115.292 -0.867 . . . . 70.140000000000001 113.31 -177.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -100.87 2.47 0.66 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.626 2.217 . . . . 71.019999999999996 114.328 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -132.54 -163.04 1.29 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.818 -0.808 . . . . 54.219999999999999 108.818 -174.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 7' ' ' ASN . 9.1 pt-20 -82.16 5.68 18.94 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.676 1.227 . . . . 71.409999999999997 110.112 171.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.428 HG23 ' HB3' ' A' ' 119' ' ' SER . 8.0 p -140.25 149.54 21.76 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-N 113.219 -1.809 . . . . 63.219999999999999 106.77 175.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.663 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -57.0 -32.38 39.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 123.313 0.645 . . . . 51.310000000000002 112.1 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.59 46.7 0.18 Allowed Glycine 0 CA--C 1.484 -1.874 0 C-N-CA 119.793 -1.194 . . . . 31.43 111.324 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 54.79 32.81 18.32 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.76 0.824 . . . . 74.219999999999999 111.669 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.402 ' HB3' HG13 ' A' ' 112' ' ' ILE . . . -71.28 -15.38 62.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.977 0.894 . . . . 63.140000000000001 109.435 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -152.01 174.47 13.62 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 104.383 -2.451 . . . . 70.200000000000003 104.383 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -48.61 -86.61 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 116.289 1.959 . . . . 64.439999999999998 116.289 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -119.02 149.73 41.15 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.957 -1.127 . . . . 72.430000000000007 107.957 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.428 ' HB3' HG23 ' A' ' 111' ' ' VAL . 6.9 p -65.0 -41.0 95.76 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.602 0.593 . . . . 75.430000000000007 112.602 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.42 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 10.7 t -68.23 -38.85 82.28 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.458 -0.497 . . . . 55.509999999999998 111.112 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.1 m -69.04 -34.13 62.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 C-N-CA 119.976 -0.689 . . . . 75.109999999999999 109.822 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.5 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 56.3 t -66.94 -46.66 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 116.35 -0.387 . . . . 71.120000000000005 110.733 177.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.08 -41.15 99.37 Favored 'General case' 0 C--O 1.209 -1.077 0 N-CA-C 109.425 -0.583 . . . . 63.509999999999998 109.425 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.56 -49.24 70.93 Favored Glycine 0 CA--C 1.502 -0.75 0 CA-C-N 116.223 -0.444 . . . . 51.340000000000003 112.159 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 122' ' ' VAL . 2.1 tmmm? -62.19 -32.64 73.31 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 123.413 0.685 . . . . 75.430000000000007 111.571 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 25.2 mmt -76.59 -44.94 32.39 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 120.338 -0.545 . . . . 64.319999999999993 110.191 176.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -58.9 -62.82 1.59 Allowed 'General case' 0 C--O 1.25 1.12 0 C-N-CA 123.912 0.885 . . . . 75.219999999999999 110.687 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.0 -42.07 60.03 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.696 -0.684 . . . . 70.319999999999993 111.866 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.583 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -58.9 -62.11 6.61 Favored Glycine 0 N--CA 1.437 -1.28 0 O-C-N 124.057 0.504 . . . . 74.109999999999999 112.043 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.464 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.5 m95 -60.82 -30.19 69.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.64 0.978 . . . . 73.540000000000006 113.64 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 73.1 m -63.4 -50.83 68.31 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 119.958 -0.697 . . . . 72.230000000000004 110.614 174.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.78 -46.15 54.77 Favored Glycine 0 C--O 1.251 1.218 0 C-N-CA 120.663 -0.779 . . . . 44.100000000000001 112.615 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 129' ' ' GLY . 52.1 mm -58.87 -57.86 9.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 123.023 0.529 . . . . 72.219999999999999 110.292 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HD23 ' A' ' 138' ' ' LEU . 93.1 t -62.97 -45.99 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 112.438 0.533 . . . . 65.409999999999997 112.438 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -57.03 -61.56 2.37 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 123.22 0.325 . . . . 74.340000000000003 111.746 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -84.65 -34.21 23.1 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 119.004 -1.078 . . . . 63.25 113.723 -172.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -70.32 -39.05 75.01 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.285 -0.966 . . . . 61.399999999999999 109.711 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.6 mm? -67.69 -48.95 65.13 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.874 -0.73 . . . . 62.020000000000003 109.778 174.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -58.25 -33.26 69.18 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.361 -0.381 . . . . 75.420000000000002 111.094 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -72.89 -48.31 38.39 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 112.188 0.44 . . . . 63.420000000000002 112.188 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.01 70.5 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.946 -0.302 . . . . 72.540000000000006 111.585 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.468 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 25.6 m -79.92 -33.08 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 120.594 -0.443 . . . . 74.129999999999995 111.556 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.48 -69.0 0.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.074 -0.65 . . . . 72.109999999999999 109.334 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -172.88 111.31 0.22 Allowed 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 123.558 0.743 . . . . 64.140000000000001 111.424 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.9 tp -74.53 106.23 6.02 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.75 -1.574 . . . . 75.140000000000001 106.75 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -106.95 5.18 27.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 114.222 1.194 . . . . 75.129999999999995 114.222 -170.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.403 ' CG ' ' H ' ' A' ' 148' ' ' HIS 0.256 7.3 p80 -152.42 -85.49 0.07 Allowed 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.571 -0.452 . . . . 53.240000000000002 111.9 173.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.403 ' H ' ' CG ' ' A' ' 147' ' ' HIS . 44.1 m80 -136.24 -74.01 0.44 Allowed 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 118.192 0.451 . . . . 71.519999999999996 111.645 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -179.73 172.95 1.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.447 0.467 . . . . 53.030000000000001 111.086 -178.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -101.99 118.43 36.9 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 105.364 -2.087 . . . . 72.409999999999997 105.364 172.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.542 ' HA ' ' CD1' ' A' ' 133' ' ' ILE . 49.9 t-80 -153.19 133.36 13.42 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.387 -0.525 . . . . 62.140000000000001 109.943 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 C--N 1.303 -1.436 0 N-CA-C 108.928 -0.767 . . . . 70.239999999999995 108.928 176.447 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 109.278 -0.638 . . . . 63.329999999999998 109.278 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.65 85.82 0.14 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.987 0.915 . . . . 63.109999999999999 111.29 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -77.09 -29.37 54.9 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.82 -1.082 . . . . 62.549999999999997 111.523 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -71.54 135.88 47.25 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.203 0.525 . . . . 63.520000000000003 110.861 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -152.71 -177.27 6.14 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.939 -1.504 . . . . 71.400000000000006 106.939 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -91.65 178.17 6.0 Favored 'General case' 0 N--CA 1.392 -3.37 0 CA-C-O 122.086 0.946 . . . . 71.519999999999996 112.459 -173.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.663 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 20.3 p30 -51.24 -49.91 60.19 Favored 'General case' 0 C--N 1.267 -3.003 0 CA-C-N 112.143 -2.299 . . . . 73.510000000000005 113.342 -174.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.62 103.66 15.6 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.894 -1.521 . . . . 62.049999999999997 106.894 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.402 ' CD1' ' HA ' ' A' ' 123' ' ' ARG . 6.2 tt -69.32 125.9 92.3 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 108.9 -0.778 . . . . 62.539999999999999 108.9 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -83.66 -158.43 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.051 2.5 . . . . 53.020000000000003 113.755 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.39 149.14 50.68 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.006 -0.997 . . . . 71.140000000000001 110.594 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 66.7 mt -123.97 139.48 50.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.82 -0.807 . . . . 73.239999999999995 108.82 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.5 m -139.58 131.38 27.52 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.904 -0.776 . . . . 42.420000000000002 108.904 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -145.88 151.43 37.86 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.376 -0.602 . . . . 63.32 109.376 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 p -117.39 151.81 36.27 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.126 -0.694 . . . . 64.340000000000003 109.126 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.533 HG21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -158.44 143.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 107.586 -1.264 . . . . 52.539999999999999 107.586 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 p -111.08 129.62 55.86 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.272 0.558 . . . . 64.349999999999994 112.438 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -101.88 139.66 37.22 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.074 -1.084 . . . . 74.230000000000004 108.074 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.527 ' CD ' ' HE ' ' A' ' 139' ' ' ARG 0.25 0.0 OUTLIER -93.29 53.36 1.91 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.826 1.298 . . . . 55.119999999999997 112.065 -177.873 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.5 160.16 52.15 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 113.332 -1.758 . . . . 71.219999999999999 108.41 -177.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HG2' ' HG2' ' A' ' 24' ' ' LYS . 28.9 Cg_endo -62.55 155.52 57.85 Favored 'Trans proline' 0 C--O 1.257 1.459 0 C-N-CA 122.803 2.335 . . . . 75.450000000000003 111.628 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 tt -56.57 -32.67 37.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.405 -0.816 . . . . 73.150000000000006 111.794 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -62.65 -40.23 96.39 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 123.12 0.262 . . . . 51.140000000000001 110.755 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 21' ' ' PRO . 14.2 mmmm -69.41 -42.49 75.0 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 116.298 -0.41 . . . . 75.209999999999994 110.869 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.477 HG21 ' HB ' ' A' ' 96' ' ' THR . 46.0 t -66.52 -42.49 90.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.55 -0.537 . . . . 74.030000000000001 109.55 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -61.89 -47.49 84.73 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.561 -0.745 . . . . 74.140000000000001 111.208 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.436 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 13.3 pt-20 -68.47 -29.51 68.16 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.78 -0.368 . . . . 74.409999999999997 111.319 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.6 m -60.75 -29.26 69.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.368 0.604 . . . . 72.150000000000006 111.27 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.581 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 15.2 m -113.1 19.62 7.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.25 -0.432 . . . . 74.439999999999998 112.147 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 27' ' ' GLU . 37.8 p -136.68 -20.7 1.32 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.077 0.769 . . . . 74.25 113.077 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.8 p -96.34 161.81 13.77 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 120.584 -0.446 . . . . 64.230000000000004 110.94 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 m -58.76 -55.52 34.07 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 123.588 0.555 . . . . 44.200000000000003 110.776 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 1.5 mp0 -57.28 -44.77 84.28 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 123.653 0.781 . . . . 72.400000000000006 110.581 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -48.87 65.34 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.4 -0.818 . . . . 53.399999999999999 113.238 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.2 mt -69.45 -43.1 81.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.411 . . . . 73.120000000000005 110.777 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.35 -31.9 72.96 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.859 0.689 . . . . 74.299999999999997 112.859 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.7 tptp 64.45 24.95 13.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 122.913 1.339 . . . . 62.310000000000002 108.557 -173.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 66.99 9.83 7.2 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 113.662 -1.608 . . . . 74.409999999999997 112.375 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.487 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 40.0 m-85 -76.46 -71.78 0.37 Allowed 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 120.807 0.337 . . . . 73.400000000000006 110.646 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.41 ' SD ' ' HB3' ' A' ' 39' ' ' PHE . 1.8 mpt? -99.12 105.64 33.47 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 110.003 -0.369 . . . . 73.340000000000003 110.003 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 39' ' ' PHE . 35.9 Cg_exo -63.69 96.17 0.2 Allowed 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 122.837 2.358 . . . . 72.519999999999996 110.858 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.422 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . 44.4 t-20 -138.95 149.87 45.25 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.629 -1.249 . . . . 73.140000000000001 107.629 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -88.93 75.12 8.09 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-O 122.076 0.941 . . . . 71.150000000000006 109.873 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 84.0 m-85 -78.79 119.81 22.53 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.622 -1.251 . . . . 73.319999999999993 107.622 172.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -117.55 146.87 43.29 Favored 'General case' 0 CA--C 1.484 -1.585 0 O-C-N 123.374 0.422 . . . . 73.209999999999994 110.23 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.421 HD13 ' CB ' ' A' ' 30' ' ' SER . 30.1 tp -78.85 104.57 9.58 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 106.838 -1.542 . . . . 72.0 106.838 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 58.2 tttm -133.33 133.67 42.82 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.148 -1.427 . . . . 74.219999999999999 107.148 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HA ' HG23 ' A' ' 68' ' ' VAL . 4.7 pt-20 -88.14 73.07 9.04 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-O 123.033 1.396 . . . . 61.310000000000002 109.102 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.0 57.03 0.19 Allowed Glycine 1 N--CA 1.392 -4.262 0 CA-C-N 112.825 -1.989 . . . . 61.130000000000003 109.992 -177.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.21 124.65 30.1 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 105.965 -1.865 . . . . 62.310000000000002 105.965 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.35 135.27 54.42 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-O 121.286 0.565 . . . . 63.350000000000001 110.766 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -128.71 146.74 50.8 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.463 -1.68 . . . . 70.239999999999995 106.463 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -110.15 140.37 44.32 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.317 0.579 . . . . 71.310000000000002 110.355 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.421 ' H ' HD23 ' A' ' 54' ' ' LEU . 2.2 pt? -130.93 150.91 51.87 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 107.123 -1.436 . . . . 72.019999999999996 107.123 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.423 ' HG2' ' HD2' ' A' ' 57' ' ' PRO . 52.0 tt0 -72.73 155.24 40.17 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.422 -1.325 . . . . 63.340000000000003 107.422 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.4 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 20.8 m -46.34 -43.76 36.46 Favored Pre-proline 0 CA--C 1.573 1.851 0 N-CA-C 116.445 2.017 . . . . 52.130000000000003 116.445 -174.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD2' ' HG2' ' A' ' 55' ' ' GLN . 8.4 Cg_endo -52.21 -67.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 122.179 1.919 . . . . 75.109999999999999 113.049 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -176.94 -179.52 0.94 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.664 0.785 . . . . 75.439999999999998 108.9 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.78 168.35 24.78 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 109.748 -1.341 . . . . 75.439999999999998 109.748 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.01 -67.5 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.8 2.333 . . . . 73.420000000000002 112.321 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.1 m -148.23 85.34 6.39 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 108.833 -0.803 . . . . 44.549999999999997 108.833 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -72.41 140.76 33.95 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.288 1.992 . . . . 74.420000000000002 111.295 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 21.5 p -129.08 141.26 51.27 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 108.488 -0.93 . . . . 74.129999999999995 108.488 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 53.4 mtmt -148.97 123.52 9.75 Favored 'General case' 0 C--O 1.198 -1.639 0 N-CA-C 108.435 -0.95 . . . . 63.299999999999997 108.435 177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 46.1 t -89.19 135.89 24.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.014 -1.106 . . . . 72.120000000000005 108.014 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.3 tp -80.36 -62.59 1.63 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.054 -0.721 . . . . 72.329999999999998 109.054 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.78 149.87 28.79 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.21 -0.905 . . . . 75.129999999999995 109.835 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG23 ' HA ' ' A' ' 48' ' ' GLU . 66.7 t -125.89 123.17 63.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.803 -0.814 . . . . 71.510000000000005 108.803 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.534 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 81.5 mm-40 -107.81 140.78 40.39 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.344 0.592 . . . . 74.340000000000003 110.291 174.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.77 123.94 88.19 Favored Pre-proline 0 C--N 1.277 -2.545 0 CA-C-N 113.873 -1.512 . . . . 72.010000000000005 109.213 -165.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo 6.86 49.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.639 1 C-N-CA 127.75 5.633 . . . . 71.329999999999998 116.603 -161.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 p -138.9 -41.5 0.48 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.105 -0.952 . . . . 74.219999999999999 112.077 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 39.3 tt0 -148.15 145.09 28.2 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 119.973 -0.691 . . . . 70.430000000000007 110.197 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.7 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.9 tm? -142.12 135.91 29.54 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.343 -0.984 . . . . 73.349999999999994 108.343 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.2 m -139.45 126.25 20.79 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 121.029 -0.268 . . . . 65.120000000000005 110.651 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 36.1 p90 -145.76 156.97 43.95 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 122.2 0.2 . . . . 74.420000000000002 111.242 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 24.0 mt-10 -120.39 124.6 45.91 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.085 -1.82 . . . . 74.209999999999994 106.085 -174.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -130.07 157.51 42.19 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 116.222 -0.445 . . . . 72.299999999999997 110.592 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 78.85 -176.33 0.09 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.267 1.827 . . . . 75.209999999999994 109.789 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.3 p -73.11 -18.47 61.29 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 114.433 1.272 . . . . 60.399999999999999 114.433 -173.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.401 ' HB2' ' NE1' ' A' ' 83' ' ' TRP . 3.7 mp0 -92.83 -18.77 22.44 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.092 -0.643 . . . . 70.319999999999993 110.989 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.89 60.63 2.88 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 120.002 -1.094 . . . . 43.439999999999998 110.54 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 95.9 m95 -78.33 121.21 24.16 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.551 -0.907 . . . . 72.129999999999995 108.551 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 76' ' ' PHE . 8.7 p -99.19 107.74 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 CA-C-O 122.516 1.151 . . . . 63.240000000000002 111.592 -173.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -99.84 146.48 8.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.41 -1.268 . . . . 63.509999999999998 108.369 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 42.4 m -130.5 135.82 48.35 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 109.139 -0.689 . . . . 53.439999999999998 109.139 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.7 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.4 m-85 -112.59 135.55 53.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.2 -1.037 . . . . 72.310000000000002 108.2 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.15 137.91 52.65 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.392 -0.966 . . . . 75.230000000000004 108.392 176.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -113.1 131.52 55.79 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.77 0.319 . . . . 73.450000000000003 111.296 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -120.7 139.06 53.6 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.231 1.013 . . . . 72.439999999999998 108.678 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -96.73 128.71 43.94 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.087 0.47 . . . . 65.310000000000002 109.996 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.56 153.54 45.08 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.981 -1.118 . . . . 73.420000000000002 107.981 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.98 57.54 5.07 Favored Glycine 0 C--N 1.289 -2.053 0 C-N-CA 121.488 -0.387 . . . . 71.239999999999995 113.667 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 171.65 -44.54 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 124.434 1.093 . . . . 75.230000000000004 108.323 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -130.78 172.59 11.83 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.167 -1.379 . . . . 73.129999999999995 109.115 -170.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.477 ' HB ' HG21 ' A' ' 25' ' ' VAL . 74.0 m -116.52 130.91 57.02 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 109.22 -0.659 . . . . 65.549999999999997 109.22 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.08 119.8 5.66 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.059 -1.216 . . . . 53.130000000000003 110.059 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -108.0 133.23 52.61 Favored 'General case' 0 C--N 1.269 -2.895 0 N-CA-C 108.082 -1.081 . . . . 74.049999999999997 108.082 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.7 m -122.77 122.51 38.87 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.761 -0.829 . . . . 44.409999999999997 108.761 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.483 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.19 139.05 36.42 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 121.854 0.835 . . . . 73.099999999999994 109.404 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.534 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 14.0 mt -136.49 128.88 45.03 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 113.334 -1.757 . . . . 73.299999999999997 108.047 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.523 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . 8.7 t-80 -120.38 125.82 48.95 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.698 -0.853 . . . . 60.420000000000002 108.698 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.7 t -142.83 159.87 41.41 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 104.777 -2.305 . . . . 75.439999999999998 104.777 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.55 -169.04 36.12 Favored Glycine 0 C--N 1.292 -1.89 0 C-N-CA 119.967 -1.111 . . . . 51.140000000000001 112.325 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -85.71 98.61 10.8 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.502 0.668 . . . . 73.319999999999993 112.421 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -98.55 136.98 37.88 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.942 -1.026 . . . . 44.32 109.155 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -115.7 145.06 33.76 Favored Pre-proline 0 C--N 1.284 -2.239 0 N-CA-C 107.558 -1.275 . . . . 60.329999999999998 107.558 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.53 89.76 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.874 1.716 . . . . 72.230000000000004 111.154 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 111' ' ' VAL . 5.2 m-20 -135.13 -176.32 4.21 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.35 -1.352 . . . . 74.319999999999993 107.35 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.663 ' O ' ' HB2' ' A' ' 7' ' ' ASN . 11.6 tm-20 -81.61 1.18 35.03 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 123.148 1.451 . . . . 52.210000000000001 108.803 174.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 109' ' ' ASN . 1.7 m -143.24 179.87 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 126.693 1.997 . . . . 64.109999999999999 107.552 175.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 112' ' ' ILE . 2.9 pt -55.65 -31.8 29.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 123.955 0.784 . . . . 65.209999999999994 113.062 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.29 -135.08 7.4 Favored Glycine 0 CA--C 1.486 -1.747 0 C-N-CA 119.893 -1.146 . . . . 34.130000000000003 111.801 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -80.07 11.2 3.56 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.904 0.705 . . . . 70.0 112.904 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.43 -15.52 63.58 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.991 -0.744 . . . . 62.420000000000002 108.991 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . 0.3 0.0 OUTLIER 59.32 10.0 1.62 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 128.515 2.726 . . . . 72.340000000000003 116.642 172.267 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.81 161.39 18.38 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.916 -0.713 . . . . 65.219999999999999 110.059 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -82.61 145.2 29.81 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.742 -0.836 . . . . 74.340000000000003 108.742 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 p -57.19 -40.4 77.31 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.919 0.711 . . . . 43.450000000000003 112.919 -176.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.1 p -67.8 -46.12 72.84 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.567 -0.288 . . . . 52.509999999999998 111.626 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.64 -33.87 62.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 C-N-CA 120.295 -0.562 . . . . 64.140000000000001 109.641 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.07 -46.14 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.275 -0.421 . . . . 72.409999999999997 110.887 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.402 ' HA ' ' CD1' ' A' ' 9' ' ' LEU . 44.4 ttm180 -66.22 -45.61 80.11 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 121.007 -0.277 . . . . 73.420000000000002 110.902 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.47 -43.21 99.03 Favored Glycine 0 N--CA 1.446 -0.657 0 O-C-N 123.608 0.568 . . . . 55.340000000000003 112.053 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -38.47 73.88 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.686 0.625 . . . . 62.43 112.686 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.82 -45.73 49.54 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.981 -0.688 . . . . 72.540000000000006 110.854 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.06 -59.2 3.67 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.441 -0.345 . . . . 62.240000000000002 111.618 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.74 -40.99 93.97 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.541 -0.624 . . . . 52.539999999999999 111.541 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.49 -60.15 8.69 Favored Glycine 0 N--CA 1.436 -1.315 0 O-C-N 124.054 0.503 . . . . 52.329999999999998 112.3 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.419 ' HE3' HG23 ' A' ' 134' ' ' VAL . 67.8 m95 -63.37 -35.68 81.21 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.592 0.96 . . . . 70.329999999999998 113.592 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.2 m -68.29 -54.54 16.85 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.166 -0.614 . . . . 65.140000000000001 110.94 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.19 -47.04 39.11 Favored Glycine 0 C--O 1.244 0.735 0 C-N-CA 120.829 -0.7 . . . . 73.200000000000003 112.95 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.711 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 46.2 mm -67.3 -49.8 68.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.955 0 CA-C-O 119.577 -0.249 . . . . 65.049999999999997 111.228 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.533 HG12 HG21 ' A' ' 16' ' ' ILE . 78.6 t -61.84 -49.6 83.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 118.793 -1.163 . . . . 50.25 112.218 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -61.6 -64.83 0.81 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.702 0.63 . . . . 61.32 112.702 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.05 -39.23 50.77 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.863 -0.735 . . . . 65.310000000000002 112.723 -172.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.711 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -69.61 -40.93 76.33 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.006 -0.677 . . . . 70.409999999999997 111.886 -176.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.2 mm? -62.63 -48.88 77.42 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 119.063 -1.055 . . . . 73.129999999999995 109.271 175.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.527 ' HE ' ' CD ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -61.0 -38.79 87.29 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.735 -0.666 . . . . 72.519999999999996 110.452 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -76.89 -36.76 56.47 Favored 'General case' 0 CA--C 1.471 -2.093 0 N-CA-C 113.721 1.008 . . . . 73.439999999999998 113.721 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 -27.42 64.02 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.131 -0.627 . . . . 43.020000000000003 110.611 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.434 HG11 HG22 ' A' ' 25' ' ' VAL . 23.8 m -80.2 -26.71 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 116.201 -0.454 . . . . 72.299999999999997 110.76 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -84.31 -60.36 2.11 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 119.98 -0.688 . . . . 74.439999999999998 111.512 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.25 154.96 40.88 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.985 1.106 . . . . 71.540000000000006 113.985 -170.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.611 ' H ' HD23 ' A' ' 145' ' ' LEU . 2.2 pt? -87.48 79.34 8.41 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 122.572 1.177 . . . . 72.450000000000003 108.354 173.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -82.48 83.22 7.61 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.713 -1.13 . . . . 52.140000000000001 109.5 -175.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -101.12 147.54 26.11 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.08 -0.964 . . . . 71.519999999999996 108.973 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -152.01 179.9 8.07 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.245 -0.65 . . . . 73.230000000000004 109.245 -171.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -68.13 138.13 55.46 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 107.99 -1.115 . . . . 75.310000000000002 107.99 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 44.7 p-80 -113.53 127.95 56.27 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 121.066 0.46 . . . . 74.439999999999998 110.484 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -70.86 -15.45 62.63 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 115.223 1.564 . . . . 74.150000000000006 115.223 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 . . . . . 0 C--N 1.299 -1.591 0 N-CA-C 108.324 -0.991 . . . . 72.439999999999998 108.324 177.352 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 107.763 -1.199 . . . . 72.140000000000001 107.763 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.13 100.78 0.63 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.435 -0.579 . . . . 73.209999999999994 109.435 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -62.28 -28.89 70.04 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.71 0.804 . . . . 71.340000000000003 109.969 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -113.71 132.89 55.64 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.324 -0.991 . . . . 71.340000000000003 108.324 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -114.91 3.5 14.58 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.364 0.602 . . . . 54.409999999999997 110.698 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -81.38 104.89 12.14 Favored 'General case' 0 N--CA 1.409 -2.479 0 CA-C-O 122.461 1.124 . . . . 63.219999999999999 109.34 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.518 ' HA ' ' HD2' ' A' ' 123' ' ' ARG . 60.9 t30 -68.32 -11.92 60.26 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 112.622 -2.081 . . . . 73.200000000000003 113.12 -175.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.61 -72.38 0.27 Allowed 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.042 0.448 . . . . 64.140000000000001 110.461 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 tt 177.99 100.99 0.13 Allowed Pre-proline 0 N--CA 1.434 -1.266 0 N-CA-C 105.775 -1.935 . . . . 64.340000000000003 105.775 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -92.96 -179.42 0.95 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.413 2.075 . . . . 40.43 110.118 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.589 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 3.2 p-10 -68.24 112.28 5.06 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.836 -0.802 . . . . 62.140000000000001 108.836 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.531 HG22 ' HB3' ' A' ' 102' ' ' HIS . 9.1 tp -97.33 125.44 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 C-N-CA 118.456 -1.298 . . . . 70.409999999999997 108.283 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 60.7 m -107.18 128.98 54.89 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 107.425 -1.324 . . . . 73.030000000000001 107.425 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -131.09 136.52 48.47 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.68 -1.23 . . . . 74.430000000000007 107.68 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -118.3 134.95 54.6 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 120.754 0.312 . . . . 61.299999999999997 111.211 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.509 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.78 139.98 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.033 0.444 . . . . 53.399999999999999 109.917 -179.091 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 p -101.09 126.74 47.81 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.137 0.494 . . . . 74.549999999999997 110.969 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.408 HD11 ' HB3' ' A' ' 138' ' ' LEU . 4.0 mm? -91.19 138.17 31.8 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.617 -0.72 . . . . 64.310000000000002 110.603 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -86.83 30.12 0.76 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 113.997 -1.456 . . . . 74.140000000000001 109.613 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.15 158.41 73.74 Favored Pre-proline 0 C--O 1.251 1.142 0 CA-C-N 115.564 -0.743 . . . . 62.229999999999997 109.37 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.97 150.76 87.61 Favored 'Trans proline' 0 C--O 1.25 1.091 0 C-N-CA 123.286 2.657 . . . . 75.129999999999995 112.109 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -40.24 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.091 -0.958 . . . . 70.519999999999996 111.68 -176.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -67.83 -35.77 79.19 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.997 -0.681 . . . . 74.430000000000007 111.179 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -72.66 -37.48 67.93 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.627 -0.509 . . . . 62.509999999999998 109.627 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.03 -41.15 89.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.908 -0.587 . . . . 61.210000000000001 109.618 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -60.02 -47.03 87.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.593 -0.73 . . . . 74.140000000000001 110.086 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -60.79 -39.79 90.17 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.362 0.665 . . . . 73.439999999999998 110.475 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.7 m -60.97 -23.29 65.23 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.536 0.734 . . . . 72.129999999999995 112.055 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.589 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 10.7 m -119.25 19.87 6.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 112.508 0.558 . . . . 73.310000000000002 112.508 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.427 ' HB2' HD12 ' A' ' 46' ' ' LEU . 61.0 p -137.46 -22.09 1.14 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.933 0.716 . . . . 63.030000000000001 112.933 176.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -91.63 154.61 18.91 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.456 -0.572 . . . . 63.420000000000002 109.456 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 27.7 t -63.01 -40.78 98.78 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.605 -0.887 . . . . 63.420000000000002 108.605 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -62.3 -48.97 77.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.678 -1.147 . . . . 71.420000000000002 109.638 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.78 -47.59 60.26 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.151 -0.931 . . . . 71.209999999999994 113.402 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HA ' HH22 ' A' ' 137' ' ' ARG . 70.2 mt -69.47 -48.46 66.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 117.601 0.7 . . . . 73.219999999999999 111.895 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.71 -45.55 78.39 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.461 0.541 . . . . 70.5 112.461 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 tttp 57.48 23.83 9.56 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 123.145 1.45 . . . . 75.129999999999995 108.63 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 65.3 13.29 8.69 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.843 2.057 . . . . 61.119999999999997 114.504 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -72.4 -44.47 62.45 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.835 0.826 . . . . 72.129999999999995 109.322 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.42 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 21.6 ptm -128.68 125.31 23.02 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 114.655 -1.157 . . . . 65.209999999999994 109.433 -176.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 40' ' ' MET . 5.0 Cg_exo -79.05 94.24 1.08 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.168 1.912 . . . . 64.510000000000005 113.385 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -140.22 143.92 36.27 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.082 -1.451 . . . . 64.120000000000005 107.082 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.79 78.86 3.28 Favored 'General case' 0 CA--C 1.469 -2.139 0 CA-C-O 121.177 0.513 . . . . 74.409999999999997 110.911 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 83.1 m-85 -68.28 126.55 29.94 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.594 -1.185 . . . . 63.43 109.009 175.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -127.45 138.75 53.04 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.987 -0.745 . . . . 65.400000000000006 108.987 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 30' ' ' SER . 5.5 tt -75.56 103.72 5.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 106.641 -1.615 . . . . 65.519999999999996 106.641 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 1.2 tpmt? -133.91 145.13 49.32 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.53 -1.656 . . . . 73.299999999999997 106.53 172.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -87.68 48.12 1.6 Allowed 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 119.298 0.954 . . . . 73.519999999999996 110.185 174.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.68 49.96 0.03 OUTLIER Glycine 0 N--CA 1.42 -2.409 0 CA-C-N 115.32 -0.855 . . . . 62.140000000000001 111.0 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -79.24 104.77 10.1 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 106.082 -1.822 . . . . 74.0 106.082 176.633 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -151.44 148.93 28.68 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 108.859 -0.793 . . . . 71.420000000000002 108.859 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -124.07 146.99 48.22 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 105.351 -2.092 . . . . 74.010000000000005 105.351 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -109.81 142.66 40.77 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.244 -0.651 . . . . 64.439999999999998 109.244 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -127.29 137.5 52.85 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.962 -0.755 . . . . 63.229999999999997 108.962 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -82.5 91.39 6.88 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.151 -1.425 . . . . 72.409999999999997 107.151 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.7 m -156.9 120.28 2.24 Favored Pre-proline 0 C--N 1.297 -1.692 0 N-CA-C 108.93 -0.767 . . . . 74.219999999999999 108.93 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.95 115.33 3.21 Favored 'Trans proline' 0 C--O 1.244 0.824 0 C-N-CA 121.74 1.627 . . . . 70.25 108.174 173.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.1 t80 71.1 94.22 0.08 Allowed 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.658 -1.238 . . . . 70.540000000000006 107.658 -170.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.41 152.85 40.2 Favored Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 115.37 -0.832 . . . . 74.140000000000001 112.904 -175.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.479 ' O ' HG22 ' A' ' 80' ' ' THR . 17.6 Cg_endo -60.08 -33.76 95.04 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.041 2.494 . . . . 75.329999999999998 112.492 177.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.2 t 70.39 92.42 0.06 OUTLIER Pre-proline 0 C--O 1.249 1.07 0 C-N-CA 123.964 0.906 . . . . 71.319999999999993 111.593 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.37 -158.62 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.97 2.446 . . . . 72.340000000000003 109.632 175.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 20.4 p -88.37 141.5 28.49 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 119.306 -0.958 . . . . 72.150000000000006 108.553 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 9.6 mtmp? -145.38 135.5 23.84 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.35 -0.982 . . . . 74.340000000000003 108.35 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 50' ' ' GLN . 30.2 t -90.28 130.61 39.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.602 -1.258 . . . . 62.119999999999997 107.602 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.2 tp -76.03 -59.91 2.55 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.055 -1.091 . . . . 75.030000000000001 108.055 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -162.16 141.08 9.33 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.352 -0.84 . . . . 61.119999999999997 109.776 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.505 HG23 HD23 ' A' ' 74' ' ' LEU . 9.4 p -116.99 120.46 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.982 0 CA-C-O 121.583 0.706 . . . . 65.0 110.036 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 2.2 mp0 -94.15 141.04 29.0 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.617 -1.174 . . . . 73.200000000000003 108.85 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 122.69 83.57 Favored Pre-proline 0 C--N 1.276 -2.613 0 CA-C-N 114.379 -1.282 . . . . 51.439999999999998 108.969 -164.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo 0.12 62.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.014 1 C-N-CA 126.771 4.981 . . . . 62.520000000000003 115.488 -159.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -143.47 -42.24 0.29 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 113.67 -1.605 . . . . 73.209999999999994 110.983 175.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.4 tt0 -150.84 145.46 25.7 Favored 'General case' 0 C--O 1.204 -1.318 0 C-N-CA 119.834 -0.746 . . . . 74.439999999999998 110.491 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.694 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.0 tm? -137.05 137.63 39.56 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.063 -1.088 . . . . 73.010000000000005 108.063 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.7 p -140.76 126.88 19.58 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.803 -0.359 . . . . 65.340000000000003 110.992 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.46 ' HD1' HD11 ' A' ' 74' ' ' LEU . 31.2 p90 -144.23 156.91 44.49 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 120.794 0.33 . . . . 72.519999999999996 111.07 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 20.6 mt-10 -121.07 136.78 54.91 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 105.963 -1.866 . . . . 75.530000000000001 105.963 -173.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -147.94 158.71 44.19 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 120.188 -0.605 . . . . 74.420000000000002 112.409 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 73.84 171.34 0.3 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.05 -1.432 . . . . 73.5 113.195 172.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 60' ' ' PRO . 11.6 p -66.47 -34.46 77.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.934 0.894 . . . . 70.340000000000003 111.862 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.405 ' O ' ' HE3' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -74.46 -15.11 60.9 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 112.438 0.533 . . . . 74.310000000000002 112.438 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.29 67.64 1.79 Allowed Glycine 0 C--O 1.247 0.91 0 C-N-CA 121.058 -0.591 . . . . 54.329999999999998 112.411 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.456 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 33.2 m95 -93.95 130.21 40.13 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.33 -0.618 . . . . 63.340000000000003 109.33 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.432 HG22 ' HG2' ' A' ' 77' ' ' GLU . 42.1 t -110.8 111.43 36.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.854 -1.165 . . . . 73.230000000000004 107.854 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.3 m -109.23 140.59 27.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 115.946 -0.57 . . . . 73.129999999999995 109.67 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 58.3 m -126.09 135.14 51.37 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.9 -0.778 . . . . 74.349999999999994 108.9 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.694 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.7 m-85 -111.25 132.59 54.23 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.793 -1.188 . . . . 73.430000000000007 107.793 177.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.57 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 27.3 mt-30 -114.35 141.45 47.61 Favored 'General case' 0 C--N 1.276 -2.614 0 O-C-N 123.643 0.589 . . . . 75.239999999999995 110.568 177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.6 tp -104.18 141.18 36.71 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.705 -0.68 . . . . 64.120000000000005 110.918 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -124.92 116.68 22.59 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 106.164 -1.791 . . . . 74.349999999999994 106.164 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -86.22 119.15 26.2 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.999 -0.546 . . . . 65.109999999999999 111.796 -173.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 74.6 mt -125.18 149.52 47.85 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.046 -1.464 . . . . 71.010000000000005 107.046 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.84 58.84 1.79 Allowed Glycine 0 C--N 1.28 -2.536 0 C-N-CA 120.44 -0.886 . . . . 63.200000000000003 112.476 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -177.15 -52.84 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.119 -1.808 . . . . 62.210000000000001 106.119 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.67 175.8 7.7 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.006 -1.479 . . . . 74.340000000000003 107.006 -175.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.1 m -120.87 130.39 53.9 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 120.341 -0.543 . . . . 62.039999999999999 109.697 -178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.52 124.79 7.86 Favored Glycine 0 N--CA 1.408 -3.216 0 N-CA-C 109.099 -1.6 . . . . 72.340000000000003 109.099 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -117.27 134.18 55.11 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 108.812 -0.81 . . . . 74.129999999999995 108.812 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 23.5 m -125.95 129.24 48.88 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.517 -0.92 . . . . 65.549999999999997 108.517 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.505 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -104.79 142.26 35.03 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.005 -0.739 . . . . 74.230000000000004 109.005 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.494 ' N ' HD13 ' A' ' 100' ' ' LEU . 3.6 mp -136.13 125.25 38.61 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 106.829 -1.545 . . . . 72.409999999999997 106.829 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.589 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 23.2 t-160 -119.3 124.33 46.4 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.09 -0.707 . . . . 53.25 109.09 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.0 t -139.44 164.09 30.79 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 106.49 -1.67 . . . . 71.030000000000001 106.49 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -110.42 160.54 13.28 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.752 -0.737 . . . . 54.520000000000003 112.099 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -84.8 22.39 1.37 Allowed 'General case' 0 CA--C 1.559 1.32 0 CA-C-O 122.623 1.201 . . . . 72.540000000000006 110.205 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' A' ' 81' ' ' GLU . 16.0 ptpt -142.96 156.65 44.91 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.453 -0.779 . . . . 64.450000000000003 110.481 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 43.5 tt0 -63.87 122.05 74.72 Favored Pre-proline 0 C--N 1.313 -0.98 0 C-N-CA 124.254 1.021 . . . . 75.109999999999999 110.773 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 107' ' ' GLU . 3.4 Cg_exo -73.71 107.08 2.32 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 122.212 1.941 . . . . 73.129999999999995 111.108 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -110.01 -156.95 0.6 Allowed 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.443 -1.317 . . . . 61.009999999999998 107.443 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -58.98 -33.3 70.51 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.232 0.924 . . . . 75.109999999999999 111.465 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.1 155.52 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 CA-C-N 116.272 -0.422 . . . . 70.319999999999993 110.355 169.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.423 ' H ' HG12 ' A' ' 112' ' ' ILE . 1.1 pt -58.47 -38.46 70.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.56 -1.2 . . . . 71.040000000000006 112.245 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.17 70.3 0.24 Allowed Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.168 -1.491 . . . . 74.420000000000002 113.016 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt 61.93 31.66 18.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.729 1.011 . . . . 75.140000000000001 113.729 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.35 -13.3 61.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.654 0.264 . . . . 73.420000000000002 110.696 174.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 m120 93.65 139.25 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.377 1.871 . . . . 72.120000000000005 112.891 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 86.27 158.68 0.08 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.391 1.876 . . . . 55.039999999999999 111.353 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HB2' HG23 ' A' ' 121' ' ' VAL . 30.9 mmmt -59.28 149.43 28.76 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.187 0.595 . . . . 74.230000000000004 112.168 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.58 -52.81 64.07 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.221 1.008 . . . . 75.200000000000003 110.592 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.8 t -60.82 -36.74 79.85 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.611 -0.722 . . . . 74.409999999999997 110.2 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 118' ' ' LYS . 71.6 t -70.25 -47.45 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.653 -0.703 . . . . 72.239999999999995 109.898 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.16 -41.18 80.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 110.701 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.518 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 74.4 ttt180 -63.22 -48.81 76.72 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.486 -0.779 . . . . 73.450000000000003 109.424 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.76 96.97 Favored Glycine 0 CA--C 1.495 -1.213 0 CA-C-N 115.231 -0.895 . . . . 60.420000000000002 112.03 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -66.55 -35.21 79.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 122.78 0.432 . . . . 71.010000000000005 111.521 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 24.1 mmt -70.92 -45.09 64.85 Favored 'General case' 0 C--O 1.211 -0.939 0 C-N-CA 120.315 -0.554 . . . . 64.510000000000005 111.003 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -67.26 -53.84 26.27 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.406 -0.918 . . . . 72.239999999999995 111.104 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.97 -45.64 95.21 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.917 -0.473 . . . . 63.539999999999999 111.917 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.65 -52.65 49.47 Favored Glycine 0 CA--C 1.487 -1.701 0 N-CA-C 111.494 -0.642 . . . . 64.519999999999996 111.494 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.402 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.7 m95 -65.15 -26.3 68.11 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 113.372 0.878 . . . . 73.030000000000001 113.372 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.1 m -67.81 -54.68 17.17 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.55 -0.537 . . . . 74.5 109.55 174.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.87 -42.4 86.19 Favored Glycine 0 C--O 1.245 0.826 0 CA-C-N 115.992 -0.549 . . . . 54.210000000000001 113.053 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.681 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 39.5 mm -65.37 -57.58 10.39 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 CA-C-O 119.599 -0.239 . . . . 72.209999999999994 110.937 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 69.6 t -57.99 -48.02 85.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 112.486 0.55 . . . . 72.120000000000005 112.486 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.509 ' HA ' HG13 ' A' ' 16' ' ' ILE . 43.4 t30 -59.69 -63.31 1.35 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.041 0.448 . . . . 75.129999999999995 111.995 -177.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -74.85 -48.27 25.92 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 112.447 0.536 . . . . 72.109999999999999 112.447 -173.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.681 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -63.56 -38.64 91.91 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 112.107 0.41 . . . . 74.239999999999995 112.107 -175.474 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.3 mm? -68.1 -48.38 65.63 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 119.298 -0.961 . . . . 64.340000000000003 110.594 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -58.42 -36.04 72.99 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.53 0.681 . . . . 74.140000000000001 109.698 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -75.97 -38.85 57.04 Favored 'General case' 0 C--O 1.185 -2.329 0 N-CA-C 112.339 0.496 . . . . 75.420000000000002 112.339 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.17 68.58 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.152 -0.619 . . . . 73.540000000000006 111.446 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.6 m -78.56 -36.09 19.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.067 -0.653 . . . . 73.219999999999999 110.213 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -87.8 -58.95 2.38 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.39 1.256 . . . . 72.120000000000005 114.39 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -130.74 115.73 17.04 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.74 0.781 . . . . 71.230000000000004 111.442 -172.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.43 25.35 0.63 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 113.593 0.961 . . . . 73.310000000000002 113.593 -174.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.79 145.85 48.42 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.873 -0.788 . . . . 62.109999999999999 108.873 173.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -111.94 156.6 21.84 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.598 -0.441 . . . . 75.540000000000006 110.595 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -123.86 153.17 41.47 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.308 -1.738 . . . . 75.209999999999994 106.308 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -114.61 116.44 28.76 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 118.764 -1.174 . . . . 71.439999999999998 110.63 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -72.49 145.71 47.34 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.402 -0.962 . . . . 74.049999999999997 108.402 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -57.93 -54.11 50.69 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 123.728 0.642 . . . . 72.239999999999995 110.028 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.2 t60 . . . . . 0 C--O 1.25 1.081 0 N-CA-C 108.2 -1.037 . . . . 62.43 108.2 178.169 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.306 0.098 . . . . 73.129999999999995 111.216 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.28 127.81 32.8 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.744 0.306 . . . . 52.32 110.574 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -100.99 -48.72 4.34 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.049 -0.523 . . . . 71.329999999999998 111.884 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -140.95 -164.33 1.72 Allowed 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 109.502 -0.555 . . . . 74.319999999999993 109.502 -172.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -78.8 96.09 5.53 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.075 -1.454 . . . . 72.120000000000005 107.075 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -114.49 80.21 1.37 Allowed 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 107.513 -1.292 . . . . 63.039999999999999 107.513 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -66.32 -36.77 83.77 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 120.623 -0.431 . . . . 72.239999999999995 109.912 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -135.2 -66.17 0.59 Allowed 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 106.945 -1.502 . . . . 64.329999999999998 106.945 177.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.456 HD11 ' HA3' ' A' ' 104' ' ' GLY . 2.4 pt? -162.53 129.72 2.58 Favored Pre-proline 0 N--CA 1.418 -2.028 0 N-CA-C 105.898 -1.889 . . . . 60.43 105.898 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -85.44 -167.94 0.45 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 121.78 1.653 . . . . 75.430000000000007 110.121 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 14.1 t70 -100.35 113.07 25.52 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 105.675 -1.972 . . . . 61.310000000000002 105.675 171.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' A' ' 102' ' ' HIS . 14.5 tt -106.86 130.79 58.23 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.982 0 C-N-CA 119.81 -0.756 . . . . 75.400000000000006 109.478 -177.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 36.2 m -114.37 128.92 56.59 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 106.984 -1.488 . . . . 63.43 106.984 178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 20.0 tptt -134.67 152.69 51.95 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.392 -1.336 . . . . 61.200000000000003 107.392 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.2 p -128.75 133.91 48.25 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 120.812 -0.355 . . . . 71.209999999999994 110.342 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.28 135.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.333 -1.358 . . . . 75.319999999999993 107.333 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.8 p -102.8 131.49 49.62 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.47 0.544 . . . . 72.420000000000002 112.47 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.9 mp -108.36 140.94 40.92 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 122.005 0.907 . . . . 75.299999999999997 113.094 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -70.36 13.42 0.17 Allowed 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 128.583 2.753 . . . . 62.549999999999997 112.779 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.483 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -130.86 164.03 44.76 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-O 118.969 -0.539 . . . . 75.109999999999999 110.107 -172.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 37.5 Cg_endo -64.8 154.95 70.14 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.85 2.367 . . . . 62.340000000000003 111.904 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.401 ' HA ' HG21 ' A' ' 96' ' ' THR . 14.0 tt -57.69 -33.35 44.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.688 -1.142 . . . . 74.239999999999995 112.666 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 10.1 pt20 -65.05 -41.31 95.3 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.364 -0.38 . . . . 72.120000000000005 111.756 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -72.64 -38.9 67.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.321 -0.4 . . . . 61.509999999999998 110.988 -173.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.468 HG11 HG21 ' A' ' 96' ' ' THR . 8.6 p -68.28 -41.0 83.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 120.385 -0.526 . . . . 74.420000000000002 109.918 178.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -62.28 -47.25 85.15 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.636 -0.711 . . . . 73.099999999999994 111.451 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 23' ' ' GLN . 11.6 pt-20 -69.0 -27.9 66.11 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 120.35 -0.54 . . . . 65.310000000000002 111.523 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.0 m -57.13 -36.38 70.63 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 121.411 0.624 . . . . 72.049999999999997 110.026 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.498 HG21 ' HE2' ' A' ' 98' ' ' PHE . 4.0 m -107.74 23.14 3.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.125 -0.489 . . . . 75.209999999999994 111.795 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.9 t -145.06 11.29 1.35 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.945 0.402 . . . . 60.109999999999999 110.743 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.0 p -117.31 162.14 18.39 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.871 -0.518 . . . . 53.240000000000002 110.335 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -51.93 -62.23 1.76 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.325 1.05 . . . . 64.120000000000005 111.467 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.58 -35.52 75.43 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.837 0.68 . . . . 63.439999999999998 112.837 -175.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.85 -48.39 72.37 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.928 -0.653 . . . . 50.299999999999997 111.743 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.496 HD12 ' CD1' ' A' ' 44' ' ' PHE . 64.1 mt -70.46 -39.37 76.24 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 CA-C-O 120.594 0.235 . . . . 54.119999999999997 111.385 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.04 -51.32 64.42 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.015 -0.539 . . . . 73.099999999999994 110.434 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.545 ' HB2' ' NH1' ' A' ' 137' ' ' ARG 0.257 0.4 OUTLIER 45.39 29.02 0.53 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.541 1.537 . . . . 72.120000000000005 114.335 177.647 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -158.32 159.35 35.81 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 102.514 -3.143 . . . . 72.549999999999997 102.514 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -86.75 52.34 2.48 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 119.979 1.263 . . . . 71.120000000000005 109.873 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 92.2 mtp -122.37 109.96 32.71 Favored Pre-proline 0 C--N 1.312 -1.057 0 N-CA-C 105.525 -2.028 . . . . 73.239999999999995 105.525 176.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.12 110.2 0.65 Allowed 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 122.617 2.212 . . . . 62.140000000000001 113.136 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -113.69 142.81 45.56 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 108.274 -1.01 . . . . 54.420000000000002 108.274 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -110.08 74.08 0.87 Allowed 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 119.704 -0.798 . . . . 63.219999999999999 109.787 -172.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.496 ' CD1' HD12 ' A' ' 35' ' ' ILE . 18.6 t80 -106.9 129.26 54.75 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.08 -0.964 . . . . 72.510000000000005 110.722 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -136.0 150.53 49.26 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.522 -1.659 . . . . 73.329999999999998 106.522 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -80.43 109.33 14.84 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 118.813 -1.155 . . . . 72.120000000000005 111.601 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 22.3 tptm -128.52 143.4 50.96 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 104.522 -2.399 . . . . 55.149999999999999 104.522 173.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -87.83 78.17 8.41 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.407 1.098 . . . . 62.240000000000002 109.239 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.36 99.2 2.22 Favored Glycine 1 N--CA 1.395 -4.084 0 N-CA-C 108.122 -1.991 . . . . 44.140000000000001 108.122 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 7.3 tt0 -153.99 117.7 4.68 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.268 -1.382 . . . . 71.530000000000001 107.268 -174.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -148.31 162.03 40.35 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-O 121.086 0.47 . . . . 71.140000000000001 110.914 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 96.6 m-85 -98.28 122.16 41.09 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 108.014 -1.106 . . . . 54.450000000000003 108.014 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -145.56 154.34 42.07 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.753 -0.658 . . . . 74.349999999999994 109.545 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.0 mp 73.44 -16.48 0.48 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.31 1.044 . . . . 74.030000000000001 112.266 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -128.1 23.65 6.05 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.125 -1.435 . . . . 74.140000000000001 107.125 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 50.1 m 75.03 143.82 0.1 Allowed Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.336 1.454 . . . . 62.149999999999999 111.157 -174.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 52' ' ' PHE . 17.2 Cg_exo -69.49 -16.44 38.67 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.452 2.101 . . . . 74.400000000000006 111.52 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -95.82 106.36 18.48 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.7 -1.222 . . . . 73.219999999999999 107.7 177.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.87 -139.51 6.72 Favored Glycine 0 C--N 1.294 -1.799 0 N-CA-C 109.099 -1.601 . . . . 71.519999999999996 109.099 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -65.39 -22.86 59.21 Favored 'Trans proline' 0 N--CA 1.473 0.293 0 C-N-CA 122.175 1.916 . . . . 73.099999999999994 109.404 174.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.9 m -134.88 134.26 21.74 Favored Pre-proline 0 N--CA 1.411 -2.376 0 N-CA-C 106.954 -1.498 . . . . 72.109999999999999 106.954 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -92.94 32.92 0.24 Allowed 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 122.747 2.298 . . . . 72.140000000000001 112.239 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.5 p -111.69 165.25 12.2 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 112.945 0.72 . . . . 62.140000000000001 112.945 -174.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 89.4 mttt -138.09 143.94 40.66 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.807 -1.923 . . . . 75.409999999999997 105.807 175.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 50' ' ' GLN . 18.2 t -91.2 136.77 23.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 107.526 -1.287 . . . . 54.140000000000001 107.526 173.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.1 tt -87.09 -58.19 2.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.863 -1.162 . . . . 63.229999999999997 107.863 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.34 145.88 10.07 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.219 -1.03 . . . . 74.109999999999999 108.219 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.81 119.8 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-O 122.207 1.003 . . . . 74.519999999999996 111.378 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 15.4 mm100 -104.92 142.51 34.64 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 113.941 -1.481 . . . . 74.340000000000003 109.064 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.81 129.19 94.26 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 114.354 -1.294 . . . . 51.32 108.262 -167.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -1.99 52.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.558 1 C-N-CA 128.105 5.87 . . . . 62.43 117.919 -160.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.0 p -137.23 -42.64 0.56 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.667 -1.151 . . . . 64.310000000000002 109.922 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 41.2 tt0 -144.35 127.28 16.39 Favored 'General case' 0 C--O 1.19 -2.042 0 C-N-CA 119.629 -0.828 . . . . 63.030000000000001 109.453 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.442 HD23 ' HD2' ' A' ' 87' ' ' PHE . 7.0 tp -133.95 127.72 32.98 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 108.589 -0.893 . . . . 74.010000000000005 108.589 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 m -135.2 127.13 29.51 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.468 -0.493 . . . . 73.230000000000004 111.269 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -142.09 156.55 45.4 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.008 0.373 . . . . 71.239999999999995 112.008 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -120.71 129.28 53.58 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.915 -1.143 . . . . 74.439999999999998 107.915 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -113.99 118.94 35.53 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.142 -1.059 . . . . 75.219999999999999 108.142 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 80' ' ' THR . 34.5 t70 -82.39 -178.85 7.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.2 -1.037 . . . . 72.450000000000003 108.2 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.403 ' H ' ' CG ' ' A' ' 79' ' ' ASP . 20.6 m 69.16 25.32 5.78 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-O 123.77 1.748 . . . . 73.430000000000007 106.515 -171.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.569 ' CB ' ' HB2' ' A' ' 115' ' ' ALA . 23.9 mm-40 59.93 45.61 12.11 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 112.231 -2.259 . . . . 71.430000000000007 113.643 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.37 -21.6 56.25 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 108.159 -1.977 . . . . 51.219999999999999 108.159 170.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 74.44 -175.53 0.14 Allowed 'General case' 0 C--O 1.245 0.845 0 C-N-CA 126.95 2.1 . . . . 74.400000000000006 112.908 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.7 p -96.85 115.04 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-O 122.19 0.995 . . . . 65.409999999999997 109.888 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.56 146.41 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 CA-C-N 114.549 -1.205 . . . . 72.409999999999997 109.046 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 92.9 m -136.79 133.46 35.98 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 108.569 -0.9 . . . . 71.439999999999998 108.569 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.442 ' HD2' HD23 ' A' ' 74' ' ' LEU . 15.5 m-85 -119.03 135.85 54.42 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.825 -1.176 . . . . 74.129999999999995 107.825 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.65 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 42.7 mt-30 -118.83 146.44 44.85 Favored 'General case' 0 C--N 1.263 -3.194 0 CA-C-N 115.57 -0.741 . . . . 71.519999999999996 110.393 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.32 126.55 55.5 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.243 -0.889 . . . . 75.239999999999995 109.351 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -114.88 116.67 28.93 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 107.629 -1.249 . . . . 41.5 107.629 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -83.18 121.16 26.71 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.764 -0.653 . . . . 75.239999999999995 110.762 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 73.8 mt -123.85 156.56 35.97 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.036 -1.098 . . . . 71.040000000000006 108.036 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.13 59.69 1.39 Allowed Glycine 0 C--N 1.282 -2.429 0 C-N-CA 120.517 -0.849 . . . . 74.310000000000002 113.121 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 175.43 -39.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.595 1.158 . . . . 72.439999999999998 108.672 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 3.8 ptpt -144.85 175.81 9.93 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.457 -1.682 . . . . 65.150000000000006 106.457 -174.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.468 HG21 HG11 ' A' ' 25' ' ' VAL . 62.6 m -116.47 131.62 56.9 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.099 -0.704 . . . . 75.549999999999997 109.099 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.4 119.0 5.35 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 108.66 -1.776 . . . . 64.409999999999997 108.66 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.498 ' HE2' HG21 ' A' ' 29' ' ' VAL . 45.3 t80 -103.86 130.38 51.44 Favored 'General case' 0 C--N 1.257 -3.448 0 N-CA-C 107.171 -1.418 . . . . 73.219999999999999 107.171 178.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 14.7 m -114.86 123.72 49.89 Favored 'General case' 0 N--CA 1.397 -3.095 0 N-CA-C 107.607 -1.257 . . . . 73.120000000000005 107.607 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.56 140.65 34.53 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 108.486 -0.931 . . . . 74.349999999999994 108.486 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 4.6 mp -135.92 123.54 35.35 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.16 0 CA-C-N 113.758 -1.565 . . . . 74.239999999999995 107.137 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.478 ' HB3' HG22 ' A' ' 12' ' ' ILE . 17.5 t60 -122.48 126.2 47.36 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.475 -0.935 . . . . 74.430000000000007 108.475 175.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -142.93 164.27 30.54 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 106.428 -1.693 . . . . 75.329999999999998 106.428 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.456 ' HA3' HD11 ' A' ' 9' ' ' LEU . . . -154.4 143.23 9.8 Favored Glycine 0 CA--C 1.48 -2.104 0 N-CA-C 109.95 -1.26 . . . . 60.119999999999997 109.95 176.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -71.58 140.03 49.65 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.311 -0.625 . . . . 74.25 109.311 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -86.5 83.46 7.64 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.069 -1.085 . . . . 70.129999999999995 108.069 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.46 ' HB2' ' HD3' ' A' ' 108' ' ' PRO . 13.6 mm-40 -87.58 -59.31 0.27 Allowed Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 114.935 -1.029 . . . . 74.209999999999994 112.858 -176.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HG2' ' O ' ' A' ' 112' ' ' ILE . 1.3 Cg_endo -88.02 -78.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 121.982 1.788 . . . . 74.109999999999999 115.986 -171.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -113.35 -169.84 1.57 Allowed 'General case' 0 C--N 1.318 -0.794 0 O-C-N 122.294 -0.254 . . . . 71.209999999999994 111.374 -172.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 8' ' ' ALA . 35.8 tt0 -63.83 -47.71 79.73 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.007 0.817 . . . . 72.5 108.82 174.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 5.2 p -94.55 176.66 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 104.859 -2.274 . . . . 62.439999999999998 104.859 171.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.479 ' O ' ' HG2' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -58.09 -39.51 73.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 119.98 1.264 . . . . 71.230000000000004 112.024 -176.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 55.18 47.41 74.33 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 111.994 -0.443 . . . . 40.210000000000001 111.994 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -166.07 -70.12 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.818 0.342 . . . . 74.120000000000005 110.93 -171.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.569 ' HB2' ' CB ' ' A' ' 81' ' ' GLU . . . -72.82 -40.79 65.52 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 116.514 2.042 . . . . 75.230000000000004 116.514 -171.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.16 100.88 0.97 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.876 -1.898 . . . . 74.019999999999996 105.876 -168.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . 0.271 36.7 mm-40 -94.93 89.01 5.47 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 114.866 1.432 . . . . 75.010000000000005 114.866 -172.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.613 ' HB3' HG12 ' A' ' 121' ' ' VAL . 52.5 tttp -179.43 91.25 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.453 -1.703 . . . . 53.420000000000002 106.926 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 m -48.44 -40.68 27.02 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 125.483 1.513 . . . . 72.450000000000003 112.912 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 25.8 t -65.14 -46.58 80.36 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 120.964 -0.294 . . . . 71.140000000000001 111.119 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 118' ' ' LYS . 9.6 p -71.13 -34.4 54.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 C-N-CA 119.73 -0.788 . . . . 55.439999999999998 110.047 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.8 -47.09 94.5 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 N-CA-C 110.443 -0.206 . . . . 63.030000000000001 110.443 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.401 ' HA ' ' HE2' ' A' ' 126' ' ' MET . 50.7 mtt180 -57.64 -52.98 63.19 Favored 'General case' 0 C--O 1.257 1.467 0 O-C-N 123.852 0.72 . . . . 72.129999999999995 110.869 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.76 -40.64 99.07 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 114.979 -1.009 . . . . 61.439999999999998 112.811 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.39 -32.53 70.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.041 0.756 . . . . 70.019999999999996 113.041 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.401 ' HE2' ' HA ' ' A' ' 123' ' ' ARG . 72.9 mtm -62.06 -54.82 36.09 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.638 -0.825 . . . . 75.540000000000006 110.244 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.98 -62.95 1.24 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.848 -0.741 . . . . 72.349999999999994 112.325 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.04 -34.95 82.91 Favored Glycine 0 CA--C 1.497 -1.043 0 CA-C-N 116.101 -0.499 . . . . 54.43 112.303 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.79 -54.34 15.34 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 111.62 -0.592 . . . . 63.329999999999998 111.62 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.45 ' O ' HG12 ' A' ' 134' ' ' VAL . 72.5 m95 -59.99 -44.56 94.43 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 112.927 0.714 . . . . 75.409999999999997 112.927 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.408 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 25.0 m -58.62 -49.5 77.25 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.469 0.48 . . . . 64.530000000000001 110.507 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.94 -46.19 60.57 Favored Glycine 0 C--O 1.25 1.14 0 C-N-CA 120.983 -0.627 . . . . 65.340000000000003 112.85 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mm -66.54 -52.54 45.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 CA-C-O 119.334 -0.365 . . . . 73.340000000000003 111.411 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 130' ' ' TRP . 4.2 p -62.93 -36.16 74.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 117.955 0.343 . . . . 53.240000000000002 111.206 -175.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.57 -64.97 0.77 Allowed 'General case' 0 C--N 1.351 0.644 0 O-C-N 123.394 0.434 . . . . 74.010000000000005 110.359 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.95 -40.45 71.99 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 112.602 0.593 . . . . 72.430000000000007 112.602 -173.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.545 ' NH1' ' HB2' ' A' ' 37' ' ' LYS . 9.2 tpp85 -62.53 -51.68 66.45 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 120.566 -0.454 . . . . 64.230000000000004 110.829 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 18' ' ' LEU . 49.9 mt -70.63 -41.08 72.67 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.328 -0.949 . . . . 75.439999999999998 111.679 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.642 ' NE ' ' HG3' ' A' ' 143' ' ' GLU . 1.1 tmt_? -60.63 -34.83 74.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.359 -0.608 . . . . 73.439999999999998 109.359 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 144' ' ' GLU . 23.3 mmmt -71.13 -42.56 69.04 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 119.995 -0.682 . . . . 73.340000000000003 111.434 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.581 ' HB2' ' HB3' ' A' ' 146' ' ' GLU . . . -66.26 -28.88 69.06 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 111.961 0.356 . . . . 44.32 111.961 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 21.4 m -88.74 -26.36 5.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 112.485 0.55 . . . . 75.040000000000006 112.485 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.642 ' HG3' ' NE ' ' A' ' 139' ' ' ARG . 5.7 mm-40 -97.37 -34.8 10.91 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.136 0.791 . . . . 72.030000000000001 113.136 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.425 ' HB3' ' HE3' ' A' ' 140' ' ' LYS . 35.9 tt0 -131.38 -78.01 0.52 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.436 0.636 . . . . 63.299999999999997 110.523 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 59.4 tp -178.27 157.06 1.03 Allowed 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 104.438 -2.43 . . . . 64.310000000000002 104.438 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.581 ' HB3' ' HB2' ' A' ' 141' ' ' ALA . 1.9 pp20? -82.58 162.85 21.81 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.749 -0.834 . . . . 65.450000000000003 108.749 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -157.58 150.63 23.34 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.064 -1.087 . . . . 64.439999999999998 108.064 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -78.22 83.24 4.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.164 -0.68 . . . . 64.109999999999999 109.164 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.35 -61.78 2.37 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.811 -1.086 . . . . 74.010000000000005 111.258 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -167.42 178.14 5.64 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.218 -1.401 . . . . 74.140000000000001 107.218 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -116.71 127.43 54.4 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.205 -1.405 . . . . 75.099999999999994 107.205 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 5.0 t60 . . . . . 0 C--N 1.296 -1.742 0 N-CA-C 107.14 -1.43 . . . . 71.129999999999995 107.14 179.504 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.505 -0.761 0 N-CA-C 109.395 -0.595 . . . . 71.349999999999994 109.395 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.38 107.06 9.53 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.745 -1.205 . . . . 63.409999999999997 107.745 175.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.419 ' CG ' ' HA2' ' A' ' 124' ' ' GLY . 5.8 tp-100 -85.07 -37.7 20.0 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.206 -0.906 . . . . 71.140000000000001 111.428 -172.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -86.53 92.02 8.74 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 113.725 1.009 . . . . 53.25 113.725 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -144.53 129.56 18.52 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 106.552 -1.647 . . . . 74.530000000000001 106.552 169.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -136.5 103.5 5.27 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-O 121.925 0.869 . . . . 75.25 112.368 -170.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 108' ' ' PRO . 32.5 t-20 -131.1 55.92 1.82 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.444 -2.058 . . . . 63.32 105.444 175.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 66.19 39.31 4.28 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 112.148 -2.296 . . . . 51.130000000000003 110.798 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp 78.57 86.09 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 125.512 1.525 . . . . 75.299999999999997 114.531 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.67 148.22 46.7 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 122.668 2.245 . . . . 71.340000000000003 109.919 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.574 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 6.3 p-10 -58.4 142.02 49.66 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 113.994 1.109 . . . . 71.230000000000004 113.994 -172.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.7 tp -121.66 137.43 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 106.493 -1.669 . . . . 53.140000000000001 106.493 171.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.8 m -118.74 128.82 54.85 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.406 -0.961 . . . . 72.209999999999994 108.406 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -133.5 132.67 41.28 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 107.662 -1.236 . . . . 72.25 107.662 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 p -118.45 139.49 51.33 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-O 120.645 0.26 . . . . 53.140000000000001 110.836 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -146.43 134.88 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.767 -0.827 . . . . 75.400000000000006 108.767 -178.329 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.03 121.8 42.87 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 120.967 0.413 . . . . 72.530000000000001 110.923 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.8 mp -101.76 137.66 39.76 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.638 -0.505 . . . . 42.020000000000003 109.638 -175.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -86.43 59.12 5.45 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.268 1.032 . . . . 75.340000000000003 110.959 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.21 161.14 46.34 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.984 -1.117 . . . . 61.210000000000001 107.984 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.94 152.16 82.16 Favored 'Trans proline' 0 C--O 1.26 1.609 0 C-N-CA 122.524 2.15 . . . . 73.420000000000002 110.442 176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -32.36 48.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.892 -0.594 . . . . 73.430000000000007 111.679 -176.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -65.15 -29.01 69.82 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.177 0.436 . . . . 75.409999999999997 112.177 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -78.92 -40.11 33.0 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.633 0.73 . . . . 72.340000000000003 110.37 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 96' ' ' THR . 7.3 p -69.43 -39.55 78.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 116.072 -0.513 . . . . 73.329999999999998 109.749 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 43.1 t90 -58.12 -47.63 82.69 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.369 0.668 . . . . 73.150000000000006 111.928 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.77 -39.37 94.09 Favored 'General case' 0 C--O 1.214 -0.816 0 C-N-CA 119.576 -0.85 . . . . 72.239999999999995 109.749 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.9 m -59.23 -31.98 69.55 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-O 121.087 0.47 . . . . 71.239999999999995 111.629 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.694 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 25.2 m -107.19 17.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 112.946 0.721 . . . . 64.299999999999997 112.946 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.5 m -139.65 -3.35 1.49 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 112.301 0.482 . . . . 71.340000000000003 112.301 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.0 p -97.22 145.99 25.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.37 -0.974 . . . . 71.219999999999999 108.37 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 p -52.03 -54.06 34.55 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.86 0.689 . . . . 72.140000000000001 112.86 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.75 -38.78 87.3 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.444 -0.798 . . . . 73.040000000000006 110.533 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -41.61 95.99 Favored Glycine 0 C--O 1.247 0.939 0 N-CA-C 112.045 -0.422 . . . . 62.420000000000002 112.045 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.6 mt -69.83 -48.32 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 O-C-N 122.545 -0.385 . . . . 72.340000000000003 110.602 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.03 -52.8 62.49 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.706 0.632 . . . . 71.5 112.706 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.1 pttm 30.49 65.35 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.741 1.756 . . . . 75.0 115.741 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 65.69 -15.15 0.12 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.216 1.932 . . . . 71.040000000000006 116.216 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -65.91 -56.52 11.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.305 -0.628 . . . . 71.319999999999993 109.305 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 15.7 tpt -159.09 116.66 1.64 Allowed Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.257 -1.386 . . . . 61.020000000000003 107.257 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -72.04 89.28 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.09 1.86 . . . . 72.430000000000007 113.223 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.563 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . 19.8 m120 -114.48 144.47 43.28 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.196 -1.409 . . . . 72.329999999999998 107.196 173.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -96.63 76.76 2.86 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.011 0.91 . . . . 65.310000000000002 110.449 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 42' ' ' ASN . 94.5 m-85 -74.88 119.3 18.88 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.832 -1.531 . . . . 71.230000000000004 109.775 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -109.41 151.31 26.84 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.126 -1.064 . . . . 70.319999999999993 108.126 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -77.2 103.18 6.99 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.493 -1.299 . . . . 72.099999999999994 107.493 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 20.4 tptm -134.03 146.12 50.07 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.305 -0.998 . . . . 75.140000000000001 108.305 174.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HB3' HG12 ' A' ' 68' ' ' VAL . 8.6 pt-20 -92.81 79.55 4.71 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.076 0.941 . . . . 64.430000000000007 108.778 173.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.64 47.37 0.53 Allowed Glycine 0 N--CA 1.416 -2.653 0 C-N-CA 119.361 -1.399 . . . . 52.32 112.863 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -85.16 129.88 34.72 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.471 -1.307 . . . . 74.439999999999998 107.471 179.681 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.05 153.5 35.22 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.497 -1.668 . . . . 70.099999999999994 106.497 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.407 ' HE2' ' SG ' ' A' ' 63' ' ' CYS . 98.3 m-85 -111.34 114.46 27.64 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.017 -0.734 . . . . 75.409999999999997 109.017 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -114.88 148.79 38.13 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.968 -0.753 . . . . 74.120000000000005 108.968 -175.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 79.74 1.65 2.16 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.755 1.622 . . . . 64.239999999999995 112.036 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -96.01 -46.42 6.52 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.311 0.577 . . . . 72.420000000000002 110.677 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.2 p -100.17 115.9 65.04 Favored Pre-proline 0 N--CA 1.421 -1.885 0 CA-C-N 115.504 -0.771 . . . . 74.230000000000004 110.177 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.63 -56.44 1.49 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.2 1.934 . . . . 64.319999999999993 109.878 176.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.6 t80 179.82 131.47 0.09 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.97 -1.122 . . . . 73.510000000000005 107.97 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.42 -96.65 0.53 Allowed Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 111.343 -0.703 . . . . 74.310000000000002 111.343 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.62 106.5 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.122 2.548 . . . . 61.409999999999997 111.56 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.5 m -99.72 136.44 20.27 Favored Pre-proline 0 C--N 1.298 -1.64 0 CA-C-N 115.719 -0.673 . . . . 74.319999999999993 111.474 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -86.6 -148.14 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.6 2.867 . . . . 72.420000000000002 111.085 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.407 ' SG ' ' HE2' ' A' ' 52' ' ' PHE . 8.4 p -102.47 147.41 26.77 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 120.838 0.351 . . . . 33.399999999999999 110.792 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -143.61 135.46 26.48 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.969 0.908 . . . . 65.530000000000001 108.685 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.1 t -90.59 136.88 22.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.617 -1.253 . . . . 73.239999999999995 107.617 175.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 tt -79.73 -61.11 2.1 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.981 -1.488 . . . . 65.150000000000006 106.981 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.0 150.02 9.38 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-N 115.15 -0.932 . . . . 75.530000000000001 109.018 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.515 HG23 HD23 ' A' ' 74' ' ' LEU . 8.5 p -123.98 119.03 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.484 0 CA-C-O 122.118 0.961 . . . . 73.239999999999995 109.565 175.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 11.4 mm100 -94.54 141.24 28.82 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 114.961 -1.018 . . . . 74.030000000000001 109.316 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 123.01 84.84 Favored Pre-proline 0 C--N 1.272 -2.78 0 CA-C-N 114.312 -1.313 . . . . 71.5 108.968 -166.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo 7.3 50.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.346 1 C-N-CA 127.638 5.559 . . . . 54.530000000000001 116.339 -160.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 p -139.81 -37.53 0.48 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.177 -0.919 . . . . 73.340000000000003 112.077 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 35.3 tt0 -150.29 148.05 28.39 Favored 'General case' 0 C--O 1.2 -1.532 0 C-N-CA 119.066 -1.053 . . . . 64.239999999999995 110.339 -176.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.687 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -141.37 132.99 27.07 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.831 -1.174 . . . . 34.310000000000002 107.831 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 p -141.03 129.13 22.06 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 120.695 -0.402 . . . . 52.310000000000002 112.019 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.459 ' HD2' HD11 ' A' ' 74' ' ' LEU . 44.7 p90 -142.8 153.55 43.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.811 0.338 . . . . 63.420000000000002 111.672 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -124.48 124.95 43.4 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 125.012 1.325 . . . . 73.519999999999996 107.783 -173.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 18.6 p-90 -143.58 155.78 44.39 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.152 -1.019 . . . . 74.209999999999994 113.232 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 76.18 160.4 0.22 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.852 1.661 . . . . 75.530000000000001 112.582 173.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 m -68.3 -30.93 70.04 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.207 1.003 . . . . 63.409999999999997 110.646 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.572 ' HG3' ' HB2' ' A' ' 115' ' ' ALA . 9.4 mm-40 -71.27 -21.49 62.08 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.033 -0.728 . . . . 73.25 109.033 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.66 80.36 0.68 Allowed Glycine 0 N--CA 1.426 -1.987 0 CA-C-N 114.882 -1.054 . . . . 70.519999999999996 114.641 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -104.92 128.59 53.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.365 -0.606 . . . . 74.129999999999995 109.365 173.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.24 111.78 29.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.625 -1.25 . . . . 65.329999999999998 107.625 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.26 149.12 19.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 120.477 -0.489 . . . . 75.319999999999993 110.377 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.451 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 39.2 m -129.47 140.77 51.18 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.491 -0.929 . . . . 71.200000000000003 108.491 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.694 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 16.0 m-85 -118.35 142.59 47.37 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.844 -1.539 . . . . 74.319999999999993 106.844 174.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.518 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 69.3 mt-30 -125.1 137.57 54.18 Favored 'General case' 0 C--N 1.268 -2.958 0 O-C-N 123.472 0.482 . . . . 73.310000000000002 110.532 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -117.36 120.06 37.01 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.457 -0.792 . . . . 75.430000000000007 109.179 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -114.06 116.71 29.58 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.586 -0.894 . . . . 71.049999999999997 108.586 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.01 118.98 23.88 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.876 0.846 . . . . 70.239999999999995 110.919 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 96.4 mt -123.15 153.11 40.46 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.449 -0.945 . . . . 71.129999999999995 108.449 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.97 50.38 4.15 Favored Glycine 0 C--N 1.287 -2.17 0 C-N-CA 120.892 -0.67 . . . . 72.549999999999997 112.411 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -179.41 -32.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.343 0.592 . . . . 72.230000000000004 109.446 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 9.6 ptpt -156.27 175.05 14.5 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.202 -1.407 . . . . 71.329999999999998 107.202 -175.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.616 HG21 HG11 ' A' ' 25' ' ' VAL . 87.8 m -119.79 128.19 53.49 Favored 'General case' 0 C--N 1.272 -2.771 0 N-CA-C 108.616 -0.883 . . . . 70.209999999999994 108.616 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.6 107.32 3.01 Favored Glycine 0 N--CA 1.412 -2.962 0 N-CA-C 109.868 -1.293 . . . . 35.450000000000003 109.868 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.509 ' CE1' HG11 ' A' ' 29' ' ' VAL . 92.8 t80 -100.54 133.35 45.11 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.939 -0.763 . . . . 74.430000000000007 108.939 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 70.4 m -126.31 125.37 42.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 119.049 -1.061 . . . . 45.299999999999997 109.161 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -104.02 141.87 35.45 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.443 -0.799 . . . . 65.540000000000006 108.851 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.5 mp -135.65 123.93 37.98 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 N-CA-C 106.024 -1.843 . . . . 70.010000000000005 106.024 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 9.7 t60 -120.55 113.73 20.7 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.486 -1.302 . . . . 45.149999999999999 107.486 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.8 t -132.57 153.84 50.6 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.543 -1.28 . . . . 74.310000000000002 107.543 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.15 167.96 20.81 Favored Glycine 0 N--CA 1.415 -2.74 0 N-CA-C 109.939 -1.265 . . . . 62.43 109.939 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 67.2 t90 -66.06 -39.32 90.0 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 106.998 -1.482 . . . . 71.109999999999999 106.998 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt 64.33 95.85 0.05 OUTLIER 'General case' 0 C--O 1.246 0.874 0 N-CA-C 115.912 1.819 . . . . 73.200000000000003 115.912 171.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -84.45 120.35 74.17 Favored Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 105.745 -1.946 . . . . 71.540000000000006 105.745 165.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.554 ' HA ' ' OD1' ' A' ' 7' ' ' ASN . 51.8 Cg_endo -65.58 78.75 0.26 Allowed 'Trans proline' 0 C--O 1.241 0.628 0 C-N-CA 123.103 2.535 . . . . 63.299999999999997 115.855 -170.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -143.92 -93.54 0.11 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.47 -0.787 . . . . 71.439999999999998 110.19 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -139.32 -64.73 0.49 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.04 0.448 . . . . 71.219999999999999 111.994 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 113' ' ' GLY . 12.3 p -118.21 155.33 20.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 116.128 -0.487 . . . . 74.310000000000002 111.503 -170.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.625 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -61.85 -36.81 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.57 0.7 . . . . 74.010000000000005 110.619 174.044 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.526 ' H ' HG22 ' A' ' 111' ' ' VAL . . . 149.3 -108.35 0.4 Allowed Glycine 0 N--CA 1.409 -3.105 0 N-CA-C 108.758 -1.737 . . . . 72.349999999999994 108.758 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -134.85 32.35 3.25 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.856 0.36 . . . . 74.030000000000001 111.318 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.572 ' HB2' ' HG3' ' A' ' 81' ' ' GLU . . . -58.78 -22.88 59.2 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 112.825 0.676 . . . . 71.409999999999997 112.825 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -153.92 -73.24 0.13 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.61 -0.268 . . . . 53.32 110.48 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -156.73 -90.03 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 111.765 0.283 . . . . 72.209999999999994 111.765 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.462 ' HB3' HG22 ' A' ' 121' ' ' VAL . 24.0 ttmm -121.03 136.37 55.0 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.051 -1.463 . . . . 74.030000000000001 107.051 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.25 -37.55 75.14 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 115.114 1.524 . . . . 62.219999999999999 115.114 -174.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.89 -46.17 79.35 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.401 0.519 . . . . 72.299999999999997 112.401 177.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 118' ' ' LYS . 14.2 m -69.97 -33.84 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.191 -0.604 . . . . 62.009999999999998 109.776 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' A' ' 126' ' ' MET . 53.6 t -64.64 -43.11 96.67 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 CA-C-N 115.732 -0.667 . . . . 74.129999999999995 111.113 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -39.82 93.32 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.214 -1.032 . . . . 72.019999999999996 108.214 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.419 ' HA2' ' CG ' ' A' ' 3' ' ' GLN . . . -59.6 -47.71 89.59 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-N 115.571 -0.74 . . . . 41.210000000000001 112.021 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -66.43 -34.41 77.9 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.274 -0.463 . . . . 71.019999999999996 111.857 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 23.5 mmt -62.06 -52.5 63.69 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 110.265 -0.272 . . . . 45.43 110.265 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.45 -52.78 64.19 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.837 0.31 . . . . 63.399999999999999 111.837 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.51 -45.99 87.27 Favored Glycine 0 C--O 1.26 1.744 0 C-N-CA 120.834 -0.698 . . . . 64.439999999999998 112.6 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.47 62.56 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 111.938 -0.465 . . . . 72.200000000000003 111.938 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.492 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.9 m95 -65.45 -22.94 66.81 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.555 0.576 . . . . 72.230000000000004 112.555 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.8 m -64.91 -55.69 17.78 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.761 -0.829 . . . . 54.520000000000003 108.761 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.45 -44.47 73.1 Favored Glycine 0 C--O 1.252 1.241 0 C-N-CA 120.648 -0.787 . . . . 65.25 113.591 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.19 -51.91 62.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 122.231 0.212 . . . . 63.350000000000001 111.464 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.558 ' HA ' HD23 ' A' ' 138' ' ' LEU . 78.9 t -63.66 -44.62 98.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.806 -0.358 . . . . 72.340000000000003 111.595 -177.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.406 ' HA ' HG13 ' A' ' 16' ' ' ILE . 32.1 t30 -55.56 -64.83 0.72 Allowed 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.794 0.684 . . . . 71.319999999999993 111.803 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -82.73 -31.83 28.23 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 119.41 -0.916 . . . . 73.319999999999993 113.202 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.429 HH11 ' HB2' ' A' ' 141' ' ' ALA . 0.2 OUTLIER -74.01 -40.2 63.07 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 118.024 -1.47 . . . . 65.420000000000002 110.179 -176.595 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.2 mm? -69.41 -46.59 66.46 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 119.552 -0.859 . . . . 75.450000000000003 110.045 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 0.9 OUTLIER -63.76 -36.16 82.97 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 115.759 -0.655 . . . . 74.400000000000006 110.658 -178.616 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.409 ' HE2' ' HB2' ' A' ' 144' ' ' GLU . 8.8 mmmm -70.76 -37.47 73.4 Favored 'General case' 0 C--O 1.198 -1.654 0 O-C-N 121.703 -0.623 . . . . 71.340000000000003 112.27 174.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.429 ' HB2' HH11 ' A' ' 137' ' ' ARG . . . -64.61 -27.98 69.31 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.254 0.549 . . . . 62.219999999999999 110.838 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 16.6 m -91.81 -22.58 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.895 -0.593 . . . . 55.32 111.953 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 61.2 mt-10 -91.85 -32.37 15.35 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.429 -0.508 . . . . 62.539999999999999 111.934 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 140' ' ' LYS . 28.7 tt0 -77.76 90.13 4.03 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.932 1.349 . . . . 72.219999999999999 110.83 -174.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.13 -149.88 0.27 Allowed 'General case' 0 C--N 1.277 -2.561 1 N-CA-C 99.102 -4.407 . . . . 72.349999999999994 99.102 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -85.4 80.1 9.23 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 120.077 1.308 . . . . 71.219999999999999 110.527 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -148.23 143.59 27.1 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.047 -1.094 . . . . 71.219999999999999 108.047 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -122.41 105.92 10.6 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.693 -0.855 . . . . 75.329999999999998 108.693 172.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -114.06 121.91 45.28 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 116.111 -0.495 . . . . 72.120000000000005 109.98 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -102.43 137.02 41.23 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.36 -0.978 . . . . 74.239999999999995 108.36 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -93.11 -60.34 1.82 Allowed 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.985 -0.746 . . . . 72.010000000000005 108.985 -173.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 . . . . . 0 N--CA 1.418 -2.03 0 N-CA-C 105.92 -1.881 . . . . 72.340000000000003 105.92 177.985 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 mmt . . . . . 0 CA--C 1.498 -1.057 0 N-CA-C 109.58 -0.526 . . . . 74.5 109.58 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.36 143.44 23.57 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 123.972 0.795 . . . . 71.129999999999995 111.861 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -80.41 -29.14 37.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.341 0.591 . . . . 74.319999999999993 109.526 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -89.6 -169.19 2.38 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.229 -1.026 . . . . 60.0 108.229 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -99.06 168.55 10.01 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.352 0.596 . . . . 54.420000000000002 110.453 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -109.3 96.41 6.28 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 114.785 -1.098 . . . . 71.099999999999994 110.782 -173.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 60.03 35.41 21.43 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 124.076 0.95 . . . . 70.439999999999998 111.051 171.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 106' ' ' LYS . . . 56.97 67.4 0.99 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.9 -1.5 . . . . 65.099999999999994 112.944 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.0 tp 68.47 90.93 0.08 OUTLIER Pre-proline 0 C--O 1.243 0.744 0 C-N-CA 124.765 1.226 . . . . 74.510000000000005 111.644 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.59 -164.97 0.21 Allowed 'Trans proline' 0 N--CA 1.436 -1.861 0 C-N-CA 122.38 2.054 . . . . 72.450000000000003 110.356 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -64.97 103.93 0.79 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.129 0.966 . . . . 75.140000000000001 111.837 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 50.0 mm -98.06 123.16 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 106.023 -1.843 . . . . 63.140000000000001 106.023 174.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 12.7 t -117.39 140.96 48.9 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 109.162 -0.681 . . . . 61.399999999999999 109.162 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -146.71 132.33 18.82 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.787 -1.19 . . . . 72.430000000000007 107.787 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.7 p -117.87 141.33 48.54 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 109.48 -0.563 . . . . 71.099999999999994 109.48 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.71 142.77 8.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.075 -1.084 . . . . 65.129999999999995 108.075 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.429 HG22 ' HA2' ' A' ' 97' ' ' GLY . 3.6 p -106.23 128.72 54.16 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.298 0.571 . . . . 71.5 111.509 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.7 mp -103.57 140.11 37.97 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.857 -0.611 . . . . 75.420000000000002 111.079 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -81.73 46.22 0.96 Allowed 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 124.277 1.031 . . . . 74.129999999999995 110.686 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.26 158.89 57.2 Favored Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 109.202 -0.666 . . . . 73.329999999999998 109.202 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.37 153.32 71.4 Favored 'Trans proline' 0 C--O 1.259 1.544 0 C-N-CA 122.77 2.313 . . . . 74.200000000000003 110.7 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -60.15 -32.58 50.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.798 -0.637 . . . . 63.229999999999997 111.482 -174.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -63.75 -39.29 93.91 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 120.698 -0.401 . . . . 74.340000000000003 111.656 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -70.9 -39.18 72.9 Favored 'General case' 0 C--O 1.212 -0.916 0 C-N-CA 120.996 -0.282 . . . . 74.040000000000006 111.133 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.513 HG21 ' HB ' ' A' ' 96' ' ' THR . 47.2 t -68.02 -41.17 84.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.412 0.625 . . . . 74.120000000000005 109.842 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.592 ' CZ2' ' HD3' ' A' ' 71' ' ' PRO . 29.4 t90 -63.66 -46.72 84.32 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.492 -1.231 . . . . 64.299999999999997 110.177 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -70.23 -29.41 66.22 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 121.036 -0.266 . . . . 74.530000000000001 111.491 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.536 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 39.7 m -56.14 -33.26 65.01 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-O 121.129 0.49 . . . . 73.140000000000001 111.735 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -108.18 16.6 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 O-C-N 121.406 -0.809 . . . . 74.519999999999996 112.044 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.605 ' HA ' HD11 ' A' ' 35' ' ' ILE . 42.5 p -137.61 0.32 2.24 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.788 0.662 . . . . 73.140000000000001 112.788 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.7 p -107.89 169.39 8.64 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 121.698 -0.627 . . . . 62.140000000000001 111.595 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.2 t -63.01 -44.71 95.25 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.914 -0.585 . . . . 74.129999999999995 109.744 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.09 -45.17 78.07 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.686 0.616 . . . . 75.329999999999998 111.165 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 28' ' ' THR . . . -72.38 -48.03 26.16 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.909 -0.663 . . . . 64.019999999999996 114.051 -175.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.605 HD11 ' HA ' ' A' ' 30' ' ' SER . 80.3 mt -69.04 -34.12 62.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 116.932 0.366 . . . . 52.25 111.114 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 40' ' ' MET . . . -52.89 -39.18 62.49 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.953 -0.567 . . . . 44.119999999999997 111.463 176.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 37' ' ' LYS . 34.4 ttpt 70.88 -60.29 0.51 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.029 0.932 . . . . 74.519999999999996 113.285 174.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -103.74 -172.21 2.07 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.807 -0.812 . . . . 73.549999999999997 108.807 -174.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -81.29 79.36 7.94 Favored 'General case' 0 C--O 1.248 1.0 0 N-CA-C 114.925 1.454 . . . . 72.239999999999995 114.925 -171.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.419 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 16.8 ptp 171.02 117.12 0.05 OUTLIER Pre-proline 0 C--N 1.312 -1.044 0 C-N-CA 126.993 2.117 . . . . 72.420000000000002 107.975 169.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.09 149.66 52.76 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.982 1.788 . . . . 51.439999999999998 111.16 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -123.94 164.34 19.5 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.757 -1.571 . . . . 74.120000000000005 106.757 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.12 65.27 8.67 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.76 0.79 . . . . 74.230000000000004 112.165 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.557 ' HB3' HD12 ' A' ' 35' ' ' ILE . 95.7 m-85 -108.62 132.78 53.55 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.4 -0.818 . . . . 73.5 109.865 171.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -139.03 150.14 45.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.19 -1.041 . . . . 73.439999999999998 108.19 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.432 HD11 ' CZ2' ' A' ' 26' ' ' TRP . 6.0 tt -75.74 104.2 6.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.766 -0.827 . . . . 73.340000000000003 108.766 -178.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.734 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 14.0 tppt? -133.97 146.07 50.12 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.882 -1.525 . . . . 72.450000000000003 106.882 172.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' CA ' HG12 ' A' ' 68' ' ' VAL . 8.1 pt-20 -79.57 54.79 1.84 Allowed 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 122.024 0.916 . . . . 54.520000000000003 109.478 170.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 130.01 64.52 0.1 Allowed Glycine 0 N--CA 1.406 -3.312 0 N-CA-C 109.977 -1.249 . . . . 74.230000000000004 109.977 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.734 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -100.0 106.35 18.12 Favored 'General case' 0 CA--C 1.47 -2.104 0 N-CA-C 106.355 -1.72 . . . . 62.130000000000003 106.355 178.22 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.45 135.44 47.14 Favored 'General case' 0 C--N 1.272 -2.796 0 C-N-CA 119.417 -0.913 . . . . 72.329999999999998 110.676 175.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -122.29 125.32 45.73 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 104.167 -2.531 . . . . 73.209999999999994 104.167 174.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -109.56 140.14 43.72 Favored 'General case' 0 C--N 1.283 -2.295 0 C-N-CA 119.435 -0.906 . . . . 75.230000000000004 111.006 -171.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.9 tp -138.8 112.95 8.65 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 103.695 -2.705 . . . . 73.349999999999994 103.695 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -70.05 138.33 52.0 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 123.395 0.434 . . . . 74.0 110.236 -173.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 m 72.42 89.92 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.746 1.218 . . . . 73.219999999999999 111.693 -176.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.45 123.41 11.1 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 122.148 1.899 . . . . 74.329999999999998 111.573 178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -128.29 -70.93 0.67 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.442 -1.318 . . . . 75.310000000000002 107.442 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.64 -84.75 1.77 Allowed Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 107.633 -2.187 . . . . 51.219999999999999 107.633 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -65.73 122.4 10.0 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 121.635 1.557 . . . . 63.509999999999998 109.067 172.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.561 ' OG ' ' HB ' ' A' ' 80' ' ' THR . 20.1 m -114.12 155.46 45.46 Favored Pre-proline 0 C--N 1.286 -2.192 0 N-CA-C 108.667 -0.864 . . . . 44.130000000000003 108.667 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.21 100.34 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.034 1.822 . . . . 62.32 112.347 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 24.7 p -88.82 143.57 26.81 Favored 'General case' 0 C--O 1.251 1.15 0 N-CA-C 107.45 -1.315 . . . . 71.209999999999994 107.45 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 34.4 mtmt -143.64 139.91 29.84 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 109.427 -0.583 . . . . 74.140000000000001 109.427 -172.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.513 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 41.8 t -90.65 129.44 41.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 N-CA-C 104.942 -2.244 . . . . 63.43 104.942 167.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.6 tp -75.06 -59.2 2.84 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.912 -0.773 . . . . 75.450000000000003 108.912 -176.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.53 140.67 14.0 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.955 -1.02 . . . . 64.209999999999994 109.274 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.498 HG23 HD13 ' A' ' 74' ' ' LEU . 9.5 p -119.28 121.0 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 N-CA-C 107.604 -1.258 . . . . 71.510000000000005 107.604 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 80.3 mm-40 -96.55 142.81 28.17 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 114.56 -1.2 . . . . 74.219999999999999 109.603 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.71 120.99 73.16 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 107.508 -1.293 . . . . 50.149999999999999 107.508 -164.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.592 ' HD3' ' CZ2' ' A' ' 26' ' ' TRP . 16.6 Cg_exo -7.54 64.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.294 1 C-N-CA 126.527 4.818 . . . . 75.099999999999994 116.844 -154.548 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 p -140.26 -40.47 0.43 Allowed 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 113.237 -1.801 . . . . 42.200000000000003 109.767 175.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 36.9 tt0 -150.54 149.22 29.65 Favored 'General case' 0 C--O 1.195 -1.81 0 C-N-CA 119.405 -0.918 . . . . 74.400000000000006 110.259 -175.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.498 HD13 HG23 ' A' ' 68' ' ' VAL . 9.8 tp -145.91 128.18 15.8 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.907 -0.775 . . . . 74.400000000000006 108.907 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.6 m -134.23 127.23 31.48 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.774 -0.37 . . . . 74.310000000000002 111.022 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.529 ' CE2' ' HE2' ' A' ' 87' ' ' PHE . 54.8 p90 -138.93 155.66 47.87 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 112.113 0.412 . . . . 61.140000000000001 112.113 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -122.76 125.88 46.38 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.003 -1.48 . . . . 71.400000000000006 107.003 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.432 ' CE3' ' HB2' ' A' ' 79' ' ' ASP . 15.7 p-90 -139.83 162.07 36.05 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.367 -0.933 . . . . 73.030000000000001 112.751 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.432 ' HB2' ' CE3' ' A' ' 78' ' ' TRP . 19.0 t70 72.89 161.84 0.25 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.612 1.565 . . . . 62.520000000000003 112.338 173.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.561 ' HB ' ' OG ' ' A' ' 61' ' ' SER . 7.4 t -73.11 -23.18 60.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.392 0.277 . . . . 73.040000000000006 111.274 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -34.25 76.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 110.154 -0.313 . . . . 71.450000000000003 110.154 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.72 75.64 1.29 Allowed Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.82 -0.627 . . . . 61.200000000000003 111.855 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -102.02 128.46 48.45 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.408 -0.96 . . . . 75.540000000000006 108.408 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.4 t -111.43 107.72 23.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 108.347 -0.983 . . . . 70.420000000000002 108.347 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.54 144.98 17.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.312 0.577 . . . . 74.219999999999999 110.363 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.458 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 39.9 m -136.42 134.23 37.52 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.801 -0.636 . . . . 73.120000000000005 109.407 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.61 ' CE1' HD23 ' A' ' 100' ' ' LEU . 39.8 m-85 -120.93 143.5 48.94 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.251 -1.018 . . . . 52.140000000000001 108.251 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.543 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 93.0 mt-30 -124.67 139.99 53.35 Favored 'General case' 0 C--N 1.278 -2.52 0 O-C-N 123.516 0.51 . . . . 72.0 110.676 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -122.6 120.22 33.13 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.722 -0.672 . . . . 71.329999999999998 110.458 -174.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -113.31 127.5 56.17 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 123.308 0.643 . . . . 74.200000000000003 109.81 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.72 120.68 26.68 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.731 -0.668 . . . . 75.400000000000006 111.366 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.6 mt -125.47 153.33 43.7 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.238 -0.892 . . . . 75.150000000000006 108.632 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.99 61.43 4.33 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 121.755 -0.26 . . . . 55.130000000000003 113.35 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 168.65 -54.49 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 125.21 1.404 . . . . 51.539999999999999 107.854 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -126.43 174.07 8.9 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 114.111 -1.404 . . . . 62.109999999999999 109.108 -167.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.513 ' HB ' HG21 ' A' ' 25' ' ' VAL . 87.7 m -119.89 130.84 55.03 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.889 -0.782 . . . . 74.530000000000001 108.889 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' A' ' 17' ' ' THR . . . -86.58 111.26 3.61 Favored Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 110.258 -1.137 . . . . 74.420000000000002 110.258 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -103.45 131.43 50.55 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 109.412 -0.588 . . . . 71.409999999999997 109.412 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.543 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 84.8 m -124.29 128.02 48.51 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.982 -1.118 . . . . 74.340000000000003 107.982 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.61 HD23 ' CE1' ' A' ' 87' ' ' PHE . 2.9 tm? -102.25 139.29 38.05 Favored 'General case' 0 N--CA 1.397 -3.079 0 N-CA-C 108.532 -0.914 . . . . 75.140000000000001 108.532 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 3.8 mp -135.68 124.43 39.1 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.268 0 N-CA-C 106.258 -1.756 . . . . 71.340000000000003 106.258 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -121.04 131.92 54.57 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.362 -0.977 . . . . 61.329999999999998 108.362 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.3 m -142.69 138.94 30.94 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.673 -1.232 . . . . 72.120000000000005 107.673 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.11 -167.01 22.2 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.227 -0.987 . . . . 65.230000000000004 110.731 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -79.78 102.49 9.09 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.861 -0.792 . . . . 74.450000000000003 108.861 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 20.9 ptmt -48.04 -41.26 25.26 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 116.692 2.108 . . . . 65.340000000000003 116.692 -173.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 59.73 -177.77 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.532 0 CA-C-N 118.449 0.568 . . . . 75.409999999999997 110.687 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -100.88 33.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.274 1.983 . . . . 63.549999999999997 109.068 167.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -125.4 172.36 9.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.183 -0.462 . . . . 70.120000000000005 110.288 -172.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -92.93 -40.62 10.49 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 117.915 0.325 . . . . 71.150000000000006 111.262 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.25 150.89 11.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 108.516 -0.92 . . . . 64.450000000000003 108.516 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.0 pt -58.76 -32.59 47.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 112.853 0.686 . . . . 61.100000000000001 112.853 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.84 -122.41 6.94 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.022 -1.085 . . . . 75.420000000000002 111.978 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -100.4 10.27 41.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.13 0.491 . . . . 72.5 109.878 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.63 -34.91 79.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.987 -1.116 . . . . 53.350000000000001 107.987 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -166.38 122.84 1.28 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.886 -1.894 . . . . 45.25 105.886 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.1 166.68 16.44 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.586 0.958 . . . . 74.140000000000001 113.586 -174.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm 71.24 87.22 0.12 Allowed 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.705 -1.134 . . . . 63.240000000000002 112.902 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.2 p -56.43 -39.81 73.72 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.469 1.108 . . . . 40.539999999999999 112.78 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 123' ' ' ARG . 3.2 p -68.18 -39.25 82.57 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.597 0.713 . . . . 75.510000000000005 110.646 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.07 -45.49 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 115.707 -0.679 . . . . 73.200000000000003 109.42 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.495 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 75.9 t -55.78 -37.56 47.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 O-C-N 123.642 0.589 . . . . 65.409999999999997 110.204 175.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 120' ' ' SER . 18.5 tpp180 -57.37 -58.65 7.33 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.184 0.594 . . . . 70.299999999999997 110.378 177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.68 -43.8 93.64 Favored Glycine 0 CA--C 1.494 -1.244 0 CA-C-N 115.678 -0.692 . . . . 75.329999999999998 112.817 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 122' ' ' VAL . 2.7 tmmm? -65.52 -38.56 90.02 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 112.66 0.615 . . . . 75.209999999999994 112.66 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 25.7 mmt -72.84 -45.9 55.88 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.231 -0.988 . . . . 60.520000000000003 110.269 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -67.91 -63.78 0.99 Allowed 'General case' 0 C--O 1.257 1.455 0 CA-C-O 121.343 0.592 . . . . 71.200000000000003 111.849 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -75.75 -33.41 51.53 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 115.779 -0.646 . . . . 63.520000000000003 112.219 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -66.77 -50.09 50.42 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 111.67 -0.572 . . . . 60.399999999999999 111.67 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.464 ' HE3' HG23 ' A' ' 134' ' ' VAL . 95.5 m95 -64.39 -31.17 72.27 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 120.054 -0.658 . . . . 64.120000000000005 111.616 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.1 m -58.47 -57.35 13.35 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 120.71 -0.396 . . . . 71.109999999999999 110.896 173.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.62 -46.7 37.9 Favored Glycine 0 C--O 1.242 0.597 0 CA-C-N 116.07 -0.514 . . . . 33.420000000000002 113.742 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.0 mt -62.57 -51.24 74.58 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 119.693 -0.194 . . . . 71.019999999999996 110.976 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.638 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 68.6 t -59.37 -43.97 91.45 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 120.786 -0.366 . . . . 62.420000000000002 111.483 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -56.1 -60.13 3.93 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 111.777 0.288 . . . . 71.450000000000003 111.777 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -77.26 -46.45 23.09 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.244 0.831 . . . . 75.349999999999994 113.244 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -64.51 -39.16 93.26 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.425 0.557 . . . . 73.409999999999997 111.725 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.692 ' HB3' HD21 ' A' ' 18' ' ' LEU . 3.9 mm? -67.25 -49.73 63.29 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.454 -0.498 . . . . 62.43 110.536 176.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -62.43 -32.54 73.41 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.952 -0.567 . . . . 74.209999999999994 109.827 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -76.51 -39.66 52.36 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 113.201 0.815 . . . . 65.430000000000007 113.201 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.32 -23.71 67.08 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.217 0.532 . . . . 71.239999999999995 111.177 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.3 m -90.24 -34.11 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 120.209 -0.596 . . . . 73.209999999999994 111.91 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.48 -31.44 26.51 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.169 0.803 . . . . 74.129999999999995 113.169 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -139.2 107.38 5.75 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.092 0.472 . . . . 53.530000000000001 109.896 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.05 159.45 16.83 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.286 -1.005 . . . . 71.230000000000004 108.286 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.85 115.15 16.37 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.266 0.555 . . . . 74.230000000000004 110.111 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -69.41 -33.81 73.55 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.171 -0.922 . . . . 72.329999999999998 111.142 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -153.66 174.55 14.35 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.365 -1.346 . . . . 72.549999999999997 107.365 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -68.82 91.81 0.47 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 122.106 0.955 . . . . 74.340000000000003 109.631 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -90.7 117.61 29.49 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.3 -0.864 . . . . 74.420000000000002 109.216 -174.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -81.18 143.75 32.13 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.254 -0.579 . . . . 71.439999999999998 109.445 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.5 p80 . . . . . 0 C--N 1.304 -1.4 0 CA-C-N 115.646 -0.707 . . . . 73.019999999999996 111.357 179.604 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 112.954 0.724 . . . . 74.430000000000007 112.954 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.05 85.02 2.25 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.318 0.58 . . . . 62.329999999999998 111.784 -177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -99.21 -28.02 13.53 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.652 -0.704 . . . . 61.200000000000003 109.629 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -67.91 121.43 16.02 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.351 -0.84 . . . . 73.010000000000005 109.775 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -120.26 115.38 23.48 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 105.747 -1.945 . . . . 54.229999999999997 105.747 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 21.0 mt-10 -132.12 -171.31 2.6 Favored 'General case' 0 N--CA 1.388 -3.558 0 N-CA-C 108.4 -0.963 . . . . 75.239999999999995 108.4 -169.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -175.84 -35.19 0.01 OUTLIER 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 104.33 -2.47 . . . . 71.109999999999999 104.33 -175.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 6' ' ' GLU . . . -127.2 179.07 5.63 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 103.945 -2.613 . . . . 71.329999999999998 103.945 168.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.51 HD21 ' CZ3' ' A' ' 83' ' ' TRP . 4.4 pp -100.38 130.2 26.33 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 118.982 -1.087 . . . . 72.25 113.109 -175.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -97.62 -160.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.651 2.901 . . . . 62.119999999999997 110.317 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 12.0 p-10 -81.6 97.46 7.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.607 1.194 . . . . 72.420000000000002 108.813 173.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 61.6 mt -91.68 128.25 43.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 114.69 -1.141 . . . . 54.450000000000003 109.019 -173.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.582 ' O ' ' HD2' ' A' ' 14' ' ' LYS . 13.6 t -120.08 140.79 50.5 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 119.648 -0.821 . . . . 72.430000000000007 110.556 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.582 ' HD2' ' O ' ' A' ' 13' ' ' THR . 5.9 mptp? -137.72 145.38 42.45 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.349 -1.352 . . . . 70.120000000000005 107.349 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -129.81 136.63 49.81 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 118.522 0.601 . . . . 43.350000000000001 110.514 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.11 141.38 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 110.06 -0.348 . . . . 74.109999999999999 110.06 -177.058 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 p -101.04 135.4 42.56 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.073 0.463 . . . . 65.310000000000002 112.09 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 139' ' ' ARG . 3.0 mm? -104.15 140.07 38.32 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.35 0.66 . . . . 72.400000000000006 110.219 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -86.11 34.22 0.62 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.136 0.494 . . . . 70.109999999999999 110.261 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -133.88 164.73 41.92 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.38 -0.6 . . . . 75.519999999999996 109.38 -174.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -66.6 153.03 79.46 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.286 1.99 . . . . 72.239999999999995 111.025 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.11 -33.26 42.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.341 -0.845 . . . . 72.219999999999999 112.452 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.19 -27.68 62.72 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.451 -0.5 . . . . 75.099999999999994 111.223 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.0 tmtm? -79.83 -31.99 40.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.958 -1.127 . . . . 71.319999999999993 107.958 -177.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG21 ' HB ' ' A' ' 96' ' ' THR . 45.4 t -71.17 -41.35 75.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.053 -1.092 . . . . 63.119999999999997 108.053 175.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.624 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 77.5 t90 -60.69 -47.17 87.47 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.639 -1.164 . . . . 74.450000000000003 111.269 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 10.5 pt-20 -59.97 -36.61 77.49 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 109.003 -0.74 . . . . 63.140000000000001 109.003 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.9 m -65.91 -7.54 17.15 Favored 'General case' 0 CA--C 1.573 1.836 0 CA-C-O 121.417 0.627 . . . . 74.239999999999995 112.646 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.562 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 11.9 m -131.48 17.19 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 O-C-N 121.306 -0.871 . . . . 54.020000000000003 111.63 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.424 ' HB3' HD13 ' A' ' 46' ' ' LEU . 51.3 m -145.32 10.03 1.26 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 116.29 -0.414 . . . . 62.310000000000002 111.833 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.3 p -110.75 -178.32 3.45 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.225 -0.657 . . . . 72.329999999999998 109.225 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 44' ' ' PHE . 19.6 p -56.64 -62.46 1.71 Allowed 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 123.711 0.632 . . . . 73.030000000000001 111.999 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.43 -31.24 71.87 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.27 -0.877 . . . . 74.099999999999994 110.844 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.89 -48.66 20.24 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.04 -1.076 . . . . 64.439999999999998 112.861 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.432 HG23 ' CE2' ' A' ' 76' ' ' PHE . 51.6 mt -68.95 -34.5 64.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 123.13 0.572 . . . . 73.400000000000006 110.895 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.41 -29.81 26.13 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-N 115.526 -0.761 . . . . 73.140000000000001 112.043 173.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt 78.8 -57.42 0.44 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.156 1.382 . . . . 74.5 110.589 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -122.74 167.12 13.87 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 105.982 -1.859 . . . . 75.450000000000003 105.982 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -71.33 92.61 1.06 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.261 0.467 . . . . 73.109999999999999 112.261 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 80.7 mmm -157.22 138.55 9.7 Favored Pre-proline 0 C--N 1.312 -1.032 0 C-N-CA 125.816 1.647 . . . . 70.239999999999995 107.446 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.96 98.99 0.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.819 1.68 . . . . 70.129999999999995 110.825 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -101.43 151.2 22.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.048 -1.464 . . . . 62.020000000000003 107.048 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -90.56 70.98 6.87 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.766 0.793 . . . . 75.219999999999999 109.46 -175.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.411 ' CE1' ' HB3' ' A' ' 32' ' ' SER . 6.9 p90 -58.9 137.19 57.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.093 -1.412 . . . . 62.219999999999999 110.711 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.86 121.88 15.67 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.928 -1.508 . . . . 72.329999999999998 106.928 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 68' ' ' VAL . 33.8 tp -94.42 101.78 13.72 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.362 -1.718 . . . . 65.219999999999999 106.362 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 1.3 tpmt? -134.94 145.58 48.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.263 -1.384 . . . . 63.009999999999998 107.263 175.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.02 61.71 7.0 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 122.69 1.234 . . . . 74.409999999999997 109.248 171.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.87 87.84 0.8 Allowed Glycine 0 N--CA 1.414 -2.783 0 CA-C-N 114.404 -1.271 . . . . 63.350000000000001 110.48 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.46 ' HB3' ' H ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -104.2 122.68 45.86 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.282 -1.748 . . . . 71.420000000000002 106.282 -178.332 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.66 152.98 49.44 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 109.513 -0.551 . . . . 74.099999999999994 109.513 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -95.74 124.66 39.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.822 0.82 . . . . 73.230000000000004 110.961 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -142.65 155.87 44.99 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.206 -1.776 . . . . 62.229999999999997 106.206 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.296 6.8 mp -83.02 72.03 10.1 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 122.239 1.019 . . . . 45.109999999999999 113.705 -175.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -140.65 8.97 2.19 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 112.82 -1.991 . . . . 72.019999999999996 106.742 170.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.7 m -144.45 151.3 50.49 Favored Pre-proline 0 N--CA 1.426 -1.639 0 N-CA-C 105.229 -2.137 . . . . 64.310000000000002 105.229 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.85 -72.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.517 1.478 . . . . 71.140000000000001 110.247 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.9 p90 179.75 179.34 0.51 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 107.511 -1.292 . . . . 72.010000000000005 107.511 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.98 122.98 7.31 Favored Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 108.663 -1.775 . . . . 42.210000000000001 108.663 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -46.63 -36.31 18.6 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 123.793 2.995 . . . . 43.530000000000001 111.758 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 m -122.66 112.6 30.78 Favored Pre-proline 0 N--CA 1.412 -2.372 0 N-CA-C 105.543 -2.021 . . . . 64.450000000000003 105.543 172.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.34 103.24 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.901 2.401 . . . . 33.420000000000002 113.313 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 86.0 m -136.27 142.94 44.0 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 121.377 0.608 . . . . 72.409999999999997 109.597 176.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 77' ' ' GLU . 92.7 mttt -137.12 132.13 33.62 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.824 -1.546 . . . . 71.200000000000003 106.824 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.46 ' H ' ' HB3' ' A' ' 50' ' ' GLN . 10.7 t -90.56 133.99 30.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 N-CA-C 107.2 -1.407 . . . . 61.009999999999998 107.2 174.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.83 -50.76 16.0 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.345 -1.354 . . . . 64.140000000000001 107.345 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.51 143.61 5.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.237 -1.347 . . . . 73.150000000000006 108.464 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.666 HG23 HD23 ' A' ' 74' ' ' LEU . 12.1 p -121.57 123.04 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 CA-C-O 121.332 0.587 . . . . 61.350000000000001 109.793 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.565 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 84.0 mm-40 -104.78 141.92 35.64 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.322 -0.854 . . . . 73.420000000000002 111.714 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.83 124.59 87.96 Favored Pre-proline 0 C--N 1.294 -1.81 0 CA-C-N 113.764 -1.562 . . . . 74.209999999999994 109.441 -164.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.624 ' HA ' ' CD1' ' A' ' 26' ' ' TRP . 81.4 Cg_exo -1.29 56.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.305 1 C-N-CA 127.491 5.46 . . . . 75.129999999999995 117.489 -159.626 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -146.59 -34.44 0.28 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.115 -0.948 . . . . 51.530000000000001 112.309 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.9 tt0 -146.37 139.76 25.87 Favored 'General case' 0 C--O 1.214 -0.774 0 C-N-CA 118.904 -1.118 . . . . 75.400000000000006 110.878 -174.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.706 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -139.78 136.7 34.36 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.259 -0.645 . . . . 70.439999999999998 109.259 -177.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.3 m -140.9 125.95 18.34 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 110.017 -0.364 . . . . 75.109999999999999 110.017 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.46 ' CD1' HD11 ' A' ' 74' ' ' LEU 0.273 12.8 p90 -146.8 158.17 43.85 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.02 0.748 . . . . 73.519999999999996 113.02 -178.429 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 64' ' ' LYS 0.27 21.7 mt-10 -119.19 131.58 55.85 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.643 -2.725 . . . . 75.299999999999997 103.643 -173.492 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.543 ' HE1' HG13 ' A' ' 85' ' ' VAL . 12.6 p-90 -153.11 163.52 39.72 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 114.733 1.383 . . . . 73.549999999999997 114.733 -168.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.412 ' HB2' ' CE3' ' A' ' 78' ' ' TRP . 3.8 t70 72.94 -167.83 0.12 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 112.009 -2.359 . . . . 72.209999999999994 112.237 170.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.444 ' HB ' ' OE2' ' A' ' 81' ' ' GLU . 1.3 m -78.53 -53.59 7.05 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.465 1.106 . . . . 74.129999999999995 112.129 -170.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.444 ' OE2' ' HB ' ' A' ' 80' ' ' THR . 2.4 mp0 -68.77 -19.62 64.32 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.375 0.509 . . . . 52.32 112.375 -176.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.33 76.33 1.3 Allowed Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.127 -1.035 . . . . 54.229999999999997 111.274 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.51 ' CZ3' HD21 ' A' ' 9' ' ' LEU . 48.7 m95 -109.4 154.42 22.61 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.188 -1.412 . . . . 74.329999999999998 107.188 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.63 123.98 27.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 121.461 0.648 . . . . 61.439999999999998 109.735 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.543 HG13 ' HE1' ' A' ' 78' ' ' TRP . 19.1 m -120.25 155.43 23.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 121.484 0.659 . . . . 73.200000000000003 111.259 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.464 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 41.9 m -131.09 137.33 49.06 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.065 -0.97 . . . . 74.230000000000004 108.573 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.9 m-85 -120.0 133.11 55.64 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.76 -1.2 . . . . 75.230000000000004 107.76 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.56 132.76 55.81 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 109.52 -0.548 . . . . 73.510000000000005 109.52 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mp -114.6 119.99 38.66 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.52 0.676 . . . . 73.349999999999994 110.724 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -103.21 123.73 47.29 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.533 -1.284 . . . . 62.399999999999999 107.533 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -82.67 128.61 34.51 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.914 -0.714 . . . . 72.129999999999995 109.71 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 74.2 mt -121.07 158.35 28.05 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.36 -1.348 . . . . 72.349999999999994 107.36 174.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.55 48.22 3.62 Favored Glycine 0 C--N 1.3 -1.444 0 O-C-N 123.305 0.378 . . . . 62.100000000000001 114.008 -174.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 172.96 -41.61 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.385 1.074 . . . . 74.310000000000002 109.237 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.5 ptpt -134.15 175.07 9.82 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.03 -0.729 . . . . 60.109999999999999 109.03 -173.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.433 ' HB ' HG21 ' A' ' 25' ' ' VAL . 88.9 m -117.72 128.16 54.62 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.817 -0.809 . . . . 63.229999999999997 108.817 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.37 107.7 3.47 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.203 -1.159 . . . . 55.340000000000003 110.203 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -97.32 133.95 41.25 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 109.257 -0.645 . . . . 70.340000000000003 109.257 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.4 m -120.41 121.81 39.35 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 108.187 -1.042 . . . . 64.010000000000005 108.187 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.59 139.71 35.89 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-O 121.854 0.835 . . . . 60.420000000000002 109.59 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.464 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 16.1 mt -137.09 124.85 32.14 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 113.239 -1.801 . . . . 63.219999999999999 107.746 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.536 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 23.7 t-160 -117.42 129.06 55.6 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.309 -0.997 . . . . 60.140000000000001 108.309 177.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -141.08 164.41 30.34 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.151 -1.426 . . . . 62.229999999999997 107.151 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.1 167.76 38.25 Favored Glycine 0 C--N 1.291 -1.932 0 C-N-CA 120.17 -1.014 . . . . 61.32 110.864 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 -88.56 59.9 5.36 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.952 0.882 . . . . 63.310000000000002 112.535 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -143.43 147.77 35.1 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 104.123 -2.547 . . . . 72.340000000000003 104.123 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.406 ' HB3' ' ND2' ' A' ' 109' ' ' ASN . 40.2 mm-40 -79.88 155.02 75.6 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 118.411 0.55 . . . . 73.530000000000001 110.259 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -69.08 -30.18 25.88 Favored 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 122.486 2.124 . . . . 74.299999999999997 110.367 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 107' ' ' GLU . 5.9 p30 -83.82 158.64 21.61 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-N 114.524 -1.217 . . . . 63.340000000000003 108.029 177.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 71.59 -160.24 0.12 Allowed 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.399 -1.334 . . . . 73.140000000000001 107.399 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.25 154.99 41.02 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 N-CA-C 107.649 -1.241 . . . . 73.030000000000001 107.649 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 35.0 pt -58.03 -31.0 40.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 113.049 0.759 . . . . 74.340000000000003 113.049 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.13 40.72 5.1 Favored Glycine 0 CA--C 1.494 -1.265 0 N-CA-C 109.76 -1.336 . . . . 73.120000000000005 109.76 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 46.04 52.05 10.4 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.909 1.684 . . . . 71.450000000000003 111.849 -175.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.02 -19.77 61.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 122.439 1.114 . . . . 50.450000000000003 108.481 173.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -132.52 -72.27 0.52 Allowed 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 113.701 -1.59 . . . . 74.519999999999996 108.713 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -149.2 -170.81 3.73 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 108.77 -0.826 . . . . 73.25 108.77 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.84 157.02 25.69 Favored 'General case' 0 C--O 1.218 -0.553 0 O-C-N 124.051 0.845 . . . . 54.299999999999997 110.784 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.1 p -56.65 -48.38 77.68 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.218 1.007 . . . . 65.310000000000002 112.72 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 p -63.07 -45.36 92.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.437 0.637 . . . . 74.140000000000001 110.704 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.06 -47.5 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.919 -1.037 . . . . 72.0 110.016 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 126' ' ' MET . 50.8 t -57.48 -41.06 78.0 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.233 0 CA-C-N 116.115 -0.493 . . . . 71.310000000000002 110.697 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -63.24 -51.69 65.17 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.24 -0.437 . . . . 74.310000000000002 111.045 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.64 -42.99 97.05 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-N 115.739 -0.664 . . . . 61.140000000000001 112.234 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -68.93 -32.53 72.2 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 115.085 -0.558 . . . . 65.109999999999999 112.363 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.427 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 23.4 mmt -67.03 -46.51 74.23 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.851 -0.74 . . . . 74.209999999999994 111.145 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.89 -58.42 3.47 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.658 -0.817 . . . . 65.099999999999994 111.783 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.33 -44.88 83.84 Favored Glycine 0 C--O 1.246 0.859 0 C-N-CA 121.058 -0.592 . . . . 63.310000000000002 112.075 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.53 -55.46 28.78 Favored Glycine 0 N--CA 1.437 -1.291 0 CA-C-O 119.316 -0.713 . . . . 62.539999999999999 112.22 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.433 ' O ' HG12 ' A' ' 134' ' ' VAL . 62.3 m95 -58.8 -43.51 90.53 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 117.837 0.818 . . . . 72.120000000000005 113.128 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 31.7 m -59.9 -47.06 87.32 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.367 0.417 . . . . 61.310000000000002 110.479 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.45 -47.24 36.23 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.557 -0.83 . . . . 74.219999999999999 112.828 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.8 mt -65.35 -46.14 91.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 122.587 0.355 . . . . 75.409999999999997 111.822 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 5.1 p -66.29 -40.45 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 119.608 -0.837 . . . . 63.109999999999999 109.717 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.593 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 34.3 t30 -58.89 -63.93 1.12 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.015 -0.539 . . . . 64.349999999999994 110.624 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -71.01 -48.8 51.05 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 113.423 0.897 . . . . 71.519999999999996 113.423 -173.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.518 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -69.83 -33.81 72.81 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.702 -0.799 . . . . 71.219999999999999 110.813 -171.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.4 mm? -70.78 -48.91 51.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.991 -1.084 . . . . 64.5 110.264 173.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 135' ' ' ASN . 1.0 OUTLIER -59.3 -40.32 85.78 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.83 -0.623 . . . . 73.420000000000002 110.959 -177.297 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 144' ' ' GLU . 25.7 mmmt -75.85 -36.02 59.75 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 112.887 0.699 . . . . 75.010000000000005 112.887 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.16 -28.2 64.09 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.617 -0.833 . . . . 71.519999999999996 110.629 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.513 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 25.8 m -79.77 -24.63 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 119.584 -0.846 . . . . 31.539999999999999 110.647 176.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.35 -87.16 0.14 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.917 0.865 . . . . 71.25 110.669 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.422 ' O ' ' HE3' ' A' ' 140' ' ' LYS . 39.1 mt-10 -143.47 107.2 4.64 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 125.09 1.356 . . . . 65.25 107.494 -172.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 37.9 tp -68.84 106.05 2.56 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.19 0.519 . . . . 74.120000000000005 110.423 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -158.47 172.18 18.78 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.432 -1.692 . . . . 65.200000000000003 106.432 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -89.55 102.43 15.11 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.835 -1.543 . . . . 62.450000000000003 106.835 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -121.44 26.81 8.63 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.72 -1.215 . . . . 74.349999999999994 107.72 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -75.52 103.31 5.59 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.063 -0.971 . . . . 73.319999999999993 111.001 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -112.51 102.2 10.31 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.882 -0.784 . . . . 64.299999999999997 108.882 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -102.08 -65.57 0.98 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.475 -0.49 . . . . 73.140000000000001 110.976 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 . . . . . 0 C--N 1.315 -0.934 0 N-CA-C 108.192 -1.04 . . . . 75.299999999999997 108.192 -177.894 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 CA--C 1.508 -0.643 0 CA-C-O 120.511 0.196 . . . . 62.229999999999997 111.172 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.63 104.53 6.22 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.42 0.629 . . . . 72.140000000000001 109.547 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -73.12 -28.71 62.42 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.848 -1.069 . . . . 74.439999999999998 109.959 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -158.33 170.88 21.23 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.598 -1.63 . . . . 75.319999999999993 106.598 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 68.19 42.18 1.79 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.814 0.816 . . . . 72.510000000000005 111.895 176.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -93.75 34.21 1.23 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.645 -1.243 . . . . 72.140000000000001 107.645 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -110.11 80.73 1.34 Allowed 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 105.022 -2.214 . . . . 73.150000000000006 105.022 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 106' ' ' LYS . . . -32.9 100.73 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 110.399 -3.091 . . . . 73.519999999999996 111.429 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.4 tp 48.66 86.78 0.14 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.315 1.446 . . . . 64.420000000000002 114.286 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.05 138.32 43.51 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.071 1.18 . . . . 41.039999999999999 109.717 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 8.2 p-10 -71.72 110.95 6.61 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.634 0.73 . . . . 72.310000000000002 109.839 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.405 HG22 ' HB3' ' A' ' 102' ' ' HIS . 10.6 tp -111.17 138.67 38.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.622 -0.717 . . . . 74.129999999999995 110.814 -173.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.3 m -111.67 133.02 54.2 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 108.023 -1.103 . . . . 73.430000000000007 108.023 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -128.14 143.07 51.03 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.892 -1.522 . . . . 73.200000000000003 106.892 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.9 m -122.75 133.48 54.47 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.977 -0.379 . . . . 60.399999999999999 109.977 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.527 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -145.84 131.79 13.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.601 -0.888 . . . . 75.120000000000005 108.601 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.75 122.62 43.0 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-O 121.458 0.647 . . . . 72.109999999999999 112.179 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 138' ' ' LEU . 6.2 mp -95.67 135.85 36.83 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 107.755 -1.202 . . . . 63.350000000000001 107.755 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -87.78 39.78 0.9 Allowed 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.169 -0.469 . . . . 72.0 109.937 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.483 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -135.92 163.86 47.37 Favored Pre-proline 0 C--O 1.245 0.823 0 C-N-CA 124.169 0.987 . . . . 71.340000000000003 109.085 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 36.4 Cg_endo -63.7 157.71 50.28 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 123.013 2.476 . . . . 63.130000000000003 112.377 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.6 tt -64.87 -27.72 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.738 -0.664 . . . . 74.030000000000001 111.859 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -71.75 -28.24 63.53 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.971 0.415 . . . . 71.200000000000003 111.717 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.59 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 4.4 tmtt? -81.18 -46.11 15.36 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.46 -0.57 . . . . 73.209999999999994 109.46 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.691 HG11 HG21 ' A' ' 96' ' ' THR . 5.4 p -59.49 -39.18 78.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.237 0.541 . . . . 73.219999999999999 109.846 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -63.35 -44.59 94.4 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.201 -0.909 . . . . 74.519999999999996 111.032 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -65.25 -33.68 76.55 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.442 -0.503 . . . . 72.439999999999998 110.465 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.7 m -59.25 -32.02 69.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.249 0.547 . . . . 71.319999999999993 111.163 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.561 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.5 m -109.46 21.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 112.298 0.481 . . . . 53.200000000000003 112.298 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.431 ' HB2' HD22 ' A' ' 46' ' ' LEU . 61.6 p -137.64 -12.24 1.55 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.406 -0.517 . . . . 74.209999999999994 112.216 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.0 p -94.55 158.81 15.37 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.632 -0.507 . . . . 74.150000000000006 109.632 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.9 m -59.9 -48.23 82.55 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 123.036 0.534 . . . . 53.100000000000001 111.195 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.83 -27.31 57.81 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.304 -0.862 . . . . 61.210000000000001 111.089 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.6 -48.81 21.31 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 119.927 -1.13 . . . . 71.430000000000007 111.58 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.499 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 68.1 mt -65.59 -33.42 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.729 0.775 . . . . 72.540000000000006 110.321 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.87 -30.04 63.48 Favored 'General case' 0 C--O 1.249 1.064 0 C-N-CA 124.578 1.151 . . . . 74.549999999999997 112.59 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 35' ' ' ILE . 3.9 mppt? 73.93 -71.89 0.12 Allowed 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 125.276 1.43 . . . . 74.239999999999995 108.557 -171.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 79.5 t90 171.33 -42.93 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.904 -1.517 . . . . 75.200000000000003 106.904 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -79.88 21.93 0.52 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.894 -1.048 . . . . 65.340000000000003 113.046 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 15.5 tpt -166.02 79.48 1.13 Allowed Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 108.277 -1.008 . . . . 73.219999999999999 108.277 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -82.74 98.62 0.89 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.07 1.846 . . . . 53.310000000000002 112.765 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -137.24 165.81 25.26 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.725 -0.843 . . . . 51.43 108.725 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -89.14 73.61 8.13 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.888 0.851 . . . . 71.109999999999999 110.081 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.4 ' HE1' ' SG ' ' A' ' 63' ' ' CYS . 93.4 m-85 -70.83 119.99 15.78 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.963 -1.017 . . . . 63.409999999999997 109.947 176.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -113.38 148.32 36.02 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 110.0 -0.37 . . . . 75.5 110.0 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.431 HD22 ' HB2' ' A' ' 30' ' ' SER . 21.5 tp -87.27 105.53 17.3 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.824 -1.176 . . . . 52.210000000000001 107.824 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -133.19 137.51 46.21 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 106.488 -1.671 . . . . 61.409999999999997 106.488 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -92.07 75.27 5.49 Favored 'General case' 0 C--N 1.257 -3.421 0 CA-C-O 122.845 1.307 . . . . 51.420000000000002 109.561 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.97 87.88 1.59 Allowed Glycine 1 N--CA 1.396 -4.001 0 CA-C-N 113.61 -1.632 . . . . 63.140000000000001 111.027 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -87.65 -75.16 0.42 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.911 -1.144 . . . . 75.109999999999999 107.911 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.98 161.74 24.85 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.143 -1.429 . . . . 62.140000000000001 107.143 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.05 148.04 46.03 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.855 1.057 . . . . 75.430000000000007 113.855 -171.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.453 ' HB2' ' NZ ' ' A' ' 64' ' ' LYS . 11.1 t60 -110.06 162.84 14.16 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 104.424 -2.436 . . . . 63.450000000000003 104.424 176.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.2 mt 72.62 16.23 4.8 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 106.492 -1.67 . . . . 65.530000000000001 106.492 -168.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 -158.37 -169.05 2.63 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 100.622 -3.844 . . . . 63.520000000000003 100.622 -176.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.2 m -108.46 115.55 57.73 Favored Pre-proline 0 C--N 1.289 -2.027 0 CA-C-N 120.356 1.434 . . . . 64.349999999999994 111.814 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.16 133.95 22.2 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 N-CA-C 107.041 -1.946 . . . . 64.540000000000006 107.041 170.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -90.81 -44.38 9.46 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.284 -0.566 . . . . 74.430000000000007 110.551 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.1 101.59 0.72 Allowed Glycine 0 C--O 1.214 -1.145 0 C-N-CA 120.198 -1.001 . . . . 60.100000000000001 112.593 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -79.64 34.85 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.362 2.708 . . . . 70.25 112.508 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.475 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 32.4 t -90.07 -56.02 0.28 Allowed Pre-proline 0 N--CA 1.434 -1.272 0 CA-C-N 116.277 -0.42 . . . . 73.25 110.556 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 61' ' ' SER . 53.5 Cg_endo -89.14 -176.01 1.26 Allowed 'Trans proline' 0 C--N 1.369 1.622 0 CA-C-N 120.313 1.148 . . . . 72.120000000000005 110.343 175.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.4 ' SG ' ' HE1' ' A' ' 44' ' ' PHE . 30.5 m -90.68 158.81 16.71 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.612 -1.255 . . . . 50.299999999999997 107.612 176.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.453 ' NZ ' ' HB2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -122.5 118.46 28.35 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-O 121.901 0.858 . . . . 64.109999999999999 110.455 -177.301 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 76' ' ' PHE . 6.7 t -79.26 137.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 114.872 -1.058 . . . . 65.310000000000002 109.339 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 tt -81.47 -57.63 3.39 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.387 -1.338 . . . . 71.400000000000006 107.387 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.04 153.6 22.47 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.542 -0.753 . . . . 64.430000000000007 109.801 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.54 119.13 52.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.712 -1.218 . . . . 23.420000000000002 107.712 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 22.5 mp0 -106.27 141.19 38.02 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.348 0.659 . . . . 75.519999999999996 110.334 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.67 129.32 94.1 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 114.226 -1.352 . . . . 63.229999999999997 108.446 -167.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo 2.52 44.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.283 1 C-N-CA 128.434 6.089 . . . . 74.319999999999993 118.602 -162.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -139.83 -35.47 0.53 Allowed 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 122.248 -0.283 . . . . 61.240000000000002 110.702 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 40.7 tt0 -145.94 145.21 30.59 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 118.508 -1.277 . . . . 74.030000000000001 109.98 -174.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.699 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -147.5 134.96 20.8 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.529 -1.285 . . . . 55.340000000000003 107.529 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.1 m -140.51 125.44 18.32 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.269 -0.572 . . . . 63.299999999999997 110.286 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.464 ' HD1' HD11 ' A' ' 74' ' ' LEU . 49.8 p90 -138.2 152.92 49.09 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 109.725 -0.472 . . . . 53.520000000000003 109.725 176.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.432 ' CD ' ' HZ2' ' A' ' 64' ' ' LYS . 37.8 mt-10 -124.73 126.08 45.1 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-N 115.475 -0.784 . . . . 62.229999999999997 110.818 -171.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.523 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 2.1 t90 -95.54 107.94 20.15 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 104.359 -2.46 . . . . 75.140000000000001 104.359 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.51 140.49 55.67 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.889 -0.596 . . . . 74.340000000000003 111.119 -171.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.1 m 70.18 82.82 0.15 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.598 1.159 . . . . 65.129999999999995 112.279 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 55.63 23.22 5.93 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.954 1.702 . . . . 73.310000000000002 113.833 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.523 ' HA3' ' HB3' ' A' ' 78' ' ' TRP . . . -93.98 -24.43 19.97 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 107.865 -2.094 . . . . 60.530000000000001 107.865 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 75.29 -177.16 0.15 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 126.128 1.771 . . . . 75.109999999999999 113.03 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.409 ' HB ' ' HG2' ' A' ' 77' ' ' GLU . 4.4 p -114.81 117.26 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.838 0.828 . . . . 74.319999999999993 109.918 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.51 144.01 16.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 CA-C-N 114.989 -1.005 . . . . 73.239999999999995 108.717 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 46.9 m -131.56 134.38 46.02 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 108.988 -0.745 . . . . 52.130000000000003 108.988 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.699 ' CD2' HD12 ' A' ' 74' ' ' LEU . 10.9 m-85 -109.99 137.41 47.8 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.452 -1.314 . . . . 63.0 107.452 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.607 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 7.0 tt0 -125.04 136.98 54.21 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.089 -1.448 . . . . 70.219999999999999 107.089 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -110.91 124.38 51.98 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.202 -0.599 . . . . 70.400000000000006 111.901 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -109.93 137.11 48.18 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 124.717 1.207 . . . . 73.329999999999998 108.383 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -97.93 117.76 32.98 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 120.608 0.242 . . . . 64.25 111.158 -176.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.2 mt -113.63 159.98 19.06 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.84 -0.8 . . . . 33.149999999999999 108.84 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.52 -26.61 71.95 Favored Glycine 0 C--N 1.293 -1.806 0 N-CA-C 114.908 0.723 . . . . 71.310000000000002 114.908 -174.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 28.0 tt0 -128.08 -0.9 5.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.88 0.84 . . . . 73.230000000000004 110.853 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -161.65 176.2 11.22 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.455 -0.778 . . . . 75.010000000000005 108.993 -173.13 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.691 HG21 HG11 ' A' ' 25' ' ' VAL . 31.2 m -116.58 128.14 55.14 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 109.556 -0.535 . . . . 74.140000000000001 109.556 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.15 112.71 3.93 Favored Glycine 0 N--CA 1.419 -2.446 0 N-CA-C 109.486 -1.445 . . . . 43.240000000000002 109.486 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -97.9 133.97 41.67 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 108.038 -1.097 . . . . 74.140000000000001 108.038 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 88' ' ' GLN . 14.0 m -117.81 121.91 42.01 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 107.991 -1.114 . . . . 42.210000000000001 107.991 -178.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.85 141.25 34.0 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 107.79 -1.189 . . . . 65.109999999999999 107.79 177.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 19.6 mt -135.2 124.77 42.81 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.404 0 N-CA-C 106.699 -1.593 . . . . 72.319999999999993 106.699 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 21.8 t-160 -117.83 120.9 39.3 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.151 -1.055 . . . . 64.099999999999994 108.151 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.9 t -141.82 164.6 29.75 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 107.161 -1.422 . . . . 64.239999999999995 107.161 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -176.73 -131.86 1.55 Allowed Glycine 0 C--N 1.285 -2.29 0 N-CA-C 109.413 -1.475 . . . . 72.329999999999998 109.413 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -84.72 78.82 9.79 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.373 -0.973 . . . . 73.5 108.373 175.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -82.84 84.9 7.22 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 114.39 -1.277 . . . . 72.129999999999995 111.277 -177.426 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -107.18 117.27 56.68 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 115.05 -0.977 . . . . 74.450000000000003 109.979 -174.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -50.78 -35.01 46.8 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 124.053 3.169 . . . . 73.219999999999999 114.921 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -142.66 85.76 1.91 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.182 0.515 . . . . 71.530000000000001 110.719 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -179.12 172.19 1.27 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 105.76 -1.941 . . . . 64.510000000000005 105.76 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.759 HG12 HD13 ' A' ' 112' ' ' ILE . 1.8 t -105.12 168.64 2.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 106.646 -1.613 . . . . 62.310000000000002 106.646 176.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.759 HD13 HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -58.15 -31.72 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.792 0.806 . . . . 30.52 111.155 177.062 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 148.12 -86.89 0.16 Allowed Glycine 0 N--CA 1.41 -3.093 0 N-CA-C 109.18 -1.568 . . . . 54.240000000000002 109.18 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 61.8 tttp -155.13 22.36 0.43 Allowed 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.45 0.643 . . . . 73.319999999999993 110.266 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.418 ' HB3' HG13 ' A' ' 112' ' ' ILE . . . -59.95 -39.15 84.61 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.155 -0.966 . . . . 64.109999999999999 111.282 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -150.85 25.03 0.75 Allowed 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.362 0.413 . . . . 64.519999999999996 110.967 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.411 ' O ' HG11 ' A' ' 111' ' ' VAL . 3.5 mp0 66.85 -41.47 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.382 1.623 . . . . 63.509999999999998 115.382 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -118.06 141.74 48.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.268 0.485 . . . . 62.5 112.159 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.672 ' OG ' ' HA ' ' A' ' 111' ' ' VAL . 70.8 m -75.07 -27.79 60.1 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.987 -0.551 . . . . 71.230000000000004 109.696 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 p -66.04 -47.17 75.28 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.633 -0.712 . . . . 73.340000000000003 111.509 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.0 m -69.92 -33.7 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 120.425 -0.51 . . . . 72.439999999999998 109.897 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.41 -46.32 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 120.155 -0.618 . . . . 70.239999999999995 110.556 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -55.31 -55.95 25.57 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.656 0.782 . . . . 63.229999999999997 111.785 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.0 -47.24 92.25 Favored Glycine 0 C--O 1.249 1.069 0 O-C-N 123.635 0.584 . . . . 62.229999999999997 112.652 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -68.44 -36.95 79.78 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 113.292 0.849 . . . . 75.530000000000001 113.292 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -34.47 71.99 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 119.469 -0.892 . . . . 72.340000000000003 110.859 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.19 -49.64 54.78 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.863 0.363 . . . . 74.400000000000006 110.875 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.45 -41.02 91.23 Favored Glycine 0 C--O 1.251 1.211 0 C-N-CA 120.624 -0.798 . . . . 55.229999999999997 111.238 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.441 ' HA2' ' CB ' ' A' ' 152' ' ' HIS . . . -61.87 -54.03 38.48 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.824 -0.688 . . . . 51.43 112.301 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.508 ' O ' HG12 ' A' ' 134' ' ' VAL . 57.5 m95 -56.99 -37.65 71.95 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 113.097 0.777 . . . . 74.340000000000003 113.097 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.5 m -57.37 -48.08 79.97 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 123.186 0.304 . . . . 73.129999999999995 110.436 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.89 -48.76 31.93 Favored Glycine 0 C--O 1.246 0.897 0 C-N-CA 120.584 -0.817 . . . . 72.549999999999997 112.332 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.24 -52.41 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.044 0.537 . . . . 75.430000000000007 111.653 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 4.2 p -71.63 -41.03 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 119.874 -0.73 . . . . 72.340000000000003 111.847 -173.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.527 ' HA ' HG13 ' A' ' 16' ' ' ILE . 26.7 t-20 -63.69 -52.18 61.77 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.988 -0.685 . . . . 54.140000000000001 111.234 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 33.5 tt0 -78.99 -44.75 21.69 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 113.183 0.808 . . . . 74.140000000000001 113.183 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.55 ' NH1' ' HB2' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -64.85 -45.3 86.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 119.147 -1.021 . . . . 64.230000000000004 109.837 -176.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.1 mm? -65.47 -52.21 54.53 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.218 0.324 . . . . 71.0 111.557 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -63.73 -35.65 81.27 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.908 0.385 . . . . 74.219999999999999 109.995 -177.456 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.488 ' NZ ' ' HB3' ' A' ' 144' ' ' GLU . 12.5 mmmt -68.65 -46.16 69.9 Favored 'General case' 0 C--O 1.173 -2.957 0 CA-C-O 119.157 -0.449 . . . . 74.519999999999996 111.088 177.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB2' ' NH1' ' A' ' 137' ' ' ARG . . . -59.48 -29.85 68.13 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.219 0.452 . . . . 73.219999999999999 112.219 -176.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 21.1 m -86.28 -24.69 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 120.19 -0.604 . . . . 74.430000000000007 112.205 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 78.6 mm-40 -86.08 -57.86 2.86 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.711 0.767 . . . . 73.209999999999994 109.958 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.488 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 2.3 tm-20 -139.7 100.26 3.91 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.267 -1.382 . . . . 72.010000000000005 107.267 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -24.79 -59.96 0.06 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 118.797 2.888 . . . . 74.400000000000006 118.797 -170.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -129.53 97.63 4.6 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.498 -1.281 . . . . 74.230000000000004 114.112 -168.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 70.6 t60 177.44 131.44 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.194 0.998 . . . . 72.049999999999997 109.047 173.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -167.99 152.76 6.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.817 -1.179 . . . . 75.030000000000001 107.817 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -174.79 106.97 0.1 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.022 -1.473 . . . . 75.430000000000007 107.022 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -121.52 -70.02 0.8 Allowed 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 112.891 0.7 . . . . 60.210000000000001 112.891 -173.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 171.43 -44.5 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 103.075 -2.935 . . . . 71.439999999999998 103.075 -172.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.441 ' CB ' ' HA2' ' A' ' 129' ' ' GLY . 96.0 m-70 . . . . . 0 N--CA 1.412 -2.35 0 N-CA-C 103.126 -2.916 . . . . 74.219999999999999 103.126 170.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.5 mtp . . . . . 0 CA--C 1.513 -0.471 0 CA-C-O 120.88 0.372 . . . . 52.5 110.12 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.29 65.37 1.25 Allowed 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.705 -0.68 . . . . 53.439999999999998 109.621 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -84.68 -27.46 27.05 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.861 -1.063 . . . . 65.530000000000001 111.323 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.56 ' ND2' ' H ' ' A' ' 5' ' ' ASN . 6.8 t30 -70.88 -169.96 0.4 Allowed 'General case' 0 CA--C 1.571 1.785 0 CA-C-N 115.576 -0.738 . . . . 74.450000000000003 111.563 -174.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.56 ' H ' ' ND2' ' A' ' 4' ' ' ASN . 8.0 t30 -52.26 -31.29 31.8 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 125.583 1.553 . . . . 72.349999999999994 113.591 -173.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HG3' ' HB3' ' A' ' 10' ' ' PRO . 1.5 pm0 -75.1 74.51 2.27 Favored 'General case' 0 C--N 1.263 -3.169 0 CA-C-N 114.593 -1.185 . . . . 72.420000000000002 113.344 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -84.57 -10.99 56.88 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.901 -1.518 . . . . 71.400000000000006 106.901 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.475 ' HB1' HG23 ' A' ' 112' ' ' ILE . . . -78.68 -72.43 0.38 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.393 1.477 . . . . 75.150000000000006 111.864 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tt -166.53 109.5 0.68 Allowed Pre-proline 0 N--CA 1.419 -1.979 0 N-CA-C 107.161 -1.422 . . . . 72.340000000000003 107.161 -172.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.44 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 2.7 Cg_exo -82.5 168.74 14.35 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 122.918 2.412 . . . . 70.310000000000002 109.522 171.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.53 107.47 1.4 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.638 -1.245 . . . . 72.109999999999999 107.638 170.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 43.2 mm -91.03 124.1 43.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.522 -0.918 . . . . 43.130000000000003 108.522 -174.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.0 m -120.37 128.39 53.19 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.433 -1.321 . . . . 64.150000000000006 107.433 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.562 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 22.4 tptt -140.2 144.56 36.65 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.701 -1.222 . . . . 72.319999999999993 107.701 -176.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.4 m -123.07 134.51 54.25 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.695 -0.402 . . . . 61.200000000000003 110.418 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.439 HG21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -141.7 131.79 25.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.919 -0.771 . . . . 72.200000000000003 108.919 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.87 117.87 32.05 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 121.809 0.814 . . . . 63.229999999999997 111.984 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.658 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.6 mp -92.7 140.07 29.91 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.796 -1.557 . . . . 64.329999999999998 106.796 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.85 15.27 3.4 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.175 0.512 . . . . 64.329999999999998 111.581 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -105.5 159.54 29.16 Favored Pre-proline 0 C--N 1.306 -1.31 0 CA-C-N 115.864 -0.607 . . . . 63.549999999999997 109.719 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.59 154.38 69.27 Favored 'Trans proline' 0 C--O 1.253 1.237 0 C-N-CA 123.028 2.485 . . . . 62.130000000000003 110.91 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.0 tt -60.63 -29.13 44.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.936 -0.575 . . . . 73.319999999999993 112.011 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.6 pt20 -62.85 -40.58 97.9 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.928 0.394 . . . . 71.409999999999997 111.198 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -68.12 -39.74 82.69 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.283 0.564 . . . . 72.400000000000006 110.909 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.467 HG21 ' HB ' ' A' ' 96' ' ' THR . 36.0 t -69.09 -40.75 81.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.328 -0.851 . . . . 61.229999999999997 109.821 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 28.7 t90 -59.06 -47.63 84.53 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 124.021 0.825 . . . . 74.319999999999993 110.397 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 34.2 mt-10 -64.4 -36.45 84.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.07 0.462 . . . . 71.319999999999993 110.731 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.4 m -67.16 -12.36 59.81 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-O 121.422 0.629 . . . . 60.210000000000001 111.976 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.669 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 16.7 m -131.06 13.62 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 120.756 -1.215 . . . . 23.329999999999998 112.906 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.6 t -139.12 4.05 2.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 120.247 -0.581 . . . . 73.099999999999994 112.259 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.4 p -111.57 168.57 9.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.198 -0.667 . . . . 62.130000000000003 109.198 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 16.4 m -60.08 -46.1 90.7 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.926 0.491 . . . . 64.430000000000007 111.447 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -71.12 -41.74 70.14 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.802 -0.635 . . . . 73.239999999999995 110.18 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . -66.21 -48.01 67.78 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 115.158 -0.928 . . . . 74.340000000000003 113.078 -177.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.07 -41.46 89.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 117.289 0.544 . . . . 73.140000000000001 111.205 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.99 -51.78 62.67 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.535 0.568 . . . . 42.509999999999998 112.535 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 62.3 mttp 56.36 27.31 11.78 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.271 0.629 . . . . 73.200000000000003 111.567 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -88.25 -70.54 0.63 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.059 -1.089 . . . . 63.109999999999999 108.059 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 t80 157.96 -41.75 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 103.868 -2.641 . . . . 62.43 103.868 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 25.9 ttt -93.65 124.86 55.73 Favored Pre-proline 0 N--CA 1.424 -1.751 0 CA-C-N 112.662 -2.063 . . . . 73.019999999999996 106.178 175.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.65 141.61 67.16 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.733 1.622 . . . . 71.319999999999993 111.398 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 32' ' ' SER . 19.7 t-20 -111.95 158.71 19.17 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 105.611 -1.996 . . . . 73.439999999999998 105.611 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.21 70.77 8.13 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.553 0.692 . . . . 74.140000000000001 111.431 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -107.67 119.87 40.64 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.564 -1.198 . . . . 65.049999999999997 108.404 172.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -121.57 150.37 41.77 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.6 -1.259 . . . . 64.200000000000003 107.6 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 46' ' ' LEU . 2.5 pt? -78.44 106.08 10.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 117.316 -1.754 . . . . 71.150000000000006 108.974 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -130.41 144.7 51.56 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 104.875 -2.269 . . . . 73.540000000000006 104.875 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 11.3 pt-20 -83.99 36.75 0.57 Allowed 'General case' 0 C--N 1.283 -2.312 0 CA-C-O 122.218 1.008 . . . . 53.409999999999997 109.76 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.8 66.52 0.01 OUTLIER Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.35 -1.5 . . . . 72.230000000000004 109.35 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 19.4 tt0 -74.16 124.17 25.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.326 -1.361 . . . . 51.229999999999997 107.326 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -132.62 150.18 52.2 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.12 0.486 . . . . 61.229999999999997 111.38 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -128.83 147.29 50.79 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.389 -1.708 . . . . 75.5 106.389 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -110.17 140.32 44.4 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.589 0.709 . . . . 73.239999999999995 112.609 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.6 mt -126.97 -175.05 3.31 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.147 -1.388 . . . . 75.109999999999999 107.714 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -77.73 -9.38 58.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.205 0.526 . . . . 73.0 110.305 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.8 p -140.16 163.74 42.0 Favored Pre-proline 0 N--CA 1.434 -1.227 0 C-N-CA 124.957 1.303 . . . . 63.119999999999997 107.948 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -87.69 1.58 6.87 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.212 1.941 . . . . 64.400000000000006 114.042 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -131.81 147.06 52.46 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.938 -0.393 . . . . 74.420000000000002 109.938 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.27 147.96 4.72 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 111.282 -0.727 . . . . 62.149999999999999 111.282 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -80.33 85.62 1.79 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.205 1.937 . . . . 64.310000000000002 111.57 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.477 ' H ' ' HD2' ' A' ' 62' ' ' PRO . 60.4 m -158.07 -56.73 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.222 0 C-N-CA 123.819 0.848 . . . . 74.340000000000003 110.865 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD2' ' H ' ' A' ' 61' ' ' SER . 37.1 Cg_endo -65.52 114.38 2.87 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 121.448 1.432 . . . . 71.010000000000005 112.574 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 14.0 p -88.26 142.41 27.77 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 105.646 -1.983 . . . . 51.020000000000003 105.646 173.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 42.9 mtpt -133.52 134.29 43.24 Favored 'General case' 0 CA--C 1.468 -2.21 0 C-N-CA 120.139 -0.625 . . . . 61.149999999999999 111.143 -169.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.2 t -90.66 133.82 31.31 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 N-CA-C 105.307 -2.108 . . . . 74.530000000000001 105.307 168.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.426 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 2.3 tm? -78.75 -56.64 4.26 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.038 -1.097 . . . . 73.340000000000003 108.038 -175.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.19 153.27 28.95 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.274 -0.875 . . . . 73.519999999999996 108.88 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.555 HG23 HD23 ' A' ' 74' ' ' LEU . 12.5 p -132.67 119.8 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 CA-C-O 121.885 0.85 . . . . 70.219999999999999 111.621 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 45.9 mt-30 -101.34 141.0 34.86 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.322 -0.854 . . . . 73.209999999999994 110.955 176.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.32 126.2 92.19 Favored Pre-proline 0 C--N 1.279 -2.468 0 CA-C-N 113.875 -1.511 . . . . 70.230000000000004 109.439 -164.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo 7.27 46.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 1 C-N-CA 127.869 5.712 . . . . 54.439999999999998 116.843 -162.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 p -138.7 -38.59 0.52 Allowed 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.773 -0.649 . . . . 73.299999999999997 112.182 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 31.1 tt0 -150.5 142.71 24.16 Favored 'General case' 0 C--O 1.208 -1.127 0 C-N-CA 118.913 -1.115 . . . . 74.420000000000002 110.221 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.685 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -138.52 137.18 36.85 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 108.746 -0.835 . . . . 63.420000000000002 108.746 -177.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.5 m -139.38 127.37 22.29 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 122.451 -0.156 . . . . 44.439999999999998 110.755 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 43.6 p90 -143.98 157.04 44.59 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.02 -0.425 . . . . 70.530000000000001 112.058 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 36.3 mt-10 -121.04 125.71 48.01 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 107.107 -1.442 . . . . 51.450000000000003 107.107 -176.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 51.3 t90 -135.33 148.49 49.48 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 111.925 0.343 . . . . 75.400000000000006 111.925 -176.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD1' HG22 ' A' ' 80' ' ' THR . 2.5 t70 77.82 -177.79 0.11 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.073 1.749 . . . . 73.510000000000005 111.909 171.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.482 HG22 ' OD1' ' A' ' 79' ' ' ASP . 1.8 t -58.34 -41.42 84.59 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 113.062 0.764 . . . . 62.409999999999997 113.062 -175.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.23 12.49 11.64 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.211 0.819 . . . . 74.420000000000002 113.211 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.96 57.45 6.9 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 123.42 0.45 . . . . 60.539999999999999 112.757 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 88.1 m95 -67.38 117.14 8.96 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 109.0 -0.741 . . . . 75.400000000000006 109.0 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 76' ' ' PHE . 7.2 p -101.84 101.16 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 CA-C-O 122.599 1.19 . . . . 74.310000000000002 109.418 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.2 m -100.26 146.85 8.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 CA-C-N 114.096 -1.411 . . . . 63.539999999999999 108.167 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.508 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 32.7 m -131.56 133.81 45.41 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 109.693 -176.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.685 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.2 m-85 -109.32 131.43 55.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.617 -1.253 . . . . 73.329999999999998 107.617 176.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.5 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 6.9 mt-30 -116.66 136.21 53.16 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 109.277 -0.638 . . . . 75.530000000000001 109.277 175.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mp -116.72 128.23 55.14 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.369 0.604 . . . . 71.5 110.552 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -102.85 119.6 39.14 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.104 -1.813 . . . . 71.239999999999995 106.104 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -81.13 111.79 17.9 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.11 0.481 . . . . 73.430000000000007 110.804 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.6 mt -120.95 148.66 43.78 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.669 -1.234 . . . . 74.140000000000001 107.669 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.06 54.24 2.53 Favored Glycine 0 C--N 1.284 -2.313 0 C-N-CA 121.027 -0.606 . . . . 62.020000000000003 112.208 -176.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -175.2 -54.51 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.652 -1.61 . . . . 72.109999999999999 106.652 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.38 175.41 8.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.027 -1.472 . . . . 74.099999999999994 107.027 -176.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.467 ' HB ' HG21 ' A' ' 25' ' ' VAL . 83.1 m -122.31 127.68 50.14 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 109.302 -0.629 . . . . 61.539999999999999 109.302 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.8 106.28 3.26 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.597 -1.401 . . . . 75.109999999999999 109.597 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -98.52 133.88 42.26 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 117.345 0.573 . . . . 72.230000000000004 109.646 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 28.9 m -123.17 120.38 33.03 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.612 -0.884 . . . . 74.310000000000002 108.612 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.63 141.62 33.23 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.961 -0.755 . . . . 72.239999999999995 108.961 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 18.2 mt -136.2 125.45 38.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.007 -1.451 . . . . 62.310000000000002 108.188 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -120.31 117.36 27.59 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.042 -1.096 . . . . 75.150000000000006 108.042 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.2 t -142.15 164.13 31.0 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 103.727 -2.694 . . . . 72.120000000000005 103.727 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.432 ' HA2' ' H ' ' A' ' 84' ' ' VAL . . . -166.65 163.3 36.89 Favored Glycine 0 CA--C 1.49 -1.514 0 C-N-CA 118.282 -1.913 . . . . 53.219999999999999 113.811 -178.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -85.55 66.27 9.58 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 122.994 1.378 . . . . 63.219999999999999 109.429 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -87.07 173.31 9.36 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.038 -1.437 . . . . 70.109999999999999 110.562 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.15 138.76 96.04 Favored Pre-proline 0 C--O 1.253 1.249 0 CA-C-N 115.352 -0.84 . . . . 72.109999999999999 110.031 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.47 87.76 1.06 Allowed 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 107.841 -1.638 . . . . 73.299999999999997 107.841 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.454 ' ND2' HG12 ' A' ' 111' ' ' VAL . 54.0 t30 -174.31 167.47 4.03 Favored 'General case' 0 C--O 1.249 1.071 0 N-CA-C 107.621 -1.252 . . . . 74.140000000000001 107.621 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 8' ' ' ALA . 20.7 pt-20 -70.26 -14.83 62.78 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.639 0.776 . . . . 74.150000000000006 112.84 -177.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 113' ' ' GLY . 14.9 p -111.91 152.38 13.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.703 -0.851 . . . . 65.109999999999999 108.703 175.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.691 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -59.63 -35.94 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.624 0.25 . . . . 74.299999999999997 111.374 176.168 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.457 ' H ' HG22 ' A' ' 111' ' ' VAL . . . 126.36 -140.28 11.95 Favored Glycine 0 N--CA 1.422 -2.284 0 N-CA-C 110.242 -1.143 . . . . 75.519999999999996 110.242 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -80.65 -2.5 46.84 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 123.533 0.733 . . . . 73.340000000000003 110.204 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.87 71.28 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.071 0.462 . . . . 42.229999999999997 109.93 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.448 ' O ' HD11 ' A' ' 112' ' ' ILE . 5.2 t30 -173.72 114.34 0.22 Allowed 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.209 -1.404 . . . . 74.099999999999994 107.209 174.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -78.74 49.47 0.9 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 114.36 1.244 . . . . 73.5 114.36 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -152.61 92.82 1.71 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.235 1.014 . . . . 73.0 108.824 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -57.01 13.57 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 123.516 0.726 . . . . 53.130000000000003 111.474 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.4 m -61.82 -33.3 73.9 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.166 -0.47 . . . . 63.450000000000003 111.375 -176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.85 -47.15 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 109.587 -0.523 . . . . 71.209999999999994 109.587 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.503 ' O ' ' HG2' ' A' ' 126' ' ' MET . 48.6 t -58.23 -43.55 86.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 O-C-N 123.822 0.701 . . . . 75.25 111.124 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -61.67 -48.95 78.49 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.159 -0.473 . . . . 65.109999999999999 110.833 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.42 -43.93 97.53 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 115.634 -0.712 . . . . 53.25 111.799 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -67.45 -34.21 76.72 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.829 -0.686 . . . . 74.340000000000003 112.193 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 25.7 mmt -66.7 -43.07 85.32 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.225 -0.59 . . . . 72.340000000000003 111.479 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.82 -61.51 1.78 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.259 -0.976 . . . . 65.310000000000002 111.772 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.37 -39.0 95.58 Favored Glycine 0 C--O 1.24 0.485 0 C-N-CA 120.928 -0.653 . . . . 61.149999999999999 112.574 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.26 -53.96 29.79 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 119.659 -0.523 . . . . 73.310000000000002 112.3 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.44 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.4 m95 -63.28 -29.53 70.84 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 117.51 0.655 . . . . 72.140000000000001 112.48 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.562 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 73.2 m -60.98 -57.4 12.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.427 -0.583 . . . . 65.450000000000003 109.427 174.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.5 -46.83 60.7 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.167 -0.539 . . . . 73.140000000000001 113.646 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.626 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 44.8 mm -59.13 -57.54 10.94 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 C-N-CA 122.728 0.411 . . . . 53.140000000000001 111.205 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.44 HG23 ' HE3' ' A' ' 130' ' ' TRP . 79.0 t -60.49 -44.1 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 O-C-N 123.096 0.248 . . . . 72.450000000000003 111.491 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 131' ' ' THR . 38.7 t-20 -54.24 -61.7 2.14 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 123.953 0.783 . . . . 74.209999999999994 111.148 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -80.89 -38.92 27.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 119.834 -0.747 . . . . 73.030000000000001 112.187 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.626 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 3.7 mmt180 -62.11 -46.64 88.17 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.372 0.533 . . . . 72.519999999999996 111.667 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.658 ' HB3' HD21 ' A' ' 18' ' ' LEU . 4.6 mm? -67.98 -48.57 65.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 120.236 -0.585 . . . . 74.450000000000003 110.467 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.592 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -61.81 -33.68 74.57 Favored 'General case' 0 C--O 1.198 -1.646 0 CA-C-N 115.734 -0.666 . . . . 73.129999999999995 109.611 -178.606 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -73.15 -35.68 66.51 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 112.879 0.696 . . . . 74.129999999999995 112.879 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.6 -32.92 71.94 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.032 0.444 . . . . 75.140000000000001 110.701 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.16 -27.0 7.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.744 -0.662 . . . . 63.549999999999997 111.602 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 64.3 mm-40 -87.33 -45.4 10.61 Favored 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 120.136 -0.626 . . . . 71.109999999999999 111.447 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.421 13.2 pt-20 59.71 -22.07 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.869 2.068 . . . . 63.210000000000001 115.489 -172.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.4 mp -73.47 168.82 18.47 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 107.804 -1.184 . . . . 73.420000000000002 107.804 168.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -77.84 75.98 4.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.417 0.627 . . . . 73.030000000000001 111.958 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -105.54 152.49 23.0 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.559 -0.904 . . . . 64.450000000000003 108.559 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -94.8 -167.92 1.73 Allowed 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.187 -0.672 . . . . 70.239999999999995 109.187 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -73.89 159.92 32.14 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.735 -1.209 . . . . 74.549999999999997 107.735 172.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -65.63 -53.73 37.51 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.322 0.582 . . . . 75.430000000000007 109.483 -175.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -177.03 -177.62 0.76 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 126.357 1.863 . . . . 72.230000000000004 106.313 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 38.7 m80 . . . . . 0 C--O 1.262 1.732 0 O-C-N 124.04 0.837 . . . . 74.109999999999999 110.244 -175.996 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 CA--C 1.495 -1.159 0 N-CA-C 108.58 -0.896 . . . . 73.019999999999996 108.58 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.29 91.58 6.24 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.572 0.701 . . . . 65.099999999999994 109.827 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -96.2 -48.38 5.66 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.407 -0.815 . . . . 70.400000000000006 109.455 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 120' ' ' SER 0.25 4.6 p-10 -92.69 71.09 4.91 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.296 1.046 . . . . 73.439999999999998 112.677 -178.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -87.32 104.24 16.22 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 107.222 -1.399 . . . . 71.349999999999994 107.222 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -111.45 80.15 1.28 Allowed 'General case' 0 C--N 1.259 -3.328 0 CA-C-N 113.912 -1.495 . . . . 61.310000000000002 110.246 -172.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -126.41 19.76 7.42 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.861 -1.063 . . . . 73.25 110.236 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 67.47 77.39 0.26 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.616 1.166 . . . . 72.209999999999994 111.597 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 tp 58.8 88.49 0.12 Allowed Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 124.72 1.208 . . . . 61.329999999999998 113.865 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -68.45 139.05 44.04 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 N-CA-C 108.475 -1.394 . . . . 63.219999999999999 108.475 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.69 153.79 42.47 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.48 0.919 . . . . 73.420000000000002 113.48 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.6 mm -121.78 138.74 51.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.067 -0.969 . . . . 73.510000000000005 110.075 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.1 m -126.01 130.82 51.93 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.827 -1.546 . . . . 70.239999999999995 106.827 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 41.0 tptt -139.75 145.37 38.2 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.849 -0.797 . . . . 55.450000000000003 108.849 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -118.56 140.63 49.59 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 117.682 0.219 . . . . 73.430000000000007 110.825 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.92 142.58 16.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.052 -0.722 . . . . 74.329999999999998 109.052 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 p -105.3 130.01 53.52 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 112.572 0.582 . . . . 73.299999999999997 112.572 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.53 141.53 33.27 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.826 -0.624 . . . . 63.43 111.038 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -78.9 9.42 4.27 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.033 0.833 . . . . 74.230000000000004 111.441 -176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -120.95 160.56 44.41 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 109.586 -0.524 . . . . 73.319999999999993 109.586 -172.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 32.5 Cg_endo -62.89 152.69 77.64 Favored 'Trans proline' 0 C--O 1.256 1.384 0 C-N-CA 123.205 2.603 . . . . 63.350000000000001 111.749 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.9 tt -56.63 -31.67 35.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.301 -0.863 . . . . 72.310000000000002 112.097 -175.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -66.58 -33.75 76.36 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.111 0.411 . . . . 74.549999999999997 112.111 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.5 -36.11 45.48 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.165 -0.68 . . . . 71.409999999999997 109.165 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 29' ' ' VAL . 46.3 t -66.07 -41.28 89.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.885 -0.783 . . . . 73.219999999999999 108.885 177.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 51.9 t90 -59.06 -47.85 83.72 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.997 -1.001 . . . . 71.299999999999997 111.718 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.42 -30.41 70.14 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.457 -0.897 . . . . 74.129999999999995 110.694 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.9 m -63.79 -22.84 67.11 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-O 121.274 0.559 . . . . 72.129999999999995 111.744 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.605 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 17.0 m -122.81 16.7 5.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 121.741 -0.6 . . . . 62.109999999999999 112.41 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.534 ' HB3' HD12 ' A' ' 46' ' ' LEU . 53.9 m -144.19 8.49 1.41 Allowed 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.163 0.801 . . . . 61.140000000000001 113.163 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.5 p -116.9 168.93 9.79 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 121.516 -0.74 . . . . 74.150000000000006 109.409 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -60.82 -54.7 41.94 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.268 -0.642 . . . . 43.43 109.268 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.97 -38.94 87.7 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.133 -0.94 . . . . 62.039999999999999 111.191 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.47 -48.74 28.44 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.687 -0.768 . . . . 40.420000000000002 113.379 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.31 -41.53 78.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 117.636 0.718 . . . . 53.140000000000001 112.785 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' A' ' 40' ' ' MET . . . -59.11 -31.17 68.68 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.558 0.947 . . . . 71.409999999999997 113.558 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 85.7 tttt 60.64 54.5 3.66 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.523 0.729 . . . . 72.230000000000004 111.324 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . 0.325 7.6 p90 52.39 -45.36 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 119.679 3.214 . . . . 74.510000000000005 119.679 171.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -78.96 -16.25 57.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 119.06 0.845 . . . . 74.219999999999999 112.933 -174.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.596 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -127.31 93.11 41.91 Favored Pre-proline 0 C--N 1.298 -1.636 0 N-CA-C 108.584 -0.895 . . . . 73.5 108.584 179.522 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.6 100.05 0.56 Allowed 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 122.467 2.111 . . . . 73.439999999999998 112.017 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.61 142.68 51.19 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.157 -0.683 . . . . 52.030000000000001 109.157 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.22 72.94 3.34 Favored 'General case' 0 CA--C 1.486 -1.511 0 CA-C-O 121.339 0.59 . . . . 52.009999999999998 111.294 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -84.85 131.14 34.56 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.923 -1.51 . . . . 75.430000000000007 106.923 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.473 ' HB3' HE22 ' A' ' 50' ' ' GLN . 53.7 tt0 -120.01 149.68 41.76 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.145 -0.687 . . . . 63.409999999999997 109.145 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' A' ' 30' ' ' SER . 6.0 tt -85.38 104.27 15.04 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 109.267 -0.642 . . . . 75.109999999999999 109.267 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.761 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 12.1 tppt? -132.94 146.01 51.41 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.586 -1.264 . . . . 73.409999999999997 107.586 168.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.486 ' HB3' HG12 ' A' ' 68' ' ' VAL . 11.4 pt-20 -87.02 77.45 9.17 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.596 1.189 . . . . 71.340000000000003 108.002 172.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.43 83.44 0.96 Allowed Glycine 0 N--CA 1.406 -3.342 0 CA-C-N 114.327 -1.306 . . . . 45.420000000000002 109.959 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.761 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 48.7 tt0 -149.42 132.85 16.61 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 108.215 -1.031 . . . . 60.229999999999997 108.215 -177.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.25 141.22 51.09 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 120.258 -0.577 . . . . 73.409999999999997 110.584 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -95.89 114.76 26.52 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.191 -1.781 . . . . 73.549999999999997 106.191 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -114.64 140.14 49.06 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 119.71 -0.796 . . . . 72.0 110.641 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 57' ' ' PRO . 36.2 tp -166.87 148.01 5.95 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 103.824 -2.658 . . . . 71.310000000000002 103.824 178.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.1 tm0? -85.56 -56.3 3.57 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.564 -0.854 . . . . 72.140000000000001 108.995 -175.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.5 m -109.51 100.8 43.49 Favored Pre-proline 0 N--CA 1.434 -1.227 0 N-CA-C 108.113 -1.069 . . . . 72.129999999999995 108.113 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.467 ' HA ' HD23 ' A' ' 54' ' ' LEU . 3.1 Cg_exo -81.79 134.9 8.68 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.145 2.563 . . . . 64.420000000000002 113.789 -176.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -123.85 101.61 7.36 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.125 -1.065 . . . . 64.540000000000006 108.125 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.09 -86.74 0.43 Allowed Glycine 0 C--N 1.305 -1.179 0 N-CA-C 110.648 -0.981 . . . . 53.409999999999997 110.648 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -93.03 136.42 1.32 Allowed 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.375 2.05 . . . . 63.340000000000003 111.827 176.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.484 ' HB2' ' NE1' ' A' ' 78' ' ' TRP . 16.1 m -78.67 163.85 58.84 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.481 -0.933 . . . . 73.25 108.481 175.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.27 110.51 0.8 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.294 1.996 . . . . 54.5 111.285 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.9 p -111.82 167.02 10.69 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 109.389 -0.597 . . . . 55.219999999999999 109.389 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 22.9 pttm -158.31 145.26 17.71 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.233 -0.655 . . . . 63.020000000000003 109.233 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.6 t -89.26 126.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 107.271 -1.381 . . . . 71.400000000000006 107.271 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 tt -74.79 -53.41 9.22 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.009 -1.478 . . . . 65.530000000000001 107.009 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.9 141.93 5.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.016 -0.993 . . . . 63.119999999999997 109.108 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.606 HG23 HD23 ' A' ' 74' ' ' LEU . 14.3 p -122.3 120.04 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-O 121.981 0.896 . . . . 70.430000000000007 108.953 173.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 84.4 mm-40 -105.17 142.14 35.48 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 114.013 -1.449 . . . . 74.040000000000006 109.778 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 135.94 95.65 Favored Pre-proline 0 C--N 1.283 -2.316 0 CA-C-N 114.569 -1.196 . . . . 61.520000000000003 109.103 -165.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -3.07 54.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.614 1 C-N-CA 128.323 6.015 . . . . 53.119999999999997 117.977 -162.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -152.23 -37.63 0.11 Allowed 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.617 -0.72 . . . . 55.420000000000002 110.809 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 35.1 tt0 -139.72 129.14 24.16 Favored 'General case' 0 C--O 1.198 -1.621 0 C-N-CA 117.351 -1.74 . . . . 64.010000000000005 112.142 -174.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.68 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -131.15 134.39 46.49 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.717 -0.845 . . . . 53.149999999999999 108.717 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.4 m -140.26 126.7 20.11 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.639 -0.255 . . . . 61.350000000000001 110.497 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HD1' HD11 ' A' ' 74' ' ' LEU . 39.9 p90 -142.45 154.7 44.79 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.813 0.34 . . . . 74.340000000000003 110.271 177.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -122.63 132.25 54.19 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.688 -0.856 . . . . 62.43 108.688 -172.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.486 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 15.6 t-105 -112.98 106.14 14.34 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.124 -1.806 . . . . 64.150000000000006 106.124 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -72.49 172.26 10.83 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.238 -0.437 . . . . 74.319999999999993 110.69 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.1 m 65.3 43.89 3.39 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 122.196 0.998 . . . . 72.530000000000001 109.448 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 64.51 32.37 11.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.352 -1.295 . . . . 71.010000000000005 113.508 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 78' ' ' TRP . . . -86.81 -17.86 59.11 Favored Glycine 0 C--O 1.238 0.373 0 N-CA-C 109.308 -1.517 . . . . 42.310000000000002 109.308 171.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 28.6 m95 81.22 -174.17 0.04 OUTLIER 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.634 1.974 . . . . 74.319999999999993 112.217 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.32 122.96 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 121.758 0.79 . . . . 70.409999999999997 110.196 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m -116.8 152.36 18.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-O 121.317 0.58 . . . . 73.230000000000004 110.198 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 34.1 m -139.49 142.22 37.33 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 109.083 -0.71 . . . . 74.319999999999993 109.083 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.68 ' CD2' HD12 ' A' ' 74' ' ' LEU . 15.0 m-85 -121.23 140.35 52.16 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.89 -1.152 . . . . 75.239999999999995 107.89 176.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.88 132.79 53.26 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.357 -1.349 . . . . 63.039999999999999 107.357 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.84 122.18 44.61 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.738 0.78 . . . . 73.120000000000005 111.988 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -102.76 125.46 49.51 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.589 -1.187 . . . . 73.349999999999994 108.92 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -84.4 125.83 32.68 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.522 -0.763 . . . . 73.239999999999995 110.603 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.6 mt -125.43 153.04 44.06 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.856 -1.535 . . . . 64.409999999999997 106.856 171.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.18 38.22 2.73 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 114.613 0.605 . . . . 31.510000000000002 114.613 -172.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -176.02 -38.66 0.01 OUTLIER 'General case' 0 C--O 1.24 0.588 0 N-CA-C 109.372 -0.603 . . . . 73.340000000000003 109.372 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -127.12 175.81 7.85 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.115 -1.068 . . . . 60.140000000000001 108.115 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.4 m -121.54 129.07 52.66 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 120.709 -0.396 . . . . 71.420000000000002 110.281 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.42 106.16 3.32 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 109.489 -1.444 . . . . 62.530000000000001 109.489 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -98.58 134.47 41.47 Favored 'General case' 0 C--N 1.27 -2.864 0 O-C-N 121.801 -0.823 . . . . 62.030000000000001 109.652 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.6 m -118.84 121.7 40.63 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.387 -0.968 . . . . 74.219999999999999 108.387 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -101.83 142.34 33.29 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.694 0.759 . . . . 71.519999999999996 109.131 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.487 ' N ' HD13 ' A' ' 100' ' ' LEU . 17.7 mt -136.15 124.44 36.43 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.911 0 CA-C-N 113.92 -1.491 . . . . 72.430000000000007 107.653 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -120.22 118.24 29.95 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.294 -1.743 . . . . 72.040000000000006 106.294 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -138.79 164.19 30.25 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.811 -1.181 . . . . 74.049999999999997 107.811 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.21 170.1 34.37 Favored Glycine 0 N--CA 1.413 -2.889 0 N-CA-C 109.777 -1.329 . . . . 51.439999999999998 109.777 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -83.86 100.62 11.09 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.003 -0.74 . . . . 74.299999999999997 109.003 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.528 ' H ' ' HD2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -79.18 79.86 5.57 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.236 1.017 . . . . 63.43 110.764 -179.246 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -85.92 -60.14 0.28 Allowed Pre-proline 0 C--N 1.304 -1.408 0 CA-C-N 115.037 -0.983 . . . . 64.239999999999995 112.226 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.8 -23.45 76.63 Favored 'Trans proline' 0 C--N 1.383 2.395 0 C-N-CA 121.701 1.601 . . . . 64.209999999999994 113.332 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 66.8 t30 61.44 19.93 10.71 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.491 1.116 . . . . 62.439999999999998 111.964 175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -130.23 -73.25 0.56 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.871 -0.788 . . . . 75.340000000000003 108.871 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.422 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 11.7 p -141.24 146.7 23.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.218 -1.401 . . . . 73.409999999999997 107.218 176.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.626 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -62.42 -39.42 84.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 112.344 0.498 . . . . 64.239999999999995 112.344 179.359 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.92 -128.61 8.83 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.663 -0.78 . . . . 54.420000000000002 112.741 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -75.42 -7.39 53.93 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.69 0.796 . . . . 71.019999999999996 111.765 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.13 -34.02 71.56 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 123.137 0.273 . . . . 63.119999999999997 110.544 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -163.06 -81.7 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 119.676 -0.809 . . . . 61.450000000000003 112.887 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -151.28 -162.1 1.47 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.698 1.199 . . . . 55.119999999999997 109.231 -173.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.506 ' HB2' HG22 ' A' ' 121' ' ' VAL . 3.7 mppt? -75.43 154.38 37.13 Favored 'General case' 0 C--O 1.212 -0.895 0 C-N-CA 122.994 0.517 . . . . 65.310000000000002 110.289 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 111' ' ' VAL . 50.0 m -60.21 -41.6 93.38 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.922 1.082 . . . . 65.409999999999997 113.922 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 4' ' ' ASN . 36.2 t -69.7 -45.87 67.27 Favored 'General case' 0 C--O 1.256 1.438 0 C-N-CA 120.116 -0.634 . . . . 74.310000000000002 111.138 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.506 HG22 ' HB2' ' A' ' 118' ' ' LYS . 27.6 m -69.94 -36.74 70.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 119.16 -1.016 . . . . 73.310000000000002 110.928 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 126' ' ' MET . 21.4 t -61.27 -45.68 98.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.253 0 O-C-N 123.167 0.292 . . . . 75.239999999999995 111.407 175.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -64.44 -40.45 95.76 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.882 -0.327 . . . . 71.409999999999997 111.237 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.03 -45.0 95.04 Favored Glycine 0 CA--C 1.492 -1.356 0 N-CA-C 111.225 -0.75 . . . . 61.310000000000002 111.225 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -68.22 -32.33 72.46 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.697 -0.752 . . . . 65.420000000000002 111.195 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 21.3 mmt -64.06 -49.37 72.59 Favored 'General case' 0 C--O 1.206 -1.21 0 C-N-CA 121.068 -0.253 . . . . 63.520000000000003 111.252 176.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.92 -51.38 62.19 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 119.839 -0.744 . . . . 63.020000000000003 110.973 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.76 -44.97 95.49 Favored Glycine 0 C--O 1.241 0.545 0 C-N-CA 121.232 -0.508 . . . . 73.230000000000004 111.981 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.55 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -62.46 -50.89 60.44 Favored Glycine 0 CA--C 1.487 -1.679 0 N-CA-C 111.352 -0.699 . . . . 44.130000000000003 111.352 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.511 ' O ' HG12 ' A' ' 134' ' ' VAL . 77.4 m95 -59.51 -37.24 77.78 Favored 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 118.83 -0.605 . . . . 70.329999999999998 112.496 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.504 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 90.1 m -54.32 -54.4 40.84 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 109.859 -0.422 . . . . 74.030000000000001 109.859 176.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.62 -45.33 67.16 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.804 -0.634 . . . . 45.530000000000001 113.538 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 129' ' ' GLY . 36.2 pt -74.68 -36.67 41.19 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.416 0 N-CA-C 113.213 0.819 . . . . 74.140000000000001 113.213 -176.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 130' ' ' TRP . 4.2 p -74.92 -38.82 44.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 118.671 -1.212 . . . . 60.340000000000003 110.494 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.3 -60.25 3.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.742 -0.383 . . . . 74.209999999999994 110.896 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.2 -43.95 66.39 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.248 0.462 . . . . 53.020000000000003 112.248 -173.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 2.0 tmm_? -70.27 -41.56 73.28 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.228 -0.589 . . . . 73.519999999999996 110.454 -173.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.0 mm? -63.96 -45.46 89.02 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 119.839 -0.744 . . . . 61.219999999999999 109.198 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -59.03 -42.28 89.81 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.815 -0.629 . . . . 71.519999999999996 110.187 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -65.27 -51.66 59.34 Favored 'General case' 0 C--O 1.166 -3.311 0 CA-C-O 119.502 -0.285 . . . . 73.420000000000002 111.382 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.2 73.48 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 123.359 0.412 . . . . 72.530000000000001 112.106 -175.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 31.2 m -74.34 -26.45 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 119.665 -0.814 . . . . 63.049999999999997 110.736 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.95 -53.28 4.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 118.815 -1.154 . . . . 52.350000000000001 112.63 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -143.63 107.15 4.59 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 124.229 1.012 . . . . 73.450000000000003 110.776 -175.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 83.0 mt -68.27 -23.11 64.73 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.069 0.548 . . . . 54.240000000000002 111.759 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -73.21 104.44 4.26 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.875 0.845 . . . . 54.020000000000003 110.421 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -148.33 144.04 27.29 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 104.957 -2.238 . . . . 74.200000000000003 104.957 171.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -120.89 133.95 55.29 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.773 -0.771 . . . . 72.200000000000003 109.766 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -158.04 148.11 20.21 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 103.504 -2.776 . . . . 74.019999999999996 103.504 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -101.26 161.99 13.22 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.933 -1.136 . . . . 74.5 107.933 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -72.37 111.29 7.44 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.395 -1.335 . . . . 54.530000000000001 107.395 170.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 . . . . . 0 C--O 1.241 0.649 0 C-N-CA 125.592 1.557 . . . . 70.409999999999997 109.54 -170.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 120.894 0.378 . . . . 71.43 111.377 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 4.2 mm? 67.95 90.24 0.09 OUTLIER Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 114.911 -1.04 . . . . 74.21 112.454 -172.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -88.32 -159.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 122.309 2.006 . . . . 64.44 109.702 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 7.8 p-10 -65.86 116.16 6.73 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.945 0.879 . . . . 73.04 111.151 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 50.0 mm -120.6 124.46 72.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 106.578 -1.638 . . . . 43.13 106.578 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.9 m -111.38 136.76 50.06 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.834 -0.802 . . . . 71.43 108.834 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -142.07 142.96 32.88 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.058 -1.089 . . . . 72.3 108.058 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.0 p -137.31 134.15 35.76 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 118.332 0.514 . . . . 34.2 109.785 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.92 131.84 13.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.236 -0.653 . . . . 74.45 109.236 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.477 ' CG2' ' HG3' ' A' ' 95' ' ' LYS . 2.7 m -94.52 120.97 35.57 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-O 121.798 0.809 . . . . 74.51 110.674 -175.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.2 mt -95.64 140.35 30.58 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.053 -0.976 . . . . 61.1 110.018 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.99 25.09 0.38 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.169 0.588 . . . . 75.55 112.21 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.84 160.47 44.56 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 122.655 0.382 . . . . 55.32 110.074 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 38.7 Cg_endo -67.4 157.41 61.9 Favored 'Trans proline' 0 C--O 1.256 1.402 0 C-N-CA 123.194 2.596 . . . . 62.15 111.55 175.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.9 tt -62.64 -27.16 42.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.785 -0.643 . . . . 75.32 112.119 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.41 -31.9 65.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.903 0.382 . . . . 75.42 111.481 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 5.0 tmtt? -79.1 -37.71 38.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 108.849 -0.797 . . . . 74.21 108.849 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 96' ' ' THR . 4.3 p -66.28 -39.84 85.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 120.074 -0.65 . . . . 71.3 110.243 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.483 ' NE1' ' HD3' ' A' ' 71' ' ' PRO . 50.2 t90 -58.11 -48.24 80.81 Favored 'General case' 0 C--O 1.213 -0.867 0 O-C-N 123.704 0.628 . . . . 64.51 111.153 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.49 -29.99 69.57 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 120.125 -0.63 . . . . 72.31 110.586 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 94.6 m -67.01 -26.27 66.7 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.993 0.425 . . . . 64.51 111.522 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.641 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.7 m -115.33 19.84 7.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 121.374 -0.829 . . . . 74.12 112.112 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.8 m -142.24 4.78 1.63 Allowed 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.842 0.682 . . . . 70.14 112.842 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.8 p -110.51 162.21 14.92 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.749 -0.834 . . . . 72.41 108.749 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -56.47 -44.78 80.89 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 123.474 0.709 . . . . 62.21 111.089 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.11 -46.61 64.46 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.402 -0.817 . . . . 70.34 111.005 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.06 -40.68 88.37 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 115.615 -0.721 . . . . 44.25 112.814 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.4 mt -68.92 -39.89 80.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 120.804 0.335 . . . . 71.35 110.842 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.387 0 CA-C-N 116.04 -0.527 . . . . 62.31 110.671 174.368 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 . . . . . 0 CA--C 1.501 -0.923 0 N-CA-C 108.261 -1.014 . . . . 74.43 108.261 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -99.1 61.54 1.24 Allowed 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.328 -0.949 . . . . 65.1 109.295 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.507 ' HD2' ' HG ' ' A' ' 63' ' ' CYS . 20.0 t80 -65.58 132.51 49.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.108 -1.405 . . . . 73.43 110.201 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -109.93 133.41 53.21 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.752 -0.462 . . . . 72.23 109.752 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 68' ' ' VAL . 15.7 tp -78.02 106.15 9.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.43 -1.322 . . . . 72.55 107.43 177.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -130.16 145.0 51.68 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.529 -1.286 . . . . 74.24 107.529 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -84.21 59.3 5.26 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.984 0.897 . . . . 71.01 109.277 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.27 77.53 0.58 Allowed Glycine 0 N--CA 1.414 -2.824 0 N-CA-C 109.38 -1.488 . . . . 64.21 109.38 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 C--N 1.314 -0.952 0 CA-C-O 121.94 0.876 . . . . 61.15 108.717 -176.615 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.507 ' HG ' ' HD2' ' A' ' 44' ' ' PHE . 3.9 p . . . . . 0 N--CA 1.408 -2.56 0 N-CA-C 107.983 -1.118 . . . . 61.04 107.983 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -133.97 140.83 47.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.756 -1.201 . . . . 75.03 107.756 -172.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.444 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 3.0 t -90.16 136.77 23.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 107.927 -1.138 . . . . 55.51 107.927 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.6 tp -83.52 -58.07 2.97 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.82 -1.178 . . . . 74.34 107.82 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.47 138.98 14.93 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.772 -1.104 . . . . 53.52 109.183 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.616 HG23 HD23 ' A' ' 74' ' ' LEU . 11.2 p -119.37 124.26 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 N-CA-C 108.978 -0.749 . . . . 74.12 108.978 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 28.2 mm-40 -105.12 140.84 37.69 Favored 'General case' 0 CA--C 1.48 -1.741 0 CA-C-N 115.663 -0.699 . . . . 72.44 109.602 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.32 126.48 92.61 Favored Pre-proline 0 C--N 1.279 -2.48 0 CA-C-N 113.604 -1.635 . . . . 72.53 109.047 -166.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.483 ' HD3' ' NE1' ' A' ' 26' ' ' TRP . 36.9 Cg_exo 5.89 42.99 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 1 C-N-CA 128.131 5.887 . . . . 32.23 118.428 -160.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 p -132.76 -39.13 0.99 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.312 -0.404 . . . . 73.24 111.867 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 40.5 tt0 -150.43 145.11 25.85 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 119.325 -0.95 . . . . 73.03 110.988 -172.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.682 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -139.25 135.11 33.54 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.676 -0.861 . . . . 73.41 108.676 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.8 m -140.54 126.04 18.96 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.689 0.28 . . . . 72.23 110.945 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.468 ' HD2' HD11 ' A' ' 74' ' ' LEU . 34.8 p90 -146.01 157.23 43.87 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 120.613 0.244 . . . . 72.03 111.02 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -120.95 123.86 43.5 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.978 -1.119 . . . . 74.3 107.978 -174.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -108.26 111.28 23.16 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 106.187 -1.783 . . . . 64.43 106.187 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.29 1.2 m-20 -79.1 10.16 3.78 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 116.808 2.151 . . . . 62.12 116.808 -170.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -75.85 94.95 3.41 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 104.529 -2.397 . . . . 75.32 104.529 167.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 83.68 -37.82 0.07 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.885 2.074 . . . . 75.22 109.718 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.94 47.45 0.56 Allowed Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 111.07 -0.812 . . . . 34.23 111.07 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -85.25 112.37 20.7 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.608 0.718 . . . . 73.54 110.402 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.1 t -101.77 117.27 46.83 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 N-CA-C 106.705 -1.591 . . . . 73.11 106.705 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.32 147.12 20.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-O 121.555 0.693 . . . . 73.45 110.518 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.526 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 46.7 m -128.88 132.73 47.75 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 115.019 -0.991 . . . . 72.41 108.711 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.682 ' CD2' HD12 ' A' ' 74' ' ' LEU . 14.4 m-85 -112.7 145.56 40.28 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.978 -1.119 . . . . 74.25 107.978 177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 69.4 mt-30 -130.84 144.17 51.26 Favored 'General case' 0 C--N 1.277 -2.573 0 O-C-N 123.591 0.557 . . . . 74.34 110.932 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.0 mt -114.9 120.9 41.53 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 123.707 0.63 . . . . 65.32 110.25 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -103.48 122.74 45.54 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.454 -0.943 . . . . 74.12 108.454 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -77.66 112.7 14.74 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.101 -0.5 . . . . 74.12 111.479 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.0 mt -125.58 160.2 30.18 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.365 -0.834 . . . . 72.33 108.963 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.76 123.94 6.89 Favored Glycine 0 N--CA 1.424 -2.152 0 N-CA-C 109.114 -1.594 . . . . 75.43 109.114 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 84.58 -10.03 0.87 Allowed 'General case' 0 CA--C 1.485 -1.522 0 C-N-CA 125.709 1.604 . . . . 64.21 111.812 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.477 ' HG3' ' CG2' ' A' ' 17' ' ' THR . 2.1 ptpt -154.99 174.87 14.56 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 108.519 -0.919 . . . . 72.05 108.519 -176.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.617 HG21 HG11 ' A' ' 25' ' ' VAL . 63.8 m -135.41 132.49 37.57 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 110.039 -0.356 . . . . 64.52 110.039 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.73 117.27 4.82 Favored Glycine 0 N--CA 1.423 -2.224 0 N-CA-C 109.831 -1.308 . . . . 73.2 109.831 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -99.77 129.98 45.94 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 108.81 -0.811 . . . . 71.44 108.81 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 37.7 m -117.38 121.41 41.01 Favored 'General case' 0 N--CA 1.408 -2.529 0 C-N-CA 119.196 -1.002 . . . . 72.42 108.778 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.54 140.01 35.41 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-O 122.265 1.031 . . . . 74.41 109.017 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 18.5 mt -136.19 124.95 37.54 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.117 0 CA-C-N 113.054 -1.885 . . . . 75.3 107.027 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.496 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . 10.3 t60 -120.25 131.87 55.11 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.919 -1.141 . . . . 74.11 107.919 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.6 m -142.88 132.48 23.77 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.696 -1.224 . . . . 23.11 107.696 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.87 127.09 9.11 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 120.497 -0.859 . . . . 64.44 111.201 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 . . . . . 0 N--CA 1.432 -1.361 0 CA-C-O 122.557 1.17 . . . . 73.25 111.432 -179.601 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 106.904 -1.517 . . . . 75.32 106.904 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 115' ' ' ALA . 9.6 pt -62.15 -43.96 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.914 0.779 . . . . 74.34 110.166 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.62 -80.05 0.37 Allowed Glycine 0 N--CA 1.422 -2.283 0 C-N-CA 119.862 -1.161 . . . . 65.01 114.451 173.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.1 mptp? -104.2 -34.12 8.48 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.694 0.628 . . . . 61.14 112.694 -168.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.604 ' HB3' HD12 ' A' ' 112' ' ' ILE . . . -65.03 -34.17 77.8 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 120.664 0.268 . . . . 63.14 111.68 -176.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.408 HD22 ' N ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -167.55 122.59 1.03 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.498 -1.297 . . . . 70.22 107.498 178.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.408 ' N ' HD22 ' A' ' 116' ' ' ASN . 10.4 tp10 -86.3 89.14 7.77 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.101 0.477 . . . . 50.21 111.584 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 31.4 tptt 179.64 152.84 0.44 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.045 -1.835 . . . . 74.32 106.045 171.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.2 p -111.76 -50.7 2.9 Favored 'General case' 0 C--N 1.286 -2.18 0 C-N-CA 120.028 -0.669 . . . . 75.5 111.37 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.2 p -63.22 -46.32 87.52 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.657 0.783 . . . . 74.45 111.187 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.91 -47.03 83.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.209 -0.905 . . . . 74.45 110.72 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.6 t -59.28 -35.03 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 116.357 -0.383 . . . . 71.41 111.237 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -66.56 -50.63 62.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.469 -0.937 . . . . 64.22 108.469 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.87 -40.53 98.42 Favored Glycine 0 C--O 1.241 0.547 0 CA-C-N 116.061 -0.518 . . . . 73.21 112.564 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -64.45 -38.77 92.2 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 122.877 0.471 . . . . 72.34 111.184 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.0 mmt -69.87 -36.83 75.82 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 121.361 -0.136 . . . . 73.15 111.353 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.49 -56.22 24.71 Favored 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 123.201 0.313 . . . . 61.24 110.737 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.83 -37.68 88.62 Favored Glycine 0 C--O 1.245 0.828 0 C-N-CA 120.672 -0.775 . . . . 62.23 111.745 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.8 -63.13 5.36 Favored Glycine 0 N--CA 1.438 -1.175 0 CA-C-N 115.309 -0.445 . . . . 62.42 112.408 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.642 ' O ' HG22 ' A' ' 134' ' ' VAL . 90.9 m95 -56.07 -45.25 79.38 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 113.342 0.867 . . . . 73.42 113.342 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.4 m -54.66 -51.44 65.48 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.708 0.63 . . . . 64.13 110.743 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.96 -43.61 64.8 Favored Glycine 0 C--O 1.25 1.125 0 C-N-CA 120.525 -0.845 . . . . 63.44 112.425 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.57 -57.6 11.35 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.848 0 CA-C-O 119.161 -0.447 . . . . 73.41 111.705 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 130' ' ' TRP . 27.4 m -64.19 -35.58 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 C-N-CA 118.906 -1.118 . . . . 75.55 112.841 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 42.3 t30 -57.81 -70.4 0.14 Allowed 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.558 0.536 . . . . 74.05 112.0 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.23 -28.13 27.49 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 118.93 -1.108 . . . . 74.23 112.062 -172.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -73.61 -38.08 65.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 118.722 -1.191 . . . . 70.14 110.804 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.5 mm? -70.78 -42.95 69.7 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 118.345 -1.342 . . . . 63.15 109.338 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 135' ' ' ASN . 2.3 tmm_? -57.73 -40.98 80.9 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 115.788 -0.642 . . . . 72.44 110.552 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -73.14 -36.67 66.7 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 113.422 0.897 . . . . 75.35 113.422 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.79 58.48 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.093 0.473 . . . . 62.15 110.968 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.471 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 32.1 m -85.36 -30.24 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 119.9 -0.72 . . . . 72.51 111.571 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -92.69 -26.19 17.9 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.102 0.779 . . . . 63.32 113.102 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 C--N 1.297 -1.708 0 N-CA-C 105.461 -2.051 . . . . 72.44 105.461 -177.443 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.519 0 N-CA-C 108.578 -0.897 . . . . 64.31 108.578 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 tp -67.33 116.54 37.73 Favored Pre-proline 0 C--N 1.313 -0.981 0 O-C-N 123.767 0.667 . . . . 72.4 110.686 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -99.78 -157.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.251 0 C-N-CA 123.01 2.473 . . . . 64.12 108.959 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.623 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 5.1 p-10 -70.37 131.77 44.61 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.006 -0.678 . . . . 72.33 110.166 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.3 tt -132.41 138.95 51.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.933 -0.765 . . . . 72.5 108.933 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 m -111.77 134.83 53.08 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.797 -0.445 . . . . 75.43 109.797 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -136.9 124.1 21.77 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.082 -1.451 . . . . 64.3 107.082 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 m -117.84 134.02 55.35 Favored 'General case' 0 C--N 1.261 -3.266 0 N-CA-C 109.244 -0.651 . . . . 61.11 109.244 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.34 133.09 28.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 109.263 -0.643 . . . . 72.41 109.263 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -97.14 125.39 41.61 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 116.198 -0.455 . . . . 72.02 111.016 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.47 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.8 mp -101.06 139.58 36.55 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.096 -0.502 . . . . 74.23 110.077 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -80.06 29.94 0.27 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.987 0.915 . . . . 72.54 111.343 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.97 157.8 74.65 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.735 -0.839 . . . . 73.51 108.735 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.93 159.8 44.39 Favored 'Trans proline' 0 C--O 1.26 1.582 0 C-N-CA 123.087 2.525 . . . . 62.31 111.756 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -66.66 -24.9 33.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.85 -0.614 . . . . 62.22 111.535 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.532 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.0 pt20 -66.11 -40.81 91.02 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.313 -0.403 . . . . 75.22 111.392 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -74.66 -39.91 61.75 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.017 0.437 . . . . 64.04 111.011 -175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.641 HG11 HG21 ' A' ' 96' ' ' THR . 7.1 p -65.03 -38.37 82.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.319 -0.4 . . . . 75.21 110.079 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -58.68 -46.92 86.16 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.81 -0.632 . . . . 74.23 109.968 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 35.6 mt-10 -61.45 -38.29 86.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.923 0.392 . . . . 61.44 110.114 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.4 m -66.65 -11.72 55.1 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-N 115.987 -0.551 . . . . 74.34 111.757 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.62 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.8 m -128.82 9.21 2.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 121.178 -0.951 . . . . 54.11 112.529 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.3 t -124.96 -9.17 7.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.584 0.23 . . . . 43.04 111.529 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.9 p -94.46 154.21 17.55 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.851 -1.537 . . . . 55.42 106.851 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.0 m -57.2 -39.46 75.46 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 118.504 0.593 . . . . 75.14 111.645 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 2.2 mp0 -65.86 -43.67 87.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.99 -1.005 . . . . 72.31 109.783 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.58 -40.64 53.37 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 115.055 -0.975 . . . . 34.13 112.886 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.35 -48.42 88.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 122.748 0.419 . . . . 45.25 110.015 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 112.62 0.6 . . . . 51.23 112.62 177.202 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 . . . . . 0 CA--C 1.505 -0.766 0 N-CA-C 112.525 0.565 . . . . 65.22 112.525 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -85.46 -2.11 57.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.243 -0.89 . . . . 72.24 111.087 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -76.87 118.83 19.85 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.829 -0.804 . . . . 70.44 108.829 -175.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.23 151.93 30.41 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.815 -0.629 . . . . 74.41 109.837 -173.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.762 HD11 HG11 ' A' ' 68' ' ' VAL . 3.0 tm? -81.65 104.88 12.37 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.961 -1.866 . . . . 65.3 105.961 175.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -134.83 137.69 43.53 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 106.168 -1.79 . . . . 62.22 106.168 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 6.5 pt-20 -91.75 70.25 5.68 Favored 'General case' 0 C--N 1.26 -3.312 0 CA-C-N 119.826 1.194 . . . . 74.21 109.821 174.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 131.19 96.42 0.71 Allowed Glycine 0 N--CA 1.401 -3.678 0 CA-C-N 113.784 -1.553 . . . . 32.35 110.91 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.295 -1.798 0 N-CA-C 106.91 -1.515 . . . . 72.41 106.91 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 26.6 p . . . . . 0 N--CA 1.425 -1.681 0 CA-C-O 120.759 0.314 . . . . 45.31 110.492 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -123.48 118.83 28.3 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 108.519 -0.919 . . . . 64.3 108.519 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 76' ' ' PHE . 28.5 t -85.51 127.05 40.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 106.472 -1.677 . . . . 72.05 106.472 174.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.7 tp -72.76 -53.39 11.74 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 124.209 0.943 . . . . 62.42 108.641 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.05 150.62 6.62 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.205 -0.907 . . . . 61.31 110.255 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.762 HG11 HD11 ' A' ' 46' ' ' LEU . 59.7 t -121.14 118.88 57.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 107.459 -1.311 . . . . 60.42 107.459 173.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 41.9 mt-30 -111.67 141.76 44.86 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 123.958 0.903 . . . . 75.24 110.149 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.18 134.25 94.76 Favored Pre-proline 0 C--N 1.287 -2.129 0 CA-C-N 114.128 -1.396 . . . . 51.14 110.184 -162.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo 0.53 48.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.175 1 C-N-CA 128.434 6.089 . . . . 73.14 117.557 -163.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 7.5 m -146.58 -45.24 0.19 Allowed 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.876 -0.602 . . . . 72.24 111.265 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 29.0 tt0 -141.38 128.55 20.92 Favored 'General case' 0 C--O 1.21 -0.978 0 C-N-CA 117.243 -1.783 . . . . 63.45 111.905 -169.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.709 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.9 tm? -133.52 132.26 40.75 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 109.318 -0.623 . . . . 73.54 109.318 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.3 m -138.12 126.21 22.83 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.728 -0.389 . . . . 60.33 110.724 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.482 ' HD2' HD11 ' A' ' 74' ' ' LEU . 39.5 p90 -146.67 154.84 41.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.399 0.142 . . . . 72.24 110.782 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -123.55 123.66 41.1 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.031 -1.1 . . . . 63.32 108.031 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -101.4 140.34 35.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.339 0.59 . . . . 55.41 112.282 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -93.2 -172.46 2.96 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 103.625 -2.731 . . . . 72.33 103.625 167.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.1 m 66.76 30.4 8.06 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 122.841 1.305 . . . . 54.23 107.497 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.49 ' OE1' ' HG3' ' A' ' 114' ' ' LYS . 7.8 mm-40 56.88 53.9 7.67 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.329 1.852 . . . . 72.34 114.266 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.44 -37.22 2.68 Favored Glycine 0 C--N 1.312 -0.785 0 N-CA-C 109.821 -1.312 . . . . 73.53 109.821 174.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.742 ' HZ2' ' HB2' ' A' ' 115' ' ' ALA . 2.8 m0 70.65 -164.85 0.15 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.706 1.603 . . . . 74.55 111.973 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -91.38 118.86 37.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.653 -0.499 . . . . 73.51 109.653 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.7 144.63 33.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.399 -0.593 . . . . 52.15 109.399 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.457 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 38.9 m -130.68 139.42 50.32 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 115.909 -0.587 . . . . 75.11 109.925 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.709 ' CD2' HD12 ' A' ' 74' ' ' LEU . 10.0 m-85 -117.73 140.17 50.04 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.915 -1.143 . . . . 70.22 107.915 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.62 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 82.8 mt-30 -130.07 140.21 50.86 Favored 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 115.689 -0.687 . . . . 71.34 110.083 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 72' ' ' THR . 75.8 mt -118.71 124.42 47.29 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.049 0.452 . . . . 75.42 110.038 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -109.55 116.55 31.99 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.784 -0.821 . . . . 72.15 108.784 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.61 111.21 15.66 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.722 -0.672 . . . . 74.13 110.738 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 81.1 mt -109.84 153.8 23.91 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.912 -1.144 . . . . 74.34 107.912 176.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.48 39.63 3.01 Favored Glycine 0 C--N 1.29 -2.002 0 C-N-CA 121.145 -0.55 . . . . 33.52 111.917 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -156.74 -42.82 0.07 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 124.405 1.082 . . . . 54.41 109.305 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.0 ptpt -155.92 177.06 11.84 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.852 -1.166 . . . . 73.21 107.852 -168.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.641 HG21 HG11 ' A' ' 25' ' ' VAL . 38.9 m -113.32 125.72 54.59 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.854 -0.795 . . . . 72.51 108.854 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.06 109.69 3.67 Favored Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 110.526 -1.03 . . . . 53.51 110.526 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -98.05 132.43 43.61 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.409 -0.96 . . . . 73.15 108.409 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 28.0 m -122.23 122.94 40.31 Favored 'General case' 0 N--CA 1.406 -2.652 0 C-N-CA 119.496 -0.882 . . . . 72.43 109.038 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.468 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -103.13 140.19 37.66 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-O 122.023 0.916 . . . . 61.32 108.678 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.8 mp -135.64 124.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.453 0 N-CA-C 105.981 -1.859 . . . . 73.54 105.981 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 24.1 t60 -114.59 131.84 56.55 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.326 -1.361 . . . . 73.12 107.326 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.7 t -137.74 150.17 47.05 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.861 -1.163 . . . . 73.41 107.861 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -104.17 158.13 16.86 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 110.525 -1.03 . . . . 70.32 110.525 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 . . . . . 0 C--N 1.318 -0.791 0 CA-C-N 117.612 0.706 . . . . 72.34 112.214 -178.376 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.477 HG22 ' H ' ' A' ' 112' ' ' ILE . 14.8 p . . . . . 0 N--CA 1.423 -1.804 0 N-CA-C 104.674 -2.343 . . . . 44.5 104.674 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.561 HD12 ' HB3' ' A' ' 115' ' ' ALA . 8.8 pt -57.53 -39.82 71.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 118.504 0.593 . . . . 70.24 111.896 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.99 -64.83 3.03 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.751 -0.261 . . . . 63.31 112.952 175.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.49 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 0.5 OUTLIER -50.82 -48.05 59.91 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 125.243 1.417 . . . . 74.22 111.884 -177.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.742 ' HB2' ' HZ2' ' A' ' 83' ' ' TRP . . . -71.57 -23.68 61.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 114.604 1.335 . . . . 72.01 114.604 -173.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 60.98 33.36 19.79 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.012 0.91 . . . . 63.52 109.208 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -109.29 -164.47 0.94 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.096 -0.956 . . . . 74.13 112.182 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.402 ' HB2' HG23 ' A' ' 122' ' ' VAL . 26.7 mmtp -76.45 -170.15 1.42 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.255 -0.884 . . . . 74.05 108.881 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.461 ' HB3' HG23 ' A' ' 111' ' ' VAL . 14.2 p -126.72 -68.22 0.82 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.251 -0.98 . . . . 72.54 112.754 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.5 t -62.34 -44.5 96.34 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 123.158 0.286 . . . . 63.13 110.561 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p -70.61 -34.07 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 119.36 -0.936 . . . . 71.43 110.313 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 112' ' ' ILE . 73.5 t -68.14 -42.81 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.648 -0.251 . . . . 72.33 110.987 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.8 ttp85 -59.24 -50.76 72.78 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.896 -0.779 . . . . 63.22 108.896 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.53 -41.76 99.63 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-N 115.736 -0.665 . . . . 43.01 113.061 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.401 ' O ' ' HA3' ' A' ' 129' ' ' GLY . 2.3 tmmm? -68.79 -32.15 71.68 Favored 'General case' 0 C--O 1.198 -1.61 0 N-CA-C 112.196 0.443 . . . . 74.14 112.196 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.462 ' HA ' ' CE ' ' A' ' 126' ' ' MET . 2.6 mmt -78.31 -42.37 30.93 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.234 -0.586 . . . . 73.35 110.604 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -56.93 -63.55 1.17 Allowed 'General case' 0 C--O 1.251 1.149 0 C-N-CA 124.232 1.013 . . . . 73.3 109.348 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.31 -34.24 64.15 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.262 -0.881 . . . . 45.24 111.722 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -61.4 -59.37 10.01 Favored Glycine 0 C--O 1.209 -1.419 0 CA-C-O 119.256 -0.746 . . . . 62.24 112.333 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.417 ' HE3' HG23 ' A' ' 134' ' ' VAL . 61.1 m95 -59.49 -38.66 81.45 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 117.931 0.866 . . . . 74.44 112.646 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.2 m -60.5 -52.91 63.17 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 120.504 -0.479 . . . . 71.21 110.796 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.49 -49.56 18.95 Favored Glycine 0 C--O 1.242 0.595 0 C-N-CA 121.162 -0.542 . . . . 74.13 113.562 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 77.3 mt -61.1 -49.64 83.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 C-N-CA 122.699 0.399 . . . . 74.25 111.154 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.523 ' HA ' HD23 ' A' ' 138' ' ' LEU . 97.3 t -63.48 -49.78 81.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.223 -0.991 . . . . 62.42 111.441 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -55.28 -63.89 1.02 Allowed 'General case' 0 C--O 1.246 0.905 0 O-C-N 123.785 0.678 . . . . 54.21 111.864 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 7.0 tp10 -81.98 -40.83 21.62 Favored 'General case' 0 C--O 1.174 -2.896 0 C-N-CA 118.424 -1.31 . . . . 61.22 113.211 -173.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.44 ' O ' ' HD3' ' A' ' 137' ' ' ARG . 2.1 tmt_? -64.19 -37.04 86.04 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.976 1.262 . . . . 71.33 110.028 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.3 mm? -69.93 -50.16 44.82 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 119.125 -1.03 . . . . 60.31 110.206 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.437 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 1.9 tmm_? -61.62 -36.52 80.98 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 121.359 0.6 . . . . 73.13 111.246 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -70.86 -47.76 57.58 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 123.746 0.818 . . . . 74.44 108.891 -177.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.01 75.01 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 111.608 0.225 . . . . 61.24 111.608 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.56 -32.17 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 119.718 -0.793 . . . . 55.24 110.923 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.49 -48.41 22.73 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 120.173 -0.611 . . . . 64.11 111.519 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.464 ' HG3' ' HE2' ' A' ' 140' ' ' LYS . 8.0 pt-20 . . . . . 0 C--N 1.312 -1.026 0 C-N-CA 123.769 0.828 . . . . 75.3 110.611 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . . . . . . 0 N--CA 1.442 -0.871 0 N-CA-C 106.638 -1.616 . . . . 62.11 106.638 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.8 tp -108.45 99.7 34.18 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 120.116 -0.634 . . . . 43.15 110.438 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 43.1 Cg_endo -95.97 -159.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.136 2.557 . . . . 74.33 110.047 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 1.6 m-20 -76.4 109.57 10.22 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.65 -0.5 . . . . 70.41 109.65 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.6 HG22 ' HB3' ' A' ' 102' ' ' HIS . 10.9 tp -102.31 128.37 55.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.268 -1.382 . . . . 74.12 107.268 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.1 m -111.04 129.11 56.01 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 109.083 -0.71 . . . . 72.23 109.083 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 25.2 mmmt -131.31 132.1 44.28 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.716 -0.674 . . . . 73.04 110.646 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 m -118.43 132.81 56.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.887 -1.153 . . . . 73.22 107.887 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.66 140.7 20.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.922 -0.77 . . . . 54.33 108.922 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 p -103.02 132.45 49.27 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.612 0.72 . . . . 75.41 112.905 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 139' ' ' ARG . 2.2 mm? -108.79 140.48 42.16 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.302 -0.863 . . . . 64.43 110.897 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -80.57 25.46 0.42 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.603 1.161 . . . . 71.02 111.314 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -131.76 165.34 36.42 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 108.678 -0.86 . . . . 73.24 108.678 -174.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 46.2 Cg_endo -72.09 161.3 45.1 Favored 'Trans proline' 0 C--O 1.257 1.456 0 C-N-CA 121.907 1.738 . . . . 75.1 111.06 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.0 tt -58.21 -31.11 41.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 115.906 -0.588 . . . . 73.34 110.795 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -56.4 -50.59 71.17 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.937 0.895 . . . . 74.31 111.729 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -73.64 -36.55 65.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.116 -0.493 . . . . 74.13 110.618 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.44 HG21 ' HB ' ' A' ' 96' ' ' THR . 46.1 t -67.69 -41.13 85.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.761 -0.459 . . . . 73.33 109.761 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 46.3 t90 -61.29 -46.98 88.09 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.962 -1.017 . . . . 74.31 110.226 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -23.63 63.73 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.312 -0.555 . . . . 72.11 111.68 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.8 m -67.49 -18.1 64.93 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 121.431 0.634 . . . . 73.34 111.337 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.576 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 9.9 m -123.05 17.5 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 O-C-N 121.463 -0.773 . . . . 65.01 110.837 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.5 m -142.12 9.08 1.88 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.15 0.796 . . . . 70.45 113.15 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.4 p -114.07 168.56 9.71 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 121.635 -0.666 . . . . 61.41 109.771 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.655 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 15.9 m -58.38 -40.55 82.61 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 123.85 0.719 . . . . 74.52 109.507 175.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -68.85 -46.88 67.36 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.692 -1.14 . . . . 75.54 110.955 -177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.5 -47.99 25.56 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.84 -0.695 . . . . 73.31 113.62 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.04 -34.29 62.55 Favored 'Isoleucine or valine' 0 C--O 1.256 1.401 0 CA-C-O 121.182 0.515 . . . . 71.13 110.722 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.737 0 CA-C-N 115.702 -0.681 . . . . 74.43 112.062 174.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.655 ' O ' ' HB3' ' A' ' 32' ' ' SER . 43.1 t-20 . . . . . 0 CA--C 1.495 -1.166 0 N-CA-C 105.935 -1.876 . . . . 63.22 105.935 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -90.81 69.61 6.51 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 113.288 0.848 . . . . 71.02 113.288 -170.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.484 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 94.0 m-85 -77.39 130.36 36.98 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.584 -1.265 . . . . 74.43 107.584 171.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -109.44 145.04 36.83 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.448 -0.945 . . . . 74.11 108.448 -174.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.0 tp -89.2 103.32 15.95 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 106.301 -1.74 . . . . 74.51 106.301 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 82.3 tttt -133.43 132.24 40.89 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.812 -1.551 . . . . 74.4 106.812 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.442 ' HA ' HG23 ' A' ' 68' ' ' VAL . 10.4 pt-20 -91.11 76.36 6.13 Favored 'General case' 0 C--N 1.258 -3.376 0 CA-C-O 122.922 1.344 . . . . 72.51 108.842 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.33 57.48 0.11 Allowed Glycine 0 N--CA 1.405 -3.415 0 CA-C-N 112.47 -2.15 . . . . 70.21 110.244 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 14.8 tt0 . . . . . 0 CA--C 1.504 -0.824 0 N-CA-C 109.403 -0.591 . . . . 73.13 109.403 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.428 -1.564 0 CA-C-O 121.183 0.516 . . . . 64.21 111.526 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 28.9 ttpp -121.52 118.01 28.22 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 105.359 -2.089 . . . . 53.51 105.359 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 50' ' ' GLN . 21.7 t -85.67 135.22 25.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 120.155 -0.618 . . . . 73.42 109.529 -174.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.3 tp -83.17 -56.14 3.95 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.043 -0.725 . . . . 72.11 109.043 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.5 149.32 16.89 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.228 -0.896 . . . . 52.13 109.997 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' ' 48' ' ' GLU . 21.9 t -126.54 119.31 53.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.524 -1.287 . . . . 74.01 107.524 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 13.1 mm-40 -103.63 141.79 35.43 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 121.24 0.543 . . . . 72.14 110.442 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.17 130.65 93.65 Favored Pre-proline 0 C--N 1.271 -2.824 0 CA-C-N 114.031 -1.44 . . . . 73.04 109.062 -167.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo 2.6 48.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.371 1 C-N-CA 128.189 5.926 . . . . 71.33 117.66 -162.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 6.9 m -142.72 -36.87 0.38 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.941 -0.572 . . . . 74.53 110.564 175.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.5 tt0 -147.77 144.61 28.36 Favored 'General case' 0 C--O 1.201 -1.451 0 C-N-CA 118.035 -1.466 . . . . 72.23 111.847 -174.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.659 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -139.0 134.46 33.09 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.015 -1.106 . . . . 65.32 108.015 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 p -141.69 126.53 18.15 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.656 -0.418 . . . . 45.22 112.115 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.55 ' HD2' HD11 ' A' ' 74' ' ' LEU . 31.1 p90 -145.23 155.77 43.44 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 110.234 -0.284 . . . . 75.11 110.234 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -122.19 134.01 54.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.722 -1.214 . . . . 72.13 107.722 -173.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -113.78 125.05 53.67 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.971 -1.122 . . . . 74.41 107.971 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.26 -28.81 69.97 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.125 1.157 . . . . 63.34 114.125 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.7 m -66.67 94.81 0.31 Allowed 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.955 0.883 . . . . 71.15 109.722 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.265 63.2 mm-40 77.56 4.71 3.05 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 127.865 2.466 . . . . 75.41 114.16 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.32 58.78 6.27 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.599 -0.728 . . . . 61.23 112.778 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -98.32 133.07 43.23 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.702 -0.399 . . . . 74.23 109.965 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.46 120.41 63.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.063 -1.088 . . . . 72.33 108.063 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.63 150.55 18.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.322 0.582 . . . . 62.11 110.918 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.521 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 88.3 m -137.87 137.68 38.34 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.577 -0.898 . . . . 74.1 108.577 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.659 ' CD2' HD12 ' A' ' 74' ' ' LEU . 26.3 m-85 -122.27 147.05 46.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.007 -1.109 . . . . 75.0 108.007 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 72' ' ' THR . 24.3 mt-30 -131.49 141.3 49.73 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 123.482 0.489 . . . . 61.42 111.127 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -112.93 124.1 51.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.1 0.476 . . . . 72.5 111.226 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.71 123.99 51.09 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 125.143 1.377 . . . . 65.15 109.475 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -84.8 123.14 30.1 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.132 -0.486 . . . . 72.13 110.832 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.7 mt -124.9 157.84 34.98 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.053 -1.091 . . . . 55.43 108.053 174.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 94' ' ' GLU . . . -82.31 50.22 4.28 Favored Glycine 0 C--N 1.3 -1.423 0 N-CA-C 115.269 0.868 . . . . 72.32 115.269 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 93' ' ' GLY . 6.1 tp10 167.65 -39.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.256 1.022 . . . . 54.52 108.983 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -126.16 175.69 7.59 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.039 -1.097 . . . . 62.5 108.039 -173.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.44 ' HB ' HG21 ' A' ' 25' ' ' VAL . 60.9 m -122.2 134.71 54.71 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.616 -0.513 . . . . 70.22 109.616 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -93.84 114.56 4.77 Favored Glycine 0 N--CA 1.416 -2.654 0 N-CA-C 109.106 -1.598 . . . . 73.43 109.106 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -101.96 134.65 44.83 Favored 'General case' 0 C--N 1.268 -2.977 0 N-CA-C 108.948 -0.76 . . . . 63.44 108.948 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 35.8 m -120.2 126.82 51.6 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 108.28 -1.007 . . . . 62.43 108.28 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -104.4 137.21 42.61 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 106.885 -1.524 . . . . 71.11 106.885 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.521 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.4 mp -135.23 123.67 39.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.747 0 N-CA-C 106.134 -1.802 . . . . 71.41 106.134 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.6 ' HB3' HG22 ' A' ' 12' ' ' ILE . 3.4 t-160 -121.27 132.33 54.74 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.533 -1.284 . . . . 65.22 107.533 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.2 t -136.19 154.57 50.91 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.461 -0.94 . . . . 65.11 108.461 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.81 170.58 53.24 Favored Glycine 0 C--O 1.262 1.867 0 N-CA-C 109.253 -1.539 . . . . 32.13 109.253 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 34.8 t-105 . . . . . 0 C--O 1.223 -0.321 0 C-N-CA 123.07 0.548 . . . . 73.44 110.202 179.481 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 119' ' ' SER . 22.1 t . . . . . 0 C--O 1.216 -0.703 0 N-CA-C 107.547 -1.279 . . . . 75.42 107.547 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.549 HD13 HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -59.85 -32.98 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 120.892 0.377 . . . . 74.32 111.164 178.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.51 -89.47 0.93 Allowed Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.905 -0.589 . . . . 61.13 114.259 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -57.53 -23.88 52.85 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 125.122 1.369 . . . . 65.13 114.68 -172.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.14 -13.98 62.73 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.906 0.384 . . . . 71.03 111.797 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.7 m120 76.06 -19.83 0.39 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.099 1.36 . . . . 70.44 114.201 175.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.47 154.94 36.71 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.865 -0.42 . . . . 52.34 109.865 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HB2' HG12 ' A' ' 121' ' ' VAL . 99.3 mttt -67.99 149.06 50.19 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.145 0.498 . . . . 63.23 111.2 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.639 ' HB3' HG13 ' A' ' 111' ' ' VAL . 3.0 p -58.29 -44.55 88.55 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 124.293 1.037 . . . . 74.35 111.814 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.4 p -65.2 -45.99 82.54 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.343 -0.844 . . . . 71.53 111.497 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 118' ' ' LYS . 7.2 p -69.84 -37.72 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 120.132 -0.627 . . . . 74.32 109.616 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.593 ' O ' ' HG3' ' A' ' 126' ' ' MET . 54.3 t -61.53 -45.88 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 120.818 -0.353 . . . . 71.24 111.134 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -55.44 -49.54 72.16 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.471 0.482 . . . . 72.02 111.138 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.22 -42.42 90.97 Favored Glycine 0 CA--C 1.5 -0.858 0 CA-C-N 115.891 -0.595 . . . . 62.44 112.781 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -68.63 -44.1 74.91 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 113.095 0.776 . . . . 72.35 113.095 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.593 ' HG3' ' O ' ' A' ' 122' ' ' VAL 0.382 0.0 OUTLIER -77.1 -29.28 54.8 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 118.196 -1.402 . . . . 74.0 113.778 -177.774 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -71.66 -55.81 7.01 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.867 -0.733 . . . . 75.52 109.119 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.37 -38.01 95.73 Favored Glycine 0 CA--C 1.5 -0.869 0 CA-C-N 115.526 -0.761 . . . . 73.31 112.254 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.82 -58.14 11.99 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 111.713 -0.555 . . . . 34.32 111.713 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.529 ' O ' ' HB ' ' A' ' 134' ' ' VAL . 94.3 m95 -64.42 -36.78 85.26 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.073 1.138 . . . . 74.22 114.073 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.0 p -67.64 -53.87 24.36 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.148 -0.621 . . . . 60.34 110.976 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.1 -48.58 38.74 Favored Glycine 0 C--O 1.246 0.9 0 C-N-CA 121.492 -0.385 . . . . 74.13 113.428 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.01 -54.0 36.94 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.281 0 CA-C-O 119.185 -0.436 . . . . 73.12 110.666 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 130' ' ' TRP . 6.2 t -58.83 -40.71 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 113.608 0.966 . . . . 75.31 113.608 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -53.76 -59.54 4.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.244 0.545 . . . . 74.14 111.043 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.24 -42.14 26.61 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 113.258 0.836 . . . . 64.3 113.258 -174.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -65.24 -41.48 94.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.225 0.466 . . . . 74.23 109.767 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.2 mm? -66.65 -51.45 56.05 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.646 -0.422 . . . . 74.14 109.922 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.432 ' HA ' HD12 ' A' ' 18' ' ' LEU . 4.6 tmm_? -64.28 -31.78 73.11 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.951 0.405 . . . . 75.24 110.99 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.41 ' HE3' ' HG3' ' A' ' 144' ' ' GLU . 11.4 mmmm -79.08 -44.72 21.53 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 113.489 0.922 . . . . 75.31 113.489 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.62 -23.89 67.41 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.624 -0.431 . . . . 61.44 111.096 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.444 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 24.0 m -85.35 -33.9 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 120.512 -0.475 . . . . 44.45 111.336 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -85.73 -70.47 0.59 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.937 0.717 . . . . 55.12 112.937 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.41 ' HG3' ' HE3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.709 0 CA-C-O 121.389 0.614 . . . . 73.11 111.801 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.026 0 N-CA-C 108.879 -0.786 . . . . 62.31 108.879 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.4 mt 54.16 78.38 0.39 Allowed Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 113.815 -1.539 . . . . 53.43 113.37 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.85 -159.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 122.635 2.223 . . . . 64.32 108.865 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 44.3 m-20 -64.49 104.33 0.78 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.242 0.46 . . . . 73.03 112.242 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 77.3 mt -93.38 126.5 45.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.46 -1.681 . . . . 71.14 106.46 174.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.2 m -111.45 127.94 55.84 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.045 -0.662 . . . . 55.44 109.713 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 29.7 mmmt -131.89 126.12 33.39 Favored 'General case' 0 C--O 1.197 -1.658 0 N-CA-C 108.955 -0.757 . . . . 64.35 108.955 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.3 m -118.1 142.66 47.18 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 119.624 -0.83 . . . . 65.21 109.825 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -150.86 141.73 16.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.42 -0.956 . . . . 65.34 108.42 -178.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.47 HG22 ' HG3' ' A' ' 95' ' ' LYS . 0.8 OUTLIER -106.61 127.08 53.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.324 -0.621 . . . . 72.12 109.324 -178.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.7 mp -106.39 140.08 39.87 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 122.998 0.519 . . . . 72.42 109.717 -175.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -75.05 -2.02 25.48 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 124.091 0.956 . . . . 74.51 112.074 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.412 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -99.07 159.78 29.33 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 116.328 -0.396 . . . . 72.34 111.825 -172.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.49 153.61 73.73 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.305 2.67 . . . . 62.11 111.778 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.7 tt -48.86 -40.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.103 0.961 . . . . 62.22 112.628 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -70.98 -29.65 65.69 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.231 -0.588 . . . . 71.43 111.954 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -73.88 -36.82 64.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.629 0.728 . . . . 73.03 109.109 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' HG22 ' A' ' 29' ' ' VAL . 58.3 t -69.72 -41.24 79.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.534 -0.913 . . . . 64.25 108.534 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -58.77 -47.95 82.93 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.293 -0.867 . . . . 75.32 111.61 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -64.65 -35.24 80.4 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.302 -0.959 . . . . 72.51 110.776 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.2 m -63.75 -23.91 67.56 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 112.177 0.436 . . . . 62.32 112.177 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 16.0 m -121.72 15.2 5.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 112.789 0.662 . . . . 61.32 112.789 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.5 t -142.76 9.72 1.77 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 119.481 -0.888 . . . . 61.13 112.66 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.7 p -122.22 171.78 8.77 Favored 'General case' 0 C--O 1.247 0.972 0 O-C-N 121.455 -0.778 . . . . 74.41 110.557 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 m -63.72 -48.86 75.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.548 -0.538 . . . . 74.21 109.548 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.29 -41.86 96.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.846 -0.615 . . . . 73.51 111.691 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.32 -49.45 20.34 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 120.078 -1.058 . . . . 40.03 114.073 -176.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.9 mt -72.14 -50.68 35.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 118.344 1.072 . . . . 64.32 112.499 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.405 0 CA-C-O 121.205 0.526 . . . . 72.51 111.301 -178.047 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 . . . . . 0 CA--C 1.488 -1.423 0 N-CA-C 107.156 -1.424 . . . . 70.31 107.156 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -105.83 79.3 1.41 Allowed 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.941 0.877 . . . . 75.45 110.525 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -90.53 119.81 31.1 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.556 -1.202 . . . . 75.5 110.546 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -119.56 153.36 35.53 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.304 -1.739 . . . . 72.24 106.304 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -74.78 104.31 5.37 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.594 -1.262 . . . . 75.33 107.594 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 50' ' ' GLN . 47.4 tttp -132.97 144.54 50.18 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.711 -1.588 . . . . 64.23 106.711 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -91.76 69.79 5.63 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-O 122.097 0.951 . . . . 72.05 108.449 174.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.95 61.1 0.19 Allowed Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 110.119 -1.193 . . . . 71.02 110.119 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.651 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.473 -2.016 0 N-CA-C 106.489 -1.671 . . . . 64.24 106.489 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 48.4 m . . . . . 0 C--O 1.246 0.889 0 CA-C-O 120.775 0.321 . . . . 73.15 111.635 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 90.8 mttt -142.02 133.68 26.92 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 116.28 -0.418 . . . . 62.24 110.65 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.501 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 36.2 t -90.58 136.71 23.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 106.271 -1.751 . . . . 73.14 106.271 175.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.8 tp -78.98 -61.42 2.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.109 -1.071 . . . . 64.25 108.109 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -162.37 153.99 18.34 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.905 -1.043 . . . . 43.14 108.877 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.573 HG23 HD23 ' A' ' 74' ' ' LEU . 12.8 p -131.19 131.82 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.34 0 CA-C-O 121.625 0.726 . . . . 63.14 110.458 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.7 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 85.7 mm-40 -110.29 141.75 42.85 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 114.363 -1.29 . . . . 71.13 108.077 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.52 136.07 96.01 Favored Pre-proline 0 C--N 1.288 -2.085 0 CA-C-N 115.024 -0.989 . . . . 72.31 109.635 -164.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo 0.59 50.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.366 1.491 1 C-N-CA 128.301 6.001 . . . . 74.03 117.484 -162.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.59 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 4.7 m -145.19 -46.83 0.23 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 112.001 0.371 . . . . 61.42 112.001 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.7 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 11.0 tp10 -132.71 126.76 33.26 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.48 -0.933 . . . . 74.42 108.48 -171.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.66 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -135.7 132.72 37.26 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.517 -0.549 . . . . 75.24 109.517 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.5 m -135.05 126.72 29.0 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 123.221 0.326 . . . . 73.31 111.432 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.43 ' HD1' HD11 ' A' ' 74' ' ' LEU . 31.9 p90 -146.23 155.64 42.83 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.003 -0.436 . . . . 71.14 111.654 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -123.05 125.8 45.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.795 -1.187 . . . . 74.33 107.795 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -139.86 160.99 38.64 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.791 -0.363 . . . . 74.2 111.492 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 83' ' ' TRP . 48.6 t0 74.31 163.69 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.042 1.337 . . . . 61.33 111.546 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.9 m -59.11 -39.37 82.08 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.389 1.075 . . . . 74.04 112.009 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -79.89 -5.12 54.95 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.007 0.743 . . . . 52.3 113.007 -178.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 105' ' ' TRP . . . 68.43 73.62 0.68 Allowed Glycine 0 N--CA 1.442 -0.946 0 O-C-N 123.594 0.559 . . . . 54.03 113.004 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.442 ' CD1' ' HB3' ' A' ' 79' ' ' ASP . 50.6 m95 -85.98 112.97 21.7 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.696 -1.224 . . . . 64.0 107.696 177.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.32 101.98 13.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 106.967 -1.494 . . . . 74.23 106.967 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.5 m -108.85 144.78 16.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 120.973 0.416 . . . . 72.21 110.309 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 7.4 m -131.3 143.02 50.22 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.689 -0.856 . . . . 72.11 108.689 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.66 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.0 m-85 -120.8 147.53 45.22 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.829 -0.804 . . . . 71.23 108.829 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.584 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 72.9 mt-30 -133.2 144.5 49.86 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 112.795 0.665 . . . . 73.32 112.795 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 72' ' ' THR . 1.9 tm? -98.03 134.16 41.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.203 -0.908 . . . . 62.25 111.361 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -123.73 116.04 22.38 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.769 -2.308 . . . . 63.04 104.769 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -93.08 115.16 27.84 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.475 -0.89 . . . . 64.44 111.321 -175.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.8 mt -103.88 153.38 20.84 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.986 -1.116 . . . . 71.0 107.986 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.33 54.64 4.91 Favored Glycine 0 C--N 1.282 -2.431 0 C-N-CA 121.087 -0.577 . . . . 33.43 112.856 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 174.59 -33.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.323 0.649 . . . . 72.34 109.908 -177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 7.2 ptpt -150.33 175.27 11.98 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.772 -0.825 . . . . 65.22 108.772 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.0 m -111.47 123.15 49.62 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 121.176 0.512 . . . . 71.31 111.101 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.99 131.09 10.36 Favored Glycine 0 N--CA 1.406 -3.343 0 N-CA-C 108.484 -1.847 . . . . 34.12 108.484 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -120.12 134.5 55.24 Favored 'General case' 0 C--N 1.261 -3.277 0 C-N-CA 122.866 0.467 . . . . 73.21 109.804 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 90.8 m -117.77 127.17 53.64 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.917 -0.772 . . . . 74.44 108.917 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.567 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -103.62 140.56 37.39 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 108.59 -0.893 . . . . 75.5 108.59 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.501 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.9 mp -136.22 124.66 36.59 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.943 0 CA-C-N 113.662 -1.608 . . . . 61.54 106.973 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 18.2 t-160 -114.47 112.77 23.52 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.584 -1.265 . . . . 72.2 107.584 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.2 m -107.31 132.36 53.21 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.302 -1.74 . . . . 52.23 106.302 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.55 154.81 20.1 Favored Glycine 0 N--CA 1.426 -2.009 0 C-N-CA 120.838 -0.696 . . . . 24.44 112.894 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.405 ' HB2' ' O ' ' A' ' 82' ' ' GLY . 73.6 t-105 . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 115.157 -0.522 . . . . 75.53 109.979 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.448 HG12 HD13 ' A' ' 112' ' ' ILE . 10.5 t . . . . . 0 C--O 1.218 -0.571 0 N-CA-C 103.622 -2.732 . . . . 73.13 103.622 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -62.39 -37.84 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.247 1.385 . . . . 73.13 113.767 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 131.22 -75.76 0.42 Allowed Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.471 -0.871 . . . . 54.33 113.847 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -117.03 5.48 12.83 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 113.735 1.013 . . . . 63.53 113.735 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.45 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -73.08 -40.36 65.1 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.589 -0.845 . . . . 71.11 111.354 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 174.91 137.44 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.174 -1.788 . . . . 44.41 106.174 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.25 -18.67 61.2 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.773 0.657 . . . . 73.33 112.773 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.591 ' HB3' HG22 ' A' ' 121' ' ' VAL . 43.0 tptt -91.37 97.77 11.3 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.413 -0.915 . . . . 75.42 110.577 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.3 t -58.48 -37.97 76.64 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.356 -1.293 . . . . 65.01 111.621 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.44 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 29.5 t -66.13 -45.07 82.33 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.964 -0.294 . . . . 50.13 111.51 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 118' ' ' LYS . 12.6 m -69.91 -34.48 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 119.453 -0.899 . . . . 75.14 109.64 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 63.0 t -66.29 -44.68 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 120.468 -0.493 . . . . 73.3 111.509 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.44 ' HG3' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -68.01 -37.15 81.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.996 -0.682 . . . . 74.13 111.276 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.428 ' N ' ' HD3' ' A' ' 123' ' ' ARG . . . -63.51 -45.59 94.41 Favored Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 111.012 -0.835 . . . . 74.32 111.012 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.28 -40.1 95.28 Favored 'General case' 0 C--O 1.193 -1.869 0 CA-C-N 115.011 -0.595 . . . . 74.2 111.95 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 24.2 mmt -69.32 -40.91 77.34 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.354 -0.538 . . . . 72.02 111.073 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.61 -57.66 11.17 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.419 0.628 . . . . 64.51 109.695 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.09 -38.63 59.41 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.47 -0.787 . . . . 63.32 112.389 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.79 -54.11 36.04 Favored Glycine 0 CA--C 1.491 -1.417 0 CA-C-O 119.72 -0.489 . . . . 54.14 112.036 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -61.91 -35.16 77.54 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 117.424 0.612 . . . . 72.3 112.456 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.2 m -62.37 -48.37 80.07 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 120.439 -0.504 . . . . 72.11 110.906 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.7 -46.44 24.32 Favored Glycine 0 C--O 1.247 0.907 0 C-N-CA 120.688 -0.768 . . . . 74.42 113.661 -177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.51 -52.32 59.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 122.347 0.259 . . . . 74.33 110.871 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.648 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 96.4 t -65.24 -48.48 83.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 119.81 -0.756 . . . . 41.35 112.318 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.403 ' HA ' HG13 ' A' ' 16' ' ' ILE . 9.1 t30 -59.39 -60.45 3.84 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 112.738 0.644 . . . . 74.53 112.738 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 32.4 tt0 -74.46 -48.98 24.15 Favored 'General case' 0 C--O 1.208 -1.091 0 C-N-CA 120.047 -0.661 . . . . 74.44 112.726 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.542 ' O ' ' HD2' ' A' ' 137' ' ' ARG . 1.2 tmm_? -67.85 -32.27 72.67 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.032 -0.667 . . . . 71.24 111.41 -170.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.648 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 3.4 mm? -70.25 -51.86 27.41 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.769 -0.772 . . . . 73.32 110.023 174.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -34.26 76.26 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.894 -0.594 . . . . 73.23 111.584 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -71.27 -51.47 24.3 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.979 -0.748 . . . . 70.42 108.979 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.14 -26.85 68.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 74.04 111.87 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.412 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 30.1 m -83.8 -30.66 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.137 -0.625 . . . . 63.4 111.979 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -79.57 -12.86 59.84 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.156 0.979 . . . . 74.43 109.745 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 N--CA 1.419 -2.001 0 N-CA-C 107.419 -1.326 . . . . 75.11 107.419 172.913 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 112.762 0.652 . . . . 61.3 112.762 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 61.75 83.97 0.2 Allowed Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 124.122 0.969 . . . . 74.03 111.855 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -89.18 -168.22 0.32 Allowed 'Trans proline' 0 N--CA 1.429 -2.32 0 C-N-CA 122.448 2.098 . . . . 65.12 112.178 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.65 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 6.3 p-10 -61.29 131.14 49.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.995 -1.002 . . . . 72.34 113.065 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.2 tp -135.99 138.74 47.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.966 -1.124 . . . . 51.43 107.966 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.7 m -117.75 133.64 55.73 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 120.85 0.357 . . . . 71.3 110.083 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -133.73 153.64 51.55 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.794 -1.928 . . . . 75.01 105.794 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.5 m -138.0 149.88 46.49 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.154 -0.966 . . . . 75.54 110.629 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.435 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.24 144.86 16.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.008 -0.738 . . . . 60.03 109.008 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.3 122.74 46.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.944 0.878 . . . . 75.22 112.156 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.618 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.8 mp -100.94 140.43 35.24 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 115.54 -0.755 . . . . 73.53 110.695 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -92.11 46.39 1.26 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.359 -1.291 . . . . 63.4 109.184 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.434 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -143.68 161.65 45.47 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.426 -0.953 . . . . 63.34 108.426 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 33.6 Cg_endo -63.15 150.22 89.23 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 122.467 2.111 . . . . 62.01 111.135 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.1 tt -56.29 -33.34 37.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.594 0.559 . . . . 71.23 112.127 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -60.9 -42.23 97.64 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 112.194 0.442 . . . . 64.31 112.194 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -74.44 -37.79 63.18 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.259 0.552 . . . . 71.12 109.605 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.516 HG13 HD22 ' A' ' 18' ' ' LEU . 76.8 t -62.85 -41.1 91.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.463 -0.789 . . . . 73.1 109.206 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.565 ' CE2' ' HD3' ' A' ' 71' ' ' PRO . 74.9 t90 -64.7 -46.09 83.82 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.141 -1.39 . . . . 72.13 109.777 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.59 -38.9 78.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.596 0.758 . . . . 72.2 110.185 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.426 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 62.8 m -57.73 -29.98 65.18 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 112.191 0.441 . . . . 72.21 112.191 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG13 HD11 ' A' ' 138' ' ' LEU . 17.4 m -110.3 18.64 6.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 O-C-N 121.852 -0.53 . . . . 63.35 112.037 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.5 p -135.7 -12.02 2.04 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.154 0.502 . . . . 63.34 112.05 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.7 p -94.75 148.86 21.85 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.09 -0.707 . . . . 73.14 109.09 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 m -53.52 -45.83 69.89 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.794 0.838 . . . . 65.23 112.709 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -69.23 -32.45 71.7 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.848 0.356 . . . . 75.33 111.458 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 28' ' ' THR . . . -72.31 -48.36 25.08 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.391 -0.909 . . . . 73.32 111.52 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.15 -32.17 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.139 0.976 . . . . 64.4 111.738 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 124.171 0.989 . . . . 65.24 112.914 -178.483 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 . . . . . 0 CA--C 1.501 -0.938 0 N-CA-C 109.779 -0.452 . . . . 63.33 109.779 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.43 73.33 10.52 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.988 0.899 . . . . 51.54 110.042 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -83.69 121.77 27.72 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.993 -2.225 . . . . 74.24 104.993 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -109.76 145.88 35.91 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 112.292 0.479 . . . . 64.33 112.292 -167.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -75.43 105.55 6.51 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.71 -1.589 . . . . 74.14 106.71 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -131.05 145.25 51.96 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.655 -1.979 . . . . 54.44 105.655 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HA ' HG12 ' A' ' 68' ' ' VAL . 5.1 pt-20 -87.36 34.04 0.69 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 118.963 0.801 . . . . 71.21 110.673 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.8 76.25 0.02 OUTLIER Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 108.501 -1.839 . . . . 64.55 108.501 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.436 ' HB3' ' H ' ' A' ' 65' ' ' VAL . 32.8 tt0 . . . . . 0 C--N 1.303 -1.437 0 N-CA-C 106.894 -1.521 . . . . 74.23 106.894 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.416 -2.14 0 CA-C-O 120.823 0.345 . . . . 72.43 110.108 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -155.24 143.45 20.2 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.518 -0.919 . . . . 65.3 108.518 -176.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.436 ' H ' ' HB3' ' A' ' 50' ' ' GLN . 27.1 t -88.91 127.44 41.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 105.71 -1.959 . . . . 73.22 105.71 173.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.403 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 2.1 tm? -70.74 -53.03 17.08 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.437 -1.32 . . . . 74.14 107.437 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.65 145.36 5.41 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.202 -0.908 . . . . 65.41 109.258 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.629 HG23 HD23 ' A' ' 74' ' ' LEU . 10.4 p -121.44 119.23 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 121.781 0.8 . . . . 65.35 109.115 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 84.2 mm-40 -113.87 141.53 47.23 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.011 -0.995 . . . . 74.4 112.509 -176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.39 133.24 94.4 Favored Pre-proline 0 C--N 1.296 -1.754 0 CA-C-N 113.498 -1.683 . . . . 63.25 108.073 -167.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.565 ' HD3' ' CE2' ' A' ' 26' ' ' TRP . 9.5 Cg_exo -11.83 62.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.99 1 C-N-CA 126.587 4.858 . . . . 74.5 118.333 -156.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.2 p -142.24 -44.67 0.33 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.179 -1.373 . . . . 62.22 109.549 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 69' ' ' GLN . 37.1 mt-10 -143.33 141.01 30.82 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 113.262 0.838 . . . . 72.04 113.262 -171.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.629 HD23 HG23 ' A' ' 68' ' ' VAL . 2.1 tm? -136.49 130.86 33.17 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 107.278 -1.378 . . . . 71.33 107.278 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -140.86 126.37 18.87 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 120.384 -0.527 . . . . 72.25 110.717 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.474 ' HD1' HD11 ' A' ' 74' ' ' LEU . 33.5 p90 -146.01 155.4 42.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.64 0.257 . . . . 74.34 111.315 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 29.0 mt-10 -121.64 136.03 54.96 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 105.552 -2.018 . . . . 54.33 105.552 -175.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -155.51 162.79 40.63 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.188 -1.005 . . . . 75.4 113.571 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.428 ' HB3' ' CD1' ' A' ' 83' ' ' TRP . 24.7 t70 75.65 163.47 0.26 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 112.809 -1.996 . . . . 74.24 112.63 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -60.59 -33.38 72.65 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.642 1.177 . . . . 72.43 111.89 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 115' ' ' ALA . 5.4 mm-40 -71.04 -33.63 70.48 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 120.722 0.296 . . . . 75.33 111.716 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.1 65.15 1.08 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.63 -0.795 . . . . 62.54 112.232 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.428 ' CD1' ' HB3' ' A' ' 79' ' ' ASP . 35.1 m95 -92.95 141.28 28.59 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.201 -1.407 . . . . 71.11 107.201 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.07 101.84 8.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 122.353 1.073 . . . . 32.31 109.121 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 m -97.54 142.69 13.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 115.435 -0.802 . . . . 71.41 110.603 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.3 m -132.31 122.0 24.43 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.334 -1.358 . . . . 74.14 107.334 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.628 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.9 m-85 -112.65 138.64 49.15 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.341 -0.985 . . . . 64.23 108.341 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.548 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 35.0 mt-30 -113.81 128.38 56.39 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 115.281 -0.872 . . . . 51.42 110.932 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.29 119.45 38.42 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.881 -1.155 . . . . 75.35 107.881 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -104.19 117.1 33.42 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.906 -1.146 . . . . 64.31 107.906 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -77.94 112.22 14.62 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.718 -0.674 . . . . 65.4 109.855 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 98.8 mt -115.21 140.91 48.68 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.14 -1.43 . . . . 73.44 107.14 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.38 58.9 4.96 Favored Glycine 0 C--N 1.276 -2.788 0 CA-C-N 115.654 -0.703 . . . . 72.01 111.907 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 179.51 -47.05 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.592 0.757 . . . . 71.35 109.307 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 9.8 ptpt -142.52 175.39 9.83 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.254 -1.388 . . . . 72.43 107.254 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.8 m -111.15 124.86 53.05 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 119.794 -0.763 . . . . 74.33 110.307 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.48 108.27 3.62 Favored Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 110.085 -1.206 . . . . 74.21 110.085 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -98.29 129.39 44.99 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.795 -0.817 . . . . 75.2 108.795 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 8.0 m -116.31 123.15 46.93 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 107.958 -1.127 . . . . 52.01 107.958 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.404 HD12 ' CE1' ' A' ' 87' ' ' PHE . 2.9 tp -100.18 119.34 38.21 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.724 -0.843 . . . . 64.13 108.724 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.01 123.17 71.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 105.928 -1.879 . . . . 64.34 105.928 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.65 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 22.9 t-160 -108.59 113.52 26.59 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.665 -1.606 . . . . 53.13 106.665 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -125.93 155.55 41.13 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 105.762 -1.94 . . . . 45.23 105.762 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.28 153.8 17.54 Favored Glycine 0 C--N 1.26 -3.684 0 N-CA-C 108.833 -1.707 . . . . 71.21 108.833 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 43.6 t90 . . . . . 0 C--N 1.29 -1.985 0 N-CA-C 108.806 -0.812 . . . . 73.3 108.806 179.624 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.434 -1.257 0 N-CA-C 109.934 -0.395 . . . . 65.24 109.934 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 115' ' ' ALA . 5.9 pt -62.21 -44.17 98.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.913 -0.585 . . . . 72.21 110.407 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.84 -52.7 3.62 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 114.413 0.525 . . . . 72.14 114.413 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.29 -42.1 16.17 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 112.861 0.689 . . . . 73.32 112.861 -172.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.64 ' HB3' HD12 ' A' ' 112' ' ' ILE . . . -67.06 -30.5 70.58 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.552 -0.459 . . . . 61.33 110.485 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.421 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 22.1 t-20 -175.51 145.17 0.71 Allowed 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.317 -1.364 . . . . 63.34 107.317 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -90.23 -17.87 26.72 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 113.172 0.804 . . . . 75.11 113.172 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.565 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 9.5 mmpt? -99.56 109.66 22.17 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.403 0.62 . . . . 70.13 110.798 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -67.48 -33.34 74.91 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.547 -0.751 . . . . 70.31 111.23 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 p -65.94 -46.67 77.33 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 111.756 0.28 . . . . 73.03 111.756 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 118' ' ' LYS . 30.2 m -70.27 -34.51 58.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 119.77 -0.772 . . . . 71.55 110.917 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 116' ' ' ASN . 99.4 t -65.86 -45.56 91.04 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 C-N-CA 120.394 -0.522 . . . . 64.24 110.594 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -61.8 -43.64 98.45 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 111.865 0.32 . . . . 74.43 111.865 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -62.51 -47.38 89.78 Favored Glycine 0 CA--C 1.497 -1.079 0 CA-C-N 115.837 -0.62 . . . . 73.41 111.925 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -72.22 -29.58 64.09 Favored 'General case' 0 C--O 1.193 -1.899 0 N-CA-C 112.796 0.665 . . . . 73.14 112.796 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.4 mmt -67.5 -48.93 65.66 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.012 -0.675 . . . . 73.45 111.66 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.33 -50.16 55.29 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.249 -0.98 . . . . 71.1 110.961 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.93 -40.2 97.04 Favored Glycine 0 C--O 1.239 0.418 0 N-CA-C 111.445 -0.662 . . . . 72.02 111.445 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.52 ' O ' HG22 ' A' ' 133' ' ' ILE . . . -64.44 -58.07 11.36 Favored Glycine 0 CA--C 1.482 -1.99 0 CA-C-O 119.007 -0.885 . . . . 74.14 111.928 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -57.67 -36.11 71.48 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.86 0.83 . . . . 75.54 112.44 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.3 m -61.1 -51.84 67.42 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 120.736 -0.385 . . . . 72.45 110.259 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.4 -50.49 15.86 Favored Glycine 0 C--O 1.25 1.113 0 C-N-CA 121.194 -0.526 . . . . 54.14 113.858 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 129' ' ' GLY . 10.5 tp -63.79 -49.27 82.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-O 119.554 -0.26 . . . . 74.42 110.879 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 71.8 t -62.84 -47.35 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 120.046 -0.662 . . . . 64.25 112.148 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.435 ' HA ' HG13 ' A' ' 16' ' ' ILE . 26.6 t-20 -55.38 -62.03 1.95 Allowed 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 111.98 0.363 . . . . 71.25 111.98 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.558 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 35.9 tt0 -80.4 -41.05 25.31 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 119.538 -0.865 . . . . 72.2 113.327 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -35.69 78.23 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.116 -1.034 . . . . 75.3 110.144 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 3.1 mm? -68.82 -51.82 36.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.129 0.49 . . . . 74.11 110.13 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.62 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 1.6 tmm_? -63.65 -36.34 83.5 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 115.691 -0.686 . . . . 71.14 110.416 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -74.7 -34.77 62.69 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 122.836 0.454 . . . . 74.34 109.789 -179.07 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.5 -26.98 63.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.469 0.652 . . . . 74.43 110.765 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.434 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 25.6 m -85.66 -25.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 C-N-CA 119.701 -0.799 . . . . 53.22 111.466 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.62 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 51.7 mt-10 -76.42 -41.89 46.11 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.628 -0.879 . . . . 74.12 108.628 174.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 . . . . . 0 CA--C 1.509 -0.626 0 C-N-CA 126.465 1.906 . . . . 62.02 110.499 -174.852 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -1.854 0 N-CA-C 106.274 -1.75 . . . . 71.3 106.274 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.569 ' H ' HD23 ' A' ' 9' ' ' LEU . 2.4 pt? -74.23 119.47 76.54 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 120.079 -0.648 . . . . 64.02 110.211 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.83 -162.14 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.162 1.908 . . . . 74.54 107.73 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -72.51 105.11 4.05 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 118.535 -1.266 . . . . 70.3 108.51 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 72.7 mt -91.25 123.67 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 106.912 -1.514 . . . . 75.41 106.912 -177.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.4 m -119.51 129.2 54.58 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 108.149 -1.056 . . . . 73.52 108.149 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -139.49 132.55 29.56 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.244 -1.391 . . . . 72.43 107.244 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 p -117.98 140.72 49.33 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 109.391 -0.596 . . . . 54.5 109.391 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.32 140.49 19.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.876 -0.787 . . . . 74.31 108.876 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' THR . 12.7 p -99.24 118.96 37.09 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.746 0.784 . . . . 72.11 112.389 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 139' ' ' ARG . 3.4 mm? -91.4 140.07 30.12 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.723 -1.126 . . . . 72.43 109.633 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.4 30.67 0.69 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.441 0.639 . . . . 75.23 110.663 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.423 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -127.83 163.92 40.15 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.256 -1.016 . . . . 75.15 108.256 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 36.0 Cg_endo -66.13 152.72 80.51 Favored 'Trans proline' 0 C--O 1.255 1.362 0 C-N-CA 122.433 2.088 . . . . 64.35 110.724 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 tt -61.26 -31.38 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.009 -0.541 . . . . 71.03 112.021 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.2 pt20 -60.29 -45.14 94.39 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.619 0.247 . . . . 61.13 110.891 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -68.06 -39.5 82.99 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.374 -0.375 . . . . 72.04 111.91 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.6 -41.1 87.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.504 -0.554 . . . . 53.33 109.504 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.545 ' CZ2' ' HD3' ' A' ' 71' ' ' PRO . 60.3 t90 -63.9 -46.61 84.07 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.153 -0.93 . . . . 65.14 110.063 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 41.2 mt-10 -63.61 -37.99 89.42 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 120.991 -0.284 . . . . 44.44 110.544 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.0 m -56.84 -36.07 69.56 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.935 0.398 . . . . 51.25 111.384 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.664 HG11 ' CE1' ' A' ' 98' ' ' PHE . 30.9 m -103.76 16.04 5.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 112.018 0.377 . . . . 73.02 112.018 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.6 t -145.88 6.63 1.05 Allowed 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.012 -0.675 . . . . 44.52 112.146 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.9 p -108.32 170.3 8.1 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 121.775 -0.578 . . . . 72.32 110.555 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 t -59.91 -62.17 2.07 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 124.143 0.902 . . . . 33.32 111.103 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -78.05 -27.92 48.81 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 119.57 -0.852 . . . . 73.41 111.883 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.93 -48.68 84.48 Favored Glycine 0 C--O 1.216 -1.018 0 N-CA-C 110.888 -0.885 . . . . 54.31 110.888 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.18 -43.76 78.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 122.026 0.917 . . . . 74.12 110.359 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.84 0 N-CA-C 113.884 1.068 . . . . 54.21 113.884 -175.456 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 CA--C 1.503 -0.852 0 N-CA-C 109.923 -0.399 . . . . 72.32 109.923 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.93 53.37 2.8 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.73 0.776 . . . . 73.12 110.765 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -72.31 152.28 42.21 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.138 -0.937 . . . . 74.34 108.573 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -137.55 151.53 48.48 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.888 -0.782 . . . . 72.14 108.888 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -75.41 104.45 5.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.539 -1.652 . . . . 72.43 106.539 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.406 ' O ' HG11 ' A' ' 65' ' ' VAL . 12.9 tptp -134.82 132.14 38.31 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 107.186 -1.412 . . . . 71.43 107.186 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -95.55 86.96 4.59 Favored 'General case' 0 C--N 1.26 -3.321 0 CA-C-O 122.674 1.225 . . . . 73.51 108.571 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.09 105.14 2.26 Favored Glycine 1 N--CA 1.395 -4.084 0 CA-C-N 113.256 -1.793 . . . . 71.33 109.564 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.781 0 N-CA-C 106.931 -1.507 . . . . 75.52 106.931 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 18.5 p . . . . . 0 N--CA 1.417 -2.075 0 CA-C-O 121.47 0.652 . . . . 41.03 111.726 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 50' ' ' GLN . 20.4 pttp -137.24 138.41 40.09 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 107.009 -1.478 . . . . 74.22 107.009 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 47' ' ' LYS . 23.5 t -88.71 135.09 26.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 C-N-CA 119.516 -0.874 . . . . 72.41 109.249 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -76.53 -60.43 2.35 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.248 -1.76 . . . . 72.53 106.248 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.95 152.93 6.72 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.19 -0.914 . . . . 54.41 108.912 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.41 118.58 57.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 105.957 -1.868 . . . . 73.23 105.957 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 14.9 mm-40 -98.42 140.18 33.06 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.871 -0.788 . . . . 63.03 108.871 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.69 126.8 93.07 Favored Pre-proline 0 C--N 1.265 -3.094 0 CA-C-N 113.739 -1.573 . . . . 64.33 107.966 -168.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.545 ' HD3' ' CZ2' ' A' ' 26' ' ' TRP . 92.0 Cg_exo 2.03 51.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.117 1 C-N-CA 127.601 5.534 . . . . 71.35 117.351 -159.228 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.2 p -138.78 -39.14 0.5 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.005 -0.998 . . . . 73.43 111.557 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 36.9 tt0 -151.2 149.0 28.92 Favored 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 119.046 -1.062 . . . . 62.52 111.347 -174.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.638 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -137.0 134.06 36.21 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.613 -1.255 . . . . 75.42 107.613 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.467 ' OG ' HG23 ' A' ' 86' ' ' THR . 22.4 m -141.62 126.53 18.21 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.819 -0.352 . . . . 24.23 111.266 177.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.477 ' HD1' HD11 ' A' ' 74' ' ' LEU . 36.6 p90 -143.91 154.0 42.89 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.819 -0.438 . . . . 73.12 109.819 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 63' ' ' CYS . 41.0 mt-10 -122.86 124.71 43.87 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 123.066 0.546 . . . . 73.14 109.585 -171.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 6.4 t-105 -117.38 115.63 25.61 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.971 -1.492 . . . . 74.14 106.971 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -82.6 152.57 25.87 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.584 -0.846 . . . . 73.31 109.16 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.6 m 74.88 84.84 0.1 Allowed 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 123.858 0.863 . . . . 74.2 110.235 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 57.87 0.41 0.11 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 127.263 2.225 . . . . 73.1 115.62 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.45 -35.41 20.18 Favored Glycine 0 C--N 1.312 -0.796 0 N-CA-C 110.645 -0.982 . . . . 75.0 110.645 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 52.3 m95 66.63 -161.82 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.272 1.429 . . . . 75.52 109.766 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 p -116.67 126.68 74.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.99 -0.744 . . . . 71.51 108.99 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.4 m -116.31 136.61 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 CA-C-N 115.299 -0.864 . . . . 41.12 110.301 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.467 HG23 ' OG ' ' A' ' 75' ' ' SER . 34.9 m -124.54 127.03 46.79 Favored 'General case' 0 C--N 1.279 -2.498 0 N-CA-C 107.535 -1.283 . . . . 74.43 107.535 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.638 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.4 m-85 -112.38 130.11 56.08 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.465 -0.939 . . . . 64.13 108.465 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.405 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 5.2 mm-40 -109.33 137.5 47.11 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.439 -0.8 . . . . 73.22 110.257 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.39 120.34 40.01 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.281 -0.872 . . . . 75.44 110.026 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -111.54 116.83 31.51 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.207 -1.034 . . . . 71.04 108.207 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.86 123.39 27.18 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.267 0.556 . . . . 71.12 109.528 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.6 mt -126.35 159.54 32.91 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.33 -0.85 . . . . 62.15 109.204 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.67 128.16 8.52 Favored Glycine 0 N--CA 1.409 -3.132 0 N-CA-C 108.693 -1.763 . . . . 63.01 108.693 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 83.89 -3.81 1.11 Allowed 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 125.011 1.324 . . . . 71.33 111.977 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -164.46 173.41 12.15 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.002 -0.74 . . . . 71.25 109.002 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 17' ' ' THR . 85.3 m -124.79 132.64 53.33 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.368 -0.604 . . . . 55.04 109.368 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.56 105.03 3.25 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 110.059 -1.216 . . . . 51.14 110.059 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.664 ' CE1' HG11 ' A' ' 29' ' ' VAL . 67.9 t80 -98.33 134.28 41.56 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.998 -0.741 . . . . 74.14 108.998 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 9.8 m -125.14 125.79 44.25 Favored 'General case' 0 N--CA 1.405 -2.678 0 C-N-CA 119.619 -0.832 . . . . 51.01 109.23 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.479 HD22 HG21 ' A' ' 134' ' ' VAL . 1.8 tp -100.26 124.04 45.22 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.074 -1.084 . . . . 72.31 108.074 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 3.5 mp -121.26 124.59 72.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 106.923 -1.51 . . . . 72.33 106.923 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -120.69 122.1 39.71 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.15 -1.056 . . . . 74.31 108.15 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -142.87 163.93 31.46 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.814 -1.551 . . . . 54.34 106.814 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -179.1 132.37 1.87 Allowed Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 108.502 -1.839 . . . . 62.44 108.502 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 31.5 t90 . . . . . 0 C--N 1.296 -1.746 0 C-N-CA 119.228 -0.989 . . . . 74.12 110.291 -178.151 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.22 -0.482 0 N-CA-C 104.82 -2.289 . . . . 64.31 104.82 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.9 pt -58.72 -32.63 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 118.418 0.554 . . . . 60.42 112.038 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.3 -113.12 3.91 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.61 -0.805 . . . . 71.42 113.702 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.84 -9.35 58.19 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.22 0.822 . . . . 65.01 113.22 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.72 -22.4 61.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.073 -0.343 . . . . 62.42 110.073 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 53.1 t30 43.01 89.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.655 1.582 . . . . 71.45 114.806 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.18 154.18 38.76 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 100.297 -3.964 . . . . 71.44 100.297 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.599 ' HB2' HG22 ' A' ' 121' ' ' VAL . 9.9 mmpt? -72.38 122.19 20.78 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 119.629 1.104 . . . . 72.41 111.776 -168.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 11.0 p -44.44 -50.47 9.33 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 125.119 1.368 . . . . 74.4 114.276 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.6 p -65.35 -45.86 82.52 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 116.337 -0.392 . . . . 64.04 112.026 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.599 HG22 ' HB2' ' A' ' 118' ' ' LYS . 11.0 m -70.62 -33.55 53.56 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 C-N-CA 119.909 -0.716 . . . . 74.12 110.346 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.54 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 69.5 t -60.22 -46.92 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 O-C-N 123.087 0.242 . . . . 54.23 110.368 176.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -57.47 -46.43 83.67 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.53 -0.759 . . . . 72.23 110.361 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.64 -47.25 50.37 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.598 -0.728 . . . . 63.0 113.0 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -62.79 -31.92 72.99 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 123.789 0.836 . . . . 64.45 112.425 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 25.8 mmt -72.71 -48.94 34.65 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.863 -0.735 . . . . 73.42 110.956 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.86 -65.74 0.63 Allowed 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.507 0.67 . . . . 72.0 110.548 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.04 -31.54 66.64 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.437 -0.801 . . . . 73.13 112.813 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -67.07 -59.3 7.06 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-O 119.408 -0.662 . . . . 74.41 112.013 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.416 ' CE3' HD21 ' A' ' 100' ' ' LEU . 97.7 m95 -61.88 -35.95 79.84 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 117.833 0.817 . . . . 72.33 112.833 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.8 m -62.28 -50.19 72.66 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 120.786 -0.366 . . . . 74.35 110.586 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.33 -48.21 19.77 Favored Glycine 0 C--O 1.247 0.939 0 C-N-CA 121.102 -0.57 . . . . 42.13 113.511 -177.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.57 -60.71 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 123.218 0.607 . . . . 64.14 110.347 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.479 HG21 HD22 ' A' ' 100' ' ' LEU . 98.0 t -57.64 -44.4 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 113.049 0.759 . . . . 74.32 113.049 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -56.4 -63.95 1.02 Allowed 'General case' 0 C--O 1.246 0.912 0 N-CA-C 112.143 0.423 . . . . 74.32 112.143 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -79.43 -34.84 41.31 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.184 0.809 . . . . 73.55 113.184 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -70.32 -39.43 74.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.534 -0.867 . . . . 75.52 111.265 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.5 mm? -70.47 -43.21 70.27 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 119.468 -0.893 . . . . 62.14 110.594 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.407 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.9 tmm_? -58.25 -37.2 74.44 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.045 -0.525 . . . . 72.24 110.094 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 8.5 mmmm -74.37 -37.1 63.55 Favored 'General case' 0 C--O 1.199 -1.558 0 N-CA-C 113.782 1.031 . . . . 64.11 113.782 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.72 -23.94 65.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.832 0.349 . . . . 41.13 111.377 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.1 m -90.81 -23.32 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 120.739 -0.384 . . . . 60.32 110.715 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -82.39 -54.56 5.12 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.122 0.416 . . . . 62.54 112.122 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 C--N 1.312 -1.052 0 N-CA-C 109.746 -0.464 . . . . 63.1 109.746 -177.686 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 112' ' ' ILE . . . . . . . . 0 CA--C 1.497 -1.071 0 CA-C-O 119.339 -0.363 . . . . 73.23 111.857 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.604 HD21 ' HE ' ' A' ' 123' ' ' ARG 0.38 4.5 mm? 97.08 85.6 0.02 OUTLIER Pre-proline 0 CA--C 1.51 -0.59 0 C-N-CA 127.27 2.228 . . . . 74.44 116.737 -176.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -91.93 -153.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.684 0 C-N-CA 123.623 2.882 . . . . 43.52 109.023 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 5.6 p-10 -58.5 146.82 34.02 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.672 0.789 . . . . 64.33 113.068 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.483 HG22 ' HB3' ' A' ' 102' ' ' HIS . 10.7 tp -152.42 139.38 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.226 -0.657 . . . . 70.11 109.226 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.1 m -113.42 140.1 48.35 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.406 -0.59 . . . . 74.35 109.406 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HD3' ' N ' ' A' ' 15' ' ' SER . 5.7 tmtt? -141.56 137.73 32.18 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.489 -1.671 . . . . 72.54 106.489 175.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.488 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 24.5 p -118.23 150.19 39.85 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.392 0.542 . . . . 71.11 111.096 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.489 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -158.65 134.7 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.582 -0.525 . . . . 74.22 109.582 177.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.34 130.95 44.45 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.404 0.621 . . . . 71.23 111.706 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 2.5 mm? -99.74 139.28 35.62 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 123.411 0.685 . . . . 73.44 109.784 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.431 ' HG3' ' NH2' ' A' ' 139' ' ' ARG . 20.8 mm-40 -92.67 27.49 2.31 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.574 0.702 . . . . 64.32 109.131 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -122.6 161.98 40.84 Favored Pre-proline 0 C--O 1.246 0.912 0 C-N-CA 123.826 0.851 . . . . 75.33 109.255 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 35.7 Cg_endo -64.9 149.49 89.44 Favored 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 122.713 2.275 . . . . 74.33 110.921 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.1 tt -56.81 -34.02 42.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.611 -0.722 . . . . 42.34 112.399 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 29.9 pt20 -64.88 -36.5 84.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.919 0.39 . . . . 55.41 111.069 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HA ' ' HG2' ' A' ' 27' ' ' GLU . 11.6 mptt -79.67 -28.74 40.74 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 112.037 0.384 . . . . 74.44 112.037 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.2 -42.14 75.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.157 -1.053 . . . . 62.2 108.157 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 54.4 t90 -59.72 -47.79 84.26 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.617 -1.174 . . . . 73.14 111.303 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.557 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 9.3 pt-20 -70.05 -27.87 65.0 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 119.925 -0.71 . . . . 72.2 112.289 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 m -59.46 -35.63 74.44 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.2 0.524 . . . . 72.0 110.401 174.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.601 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 26.4 m -106.9 25.1 2.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 112.186 0.439 . . . . 64.44 112.186 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.557 ' OG ' ' HA ' ' A' ' 27' ' ' GLU . 60.2 p -141.37 -11.33 0.94 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.733 0.642 . . . . 75.43 112.733 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -94.25 161.63 14.18 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 120.306 -0.558 . . . . 72.13 111.434 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -50.12 -56.53 10.53 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 125.772 1.629 . . . . 65.21 111.553 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.14 -33.3 56.73 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.947 0.721 . . . . 72.5 112.947 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.99 -48.2 67.7 Favored Glycine 0 CA--C 1.505 -0.592 0 C-N-CA 120.905 -0.664 . . . . 75.32 111.691 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 30' ' ' SER . 63.3 mt -70.42 -45.42 75.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.204 0.526 . . . . 60.12 111.383 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 112.859 0.688 . . . . 55.15 112.859 -176.212 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.3 t30 . . . . . 0 CA--C 1.484 -1.566 0 N-CA-C 104.278 -2.49 . . . . 73.05 104.278 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -93.44 79.25 4.38 Favored 'General case' 0 C--N 1.281 -2.379 0 C-N-CA 118.741 -1.184 . . . . 75.02 113.082 -171.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.438 ' HB3' HD12 ' A' ' 35' ' ' ILE . 99.6 m-85 -75.16 119.04 18.76 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.43 -1.692 . . . . 73.45 106.43 168.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -125.09 153.4 42.99 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.893 -1.521 . . . . 71.55 106.893 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.652 HD12 HG21 ' A' ' 68' ' ' VAL . 3.5 mm? -74.09 102.9 4.36 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 116.689 -2.004 . . . . 44.04 107.996 175.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 39.5 tptt -132.73 132.79 42.7 Favored 'General case' 0 N--CA 1.391 -3.418 0 N-CA-C 105.694 -1.965 . . . . 61.3 105.694 171.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -86.4 66.63 9.61 Favored 'General case' 0 C--N 1.259 -3.36 0 CA-C-O 122.27 1.033 . . . . 61.5 109.23 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 123.43 51.9 0.21 Allowed Glycine 0 N--CA 1.397 -3.921 0 CA-C-N 114.579 -1.191 . . . . 64.42 110.142 -176.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.573 ' H ' ' HB ' ' A' ' 65' ' ' VAL . 12.2 tt0 . . . . . 0 CA--C 1.498 -1.054 0 N-CA-C 106.534 -1.654 . . . . 65.42 106.534 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.425 -1.716 0 N-CA-C 108.176 -1.046 . . . . 60.23 108.176 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -143.07 147.11 34.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.394 -1.706 . . . . 74.03 106.394 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.573 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 42.9 t -90.32 137.45 21.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.636 -1.246 . . . . 64.24 107.636 177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 2.3 tm? -77.74 -61.56 1.95 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.084 -1.45 . . . . 74.43 107.084 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.56 156.76 10.02 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.119 -1.067 . . . . 64.1 108.119 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.652 HG21 HD12 ' A' ' 46' ' ' LEU . 13.5 p -125.04 135.17 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-O 121.177 0.513 . . . . 61.54 110.396 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 71.9 mm-40 -102.81 141.16 36.09 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.314 -0.995 . . . . 75.41 108.314 173.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.88 127.04 93.33 Favored Pre-proline 0 C--N 1.266 -3.031 0 N-CA-C 107.401 -1.333 . . . . 74.1 107.401 -168.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo 4.12 48.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.077 1 C-N-CA 127.628 5.552 . . . . 72.2 117.895 -161.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -137.65 -35.24 0.66 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.264 -0.425 . . . . 74.22 109.983 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 38.8 tt0 -149.55 148.28 29.18 Favored 'General case' 0 C--O 1.205 -1.237 0 C-N-CA 118.574 -1.25 . . . . 74.33 110.363 -175.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.639 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -143.04 130.91 21.55 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 107.705 -1.22 . . . . 55.54 107.705 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -132.66 127.1 34.13 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 110.224 -0.287 . . . . 62.45 110.224 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.421 ' HA ' ' H ' ' A' ' 66' ' ' LEU 0.254 35.8 p90 -145.81 157.84 43.9 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.208 -0.308 . . . . 73.4 111.768 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.262 36.1 mt-10 -120.07 144.67 47.46 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 123.624 0.77 . . . . 74.33 109.97 -169.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -114.67 120.47 40.23 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.0 -2.222 . . . . 72.23 105.0 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -83.11 10.61 7.79 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.619 0.723 . . . . 74.54 112.866 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.4 p -90.76 92.64 8.89 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 107.857 -1.164 . . . . 74.35 107.857 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 78.08 6.93 2.6 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.91 1.284 . . . . 64.44 112.403 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.87 62.73 3.07 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 114.805 -1.089 . . . . 61.32 113.777 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -100.28 150.64 22.36 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.825 -0.75 . . . . 74.04 109.742 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.13 109.93 2.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 108.216 -1.031 . . . . 75.14 108.216 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.11 154.67 5.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 115.86 -0.609 . . . . 42.51 109.817 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 15.3 m -139.89 140.3 36.43 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.179 -0.674 . . . . 70.45 109.179 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.639 ' CD2' HD12 ' A' ' 74' ' ' LEU . 15.0 m-85 -113.66 139.59 48.92 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.578 -1.267 . . . . 74.55 107.578 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.22 133.74 55.41 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.094 -1.076 . . . . 73.22 108.094 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.03 128.02 56.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.453 0.644 . . . . 74.15 109.948 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -115.96 130.84 57.0 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.692 -1.225 . . . . 74.42 107.692 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -94.29 121.17 35.53 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.417 0.627 . . . . 72.14 109.798 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 81.1 mt -114.2 156.0 25.06 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.245 -1.02 . . . . 60.23 108.245 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.95 49.57 4.25 Favored Glycine 0 C--N 1.289 -2.072 0 CA-C-N 116.255 -0.43 . . . . 51.31 112.137 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -177.17 -40.56 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.808 0.813 . . . . 60.44 109.118 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 9.2 ptpt -149.42 175.97 11.0 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 115.461 -0.79 . . . . 74.53 108.961 -171.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 64.8 m -108.22 130.4 55.15 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 109.03 -0.73 . . . . 54.34 109.03 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.53 124.4 7.59 Favored Glycine 0 N--CA 1.416 -2.675 0 N-CA-C 110.072 -1.211 . . . . 74.33 110.072 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CE1' HG11 ' A' ' 29' ' ' VAL . 93.1 t80 -112.06 134.33 53.68 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-O 121.195 0.522 . . . . 71.31 110.077 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 m -124.01 126.3 46.04 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.976 -1.12 . . . . 70.24 107.976 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.521 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -103.03 138.7 39.55 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.84 0.829 . . . . 73.33 108.788 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 100' ' ' LEU . 4.0 mp -135.53 124.86 41.14 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.033 0 CA-C-N 113.457 -1.701 . . . . 64.14 107.673 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 4.3 t60 -112.77 127.38 56.13 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 104.807 -2.294 . . . . 71.13 104.807 173.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -142.24 164.86 29.02 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.66 -1.978 . . . . 74.21 105.66 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.11 178.71 39.37 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 119.698 -1.239 . . . . 44.04 111.848 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 105.192 -2.151 . . . . 71.13 105.192 178.0 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 119' ' ' SER . 14.5 t . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 105.73 -1.952 . . . . 74.41 105.73 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 8' ' ' ALA . 6.9 pt -62.07 -32.85 55.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 118.428 0.558 . . . . 52.24 111.959 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.77 -127.28 6.48 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.563 -0.827 . . . . 64.41 112.467 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -69.75 -9.32 54.08 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.713 1.205 . . . . 55.11 114.023 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.44 84.24 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.035 0.754 . . . . 75.15 113.035 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -148.46 165.31 31.54 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 122.432 -0.167 . . . . 71.24 110.793 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.04 -68.24 0.33 Allowed 'General case' 0 C--N 1.316 -0.871 0 O-C-N 124.615 1.197 . . . . 65.3 111.243 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.455 ' HE2' HG13 ' A' ' 121' ' ' VAL . 34.1 mtmm -106.34 151.35 24.98 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 113.245 0.831 . . . . 71.05 113.245 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.443 ' HB2' HG22 ' A' ' 111' ' ' VAL . 9.0 t -77.15 -30.19 54.93 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.349 -0.982 . . . . 71.44 108.349 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.3 t -64.48 -41.68 96.33 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.09 -0.504 . . . . 71.11 110.574 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.455 HG13 ' HE2' ' A' ' 118' ' ' LYS . 33.0 m -70.69 -33.5 53.12 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.763 0 C-N-CA 119.698 -0.801 . . . . 65.45 110.33 177.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 118' ' ' LYS . 76.4 t -65.2 -41.67 92.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.254 -0.43 . . . . 53.51 110.067 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.604 ' HE ' HD21 ' A' ' 9' ' ' LEU . 2.9 tpm_? -54.44 -52.81 60.62 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.518 -0.765 . . . . 73.53 109.474 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -62.51 -54.31 35.08 Favored Glycine 0 CA--C 1.505 -0.576 0 O-C-N 123.623 0.577 . . . . 54.42 113.232 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -60.35 -41.01 92.77 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.483 0.92 . . . . 63.35 113.483 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.94 -39.59 42.28 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.226 -0.99 . . . . 72.03 110.98 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -67.39 -61.51 1.87 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.73 -0.47 . . . . 53.42 109.73 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -69.91 -32.34 69.95 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.262 -0.881 . . . . 71.31 111.895 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.76 -58.73 7.92 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-O 119.776 -0.458 . . . . 61.23 112.507 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -63.58 -36.69 84.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 113.281 0.845 . . . . 75.34 113.281 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.9 p -65.58 -51.31 60.74 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.767 -0.773 . . . . 70.54 111.412 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.54 -47.92 32.13 Favored Glycine 0 C--O 1.245 0.801 0 C-N-CA 121.01 -0.614 . . . . 60.52 113.329 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.619 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 45.9 mm -65.25 -51.26 67.2 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 N-CA-C 111.475 0.176 . . . . 71.51 111.475 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.521 HG21 ' HG ' ' A' ' 100' ' ' LEU . 97.5 t -62.14 -48.92 86.2 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.575 0 C-N-CA 119.269 -0.972 . . . . 71.21 110.68 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.489 ' HA ' HG13 ' A' ' 16' ' ' ILE . 9.7 t30 -60.76 -63.68 1.21 Allowed 'General case' 0 C--O 1.252 1.235 0 C-N-CA 119.654 -0.818 . . . . 74.31 112.741 -175.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.69 -41.11 18.09 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 118.773 -1.171 . . . . 71.51 112.737 -174.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.619 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 14.4 tpp180 -70.55 -37.55 74.05 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.023 -0.671 . . . . 74.3 111.851 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 0.1 OUTLIER -68.22 -44.31 76.04 Favored 'General case' 0 C--O 1.251 1.139 0 N-CA-C 107.314 -1.365 . . . . 75.3 107.314 177.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.636 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -60.5 -36.95 79.58 Favored 'General case' 0 C--O 1.203 -1.378 0 CA-C-N 116.046 -0.525 . . . . 70.03 110.495 177.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 10.9 mmmm -73.33 -35.6 66.06 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 114.616 1.339 . . . . 74.22 114.616 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.97 -33.94 76.46 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.488 -0.485 . . . . 74.43 109.707 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.436 HG21 ' HB3' ' A' ' 18' ' ' LEU . 11.0 m -85.04 -21.56 7.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-N 116.015 -0.539 . . . . 63.21 111.927 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 78.8 mm-40 -77.68 -33.05 53.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.331 -0.548 . . . . 63.35 109.914 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 . . . . . 0 CA--C 1.548 0.869 0 CA-C-N 115.905 -0.589 . . . . 63.53 110.332 178.727 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.423 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 106.668 -1.605 . . . . 73.21 106.668 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.7 tp -111.25 96.37 30.45 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.628 -0.879 . . . . 75.35 108.628 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 2.7 Cg_exo -75.92 -179.43 5.18 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.126 2.551 . . . . 62.01 112.829 -177.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 8.4 m-20 -65.09 124.27 21.68 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.344 -0.844 . . . . 74.44 111.033 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 49.4 mt -110.3 130.71 63.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.407 -1.331 . . . . 74.32 107.407 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 m -126.25 129.17 48.39 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.746 -0.835 . . . . 72.33 108.746 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.433 ' HE3' ' HB ' ' A' ' 16' ' ' ILE . 9.5 tmtm? -141.41 133.9 28.32 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.285 -1.376 . . . . 72.12 107.285 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 m -116.69 139.57 50.4 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 107.278 -1.379 . . . . 74.35 107.278 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.457 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -148.59 133.83 10.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.512 -0.921 . . . . 74.4 108.512 -178.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.425 ' CG2' ' HG3' ' A' ' 95' ' ' LYS . 3.4 m -104.37 125.59 50.73 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.775 -0.824 . . . . 70.11 108.775 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.7 mp -102.44 140.5 36.64 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.065 -0.516 . . . . 75.52 110.415 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -82.86 51.31 1.88 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.908 -0.775 . . . . 72.52 108.908 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.34 159.55 51.62 Favored Pre-proline 0 N--CA 1.433 -1.285 0 CA-C-N 115.787 -0.642 . . . . 72.1 109.838 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.25 156.47 55.47 Favored 'Trans proline' 0 C--O 1.262 1.713 0 C-N-CA 122.944 2.429 . . . . 71.11 111.199 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.8 tt -64.72 -29.83 48.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.64 -0.709 . . . . 74.32 112.014 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -72.07 -28.78 63.55 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.695 -0.802 . . . . 70.3 111.796 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -77.37 -41.73 39.12 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.712 -0.395 . . . . 75.42 109.975 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.533 HG11 HG21 ' A' ' 96' ' ' THR . 7.1 p -65.47 -39.1 84.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.48 -0.563 . . . . 75.54 109.48 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.463 ' NE1' ' HD3' ' A' ' 71' ' ' PRO . 66.9 t90 -58.89 -47.19 85.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.192 -0.913 . . . . 74.32 111.376 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.03 -33.25 75.13 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 119.398 -0.921 . . . . 62.51 110.19 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 94.9 m -62.02 -15.41 44.04 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 121.583 0.706 . . . . 42.21 112.129 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.451 HG11 ' CE1' ' A' ' 98' ' ' PHE . 20.3 m -121.83 7.53 5.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.082 -1.011 . . . . 61.54 112.009 176.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.416 ' HB3' HD22 ' A' ' 46' ' ' LEU . 18.7 m -127.71 -11.62 5.5 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.753 0.649 . . . . 54.12 112.753 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.5 p -91.61 163.23 14.19 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.106 -0.701 . . . . 74.44 109.106 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.564 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 9.3 m -53.36 -47.09 69.72 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.153 0.581 . . . . 72.31 111.615 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 32' ' ' SER . 1.4 mp0 -64.92 -48.77 72.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.721 -0.672 . . . . 73.04 110.729 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.26 -43.66 94.92 Favored Glycine 0 C--O 1.247 0.962 0 CA-C-N 115.427 -0.806 . . . . 33.23 113.233 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.85 -43.72 97.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 109.907 -0.405 . . . . 74.52 109.907 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 112.199 0.444 . . . . 25.45 112.199 176.167 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.564 ' O ' ' HB3' ' A' ' 32' ' ' SER . 12.7 m120 . . . . . 0 CA--C 1.489 -1.387 0 N-CA-C 106.066 -1.827 . . . . 73.12 106.066 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -92.72 70.66 4.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 112.554 0.576 . . . . 71.44 112.554 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -78.51 119.95 22.53 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 106.206 -1.775 . . . . 65.32 106.206 172.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -124.5 149.58 46.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 112.688 0.625 . . . . 64.43 112.688 -171.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 30' ' ' SER . 23.1 tp -82.76 106.13 14.35 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.211 -0.904 . . . . 62.43 108.793 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -133.67 141.54 47.63 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.223 -2.139 . . . . 73.35 105.223 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.581 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 7.8 pt-20 -93.96 75.94 4.15 Favored 'General case' 0 C--N 1.27 -2.852 0 CA-C-N 120.185 1.357 . . . . 54.11 110.745 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.55 72.43 0.19 Allowed Glycine 1 N--CA 1.391 -4.348 0 CA-C-N 113.332 -1.758 . . . . 63.12 109.959 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.291 -1.95 0 N-CA-C 105.287 -2.116 . . . . 70.15 105.287 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.438 -1.05 0 CA-C-O 120.963 0.411 . . . . 65.3 111.452 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -134.56 129.33 34.86 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.779 -1.563 . . . . 75.1 106.779 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.2 t -91.2 136.7 23.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 C-N-CA 118.132 -1.427 . . . . 70.22 108.816 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.448 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 1.9 tm? -87.45 -60.24 2.03 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.984 -1.117 . . . . 71.2 107.984 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.88 136.47 14.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.299 -0.409 . . . . 75.13 110.739 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 48' ' ' GLU . 47.3 t -118.11 119.27 60.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.595 -0.891 . . . . 72.35 108.595 176.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 42.7 mt-30 -116.14 140.88 48.84 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.705 -0.68 . . . . 63.23 110.491 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.39 131.51 93.23 Favored Pre-proline 0 C--N 1.281 -2.389 0 CA-C-N 113.9 -1.5 . . . . 72.32 110.314 -162.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HD3' ' NE1' ' A' ' 26' ' ' TRP . 55.3 Cg_exo 2.26 49.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.261 1 C-N-CA 128.144 5.896 . . . . 73.22 117.319 -162.293 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 p -140.71 -48.25 0.42 Allowed 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.538 -0.755 . . . . 74.31 111.138 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 32.1 tt0 -140.15 128.43 22.53 Favored 'General case' 0 C--O 1.21 -0.976 0 C-N-CA 118.802 -1.159 . . . . 70.44 110.852 -172.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.551 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -133.19 132.21 41.29 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 109.504 -0.554 . . . . 61.04 109.504 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.7 t -140.37 126.99 20.29 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.778 -0.453 . . . . 70.34 109.778 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.451 ' HD1' HD11 ' A' ' 74' ' ' LEU . 32.2 p90 -146.17 159.45 43.29 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 122.884 0.473 . . . . 71.02 111.098 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HG2' HG22 ' A' ' 84' ' ' VAL . 24.9 mt-10 -117.74 122.69 44.14 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 104.679 -2.341 . . . . 71.11 104.679 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -110.63 147.79 33.54 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.124 -0.944 . . . . 73.52 111.188 -173.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 t70 71.83 -174.93 0.17 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.753 1.621 . . . . 53.43 109.902 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.5 t -85.11 -5.4 59.34 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.598 -0.688 . . . . 73.42 110.35 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.405 ' OE1' ' HB2' ' A' ' 115' ' ' ALA . 14.3 mm-40 -85.3 -37.48 19.93 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.789 -0.641 . . . . 73.2 110.307 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.95 60.85 1.06 Allowed Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.254 -1.138 . . . . 73.43 110.254 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -81.39 106.22 13.19 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 107.851 -1.166 . . . . 75.32 107.851 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.444 HG23 ' HB2' ' A' ' 105' ' ' TRP . 84.4 t -84.92 106.05 14.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.123 -1.066 . . . . 70.43 108.123 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.21 134.86 49.91 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 108.74 -0.837 . . . . 73.31 108.74 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.7 m -125.56 130.44 51.7 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.568 -0.901 . . . . 60.3 108.568 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.551 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.1 m-85 -116.41 133.58 55.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.432 -0.951 . . . . 71.24 108.432 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.522 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -111.43 130.61 55.65 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 115.389 -0.823 . . . . 74.31 109.634 177.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.38 122.17 45.73 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.559 -0.746 . . . . 74.51 109.521 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -112.91 120.28 40.86 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.152 -1.055 . . . . 74.43 108.152 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -80.6 117.61 21.45 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.367 0.604 . . . . 72.41 109.772 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 7.0 mp -109.92 158.67 17.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.501 -1.666 . . . . 70.2 106.501 172.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -62.07 -37.27 94.18 Favored Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.964 -0.636 . . . . 74.14 114.371 -173.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -120.18 -3.2 10.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 117.393 0.597 . . . . 73.33 111.731 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.0 ptpt -153.17 175.78 12.66 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.61 -0.885 . . . . 24.0 108.61 -173.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.533 HG21 HG11 ' A' ' 25' ' ' VAL . 51.8 m -129.29 124.25 33.92 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.869 -0.732 . . . . 73.21 111.231 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.422 ' N ' HD13 ' A' ' 92' ' ' LEU . . . -84.18 113.44 3.74 Favored Glycine 0 N--CA 1.423 -2.207 0 N-CA-C 110.202 -1.159 . . . . 33.53 110.202 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.451 ' CE1' HG11 ' A' ' 29' ' ' VAL . 79.5 t80 -104.14 132.65 50.17 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 108.576 -0.898 . . . . 64.23 108.576 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 12.4 m -121.17 122.07 39.18 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.308 -0.997 . . . . 72.14 108.308 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.514 HD13 HG21 ' A' ' 134' ' ' VAL . 4.2 tp -100.78 124.47 46.47 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.821 -0.807 . . . . 72.44 108.821 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.54 124.29 66.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 106.87 -1.53 . . . . 64.13 106.87 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 8.0 t60 -112.02 113.65 26.06 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.948 -1.131 . . . . 73.32 107.948 177.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.2 m -118.28 132.87 56.27 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.137 -1.06 . . . . 73.44 108.137 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.28 132.51 11.27 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.117 -0.793 . . . . 65.31 111.117 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.444 ' HB2' HG23 ' A' ' 84' ' ' VAL . 83.0 t90 . . . . . 0 C--N 1.31 -1.146 0 CA-C-O 121.414 0.626 . . . . 71.04 109.756 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.432 -1.342 0 N-CA-C 108.14 -1.059 . . . . 73.41 108.14 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 pt -58.26 -33.16 46.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 124.347 1.059 . . . . 61.21 113.15 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.93 -137.23 8.98 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 108.807 -1.717 . . . . 71.02 108.807 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -104.28 18.76 21.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.759 0.79 . . . . 72.32 109.325 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.405 ' HB2' ' OE1' ' A' ' 81' ' ' GLU . . . -60.12 -39.5 86.48 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.838 0.828 . . . . 74.21 109.716 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -139.72 143.52 37.07 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.258 -1.756 . . . . 54.14 106.258 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -70.32 -23.84 62.9 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 113.659 0.985 . . . . 73.14 113.659 -172.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.543 ' HB2' HG23 ' A' ' 122' ' ' VAL . 75.6 mmtt -111.44 -176.51 2.96 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 122.002 -0.436 . . . . 52.4 109.876 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.1 p -130.81 -73.47 0.54 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 111.659 0.244 . . . . 64.24 111.659 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -62.06 -36.06 80.52 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 123.443 0.697 . . . . 72.12 109.295 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.66 -45.51 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.366 -0.834 . . . . 70.13 110.011 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.543 HG23 ' HB2' ' A' ' 118' ' ' LYS . 72.9 t -61.37 -38.96 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 116.336 -0.393 . . . . 74.03 111.023 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.45 ' NH1' ' HB2' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -62.9 -45.34 92.98 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.833 -0.803 . . . . 74.42 108.833 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.42 -49.72 59.35 Favored Glycine 0 C--O 1.245 0.812 0 CA-C-N 115.738 -0.664 . . . . 63.34 111.987 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -60.5 -39.38 87.53 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.408 0.683 . . . . 72.42 112.259 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.9 mmt -68.55 -38.49 80.82 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.55 -0.46 . . . . 62.42 111.313 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.45 ' HB2' ' NH1' ' A' ' 123' ' ' ARG . 12.6 t70 -61.47 -53.11 60.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.194 -0.669 . . . . 61.53 109.194 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.37 -45.28 91.28 Favored Glycine 0 C--O 1.249 1.07 0 CA-C-N 115.108 -0.951 . . . . 73.2 111.89 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.33 -54.22 39.72 Favored Glycine 0 C--O 1.217 -0.952 0 O-C-N 123.999 0.47 . . . . 72.44 112.826 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.408 ' CE3' HD21 ' A' ' 100' ' ' LEU . 85.6 m95 -60.63 -34.95 75.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.7 0.63 . . . . 74.04 112.7 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.407 ' HA ' ' HG3' ' A' ' 14' ' ' LYS . 63.7 m -64.41 -55.16 22.85 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.163 0.289 . . . . 72.31 110.628 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.71 -48.21 51.07 Favored Glycine 0 C--O 1.248 0.972 0 C-N-CA 121.327 -0.463 . . . . 75.42 112.859 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.5 -57.44 12.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 CA-C-O 118.945 -0.55 . . . . 61.45 111.897 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.514 HG21 HD13 ' A' ' 100' ' ' LEU . 93.9 t -57.93 -42.2 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 119.079 -1.048 . . . . 62.15 112.804 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.457 ' HA ' HG13 ' A' ' 16' ' ' ILE . 36.9 t30 -54.73 -67.84 0.23 Allowed 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.473 0.483 . . . . 71.34 111.947 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -76.09 -40.33 53.29 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 120.355 -0.538 . . . . 62.15 111.982 -173.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 137' ' ' ARG . 4.3 tpp180 -66.37 -44.07 84.21 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 119.444 -0.903 . . . . 73.54 111.723 -172.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.532 ' HB3' HD21 ' A' ' 18' ' ' LEU . 10.8 mp -70.83 -43.83 67.74 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.789 -0.765 . . . . 62.12 111.419 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -60.56 -36.28 78.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.941 0.4 . . . . 60.24 110.381 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -75.63 -37.5 59.66 Favored 'General case' 0 C--O 1.185 -2.296 0 C-N-CA 119.807 -0.757 . . . . 71.52 112.25 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.04 -33.96 76.93 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.032 0.444 . . . . 45.42 110.756 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 28.1 m -78.96 -28.33 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 120.482 -0.487 . . . . 70.15 110.901 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -82.37 -73.67 0.38 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.416 0.627 . . . . 73.22 110.694 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 . . . . . 0 N--CA 1.431 -1.391 0 CA-C-N 115.019 -0.991 . . . . 72.21 109.19 -174.339 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 112' ' ' ILE . . . . . . . . 0 CA--C 1.504 -0.811 0 N-CA-C 107.592 -1.262 . . . . 45.22 107.592 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 9' ' ' LEU . 2.2 tm? 86.89 81.15 0.05 OUTLIER Pre-proline 0 N--CA 1.411 -2.386 0 C-N-CA 129.351 3.06 . . . . 63.15 107.977 -163.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -102.27 -153.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 123.727 2.952 . . . . 70.43 110.698 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 1.1 m-20 -55.95 103.4 0.1 Allowed 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 123.893 0.746 . . . . 73.23 111.431 175.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.516 HG22 ' HB3' ' A' ' 102' ' ' HIS . 9.6 tp -102.65 131.63 50.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.952 -1.87 . . . . 74.1 105.952 170.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.9 m -117.66 129.49 55.77 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.002 0.429 . . . . 64.24 109.89 -176.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -131.57 126.35 34.61 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.556 -1.276 . . . . 64.23 107.556 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.1 m -116.95 133.65 55.74 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.932 -0.396 . . . . 71.42 109.932 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.422 HG21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -145.88 139.54 21.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.874 -0.787 . . . . 73.15 108.874 -175.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 p -97.67 125.11 42.25 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.208 0.527 . . . . 55.33 111.656 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.07 139.57 30.81 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.763 -0.653 . . . . 74.34 109.667 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -82.07 30.62 0.39 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.935 0.772 . . . . 73.32 111.105 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.468 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -129.23 159.57 68.39 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 116.071 -0.513 . . . . 75.21 110.732 -173.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.74 156.44 42.98 Favored 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 123.505 2.803 . . . . 74.21 112.042 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.593 HG12 HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -52.07 -41.72 33.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.167 -0.924 . . . . 62.21 111.107 -177.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -68.35 -34.85 76.82 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 119.98 -0.688 . . . . 74.02 111.033 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HA ' ' HG2' ' A' ' 27' ' ' GLU . 22.7 tptm -71.51 -38.47 71.12 Favored 'General case' 0 N--CA 1.441 -0.901 0 O-C-N 123.297 0.373 . . . . 75.41 110.38 -174.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.572 HG21 ' HB ' ' A' ' 96' ' ' THR . 47.8 t -71.11 -41.18 75.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.097 -0.705 . . . . 70.14 109.097 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 45.8 t90 -59.83 -47.69 84.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.474 -0.785 . . . . 73.44 111.444 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 11.5 pt-20 -66.29 -32.1 73.31 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.695 0.283 . . . . 42.11 110.64 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.3 m -65.66 -15.33 62.67 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 121.655 0.741 . . . . 74.53 111.683 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 13.6 m -125.3 18.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 O-C-N 121.138 -0.976 . . . . 72.24 112.276 177.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 p -134.33 -12.55 2.42 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.499 0.555 . . . . 75.52 112.499 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.9 p -94.53 163.35 13.43 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.135 -0.691 . . . . 61.01 109.135 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.59 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 17.9 t -56.64 -53.17 60.73 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 123.612 0.57 . . . . 74.04 111.094 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -57.21 -40.34 77.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.45 -0.796 . . . . 45.34 111.369 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.7 -48.01 24.17 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 120.824 -0.703 . . . . 75.12 113.372 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.3 mt -67.05 -33.29 62.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 122.699 0.4 . . . . 72.15 111.766 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 115.449 1.648 . . . . 71.22 115.449 -174.812 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 . . . . . 0 CA--C 1.496 -1.131 0 N-CA-C 110.03 -0.359 . . . . 65.02 110.03 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -137.39 69.58 1.4 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.503 0.668 . . . . 72.14 109.936 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.59 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 86.0 m-85 -91.61 136.37 33.18 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.812 -0.631 . . . . 74.34 110.015 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -137.52 143.5 41.67 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.67 -0.863 . . . . 62.14 108.67 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.57 ' H ' HD23 ' A' ' 46' ' ' LEU . 2.3 pt? -75.62 106.42 7.17 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.062 0.934 . . . . 73.12 110.017 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 15.8 tppt? -131.26 145.13 51.77 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.984 -1.858 . . . . 71.05 105.984 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.18 77.77 6.68 Favored 'General case' 0 C--N 1.278 -2.52 0 C-N-CA 118.773 -1.171 . . . . 73.41 109.223 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.87 67.53 0.31 Allowed Glycine 0 N--CA 1.413 -2.864 0 CA-C-N 114.695 -1.139 . . . . 71.34 112.973 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.585 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.271 0 N-CA-C 106.873 -1.528 . . . . 70.53 106.873 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.413 ' HG ' ' HE1' ' A' ' 44' ' ' PHE . 8.2 p . . . . . 0 N--CA 1.43 -1.44 0 CA-C-O 121.24 0.543 . . . . 52.1 111.883 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -154.33 127.25 8.24 Favored 'General case' 0 C--O 1.193 -1.886 0 C-N-CA 125.478 1.511 . . . . 72.01 107.23 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -89.99 123.91 42.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 106.9 -1.519 . . . . 74.04 106.9 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 tt -72.92 -60.27 2.31 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.567 -1.271 . . . . 74.3 107.567 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.33 150.01 8.89 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.522 -0.763 . . . . 54.21 109.638 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.533 HG23 HD23 ' A' ' 74' ' ' LEU . 9.6 p -121.89 131.85 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 121.208 0.527 . . . . 75.52 109.757 176.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 75.3 mm-40 -104.08 141.41 36.27 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.201 -0.909 . . . . 74.34 109.193 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.11 126.98 93.35 Favored Pre-proline 0 C--N 1.276 -2.594 0 CA-C-N 114.268 -1.333 . . . . 75.33 108.623 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo 6.75 44.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.357 1 C-N-CA 128.096 5.864 . . . . 74.13 117.715 -162.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 p -137.14 -38.5 0.62 Allowed 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.707 -0.679 . . . . 65.21 112.139 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 30.2 tt0 -150.77 147.81 27.75 Favored 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 118.316 -1.354 . . . . 63.41 111.252 -173.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.691 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.6 tm? -142.02 136.1 29.92 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.068 -0.716 . . . . 53.43 109.068 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 p -140.64 127.64 20.72 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.241 0.46 . . . . 73.03 112.241 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.455 ' HD1' HD11 ' A' ' 74' ' ' LEU . 43.3 p90 -141.37 156.05 45.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.413 -0.358 . . . . 71.44 110.638 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -121.25 148.87 43.7 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.242 -1.392 . . . . 71.33 107.242 -171.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.408 ' HD1' ' OG1' ' A' ' 80' ' ' THR . 9.3 t-105 -119.36 126.52 51.61 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.79 -1.559 . . . . 65.01 106.79 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -70.06 -17.1 63.23 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.606 0.965 . . . . 70.0 113.606 -170.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.408 ' OG1' ' HD1' ' A' ' 78' ' ' TRP . 67.8 p -79.49 95.41 5.8 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 120.369 -0.533 . . . . 64.23 109.911 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 82.7 -15.79 0.64 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.289 1.436 . . . . 73.25 113.461 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.85 54.61 0.81 Allowed Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.049 -1.072 . . . . 51.44 114.231 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -92.81 149.44 21.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.835 -1.172 . . . . 74.03 107.835 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.7 p -142.84 124.82 12.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.156 -0.683 . . . . 73.02 109.156 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.2 149.96 21.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 121.418 0.627 . . . . 63.33 110.446 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.1 m -135.67 137.76 42.13 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.721 -0.672 . . . . 63.31 109.761 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.691 ' CD2' HD12 ' A' ' 74' ' ' LEU . 12.5 m-85 -113.74 129.09 56.63 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 107.396 -1.335 . . . . 73.34 107.396 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.553 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -112.13 134.16 53.85 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 105.91 -1.885 . . . . 70.13 105.91 177.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.593 HD21 HG12 ' A' ' 22' ' ' ILE . 6.9 tt -115.3 126.41 54.44 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.228 -0.656 . . . . 50.24 109.228 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -111.09 116.71 31.6 Favored 'General case' 0 N--CA 1.415 -2.175 0 N-CA-C 107.922 -1.14 . . . . 72.41 107.922 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -80.03 116.91 20.42 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.854 0.835 . . . . 73.14 110.364 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -120.96 159.86 24.72 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.662 -1.236 . . . . 50.35 107.662 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.57 140.82 19.21 Favored Glycine 0 C--N 1.268 -3.2 0 N-CA-C 107.599 -2.201 . . . . 51.32 107.599 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 84.63 -24.88 0.14 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.147 1.379 . . . . 74.15 111.339 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.5 175.36 14.13 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.82 -0.807 . . . . 72.31 108.82 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.572 ' HB ' HG21 ' A' ' 25' ' ' VAL . 84.8 m -126.59 129.98 49.63 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.273 -0.64 . . . . 71.05 109.273 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.61 109.89 3.6 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 110.972 -0.851 . . . . 75.25 110.972 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.422 ' CE1' HG11 ' A' ' 29' ' ' VAL . 88.4 t80 -98.5 134.14 41.88 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 109.094 -0.706 . . . . 70.21 109.094 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' A' ' 88' ' ' GLN . 23.7 m -123.11 118.93 28.82 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.331 -0.989 . . . . 44.43 108.331 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.56 140.8 34.31 Favored 'General case' 0 N--CA 1.41 -2.432 0 N-CA-C 108.876 -0.787 . . . . 61.4 108.876 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 100' ' ' LEU . 18.5 mt -136.07 124.75 37.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.856 0 CA-C-N 113.56 -1.655 . . . . 63.34 107.821 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.516 ' HB3' HG22 ' A' ' 12' ' ' ILE . 6.1 t60 -118.92 125.19 48.88 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.048 -1.834 . . . . 73.1 106.048 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.6 t -142.29 165.54 27.14 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 106.871 -1.529 . . . . 63.11 106.871 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -135.51 156.55 22.77 Favored Glycine 0 C--N 1.289 -2.074 0 N-CA-C 109.197 -1.561 . . . . 72.02 109.197 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 . . . . . 0 C--N 1.304 -1.411 0 CA-C-N 117.527 0.663 . . . . 72.44 112.289 -178.699 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.428 HG23 ' HB3' ' A' ' 119' ' ' SER . 8.0 p . . . . . 0 N--CA 1.419 -1.993 0 N-CA-C 106.77 -1.567 . . . . 63.22 106.77 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.663 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -57.0 -32.38 39.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 123.313 0.645 . . . . 51.31 112.1 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.59 46.7 0.18 Allowed Glycine 0 CA--C 1.484 -1.874 0 C-N-CA 119.793 -1.194 . . . . 31.43 111.324 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 54.79 32.81 18.32 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.76 0.824 . . . . 74.22 111.669 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.402 ' HB3' HG13 ' A' ' 112' ' ' ILE . . . -71.28 -15.38 62.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.977 0.894 . . . . 63.14 109.435 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -152.01 174.47 13.62 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 104.383 -2.451 . . . . 70.2 104.383 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -48.61 -86.61 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 116.289 1.959 . . . . 64.44 116.289 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -119.02 149.73 41.15 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.957 -1.127 . . . . 72.43 107.957 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.428 ' HB3' HG23 ' A' ' 111' ' ' VAL . 6.9 p -65.0 -41.0 95.76 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.602 0.593 . . . . 75.43 112.602 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.7 t -68.23 -38.85 82.28 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.458 -0.497 . . . . 55.51 111.112 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.1 m -69.04 -34.13 62.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 C-N-CA 119.976 -0.689 . . . . 75.11 109.822 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.5 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 56.3 t -66.94 -46.66 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 116.35 -0.387 . . . . 71.12 110.733 177.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.08 -41.15 99.37 Favored 'General case' 0 C--O 1.209 -1.077 0 N-CA-C 109.425 -0.583 . . . . 63.51 109.425 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.56 -49.24 70.93 Favored Glycine 0 CA--C 1.502 -0.75 0 CA-C-N 116.223 -0.444 . . . . 51.34 112.159 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 122' ' ' VAL . 2.1 tmmm? -62.19 -32.64 73.31 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 123.413 0.685 . . . . 75.43 111.571 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 25.2 mmt -76.59 -44.94 32.39 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 120.338 -0.545 . . . . 64.32 110.191 176.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -58.9 -62.82 1.59 Allowed 'General case' 0 C--O 1.25 1.12 0 C-N-CA 123.912 0.885 . . . . 75.22 110.687 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.0 -42.07 60.03 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.696 -0.684 . . . . 70.32 111.866 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.583 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -58.9 -62.11 6.61 Favored Glycine 0 N--CA 1.437 -1.28 0 O-C-N 124.057 0.504 . . . . 74.11 112.043 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.464 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.5 m95 -60.82 -30.19 69.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.64 0.978 . . . . 73.54 113.64 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 73.1 m -63.4 -50.83 68.31 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 119.958 -0.697 . . . . 72.23 110.614 174.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.78 -46.15 54.77 Favored Glycine 0 C--O 1.251 1.218 0 C-N-CA 120.663 -0.779 . . . . 44.1 112.615 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 129' ' ' GLY . 52.1 mm -58.87 -57.86 9.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 123.023 0.529 . . . . 72.22 110.292 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HD23 ' A' ' 138' ' ' LEU . 93.1 t -62.97 -45.99 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 112.438 0.533 . . . . 65.41 112.438 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -57.03 -61.56 2.37 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 123.22 0.325 . . . . 74.34 111.746 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -84.65 -34.21 23.1 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 119.004 -1.078 . . . . 63.25 113.723 -172.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -70.32 -39.05 75.01 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.285 -0.966 . . . . 61.4 109.711 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.6 mm? -67.69 -48.95 65.13 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.874 -0.73 . . . . 62.02 109.778 174.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -58.25 -33.26 69.18 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.361 -0.381 . . . . 75.42 111.094 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -72.89 -48.31 38.39 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 112.188 0.44 . . . . 63.42 112.188 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.01 70.5 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.946 -0.302 . . . . 72.54 111.585 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.468 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 25.6 m -79.92 -33.08 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 120.594 -0.443 . . . . 74.13 111.556 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.48 -69.0 0.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.074 -0.65 . . . . 72.11 109.334 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 . . . . . 0 CA--C 1.505 -0.776 0 C-N-CA 123.558 0.743 . . . . 64.14 111.424 174.756 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -1.931 0 N-CA-C 106.894 -1.521 . . . . 62.05 106.894 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.402 ' CD1' ' HA ' ' A' ' 123' ' ' ARG . 6.2 tt -69.32 125.9 92.3 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 108.9 -0.778 . . . . 62.54 108.9 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -83.66 -158.43 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.051 2.5 . . . . 53.02 113.755 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.39 149.14 50.68 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.006 -0.997 . . . . 71.14 110.594 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 66.7 mt -123.97 139.48 50.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.82 -0.807 . . . . 73.24 108.82 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.5 m -139.58 131.38 27.52 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.904 -0.776 . . . . 42.42 108.904 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -145.88 151.43 37.86 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.376 -0.602 . . . . 63.32 109.376 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 p -117.39 151.81 36.27 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.126 -0.694 . . . . 64.34 109.126 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.533 HG21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -158.44 143.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 107.586 -1.264 . . . . 52.54 107.586 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 p -111.08 129.62 55.86 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.272 0.558 . . . . 64.35 112.438 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -101.88 139.66 37.22 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.074 -1.084 . . . . 74.23 108.074 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.527 ' CD ' ' HE ' ' A' ' 139' ' ' ARG 0.25 0.0 OUTLIER -93.29 53.36 1.91 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.826 1.298 . . . . 55.12 112.065 -177.873 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.5 160.16 52.15 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 113.332 -1.758 . . . . 71.22 108.41 -177.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HG2' ' HG2' ' A' ' 24' ' ' LYS . 28.9 Cg_endo -62.55 155.52 57.85 Favored 'Trans proline' 0 C--O 1.257 1.459 0 C-N-CA 122.803 2.335 . . . . 75.45 111.628 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 tt -56.57 -32.67 37.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.405 -0.816 . . . . 73.15 111.794 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -62.65 -40.23 96.39 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 123.12 0.262 . . . . 51.14 110.755 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 21' ' ' PRO . 14.2 mmmm -69.41 -42.49 75.0 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 116.298 -0.41 . . . . 75.21 110.869 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.477 HG21 ' HB ' ' A' ' 96' ' ' THR . 46.0 t -66.52 -42.49 90.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.55 -0.537 . . . . 74.03 109.55 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -61.89 -47.49 84.73 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.561 -0.745 . . . . 74.14 111.208 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.436 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 13.3 pt-20 -68.47 -29.51 68.16 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.78 -0.368 . . . . 74.41 111.319 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.6 m -60.75 -29.26 69.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.368 0.604 . . . . 72.15 111.27 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.581 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 15.2 m -113.1 19.62 7.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.25 -0.432 . . . . 74.44 112.147 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 27' ' ' GLU . 37.8 p -136.68 -20.7 1.32 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.077 0.769 . . . . 74.25 113.077 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.8 p -96.34 161.81 13.77 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 120.584 -0.446 . . . . 64.23 110.94 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 m -58.76 -55.52 34.07 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 123.588 0.555 . . . . 44.2 110.776 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 1.5 mp0 -57.28 -44.77 84.28 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 123.653 0.781 . . . . 72.4 110.581 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -48.87 65.34 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.4 -0.818 . . . . 53.4 113.238 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.2 mt -69.45 -43.1 81.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.411 . . . . 73.12 110.777 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.897 0 N-CA-C 112.859 0.689 . . . . 74.3 112.859 177.782 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.422 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . 44.4 t-20 . . . . . 0 N--CA 1.434 -1.27 0 N-CA-C 107.629 -1.249 . . . . 73.14 107.629 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -88.93 75.12 8.09 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-O 122.076 0.941 . . . . 71.15 109.873 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 84.0 m-85 -78.79 119.81 22.53 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.622 -1.251 . . . . 73.32 107.622 172.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -117.55 146.87 43.29 Favored 'General case' 0 CA--C 1.484 -1.585 0 O-C-N 123.374 0.422 . . . . 73.21 110.23 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.421 HD13 ' CB ' ' A' ' 30' ' ' SER . 30.1 tp -78.85 104.57 9.58 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 106.838 -1.542 . . . . 72.0 106.838 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 58.2 tttm -133.33 133.67 42.82 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.148 -1.427 . . . . 74.22 107.148 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HA ' HG23 ' A' ' 68' ' ' VAL . 4.7 pt-20 -88.14 73.07 9.04 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-O 123.033 1.396 . . . . 61.31 109.102 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.0 57.03 0.19 Allowed Glycine 1 N--CA 1.392 -4.262 0 CA-C-N 112.825 -1.989 . . . . 61.13 109.992 -177.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.311 -1.105 0 N-CA-C 105.965 -1.865 . . . . 62.31 105.965 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.423 -1.82 0 N-CA-C 108.488 -0.93 . . . . 74.13 108.488 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 53.4 mtmt -148.97 123.52 9.75 Favored 'General case' 0 C--O 1.198 -1.639 0 N-CA-C 108.435 -0.95 . . . . 63.3 108.435 177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 46.1 t -89.19 135.89 24.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.014 -1.106 . . . . 72.12 108.014 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.3 tp -80.36 -62.59 1.63 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.054 -0.721 . . . . 72.33 109.054 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.78 149.87 28.79 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.21 -0.905 . . . . 75.13 109.835 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG23 ' HA ' ' A' ' 48' ' ' GLU . 66.7 t -125.89 123.17 63.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.803 -0.814 . . . . 71.51 108.803 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.534 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 81.5 mm-40 -107.81 140.78 40.39 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.344 0.592 . . . . 74.34 110.291 174.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.77 123.94 88.19 Favored Pre-proline 0 C--N 1.277 -2.545 0 CA-C-N 113.873 -1.512 . . . . 72.01 109.213 -165.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo 6.86 49.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.639 1 C-N-CA 127.75 5.633 . . . . 71.33 116.603 -161.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 p -138.9 -41.5 0.48 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.105 -0.952 . . . . 74.22 112.077 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 39.3 tt0 -148.15 145.09 28.2 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 119.973 -0.691 . . . . 70.43 110.197 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.7 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.9 tm? -142.12 135.91 29.54 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.343 -0.984 . . . . 73.35 108.343 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.2 m -139.45 126.25 20.79 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 121.029 -0.268 . . . . 65.12 110.651 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 36.1 p90 -145.76 156.97 43.95 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 122.2 0.2 . . . . 74.42 111.242 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 24.0 mt-10 -120.39 124.6 45.91 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.085 -1.82 . . . . 74.21 106.085 -174.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -130.07 157.51 42.19 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 116.222 -0.445 . . . . 72.3 110.592 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 78.85 -176.33 0.09 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.267 1.827 . . . . 75.21 109.789 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.3 p -73.11 -18.47 61.29 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 114.433 1.272 . . . . 60.4 114.433 -173.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.401 ' HB2' ' NE1' ' A' ' 83' ' ' TRP . 3.7 mp0 -92.83 -18.77 22.44 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.092 -0.643 . . . . 70.32 110.989 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.89 60.63 2.88 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 120.002 -1.094 . . . . 43.44 110.54 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 95.9 m95 -78.33 121.21 24.16 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.551 -0.907 . . . . 72.13 108.551 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 76' ' ' PHE . 8.7 p -99.19 107.74 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 CA-C-O 122.516 1.151 . . . . 63.24 111.592 -173.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -99.84 146.48 8.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.41 -1.268 . . . . 63.51 108.369 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 42.4 m -130.5 135.82 48.35 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 109.139 -0.689 . . . . 53.44 109.139 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.7 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.4 m-85 -112.59 135.55 53.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.2 -1.037 . . . . 72.31 108.2 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.15 137.91 52.65 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.392 -0.966 . . . . 75.23 108.392 176.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -113.1 131.52 55.79 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.77 0.319 . . . . 73.45 111.296 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -120.7 139.06 53.6 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.231 1.013 . . . . 72.44 108.678 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -96.73 128.71 43.94 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.087 0.47 . . . . 65.31 109.996 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.56 153.54 45.08 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.981 -1.118 . . . . 73.42 107.981 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.98 57.54 5.07 Favored Glycine 0 C--N 1.289 -2.053 0 C-N-CA 121.488 -0.387 . . . . 71.24 113.667 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 171.65 -44.54 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 124.434 1.093 . . . . 75.23 108.323 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -130.78 172.59 11.83 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.167 -1.379 . . . . 73.13 109.115 -170.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.477 ' HB ' HG21 ' A' ' 25' ' ' VAL . 74.0 m -116.52 130.91 57.02 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 109.22 -0.659 . . . . 65.55 109.22 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.08 119.8 5.66 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.059 -1.216 . . . . 53.13 110.059 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -108.0 133.23 52.61 Favored 'General case' 0 C--N 1.269 -2.895 0 N-CA-C 108.082 -1.081 . . . . 74.05 108.082 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.7 m -122.77 122.51 38.87 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.761 -0.829 . . . . 44.41 108.761 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.483 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.19 139.05 36.42 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 121.854 0.835 . . . . 73.1 109.404 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.534 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 14.0 mt -136.49 128.88 45.03 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 113.334 -1.757 . . . . 73.3 108.047 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.523 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . 8.7 t-80 -120.38 125.82 48.95 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.698 -0.853 . . . . 60.42 108.698 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.7 t -142.83 159.87 41.41 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 104.777 -2.305 . . . . 75.44 104.777 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.55 -169.04 36.12 Favored Glycine 0 C--N 1.292 -1.89 0 C-N-CA 119.967 -1.111 . . . . 51.14 112.325 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 97.9 m95 . . . . . 0 C--N 1.31 -1.14 0 CA-C-O 121.502 0.668 . . . . 73.32 112.421 -179.426 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.434 -1.23 0 N-CA-C 107.552 -1.277 . . . . 64.11 107.552 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 112' ' ' ILE . 2.9 pt -55.65 -31.8 29.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 123.955 0.784 . . . . 65.21 113.062 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.29 -135.08 7.4 Favored Glycine 0 CA--C 1.486 -1.747 0 C-N-CA 119.893 -1.146 . . . . 34.13 111.801 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -80.07 11.2 3.56 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.904 0.705 . . . . 70.0 112.904 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.43 -15.52 63.58 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.991 -0.744 . . . . 62.42 108.991 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . 0.3 0.0 OUTLIER 59.32 10.0 1.62 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 128.515 2.726 . . . . 72.34 116.642 172.267 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.81 161.39 18.38 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.916 -0.713 . . . . 65.22 110.059 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -82.61 145.2 29.81 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.742 -0.836 . . . . 74.34 108.742 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 p -57.19 -40.4 77.31 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.919 0.711 . . . . 43.45 112.919 -176.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.1 p -67.8 -46.12 72.84 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.567 -0.288 . . . . 52.51 111.626 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.64 -33.87 62.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 C-N-CA 120.295 -0.562 . . . . 64.14 109.641 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.07 -46.14 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.275 -0.421 . . . . 72.41 110.887 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.402 ' HA ' ' CD1' ' A' ' 9' ' ' LEU . 44.4 ttm180 -66.22 -45.61 80.11 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 121.007 -0.277 . . . . 73.42 110.902 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.47 -43.21 99.03 Favored Glycine 0 N--CA 1.446 -0.657 0 O-C-N 123.608 0.568 . . . . 55.34 112.053 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -38.47 73.88 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.686 0.625 . . . . 62.43 112.686 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.82 -45.73 49.54 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.981 -0.688 . . . . 72.54 110.854 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.06 -59.2 3.67 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.441 -0.345 . . . . 62.24 111.618 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.74 -40.99 93.97 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.541 -0.624 . . . . 52.54 111.541 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.49 -60.15 8.69 Favored Glycine 0 N--CA 1.436 -1.315 0 O-C-N 124.054 0.503 . . . . 52.33 112.3 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.419 ' HE3' HG23 ' A' ' 134' ' ' VAL . 67.8 m95 -63.37 -35.68 81.21 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.592 0.96 . . . . 70.33 113.592 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.2 m -68.29 -54.54 16.85 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.166 -0.614 . . . . 65.14 110.94 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.19 -47.04 39.11 Favored Glycine 0 C--O 1.244 0.735 0 C-N-CA 120.829 -0.7 . . . . 73.2 112.95 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.711 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 46.2 mm -67.3 -49.8 68.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.955 0 CA-C-O 119.577 -0.249 . . . . 65.05 111.228 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.533 HG12 HG21 ' A' ' 16' ' ' ILE . 78.6 t -61.84 -49.6 83.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 118.793 -1.163 . . . . 50.25 112.218 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -61.6 -64.83 0.81 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.702 0.63 . . . . 61.32 112.702 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.05 -39.23 50.77 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.863 -0.735 . . . . 65.31 112.723 -172.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.711 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -69.61 -40.93 76.33 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.006 -0.677 . . . . 70.41 111.886 -176.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.2 mm? -62.63 -48.88 77.42 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 119.063 -1.055 . . . . 73.13 109.271 175.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.527 ' HE ' ' CD ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -61.0 -38.79 87.29 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.735 -0.666 . . . . 72.52 110.452 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -76.89 -36.76 56.47 Favored 'General case' 0 CA--C 1.471 -2.093 0 N-CA-C 113.721 1.008 . . . . 73.44 113.721 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 -27.42 64.02 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.131 -0.627 . . . . 43.02 110.611 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.434 HG11 HG22 ' A' ' 25' ' ' VAL . 23.8 m -80.2 -26.71 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 116.201 -0.454 . . . . 72.3 110.76 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -84.31 -60.36 2.11 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 119.98 -0.688 . . . . 74.44 111.512 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 113.985 1.106 . . . . 71.54 113.985 -170.298 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 121.042 0.448 . . . . 64.14 110.461 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 tt 177.99 100.99 0.13 Allowed Pre-proline 0 N--CA 1.434 -1.266 0 N-CA-C 105.775 -1.935 . . . . 64.34 105.775 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -92.96 -179.42 0.95 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.413 2.075 . . . . 40.43 110.118 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.589 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 3.2 p-10 -68.24 112.28 5.06 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.836 -0.802 . . . . 62.14 108.836 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.531 HG22 ' HB3' ' A' ' 102' ' ' HIS . 9.1 tp -97.33 125.44 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 C-N-CA 118.456 -1.298 . . . . 70.41 108.283 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 60.7 m -107.18 128.98 54.89 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 107.425 -1.324 . . . . 73.03 107.425 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -131.09 136.52 48.47 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.68 -1.23 . . . . 74.43 107.68 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -118.3 134.95 54.6 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 120.754 0.312 . . . . 61.3 111.211 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.509 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.78 139.98 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.033 0.444 . . . . 53.4 109.917 -179.091 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 p -101.09 126.74 47.81 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.137 0.494 . . . . 74.55 110.969 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.408 HD11 ' HB3' ' A' ' 138' ' ' LEU . 4.0 mm? -91.19 138.17 31.8 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.617 -0.72 . . . . 64.31 110.603 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -86.83 30.12 0.76 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 113.997 -1.456 . . . . 74.14 109.613 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.15 158.41 73.74 Favored Pre-proline 0 C--O 1.251 1.142 0 CA-C-N 115.564 -0.743 . . . . 62.23 109.37 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.97 150.76 87.61 Favored 'Trans proline' 0 C--O 1.25 1.091 0 C-N-CA 123.286 2.657 . . . . 75.13 112.109 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -40.24 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.091 -0.958 . . . . 70.52 111.68 -176.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -67.83 -35.77 79.19 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.997 -0.681 . . . . 74.43 111.179 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -72.66 -37.48 67.93 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.627 -0.509 . . . . 62.51 109.627 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.03 -41.15 89.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.908 -0.587 . . . . 61.21 109.618 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -60.02 -47.03 87.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.593 -0.73 . . . . 74.14 110.086 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -60.79 -39.79 90.17 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.362 0.665 . . . . 73.44 110.475 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.7 m -60.97 -23.29 65.23 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.536 0.734 . . . . 72.13 112.055 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.589 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 10.7 m -119.25 19.87 6.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 112.508 0.558 . . . . 73.31 112.508 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.427 ' HB2' HD12 ' A' ' 46' ' ' LEU . 61.0 p -137.46 -22.09 1.14 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.933 0.716 . . . . 63.03 112.933 176.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -91.63 154.61 18.91 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.456 -0.572 . . . . 63.42 109.456 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 27.7 t -63.01 -40.78 98.78 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.605 -0.887 . . . . 63.42 108.605 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -62.3 -48.97 77.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.678 -1.147 . . . . 71.42 109.638 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.78 -47.59 60.26 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.151 -0.931 . . . . 71.21 113.402 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HA ' HH22 ' A' ' 137' ' ' ARG . 70.2 mt -69.47 -48.46 66.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 117.601 0.7 . . . . 73.22 111.895 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.087 0 N-CA-C 112.461 0.541 . . . . 70.5 112.461 179.579 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 CA--C 1.488 -1.424 0 N-CA-C 107.082 -1.451 . . . . 64.12 107.082 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.79 78.86 3.28 Favored 'General case' 0 CA--C 1.469 -2.139 0 CA-C-O 121.177 0.513 . . . . 74.41 110.911 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 83.1 m-85 -68.28 126.55 29.94 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.594 -1.185 . . . . 63.43 109.009 175.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -127.45 138.75 53.04 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.987 -0.745 . . . . 65.4 108.987 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 30' ' ' SER . 5.5 tt -75.56 103.72 5.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 106.641 -1.615 . . . . 65.52 106.641 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 1.2 tpmt? -133.91 145.13 49.32 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.53 -1.656 . . . . 73.3 106.53 172.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -87.68 48.12 1.6 Allowed 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 119.298 0.954 . . . . 73.52 110.185 174.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.68 49.96 0.03 OUTLIER Glycine 0 N--CA 1.42 -2.409 0 CA-C-N 115.32 -0.855 . . . . 62.14 111.0 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.5 OUTLIER . . . . . 0 CA--C 1.487 -1.463 0 N-CA-C 106.082 -1.822 . . . . 74.0 106.082 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 20.4 p . . . . . 0 N--CA 1.429 -1.503 0 N-CA-C 108.553 -0.906 . . . . 72.15 108.553 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 9.6 mtmp? -145.38 135.5 23.84 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.35 -0.982 . . . . 74.34 108.35 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 50' ' ' GLN . 30.2 t -90.28 130.61 39.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.602 -1.258 . . . . 62.12 107.602 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.2 tp -76.03 -59.91 2.55 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.055 -1.091 . . . . 75.03 108.055 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -162.16 141.08 9.33 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.352 -0.84 . . . . 61.12 109.776 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.505 HG23 HD23 ' A' ' 74' ' ' LEU . 9.4 p -116.99 120.46 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.982 0 CA-C-O 121.583 0.706 . . . . 65.0 110.036 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 2.2 mp0 -94.15 141.04 29.0 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.617 -1.174 . . . . 73.2 108.85 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 122.69 83.57 Favored Pre-proline 0 C--N 1.276 -2.613 0 CA-C-N 114.379 -1.282 . . . . 51.44 108.969 -164.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo 0.12 62.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.014 1 C-N-CA 126.771 4.981 . . . . 62.52 115.488 -159.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -143.47 -42.24 0.29 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 113.67 -1.605 . . . . 73.21 110.983 175.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.4 tt0 -150.84 145.46 25.7 Favored 'General case' 0 C--O 1.204 -1.318 0 C-N-CA 119.834 -0.746 . . . . 74.44 110.491 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.694 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.0 tm? -137.05 137.63 39.56 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.063 -1.088 . . . . 73.01 108.063 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.7 p -140.76 126.88 19.58 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.803 -0.359 . . . . 65.34 110.992 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.46 ' HD1' HD11 ' A' ' 74' ' ' LEU . 31.2 p90 -144.23 156.91 44.49 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 120.794 0.33 . . . . 72.52 111.07 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 20.6 mt-10 -121.07 136.78 54.91 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 105.963 -1.866 . . . . 75.53 105.963 -173.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -147.94 158.71 44.19 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 120.188 -0.605 . . . . 74.42 112.409 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 73.84 171.34 0.3 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.05 -1.432 . . . . 73.5 113.195 172.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.6 p -66.47 -34.46 77.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.934 0.894 . . . . 70.34 111.862 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.46 -15.11 60.9 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 112.438 0.533 . . . . 74.31 112.438 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.29 67.64 1.79 Allowed Glycine 0 C--O 1.247 0.91 0 C-N-CA 121.058 -0.591 . . . . 54.33 112.411 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.456 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 33.2 m95 -93.95 130.21 40.13 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.33 -0.618 . . . . 63.34 109.33 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.432 HG22 ' HG2' ' A' ' 77' ' ' GLU . 42.1 t -110.8 111.43 36.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.854 -1.165 . . . . 73.23 107.854 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.3 m -109.23 140.59 27.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 115.946 -0.57 . . . . 73.13 109.67 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 58.3 m -126.09 135.14 51.37 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.9 -0.778 . . . . 74.35 108.9 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.694 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.7 m-85 -111.25 132.59 54.23 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.793 -1.188 . . . . 73.43 107.793 177.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.57 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 27.3 mt-30 -114.35 141.45 47.61 Favored 'General case' 0 C--N 1.276 -2.614 0 O-C-N 123.643 0.589 . . . . 75.24 110.568 177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.6 tp -104.18 141.18 36.71 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.705 -0.68 . . . . 64.12 110.918 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -124.92 116.68 22.59 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 106.164 -1.791 . . . . 74.35 106.164 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -86.22 119.15 26.2 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.999 -0.546 . . . . 65.11 111.796 -173.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 74.6 mt -125.18 149.52 47.85 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.046 -1.464 . . . . 71.01 107.046 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.84 58.84 1.79 Allowed Glycine 0 C--N 1.28 -2.536 0 C-N-CA 120.44 -0.886 . . . . 63.2 112.476 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -177.15 -52.84 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.119 -1.808 . . . . 62.21 106.119 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.67 175.8 7.7 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.006 -1.479 . . . . 74.34 107.006 -175.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.1 m -120.87 130.39 53.9 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 120.341 -0.543 . . . . 62.04 109.697 -178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.52 124.79 7.86 Favored Glycine 0 N--CA 1.408 -3.216 0 N-CA-C 109.099 -1.6 . . . . 72.34 109.099 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -117.27 134.18 55.11 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 108.812 -0.81 . . . . 74.13 108.812 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 23.5 m -125.95 129.24 48.88 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.517 -0.92 . . . . 65.55 108.517 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.505 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -104.79 142.26 35.03 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.005 -0.739 . . . . 74.23 109.005 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.494 ' N ' HD13 ' A' ' 100' ' ' LEU . 3.6 mp -136.13 125.25 38.61 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 106.829 -1.545 . . . . 72.41 106.829 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.589 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 23.2 t-160 -119.3 124.33 46.4 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.09 -0.707 . . . . 53.25 109.09 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.0 t -139.44 164.09 30.79 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 106.49 -1.67 . . . . 71.03 106.49 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -110.42 160.54 13.28 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.752 -0.737 . . . . 54.52 112.099 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 . . . . . 0 CA--C 1.559 1.32 0 CA-C-O 122.623 1.201 . . . . 72.54 110.205 179.656 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.485 -1.542 0 CA-C-O 120.902 0.382 . . . . 70.32 110.355 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.423 ' H ' HG12 ' A' ' 112' ' ' ILE . 1.1 pt -58.47 -38.46 70.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.56 -1.2 . . . . 71.04 112.245 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.17 70.3 0.24 Allowed Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.168 -1.491 . . . . 74.42 113.016 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt 61.93 31.66 18.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.729 1.011 . . . . 75.14 113.729 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.35 -13.3 61.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.654 0.264 . . . . 73.42 110.696 174.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 m120 93.65 139.25 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.377 1.871 . . . . 72.12 112.891 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 86.27 158.68 0.08 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.391 1.876 . . . . 55.04 111.353 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HB2' HG23 ' A' ' 121' ' ' VAL . 30.9 mmmt -59.28 149.43 28.76 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.187 0.595 . . . . 74.23 112.168 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.58 -52.81 64.07 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.221 1.008 . . . . 75.2 110.592 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.8 t -60.82 -36.74 79.85 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.611 -0.722 . . . . 74.41 110.2 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 118' ' ' LYS . 71.6 t -70.25 -47.45 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.653 -0.703 . . . . 72.24 109.898 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.16 -41.18 80.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.208 -0.451 . . . . 75.2 110.701 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -63.22 -48.81 76.72 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.486 -0.779 . . . . 73.45 109.424 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.76 96.97 Favored Glycine 0 CA--C 1.495 -1.213 0 CA-C-N 115.231 -0.895 . . . . 60.42 112.03 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -66.55 -35.21 79.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 122.78 0.432 . . . . 71.01 111.521 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 24.1 mmt -70.92 -45.09 64.85 Favored 'General case' 0 C--O 1.211 -0.939 0 C-N-CA 120.315 -0.554 . . . . 64.51 111.003 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -67.26 -53.84 26.27 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.406 -0.918 . . . . 72.24 111.104 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.97 -45.64 95.21 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.917 -0.473 . . . . 63.54 111.917 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.65 -52.65 49.47 Favored Glycine 0 CA--C 1.487 -1.701 0 N-CA-C 111.494 -0.642 . . . . 64.52 111.494 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.402 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.7 m95 -65.15 -26.3 68.11 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 113.372 0.878 . . . . 73.03 113.372 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.1 m -67.81 -54.68 17.17 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.55 -0.537 . . . . 74.5 109.55 174.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.87 -42.4 86.19 Favored Glycine 0 C--O 1.245 0.826 0 CA-C-N 115.992 -0.549 . . . . 54.21 113.053 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.681 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 39.5 mm -65.37 -57.58 10.39 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 CA-C-O 119.599 -0.239 . . . . 72.21 110.937 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 69.6 t -57.99 -48.02 85.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 112.486 0.55 . . . . 72.12 112.486 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.509 ' HA ' HG13 ' A' ' 16' ' ' ILE . 43.4 t30 -59.69 -63.31 1.35 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.041 0.448 . . . . 75.13 111.995 -177.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -74.85 -48.27 25.92 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 112.447 0.536 . . . . 72.11 112.447 -173.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.681 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -63.56 -38.64 91.91 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 112.107 0.41 . . . . 74.24 112.107 -175.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.3 mm? -68.1 -48.38 65.63 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 119.298 -0.961 . . . . 64.34 110.594 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -58.42 -36.04 72.99 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.53 0.681 . . . . 74.14 109.698 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -75.97 -38.85 57.04 Favored 'General case' 0 C--O 1.185 -2.329 0 N-CA-C 112.339 0.496 . . . . 75.42 112.339 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.17 68.58 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.152 -0.619 . . . . 73.54 111.446 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.6 m -78.56 -36.09 19.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.067 -0.653 . . . . 73.22 110.213 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -87.8 -58.95 2.38 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.39 1.256 . . . . 72.12 114.39 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--N 1.308 -1.224 0 CA-C-O 121.74 0.781 . . . . 71.23 111.442 -172.722 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . . . . . . 0 CA--C 1.491 -1.323 0 N-CA-C 106.945 -1.502 . . . . 64.33 106.945 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.456 HD11 ' HA3' ' A' ' 104' ' ' GLY . 2.4 pt? -162.53 129.72 2.58 Favored Pre-proline 0 N--CA 1.418 -2.028 0 N-CA-C 105.898 -1.889 . . . . 60.43 105.898 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -85.44 -167.94 0.45 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 121.78 1.653 . . . . 75.43 110.121 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 14.1 t70 -100.35 113.07 25.52 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 105.675 -1.972 . . . . 61.31 105.675 171.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' A' ' 102' ' ' HIS . 14.5 tt -106.86 130.79 58.23 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.982 0 C-N-CA 119.81 -0.756 . . . . 75.4 109.478 -177.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 36.2 m -114.37 128.92 56.59 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 106.984 -1.488 . . . . 63.43 106.984 178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.408 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 20.0 tptt -134.67 152.69 51.95 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.392 -1.336 . . . . 61.2 107.392 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.2 p -128.75 133.91 48.25 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 120.812 -0.355 . . . . 71.21 110.342 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.28 135.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.333 -1.358 . . . . 75.32 107.333 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.8 p -102.8 131.49 49.62 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.47 0.544 . . . . 72.42 112.47 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.9 mp -108.36 140.94 40.92 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 122.005 0.907 . . . . 75.3 113.094 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -70.36 13.42 0.17 Allowed 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 128.583 2.753 . . . . 62.55 112.779 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.483 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -130.86 164.03 44.76 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-O 118.969 -0.539 . . . . 75.11 110.107 -172.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 37.5 Cg_endo -64.8 154.95 70.14 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.85 2.367 . . . . 62.34 111.904 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.401 ' HA ' HG21 ' A' ' 96' ' ' THR . 14.0 tt -57.69 -33.35 44.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.688 -1.142 . . . . 74.24 112.666 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 3.9 pt20 -65.05 -41.31 95.3 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.364 -0.38 . . . . 72.12 111.756 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -72.64 -38.9 67.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.321 -0.4 . . . . 61.51 110.988 -173.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.468 HG11 HG21 ' A' ' 96' ' ' THR . 8.6 p -68.28 -41.0 83.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 120.385 -0.526 . . . . 74.42 109.918 178.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -62.28 -47.25 85.15 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.636 -0.711 . . . . 73.1 111.451 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 23' ' ' GLN . 11.6 pt-20 -69.0 -27.9 66.11 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 120.35 -0.54 . . . . 65.31 111.523 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.0 m -57.13 -36.38 70.63 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 121.411 0.624 . . . . 72.05 110.026 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.498 HG21 ' HE2' ' A' ' 98' ' ' PHE . 4.0 m -107.74 23.14 3.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.125 -0.489 . . . . 75.21 111.795 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.9 t -145.06 11.29 1.35 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.945 0.402 . . . . 60.11 110.743 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.0 p -117.31 162.14 18.39 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.871 -0.518 . . . . 53.24 110.335 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -51.93 -62.23 1.76 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.325 1.05 . . . . 64.12 111.467 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.58 -35.52 75.43 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.837 0.68 . . . . 63.44 112.837 -175.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.85 -48.39 72.37 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.928 -0.653 . . . . 50.3 111.743 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.496 HD12 ' CD1' ' A' ' 44' ' ' PHE . 64.1 mt -70.46 -39.37 76.24 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 CA-C-O 120.594 0.235 . . . . 54.12 111.385 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.261 0 CA-C-N 116.015 -0.539 . . . . 73.1 110.434 176.183 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 . . . . . 0 CA--C 1.475 -1.909 0 N-CA-C 108.274 -1.01 . . . . 54.42 108.274 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -110.08 74.08 0.87 Allowed 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 119.704 -0.798 . . . . 63.22 109.787 -172.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.496 ' CD1' HD12 ' A' ' 35' ' ' ILE . 18.6 t80 -106.9 129.26 54.75 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.08 -0.964 . . . . 72.51 110.722 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -136.0 150.53 49.26 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.522 -1.659 . . . . 73.33 106.522 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -80.43 109.33 14.84 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 118.813 -1.155 . . . . 72.12 111.601 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 22.3 tptm -128.52 143.4 50.96 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 104.522 -2.399 . . . . 55.15 104.522 173.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -87.83 78.17 8.41 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.407 1.098 . . . . 62.24 109.239 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.36 99.2 2.22 Favored Glycine 1 N--CA 1.395 -4.084 0 N-CA-C 108.122 -1.991 . . . . 44.14 108.122 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 7.3 tt0 . . . . . 0 C--N 1.29 -1.998 0 N-CA-C 107.268 -1.382 . . . . 71.53 107.268 -174.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.424 -1.733 0 N-CA-C 112.945 0.72 . . . . 62.14 112.945 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 89.4 mttt -138.09 143.94 40.66 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.807 -1.923 . . . . 75.41 105.807 175.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 50' ' ' GLN . 18.2 t -91.2 136.77 23.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 107.526 -1.287 . . . . 54.14 107.526 173.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.1 tt -87.09 -58.19 2.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.863 -1.162 . . . . 63.23 107.863 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.34 145.88 10.07 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.219 -1.03 . . . . 74.11 108.219 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.81 119.8 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-O 122.207 1.003 . . . . 74.52 111.378 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 15.4 mm100 -104.92 142.51 34.64 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 113.941 -1.481 . . . . 74.34 109.064 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.81 129.19 94.26 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 114.354 -1.294 . . . . 51.32 108.262 -167.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -1.99 52.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.558 1 C-N-CA 128.105 5.87 . . . . 62.43 117.919 -160.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.0 p -137.23 -42.64 0.56 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.667 -1.151 . . . . 64.31 109.922 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 41.2 tt0 -144.35 127.28 16.39 Favored 'General case' 0 C--O 1.19 -2.042 0 C-N-CA 119.629 -0.828 . . . . 63.03 109.453 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.442 HD23 ' HD2' ' A' ' 87' ' ' PHE . 7.0 tp -133.95 127.72 32.98 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 108.589 -0.893 . . . . 74.01 108.589 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 m -135.2 127.13 29.51 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.468 -0.493 . . . . 73.23 111.269 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -142.09 156.55 45.4 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.008 0.373 . . . . 71.24 112.008 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -120.71 129.28 53.58 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.915 -1.143 . . . . 74.44 107.915 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -113.99 118.94 35.53 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.142 -1.059 . . . . 75.22 108.142 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 80' ' ' THR . 34.5 t70 -82.39 -178.85 7.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.2 -1.037 . . . . 72.45 108.2 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.403 ' H ' ' CG ' ' A' ' 79' ' ' ASP . 20.6 m 69.16 25.32 5.78 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-O 123.77 1.748 . . . . 73.43 106.515 -171.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.569 ' CB ' ' HB2' ' A' ' 115' ' ' ALA . 23.9 mm-40 59.93 45.61 12.11 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 112.231 -2.259 . . . . 71.43 113.643 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.37 -21.6 56.25 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 108.159 -1.977 . . . . 51.22 108.159 170.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 74.44 -175.53 0.14 Allowed 'General case' 0 C--O 1.245 0.845 0 C-N-CA 126.95 2.1 . . . . 74.4 112.908 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.7 p -96.85 115.04 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-O 122.19 0.995 . . . . 65.41 109.888 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.56 146.41 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 CA-C-N 114.549 -1.205 . . . . 72.41 109.046 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 92.9 m -136.79 133.46 35.98 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 108.569 -0.9 . . . . 71.44 108.569 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.442 ' HD2' HD23 ' A' ' 74' ' ' LEU . 15.5 m-85 -119.03 135.85 54.42 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.825 -1.176 . . . . 74.13 107.825 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.65 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 42.7 mt-30 -118.83 146.44 44.85 Favored 'General case' 0 C--N 1.263 -3.194 0 CA-C-N 115.57 -0.741 . . . . 71.52 110.393 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.32 126.55 55.5 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.243 -0.889 . . . . 75.24 109.351 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -114.88 116.67 28.93 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 107.629 -1.249 . . . . 41.5 107.629 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -83.18 121.16 26.71 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.764 -0.653 . . . . 75.24 110.762 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 73.8 mt -123.85 156.56 35.97 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.036 -1.098 . . . . 71.04 108.036 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.13 59.69 1.39 Allowed Glycine 0 C--N 1.282 -2.429 0 C-N-CA 120.517 -0.849 . . . . 74.31 113.121 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 175.43 -39.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.595 1.158 . . . . 72.44 108.672 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 3.8 ptpt -144.85 175.81 9.93 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.457 -1.682 . . . . 65.15 106.457 -174.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.468 HG21 HG11 ' A' ' 25' ' ' VAL . 62.6 m -116.47 131.62 56.9 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.099 -0.704 . . . . 75.55 109.099 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.4 119.0 5.35 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 108.66 -1.776 . . . . 64.41 108.66 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.498 ' HE2' HG21 ' A' ' 29' ' ' VAL . 45.3 t80 -103.86 130.38 51.44 Favored 'General case' 0 C--N 1.257 -3.448 0 N-CA-C 107.171 -1.418 . . . . 73.22 107.171 178.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 14.7 m -114.86 123.72 49.89 Favored 'General case' 0 N--CA 1.397 -3.095 0 N-CA-C 107.607 -1.257 . . . . 73.12 107.607 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.56 140.65 34.53 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 108.486 -0.931 . . . . 74.35 108.486 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 4.6 mp -135.92 123.54 35.35 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.16 0 CA-C-N 113.758 -1.565 . . . . 74.24 107.137 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.478 ' HB3' HG22 ' A' ' 12' ' ' ILE . 17.5 t60 -122.48 126.2 47.36 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.475 -0.935 . . . . 74.43 108.475 175.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -142.93 164.27 30.54 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 106.428 -1.693 . . . . 75.33 106.428 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.456 ' HA3' HD11 ' A' ' 9' ' ' LEU . . . -154.4 143.23 9.8 Favored Glycine 0 CA--C 1.48 -2.104 0 N-CA-C 109.95 -1.26 . . . . 60.12 109.95 176.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 8.0 m95 . . . . . 0 C--N 1.303 -1.437 0 N-CA-C 109.311 -0.625 . . . . 74.25 109.311 -176.959 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 5.2 p . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 104.859 -2.274 . . . . 62.44 104.859 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.09 -39.51 73.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 119.98 1.264 . . . . 71.23 112.024 -176.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 55.18 47.41 74.33 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 111.994 -0.443 . . . . 40.21 111.994 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -166.07 -70.12 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.818 0.342 . . . . 74.12 110.93 -171.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.569 ' HB2' ' CB ' ' A' ' 81' ' ' GLU . . . -72.82 -40.79 65.52 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 116.514 2.042 . . . . 75.23 116.514 -171.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.16 100.88 0.97 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.876 -1.898 . . . . 74.02 105.876 -168.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . 0.271 36.7 mm-40 -94.93 89.01 5.47 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 114.866 1.432 . . . . 75.01 114.866 -172.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.613 ' HB3' HG12 ' A' ' 121' ' ' VAL . 52.5 tttp -179.43 91.25 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.453 -1.703 . . . . 53.42 106.926 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 m -48.44 -40.68 27.02 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 125.483 1.513 . . . . 72.45 112.912 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 25.8 t -65.14 -46.58 80.36 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 120.964 -0.294 . . . . 71.14 111.119 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 118' ' ' LYS . 9.6 p -71.13 -34.4 54.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 C-N-CA 119.73 -0.788 . . . . 55.44 110.047 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.8 -47.09 94.5 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 N-CA-C 110.443 -0.206 . . . . 63.03 110.443 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.401 ' HA ' ' HE2' ' A' ' 126' ' ' MET . 50.7 mtt180 -57.64 -52.98 63.19 Favored 'General case' 0 C--O 1.257 1.467 0 O-C-N 123.852 0.72 . . . . 72.13 110.869 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.76 -40.64 99.07 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 114.979 -1.009 . . . . 61.44 112.811 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.39 -32.53 70.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.041 0.756 . . . . 70.02 113.041 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.401 ' HE2' ' HA ' ' A' ' 123' ' ' ARG . 72.9 mtm -62.06 -54.82 36.09 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.638 -0.825 . . . . 75.54 110.244 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.98 -62.95 1.24 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.848 -0.741 . . . . 72.35 112.325 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.04 -34.95 82.91 Favored Glycine 0 CA--C 1.497 -1.043 0 CA-C-N 116.101 -0.499 . . . . 54.43 112.303 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.79 -54.34 15.34 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 111.62 -0.592 . . . . 63.33 111.62 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.45 ' O ' HG12 ' A' ' 134' ' ' VAL . 72.5 m95 -59.99 -44.56 94.43 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 112.927 0.714 . . . . 75.41 112.927 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.408 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 25.0 m -58.62 -49.5 77.25 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.469 0.48 . . . . 64.53 110.507 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.94 -46.19 60.57 Favored Glycine 0 C--O 1.25 1.14 0 C-N-CA 120.983 -0.627 . . . . 65.34 112.85 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mm -66.54 -52.54 45.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 CA-C-O 119.334 -0.365 . . . . 73.34 111.411 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 130' ' ' TRP . 4.2 p -62.93 -36.16 74.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 117.955 0.343 . . . . 53.24 111.206 -175.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.57 -64.97 0.77 Allowed 'General case' 0 C--N 1.351 0.644 0 O-C-N 123.394 0.434 . . . . 74.01 110.359 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.95 -40.45 71.99 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 112.602 0.593 . . . . 72.43 112.602 -173.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -62.53 -51.68 66.45 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 120.566 -0.454 . . . . 64.23 110.829 -177.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 18' ' ' LEU . 49.9 mt -70.63 -41.08 72.67 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.328 -0.949 . . . . 75.44 111.679 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.642 ' NE ' ' HG3' ' A' ' 143' ' ' GLU . 1.1 tmt_? -60.63 -34.83 74.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.359 -0.608 . . . . 73.44 109.359 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 144' ' ' GLU . 23.3 mmmt -71.13 -42.56 69.04 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 119.995 -0.682 . . . . 73.34 111.434 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.26 -28.88 69.06 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 111.961 0.356 . . . . 44.32 111.961 -176.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 21.4 m -88.74 -26.36 5.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 112.485 0.55 . . . . 75.04 112.485 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.642 ' HG3' ' NE ' ' A' ' 139' ' ' ARG . 5.7 mm-40 -97.37 -34.8 10.91 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.136 0.791 . . . . 72.03 113.136 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.425 ' HB3' ' HE3' ' A' ' 140' ' ' LYS . 35.9 tt0 . . . . . 0 C--N 1.307 -1.265 0 CA-C-O 121.436 0.636 . . . . 63.3 110.523 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 121.201 0.524 . . . . 51.13 110.798 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp 78.57 86.09 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 125.512 1.525 . . . . 75.3 114.531 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.67 148.22 46.7 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 122.668 2.245 . . . . 71.34 109.919 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.574 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 6.3 p-10 -58.4 142.02 49.66 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 113.994 1.109 . . . . 71.23 113.994 -172.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.7 tp -121.66 137.43 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 106.493 -1.669 . . . . 53.14 106.493 171.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.8 m -118.74 128.82 54.85 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.406 -0.961 . . . . 72.21 108.406 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -133.5 132.67 41.28 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 107.662 -1.236 . . . . 72.25 107.662 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 p -118.45 139.49 51.33 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-O 120.645 0.26 . . . . 53.14 110.836 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -146.43 134.88 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.767 -0.827 . . . . 75.4 108.767 -178.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.03 121.8 42.87 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 120.967 0.413 . . . . 72.53 110.923 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.8 mp -101.76 137.66 39.76 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.638 -0.505 . . . . 42.02 109.638 -175.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -86.43 59.12 5.45 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.268 1.032 . . . . 75.34 110.959 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.21 161.14 46.34 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.984 -1.117 . . . . 61.21 107.984 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.94 152.16 82.16 Favored 'Trans proline' 0 C--O 1.26 1.609 0 C-N-CA 122.524 2.15 . . . . 73.42 110.442 176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -32.36 48.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.892 -0.594 . . . . 73.43 111.679 -176.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -65.15 -29.01 69.82 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.177 0.436 . . . . 75.41 112.177 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -78.92 -40.11 33.0 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.633 0.73 . . . . 72.34 110.37 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 96' ' ' THR . 7.3 p -69.43 -39.55 78.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 116.072 -0.513 . . . . 73.33 109.749 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 43.1 t90 -58.12 -47.63 82.69 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.369 0.668 . . . . 73.15 111.928 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.77 -39.37 94.09 Favored 'General case' 0 C--O 1.214 -0.816 0 C-N-CA 119.576 -0.85 . . . . 72.24 109.749 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.9 m -59.23 -31.98 69.55 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-O 121.087 0.47 . . . . 71.24 111.629 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.694 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 25.2 m -107.19 17.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 112.946 0.721 . . . . 64.3 112.946 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.5 m -139.65 -3.35 1.49 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 112.301 0.482 . . . . 71.34 112.301 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.0 p -97.22 145.99 25.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.37 -0.974 . . . . 71.22 108.37 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 p -52.03 -54.06 34.55 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.86 0.689 . . . . 72.14 112.86 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.75 -38.78 87.3 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.444 -0.798 . . . . 73.04 110.533 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -41.61 95.99 Favored Glycine 0 C--O 1.247 0.939 0 N-CA-C 112.045 -0.422 . . . . 62.42 112.045 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.6 mt -69.83 -48.32 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 O-C-N 122.545 -0.385 . . . . 72.34 110.602 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.706 0.632 . . . . 71.5 112.706 -177.837 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.563 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . 19.8 m120 . . . . . 0 CA--C 1.493 -1.244 0 N-CA-C 107.196 -1.409 . . . . 72.33 107.196 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -96.63 76.76 2.86 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.011 0.91 . . . . 65.31 110.449 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 42' ' ' ASN . 94.5 m-85 -74.88 119.3 18.88 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.832 -1.531 . . . . 71.23 109.775 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -109.41 151.31 26.84 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.126 -1.064 . . . . 70.32 108.126 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -77.2 103.18 6.99 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.493 -1.299 . . . . 72.1 107.493 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 20.4 tptm -134.03 146.12 50.07 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.305 -0.998 . . . . 75.14 108.305 174.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HB3' HG12 ' A' ' 68' ' ' VAL . 8.6 pt-20 -92.81 79.55 4.71 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.076 0.941 . . . . 64.43 108.778 173.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.64 47.37 0.53 Allowed Glycine 0 N--CA 1.416 -2.653 0 C-N-CA 119.361 -1.399 . . . . 52.32 112.863 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.011 0 N-CA-C 107.471 -1.307 . . . . 74.44 107.471 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.439 -1.012 0 CA-C-O 120.838 0.351 . . . . 33.4 110.792 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -143.61 135.46 26.48 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.969 0.908 . . . . 65.53 108.685 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.1 t -90.59 136.88 22.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.617 -1.253 . . . . 73.24 107.617 175.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 tt -79.73 -61.11 2.1 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.981 -1.488 . . . . 65.15 106.981 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.0 150.02 9.38 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-N 115.15 -0.932 . . . . 75.53 109.018 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.515 HG23 HD23 ' A' ' 74' ' ' LEU . 8.5 p -123.98 119.03 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.484 0 CA-C-O 122.118 0.961 . . . . 73.24 109.565 175.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 11.4 mm100 -94.54 141.24 28.82 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 114.961 -1.018 . . . . 74.03 109.316 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 123.01 84.84 Favored Pre-proline 0 C--N 1.272 -2.78 0 CA-C-N 114.312 -1.313 . . . . 71.5 108.968 -166.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo 7.3 50.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.346 1 C-N-CA 127.638 5.559 . . . . 54.53 116.339 -160.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 p -139.81 -37.53 0.48 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.177 -0.919 . . . . 73.34 112.077 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 35.3 tt0 -150.29 148.05 28.39 Favored 'General case' 0 C--O 1.2 -1.532 0 C-N-CA 119.066 -1.053 . . . . 64.24 110.339 -176.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.687 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -141.37 132.99 27.07 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.831 -1.174 . . . . 34.31 107.831 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 p -141.03 129.13 22.06 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 120.695 -0.402 . . . . 52.31 112.019 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.459 ' HD2' HD11 ' A' ' 74' ' ' LEU . 44.7 p90 -142.8 153.55 43.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.811 0.338 . . . . 63.42 111.672 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -124.48 124.95 43.4 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 125.012 1.325 . . . . 73.52 107.783 -173.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 18.6 p-90 -143.58 155.78 44.39 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.152 -1.019 . . . . 74.21 113.232 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 76.18 160.4 0.22 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.852 1.661 . . . . 75.53 112.582 173.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 m -68.3 -30.93 70.04 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.207 1.003 . . . . 63.41 110.646 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.572 ' HG3' ' HB2' ' A' ' 115' ' ' ALA . 9.4 mm-40 -71.27 -21.49 62.08 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.033 -0.728 . . . . 73.25 109.033 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.66 80.36 0.68 Allowed Glycine 0 N--CA 1.426 -1.987 0 CA-C-N 114.882 -1.054 . . . . 70.52 114.641 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -104.92 128.59 53.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.365 -0.606 . . . . 74.13 109.365 173.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.24 111.78 29.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.625 -1.25 . . . . 65.33 107.625 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.26 149.12 19.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 120.477 -0.489 . . . . 75.32 110.377 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.451 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 39.2 m -129.47 140.77 51.18 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.491 -0.929 . . . . 71.2 108.491 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.694 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 16.0 m-85 -118.35 142.59 47.37 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.844 -1.539 . . . . 74.32 106.844 174.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.518 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 69.3 mt-30 -125.1 137.57 54.18 Favored 'General case' 0 C--N 1.268 -2.958 0 O-C-N 123.472 0.482 . . . . 73.31 110.532 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -117.36 120.06 37.01 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.457 -0.792 . . . . 75.43 109.179 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -114.06 116.71 29.58 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.586 -0.894 . . . . 71.05 108.586 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.01 118.98 23.88 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.876 0.846 . . . . 70.24 110.919 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 96.4 mt -123.15 153.11 40.46 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.449 -0.945 . . . . 71.13 108.449 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.97 50.38 4.15 Favored Glycine 0 C--N 1.287 -2.17 0 C-N-CA 120.892 -0.67 . . . . 72.55 112.411 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -179.41 -32.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.343 0.592 . . . . 72.23 109.446 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 9.6 ptpt -156.27 175.05 14.5 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.202 -1.407 . . . . 71.33 107.202 -175.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.616 HG21 HG11 ' A' ' 25' ' ' VAL . 87.8 m -119.79 128.19 53.49 Favored 'General case' 0 C--N 1.272 -2.771 0 N-CA-C 108.616 -0.883 . . . . 70.21 108.616 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.6 107.32 3.01 Favored Glycine 0 N--CA 1.412 -2.962 0 N-CA-C 109.868 -1.293 . . . . 35.45 109.868 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.509 ' CE1' HG11 ' A' ' 29' ' ' VAL . 92.8 t80 -100.54 133.35 45.11 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.939 -0.763 . . . . 74.43 108.939 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 70.4 m -126.31 125.37 42.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 119.049 -1.061 . . . . 45.3 109.161 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -104.02 141.87 35.45 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.443 -0.799 . . . . 65.54 108.851 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.5 mp -135.65 123.93 37.98 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 N-CA-C 106.024 -1.843 . . . . 70.01 106.024 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 9.7 t60 -120.55 113.73 20.7 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.486 -1.302 . . . . 45.15 107.486 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.8 t -132.57 153.84 50.6 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.543 -1.28 . . . . 74.31 107.543 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.15 167.96 20.81 Favored Glycine 0 N--CA 1.415 -2.74 0 N-CA-C 109.939 -1.265 . . . . 62.43 109.939 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 67.2 t90 . . . . . 0 C--N 1.311 -1.084 0 N-CA-C 106.998 -1.482 . . . . 71.11 106.998 175.734 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 113' ' ' GLY . 12.3 p . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 120.528 0.204 . . . . 74.31 111.503 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.625 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -61.85 -36.81 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.57 0.7 . . . . 74.01 110.619 174.044 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.526 ' H ' HG22 ' A' ' 111' ' ' VAL . . . 149.3 -108.35 0.4 Allowed Glycine 0 N--CA 1.409 -3.105 0 N-CA-C 108.758 -1.737 . . . . 72.35 108.758 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -134.85 32.35 3.25 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.856 0.36 . . . . 74.03 111.318 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.572 ' HB2' ' HG3' ' A' ' 81' ' ' GLU . . . -58.78 -22.88 59.2 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 112.825 0.676 . . . . 71.41 112.825 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -153.92 -73.24 0.13 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.61 -0.268 . . . . 53.32 110.48 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -156.73 -90.03 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 111.765 0.283 . . . . 72.21 111.765 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.462 ' HB3' HG22 ' A' ' 121' ' ' VAL . 24.0 ttmm -121.03 136.37 55.0 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.051 -1.463 . . . . 74.03 107.051 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.25 -37.55 75.14 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 115.114 1.524 . . . . 62.22 115.114 -174.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.89 -46.17 79.35 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.401 0.519 . . . . 72.3 112.401 177.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 118' ' ' LYS . 14.2 m -69.97 -33.84 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.191 -0.604 . . . . 62.01 109.776 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' A' ' 126' ' ' MET . 53.6 t -64.64 -43.11 96.67 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 CA-C-N 115.732 -0.667 . . . . 74.13 111.113 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -39.82 93.32 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.214 -1.032 . . . . 72.02 108.214 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -59.6 -47.71 89.59 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-N 115.571 -0.74 . . . . 41.21 112.021 177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -66.43 -34.41 77.9 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.274 -0.463 . . . . 71.02 111.857 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 23.5 mmt -62.06 -52.5 63.69 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 110.265 -0.272 . . . . 45.43 110.265 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.45 -52.78 64.19 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.837 0.31 . . . . 63.4 111.837 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.51 -45.99 87.27 Favored Glycine 0 C--O 1.26 1.744 0 C-N-CA 120.834 -0.698 . . . . 64.44 112.6 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.47 62.56 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 111.938 -0.465 . . . . 72.2 111.938 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.492 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.9 m95 -65.45 -22.94 66.81 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.555 0.576 . . . . 72.23 112.555 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.8 m -64.91 -55.69 17.78 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.761 -0.829 . . . . 54.52 108.761 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.45 -44.47 73.1 Favored Glycine 0 C--O 1.252 1.241 0 C-N-CA 120.648 -0.787 . . . . 65.25 113.591 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.19 -51.91 62.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 122.231 0.212 . . . . 63.35 111.464 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.558 ' HA ' HD23 ' A' ' 138' ' ' LEU . 78.9 t -63.66 -44.62 98.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.806 -0.358 . . . . 72.34 111.595 -177.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.406 ' HA ' HG13 ' A' ' 16' ' ' ILE . 32.1 t30 -55.56 -64.83 0.72 Allowed 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.794 0.684 . . . . 71.32 111.803 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -82.73 -31.83 28.23 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 119.41 -0.916 . . . . 73.32 113.202 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.429 HH11 ' HB2' ' A' ' 141' ' ' ALA . 0.2 OUTLIER -74.01 -40.2 63.07 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 118.024 -1.47 . . . . 65.42 110.179 -176.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.2 mm? -69.41 -46.59 66.46 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 119.552 -0.859 . . . . 75.45 110.045 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 0.9 OUTLIER -63.76 -36.16 82.97 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 115.759 -0.655 . . . . 74.4 110.658 -178.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.409 ' HE2' ' HB2' ' A' ' 144' ' ' GLU . 8.8 mmmm -70.76 -37.47 73.4 Favored 'General case' 0 C--O 1.198 -1.654 0 O-C-N 121.703 -0.623 . . . . 71.34 112.27 174.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.429 ' HB2' HH11 ' A' ' 137' ' ' ARG . . . -64.61 -27.98 69.31 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.254 0.549 . . . . 62.22 110.838 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 16.6 m -91.81 -22.58 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.895 -0.593 . . . . 55.32 111.953 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 61.2 mt-10 -91.85 -32.37 15.35 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.429 -0.508 . . . . 62.54 111.934 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 140' ' ' LYS . 28.7 tt0 . . . . . 0 N--CA 1.44 -0.946 0 CA-C-O 122.932 1.349 . . . . 72.22 110.83 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 112.944 0.72 . . . . 65.1 112.944 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.0 tp 68.47 90.93 0.08 OUTLIER Pre-proline 0 C--O 1.243 0.744 0 C-N-CA 124.765 1.226 . . . . 74.51 111.644 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.59 -164.97 0.21 Allowed 'Trans proline' 0 N--CA 1.436 -1.861 0 C-N-CA 122.38 2.054 . . . . 72.45 110.356 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -64.97 103.93 0.79 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.129 0.966 . . . . 75.14 111.837 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 50.0 mm -98.06 123.16 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 106.023 -1.843 . . . . 63.14 106.023 174.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 12.7 t -117.39 140.96 48.9 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 109.162 -0.681 . . . . 61.4 109.162 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -146.71 132.33 18.82 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.787 -1.19 . . . . 72.43 107.787 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.7 p -117.87 141.33 48.54 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 109.48 -0.563 . . . . 71.1 109.48 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.71 142.77 8.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.075 -1.084 . . . . 65.13 108.075 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.429 HG22 ' HA2' ' A' ' 97' ' ' GLY . 3.6 p -106.23 128.72 54.16 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.298 0.571 . . . . 71.5 111.509 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.7 mp -103.57 140.11 37.97 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.857 -0.611 . . . . 75.42 111.079 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -81.73 46.22 0.96 Allowed 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 124.277 1.031 . . . . 74.13 110.686 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.26 158.89 57.2 Favored Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 109.202 -0.666 . . . . 73.33 109.202 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.37 153.32 71.4 Favored 'Trans proline' 0 C--O 1.259 1.544 0 C-N-CA 122.77 2.313 . . . . 74.2 110.7 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -60.15 -32.58 50.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.798 -0.637 . . . . 63.23 111.482 -174.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.75 -39.29 93.91 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 120.698 -0.401 . . . . 74.34 111.656 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -70.9 -39.18 72.9 Favored 'General case' 0 C--O 1.212 -0.916 0 C-N-CA 120.996 -0.282 . . . . 74.04 111.133 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.513 HG21 ' HB ' ' A' ' 96' ' ' THR . 47.2 t -68.02 -41.17 84.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.412 0.625 . . . . 74.12 109.842 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.592 ' CZ2' ' HD3' ' A' ' 71' ' ' PRO . 29.4 t90 -63.66 -46.72 84.32 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.492 -1.231 . . . . 64.3 110.177 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -70.23 -29.41 66.22 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 121.036 -0.266 . . . . 74.53 111.491 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.536 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 39.7 m -56.14 -33.26 65.01 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-O 121.129 0.49 . . . . 73.14 111.735 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -108.18 16.6 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 O-C-N 121.406 -0.809 . . . . 74.52 112.044 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.605 ' HA ' HD11 ' A' ' 35' ' ' ILE . 42.5 p -137.61 0.32 2.24 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.788 0.662 . . . . 73.14 112.788 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.7 p -107.89 169.39 8.64 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 121.698 -0.627 . . . . 62.14 111.595 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.2 t -63.01 -44.71 95.25 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.914 -0.585 . . . . 74.13 109.744 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.09 -45.17 78.07 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.686 0.616 . . . . 75.33 111.165 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 28' ' ' THR . . . -72.38 -48.03 26.16 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.909 -0.663 . . . . 64.02 114.051 -175.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.605 HD11 ' HA ' ' A' ' 30' ' ' SER . 80.3 mt -69.04 -34.12 62.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 116.932 0.366 . . . . 52.25 111.114 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.791 0 CA-C-N 115.953 -0.567 . . . . 44.12 111.463 176.656 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 106.757 -1.571 . . . . 74.12 106.757 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.12 65.27 8.67 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.76 0.79 . . . . 74.23 112.165 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.557 ' HB3' HD12 ' A' ' 35' ' ' ILE . 95.7 m-85 -108.62 132.78 53.55 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.4 -0.818 . . . . 73.5 109.865 171.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -139.03 150.14 45.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.19 -1.041 . . . . 73.44 108.19 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.432 HD11 ' CZ2' ' A' ' 26' ' ' TRP . 6.0 tt -75.74 104.2 6.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.766 -0.827 . . . . 73.34 108.766 -178.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.734 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 14.0 tppt? -133.97 146.07 50.12 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.882 -1.525 . . . . 72.45 106.882 172.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.41 ' CA ' HG12 ' A' ' 68' ' ' VAL . 8.1 pt-20 -79.57 54.79 1.84 Allowed 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 122.024 0.916 . . . . 54.52 109.478 170.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 130.01 64.52 0.1 Allowed Glycine 0 N--CA 1.406 -3.312 0 N-CA-C 109.977 -1.249 . . . . 74.23 109.977 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.734 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.47 -2.104 0 N-CA-C 106.355 -1.72 . . . . 62.13 106.355 178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 C--O 1.251 1.15 0 N-CA-C 107.45 -1.315 . . . . 71.21 107.45 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 34.4 mtmt -143.64 139.91 29.84 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 109.427 -0.583 . . . . 74.14 109.427 -172.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.513 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 41.8 t -90.65 129.44 41.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 N-CA-C 104.942 -2.244 . . . . 63.43 104.942 167.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.6 tp -75.06 -59.2 2.84 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.912 -0.773 . . . . 75.45 108.912 -176.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.53 140.67 14.0 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.955 -1.02 . . . . 64.21 109.274 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.498 HG23 HD13 ' A' ' 74' ' ' LEU . 9.5 p -119.28 121.0 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 N-CA-C 107.604 -1.258 . . . . 71.51 107.604 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 14.7 mm100 -96.55 142.81 28.17 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 114.56 -1.2 . . . . 74.22 109.603 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.71 120.99 73.16 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 107.508 -1.293 . . . . 50.15 107.508 -164.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.592 ' HD3' ' CZ2' ' A' ' 26' ' ' TRP . 16.6 Cg_exo -7.54 64.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.294 1 C-N-CA 126.527 4.818 . . . . 75.1 116.844 -154.548 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 p -140.26 -40.47 0.43 Allowed 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 113.237 -1.801 . . . . 42.2 109.767 175.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 36.9 tt0 -150.54 149.22 29.65 Favored 'General case' 0 C--O 1.195 -1.81 0 C-N-CA 119.405 -0.918 . . . . 74.4 110.259 -175.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.498 HD13 HG23 ' A' ' 68' ' ' VAL . 9.8 tp -145.91 128.18 15.8 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.907 -0.775 . . . . 74.4 108.907 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.6 m -134.23 127.23 31.48 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.774 -0.37 . . . . 74.31 111.022 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.529 ' CE2' ' HE2' ' A' ' 87' ' ' PHE . 54.8 p90 -138.93 155.66 47.87 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 112.113 0.412 . . . . 61.14 112.113 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -122.76 125.88 46.38 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.003 -1.48 . . . . 71.4 107.003 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.432 ' CE3' ' HB2' ' A' ' 79' ' ' ASP . 15.7 p-90 -139.83 162.07 36.05 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.367 -0.933 . . . . 73.03 112.751 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.432 ' HB2' ' CE3' ' A' ' 78' ' ' TRP . 19.0 t70 72.89 161.84 0.25 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.612 1.565 . . . . 62.52 112.338 173.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.4 t -73.11 -23.18 60.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.392 0.277 . . . . 73.04 111.274 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -34.25 76.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 110.154 -0.313 . . . . 71.45 110.154 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.72 75.64 1.29 Allowed Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.82 -0.627 . . . . 61.2 111.855 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -102.02 128.46 48.45 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.408 -0.96 . . . . 75.54 108.408 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.4 t -111.43 107.72 23.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 108.347 -0.983 . . . . 70.42 108.347 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.54 144.98 17.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.312 0.577 . . . . 74.22 110.363 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.458 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 39.9 m -136.42 134.23 37.52 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.801 -0.636 . . . . 73.12 109.407 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.61 ' CE1' HD23 ' A' ' 100' ' ' LEU . 39.8 m-85 -120.93 143.5 48.94 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.251 -1.018 . . . . 52.14 108.251 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.543 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 93.0 mt-30 -124.67 139.99 53.35 Favored 'General case' 0 C--N 1.278 -2.52 0 O-C-N 123.516 0.51 . . . . 72.0 110.676 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -122.6 120.22 33.13 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.722 -0.672 . . . . 71.33 110.458 -174.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -113.31 127.5 56.17 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 123.308 0.643 . . . . 74.2 109.81 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.72 120.68 26.68 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.731 -0.668 . . . . 75.4 111.366 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.6 mt -125.47 153.33 43.7 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.238 -0.892 . . . . 75.15 108.632 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.99 61.43 4.33 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 121.755 -0.26 . . . . 55.13 113.35 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 168.65 -54.49 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 125.21 1.404 . . . . 51.54 107.854 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -126.43 174.07 8.9 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 114.111 -1.404 . . . . 62.11 109.108 -167.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.513 ' HB ' HG21 ' A' ' 25' ' ' VAL . 87.7 m -119.89 130.84 55.03 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.889 -0.782 . . . . 74.53 108.889 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' A' ' 17' ' ' THR . . . -86.58 111.26 3.61 Favored Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 110.258 -1.137 . . . . 74.42 110.258 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -103.45 131.43 50.55 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 109.412 -0.588 . . . . 71.41 109.412 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.543 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 84.8 m -124.29 128.02 48.51 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.982 -1.118 . . . . 74.34 107.982 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.61 HD23 ' CE1' ' A' ' 87' ' ' PHE . 2.9 tm? -102.25 139.29 38.05 Favored 'General case' 0 N--CA 1.397 -3.079 0 N-CA-C 108.532 -0.914 . . . . 75.14 108.532 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 3.8 mp -135.68 124.43 39.1 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.268 0 N-CA-C 106.258 -1.756 . . . . 71.34 106.258 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -121.04 131.92 54.57 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.362 -0.977 . . . . 61.33 108.362 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.3 m -142.69 138.94 30.94 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.673 -1.232 . . . . 72.12 107.673 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.11 -167.01 22.2 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.227 -0.987 . . . . 65.23 110.731 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 . . . . . 0 N--CA 1.426 -1.667 0 N-CA-C 108.861 -0.792 . . . . 74.45 108.861 175.921 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 108.516 -0.92 . . . . 64.45 108.516 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.0 pt -58.76 -32.59 47.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 112.853 0.686 . . . . 61.1 112.853 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.84 -122.41 6.94 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.022 -1.085 . . . . 75.42 111.978 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -100.4 10.27 41.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.13 0.491 . . . . 72.5 109.878 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.63 -34.91 79.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.987 -1.116 . . . . 53.35 107.987 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -166.38 122.84 1.28 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.886 -1.894 . . . . 45.25 105.886 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.1 166.68 16.44 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.586 0.958 . . . . 74.14 113.586 -174.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm 71.24 87.22 0.12 Allowed 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.705 -1.134 . . . . 63.24 112.902 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.2 p -56.43 -39.81 73.72 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.469 1.108 . . . . 40.54 112.78 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 123' ' ' ARG . 3.2 p -68.18 -39.25 82.57 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.597 0.713 . . . . 75.51 110.646 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.07 -45.49 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 115.707 -0.679 . . . . 73.2 109.42 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.495 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 75.9 t -55.78 -37.56 47.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 O-C-N 123.642 0.589 . . . . 65.41 110.204 175.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 120' ' ' SER . 18.5 tpp180 -57.37 -58.65 7.33 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.184 0.594 . . . . 70.3 110.378 177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.68 -43.8 93.64 Favored Glycine 0 CA--C 1.494 -1.244 0 CA-C-N 115.678 -0.692 . . . . 75.33 112.817 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 122' ' ' VAL . 2.7 tmmm? -65.52 -38.56 90.02 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 112.66 0.615 . . . . 75.21 112.66 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 25.7 mmt -72.84 -45.9 55.88 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.231 -0.988 . . . . 60.52 110.269 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -67.91 -63.78 0.99 Allowed 'General case' 0 C--O 1.257 1.455 0 CA-C-O 121.343 0.592 . . . . 71.2 111.849 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -75.75 -33.41 51.53 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 115.779 -0.646 . . . . 63.52 112.219 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -66.77 -50.09 50.42 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 111.67 -0.572 . . . . 60.4 111.67 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.464 ' HE3' HG23 ' A' ' 134' ' ' VAL . 95.5 m95 -64.39 -31.17 72.27 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 120.054 -0.658 . . . . 64.12 111.616 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.1 m -58.47 -57.35 13.35 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 120.71 -0.396 . . . . 71.11 110.896 173.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.62 -46.7 37.9 Favored Glycine 0 C--O 1.242 0.597 0 CA-C-N 116.07 -0.514 . . . . 33.42 113.742 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.0 mt -62.57 -51.24 74.58 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 119.693 -0.194 . . . . 71.02 110.976 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.638 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 68.6 t -59.37 -43.97 91.45 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 120.786 -0.366 . . . . 62.42 111.483 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -56.1 -60.13 3.93 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 111.777 0.288 . . . . 71.45 111.777 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -77.26 -46.45 23.09 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.244 0.831 . . . . 75.35 113.244 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -64.51 -39.16 93.26 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.425 0.557 . . . . 73.41 111.725 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.692 ' HB3' HD21 ' A' ' 18' ' ' LEU . 3.9 mm? -67.25 -49.73 63.29 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.454 -0.498 . . . . 62.43 110.536 176.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -62.43 -32.54 73.41 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.952 -0.567 . . . . 74.21 109.827 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -76.51 -39.66 52.36 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 113.201 0.815 . . . . 65.43 113.201 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.32 -23.71 67.08 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.217 0.532 . . . . 71.24 111.177 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.3 m -90.24 -34.11 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 120.209 -0.596 . . . . 73.21 111.91 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.48 -31.44 26.51 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.169 0.803 . . . . 74.13 113.169 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 121.092 0.472 . . . . 53.53 109.896 -177.819 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.518 0 N-CA-C 103.945 -2.613 . . . . 71.33 103.945 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.51 HD21 ' CZ3' ' A' ' 83' ' ' TRP . 4.4 pp -100.38 130.2 26.33 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 118.982 -1.087 . . . . 72.25 113.109 -175.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -97.62 -160.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.651 2.901 . . . . 62.12 110.317 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 12.0 p-10 -81.6 97.46 7.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.607 1.194 . . . . 72.42 108.813 173.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 61.6 mt -91.68 128.25 43.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 114.69 -1.141 . . . . 54.45 109.019 -173.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.582 ' O ' ' HD2' ' A' ' 14' ' ' LYS . 13.6 t -120.08 140.79 50.5 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 119.648 -0.821 . . . . 72.43 110.556 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.582 ' HD2' ' O ' ' A' ' 13' ' ' THR . 5.9 mptp? -137.72 145.38 42.45 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.349 -1.352 . . . . 70.12 107.349 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -129.81 136.63 49.81 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 118.522 0.601 . . . . 43.35 110.514 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.11 141.38 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 110.06 -0.348 . . . . 74.11 110.06 -177.058 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 p -101.04 135.4 42.56 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.073 0.463 . . . . 65.31 112.09 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 139' ' ' ARG . 3.0 mm? -104.15 140.07 38.32 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.35 0.66 . . . . 72.4 110.219 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -86.11 34.22 0.62 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.136 0.494 . . . . 70.11 110.261 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -133.88 164.73 41.92 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.38 -0.6 . . . . 75.52 109.38 -174.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -66.6 153.03 79.46 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.286 1.99 . . . . 72.24 111.025 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.11 -33.26 42.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.341 -0.845 . . . . 72.22 112.452 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.19 -27.68 62.72 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.451 -0.5 . . . . 75.1 111.223 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.0 tmtm? -79.83 -31.99 40.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.958 -1.127 . . . . 71.32 107.958 -177.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG21 ' HB ' ' A' ' 96' ' ' THR . 45.4 t -71.17 -41.35 75.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.053 -1.092 . . . . 63.12 108.053 175.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.624 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 77.5 t90 -60.69 -47.17 87.47 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.639 -1.164 . . . . 74.45 111.269 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 10.5 pt-20 -59.97 -36.61 77.49 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 109.003 -0.74 . . . . 63.14 109.003 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.9 m -65.91 -7.54 17.15 Favored 'General case' 0 CA--C 1.573 1.836 0 CA-C-O 121.417 0.627 . . . . 74.24 112.646 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.562 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 11.9 m -131.48 17.19 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 O-C-N 121.306 -0.871 . . . . 54.02 111.63 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.424 ' HB3' HD13 ' A' ' 46' ' ' LEU . 51.3 m -145.32 10.03 1.26 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 116.29 -0.414 . . . . 62.31 111.833 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.3 p -110.75 -178.32 3.45 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.225 -0.657 . . . . 72.33 109.225 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 44' ' ' PHE . 19.6 p -56.64 -62.46 1.71 Allowed 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 123.711 0.632 . . . . 73.03 111.999 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.43 -31.24 71.87 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.27 -0.877 . . . . 74.1 110.844 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.89 -48.66 20.24 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.04 -1.076 . . . . 64.44 112.861 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.432 HG23 ' CE2' ' A' ' 76' ' ' PHE . 51.6 mt -68.95 -34.5 64.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 123.13 0.572 . . . . 73.4 110.895 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-N 115.526 -0.761 . . . . 73.14 112.043 173.801 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 107.048 -1.464 . . . . 62.02 107.048 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -90.56 70.98 6.87 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.766 0.793 . . . . 75.22 109.46 -175.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.411 ' CE1' ' HB3' ' A' ' 32' ' ' SER . 6.9 p90 -58.9 137.19 57.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.093 -1.412 . . . . 62.22 110.711 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.86 121.88 15.67 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.928 -1.508 . . . . 72.33 106.928 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 68' ' ' VAL . 33.8 tp -94.42 101.78 13.72 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.362 -1.718 . . . . 65.22 106.362 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 1.3 tpmt? -134.94 145.58 48.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.263 -1.384 . . . . 63.01 107.263 175.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.02 61.71 7.0 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 122.69 1.234 . . . . 74.41 109.248 171.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.87 87.84 0.8 Allowed Glycine 0 N--CA 1.414 -2.783 0 CA-C-N 114.404 -1.271 . . . . 63.35 110.48 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.46 ' HB3' ' H ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.429 0 N-CA-C 106.282 -1.748 . . . . 71.42 106.282 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 86.0 m . . . . . 0 N--CA 1.428 -1.536 0 CA-C-O 121.377 0.608 . . . . 72.41 109.597 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 77' ' ' GLU . 92.7 mttt -137.12 132.13 33.62 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.824 -1.546 . . . . 71.2 106.824 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.46 ' H ' ' HB3' ' A' ' 50' ' ' GLN . 10.7 t -90.56 133.99 30.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 N-CA-C 107.2 -1.407 . . . . 61.01 107.2 174.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.83 -50.76 16.0 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.345 -1.354 . . . . 64.14 107.345 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.51 143.61 5.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.237 -1.347 . . . . 73.15 108.464 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.666 HG23 HD23 ' A' ' 74' ' ' LEU . 12.1 p -121.57 123.04 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 CA-C-O 121.332 0.587 . . . . 61.35 109.793 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.565 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 84.0 mm-40 -104.78 141.92 35.64 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.322 -0.854 . . . . 73.42 111.714 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.83 124.59 87.96 Favored Pre-proline 0 C--N 1.294 -1.81 0 CA-C-N 113.764 -1.562 . . . . 74.21 109.441 -164.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.624 ' HA ' ' CD1' ' A' ' 26' ' ' TRP . 81.4 Cg_exo -1.29 56.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.305 1 C-N-CA 127.491 5.46 . . . . 75.13 117.489 -159.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -146.59 -34.44 0.28 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.115 -0.948 . . . . 51.53 112.309 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.9 tt0 -146.37 139.76 25.87 Favored 'General case' 0 C--O 1.214 -0.774 0 C-N-CA 118.904 -1.118 . . . . 75.4 110.878 -174.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.706 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -139.78 136.7 34.36 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.259 -0.645 . . . . 70.44 109.259 -177.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.3 m -140.9 125.95 18.34 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 110.017 -0.364 . . . . 75.11 110.017 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.46 ' CD1' HD11 ' A' ' 74' ' ' LEU 0.273 12.8 p90 -146.8 158.17 43.85 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.02 0.748 . . . . 73.52 113.02 -178.429 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 64' ' ' LYS 0.27 21.7 mt-10 -119.19 131.58 55.85 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.643 -2.725 . . . . 75.3 103.643 -173.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.543 ' HE1' HG13 ' A' ' 85' ' ' VAL . 12.6 p-90 -153.11 163.52 39.72 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 114.733 1.383 . . . . 73.55 114.733 -168.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.412 ' HB2' ' CE3' ' A' ' 78' ' ' TRP . 3.8 t70 72.94 -167.83 0.12 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 112.009 -2.359 . . . . 72.21 112.237 170.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.444 ' HB ' ' OE2' ' A' ' 81' ' ' GLU . 1.3 m -78.53 -53.59 7.05 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.465 1.106 . . . . 74.13 112.129 -170.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.444 ' OE2' ' HB ' ' A' ' 80' ' ' THR . 2.4 mp0 -68.77 -19.62 64.32 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.375 0.509 . . . . 52.32 112.375 -176.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.33 76.33 1.3 Allowed Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.127 -1.035 . . . . 54.23 111.274 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.51 ' CZ3' HD21 ' A' ' 9' ' ' LEU . 48.7 m95 -109.4 154.42 22.61 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.188 -1.412 . . . . 74.33 107.188 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.63 123.98 27.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 121.461 0.648 . . . . 61.44 109.735 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.543 HG13 ' HE1' ' A' ' 78' ' ' TRP . 19.1 m -120.25 155.43 23.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 121.484 0.659 . . . . 73.2 111.259 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.464 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 41.9 m -131.09 137.33 49.06 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.065 -0.97 . . . . 74.23 108.573 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.9 m-85 -120.0 133.11 55.64 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.76 -1.2 . . . . 75.23 107.76 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.56 132.76 55.81 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 109.52 -0.548 . . . . 73.51 109.52 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mp -114.6 119.99 38.66 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.52 0.676 . . . . 73.35 110.724 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -103.21 123.73 47.29 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.533 -1.284 . . . . 62.4 107.533 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -82.67 128.61 34.51 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.914 -0.714 . . . . 72.13 109.71 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 74.2 mt -121.07 158.35 28.05 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.36 -1.348 . . . . 72.35 107.36 174.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.55 48.22 3.62 Favored Glycine 0 C--N 1.3 -1.444 0 O-C-N 123.305 0.378 . . . . 62.1 114.008 -174.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 172.96 -41.61 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.385 1.074 . . . . 74.31 109.237 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.5 ptpt -134.15 175.07 9.82 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.03 -0.729 . . . . 60.11 109.03 -173.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.433 ' HB ' HG21 ' A' ' 25' ' ' VAL . 88.9 m -117.72 128.16 54.62 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.817 -0.809 . . . . 63.23 108.817 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.37 107.7 3.47 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.203 -1.159 . . . . 55.34 110.203 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -97.32 133.95 41.25 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 109.257 -0.645 . . . . 70.34 109.257 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.4 m -120.41 121.81 39.35 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 108.187 -1.042 . . . . 64.01 108.187 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.59 139.71 35.89 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-O 121.854 0.835 . . . . 60.42 109.59 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.464 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 16.1 mt -137.09 124.85 32.14 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 113.239 -1.801 . . . . 63.22 107.746 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.536 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 23.7 t-160 -117.42 129.06 55.6 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.309 -0.997 . . . . 60.14 108.309 177.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -141.08 164.41 30.34 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.151 -1.426 . . . . 62.23 107.151 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.1 167.76 38.25 Favored Glycine 0 C--N 1.291 -1.932 0 C-N-CA 120.17 -1.014 . . . . 61.32 110.864 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 . . . . . 0 C--N 1.307 -1.24 0 CA-C-O 121.952 0.882 . . . . 63.31 112.535 -177.519 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.412 -2.362 0 N-CA-C 107.649 -1.241 . . . . 73.03 107.649 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 35.0 pt -58.03 -31.0 40.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 113.049 0.759 . . . . 74.34 113.049 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.13 40.72 5.1 Favored Glycine 0 CA--C 1.494 -1.265 0 N-CA-C 109.76 -1.336 . . . . 73.12 109.76 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 46.04 52.05 10.4 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.909 1.684 . . . . 71.45 111.849 -175.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.02 -19.77 61.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 122.439 1.114 . . . . 50.45 108.481 173.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -132.52 -72.27 0.52 Allowed 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 113.701 -1.59 . . . . 74.52 108.713 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -149.2 -170.81 3.73 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 108.77 -0.826 . . . . 73.25 108.77 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.84 157.02 25.69 Favored 'General case' 0 C--O 1.218 -0.553 0 O-C-N 124.051 0.845 . . . . 54.3 110.784 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.1 p -56.65 -48.38 77.68 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.218 1.007 . . . . 65.31 112.72 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 p -63.07 -45.36 92.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.437 0.637 . . . . 74.14 110.704 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.06 -47.5 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.919 -1.037 . . . . 72.0 110.016 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 126' ' ' MET . 50.8 t -57.48 -41.06 78.0 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.233 0 CA-C-N 116.115 -0.493 . . . . 71.31 110.697 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -63.24 -51.69 65.17 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.24 -0.437 . . . . 74.31 111.045 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.64 -42.99 97.05 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-N 115.739 -0.664 . . . . 61.14 112.234 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -68.93 -32.53 72.2 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 115.085 -0.558 . . . . 65.11 112.363 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.427 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 23.4 mmt -67.03 -46.51 74.23 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.851 -0.74 . . . . 74.21 111.145 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.89 -58.42 3.47 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.658 -0.817 . . . . 65.1 111.783 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.33 -44.88 83.84 Favored Glycine 0 C--O 1.246 0.859 0 C-N-CA 121.058 -0.592 . . . . 63.31 112.075 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.53 -55.46 28.78 Favored Glycine 0 N--CA 1.437 -1.291 0 CA-C-O 119.316 -0.713 . . . . 62.54 112.22 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.433 ' O ' HG12 ' A' ' 134' ' ' VAL . 62.3 m95 -58.8 -43.51 90.53 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 117.837 0.818 . . . . 72.12 113.128 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 31.7 m -59.9 -47.06 87.32 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.367 0.417 . . . . 61.31 110.479 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.45 -47.24 36.23 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.557 -0.83 . . . . 74.22 112.828 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.8 mt -65.35 -46.14 91.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 122.587 0.355 . . . . 75.41 111.822 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 5.1 p -66.29 -40.45 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 119.608 -0.837 . . . . 63.11 109.717 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.593 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 34.3 t30 -58.89 -63.93 1.12 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.015 -0.539 . . . . 64.35 110.624 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -71.01 -48.8 51.05 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 113.423 0.897 . . . . 71.52 113.423 -173.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.518 ' O ' ' HD2' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -69.83 -33.81 72.81 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.702 -0.799 . . . . 71.22 110.813 -171.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.4 mm? -70.78 -48.91 51.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.991 -1.084 . . . . 64.5 110.264 173.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 135' ' ' ASN . 1.0 OUTLIER -59.3 -40.32 85.78 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.83 -0.623 . . . . 73.42 110.959 -177.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 144' ' ' GLU . 25.7 mmmt -75.85 -36.02 59.75 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 112.887 0.699 . . . . 75.01 112.887 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.16 -28.2 64.09 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.617 -0.833 . . . . 71.52 110.629 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.513 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 25.8 m -79.77 -24.63 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 119.584 -0.846 . . . . 31.54 110.647 176.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.35 -87.16 0.14 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.917 0.865 . . . . 71.25 110.669 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.422 ' O ' ' HE3' ' A' ' 140' ' ' LYS . 39.1 mt-10 . . . . . 0 N--CA 1.432 -1.326 0 C-N-CA 125.09 1.356 . . . . 65.25 107.494 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.656 0 N-CA-C 111.429 0.159 . . . . 73.52 111.429 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.4 tp 48.66 86.78 0.14 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.315 1.446 . . . . 64.42 114.286 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.05 138.32 43.51 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.071 1.18 . . . . 41.04 109.717 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 8.2 p-10 -71.72 110.95 6.61 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.634 0.73 . . . . 72.31 109.839 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.405 HG22 ' HB3' ' A' ' 102' ' ' HIS . 10.6 tp -111.17 138.67 38.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.622 -0.717 . . . . 74.13 110.814 -173.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.3 m -111.67 133.02 54.2 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 108.023 -1.103 . . . . 73.43 108.023 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -128.14 143.07 51.03 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.892 -1.522 . . . . 73.2 106.892 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.9 m -122.75 133.48 54.47 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.977 -0.379 . . . . 60.4 109.977 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.527 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -145.84 131.79 13.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.601 -0.888 . . . . 75.12 108.601 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.75 122.62 43.0 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-O 121.458 0.647 . . . . 72.11 112.179 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 138' ' ' LEU . 6.2 mp -95.67 135.85 36.83 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 107.755 -1.202 . . . . 63.35 107.755 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -87.78 39.78 0.9 Allowed 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.169 -0.469 . . . . 72.0 109.937 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.483 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -135.92 163.86 47.37 Favored Pre-proline 0 C--O 1.245 0.823 0 C-N-CA 124.169 0.987 . . . . 71.34 109.085 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 36.4 Cg_endo -63.7 157.71 50.28 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 123.013 2.476 . . . . 63.13 112.377 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.6 tt -64.87 -27.72 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.738 -0.664 . . . . 74.03 111.859 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -71.75 -28.24 63.53 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.971 0.415 . . . . 71.2 111.717 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.59 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 4.4 tmtt? -81.18 -46.11 15.36 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.46 -0.57 . . . . 73.21 109.46 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.691 HG11 HG21 ' A' ' 96' ' ' THR . 5.4 p -59.49 -39.18 78.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.237 0.541 . . . . 73.22 109.846 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -63.35 -44.59 94.4 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.201 -0.909 . . . . 74.52 111.032 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -65.25 -33.68 76.55 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.442 -0.503 . . . . 72.44 110.465 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.7 m -59.25 -32.02 69.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.249 0.547 . . . . 71.32 111.163 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.561 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.5 m -109.46 21.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 112.298 0.481 . . . . 53.2 112.298 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.431 ' HB2' HD22 ' A' ' 46' ' ' LEU . 61.6 p -137.64 -12.24 1.55 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.406 -0.517 . . . . 74.21 112.216 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.0 p -94.55 158.81 15.37 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.632 -0.507 . . . . 74.15 109.632 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.9 m -59.9 -48.23 82.55 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 123.036 0.534 . . . . 53.1 111.195 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.83 -27.31 57.81 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.304 -0.862 . . . . 61.21 111.089 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.6 -48.81 21.31 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 119.927 -1.13 . . . . 71.43 111.58 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.1 mt -65.59 -33.42 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.729 0.775 . . . . 72.54 110.321 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 C-N-CA 124.578 1.151 . . . . 74.55 112.59 177.941 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 C--O 1.243 0.749 0 N-CA-C 108.725 -0.843 . . . . 51.43 108.725 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -89.14 73.61 8.13 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.888 0.851 . . . . 71.11 110.081 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.4 ' HE1' ' SG ' ' A' ' 63' ' ' CYS . 93.4 m-85 -70.83 119.99 15.78 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.963 -1.017 . . . . 63.41 109.947 176.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -113.38 148.32 36.02 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 110.0 -0.37 . . . . 75.5 110.0 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.431 HD22 ' HB2' ' A' ' 30' ' ' SER . 21.5 tp -87.27 105.53 17.3 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.824 -1.176 . . . . 52.21 107.824 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -133.19 137.51 46.21 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 106.488 -1.671 . . . . 61.41 106.488 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -92.07 75.27 5.49 Favored 'General case' 0 C--N 1.257 -3.421 0 CA-C-O 122.845 1.307 . . . . 51.42 109.561 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.97 87.88 1.59 Allowed Glycine 1 N--CA 1.396 -4.001 0 CA-C-N 113.61 -1.632 . . . . 63.14 111.027 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--N 1.303 -1.415 0 N-CA-C 107.911 -1.144 . . . . 75.11 107.911 -178.306 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.4 ' SG ' ' HE1' ' A' ' 44' ' ' PHE . 30.5 m . . . . . 0 N--CA 1.425 -1.714 0 N-CA-C 107.612 -1.255 . . . . 50.3 107.612 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.5 118.46 28.35 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-O 121.901 0.858 . . . . 64.11 110.455 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 76' ' ' PHE . 6.7 t -79.26 137.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 114.872 -1.058 . . . . 65.31 109.339 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 tt -81.47 -57.63 3.39 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.387 -1.338 . . . . 71.4 107.387 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.04 153.6 22.47 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.542 -0.753 . . . . 64.43 109.801 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.54 119.13 52.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.712 -1.218 . . . . 23.42 107.712 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 22.5 mp0 -106.27 141.19 38.02 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.348 0.659 . . . . 75.52 110.334 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.67 129.32 94.1 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 114.226 -1.352 . . . . 63.23 108.446 -167.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo 2.52 44.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.283 1 C-N-CA 128.434 6.089 . . . . 74.32 118.602 -162.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -139.83 -35.47 0.53 Allowed 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 122.248 -0.283 . . . . 61.24 110.702 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 40.7 tt0 -145.94 145.21 30.59 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 118.508 -1.277 . . . . 74.03 109.98 -174.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.699 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -147.5 134.96 20.8 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.529 -1.285 . . . . 55.34 107.529 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.1 m -140.51 125.44 18.32 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.269 -0.572 . . . . 63.3 110.286 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.464 ' HD1' HD11 ' A' ' 74' ' ' LEU . 49.8 p90 -138.2 152.92 49.09 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 109.725 -0.472 . . . . 53.52 109.725 176.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.409 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 37.8 mt-10 -124.73 126.08 45.1 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-N 115.475 -0.784 . . . . 62.23 110.818 -171.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.523 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 2.1 t90 -95.54 107.94 20.15 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 104.359 -2.46 . . . . 75.14 104.359 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.51 140.49 55.67 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.889 -0.596 . . . . 74.34 111.119 -171.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.1 m 70.18 82.82 0.15 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.598 1.159 . . . . 65.13 112.279 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 55.63 23.22 5.93 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.954 1.702 . . . . 73.31 113.833 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.523 ' HA3' ' HB3' ' A' ' 78' ' ' TRP . . . -93.98 -24.43 19.97 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 107.865 -2.094 . . . . 60.53 107.865 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 75.29 -177.16 0.15 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 126.128 1.771 . . . . 75.11 113.03 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.409 ' HB ' ' HG2' ' A' ' 77' ' ' GLU . 4.4 p -114.81 117.26 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.838 0.828 . . . . 74.32 109.918 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.51 144.01 16.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 CA-C-N 114.989 -1.005 . . . . 73.24 108.717 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 46.9 m -131.56 134.38 46.02 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 108.988 -0.745 . . . . 52.13 108.988 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.699 ' CD2' HD12 ' A' ' 74' ' ' LEU . 10.9 m-85 -109.99 137.41 47.8 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.452 -1.314 . . . . 63.0 107.452 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.607 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 7.0 tt0 -125.04 136.98 54.21 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.089 -1.448 . . . . 70.22 107.089 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -110.91 124.38 51.98 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.202 -0.599 . . . . 70.4 111.901 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -109.93 137.11 48.18 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 124.717 1.207 . . . . 73.33 108.383 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -97.93 117.76 32.98 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 120.608 0.242 . . . . 64.25 111.158 -176.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.2 mt -113.63 159.98 19.06 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.84 -0.8 . . . . 33.15 108.84 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.52 -26.61 71.95 Favored Glycine 0 C--N 1.293 -1.806 0 N-CA-C 114.908 0.723 . . . . 71.31 114.908 -174.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 28.0 tt0 -128.08 -0.9 5.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.88 0.84 . . . . 73.23 110.853 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -161.65 176.2 11.22 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.455 -0.778 . . . . 75.01 108.993 -173.13 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.691 HG21 HG11 ' A' ' 25' ' ' VAL . 31.2 m -116.58 128.14 55.14 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 109.556 -0.535 . . . . 74.14 109.556 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.15 112.71 3.93 Favored Glycine 0 N--CA 1.419 -2.446 0 N-CA-C 109.486 -1.445 . . . . 43.24 109.486 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -97.9 133.97 41.67 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 108.038 -1.097 . . . . 74.14 108.038 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 88' ' ' GLN . 14.0 m -117.81 121.91 42.01 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 107.991 -1.114 . . . . 42.21 107.991 -178.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.85 141.25 34.0 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 107.79 -1.189 . . . . 65.11 107.79 177.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 19.6 mt -135.2 124.77 42.81 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.404 0 N-CA-C 106.699 -1.593 . . . . 72.32 106.699 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 21.8 t-160 -117.83 120.9 39.3 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.151 -1.055 . . . . 64.1 108.151 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.9 t -141.82 164.6 29.75 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 107.161 -1.422 . . . . 64.24 107.161 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -176.73 -131.86 1.55 Allowed Glycine 0 C--N 1.285 -2.29 0 N-CA-C 109.413 -1.475 . . . . 72.33 109.413 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 . . . . . 0 C--N 1.301 -1.506 0 N-CA-C 108.373 -0.973 . . . . 73.5 108.373 175.863 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.759 HG12 HD13 ' A' ' 112' ' ' ILE . 1.8 t . . . . . 0 N--CA 1.439 -0.985 0 N-CA-C 106.646 -1.613 . . . . 62.31 106.646 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.759 HD13 HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -58.15 -31.72 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.792 0.806 . . . . 30.52 111.155 177.062 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 148.12 -86.89 0.16 Allowed Glycine 0 N--CA 1.41 -3.093 0 N-CA-C 109.18 -1.568 . . . . 54.24 109.18 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 61.8 tttp -155.13 22.36 0.43 Allowed 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.45 0.643 . . . . 73.32 110.266 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.418 ' HB3' HG13 ' A' ' 112' ' ' ILE . . . -59.95 -39.15 84.61 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.155 -0.966 . . . . 64.11 111.282 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -150.85 25.03 0.75 Allowed 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.362 0.413 . . . . 64.52 110.967 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.411 ' O ' HG11 ' A' ' 111' ' ' VAL . 3.5 mp0 66.85 -41.47 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.382 1.623 . . . . 63.51 115.382 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -118.06 141.74 48.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.268 0.485 . . . . 62.5 112.159 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.672 ' OG ' ' HA ' ' A' ' 111' ' ' VAL . 70.8 m -75.07 -27.79 60.1 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.987 -0.551 . . . . 71.23 109.696 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 p -66.04 -47.17 75.28 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.633 -0.712 . . . . 73.34 111.509 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.0 m -69.92 -33.7 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 120.425 -0.51 . . . . 72.44 109.897 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.41 -46.32 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 120.155 -0.618 . . . . 70.24 110.556 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -55.31 -55.95 25.57 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.656 0.782 . . . . 63.23 111.785 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.0 -47.24 92.25 Favored Glycine 0 C--O 1.249 1.069 0 O-C-N 123.635 0.584 . . . . 62.23 112.652 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -68.44 -36.95 79.78 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 113.292 0.849 . . . . 75.53 113.292 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -34.47 71.99 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 119.469 -0.892 . . . . 72.34 110.859 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.19 -49.64 54.78 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.863 0.363 . . . . 74.4 110.875 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.45 -41.02 91.23 Favored Glycine 0 C--O 1.251 1.211 0 C-N-CA 120.624 -0.798 . . . . 55.23 111.238 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.87 -54.03 38.48 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.824 -0.688 . . . . 51.43 112.301 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.508 ' O ' HG12 ' A' ' 134' ' ' VAL . 57.5 m95 -56.99 -37.65 71.95 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 113.097 0.777 . . . . 74.34 113.097 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.5 m -57.37 -48.08 79.97 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 123.186 0.304 . . . . 73.13 110.436 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.89 -48.76 31.93 Favored Glycine 0 C--O 1.246 0.897 0 C-N-CA 120.584 -0.817 . . . . 72.55 112.332 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.24 -52.41 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.044 0.537 . . . . 75.43 111.653 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 4.2 p -71.63 -41.03 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 119.874 -0.73 . . . . 72.34 111.847 -173.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.527 ' HA ' HG13 ' A' ' 16' ' ' ILE . 26.7 t-20 -63.69 -52.18 61.77 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.988 -0.685 . . . . 54.14 111.234 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 33.5 tt0 -78.99 -44.75 21.69 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 113.183 0.808 . . . . 74.14 113.183 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.55 ' NH1' ' HB2' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -64.85 -45.3 86.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 119.147 -1.021 . . . . 64.23 109.837 -176.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.1 mm? -65.47 -52.21 54.53 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.218 0.324 . . . . 71.0 111.557 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -63.73 -35.65 81.27 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.908 0.385 . . . . 74.22 109.995 -177.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.488 ' NZ ' ' HB3' ' A' ' 144' ' ' GLU . 12.5 mmmt -68.65 -46.16 69.9 Favored 'General case' 0 C--O 1.173 -2.957 0 CA-C-O 119.157 -0.449 . . . . 74.52 111.088 177.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB2' ' NH1' ' A' ' 137' ' ' ARG . . . -59.48 -29.85 68.13 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.219 0.452 . . . . 73.22 112.219 -176.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 21.1 m -86.28 -24.69 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 120.19 -0.604 . . . . 74.43 112.205 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 78.6 mm-40 -86.08 -57.86 2.86 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.711 0.767 . . . . 73.21 109.958 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.488 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 2.3 tm-20 . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 107.267 -1.382 . . . . 72.01 107.267 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.475 ' HB1' HG23 ' A' ' 112' ' ' ILE . . . . . . . . 0 N--CA 1.444 -0.769 0 CA-C-O 121.643 0.735 . . . . 75.15 111.864 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tt -166.53 109.5 0.68 Allowed Pre-proline 0 N--CA 1.419 -1.979 0 N-CA-C 107.161 -1.422 . . . . 72.34 107.161 -172.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -82.5 168.74 14.35 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 122.918 2.412 . . . . 70.31 109.522 171.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.53 107.47 1.4 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.638 -1.245 . . . . 72.11 107.638 170.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 43.2 mm -91.03 124.1 43.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.522 -0.918 . . . . 43.13 108.522 -174.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.0 m -120.37 128.39 53.19 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.433 -1.321 . . . . 64.15 107.433 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.562 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 22.4 tptt -140.2 144.56 36.65 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.701 -1.222 . . . . 72.32 107.701 -176.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.4 m -123.07 134.51 54.25 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.695 -0.402 . . . . 61.2 110.418 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.439 HG21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -141.7 131.79 25.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.919 -0.771 . . . . 72.2 108.919 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.87 117.87 32.05 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 121.809 0.814 . . . . 63.23 111.984 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.658 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.6 mp -92.7 140.07 29.91 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.796 -1.557 . . . . 64.33 106.796 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.85 15.27 3.4 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.175 0.512 . . . . 64.33 111.581 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -105.5 159.54 29.16 Favored Pre-proline 0 C--N 1.306 -1.31 0 CA-C-N 115.864 -0.607 . . . . 63.55 109.719 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.59 154.38 69.27 Favored 'Trans proline' 0 C--O 1.253 1.237 0 C-N-CA 123.028 2.485 . . . . 62.13 110.91 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.0 tt -60.63 -29.13 44.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.936 -0.575 . . . . 73.32 112.011 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.6 pt20 -62.85 -40.58 97.9 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.928 0.394 . . . . 71.41 111.198 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -68.12 -39.74 82.69 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.283 0.564 . . . . 72.4 110.909 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.467 HG21 ' HB ' ' A' ' 96' ' ' THR . 36.0 t -69.09 -40.75 81.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.328 -0.851 . . . . 61.23 109.821 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 28.7 t90 -59.06 -47.63 84.53 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 124.021 0.825 . . . . 74.32 110.397 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 34.2 mt-10 -64.4 -36.45 84.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.07 0.462 . . . . 71.32 110.731 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.4 m -67.16 -12.36 59.81 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-O 121.422 0.629 . . . . 60.21 111.976 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.669 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 16.7 m -131.06 13.62 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 120.756 -1.215 . . . . 23.33 112.906 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.6 t -139.12 4.05 2.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 120.247 -0.581 . . . . 73.1 112.259 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.4 p -111.57 168.57 9.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.198 -0.667 . . . . 62.13 109.198 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 16.4 m -60.08 -46.1 90.7 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.926 0.491 . . . . 64.43 111.447 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -71.12 -41.74 70.14 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.802 -0.635 . . . . 73.24 110.18 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.21 -48.01 67.78 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 115.158 -0.928 . . . . 74.34 113.078 -177.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.07 -41.46 89.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 117.289 0.544 . . . . 73.14 111.205 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 112.535 0.568 . . . . 42.51 112.535 -179.418 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 32' ' ' SER . 19.7 t-20 . . . . . 0 CA--C 1.494 -1.185 0 N-CA-C 105.611 -1.996 . . . . 73.44 105.611 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.21 70.77 8.13 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.553 0.692 . . . . 74.14 111.431 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -107.67 119.87 40.64 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.564 -1.198 . . . . 65.05 108.404 172.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -121.57 150.37 41.77 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.6 -1.259 . . . . 64.2 107.6 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 46' ' ' LEU . 2.5 pt? -78.44 106.08 10.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 117.316 -1.754 . . . . 71.15 108.974 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -130.41 144.7 51.56 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 104.875 -2.269 . . . . 73.54 104.875 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 11.3 pt-20 -83.99 36.75 0.57 Allowed 'General case' 0 C--N 1.283 -2.312 0 CA-C-O 122.218 1.008 . . . . 53.41 109.76 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.8 66.52 0.01 OUTLIER Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.35 -1.5 . . . . 72.23 109.35 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 19.4 tt0 . . . . . 0 C--N 1.314 -0.947 0 N-CA-C 107.326 -1.361 . . . . 51.23 107.326 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.419 -1.992 0 N-CA-C 105.646 -1.983 . . . . 51.02 105.646 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 42.9 mtpt -133.52 134.29 43.24 Favored 'General case' 0 CA--C 1.468 -2.21 0 C-N-CA 120.139 -0.625 . . . . 61.15 111.143 -169.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.2 t -90.66 133.82 31.31 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 N-CA-C 105.307 -2.108 . . . . 74.53 105.307 168.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.426 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 2.3 tm? -78.75 -56.64 4.26 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.038 -1.097 . . . . 73.34 108.038 -175.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.19 153.27 28.95 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.274 -0.875 . . . . 73.52 108.88 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.555 HG23 HD23 ' A' ' 74' ' ' LEU . 12.5 p -132.67 119.8 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 CA-C-O 121.885 0.85 . . . . 70.22 111.621 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 45.9 mt-30 -101.34 141.0 34.86 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.322 -0.854 . . . . 73.21 110.955 176.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.32 126.2 92.19 Favored Pre-proline 0 C--N 1.279 -2.468 0 CA-C-N 113.875 -1.511 . . . . 70.23 109.439 -164.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo 7.27 46.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 1 C-N-CA 127.869 5.712 . . . . 54.44 116.843 -162.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 p -138.7 -38.59 0.52 Allowed 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.773 -0.649 . . . . 73.3 112.182 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 31.1 tt0 -150.5 142.71 24.16 Favored 'General case' 0 C--O 1.208 -1.127 0 C-N-CA 118.913 -1.115 . . . . 74.42 110.221 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.685 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -138.52 137.18 36.85 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 108.746 -0.835 . . . . 63.42 108.746 -177.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.5 m -139.38 127.37 22.29 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 122.451 -0.156 . . . . 44.44 110.755 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 43.6 p90 -143.98 157.04 44.59 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.02 -0.425 . . . . 70.53 112.058 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 36.3 mt-10 -121.04 125.71 48.01 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 107.107 -1.442 . . . . 51.45 107.107 -176.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 51.3 t90 -135.33 148.49 49.48 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 111.925 0.343 . . . . 75.4 111.925 -176.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD1' HG22 ' A' ' 80' ' ' THR . 2.5 t70 77.82 -177.79 0.11 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.073 1.749 . . . . 73.51 111.909 171.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.482 HG22 ' OD1' ' A' ' 79' ' ' ASP . 1.8 t -58.34 -41.42 84.59 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 113.062 0.764 . . . . 62.41 113.062 -175.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.23 12.49 11.64 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.211 0.819 . . . . 74.42 113.211 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.96 57.45 6.9 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 123.42 0.45 . . . . 60.54 112.757 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 88.1 m95 -67.38 117.14 8.96 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 109.0 -0.741 . . . . 75.4 109.0 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 76' ' ' PHE . 7.2 p -101.84 101.16 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 CA-C-O 122.599 1.19 . . . . 74.31 109.418 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.2 m -100.26 146.85 8.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 CA-C-N 114.096 -1.411 . . . . 63.54 108.167 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.508 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 32.7 m -131.56 133.81 45.41 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 116.126 -0.488 . . . . 74.42 109.693 -176.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.685 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.2 m-85 -109.32 131.43 55.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.617 -1.253 . . . . 73.33 107.617 176.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.516 HE21 HD11 ' A' ' 101' ' ' ILE . 5.3 mt-30 -116.66 136.21 53.16 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 109.277 -0.638 . . . . 75.53 109.277 175.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mp -116.72 128.23 55.14 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.369 0.604 . . . . 71.5 110.552 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -102.85 119.6 39.14 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.104 -1.813 . . . . 71.24 106.104 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -81.13 111.79 17.9 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.11 0.481 . . . . 73.43 110.804 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.6 mt -120.95 148.66 43.78 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.669 -1.234 . . . . 74.14 107.669 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.06 54.24 2.53 Favored Glycine 0 C--N 1.284 -2.313 0 C-N-CA 121.027 -0.606 . . . . 62.02 112.208 -176.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -175.2 -54.51 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.652 -1.61 . . . . 72.11 106.652 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.38 175.41 8.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.027 -1.472 . . . . 74.1 107.027 -176.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.467 ' HB ' HG21 ' A' ' 25' ' ' VAL . 83.1 m -122.31 127.68 50.14 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 109.302 -0.629 . . . . 61.54 109.302 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.8 106.28 3.26 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.597 -1.401 . . . . 75.11 109.597 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -98.52 133.88 42.26 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 117.345 0.573 . . . . 72.23 109.646 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 28.9 m -123.17 120.38 33.03 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.612 -0.884 . . . . 74.31 108.612 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.63 141.62 33.23 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.961 -0.755 . . . . 72.24 108.961 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 18.2 mt -136.2 125.45 38.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.007 -1.451 . . . . 62.31 108.188 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -120.31 117.36 27.59 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.042 -1.096 . . . . 75.15 108.042 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.2 t -142.15 164.13 31.0 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 103.727 -2.694 . . . . 72.12 103.727 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.432 ' HA2' ' H ' ' A' ' 84' ' ' VAL . . . -166.65 163.3 36.89 Favored Glycine 0 CA--C 1.49 -1.514 0 C-N-CA 118.282 -1.913 . . . . 53.22 113.811 -178.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 29.6 t90 . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 122.994 1.378 . . . . 63.22 109.429 179.222 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 113' ' ' GLY . 14.9 p . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 108.703 -0.851 . . . . 65.11 108.703 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.691 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -59.63 -35.94 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.624 0.25 . . . . 74.3 111.374 176.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.457 ' H ' HG22 ' A' ' 111' ' ' VAL . . . 126.36 -140.28 11.95 Favored Glycine 0 N--CA 1.422 -2.284 0 N-CA-C 110.242 -1.143 . . . . 75.52 110.242 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -80.65 -2.5 46.84 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 123.533 0.733 . . . . 73.34 110.204 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.87 71.28 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.071 0.462 . . . . 42.23 109.93 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.448 ' O ' HD11 ' A' ' 112' ' ' ILE . 5.2 t30 -173.72 114.34 0.22 Allowed 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.209 -1.404 . . . . 74.1 107.209 174.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -78.74 49.47 0.9 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 114.36 1.244 . . . . 73.5 114.36 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -152.61 92.82 1.71 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.235 1.014 . . . . 73.0 108.824 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.74 -57.01 13.57 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 123.516 0.726 . . . . 53.13 111.474 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.4 m -61.82 -33.3 73.9 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.166 -0.47 . . . . 63.45 111.375 -176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.85 -47.15 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 109.587 -0.523 . . . . 71.21 109.587 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.503 ' O ' ' HG2' ' A' ' 126' ' ' MET . 48.6 t -58.23 -43.55 86.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 O-C-N 123.822 0.701 . . . . 75.25 111.124 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -61.67 -48.95 78.49 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.159 -0.473 . . . . 65.11 110.833 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.42 -43.93 97.53 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 115.634 -0.712 . . . . 53.25 111.799 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -67.45 -34.21 76.72 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.829 -0.686 . . . . 74.34 112.193 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 25.7 mmt -66.7 -43.07 85.32 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.225 -0.59 . . . . 72.34 111.479 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.82 -61.51 1.78 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.259 -0.976 . . . . 65.31 111.772 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.37 -39.0 95.58 Favored Glycine 0 C--O 1.24 0.485 0 C-N-CA 120.928 -0.653 . . . . 61.15 112.574 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.26 -53.96 29.79 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 119.659 -0.523 . . . . 73.31 112.3 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.44 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.4 m95 -63.28 -29.53 70.84 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 117.51 0.655 . . . . 72.14 112.48 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.562 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 73.2 m -60.98 -57.4 12.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.427 -0.583 . . . . 65.45 109.427 174.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.5 -46.83 60.7 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.167 -0.539 . . . . 73.14 113.646 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.626 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 44.8 mm -59.13 -57.54 10.94 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 C-N-CA 122.728 0.411 . . . . 53.14 111.205 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.44 HG23 ' HE3' ' A' ' 130' ' ' TRP . 79.0 t -60.49 -44.1 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 O-C-N 123.096 0.248 . . . . 72.45 111.491 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 131' ' ' THR . 38.7 t-20 -54.24 -61.7 2.14 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 123.953 0.783 . . . . 74.21 111.148 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -80.89 -38.92 27.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 119.834 -0.747 . . . . 73.03 112.187 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.626 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 3.7 mmt180 -62.11 -46.64 88.17 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.372 0.533 . . . . 72.52 111.667 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.658 ' HB3' HD21 ' A' ' 18' ' ' LEU . 4.6 mm? -67.98 -48.57 65.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 120.236 -0.585 . . . . 74.45 110.467 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.592 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -61.81 -33.68 74.57 Favored 'General case' 0 C--O 1.198 -1.646 0 CA-C-N 115.734 -0.666 . . . . 73.13 109.611 -178.606 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -73.15 -35.68 66.51 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 112.879 0.696 . . . . 74.13 112.879 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.6 -32.92 71.94 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.032 0.444 . . . . 75.14 110.701 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.16 -27.0 7.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.744 -0.662 . . . . 63.55 111.602 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 64.3 mm-40 -87.33 -45.4 10.61 Favored 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 120.136 -0.626 . . . . 71.11 111.447 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.421 13.2 pt-20 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 126.869 2.068 . . . . 63.21 115.489 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.362 0 CA-C-O 120.879 0.371 . . . . 72.21 111.597 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 tp 58.8 88.49 0.12 Allowed Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 124.72 1.208 . . . . 61.33 113.865 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -68.45 139.05 44.04 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 N-CA-C 108.475 -1.394 . . . . 63.22 108.475 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.69 153.79 42.47 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.48 0.919 . . . . 73.42 113.48 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.6 mm -121.78 138.74 51.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.067 -0.969 . . . . 73.51 110.075 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.1 m -126.01 130.82 51.93 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.827 -1.546 . . . . 70.24 106.827 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 41.0 tptt -139.75 145.37 38.2 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.849 -0.797 . . . . 55.45 108.849 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -118.56 140.63 49.59 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 117.682 0.219 . . . . 73.43 110.825 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.92 142.58 16.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.052 -0.722 . . . . 74.33 109.052 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 p -105.3 130.01 53.52 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 112.572 0.582 . . . . 73.3 112.572 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.53 141.53 33.27 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.826 -0.624 . . . . 63.43 111.038 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -78.9 9.42 4.27 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.033 0.833 . . . . 74.23 111.441 -176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -120.95 160.56 44.41 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 109.586 -0.524 . . . . 73.32 109.586 -172.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 32.5 Cg_endo -62.89 152.69 77.64 Favored 'Trans proline' 0 C--O 1.256 1.384 0 C-N-CA 123.205 2.603 . . . . 63.35 111.749 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.9 tt -56.63 -31.67 35.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.301 -0.863 . . . . 72.31 112.097 -175.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.58 -33.75 76.36 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.111 0.411 . . . . 74.55 112.111 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.5 -36.11 45.48 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.165 -0.68 . . . . 71.41 109.165 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 29' ' ' VAL . 46.3 t -66.07 -41.28 89.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.885 -0.783 . . . . 73.22 108.885 177.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 51.9 t90 -59.06 -47.85 83.72 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.997 -1.001 . . . . 71.3 111.718 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.42 -30.41 70.14 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.457 -0.897 . . . . 74.13 110.694 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.9 m -63.79 -22.84 67.11 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-O 121.274 0.559 . . . . 72.13 111.744 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.605 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 17.0 m -122.81 16.7 5.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 121.741 -0.6 . . . . 62.11 112.41 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.534 ' HB3' HD12 ' A' ' 46' ' ' LEU . 53.9 m -144.19 8.49 1.41 Allowed 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.163 0.801 . . . . 61.14 113.163 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.5 p -116.9 168.93 9.79 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 121.516 -0.74 . . . . 74.15 109.409 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -60.82 -54.7 41.94 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.268 -0.642 . . . . 43.43 109.268 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.97 -38.94 87.7 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.133 -0.94 . . . . 62.04 111.191 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.47 -48.74 28.44 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.687 -0.768 . . . . 40.42 113.379 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.31 -41.53 78.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 117.636 0.718 . . . . 53.14 112.785 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 113.558 0.947 . . . . 71.41 113.558 -176.32 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 109.157 -0.683 . . . . 52.03 109.157 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.22 72.94 3.34 Favored 'General case' 0 CA--C 1.486 -1.511 0 CA-C-O 121.339 0.59 . . . . 52.01 111.294 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -84.85 131.14 34.56 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.923 -1.51 . . . . 75.43 106.923 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.473 ' HB3' HE22 ' A' ' 50' ' ' GLN . 53.7 tt0 -120.01 149.68 41.76 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.145 -0.687 . . . . 63.41 109.145 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' A' ' 30' ' ' SER . 6.0 tt -85.38 104.27 15.04 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 109.267 -0.642 . . . . 75.11 109.267 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.761 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 12.1 tppt? -132.94 146.01 51.41 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.586 -1.264 . . . . 73.41 107.586 168.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.486 ' HB3' HG12 ' A' ' 68' ' ' VAL . 11.4 pt-20 -87.02 77.45 9.17 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.596 1.189 . . . . 71.34 108.002 172.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.43 83.44 0.96 Allowed Glycine 0 N--CA 1.406 -3.342 0 CA-C-N 114.327 -1.306 . . . . 45.42 109.959 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.761 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 48.7 tt0 . . . . . 0 CA--C 1.487 -1.479 0 N-CA-C 108.215 -1.031 . . . . 60.23 108.215 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.427 -1.595 0 N-CA-C 109.389 -0.597 . . . . 55.22 109.389 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 22.9 pttm -158.31 145.26 17.71 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.233 -0.655 . . . . 63.02 109.233 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.6 t -89.26 126.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 107.271 -1.381 . . . . 71.4 107.271 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 tt -74.79 -53.41 9.22 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.009 -1.478 . . . . 65.53 107.009 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.9 141.93 5.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.016 -0.993 . . . . 63.12 109.108 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.606 HG23 HD23 ' A' ' 74' ' ' LEU . 14.3 p -122.3 120.04 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-O 121.981 0.896 . . . . 70.43 108.953 173.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 84.4 mm-40 -105.17 142.14 35.48 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 114.013 -1.449 . . . . 74.04 109.778 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 135.94 95.65 Favored Pre-proline 0 C--N 1.283 -2.316 0 CA-C-N 114.569 -1.196 . . . . 61.52 109.103 -165.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -3.07 54.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.614 1 C-N-CA 128.323 6.015 . . . . 53.12 117.977 -162.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -152.23 -37.63 0.11 Allowed 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.617 -0.72 . . . . 55.42 110.809 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 35.1 tt0 -139.72 129.14 24.16 Favored 'General case' 0 C--O 1.198 -1.621 0 C-N-CA 117.351 -1.74 . . . . 64.01 112.142 -174.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.68 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -131.15 134.39 46.49 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.717 -0.845 . . . . 53.15 108.717 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.4 m -140.26 126.7 20.11 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.639 -0.255 . . . . 61.35 110.497 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HD1' HD11 ' A' ' 74' ' ' LEU . 39.9 p90 -142.45 154.7 44.79 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.813 0.34 . . . . 74.34 110.271 177.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -122.63 132.25 54.19 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.688 -0.856 . . . . 62.43 108.688 -172.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.486 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 15.6 t-105 -112.98 106.14 14.34 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.124 -1.806 . . . . 64.15 106.124 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -72.49 172.26 10.83 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.238 -0.437 . . . . 74.32 110.69 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.1 m 65.3 43.89 3.39 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 122.196 0.998 . . . . 72.53 109.448 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 64.51 32.37 11.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.352 -1.295 . . . . 71.01 113.508 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 78' ' ' TRP . . . -86.81 -17.86 59.11 Favored Glycine 0 C--O 1.238 0.373 0 N-CA-C 109.308 -1.517 . . . . 42.31 109.308 171.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 28.6 m95 81.22 -174.17 0.04 OUTLIER 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.634 1.974 . . . . 74.32 112.217 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.32 122.96 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 121.758 0.79 . . . . 70.41 110.196 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m -116.8 152.36 18.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-O 121.317 0.58 . . . . 73.23 110.198 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 34.1 m -139.49 142.22 37.33 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 109.083 -0.71 . . . . 74.32 109.083 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.68 ' CD2' HD12 ' A' ' 74' ' ' LEU . 15.0 m-85 -121.23 140.35 52.16 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.89 -1.152 . . . . 75.24 107.89 176.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.88 132.79 53.26 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.357 -1.349 . . . . 63.04 107.357 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.84 122.18 44.61 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.738 0.78 . . . . 73.12 111.988 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -102.76 125.46 49.51 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.589 -1.187 . . . . 73.35 108.92 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -84.4 125.83 32.68 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.522 -0.763 . . . . 73.24 110.603 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.6 mt -125.43 153.04 44.06 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.856 -1.535 . . . . 64.41 106.856 171.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.18 38.22 2.73 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 114.613 0.605 . . . . 31.51 114.613 -172.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -176.02 -38.66 0.01 OUTLIER 'General case' 0 C--O 1.24 0.588 0 N-CA-C 109.372 -0.603 . . . . 73.34 109.372 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -127.12 175.81 7.85 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.115 -1.068 . . . . 60.14 108.115 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.4 m -121.54 129.07 52.66 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 120.709 -0.396 . . . . 71.42 110.281 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.42 106.16 3.32 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 109.489 -1.444 . . . . 62.53 109.489 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -98.58 134.47 41.47 Favored 'General case' 0 C--N 1.27 -2.864 0 O-C-N 121.801 -0.823 . . . . 62.03 109.652 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.6 m -118.84 121.7 40.63 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.387 -0.968 . . . . 74.22 108.387 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -101.83 142.34 33.29 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.694 0.759 . . . . 71.52 109.131 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.487 ' N ' HD13 ' A' ' 100' ' ' LEU . 17.7 mt -136.15 124.44 36.43 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.911 0 CA-C-N 113.92 -1.491 . . . . 72.43 107.653 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -120.22 118.24 29.95 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.294 -1.743 . . . . 72.04 106.294 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -138.79 164.19 30.25 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.811 -1.181 . . . . 74.05 107.811 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.21 170.1 34.37 Favored Glycine 0 N--CA 1.413 -2.889 0 N-CA-C 109.777 -1.329 . . . . 51.44 109.777 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 . . . . . 0 C--N 1.292 -1.917 0 N-CA-C 109.003 -0.74 . . . . 74.3 109.003 -176.708 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.422 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 11.7 p . . . . . 0 N--CA 1.432 -1.343 0 N-CA-C 107.218 -1.401 . . . . 73.41 107.218 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.626 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -62.42 -39.42 84.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 112.344 0.498 . . . . 64.24 112.344 179.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.92 -128.61 8.83 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.663 -0.78 . . . . 54.42 112.741 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -75.42 -7.39 53.93 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.69 0.796 . . . . 71.02 111.765 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.13 -34.02 71.56 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 123.137 0.273 . . . . 63.12 110.544 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -163.06 -81.7 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 119.676 -0.809 . . . . 61.45 112.887 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -151.28 -162.1 1.47 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.698 1.199 . . . . 55.12 109.231 -173.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.506 ' HB2' HG22 ' A' ' 121' ' ' VAL . 3.7 mppt? -75.43 154.38 37.13 Favored 'General case' 0 C--O 1.212 -0.895 0 C-N-CA 122.994 0.517 . . . . 65.31 110.289 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 111' ' ' VAL . 50.0 m -60.21 -41.6 93.38 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.922 1.082 . . . . 65.41 113.922 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.2 t -69.7 -45.87 67.27 Favored 'General case' 0 C--O 1.256 1.438 0 C-N-CA 120.116 -0.634 . . . . 74.31 111.138 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.506 HG22 ' HB2' ' A' ' 118' ' ' LYS . 27.6 m -69.94 -36.74 70.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 119.16 -1.016 . . . . 73.31 110.928 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 126' ' ' MET . 21.4 t -61.27 -45.68 98.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.253 0 O-C-N 123.167 0.292 . . . . 75.24 111.407 175.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -64.44 -40.45 95.76 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.882 -0.327 . . . . 71.41 111.237 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.03 -45.0 95.04 Favored Glycine 0 CA--C 1.492 -1.356 0 N-CA-C 111.225 -0.75 . . . . 61.31 111.225 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -68.22 -32.33 72.46 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.697 -0.752 . . . . 65.42 111.195 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 21.3 mmt -64.06 -49.37 72.59 Favored 'General case' 0 C--O 1.206 -1.21 0 C-N-CA 121.068 -0.253 . . . . 63.52 111.252 176.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.92 -51.38 62.19 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 119.839 -0.744 . . . . 63.02 110.973 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.76 -44.97 95.49 Favored Glycine 0 C--O 1.241 0.545 0 C-N-CA 121.232 -0.508 . . . . 73.23 111.981 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.55 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -62.46 -50.89 60.44 Favored Glycine 0 CA--C 1.487 -1.679 0 N-CA-C 111.352 -0.699 . . . . 44.13 111.352 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.511 ' O ' HG12 ' A' ' 134' ' ' VAL . 77.4 m95 -59.51 -37.24 77.78 Favored 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 118.83 -0.605 . . . . 70.33 112.496 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.504 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 90.1 m -54.32 -54.4 40.84 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 109.859 -0.422 . . . . 74.03 109.859 176.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.62 -45.33 67.16 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.804 -0.634 . . . . 45.53 113.538 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 129' ' ' GLY . 36.2 pt -74.68 -36.67 41.19 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.416 0 N-CA-C 113.213 0.819 . . . . 74.14 113.213 -176.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 130' ' ' TRP . 4.2 p -74.92 -38.82 44.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 118.671 -1.212 . . . . 60.34 110.494 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.3 -60.25 3.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.742 -0.383 . . . . 74.21 110.896 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.2 -43.95 66.39 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.248 0.462 . . . . 53.02 112.248 -173.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.505 ' O ' ' HD2' ' A' ' 137' ' ' ARG . 2.0 tmm_? -70.27 -41.56 73.28 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.228 -0.589 . . . . 73.52 110.454 -173.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.0 mm? -63.96 -45.46 89.02 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 119.839 -0.744 . . . . 61.22 109.198 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -59.03 -42.28 89.81 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.815 -0.629 . . . . 71.52 110.187 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -65.27 -51.66 59.34 Favored 'General case' 0 C--O 1.166 -3.311 0 CA-C-O 119.502 -0.285 . . . . 73.42 111.382 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.2 73.48 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 123.359 0.412 . . . . 72.53 112.106 -175.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 31.2 m -74.34 -26.45 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 119.665 -0.814 . . . . 63.05 110.736 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.95 -53.28 4.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 118.815 -1.154 . . . . 52.35 112.63 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--N 1.304 -1.371 0 C-N-CA 124.229 1.012 . . . . 73.45 110.776 -175.87 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.254 0.074 . . . . 75.41 110.824 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.52 -29.16 62.29 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.693 0.282 . . . . 63.02 111.401 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.23 -28.09 64.98 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.204 0.526 . . . . 73.31 111.351 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -84.76 96.03 9.13 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 113.535 0.939 . . . . 71.21 113.535 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -160.26 127.64 4.48 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 106.192 -1.781 . . . . 71.43 106.192 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HG2' ' HG2' ' A' ' 110' ' ' GLU . 40.4 mt-10 63.95 78.95 0.27 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 122.577 1.18 . . . . 72.42 109.938 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -114.82 -75.49 0.59 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.216 -1.356 . . . . 70.32 110.279 -172.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 50.75 26.18 2.44 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.191 0.996 . . . . 71.43 111.377 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.254 4.2 mm? 67.95 90.24 0.09 OUTLIER Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 114.911 -1.04 . . . . 74.21 112.454 -172.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -88.32 -159.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 122.309 2.006 . . . . 64.44 109.702 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 7.8 p-10 -65.86 116.16 6.73 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.945 0.879 . . . . 73.04 111.151 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 50.0 mm -120.6 124.46 72.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 106.578 -1.638 . . . . 43.13 106.578 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.9 m -111.38 136.76 50.06 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.834 -0.802 . . . . 71.43 108.834 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -142.07 142.96 32.88 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.058 -1.089 . . . . 72.3 108.058 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.0 p -137.31 134.15 35.76 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 118.332 0.514 . . . . 34.2 109.785 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.92 131.84 13.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.236 -0.653 . . . . 74.45 109.236 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.477 ' CG2' ' HG3' ' A' ' 95' ' ' LYS . 2.7 m -94.52 120.97 35.57 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-O 121.798 0.809 . . . . 74.51 110.674 -175.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.2 mt -95.64 140.35 30.58 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.053 -0.976 . . . . 61.1 110.018 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -79.99 25.09 0.38 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.169 0.588 . . . . 75.55 112.21 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.84 160.47 44.56 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 122.655 0.382 . . . . 55.32 110.074 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 38.7 Cg_endo -67.4 157.41 61.9 Favored 'Trans proline' 0 C--O 1.256 1.402 0 C-N-CA 123.194 2.596 . . . . 62.15 111.55 175.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.9 tt -62.64 -27.16 42.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.785 -0.643 . . . . 75.32 112.119 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.41 -31.9 65.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.903 0.382 . . . . 75.42 111.481 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 5.0 tmtt? -79.1 -37.71 38.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 108.849 -0.797 . . . . 74.21 108.849 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 96' ' ' THR . 4.3 p -66.28 -39.84 85.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 120.074 -0.65 . . . . 71.3 110.243 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.483 ' NE1' ' HD3' ' A' ' 71' ' ' PRO . 50.2 t90 -58.11 -48.24 80.81 Favored 'General case' 0 C--O 1.213 -0.867 0 O-C-N 123.704 0.628 . . . . 64.51 111.153 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.49 -29.99 69.57 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 120.125 -0.63 . . . . 72.31 110.586 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 94.6 m -67.01 -26.27 66.7 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.993 0.425 . . . . 64.51 111.522 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.641 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.7 m -115.33 19.84 7.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 121.374 -0.829 . . . . 74.12 112.112 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.8 m -142.24 4.78 1.63 Allowed 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.842 0.682 . . . . 70.14 112.842 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.8 p -110.51 162.21 14.92 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.749 -0.834 . . . . 72.41 108.749 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -56.47 -44.78 80.89 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 123.474 0.709 . . . . 62.21 111.089 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.11 -46.61 64.46 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.402 -0.817 . . . . 70.34 111.005 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.06 -40.68 88.37 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 115.615 -0.721 . . . . 44.25 112.814 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.4 mt -68.92 -39.89 80.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 120.804 0.335 . . . . 71.35 110.842 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -63.09 -30.5 71.64 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.04 -0.527 . . . . 62.31 110.671 174.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.8 mttp 70.28 20.22 6.27 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.126 1.371 . . . . 63.34 109.347 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 98.0 m95 64.23 12.46 7.14 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.637 1.175 . . . . 64.14 111.827 -175.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -104.7 84.97 2.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.185 -1.783 . . . . 75.11 106.185 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.9 mpt? 69.09 86.23 0.12 Allowed Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 114.687 -1.142 . . . . 73.34 109.304 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.428 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 17.2 Cg_exo -67.01 114.1 3.06 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.752 2.301 . . . . 70.45 112.507 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -100.52 164.56 11.84 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.261 -1.014 . . . . 74.43 108.261 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -99.1 61.54 1.24 Allowed 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.328 -0.949 . . . . 65.1 109.295 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.507 ' HD2' ' HG ' ' A' ' 63' ' ' CYS . 20.0 t80 -65.58 132.51 49.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.108 -1.405 . . . . 73.43 110.201 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -109.93 133.41 53.21 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.752 -0.462 . . . . 72.23 109.752 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 68' ' ' VAL . 15.7 tp -78.02 106.15 9.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.43 -1.322 . . . . 72.55 107.43 177.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -130.16 145.0 51.68 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.529 -1.286 . . . . 74.24 107.529 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -84.21 59.3 5.26 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.984 0.897 . . . . 71.01 109.277 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.27 77.53 0.58 Allowed Glycine 0 N--CA 1.414 -2.824 0 N-CA-C 109.38 -1.488 . . . . 64.21 109.38 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -75.43 -44.48 44.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.94 0.876 . . . . 61.15 108.717 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -143.93 156.97 44.62 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.299 -2.112 . . . . 45.42 105.299 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -109.79 147.73 32.73 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.989 -0.745 . . . . 72.34 108.989 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.46 ' CE1' ' HZ1' ' A' ' 106' ' ' LYS . 16.3 t-160 -109.38 137.76 46.76 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.63 -1.248 . . . . 75.12 107.63 -171.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.5 mp -146.31 -50.22 0.22 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.643 -0.873 . . . . 75.22 108.643 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -111.31 163.28 14.13 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.037 -0.983 . . . . 73.33 108.595 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -80.68 116.6 63.21 Favored Pre-proline 0 N--CA 1.425 -1.679 0 N-CA-C 108.626 -0.879 . . . . 74.04 108.626 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.431 ' HB3' ' OG ' ' A' ' 61' ' ' SER . 73.6 Cg_exo -55.47 106.3 0.18 Allowed 'Trans proline' 0 C--O 1.248 1.024 0 C-N-CA 123.012 2.475 . . . . 73.41 113.401 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -86.98 -34.41 19.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.082 -1.451 . . . . 74.44 107.082 174.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.73 147.62 20.6 Favored Glycine 0 N--CA 1.417 -2.602 0 N-CA-C 108.899 -1.68 . . . . 34.52 108.899 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -48.53 114.45 1.2 Allowed 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 123.697 2.932 . . . . 75.1 113.133 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' A' ' 57' ' ' PRO . 34.2 m -130.2 139.72 36.48 Favored Pre-proline 0 N--CA 1.424 -1.742 0 N-CA-C 108.476 -0.935 . . . . 72.33 108.476 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.0 -160.52 0.1 Allowed 'Trans proline' 0 C--O 1.262 1.694 0 C-N-CA 122.249 1.966 . . . . 71.34 112.242 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.507 ' HG ' ' HD2' ' A' ' 44' ' ' PHE . 3.9 p -87.03 142.81 27.66 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 107.983 -1.118 . . . . 61.04 107.983 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -133.97 140.83 47.0 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.756 -1.201 . . . . 75.03 107.756 -172.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.444 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 3.0 t -90.16 136.77 23.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 107.927 -1.138 . . . . 55.51 107.927 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.6 tp -83.52 -58.07 2.97 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.82 -1.178 . . . . 74.34 107.82 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.47 138.98 14.93 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.772 -1.104 . . . . 53.52 109.183 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.616 HG23 HD23 ' A' ' 74' ' ' LEU . 11.2 p -119.37 124.26 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 N-CA-C 108.978 -0.749 . . . . 74.12 108.978 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 28.2 mm-40 -105.12 140.84 37.69 Favored 'General case' 0 CA--C 1.48 -1.741 0 CA-C-N 115.663 -0.699 . . . . 72.44 109.602 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.32 126.48 92.61 Favored Pre-proline 0 C--N 1.279 -2.48 0 CA-C-N 113.604 -1.635 . . . . 72.53 109.047 -166.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.483 ' HD3' ' NE1' ' A' ' 26' ' ' TRP . 36.9 Cg_exo 5.89 42.99 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 1 C-N-CA 128.131 5.887 . . . . 32.23 118.428 -160.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 p -132.76 -39.13 0.99 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.312 -0.404 . . . . 73.24 111.867 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 40.5 tt0 -150.43 145.11 25.85 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 119.325 -0.95 . . . . 73.03 110.988 -172.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.682 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -139.25 135.11 33.54 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.676 -0.861 . . . . 73.41 108.676 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.8 m -140.54 126.04 18.96 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.689 0.28 . . . . 72.23 110.945 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.468 ' HD2' HD11 ' A' ' 74' ' ' LEU . 34.8 p90 -146.01 157.23 43.87 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 120.613 0.244 . . . . 72.03 111.02 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -120.95 123.86 43.5 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.978 -1.119 . . . . 74.3 107.978 -174.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -108.26 111.28 23.16 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 106.187 -1.783 . . . . 64.43 106.187 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.29 1.2 m-20 -79.1 10.16 3.78 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 116.808 2.151 . . . . 62.12 116.808 -170.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -75.85 94.95 3.41 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 104.529 -2.397 . . . . 75.32 104.529 167.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 83.68 -37.82 0.07 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.885 2.074 . . . . 75.22 109.718 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.94 47.45 0.56 Allowed Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 111.07 -0.812 . . . . 34.23 111.07 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -85.25 112.37 20.7 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.608 0.718 . . . . 73.54 110.402 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.1 t -101.77 117.27 46.83 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 N-CA-C 106.705 -1.591 . . . . 73.11 106.705 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.32 147.12 20.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-O 121.555 0.693 . . . . 73.45 110.518 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.526 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 46.7 m -128.88 132.73 47.75 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 115.019 -0.991 . . . . 72.41 108.711 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.682 ' CD2' HD12 ' A' ' 74' ' ' LEU . 14.4 m-85 -112.7 145.56 40.28 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.978 -1.119 . . . . 74.25 107.978 177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 69.4 mt-30 -130.84 144.17 51.26 Favored 'General case' 0 C--N 1.277 -2.573 0 O-C-N 123.591 0.557 . . . . 74.34 110.932 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.0 mt -114.9 120.9 41.53 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 123.707 0.63 . . . . 65.32 110.25 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -103.48 122.74 45.54 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.454 -0.943 . . . . 74.12 108.454 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -77.66 112.7 14.74 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.101 -0.5 . . . . 74.12 111.479 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.0 mt -125.58 160.2 30.18 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.365 -0.834 . . . . 72.33 108.963 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.76 123.94 6.89 Favored Glycine 0 N--CA 1.424 -2.152 0 N-CA-C 109.114 -1.594 . . . . 75.43 109.114 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 84.58 -10.03 0.87 Allowed 'General case' 0 CA--C 1.485 -1.522 0 C-N-CA 125.709 1.604 . . . . 64.21 111.812 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.477 ' HG3' ' CG2' ' A' ' 17' ' ' THR . 2.1 ptpt -154.99 174.87 14.56 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 108.519 -0.919 . . . . 72.05 108.519 -176.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.617 HG21 HG11 ' A' ' 25' ' ' VAL . 63.8 m -135.41 132.49 37.57 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 110.039 -0.356 . . . . 64.52 110.039 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.73 117.27 4.82 Favored Glycine 0 N--CA 1.423 -2.224 0 N-CA-C 109.831 -1.308 . . . . 73.2 109.831 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -99.77 129.98 45.94 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 108.81 -0.811 . . . . 71.44 108.81 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 37.7 m -117.38 121.41 41.01 Favored 'General case' 0 N--CA 1.408 -2.529 0 C-N-CA 119.196 -1.002 . . . . 72.42 108.778 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.54 140.01 35.41 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-O 122.265 1.031 . . . . 74.41 109.017 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 18.5 mt -136.19 124.95 37.54 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.117 0 CA-C-N 113.054 -1.885 . . . . 75.3 107.027 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.496 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . 10.3 t60 -120.25 131.87 55.11 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.919 -1.141 . . . . 74.11 107.919 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.6 m -142.88 132.48 23.77 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.696 -1.224 . . . . 23.11 107.696 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.87 127.09 9.11 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 120.497 -0.859 . . . . 64.44 111.201 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -128.25 124.59 37.03 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 122.557 1.17 . . . . 73.25 111.432 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.46 ' HZ1' ' CE1' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -177.18 -156.55 0.04 OUTLIER 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 100.611 -3.848 . . . . 74.42 100.611 -176.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 106' ' ' LYS . 1.5 mp0 -70.08 129.32 90.86 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 106.959 -1.497 . . . . 74.3 106.959 168.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.7 92.46 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.106 1.871 . . . . 75.35 110.853 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -95.84 175.65 6.42 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.12 -1.437 . . . . 73.01 107.12 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.44 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 60.7 mt-10 -86.19 -26.49 25.08 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 121.541 0.686 . . . . 74.41 109.437 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.3 t -119.95 162.24 18.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 106.904 -1.517 . . . . 75.32 106.904 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 115' ' ' ALA . 9.6 pt -62.15 -43.96 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.914 0.779 . . . . 74.34 110.166 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.62 -80.05 0.37 Allowed Glycine 0 N--CA 1.422 -2.283 0 C-N-CA 119.862 -1.161 . . . . 65.01 114.451 173.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.1 mptp? -104.2 -34.12 8.48 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.694 0.628 . . . . 61.14 112.694 -168.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.604 ' HB3' HD12 ' A' ' 112' ' ' ILE . . . -65.03 -34.17 77.8 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 120.664 0.268 . . . . 63.14 111.68 -176.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.408 HD22 ' N ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -167.55 122.59 1.03 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.498 -1.297 . . . . 70.22 107.498 178.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.408 ' N ' HD22 ' A' ' 116' ' ' ASN . 10.4 tp10 -86.3 89.14 7.77 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.101 0.477 . . . . 50.21 111.584 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 31.4 tptt 179.64 152.84 0.44 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.045 -1.835 . . . . 74.32 106.045 171.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.2 p -111.76 -50.7 2.9 Favored 'General case' 0 C--N 1.286 -2.18 0 C-N-CA 120.028 -0.669 . . . . 75.5 111.37 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.2 p -63.22 -46.32 87.52 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.657 0.783 . . . . 74.45 111.187 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.91 -47.03 83.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.209 -0.905 . . . . 74.45 110.72 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.6 t -59.28 -35.03 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 116.357 -0.383 . . . . 71.41 111.237 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -66.56 -50.63 62.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.469 -0.937 . . . . 64.22 108.469 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.87 -40.53 98.42 Favored Glycine 0 C--O 1.241 0.547 0 CA-C-N 116.061 -0.518 . . . . 73.21 112.564 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -64.45 -38.77 92.2 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 122.877 0.471 . . . . 72.34 111.184 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.0 mmt -69.87 -36.83 75.82 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 121.361 -0.136 . . . . 73.15 111.353 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.49 -56.22 24.71 Favored 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 123.201 0.313 . . . . 61.24 110.737 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.83 -37.68 88.62 Favored Glycine 0 C--O 1.245 0.828 0 C-N-CA 120.672 -0.775 . . . . 62.23 111.745 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.8 -63.13 5.36 Favored Glycine 0 N--CA 1.438 -1.175 0 CA-C-N 115.309 -0.445 . . . . 62.42 112.408 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.642 ' O ' HG22 ' A' ' 134' ' ' VAL . 90.9 m95 -56.07 -45.25 79.38 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 113.342 0.867 . . . . 73.42 113.342 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.4 m -54.66 -51.44 65.48 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.708 0.63 . . . . 64.13 110.743 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.96 -43.61 64.8 Favored Glycine 0 C--O 1.25 1.125 0 C-N-CA 120.525 -0.845 . . . . 63.44 112.425 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.57 -57.6 11.35 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.848 0 CA-C-O 119.161 -0.447 . . . . 73.41 111.705 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 130' ' ' TRP . 27.4 m -64.19 -35.58 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 C-N-CA 118.906 -1.118 . . . . 75.55 112.841 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 42.3 t30 -57.81 -70.4 0.14 Allowed 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.558 0.536 . . . . 74.05 112.0 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.23 -28.13 27.49 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 118.93 -1.108 . . . . 74.23 112.062 -172.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -73.61 -38.08 65.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 118.722 -1.191 . . . . 70.14 110.804 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.5 mm? -70.78 -42.95 69.7 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 118.345 -1.342 . . . . 63.15 109.338 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 135' ' ' ASN . 2.3 tmm_? -57.73 -40.98 80.9 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 115.788 -0.642 . . . . 72.44 110.552 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -73.14 -36.67 66.7 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 113.422 0.897 . . . . 75.35 113.422 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.79 58.48 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.093 0.473 . . . . 62.15 110.968 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.471 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 32.1 m -85.36 -30.24 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 119.9 -0.72 . . . . 72.51 111.571 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -92.69 -26.19 17.9 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.102 0.779 . . . . 63.32 113.102 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.5 ' HG2' ' H ' ' A' ' 145' ' ' LEU . 28.2 tt0 -150.76 -137.63 0.08 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 105.461 -2.051 . . . . 72.44 105.461 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.5 ' H ' ' HG2' ' A' ' 144' ' ' GLU . 1.9 pt? -142.33 -66.21 0.4 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.736 -0.468 . . . . 70.53 109.736 173.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -170.34 154.57 4.85 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 123.406 0.683 . . . . 65.52 109.599 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -159.27 -81.41 0.05 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.945 -1.131 . . . . 73.01 107.945 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -148.46 100.59 3.15 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.901 -0.777 . . . . 74.35 108.901 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -148.9 126.19 11.5 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 123.981 0.912 . . . . 74.53 108.66 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -84.69 125.72 32.76 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.767 -0.457 . . . . 75.31 109.767 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -119.55 154.62 33.59 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.242 -1.021 . . . . 74.41 108.242 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 . . . . . 0 C--N 1.3 -1.55 0 N-CA-C 109.086 -0.709 . . . . 75.12 109.086 179.664 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 CA--C 1.504 -0.818 0 N-CA-C 109.75 -0.463 . . . . 63.11 109.75 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.57 129.91 55.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.591 -0.277 . . . . 72.21 111.1 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.57 -28.29 22.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.478 -0.564 . . . . 60.24 109.478 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -89.55 -170.0 2.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.871 -1.159 . . . . 63.45 107.871 171.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -133.3 18.01 4.03 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 118.975 0.807 . . . . 74.14 111.999 -172.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -147.11 139.61 24.79 Favored 'General case' 0 N--CA 1.402 -2.847 0 CA-C-O 121.686 0.755 . . . . 75.51 110.651 -174.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -64.54 -44.82 89.6 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 113.919 -1.491 . . . . 75.13 109.716 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.16 118.62 23.71 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.142 -0.935 . . . . 64.31 108.578 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 tp -67.33 116.54 37.73 Favored Pre-proline 0 C--N 1.313 -0.981 0 O-C-N 123.767 0.667 . . . . 72.4 110.686 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -99.78 -157.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.251 0 C-N-CA 123.01 2.473 . . . . 64.12 108.959 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.623 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 5.1 p-10 -70.37 131.77 44.61 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.006 -0.678 . . . . 72.33 110.166 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.3 tt -132.41 138.95 51.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.933 -0.765 . . . . 72.5 108.933 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 m -111.77 134.83 53.08 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.797 -0.445 . . . . 75.43 109.797 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -136.9 124.1 21.77 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.082 -1.451 . . . . 64.3 107.082 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 m -117.84 134.02 55.35 Favored 'General case' 0 C--N 1.261 -3.266 0 N-CA-C 109.244 -0.651 . . . . 61.11 109.244 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.34 133.09 28.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 109.263 -0.643 . . . . 72.41 109.263 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -97.14 125.39 41.61 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 116.198 -0.455 . . . . 72.02 111.016 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.47 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.8 mp -101.06 139.58 36.55 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.096 -0.502 . . . . 74.23 110.077 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -80.06 29.94 0.27 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.987 0.915 . . . . 72.54 111.343 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.97 157.8 74.65 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 108.735 -0.839 . . . . 73.51 108.735 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.93 159.8 44.39 Favored 'Trans proline' 0 C--O 1.26 1.582 0 C-N-CA 123.087 2.525 . . . . 62.31 111.756 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -66.66 -24.9 33.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.85 -0.614 . . . . 62.22 111.535 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.532 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.0 pt20 -66.11 -40.81 91.02 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.313 -0.403 . . . . 75.22 111.392 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -74.66 -39.91 61.75 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.017 0.437 . . . . 64.04 111.011 -175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.641 HG11 HG21 ' A' ' 96' ' ' THR . 7.1 p -65.03 -38.37 82.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.319 -0.4 . . . . 75.21 110.079 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -58.68 -46.92 86.16 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.81 -0.632 . . . . 74.23 109.968 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 35.6 mt-10 -61.45 -38.29 86.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.923 0.392 . . . . 61.44 110.114 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.4 m -66.65 -11.72 55.1 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-N 115.987 -0.551 . . . . 74.34 111.757 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.62 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.8 m -128.82 9.21 2.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 121.178 -0.951 . . . . 54.11 112.529 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.3 t -124.96 -9.17 7.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.584 0.23 . . . . 43.04 111.529 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.9 p -94.46 154.21 17.55 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.851 -1.537 . . . . 55.42 106.851 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.0 m -57.2 -39.46 75.46 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 118.504 0.593 . . . . 75.14 111.645 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 2.2 mp0 -65.86 -43.67 87.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.99 -1.005 . . . . 72.31 109.783 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.641 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . -72.58 -40.64 53.37 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 115.055 -0.975 . . . . 34.13 112.886 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.35 -48.42 88.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 122.748 0.419 . . . . 45.25 110.015 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.64 -52.98 54.57 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.62 0.6 . . . . 51.23 112.62 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.641 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 28.3 mtmm 69.36 -47.74 0.59 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 123.904 0.882 . . . . 64.15 113.206 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -56.43 -49.83 73.41 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.325 2.25 . . . . 74.31 109.902 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.51 ' CE2' ' HD2' ' A' ' 41' ' ' PRO . 32.9 t80 -135.64 167.95 20.17 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 106.182 -1.784 . . . . 72.51 106.182 -177.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.576 ' HB3' ' HD3' ' A' ' 41' ' ' PRO 0.271 49.5 ttm -87.4 -72.34 0.07 OUTLIER Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 113.958 1.095 . . . . 74.11 113.958 -179.084 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 40' ' ' MET . 7.1 Cg_exo -73.44 114.74 4.12 Favored 'Trans proline' 0 C--N 1.378 2.126 0 CA-C-N 121.726 1.652 . . . . 53.44 111.629 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.438 HD21 ' HB3' ' A' ' 39' ' ' PHE . 35.2 m-80 -140.14 162.67 34.68 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 112.525 0.565 . . . . 65.22 112.525 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -85.46 -2.11 57.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.243 -0.89 . . . . 72.24 111.087 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -76.87 118.83 19.85 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.829 -0.804 . . . . 70.44 108.829 -175.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.23 151.93 30.41 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.815 -0.629 . . . . 74.41 109.837 -173.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.762 HD11 HG11 ' A' ' 68' ' ' VAL . 3.0 tm? -81.65 104.88 12.37 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.961 -1.866 . . . . 65.3 105.961 175.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -134.83 137.69 43.53 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 106.168 -1.79 . . . . 62.22 106.168 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 6.5 pt-20 -91.75 70.25 5.68 Favored 'General case' 0 C--N 1.26 -3.312 0 CA-C-N 119.826 1.194 . . . . 74.21 109.821 174.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 131.19 96.42 0.71 Allowed Glycine 0 N--CA 1.401 -3.678 0 CA-C-N 113.784 -1.553 . . . . 32.35 110.91 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.44 150.83 50.62 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.91 -1.515 . . . . 72.41 106.91 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -131.73 150.19 52.23 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.686 0.616 . . . . 73.43 110.2 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -95.6 146.69 24.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.288 -1.375 . . . . 62.34 107.288 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -121.82 143.29 49.49 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.207 -1.035 . . . . 75.31 108.207 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.5 tp -78.46 42.15 0.42 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 122.239 1.019 . . . . 74.52 110.935 -174.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -85.37 -29.06 24.76 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 107.971 -1.122 . . . . 75.12 107.971 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.5 m 55.92 77.9 0.41 Allowed Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 114.399 -1.273 . . . . 70.23 112.213 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -74.92 167.91 26.01 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.049 2.5 . . . . 53.45 110.958 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -81.93 131.94 35.26 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 110.0 -0.371 . . . . 74.13 110.0 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.12 -125.49 7.2 Favored Glycine 0 N--CA 1.418 -2.509 0 N-CA-C 110.334 -1.106 . . . . 53.3 110.334 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -83.43 149.65 13.13 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 C-N-CA 121.975 1.783 . . . . 72.13 111.672 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 50.4 m -78.71 135.53 59.86 Favored Pre-proline 0 N--CA 1.422 -1.849 0 N-CA-C 108.01 -1.108 . . . . 73.31 108.01 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 32.3 Cg_exo -55.42 149.11 48.61 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 123.212 2.608 . . . . 35.13 113.593 -174.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 26.6 p -110.27 167.23 10.35 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 115.46 -0.791 . . . . 45.31 110.492 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -123.48 118.83 28.3 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 108.519 -0.919 . . . . 64.3 108.519 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 76' ' ' PHE . 28.5 t -85.51 127.05 40.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 106.472 -1.677 . . . . 72.05 106.472 174.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.7 tp -72.76 -53.39 11.74 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 124.209 0.943 . . . . 62.42 108.641 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.05 150.62 6.62 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.205 -0.907 . . . . 61.31 110.255 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.762 HG11 HD11 ' A' ' 46' ' ' LEU . 59.7 t -121.14 118.88 57.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 107.459 -1.311 . . . . 60.42 107.459 173.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 41.9 mt-30 -111.67 141.76 44.86 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 123.958 0.903 . . . . 75.24 110.149 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.18 134.25 94.76 Favored Pre-proline 0 C--N 1.287 -2.129 0 CA-C-N 114.128 -1.396 . . . . 51.14 110.184 -162.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo 0.53 48.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.175 1 C-N-CA 128.434 6.089 . . . . 73.14 117.557 -163.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 7.5 m -146.58 -45.24 0.19 Allowed 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.876 -0.602 . . . . 72.24 111.265 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 29.0 tt0 -141.38 128.55 20.92 Favored 'General case' 0 C--O 1.21 -0.978 0 C-N-CA 117.243 -1.783 . . . . 63.45 111.905 -169.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.709 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.9 tm? -133.52 132.26 40.75 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 109.318 -0.623 . . . . 73.54 109.318 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.3 m -138.12 126.21 22.83 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.728 -0.389 . . . . 60.33 110.724 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.482 ' HD2' HD11 ' A' ' 74' ' ' LEU . 39.5 p90 -146.67 154.84 41.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.399 0.142 . . . . 72.24 110.782 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -123.55 123.66 41.1 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.031 -1.1 . . . . 63.32 108.031 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -101.4 140.34 35.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.339 0.59 . . . . 55.41 112.282 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -93.2 -172.46 2.96 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 103.625 -2.731 . . . . 72.33 103.625 167.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.1 m 66.76 30.4 8.06 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 122.841 1.305 . . . . 54.23 107.497 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.49 ' OE1' ' HG3' ' A' ' 114' ' ' LYS . 7.8 mm-40 56.88 53.9 7.67 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.329 1.852 . . . . 72.34 114.266 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.44 -37.22 2.68 Favored Glycine 0 C--N 1.312 -0.785 0 N-CA-C 109.821 -1.312 . . . . 73.53 109.821 174.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.742 ' HZ2' ' HB2' ' A' ' 115' ' ' ALA . 2.8 m0 70.65 -164.85 0.15 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.706 1.603 . . . . 74.55 111.973 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -91.38 118.86 37.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.653 -0.499 . . . . 73.51 109.653 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.7 144.63 33.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.399 -0.593 . . . . 52.15 109.399 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.457 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 38.9 m -130.68 139.42 50.32 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 115.909 -0.587 . . . . 75.11 109.925 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.709 ' CD2' HD12 ' A' ' 74' ' ' LEU . 10.0 m-85 -117.73 140.17 50.04 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.915 -1.143 . . . . 70.22 107.915 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.62 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 82.8 mt-30 -130.07 140.21 50.86 Favored 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 115.689 -0.687 . . . . 71.34 110.083 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 72' ' ' THR . 75.8 mt -118.71 124.42 47.29 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.049 0.452 . . . . 75.42 110.038 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -109.55 116.55 31.99 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.784 -0.821 . . . . 72.15 108.784 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.61 111.21 15.66 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.722 -0.672 . . . . 74.13 110.738 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 81.1 mt -109.84 153.8 23.91 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.912 -1.144 . . . . 74.34 107.912 176.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.48 39.63 3.01 Favored Glycine 0 C--N 1.29 -2.002 0 C-N-CA 121.145 -0.55 . . . . 33.52 111.917 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -156.74 -42.82 0.07 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 124.405 1.082 . . . . 54.41 109.305 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.0 ptpt -155.92 177.06 11.84 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.852 -1.166 . . . . 73.21 107.852 -168.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.641 HG21 HG11 ' A' ' 25' ' ' VAL . 38.9 m -113.32 125.72 54.59 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.854 -0.795 . . . . 72.51 108.854 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.06 109.69 3.67 Favored Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 110.526 -1.03 . . . . 53.51 110.526 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -98.05 132.43 43.61 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.409 -0.96 . . . . 73.15 108.409 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 28.0 m -122.23 122.94 40.31 Favored 'General case' 0 N--CA 1.406 -2.652 0 C-N-CA 119.496 -0.882 . . . . 72.43 109.038 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.468 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -103.13 140.19 37.66 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-O 122.023 0.916 . . . . 61.32 108.678 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.8 mp -135.64 124.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.453 0 N-CA-C 105.981 -1.859 . . . . 73.54 105.981 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 24.1 t60 -114.59 131.84 56.55 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.326 -1.361 . . . . 73.12 107.326 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.7 t -137.74 150.17 47.05 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.861 -1.163 . . . . 73.41 107.861 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -104.17 158.13 16.86 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 110.525 -1.03 . . . . 70.32 110.525 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -129.53 92.86 3.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 117.612 0.706 . . . . 72.34 112.214 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -179.27 -75.33 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.194 -1.409 . . . . 64.24 107.194 171.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.486 ' HG3' ' ND2' ' A' ' 109' ' ' ASN . 11.3 pt-20 176.03 141.88 0.22 Allowed Pre-proline 0 C--O 1.242 0.667 0 C-N-CA 125.165 1.386 . . . . 64.44 107.92 177.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -73.79 120.18 6.27 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.46 1.44 . . . . 54.21 109.841 174.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.486 ' ND2' ' HG3' ' A' ' 107' ' ' GLU . 0.7 OUTLIER -99.81 -160.55 0.81 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.685 -1.598 . . . . 71.24 106.685 178.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.98 -10.42 59.35 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 122.396 1.093 . . . . 72.12 109.115 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 109' ' ' ASN . 14.8 p -142.5 176.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 N-CA-C 104.674 -2.343 . . . . 44.5 104.674 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.561 HD12 ' HB3' ' A' ' 115' ' ' ALA . 8.8 pt -57.53 -39.82 71.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 118.504 0.593 . . . . 70.24 111.896 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.99 -64.83 3.03 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.751 -0.261 . . . . 63.31 112.952 175.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.49 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 0.5 OUTLIER -50.82 -48.05 59.91 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 125.243 1.417 . . . . 74.22 111.884 -177.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.742 ' HB2' ' HZ2' ' A' ' 83' ' ' TRP . . . -71.57 -23.68 61.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 114.604 1.335 . . . . 72.01 114.604 -173.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 60.98 33.36 19.79 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 122.012 0.91 . . . . 63.52 109.208 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -109.29 -164.47 0.94 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.096 -0.956 . . . . 74.13 112.182 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.402 ' HB2' HG23 ' A' ' 122' ' ' VAL . 26.7 mmtp -76.45 -170.15 1.42 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.255 -0.884 . . . . 74.05 108.881 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.461 ' HB3' HG23 ' A' ' 111' ' ' VAL . 14.2 p -126.72 -68.22 0.82 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.251 -0.98 . . . . 72.54 112.754 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.5 t -62.34 -44.5 96.34 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 123.158 0.286 . . . . 63.13 110.561 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p -70.61 -34.07 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 119.36 -0.936 . . . . 71.43 110.313 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 112' ' ' ILE . 73.5 t -68.14 -42.81 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.648 -0.251 . . . . 72.33 110.987 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.8 ttp85 -59.24 -50.76 72.78 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.896 -0.779 . . . . 63.22 108.896 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.53 -41.76 99.63 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-N 115.736 -0.665 . . . . 43.01 113.061 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.401 ' O ' ' HA3' ' A' ' 129' ' ' GLY . 2.3 tmmm? -68.79 -32.15 71.68 Favored 'General case' 0 C--O 1.198 -1.61 0 N-CA-C 112.196 0.443 . . . . 74.14 112.196 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.462 ' HA ' ' CE ' ' A' ' 126' ' ' MET . 2.6 mmt -78.31 -42.37 30.93 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.234 -0.586 . . . . 73.35 110.604 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -56.93 -63.55 1.17 Allowed 'General case' 0 C--O 1.251 1.149 0 C-N-CA 124.232 1.013 . . . . 73.3 109.348 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.31 -34.24 64.15 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.262 -0.881 . . . . 45.24 111.722 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -61.4 -59.37 10.01 Favored Glycine 0 C--O 1.209 -1.419 0 CA-C-O 119.256 -0.746 . . . . 62.24 112.333 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.417 ' HE3' HG23 ' A' ' 134' ' ' VAL . 61.1 m95 -59.49 -38.66 81.45 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 117.931 0.866 . . . . 74.44 112.646 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.2 m -60.5 -52.91 63.17 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 120.504 -0.479 . . . . 71.21 110.796 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.49 -49.56 18.95 Favored Glycine 0 C--O 1.242 0.595 0 C-N-CA 121.162 -0.542 . . . . 74.13 113.562 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 77.3 mt -61.1 -49.64 83.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 C-N-CA 122.699 0.399 . . . . 74.25 111.154 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.523 ' HA ' HD23 ' A' ' 138' ' ' LEU . 97.3 t -63.48 -49.78 81.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.223 -0.991 . . . . 62.42 111.441 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -55.28 -63.89 1.02 Allowed 'General case' 0 C--O 1.246 0.905 0 O-C-N 123.785 0.678 . . . . 54.21 111.864 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 7.0 tp10 -81.98 -40.83 21.62 Favored 'General case' 0 C--O 1.174 -2.896 0 C-N-CA 118.424 -1.31 . . . . 61.22 113.211 -173.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.523 ' NH2' ' HA ' ' A' ' 37' ' ' LYS . 2.1 tmt_? -64.19 -37.04 86.04 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.976 1.262 . . . . 71.33 110.028 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.3 mm? -69.93 -50.16 44.82 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 119.125 -1.03 . . . . 60.31 110.206 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.437 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 1.9 tmm_? -61.62 -36.52 80.98 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 121.359 0.6 . . . . 73.13 111.246 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -70.86 -47.76 57.58 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 123.746 0.818 . . . . 74.44 108.891 -177.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.01 75.01 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 111.608 0.225 . . . . 61.24 111.608 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.56 -32.17 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 119.718 -0.793 . . . . 55.24 110.923 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.49 -48.41 22.73 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 120.173 -0.611 . . . . 64.11 111.519 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.464 ' HG3' ' HE2' ' A' ' 140' ' ' LYS . 8.0 pt-20 -171.71 105.38 0.2 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.769 0.828 . . . . 75.3 110.611 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 57.7 tp -70.36 97.01 1.2 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.561 0.696 . . . . 64.23 110.463 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -97.06 -44.49 6.96 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.428 -0.806 . . . . 74.54 111.969 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -144.82 173.99 11.38 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.671 0.272 . . . . 73.31 110.441 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.94 174.34 7.21 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.788 -0.819 . . . . 73.34 108.788 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -156.11 132.01 9.81 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.207 -0.597 . . . . 72.13 110.294 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -145.33 164.32 31.82 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.988 -1.116 . . . . 72.24 107.988 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -125.43 141.63 51.95 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.162 -0.681 . . . . 73.0 109.162 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 60.4 m80 . . . . . 0 C--N 1.303 -1.442 0 N-CA-C 109.428 -0.582 . . . . 72.15 109.428 -177.353 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.51 -0.594 0 N-CA-C 108.613 -0.884 . . . . 64.14 108.613 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 68.52 -39.18 0.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.993 1.849 . . . . 51.13 115.993 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -61.42 -31.08 71.0 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 123.262 0.625 . . . . 74.41 112.274 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.628 ' ND2' ' HB2' ' A' ' 127' ' ' ASP . 28.6 p-10 -86.46 35.9 0.68 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.704 0.764 . . . . 72.02 110.451 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -75.4 1.45 13.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.083 0.953 . . . . 64.24 112.922 -175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.24 -1.52 30.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.755 0.65 . . . . 72.15 112.755 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.411 HD21 HG22 ' A' ' 111' ' ' VAL . 10.5 t30 76.7 -27.64 0.18 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.138 1.375 . . . . 65.44 113.224 170.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -97.88 -163.26 1.03 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.638 -1.616 . . . . 62.11 106.638 172.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.8 tp -108.45 99.7 34.18 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 120.116 -0.634 . . . . 43.15 110.438 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 43.1 Cg_endo -95.97 -159.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.136 2.557 . . . . 74.33 110.047 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 1.6 m-20 -76.4 109.57 10.22 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.65 -0.5 . . . . 70.41 109.65 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.6 HG22 ' HB3' ' A' ' 102' ' ' HIS . 10.9 tp -102.31 128.37 55.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.268 -1.382 . . . . 74.12 107.268 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.1 m -111.04 129.11 56.01 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 109.083 -0.71 . . . . 72.23 109.083 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 25.2 mmmt -131.31 132.1 44.28 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.716 -0.674 . . . . 73.04 110.646 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 m -118.43 132.81 56.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.887 -1.153 . . . . 73.22 107.887 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.66 140.7 20.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.922 -0.77 . . . . 54.33 108.922 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 p -103.02 132.45 49.27 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.612 0.72 . . . . 75.41 112.905 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 139' ' ' ARG . 2.2 mm? -108.79 140.48 42.16 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.302 -0.863 . . . . 64.43 110.897 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -80.57 25.46 0.42 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.603 1.161 . . . . 71.02 111.314 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -131.76 165.34 36.42 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 108.678 -0.86 . . . . 73.24 108.678 -174.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 46.2 Cg_endo -72.09 161.3 45.1 Favored 'Trans proline' 0 C--O 1.257 1.456 0 C-N-CA 121.907 1.738 . . . . 75.1 111.06 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.0 tt -58.21 -31.11 41.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 115.906 -0.588 . . . . 73.34 110.795 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -56.4 -50.59 71.17 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.937 0.895 . . . . 74.31 111.729 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -73.64 -36.55 65.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.116 -0.493 . . . . 74.13 110.618 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.44 HG21 ' HB ' ' A' ' 96' ' ' THR . 46.1 t -67.69 -41.13 85.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.761 -0.459 . . . . 73.33 109.761 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 46.3 t90 -61.29 -46.98 88.09 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.962 -1.017 . . . . 74.31 110.226 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -23.63 63.73 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.312 -0.555 . . . . 72.11 111.68 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.8 m -67.49 -18.1 64.93 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 121.431 0.634 . . . . 73.34 111.337 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.576 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 9.9 m -123.05 17.5 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 O-C-N 121.463 -0.773 . . . . 65.01 110.837 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.5 m -142.12 9.08 1.88 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.15 0.796 . . . . 70.45 113.15 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.4 p -114.07 168.56 9.71 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 121.635 -0.666 . . . . 61.41 109.771 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.655 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 15.9 m -58.38 -40.55 82.61 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 123.85 0.719 . . . . 74.52 109.507 175.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -68.85 -46.88 67.36 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.692 -1.14 . . . . 75.54 110.955 -177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.5 -47.99 25.56 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.84 -0.695 . . . . 73.31 113.62 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.04 -34.29 62.55 Favored 'Isoleucine or valine' 0 C--O 1.256 1.401 0 CA-C-O 121.182 0.515 . . . . 71.13 110.722 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.61 -30.56 43.26 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.702 -0.681 . . . . 74.43 112.062 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm 74.7 -57.74 0.6 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.912 1.285 . . . . 73.21 111.499 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -92.55 155.02 18.07 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 104.875 -2.269 . . . . 74.54 104.875 171.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -75.2 87.22 2.45 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.842 0.83 . . . . 71.43 110.042 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 59.4 mtm -131.3 118.18 17.08 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.594 -1.262 . . . . 72.21 107.594 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.71 96.71 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.43 2.087 . . . . 75.01 112.145 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.655 ' O ' ' HB3' ' A' ' 32' ' ' SER . 43.1 t-20 -134.34 143.2 47.54 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.935 -1.876 . . . . 63.22 105.935 176.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -90.81 69.61 6.51 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 113.288 0.848 . . . . 71.02 113.288 -170.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.484 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 94.0 m-85 -77.39 130.36 36.98 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.584 -1.265 . . . . 74.43 107.584 171.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -109.44 145.04 36.83 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.448 -0.945 . . . . 74.11 108.448 -174.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.0 tp -89.2 103.32 15.95 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 106.301 -1.74 . . . . 74.51 106.301 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 82.3 tttt -133.43 132.24 40.89 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.812 -1.551 . . . . 74.4 106.812 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.442 ' HA ' HG23 ' A' ' 68' ' ' VAL . 10.4 pt-20 -91.11 76.36 6.13 Favored 'General case' 0 C--N 1.258 -3.376 0 CA-C-O 122.922 1.344 . . . . 72.51 108.842 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.33 57.48 0.11 Allowed Glycine 0 N--CA 1.405 -3.415 0 CA-C-N 112.47 -2.15 . . . . 70.21 110.244 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 14.8 tt0 -91.43 142.64 27.45 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 109.403 -0.591 . . . . 73.13 109.403 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.75 147.88 43.4 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.466 -0.939 . . . . 74.35 108.466 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -129.82 147.04 51.55 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.145 -0.622 . . . . 71.54 109.943 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -133.51 140.0 46.97 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.628 -1.619 . . . . 63.52 106.628 175.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.44 75.64 10.23 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.513 -1.292 . . . . 74.42 107.513 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -89.94 -46.65 8.39 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.675 -1.148 . . . . 75.2 109.999 -174.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.2 t -114.94 -62.53 0.03 OUTLIER Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-O 119.1 -0.476 . . . . 72.52 109.866 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.43 123.75 9.79 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 121.263 1.309 . . . . 71.3 110.374 173.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -104.68 -25.1 12.84 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.601 0.715 . . . . 73.25 109.232 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.52 -68.24 1.43 Allowed Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.241 -0.89 . . . . 74.25 112.538 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.81 104.62 0.48 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.562 2.175 . . . . 61.33 111.416 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.5 p -85.64 113.72 52.66 Favored Pre-proline 0 N--CA 1.425 -1.678 0 CA-C-N 115.493 -0.776 . . . . 65.05 110.862 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.77 -179.97 4.7 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.343 2.029 . . . . 74.32 111.115 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 12.1 p -110.53 169.9 8.44 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.183 0.516 . . . . 64.21 111.526 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 28.9 ttpp -121.52 118.01 28.22 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 105.359 -2.089 . . . . 53.51 105.359 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 50' ' ' GLN . 21.7 t -85.67 135.22 25.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 120.155 -0.618 . . . . 73.42 109.529 -174.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.3 tp -83.17 -56.14 3.95 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.043 -0.725 . . . . 72.11 109.043 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.5 149.32 16.89 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.228 -0.896 . . . . 52.13 109.997 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' ' 48' ' ' GLU . 21.9 t -126.54 119.31 53.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.524 -1.287 . . . . 74.01 107.524 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 13.1 mm-40 -103.63 141.79 35.43 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 121.24 0.543 . . . . 72.14 110.442 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.17 130.65 93.65 Favored Pre-proline 0 C--N 1.271 -2.824 0 CA-C-N 114.031 -1.44 . . . . 73.04 109.062 -167.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo 2.6 48.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.371 1 C-N-CA 128.189 5.926 . . . . 71.33 117.66 -162.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 6.9 m -142.72 -36.87 0.38 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.941 -0.572 . . . . 74.53 110.564 175.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.5 tt0 -147.77 144.61 28.36 Favored 'General case' 0 C--O 1.201 -1.451 0 C-N-CA 118.035 -1.466 . . . . 72.23 111.847 -174.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.659 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -139.0 134.46 33.09 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.015 -1.106 . . . . 65.32 108.015 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 p -141.69 126.53 18.15 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.656 -0.418 . . . . 45.22 112.115 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.55 ' HD2' HD11 ' A' ' 74' ' ' LEU . 31.1 p90 -145.23 155.77 43.44 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 110.234 -0.284 . . . . 75.11 110.234 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -122.19 134.01 54.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.722 -1.214 . . . . 72.13 107.722 -173.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -113.78 125.05 53.67 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.971 -1.122 . . . . 74.41 107.971 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.26 -28.81 69.97 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.125 1.157 . . . . 63.34 114.125 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.7 m -66.67 94.81 0.31 Allowed 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.955 0.883 . . . . 71.15 109.722 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.265 63.2 mm-40 77.56 4.71 3.05 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 127.865 2.466 . . . . 75.41 114.16 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.32 58.78 6.27 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.599 -0.728 . . . . 61.23 112.778 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -98.32 133.07 43.23 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.702 -0.399 . . . . 74.23 109.965 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.46 120.41 63.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.063 -1.088 . . . . 72.33 108.063 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.63 150.55 18.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.322 0.582 . . . . 62.11 110.918 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.521 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 88.3 m -137.87 137.68 38.34 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.577 -0.898 . . . . 74.1 108.577 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.659 ' CD2' HD12 ' A' ' 74' ' ' LEU . 26.3 m-85 -122.27 147.05 46.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.007 -1.109 . . . . 75.0 108.007 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 72' ' ' THR . 24.3 mt-30 -131.49 141.3 49.73 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 123.482 0.489 . . . . 61.42 111.127 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -112.93 124.1 51.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.1 0.476 . . . . 72.5 111.226 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.71 123.99 51.09 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 125.143 1.377 . . . . 65.15 109.475 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -84.8 123.14 30.1 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.132 -0.486 . . . . 72.13 110.832 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.7 mt -124.9 157.84 34.98 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.053 -1.091 . . . . 55.43 108.053 174.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 94' ' ' GLU . . . -82.31 50.22 4.28 Favored Glycine 0 C--N 1.3 -1.423 0 N-CA-C 115.269 0.868 . . . . 72.32 115.269 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 93' ' ' GLY . 6.1 tp10 167.65 -39.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.256 1.022 . . . . 54.52 108.983 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -126.16 175.69 7.59 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.039 -1.097 . . . . 62.5 108.039 -173.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.44 ' HB ' HG21 ' A' ' 25' ' ' VAL . 60.9 m -122.2 134.71 54.71 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.616 -0.513 . . . . 70.22 109.616 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -93.84 114.56 4.77 Favored Glycine 0 N--CA 1.416 -2.654 0 N-CA-C 109.106 -1.598 . . . . 73.43 109.106 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -101.96 134.65 44.83 Favored 'General case' 0 C--N 1.268 -2.977 0 N-CA-C 108.948 -0.76 . . . . 63.44 108.948 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 35.8 m -120.2 126.82 51.6 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 108.28 -1.007 . . . . 62.43 108.28 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -104.4 137.21 42.61 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 106.885 -1.524 . . . . 71.11 106.885 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.521 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.4 mp -135.23 123.67 39.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.747 0 N-CA-C 106.134 -1.802 . . . . 71.41 106.134 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.6 ' HB3' HG22 ' A' ' 12' ' ' ILE . 3.4 t-160 -121.27 132.33 54.74 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.533 -1.284 . . . . 65.22 107.533 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.2 t -136.19 154.57 50.91 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.461 -0.94 . . . . 65.11 108.461 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.81 170.58 53.24 Favored Glycine 0 C--O 1.262 1.867 0 N-CA-C 109.253 -1.539 . . . . 32.13 109.253 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 34.8 t-105 -52.75 -60.23 3.52 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 123.07 0.548 . . . . 73.44 110.202 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp 170.14 110.86 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 123.977 0.911 . . . . 65.32 109.295 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 176.03 124.1 0.15 Allowed Pre-proline 0 C--N 1.329 -0.321 0 O-C-N 124.527 1.142 . . . . 75.41 108.823 171.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -92.78 41.06 0.26 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.022 2.481 . . . . 53.42 111.303 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -86.66 -172.15 3.88 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.292 -0.413 . . . . 64.14 111.364 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -91.69 -38.82 12.19 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.134 1.161 . . . . 63.04 114.134 -172.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 119' ' ' SER . 22.1 t -129.68 155.6 41.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.547 -1.279 . . . . 75.42 107.547 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.549 HD13 HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -59.85 -32.98 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 120.892 0.377 . . . . 74.32 111.164 178.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.51 -89.47 0.93 Allowed Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.905 -0.589 . . . . 61.13 114.259 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -57.53 -23.88 52.85 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 125.122 1.369 . . . . 65.13 114.68 -172.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.14 -13.98 62.73 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.906 0.384 . . . . 71.03 111.797 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.7 m120 76.06 -19.83 0.39 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.099 1.36 . . . . 70.44 114.201 175.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.47 154.94 36.71 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.865 -0.42 . . . . 52.34 109.865 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HB2' HG12 ' A' ' 121' ' ' VAL . 99.3 mttt -67.99 149.06 50.19 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.145 0.498 . . . . 63.23 111.2 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.639 ' HB3' HG13 ' A' ' 111' ' ' VAL . 3.0 p -58.29 -44.55 88.55 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 124.293 1.037 . . . . 74.35 111.814 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.4 p -65.2 -45.99 82.54 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.343 -0.844 . . . . 71.53 111.497 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 118' ' ' LYS . 7.2 p -69.84 -37.72 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 120.132 -0.627 . . . . 74.32 109.616 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.593 ' O ' ' HG3' ' A' ' 126' ' ' MET . 54.3 t -61.53 -45.88 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 120.818 -0.353 . . . . 71.24 111.134 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -55.44 -49.54 72.16 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.471 0.482 . . . . 72.02 111.138 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.22 -42.42 90.97 Favored Glycine 0 CA--C 1.5 -0.858 0 CA-C-N 115.891 -0.595 . . . . 62.44 112.781 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -68.63 -44.1 74.91 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 113.095 0.776 . . . . 72.35 113.095 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.593 ' HG3' ' O ' ' A' ' 122' ' ' VAL 0.382 0.0 OUTLIER -77.1 -29.28 54.8 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 118.196 -1.402 . . . . 74.0 113.778 -177.774 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.628 ' HB2' ' ND2' ' A' ' 4' ' ' ASN . 27.0 t70 -71.66 -55.81 7.01 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.867 -0.733 . . . . 75.52 109.119 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.37 -38.01 95.73 Favored Glycine 0 CA--C 1.5 -0.869 0 CA-C-N 115.526 -0.761 . . . . 73.31 112.254 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.82 -58.14 11.99 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 111.713 -0.555 . . . . 34.32 111.713 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.529 ' O ' ' HB ' ' A' ' 134' ' ' VAL . 94.3 m95 -64.42 -36.78 85.26 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.073 1.138 . . . . 74.22 114.073 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.0 p -67.64 -53.87 24.36 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.148 -0.621 . . . . 60.34 110.976 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.1 -48.58 38.74 Favored Glycine 0 C--O 1.246 0.9 0 C-N-CA 121.492 -0.385 . . . . 74.13 113.428 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.414 HG12 ' NE2' ' A' ' 149' ' ' HIS . 77.0 mt -64.01 -54.0 36.94 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.281 0 CA-C-O 119.185 -0.436 . . . . 73.12 110.666 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 130' ' ' TRP . 6.2 t -58.83 -40.71 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 113.608 0.966 . . . . 75.31 113.608 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -53.76 -59.54 4.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.244 0.545 . . . . 74.14 111.043 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.24 -42.14 26.61 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 113.258 0.836 . . . . 64.3 113.258 -174.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 148' ' ' HIS . 1.9 tmt_? -65.24 -41.48 94.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.225 0.466 . . . . 74.23 109.767 -174.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.2 mm? -66.65 -51.45 56.05 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 120.646 -0.422 . . . . 74.14 109.922 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.432 ' HA ' HD12 ' A' ' 18' ' ' LEU . 4.6 tmm_? -64.28 -31.78 73.11 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.951 0.405 . . . . 75.24 110.99 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.41 ' HE3' ' HG3' ' A' ' 144' ' ' GLU . 11.4 mmmm -79.08 -44.72 21.53 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 113.489 0.922 . . . . 75.31 113.489 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.62 -23.89 67.41 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.624 -0.431 . . . . 61.44 111.096 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.444 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 24.0 m -85.35 -33.9 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 120.512 -0.475 . . . . 44.45 111.336 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -85.73 -70.47 0.59 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.937 0.717 . . . . 55.12 112.937 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.41 ' HG3' ' HE3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -137.92 141.73 40.6 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.389 0.614 . . . . 73.11 111.801 -178.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.668 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -93.13 17.07 11.53 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.392 1.256 . . . . 74.44 114.392 -171.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -77.61 -56.52 4.45 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.467 -0.938 . . . . 62.42 108.467 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -128.04 108.37 10.6 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.154 -0.618 . . . . 72.03 109.749 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 137' ' ' ARG . 55.3 p-80 -82.32 -10.22 59.17 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.894 -0.594 . . . . 72.21 110.907 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 151' ' ' HIS . 13.7 t-80 -157.21 126.59 6.02 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.2 -1.778 . . . . 71.33 106.2 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -83.0 -25.03 32.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.061 0.458 . . . . 65.15 110.523 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.558 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 54.6 t-80 -77.82 111.88 14.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.654 -0.703 . . . . 64.31 109.572 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.3 p80 . . . . . 0 C--N 1.283 -2.304 0 CA-C-N 114.385 -1.279 . . . . 72.3 110.161 177.866 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 CA--C 1.51 -0.592 0 N-CA-C 110.033 -0.358 . . . . 71.2 110.033 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.66 122.39 9.26 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.786 -0.45 . . . . 74.13 109.786 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -75.35 -40.04 58.66 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.747 -1.575 . . . . 71.32 106.747 173.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -137.61 133.09 33.98 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 106.333 -1.729 . . . . 74.22 106.333 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -91.93 60.49 3.87 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.501 -0.926 . . . . 70.43 108.501 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' HB2' HD23 ' A' ' 9' ' ' LEU 0.327 0.6 OUTLIER 36.27 60.32 0.88 Allowed 'General case' 0 C--N 1.345 0.398 0 C-N-CA 125.987 1.715 . . . . 74.02 115.548 178.854 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -80.63 -43.74 19.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.154 -0.475 . . . . 74.34 111.209 -177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 106' ' ' LYS . . . -117.09 19.98 13.98 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.879 -0.786 . . . . 62.31 108.879 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 6' ' ' GLU . 75.4 mt 54.16 78.38 0.39 Allowed Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 113.815 -1.539 . . . . 53.43 113.37 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.85 -159.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 122.635 2.223 . . . . 64.32 108.865 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 44.3 m-20 -64.49 104.33 0.78 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.242 0.46 . . . . 73.03 112.242 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 77.3 mt -93.38 126.5 45.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.46 -1.681 . . . . 71.14 106.46 174.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.2 m -111.45 127.94 55.84 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.045 -0.662 . . . . 55.44 109.713 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 29.7 mmmt -131.89 126.12 33.39 Favored 'General case' 0 C--O 1.197 -1.658 0 N-CA-C 108.955 -0.757 . . . . 64.35 108.955 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.3 m -118.1 142.66 47.18 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 119.624 -0.83 . . . . 65.21 109.825 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -150.86 141.73 16.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.42 -0.956 . . . . 65.34 108.42 -178.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.47 HG22 ' HG3' ' A' ' 95' ' ' LYS . 0.8 OUTLIER -106.61 127.08 53.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.324 -0.621 . . . . 72.12 109.324 -178.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.7 mp -106.39 140.08 39.87 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 122.998 0.519 . . . . 72.42 109.717 -175.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -75.05 -2.02 25.48 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 124.091 0.956 . . . . 74.51 112.074 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.412 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -99.07 159.78 29.33 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 116.328 -0.396 . . . . 72.34 111.825 -172.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.49 153.61 73.73 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.305 2.67 . . . . 62.11 111.778 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.7 tt -48.86 -40.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.103 0.961 . . . . 62.22 112.628 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -70.98 -29.65 65.69 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.231 -0.588 . . . . 71.43 111.954 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -73.88 -36.82 64.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.629 0.728 . . . . 73.03 109.109 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' HG22 ' A' ' 29' ' ' VAL . 58.3 t -69.72 -41.24 79.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.534 -0.913 . . . . 64.25 108.534 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -58.77 -47.95 82.93 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.293 -0.867 . . . . 75.32 111.61 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -64.65 -35.24 80.4 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.302 -0.959 . . . . 72.51 110.776 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.2 m -63.75 -23.91 67.56 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 112.177 0.436 . . . . 62.32 112.177 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 16.0 m -121.72 15.2 5.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 112.789 0.662 . . . . 61.32 112.789 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.5 t -142.76 9.72 1.77 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 119.481 -0.888 . . . . 61.13 112.66 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.7 p -122.22 171.78 8.77 Favored 'General case' 0 C--O 1.247 0.972 0 O-C-N 121.455 -0.778 . . . . 74.41 110.557 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 m -63.72 -48.86 75.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.548 -0.538 . . . . 74.21 109.548 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.29 -41.86 96.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.846 -0.615 . . . . 73.51 111.691 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.32 -49.45 20.34 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 120.078 -1.058 . . . . 40.03 114.073 -176.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.9 mt -72.14 -50.68 35.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 118.344 1.072 . . . . 64.32 112.499 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.8 -48.32 69.33 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.205 0.526 . . . . 72.51 111.301 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.601 ' HE2' ' HA ' ' A' ' 37' ' ' LYS . 0.5 OUTLIER 62.71 7.04 2.31 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.931 1.292 . . . . 61.22 112.262 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.5 m95 73.53 23.73 2.39 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.649 1.18 . . . . 75.24 113.22 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -68.13 -52.13 38.29 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 104.614 -2.365 . . . . 75.03 104.614 168.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.4 mmt -132.85 131.08 21.82 Favored Pre-proline 0 N--CA 1.426 -1.641 0 N-CA-C 105.422 -2.066 . . . . 75.15 105.422 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.79 105.47 1.32 Allowed 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 121.395 1.397 . . . . 72.34 109.877 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -121.22 149.61 42.59 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.156 -1.424 . . . . 70.31 107.156 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -105.83 79.3 1.41 Allowed 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.941 0.877 . . . . 75.45 110.525 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -90.53 119.81 31.1 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.556 -1.202 . . . . 75.5 110.546 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -119.56 153.36 35.53 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.304 -1.739 . . . . 72.24 106.304 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -74.78 104.31 5.37 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.594 -1.262 . . . . 75.33 107.594 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 50' ' ' GLN . 47.4 tttp -132.97 144.54 50.18 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.711 -1.588 . . . . 64.23 106.711 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -91.76 69.79 5.63 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-O 122.097 0.951 . . . . 72.05 108.449 174.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.95 61.1 0.19 Allowed Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 110.119 -1.193 . . . . 71.02 110.119 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.651 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -95.55 112.72 24.39 Favored 'General case' 0 CA--C 1.473 -2.016 0 N-CA-C 106.489 -1.671 . . . . 64.24 106.489 -179.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.56 134.46 55.03 Favored 'General case' 0 C--N 1.276 -2.621 0 C-N-CA 119.283 -0.967 . . . . 64.43 109.425 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -110.57 117.87 34.68 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 103.411 -2.811 . . . . 62.33 103.411 173.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -109.47 162.61 14.21 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.891 0.377 . . . . 74.24 111.239 -169.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.63 148.76 44.47 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.106 -0.952 . . . . 74.25 109.438 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -85.99 147.51 26.18 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.126 -1.064 . . . . 71.14 108.126 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.1 m 71.27 103.03 0.03 OUTLIER Pre-proline 0 C--O 1.214 -0.771 0 O-C-N 124.72 1.262 . . . . 74.03 109.193 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.92 98.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 123.294 2.663 . . . . 74.24 114.953 -172.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -102.2 176.32 5.23 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.075 -1.083 . . . . 73.31 108.075 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.94 147.18 49.2 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.591 -1.404 . . . . 60.34 109.591 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.49 89.84 0.12 Allowed 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.542 2.161 . . . . 70.52 113.794 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.403 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 16.5 m -86.93 -47.34 0.51 Allowed Pre-proline 0 C--N 1.299 -1.618 0 CA-C-N 115.585 -0.734 . . . . 74.41 110.321 173.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 61' ' ' SER . 10.9 Cg_exo -75.78 145.55 28.98 Favored 'Trans proline' 0 C--N 1.386 2.525 0 C-N-CA 121.423 1.416 . . . . 74.32 109.202 172.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 48.4 m -89.23 168.8 11.99 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.775 0.321 . . . . 73.15 111.635 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 90.8 mttt -142.02 133.68 26.92 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 116.28 -0.418 . . . . 62.24 110.65 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.501 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 36.2 t -90.58 136.71 23.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 106.271 -1.751 . . . . 73.14 106.271 175.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.8 tp -78.98 -61.42 2.02 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.109 -1.071 . . . . 64.25 108.109 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -162.37 153.99 18.34 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.905 -1.043 . . . . 43.14 108.877 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.573 HG23 HD23 ' A' ' 74' ' ' LEU . 12.8 p -131.19 131.82 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.34 0 CA-C-O 121.625 0.726 . . . . 63.14 110.458 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.7 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 85.7 mm-40 -110.29 141.75 42.85 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 114.363 -1.29 . . . . 71.13 108.077 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.52 136.07 96.01 Favored Pre-proline 0 C--N 1.288 -2.085 0 CA-C-N 115.024 -0.989 . . . . 72.31 109.635 -164.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo 0.59 50.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.366 1.491 1 C-N-CA 128.301 6.001 . . . . 74.03 117.484 -162.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.59 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 4.7 m -145.19 -46.83 0.23 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 112.001 0.371 . . . . 61.42 112.001 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.7 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 11.0 tp10 -132.71 126.76 33.26 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.48 -0.933 . . . . 74.42 108.48 -171.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.66 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -135.7 132.72 37.26 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.517 -0.549 . . . . 75.24 109.517 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.5 m -135.05 126.72 29.0 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 123.221 0.326 . . . . 73.31 111.432 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.43 ' HD1' HD11 ' A' ' 74' ' ' LEU . 31.9 p90 -146.23 155.64 42.83 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.003 -0.436 . . . . 71.14 111.654 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -123.05 125.8 45.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.795 -1.187 . . . . 74.33 107.795 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -139.86 160.99 38.64 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.791 -0.363 . . . . 74.2 111.492 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 83' ' ' TRP . 48.6 t0 74.31 163.69 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.042 1.337 . . . . 61.33 111.546 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.9 m -59.11 -39.37 82.08 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.389 1.075 . . . . 74.04 112.009 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -79.89 -5.12 54.95 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.007 0.743 . . . . 52.3 113.007 -178.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 105' ' ' TRP . . . 68.43 73.62 0.68 Allowed Glycine 0 N--CA 1.442 -0.946 0 O-C-N 123.594 0.559 . . . . 54.03 113.004 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.442 ' CD1' ' HB3' ' A' ' 79' ' ' ASP . 50.6 m95 -85.98 112.97 21.7 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.696 -1.224 . . . . 64.0 107.696 177.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.32 101.98 13.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 106.967 -1.494 . . . . 74.23 106.967 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.5 m -108.85 144.78 16.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 120.973 0.416 . . . . 72.21 110.309 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 7.4 m -131.3 143.02 50.22 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.689 -0.856 . . . . 72.11 108.689 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.66 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.0 m-85 -120.8 147.53 45.22 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.829 -0.804 . . . . 71.23 108.829 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.584 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 72.9 mt-30 -133.2 144.5 49.86 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 112.795 0.665 . . . . 73.32 112.795 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 72' ' ' THR . 1.9 tm? -98.03 134.16 41.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.203 -0.908 . . . . 62.25 111.361 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -123.73 116.04 22.38 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.769 -2.308 . . . . 63.04 104.769 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -93.08 115.16 27.84 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.475 -0.89 . . . . 64.44 111.321 -175.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.8 mt -103.88 153.38 20.84 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.986 -1.116 . . . . 71.0 107.986 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.33 54.64 4.91 Favored Glycine 0 C--N 1.282 -2.431 0 C-N-CA 121.087 -0.577 . . . . 33.43 112.856 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 174.59 -33.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.323 0.649 . . . . 72.34 109.908 -177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 7.2 ptpt -150.33 175.27 11.98 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.772 -0.825 . . . . 65.22 108.772 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.0 m -111.47 123.15 49.62 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 121.176 0.512 . . . . 71.31 111.101 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.99 131.09 10.36 Favored Glycine 0 N--CA 1.406 -3.343 0 N-CA-C 108.484 -1.847 . . . . 34.12 108.484 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -120.12 134.5 55.24 Favored 'General case' 0 C--N 1.261 -3.277 0 C-N-CA 122.866 0.467 . . . . 73.21 109.804 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 90.8 m -117.77 127.17 53.64 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.917 -0.772 . . . . 74.44 108.917 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.567 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -103.62 140.56 37.39 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 108.59 -0.893 . . . . 75.5 108.59 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.501 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.9 mp -136.22 124.66 36.59 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.943 0 CA-C-N 113.662 -1.608 . . . . 61.54 106.973 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.538 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 18.2 t-160 -114.47 112.77 23.52 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.584 -1.265 . . . . 72.2 107.584 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.2 m -107.31 132.36 53.21 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.302 -1.74 . . . . 52.23 106.302 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.55 154.81 20.1 Favored Glycine 0 N--CA 1.426 -2.009 0 C-N-CA 120.838 -0.696 . . . . 24.44 112.894 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.405 ' HB2' ' O ' ' A' ' 82' ' ' GLY . 73.6 t-105 -68.98 -43.34 75.11 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.157 -0.522 . . . . 75.53 109.979 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 20.4 ptmt 38.16 91.0 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.306 1.595 . . . . 74.12 115.306 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.557 ' HB2' ' HD3' ' A' ' 108' ' ' PRO . 47.1 mt-10 -62.14 -52.66 65.56 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 120.341 -0.544 . . . . 72.15 110.29 176.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 107' ' ' GLU . 77.8 Cg_endo -102.0 -170.82 0.08 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.717 0 C-N-CA 121.831 1.688 . . . . 52.32 110.478 171.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -113.36 21.96 14.69 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.793 0.806 . . . . 71.31 109.06 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.71 -64.04 1.11 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.643 -1.162 . . . . 72.41 109.378 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.448 HG12 HD13 ' A' ' 112' ' ' ILE . 10.5 t -139.66 172.76 12.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 103.622 -2.732 . . . . 73.13 103.622 177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -62.39 -37.84 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.247 1.385 . . . . 73.13 113.767 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 131.22 -75.76 0.42 Allowed Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.471 -0.871 . . . . 54.33 113.847 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -117.03 5.48 12.83 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 113.735 1.013 . . . . 63.53 113.735 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.45 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -73.08 -40.36 65.1 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.589 -0.845 . . . . 71.11 111.354 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 174.91 137.44 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.174 -1.788 . . . . 44.41 106.174 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.25 -18.67 61.2 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.773 0.657 . . . . 73.33 112.773 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.591 ' HB3' HG22 ' A' ' 121' ' ' VAL . 43.0 tptt -91.37 97.77 11.3 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.413 -0.915 . . . . 75.42 110.577 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.3 t -58.48 -37.97 76.64 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.356 -1.293 . . . . 65.01 111.621 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.44 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 29.5 t -66.13 -45.07 82.33 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.964 -0.294 . . . . 50.13 111.51 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 118' ' ' LYS . 12.6 m -69.91 -34.48 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 119.453 -0.899 . . . . 75.14 109.64 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 63.0 t -66.29 -44.68 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 120.468 -0.493 . . . . 73.3 111.509 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.44 ' HG3' ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -68.01 -37.15 81.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.996 -0.682 . . . . 74.13 111.276 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.428 ' N ' ' HD3' ' A' ' 123' ' ' ARG . . . -63.51 -45.59 94.41 Favored Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 111.012 -0.835 . . . . 74.32 111.012 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.28 -40.1 95.28 Favored 'General case' 0 C--O 1.193 -1.869 0 CA-C-N 115.011 -0.595 . . . . 74.2 111.95 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 24.2 mmt -69.32 -40.91 77.34 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.354 -0.538 . . . . 72.02 111.073 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.61 -57.66 11.17 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.419 0.628 . . . . 64.51 109.695 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.09 -38.63 59.41 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.47 -0.787 . . . . 63.32 112.389 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.79 -54.11 36.04 Favored Glycine 0 CA--C 1.491 -1.417 0 CA-C-O 119.72 -0.489 . . . . 54.14 112.036 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -61.91 -35.16 77.54 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 117.424 0.612 . . . . 72.3 112.456 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 87.2 m -62.37 -48.37 80.07 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 120.439 -0.504 . . . . 72.11 110.906 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.7 -46.44 24.32 Favored Glycine 0 C--O 1.247 0.907 0 C-N-CA 120.688 -0.768 . . . . 74.42 113.661 -177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.51 -52.32 59.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 122.347 0.259 . . . . 74.33 110.871 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.648 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 96.4 t -65.24 -48.48 83.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 119.81 -0.756 . . . . 41.35 112.318 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.403 ' HA ' HG13 ' A' ' 16' ' ' ILE . 9.1 t30 -59.39 -60.45 3.84 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 112.738 0.644 . . . . 74.53 112.738 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 32.4 tt0 -74.46 -48.98 24.15 Favored 'General case' 0 C--O 1.208 -1.091 0 C-N-CA 120.047 -0.661 . . . . 74.44 112.726 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.542 ' O ' ' HD2' ' A' ' 137' ' ' ARG . 1.2 tmm_? -67.85 -32.27 72.67 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.032 -0.667 . . . . 71.24 111.41 -170.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.648 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 3.4 mm? -70.25 -51.86 27.41 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.769 -0.772 . . . . 73.32 110.023 174.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -34.26 76.26 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.894 -0.594 . . . . 73.23 111.584 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -71.27 -51.47 24.3 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.979 -0.748 . . . . 70.42 108.979 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.14 -26.85 68.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 74.04 111.87 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.412 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 30.1 m -83.8 -30.66 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.137 -0.625 . . . . 63.4 111.979 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -79.57 -12.86 59.84 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.156 0.979 . . . . 74.43 109.745 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -85.38 71.31 10.83 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 107.419 -1.326 . . . . 75.11 107.419 172.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.473 ' H ' HD23 ' A' ' 145' ' ' LEU . 2.3 pt? -113.52 138.28 50.36 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.15 -0.477 . . . . 74.04 110.978 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -81.12 109.45 15.69 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.3 -0.864 . . . . 72.24 110.556 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -88.38 -30.69 19.33 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.481 -1.303 . . . . 74.2 107.481 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -88.2 73.74 8.88 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 107.047 -1.464 . . . . 75.23 107.047 172.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -119.38 -8.01 10.12 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.936 -1.029 . . . . 71.22 108.487 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -163.07 144.72 9.9 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 103.893 -2.632 . . . . 74.54 103.893 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -84.84 123.89 30.97 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.319 -0.952 . . . . 64.31 110.061 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 76.1 m80 . . . . . 0 C--N 1.293 -1.891 0 N-CA-C 108.743 -0.836 . . . . 75.15 108.743 178.453 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.507 -0.696 0 N-CA-C 108.472 -0.936 . . . . 74.34 108.472 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.46 119.39 30.82 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.364 -0.606 . . . . 51.31 109.364 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -81.34 -28.45 34.49 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.515 -0.766 . . . . 63.33 110.116 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -56.27 107.77 0.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.623 -0.717 . . . . 63.34 112.225 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -138.94 27.0 2.43 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.672 1.225 . . . . 62.45 107.818 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -99.93 24.42 8.52 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 113.811 -1.541 . . . . 73.11 110.502 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -123.4 71.67 1.09 Allowed 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 122.576 1.179 . . . . 74.12 111.554 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 66.74 30.01 8.3 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 112.013 -2.358 . . . . 61.3 112.762 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 61.75 83.97 0.2 Allowed Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 124.122 0.969 . . . . 74.03 111.855 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -89.18 -168.22 0.32 Allowed 'Trans proline' 0 N--CA 1.429 -2.32 0 C-N-CA 122.448 2.098 . . . . 65.12 112.178 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.65 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 6.3 p-10 -61.29 131.14 49.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.995 -1.002 . . . . 72.34 113.065 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.2 tp -135.99 138.74 47.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.966 -1.124 . . . . 51.43 107.966 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.7 m -117.75 133.64 55.73 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 120.85 0.357 . . . . 71.3 110.083 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -133.73 153.64 51.55 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.794 -1.928 . . . . 75.01 105.794 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.5 m -138.0 149.88 46.49 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.154 -0.966 . . . . 75.54 110.629 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.435 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.24 144.86 16.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.008 -0.738 . . . . 60.03 109.008 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.3 122.74 46.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.944 0.878 . . . . 75.22 112.156 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.618 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.8 mp -100.94 140.43 35.24 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 115.54 -0.755 . . . . 73.53 110.695 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -92.11 46.39 1.26 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.359 -1.291 . . . . 63.4 109.184 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.434 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -143.68 161.65 45.47 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.426 -0.953 . . . . 63.34 108.426 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 33.6 Cg_endo -63.15 150.22 89.23 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 122.467 2.111 . . . . 62.01 111.135 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.1 tt -56.29 -33.34 37.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.594 0.559 . . . . 71.23 112.127 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -60.9 -42.23 97.64 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 112.194 0.442 . . . . 64.31 112.194 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -74.44 -37.79 63.18 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.259 0.552 . . . . 71.12 109.605 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.516 HG13 HD22 ' A' ' 18' ' ' LEU . 76.8 t -62.85 -41.1 91.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.463 -0.789 . . . . 73.1 109.206 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.565 ' CE2' ' HD3' ' A' ' 71' ' ' PRO . 74.9 t90 -64.7 -46.09 83.82 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.141 -1.39 . . . . 72.13 109.777 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.59 -38.9 78.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.596 0.758 . . . . 72.2 110.185 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.426 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 62.8 m -57.73 -29.98 65.18 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 112.191 0.441 . . . . 72.21 112.191 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG13 HD11 ' A' ' 138' ' ' LEU . 17.4 m -110.3 18.64 6.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 O-C-N 121.852 -0.53 . . . . 63.35 112.037 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.5 p -135.7 -12.02 2.04 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.154 0.502 . . . . 63.34 112.05 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.7 p -94.75 148.86 21.85 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.09 -0.707 . . . . 73.14 109.09 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 m -53.52 -45.83 69.89 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.794 0.838 . . . . 65.23 112.709 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -69.23 -32.45 71.7 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.848 0.356 . . . . 75.33 111.458 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 28' ' ' THR . . . -72.31 -48.36 25.08 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.391 -0.909 . . . . 73.32 111.52 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.15 -32.17 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.139 0.976 . . . . 64.4 111.738 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.85 -29.18 11.13 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.171 0.989 . . . . 65.24 112.914 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 71.5 1.97 4.08 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.871 0.693 . . . . 53.11 112.871 170.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 57.5 t90 63.36 62.75 0.94 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.7 1.238 . . . . 73.42 108.154 -174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -143.77 -58.11 0.39 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.803 -1.544 . . . . 63.04 107.856 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 55.5 ttm -147.27 111.22 4.01 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 108.393 -0.966 . . . . 72.34 108.393 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.14 103.33 0.62 Allowed 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.312 2.008 . . . . 71.35 111.463 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -126.85 155.5 42.83 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.976 -0.557 . . . . 63.33 109.779 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.43 73.33 10.52 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.988 0.899 . . . . 51.54 110.042 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -83.69 121.77 27.72 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.993 -2.225 . . . . 74.24 104.993 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -109.76 145.88 35.91 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 112.292 0.479 . . . . 64.33 112.292 -167.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -75.43 105.55 6.51 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.71 -1.589 . . . . 74.14 106.71 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -131.05 145.25 51.96 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.655 -1.979 . . . . 54.44 105.655 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HA ' HG12 ' A' ' 68' ' ' VAL . 5.1 pt-20 -87.36 34.04 0.69 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 118.963 0.801 . . . . 71.21 110.673 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.8 76.25 0.02 OUTLIER Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 108.501 -1.839 . . . . 64.55 108.501 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.436 ' HB3' ' H ' ' A' ' 65' ' ' VAL . 32.8 tt0 -87.21 162.11 17.65 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.894 -1.521 . . . . 74.23 106.894 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -118.76 159.51 23.57 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.013 -1.106 . . . . 62.32 108.013 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -96.13 139.98 31.51 Favored 'General case' 0 N--CA 1.422 -1.848 0 C-N-CA 119.865 -0.734 . . . . 73.25 109.631 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -138.23 154.76 49.08 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.836 -1.542 . . . . 55.23 106.836 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.6 mt -74.89 81.32 2.15 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.833 0.825 . . . . 65.23 108.906 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -137.35 15.53 2.98 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.244 -1.344 . . . . 75.14 110.428 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.8 p -101.82 107.58 52.58 Favored Pre-proline 0 N--CA 1.428 -1.564 0 N-CA-C 108.243 -1.021 . . . . 62.33 108.243 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -53.19 124.16 14.97 Favored 'Trans proline' 0 C--O 1.247 0.961 0 C-N-CA 123.589 2.86 . . . . 75.53 113.542 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.0 t80 70.22 -64.05 0.37 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.631 1.572 . . . . 74.12 113.271 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.82 109.48 3.85 Favored Glycine 0 C--N 1.309 -0.92 0 CA-C-O 119.384 -0.676 . . . . 74.43 111.982 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.84 110.39 0.97 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.726 2.284 . . . . 63.23 110.41 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.0 m -116.51 99.27 52.67 Favored Pre-proline 0 N--CA 1.419 -1.987 0 CA-C-N 115.868 -0.605 . . . . 73.21 110.152 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.517 ' HD2' ' HA ' ' A' ' 80' ' ' THR . 30.0 Cg_endo -71.28 101.39 1.11 Allowed 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 122.212 1.942 . . . . 74.05 110.485 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.1 p -122.35 141.77 51.21 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 115.346 -0.843 . . . . 72.43 110.108 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -155.24 143.45 20.2 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.518 -0.919 . . . . 65.3 108.518 -176.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.436 ' H ' ' HB3' ' A' ' 50' ' ' GLN . 27.1 t -88.91 127.44 41.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 105.71 -1.959 . . . . 73.22 105.71 173.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.403 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 2.1 tm? -70.74 -53.03 17.08 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.437 -1.32 . . . . 74.14 107.437 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.65 145.36 5.41 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.202 -0.908 . . . . 65.41 109.258 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.629 HG23 HD23 ' A' ' 74' ' ' LEU . 10.4 p -121.44 119.23 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 121.781 0.8 . . . . 65.35 109.115 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 84.2 mm-40 -113.87 141.53 47.23 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.011 -0.995 . . . . 74.4 112.509 -176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.39 133.24 94.4 Favored Pre-proline 0 C--N 1.296 -1.754 0 CA-C-N 113.498 -1.683 . . . . 63.25 108.073 -167.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.565 ' HD3' ' CE2' ' A' ' 26' ' ' TRP . 9.5 Cg_exo -11.83 62.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.99 1 C-N-CA 126.587 4.858 . . . . 74.5 118.333 -156.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.2 p -142.24 -44.67 0.33 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.179 -1.373 . . . . 62.22 109.549 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 69' ' ' GLN . 37.1 mt-10 -143.33 141.01 30.82 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 113.262 0.838 . . . . 72.04 113.262 -171.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.629 HD23 HG23 ' A' ' 68' ' ' VAL . 2.1 tm? -136.49 130.86 33.17 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 107.278 -1.378 . . . . 71.33 107.278 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -140.86 126.37 18.87 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 120.384 -0.527 . . . . 72.25 110.717 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.474 ' HD1' HD11 ' A' ' 74' ' ' LEU . 33.5 p90 -146.01 155.4 42.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.64 0.257 . . . . 74.34 111.315 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 29.0 mt-10 -121.64 136.03 54.96 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 105.552 -2.018 . . . . 54.33 105.552 -175.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -155.51 162.79 40.63 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.188 -1.005 . . . . 75.4 113.571 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.428 ' HB3' ' CD1' ' A' ' 83' ' ' TRP . 24.7 t70 75.65 163.47 0.26 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 112.809 -1.996 . . . . 74.24 112.63 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.517 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 8.3 m -60.59 -33.38 72.65 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.642 1.177 . . . . 72.43 111.89 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 115' ' ' ALA . 5.4 mm-40 -71.04 -33.63 70.48 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 120.722 0.296 . . . . 75.33 111.716 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.1 65.15 1.08 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.63 -0.795 . . . . 62.54 112.232 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.428 ' CD1' ' HB3' ' A' ' 79' ' ' ASP . 35.1 m95 -92.95 141.28 28.59 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.201 -1.407 . . . . 71.11 107.201 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.07 101.84 8.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 122.353 1.073 . . . . 32.31 109.121 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 m -97.54 142.69 13.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 115.435 -0.802 . . . . 71.41 110.603 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.3 m -132.31 122.0 24.43 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.334 -1.358 . . . . 74.14 107.334 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.628 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.9 m-85 -112.65 138.64 49.15 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.341 -0.985 . . . . 64.23 108.341 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.548 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 35.0 mt-30 -113.81 128.38 56.39 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 115.281 -0.872 . . . . 51.42 110.932 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.29 119.45 38.42 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.881 -1.155 . . . . 75.35 107.881 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -104.19 117.1 33.42 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.906 -1.146 . . . . 64.31 107.906 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -77.94 112.22 14.62 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.718 -0.674 . . . . 65.4 109.855 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 98.8 mt -115.21 140.91 48.68 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.14 -1.43 . . . . 73.44 107.14 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.38 58.9 4.96 Favored Glycine 0 C--N 1.276 -2.788 0 CA-C-N 115.654 -0.703 . . . . 72.01 111.907 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 179.51 -47.05 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.592 0.757 . . . . 71.35 109.307 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 9.8 ptpt -142.52 175.39 9.83 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.254 -1.388 . . . . 72.43 107.254 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.8 m -111.15 124.86 53.05 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 119.794 -0.763 . . . . 74.33 110.307 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.48 108.27 3.62 Favored Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 110.085 -1.206 . . . . 74.21 110.085 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -98.29 129.39 44.99 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.795 -0.817 . . . . 75.2 108.795 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 8.0 m -116.31 123.15 46.93 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 107.958 -1.127 . . . . 52.01 107.958 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.404 HD12 ' CE1' ' A' ' 87' ' ' PHE . 2.9 tp -100.18 119.34 38.21 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.724 -0.843 . . . . 64.13 108.724 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.01 123.17 71.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 105.928 -1.879 . . . . 64.34 105.928 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.65 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 22.9 t-160 -108.59 113.52 26.59 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.665 -1.606 . . . . 53.13 106.665 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -125.93 155.55 41.13 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 105.762 -1.94 . . . . 45.23 105.762 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.28 153.8 17.54 Favored Glycine 0 C--N 1.26 -3.684 0 N-CA-C 108.833 -1.707 . . . . 71.21 108.833 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 43.6 t90 -148.29 95.0 2.39 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.806 -0.812 . . . . 73.3 108.806 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -83.08 -56.18 3.94 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.78 -1.193 . . . . 71.4 107.78 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -175.46 154.98 1.65 Allowed Pre-proline 0 N--CA 1.441 -0.896 0 N-CA-C 106.954 -1.499 . . . . 54.21 106.954 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -69.82 110.14 2.49 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 121.701 1.6 . . . . 74.22 109.287 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -158.88 -177.62 6.65 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 105.629 -1.989 . . . . 54.34 105.629 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -88.07 -31.32 19.31 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 118.866 0.757 . . . . 60.3 109.572 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.05 152.6 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 116.161 -0.472 . . . . 65.24 109.934 -175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 115' ' ' ALA . 5.9 pt -62.21 -44.17 98.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.913 -0.585 . . . . 72.21 110.407 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.84 -52.7 3.62 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 114.413 0.525 . . . . 72.14 114.413 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.29 -42.1 16.17 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 112.861 0.689 . . . . 73.32 112.861 -172.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.64 ' HB3' HD12 ' A' ' 112' ' ' ILE . . . -67.06 -30.5 70.58 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.552 -0.459 . . . . 61.33 110.485 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.421 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 22.1 t-20 -175.51 145.17 0.71 Allowed 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.317 -1.364 . . . . 63.34 107.317 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -90.23 -17.87 26.72 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 113.172 0.804 . . . . 75.11 113.172 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.565 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 9.5 mmpt? -99.56 109.66 22.17 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.403 0.62 . . . . 70.13 110.798 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -67.48 -33.34 74.91 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.547 -0.751 . . . . 70.31 111.23 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 p -65.94 -46.67 77.33 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 111.756 0.28 . . . . 73.03 111.756 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 118' ' ' LYS . 30.2 m -70.27 -34.51 58.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 119.77 -0.772 . . . . 71.55 110.917 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 116' ' ' ASN . 99.4 t -65.86 -45.56 91.04 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 C-N-CA 120.394 -0.522 . . . . 64.24 110.594 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -61.8 -43.64 98.45 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 111.865 0.32 . . . . 74.43 111.865 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -62.51 -47.38 89.78 Favored Glycine 0 CA--C 1.497 -1.079 0 CA-C-N 115.837 -0.62 . . . . 73.41 111.925 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -72.22 -29.58 64.09 Favored 'General case' 0 C--O 1.193 -1.899 0 N-CA-C 112.796 0.665 . . . . 73.14 112.796 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.4 mmt -67.5 -48.93 65.66 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.012 -0.675 . . . . 73.45 111.66 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.33 -50.16 55.29 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.249 -0.98 . . . . 71.1 110.961 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.93 -40.2 97.04 Favored Glycine 0 C--O 1.239 0.418 0 N-CA-C 111.445 -0.662 . . . . 72.02 111.445 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.52 ' O ' HG22 ' A' ' 133' ' ' ILE . . . -64.44 -58.07 11.36 Favored Glycine 0 CA--C 1.482 -1.99 0 CA-C-O 119.007 -0.885 . . . . 74.14 111.928 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -57.67 -36.11 71.48 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.86 0.83 . . . . 75.54 112.44 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.3 m -61.1 -51.84 67.42 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 120.736 -0.385 . . . . 72.45 110.259 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.4 -50.49 15.86 Favored Glycine 0 C--O 1.25 1.113 0 C-N-CA 121.194 -0.526 . . . . 54.14 113.858 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 129' ' ' GLY . 10.5 tp -63.79 -49.27 82.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-O 119.554 -0.26 . . . . 74.42 110.879 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 71.8 t -62.84 -47.35 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 120.046 -0.662 . . . . 64.25 112.148 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.435 ' HA ' HG13 ' A' ' 16' ' ' ILE . 26.6 t-20 -55.38 -62.03 1.95 Allowed 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 111.98 0.363 . . . . 71.25 111.98 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.558 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 35.9 tt0 -80.4 -41.05 25.31 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 119.538 -0.865 . . . . 72.2 113.327 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -35.69 78.23 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.116 -1.034 . . . . 75.3 110.144 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 3.1 mm? -68.82 -51.82 36.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.129 0.49 . . . . 74.11 110.13 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.62 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 1.6 tmm_? -63.65 -36.34 83.5 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 115.691 -0.686 . . . . 71.14 110.416 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -74.7 -34.77 62.69 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 122.836 0.454 . . . . 74.34 109.789 -179.07 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.5 -26.98 63.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.469 0.652 . . . . 74.43 110.765 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.434 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 25.6 m -85.66 -25.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 C-N-CA 119.701 -0.799 . . . . 53.22 111.466 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.62 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 51.7 mt-10 -76.42 -41.89 46.11 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.628 -0.879 . . . . 74.12 108.628 174.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 72.61 173.75 0.3 Allowed 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 126.465 1.906 . . . . 62.02 110.499 -174.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.546 ' H ' HD23 ' A' ' 145' ' ' LEU . 2.4 pt? -118.01 151.57 37.21 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 121.175 0.512 . . . . 74.11 109.687 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 149' ' ' HIS . 11.1 tp10 -101.46 161.61 13.51 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 106.514 -1.661 . . . . 73.04 106.514 176.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -56.01 125.77 22.97 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.664 -0.495 . . . . 71.21 109.664 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 27.8 p80 54.95 15.69 1.24 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 126.413 1.885 . . . . 70.14 113.422 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 146' ' ' GLU . 20.6 t60 -103.65 74.46 1.25 Allowed 'General case' 0 C--O 1.247 0.96 0 CA-C-O 121.868 0.842 . . . . 74.41 109.07 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -99.75 161.28 13.71 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.868 -1.06 . . . . 75.21 109.153 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -122.24 143.99 49.25 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.18 -0.674 . . . . 75.13 109.18 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 . . . . . 0 C--N 1.309 -1.161 0 N-CA-C 109.133 -0.691 . . . . 73.5 109.133 179.316 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 C--O 1.235 0.307 0 N-CA-C 109.415 -0.587 . . . . 65.43 109.415 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.51 166.39 10.95 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.749 -0.834 . . . . 70.15 108.749 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -85.06 -28.33 25.73 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.055 0.455 . . . . 52.11 110.316 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -56.39 133.56 53.08 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 114.87 -1.059 . . . . 53.13 112.644 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -110.76 13.87 22.3 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.281 -1.378 . . . . 74.31 107.281 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -138.46 122.66 18.09 Favored 'General case' 0 N--CA 1.39 -3.442 0 N-CA-C 106.403 -1.703 . . . . 75.2 106.403 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -93.18 3.0 56.42 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 114.697 -1.138 . . . . 75.23 109.993 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.15 141.3 28.71 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 106.274 -1.75 . . . . 71.3 106.274 173.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.569 ' H ' HD23 ' A' ' 9' ' ' LEU . 2.4 pt? -74.23 119.47 76.54 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 120.079 -0.648 . . . . 64.02 110.211 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.83 -162.14 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.162 1.908 . . . . 74.54 107.73 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -72.51 105.11 4.05 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 118.535 -1.266 . . . . 70.3 108.51 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 72.7 mt -91.25 123.67 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 106.912 -1.514 . . . . 75.41 106.912 -177.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.4 m -119.51 129.2 54.58 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 108.149 -1.056 . . . . 73.52 108.149 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -139.49 132.55 29.56 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.244 -1.391 . . . . 72.43 107.244 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 p -117.98 140.72 49.33 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 109.391 -0.596 . . . . 54.5 109.391 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.32 140.49 19.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.876 -0.787 . . . . 74.31 108.876 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' THR . 12.7 p -99.24 118.96 37.09 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.746 0.784 . . . . 72.11 112.389 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 139' ' ' ARG . 3.4 mm? -91.4 140.07 30.12 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.723 -1.126 . . . . 72.43 109.633 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.4 30.67 0.69 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.441 0.639 . . . . 75.23 110.663 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.423 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -127.83 163.92 40.15 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.256 -1.016 . . . . 75.15 108.256 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 36.0 Cg_endo -66.13 152.72 80.51 Favored 'Trans proline' 0 C--O 1.255 1.362 0 C-N-CA 122.433 2.088 . . . . 64.35 110.724 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 tt -61.26 -31.38 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.009 -0.541 . . . . 71.03 112.021 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.2 pt20 -60.29 -45.14 94.39 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.619 0.247 . . . . 61.13 110.891 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -68.06 -39.5 82.99 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.374 -0.375 . . . . 72.04 111.91 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.6 -41.1 87.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.504 -0.554 . . . . 53.33 109.504 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.545 ' CZ2' ' HD3' ' A' ' 71' ' ' PRO . 60.3 t90 -63.9 -46.61 84.07 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.153 -0.93 . . . . 65.14 110.063 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 41.2 mt-10 -63.61 -37.99 89.42 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 120.991 -0.284 . . . . 44.44 110.544 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.0 m -56.84 -36.07 69.56 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.935 0.398 . . . . 51.25 111.384 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.664 HG11 ' CE1' ' A' ' 98' ' ' PHE . 30.9 m -103.76 16.04 5.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 112.018 0.377 . . . . 73.02 112.018 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.6 t -145.88 6.63 1.05 Allowed 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.012 -0.675 . . . . 44.52 112.146 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.9 p -108.32 170.3 8.1 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 121.775 -0.578 . . . . 72.32 110.555 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 t -59.91 -62.17 2.07 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 124.143 0.902 . . . . 33.32 111.103 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -78.05 -27.92 48.81 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 119.57 -0.852 . . . . 73.41 111.883 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.93 -48.68 84.48 Favored Glycine 0 C--O 1.216 -1.018 0 N-CA-C 110.888 -0.885 . . . . 54.31 110.888 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.18 -43.76 78.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 122.026 0.917 . . . . 74.12 110.359 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 41' ' ' PRO . . . -64.79 -36.12 83.3 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 113.884 1.068 . . . . 54.21 113.884 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.78 1.88 11.45 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 112.254 0.465 . . . . 73.14 112.254 -174.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.452 ' CZ2' HG12 ' A' ' 29' ' ' VAL . 19.2 m0 -89.3 -39.02 13.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 121.036 -0.266 . . . . 75.41 110.361 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -133.93 -56.01 0.87 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.962 1.468 . . . . 72.44 114.962 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 84.6 mtp -147.89 139.82 14.12 Favored Pre-proline 0 CA--C 1.513 -0.454 0 N-CA-C 109.651 -0.499 . . . . 73.35 109.651 -174.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 33.3 Cg_endo -68.06 108.83 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.42 2.08 . . . . 65.31 111.894 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -132.9 144.16 49.98 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.698 -0.683 . . . . 72.32 109.923 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.93 53.37 2.8 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.73 0.776 . . . . 73.12 110.765 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -72.31 152.28 42.21 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.138 -0.937 . . . . 74.34 108.573 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -137.55 151.53 48.48 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.888 -0.782 . . . . 72.14 108.888 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -75.41 104.45 5.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.539 -1.652 . . . . 72.43 106.539 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.406 ' O ' HG11 ' A' ' 65' ' ' VAL . 12.9 tptp -134.82 132.14 38.31 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 107.186 -1.412 . . . . 71.43 107.186 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -95.55 86.96 4.59 Favored 'General case' 0 C--N 1.26 -3.321 0 CA-C-O 122.674 1.225 . . . . 73.51 108.571 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.09 105.14 2.26 Favored Glycine 1 N--CA 1.395 -4.084 0 CA-C-N 113.256 -1.793 . . . . 71.33 109.564 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -150.55 149.49 29.99 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.931 -1.507 . . . . 75.52 106.931 -178.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.08 154.2 45.83 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.563 -0.903 . . . . 74.01 108.563 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -128.75 147.67 50.79 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.097 0.475 . . . . 73.14 111.286 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -115.81 153.12 32.03 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.304 -0.998 . . . . 74.53 108.304 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.2 mt 73.54 65.62 0.1 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.479 1.112 . . . . 74.51 110.064 -176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.04 109.61 1.87 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.367 -1.288 . . . . 72.32 110.466 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.9 p -153.72 148.48 19.65 Favored Pre-proline 0 N--CA 1.417 -2.12 0 N-CA-C 107.277 -1.379 . . . . 72.21 107.277 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.61 -40.35 85.84 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.893 2.396 . . . . 64.13 112.414 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -131.65 143.22 50.15 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.828 -0.804 . . . . 75.54 108.828 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.27 -101.02 0.25 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.213 -0.755 . . . . 41.4 111.213 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.55 2.63 7.97 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 122.753 2.302 . . . . 61.44 111.805 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.1 t 71.63 112.94 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.211 1.405 . . . . 74.43 110.14 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -80.12 44.25 1.69 Allowed 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 123.686 2.924 . . . . 74.34 113.09 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 18.5 p -116.52 142.7 46.53 Favored 'General case' 0 N--CA 1.417 -2.075 0 CA-C-O 121.47 0.652 . . . . 41.03 111.726 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 50' ' ' GLN . 20.4 pttp -137.24 138.41 40.09 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 107.009 -1.478 . . . . 74.22 107.009 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 47' ' ' LYS . 23.5 t -88.71 135.09 26.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 C-N-CA 119.516 -0.874 . . . . 72.41 109.249 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -76.53 -60.43 2.35 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.248 -1.76 . . . . 72.53 106.248 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.95 152.93 6.72 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.19 -0.914 . . . . 54.41 108.912 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.41 118.58 57.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 105.957 -1.868 . . . . 73.23 105.957 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 14.9 mm-40 -98.42 140.18 33.06 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.871 -0.788 . . . . 63.03 108.871 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.69 126.8 93.07 Favored Pre-proline 0 C--N 1.265 -3.094 0 CA-C-N 113.739 -1.573 . . . . 64.33 107.966 -168.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.545 ' HD3' ' CZ2' ' A' ' 26' ' ' TRP . 92.0 Cg_exo 2.03 51.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.117 1 C-N-CA 127.601 5.534 . . . . 71.35 117.351 -159.228 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.2 p -138.78 -39.14 0.5 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.005 -0.998 . . . . 73.43 111.557 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 36.9 tt0 -151.2 149.0 28.92 Favored 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 119.046 -1.062 . . . . 62.52 111.347 -174.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.638 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -137.0 134.06 36.21 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.613 -1.255 . . . . 75.42 107.613 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.467 ' OG ' HG23 ' A' ' 86' ' ' THR . 22.4 m -141.62 126.53 18.21 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.819 -0.352 . . . . 24.23 111.266 177.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.477 ' HD1' HD11 ' A' ' 74' ' ' LEU . 36.6 p90 -143.91 154.0 42.89 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.819 -0.438 . . . . 73.12 109.819 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 63' ' ' CYS . 41.0 mt-10 -122.86 124.71 43.87 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 123.066 0.546 . . . . 73.14 109.585 -171.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 6.4 t-105 -117.38 115.63 25.61 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.971 -1.492 . . . . 74.14 106.971 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -82.6 152.57 25.87 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.584 -0.846 . . . . 73.31 109.16 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.6 m 74.88 84.84 0.1 Allowed 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 123.858 0.863 . . . . 74.2 110.235 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 57.87 0.41 0.11 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 127.263 2.225 . . . . 73.1 115.62 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.45 -35.41 20.18 Favored Glycine 0 C--N 1.312 -0.796 0 N-CA-C 110.645 -0.982 . . . . 75.0 110.645 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 52.3 m95 66.63 -161.82 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.272 1.429 . . . . 75.52 109.766 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 p -116.67 126.68 74.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.99 -0.744 . . . . 71.51 108.99 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.4 m -116.31 136.61 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 CA-C-N 115.299 -0.864 . . . . 41.12 110.301 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.467 HG23 ' OG ' ' A' ' 75' ' ' SER . 34.9 m -124.54 127.03 46.79 Favored 'General case' 0 C--N 1.279 -2.498 0 N-CA-C 107.535 -1.283 . . . . 74.43 107.535 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.638 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.4 m-85 -112.38 130.11 56.08 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.465 -0.939 . . . . 64.13 108.465 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.405 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 5.2 mm-40 -109.33 137.5 47.11 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.439 -0.8 . . . . 73.22 110.257 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.39 120.34 40.01 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.281 -0.872 . . . . 75.44 110.026 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -111.54 116.83 31.51 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.207 -1.034 . . . . 71.04 108.207 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.86 123.39 27.18 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.267 0.556 . . . . 71.12 109.528 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.6 mt -126.35 159.54 32.91 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.33 -0.85 . . . . 62.15 109.204 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.67 128.16 8.52 Favored Glycine 0 N--CA 1.409 -3.132 0 N-CA-C 108.693 -1.763 . . . . 63.01 108.693 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 83.89 -3.81 1.11 Allowed 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 125.011 1.324 . . . . 71.33 111.977 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -164.46 173.41 12.15 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.002 -0.74 . . . . 71.25 109.002 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 17' ' ' THR . 85.3 m -124.79 132.64 53.33 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.368 -0.604 . . . . 55.04 109.368 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.56 105.03 3.25 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 110.059 -1.216 . . . . 51.14 110.059 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.664 ' CE1' HG11 ' A' ' 29' ' ' VAL . 67.9 t80 -98.33 134.28 41.56 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.998 -0.741 . . . . 74.14 108.998 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 9.8 m -125.14 125.79 44.25 Favored 'General case' 0 N--CA 1.405 -2.678 0 C-N-CA 119.619 -0.832 . . . . 51.01 109.23 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.479 HD22 HG21 ' A' ' 134' ' ' VAL . 1.8 tp -100.26 124.04 45.22 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.074 -1.084 . . . . 72.31 108.074 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 3.5 mp -121.26 124.59 72.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 106.923 -1.51 . . . . 72.33 106.923 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -120.69 122.1 39.71 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.15 -1.056 . . . . 74.31 108.15 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -142.87 163.93 31.46 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.814 -1.551 . . . . 54.34 106.814 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -179.1 132.37 1.87 Allowed Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 108.502 -1.839 . . . . 62.44 108.502 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -92.15 144.66 25.2 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.228 -0.989 . . . . 74.12 110.291 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.528 ' HD2' ' N ' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -127.7 -73.05 0.61 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 106.293 -1.743 . . . . 73.34 106.293 -177.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.517 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 32.9 tt0 167.27 -57.63 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 127.772 2.429 . . . . 74.34 108.443 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 107' ' ' GLU . 72.1 Cg_endo -82.34 146.78 14.06 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 121.12 1.213 . . . . 70.32 112.764 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -100.97 -20.64 15.33 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.783 -1.098 . . . . 64.13 108.815 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -63.5 -48.03 79.29 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.718 -0.674 . . . . 74.11 111.897 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.73 166.58 13.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 N-CA-C 104.82 -2.289 . . . . 64.31 104.82 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.9 pt -58.72 -32.63 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 118.418 0.554 . . . . 60.42 112.038 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.3 -113.12 3.91 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.61 -0.805 . . . . 71.42 113.702 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.84 -9.35 58.19 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.22 0.822 . . . . 65.01 113.22 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.72 -22.4 61.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.073 -0.343 . . . . 62.42 110.073 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 53.1 t30 43.01 89.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.655 1.582 . . . . 71.45 114.806 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.18 154.18 38.76 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 100.297 -3.964 . . . . 71.44 100.297 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.599 ' HB2' HG22 ' A' ' 121' ' ' VAL . 9.9 mmpt? -72.38 122.19 20.78 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 119.629 1.104 . . . . 72.41 111.776 -168.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 11.0 p -44.44 -50.47 9.33 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 125.119 1.368 . . . . 74.4 114.276 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.6 p -65.35 -45.86 82.52 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 116.337 -0.392 . . . . 64.04 112.026 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.599 HG22 ' HB2' ' A' ' 118' ' ' LYS . 11.0 m -70.62 -33.55 53.56 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 C-N-CA 119.909 -0.716 . . . . 74.12 110.346 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.54 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 69.5 t -60.22 -46.92 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 O-C-N 123.087 0.242 . . . . 54.23 110.368 176.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -57.47 -46.43 83.67 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.53 -0.759 . . . . 72.23 110.361 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.64 -47.25 50.37 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.598 -0.728 . . . . 63.0 113.0 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -62.79 -31.92 72.99 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 123.789 0.836 . . . . 64.45 112.425 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 25.8 mmt -72.71 -48.94 34.65 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.863 -0.735 . . . . 73.42 110.956 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.86 -65.74 0.63 Allowed 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.507 0.67 . . . . 72.0 110.548 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.04 -31.54 66.64 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.437 -0.801 . . . . 73.13 112.813 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -67.07 -59.3 7.06 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-O 119.408 -0.662 . . . . 74.41 112.013 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.416 ' CE3' HD21 ' A' ' 100' ' ' LEU . 97.7 m95 -61.88 -35.95 79.84 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 117.833 0.817 . . . . 72.33 112.833 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.8 m -62.28 -50.19 72.66 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 120.786 -0.366 . . . . 74.35 110.586 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.33 -48.21 19.77 Favored Glycine 0 C--O 1.247 0.939 0 C-N-CA 121.102 -0.57 . . . . 42.13 113.511 -177.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.57 -60.71 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 123.218 0.607 . . . . 64.14 110.347 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.479 HG21 HD22 ' A' ' 100' ' ' LEU . 98.0 t -57.64 -44.4 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 113.049 0.759 . . . . 74.32 113.049 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -56.4 -63.95 1.02 Allowed 'General case' 0 C--O 1.246 0.912 0 N-CA-C 112.143 0.423 . . . . 74.32 112.143 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -79.43 -34.84 41.31 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.184 0.809 . . . . 73.55 113.184 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -70.32 -39.43 74.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.534 -0.867 . . . . 75.52 111.265 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.5 mm? -70.47 -43.21 70.27 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 119.468 -0.893 . . . . 62.14 110.594 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.407 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.9 tmm_? -58.25 -37.2 74.44 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.045 -0.525 . . . . 72.24 110.094 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 8.5 mmmm -74.37 -37.1 63.55 Favored 'General case' 0 C--O 1.199 -1.558 0 N-CA-C 113.782 1.031 . . . . 64.11 113.782 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.72 -23.94 65.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.832 0.349 . . . . 41.13 111.377 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.1 m -90.81 -23.32 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 120.739 -0.384 . . . . 60.32 110.715 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -82.39 -54.56 5.12 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.122 0.416 . . . . 62.54 112.122 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -129.64 -172.3 2.72 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.746 -0.464 . . . . 63.1 109.746 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.3 mt -132.42 89.5 2.66 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.272 -0.64 . . . . 65.32 109.272 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -65.46 139.65 58.53 Favored 'General case' 0 C--O 1.256 1.408 0 N-CA-C 114.169 1.174 . . . . 74.34 114.169 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -70.02 143.0 52.67 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.507 -2.405 . . . . 62.51 104.507 168.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -58.35 115.72 3.16 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 118.719 0.69 . . . . 65.34 111.76 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -67.26 116.48 8.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.024 -0.989 . . . . 64.52 109.654 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -70.97 127.28 32.05 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.206 -0.664 . . . . 64.25 109.206 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -61.34 138.55 58.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.809 0.814 . . . . 72.2 112.896 -172.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--N 1.281 -2.41 0 N-CA-C 105.515 -2.031 . . . . 74.13 105.515 177.174 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 108.298 -1.001 . . . . 75.14 108.298 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.65 23.33 5.45 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.026 0.441 . . . . 72.03 111.367 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -99.45 -48.8 4.65 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.073 0.768 . . . . 71.13 113.073 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 5' ' ' ASN . 47.8 t30 -104.72 80.81 1.69 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 119.553 -0.859 . . . . 64.22 113.096 -176.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 4' ' ' ASN . 6.6 p30 165.66 160.26 0.03 OUTLIER 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 126.633 1.973 . . . . 73.25 107.177 169.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 7' ' ' ASN . 0.7 OUTLIER -96.77 -69.11 0.77 Allowed 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 113.402 0.889 . . . . 73.41 113.402 -177.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.449 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 21.7 t-20 74.05 -24.47 0.21 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.19 1.396 . . . . 74.41 113.254 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 112' ' ' ILE . . . 79.55 -46.65 0.35 Allowed 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 126.734 2.014 . . . . 73.23 111.857 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.604 HD21 ' HE ' ' A' ' 123' ' ' ARG 0.38 4.5 mm? 97.08 85.6 0.02 OUTLIER Pre-proline 0 CA--C 1.51 -0.59 0 C-N-CA 127.27 2.228 . . . . 74.44 116.737 -176.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -91.93 -153.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.684 0 C-N-CA 123.623 2.882 . . . . 43.52 109.023 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 5.6 p-10 -58.5 146.82 34.02 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.672 0.789 . . . . 64.33 113.068 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.483 HG22 ' HB3' ' A' ' 102' ' ' HIS . 10.7 tp -152.42 139.38 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.226 -0.657 . . . . 70.11 109.226 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.1 m -113.42 140.1 48.35 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.406 -0.59 . . . . 74.35 109.406 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HD3' ' N ' ' A' ' 15' ' ' SER . 5.7 tmtt? -141.56 137.73 32.18 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.489 -1.671 . . . . 72.54 106.489 175.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.488 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 24.5 p -118.23 150.19 39.85 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.392 0.542 . . . . 71.11 111.096 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.489 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -158.65 134.7 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.582 -0.525 . . . . 74.22 109.582 177.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.34 130.95 44.45 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.404 0.621 . . . . 71.23 111.706 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 2.5 mm? -99.74 139.28 35.62 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 123.411 0.685 . . . . 73.44 109.784 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.431 ' HG3' ' NH2' ' A' ' 139' ' ' ARG . 20.8 mm-40 -92.67 27.49 2.31 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.574 0.702 . . . . 64.32 109.131 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -122.6 161.98 40.84 Favored Pre-proline 0 C--O 1.246 0.912 0 C-N-CA 123.826 0.851 . . . . 75.33 109.255 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 35.7 Cg_endo -64.9 149.49 89.44 Favored 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 122.713 2.275 . . . . 74.33 110.921 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.1 tt -56.81 -34.02 42.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.611 -0.722 . . . . 42.34 112.399 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 29.9 pt20 -64.88 -36.5 84.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.919 0.39 . . . . 55.41 111.069 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HG2' HD12 ' A' ' 145' ' ' LEU . 11.6 mptt -79.67 -28.74 40.74 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 112.037 0.384 . . . . 74.44 112.037 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.2 -42.14 75.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.157 -1.053 . . . . 62.2 108.157 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 54.4 t90 -59.72 -47.79 84.26 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.617 -1.174 . . . . 73.14 111.303 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.557 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 9.3 pt-20 -70.05 -27.87 65.0 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 119.925 -0.71 . . . . 72.2 112.289 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 m -59.46 -35.63 74.44 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.2 0.524 . . . . 72.0 110.401 174.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.601 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 26.4 m -106.9 25.1 2.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 112.186 0.439 . . . . 64.44 112.186 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.557 ' OG ' ' HA ' ' A' ' 27' ' ' GLU . 60.2 p -141.37 -11.33 0.94 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.733 0.642 . . . . 75.43 112.733 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.0 p -94.25 161.63 14.18 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 120.306 -0.558 . . . . 72.13 111.434 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -50.12 -56.53 10.53 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 125.772 1.629 . . . . 65.21 111.553 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.14 -33.3 56.73 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.947 0.721 . . . . 72.5 112.947 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.99 -48.2 67.7 Favored Glycine 0 CA--C 1.505 -0.592 0 C-N-CA 120.905 -0.664 . . . . 75.32 111.691 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 30' ' ' SER . 63.3 mt -70.42 -45.42 75.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.204 0.526 . . . . 60.12 111.383 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.04 -50.28 66.84 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 112.859 0.688 . . . . 55.15 112.859 -176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? 65.14 7.83 4.38 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 123.213 1.482 . . . . 63.24 109.698 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -95.41 158.69 15.35 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 113.583 -1.644 . . . . 61.44 107.019 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -86.89 -18.92 29.72 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.944 0.878 . . . . 54.23 109.204 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 26.8 ttt -93.4 116.28 66.26 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 106.983 -1.488 . . . . 65.53 106.983 172.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 40' ' ' MET . 6.1 Cg_exo -76.32 121.09 5.9 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.764 1.643 . . . . 65.54 113.538 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -100.17 144.12 29.57 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 104.278 -2.49 . . . . 73.05 104.278 170.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -93.44 79.25 4.38 Favored 'General case' 0 C--N 1.281 -2.379 0 C-N-CA 118.741 -1.184 . . . . 75.02 113.082 -171.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.438 ' HB3' HD12 ' A' ' 35' ' ' ILE . 99.6 m-85 -75.16 119.04 18.76 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.43 -1.692 . . . . 73.45 106.43 168.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -125.09 153.4 42.99 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.893 -1.521 . . . . 71.55 106.893 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.652 HD12 HG21 ' A' ' 68' ' ' VAL . 3.5 mm? -74.09 102.9 4.36 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 116.689 -2.004 . . . . 44.04 107.996 175.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 39.5 tptt -132.73 132.79 42.7 Favored 'General case' 0 N--CA 1.391 -3.418 0 N-CA-C 105.694 -1.965 . . . . 61.3 105.694 171.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -86.4 66.63 9.61 Favored 'General case' 0 C--N 1.259 -3.36 0 CA-C-O 122.27 1.033 . . . . 61.5 109.23 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 123.43 51.9 0.21 Allowed Glycine 0 N--CA 1.397 -3.921 0 CA-C-N 114.579 -1.191 . . . . 64.42 110.142 -176.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.573 ' H ' ' HB ' ' A' ' 65' ' ' VAL . 12.2 tt0 -73.82 96.97 2.66 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 106.534 -1.654 . . . . 65.42 106.534 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.14 141.31 48.94 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-O 122.017 0.913 . . . . 60.32 113.16 -177.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -129.7 144.52 51.33 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 104.65 -2.352 . . . . 72.32 104.65 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -110.23 139.49 45.34 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.705 -0.85 . . . . 73.13 108.705 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 54' ' ' LEU . 2.3 pt? -97.08 176.91 5.77 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.291 0.567 . . . . 75.12 111.707 -173.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -124.2 -161.64 1.01 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.427 -1.694 . . . . 73.32 106.427 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.466 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 26.5 m -56.59 -50.07 89.96 Favored Pre-proline 0 CA--C 1.566 1.596 0 CA-C-N 118.29 0.496 . . . . 72.5 111.223 174.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 56' ' ' SER . 11.4 Cg_exo -75.57 146.36 30.6 Favored 'Trans proline' 0 C--N 1.373 1.828 0 N-CA-C 108.614 -1.341 . . . . 73.33 108.614 168.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -55.5 -42.08 73.95 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.285 0.365 . . . . 63.11 111.932 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.85 -113.13 4.22 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 111.463 -0.655 . . . . 72.34 111.463 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.1 -161.5 0.15 Allowed 'Trans proline' 0 C--O 1.244 0.808 0 C-N-CA 123.149 2.566 . . . . 64.31 110.535 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.8 m -81.83 116.64 64.47 Favored Pre-proline 0 N--CA 1.427 -1.604 0 N-CA-C 107.84 -1.17 . . . . 73.44 107.84 174.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.46 81.02 0.13 Allowed 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 123.245 2.63 . . . . 64.4 114.273 -176.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 9.5 p -143.8 144.41 31.78 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.176 -1.046 . . . . 60.23 108.176 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -143.07 147.11 34.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.394 -1.706 . . . . 74.03 106.394 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.573 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 42.9 t -90.32 137.45 21.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.636 -1.246 . . . . 64.24 107.636 177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 2.3 tm? -77.74 -61.56 1.95 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.084 -1.45 . . . . 74.43 107.084 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -167.56 156.76 10.02 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.119 -1.067 . . . . 64.1 108.119 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.652 HG21 HD12 ' A' ' 46' ' ' LEU . 13.5 p -125.04 135.17 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-O 121.177 0.513 . . . . 61.54 110.396 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 71.9 mm-40 -102.81 141.16 36.09 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.314 -0.995 . . . . 75.41 108.314 173.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.88 127.04 93.33 Favored Pre-proline 0 C--N 1.266 -3.031 0 N-CA-C 107.401 -1.333 . . . . 74.1 107.401 -168.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo 4.12 48.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.077 1 C-N-CA 127.628 5.552 . . . . 72.2 117.895 -161.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -137.65 -35.24 0.66 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.264 -0.425 . . . . 74.22 109.983 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 38.8 tt0 -149.55 148.28 29.18 Favored 'General case' 0 C--O 1.205 -1.237 0 C-N-CA 118.574 -1.25 . . . . 74.33 110.363 -175.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.639 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -143.04 130.91 21.55 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 107.705 -1.22 . . . . 55.54 107.705 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -132.66 127.1 34.13 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 110.224 -0.287 . . . . 62.45 110.224 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.421 ' HA ' ' H ' ' A' ' 66' ' ' LEU 0.254 35.8 p90 -145.81 157.84 43.9 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.208 -0.308 . . . . 73.4 111.768 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.262 36.1 mt-10 -120.07 144.67 47.46 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 123.624 0.77 . . . . 74.33 109.97 -169.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -114.67 120.47 40.23 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.0 -2.222 . . . . 72.23 105.0 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -83.11 10.61 7.79 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.619 0.723 . . . . 74.54 112.866 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.4 p -90.76 92.64 8.89 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 107.857 -1.164 . . . . 74.35 107.857 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 78.08 6.93 2.6 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.91 1.284 . . . . 64.44 112.403 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.87 62.73 3.07 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 114.805 -1.089 . . . . 61.32 113.777 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -100.28 150.64 22.36 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.825 -0.75 . . . . 74.04 109.742 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.13 109.93 2.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 108.216 -1.031 . . . . 75.14 108.216 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.11 154.67 5.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 115.86 -0.609 . . . . 42.51 109.817 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 15.3 m -139.89 140.3 36.43 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.179 -0.674 . . . . 70.45 109.179 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.639 ' CD2' HD12 ' A' ' 74' ' ' LEU . 15.0 m-85 -113.66 139.59 48.92 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.578 -1.267 . . . . 74.55 107.578 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.22 133.74 55.41 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.094 -1.076 . . . . 73.22 108.094 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.03 128.02 56.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.453 0.644 . . . . 74.15 109.948 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -115.96 130.84 57.0 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.692 -1.225 . . . . 74.42 107.692 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -94.29 121.17 35.53 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.417 0.627 . . . . 72.14 109.798 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 81.1 mt -114.2 156.0 25.06 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.245 -1.02 . . . . 60.23 108.245 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.95 49.57 4.25 Favored Glycine 0 C--N 1.289 -2.072 0 CA-C-N 116.255 -0.43 . . . . 51.31 112.137 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -177.17 -40.56 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.808 0.813 . . . . 60.44 109.118 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 9.2 ptpt -149.42 175.97 11.0 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 115.461 -0.79 . . . . 74.53 108.961 -171.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 64.8 m -108.22 130.4 55.15 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 109.03 -0.73 . . . . 54.34 109.03 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.53 124.4 7.59 Favored Glycine 0 N--CA 1.416 -2.675 0 N-CA-C 110.072 -1.211 . . . . 74.33 110.072 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CE1' HG11 ' A' ' 29' ' ' VAL . 93.1 t80 -112.06 134.33 53.68 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-O 121.195 0.522 . . . . 71.31 110.077 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 m -124.01 126.3 46.04 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.976 -1.12 . . . . 70.24 107.976 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.521 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -103.03 138.7 39.55 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.84 0.829 . . . . 73.33 108.788 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 100' ' ' LEU . 4.0 mp -135.53 124.86 41.14 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.033 0 CA-C-N 113.457 -1.701 . . . . 64.14 107.673 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 4.3 t60 -112.77 127.38 56.13 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 104.807 -2.294 . . . . 71.13 104.807 173.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -142.24 164.86 29.02 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.66 -1.978 . . . . 74.21 105.66 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.11 178.71 39.37 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 119.698 -1.239 . . . . 44.04 111.848 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -74.42 114.64 13.04 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.192 -2.151 . . . . 71.13 105.192 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -78.87 77.03 5.35 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 115.003 1.482 . . . . 73.05 115.003 -169.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.489 ' H ' ' HD2' ' A' ' 108' ' ' PRO . 38.5 mt-10 -102.28 -44.83 0.19 Allowed Pre-proline 0 C--N 1.289 -2.039 0 CA-C-N 113.639 -1.619 . . . . 72.12 109.915 170.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.489 ' HD2' ' H ' ' A' ' 107' ' ' GLU . 26.2 Cg_exo -39.52 106.8 0.06 OUTLIER 'Trans proline' 1 C--N 1.422 4.43 0 C-N-CA 123.562 2.841 . . . . 44.33 113.788 178.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -101.43 -64.52 1.05 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.545 -0.752 . . . . 72.55 109.055 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -101.66 -42.76 6.08 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.654 -0.869 . . . . 72.42 108.654 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 119' ' ' SER . 14.5 t -133.58 155.33 40.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 105.73 -1.952 . . . . 74.41 105.73 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 8' ' ' ALA . 6.9 pt -62.07 -32.85 55.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 118.428 0.558 . . . . 52.24 111.959 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.77 -127.28 6.48 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.563 -0.827 . . . . 64.41 112.467 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -69.75 -9.32 54.08 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.713 1.205 . . . . 55.11 114.023 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.44 84.24 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.035 0.754 . . . . 75.15 113.035 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -148.46 165.31 31.54 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 122.432 -0.167 . . . . 71.24 110.793 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.04 -68.24 0.33 Allowed 'General case' 0 C--N 1.316 -0.871 0 O-C-N 124.615 1.197 . . . . 65.3 111.243 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.455 ' HE2' HG13 ' A' ' 121' ' ' VAL . 34.1 mtmm -106.34 151.35 24.98 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 113.245 0.831 . . . . 71.05 113.245 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.443 ' HB2' HG22 ' A' ' 111' ' ' VAL . 9.0 t -77.15 -30.19 54.93 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.349 -0.982 . . . . 71.44 108.349 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.3 t -64.48 -41.68 96.33 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.09 -0.504 . . . . 71.11 110.574 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.455 HG13 ' HE2' ' A' ' 118' ' ' LYS . 33.0 m -70.69 -33.5 53.12 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.763 0 C-N-CA 119.698 -0.801 . . . . 65.45 110.33 177.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 118' ' ' LYS . 76.4 t -65.2 -41.67 92.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.254 -0.43 . . . . 53.51 110.067 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.604 ' HE ' HD21 ' A' ' 9' ' ' LEU . 2.9 tpm_? -54.44 -52.81 60.62 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.518 -0.765 . . . . 73.53 109.474 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -62.51 -54.31 35.08 Favored Glycine 0 CA--C 1.505 -0.576 0 O-C-N 123.623 0.577 . . . . 54.42 113.232 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -60.35 -41.01 92.77 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.483 0.92 . . . . 63.35 113.483 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.94 -39.59 42.28 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.226 -0.99 . . . . 72.03 110.98 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -67.39 -61.51 1.87 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.73 -0.47 . . . . 53.42 109.73 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -69.91 -32.34 69.95 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.262 -0.881 . . . . 71.31 111.895 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.76 -58.73 7.92 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-O 119.776 -0.458 . . . . 61.23 112.507 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -63.58 -36.69 84.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 113.281 0.845 . . . . 75.34 113.281 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.9 p -65.58 -51.31 60.74 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.767 -0.773 . . . . 70.54 111.412 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.54 -47.92 32.13 Favored Glycine 0 C--O 1.245 0.801 0 C-N-CA 121.01 -0.614 . . . . 60.52 113.329 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.619 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 45.9 mm -65.25 -51.26 67.2 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 N-CA-C 111.475 0.176 . . . . 71.51 111.475 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.521 HG21 ' HG ' ' A' ' 100' ' ' LEU . 97.5 t -62.14 -48.92 86.2 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.575 0 C-N-CA 119.269 -0.972 . . . . 71.21 110.68 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.489 ' HA ' HG13 ' A' ' 16' ' ' ILE . 9.7 t30 -60.76 -63.68 1.21 Allowed 'General case' 0 C--O 1.252 1.235 0 C-N-CA 119.654 -0.818 . . . . 74.31 112.741 -175.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.69 -41.11 18.09 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 118.773 -1.171 . . . . 71.51 112.737 -174.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.619 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 14.4 tpp180 -70.55 -37.55 74.05 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.023 -0.671 . . . . 74.3 111.851 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 0.1 OUTLIER -68.22 -44.31 76.04 Favored 'General case' 0 C--O 1.251 1.139 0 N-CA-C 107.314 -1.365 . . . . 75.3 107.314 177.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.636 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -60.5 -36.95 79.58 Favored 'General case' 0 C--O 1.203 -1.378 0 CA-C-N 116.046 -0.525 . . . . 70.03 110.495 177.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.511 ' HE3' ' NE2' ' A' ' 150' ' ' HIS . 10.9 mmmm -73.33 -35.6 66.06 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 114.616 1.339 . . . . 74.22 114.616 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.97 -33.94 76.46 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.488 -0.485 . . . . 74.43 109.707 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.436 HG21 ' HB3' ' A' ' 18' ' ' LEU . 11.0 m -85.04 -21.56 7.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-N 116.015 -0.539 . . . . 63.21 111.927 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 78.8 mm-40 -77.68 -33.05 53.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.331 -0.548 . . . . 63.35 109.914 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -87.73 20.39 3.02 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.905 -0.589 . . . . 63.53 110.332 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.432 HD12 ' HG2' ' A' ' 24' ' ' LYS . 1.6 pt? -61.44 -28.96 69.65 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.758 1.223 . . . . 73.4 114.29 -173.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.533 ' HG2' ' H ' ' A' ' 147' ' ' HIS . 36.1 tt0 -152.67 -168.02 2.92 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 105.584 -2.006 . . . . 71.14 105.584 -170.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.533 ' H ' ' HG2' ' A' ' 146' ' ' GLU . 33.7 m80 -74.84 78.74 2.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.928 0.871 . . . . 72.22 109.201 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -130.41 101.39 5.72 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.135 -1.432 . . . . 72.43 107.135 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -98.79 132.46 44.13 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.966 -0.561 . . . . 71.35 109.734 -176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.511 ' NE2' ' HE3' ' A' ' 140' ' ' LYS . 43.8 p-80 -155.96 -174.65 5.05 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.312 -0.996 . . . . 74.43 108.312 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -65.48 140.0 58.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 74.15 111.555 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 N--CA 1.431 -1.383 0 N-CA-C 107.455 -1.313 . . . . 53.22 107.455 178.404 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 110.084 -0.339 . . . . 51.33 110.084 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.85 96.5 4.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.097 -0.705 . . . . 71.11 109.097 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -99.33 -29.34 12.84 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.43 -0.805 . . . . 64.21 110.356 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -99.49 135.84 40.3 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.79 -0.641 . . . . 54.45 111.65 -175.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.36 130.2 42.23 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 105.387 -2.079 . . . . 55.31 105.387 169.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.01 112.38 6.43 Favored 'General case' 0 C--N 1.269 -2.895 0 CA-C-O 121.722 0.772 . . . . 72.33 111.471 -172.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 119' ' ' SER . 29.6 t-20 -163.48 -43.32 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 105.807 -1.923 . . . . 62.44 105.807 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.423 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -104.24 -165.25 1.13 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.668 -1.605 . . . . 73.21 106.668 171.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.7 tp -111.25 96.37 30.45 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.628 -0.879 . . . . 75.35 108.628 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 2.7 Cg_exo -75.92 -179.43 5.18 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.126 2.551 . . . . 62.01 112.829 -177.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 8.4 m-20 -65.09 124.27 21.68 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.344 -0.844 . . . . 74.44 111.033 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 49.4 mt -110.3 130.71 63.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.407 -1.331 . . . . 74.32 107.407 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 m -126.25 129.17 48.39 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.746 -0.835 . . . . 72.33 108.746 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.433 ' HE3' ' HB ' ' A' ' 16' ' ' ILE . 9.5 tmtm? -141.41 133.9 28.32 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.285 -1.376 . . . . 72.12 107.285 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 m -116.69 139.57 50.4 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 107.278 -1.379 . . . . 74.35 107.278 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.457 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -148.59 133.83 10.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.512 -0.921 . . . . 74.4 108.512 -178.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.425 ' CG2' ' HG3' ' A' ' 95' ' ' LYS . 3.4 m -104.37 125.59 50.73 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.775 -0.824 . . . . 70.11 108.775 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.7 mp -102.44 140.5 36.64 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.065 -0.516 . . . . 75.52 110.415 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -82.86 51.31 1.88 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.908 -0.775 . . . . 72.52 108.908 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.34 159.55 51.62 Favored Pre-proline 0 N--CA 1.433 -1.285 0 CA-C-N 115.787 -0.642 . . . . 72.1 109.838 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.25 156.47 55.47 Favored 'Trans proline' 0 C--O 1.262 1.713 0 C-N-CA 122.944 2.429 . . . . 71.11 111.199 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.8 tt -64.72 -29.83 48.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.64 -0.709 . . . . 74.32 112.014 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -72.07 -28.78 63.55 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.695 -0.802 . . . . 70.3 111.796 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -77.37 -41.73 39.12 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.712 -0.395 . . . . 75.42 109.975 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.533 HG11 HG21 ' A' ' 96' ' ' THR . 7.1 p -65.47 -39.1 84.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.48 -0.563 . . . . 75.54 109.48 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.463 ' NE1' ' HD3' ' A' ' 71' ' ' PRO . 66.9 t90 -58.89 -47.19 85.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.192 -0.913 . . . . 74.32 111.376 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.03 -33.25 75.13 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 119.398 -0.921 . . . . 62.51 110.19 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 94.9 m -62.02 -15.41 44.04 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 121.583 0.706 . . . . 42.21 112.129 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.451 HG11 ' CE1' ' A' ' 98' ' ' PHE . 20.3 m -121.83 7.53 5.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.082 -1.011 . . . . 61.54 112.009 176.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.416 ' HB3' HD22 ' A' ' 46' ' ' LEU . 18.7 m -127.71 -11.62 5.5 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.753 0.649 . . . . 54.12 112.753 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.5 p -91.61 163.23 14.19 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.106 -0.701 . . . . 74.44 109.106 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.564 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 9.3 m -53.36 -47.09 69.72 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.153 0.581 . . . . 72.31 111.615 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 32' ' ' SER . 1.4 mp0 -64.92 -48.77 72.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.721 -0.672 . . . . 73.04 110.729 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . -65.26 -43.66 94.92 Favored Glycine 0 C--O 1.247 0.962 0 CA-C-N 115.427 -0.806 . . . . 33.23 113.233 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.85 -43.72 97.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 109.907 -0.405 . . . . 74.52 109.907 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.7 -50.97 67.09 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.199 0.444 . . . . 25.45 112.199 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 22.9 mtmm 67.41 21.89 9.57 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.309 1.052 . . . . 75.42 110.536 -175.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -144.65 148.21 33.99 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 104.109 -2.552 . . . . 71.32 104.109 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -81.83 71.43 8.86 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.796 0.808 . . . . 70.22 110.211 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 57.4 tpp -124.11 122.03 26.19 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 107.958 -1.127 . . . . 74.23 107.958 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -75.56 84.88 1.67 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.96 1.773 . . . . 70.13 112.621 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.564 ' O ' ' HB3' ' A' ' 32' ' ' SER . 12.7 m120 -128.03 143.87 51.09 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.066 -1.827 . . . . 73.12 106.066 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -92.72 70.66 4.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 112.554 0.576 . . . . 71.44 112.554 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -78.51 119.95 22.53 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 106.206 -1.775 . . . . 65.32 106.206 172.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -124.5 149.58 46.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 112.688 0.625 . . . . 64.43 112.688 -171.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 30' ' ' SER . 23.1 tp -82.76 106.13 14.35 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.211 -0.904 . . . . 62.43 108.793 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -133.67 141.54 47.63 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.223 -2.139 . . . . 73.35 105.223 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.581 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 7.8 pt-20 -93.96 75.94 4.15 Favored 'General case' 0 C--N 1.27 -2.852 0 CA-C-N 120.185 1.357 . . . . 54.11 110.745 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.55 72.43 0.19 Allowed Glycine 1 N--CA 1.391 -4.348 0 CA-C-N 113.332 -1.758 . . . . 63.12 109.959 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.6 120.17 40.01 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 105.287 -2.116 . . . . 70.15 105.287 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -119.14 163.48 16.97 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.694 -0.484 . . . . 74.13 109.694 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -93.29 128.14 39.17 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.05 0.929 . . . . 73.53 111.674 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -122.72 140.45 52.86 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.208 -1.775 . . . . 73.01 106.208 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.66 82.65 3.3 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 122.093 0.949 . . . . 72.22 111.414 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -107.97 -168.36 1.36 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.577 -1.638 . . . . 61.54 106.577 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m -67.07 137.08 94.32 Favored Pre-proline 0 N--CA 1.432 -1.352 0 N-CA-C 107.246 -1.39 . . . . 51.01 107.246 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -30.93 97.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.781 1 C-N-CA 125.46 4.107 . . . . 74.5 115.68 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -104.05 86.13 2.52 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.058 -1.09 . . . . 54.14 108.058 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.41 112.67 1.0 Allowed Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.223 -0.898 . . . . 74.1 111.012 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -58.19 -32.72 96.4 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.634 2.223 . . . . 70.43 111.334 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.2 m -94.45 105.38 17.76 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 107.68 -1.23 . . . . 70.34 107.68 172.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.79 131.92 42.45 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.605 2.204 . . . . 74.02 111.057 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 65.1 m -129.75 146.12 51.52 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.411 -0.516 . . . . 65.3 111.452 -177.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -134.56 129.33 34.86 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.779 -1.563 . . . . 75.1 106.779 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.2 t -91.2 136.7 23.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 C-N-CA 118.132 -1.427 . . . . 70.22 108.816 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.448 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 1.9 tm? -87.45 -60.24 2.03 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.984 -1.117 . . . . 71.2 107.984 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.88 136.47 14.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.299 -0.409 . . . . 75.13 110.739 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 48' ' ' GLU . 47.3 t -118.11 119.27 60.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.595 -0.891 . . . . 72.35 108.595 176.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 42.7 mt-30 -116.14 140.88 48.84 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.705 -0.68 . . . . 63.23 110.491 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.39 131.51 93.23 Favored Pre-proline 0 C--N 1.281 -2.389 0 CA-C-N 113.9 -1.5 . . . . 72.32 110.314 -162.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HD3' ' NE1' ' A' ' 26' ' ' TRP . 55.3 Cg_exo 2.26 49.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.261 1 C-N-CA 128.144 5.896 . . . . 73.22 117.319 -162.293 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 p -140.71 -48.25 0.42 Allowed 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.538 -0.755 . . . . 74.31 111.138 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 32.1 tt0 -140.15 128.43 22.53 Favored 'General case' 0 C--O 1.21 -0.976 0 C-N-CA 118.802 -1.159 . . . . 70.44 110.852 -172.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.551 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -133.19 132.21 41.29 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 109.504 -0.554 . . . . 61.04 109.504 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.7 t -140.37 126.99 20.29 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.778 -0.453 . . . . 70.34 109.778 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.451 ' HD1' HD11 ' A' ' 74' ' ' LEU . 32.2 p90 -146.17 159.45 43.29 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 122.884 0.473 . . . . 71.02 111.098 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HG2' HG22 ' A' ' 84' ' ' VAL . 24.9 mt-10 -117.74 122.69 44.14 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 104.679 -2.341 . . . . 71.11 104.679 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -110.63 147.79 33.54 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.124 -0.944 . . . . 73.52 111.188 -173.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 t70 71.83 -174.93 0.17 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.753 1.621 . . . . 53.43 109.902 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.5 t -85.11 -5.4 59.34 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.598 -0.688 . . . . 73.42 110.35 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.405 ' OE1' ' HB2' ' A' ' 115' ' ' ALA . 14.3 mm-40 -85.3 -37.48 19.93 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.789 -0.641 . . . . 73.2 110.307 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.95 60.85 1.06 Allowed Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.254 -1.138 . . . . 73.43 110.254 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -81.39 106.22 13.19 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 107.851 -1.166 . . . . 75.32 107.851 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.444 HG23 ' HB2' ' A' ' 105' ' ' TRP . 84.4 t -84.92 106.05 14.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.123 -1.066 . . . . 70.43 108.123 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.21 134.86 49.91 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 108.74 -0.837 . . . . 73.31 108.74 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.7 m -125.56 130.44 51.7 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.568 -0.901 . . . . 60.3 108.568 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.551 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.1 m-85 -116.41 133.58 55.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.432 -0.951 . . . . 71.24 108.432 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.522 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -111.43 130.61 55.65 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 115.389 -0.823 . . . . 74.31 109.634 177.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.38 122.17 45.73 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.559 -0.746 . . . . 74.51 109.521 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -112.91 120.28 40.86 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.152 -1.055 . . . . 74.43 108.152 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -80.6 117.61 21.45 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.367 0.604 . . . . 72.41 109.772 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 7.0 mp -109.92 158.67 17.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.501 -1.666 . . . . 70.2 106.501 172.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -62.07 -37.27 94.18 Favored Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.964 -0.636 . . . . 74.14 114.371 -173.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -120.18 -3.2 10.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 117.393 0.597 . . . . 73.33 111.731 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.0 ptpt -153.17 175.78 12.66 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.61 -0.885 . . . . 24.0 108.61 -173.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.533 HG21 HG11 ' A' ' 25' ' ' VAL . 51.8 m -129.29 124.25 33.92 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.869 -0.732 . . . . 73.21 111.231 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.422 ' N ' HD13 ' A' ' 92' ' ' LEU . . . -84.18 113.44 3.74 Favored Glycine 0 N--CA 1.423 -2.207 0 N-CA-C 110.202 -1.159 . . . . 33.53 110.202 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.451 ' CE1' HG11 ' A' ' 29' ' ' VAL . 79.5 t80 -104.14 132.65 50.17 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 108.576 -0.898 . . . . 64.23 108.576 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 12.4 m -121.17 122.07 39.18 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.308 -0.997 . . . . 72.14 108.308 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.514 HD13 HG21 ' A' ' 134' ' ' VAL . 4.2 tp -100.78 124.47 46.47 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.821 -0.807 . . . . 72.44 108.821 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.54 124.29 66.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 106.87 -1.53 . . . . 64.13 106.87 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 8.0 t60 -112.02 113.65 26.06 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.948 -1.131 . . . . 73.32 107.948 177.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.2 m -118.28 132.87 56.27 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.137 -1.06 . . . . 73.44 108.137 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.28 132.51 11.27 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.117 -0.793 . . . . 65.31 111.117 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.444 ' HB2' HG23 ' A' ' 84' ' ' VAL . 83.0 t90 -95.16 -22.77 17.63 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.414 0.626 . . . . 71.04 109.756 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -114.73 97.75 6.45 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.539 0.685 . . . . 74.34 111.93 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -136.04 70.14 63.4 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 107.578 -1.267 . . . . 73.3 107.578 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.48 -39.08 0.44 Allowed 'Trans proline' 0 C--O 1.246 0.912 0 C-N-CA 122.464 2.11 . . . . 65.53 112.954 -174.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -102.6 -164.75 1.11 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.073 -1.454 . . . . 75.05 107.073 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -67.04 -29.77 69.65 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.229 -1.026 . . . . 73.53 108.229 171.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.0 p -111.87 162.23 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-N 114.639 -1.164 . . . . 73.41 108.14 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 pt -58.26 -33.16 46.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 124.347 1.059 . . . . 61.21 113.15 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.93 -137.23 8.98 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 108.807 -1.717 . . . . 71.02 108.807 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -104.28 18.76 21.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.759 0.79 . . . . 72.32 109.325 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.405 ' HB2' ' OE1' ' A' ' 81' ' ' GLU . . . -60.12 -39.5 86.48 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.838 0.828 . . . . 74.21 109.716 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -139.72 143.52 37.07 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.258 -1.756 . . . . 54.14 106.258 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -70.32 -23.84 62.9 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 113.659 0.985 . . . . 73.14 113.659 -172.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.543 ' HB2' HG23 ' A' ' 122' ' ' VAL . 75.6 mmtt -111.44 -176.51 2.96 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 122.002 -0.436 . . . . 52.4 109.876 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 7' ' ' ASN . 17.1 p -130.81 -73.47 0.54 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 111.659 0.244 . . . . 64.24 111.659 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -62.06 -36.06 80.52 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 123.443 0.697 . . . . 72.12 109.295 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.66 -45.51 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.366 -0.834 . . . . 70.13 110.011 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.543 HG23 ' HB2' ' A' ' 118' ' ' LYS . 72.9 t -61.37 -38.96 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 116.336 -0.393 . . . . 74.03 111.023 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.45 ' NH1' ' HB2' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -62.9 -45.34 92.98 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.833 -0.803 . . . . 74.42 108.833 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.42 -49.72 59.35 Favored Glycine 0 C--O 1.245 0.812 0 CA-C-N 115.738 -0.664 . . . . 63.34 111.987 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -60.5 -39.38 87.53 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.408 0.683 . . . . 72.42 112.259 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 21.9 mmt -68.55 -38.49 80.82 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.55 -0.46 . . . . 62.42 111.313 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.45 ' HB2' ' NH1' ' A' ' 123' ' ' ARG . 12.6 t70 -61.47 -53.11 60.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.194 -0.669 . . . . 61.53 109.194 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.37 -45.28 91.28 Favored Glycine 0 C--O 1.249 1.07 0 CA-C-N 115.108 -0.951 . . . . 73.2 111.89 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.33 -54.22 39.72 Favored Glycine 0 C--O 1.217 -0.952 0 O-C-N 123.999 0.47 . . . . 72.44 112.826 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.408 ' CE3' HD21 ' A' ' 100' ' ' LEU . 85.6 m95 -60.63 -34.95 75.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.7 0.63 . . . . 74.04 112.7 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.407 ' HA ' ' HG3' ' A' ' 14' ' ' LYS . 63.7 m -64.41 -55.16 22.85 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.163 0.289 . . . . 72.31 110.628 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.71 -48.21 51.07 Favored Glycine 0 C--O 1.248 0.972 0 C-N-CA 121.327 -0.463 . . . . 75.42 112.859 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.5 -57.44 12.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 CA-C-O 118.945 -0.55 . . . . 61.45 111.897 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.514 HG21 HD13 ' A' ' 100' ' ' LEU . 93.9 t -57.93 -42.2 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 119.079 -1.048 . . . . 62.15 112.804 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.457 ' HA ' HG13 ' A' ' 16' ' ' ILE . 36.9 t30 -54.73 -67.84 0.23 Allowed 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.473 0.483 . . . . 71.34 111.947 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -76.09 -40.33 53.29 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 120.355 -0.538 . . . . 62.15 111.982 -173.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 137' ' ' ARG . 4.3 tpp180 -66.37 -44.07 84.21 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 119.444 -0.903 . . . . 73.54 111.723 -172.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.532 ' HB3' HD21 ' A' ' 18' ' ' LEU . 10.8 mp -70.83 -43.83 67.74 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.789 -0.765 . . . . 62.12 111.419 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -60.56 -36.28 78.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.941 0.4 . . . . 60.24 110.381 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -75.63 -37.5 59.66 Favored 'General case' 0 C--O 1.185 -2.296 0 C-N-CA 119.807 -0.757 . . . . 71.52 112.25 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.04 -33.96 76.93 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.032 0.444 . . . . 45.42 110.756 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 28.1 m -78.96 -28.33 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 120.482 -0.487 . . . . 70.15 110.901 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -82.37 -73.67 0.38 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.416 0.627 . . . . 73.22 110.694 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -120.43 100.32 7.08 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.019 -0.991 . . . . 72.21 109.19 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.624 ' H ' HD23 ' A' ' 145' ' ' LEU . 2.5 pt? -88.69 0.09 56.78 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.434 0.635 . . . . 74.23 111.08 -176.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -81.94 -171.78 3.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.087 -0.961 . . . . 75.23 108.958 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.523 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . 4.5 p80 -66.58 98.09 0.48 Allowed 'General case' 0 CA--C 1.55 0.947 0 CA-C-O 122.064 0.935 . . . . 71.11 111.162 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . 0.258 6.0 p-80 -89.65 80.17 6.67 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 122.368 1.08 . . . . 74.21 113.03 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.523 ' CE1' ' HB2' ' A' ' 147' ' ' HIS . 6.5 p-80 -159.78 115.99 2.49 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.444 -1.707 . . . . 62.23 107.363 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -177.17 -175.03 0.54 Allowed 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.129 -0.693 . . . . 75.22 109.129 -173.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -64.03 103.15 0.56 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.637 -0.875 . . . . 75.12 108.637 172.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 . . . . . 0 C--N 1.285 -2.225 0 N-CA-C 108.151 -1.055 . . . . 54.11 108.151 -176.787 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 110.155 -0.313 . . . . 71.12 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.86 87.99 0.11 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.358 1.063 . . . . 71.2 113.265 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -76.02 -29.22 58.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.526 0.679 . . . . 72.42 109.594 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -129.32 157.74 41.06 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.256 -1.016 . . . . 70.12 108.256 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.402 ' ND2' ' H ' ' A' ' 7' ' ' ASN . 2.9 p-10 -100.57 -166.48 1.32 Allowed 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 106.313 -1.736 . . . . 75.31 106.313 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 8' ' ' ALA . 1.7 mp0 -63.91 -40.06 95.62 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.585 0.707 . . . . 73.24 110.923 -175.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 3.3 t-20 72.73 -35.89 0.34 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 126.705 2.002 . . . . 61.22 112.1 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 112' ' ' ILE . . . 159.26 -31.12 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 127.285 2.234 . . . . 45.22 107.592 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 9' ' ' LEU . 2.2 tm? 86.89 81.15 0.05 OUTLIER Pre-proline 0 N--CA 1.411 -2.386 0 C-N-CA 129.351 3.06 . . . . 63.15 107.977 -163.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HG3' ' OD1' ' A' ' 7' ' ' ASN . 14.7 Cg_endo -102.27 -153.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 123.727 2.952 . . . . 70.43 110.698 -177.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 1.1 m-20 -55.95 103.4 0.1 Allowed 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 123.893 0.746 . . . . 73.23 111.431 175.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.516 HG22 ' HB3' ' A' ' 102' ' ' HIS . 9.6 tp -102.65 131.63 50.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.952 -1.87 . . . . 74.1 105.952 170.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.9 m -117.66 129.49 55.77 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.002 0.429 . . . . 64.24 109.89 -176.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -131.57 126.35 34.61 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.556 -1.276 . . . . 64.23 107.556 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.1 m -116.95 133.65 55.74 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.932 -0.396 . . . . 71.42 109.932 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.422 HG21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -145.88 139.54 21.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.874 -0.787 . . . . 73.15 108.874 -175.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 p -97.67 125.11 42.25 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.208 0.527 . . . . 55.33 111.656 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.07 139.57 30.81 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.763 -0.653 . . . . 74.34 109.667 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -82.07 30.62 0.39 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.935 0.772 . . . . 73.32 111.105 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' CB ' ' HB ' ' A' ' 142' ' ' VAL . . . -129.23 159.57 68.39 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 116.071 -0.513 . . . . 75.21 110.732 -173.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.74 156.44 42.98 Favored 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 123.505 2.803 . . . . 74.21 112.042 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.593 HG12 HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -52.07 -41.72 33.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.167 -0.924 . . . . 62.21 111.107 -177.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -68.35 -34.85 76.82 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 119.98 -0.688 . . . . 74.02 111.033 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HA ' ' HG2' ' A' ' 27' ' ' GLU . 22.7 tptm -71.51 -38.47 71.12 Favored 'General case' 0 N--CA 1.441 -0.901 0 O-C-N 123.297 0.373 . . . . 75.41 110.38 -174.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.572 HG21 ' HB ' ' A' ' 96' ' ' THR . 47.8 t -71.11 -41.18 75.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.097 -0.705 . . . . 70.14 109.097 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 45.8 t90 -59.83 -47.69 84.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.474 -0.785 . . . . 73.44 111.444 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 11.5 pt-20 -66.29 -32.1 73.31 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.695 0.283 . . . . 42.11 110.64 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.3 m -65.66 -15.33 62.67 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 121.655 0.741 . . . . 74.53 111.683 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 13.6 m -125.3 18.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 O-C-N 121.138 -0.976 . . . . 72.24 112.276 177.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.0 p -134.33 -12.55 2.42 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.499 0.555 . . . . 75.52 112.499 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.9 p -94.53 163.35 13.43 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.135 -0.691 . . . . 61.01 109.135 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.59 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 17.9 t -56.64 -53.17 60.73 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 123.612 0.57 . . . . 74.04 111.094 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -57.21 -40.34 77.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.45 -0.796 . . . . 45.34 111.369 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.7 -48.01 24.17 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 120.824 -0.703 . . . . 75.12 113.372 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.3 mt -67.05 -33.29 62.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 122.699 0.4 . . . . 72.15 111.766 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.3 -30.56 28.8 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.449 1.648 . . . . 71.22 115.449 -174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.536 ' HE2' ' NE2' ' A' ' 151' ' ' HIS . 83.4 tttt 74.14 -48.76 0.66 Allowed 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 124.085 0.954 . . . . 71.12 110.404 -178.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.496 ' HA ' ' CE1' ' A' ' 149' ' ' HIS . 65.1 m95 -94.87 -159.98 0.75 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.683 -1.599 . . . . 75.02 106.683 175.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -105.83 -91.04 0.4 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.302 -1.74 . . . . 75.13 106.302 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 65.7 mtt 53.24 175.71 0.03 OUTLIER Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 124.5 1.12 . . . . 73.04 113.818 173.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.17 109.72 2.39 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.561 1.507 . . . . 72.01 109.971 170.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -139.67 152.81 47.02 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 110.03 -0.359 . . . . 65.02 110.03 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -137.39 69.58 1.4 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.503 0.668 . . . . 72.14 109.936 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.59 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 86.0 m-85 -91.61 136.37 33.18 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.812 -0.631 . . . . 74.34 110.015 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -137.52 143.5 41.67 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.67 -0.863 . . . . 62.14 108.67 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.57 ' H ' HD23 ' A' ' 46' ' ' LEU . 2.3 pt? -75.62 106.42 7.17 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.062 0.934 . . . . 73.12 110.017 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 15.8 tppt? -131.26 145.13 51.77 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.984 -1.858 . . . . 71.05 105.984 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.18 77.77 6.68 Favored 'General case' 0 C--N 1.278 -2.52 0 C-N-CA 118.773 -1.171 . . . . 73.41 109.223 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.87 67.53 0.31 Allowed Glycine 0 N--CA 1.413 -2.864 0 CA-C-N 114.695 -1.139 . . . . 71.34 112.973 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.585 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -138.0 127.16 24.37 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.873 -1.528 . . . . 70.53 106.873 -178.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -120.71 145.3 47.63 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 113.364 0.875 . . . . 75.24 113.364 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.411 ' HB3' ' H ' ' A' ' 63' ' ' CYS . 55.3 t80 -95.46 115.23 27.14 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.681 -1.229 . . . . 63.01 107.681 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.415 ' CE1' HE21 ' A' ' 55' ' ' GLN . 30.1 t-80 -145.19 139.23 27.08 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.527 -0.761 . . . . 72.11 109.564 -177.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.53 154.54 18.64 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.653 -1.98 . . . . 73.11 105.653 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.415 HE21 ' CE1' ' A' ' 53' ' ' HIS . 77.1 mt-30 -121.01 86.93 2.66 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.455 0.645 . . . . 75.33 110.749 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.4 m -160.0 143.27 10.27 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 106.828 -1.545 . . . . 54.34 106.828 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.6 85.13 0.38 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.321 2.014 . . . . 74.21 113.753 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -137.3 -70.45 0.45 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.623 -0.717 . . . . 74.33 110.189 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.89 68.75 1.52 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.327 -1.109 . . . . 63.31 110.327 -173.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.87 -80.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.658 2.238 . . . . 52.43 111.808 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.1 m -137.39 81.28 31.23 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 109.045 -0.724 . . . . 62.45 109.045 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -68.4 100.93 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.207 2.604 . . . . 75.52 110.937 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.413 ' HG ' ' HE1' ' A' ' 44' ' ' PHE . 8.2 p -134.08 169.53 17.01 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.935 -0.575 . . . . 52.1 111.883 -173.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 15.0 tptm -154.33 127.25 8.24 Favored 'General case' 0 C--O 1.193 -1.886 0 C-N-CA 125.478 1.511 . . . . 72.01 107.23 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -89.99 123.91 42.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 106.9 -1.519 . . . . 74.04 106.9 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 tt -72.92 -60.27 2.31 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.567 -1.271 . . . . 74.3 107.567 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.33 150.01 8.89 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.522 -0.763 . . . . 54.21 109.638 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.533 HG23 HD23 ' A' ' 74' ' ' LEU . 9.6 p -121.89 131.85 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 121.208 0.527 . . . . 75.52 109.757 176.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 75.3 mm-40 -104.08 141.41 36.27 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.201 -0.909 . . . . 74.34 109.193 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.11 126.98 93.35 Favored Pre-proline 0 C--N 1.276 -2.594 0 CA-C-N 114.268 -1.333 . . . . 75.33 108.623 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo 6.75 44.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.357 1 C-N-CA 128.096 5.864 . . . . 74.13 117.715 -162.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 p -137.14 -38.5 0.62 Allowed 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.707 -0.679 . . . . 65.21 112.139 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 30.2 tt0 -150.77 147.81 27.75 Favored 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 118.316 -1.354 . . . . 63.41 111.252 -173.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.691 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.6 tm? -142.02 136.1 29.92 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.068 -0.716 . . . . 53.43 109.068 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 p -140.64 127.64 20.72 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.241 0.46 . . . . 73.03 112.241 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.455 ' HD1' HD11 ' A' ' 74' ' ' LEU . 43.3 p90 -141.37 156.05 45.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.413 -0.358 . . . . 71.44 110.638 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -121.25 148.87 43.7 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.242 -1.392 . . . . 71.33 107.242 -171.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.408 ' HD1' ' OG1' ' A' ' 80' ' ' THR . 9.3 t-105 -119.36 126.52 51.61 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.79 -1.559 . . . . 65.01 106.79 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -70.06 -17.1 63.23 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.606 0.965 . . . . 70.0 113.606 -170.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.408 ' OG1' ' HD1' ' A' ' 78' ' ' TRP . 67.8 p -79.49 95.41 5.8 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 120.369 -0.533 . . . . 64.23 109.911 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 82.7 -15.79 0.64 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.289 1.436 . . . . 73.25 113.461 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.85 54.61 0.81 Allowed Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.049 -1.072 . . . . 51.44 114.231 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -92.81 149.44 21.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.835 -1.172 . . . . 74.03 107.835 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.7 p -142.84 124.82 12.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.156 -0.683 . . . . 73.02 109.156 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.2 149.96 21.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 121.418 0.627 . . . . 63.33 110.446 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.1 m -135.67 137.76 42.13 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.721 -0.672 . . . . 63.31 109.761 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.691 ' CD2' HD12 ' A' ' 74' ' ' LEU . 12.5 m-85 -113.74 129.09 56.63 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 107.396 -1.335 . . . . 73.34 107.396 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.553 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -112.13 134.16 53.85 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 105.91 -1.885 . . . . 70.13 105.91 177.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.593 HD21 HG12 ' A' ' 22' ' ' ILE . 6.9 tt -115.3 126.41 54.44 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.228 -0.656 . . . . 50.24 109.228 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -111.09 116.71 31.6 Favored 'General case' 0 N--CA 1.415 -2.175 0 N-CA-C 107.922 -1.14 . . . . 72.41 107.922 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -80.03 116.91 20.42 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.854 0.835 . . . . 73.14 110.364 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -120.96 159.86 24.72 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.662 -1.236 . . . . 50.35 107.662 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.57 140.82 19.21 Favored Glycine 0 C--N 1.268 -3.2 0 N-CA-C 107.599 -2.201 . . . . 51.32 107.599 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 84.63 -24.88 0.14 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.147 1.379 . . . . 74.15 111.339 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.5 175.36 14.13 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.82 -0.807 . . . . 72.31 108.82 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.572 ' HB ' HG21 ' A' ' 25' ' ' VAL . 84.8 m -126.59 129.98 49.63 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.273 -0.64 . . . . 71.05 109.273 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.61 109.89 3.6 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 110.972 -0.851 . . . . 75.25 110.972 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.422 ' CE1' HG11 ' A' ' 29' ' ' VAL . 88.4 t80 -98.5 134.14 41.88 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 109.094 -0.706 . . . . 70.21 109.094 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' A' ' 88' ' ' GLN . 23.7 m -123.11 118.93 28.82 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.331 -0.989 . . . . 44.43 108.331 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.56 140.8 34.31 Favored 'General case' 0 N--CA 1.41 -2.432 0 N-CA-C 108.876 -0.787 . . . . 61.4 108.876 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 100' ' ' LEU . 18.5 mt -136.07 124.75 37.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.856 0 CA-C-N 113.56 -1.655 . . . . 63.34 107.821 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.516 ' HB3' HG22 ' A' ' 12' ' ' ILE . 6.1 t60 -118.92 125.19 48.88 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.048 -1.834 . . . . 73.1 106.048 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.6 t -142.29 165.54 27.14 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 106.871 -1.529 . . . . 63.11 106.871 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -135.51 156.55 22.77 Favored Glycine 0 C--N 1.289 -2.074 0 N-CA-C 109.197 -1.561 . . . . 72.02 109.197 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -104.3 16.3 26.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 117.527 0.663 . . . . 72.44 112.289 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -135.4 92.2 2.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.672 -1.233 . . . . 73.24 107.672 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.431 ' HB3' HG22 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -158.81 82.32 2.63 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 115.292 -0.867 . . . . 70.14 113.31 -177.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -100.87 2.47 0.66 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.626 2.217 . . . . 71.02 114.328 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -132.54 -163.04 1.29 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.818 -0.808 . . . . 54.22 108.818 -174.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 7' ' ' ASN . 9.1 pt-20 -82.16 5.68 18.94 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.676 1.227 . . . . 71.41 110.112 171.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.428 HG23 ' HB3' ' A' ' 119' ' ' SER . 8.0 p -140.25 149.54 21.76 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-N 113.219 -1.809 . . . . 63.22 106.77 175.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.663 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -57.0 -32.38 39.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 123.313 0.645 . . . . 51.31 112.1 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.59 46.7 0.18 Allowed Glycine 0 CA--C 1.484 -1.874 0 C-N-CA 119.793 -1.194 . . . . 31.43 111.324 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 54.79 32.81 18.32 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.76 0.824 . . . . 74.22 111.669 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.402 ' HB3' HG13 ' A' ' 112' ' ' ILE . . . -71.28 -15.38 62.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.977 0.894 . . . . 63.14 109.435 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -152.01 174.47 13.62 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 104.383 -2.451 . . . . 70.2 104.383 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -48.61 -86.61 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 116.289 1.959 . . . . 64.44 116.289 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -119.02 149.73 41.15 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.957 -1.127 . . . . 72.43 107.957 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.428 ' HB3' HG23 ' A' ' 111' ' ' VAL . 6.9 p -65.0 -41.0 95.76 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.602 0.593 . . . . 75.43 112.602 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.42 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 10.7 t -68.23 -38.85 82.28 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.458 -0.497 . . . . 55.51 111.112 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.1 m -69.04 -34.13 62.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 C-N-CA 119.976 -0.689 . . . . 75.11 109.822 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.5 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 56.3 t -66.94 -46.66 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 116.35 -0.387 . . . . 71.12 110.733 177.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.08 -41.15 99.37 Favored 'General case' 0 C--O 1.209 -1.077 0 N-CA-C 109.425 -0.583 . . . . 63.51 109.425 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.56 -49.24 70.93 Favored Glycine 0 CA--C 1.502 -0.75 0 CA-C-N 116.223 -0.444 . . . . 51.34 112.159 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 122' ' ' VAL . 2.1 tmmm? -62.19 -32.64 73.31 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 123.413 0.685 . . . . 75.43 111.571 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 25.2 mmt -76.59 -44.94 32.39 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 120.338 -0.545 . . . . 64.32 110.191 176.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -58.9 -62.82 1.59 Allowed 'General case' 0 C--O 1.25 1.12 0 C-N-CA 123.912 0.885 . . . . 75.22 110.687 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -71.0 -42.07 60.03 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.696 -0.684 . . . . 70.32 111.866 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.583 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -58.9 -62.11 6.61 Favored Glycine 0 N--CA 1.437 -1.28 0 O-C-N 124.057 0.504 . . . . 74.11 112.043 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.464 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.5 m95 -60.82 -30.19 69.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.64 0.978 . . . . 73.54 113.64 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 73.1 m -63.4 -50.83 68.31 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 119.958 -0.697 . . . . 72.23 110.614 174.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.78 -46.15 54.77 Favored Glycine 0 C--O 1.251 1.218 0 C-N-CA 120.663 -0.779 . . . . 44.1 112.615 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 129' ' ' GLY . 52.1 mm -58.87 -57.86 9.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 123.023 0.529 . . . . 72.22 110.292 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HD23 ' A' ' 138' ' ' LEU . 93.1 t -62.97 -45.99 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 112.438 0.533 . . . . 65.41 112.438 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -57.03 -61.56 2.37 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 123.22 0.325 . . . . 74.34 111.746 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -84.65 -34.21 23.1 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 119.004 -1.078 . . . . 63.25 113.723 -172.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -70.32 -39.05 75.01 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.285 -0.966 . . . . 61.4 109.711 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.6 mm? -67.69 -48.95 65.13 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.874 -0.73 . . . . 62.02 109.778 174.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -58.25 -33.26 69.18 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.361 -0.381 . . . . 75.42 111.094 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -72.89 -48.31 38.39 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 112.188 0.44 . . . . 63.42 112.188 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.01 70.5 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.946 -0.302 . . . . 72.54 111.585 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.468 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 25.6 m -79.92 -33.08 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 120.594 -0.443 . . . . 74.13 111.556 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.48 -69.0 0.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.074 -0.65 . . . . 72.11 109.334 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -172.88 111.31 0.22 Allowed 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 123.558 0.743 . . . . 64.14 111.424 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.9 tp -74.53 106.23 6.02 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.75 -1.574 . . . . 75.14 106.75 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -106.95 5.18 27.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 114.222 1.194 . . . . 75.13 114.222 -170.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.403 ' CG ' ' H ' ' A' ' 148' ' ' HIS 0.256 7.3 p80 -152.42 -85.49 0.07 Allowed 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.571 -0.452 . . . . 53.24 111.9 173.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.403 ' H ' ' CG ' ' A' ' 147' ' ' HIS . 44.1 m80 -136.24 -74.01 0.44 Allowed 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 118.192 0.451 . . . . 71.52 111.645 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -179.73 172.95 1.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.447 0.467 . . . . 53.03 111.086 -178.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -101.99 118.43 36.9 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 105.364 -2.087 . . . . 72.41 105.364 172.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.542 ' HA ' ' CD1' ' A' ' 133' ' ' ILE . 49.9 t-80 -153.19 133.36 13.42 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.387 -0.525 . . . . 62.14 109.943 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 C--N 1.303 -1.436 0 N-CA-C 108.928 -0.767 . . . . 70.24 108.928 176.447 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 109.278 -0.638 . . . . 63.33 109.278 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.65 85.82 0.14 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.987 0.915 . . . . 63.11 111.29 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -77.09 -29.37 54.9 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.82 -1.082 . . . . 62.55 111.523 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -71.54 135.88 47.25 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.203 0.525 . . . . 63.52 110.861 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -152.71 -177.27 6.14 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.939 -1.504 . . . . 71.4 106.939 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -91.65 178.17 6.0 Favored 'General case' 0 N--CA 1.392 -3.37 0 CA-C-O 122.086 0.946 . . . . 71.52 112.459 -173.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.663 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 20.3 p30 -51.24 -49.91 60.19 Favored 'General case' 0 C--N 1.267 -3.003 0 CA-C-N 112.143 -2.299 . . . . 73.51 113.342 -174.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.62 103.66 15.6 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.894 -1.521 . . . . 62.05 106.894 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.402 ' CD1' ' HA ' ' A' ' 123' ' ' ARG . 6.2 tt -69.32 125.9 92.3 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 108.9 -0.778 . . . . 62.54 108.9 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -83.66 -158.43 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.051 2.5 . . . . 53.02 113.755 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.39 149.14 50.68 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.006 -0.997 . . . . 71.14 110.594 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 66.7 mt -123.97 139.48 50.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.82 -0.807 . . . . 73.24 108.82 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.5 m -139.58 131.38 27.52 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.904 -0.776 . . . . 42.42 108.904 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -145.88 151.43 37.86 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.376 -0.602 . . . . 63.32 109.376 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 p -117.39 151.81 36.27 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.126 -0.694 . . . . 64.34 109.126 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.533 HG21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -158.44 143.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 107.586 -1.264 . . . . 52.54 107.586 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.0 p -111.08 129.62 55.86 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.272 0.558 . . . . 64.35 112.438 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -101.88 139.66 37.22 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.074 -1.084 . . . . 74.23 108.074 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.527 ' CD ' ' HE ' ' A' ' 139' ' ' ARG 0.25 0.0 OUTLIER -93.29 53.36 1.91 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.826 1.298 . . . . 55.12 112.065 -177.873 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.5 160.16 52.15 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 113.332 -1.758 . . . . 71.22 108.41 -177.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HG2' ' HG2' ' A' ' 24' ' ' LYS . 28.9 Cg_endo -62.55 155.52 57.85 Favored 'Trans proline' 0 C--O 1.257 1.459 0 C-N-CA 122.803 2.335 . . . . 75.45 111.628 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 tt -56.57 -32.67 37.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.405 -0.816 . . . . 73.15 111.794 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -62.65 -40.23 96.39 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 123.12 0.262 . . . . 51.14 110.755 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 21' ' ' PRO . 14.2 mmmm -69.41 -42.49 75.0 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 116.298 -0.41 . . . . 75.21 110.869 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.477 HG21 ' HB ' ' A' ' 96' ' ' THR . 46.0 t -66.52 -42.49 90.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.55 -0.537 . . . . 74.03 109.55 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -61.89 -47.49 84.73 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.561 -0.745 . . . . 74.14 111.208 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.436 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 13.3 pt-20 -68.47 -29.51 68.16 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.78 -0.368 . . . . 74.41 111.319 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.6 m -60.75 -29.26 69.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.368 0.604 . . . . 72.15 111.27 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.581 ' HB ' ' CE2' ' A' ' 87' ' ' PHE . 15.2 m -113.1 19.62 7.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.25 -0.432 . . . . 74.44 112.147 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 27' ' ' GLU . 37.8 p -136.68 -20.7 1.32 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.077 0.769 . . . . 74.25 113.077 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.8 p -96.34 161.81 13.77 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 120.584 -0.446 . . . . 64.23 110.94 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 m -58.76 -55.52 34.07 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 123.588 0.555 . . . . 44.2 110.776 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 1.5 mp0 -57.28 -44.77 84.28 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 123.653 0.781 . . . . 72.4 110.581 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -48.87 65.34 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.4 -0.818 . . . . 53.4 113.238 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.2 mt -69.45 -43.1 81.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.411 . . . . 73.12 110.777 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.35 -31.9 72.96 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.859 0.689 . . . . 74.3 112.859 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.7 tptp 64.45 24.95 13.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 122.913 1.339 . . . . 62.31 108.557 -173.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 66.99 9.83 7.2 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 113.662 -1.608 . . . . 74.41 112.375 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.487 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 40.0 m-85 -76.46 -71.78 0.37 Allowed 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 120.807 0.337 . . . . 73.4 110.646 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.41 ' SD ' ' HB3' ' A' ' 39' ' ' PHE . 1.8 mpt? -99.12 105.64 33.47 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 110.003 -0.369 . . . . 73.34 110.003 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 39' ' ' PHE . 35.9 Cg_exo -63.69 96.17 0.2 Allowed 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 122.837 2.358 . . . . 72.52 110.858 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.422 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . 44.4 t-20 -138.95 149.87 45.25 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.629 -1.249 . . . . 73.14 107.629 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -88.93 75.12 8.09 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-O 122.076 0.941 . . . . 71.15 109.873 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 84.0 m-85 -78.79 119.81 22.53 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.622 -1.251 . . . . 73.32 107.622 172.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -117.55 146.87 43.29 Favored 'General case' 0 CA--C 1.484 -1.585 0 O-C-N 123.374 0.422 . . . . 73.21 110.23 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.421 HD13 ' CB ' ' A' ' 30' ' ' SER . 30.1 tp -78.85 104.57 9.58 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 106.838 -1.542 . . . . 72.0 106.838 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 58.2 tttm -133.33 133.67 42.82 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.148 -1.427 . . . . 74.22 107.148 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HA ' HG23 ' A' ' 68' ' ' VAL . 4.7 pt-20 -88.14 73.07 9.04 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-O 123.033 1.396 . . . . 61.31 109.102 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.0 57.03 0.19 Allowed Glycine 1 N--CA 1.392 -4.262 0 CA-C-N 112.825 -1.989 . . . . 61.13 109.992 -177.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.21 124.65 30.1 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 105.965 -1.865 . . . . 62.31 105.965 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.35 135.27 54.42 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-O 121.286 0.565 . . . . 63.35 110.766 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -128.71 146.74 50.8 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.463 -1.68 . . . . 70.24 106.463 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -110.15 140.37 44.32 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.317 0.579 . . . . 71.31 110.355 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.421 ' H ' HD23 ' A' ' 54' ' ' LEU . 2.2 pt? -130.93 150.91 51.87 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 107.123 -1.436 . . . . 72.02 107.123 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.423 ' HG2' ' HD2' ' A' ' 57' ' ' PRO . 52.0 tt0 -72.73 155.24 40.17 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.422 -1.325 . . . . 63.34 107.422 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.4 ' N ' ' HD2' ' A' ' 57' ' ' PRO . 20.8 m -46.34 -43.76 36.46 Favored Pre-proline 0 CA--C 1.573 1.851 0 N-CA-C 116.445 2.017 . . . . 52.13 116.445 -174.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD2' ' HG2' ' A' ' 55' ' ' GLN . 8.4 Cg_endo -52.21 -67.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 122.179 1.919 . . . . 75.11 113.049 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -176.94 -179.52 0.94 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.664 0.785 . . . . 75.44 108.9 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.78 168.35 24.78 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 109.748 -1.341 . . . . 75.44 109.748 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.01 -67.5 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.8 2.333 . . . . 73.42 112.321 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.1 m -148.23 85.34 6.39 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 108.833 -0.803 . . . . 44.55 108.833 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -72.41 140.76 33.95 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.288 1.992 . . . . 74.42 111.295 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 21.5 p -129.08 141.26 51.27 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 108.488 -0.93 . . . . 74.13 108.488 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 53.4 mtmt -148.97 123.52 9.75 Favored 'General case' 0 C--O 1.198 -1.639 0 N-CA-C 108.435 -0.95 . . . . 63.3 108.435 177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 46.1 t -89.19 135.89 24.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.014 -1.106 . . . . 72.12 108.014 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.3 tp -80.36 -62.59 1.63 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.054 -0.721 . . . . 72.33 109.054 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.78 149.87 28.79 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.21 -0.905 . . . . 75.13 109.835 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG23 ' HA ' ' A' ' 48' ' ' GLU . 66.7 t -125.89 123.17 63.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.803 -0.814 . . . . 71.51 108.803 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.534 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 81.5 mm-40 -107.81 140.78 40.39 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.344 0.592 . . . . 74.34 110.291 174.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.77 123.94 88.19 Favored Pre-proline 0 C--N 1.277 -2.545 0 CA-C-N 113.873 -1.512 . . . . 72.01 109.213 -165.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo 6.86 49.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.639 1 C-N-CA 127.75 5.633 . . . . 71.33 116.603 -161.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 p -138.9 -41.5 0.48 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.105 -0.952 . . . . 74.22 112.077 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 39.3 tt0 -148.15 145.09 28.2 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 119.973 -0.691 . . . . 70.43 110.197 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.7 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.9 tm? -142.12 135.91 29.54 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.343 -0.984 . . . . 73.35 108.343 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.2 m -139.45 126.25 20.79 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 121.029 -0.268 . . . . 65.12 110.651 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 36.1 p90 -145.76 156.97 43.95 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 122.2 0.2 . . . . 74.42 111.242 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 24.0 mt-10 -120.39 124.6 45.91 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.085 -1.82 . . . . 74.21 106.085 -174.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -130.07 157.51 42.19 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 116.222 -0.445 . . . . 72.3 110.592 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 78.85 -176.33 0.09 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.267 1.827 . . . . 75.21 109.789 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.3 p -73.11 -18.47 61.29 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 114.433 1.272 . . . . 60.4 114.433 -173.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.401 ' HB2' ' NE1' ' A' ' 83' ' ' TRP . 3.7 mp0 -92.83 -18.77 22.44 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.092 -0.643 . . . . 70.32 110.989 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.89 60.63 2.88 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 120.002 -1.094 . . . . 43.44 110.54 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 95.9 m95 -78.33 121.21 24.16 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.551 -0.907 . . . . 72.13 108.551 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 76' ' ' PHE . 8.7 p -99.19 107.74 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 CA-C-O 122.516 1.151 . . . . 63.24 111.592 -173.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -99.84 146.48 8.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.41 -1.268 . . . . 63.51 108.369 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 42.4 m -130.5 135.82 48.35 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 109.139 -0.689 . . . . 53.44 109.139 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.7 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.4 m-85 -112.59 135.55 53.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.2 -1.037 . . . . 72.31 108.2 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.15 137.91 52.65 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.392 -0.966 . . . . 75.23 108.392 176.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -113.1 131.52 55.79 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.77 0.319 . . . . 73.45 111.296 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -120.7 139.06 53.6 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.231 1.013 . . . . 72.44 108.678 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -96.73 128.71 43.94 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.087 0.47 . . . . 65.31 109.996 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.56 153.54 45.08 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.981 -1.118 . . . . 73.42 107.981 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.98 57.54 5.07 Favored Glycine 0 C--N 1.289 -2.053 0 C-N-CA 121.488 -0.387 . . . . 71.24 113.667 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 171.65 -44.54 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 124.434 1.093 . . . . 75.23 108.323 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -130.78 172.59 11.83 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.167 -1.379 . . . . 73.13 109.115 -170.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.477 ' HB ' HG21 ' A' ' 25' ' ' VAL . 74.0 m -116.52 130.91 57.02 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 109.22 -0.659 . . . . 65.55 109.22 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.08 119.8 5.66 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.059 -1.216 . . . . 53.13 110.059 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -108.0 133.23 52.61 Favored 'General case' 0 C--N 1.269 -2.895 0 N-CA-C 108.082 -1.081 . . . . 74.05 108.082 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.7 m -122.77 122.51 38.87 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.761 -0.829 . . . . 44.41 108.761 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.483 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.19 139.05 36.42 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 121.854 0.835 . . . . 73.1 109.404 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.534 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 14.0 mt -136.49 128.88 45.03 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 113.334 -1.757 . . . . 73.3 108.047 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.523 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . 8.7 t-80 -120.38 125.82 48.95 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.698 -0.853 . . . . 60.42 108.698 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.7 t -142.83 159.87 41.41 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 104.777 -2.305 . . . . 75.44 104.777 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.55 -169.04 36.12 Favored Glycine 0 C--N 1.292 -1.89 0 C-N-CA 119.967 -1.111 . . . . 51.14 112.325 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -85.71 98.61 10.8 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.502 0.668 . . . . 73.32 112.421 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -98.55 136.98 37.88 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.942 -1.026 . . . . 44.32 109.155 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -115.7 145.06 33.76 Favored Pre-proline 0 C--N 1.284 -2.239 0 N-CA-C 107.558 -1.275 . . . . 60.33 107.558 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.471 ' C ' HD22 ' A' ' 109' ' ' ASN . 14.2 Cg_exo -70.53 89.76 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.874 1.716 . . . . 72.23 111.154 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.471 HD22 ' C ' ' A' ' 108' ' ' PRO . 0.9 OUTLIER -135.13 -176.32 4.21 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.35 -1.352 . . . . 74.32 107.35 178.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.663 ' O ' ' HB2' ' A' ' 7' ' ' ASN . 11.6 tm-20 -81.61 1.18 35.03 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 123.148 1.451 . . . . 52.21 108.803 174.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 109' ' ' ASN . 1.7 m -143.24 179.87 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 126.693 1.997 . . . . 64.11 107.552 175.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 112' ' ' ILE . 2.9 pt -55.65 -31.8 29.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 123.955 0.784 . . . . 65.21 113.062 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.29 -135.08 7.4 Favored Glycine 0 CA--C 1.486 -1.747 0 C-N-CA 119.893 -1.146 . . . . 34.13 111.801 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -80.07 11.2 3.56 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.904 0.705 . . . . 70.0 112.904 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.43 -15.52 63.58 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.991 -0.744 . . . . 62.42 108.991 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . 0.3 0.0 OUTLIER 59.32 10.0 1.62 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 128.515 2.726 . . . . 72.34 116.642 172.267 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.81 161.39 18.38 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.916 -0.713 . . . . 65.22 110.059 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -82.61 145.2 29.81 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.742 -0.836 . . . . 74.34 108.742 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 p -57.19 -40.4 77.31 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.919 0.711 . . . . 43.45 112.919 -176.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.1 p -67.8 -46.12 72.84 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.567 -0.288 . . . . 52.51 111.626 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.64 -33.87 62.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 C-N-CA 120.295 -0.562 . . . . 64.14 109.641 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.07 -46.14 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.275 -0.421 . . . . 72.41 110.887 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.402 ' HA ' ' CD1' ' A' ' 9' ' ' LEU . 44.4 ttm180 -66.22 -45.61 80.11 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 121.007 -0.277 . . . . 73.42 110.902 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.47 -43.21 99.03 Favored Glycine 0 N--CA 1.446 -0.657 0 O-C-N 123.608 0.568 . . . . 55.34 112.053 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -38.47 73.88 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.686 0.625 . . . . 62.43 112.686 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.82 -45.73 49.54 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.981 -0.688 . . . . 72.54 110.854 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.06 -59.2 3.67 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.441 -0.345 . . . . 62.24 111.618 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.74 -40.99 93.97 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.541 -0.624 . . . . 52.54 111.541 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.49 -60.15 8.69 Favored Glycine 0 N--CA 1.436 -1.315 0 O-C-N 124.054 0.503 . . . . 52.33 112.3 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.419 ' HE3' HG23 ' A' ' 134' ' ' VAL . 67.8 m95 -63.37 -35.68 81.21 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.592 0.96 . . . . 70.33 113.592 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.2 m -68.29 -54.54 16.85 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.166 -0.614 . . . . 65.14 110.94 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.19 -47.04 39.11 Favored Glycine 0 C--O 1.244 0.735 0 C-N-CA 120.829 -0.7 . . . . 73.2 112.95 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.711 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 46.2 mm -67.3 -49.8 68.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.955 0 CA-C-O 119.577 -0.249 . . . . 65.05 111.228 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.533 HG12 HG21 ' A' ' 16' ' ' ILE . 78.6 t -61.84 -49.6 83.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 118.793 -1.163 . . . . 50.25 112.218 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -61.6 -64.83 0.81 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.702 0.63 . . . . 61.32 112.702 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.05 -39.23 50.77 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.863 -0.735 . . . . 65.31 112.723 -172.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.711 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -69.61 -40.93 76.33 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.006 -0.677 . . . . 70.41 111.886 -176.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.2 mm? -62.63 -48.88 77.42 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 119.063 -1.055 . . . . 73.13 109.271 175.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.527 ' HE ' ' CD ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -61.0 -38.79 87.29 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.735 -0.666 . . . . 72.52 110.452 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -76.89 -36.76 56.47 Favored 'General case' 0 CA--C 1.471 -2.093 0 N-CA-C 113.721 1.008 . . . . 73.44 113.721 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 -27.42 64.02 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.131 -0.627 . . . . 43.02 110.611 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.434 HG11 HG22 ' A' ' 25' ' ' VAL . 23.8 m -80.2 -26.71 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 116.201 -0.454 . . . . 72.3 110.76 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -84.31 -60.36 2.11 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 119.98 -0.688 . . . . 74.44 111.512 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.25 154.96 40.88 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.985 1.106 . . . . 71.54 113.985 -170.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.611 ' H ' HD23 ' A' ' 145' ' ' LEU . 2.2 pt? -87.48 79.34 8.41 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 122.572 1.177 . . . . 72.45 108.354 173.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -82.48 83.22 7.61 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.713 -1.13 . . . . 52.14 109.5 -175.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -101.12 147.54 26.11 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.08 -0.964 . . . . 71.52 108.973 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -152.01 179.9 8.07 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.245 -0.65 . . . . 73.23 109.245 -171.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -68.13 138.13 55.46 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 107.99 -1.115 . . . . 75.31 107.99 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 44.7 p-80 -113.53 127.95 56.27 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 121.066 0.46 . . . . 74.44 110.484 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -70.86 -15.45 62.63 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 115.223 1.564 . . . . 74.15 115.223 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 . . . . . 0 C--N 1.299 -1.591 0 N-CA-C 108.324 -0.991 . . . . 72.44 108.324 177.352 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 107.763 -1.199 . . . . 72.14 107.763 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.13 100.78 0.63 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.435 -0.579 . . . . 73.21 109.435 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -62.28 -28.89 70.04 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.71 0.804 . . . . 71.34 109.969 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.71 132.89 55.64 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.324 -0.991 . . . . 71.34 108.324 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -114.91 3.5 14.58 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.364 0.602 . . . . 54.41 110.698 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -81.38 104.89 12.14 Favored 'General case' 0 N--CA 1.409 -2.479 0 CA-C-O 122.461 1.124 . . . . 63.22 109.34 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.518 ' HA ' ' HD2' ' A' ' 123' ' ' ARG . 60.9 t30 -68.32 -11.92 60.26 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 112.622 -2.081 . . . . 73.2 113.12 -175.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.61 -72.38 0.27 Allowed 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.042 0.448 . . . . 64.14 110.461 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 tt 177.99 100.99 0.13 Allowed Pre-proline 0 N--CA 1.434 -1.266 0 N-CA-C 105.775 -1.935 . . . . 64.34 105.775 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -92.96 -179.42 0.95 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.413 2.075 . . . . 40.43 110.118 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.589 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 3.2 p-10 -68.24 112.28 5.06 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.836 -0.802 . . . . 62.14 108.836 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.531 HG22 ' HB3' ' A' ' 102' ' ' HIS . 9.1 tp -97.33 125.44 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 C-N-CA 118.456 -1.298 . . . . 70.41 108.283 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 60.7 m -107.18 128.98 54.89 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 107.425 -1.324 . . . . 73.03 107.425 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -131.09 136.52 48.47 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.68 -1.23 . . . . 74.43 107.68 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -118.3 134.95 54.6 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 120.754 0.312 . . . . 61.3 111.211 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.509 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.78 139.98 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.033 0.444 . . . . 53.4 109.917 -179.091 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 p -101.09 126.74 47.81 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.137 0.494 . . . . 74.55 110.969 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.408 HD11 ' HB3' ' A' ' 138' ' ' LEU . 4.0 mm? -91.19 138.17 31.8 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.617 -0.72 . . . . 64.31 110.603 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -86.83 30.12 0.76 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 113.997 -1.456 . . . . 74.14 109.613 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.15 158.41 73.74 Favored Pre-proline 0 C--O 1.251 1.142 0 CA-C-N 115.564 -0.743 . . . . 62.23 109.37 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.97 150.76 87.61 Favored 'Trans proline' 0 C--O 1.25 1.091 0 C-N-CA 123.286 2.657 . . . . 75.13 112.109 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -40.24 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.091 -0.958 . . . . 70.52 111.68 -176.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -67.83 -35.77 79.19 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.997 -0.681 . . . . 74.43 111.179 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -72.66 -37.48 67.93 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.627 -0.509 . . . . 62.51 109.627 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.03 -41.15 89.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.908 -0.587 . . . . 61.21 109.618 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -60.02 -47.03 87.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.593 -0.73 . . . . 74.14 110.086 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -60.79 -39.79 90.17 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.362 0.665 . . . . 73.44 110.475 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.7 m -60.97 -23.29 65.23 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.536 0.734 . . . . 72.13 112.055 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.589 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 10.7 m -119.25 19.87 6.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 112.508 0.558 . . . . 73.31 112.508 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.427 ' HB2' HD12 ' A' ' 46' ' ' LEU . 61.0 p -137.46 -22.09 1.14 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.933 0.716 . . . . 63.03 112.933 176.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -91.63 154.61 18.91 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.456 -0.572 . . . . 63.42 109.456 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 27.7 t -63.01 -40.78 98.78 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.605 -0.887 . . . . 63.42 108.605 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -62.3 -48.97 77.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.678 -1.147 . . . . 71.42 109.638 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.78 -47.59 60.26 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.151 -0.931 . . . . 71.21 113.402 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HA ' HH22 ' A' ' 137' ' ' ARG . 70.2 mt -69.47 -48.46 66.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 117.601 0.7 . . . . 73.22 111.895 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.71 -45.55 78.39 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.461 0.541 . . . . 70.5 112.461 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 tttp 57.48 23.83 9.56 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 123.145 1.45 . . . . 75.13 108.63 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 65.3 13.29 8.69 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.843 2.057 . . . . 61.12 114.504 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -72.4 -44.47 62.45 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.835 0.826 . . . . 72.13 109.322 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.42 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 21.6 ptm -128.68 125.31 23.02 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 114.655 -1.157 . . . . 65.21 109.433 -176.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 40' ' ' MET . 5.0 Cg_exo -79.05 94.24 1.08 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.168 1.912 . . . . 64.51 113.385 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -140.22 143.92 36.27 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.082 -1.451 . . . . 64.12 107.082 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.79 78.86 3.28 Favored 'General case' 0 CA--C 1.469 -2.139 0 CA-C-O 121.177 0.513 . . . . 74.41 110.911 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' ' 32' ' ' SER . 83.1 m-85 -68.28 126.55 29.94 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.594 -1.185 . . . . 63.43 109.009 175.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -127.45 138.75 53.04 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.987 -0.745 . . . . 65.4 108.987 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 30' ' ' SER . 5.5 tt -75.56 103.72 5.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 106.641 -1.615 . . . . 65.52 106.641 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 1.2 tpmt? -133.91 145.13 49.32 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.53 -1.656 . . . . 73.3 106.53 172.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -87.68 48.12 1.6 Allowed 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 119.298 0.954 . . . . 73.52 110.185 174.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.68 49.96 0.03 OUTLIER Glycine 0 N--CA 1.42 -2.409 0 CA-C-N 115.32 -0.855 . . . . 62.14 111.0 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -79.24 104.77 10.1 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 106.082 -1.822 . . . . 74.0 106.082 176.633 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -151.44 148.93 28.68 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 108.859 -0.793 . . . . 71.42 108.859 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -124.07 146.99 48.22 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 105.351 -2.092 . . . . 74.01 105.351 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -109.81 142.66 40.77 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.244 -0.651 . . . . 64.44 109.244 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -127.29 137.5 52.85 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.962 -0.755 . . . . 63.23 108.962 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -82.5 91.39 6.88 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.151 -1.425 . . . . 72.41 107.151 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.7 m -156.9 120.28 2.24 Favored Pre-proline 0 C--N 1.297 -1.692 0 N-CA-C 108.93 -0.767 . . . . 74.22 108.93 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.95 115.33 3.21 Favored 'Trans proline' 0 C--O 1.244 0.824 0 C-N-CA 121.74 1.627 . . . . 70.25 108.174 173.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.1 t80 71.1 94.22 0.08 Allowed 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.658 -1.238 . . . . 70.54 107.658 -170.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.41 152.85 40.2 Favored Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 115.37 -0.832 . . . . 74.14 112.904 -175.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.479 ' O ' HG22 ' A' ' 80' ' ' THR . 17.6 Cg_endo -60.08 -33.76 95.04 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.041 2.494 . . . . 75.33 112.492 177.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.2 t 70.39 92.42 0.06 OUTLIER Pre-proline 0 C--O 1.249 1.07 0 C-N-CA 123.964 0.906 . . . . 71.32 111.593 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.37 -158.62 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.97 2.446 . . . . 72.34 109.632 175.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 20.4 p -88.37 141.5 28.49 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 119.306 -0.958 . . . . 72.15 108.553 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 9.6 mtmp? -145.38 135.5 23.84 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.35 -0.982 . . . . 74.34 108.35 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 50' ' ' GLN . 30.2 t -90.28 130.61 39.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.602 -1.258 . . . . 62.12 107.602 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.2 tp -76.03 -59.91 2.55 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.055 -1.091 . . . . 75.03 108.055 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -162.16 141.08 9.33 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.352 -0.84 . . . . 61.12 109.776 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.505 HG23 HD23 ' A' ' 74' ' ' LEU . 9.4 p -116.99 120.46 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.982 0 CA-C-O 121.583 0.706 . . . . 65.0 110.036 175.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 2.2 mp0 -94.15 141.04 29.0 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.617 -1.174 . . . . 73.2 108.85 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 122.69 83.57 Favored Pre-proline 0 C--N 1.276 -2.613 0 CA-C-N 114.379 -1.282 . . . . 51.44 108.969 -164.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo 0.12 62.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.014 1 C-N-CA 126.771 4.981 . . . . 62.52 115.488 -159.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -143.47 -42.24 0.29 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 113.67 -1.605 . . . . 73.21 110.983 175.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.4 tt0 -150.84 145.46 25.7 Favored 'General case' 0 C--O 1.204 -1.318 0 C-N-CA 119.834 -0.746 . . . . 74.44 110.491 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.694 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.0 tm? -137.05 137.63 39.56 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.063 -1.088 . . . . 73.01 108.063 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.7 p -140.76 126.88 19.58 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.803 -0.359 . . . . 65.34 110.992 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.46 ' HD1' HD11 ' A' ' 74' ' ' LEU . 31.2 p90 -144.23 156.91 44.49 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 120.794 0.33 . . . . 72.52 111.07 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 20.6 mt-10 -121.07 136.78 54.91 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 105.963 -1.866 . . . . 75.53 105.963 -173.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -147.94 158.71 44.19 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 120.188 -0.605 . . . . 74.42 112.409 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 73.84 171.34 0.3 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.05 -1.432 . . . . 73.5 113.195 172.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 60' ' ' PRO . 11.6 p -66.47 -34.46 77.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.934 0.894 . . . . 70.34 111.862 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.405 ' O ' ' HE3' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -74.46 -15.11 60.9 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 112.438 0.533 . . . . 74.31 112.438 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.29 67.64 1.79 Allowed Glycine 0 C--O 1.247 0.91 0 C-N-CA 121.058 -0.591 . . . . 54.33 112.411 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.456 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 33.2 m95 -93.95 130.21 40.13 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.33 -0.618 . . . . 63.34 109.33 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.432 HG22 ' HG2' ' A' ' 77' ' ' GLU . 42.1 t -110.8 111.43 36.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.854 -1.165 . . . . 73.23 107.854 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.3 m -109.23 140.59 27.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 115.946 -0.57 . . . . 73.13 109.67 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 58.3 m -126.09 135.14 51.37 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.9 -0.778 . . . . 74.35 108.9 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.694 ' CD2' HD12 ' A' ' 74' ' ' LEU . 11.7 m-85 -111.25 132.59 54.23 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.793 -1.188 . . . . 73.43 107.793 177.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.57 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 27.3 mt-30 -114.35 141.45 47.61 Favored 'General case' 0 C--N 1.276 -2.614 0 O-C-N 123.643 0.589 . . . . 75.24 110.568 177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.6 tp -104.18 141.18 36.71 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.705 -0.68 . . . . 64.12 110.918 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -124.92 116.68 22.59 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 106.164 -1.791 . . . . 74.35 106.164 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -86.22 119.15 26.2 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.999 -0.546 . . . . 65.11 111.796 -173.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 74.6 mt -125.18 149.52 47.85 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.046 -1.464 . . . . 71.01 107.046 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.84 58.84 1.79 Allowed Glycine 0 C--N 1.28 -2.536 0 C-N-CA 120.44 -0.886 . . . . 63.2 112.476 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -177.15 -52.84 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.119 -1.808 . . . . 62.21 106.119 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.67 175.8 7.7 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.006 -1.479 . . . . 74.34 107.006 -175.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.1 m -120.87 130.39 53.9 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 120.341 -0.543 . . . . 62.04 109.697 -178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.52 124.79 7.86 Favored Glycine 0 N--CA 1.408 -3.216 0 N-CA-C 109.099 -1.6 . . . . 72.34 109.099 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -117.27 134.18 55.11 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 108.812 -0.81 . . . . 74.13 108.812 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 23.5 m -125.95 129.24 48.88 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.517 -0.92 . . . . 65.55 108.517 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.505 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -104.79 142.26 35.03 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.005 -0.739 . . . . 74.23 109.005 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.494 ' N ' HD13 ' A' ' 100' ' ' LEU . 3.6 mp -136.13 125.25 38.61 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 106.829 -1.545 . . . . 72.41 106.829 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.589 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 23.2 t-160 -119.3 124.33 46.4 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.09 -0.707 . . . . 53.25 109.09 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.0 t -139.44 164.09 30.79 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 106.49 -1.67 . . . . 71.03 106.49 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -110.42 160.54 13.28 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.752 -0.737 . . . . 54.52 112.099 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -84.8 22.39 1.37 Allowed 'General case' 0 CA--C 1.559 1.32 0 CA-C-O 122.623 1.201 . . . . 72.54 110.205 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' A' ' 81' ' ' GLU . 16.0 ptpt -142.96 156.65 44.91 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.453 -0.779 . . . . 64.45 110.481 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 43.5 tt0 -63.87 122.05 74.72 Favored Pre-proline 0 C--N 1.313 -0.98 0 C-N-CA 124.254 1.021 . . . . 75.11 110.773 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 107' ' ' GLU . 3.4 Cg_exo -73.71 107.08 2.32 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 122.212 1.941 . . . . 73.13 111.108 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -110.01 -156.95 0.6 Allowed 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.443 -1.317 . . . . 61.01 107.443 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -58.98 -33.3 70.51 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.232 0.924 . . . . 75.11 111.465 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.1 155.52 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 CA-C-N 116.272 -0.422 . . . . 70.32 110.355 169.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.423 ' H ' HG12 ' A' ' 112' ' ' ILE . 1.1 pt -58.47 -38.46 70.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.56 -1.2 . . . . 71.04 112.245 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.17 70.3 0.24 Allowed Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.168 -1.491 . . . . 74.42 113.016 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt 61.93 31.66 18.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.729 1.011 . . . . 75.14 113.729 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.35 -13.3 61.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.654 0.264 . . . . 73.42 110.696 174.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 m120 93.65 139.25 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.377 1.871 . . . . 72.12 112.891 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 86.27 158.68 0.08 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.391 1.876 . . . . 55.04 111.353 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HB2' HG23 ' A' ' 121' ' ' VAL . 30.9 mmmt -59.28 149.43 28.76 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.187 0.595 . . . . 74.23 112.168 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.58 -52.81 64.07 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.221 1.008 . . . . 75.2 110.592 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.8 t -60.82 -36.74 79.85 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.611 -0.722 . . . . 74.41 110.2 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 118' ' ' LYS . 71.6 t -70.25 -47.45 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.653 -0.703 . . . . 72.24 109.898 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.16 -41.18 80.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.208 -0.451 . . . . 75.2 110.701 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.518 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 74.4 ttt180 -63.22 -48.81 76.72 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.486 -0.779 . . . . 73.45 109.424 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.76 96.97 Favored Glycine 0 CA--C 1.495 -1.213 0 CA-C-N 115.231 -0.895 . . . . 60.42 112.03 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -66.55 -35.21 79.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 122.78 0.432 . . . . 71.01 111.521 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 24.1 mmt -70.92 -45.09 64.85 Favored 'General case' 0 C--O 1.211 -0.939 0 C-N-CA 120.315 -0.554 . . . . 64.51 111.003 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -67.26 -53.84 26.27 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.406 -0.918 . . . . 72.24 111.104 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.97 -45.64 95.21 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.917 -0.473 . . . . 63.54 111.917 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.65 -52.65 49.47 Favored Glycine 0 CA--C 1.487 -1.701 0 N-CA-C 111.494 -0.642 . . . . 64.52 111.494 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.402 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.7 m95 -65.15 -26.3 68.11 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 113.372 0.878 . . . . 73.03 113.372 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.1 m -67.81 -54.68 17.17 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.55 -0.537 . . . . 74.5 109.55 174.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.87 -42.4 86.19 Favored Glycine 0 C--O 1.245 0.826 0 CA-C-N 115.992 -0.549 . . . . 54.21 113.053 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.681 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 39.5 mm -65.37 -57.58 10.39 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 CA-C-O 119.599 -0.239 . . . . 72.21 110.937 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 69.6 t -57.99 -48.02 85.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 112.486 0.55 . . . . 72.12 112.486 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.509 ' HA ' HG13 ' A' ' 16' ' ' ILE . 43.4 t30 -59.69 -63.31 1.35 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.041 0.448 . . . . 75.13 111.995 -177.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -74.85 -48.27 25.92 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 112.447 0.536 . . . . 72.11 112.447 -173.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.681 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -63.56 -38.64 91.91 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 112.107 0.41 . . . . 74.24 112.107 -175.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.3 mm? -68.1 -48.38 65.63 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 119.298 -0.961 . . . . 64.34 110.594 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -58.42 -36.04 72.99 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.53 0.681 . . . . 74.14 109.698 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -75.97 -38.85 57.04 Favored 'General case' 0 C--O 1.185 -2.329 0 N-CA-C 112.339 0.496 . . . . 75.42 112.339 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.17 68.58 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.152 -0.619 . . . . 73.54 111.446 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.6 m -78.56 -36.09 19.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.067 -0.653 . . . . 73.22 110.213 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -87.8 -58.95 2.38 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.39 1.256 . . . . 72.12 114.39 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -130.74 115.73 17.04 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.74 0.781 . . . . 71.23 111.442 -172.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.43 25.35 0.63 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 113.593 0.961 . . . . 73.31 113.593 -174.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.79 145.85 48.42 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.873 -0.788 . . . . 62.11 108.873 173.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -111.94 156.6 21.84 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.598 -0.441 . . . . 75.54 110.595 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -123.86 153.17 41.47 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.308 -1.738 . . . . 75.21 106.308 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -114.61 116.44 28.76 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 118.764 -1.174 . . . . 71.44 110.63 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -72.49 145.71 47.34 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.402 -0.962 . . . . 74.05 108.402 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -57.93 -54.11 50.69 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 123.728 0.642 . . . . 72.24 110.028 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.2 t60 . . . . . 0 C--O 1.25 1.081 0 N-CA-C 108.2 -1.037 . . . . 62.43 108.2 178.169 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.306 0.098 . . . . 73.13 111.216 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.28 127.81 32.8 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.744 0.306 . . . . 52.32 110.574 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -100.99 -48.72 4.34 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.049 -0.523 . . . . 71.33 111.884 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -140.95 -164.33 1.72 Allowed 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 109.502 -0.555 . . . . 74.32 109.502 -172.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -78.8 96.09 5.53 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.075 -1.454 . . . . 72.12 107.075 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -114.49 80.21 1.37 Allowed 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 107.513 -1.292 . . . . 63.04 107.513 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -66.32 -36.77 83.77 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 120.623 -0.431 . . . . 72.24 109.912 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -135.2 -66.17 0.59 Allowed 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 106.945 -1.502 . . . . 64.33 106.945 177.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.456 HD11 ' HA3' ' A' ' 104' ' ' GLY . 2.4 pt? -162.53 129.72 2.58 Favored Pre-proline 0 N--CA 1.418 -2.028 0 N-CA-C 105.898 -1.889 . . . . 60.43 105.898 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -85.44 -167.94 0.45 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 121.78 1.653 . . . . 75.43 110.121 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 14.1 t70 -100.35 113.07 25.52 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 105.675 -1.972 . . . . 61.31 105.675 171.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' A' ' 102' ' ' HIS . 14.5 tt -106.86 130.79 58.23 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.982 0 C-N-CA 119.81 -0.756 . . . . 75.4 109.478 -177.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 36.2 m -114.37 128.92 56.59 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 106.984 -1.488 . . . . 63.43 106.984 178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 20.0 tptt -134.67 152.69 51.95 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.392 -1.336 . . . . 61.2 107.392 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.2 p -128.75 133.91 48.25 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 120.812 -0.355 . . . . 71.21 110.342 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.28 135.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.333 -1.358 . . . . 75.32 107.333 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.8 p -102.8 131.49 49.62 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.47 0.544 . . . . 72.42 112.47 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.9 mp -108.36 140.94 40.92 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 122.005 0.907 . . . . 75.3 113.094 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -70.36 13.42 0.17 Allowed 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 128.583 2.753 . . . . 62.55 112.779 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.483 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -130.86 164.03 44.76 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-O 118.969 -0.539 . . . . 75.11 110.107 -172.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 37.5 Cg_endo -64.8 154.95 70.14 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.85 2.367 . . . . 62.34 111.904 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.401 ' HA ' HG21 ' A' ' 96' ' ' THR . 14.0 tt -57.69 -33.35 44.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.688 -1.142 . . . . 74.24 112.666 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 3.9 pt20 -65.05 -41.31 95.3 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.364 -0.38 . . . . 72.12 111.756 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -72.64 -38.9 67.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.321 -0.4 . . . . 61.51 110.988 -173.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.468 HG11 HG21 ' A' ' 96' ' ' THR . 8.6 p -68.28 -41.0 83.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 120.385 -0.526 . . . . 74.42 109.918 178.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -62.28 -47.25 85.15 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.636 -0.711 . . . . 73.1 111.451 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 23' ' ' GLN . 11.6 pt-20 -69.0 -27.9 66.11 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 120.35 -0.54 . . . . 65.31 111.523 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.0 m -57.13 -36.38 70.63 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 121.411 0.624 . . . . 72.05 110.026 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.498 HG21 ' HE2' ' A' ' 98' ' ' PHE . 4.0 m -107.74 23.14 3.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.125 -0.489 . . . . 75.21 111.795 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.9 t -145.06 11.29 1.35 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.945 0.402 . . . . 60.11 110.743 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.0 p -117.31 162.14 18.39 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.871 -0.518 . . . . 53.24 110.335 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -51.93 -62.23 1.76 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.325 1.05 . . . . 64.12 111.467 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.58 -35.52 75.43 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.837 0.68 . . . . 63.44 112.837 -175.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.85 -48.39 72.37 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.928 -0.653 . . . . 50.3 111.743 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.496 HD12 ' CD1' ' A' ' 44' ' ' PHE . 64.1 mt -70.46 -39.37 76.24 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 CA-C-O 120.594 0.235 . . . . 54.12 111.385 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.04 -51.32 64.42 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.015 -0.539 . . . . 73.1 110.434 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.545 ' HB2' ' NH1' ' A' ' 137' ' ' ARG 0.257 0.4 OUTLIER 45.39 29.02 0.53 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.541 1.537 . . . . 72.12 114.335 177.647 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -158.32 159.35 35.81 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 102.514 -3.143 . . . . 72.55 102.514 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -86.75 52.34 2.48 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 119.979 1.263 . . . . 71.12 109.873 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 92.2 mtp -122.37 109.96 32.71 Favored Pre-proline 0 C--N 1.312 -1.057 0 N-CA-C 105.525 -2.028 . . . . 73.24 105.525 176.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.12 110.2 0.65 Allowed 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 122.617 2.212 . . . . 62.14 113.136 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -113.69 142.81 45.56 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 108.274 -1.01 . . . . 54.42 108.274 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -110.08 74.08 0.87 Allowed 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 119.704 -0.798 . . . . 63.22 109.787 -172.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.496 ' CD1' HD12 ' A' ' 35' ' ' ILE . 18.6 t80 -106.9 129.26 54.75 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.08 -0.964 . . . . 72.51 110.722 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -136.0 150.53 49.26 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.522 -1.659 . . . . 73.33 106.522 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -80.43 109.33 14.84 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 118.813 -1.155 . . . . 72.12 111.601 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 22.3 tptm -128.52 143.4 50.96 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 104.522 -2.399 . . . . 55.15 104.522 173.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -87.83 78.17 8.41 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.407 1.098 . . . . 62.24 109.239 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.36 99.2 2.22 Favored Glycine 1 N--CA 1.395 -4.084 0 N-CA-C 108.122 -1.991 . . . . 44.14 108.122 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 7.3 tt0 -153.99 117.7 4.68 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.268 -1.382 . . . . 71.53 107.268 -174.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -148.31 162.03 40.35 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-O 121.086 0.47 . . . . 71.14 110.914 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 96.6 m-85 -98.28 122.16 41.09 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 108.014 -1.106 . . . . 54.45 108.014 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -145.56 154.34 42.07 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.753 -0.658 . . . . 74.35 109.545 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.0 mp 73.44 -16.48 0.48 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.31 1.044 . . . . 74.03 112.266 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -128.1 23.65 6.05 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.125 -1.435 . . . . 74.14 107.125 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 50.1 m 75.03 143.82 0.1 Allowed Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.336 1.454 . . . . 62.15 111.157 -174.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 52' ' ' PHE . 17.2 Cg_exo -69.49 -16.44 38.67 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.452 2.101 . . . . 74.4 111.52 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -95.82 106.36 18.48 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.7 -1.222 . . . . 73.22 107.7 177.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.87 -139.51 6.72 Favored Glycine 0 C--N 1.294 -1.799 0 N-CA-C 109.099 -1.601 . . . . 71.52 109.099 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -65.39 -22.86 59.21 Favored 'Trans proline' 0 N--CA 1.473 0.293 0 C-N-CA 122.175 1.916 . . . . 73.1 109.404 174.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.9 m -134.88 134.26 21.74 Favored Pre-proline 0 N--CA 1.411 -2.376 0 N-CA-C 106.954 -1.498 . . . . 72.11 106.954 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -92.94 32.92 0.24 Allowed 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 122.747 2.298 . . . . 72.14 112.239 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.5 p -111.69 165.25 12.2 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 112.945 0.72 . . . . 62.14 112.945 -174.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 89.4 mttt -138.09 143.94 40.66 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.807 -1.923 . . . . 75.41 105.807 175.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 50' ' ' GLN . 18.2 t -91.2 136.77 23.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 107.526 -1.287 . . . . 54.14 107.526 173.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.1 tt -87.09 -58.19 2.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.863 -1.162 . . . . 63.23 107.863 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.34 145.88 10.07 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.219 -1.03 . . . . 74.11 108.219 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.81 119.8 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-O 122.207 1.003 . . . . 74.52 111.378 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 15.4 mm100 -104.92 142.51 34.64 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 113.941 -1.481 . . . . 74.34 109.064 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.81 129.19 94.26 Favored Pre-proline 0 C--N 1.277 -2.565 0 CA-C-N 114.354 -1.294 . . . . 51.32 108.262 -167.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -1.99 52.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.558 1 C-N-CA 128.105 5.87 . . . . 62.43 117.919 -160.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.0 p -137.23 -42.64 0.56 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.667 -1.151 . . . . 64.31 109.922 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 41.2 tt0 -144.35 127.28 16.39 Favored 'General case' 0 C--O 1.19 -2.042 0 C-N-CA 119.629 -0.828 . . . . 63.03 109.453 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.442 HD23 ' HD2' ' A' ' 87' ' ' PHE . 7.0 tp -133.95 127.72 32.98 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 108.589 -0.893 . . . . 74.01 108.589 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 m -135.2 127.13 29.51 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.468 -0.493 . . . . 73.23 111.269 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -142.09 156.55 45.4 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.008 0.373 . . . . 71.24 112.008 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -120.71 129.28 53.58 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.915 -1.143 . . . . 74.44 107.915 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -113.99 118.94 35.53 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.142 -1.059 . . . . 75.22 108.142 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 80' ' ' THR . 34.5 t70 -82.39 -178.85 7.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.2 -1.037 . . . . 72.45 108.2 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.403 ' H ' ' CG ' ' A' ' 79' ' ' ASP . 20.6 m 69.16 25.32 5.78 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-O 123.77 1.748 . . . . 73.43 106.515 -171.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.569 ' CB ' ' HB2' ' A' ' 115' ' ' ALA . 23.9 mm-40 59.93 45.61 12.11 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 112.231 -2.259 . . . . 71.43 113.643 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.37 -21.6 56.25 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 108.159 -1.977 . . . . 51.22 108.159 170.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 74.44 -175.53 0.14 Allowed 'General case' 0 C--O 1.245 0.845 0 C-N-CA 126.95 2.1 . . . . 74.4 112.908 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.7 p -96.85 115.04 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-O 122.19 0.995 . . . . 65.41 109.888 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.56 146.41 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 CA-C-N 114.549 -1.205 . . . . 72.41 109.046 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 92.9 m -136.79 133.46 35.98 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 108.569 -0.9 . . . . 71.44 108.569 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.442 ' HD2' HD23 ' A' ' 74' ' ' LEU . 15.5 m-85 -119.03 135.85 54.42 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.825 -1.176 . . . . 74.13 107.825 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.65 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 42.7 mt-30 -118.83 146.44 44.85 Favored 'General case' 0 C--N 1.263 -3.194 0 CA-C-N 115.57 -0.741 . . . . 71.52 110.393 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.32 126.55 55.5 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.243 -0.889 . . . . 75.24 109.351 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -114.88 116.67 28.93 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 107.629 -1.249 . . . . 41.5 107.629 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -83.18 121.16 26.71 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.764 -0.653 . . . . 75.24 110.762 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 73.8 mt -123.85 156.56 35.97 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.036 -1.098 . . . . 71.04 108.036 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.13 59.69 1.39 Allowed Glycine 0 C--N 1.282 -2.429 0 C-N-CA 120.517 -0.849 . . . . 74.31 113.121 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 175.43 -39.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.595 1.158 . . . . 72.44 108.672 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 3.8 ptpt -144.85 175.81 9.93 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.457 -1.682 . . . . 65.15 106.457 -174.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.468 HG21 HG11 ' A' ' 25' ' ' VAL . 62.6 m -116.47 131.62 56.9 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.099 -0.704 . . . . 75.55 109.099 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.4 119.0 5.35 Favored Glycine 0 N--CA 1.409 -3.162 0 N-CA-C 108.66 -1.776 . . . . 64.41 108.66 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.498 ' HE2' HG21 ' A' ' 29' ' ' VAL . 45.3 t80 -103.86 130.38 51.44 Favored 'General case' 0 C--N 1.257 -3.448 0 N-CA-C 107.171 -1.418 . . . . 73.22 107.171 178.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 14.7 m -114.86 123.72 49.89 Favored 'General case' 0 N--CA 1.397 -3.095 0 N-CA-C 107.607 -1.257 . . . . 73.12 107.607 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.56 140.65 34.53 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 108.486 -0.931 . . . . 74.35 108.486 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 4.6 mp -135.92 123.54 35.35 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.16 0 CA-C-N 113.758 -1.565 . . . . 74.24 107.137 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.478 ' HB3' HG22 ' A' ' 12' ' ' ILE . 17.5 t60 -122.48 126.2 47.36 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.475 -0.935 . . . . 74.43 108.475 175.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -142.93 164.27 30.54 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 106.428 -1.693 . . . . 75.33 106.428 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.456 ' HA3' HD11 ' A' ' 9' ' ' LEU . . . -154.4 143.23 9.8 Favored Glycine 0 CA--C 1.48 -2.104 0 N-CA-C 109.95 -1.26 . . . . 60.12 109.95 176.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -71.58 140.03 49.65 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.311 -0.625 . . . . 74.25 109.311 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -86.5 83.46 7.64 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.069 -1.085 . . . . 70.13 108.069 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.46 ' HB2' ' HD3' ' A' ' 108' ' ' PRO . 13.6 mm-40 -87.58 -59.31 0.27 Allowed Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 114.935 -1.029 . . . . 74.21 112.858 -176.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HG2' ' O ' ' A' ' 112' ' ' ILE . 1.3 Cg_endo -88.02 -78.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 121.982 1.788 . . . . 74.11 115.986 -171.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.35 -169.84 1.57 Allowed 'General case' 0 C--N 1.318 -0.794 0 O-C-N 122.294 -0.254 . . . . 71.21 111.374 -172.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 8' ' ' ALA . 35.8 tt0 -63.83 -47.71 79.73 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.007 0.817 . . . . 72.5 108.82 174.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 5.2 p -94.55 176.66 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 104.859 -2.274 . . . . 62.44 104.859 171.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.479 ' O ' ' HG2' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -58.09 -39.51 73.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 119.98 1.264 . . . . 71.23 112.024 -176.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 55.18 47.41 74.33 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 111.994 -0.443 . . . . 40.21 111.994 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -166.07 -70.12 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.818 0.342 . . . . 74.12 110.93 -171.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.569 ' HB2' ' CB ' ' A' ' 81' ' ' GLU . . . -72.82 -40.79 65.52 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 116.514 2.042 . . . . 75.23 116.514 -171.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.16 100.88 0.97 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 105.876 -1.898 . . . . 74.02 105.876 -168.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . 0.271 36.7 mm-40 -94.93 89.01 5.47 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 114.866 1.432 . . . . 75.01 114.866 -172.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.613 ' HB3' HG12 ' A' ' 121' ' ' VAL . 52.5 tttp -179.43 91.25 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.453 -1.703 . . . . 53.42 106.926 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 m -48.44 -40.68 27.02 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 125.483 1.513 . . . . 72.45 112.912 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 25.8 t -65.14 -46.58 80.36 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 120.964 -0.294 . . . . 71.14 111.119 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 118' ' ' LYS . 9.6 p -71.13 -34.4 54.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 C-N-CA 119.73 -0.788 . . . . 55.44 110.047 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.8 -47.09 94.5 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 N-CA-C 110.443 -0.206 . . . . 63.03 110.443 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.401 ' HA ' ' HE2' ' A' ' 126' ' ' MET . 50.7 mtt180 -57.64 -52.98 63.19 Favored 'General case' 0 C--O 1.257 1.467 0 O-C-N 123.852 0.72 . . . . 72.13 110.869 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.76 -40.64 99.07 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 114.979 -1.009 . . . . 61.44 112.811 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.39 -32.53 70.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.041 0.756 . . . . 70.02 113.041 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.401 ' HE2' ' HA ' ' A' ' 123' ' ' ARG . 72.9 mtm -62.06 -54.82 36.09 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.638 -0.825 . . . . 75.54 110.244 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.98 -62.95 1.24 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.848 -0.741 . . . . 72.35 112.325 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.04 -34.95 82.91 Favored Glycine 0 CA--C 1.497 -1.043 0 CA-C-N 116.101 -0.499 . . . . 54.43 112.303 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.79 -54.34 15.34 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 111.62 -0.592 . . . . 63.33 111.62 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.45 ' O ' HG12 ' A' ' 134' ' ' VAL . 72.5 m95 -59.99 -44.56 94.43 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 112.927 0.714 . . . . 75.41 112.927 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.408 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 25.0 m -58.62 -49.5 77.25 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.469 0.48 . . . . 64.53 110.507 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.94 -46.19 60.57 Favored Glycine 0 C--O 1.25 1.14 0 C-N-CA 120.983 -0.627 . . . . 65.34 112.85 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mm -66.54 -52.54 45.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 CA-C-O 119.334 -0.365 . . . . 73.34 111.411 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 130' ' ' TRP . 4.2 p -62.93 -36.16 74.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 117.955 0.343 . . . . 53.24 111.206 -175.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.57 -64.97 0.77 Allowed 'General case' 0 C--N 1.351 0.644 0 O-C-N 123.394 0.434 . . . . 74.01 110.359 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.95 -40.45 71.99 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 112.602 0.593 . . . . 72.43 112.602 -173.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.545 ' NH1' ' HB2' ' A' ' 37' ' ' LYS . 9.2 tpp85 -62.53 -51.68 66.45 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 120.566 -0.454 . . . . 64.23 110.829 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 18' ' ' LEU . 49.9 mt -70.63 -41.08 72.67 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.328 -0.949 . . . . 75.44 111.679 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.642 ' NE ' ' HG3' ' A' ' 143' ' ' GLU . 1.1 tmt_? -60.63 -34.83 74.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.359 -0.608 . . . . 73.44 109.359 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 144' ' ' GLU . 23.3 mmmt -71.13 -42.56 69.04 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 119.995 -0.682 . . . . 73.34 111.434 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.581 ' HB2' ' HB3' ' A' ' 146' ' ' GLU . . . -66.26 -28.88 69.06 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 111.961 0.356 . . . . 44.32 111.961 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 20' ' ' ALA . 21.4 m -88.74 -26.36 5.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 112.485 0.55 . . . . 75.04 112.485 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.642 ' HG3' ' NE ' ' A' ' 139' ' ' ARG . 5.7 mm-40 -97.37 -34.8 10.91 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.136 0.791 . . . . 72.03 113.136 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.425 ' HB3' ' HE3' ' A' ' 140' ' ' LYS . 35.9 tt0 -131.38 -78.01 0.52 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.436 0.636 . . . . 63.3 110.523 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 59.4 tp -178.27 157.06 1.03 Allowed 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 104.438 -2.43 . . . . 64.31 104.438 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.581 ' HB3' ' HB2' ' A' ' 141' ' ' ALA . 1.9 pp20? -82.58 162.85 21.81 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.749 -0.834 . . . . 65.45 108.749 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -157.58 150.63 23.34 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.064 -1.087 . . . . 64.44 108.064 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -78.22 83.24 4.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.164 -0.68 . . . . 64.11 109.164 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.35 -61.78 2.37 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.811 -1.086 . . . . 74.01 111.258 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -167.42 178.14 5.64 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.218 -1.401 . . . . 74.14 107.218 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -116.71 127.43 54.4 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.205 -1.405 . . . . 75.1 107.205 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 5.0 t60 . . . . . 0 C--N 1.296 -1.742 0 N-CA-C 107.14 -1.43 . . . . 71.13 107.14 179.504 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.505 -0.761 0 N-CA-C 109.395 -0.595 . . . . 71.35 109.395 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.38 107.06 9.53 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.745 -1.205 . . . . 63.41 107.745 175.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.419 ' CG ' ' HA2' ' A' ' 124' ' ' GLY . 5.8 tp-100 -85.07 -37.7 20.0 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.206 -0.906 . . . . 71.14 111.428 -172.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -86.53 92.02 8.74 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 113.725 1.009 . . . . 53.25 113.725 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -144.53 129.56 18.52 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 106.552 -1.647 . . . . 74.53 106.552 169.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -136.5 103.5 5.27 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-O 121.925 0.869 . . . . 75.25 112.368 -170.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 108' ' ' PRO . 32.5 t-20 -131.1 55.92 1.82 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.444 -2.058 . . . . 63.32 105.444 175.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 66.19 39.31 4.28 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 112.148 -2.296 . . . . 51.13 110.798 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp 78.57 86.09 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 125.512 1.525 . . . . 75.3 114.531 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.67 148.22 46.7 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 122.668 2.245 . . . . 71.34 109.919 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.574 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 6.3 p-10 -58.4 142.02 49.66 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 113.994 1.109 . . . . 71.23 113.994 -172.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.7 tp -121.66 137.43 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 106.493 -1.669 . . . . 53.14 106.493 171.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.8 m -118.74 128.82 54.85 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.406 -0.961 . . . . 72.21 108.406 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -133.5 132.67 41.28 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 107.662 -1.236 . . . . 72.25 107.662 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 p -118.45 139.49 51.33 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-O 120.645 0.26 . . . . 53.14 110.836 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -146.43 134.88 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.767 -0.827 . . . . 75.4 108.767 -178.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.03 121.8 42.87 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 120.967 0.413 . . . . 72.53 110.923 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 138' ' ' LEU . 4.8 mp -101.76 137.66 39.76 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.638 -0.505 . . . . 42.02 109.638 -175.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -86.43 59.12 5.45 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.268 1.032 . . . . 75.34 110.959 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.21 161.14 46.34 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.984 -1.117 . . . . 61.21 107.984 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.94 152.16 82.16 Favored 'Trans proline' 0 C--O 1.26 1.609 0 C-N-CA 122.524 2.15 . . . . 73.42 110.442 176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -32.36 48.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.892 -0.594 . . . . 73.43 111.679 -176.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -65.15 -29.01 69.82 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.177 0.436 . . . . 75.41 112.177 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -78.92 -40.11 33.0 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.633 0.73 . . . . 72.34 110.37 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 96' ' ' THR . 7.3 p -69.43 -39.55 78.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 116.072 -0.513 . . . . 73.33 109.749 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 43.1 t90 -58.12 -47.63 82.69 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.369 0.668 . . . . 73.15 111.928 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.77 -39.37 94.09 Favored 'General case' 0 C--O 1.214 -0.816 0 C-N-CA 119.576 -0.85 . . . . 72.24 109.749 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.9 m -59.23 -31.98 69.55 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-O 121.087 0.47 . . . . 71.24 111.629 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.694 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 25.2 m -107.19 17.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 112.946 0.721 . . . . 64.3 112.946 -178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.5 m -139.65 -3.35 1.49 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 112.301 0.482 . . . . 71.34 112.301 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.0 p -97.22 145.99 25.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.37 -0.974 . . . . 71.22 108.37 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 p -52.03 -54.06 34.55 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.86 0.689 . . . . 72.14 112.86 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.75 -38.78 87.3 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.444 -0.798 . . . . 73.04 110.533 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -41.61 95.99 Favored Glycine 0 C--O 1.247 0.939 0 N-CA-C 112.045 -0.422 . . . . 62.42 112.045 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.6 mt -69.83 -48.32 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 O-C-N 122.545 -0.385 . . . . 72.34 110.602 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.03 -52.8 62.49 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.706 0.632 . . . . 71.5 112.706 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.1 pttm 30.49 65.35 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.741 1.756 . . . . 75.0 115.741 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 65.69 -15.15 0.12 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.216 1.932 . . . . 71.04 116.216 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -65.91 -56.52 11.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.305 -0.628 . . . . 71.32 109.305 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 15.7 tpt -159.09 116.66 1.64 Allowed Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.257 -1.386 . . . . 61.02 107.257 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -72.04 89.28 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.09 1.86 . . . . 72.43 113.223 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.563 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . 19.8 m120 -114.48 144.47 43.28 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.196 -1.409 . . . . 72.33 107.196 173.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -96.63 76.76 2.86 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.011 0.91 . . . . 65.31 110.449 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 42' ' ' ASN . 94.5 m-85 -74.88 119.3 18.88 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.832 -1.531 . . . . 71.23 109.775 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -109.41 151.31 26.84 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.126 -1.064 . . . . 70.32 108.126 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -77.2 103.18 6.99 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.493 -1.299 . . . . 72.1 107.493 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 20.4 tptm -134.03 146.12 50.07 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.305 -0.998 . . . . 75.14 108.305 174.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HB3' HG12 ' A' ' 68' ' ' VAL . 8.6 pt-20 -92.81 79.55 4.71 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.076 0.941 . . . . 64.43 108.778 173.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.64 47.37 0.53 Allowed Glycine 0 N--CA 1.416 -2.653 0 C-N-CA 119.361 -1.399 . . . . 52.32 112.863 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -85.16 129.88 34.72 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.471 -1.307 . . . . 74.44 107.471 179.681 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.05 153.5 35.22 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.497 -1.668 . . . . 70.1 106.497 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.407 ' HE2' ' SG ' ' A' ' 63' ' ' CYS . 98.3 m-85 -111.34 114.46 27.64 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.017 -0.734 . . . . 75.41 109.017 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -114.88 148.79 38.13 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.968 -0.753 . . . . 74.12 108.968 -175.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 79.74 1.65 2.16 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.755 1.622 . . . . 64.24 112.036 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -96.01 -46.42 6.52 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.311 0.577 . . . . 72.42 110.677 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.2 p -100.17 115.9 65.04 Favored Pre-proline 0 N--CA 1.421 -1.885 0 CA-C-N 115.504 -0.771 . . . . 74.23 110.177 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.63 -56.44 1.49 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.2 1.934 . . . . 64.32 109.878 176.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.6 t80 179.82 131.47 0.09 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.97 -1.122 . . . . 73.51 107.97 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.42 -96.65 0.53 Allowed Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 111.343 -0.703 . . . . 74.31 111.343 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.62 106.5 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.122 2.548 . . . . 61.41 111.56 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.5 m -99.72 136.44 20.27 Favored Pre-proline 0 C--N 1.298 -1.64 0 CA-C-N 115.719 -0.673 . . . . 74.32 111.474 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -86.6 -148.14 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.6 2.867 . . . . 72.42 111.085 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.407 ' SG ' ' HE2' ' A' ' 52' ' ' PHE . 8.4 p -102.47 147.41 26.77 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 120.838 0.351 . . . . 33.4 110.792 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -143.61 135.46 26.48 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.969 0.908 . . . . 65.53 108.685 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.1 t -90.59 136.88 22.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.617 -1.253 . . . . 73.24 107.617 175.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 tt -79.73 -61.11 2.1 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.981 -1.488 . . . . 65.15 106.981 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.0 150.02 9.38 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-N 115.15 -0.932 . . . . 75.53 109.018 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.515 HG23 HD23 ' A' ' 74' ' ' LEU . 8.5 p -123.98 119.03 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.484 0 CA-C-O 122.118 0.961 . . . . 73.24 109.565 175.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 11.4 mm100 -94.54 141.24 28.82 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 114.961 -1.018 . . . . 74.03 109.316 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 123.01 84.84 Favored Pre-proline 0 C--N 1.272 -2.78 0 CA-C-N 114.312 -1.313 . . . . 71.5 108.968 -166.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo 7.3 50.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.346 1 C-N-CA 127.638 5.559 . . . . 54.53 116.339 -160.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 p -139.81 -37.53 0.48 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.177 -0.919 . . . . 73.34 112.077 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 35.3 tt0 -150.29 148.05 28.39 Favored 'General case' 0 C--O 1.2 -1.532 0 C-N-CA 119.066 -1.053 . . . . 64.24 110.339 -176.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.687 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -141.37 132.99 27.07 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.831 -1.174 . . . . 34.31 107.831 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 p -141.03 129.13 22.06 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 120.695 -0.402 . . . . 52.31 112.019 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.459 ' HD2' HD11 ' A' ' 74' ' ' LEU . 44.7 p90 -142.8 153.55 43.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.811 0.338 . . . . 63.42 111.672 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -124.48 124.95 43.4 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 125.012 1.325 . . . . 73.52 107.783 -173.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 18.6 p-90 -143.58 155.78 44.39 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.152 -1.019 . . . . 74.21 113.232 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 76.18 160.4 0.22 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.852 1.661 . . . . 75.53 112.582 173.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 m -68.3 -30.93 70.04 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.207 1.003 . . . . 63.41 110.646 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.572 ' HG3' ' HB2' ' A' ' 115' ' ' ALA . 9.4 mm-40 -71.27 -21.49 62.08 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.033 -0.728 . . . . 73.25 109.033 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.66 80.36 0.68 Allowed Glycine 0 N--CA 1.426 -1.987 0 CA-C-N 114.882 -1.054 . . . . 70.52 114.641 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -104.92 128.59 53.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.365 -0.606 . . . . 74.13 109.365 173.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.24 111.78 29.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.625 -1.25 . . . . 65.33 107.625 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.26 149.12 19.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 120.477 -0.489 . . . . 75.32 110.377 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.451 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 39.2 m -129.47 140.77 51.18 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.491 -0.929 . . . . 71.2 108.491 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.694 ' CD2' ' HB ' ' A' ' 29' ' ' VAL . 16.0 m-85 -118.35 142.59 47.37 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.844 -1.539 . . . . 74.32 106.844 174.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.518 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 69.3 mt-30 -125.1 137.57 54.18 Favored 'General case' 0 C--N 1.268 -2.958 0 O-C-N 123.472 0.482 . . . . 73.31 110.532 176.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -117.36 120.06 37.01 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.457 -0.792 . . . . 75.43 109.179 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -114.06 116.71 29.58 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.586 -0.894 . . . . 71.05 108.586 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.01 118.98 23.88 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.876 0.846 . . . . 70.24 110.919 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 96.4 mt -123.15 153.11 40.46 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.449 -0.945 . . . . 71.13 108.449 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.97 50.38 4.15 Favored Glycine 0 C--N 1.287 -2.17 0 C-N-CA 120.892 -0.67 . . . . 72.55 112.411 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -179.41 -32.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.343 0.592 . . . . 72.23 109.446 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 9.6 ptpt -156.27 175.05 14.5 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.202 -1.407 . . . . 71.33 107.202 -175.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.616 HG21 HG11 ' A' ' 25' ' ' VAL . 87.8 m -119.79 128.19 53.49 Favored 'General case' 0 C--N 1.272 -2.771 0 N-CA-C 108.616 -0.883 . . . . 70.21 108.616 173.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.6 107.32 3.01 Favored Glycine 0 N--CA 1.412 -2.962 0 N-CA-C 109.868 -1.293 . . . . 35.45 109.868 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.509 ' CE1' HG11 ' A' ' 29' ' ' VAL . 92.8 t80 -100.54 133.35 45.11 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.939 -0.763 . . . . 74.43 108.939 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 70.4 m -126.31 125.37 42.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 119.049 -1.061 . . . . 45.3 109.161 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 134' ' ' VAL . 3.4 tm? -104.02 141.87 35.45 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.443 -0.799 . . . . 65.54 108.851 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.5 mp -135.65 123.93 37.98 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 N-CA-C 106.024 -1.843 . . . . 70.01 106.024 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 9.7 t60 -120.55 113.73 20.7 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.486 -1.302 . . . . 45.15 107.486 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.8 t -132.57 153.84 50.6 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.543 -1.28 . . . . 74.31 107.543 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.15 167.96 20.81 Favored Glycine 0 N--CA 1.415 -2.74 0 N-CA-C 109.939 -1.265 . . . . 62.43 109.939 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 67.2 t90 -66.06 -39.32 90.0 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 106.998 -1.482 . . . . 71.11 106.998 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt 64.33 95.85 0.05 OUTLIER 'General case' 0 C--O 1.246 0.874 0 N-CA-C 115.912 1.819 . . . . 73.2 115.912 171.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -84.45 120.35 74.17 Favored Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 105.745 -1.946 . . . . 71.54 105.745 165.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.554 ' HA ' ' OD1' ' A' ' 7' ' ' ASN . 51.8 Cg_endo -65.58 78.75 0.26 Allowed 'Trans proline' 0 C--O 1.241 0.628 0 C-N-CA 123.103 2.535 . . . . 63.3 115.855 -170.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -143.92 -93.54 0.11 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.47 -0.787 . . . . 71.44 110.19 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -139.32 -64.73 0.49 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.04 0.448 . . . . 71.22 111.994 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 113' ' ' GLY . 12.3 p -118.21 155.33 20.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 116.128 -0.487 . . . . 74.31 111.503 -170.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.625 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -61.85 -36.81 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.57 0.7 . . . . 74.01 110.619 174.044 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.526 ' H ' HG22 ' A' ' 111' ' ' VAL . . . 149.3 -108.35 0.4 Allowed Glycine 0 N--CA 1.409 -3.105 0 N-CA-C 108.758 -1.737 . . . . 72.35 108.758 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -134.85 32.35 3.25 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.856 0.36 . . . . 74.03 111.318 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.572 ' HB2' ' HG3' ' A' ' 81' ' ' GLU . . . -58.78 -22.88 59.2 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 112.825 0.676 . . . . 71.41 112.825 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -153.92 -73.24 0.13 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.61 -0.268 . . . . 53.32 110.48 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -156.73 -90.03 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 111.765 0.283 . . . . 72.21 111.765 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.462 ' HB3' HG22 ' A' ' 121' ' ' VAL . 24.0 ttmm -121.03 136.37 55.0 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.051 -1.463 . . . . 74.03 107.051 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.25 -37.55 75.14 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 115.114 1.524 . . . . 62.22 115.114 -174.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.89 -46.17 79.35 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.401 0.519 . . . . 72.3 112.401 177.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 118' ' ' LYS . 14.2 m -69.97 -33.84 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.191 -0.604 . . . . 62.01 109.776 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' A' ' 126' ' ' MET . 53.6 t -64.64 -43.11 96.67 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 CA-C-N 115.732 -0.667 . . . . 74.13 111.113 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -39.82 93.32 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.214 -1.032 . . . . 72.02 108.214 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.419 ' HA2' ' CG ' ' A' ' 3' ' ' GLN . . . -59.6 -47.71 89.59 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-N 115.571 -0.74 . . . . 41.21 112.021 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -66.43 -34.41 77.9 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.274 -0.463 . . . . 71.02 111.857 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 23.5 mmt -62.06 -52.5 63.69 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 110.265 -0.272 . . . . 45.43 110.265 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.45 -52.78 64.19 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.837 0.31 . . . . 63.4 111.837 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.51 -45.99 87.27 Favored Glycine 0 C--O 1.26 1.744 0 C-N-CA 120.834 -0.698 . . . . 64.44 112.6 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.47 62.56 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 111.938 -0.465 . . . . 72.2 111.938 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.492 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.9 m95 -65.45 -22.94 66.81 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.555 0.576 . . . . 72.23 112.555 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.8 m -64.91 -55.69 17.78 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.761 -0.829 . . . . 54.52 108.761 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.45 -44.47 73.1 Favored Glycine 0 C--O 1.252 1.241 0 C-N-CA 120.648 -0.787 . . . . 65.25 113.591 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.19 -51.91 62.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 122.231 0.212 . . . . 63.35 111.464 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.558 ' HA ' HD23 ' A' ' 138' ' ' LEU . 78.9 t -63.66 -44.62 98.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.806 -0.358 . . . . 72.34 111.595 -177.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.406 ' HA ' HG13 ' A' ' 16' ' ' ILE . 32.1 t30 -55.56 -64.83 0.72 Allowed 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.794 0.684 . . . . 71.32 111.803 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -82.73 -31.83 28.23 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 119.41 -0.916 . . . . 73.32 113.202 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.429 HH11 ' HB2' ' A' ' 141' ' ' ALA . 0.2 OUTLIER -74.01 -40.2 63.07 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 118.024 -1.47 . . . . 65.42 110.179 -176.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 134' ' ' VAL . 4.2 mm? -69.41 -46.59 66.46 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 119.552 -0.859 . . . . 75.45 110.045 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 0.9 OUTLIER -63.76 -36.16 82.97 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 115.759 -0.655 . . . . 74.4 110.658 -178.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.409 ' HE2' ' HB2' ' A' ' 144' ' ' GLU . 8.8 mmmm -70.76 -37.47 73.4 Favored 'General case' 0 C--O 1.198 -1.654 0 O-C-N 121.703 -0.623 . . . . 71.34 112.27 174.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.429 ' HB2' HH11 ' A' ' 137' ' ' ARG . . . -64.61 -27.98 69.31 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.254 0.549 . . . . 62.22 110.838 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 16.6 m -91.81 -22.58 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.895 -0.593 . . . . 55.32 111.953 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 61.2 mt-10 -91.85 -32.37 15.35 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.429 -0.508 . . . . 62.54 111.934 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 140' ' ' LYS . 28.7 tt0 -77.76 90.13 4.03 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.932 1.349 . . . . 72.22 110.83 -174.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.13 -149.88 0.27 Allowed 'General case' 0 C--N 1.277 -2.561 1 N-CA-C 99.102 -4.407 . . . . 72.35 99.102 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -85.4 80.1 9.23 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 120.077 1.308 . . . . 71.22 110.527 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -148.23 143.59 27.1 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.047 -1.094 . . . . 71.22 108.047 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -122.41 105.92 10.6 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.693 -0.855 . . . . 75.33 108.693 172.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -114.06 121.91 45.28 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 116.111 -0.495 . . . . 72.12 109.98 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -102.43 137.02 41.23 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.36 -0.978 . . . . 74.24 108.36 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -93.11 -60.34 1.82 Allowed 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.985 -0.746 . . . . 72.01 108.985 -173.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 . . . . . 0 N--CA 1.418 -2.03 0 N-CA-C 105.92 -1.881 . . . . 72.34 105.92 177.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 mmt . . . . . 0 CA--C 1.498 -1.057 0 N-CA-C 109.58 -0.526 . . . . 74.5 109.58 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.36 143.44 23.57 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 123.972 0.795 . . . . 71.13 111.861 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -80.41 -29.14 37.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.341 0.591 . . . . 74.32 109.526 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.6 -169.19 2.38 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.229 -1.026 . . . . 60.0 108.229 175.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.06 168.55 10.01 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.352 0.596 . . . . 54.42 110.453 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -109.3 96.41 6.28 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 114.785 -1.098 . . . . 71.1 110.782 -173.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 t30 60.03 35.41 21.43 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 124.076 0.95 . . . . 70.44 111.051 171.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 106' ' ' LYS . . . 56.97 67.4 0.99 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.9 -1.5 . . . . 65.1 112.944 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.0 tp 68.47 90.93 0.08 OUTLIER Pre-proline 0 C--O 1.243 0.744 0 C-N-CA 124.765 1.226 . . . . 74.51 111.644 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.59 -164.97 0.21 Allowed 'Trans proline' 0 N--CA 1.436 -1.861 0 C-N-CA 122.38 2.054 . . . . 72.45 110.356 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -64.97 103.93 0.79 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.129 0.966 . . . . 75.14 111.837 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 50.0 mm -98.06 123.16 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 106.023 -1.843 . . . . 63.14 106.023 174.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 12.7 t -117.39 140.96 48.9 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 109.162 -0.681 . . . . 61.4 109.162 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -146.71 132.33 18.82 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.787 -1.19 . . . . 72.43 107.787 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.7 p -117.87 141.33 48.54 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 109.48 -0.563 . . . . 71.1 109.48 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.71 142.77 8.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.075 -1.084 . . . . 65.13 108.075 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.429 HG22 ' HA2' ' A' ' 97' ' ' GLY . 3.6 p -106.23 128.72 54.16 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.298 0.571 . . . . 71.5 111.509 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.7 mp -103.57 140.11 37.97 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.857 -0.611 . . . . 75.42 111.079 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -81.73 46.22 0.96 Allowed 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 124.277 1.031 . . . . 74.13 110.686 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.26 158.89 57.2 Favored Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 109.202 -0.666 . . . . 73.33 109.202 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.37 153.32 71.4 Favored 'Trans proline' 0 C--O 1.259 1.544 0 C-N-CA 122.77 2.313 . . . . 74.2 110.7 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -60.15 -32.58 50.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.798 -0.637 . . . . 63.23 111.482 -174.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.75 -39.29 93.91 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 120.698 -0.401 . . . . 74.34 111.656 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -70.9 -39.18 72.9 Favored 'General case' 0 C--O 1.212 -0.916 0 C-N-CA 120.996 -0.282 . . . . 74.04 111.133 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.513 HG21 ' HB ' ' A' ' 96' ' ' THR . 47.2 t -68.02 -41.17 84.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.412 0.625 . . . . 74.12 109.842 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.592 ' CZ2' ' HD3' ' A' ' 71' ' ' PRO . 29.4 t90 -63.66 -46.72 84.32 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.492 -1.231 . . . . 64.3 110.177 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -70.23 -29.41 66.22 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 121.036 -0.266 . . . . 74.53 111.491 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.536 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 39.7 m -56.14 -33.26 65.01 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-O 121.129 0.49 . . . . 73.14 111.735 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -108.18 16.6 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 O-C-N 121.406 -0.809 . . . . 74.52 112.044 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.605 ' HA ' HD11 ' A' ' 35' ' ' ILE . 42.5 p -137.61 0.32 2.24 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.788 0.662 . . . . 73.14 112.788 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.7 p -107.89 169.39 8.64 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 121.698 -0.627 . . . . 62.14 111.595 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.2 t -63.01 -44.71 95.25 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.914 -0.585 . . . . 74.13 109.744 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.09 -45.17 78.07 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.686 0.616 . . . . 75.33 111.165 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 28' ' ' THR . . . -72.38 -48.03 26.16 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.909 -0.663 . . . . 64.02 114.051 -175.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.605 HD11 ' HA ' ' A' ' 30' ' ' SER . 80.3 mt -69.04 -34.12 62.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 CA-C-N 116.932 0.366 . . . . 52.25 111.114 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 40' ' ' MET . . . -52.89 -39.18 62.49 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.953 -0.567 . . . . 44.12 111.463 176.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 37' ' ' LYS . 34.4 ttpt 70.88 -60.29 0.51 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.029 0.932 . . . . 74.52 113.285 174.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -103.74 -172.21 2.07 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.807 -0.812 . . . . 73.55 108.807 -174.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.454 ' HB3' ' CE1' ' A' ' 152' ' ' HIS . 58.8 t80 -81.29 79.36 7.94 Favored 'General case' 0 C--O 1.248 1.0 0 N-CA-C 114.925 1.454 . . . . 72.24 114.925 -171.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.419 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 16.8 ptp 171.02 117.12 0.05 OUTLIER Pre-proline 0 C--N 1.312 -1.044 0 C-N-CA 126.993 2.117 . . . . 72.42 107.975 169.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.09 149.66 52.76 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.982 1.788 . . . . 51.44 111.16 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -123.94 164.34 19.5 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.757 -1.571 . . . . 74.12 106.757 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.12 65.27 8.67 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.76 0.79 . . . . 74.23 112.165 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.557 ' HB3' HD12 ' A' ' 35' ' ' ILE . 95.7 m-85 -108.62 132.78 53.55 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.4 -0.818 . . . . 73.5 109.865 171.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -139.03 150.14 45.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.19 -1.041 . . . . 73.44 108.19 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.432 HD11 ' CZ2' ' A' ' 26' ' ' TRP . 6.0 tt -75.74 104.2 6.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.766 -0.827 . . . . 73.34 108.766 -178.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.734 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 14.0 tppt? -133.97 146.07 50.12 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.882 -1.525 . . . . 72.45 106.882 172.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' CA ' HG12 ' A' ' 68' ' ' VAL . 8.1 pt-20 -79.57 54.79 1.84 Allowed 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 122.024 0.916 . . . . 54.52 109.478 170.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 65' ' ' VAL . . . 130.01 64.52 0.1 Allowed Glycine 0 N--CA 1.406 -3.312 0 N-CA-C 109.977 -1.249 . . . . 74.23 109.977 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.734 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -100.0 106.35 18.12 Favored 'General case' 0 CA--C 1.47 -2.104 0 N-CA-C 106.355 -1.72 . . . . 62.13 106.355 178.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.45 135.44 47.14 Favored 'General case' 0 C--N 1.272 -2.796 0 C-N-CA 119.417 -0.913 . . . . 72.33 110.676 175.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -122.29 125.32 45.73 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 104.167 -2.531 . . . . 73.21 104.167 174.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -109.56 140.14 43.72 Favored 'General case' 0 C--N 1.283 -2.295 0 C-N-CA 119.435 -0.906 . . . . 75.23 111.006 -171.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.9 tp -138.8 112.95 8.65 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 103.695 -2.705 . . . . 73.35 103.695 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -70.05 138.33 52.0 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 123.395 0.434 . . . . 74.0 110.236 -173.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 m 72.42 89.92 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.746 1.218 . . . . 73.22 111.693 -176.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.45 123.41 11.1 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 122.148 1.899 . . . . 74.33 111.573 178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -128.29 -70.93 0.67 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.442 -1.318 . . . . 75.31 107.442 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.64 -84.75 1.77 Allowed Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 107.633 -2.187 . . . . 51.22 107.633 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -65.73 122.4 10.0 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 121.635 1.557 . . . . 63.51 109.067 172.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.561 ' OG ' ' HB ' ' A' ' 80' ' ' THR . 20.1 m -114.12 155.46 45.46 Favored Pre-proline 0 C--N 1.286 -2.192 0 N-CA-C 108.667 -0.864 . . . . 44.13 108.667 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.21 100.34 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.034 1.822 . . . . 62.32 112.347 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 24.7 p -88.82 143.57 26.81 Favored 'General case' 0 C--O 1.251 1.15 0 N-CA-C 107.45 -1.315 . . . . 71.21 107.45 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 34.4 mtmt -143.64 139.91 29.84 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 109.427 -0.583 . . . . 74.14 109.427 -172.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.513 ' HB ' ' H ' ' A' ' 50' ' ' GLN . 41.8 t -90.65 129.44 41.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 N-CA-C 104.942 -2.244 . . . . 63.43 104.942 167.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.6 tp -75.06 -59.2 2.84 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.912 -0.773 . . . . 75.45 108.912 -176.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.53 140.67 14.0 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.955 -1.02 . . . . 64.21 109.274 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.498 HG23 HD13 ' A' ' 74' ' ' LEU . 9.5 p -119.28 121.0 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 N-CA-C 107.604 -1.258 . . . . 71.51 107.604 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 14.7 mm100 -96.55 142.81 28.17 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 114.56 -1.2 . . . . 74.22 109.603 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.71 120.99 73.16 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 107.508 -1.293 . . . . 50.15 107.508 -164.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.592 ' HD3' ' CZ2' ' A' ' 26' ' ' TRP . 16.6 Cg_exo -7.54 64.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.294 1 C-N-CA 126.527 4.818 . . . . 75.1 116.844 -154.548 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 p -140.26 -40.47 0.43 Allowed 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 113.237 -1.801 . . . . 42.2 109.767 175.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 36.9 tt0 -150.54 149.22 29.65 Favored 'General case' 0 C--O 1.195 -1.81 0 C-N-CA 119.405 -0.918 . . . . 74.4 110.259 -175.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.498 HD13 HG23 ' A' ' 68' ' ' VAL . 9.8 tp -145.91 128.18 15.8 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.907 -0.775 . . . . 74.4 108.907 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.6 m -134.23 127.23 31.48 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.774 -0.37 . . . . 74.31 111.022 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.529 ' CE2' ' HE2' ' A' ' 87' ' ' PHE . 54.8 p90 -138.93 155.66 47.87 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 112.113 0.412 . . . . 61.14 112.113 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -122.76 125.88 46.38 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.003 -1.48 . . . . 71.4 107.003 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.432 ' CE3' ' HB2' ' A' ' 79' ' ' ASP . 15.7 p-90 -139.83 162.07 36.05 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.367 -0.933 . . . . 73.03 112.751 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.432 ' HB2' ' CE3' ' A' ' 78' ' ' TRP . 19.0 t70 72.89 161.84 0.25 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.612 1.565 . . . . 62.52 112.338 173.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.561 ' HB ' ' OG ' ' A' ' 61' ' ' SER . 7.4 t -73.11 -23.18 60.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.392 0.277 . . . . 73.04 111.274 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -34.25 76.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 110.154 -0.313 . . . . 71.45 110.154 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.72 75.64 1.29 Allowed Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.82 -0.627 . . . . 61.2 111.855 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -102.02 128.46 48.45 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.408 -0.96 . . . . 75.54 108.408 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.4 t -111.43 107.72 23.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 108.347 -0.983 . . . . 70.42 108.347 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.54 144.98 17.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.312 0.577 . . . . 74.22 110.363 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.458 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 39.9 m -136.42 134.23 37.52 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.801 -0.636 . . . . 73.12 109.407 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.61 ' CE1' HD23 ' A' ' 100' ' ' LEU . 39.8 m-85 -120.93 143.5 48.94 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.251 -1.018 . . . . 52.14 108.251 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.543 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 93.0 mt-30 -124.67 139.99 53.35 Favored 'General case' 0 C--N 1.278 -2.52 0 O-C-N 123.516 0.51 . . . . 72.0 110.676 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -122.6 120.22 33.13 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.722 -0.672 . . . . 71.33 110.458 -174.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -113.31 127.5 56.17 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 123.308 0.643 . . . . 74.2 109.81 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.72 120.68 26.68 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.731 -0.668 . . . . 75.4 111.366 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.6 mt -125.47 153.33 43.7 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.238 -0.892 . . . . 75.15 108.632 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.99 61.43 4.33 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 121.755 -0.26 . . . . 55.13 113.35 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 168.65 -54.49 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 125.21 1.404 . . . . 51.54 107.854 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -126.43 174.07 8.9 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 114.111 -1.404 . . . . 62.11 109.108 -167.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.513 ' HB ' HG21 ' A' ' 25' ' ' VAL . 87.7 m -119.89 130.84 55.03 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.889 -0.782 . . . . 74.53 108.889 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' A' ' 17' ' ' THR . . . -86.58 111.26 3.61 Favored Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 110.258 -1.137 . . . . 74.42 110.258 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -103.45 131.43 50.55 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 109.412 -0.588 . . . . 71.41 109.412 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.543 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 84.8 m -124.29 128.02 48.51 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.982 -1.118 . . . . 74.34 107.982 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.61 HD23 ' CE1' ' A' ' 87' ' ' PHE . 2.9 tm? -102.25 139.29 38.05 Favored 'General case' 0 N--CA 1.397 -3.079 0 N-CA-C 108.532 -0.914 . . . . 75.14 108.532 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 3.8 mp -135.68 124.43 39.1 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.268 0 N-CA-C 106.258 -1.756 . . . . 71.34 106.258 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -121.04 131.92 54.57 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.362 -0.977 . . . . 61.33 108.362 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.3 m -142.69 138.94 30.94 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.673 -1.232 . . . . 72.12 107.673 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.11 -167.01 22.2 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.227 -0.987 . . . . 65.23 110.731 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -79.78 102.49 9.09 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.861 -0.792 . . . . 74.45 108.861 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 20.9 ptmt -48.04 -41.26 25.26 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 116.692 2.108 . . . . 65.34 116.692 -173.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 59.73 -177.77 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.532 0 CA-C-N 118.449 0.568 . . . . 75.41 110.687 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -100.88 33.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.274 1.983 . . . . 63.55 109.068 167.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -125.4 172.36 9.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.183 -0.462 . . . . 70.12 110.288 -172.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -92.93 -40.62 10.49 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 117.915 0.325 . . . . 71.15 111.262 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.25 150.89 11.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 108.516 -0.92 . . . . 64.45 108.516 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.0 pt -58.76 -32.59 47.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 112.853 0.686 . . . . 61.1 112.853 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.84 -122.41 6.94 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.022 -1.085 . . . . 75.42 111.978 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -100.4 10.27 41.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.13 0.491 . . . . 72.5 109.878 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.63 -34.91 79.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.987 -1.116 . . . . 53.35 107.987 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -166.38 122.84 1.28 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.886 -1.894 . . . . 45.25 105.886 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.1 166.68 16.44 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.586 0.958 . . . . 74.14 113.586 -174.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm 71.24 87.22 0.12 Allowed 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.705 -1.134 . . . . 63.24 112.902 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.2 p -56.43 -39.81 73.72 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.469 1.108 . . . . 40.54 112.78 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 123' ' ' ARG . 3.2 p -68.18 -39.25 82.57 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.597 0.713 . . . . 75.51 110.646 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.07 -45.49 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 115.707 -0.679 . . . . 73.2 109.42 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.495 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 75.9 t -55.78 -37.56 47.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 O-C-N 123.642 0.589 . . . . 65.41 110.204 175.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 120' ' ' SER . 18.5 tpp180 -57.37 -58.65 7.33 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.184 0.594 . . . . 70.3 110.378 177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.68 -43.8 93.64 Favored Glycine 0 CA--C 1.494 -1.244 0 CA-C-N 115.678 -0.692 . . . . 75.33 112.817 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 122' ' ' VAL . 2.7 tmmm? -65.52 -38.56 90.02 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 112.66 0.615 . . . . 75.21 112.66 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 25.7 mmt -72.84 -45.9 55.88 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.231 -0.988 . . . . 60.52 110.269 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -67.91 -63.78 0.99 Allowed 'General case' 0 C--O 1.257 1.455 0 CA-C-O 121.343 0.592 . . . . 71.2 111.849 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -75.75 -33.41 51.53 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 115.779 -0.646 . . . . 63.52 112.219 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 125' ' ' LYS . . . -66.77 -50.09 50.42 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 111.67 -0.572 . . . . 60.4 111.67 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.464 ' HE3' HG23 ' A' ' 134' ' ' VAL . 95.5 m95 -64.39 -31.17 72.27 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 120.054 -0.658 . . . . 64.12 111.616 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.1 m -58.47 -57.35 13.35 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 120.71 -0.396 . . . . 71.11 110.896 173.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.62 -46.7 37.9 Favored Glycine 0 C--O 1.242 0.597 0 CA-C-N 116.07 -0.514 . . . . 33.42 113.742 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.0 mt -62.57 -51.24 74.58 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 119.693 -0.194 . . . . 71.02 110.976 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.638 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 68.6 t -59.37 -43.97 91.45 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 120.786 -0.366 . . . . 62.42 111.483 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -56.1 -60.13 3.93 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 111.777 0.288 . . . . 71.45 111.777 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -77.26 -46.45 23.09 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.244 0.831 . . . . 75.35 113.244 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -64.51 -39.16 93.26 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.425 0.557 . . . . 73.41 111.725 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.692 ' HB3' HD21 ' A' ' 18' ' ' LEU . 3.9 mm? -67.25 -49.73 63.29 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.454 -0.498 . . . . 62.43 110.536 176.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -62.43 -32.54 73.41 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.952 -0.567 . . . . 74.21 109.827 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -76.51 -39.66 52.36 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 113.201 0.815 . . . . 65.43 113.201 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.32 -23.71 67.08 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.217 0.532 . . . . 71.24 111.177 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.3 m -90.24 -34.11 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 120.209 -0.596 . . . . 73.21 111.91 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.48 -31.44 26.51 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.169 0.803 . . . . 74.13 113.169 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -139.2 107.38 5.75 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.092 0.472 . . . . 53.53 109.896 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.05 159.45 16.83 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.286 -1.005 . . . . 71.23 108.286 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.85 115.15 16.37 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.266 0.555 . . . . 74.23 110.111 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -69.41 -33.81 73.55 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.171 -0.922 . . . . 72.33 111.142 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -153.66 174.55 14.35 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.365 -1.346 . . . . 72.55 107.365 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -68.82 91.81 0.47 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 122.106 0.955 . . . . 74.34 109.631 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -90.7 117.61 29.49 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.3 -0.864 . . . . 74.42 109.216 -174.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -81.18 143.75 32.13 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.254 -0.579 . . . . 71.44 109.445 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.454 ' CE1' ' HB3' ' A' ' 39' ' ' PHE . 1.3 p-80 . . . . . 0 C--N 1.304 -1.4 0 CA-C-N 115.646 -0.707 . . . . 73.02 111.357 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 112.954 0.724 . . . . 74.43 112.954 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.05 85.02 2.25 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.318 0.58 . . . . 62.33 111.784 -177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -99.21 -28.02 13.53 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.652 -0.704 . . . . 61.2 109.629 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -67.91 121.43 16.02 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.351 -0.84 . . . . 73.01 109.775 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -120.26 115.38 23.48 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 105.747 -1.945 . . . . 54.23 105.747 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 21.0 mt-10 -132.12 -171.31 2.6 Favored 'General case' 0 N--CA 1.388 -3.558 0 N-CA-C 108.4 -0.963 . . . . 75.24 108.4 -169.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -175.84 -35.19 0.01 OUTLIER 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 104.33 -2.47 . . . . 71.11 104.33 -175.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 6' ' ' GLU . . . -127.2 179.07 5.63 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 103.945 -2.613 . . . . 71.33 103.945 168.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.51 HD21 ' CZ3' ' A' ' 83' ' ' TRP . 4.4 pp -100.38 130.2 26.33 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 118.982 -1.087 . . . . 72.25 113.109 -175.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -97.62 -160.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.651 2.901 . . . . 62.12 110.317 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 12.0 p-10 -81.6 97.46 7.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.607 1.194 . . . . 72.42 108.813 173.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 102' ' ' HIS . 61.6 mt -91.68 128.25 43.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 114.69 -1.141 . . . . 54.45 109.019 -173.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.582 ' O ' ' HD2' ' A' ' 14' ' ' LYS . 13.6 t -120.08 140.79 50.5 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 119.648 -0.821 . . . . 72.43 110.556 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.582 ' HD2' ' O ' ' A' ' 13' ' ' THR . 5.9 mptp? -137.72 145.38 42.45 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.349 -1.352 . . . . 70.12 107.349 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -129.81 136.63 49.81 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 118.522 0.601 . . . . 43.35 110.514 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.11 141.38 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 110.06 -0.348 . . . . 74.11 110.06 -177.058 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 p -101.04 135.4 42.56 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.073 0.463 . . . . 65.31 112.09 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 139' ' ' ARG . 3.0 mm? -104.15 140.07 38.32 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.35 0.66 . . . . 72.4 110.219 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -86.11 34.22 0.62 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.136 0.494 . . . . 70.11 110.261 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -133.88 164.73 41.92 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.38 -0.6 . . . . 75.52 109.38 -174.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -66.6 153.03 79.46 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.286 1.99 . . . . 72.24 111.025 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.11 -33.26 42.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.341 -0.845 . . . . 72.22 112.452 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.19 -27.68 62.72 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.451 -0.5 . . . . 75.1 111.223 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.0 tmtm? -79.83 -31.99 40.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.958 -1.127 . . . . 71.32 107.958 -177.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG21 ' HB ' ' A' ' 96' ' ' THR . 45.4 t -71.17 -41.35 75.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.053 -1.092 . . . . 63.12 108.053 175.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.624 ' CD1' ' HA ' ' A' ' 71' ' ' PRO . 77.5 t90 -60.69 -47.17 87.47 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.639 -1.164 . . . . 74.45 111.269 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 10.5 pt-20 -59.97 -36.61 77.49 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 109.003 -0.74 . . . . 63.14 109.003 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.9 m -65.91 -7.54 17.15 Favored 'General case' 0 CA--C 1.573 1.836 0 CA-C-O 121.417 0.627 . . . . 74.24 112.646 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.562 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 11.9 m -131.48 17.19 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 O-C-N 121.306 -0.871 . . . . 54.02 111.63 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.424 ' HB3' HD13 ' A' ' 46' ' ' LEU . 51.3 m -145.32 10.03 1.26 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 116.29 -0.414 . . . . 62.31 111.833 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.3 p -110.75 -178.32 3.45 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.225 -0.657 . . . . 72.33 109.225 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 44' ' ' PHE . 19.6 p -56.64 -62.46 1.71 Allowed 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 123.711 0.632 . . . . 73.03 111.999 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.43 -31.24 71.87 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.27 -0.877 . . . . 74.1 110.844 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.89 -48.66 20.24 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.04 -1.076 . . . . 64.44 112.861 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.432 HG23 ' CE2' ' A' ' 76' ' ' PHE . 51.6 mt -68.95 -34.5 64.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 123.13 0.572 . . . . 73.4 110.895 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.41 -29.81 26.13 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-N 115.526 -0.761 . . . . 73.14 112.043 173.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt 78.8 -57.42 0.44 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.156 1.382 . . . . 74.5 110.589 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -122.74 167.12 13.87 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 105.982 -1.859 . . . . 75.45 105.982 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -71.33 92.61 1.06 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.261 0.467 . . . . 73.11 112.261 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 80.7 mmm -157.22 138.55 9.7 Favored Pre-proline 0 C--N 1.312 -1.032 0 C-N-CA 125.816 1.647 . . . . 70.24 107.446 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.96 98.99 0.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.819 1.68 . . . . 70.13 110.825 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -101.43 151.2 22.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.048 -1.464 . . . . 62.02 107.048 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -90.56 70.98 6.87 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.766 0.793 . . . . 75.22 109.46 -175.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.411 ' CE1' ' HB3' ' A' ' 32' ' ' SER . 6.9 p90 -58.9 137.19 57.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.093 -1.412 . . . . 62.22 110.711 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.86 121.88 15.67 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.928 -1.508 . . . . 72.33 106.928 173.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 68' ' ' VAL . 33.8 tp -94.42 101.78 13.72 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.362 -1.718 . . . . 65.22 106.362 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 1.3 tpmt? -134.94 145.58 48.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.263 -1.384 . . . . 63.01 107.263 175.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.02 61.71 7.0 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 122.69 1.234 . . . . 74.41 109.248 171.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.87 87.84 0.8 Allowed Glycine 0 N--CA 1.414 -2.783 0 CA-C-N 114.404 -1.271 . . . . 63.35 110.48 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.46 ' HB3' ' H ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -104.2 122.68 45.86 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.282 -1.748 . . . . 71.42 106.282 -178.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.66 152.98 49.44 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 109.513 -0.551 . . . . 74.1 109.513 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -95.74 124.66 39.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.822 0.82 . . . . 73.23 110.961 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -142.65 155.87 44.99 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.206 -1.776 . . . . 62.23 106.206 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . 0.296 6.8 mp -83.02 72.03 10.1 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 122.239 1.019 . . . . 45.11 113.705 -175.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -140.65 8.97 2.19 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 112.82 -1.991 . . . . 72.02 106.742 170.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.7 m -144.45 151.3 50.49 Favored Pre-proline 0 N--CA 1.426 -1.639 0 N-CA-C 105.229 -2.137 . . . . 64.31 105.229 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.85 -72.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.517 1.478 . . . . 71.14 110.247 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.9 p90 179.75 179.34 0.51 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 107.511 -1.292 . . . . 72.01 107.511 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.98 122.98 7.31 Favored Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 108.663 -1.775 . . . . 42.21 108.663 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -46.63 -36.31 18.6 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 123.793 2.995 . . . . 43.53 111.758 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 m -122.66 112.6 30.78 Favored Pre-proline 0 N--CA 1.412 -2.372 0 N-CA-C 105.543 -2.021 . . . . 64.45 105.543 172.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.34 103.24 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.901 2.401 . . . . 33.42 113.313 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 86.0 m -136.27 142.94 44.0 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 121.377 0.608 . . . . 72.41 109.597 176.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 77' ' ' GLU . 92.7 mttt -137.12 132.13 33.62 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.824 -1.546 . . . . 71.2 106.824 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.46 ' H ' ' HB3' ' A' ' 50' ' ' GLN . 10.7 t -90.56 133.99 30.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 N-CA-C 107.2 -1.407 . . . . 61.01 107.2 174.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.83 -50.76 16.0 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.345 -1.354 . . . . 64.14 107.345 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.51 143.61 5.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.237 -1.347 . . . . 73.15 108.464 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.666 HG23 HD23 ' A' ' 74' ' ' LEU . 12.1 p -121.57 123.04 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 CA-C-O 121.332 0.587 . . . . 61.35 109.793 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.565 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 84.0 mm-40 -104.78 141.92 35.64 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.322 -0.854 . . . . 73.42 111.714 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.83 124.59 87.96 Favored Pre-proline 0 C--N 1.294 -1.81 0 CA-C-N 113.764 -1.562 . . . . 74.21 109.441 -164.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.624 ' HA ' ' CD1' ' A' ' 26' ' ' TRP . 81.4 Cg_exo -1.29 56.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.305 1 C-N-CA 127.491 5.46 . . . . 75.13 117.489 -159.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -146.59 -34.44 0.28 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.115 -0.948 . . . . 51.53 112.309 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 43.9 tt0 -146.37 139.76 25.87 Favored 'General case' 0 C--O 1.214 -0.774 0 C-N-CA 118.904 -1.118 . . . . 75.4 110.878 -174.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.706 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.4 tm? -139.78 136.7 34.36 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.259 -0.645 . . . . 70.44 109.259 -177.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.3 m -140.9 125.95 18.34 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 110.017 -0.364 . . . . 75.11 110.017 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.46 ' CD1' HD11 ' A' ' 74' ' ' LEU 0.273 12.8 p90 -146.8 158.17 43.85 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.02 0.748 . . . . 73.52 113.02 -178.429 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 64' ' ' LYS 0.27 21.7 mt-10 -119.19 131.58 55.85 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.643 -2.725 . . . . 75.3 103.643 -173.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.543 ' HE1' HG13 ' A' ' 85' ' ' VAL . 12.6 p-90 -153.11 163.52 39.72 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 114.733 1.383 . . . . 73.55 114.733 -168.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.412 ' HB2' ' CE3' ' A' ' 78' ' ' TRP . 3.8 t70 72.94 -167.83 0.12 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 112.009 -2.359 . . . . 72.21 112.237 170.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.444 ' HB ' ' OE2' ' A' ' 81' ' ' GLU . 1.3 m -78.53 -53.59 7.05 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.465 1.106 . . . . 74.13 112.129 -170.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.444 ' OE2' ' HB ' ' A' ' 80' ' ' THR . 2.4 mp0 -68.77 -19.62 64.32 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.375 0.509 . . . . 52.32 112.375 -176.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.33 76.33 1.3 Allowed Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.127 -1.035 . . . . 54.23 111.274 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.51 ' CZ3' HD21 ' A' ' 9' ' ' LEU . 48.7 m95 -109.4 154.42 22.61 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.188 -1.412 . . . . 74.33 107.188 178.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.63 123.98 27.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 121.461 0.648 . . . . 61.44 109.735 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.543 HG13 ' HE1' ' A' ' 78' ' ' TRP . 19.1 m -120.25 155.43 23.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 121.484 0.659 . . . . 73.2 111.259 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.464 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 41.9 m -131.09 137.33 49.06 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.065 -0.97 . . . . 74.23 108.573 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.9 m-85 -120.0 133.11 55.64 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.76 -1.2 . . . . 75.23 107.76 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.56 132.76 55.81 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 109.52 -0.548 . . . . 73.51 109.52 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mp -114.6 119.99 38.66 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.52 0.676 . . . . 73.35 110.724 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -103.21 123.73 47.29 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.533 -1.284 . . . . 62.4 107.533 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -82.67 128.61 34.51 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.914 -0.714 . . . . 72.13 109.71 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 74.2 mt -121.07 158.35 28.05 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.36 -1.348 . . . . 72.35 107.36 174.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.55 48.22 3.62 Favored Glycine 0 C--N 1.3 -1.444 0 O-C-N 123.305 0.378 . . . . 62.1 114.008 -174.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 172.96 -41.61 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.385 1.074 . . . . 74.31 109.237 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 8.5 ptpt -134.15 175.07 9.82 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.03 -0.729 . . . . 60.11 109.03 -173.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.433 ' HB ' HG21 ' A' ' 25' ' ' VAL . 88.9 m -117.72 128.16 54.62 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.817 -0.809 . . . . 63.23 108.817 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.37 107.7 3.47 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.203 -1.159 . . . . 55.34 110.203 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -97.32 133.95 41.25 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 109.257 -0.645 . . . . 70.34 109.257 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.4 m -120.41 121.81 39.35 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 108.187 -1.042 . . . . 64.01 108.187 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -100.59 139.71 35.89 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-O 121.854 0.835 . . . . 60.42 109.59 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.464 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 16.1 mt -137.09 124.85 32.14 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 113.239 -1.801 . . . . 63.22 107.746 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.536 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 23.7 t-160 -117.42 129.06 55.6 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.309 -0.997 . . . . 60.14 108.309 177.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -141.08 164.41 30.34 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.151 -1.426 . . . . 62.23 107.151 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.1 167.76 38.25 Favored Glycine 0 C--N 1.291 -1.932 0 C-N-CA 120.17 -1.014 . . . . 61.32 110.864 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 -88.56 59.9 5.36 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.952 0.882 . . . . 63.31 112.535 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -143.43 147.77 35.1 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 104.123 -2.547 . . . . 72.34 104.123 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -79.88 155.02 75.6 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 118.411 0.55 . . . . 73.53 110.259 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -69.08 -30.18 25.88 Favored 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 122.486 2.124 . . . . 74.3 110.367 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.527 HD22 ' HG3' ' A' ' 110' ' ' GLU . 4.7 p-10 -83.82 158.64 21.61 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-N 114.524 -1.217 . . . . 63.34 108.029 177.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.527 ' HG3' HD22 ' A' ' 109' ' ' ASN . 85.7 mt-10 71.59 -160.24 0.12 Allowed 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.399 -1.334 . . . . 73.14 107.399 -175.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.25 154.99 41.02 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 N-CA-C 107.649 -1.241 . . . . 73.03 107.649 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 35.0 pt -58.03 -31.0 40.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 113.049 0.759 . . . . 74.34 113.049 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.13 40.72 5.1 Favored Glycine 0 CA--C 1.494 -1.265 0 N-CA-C 109.76 -1.336 . . . . 73.12 109.76 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 46.04 52.05 10.4 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.909 1.684 . . . . 71.45 111.849 -175.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.02 -19.77 61.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 122.439 1.114 . . . . 50.45 108.481 173.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -132.52 -72.27 0.52 Allowed 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 113.701 -1.59 . . . . 74.52 108.713 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -149.2 -170.81 3.73 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 108.77 -0.826 . . . . 73.25 108.77 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.84 157.02 25.69 Favored 'General case' 0 C--O 1.218 -0.553 0 O-C-N 124.051 0.845 . . . . 54.3 110.784 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.1 p -56.65 -48.38 77.68 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.218 1.007 . . . . 65.31 112.72 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 p -63.07 -45.36 92.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.437 0.637 . . . . 74.14 110.704 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.06 -47.5 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.919 -1.037 . . . . 72.0 110.016 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 126' ' ' MET . 50.8 t -57.48 -41.06 78.0 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.233 0 CA-C-N 116.115 -0.493 . . . . 71.31 110.697 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -63.24 -51.69 65.17 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.24 -0.437 . . . . 74.31 111.045 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.64 -42.99 97.05 Favored Glycine 0 CA--C 1.498 -1.023 0 CA-C-N 115.739 -0.664 . . . . 61.14 112.234 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -68.93 -32.53 72.2 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 115.085 -0.558 . . . . 65.11 112.363 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.427 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 23.4 mmt -67.03 -46.51 74.23 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.851 -0.74 . . . . 74.21 111.145 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.89 -58.42 3.47 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.658 -0.817 . . . . 65.1 111.783 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.33 -44.88 83.84 Favored Glycine 0 C--O 1.246 0.859 0 C-N-CA 121.058 -0.592 . . . . 63.31 112.075 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.53 -55.46 28.78 Favored Glycine 0 N--CA 1.437 -1.291 0 CA-C-O 119.316 -0.713 . . . . 62.54 112.22 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.433 ' O ' HG12 ' A' ' 134' ' ' VAL . 62.3 m95 -58.8 -43.51 90.53 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 117.837 0.818 . . . . 72.12 113.128 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 31.7 m -59.9 -47.06 87.32 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.367 0.417 . . . . 61.31 110.479 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.45 -47.24 36.23 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.557 -0.83 . . . . 74.22 112.828 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.8 mt -65.35 -46.14 91.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 122.587 0.355 . . . . 75.41 111.822 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 5.1 p -66.29 -40.45 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 119.608 -0.837 . . . . 63.11 109.717 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.593 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 34.3 t30 -58.89 -63.93 1.12 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.015 -0.539 . . . . 64.35 110.624 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -71.01 -48.8 51.05 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 113.423 0.897 . . . . 71.52 113.423 -173.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.518 ' O ' ' HD2' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -69.83 -33.81 72.81 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.702 -0.799 . . . . 71.22 110.813 -171.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.4 mm? -70.78 -48.91 51.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.991 -1.084 . . . . 64.5 110.264 173.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 135' ' ' ASN . 1.0 OUTLIER -59.3 -40.32 85.78 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.83 -0.623 . . . . 73.42 110.959 -177.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 144' ' ' GLU . 25.7 mmmt -75.85 -36.02 59.75 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 112.887 0.699 . . . . 75.01 112.887 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.16 -28.2 64.09 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.617 -0.833 . . . . 71.52 110.629 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.513 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 25.8 m -79.77 -24.63 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 119.584 -0.846 . . . . 31.54 110.647 176.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.35 -87.16 0.14 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.917 0.865 . . . . 71.25 110.669 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.422 ' O ' ' HE3' ' A' ' 140' ' ' LYS . 39.1 mt-10 -143.47 107.2 4.64 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 125.09 1.356 . . . . 65.25 107.494 -172.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 37.9 tp -68.84 106.05 2.56 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.19 0.519 . . . . 74.12 110.423 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -158.47 172.18 18.78 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.432 -1.692 . . . . 65.2 106.432 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -89.55 102.43 15.11 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.835 -1.543 . . . . 62.45 106.835 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -121.44 26.81 8.63 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.72 -1.215 . . . . 74.35 107.72 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -75.52 103.31 5.59 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.063 -0.971 . . . . 73.32 111.001 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -112.51 102.2 10.31 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.882 -0.784 . . . . 64.3 108.882 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -102.08 -65.57 0.98 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.475 -0.49 . . . . 73.14 110.976 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 . . . . . 0 C--N 1.315 -0.934 0 N-CA-C 108.192 -1.04 . . . . 75.3 108.192 -177.894 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 CA--C 1.508 -0.643 0 CA-C-O 120.511 0.196 . . . . 62.23 111.172 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.63 104.53 6.22 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.42 0.629 . . . . 72.14 109.547 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -73.12 -28.71 62.42 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.848 -1.069 . . . . 74.44 109.959 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -158.33 170.88 21.23 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.598 -1.63 . . . . 75.32 106.598 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 68.19 42.18 1.79 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.814 0.816 . . . . 72.51 111.895 176.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -93.75 34.21 1.23 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.645 -1.243 . . . . 72.14 107.645 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -110.11 80.73 1.34 Allowed 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 105.022 -2.214 . . . . 73.15 105.022 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 106' ' ' LYS . . . -32.9 100.73 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 110.399 -3.091 . . . . 73.52 111.429 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.4 tp 48.66 86.78 0.14 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.315 1.446 . . . . 64.42 114.286 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.05 138.32 43.51 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.071 1.18 . . . . 41.04 109.717 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 102' ' ' HIS . 8.2 p-10 -71.72 110.95 6.61 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.634 0.73 . . . . 72.31 109.839 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.405 HG22 ' HB3' ' A' ' 102' ' ' HIS . 10.6 tp -111.17 138.67 38.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.622 -0.717 . . . . 74.13 110.814 -173.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.3 m -111.67 133.02 54.2 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 108.023 -1.103 . . . . 73.43 108.023 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -128.14 143.07 51.03 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.892 -1.522 . . . . 73.2 106.892 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.9 m -122.75 133.48 54.47 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.977 -0.379 . . . . 60.4 109.977 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.527 HG13 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -145.84 131.79 13.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.601 -0.888 . . . . 75.12 108.601 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.75 122.62 43.0 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-O 121.458 0.647 . . . . 72.11 112.179 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 138' ' ' LEU . 6.2 mp -95.67 135.85 36.83 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 107.755 -1.202 . . . . 63.35 107.755 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -87.78 39.78 0.9 Allowed 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.169 -0.469 . . . . 72.0 109.937 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.483 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -135.92 163.86 47.37 Favored Pre-proline 0 C--O 1.245 0.823 0 C-N-CA 124.169 0.987 . . . . 71.34 109.085 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 36.4 Cg_endo -63.7 157.71 50.28 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 123.013 2.476 . . . . 63.13 112.377 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.6 tt -64.87 -27.72 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.738 -0.664 . . . . 74.03 111.859 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -71.75 -28.24 63.53 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.971 0.415 . . . . 71.2 111.717 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.59 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 4.4 tmtt? -81.18 -46.11 15.36 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.46 -0.57 . . . . 73.21 109.46 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.691 HG11 HG21 ' A' ' 96' ' ' THR . 5.4 p -59.49 -39.18 78.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.237 0.541 . . . . 73.22 109.846 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -63.35 -44.59 94.4 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.201 -0.909 . . . . 74.52 111.032 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -65.25 -33.68 76.55 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.442 -0.503 . . . . 72.44 110.465 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.7 m -59.25 -32.02 69.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.249 0.547 . . . . 71.32 111.163 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.561 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 15.5 m -109.46 21.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 112.298 0.481 . . . . 53.2 112.298 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.431 ' HB2' HD22 ' A' ' 46' ' ' LEU . 61.6 p -137.64 -12.24 1.55 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.406 -0.517 . . . . 74.21 112.216 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.0 p -94.55 158.81 15.37 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.632 -0.507 . . . . 74.15 109.632 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.9 m -59.9 -48.23 82.55 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 123.036 0.534 . . . . 53.1 111.195 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.83 -27.31 57.81 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.304 -0.862 . . . . 61.21 111.089 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.6 -48.81 21.31 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 119.927 -1.13 . . . . 71.43 111.58 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.499 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 68.1 mt -65.59 -33.42 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.729 0.775 . . . . 72.54 110.321 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.87 -30.04 63.48 Favored 'General case' 0 C--O 1.249 1.064 0 C-N-CA 124.578 1.151 . . . . 74.55 112.59 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 35' ' ' ILE . 3.9 mppt? 73.93 -71.89 0.12 Allowed 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 125.276 1.43 . . . . 74.24 108.557 -171.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 79.5 t90 171.33 -42.93 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.904 -1.517 . . . . 75.2 106.904 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -79.88 21.93 0.52 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.894 -1.048 . . . . 65.34 113.046 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 15.5 tpt -166.02 79.48 1.13 Allowed Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 108.277 -1.008 . . . . 73.22 108.277 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -82.74 98.62 0.89 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.07 1.846 . . . . 53.31 112.765 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -137.24 165.81 25.26 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.725 -0.843 . . . . 51.43 108.725 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -89.14 73.61 8.13 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.888 0.851 . . . . 71.11 110.081 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.4 ' HE1' ' SG ' ' A' ' 63' ' ' CYS . 93.4 m-85 -70.83 119.99 15.78 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.963 -1.017 . . . . 63.41 109.947 176.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -113.38 148.32 36.02 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 110.0 -0.37 . . . . 75.5 110.0 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.431 HD22 ' HB2' ' A' ' 30' ' ' SER . 21.5 tp -87.27 105.53 17.3 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.824 -1.176 . . . . 52.21 107.824 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -133.19 137.51 46.21 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 106.488 -1.671 . . . . 61.41 106.488 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -92.07 75.27 5.49 Favored 'General case' 0 C--N 1.257 -3.421 0 CA-C-O 122.845 1.307 . . . . 51.42 109.561 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.97 87.88 1.59 Allowed Glycine 1 N--CA 1.396 -4.001 0 CA-C-N 113.61 -1.632 . . . . 63.14 111.027 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -87.65 -75.16 0.42 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.911 -1.144 . . . . 75.11 107.911 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.98 161.74 24.85 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.143 -1.429 . . . . 62.14 107.143 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.05 148.04 46.03 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.855 1.057 . . . . 75.43 113.855 -171.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.453 ' HB2' ' NZ ' ' A' ' 64' ' ' LYS . 11.1 t60 -110.06 162.84 14.16 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 104.424 -2.436 . . . . 63.45 104.424 176.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.2 mt 72.62 16.23 4.8 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 106.492 -1.67 . . . . 65.53 106.492 -168.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 -158.37 -169.05 2.63 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 100.622 -3.844 . . . . 63.52 100.622 -176.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.2 m -108.46 115.55 57.73 Favored Pre-proline 0 C--N 1.289 -2.027 0 CA-C-N 120.356 1.434 . . . . 64.35 111.814 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.16 133.95 22.2 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 N-CA-C 107.041 -1.946 . . . . 64.54 107.041 170.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -90.81 -44.38 9.46 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.284 -0.566 . . . . 74.43 110.551 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.1 101.59 0.72 Allowed Glycine 0 C--O 1.214 -1.145 0 C-N-CA 120.198 -1.001 . . . . 60.1 112.593 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -79.64 34.85 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.362 2.708 . . . . 70.25 112.508 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.475 ' HB3' ' HD3' ' A' ' 62' ' ' PRO . 32.4 t -90.07 -56.02 0.28 Allowed Pre-proline 0 N--CA 1.434 -1.272 0 CA-C-N 116.277 -0.42 . . . . 73.25 110.556 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 61' ' ' SER . 53.5 Cg_endo -89.14 -176.01 1.26 Allowed 'Trans proline' 0 C--N 1.369 1.622 0 CA-C-N 120.313 1.148 . . . . 72.12 110.343 175.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.4 ' SG ' ' HE1' ' A' ' 44' ' ' PHE . 30.5 m -90.68 158.81 16.71 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.612 -1.255 . . . . 50.3 107.612 176.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.453 ' NZ ' ' HB2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -122.5 118.46 28.35 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-O 121.901 0.858 . . . . 64.11 110.455 -177.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 76' ' ' PHE . 6.7 t -79.26 137.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 114.872 -1.058 . . . . 65.31 109.339 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 tt -81.47 -57.63 3.39 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.387 -1.338 . . . . 71.4 107.387 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.04 153.6 22.47 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.542 -0.753 . . . . 64.43 109.801 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.54 119.13 52.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.712 -1.218 . . . . 23.42 107.712 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 22.5 mp0 -106.27 141.19 38.02 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.348 0.659 . . . . 75.52 110.334 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.67 129.32 94.1 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 114.226 -1.352 . . . . 63.23 108.446 -167.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo 2.52 44.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.283 1 C-N-CA 128.434 6.089 . . . . 74.32 118.602 -162.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -139.83 -35.47 0.53 Allowed 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 122.248 -0.283 . . . . 61.24 110.702 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 40.7 tt0 -145.94 145.21 30.59 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 118.508 -1.277 . . . . 74.03 109.98 -174.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.699 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.7 tm? -147.5 134.96 20.8 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.529 -1.285 . . . . 55.34 107.529 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.1 m -140.51 125.44 18.32 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.269 -0.572 . . . . 63.3 110.286 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.464 ' HD1' HD11 ' A' ' 74' ' ' LEU . 49.8 p90 -138.2 152.92 49.09 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 109.725 -0.472 . . . . 53.52 109.725 176.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.432 ' CD ' ' HZ2' ' A' ' 64' ' ' LYS . 37.8 mt-10 -124.73 126.08 45.1 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-N 115.475 -0.784 . . . . 62.23 110.818 -171.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.523 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 2.1 t90 -95.54 107.94 20.15 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 104.359 -2.46 . . . . 75.14 104.359 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.51 140.49 55.67 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.889 -0.596 . . . . 74.34 111.119 -171.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.1 m 70.18 82.82 0.15 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.598 1.159 . . . . 65.13 112.279 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 55.63 23.22 5.93 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.954 1.702 . . . . 73.31 113.833 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.523 ' HA3' ' HB3' ' A' ' 78' ' ' TRP . . . -93.98 -24.43 19.97 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 107.865 -2.094 . . . . 60.53 107.865 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 75.29 -177.16 0.15 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 126.128 1.771 . . . . 75.11 113.03 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.409 ' HB ' ' HG2' ' A' ' 77' ' ' GLU . 4.4 p -114.81 117.26 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.838 0.828 . . . . 74.32 109.918 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.51 144.01 16.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 CA-C-N 114.989 -1.005 . . . . 73.24 108.717 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 46.9 m -131.56 134.38 46.02 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 108.988 -0.745 . . . . 52.13 108.988 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.699 ' CD2' HD12 ' A' ' 74' ' ' LEU . 10.9 m-85 -109.99 137.41 47.8 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.452 -1.314 . . . . 63.0 107.452 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.607 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 7.0 tt0 -125.04 136.98 54.21 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.089 -1.448 . . . . 70.22 107.089 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -110.91 124.38 51.98 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.202 -0.599 . . . . 70.4 111.901 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -109.93 137.11 48.18 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 124.717 1.207 . . . . 73.33 108.383 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -97.93 117.76 32.98 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 120.608 0.242 . . . . 64.25 111.158 -176.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.2 mt -113.63 159.98 19.06 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.84 -0.8 . . . . 33.15 108.84 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.52 -26.61 71.95 Favored Glycine 0 C--N 1.293 -1.806 0 N-CA-C 114.908 0.723 . . . . 71.31 114.908 -174.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 28.0 tt0 -128.08 -0.9 5.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.88 0.84 . . . . 73.23 110.853 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -161.65 176.2 11.22 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.455 -0.778 . . . . 75.01 108.993 -173.13 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.691 HG21 HG11 ' A' ' 25' ' ' VAL . 31.2 m -116.58 128.14 55.14 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 109.556 -0.535 . . . . 74.14 109.556 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.15 112.71 3.93 Favored Glycine 0 N--CA 1.419 -2.446 0 N-CA-C 109.486 -1.445 . . . . 43.24 109.486 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -97.9 133.97 41.67 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 108.038 -1.097 . . . . 74.14 108.038 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 88' ' ' GLN . 14.0 m -117.81 121.91 42.01 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 107.991 -1.114 . . . . 42.21 107.991 -178.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.85 141.25 34.0 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 107.79 -1.189 . . . . 65.11 107.79 177.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 19.6 mt -135.2 124.77 42.81 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.404 0 N-CA-C 106.699 -1.593 . . . . 72.32 106.699 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 21.8 t-160 -117.83 120.9 39.3 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.151 -1.055 . . . . 64.1 108.151 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.9 t -141.82 164.6 29.75 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 107.161 -1.422 . . . . 64.24 107.161 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -176.73 -131.86 1.55 Allowed Glycine 0 C--N 1.285 -2.29 0 N-CA-C 109.413 -1.475 . . . . 72.33 109.413 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -84.72 78.82 9.79 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.373 -0.973 . . . . 73.5 108.373 175.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -82.84 84.9 7.22 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 114.39 -1.277 . . . . 72.13 111.277 -177.426 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -107.18 117.27 56.68 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 115.05 -0.977 . . . . 74.45 109.979 -174.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -50.78 -35.01 46.8 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 124.053 3.169 . . . . 73.22 114.921 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -142.66 85.76 1.91 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.182 0.515 . . . . 71.53 110.719 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -179.12 172.19 1.27 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 105.76 -1.941 . . . . 64.51 105.76 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.759 HG12 HD13 ' A' ' 112' ' ' ILE . 1.8 t -105.12 168.64 2.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 106.646 -1.613 . . . . 62.31 106.646 176.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.759 HD13 HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -58.15 -31.72 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.792 0.806 . . . . 30.52 111.155 177.062 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 148.12 -86.89 0.16 Allowed Glycine 0 N--CA 1.41 -3.093 0 N-CA-C 109.18 -1.568 . . . . 54.24 109.18 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 61.8 tttp -155.13 22.36 0.43 Allowed 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.45 0.643 . . . . 73.32 110.266 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.418 ' HB3' HG13 ' A' ' 112' ' ' ILE . . . -59.95 -39.15 84.61 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.155 -0.966 . . . . 64.11 111.282 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -150.85 25.03 0.75 Allowed 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.362 0.413 . . . . 64.52 110.967 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.411 ' O ' HG11 ' A' ' 111' ' ' VAL . 3.5 mp0 66.85 -41.47 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.382 1.623 . . . . 63.51 115.382 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -118.06 141.74 48.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.268 0.485 . . . . 62.5 112.159 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.672 ' OG ' ' HA ' ' A' ' 111' ' ' VAL . 70.8 m -75.07 -27.79 60.1 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.987 -0.551 . . . . 71.23 109.696 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 p -66.04 -47.17 75.28 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.633 -0.712 . . . . 73.34 111.509 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.0 m -69.92 -33.7 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 120.425 -0.51 . . . . 72.44 109.897 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.41 -46.32 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 120.155 -0.618 . . . . 70.24 110.556 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -55.31 -55.95 25.57 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.656 0.782 . . . . 63.23 111.785 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.0 -47.24 92.25 Favored Glycine 0 C--O 1.249 1.069 0 O-C-N 123.635 0.584 . . . . 62.23 112.652 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -68.44 -36.95 79.78 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 113.292 0.849 . . . . 75.53 113.292 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -34.47 71.99 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 119.469 -0.892 . . . . 72.34 110.859 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.19 -49.64 54.78 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.863 0.363 . . . . 74.4 110.875 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.45 -41.02 91.23 Favored Glycine 0 C--O 1.251 1.211 0 C-N-CA 120.624 -0.798 . . . . 55.23 111.238 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.441 ' HA2' ' CB ' ' A' ' 152' ' ' HIS . . . -61.87 -54.03 38.48 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.824 -0.688 . . . . 51.43 112.301 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.508 ' O ' HG12 ' A' ' 134' ' ' VAL . 57.5 m95 -56.99 -37.65 71.95 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 113.097 0.777 . . . . 74.34 113.097 178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.5 m -57.37 -48.08 79.97 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 123.186 0.304 . . . . 73.13 110.436 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.89 -48.76 31.93 Favored Glycine 0 C--O 1.246 0.897 0 C-N-CA 120.584 -0.817 . . . . 72.55 112.332 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.24 -52.41 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.044 0.537 . . . . 75.43 111.653 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 4.2 p -71.63 -41.03 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 119.874 -0.73 . . . . 72.34 111.847 -173.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.527 ' HA ' HG13 ' A' ' 16' ' ' ILE . 26.7 t-20 -63.69 -52.18 61.77 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.988 -0.685 . . . . 54.14 111.234 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 33.5 tt0 -78.99 -44.75 21.69 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 113.183 0.808 . . . . 74.14 113.183 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.55 ' NH1' ' HB2' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -64.85 -45.3 86.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 119.147 -1.021 . . . . 64.23 109.837 -176.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.1 mm? -65.47 -52.21 54.53 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.218 0.324 . . . . 71.0 111.557 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -63.73 -35.65 81.27 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.908 0.385 . . . . 74.22 109.995 -177.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.488 ' NZ ' ' HB3' ' A' ' 144' ' ' GLU . 12.5 mmmt -68.65 -46.16 69.9 Favored 'General case' 0 C--O 1.173 -2.957 0 CA-C-O 119.157 -0.449 . . . . 74.52 111.088 177.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB2' ' NH1' ' A' ' 137' ' ' ARG . . . -59.48 -29.85 68.13 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.219 0.452 . . . . 73.22 112.219 -176.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 21.1 m -86.28 -24.69 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 120.19 -0.604 . . . . 74.43 112.205 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 78.6 mm-40 -86.08 -57.86 2.86 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.711 0.767 . . . . 73.21 109.958 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.488 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 2.3 tm-20 -139.7 100.26 3.91 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.267 -1.382 . . . . 72.01 107.267 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -24.79 -59.96 0.06 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 118.797 2.888 . . . . 74.4 118.797 -170.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -129.53 97.63 4.6 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.498 -1.281 . . . . 74.23 114.112 -168.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 70.6 t60 177.44 131.44 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.194 0.998 . . . . 72.05 109.047 173.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -167.99 152.76 6.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.817 -1.179 . . . . 75.03 107.817 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -174.79 106.97 0.1 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.022 -1.473 . . . . 75.43 107.022 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -121.52 -70.02 0.8 Allowed 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 112.891 0.7 . . . . 60.21 112.891 -173.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 171.43 -44.5 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 103.075 -2.935 . . . . 71.44 103.075 -172.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.441 ' CB ' ' HA2' ' A' ' 129' ' ' GLY . 96.0 m-70 . . . . . 0 N--CA 1.412 -2.35 0 N-CA-C 103.126 -2.916 . . . . 74.22 103.126 170.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.5 mtp . . . . . 0 CA--C 1.513 -0.471 0 CA-C-O 120.88 0.372 . . . . 52.5 110.12 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.29 65.37 1.25 Allowed 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.705 -0.68 . . . . 53.44 109.621 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -84.68 -27.46 27.05 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.861 -1.063 . . . . 65.53 111.323 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.56 ' ND2' ' H ' ' A' ' 5' ' ' ASN . 6.8 t30 -70.88 -169.96 0.4 Allowed 'General case' 0 CA--C 1.571 1.785 0 CA-C-N 115.576 -0.738 . . . . 74.45 111.563 -174.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.56 ' H ' ' ND2' ' A' ' 4' ' ' ASN . 8.0 t30 -52.26 -31.29 31.8 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 125.583 1.553 . . . . 72.35 113.591 -173.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HG3' ' HB3' ' A' ' 10' ' ' PRO . 1.5 pm0 -75.1 74.51 2.27 Favored 'General case' 0 C--N 1.263 -3.169 0 CA-C-N 114.593 -1.185 . . . . 72.42 113.344 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.45 HD22 ' HB2' ' A' ' 119' ' ' SER . 6.5 t30 -84.57 -10.99 56.88 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.901 -1.518 . . . . 71.4 106.901 174.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.475 ' HB1' HG23 ' A' ' 112' ' ' ILE . . . -78.68 -72.43 0.38 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.393 1.477 . . . . 75.15 111.864 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tt -166.53 109.5 0.68 Allowed Pre-proline 0 N--CA 1.419 -1.979 0 N-CA-C 107.161 -1.422 . . . . 72.34 107.161 -172.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.44 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 2.7 Cg_exo -82.5 168.74 14.35 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 122.918 2.412 . . . . 70.31 109.522 171.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.53 107.47 1.4 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.638 -1.245 . . . . 72.11 107.638 170.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 43.2 mm -91.03 124.1 43.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.522 -0.918 . . . . 43.13 108.522 -174.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.0 m -120.37 128.39 53.19 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.433 -1.321 . . . . 64.15 107.433 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.562 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 22.4 tptt -140.2 144.56 36.65 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.701 -1.222 . . . . 72.32 107.701 -176.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.4 m -123.07 134.51 54.25 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.695 -0.402 . . . . 61.2 110.418 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.439 HG21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -141.7 131.79 25.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.919 -0.771 . . . . 72.2 108.919 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.87 117.87 32.05 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 121.809 0.814 . . . . 63.23 111.984 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.658 HD21 ' HB3' ' A' ' 138' ' ' LEU . 5.6 mp -92.7 140.07 29.91 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.796 -1.557 . . . . 64.33 106.796 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.85 15.27 3.4 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.175 0.512 . . . . 64.33 111.581 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -105.5 159.54 29.16 Favored Pre-proline 0 C--N 1.306 -1.31 0 CA-C-N 115.864 -0.607 . . . . 63.55 109.719 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.59 154.38 69.27 Favored 'Trans proline' 0 C--O 1.253 1.237 0 C-N-CA 123.028 2.485 . . . . 62.13 110.91 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.0 tt -60.63 -29.13 44.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.936 -0.575 . . . . 73.32 112.011 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 20.6 pt20 -62.85 -40.58 97.9 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.928 0.394 . . . . 71.41 111.198 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -68.12 -39.74 82.69 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.283 0.564 . . . . 72.4 110.909 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.467 HG21 ' HB ' ' A' ' 96' ' ' THR . 36.0 t -69.09 -40.75 81.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.328 -0.851 . . . . 61.23 109.821 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 28.7 t90 -59.06 -47.63 84.53 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 124.021 0.825 . . . . 74.32 110.397 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 34.2 mt-10 -64.4 -36.45 84.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.07 0.462 . . . . 71.32 110.731 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.4 m -67.16 -12.36 59.81 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-O 121.422 0.629 . . . . 60.21 111.976 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.669 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 16.7 m -131.06 13.62 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 120.756 -1.215 . . . . 23.33 112.906 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.6 t -139.12 4.05 2.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 120.247 -0.581 . . . . 73.1 112.259 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.4 p -111.57 168.57 9.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.198 -0.667 . . . . 62.13 109.198 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 16.4 m -60.08 -46.1 90.7 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.926 0.491 . . . . 64.43 111.447 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -71.12 -41.74 70.14 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.802 -0.635 . . . . 73.24 110.18 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . -66.21 -48.01 67.78 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 115.158 -0.928 . . . . 74.34 113.078 -177.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.07 -41.46 89.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 117.289 0.544 . . . . 73.14 111.205 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.99 -51.78 62.67 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.535 0.568 . . . . 42.51 112.535 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 62.3 mttp 56.36 27.31 11.78 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.271 0.629 . . . . 73.2 111.567 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -88.25 -70.54 0.63 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.059 -1.089 . . . . 63.11 108.059 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 t80 157.96 -41.75 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 103.868 -2.641 . . . . 62.43 103.868 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 25.9 ttt -93.65 124.86 55.73 Favored Pre-proline 0 N--CA 1.424 -1.751 0 CA-C-N 112.662 -2.063 . . . . 73.02 106.178 175.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.65 141.61 67.16 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.733 1.622 . . . . 71.32 111.398 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 32' ' ' SER . 19.7 t-20 -111.95 158.71 19.17 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 105.611 -1.996 . . . . 73.44 105.611 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.21 70.77 8.13 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.553 0.692 . . . . 74.14 111.431 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -107.67 119.87 40.64 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.564 -1.198 . . . . 65.05 108.404 172.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -121.57 150.37 41.77 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.6 -1.259 . . . . 64.2 107.6 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 46' ' ' LEU . 2.5 pt? -78.44 106.08 10.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 117.316 -1.754 . . . . 71.15 108.974 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -130.41 144.7 51.56 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 104.875 -2.269 . . . . 73.54 104.875 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 11.3 pt-20 -83.99 36.75 0.57 Allowed 'General case' 0 C--N 1.283 -2.312 0 CA-C-O 122.218 1.008 . . . . 53.41 109.76 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.8 66.52 0.01 OUTLIER Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.35 -1.5 . . . . 72.23 109.35 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 19.4 tt0 -74.16 124.17 25.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.326 -1.361 . . . . 51.23 107.326 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -132.62 150.18 52.2 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.12 0.486 . . . . 61.23 111.38 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -128.83 147.29 50.79 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.389 -1.708 . . . . 75.5 106.389 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -110.17 140.32 44.4 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.589 0.709 . . . . 73.24 112.609 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.6 mt -126.97 -175.05 3.31 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.147 -1.388 . . . . 75.11 107.714 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -77.73 -9.38 58.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.205 0.526 . . . . 73.0 110.305 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.8 p -140.16 163.74 42.0 Favored Pre-proline 0 N--CA 1.434 -1.227 0 C-N-CA 124.957 1.303 . . . . 63.12 107.948 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -87.69 1.58 6.87 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.212 1.941 . . . . 64.4 114.042 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -131.81 147.06 52.46 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.938 -0.393 . . . . 74.42 109.938 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.27 147.96 4.72 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 111.282 -0.727 . . . . 62.15 111.282 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -80.33 85.62 1.79 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.205 1.937 . . . . 64.31 111.57 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.477 ' H ' ' HD2' ' A' ' 62' ' ' PRO . 60.4 m -158.07 -56.73 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.222 0 C-N-CA 123.819 0.848 . . . . 74.34 110.865 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD2' ' H ' ' A' ' 61' ' ' SER . 37.1 Cg_endo -65.52 114.38 2.87 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 121.448 1.432 . . . . 71.01 112.574 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 14.0 p -88.26 142.41 27.77 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 105.646 -1.983 . . . . 51.02 105.646 173.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 42.9 mtpt -133.52 134.29 43.24 Favored 'General case' 0 CA--C 1.468 -2.21 0 C-N-CA 120.139 -0.625 . . . . 61.15 111.143 -169.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.2 t -90.66 133.82 31.31 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 N-CA-C 105.307 -2.108 . . . . 74.53 105.307 168.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.426 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 2.3 tm? -78.75 -56.64 4.26 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.038 -1.097 . . . . 73.34 108.038 -175.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.19 153.27 28.95 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.274 -0.875 . . . . 73.52 108.88 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.555 HG23 HD23 ' A' ' 74' ' ' LEU . 12.5 p -132.67 119.8 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 CA-C-O 121.885 0.85 . . . . 70.22 111.621 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 45.9 mt-30 -101.34 141.0 34.86 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.322 -0.854 . . . . 73.21 110.955 176.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.32 126.2 92.19 Favored Pre-proline 0 C--N 1.279 -2.468 0 CA-C-N 113.875 -1.511 . . . . 70.23 109.439 -164.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo 7.27 46.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 1 C-N-CA 127.869 5.712 . . . . 54.44 116.843 -162.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 p -138.7 -38.59 0.52 Allowed 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.773 -0.649 . . . . 73.3 112.182 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 31.1 tt0 -150.5 142.71 24.16 Favored 'General case' 0 C--O 1.208 -1.127 0 C-N-CA 118.913 -1.115 . . . . 74.42 110.221 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.685 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -138.52 137.18 36.85 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 108.746 -0.835 . . . . 63.42 108.746 -177.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.5 m -139.38 127.37 22.29 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 122.451 -0.156 . . . . 44.44 110.755 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 43.6 p90 -143.98 157.04 44.59 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.02 -0.425 . . . . 70.53 112.058 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 36.3 mt-10 -121.04 125.71 48.01 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 107.107 -1.442 . . . . 51.45 107.107 -176.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 51.3 t90 -135.33 148.49 49.48 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 111.925 0.343 . . . . 75.4 111.925 -176.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD1' HG22 ' A' ' 80' ' ' THR . 2.5 t70 77.82 -177.79 0.11 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.073 1.749 . . . . 73.51 111.909 171.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.482 HG22 ' OD1' ' A' ' 79' ' ' ASP . 1.8 t -58.34 -41.42 84.59 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 113.062 0.764 . . . . 62.41 113.062 -175.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.23 12.49 11.64 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.211 0.819 . . . . 74.42 113.211 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.96 57.45 6.9 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 123.42 0.45 . . . . 60.54 112.757 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 88.1 m95 -67.38 117.14 8.96 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 109.0 -0.741 . . . . 75.4 109.0 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 76' ' ' PHE . 7.2 p -101.84 101.16 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 CA-C-O 122.599 1.19 . . . . 74.31 109.418 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.2 m -100.26 146.85 8.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 CA-C-N 114.096 -1.411 . . . . 63.54 108.167 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.508 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 32.7 m -131.56 133.81 45.41 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 116.126 -0.488 . . . . 74.42 109.693 -176.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.685 ' CD2' HD12 ' A' ' 74' ' ' LEU . 13.2 m-85 -109.32 131.43 55.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.617 -1.253 . . . . 73.33 107.617 176.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.516 HE21 HD11 ' A' ' 101' ' ' ILE . 5.3 mt-30 -116.66 136.21 53.16 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 109.277 -0.638 . . . . 75.53 109.277 175.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mp -116.72 128.23 55.14 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.369 0.604 . . . . 71.5 110.552 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -102.85 119.6 39.14 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.104 -1.813 . . . . 71.24 106.104 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -81.13 111.79 17.9 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.11 0.481 . . . . 73.43 110.804 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.6 mt -120.95 148.66 43.78 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.669 -1.234 . . . . 74.14 107.669 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.06 54.24 2.53 Favored Glycine 0 C--N 1.284 -2.313 0 C-N-CA 121.027 -0.606 . . . . 62.02 112.208 -176.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -175.2 -54.51 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.652 -1.61 . . . . 72.11 106.652 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.38 175.41 8.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.027 -1.472 . . . . 74.1 107.027 -176.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.467 ' HB ' HG21 ' A' ' 25' ' ' VAL . 83.1 m -122.31 127.68 50.14 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 109.302 -0.629 . . . . 61.54 109.302 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.8 106.28 3.26 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.597 -1.401 . . . . 75.11 109.597 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -98.52 133.88 42.26 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 117.345 0.573 . . . . 72.23 109.646 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 28.9 m -123.17 120.38 33.03 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.612 -0.884 . . . . 74.31 108.612 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.5 tm? -100.63 141.62 33.23 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.961 -0.755 . . . . 72.24 108.961 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 18.2 mt -136.2 125.45 38.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.007 -1.451 . . . . 62.31 108.188 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -120.31 117.36 27.59 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.042 -1.096 . . . . 75.15 108.042 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.2 t -142.15 164.13 31.0 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 103.727 -2.694 . . . . 72.12 103.727 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.432 ' HA2' ' H ' ' A' ' 84' ' ' VAL . . . -166.65 163.3 36.89 Favored Glycine 0 CA--C 1.49 -1.514 0 C-N-CA 118.282 -1.913 . . . . 53.22 113.811 -178.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -85.55 66.27 9.58 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 122.994 1.378 . . . . 63.22 109.429 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -87.07 173.31 9.36 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.038 -1.437 . . . . 70.11 110.562 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.15 138.76 96.04 Favored Pre-proline 0 C--O 1.253 1.249 0 CA-C-N 115.352 -0.84 . . . . 72.11 110.031 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.47 87.76 1.06 Allowed 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 107.841 -1.638 . . . . 73.3 107.841 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.454 ' ND2' HG12 ' A' ' 111' ' ' VAL . 54.0 t30 -174.31 167.47 4.03 Favored 'General case' 0 C--O 1.249 1.071 0 N-CA-C 107.621 -1.252 . . . . 74.14 107.621 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 8' ' ' ALA . 20.7 pt-20 -70.26 -14.83 62.78 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.639 0.776 . . . . 74.15 112.84 -177.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 113' ' ' GLY . 14.9 p -111.91 152.38 13.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.703 -0.851 . . . . 65.11 108.703 175.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.691 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -59.63 -35.94 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.624 0.25 . . . . 74.3 111.374 176.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.457 ' H ' HG22 ' A' ' 111' ' ' VAL . . . 126.36 -140.28 11.95 Favored Glycine 0 N--CA 1.422 -2.284 0 N-CA-C 110.242 -1.143 . . . . 75.52 110.242 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -80.65 -2.5 46.84 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 123.533 0.733 . . . . 73.34 110.204 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.87 71.28 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.071 0.462 . . . . 42.23 109.93 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.448 ' O ' HD11 ' A' ' 112' ' ' ILE . 5.2 t30 -173.72 114.34 0.22 Allowed 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.209 -1.404 . . . . 74.1 107.209 174.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -78.74 49.47 0.9 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 114.36 1.244 . . . . 73.5 114.36 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -152.61 92.82 1.71 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.235 1.014 . . . . 73.0 108.824 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.45 ' HB2' HD22 ' A' ' 7' ' ' ASN . 0.8 OUTLIER -61.74 -57.01 13.57 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 123.516 0.726 . . . . 53.13 111.474 -175.681 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.4 m -61.82 -33.3 73.9 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.166 -0.47 . . . . 63.45 111.375 -176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.85 -47.15 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 109.587 -0.523 . . . . 71.21 109.587 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.503 ' O ' ' HG2' ' A' ' 126' ' ' MET . 48.6 t -58.23 -43.55 86.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 O-C-N 123.822 0.701 . . . . 75.25 111.124 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -61.67 -48.95 78.49 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.159 -0.473 . . . . 65.11 110.833 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.42 -43.93 97.53 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 115.634 -0.712 . . . . 53.25 111.799 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -67.45 -34.21 76.72 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.829 -0.686 . . . . 74.34 112.193 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 25.7 mmt -66.7 -43.07 85.32 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.225 -0.59 . . . . 72.34 111.479 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.82 -61.51 1.78 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.259 -0.976 . . . . 65.31 111.772 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.37 -39.0 95.58 Favored Glycine 0 C--O 1.24 0.485 0 C-N-CA 120.928 -0.653 . . . . 61.15 112.574 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.26 -53.96 29.79 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 119.659 -0.523 . . . . 73.31 112.3 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.44 ' HE3' HG23 ' A' ' 134' ' ' VAL . 96.4 m95 -63.28 -29.53 70.84 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 117.51 0.655 . . . . 72.14 112.48 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.562 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 73.2 m -60.98 -57.4 12.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.427 -0.583 . . . . 65.45 109.427 174.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.5 -46.83 60.7 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.167 -0.539 . . . . 73.14 113.646 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.626 ' O ' ' HB2' ' A' ' 137' ' ' ARG . 44.8 mm -59.13 -57.54 10.94 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 C-N-CA 122.728 0.411 . . . . 53.14 111.205 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.44 HG23 ' HE3' ' A' ' 130' ' ' TRP . 79.0 t -60.49 -44.1 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 O-C-N 123.096 0.248 . . . . 72.45 111.491 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 131' ' ' THR . 38.7 t-20 -54.24 -61.7 2.14 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 123.953 0.783 . . . . 74.21 111.148 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -80.89 -38.92 27.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 119.834 -0.747 . . . . 73.03 112.187 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.626 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 3.7 mmt180 -62.11 -46.64 88.17 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.372 0.533 . . . . 72.52 111.667 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.658 ' HB3' HD21 ' A' ' 18' ' ' LEU . 4.6 mm? -67.98 -48.57 65.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 120.236 -0.585 . . . . 74.45 110.467 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.592 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -61.81 -33.68 74.57 Favored 'General case' 0 C--O 1.198 -1.646 0 CA-C-N 115.734 -0.666 . . . . 73.13 109.611 -178.606 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -73.15 -35.68 66.51 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 112.879 0.696 . . . . 74.13 112.879 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.6 -32.92 71.94 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.032 0.444 . . . . 75.14 110.701 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.16 -27.0 7.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.744 -0.662 . . . . 63.55 111.602 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 64.3 mm-40 -87.33 -45.4 10.61 Favored 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 120.136 -0.626 . . . . 71.11 111.447 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.421 13.2 pt-20 59.71 -22.07 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.869 2.068 . . . . 63.21 115.489 -172.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.4 mp -73.47 168.82 18.47 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 107.804 -1.184 . . . . 73.42 107.804 168.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -77.84 75.98 4.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.417 0.627 . . . . 73.03 111.958 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -105.54 152.49 23.0 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.559 -0.904 . . . . 64.45 108.559 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -94.8 -167.92 1.73 Allowed 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.187 -0.672 . . . . 70.24 109.187 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -73.89 159.92 32.14 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.735 -1.209 . . . . 74.55 107.735 172.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -65.63 -53.73 37.51 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.322 0.582 . . . . 75.43 109.483 -175.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -177.03 -177.62 0.76 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 126.357 1.863 . . . . 72.23 106.313 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 38.7 m80 . . . . . 0 C--O 1.262 1.732 0 O-C-N 124.04 0.837 . . . . 74.11 110.244 -175.996 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 CA--C 1.495 -1.159 0 N-CA-C 108.58 -0.896 . . . . 73.02 108.58 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.29 91.58 6.24 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.572 0.701 . . . . 65.1 109.827 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -96.2 -48.38 5.66 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.407 -0.815 . . . . 70.4 109.455 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 120' ' ' SER 0.25 4.6 p-10 -92.69 71.09 4.91 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.296 1.046 . . . . 73.44 112.677 -178.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -87.32 104.24 16.22 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 107.222 -1.399 . . . . 71.35 107.222 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -111.45 80.15 1.28 Allowed 'General case' 0 C--N 1.259 -3.328 0 CA-C-N 113.912 -1.495 . . . . 61.31 110.246 -172.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -126.41 19.76 7.42 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.861 -1.063 . . . . 73.25 110.236 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 67.47 77.39 0.26 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.616 1.166 . . . . 72.21 111.597 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 tp 58.8 88.49 0.12 Allowed Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 124.72 1.208 . . . . 61.33 113.865 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -68.45 139.05 44.04 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 N-CA-C 108.475 -1.394 . . . . 63.22 108.475 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.69 153.79 42.47 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 113.48 0.919 . . . . 73.42 113.48 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.6 mm -121.78 138.74 51.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.067 -0.969 . . . . 73.51 110.075 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.1 m -126.01 130.82 51.93 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.827 -1.546 . . . . 70.24 106.827 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HE2' ' OG1' ' A' ' 131' ' ' THR . 41.0 tptt -139.75 145.37 38.2 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.849 -0.797 . . . . 55.45 108.849 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -118.56 140.63 49.59 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 117.682 0.219 . . . . 73.43 110.825 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.92 142.58 16.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.052 -0.722 . . . . 74.33 109.052 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 p -105.3 130.01 53.52 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 112.572 0.582 . . . . 73.3 112.572 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.53 141.53 33.27 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.826 -0.624 . . . . 63.43 111.038 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -78.9 9.42 4.27 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.033 0.833 . . . . 74.23 111.441 -176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -120.95 160.56 44.41 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 109.586 -0.524 . . . . 73.32 109.586 -172.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 32.5 Cg_endo -62.89 152.69 77.64 Favored 'Trans proline' 0 C--O 1.256 1.384 0 C-N-CA 123.205 2.603 . . . . 63.35 111.749 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.9 tt -56.63 -31.67 35.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.301 -0.863 . . . . 72.31 112.097 -175.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.58 -33.75 76.36 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.111 0.411 . . . . 74.55 112.111 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.5 -36.11 45.48 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.165 -0.68 . . . . 71.41 109.165 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 29' ' ' VAL . 46.3 t -66.07 -41.28 89.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.885 -0.783 . . . . 73.22 108.885 177.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 51.9 t90 -59.06 -47.85 83.72 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.997 -1.001 . . . . 71.3 111.718 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.42 -30.41 70.14 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.457 -0.897 . . . . 74.13 110.694 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.9 m -63.79 -22.84 67.11 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-O 121.274 0.559 . . . . 72.13 111.744 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.605 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 17.0 m -122.81 16.7 5.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 121.741 -0.6 . . . . 62.11 112.41 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.534 ' HB3' HD12 ' A' ' 46' ' ' LEU . 53.9 m -144.19 8.49 1.41 Allowed 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.163 0.801 . . . . 61.14 113.163 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.5 p -116.9 168.93 9.79 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 121.516 -0.74 . . . . 74.15 109.409 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -60.82 -54.7 41.94 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.268 -0.642 . . . . 43.43 109.268 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.97 -38.94 87.7 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.133 -0.94 . . . . 62.04 111.191 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.47 -48.74 28.44 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.687 -0.768 . . . . 40.42 113.379 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.31 -41.53 78.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 117.636 0.718 . . . . 53.14 112.785 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' A' ' 40' ' ' MET . . . -59.11 -31.17 68.68 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.558 0.947 . . . . 71.41 113.558 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 85.7 tttt 60.64 54.5 3.66 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.523 0.729 . . . . 72.23 111.324 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . 0.325 7.6 p90 52.39 -45.36 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 119.679 3.214 . . . . 74.51 119.679 171.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -78.96 -16.25 57.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 119.06 0.845 . . . . 74.22 112.933 -174.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.596 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -127.31 93.11 41.91 Favored Pre-proline 0 C--N 1.298 -1.636 0 N-CA-C 108.584 -0.895 . . . . 73.5 108.584 179.522 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.6 100.05 0.56 Allowed 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 122.467 2.111 . . . . 73.44 112.017 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.61 142.68 51.19 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.157 -0.683 . . . . 52.03 109.157 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.22 72.94 3.34 Favored 'General case' 0 CA--C 1.486 -1.511 0 CA-C-O 121.339 0.59 . . . . 52.01 111.294 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -84.85 131.14 34.56 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.923 -1.51 . . . . 75.43 106.923 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.473 ' HB3' HE22 ' A' ' 50' ' ' GLN . 53.7 tt0 -120.01 149.68 41.76 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.145 -0.687 . . . . 63.41 109.145 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' A' ' 30' ' ' SER . 6.0 tt -85.38 104.27 15.04 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 109.267 -0.642 . . . . 75.11 109.267 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.761 ' HB3' ' HB2' ' A' ' 50' ' ' GLN . 12.1 tppt? -132.94 146.01 51.41 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.586 -1.264 . . . . 73.41 107.586 168.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.486 ' HB3' HG12 ' A' ' 68' ' ' VAL . 11.4 pt-20 -87.02 77.45 9.17 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.596 1.189 . . . . 71.34 108.002 172.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.43 83.44 0.96 Allowed Glycine 0 N--CA 1.406 -3.342 0 CA-C-N 114.327 -1.306 . . . . 45.42 109.959 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.761 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 48.7 tt0 -149.42 132.85 16.61 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 108.215 -1.031 . . . . 60.23 108.215 -177.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.25 141.22 51.09 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 120.258 -0.577 . . . . 73.41 110.584 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -95.89 114.76 26.52 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.191 -1.781 . . . . 73.55 106.191 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -114.64 140.14 49.06 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 119.71 -0.796 . . . . 72.0 110.641 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 57' ' ' PRO . 36.2 tp -166.87 148.01 5.95 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 103.824 -2.658 . . . . 71.31 103.824 178.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.1 tm0? -85.56 -56.3 3.57 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.564 -0.854 . . . . 72.14 108.995 -175.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.5 m -109.51 100.8 43.49 Favored Pre-proline 0 N--CA 1.434 -1.227 0 N-CA-C 108.113 -1.069 . . . . 72.13 108.113 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.467 ' HA ' HD23 ' A' ' 54' ' ' LEU . 3.1 Cg_exo -81.79 134.9 8.68 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.145 2.563 . . . . 64.42 113.789 -176.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -123.85 101.61 7.36 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.125 -1.065 . . . . 64.54 108.125 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.09 -86.74 0.43 Allowed Glycine 0 C--N 1.305 -1.179 0 N-CA-C 110.648 -0.981 . . . . 53.41 110.648 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -93.03 136.42 1.32 Allowed 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.375 2.05 . . . . 63.34 111.827 176.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.484 ' HB2' ' NE1' ' A' ' 78' ' ' TRP . 16.1 m -78.67 163.85 58.84 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.481 -0.933 . . . . 73.25 108.481 175.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.27 110.51 0.8 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.294 1.996 . . . . 54.5 111.285 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.9 p -111.82 167.02 10.69 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 109.389 -0.597 . . . . 55.22 109.389 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 22.9 pttm -158.31 145.26 17.71 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.233 -0.655 . . . . 63.02 109.233 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.6 t -89.26 126.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 107.271 -1.381 . . . . 71.4 107.271 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 tt -74.79 -53.41 9.22 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.009 -1.478 . . . . 65.53 107.009 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.9 141.93 5.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.016 -0.993 . . . . 63.12 109.108 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.606 HG23 HD23 ' A' ' 74' ' ' LEU . 14.3 p -122.3 120.04 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-O 121.981 0.896 . . . . 70.43 108.953 173.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 73' ' ' GLU . 84.4 mm-40 -105.17 142.14 35.48 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 114.013 -1.449 . . . . 74.04 109.778 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 135.94 95.65 Favored Pre-proline 0 C--N 1.283 -2.316 0 CA-C-N 114.569 -1.196 . . . . 61.52 109.103 -165.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -3.07 54.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.614 1 C-N-CA 128.323 6.015 . . . . 53.12 117.977 -162.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -152.23 -37.63 0.11 Allowed 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.617 -0.72 . . . . 55.42 110.809 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 35.1 tt0 -139.72 129.14 24.16 Favored 'General case' 0 C--O 1.198 -1.621 0 C-N-CA 117.351 -1.74 . . . . 64.01 112.142 -174.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.68 HD12 ' CD2' ' A' ' 87' ' ' PHE . 2.3 tm? -131.15 134.39 46.49 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.717 -0.845 . . . . 53.15 108.717 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.4 m -140.26 126.7 20.11 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.639 -0.255 . . . . 61.35 110.497 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HD1' HD11 ' A' ' 74' ' ' LEU . 39.9 p90 -142.45 154.7 44.79 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.813 0.34 . . . . 74.34 110.271 177.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -122.63 132.25 54.19 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.688 -0.856 . . . . 62.43 108.688 -172.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.486 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 15.6 t-105 -112.98 106.14 14.34 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.124 -1.806 . . . . 64.15 106.124 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -72.49 172.26 10.83 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.238 -0.437 . . . . 74.32 110.69 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.1 m 65.3 43.89 3.39 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 122.196 0.998 . . . . 72.53 109.448 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 64.51 32.37 11.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.352 -1.295 . . . . 71.01 113.508 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 78' ' ' TRP . . . -86.81 -17.86 59.11 Favored Glycine 0 C--O 1.238 0.373 0 N-CA-C 109.308 -1.517 . . . . 42.31 109.308 171.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 28.6 m95 81.22 -174.17 0.04 OUTLIER 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.634 1.974 . . . . 74.32 112.217 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.32 122.96 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 121.758 0.79 . . . . 70.41 110.196 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 m -116.8 152.36 18.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-O 121.317 0.58 . . . . 73.23 110.198 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 34.1 m -139.49 142.22 37.33 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 109.083 -0.71 . . . . 74.32 109.083 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.68 ' CD2' HD12 ' A' ' 74' ' ' LEU . 15.0 m-85 -121.23 140.35 52.16 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.89 -1.152 . . . . 75.24 107.89 176.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.88 132.79 53.26 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.357 -1.349 . . . . 63.04 107.357 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.84 122.18 44.61 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.738 0.78 . . . . 73.12 111.988 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -102.76 125.46 49.51 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.589 -1.187 . . . . 73.35 108.92 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -84.4 125.83 32.68 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.522 -0.763 . . . . 73.24 110.603 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.6 mt -125.43 153.04 44.06 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.856 -1.535 . . . . 64.41 106.856 171.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.18 38.22 2.73 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 114.613 0.605 . . . . 31.51 114.613 -172.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -176.02 -38.66 0.01 OUTLIER 'General case' 0 C--O 1.24 0.588 0 N-CA-C 109.372 -0.603 . . . . 73.34 109.372 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -127.12 175.81 7.85 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.115 -1.068 . . . . 60.14 108.115 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.4 m -121.54 129.07 52.66 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 120.709 -0.396 . . . . 71.42 110.281 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.42 106.16 3.32 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 109.489 -1.444 . . . . 62.53 109.489 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -98.58 134.47 41.47 Favored 'General case' 0 C--N 1.27 -2.864 0 O-C-N 121.801 -0.823 . . . . 62.03 109.652 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.6 m -118.84 121.7 40.63 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.387 -0.968 . . . . 74.22 108.387 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 101' ' ' ILE . 3.4 tm? -101.83 142.34 33.29 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.694 0.759 . . . . 71.52 109.131 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.487 ' N ' HD13 ' A' ' 100' ' ' LEU . 17.7 mt -136.15 124.44 36.43 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.911 0 CA-C-N 113.92 -1.491 . . . . 72.43 107.653 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -120.22 118.24 29.95 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.294 -1.743 . . . . 72.04 106.294 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -138.79 164.19 30.25 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.811 -1.181 . . . . 74.05 107.811 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.21 170.1 34.37 Favored Glycine 0 N--CA 1.413 -2.889 0 N-CA-C 109.777 -1.329 . . . . 51.44 109.777 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -83.86 100.62 11.09 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.003 -0.74 . . . . 74.3 109.003 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.528 ' HD2' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -79.18 79.86 5.57 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.236 1.017 . . . . 63.43 110.764 -179.246 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -85.92 -60.14 0.28 Allowed Pre-proline 0 C--N 1.304 -1.408 0 CA-C-N 115.037 -0.983 . . . . 64.24 112.226 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.8 -23.45 76.63 Favored 'Trans proline' 0 C--N 1.383 2.395 0 C-N-CA 121.701 1.601 . . . . 64.21 113.332 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 66.8 t30 61.44 19.93 10.71 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.491 1.116 . . . . 62.44 111.964 175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -130.23 -73.25 0.56 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.871 -0.788 . . . . 75.34 108.871 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.422 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 11.7 p -141.24 146.7 23.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.218 -1.401 . . . . 73.41 107.218 176.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.626 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -62.42 -39.42 84.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 112.344 0.498 . . . . 64.24 112.344 179.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.92 -128.61 8.83 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.663 -0.78 . . . . 54.42 112.741 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -75.42 -7.39 53.93 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.69 0.796 . . . . 71.02 111.765 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.13 -34.02 71.56 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 123.137 0.273 . . . . 63.12 110.544 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -163.06 -81.7 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 119.676 -0.809 . . . . 61.45 112.887 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -151.28 -162.1 1.47 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.698 1.199 . . . . 55.12 109.231 -173.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.506 ' HB2' HG22 ' A' ' 121' ' ' VAL . 3.7 mppt? -75.43 154.38 37.13 Favored 'General case' 0 C--O 1.212 -0.895 0 C-N-CA 122.994 0.517 . . . . 65.31 110.289 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 111' ' ' VAL . 50.0 m -60.21 -41.6 93.38 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.922 1.082 . . . . 65.41 113.922 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 4' ' ' ASN . 36.2 t -69.7 -45.87 67.27 Favored 'General case' 0 C--O 1.256 1.438 0 C-N-CA 120.116 -0.634 . . . . 74.31 111.138 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.506 HG22 ' HB2' ' A' ' 118' ' ' LYS . 27.6 m -69.94 -36.74 70.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 119.16 -1.016 . . . . 73.31 110.928 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 126' ' ' MET . 21.4 t -61.27 -45.68 98.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.253 0 O-C-N 123.167 0.292 . . . . 75.24 111.407 175.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -64.44 -40.45 95.76 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.882 -0.327 . . . . 71.41 111.237 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.03 -45.0 95.04 Favored Glycine 0 CA--C 1.492 -1.356 0 N-CA-C 111.225 -0.75 . . . . 61.31 111.225 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -68.22 -32.33 72.46 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.697 -0.752 . . . . 65.42 111.195 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 122' ' ' VAL . 21.3 mmt -64.06 -49.37 72.59 Favored 'General case' 0 C--O 1.206 -1.21 0 C-N-CA 121.068 -0.253 . . . . 63.52 111.252 176.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.92 -51.38 62.19 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 119.839 -0.744 . . . . 63.02 110.973 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.76 -44.97 95.49 Favored Glycine 0 C--O 1.241 0.545 0 C-N-CA 121.232 -0.508 . . . . 73.23 111.981 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.55 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -62.46 -50.89 60.44 Favored Glycine 0 CA--C 1.487 -1.679 0 N-CA-C 111.352 -0.699 . . . . 44.13 111.352 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.511 ' O ' HG12 ' A' ' 134' ' ' VAL . 77.4 m95 -59.51 -37.24 77.78 Favored 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 118.83 -0.605 . . . . 70.33 112.496 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.504 ' OG1' ' HE2' ' A' ' 14' ' ' LYS . 90.1 m -54.32 -54.4 40.84 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 109.859 -0.422 . . . . 74.03 109.859 176.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.62 -45.33 67.16 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.804 -0.634 . . . . 45.53 113.538 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 129' ' ' GLY . 36.2 pt -74.68 -36.67 41.19 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.416 0 N-CA-C 113.213 0.819 . . . . 74.14 113.213 -176.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 130' ' ' TRP . 4.2 p -74.92 -38.82 44.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 118.671 -1.212 . . . . 60.34 110.494 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.3 -60.25 3.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.742 -0.383 . . . . 74.21 110.896 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.2 -43.95 66.39 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.248 0.462 . . . . 53.02 112.248 -173.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.505 ' O ' ' HD2' ' A' ' 137' ' ' ARG . 2.0 tmm_? -70.27 -41.56 73.28 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.228 -0.589 . . . . 73.52 110.454 -173.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 4.0 mm? -63.96 -45.46 89.02 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 119.839 -0.744 . . . . 61.22 109.198 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -59.03 -42.28 89.81 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.815 -0.629 . . . . 71.52 110.187 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -65.27 -51.66 59.34 Favored 'General case' 0 C--O 1.166 -3.311 0 CA-C-O 119.502 -0.285 . . . . 73.42 111.382 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.24 -32.2 73.48 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 123.359 0.412 . . . . 72.53 112.106 -175.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 31.2 m -74.34 -26.45 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 119.665 -0.814 . . . . 63.05 110.736 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.95 -53.28 4.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 118.815 -1.154 . . . . 52.35 112.63 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -143.63 107.15 4.59 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 124.229 1.012 . . . . 73.45 110.776 -175.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 83.0 mt -68.27 -23.11 64.73 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.069 0.548 . . . . 54.24 111.759 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -73.21 104.44 4.26 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.875 0.845 . . . . 54.02 110.421 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -148.33 144.04 27.29 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 104.957 -2.238 . . . . 74.2 104.957 171.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -120.89 133.95 55.29 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.773 -0.771 . . . . 72.2 109.766 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -158.04 148.11 20.21 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 103.504 -2.776 . . . . 74.02 103.504 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -101.26 161.99 13.22 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.933 -1.136 . . . . 74.5 107.933 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -72.37 111.29 7.44 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.395 -1.335 . . . . 54.53 107.395 170.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 . . . . . 0 C--O 1.241 0.649 0 C-N-CA 125.592 1.557 . . . . 70.41 109.54 -170.95 . . . . . . . . 0 0 . 1 stop_ save_